Citrus Sinensis ID: 042871

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------59
Protein Sequence
MVVPYIAKSTFQEGKHKMYPQDLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTTAKASTTQTSTTQPSTP
Secondary Structure (PSIPRED)
cccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccEEcccHHHHHHHHccccccccccccccccccccccccccccHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccccccEEEEEEEEEcccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHHccccccccccccccEEEEEEEccccEEEEEEccccccHHHHHHHHHHHHcccccccccEEcEEccccEEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccccccccccccccccccccEEEEEEccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccEEEEcccccccccccHHHHHHHEEEEEEEEEEccccccccccccEEEEEEEEccccccccccccccccccccccccccccEEEEEcccccccEEEEEccccccEEEEEEHHHcccccccccccccccccccccccccccccccccccccccHHHccccccccEEEccccccccccccccccccHHHHHHHHHHcccEEEEEEccccEEEEEccccEcHHHcccccccEEEEEccHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEccccccHHHHHHHHHHHHccccccEccEEEEEcccccEEEEEEcccccEHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccHHHEEEcccccEEEccccccEEccccccEccEEEEEEcccccHHHHHcccEcccccHHHHHEEEEHHHcccccHHHccccccHHHccHHHcccccHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mvvpyiakstfqegkhkmypqdlSFMFIFIIIITAVTelthcqpspvdcslhfqfsslsnnssceggdwggflpnkccdSAFQKYLYALGQRAnqtgniylnsseqRSCLTSMKRLEEDAFACGIekltsgagacsnysVADVSKMLGNKLIKfnedckfvssdgewdqICGVCVQsweeikgphfasskaesiDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILIGGLVVVGVVAIIIIASCICLKryyksnppakitsfkgvqlkdpgcprytirEVHYATEKLnelnligegitgkvykgklsnnQHVAIKHITNEGNVETFVREVASsshvrhpnLVALLGYCLRVDEcfliyelcpngnlaewlfgkdkCLSWIQRLEIAIDSARGLWFLHsysegcivhrdikptnillgpnfeaklsdfglskvidigetyassevrgtfgyldpeyrsnckvnssgdvySFGIVLLQILSGKKAKVLTRAGsaleladpkldreysIEAFDLTLQLALSCTalthqrppmEQVFVTLQKALDisttakasttqtsttqpstp
Flexible Loop (DISEMBL)
MVVPYIakstfqegkhKMYPQDLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPpakitsfkgvqlkdpgcpRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAgsaleladpklDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISttakasttqtsttqpstp
Low Complexity Region (SEG)
MVVPYIAKSTFQEGKHKMYPQDLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTgiwiligglvvvgvvaiiiiaSCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDIsttakasttqtsttqpstp
Disordered region (IsUnstruct)
*****I****F**GKHKMYPQDLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSS**RSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDI*******************
Disordered Region (DISOPRED)
*VVPYIA**************DLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQ**********EEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAA************************IGGLVVVGVVAIIIIASCICLK***********************CPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI**********TF**EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKA**********************
Disordered Region (DISEMBL)
MVVPYIAKSTFQEGKHKMYPQDLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGP*********IDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDIST*****************
Disordered Region (DISPRO)
MVVPYIAKSTFQEGKHKMYPQDLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILIGGLVVVGVVAIIIIASCICLKRYYKSN***************PGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDIS**A***************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVVPYIAKSTFQEGKHKMYPQDLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTTAKASTTQTSTTQPSTP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	588	2.2.26 [Sep-21-2011]
C0LGE0	1014	Probable LRR receptor-lik	yes	no	0.515	0.298	0.389	7e-51
Q8LEB6	484	Probable receptor-like pr	no	no	0.488	0.592	0.369	1e-49
Q9SJG2	494	Probable receptor-like pr	no	no	0.447	0.532	0.389	2e-49
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.518	0.294	0.374	3e-49
C0LGG7	953	Probable LRR receptor-lik	no	no	0.537	0.331	0.359	6e-49
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.518	0.293	0.374	9e-49
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.547	0.627	0.363	8e-48
Q9M2S4	684	L-type lectin-domain cont	no	no	0.459	0.394	0.376	1e-47
Q9FID8	873	Putative receptor-like pr	no	no	0.469	0.316	0.384	2e-47
Q9SA72	849	Probable receptor-like pr	no	no	0.544	0.376	0.355	2e-47

>sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1

 Score =  202 bits (513), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 130/334 (38%), Positives = 182/334 (54%), Gaps = 31/334 (9%)

Query: 250 IWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHY 309
           I + +G  V    + + II      KR  K++   ++   +G+ L+      +T+R++  
Sbjct: 620 IILKVGVPVAAATLLLFIIVGVFWKKRRDKNDIDKEL---RGLDLQ---TGTFTLRQIKA 673

Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHP 366
           AT+  +    IGEG  G VYKG+LS  + +A+K ++    +GN E FV E+   S ++HP
Sbjct: 674 ATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNRE-FVNEIGMISALQHP 732

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC----LSWIQRLEIAIDSARGLWF 422
           NLV L G C+  ++  L+YE   N  L+  LFGKD+     L W  R +I +  A+GL F
Sbjct: 733 NLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTF 792

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           LH  S   IVHRDIK +N+LL  +  AK+SDFGL+K+ D G T+ S+ + GT GY+ PEY
Sbjct: 793 LHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEY 852

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGKK----------------AKVLTRAGSALELADPK 526
                +    DVYSFG+V L+I+SGK                 A VL   GS LEL DP 
Sbjct: 853 AMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELVDPT 912

Query: 527 LDREYSIEAFDLTLQLALSCT-ALTHQRPPMEQV 559
           L  +YS E   L L +AL CT A    RP M QV
Sbjct: 913 LASDYSEEEAMLMLNVALMCTNASPTLRPTMSQV 946

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1

 Score =  198 bits (503), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 115/311 (36%), Positives = 178/311 (57%), Gaps = 24/311 (7%)

Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVR-EVAS 359
           +T+R++  AT + +  N+IG+G  G VY+G L N   VA+K + N  G  +   R EV +
Sbjct: 154 FTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEA 213

Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAIDS 416
             HVRH NLV LLGYC+   +  L+YE   NGNL +WL G ++    L+W  R++I I +
Sbjct: 214 IGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGT 273

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
           A+ L +LH   E  +VHRDIK +NIL+   F +K+SDFGL+K++   +++ ++ V GTFG
Sbjct: 274 AKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFG 333

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA----------------KVLTRAGSAL 520
           Y+ PEY ++  +N   DVYSFG+VLL+ ++G+                  K++ +   + 
Sbjct: 334 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSE 393

Query: 521 ELADPKLDREYSIEAFDLTLQLALSCT-ALTHQRPPMEQVFVTLQ-KALDIST-TAKAST 577
           E+ DP L+ + S  A   TL  AL C   ++ +RP M QV   L+ +   I+    +   
Sbjct: 394 EVVDPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEEYPIAREDRRRRR 453

Query: 578 TQTSTTQPSTP 588
           +Q  TT+ S P
Sbjct: 454 SQNGTTRDSDP 464

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1

 Score =  197 bits (502), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 111/285 (38%), Positives = 163/285 (57%), Gaps = 22/285 (7%)

Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVR-EVAS 359
           +T+R++  AT +   +N++GEG  G VY+GKL N   VA+K + N  G  E   R EV +
Sbjct: 171 FTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEA 230

Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDS 416
             HVRH NLV LLGYC+      L+YE   +GNL +WL G   +   L+W  R++I   +
Sbjct: 231 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGT 290

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
           A+ L +LH   E  +VHRDIK +NIL+   F AKLSDFGL+K++D GE++ ++ V GTFG
Sbjct: 291 AQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFG 350

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA----------------KVLTRAGSAL 520
           Y+ PEY +   +N   D+YSFG++LL+ ++G+                  K++     A 
Sbjct: 351 YVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 410

Query: 521 ELADPKLDREYSIEAFDLTLQLALSCT-ALTHQRPPMEQVFVTLQ 564
           E+ DP+L+   S  A    L ++L C      +RP M QV   L+
Sbjct: 411 EVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLE 455

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  196 bits (499), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 128/342 (37%), Positives = 180/342 (52%), Gaps = 37/342 (10%)

Query: 261 GVVAIIIIASCIC----------LKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYA 310
           GVVA I+IA+C+           L  Y       +    +G+ L+      +T++++  A
Sbjct: 607 GVVAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQ---TGSFTLKQIKRA 663

Query: 311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITN---EGNVETFVREVASSSHVRHPN 367
           T   +  N IGEG  G VYKG L++   +A+K +++   +GN E FV E+   S ++HPN
Sbjct: 664 TNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNRE-FVTEIGMISALQHPN 722

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAIDSARGLWFLH 424
           LV L G C+   E  L+YE   N +LA  LFG +K    L W  R ++ I  A+GL +LH
Sbjct: 723 LVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLH 782

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
             S   IVHRDIK TN+LL  +  AK+SDFGL+K+ +   T+ S+ + GT GY+ PEY  
Sbjct: 783 EESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAM 842

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKK----------------AKVLTRAGSALELADPKLD 528
              +    DVYSFG+V L+I+SGK                 A VL   GS LEL DP L 
Sbjct: 843 RGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLG 902

Query: 529 REYSIEAFDLTLQLALSCTALTHQ-RPPMEQVFVTLQKALDI 569
             +S +     L +AL CT  +   RPPM  V   LQ  + +
Sbjct: 903 TSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKV 944

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  196 bits (497), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 124/345 (35%), Positives = 181/345 (52%), Gaps = 29/345 (8%)

Query: 257 LVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNE 316
           LVV+  + I+ +      K+ Y  +       FK ++L       +++R++  AT   + 
Sbjct: 570 LVVILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELM---IASFSLRQIKIATNNFDS 626

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLG 373
            N IGEG  G VYKGKL +   +A+K ++    +GN E F+ E+   S + HPNLV L G
Sbjct: 627 ANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNRE-FLNEIGMISALHHPNLVKLYG 685

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAIDSARGLWFLHSYSEGC 430
            C+   +  L+YE   N +LA  LFG  +    L W  R +I I  ARGL +LH  S   
Sbjct: 686 CCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLK 745

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IVHRDIK TN+LL      K+SDFGL+K+ +   T+ S+ + GTFGY+ PEY     +  
Sbjct: 746 IVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTD 805

Query: 491 SGDVYSFGIVLLQILSGKKAK----------------VLTRAGSALELADPKLDREYSIE 534
             DVYSFGIV L+I+ G+  K                VL    + LEL DP+L  EY+ E
Sbjct: 806 KADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNRE 865

Query: 535 AFDLTLQLALSCTALTH-QRPPMEQVFVTLQ--KALDISTTAKAS 576
                +Q+A+ CT+    +RP M +V   L+  K +++    +AS
Sbjct: 866 EAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKLEEAS 910

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  195 bits (495), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 128/342 (37%), Positives = 179/342 (52%), Gaps = 37/342 (10%)

Query: 261 GVVAIIIIASC----------ICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYA 310
           G VA I+IA+C          + L  Y       +    +G+ L+      +T++++  A
Sbjct: 609 GAVAGIVIAACAVFGLLVLVILRLTGYLGGKEVDENEELRGLDLQ---TGSFTLKQIKRA 665

Query: 311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITN---EGNVETFVREVASSSHVRHPN 367
           T   +  N IGEG  G VYKG L++   +A+K +++   +GN E FV E+   S ++HPN
Sbjct: 666 TNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNRE-FVTEIGMISALQHPN 724

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAIDSARGLWFLH 424
           LV L G C+   E  L+YE   N +LA  LFG +K    L W  R +I I  A+GL +LH
Sbjct: 725 LVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLH 784

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
             S   IVHRDIK TN+LL  +  AK+SDFGL+K+ D   T+ S+ + GT GY+ PEY  
Sbjct: 785 EESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAM 844

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKK----------------AKVLTRAGSALELADPKLD 528
              +    DVYSFG+V L+I+SGK                 A VL   GS LEL DP L 
Sbjct: 845 RGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLELVDPDLG 904

Query: 529 REYSIEAFDLTLQLALSCTALTHQ-RPPMEQVFVTLQKALDI 569
             +S +     L +AL CT  +   RPPM  V   L+  + +
Sbjct: 905 TSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKV 946

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  192 bits (487), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 129/355 (36%), Positives = 189/355 (53%), Gaps = 33/355 (9%)

Query: 256 GLVVVGVVAIIIIASCICLKRYYKSNP--PAKITSFKGVQLKDPGCPRYTIREVHYATEK 313
           G+ + G V ++ +   +C K+  + +   PA I    G+         +T  E+  AT K
Sbjct: 128 GISIGGGVFVLTLIFFLCKKKRPRDDKALPAPIGLVLGIHQST-----FTYGELARATNK 182

Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVA 370
            +E NL+GEG  G VYKG L+N   VA+K +   + +G  E F  EV   S + H NLV+
Sbjct: 183 FSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKE-FQAEVNIISQIHHRNLVS 241

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEG 429
           L+GYC+   +  L+YE  PN  L   L GK +  + W  RL+IA+ S++GL +LH     
Sbjct: 242 LVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSSKGLSYLHENCNP 301

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            I+HRDIK  NIL+   FEAK++DFGL+K+     T+ S+ V GTFGYL PEY ++ K+ 
Sbjct: 302 KIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFGYLAPEYAASGKLT 361

Query: 490 SSGDVYSFGIVLLQILSGKKA-----------------KVLTRA--GSALE-LADPKLDR 529
              DVYSFG+VLL++++G++                   +L +A   S  E LAD KL+ 
Sbjct: 362 EKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNN 421

Query: 530 EYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQKALDISTTAKASTTQTSTT 583
           EY  E     +  A +C   T  +RP M+QV   L+  +  S   +  T   S T
Sbjct: 422 EYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISPSDLNQGITPGHSNT 476

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  191 bits (485), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 110/292 (37%), Positives = 168/292 (57%), Gaps = 22/292 (7%)

Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGN--VET 352
           D G  R++ RE+  AT    +  L+G G  GKVYKGKL  +++ VA+K I++E    V  
Sbjct: 328 DFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVRE 387

Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK--CLSWIQRL 410
           F+ EV+S  H+RH NLV LLG+C R D+  L+Y+  PNG+L  +LF ++    L+W QR 
Sbjct: 388 FMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRF 447

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
           +I    A GL +LH   E  ++HRDIK  N+LL      ++ DFGL+K+ + G    ++ 
Sbjct: 448 KIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATR 507

Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK--------------VLTR- 515
           V GTFGYL PE   + K+ +S DVY+FG VLL++  G++                V +R 
Sbjct: 508 VVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDWVWSRW 567

Query: 516 -AGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQ-RPPMEQVFVTLQK 565
            +G   ++ D +L+ E+  E   + ++L L C+  + + RP M QV + L+K
Sbjct: 568 QSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEK 619

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1

 Score =  191 bits (484), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 116/302 (38%), Positives = 170/302 (56%), Gaps = 26/302 (8%)

Query: 299 CPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKH--ITNEGNVETFVR 355
           C R++I E+  AT    +  +IG G  G VYKG++      VA+K   IT+    + F  
Sbjct: 503 CRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFET 562

Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC----LSWIQRLE 411
           E+   S +RH +LV+L+GYC   +E  L+YE  P+G L + LF +DK     LSW +RLE
Sbjct: 563 ELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLE 622

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV--IDIGETYASS 469
           I I +ARGL +LH+ ++  I+HRDIK TNILL  NF  K+SDFGLS+V      +T+ S+
Sbjct: 623 ICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVST 682

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLT--------------- 514
            V+GTFGYLDPEY     +    DVYSFG+VLL++L  +  ++ +               
Sbjct: 683 VVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSN 742

Query: 515 -RAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT 572
            R G+  ++ D  L  + +  + +   ++A+ C      +RPPM  V   L+ AL +  T
Sbjct: 743 YRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPMNDVVWALEFALQLHET 802

Query: 573 AK 574
           AK
Sbjct: 803 AK 804

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  190 bits (483), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 130/366 (35%), Positives = 184/366 (50%), Gaps = 46/366 (12%)

Query: 250 IWILIGG--LVVVGVVAIIIIASCICLKRYYKS-----NPPAKITSFKGVQLKDPGCP-- 300
           IWI +G    +++  V + I+  C+C KR  KS     NPP     F  V          
Sbjct: 431 IWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKAT 490

Query: 301 ----------------RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI 344
                           ++T+ E+  AT+  ++   IG G  GKVY+G+L +   +AIK  
Sbjct: 491 GGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRA 550

Query: 345 T--NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD- 401
           T  ++  +  F  E+   S +RH +LV+L+G+C   +E  L+YE   NG L   LFG + 
Sbjct: 551 TPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNL 610

Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-I 460
             LSW QRLE  I SARGL +LH+ SE  I+HRD+K TNILL  NF AK+SDFGLSK   
Sbjct: 611 PPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGP 670

Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
            +  T+ S+ V+G+FGYLDPEY    ++    DVYSFG+VL + +  +     T     +
Sbjct: 671 SMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQI 730

Query: 521 ELA----------------DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTL 563
            LA                D  L   YS E+ +   ++A  C A     RP M +V  +L
Sbjct: 731 NLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSL 790

Query: 564 QKALDI 569
           +  L I
Sbjct: 791 EYVLQI 796

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	588
147857438	623	hypothetical protein VITISV_020546 [Viti	0.945	0.892	0.585	0.0
225452508	594	PREDICTED: nodulation receptor kinase-li	0.921	0.912	0.588	0.0
255552628	605	serine-threonine protein kinase, plant-t	0.933	0.907	0.576	0.0
296087690	610	unnamed protein product [Vitis vinifera]	0.877	0.845	0.596	0.0
359473441	595	PREDICTED: nodulation receptor kinase-li	0.945	0.934	0.504	1e-163
356565948	573	PREDICTED: probable LRR receptor-like se	0.879	0.902	0.518	1e-155
255568750	499	serine-threonine protein kinase, plant-t	0.464	0.547	0.649	1e-109
296086548	321	unnamed protein product [Vitis vinifera]	0.481	0.881	0.620	1e-105
115458858	425	Os04g0465900 [Oryza sativa Japonica Grou	0.474	0.656	0.630	1e-102
125548644	359	hypothetical protein OsI_16236 [Oryza sa	0.474	0.777	0.630	1e-102

>gi|147857438|emb|CAN80789.1| hypothetical protein VITISV_020546 [Vitis vinifera]

 Score =  674 bits (1739), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/596 (58%), Positives = 422/596 (70%), Gaps = 40/596 (6%)

Query: 23  LSFMFI-FIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSA 81
           L  +F+ +I I+        C PS  DC L FQ S  S++SSCE GDWG FL   CC +A
Sbjct: 17  LKLLFVVYIFIVIGAVNFAVCHPSASDCILDFQ-SLSSSSSSCEEGDWGSFLNKGCCGAA 75

Query: 82  FQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVA 141
           F  YLY+LG+ AN+TG +YLNS+EQR+CLTSMKR E DAF+CGIEKLTSG G CS++SV 
Sbjct: 76  FGGYLYSLGKHANETGKVYLNSTEQRNCLTSMKRXEADAFSCGIEKLTSGTGGCSDFSVF 135

Query: 142 DVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVC 201
           DV++ LG++     E+CKFVS DGEWDQ C  CV SWE+I+G H       ++  E++VC
Sbjct: 136 DVTEKLGDEFRSLEENCKFVSPDGEWDQSCSSCVTSWEDIRGIH------STLKDETDVC 189

Query: 202 RFAAMVSLISSRIGDEKYAQNVFTCLAAQDI-----YITKQTLA----EMKMTH-----K 247
           RFA +VSLISSR  DE +   ++TCL  QDI     +    T +    E   +H      
Sbjct: 190 RFAVLVSLISSRTEDESWFGKIYTCLREQDIDKGHFHFQSNTRSSGRDETSRSHTKFKIS 249

Query: 248 TGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREV 307
           TG+W LIGGL+ + +  II I     L+R+ KS    K  + K V  + PGC + +I+EV
Sbjct: 250 TGLWFLIGGLIAMAL--IITIGIWFLLRRWCKSYAIPKRAALKAVAPEGPGCMKISIKEV 307

Query: 308 HYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPN 367
           + AT  LNE N+IGEG  GKVY+G L NNQHVA+KHI N+ ++ETFVRE+ S S ++HPN
Sbjct: 308 YSATNNLNEKNIIGEGTAGKVYRGILQNNQHVAVKHIINDNHMETFVREIXSLSXIKHPN 367

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           LVALLGYC   DECFL+YELCPBGNL+EWLFGKDK LSWIQRLEIAIDSA+GL FLH+Y 
Sbjct: 368 LVALLGYCEVEDECFLVYELCPBGNLSEWLFGKDKVLSWIQRLEIAIDSAQGLLFLHTYP 427

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
            GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID GE++ SSEVRGTFGY+DPEY+SN  
Sbjct: 428 AGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDQGESHVSSEVRGTFGYMDPEYQSNHH 487

Query: 488 VNSSGDVYSFGIVLLQILSGKK----------------AKVLTRAGSALELADPKLDREY 531
           VNSSGDVYSFGIVLLQILSGKK                AK+LT+ GS  E  DPKLD EY
Sbjct: 488 VNSSGDVYSFGIVLLQILSGKKVINLNLGRNRCLSDKMAKILTKDGSITEFVDPKLDGEY 547

Query: 532 SIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTTAKASTTQTSTTQPST 587
           S EAFDL L+LALSCT+L  QRP MEQV + L+KAL IST AKA T Q +  + S+
Sbjct: 548 SAEAFDLILKLALSCTSLKQQRPSMEQVVLRLEKALXISTMAKACTPQLTPNRLSS 603

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452508|ref|XP_002274835.1| PREDICTED: nodulation receptor kinase-like [Vitis vinifera]

 Score =  668 bits (1723), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/581 (58%), Positives = 413/581 (71%), Gaps = 39/581 (6%)

Query: 23  LSFMFI-FIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSA 81
           L  +F+ +I I+        C PS  DC L FQ S  S++SSCE GDWG FL   CC +A
Sbjct: 17  LKLLFVVYIFIVIGAVNFAVCHPSASDCILDFQ-SLSSSSSSCEEGDWGSFLNKGCCGAA 75

Query: 82  FQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVA 141
           F  YLY+LG+ AN+TG +YLNS+EQR+CLTSMKR E DA +CGIEKLTSG G CS++ V 
Sbjct: 76  FGGYLYSLGKHANETGKVYLNSTEQRNCLTSMKRFEADAVSCGIEKLTSGTGGCSDFFVF 135

Query: 142 DVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVC 201
           DV++ LG++     E+CKFVS DGEWDQ C  CV SWE+I+G H       ++  E++VC
Sbjct: 136 DVTEKLGDEFRSLEENCKFVSPDGEWDQSCSSCVTSWEDIRGIH------STLKDETDVC 189

Query: 202 RFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILIGGLVVVG 261
           RFA +VSLISSR  DE +   ++TCL  QDI                G+W LIGGL+ + 
Sbjct: 190 RFAVLVSLISSRTEDESWFGKIYTCLREQDI--------------DKGLWFLIGGLIAMA 235

Query: 262 VVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIG 321
           +  II I     L+R+ KS    K  + K V  + PGC + +I+EV+ AT  LNE N+IG
Sbjct: 236 L--IITIGIWFLLRRWCKSYAIPKRAALKAVAPEGPGCMKISIKEVYSATNNLNEKNIIG 293

Query: 322 EGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDEC 381
           EG  GKVY+G L NNQHVA+KHI N+ ++ETFVRE+ S SH++HPNLVALLGYC   DEC
Sbjct: 294 EGTAGKVYRGILQNNQHVAVKHIINDNHMETFVREITSLSHIKHPNLVALLGYCEVEDEC 353

Query: 382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNI 441
           FL+YELCP+GNL+EWLFGKDK LSWIQRLEIAIDSA+GL FLH+Y  GCIVHRDIKPTNI
Sbjct: 354 FLVYELCPDGNLSEWLFGKDKVLSWIQRLEIAIDSAQGLLFLHTYPAGCIVHRDIKPTNI 413

Query: 442 LLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVL 501
           LLG NFEAKLSDFGLSKVID GE++ SSEVRGTFGY+DPEY+SN  VN SGDVYSFGIVL
Sbjct: 414 LLGANFEAKLSDFGLSKVIDQGESHVSSEVRGTFGYMDPEYQSNHHVNPSGDVYSFGIVL 473

Query: 502 LQILSGKK---------------AKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC 546
           LQILSGKK               AK+LT+ GS  E  DPKLD EYS EAFDL L+LALSC
Sbjct: 474 LQILSGKKVINLNLKKPMSLDKMAKILTKDGSITEFVDPKLDGEYSAEAFDLILKLALSC 533

Query: 547 TALTHQRPPMEQVFVTLQKALDISTTAKASTTQTSTTQPST 587
           T+L  QRP MEQV + L+KAL+IST AKA T Q +  + S+
Sbjct: 534 TSLKQQRPSMEQVVLRLEKALEISTMAKACTPQLTPNRLSS 574

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255552628|ref|XP_002517357.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223543368|gb|EEF44899.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  654 bits (1687), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/593 (57%), Positives = 417/593 (70%), Gaps = 44/593 (7%)

Query: 28  IFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNN--SSCEGGDWGGFLPNKCCDSAFQKY 85
           IFI++IT    ++  QP  V C+L   FS L +   S+C  GDWGGFL   CC S F  Y
Sbjct: 24  IFILMITLRVPVS--QPLEVTCTLDLSFS-LPDYYVSNCIEGDWGGFLSKNCCGSTFHAY 80

Query: 86  LYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSK 145
           L++LG+RAN+TG IYL+S EQRSCL  M + E + F+CGI+KLTSG G CS++SVA+V++
Sbjct: 81  LHSLGRRANRTGFIYLDSDEQRSCLDEMGKYEAEDFSCGIDKLTSGGGGCSDFSVANVTR 140

Query: 146 MLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAA 205
            LG KL +  E+CKF  SD E DQ C  CV SW++IKG H +S+        + +CRFA 
Sbjct: 141 RLGGKLKRLTENCKFEDSDKESDQSCRSCVSSWQDIKGHHSSSN--------ANICRFAV 192

Query: 206 MVSLISSRIGDEKYAQNVFTCLAAQD--------------IYITKQTLAEMKMTHK-TGI 250
           +V+L S+RI D  Y   V+ CLA Q+                 T  +L  + ++ +  GI
Sbjct: 193 LVALTSTRIDDNSYINRVYRCLANQNNDTESAETAVKSKPKISTGDSLQPLMISIRLQGI 252

Query: 251 WILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYA 310
           WILIG L       II IA+ I  +R  KS  P +  +FK +QL++  CP++ +REV+ A
Sbjct: 253 WILIGCLFA-ATAMIITIAANIVSRRRLKSKVPLEKNAFKNLQLENSRCPKFPLREVYLA 311

Query: 311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVA 370
           T  L++ NLIGEG  GKVYKG LSN+QHVAIKHI N+GN ET VREV S SHVRHPNLVA
Sbjct: 312 TNNLSDENLIGEGTAGKVYKGVLSNSQHVAIKHIINDGNRETVVREVTSLSHVRHPNLVA 371

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LLG C+R DECF++YELCPNGNL++W+FGKDK LSWIQRL+IAIDSAR L FLH+YSEGC
Sbjct: 372 LLGCCIREDECFILYELCPNGNLSQWIFGKDKILSWIQRLQIAIDSARALCFLHTYSEGC 431

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IVHRDIKPTNILLG NFEAKLSDFGLSKVI  GETYASSEVRGTFGY+DPEY+SN +VNS
Sbjct: 432 IVHRDIKPTNILLGQNFEAKLSDFGLSKVISQGETYASSEVRGTFGYVDPEYQSNRQVNS 491

Query: 491 SGDVYSFGIVLLQILSGKK---------------AKVLTRAGSALELADPKLDREYSIEA 535
           SGDVYSFGIVLLQILSGKK               AK LTR GS +E ADPKLD EYS EA
Sbjct: 492 SGDVYSFGIVLLQILSGKKVINMNLKKPMPIDKMAKALTRGGSIIEFADPKLDGEYSAEA 551

Query: 536 FDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTTAKASTTQTSTTQPSTP 588
           F L  +LALSCTAL   RP MEQV + L++AL +ST A+AST +T+  + S P
Sbjct: 552 FVLIFKLALSCTALKQLRPSMEQVVIKLEEALVVSTRARASTPETTPNRFSIP 604

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296087690|emb|CBI34946.3| unnamed protein product [Vitis vinifera]

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/553 (59%), Positives = 398/553 (71%), Gaps = 37/553 (6%)

Query: 64  CEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFAC 123
           CE GDWG FL   CC +AF  YLY+LG+ AN+TG +YLNS+EQR+CLTSMKR E DA +C
Sbjct: 46  CEEGDWGSFLNKGCCGAAFGGYLYSLGKHANETGKVYLNSTEQRNCLTSMKRFEADAVSC 105

Query: 124 GIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWDQICGVCVQSWEEIKG 183
           GIEKLTSG G CS++ V DV++ LG++     E+CKFVS DGEWDQ C  CV SWE+I+G
Sbjct: 106 GIEKLTSGTGGCSDFFVFDVTEKLGDEFRSLEENCKFVSPDGEWDQSCSSCVTSWEDIRG 165

Query: 184 PHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDI-----YITKQT 238
            H       ++  E++VCRFA +VSLISSR  DE +   ++TCL  QDI     +    T
Sbjct: 166 IH------STLKDETDVCRFAVLVSLISSRTEDESWFGKIYTCLREQDIDKGHFHFQSNT 219

Query: 239 LA----EMKMTH-----KTGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSF 289
            +    E   +H      TG+W LIGGL+ + +  II I     L+R+ KS    K  + 
Sbjct: 220 RSSGRDETSRSHTKFKISTGLWFLIGGLIAMAL--IITIGIWFLLRRWCKSYAIPKRAAL 277

Query: 290 KGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN 349
           K V  + PGC + +I+EV+ AT  LNE N+IGEG  GKVY+G L NNQHVA+KHI N+ +
Sbjct: 278 KAVAPEGPGCMKISIKEVYSATNNLNEKNIIGEGTAGKVYRGILQNNQHVAVKHIINDNH 337

Query: 350 VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQR 409
           +ETFVRE+ S SH++HPNLVALLGYC   DECFL+YELCP+GNL+EWLFGKDK LSWIQR
Sbjct: 338 METFVREITSLSHIKHPNLVALLGYCEVEDECFLVYELCPDGNLSEWLFGKDKVLSWIQR 397

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           LEIAIDSA+GL FLH+Y  GCIVHRDIKPTNILLG NFEAKLSDFGLSKVID GE++ SS
Sbjct: 398 LEIAIDSAQGLLFLHTYPAGCIVHRDIKPTNILLGANFEAKLSDFGLSKVIDQGESHVSS 457

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK---------------AKVLT 514
           EVRGTFGY+DPEY+SN  VN SGDVYSFGIVLLQILSGKK               AK+LT
Sbjct: 458 EVRGTFGYMDPEYQSNHHVNPSGDVYSFGIVLLQILSGKKVINLNLKKPMSLDKMAKILT 517

Query: 515 RAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTTAK 574
           + GS  E  DPKLD EYS EAFDL L+LALSCT+L  QRP MEQV + L+KAL+IST AK
Sbjct: 518 KDGSITEFVDPKLDGEYSAEAFDLILKLALSCTSLKQQRPSMEQVVLRLEKALEISTMAK 577

Query: 575 ASTTQTSTTQPST 587
           A T Q +  + S+
Sbjct: 578 ACTPQLTPNRLSS 590

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359473441|ref|XP_002264586.2| PREDICTED: nodulation receptor kinase-like [Vitis vinifera]

 Score =  581 bits (1497), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 304/602 (50%), Positives = 402/602 (66%), Gaps = 46/602 (7%)

Query: 10  TFQEGKHKMYPQDLSFMFIFIIIITAVTELTHCQPSPVDCSLHFQFSSLSNNSSCEGGDW 69
           +F   KH+  P  + F+ +  II + ++EL        DCSL  QFSS  N+S  E G+W
Sbjct: 6   SFNPVKHQKPPTSIIFIILTTIISSVLSELL-----VTDCSLDIQFSSPGNDSYSEAGNW 60

Query: 70  GGFLPNKCCDSAFQKYLYALGQRANQTGNIYLNSSEQRSCLTSMKRLEEDAFACGIEKLT 129
           GGFL +K C  AF+ YLYALG++AN+TG I+ NS+EQ++CL SMK + ED  +CGIE+L 
Sbjct: 61  GGFLYHKGCAVAFEGYLYALGRQANKTGRIFSNSTEQKNCLDSMKSIGEDGLSCGIERLV 120

Query: 130 SGAGACSNYSVADVSKMLGNKLIKFNEDCKFVSSDGEWD-QICGVCVQSWEEIKGPHFAS 188
           +GA  CS+Y+V DV   LG +L K  EDC+ + S+G+ D Q C  C++SW+EI G     
Sbjct: 121 TGASDCSDYTVKDVDDKLGKRLRKLGEDCQSLGSEGKPDHQDCNACLRSWDEIGG----- 175

Query: 189 SKAESIDIESEVCRFAAMVSLISSRIGDEKYAQNVFTCLAAQDIYITKQTLAEMKMTHK- 247
               S D  ++VCRF+ +VSLIS RIG++K+ Q V  CL  Q   +   ++ +     K 
Sbjct: 176 ----SGDERADVCRFSVLVSLISKRIGEKKWVQEVCRCLRKQSTPMAMGSVEKKPNIRKG 231

Query: 248 -------------TGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGVQL 294
                        TG++ +IGGL+  G+  I++IAS I   R +K + P    +    + 
Sbjct: 232 EPSLLSPINNISITGLYFVIGGLM--GIAVIVLIASWILCSRRHKDDYPKGKDASDDSES 289

Query: 295 KDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFV 354
           ++  C   +I+E++ AT  L+  N IG+GI GKVY+G LSN QH+A+KHI +   VETF+
Sbjct: 290 EEFRCLNISIKEIYSATNNLSASNFIGQGIAGKVYRGMLSNGQHIAVKHIFDNECVETFI 349

Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI 414
           REV S SHVRHPNLV LLGYC + +ECFL+YELC NGNL+EWL+GKDK LSWI RLEIAI
Sbjct: 350 REVTSLSHVRHPNLVTLLGYCEKEEECFLVYELCHNGNLSEWLYGKDKVLSWILRLEIAI 409

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
           D ARGLWFLH+Y EGCIVHRDIKPTNIL+  NF AKLSDFGLSKV+D+ ++Y SSEVRGT
Sbjct: 410 DCARGLWFLHTYPEGCIVHRDIKPTNILISANFHAKLSDFGLSKVMDLDQSYVSSEVRGT 469

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK---------------AKVLTRAGSA 519
           FGY+DPEY+ N  VNSSGD+YSFGIVLLQILSGK+               A+ L +  + 
Sbjct: 470 FGYVDPEYQINHHVNSSGDIYSFGIVLLQILSGKRVLNLNSKKPMPLDKMARFLMKGRNI 529

Query: 520 LELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTTAKASTTQ 579
            E ADPKL+ EYS+EAF+L L+LAL+CT L   RP +EQV + L+KALDIS   + +   
Sbjct: 530 SEFADPKLNGEYSVEAFELILELALTCTGLKKHRPSIEQVVIILEKALDISRRVELTAPH 589

Query: 580 TS 581
           ++
Sbjct: 590 ST 591

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356565948|ref|XP_003551197.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g28960-like [Glycine max]

 Score =  556 bits (1432), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 283/546 (51%), Positives = 362/546 (66%), Gaps = 29/546 (5%)

Query: 43  QPSPVDCSLHFQFSSLSNNSSCEGGDWGGFLPNKCCDSAFQKYLYALGQRANQTGNIYLN 102
           + S  +C L  QFS    +S+CE  +WGGF  + CC   F  YLYALG RANQTG I+LN
Sbjct: 38  RTSVYNCVLDIQFSPSLISSNCELYNWGGF-THGCCGPYFDDYLYALGLRANQTGKIFLN 96

Query: 103 SSEQRSCLTSMKRLEEDAFACGIEKLTSGAGACSNYSVADVSKMLGNKLIKFNEDCKFVS 162
           SSEQ +C+ SM+  +++    GIEKLTSG G CS+Y++ DV    G+   + NEDC    
Sbjct: 97  SSEQENCIASMQAFDKNFTCYGIEKLTSGVGGCSDYTITDVINHHGDNFRRLNEDCMPFR 156

Query: 163 SDGEWDQICGVCVQSWEEIKGPHFASSKAESIDIESEVCRFAAMVSLISSRIGDEKYAQN 222
            +G  ++ C  C+++WE+I     ++  +ES +I   +CRFA +VS+ S+RI D +  Q 
Sbjct: 157 RNGRPNETCTKCLKAWEDISAKSDSTRGSESANINVYLCRFAVLVSITSTRIYDRESIQE 216

Query: 223 VFTCLAAQDIYITKQTL---AEMKMTHKTGIWILIGGLVVVGVVAIIIIASCICLKRYYK 279
           V+  L    +    Q +   A       +G+WI  G   + GV A++ +A+        K
Sbjct: 217 VYKYLGEHTLSAVNQEVKVKASANANINSGLWIAFG---ITGVTAVVFLAALALFITRIK 273

Query: 280 SNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV 339
           S P  +  S       D   P+ T+++V+ AT  L+  N IG+GI GKVYKG LSNNQ V
Sbjct: 274 SAPTVQDES-------DSTSPKITLKDVYVATNNLSASNFIGQGIAGKVYKGVLSNNQSV 326

Query: 340 AIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFG 399
           A+KHITNEG +ETFVREV S SHVRH NLVALLGYC    ECFL+YELC NGNL+EWLFG
Sbjct: 327 AVKHITNEGYMETFVREVRSLSHVRHQNLVALLGYCESEAECFLVYELCHNGNLSEWLFG 386

Query: 400 KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
             K LSWIQRLEI IDSARGL FLH+Y  GCIVHRDIKP+NIL+  NF+AKLSDFGLS+V
Sbjct: 387 NGKVLSWIQRLEIVIDSARGLEFLHTYPNGCIVHRDIKPSNILIDANFQAKLSDFGLSRV 446

Query: 460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK---------- 509
           +D+G++Y SSEVRGTFGY+DPEYR+N  V +SGDVYSFGIVLLQ+LSG++          
Sbjct: 447 MDLGQSYVSSEVRGTFGYIDPEYRTNHHVKASGDVYSFGIVLLQLLSGQRVLNIDFQRPM 506

Query: 510 -----AKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQ 564
                A+ + R G   E ADPKL REYS+EAFD+ L+LALSC  L  QRP +EQV  +L+
Sbjct: 507 SLGKMARDVVRGGDMSEFADPKLKREYSVEAFDIVLKLALSCIGLKQQRPSIEQVLYSLE 566

Query: 565 KALDIS 570
           KALDIS
Sbjct: 567 KALDIS 572

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255568750|ref|XP_002525346.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223535309|gb|EEF36984.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  401 bits (1030), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 187/288 (64%), Positives = 232/288 (80%), Gaps = 15/288 (5%)

Query: 305 REVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR 364
           RE++ AT  LNE+NLIG+GI GKVY+G LSN + VA+KHI ++G  ETFVREV S SH+R
Sbjct: 212 REIYLATGNLNEVNLIGQGIAGKVYRGMLSNGKDVAVKHIIDDGYAETFVREVTSLSHIR 271

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           HPNLVALLG+C   D+CFL+YELC NGNL+EWL+GKDK LSWIQRLEIAI+SARGLWFLH
Sbjct: 272 HPNLVALLGFCQHKDDCFLVYELCHNGNLSEWLYGKDKFLSWIQRLEIAINSARGLWFLH 331

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
           +Y EGCIVHRDIKPTNIL+   F+AKLSDFGLSKV+D+G++Y SSEVRGTFGY+DPEYR+
Sbjct: 332 TYPEGCIVHRDIKPTNILIDAEFQAKLSDFGLSKVMDVGQSYVSSEVRGTFGYVDPEYRT 391

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKK---------------AKVLTRAGSALELADPKLDR 529
           N +VN+ GDVYSFGIVLLQ++SG++               AK L++ G+  E ADPKL+ 
Sbjct: 392 NHRVNAKGDVYSFGIVLLQLISGQRVINLNLHRPVQLNKMAKFLSKGGNITEFADPKLNG 451

Query: 530 EYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTTAKAST 577
           +YS++AFDL L+LALSCT +  +RP MEQV + L++ALDIS   K+ T
Sbjct: 452 DYSVKAFDLVLKLALSCTGVKQERPSMEQVVLRLEEALDISMRMKSIT 499

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296086548|emb|CBI32137.3| unnamed protein product [Vitis vinifera]

 Score =  387 bits (995), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 185/298 (62%), Positives = 226/298 (75%), Gaps = 15/298 (5%)

Query: 299 CPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVA 358
           C   +I+E++ AT  L+  N IG+GI GKVY+G LSN QH+A+KHI +   VETF+REV 
Sbjct: 20  CLNISIKEIYSATNNLSASNFIGQGIAGKVYRGMLSNGQHIAVKHIFDNECVETFIREVT 79

Query: 359 SSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           S SHVRHPNLV LLGYC + +ECFL+YELC NGNL+EWL+GKDK LSWI RLEIAID AR
Sbjct: 80  SLSHVRHPNLVTLLGYCEKEEECFLVYELCHNGNLSEWLYGKDKVLSWILRLEIAIDCAR 139

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           GLWFLH+Y EGCIVHRDIKPTNIL+  NF AKLSDFGLSKV+D+ ++Y SSEVRGTFGY+
Sbjct: 140 GLWFLHTYPEGCIVHRDIKPTNILISANFHAKLSDFGLSKVMDLDQSYVSSEVRGTFGYV 199

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGKK---------------AKVLTRAGSALELA 523
           DPEY+ N  VNSSGD+YSFGIVLLQILSGK+               A+ L +  +  E A
Sbjct: 200 DPEYQINHHVNSSGDIYSFGIVLLQILSGKRVLNLNSKKPMPLDKMARFLMKGRNISEFA 259

Query: 524 DPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTTAKASTTQTS 581
           DPKL+ EYS+EAF+L L+LAL+CT L   RP +EQV + L+KALDIS   + +   ++
Sbjct: 260 DPKLNGEYSVEAFELILELALTCTGLKKHRPSIEQVVIILEKALDISRRVELTAPHST 317

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115458858|ref|NP_001053029.1| Os04g0465900 [Oryza sativa Japonica Group] gi|21741228|emb|CAD40939.1| OSJNBb0048E02.15 [Oryza sativa Japonica Group] gi|113564600|dbj|BAF14943.1| Os04g0465900 [Oryza sativa Japonica Group] gi|116309719|emb|CAH66764.1| OSIGBa0115M15.2 [Oryza sativa Indica Group] gi|125590673|gb|EAZ31023.1| hypothetical protein OsJ_15106 [Oryza sativa Japonica Group]

 Score =  377 bits (969), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 186/295 (63%), Positives = 224/295 (75%), Gaps = 16/295 (5%)

Query: 292 VQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVE 351
           V+ ++  C +   +E++ ATE L+ LN+IG+GI GKVYKG L+N   VA+KHI    + E
Sbjct: 114 VEYEEVTCKQMCTKEIYDATENLSPLNVIGQGIAGKVYKGVLANGWPVAVKHIVKNEHAE 173

Query: 352 TFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
           TF+REV S SHVRHPNLV+L GYC   +ECFL+YELC NGNL+EWLFGKDK LSWIQRL+
Sbjct: 174 TFLREVTSLSHVRHPNLVSLRGYCDGQEECFLVYELCINGNLSEWLFGKDKNLSWIQRLQ 233

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
           IA+ SA GLWFLH Y EGCIVHRD+KPTNILLG + E KLSDFGLS+VIDIG ++ SSEV
Sbjct: 234 IALGSACGLWFLHIYPEGCIVHRDVKPTNILLGVDMEPKLSDFGLSRVIDIGVSHVSSEV 293

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK----------------AKVLTR 515
           RGTFGY+DPEYR N KVN++GDVYSFG+VLLQ+LSGK+                A +L R
Sbjct: 294 RGTFGYVDPEYRHNHKVNAAGDVYSFGMVLLQLLSGKRAINIMNTAKPMSLDRMASMLIR 353

Query: 516 AGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDIS 570
            G+ LE ADP+L+ EYS EAFDL+L+LALSCT    QRP MEQV   L+KAL IS
Sbjct: 354 EGNVLEFADPRLNGEYSTEAFDLSLKLALSCTGHKKQRPSMEQVVSHLEKALKIS 408

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|125548644|gb|EAY94466.1| hypothetical protein OsI_16236 [Oryza sativa Indica Group]

 Score =  377 bits (968), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 186/295 (63%), Positives = 224/295 (75%), Gaps = 16/295 (5%)

Query: 292 VQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVE 351
           V+ ++  C +   +E++ ATE L+ LN+IG+GI GKVYKG L+N   VA+KHI    + E
Sbjct: 48  VEYEEVTCKQMCTKEIYDATENLSPLNVIGQGIAGKVYKGVLANGWPVAVKHIVKNEHAE 107

Query: 352 TFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
           TF+REV S SHVRHPNLV+L GYC   +ECFL+YELC NGNL+EWLFGKDK LSWIQRL+
Sbjct: 108 TFLREVTSLSHVRHPNLVSLRGYCDGQEECFLVYELCINGNLSEWLFGKDKNLSWIQRLQ 167

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
           IA+ SA GLWFLH Y EGCIVHRD+KPTNILLG + E KLSDFGLS+VIDIG ++ SSEV
Sbjct: 168 IALGSACGLWFLHIYPEGCIVHRDVKPTNILLGVDMEPKLSDFGLSRVIDIGVSHVSSEV 227

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK----------------AKVLTR 515
           RGTFGY+DPEYR N KVN++GDVYSFG+VLLQ+LSGK+                A +L R
Sbjct: 228 RGTFGYVDPEYRHNHKVNAAGDVYSFGMVLLQLLSGKRAINIMNTAKPMSLDRMASMLIR 287

Query: 516 AGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDIS 570
            G+ LE ADP+L+ EYS EAFDL+L+LALSCT    QRP MEQV   L+KAL IS
Sbjct: 288 EGNVLEFADPRLNGEYSTEAFDLSLKLALSCTGHKKQRPSMEQVVSHLEKALKIS 342

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	588
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.355	0.312	0.397	1e-46
TAIR|locus:2119936	669	AT4G29050 [Arabidopsis thalian	0.391	0.343	0.417	2.4e-46
TAIR|locus:2077730	512	AT3G59110 [Arabidopsis thalian	0.379	0.435	0.429	4.8e-46
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.387	0.349	0.418	2.9e-45
TAIR|locus:2027559	492	AT1G56720 [Arabidopsis thalian	0.379	0.453	0.425	3.4e-45
TAIR|locus:2008565	929	AT1G67720 [Arabidopsis thalian	0.374	0.236	0.419	5.3e-45
TAIR|locus:2045620	494	AT2G42960 [Arabidopsis thalian	0.431	0.514	0.385	7.1e-45
TAIR|locus:2066133	880	AT2G28960 [Arabidopsis thalian	0.493	0.329	0.369	7.3e-45
TAIR|locus:2177202	873	AT5G39000 [Arabidopsis thalian	0.352	0.237	0.458	8.3e-45
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.392	0.356	0.383	8.7e-45

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 424 (154.3 bits), Expect = 1.0e-46, Sum P(3) = 1.0e-46
 Identities = 85/214 (39%), Positives = 133/214 (62%)

Query:   301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI--TNEGNVETFVREVA 358
             +++ + +  AT+K ++ N+IG G  G+VY+GKLS+   VA+K +  T+    E F  E  
Sbjct:   332 QFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAV 391

Query:   359 SSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--GKDKCLSWIQRLEIAIDS 416
               S ++H NLV LLG+CL  +E  L+YE  PN +L  +LF   K   L W +R  I    
Sbjct:   392 LVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGI 451

Query:   417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTF 475
             ARG+ +LH  S   I+HRD+K +NILL  +   K++DFG++++  + ++ A++  + GTF
Sbjct:   452 ARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTF 511

Query:   476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK 509
             GY+ PEY      +   DVYSFG+++L+I+SGKK
Sbjct:   512 GYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKK 545

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)]

 Score = 461 (167.3 bits), Expect = 2.4e-46, Sum P(2) = 2.4e-46
 Identities = 99/237 (41%), Positives = 147/237 (62%)

Query:   298 GCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGN--VETFV 354
             G  R+  ++++ AT+      L+G+G  GKVYKG LS +N  +A+K ++++    +  FV
Sbjct:   328 GPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFV 387

Query:   355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIA 413
              E+A+   +RHPNLV LLGYC R  E +L+Y+  P G+L ++L+ + ++ L W QR +I 
Sbjct:   388 AEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQSLDWSQRFKII 447

Query:   414 IDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG 473
              D A GL +LH      I+HRDIKP N+LL  +   KL DFGL+K+ + G    +S V G
Sbjct:   448 KDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAG 507

Query:   474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE--LADPKLD 528
             TFGY+ PE     K ++S DV++FGI++L+I  G++  VL RA S  E  L D  LD
Sbjct:   508 TFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRP-VLPRASSPSEMVLTDWVLD 563

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)]

 Score = 483 (175.1 bits), Expect = 4.8e-46, P = 4.8e-46
 Identities = 98/228 (42%), Positives = 143/228 (62%)

Query:   302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVR-EVAS 359
             +T+R++  AT +    N+IGEG  G VYKG+L N   VA+K + N  G  E   R EV +
Sbjct:   178 FTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEA 237

Query:   360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---FGKDKCLSWIQRLEIAIDS 416
               HVRH NLV LLGYC+      L+YE   +GNL +WL    GK   L+W  R++I + +
Sbjct:   238 IGHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGT 297

Query:   417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
             A+ L +LH   E  +VHRDIK +NIL+  +F AKLSDFGL+K++D GE++ ++ V GTFG
Sbjct:   298 AQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFG 357

Query:   477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD 524
             Y+ PEY +   +N   D+YSFG++LL+ ++G+      R  + + L +
Sbjct:   358 YVAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVE 405

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 443 (161.0 bits), Expect = 2.9e-45, Sum P(2) = 2.9e-45
 Identities = 98/234 (41%), Positives = 144/234 (61%)

Query:   302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVET-FVREVAS 359
             +T  E+  AT   +E NL+G+G  G V+KG L + + VA+K +    G  E  F  EV  
Sbjct:   268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query:   360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-CLSWIQRLEIAIDSAR 418
              S V H +LV+L+GYC+   +  L+YE  PN NL   L GK +  + W  RL+IA+ SA+
Sbjct:   328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387

Query:   419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
             GL +LH      I+HRDIK +NIL+   FEAK++DFGL+K+     T+ S+ V GTFGYL
Sbjct:   388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYL 447

Query:   479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGKK---AKVLTRAGSALELADPKLDR 529
              PEY ++ K+    DV+SFG+VLL++++G++   A  +    S ++ A P L+R
Sbjct:   448 APEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNR 501

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)]

 Score = 475 (172.3 bits), Expect = 3.4e-45, P = 3.4e-45
 Identities = 97/228 (42%), Positives = 144/228 (63%)

Query:   302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVR-EVAS 359
             +T+R++  AT + ++ N+IGEG  G VY+G+L N   VA+K I N+ G  E   R EV +
Sbjct:   167 FTLRDLETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVDA 226

Query:   360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK---CLSWIQRLEIAIDS 416
               HVRH NLV LLGYC+      L+YE   NGNL +WL G  +    L+W  R+++ I +
Sbjct:   227 IGHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIGT 286

Query:   417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
             ++ L +LH   E  +VHRDIK +NIL+   F AK+SDFGL+K++  G+++ ++ V GTFG
Sbjct:   287 SKALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 346

Query:   477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD 524
             Y+ PEY ++  +N   DVYSFG+VLL+ ++G+      R    + L D
Sbjct:   347 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVD 394

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)]

 Score = 435 (158.2 bits), Expect = 5.3e-45, Sum P(2) = 5.3e-45
 Identities = 96/229 (41%), Positives = 140/229 (61%)

Query:   287 TSFKGVQLKDPGCPRY-TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT 345
             ++ +G  L D G   + ++  +  AT+  ++   +G G  G VY G++ + + VA+K IT
Sbjct:   580 SAVRGGHLLDEGVAYFISLPVLEEATDNFSKK--VGRGSFGSVYYGRMKDGKEVAVK-IT 636

Query:   346 NEGNVET---FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD- 401
              + +      FV EVA  S + H NLV L+GYC   D   L+YE   NG+L + L G   
Sbjct:   637 ADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSD 696

Query:   402 -KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
              K L W+ RL+IA D+A+GL +LH+     I+HRD+K +NILL  N  AK+SDFGLS+  
Sbjct:   697 YKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQT 756

Query:   461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK 509
             +   T+ SS  +GT GYLDPEY ++ ++    DVYSFG+VL ++LSGKK
Sbjct:   757 EEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKK 805

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)]

 Score = 472 (171.2 bits), Expect = 7.1e-45, P = 7.1e-45
 Identities = 106/275 (38%), Positives = 158/275 (57%)

Query:   302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVR-EVAS 359
             +T+R++  AT +   +N++GEG  G VY+GKL N   VA+K + N  G  E   R EV +
Sbjct:   171 FTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEA 230

Query:   360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAIDS 416
               HVRH NLV LLGYC+      L+YE   +GNL +WL G  +    L+W  R++I   +
Sbjct:   231 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGT 290

Query:   417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
             A+ L +LH   E  +VHRDIK +NIL+   F AKLSDFGL+K++D GE++ ++ V GTFG
Sbjct:   291 AQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFG 350

Query:   477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA----------------KVLTRAGSAL 520
             Y+ PEY +   +N   D+YSFG++LL+ ++G+                  K++     A 
Sbjct:   351 YVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 410

Query:   521 ELADPKLDREYSIEAFDLTLQLALSCTALTHQRPP 555
             E+ DP+L+   S  A    L ++L C     ++ P
Sbjct:   411 EVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRP 445

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2066133 AT2G28960 [Arabidopsis thaliana (taxid:3702)]

 Score = 468 (169.8 bits), Expect = 7.3e-45, Sum P(2) = 7.3e-45
 Identities = 118/319 (36%), Positives = 173/319 (54%)

Query:   278 YKSNPPAKITSFKGVQLKDPGCP-------RYTIREVHYATEKLNELNLIGEGITGKVYK 330
             +K   P ++ S   VQ   P  P       R+T  EV   T+    +  +GEG  G VY 
Sbjct:   532 FKKRRPTQVDSLPTVQHGLPNRPSIFTQTKRFTYSEVEALTDNFERV--LGEGGFGVVYH 589

Query:   331 GKLSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC 388
             G L+  Q +A+K ++       + F  EV     V H NLV+L+GYC       L+YE  
Sbjct:   590 GILNGTQPIAVKLLSQSSVQGYKEFKAEVELLLRVHHVNLVSLVGYCDEESNLALLYEYA 649

Query:   389 PNGNLAEWLFGK--DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
             PNG+L + L G+     L W  RL+I +++A+GL +LH+  +  +VHRD+K TNILL  +
Sbjct:   650 PNGDLKQHLSGERGGSPLKWSSRLKIVVETAQGLEYLHTGCKPPMVHRDVKTTNILLDEH 709

Query:   447 FEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
             F+AKL+DFGLS+   +G ET+ S+ V GT GYLDPEY    ++N   DVYSFGIVLL+I+
Sbjct:   710 FQAKLADFGLSRSFPVGGETHVSTAVAGTPGYLDPEYYRTNRLNEKSDVYSFGIVLLEII 769

Query:   506 SGKKAKVLTRA--------------GSALELADPKLDREYSIEAFDLTLQLALSCT-ALT 550
             + +     TR               G    + DP+L+R+Y   +    L++A+SC    +
Sbjct:   770 TSRPVIQQTREKPHIAAWVGYMLTKGDIENVVDPRLNRDYEPTSVWKALEIAMSCVNPSS 829

Query:   551 HQRPPMEQVFVTLQKALDI 569
              +RP M QV   L++ L +
Sbjct:   830 EKRPTMSQVTNELKQCLTL 848

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010043 "response to zinc ion" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2177202 AT5G39000 [Arabidopsis thaliana (taxid:3702)]

 Score = 451 (163.8 bits), Expect = 8.3e-45, Sum P(2) = 8.3e-45
 Identities = 99/216 (45%), Positives = 136/216 (62%)

Query:   299 CPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKH--ITNEGNVETFVR 355
             C R++I E+  AT    +  +IG G  G VYKG++      VA+K   IT+    + F  
Sbjct:   503 CRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFET 562

Query:   356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC----LSWIQRLE 411
             E+   S +RH +LV+L+GYC   +E  L+YE  P+G L + LF +DK     LSW +RLE
Sbjct:   563 ELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLE 622

Query:   412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV--IDIGETYASS 469
             I I +ARGL +LH+ ++  I+HRDIK TNILL  NF  K+SDFGLS+V      +T+ S+
Sbjct:   623 ICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVST 682

Query:   470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
              V+GTFGYLDPEY     +    DVYSFG+VLL++L
Sbjct:   683 VVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVL 718

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 411 (149.7 bits), Expect = 8.7e-45, Sum P(3) = 8.7e-45
 Identities = 92/240 (38%), Positives = 138/240 (57%)

Query:   302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKH---ITNEGNVETFVREVA 358
             +T RE+H  T+  +  N++G G  G VY+GKL +   VA+K    I        F  E+ 
Sbjct:   291 FTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELE 350

Query:   359 SSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
               S   H NL+ L+GYC    E  L+Y   PNG++A  L  K   L W  R  IAI +AR
Sbjct:   351 MISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKSKP-ALDWNMRKRIAIGAAR 409

Query:   419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
             GL +LH   +  I+HRD+K  NILL   FEA + DFGL+K+++  +++ ++ VRGT G++
Sbjct:   410 GLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHI 469

Query:   479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA----KVLTRAGSALELADPKLDREYSIE 534
              PEY S  + +   DV+ FGI+LL++++G +A    K +++ G+ LE    KL  E  +E
Sbjct:   470 APEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLEWVR-KLHEEMKVE 528

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	588
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-23
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-07
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  166 bits (423), Expect = 4e-48
 Identities = 64/191 (33%), Positives = 99/191 (51%), Gaps = 10/191 (5%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLGYC 375
           +GEG  G VY  +     + VAIK I    +   +E  +RE+     + HPN+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
              +  +L+ E C  G+L + L   +  LS  + L I +    GL +LHS     I+HRD
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRD 117

Query: 436 IKPTNILLG-PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNCKVNSSGD 493
           +KP NILL   N + KL+DFGLSK++   ++   + V GT  Y+ PE        +   D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSD 176

Query: 494 VYSFGIVLLQI 504
           ++S G++L ++
Sbjct: 177 IWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  151 bits (384), Expect = 5e-42
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 11/195 (5%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALLGY 374
           +G G  G VYK K     + VA+K +          +T  RE+     + HPN+V L+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
               D  +L+ E C  G+L ++L  +   LS  +  +IA+   RGL +LHS     I+HR
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSNG---IIHR 122

Query: 435 DIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNCKVNSSGD 493
           D+KP NILL  N   K++DFGL+K +    +  ++ V GT  Y+ PE            D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVD 181

Query: 494 VYSFGIVLLQILSGK 508
           V+S G++L ++L+GK
Sbjct: 182 VWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  145 bits (368), Expect = 9e-40
 Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 12/202 (5%)

Query: 314 LNELNLIGEGITGKVYKGKLSNNQH-----VAIK---HITNEGNVETFVREVASSSHVRH 365
           L     +GEG  G+VYKG L          VA+K      +E  +E F+RE      + H
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSARGLWFLH 424
           PN+V LLG C   +   ++ E  P G+L ++L   + K LS    L  A+  ARG+ +L 
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
           S      +HRD+   N L+G N   K+SDFGLS+ +   + Y     +    ++ PE   
Sbjct: 121 S---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 485 NCKVNSSGDVYSFGIVLLQILS 506
             K  S  DV+SFG++L +I +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  145 bits (368), Expect = 9e-40
 Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 11/201 (5%)

Query: 314 LNELNLIGEGITGKVYKGKLSNNQH-----VAIK---HITNEGNVETFVREVASSSHVRH 365
           L     +GEG  G+VYKGKL          VA+K      +E  +E F+RE      + H
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           PN+V LLG C   +  +++ E    G+L  +L      LS    L  A+  ARG+ +L S
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                 +HRD+   N L+G N   K+SDFGLS+ +   + Y     +    ++ PE    
Sbjct: 121 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 486 CKVNSSGDVYSFGIVLLQILS 506
            K  S  DV+SFG++L +I +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  143 bits (363), Expect = 5e-39
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 10/196 (5%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALL 372
           L  +GEG  GKVY  +     + VAIK I  +    + E  +RE+     ++HPN+V L 
Sbjct: 4   LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
                 D+ +L+ E C  G+L + L  K   LS  +           L +LHS     IV
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSK---GIV 119

Query: 433 HRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSG 492
           HRD+KP NILL  +   KL+DFGL++ +D GE   +    GT  Y+ PE         + 
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAPEVLLGKGYGKAV 177

Query: 493 DVYSFGIVLLQILSGK 508
           D++S G++L ++L+GK
Sbjct: 178 DIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  143 bits (362), Expect = 8e-39
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 27/209 (12%)

Query: 318 NLIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
             +GEG  G+VYKGKL         VA+K      +E   + F++E      + HPN+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL--------FGKDKCLSWIQRLEIAIDSARGLWF 422
           LLG C   +  +L+ E    G+L ++L          +   LS    L  AI  A+G+ +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-----VRGTFGY 477
           L S      VHRD+   N L+G +   K+SDFGLS+ +   + Y         +R    +
Sbjct: 121 LASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           + PE   +    S  DV+SFG++L +I +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  139 bits (354), Expect = 1e-37
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 314 LNELNLIGEGITGKVYKGKL-----SNNQHVAIK---HITNEGNVETFVREVASSSHVRH 365
           L     +GEG  G+VYKG L          VA+K      +E   E F+ E +    + H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           PN+V LLG C + +  +++ E  P G+L ++L    + L+    L++A+  A+G+ +L S
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-----VRGTFGYLDP 480
                 VHRD+   N L+  N   K+SDFGLS+ I   + Y         ++    ++ P
Sbjct: 121 ---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAP 173

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   + K  S  DV+SFG++L +I + 
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (285), Expect = 2e-28
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 24/203 (11%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIK--HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           L  IG+G  G+VYK +     + VAIK   + ++   E  + E+      +HPN+V   G
Sbjct: 5   LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCL--SWIQRLEIAIDSARGLWFLHSYSEGCI 431
             L+ DE +++ E C  G+L + L   ++ L  S I    +  +  +GL +LHS     I
Sbjct: 65  SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY--VCKELLKGLEYLHSNG---I 119

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE------YRSN 485
           +HRDIK  NILL  + E KL DFGLS    + +T A + + GT  ++ PE      Y  +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPY--D 175

Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
            K     D++S GI  +++  GK
Sbjct: 176 YKA----DIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  112 bits (283), Expect = 5e-28
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 318 NLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALL 372
            L+G G  G VY        + +A+K +     +E  +E   RE+   S ++HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 373 GYCL-RVDECFLIY-ELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           G           I+ E    G+L+  L  FGK      I++         GL +LHS   
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVIRKY--TRQILEGLAYLHSN-- 120

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDPEYRSNCK 487
             IVHRDIK  NIL+  +   KL+DFG +K +   ET   +  VRGT  ++ PE     +
Sbjct: 121 -GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
              + D++S G  ++++ +GK
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 61/190 (32%), Positives = 101/190 (53%), Gaps = 10/190 (5%)

Query: 319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGN-VETFVREVASSSHVRHPNLVALLGYCLR 377
            IG+G  G V  G     Q VA+K + ++    + F+ E +  + +RHPNLV LLG  L+
Sbjct: 13  TIGKGEFGDVMLGDYRG-QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
            +  +++ E    G+L ++L  + +  ++  Q+L  A+D   G+ +L   +    VHRD+
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDL 128

Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
              N+L+  +  AK+SDFGL+K    G+      V+ T     PE     K ++  DV+S
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVWS 184

Query: 497 FGIVLLQILS 506
           FGI+L +I S
Sbjct: 185 FGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (276), Expect = 2e-26
 Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHP-NLVA 370
           L  +GEG  G+VY  +  + + VA+K       +    VE F+RE+   + + HP N+V 
Sbjct: 5   LRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           L  +       +L+ E    G+L + L   G+   LS  + L I       L +LH    
Sbjct: 63  LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---S 119

Query: 429 GCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDIGET-----YASSEVRGTFGYLDPEY 482
             I+HRDIKP NILL  +    KL DFGL+K++    +        S   GT GY+ PE 
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 483 ---RSNCKVNSSGDVYSFGIVLLQILSGK 508
               S    +SS D++S GI L ++L+G 
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (263), Expect = 4e-25
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 40/221 (18%)

Query: 319 LIGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSSHV-RHPNLVAL 371
           +IGEG    V   K    N+  AIK      +  E  V+    E    + +  HP ++ L
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 372 LGYCLRVDEC-FLIYELCPNGNLAEWL--FGK--DKCLSWIQRLEIAIDSARGLWFLHSY 426
             Y  + +E  + + E  PNG L +++  +G   +KC  +    EI +     L +LHS 
Sbjct: 68  Y-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYA-AEILL----ALEYLHSK 121

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID--------------IGETYASSEVR 472
               I+HRD+KP NILL  +   K++DFG +KV+D              I      +  R
Sbjct: 122 G---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 473 -----GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
                GT  Y+ PE  +      S D+++ G ++ Q+L+GK
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (258), Expect = 9e-25
 Identities = 71/201 (35%), Positives = 113/201 (56%), Gaps = 13/201 (6%)

Query: 314 LNELNL---IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVA 370
           L +L L   IGEG  G V +G+ +  Q VA+K+I  +   + F+ E A  + + H NLV 
Sbjct: 5   LQKLTLGEIIGEGEFGAVLQGEYTG-QKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVR 63

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-SWIQRLEIAIDSARGLWFLHSYSEG 429
           LLG  L  +  +++ EL   GNL  +L  + + L S IQ L+ ++D A G+ +L S    
Sbjct: 64  LLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK-- 120

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            +VHRD+   NIL+  +  AK+SDFGL++V  +G   +   V+ T     PE   + K +
Sbjct: 121 -LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFS 175

Query: 490 SSGDVYSFGIVLLQILSGKKA 510
           S  DV+S+G++L ++ S  +A
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  103 bits (258), Expect = 1e-24
 Identities = 56/192 (29%), Positives = 104/192 (54%), Gaps = 11/192 (5%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+V++G   N   VAIK +   +    + F +EV +   +RH +L++L   C  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 378 VDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
            +  ++I EL   G+L  +L   + + L     +++A   A G+ +L   +    +HRD+
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDL 130

Query: 437 KPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDV 494
              NIL+G +   K++DFGL+++I  D+   Y SS+ +  + +  PE  S+   ++  DV
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDV---YLSSDKKIPYKWTAPEAASHGTFSTKSDV 187

Query: 495 YSFGIVLLQILS 506
           +SFGI+L ++ +
Sbjct: 188 WSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 2e-24
 Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 7/193 (3%)

Query: 319 LIGEGITGKVYKGKLSNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYC 375
            IG+G  G VYKG L  N  VA+K   +         F++E        HPN+V L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
           ++    +++ EL P G+L  +L  K   L+  + L++++D+A G+ +L   S+ CI HRD
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE--SKNCI-HRD 118

Query: 436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT-FGYLDPEYRSNCKVNSSGDV 494
           +   N L+G N   K+SDFG+S+  + G    S  ++     +  PE  +  +  S  DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 495 YSFGIVLLQILSG 507
           +S+GI+L +  S 
Sbjct: 179 WSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  102 bits (256), Expect = 3e-24
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 36/216 (16%)

Query: 320 IGEGITGKVYKGKL------SNNQHVAIKHITNEGNVET---FVREVASSSHVRHPNLVA 370
           +GEG  GKVYKG+L       +   VAIK +      +    F +E    S ++HPN+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF---------------GKDKCLSWIQRLEIAID 415
           LLG C +     +++E   +G+L E+L                     L     L IAI 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-----ASSE 470
            A G+ +L S+     VHRD+   N L+G     K+SDFGLS+ I   + Y     +   
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           VR    ++ PE     K  +  D++SFG+VL +I S
Sbjct: 190 VR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 22/222 (9%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G V+ GK      VAIK I  EG  + + F+ E      + HPNLV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
               F++ E   NG L  +L  +   L     L++  D    + +L        +HRD+ 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127

Query: 438 PTNILLGPNFEAKLSDFGLSK-VIDIGETYASSEVRGT---FGYLDPEYRSNCKVNSSGD 493
             N L+G +   K+SDFGL++ V+D  + Y SS+  GT     +  PE     + +S  D
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQ--GTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 494 VYSFGIVLLQILSGKK--------AKVLTRAGSALELADPKL 527
           V+SFG+++ ++ S  K        ++V+    +   L  PKL
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL 225

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 5e-24
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVAL 371
           L  +GEG  G VYK +     + VA+K I      EG   T +RE++    ++HPN+V L
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKC-----LSWIQRLEIAIDSARGLWFLHSY 426
           L       + +L++E C   +L ++L   DK       + I+   I     RGL + HS 
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYL---DKRPGPLSPNLIKS--IMYQLLRGLAYCHS- 116

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
               I+HRD+KP NIL+  +   KL+DFGL++   I     + EV  T  Y  PE     
Sbjct: 117 --HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGS 173

Query: 487 KVNSSG-DVYSFGIVLLQILSGK 508
           K  S+  D++S G +  ++++GK
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =   99 bits (250), Expect = 1e-23
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 12/203 (5%)

Query: 312 EKLNELNLIGEGITGKVYKG--KLSNNQHVAIK--HITNEGNVE-TFVREVASSSHVRHP 366
             L  + ++G+G +G VYK   K +  +  A+K  H+  +       +RE+ +      P
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTG-KIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
            +V   G   +  E  ++ E    G+LA+ L  K   +       IA    +GL +LH+ 
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
               I+HRDIKP+N+L+    E K++DFG+SKV++      ++ V GT  Y+ PE R   
Sbjct: 119 RH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-RIQG 174

Query: 487 KVNS-SGDVYSFGIVLLQILSGK 508
           +  S + D++S G+ LL+   GK
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 65/192 (33%), Positives = 104/192 (54%), Gaps = 8/192 (4%)

Query: 319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNVE---TFVREVASSSHVRHPNLVALLGYC 375
           L+G+G  G+V+KG L +   VA+K    +   E    F+ E        HPN+V L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
            +    +++ EL P G+   +L  K   L   Q ++ A+D+A G+ +L S  + CI HRD
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES--KNCI-HRD 118

Query: 436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT-FGYLDPEYRSNCKVNSSGDV 494
           +   N L+G N   K+SDFG+S+  D G  Y+SS ++     +  PE  +  + +S  DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 495 YSFGIVLLQILS 506
           +S+GI+L +  S
Sbjct: 178 WSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (250), Expect = 1e-23
 Identities = 68/205 (33%), Positives = 99/205 (48%), Gaps = 17/205 (8%)

Query: 317 LNLIGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFVREVASSSHV----RHPNLVAL 371
            N IG G  GKVY    L   + +A+K I  + N    ++E+A    V    +HPNLV  
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
            G  +  ++ ++  E C  G L E L  G+      I+   + +    GL +LHS+    
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHG--- 119

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG---YLDPEYRSNCK 487
           IVHRDIKP NI L  N   KL DFG +  +    T    EV+   G   Y+ PE  +  K
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 488 VNSSG---DVYSFGIVLLQILSGKK 509
               G   D++S G V+L++ +GK+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 40/207 (19%)

Query: 316 ELNLIGEGITGKVYKGKLSNNQH-VAIKHI---TNEGNVETF-VREVASSSHVR---HPN 367
           EL  IGEG  G VYK +  N    VA+K +    +E  +    +RE+A    +    HPN
Sbjct: 3   ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 368 LVALLGYCL--RVDECFLIY--------------ELCPNGNLAEWLFGKDKCLSWIQRLE 411
           +V LL  C   R D    +                 CP   L        K L   Q L 
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE---TIKDLMR-QLL- 117

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
                 RG+ FLHS+    IVHRD+KP NIL+  + + K++DFGL+++       A + V
Sbjct: 118 ------RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTSV 166

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFG 498
             T  Y  PE        +  D++S G
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 35/232 (15%)

Query: 289 FKGVQLKD---PGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSN-NQHVAIK-- 342
                LKD    G PR          E    L  IGEG +G+VYK       + VAIK  
Sbjct: 3   ELKAALKDIVSEGDPR----------ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM 52

Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDEC-FLIYELCPNGNLAEWLFGKD 401
            +  + N E  + E+      +HPN+V        V +  +++ E    G+L + +    
Sbjct: 53  RLRKQ-NKELIINEILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNF 110

Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
             ++  Q   +  +  +GL +LHS  +  I HRDIK  NILL  +   KL+DFG +  + 
Sbjct: 111 VRMNEPQIAYVCREVLQGLEYLHS--QNVI-HRDIKSDNILLSKDGSVKLADFGFAAQLT 167

Query: 462 IGETYASSEVRGTFGYLDPE------YRSNCKVNSSGDVYSFGIVLLQILSG 507
             ++  +S V GT  ++ PE      Y    KV    D++S GI+ +++  G
Sbjct: 168 KEKSKRNSVV-GTPYWMAPEVIKRKDY--GPKV----DIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  103 bits (258), Expect = 6e-23
 Identities = 91/353 (25%), Positives = 146/353 (41%), Gaps = 38/353 (10%)

Query: 243 KMTHKTGIWILIGGLVVVGVVAIIIIASCICLKRYYKSNPPAKITSFKGV---QLKDPGC 299
           K   KT  W       +   + + ++A      R   +    ++ +  G    Q  D   
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKV 679

Query: 300 PR-YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHITNEGNVETFVREV 357
            +  TI ++      L E N+I  G  G  YKGK   N     +K I +  ++ +   E+
Sbjct: 680 SKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS--SEI 734

Query: 358 ASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA 417
           A    ++HPN+V L+G C      +LI+E     NL+E L      LSW +R +IAI  A
Sbjct: 735 ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIA 790

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGY 477
           + L FLH      +V  ++ P  I++    E  L    L  ++        S       Y
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AY 844

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELA------------ 523
           + PE R    +    D+Y FG++L+++L+GK          GS +E A            
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW 904

Query: 524 -DPKLDREYSIEAFDL--TLQLALSCTALTHQ-RPPMEQVFVTLQKALDISTT 572
            DP +  + S+   ++   + LAL CTA     RP    V  TL+ A   S++
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957

Length = 968

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 97.3 bits (242), Expect = 1e-22
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 8/202 (3%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G V+ G     + VAIK I  EG +  E F+ E      + HP LV L G C  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
                L++E   +G L+++L  +    S    L + +D   G+ +L       ++HRD+ 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127

Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDPEYRSNCKVNSSGDVYS 496
             N L+G N   K+SDFG+++ + + + Y SS   +    +  PE  S  K +S  DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 497 FGIVLLQILSGKKAKVLTRAGS 518
           FG+++ ++ S  K     R+ S
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNS 208

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 97.2 bits (243), Expect = 1e-22
 Identities = 80/275 (29%), Positives = 119/275 (43%), Gaps = 57/275 (20%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVAL 371
           +  IG+G  GKVY  +  S+ +   +K I     +E   E  + EV     + HPN++  
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK- 63

Query: 372 LGYCLRVDECFL-------IYELCPNGNLAEWL---------FGKDKCLSWIQRLEIAID 415
             Y     E F        + E    G+L++ +         F +++ L W  +L +A+ 
Sbjct: 64  --YY----ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
                 +LHS     I+HRDIKP NI L  N   KL DFG+SKV+      A + V GT 
Sbjct: 118 ------YLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTP 167

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-------PKLD 528
            YL PE   N   N   D++S G VL ++ + K         + LELA        P + 
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP---FEGENLLELALKILKGQYPPIP 224

Query: 529 REYSIEAFDLTLQLALSCTALT---HQRPPMEQVF 560
            +YS E  +L   L      L     +RP + Q+ 
Sbjct: 225 SQYSSELRNLVSSL------LQKDPEERPSIAQIL 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 59/191 (30%), Positives = 104/191 (54%), Gaps = 8/191 (4%)

Query: 318 NLIGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYC 375
           + +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
            R    ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HR
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128

Query: 435 DIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGD 493
           D+   N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   D
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 494 VYSFGIVLLQI 504
           V++FG++L +I
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 55/189 (29%), Positives = 98/189 (51%), Gaps = 5/189 (2%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G G  G+V++G  +N   VA+K +     + + F+ E      +RHP L+ L   C   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 379 DECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ EL   G+L E+L G   + L   Q +++A   A G+ +L + +    +HRD+ 
Sbjct: 74  EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLA 130

Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             N+L+G N   K++DFGL++VI      A    +    +  PE     + +   DV+SF
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190

Query: 498 GIVLLQILS 506
           GI+L +I++
Sbjct: 191 GILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 57/188 (30%), Positives = 96/188 (51%), Gaps = 7/188 (3%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGN--VETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+V+ G  +    VA+K +   G    E F++E      +RH  LV L   C  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 378 VDECFLIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
            +  +++ E    G+L ++L  G+ K L   Q +++A   A G+ +L S +    +HRD+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDL 129

Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
              NIL+G N   K++DFGL+++I+  E  A    +    +  PE  +  +     DV+S
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS 189

Query: 497 FGIVLLQI 504
           FGI+L +I
Sbjct: 190 FGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 63/203 (31%), Positives = 108/203 (53%), Gaps = 24/203 (11%)

Query: 318 NLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALL 372
           +LIG G  G VYKG  L     VAIK I+ E      +++ ++E+    +++HPN+V  +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 373 GYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWI-QRLEIAIDSARGLWFLHSY 426
           G     D  ++I E   NG+L + +     F +     ++ Q L+       GL +LH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYLHE- 117

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYLDPEYRSN 485
            +G ++HRDIK  NIL   +   KL+DFG++ K+ D+ +  AS  V GT  ++ PE    
Sbjct: 118 -QG-VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEM 173

Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
              +++ D++S G  ++++L+G 
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 75/265 (28%), Positives = 120/265 (45%), Gaps = 27/265 (10%)

Query: 318 NLIGEGITGKVYKGKLSNNQH----VAIKHI---TNEGNVETFVREVASSSHVRHPNLVA 370
            +IG G  G+V +G+L         VAIK +   +++     F+ E +      HPN++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L G   +     +I E   NG+L ++L   D   +  Q + +    A G+ +L   SE  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-TYASSEVRGTFGYLDPEYRSNCKVN 489
            VHRD+   NIL+  N   K+SDFGLS+ ++  E TY +   +    +  PE  +  K  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186

Query: 490 SSGDVYSFGIVLLQILS-GKKA-------KVLTRAGSALELADPKLDREYSIEAFDLTLQ 541
           S+ DV+SFGIV+ +++S G++         V+        L  P        +      Q
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM-------DCPSALYQ 239

Query: 542 LALSC-TALTHQRPPMEQVFVTLQK 565
           L L C     ++RP   Q+  TL K
Sbjct: 240 LMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 14/196 (7%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALLGY 374
           IGEG  G V+K K     + VA+K +       G     +RE+ +    +HP +V LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66

Query: 375 CLRVDECF-LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
                  F L+ E  P+  L+E L  +++ L   Q         +G+ ++H+     I+H
Sbjct: 67  VFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMH 122

Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE--YRSNCKVNSS 491
           RD+KP N+L+  +   K++DFGL+++    E    S    T  Y  PE  Y +  K +  
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPG 181

Query: 492 GDVYSFGIVLLQILSG 507
            D+++ G +  ++L+G
Sbjct: 182 VDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 58/192 (30%), Positives = 98/192 (51%), Gaps = 7/192 (3%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
            +GEG  G VYK       Q VAIK +  E +++  ++E++       P +V   G   +
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             + +++ E C  G++++ +   +K L+  +   I   + +GL +LHS      +HRDIK
Sbjct: 70  NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIK 126

Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDPEYRSNCKVNSSGDVYS 496
             NILL    +AKL+DFG+S    + +T A    V GT  ++ PE       N+  D++S
Sbjct: 127 AGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184

Query: 497 FGIVLLQILSGK 508
            GI  +++  GK
Sbjct: 185 LGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 92.1 bits (229), Expect = 9e-21
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 39/220 (17%)

Query: 320 IGEGITGKVYKGKLSNNQH------VAIKHI---TNEGNVETFVREVASSSHVRHPNLVA 370
           +GEG  GKV+ G+  + +       VA+K +    +    + F RE    ++ +H N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL--FGKD-----------KCLSWIQRLEIAIDSA 417
             G C   D   +++E   +G+L ++L   G D             L+  Q L+IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT--- 474
            G+ +L S      VHRD+   N L+G +   K+ DFG+S+ +   + Y    V G    
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTML 186

Query: 475 -FGYLDPE---YRSNCKVNSSGDVYSFGIVLLQILS-GKK 509
              ++ PE   YR   K  +  DV+SFG+VL +I + GK+
Sbjct: 187 PIRWMPPESIMYR---KFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 17/208 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQ-----HVAIK---HITNEGNVETFVREVASSSHV 363
             L  +  +GEG  GKV   +           VA+K   H   E +   F RE+     +
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 364 RHPNLVALLGYC--LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW 421
            H N+V   G C         LI E  P+G+L ++L      ++  + L  +    +G+ 
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD 123

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYL 478
           +L S  +  I HRD+   NIL+      K+SDFGL+KV+   + Y   +  G    F Y 
Sbjct: 124 YLGS--QRYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            PE     K +S+ DV+SFG+ L ++ +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 314 LNELNLIGEGITGKVYKGKLSNNQHV-AIKHITNEGNVETF---VREVASSSHVRHPNLV 369
           L  L  +G G +G V K        + A+K I  E N       +RE+        P +V
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL---EIAIDSARGLWFLHSY 426
              G      +  +  E    G+L + L    +    I      +IA+   +GL +LH  
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK--VIDIGETYASSEVRGTFGYLDPEYRS 484
            +  I+HRD+KP+NIL+    + KL DFG+S   V  + +T+      GT  Y+ PE   
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQ 172

Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G+ L+++ +G+
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 11/195 (5%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGY 374
           IGEG  G VYK +     + VAIK I     +EG  +T +RE+     + HPN++ LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
                + +L++E   + +L + +  + + L             +GL F HS+    I+HR
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHR 122

Query: 435 DIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSG-D 493
           D+KP N+L+      KL+DFGL++         +  V  T  Y  PE     K  S+  D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYSTPVD 181

Query: 494 VYSFGIVLLQILSGK 508
           ++S G +  ++LS +
Sbjct: 182 IWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 74/266 (27%), Positives = 118/266 (44%), Gaps = 26/266 (9%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLV 369
           + L  L  +G G  G V  GK      VAIK I  EG++  + F+ E      + H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLV 62

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
            L G C +    +++ E   NG L  +L    K     Q LE+  D   G+ +L S    
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ-- 120

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDPEYRSNCK 487
             +HRD+   N L+      K+SDFGLS+ + + + Y SS V   F   +  PE     K
Sbjct: 121 -FIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSS-VGSKFPVRWSPPEVLLYSK 177

Query: 488 VNSSGDVYSFGIVLLQILS-GK-------KAKVLTRAGSALELADPKLDREYSIEAFDLT 539
            +S  DV++FG+++ ++ S GK        ++ + +    L L  P L       A +  
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHL-------ASEKV 230

Query: 540 LQLALSC-TALTHQRPPMEQVFVTLQ 564
             +  SC      +RP  +Q+  +++
Sbjct: 231 YAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 19/224 (8%)

Query: 319 LIGEGITGKVYKG--KLSNNQH--VAIKHITNE---GNVETFVREVASSSHVRHPNLVAL 371
            +G+G  G V +G    S  +   VA+K + ++     ++ F++E A    + H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW--IQRL-EIAIDSARGLWFLHSYSE 428
            G  L      ++ EL P G+L + L  +   L    I  L + A+  A G+ +L S   
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRYLESKR- 117

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE--VRGTFGYLDPEYRSNC 486
              +HRD+   NILL  + + K+ DFGL + +   E +   E  ++  F +  PE     
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 487 KVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDR 529
             + + DV+ FG+ L ++ + G++          L+  D + +R
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER 219

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.4 bits (222), Expect = 7e-20
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 12/199 (6%)

Query: 319 LIGEGITGKVYKG----KLSNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVAL 371
            IGEG  G VY+G      +    VA+K   N       E F++E        HP++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
           +G     +  +++ EL P G L  +L      L     +  +   +  L +L S      
Sbjct: 73  IGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---F 128

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           VHRDI   N+L+      KL DFGLS+ ++    Y +S+ +    ++ PE  +  +  S+
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188

Query: 492 GDVYSFGIVLLQILS-GKK 509
            DV+ FG+ + +IL  G K
Sbjct: 189 SDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.9 bits (220), Expect = 8e-20
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 25/206 (12%)

Query: 317 LNLIGEGITGKVY--KGKLSNNQHVAIKHITNEGNV----ETFVREVASSSHVRHPNLVA 370
           +  IGEG  GK+Y  K K S+++H  IK I          E   +EV   + ++HPN+V 
Sbjct: 5   IKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEW-------LFGKDKCLSWIQRLEIAIDSARGLWFL 423
                      F++ E C  G+L +        LF +D+ LSW   ++I++    GL  +
Sbjct: 64  FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISL----GLKHI 117

Query: 424 HSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           H      I+HRDIK  NI L  N   AKL DFG+++ ++     A + V GT  YL PE 
Sbjct: 118 HDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEI 173

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
             N   N+  D++S G VL ++ + K
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 25/211 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHITNEGNVE---TFVREVASSSHVRHPN 367
           EK+ EL+ +GEG  G V K +L N   + A+K IT + N +     +RE+  +   + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 368 LVALLGYCLRVDECFL--IYELCPNGNLAEWLFGKDKCLSWIQR----LEIAIDSARGLW 421
           +V   G  L      +    E C  G+L + ++ K K            +IA    +GL 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG----Y 477
           +LHS     I+HRDIKP+NILL    + KL DFG+S     GE    + + GTF     Y
Sbjct: 120 YLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS-----GE--LVNSLAGTFTGTSFY 169

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           + PE       + + DV+S G+ LL++   +
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)

Query: 316 ELNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVA 370
            L  IG+G  G V K +  S+ + +  K I      E   +  V EV     ++HPN+V 
Sbjct: 4   VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV- 62

Query: 371 LLGYCLR-VDE----CFLIYELCPNGNLAEWLFGKDKCLSWIQRLE------IAIDSARG 419
              Y  R +D      +++ E C  G+LA+ +    KC    + +E      I       
Sbjct: 63  --RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEEFIWRILTQLLLA 117

Query: 420 LWFLH--SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGY 477
           L+  H  S     ++HRD+KP NI L  N   KL DFGL+K++    ++A + V GT  Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYY 176

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           + PE  ++   +   D++S G ++ ++ +  
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 12/197 (6%)

Query: 319 LIGEGITGKVYKGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V++G L         VAIK +     E   + F+ E +      H N++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     +I E   NG L ++L   D   S  Q + +    A G+ +L   S+   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNY 128

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           VHRD+   NIL+  N E K+SDFGLS+V+  D   TY +S  +    +  PE  +  K  
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 490 SSGDVYSFGIVLLQILS 506
           S+ DV+SFGIV+ +++S
Sbjct: 189 SASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 320 IGEGITGKVYKG--KLSNNQH--VAIKHITNE---GNVETFVREVASSSHVRHPNLVALL 372
           +G G  G V KG   + + +   VA+K +  E      + F+RE +  + + HP +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC-I 431
           G C   +   L+ EL P G L ++L  K + +      E+A   A G+ +L    E    
Sbjct: 63  GVCKG-EPLMLVMELAPLGPLLKYLK-KRREIPVSDLKELAHQVAMGMAYL----ESKHF 116

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVN 489
           VHRD+   N+LL    +AK+SDFG+S+ +  G  Y  +   G +   +  PE  +  K +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 490 SSGDVYSFGIVLLQILS 506
           S  DV+S+G+ L +  S
Sbjct: 177 SKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 21/200 (10%)

Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  GKV   +  +   + A+K      I     VE  + E    S + HP +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 374 YCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLS--WIQRL--EIAIDSARGLWFLHSYSE 428
           Y  + +E  +L+ E  P G L      K+   S    +    EI +     L +LHS   
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARFYAAEIVL----ALEYLHSLG- 113

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             I++RD+KP NILL  +   KL+DFGL+K +    +  ++   GT  YL PE       
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGY 170

Query: 489 NSSGDVYSFGIVLLQILSGK 508
             + D +S G++L ++L+GK
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 81/259 (31%), Positives = 110/259 (42%), Gaps = 70/259 (27%)

Query: 294 LKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVET 352
           L DP    + + EV            IGEG  GKVYK +     Q VAIK +    + E 
Sbjct: 1   LPDPT-GIFELVEV------------IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE 47

Query: 353 FVRE----VASSSHVRHPNLVALLG-YCLRV-----DECFLIYELCPNG---NLAEWLFG 399
            ++E    +   S+  HPN+    G +  +      D+ +L+ ELC  G   +L + L  
Sbjct: 48  EIKEEYNILRKYSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK 105

Query: 400 KDKCLS--WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS 457
           K K L   WI    I  ++ RGL +LH      ++HRDIK  NILL  N E KL DFG+S
Sbjct: 106 KGKRLKEEWIAY--ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS 160

Query: 458 KVID---------IGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
             +D         IG  Y  + EV       D  Y +        DV+S GI        
Sbjct: 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARS------DVWSLGI-------- 206

Query: 508 KKAKVLTRAGSALELADPK 526
                     +A+ELAD K
Sbjct: 207 ----------TAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHP 366
            K   L ++GEG  G V K +  +  + VAIK       +E   +T +REV     +RH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSARGL 420
           N+V L     R    +L++E      L E L         D   S+I +L       + +
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL------LQAI 113

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            + HS++   I+HRDIKP NIL+  +   KL DFG ++ +        ++   T  Y  P
Sbjct: 114 AYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 481 EYR-SNCKVNSSGDVYSFGIVLLQILSG 507
           E    +       DV++ G ++ ++L G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.0 bits (215), Expect = 9e-19
 Identities = 87/286 (30%), Positives = 131/286 (45%), Gaps = 51/286 (17%)

Query: 318 NLIGEGITGKVYKG---KLSNNQHVAIKHITNEGNVETFVREVASSSHV-----RHPNLV 369
           ++IGEG  G+V +    K     + AIK +  E   E   R+ A    V      HPN++
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKML-KEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCLSWIQRLEIAI 414
            LLG C      ++  E  P GNL ++L                G    L+  Q L+ A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
           D A G+ +L   SE   +HRD+   N+L+G N  +K++DFGLS+    GE      V+ T
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GE---EVYVKKT 176

Query: 475 FGYLDPEYRSNCKVNSS-----GDVYSFGIVLLQILS--GKKAKVLTRAGSALELADPKL 527
            G L   + +   +N S      DV+SFG++L +I+S  G     +T A    EL + KL
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----ELYE-KL 231

Query: 528 DREYSIE----AFDLTLQLALSC-TALTHQRPPMEQVFVTLQKALD 568
            + Y +E      D   +L   C     ++RPP  Q+ V L + L+
Sbjct: 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 18/198 (9%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVRHPNL 368
           E    +  IG G  G VYK + ++  + VAIK I      + E   +E++     RHPN+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           VA  G  LR D+ +++ E C  G+L +        LS +Q   +  ++ +GL +LH   +
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF-G---YLDPEY-- 482
              +HRDIK  NILL  + + KL+DFG+S  +      A+   R +F G   ++ PE   
Sbjct: 123 ---IHRDIKGANILLTEDGDVKLADFGVSAQLT-----ATIAKRKSFIGTPYWMAPEVAA 174

Query: 483 -RSNCKVNSSGDVYSFGI 499
                  +   D+++ GI
Sbjct: 175 VERKGGYDGKCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 72/262 (27%), Positives = 127/262 (48%), Gaps = 22/262 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           ++L  L  IG+G  G V  G    N+ VA+K I N+   + F+ E +  + +RH NLV L
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 372 LGYCLRVDE---CFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYS 427
           LG  + V+E    +++ E    G+L ++L  + + +     L + ++D    + +L + +
Sbjct: 65  LG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
               VHRD+   N+L+  +  AK+SDFGL+K     +      V+ T     PE     K
Sbjct: 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175

Query: 488 VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFD----LTLQLA 543
            ++  DV+SFGI+L +I S  +   +      L+   P++++ Y ++A D    +   + 
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR---VPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232

Query: 544 LSCTAL-THQRPPMEQVFVTLQ 564
             C  L    RP   Q+   L+
Sbjct: 233 KQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 51/286 (17%)

Query: 318 NLIGEGITGKVYKGKLSNN---QHVAIKHITNEGNVETFVREVASSSHV-----RHPNLV 369
           ++IGEG  G+V K ++  +      AIK +  E   +   R+ A    V      HPN++
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCLSWIQRLEIAI 414
            LLG C      +L  E  P+GNL ++L                     LS  Q L  A 
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
           D ARG+ +L   S+   +HRD+   NIL+G N+ AK++DFGLS+    G+      V+ T
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQ---EVYVKKT 169

Query: 475 FGYLDPEYRSNCKVNSS-----GDVYSFGIVLLQILS--GKKAKVLTRAGSALELADPKL 527
            G L   + +   +N S      DV+S+G++L +I+S  G     +T A    EL + KL
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE-KL 224

Query: 528 DREYSIE----AFDLTLQLALSC-TALTHQRPPMEQVFVTLQKALD 568
            + Y +E      D    L   C     ++RP   Q+ V+L + L+
Sbjct: 225 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.9 bits (211), Expect = 4e-18
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 54/221 (24%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI-------TNEGNVETFVREVASSSHVRHPNL 368
              +GEG    VYK +     + VAIK I         +G   T +RE+     ++HPN+
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 369 VALLGYCLRVDECF-------LIYELCPNGNLAEWLFGKDKCL--------SWIQRLEIA 413
           + LL       + F       L++E     +L E +  KDK +        S++      
Sbjct: 65  IGLL-------DVFGHKSNINLVFEFME-TDL-EKVI-KDKSIVLTPADIKSYMLMT--- 111

Query: 414 IDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG 473
               RGL +LHS     I+HRD+KP N+L+  +   KL+DFGL++      ++ S   + 
Sbjct: 112 ---LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR------SFGSPNRKM 159

Query: 474 TFGYLDPEYRS-----NCKVNSSG-DVYSFGIVLLQILSGK 508
           T   +   YR+       +    G D++S G +  ++L   
Sbjct: 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 22/203 (10%)

Query: 319 LIGEGITGKVYKGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V +G+L         VAIK +     E     F+ E +      HPN++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     +I E   NG L  +L   D   + IQ + +    A G+ +L   SE   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE---TYASS-----EVRGTFGYLDPEYR 483
           VHRD+   NIL+  N   K+SDFGLS+ ++      TY SS      +R T     PE  
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT----APEAI 183

Query: 484 SNCKVNSSGDVYSFGIVLLQILS 506
           +  K  S+ DV+S+GIV+ +++S
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 6e-18
 Identities = 55/166 (33%), Positives = 80/166 (48%), Gaps = 32/166 (19%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE----TFVREVASSSHVRHP 366
           EK+ +   IGEG  G+VYK +     + VA+K I  E   E    T +RE+     +RHP
Sbjct: 2   EKIAQ---IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHP 58

Query: 367 NLVALLGYCLRVDE----CFLIYELCP---NGNLA--EWLFGKD--KCLSWIQRLEIAID 415
           N+V L    +   +     ++++E       G L   E  F +   KC    Q LE    
Sbjct: 59  NIVRL--KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM-KQLLE---- 111

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
              GL +LHS     I+HRDIK +NIL+  +   KL+DFGL++   
Sbjct: 112 ---GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYT 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 42/222 (18%)

Query: 320 IGEGITGKVYK----GKLSNNQH--VAIKHITNEGNVET---FVREVASSSHVRHPNLVA 370
           IG+G  G+V++    G L       VA+K +  E + +    F RE A  +   HPN+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL--------------------FGKDKC-LSWIQR 409
           LLG C       L++E    G+L E+L                     G +   LS  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           L IA   A G+ +L   SE   VHRD+   N L+G N   K++DFGLS+ I   + Y +S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 470 E-----VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           E     +R    ++ PE     +  +  DV+++G+VL +I S
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 16/205 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHP 366
           EKLN    IGEG  G VY+ +  ++ + VA+K +      +G   + +RE+    ++RHP
Sbjct: 10  EKLNR---IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 367 NLVALLGYCL--RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           N+V L    +   +D  FL+ E C   +LA  L       S  Q   + +   RGL +LH
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
              E  I+HRD+K +N+LL      K++DFGL++   +     + +V  T  Y  PE   
Sbjct: 126 ---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLL 181

Query: 485 NCKVNSSG-DVYSFGIVLLQILSGK 508
            C   ++  D+++ G +L ++L+ K
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 314 LNELNLIGEGITGKVYKG-----KLSNNQHVAIKHITNEG---NVETFVREVASSSHVRH 365
           L ++ ++G G  G VYKG            VAIK +  E      +  + E    + V H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSARG 419
           P++V LLG CL      LI +L P G L +++       G    L+W       +  A+G
Sbjct: 69  PHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKG 121

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYL 478
           + +L    E  +VHRD+   N+L+      K++DFGL+K++D+ E  Y +   +    ++
Sbjct: 122 MSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILS-GKK 509
             E   +       DV+S+G+ + ++++ G K
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 9/209 (4%)

Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHI--TNEGNVETFVREVAS 359
           TI  V    +K      IG+G +G VY    ++  Q VAIK +    +   E  + E+  
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
               +HPN+V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + 
Sbjct: 70  MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 127

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L FLHS     ++HRDIK  NILLG +   KL+DFG    I   ++  S+ V GT  ++ 
Sbjct: 128 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 183

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE  +        D++S GI+ ++++ G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 12/200 (6%)

Query: 316 ELNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVAL 371
           +L  +GEG    VYKG+  +  + VA+K I     EG   T +RE++    ++H N+V L
Sbjct: 4   QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
                  ++  L++E   + +L +++   G    L             +G+ F H   E 
Sbjct: 64  HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---EN 119

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV- 488
            ++HRD+KP N+L+    E KL+DFGL++   I     S+EV  T  Y  P+     +  
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTY 178

Query: 489 NSSGDVYSFGIVLLQILSGK 508
           ++S D++S G ++ ++++G+
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 28/212 (13%)

Query: 320 IGEGITGKVYKGKL-----SNNQHVAIKHITNEGNVE---TFVREVASSSHVRHPNLVAL 371
           +GE   GK+YKG L      + Q VAIK + +  N +    F +E +  + + HPN+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKD----------------KCLSWIQRLEIAID 415
           LG   +     +++E    G+L E+L  +                   L     L IAI 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGT 474
            A G+ +L S+     VH+D+   NIL+G     K+SD GLS+ I   + Y    +    
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             ++ PE     K +S  D++SFG+VL +I S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 29/221 (13%)

Query: 312 EKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHI---TNEGNVETFVREVASSSH 362
           ++L     +GEG  G+V K         +    VA+K +     E ++   V E+     
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 363 V-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---------FGKDKCLSWIQRL-- 410
           + +H N++ LLG C +    +++ E   +GNL ++L            D      + L  
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 411 ----EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY 466
                 A   ARG+ FL S  + CI HRD+   N+L+  +   K++DFGL++ I   + Y
Sbjct: 132 KDLVSFAYQVARGMEFLAS--KKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 467 -ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             ++  R    ++ PE   +       DV+SFG++L +I +
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 12/197 (6%)

Query: 319 LIGEGITGKVYKGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V  G+L         VAIK +     E     F+ E +      HPN++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     ++ E   NG+L  +L   D   + IQ + +    A G+ +L   S+   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGY 127

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           VHRD+   NIL+  N   K+SDFGLS+V+  D    Y +   +    +  PE  +  K  
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187

Query: 490 SSGDVYSFGIVLLQILS 506
           S+ DV+S+GIV+ +++S
Sbjct: 188 SASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 14/200 (7%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  +G+G  G VYK K LS+NQ  A+K +     ++   E  V E+   + V HPN+++ 
Sbjct: 5   LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI---AIDSARGLWFLHSYSE 428
               L  ++  ++ E  P G+L++ +  + K    I   EI    I   RGL  LH    
Sbjct: 65  KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK- 123

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             I+HRD+K  NILL  N   K+ D G+SKV+            GT  Y+ PE       
Sbjct: 124 --ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAPEVWKGRPY 178

Query: 489 NSSGDVYSFGIVLLQILSGK 508
           +   D++S G +L ++ +  
Sbjct: 179 SYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 81.3 bits (200), Expect = 4e-17
 Identities = 56/188 (29%), Positives = 98/188 (52%), Gaps = 8/188 (4%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT-NEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L  Y +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 71

Query: 379 DE-CFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +E  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128

Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           +  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 497 FGIVLLQI 504
           FGI+L ++
Sbjct: 189 FGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 72/259 (27%), Positives = 113/259 (43%), Gaps = 24/259 (9%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G V+ GK      VAIK I NEG +  E F+ E      + HP LV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
               +++ E   NG L  +L  +   LS    L +  D   G+ +L   S    +HRD+ 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLA 127

Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             N L+      K+SDFG+++ +   E  +SS  +    +  PE  +  K +S  DV+SF
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187

Query: 498 GIVLLQILSGKKA--------KVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTAL 549
           G+++ ++ +  K         +V+        L  PKL      E       +  SC   
Sbjct: 188 GVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE-------VMYSC--- 237

Query: 550 THQRPPMEQVFVTLQKALD 568
            H++P     F  L +A+ 
Sbjct: 238 WHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.7 bits (201), Expect = 5e-17
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 9/209 (4%)

Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHIT--NEGNVETFVREVAS 359
           TI  +    +K      IG+G +G V+    ++  Q VAIK I    +   E  + E+  
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
              +++PN+V  L   L  DE F++ E    G+L + +   + C+   Q   +  +  + 
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQA 127

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L FLH+     ++HRDIK  N+LLG +   KL+DFG    I   ++  S+ V GT  ++ 
Sbjct: 128 LEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 183

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE  +        D++S GI+ ++++ G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 88/295 (29%), Positives = 135/295 (45%), Gaps = 51/295 (17%)

Query: 318 NLIGEGITGKVYKGKLSNN---QHVAIKHITNEGNVETFVREVASSSHV-----RHPNLV 369
           ++IGEG  G+V K ++  +      AIK +    + +   R+ A    V      HPN++
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 71

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCLSWIQRLEIAI 414
            LLG C      +L  E  P+GNL ++L                     LS  Q L  A 
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
           D ARG+ +L   S+   +HRD+   NIL+G N+ AK++DFGLS+     E Y    V+ T
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVY----VKKT 181

Query: 475 FGYLDPEYRSNCKVNSS-----GDVYSFGIVLLQILS--GKKAKVLTRAGSALELADPKL 527
            G L   + +   +N S      DV+S+G++L +I+S  G     +T A    EL + KL
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE-KL 236

Query: 528 DREYSIE----AFDLTLQLALSC-TALTHQRPPMEQVFVTLQKALDISTTAKAST 577
            + Y +E      D    L   C     ++RP   Q+ V+L + L+   T   +T
Sbjct: 237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 291

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 80.5 bits (199), Expect = 6e-17
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 23/203 (11%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHI-------TNEGNVETFVREVASSSHVRHPNLVA 370
           L+G G  G VY+G  L +    A+K +       T +  V+   +E+A  S ++HPN+V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL--FG--KDKCLSWIQRLEIAIDSARGLWFLHSY 426
            LG     D  ++  EL P G+LA+ L  +G   +  +    R  +      GL +LH  
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-RSN 485
           +    VHRDIK  NIL+  N   KL+DFG++K + +  ++A S  +G+  ++ PE     
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKS-FKGSPYWMAPEVIAQQ 176

Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
                + D++S G  +L++ +GK
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 72/268 (26%), Positives = 114/268 (42%), Gaps = 38/268 (14%)

Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHI--------TNEGNVETFVREVASSSHVRHPNLV 369
            ++G+G  G VY G  +  Q +A+K +          E   E    EV     ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
             LG CL  +   +  E  P G+++  L  FG      + +  +  +D   G+ +LH   
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLH--- 119

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID-IGETYASSE----VRGTFGYLDPEY 482
             C+VHRDIK  N++L PN   KL DFG ++ +  +G     S     + GT  ++ PE 
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK---------KAKVLTRAGSALELADPKLDREYSI 533
            +        D++S G  + ++ +GK          A     A   L    P+L   +S 
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM---PRLPDSFSA 236

Query: 534 EAFDLTLQLALSC-TALTHQRPPMEQVF 560
            A D       SC T   H+RP   Q+ 
Sbjct: 237 AAIDFV----TSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 9/200 (4%)

Query: 312 EKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNL 368
           +K      IG+G +G VY    ++  Q VAI+ +    +   E  + E+      ++PN+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + L FLHS   
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ- 136

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             ++HRDIK  NILLG +   KL+DFG    I   E    S + GT  ++ PE  +    
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 489 NSSGDVYSFGIVLLQILSGK 508
               D++S GI+ ++++ G+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 318 NLIGEGITGKVYKGKL-------SNNQHVAIKHITNEGNVE---TFVREVASSSHVRHPN 367
           N +G G  G+VY+G         S    VA+K +      +    F++E    S+  HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK------CLSWIQRLEIAIDSARGLW 421
           +V LLG CL  +  ++I EL   G+L  +L            L+  + L+I +D A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEA-----KLSDFGLSKVIDIGETYASSEVRG--- 473
           +L        +HRD+   N L+           K+ DFGL++ I   + Y      G   
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174

Query: 474 -TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
               ++ PE   + K  +  DV+SFG+++ +IL+
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 80.2 bits (197), Expect = 2e-16
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 9/200 (4%)

Query: 312 EKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNL 368
           +K      IG+G +G VY    ++  Q VAIK +    +   E  + E+      ++PN+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + L FLHS   
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQ- 135

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             ++HRDIK  NILLG +   KL+DFG    I   ++  S+ V GT  ++ PE  +    
Sbjct: 136 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 489 NSSGDVYSFGIVLLQILSGK 508
               D++S GI+ ++++ G+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 10/204 (4%)

Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEGNVE----TFVREVASSSHVRHPN 367
           K  ++ ++G G  G V+  +   +Q  V IK I  E   +        E      + HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           ++      L      ++ E  P G LAE++  + +C S +    I     + L  LH   
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 428 EGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
              I+HRD+K  NILL  +    K+ DFG+SK++       +  V GT  Y+ PE     
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGK 176

Query: 487 KVNSSGDVYSFGIVLLQILSGKKA 510
             N   D+++ G VL ++ S K+A
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 82.6 bits (204), Expect = 3e-16
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 32/214 (14%)

Query: 337 QHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVALL--GYCLRVDECFLIYELCP 389
             VAIK         E     F RE A  + + HPN+VALL  G        F ++E  P
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVP 62

Query: 390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL-----G 444
              L E L   D  L   +   + +     L    ++++G IVHRD+KP NI++      
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDAL--ACAHNQG-IVHRDLKPQNIMVSQTGVR 118

Query: 445 PNFEAKLSDFGLSKV------IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
           P+  AK+ DFG+  +       D+     ++EV GT  Y  PE      V  + D+Y++G
Sbjct: 119 PH--AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 499 IVLLQILSGKK-------AKVLTRAGSALELADP 525
           ++ L+ L+G++       A++L +  S ++++ P
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP 210

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 28/219 (12%)

Query: 306 EVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSH 362
           E  Y  ++  E  ++G+G  G VY  + LS    +AIK I   +   V+    E+A  S+
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 363 VRHPNLVALLGYCLRVDECFLIY-ELCPNGNLA-----EW--LFGKDKCLSWI--QRLEI 412
           ++H N+V  LG     +  F I+ E  P G+L+     +W  L   ++ + +   Q LE 
Sbjct: 62  LKHRNIVQYLGSDS-ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYASSEV 471
                 GL +LH   +  IVHRDIK  N+L+   +   K+SDFG SK +  G    +   
Sbjct: 120 ------GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETF 169

Query: 472 RGTFGYLDPEY--RSNCKVNSSGDVYSFGIVLLQILSGK 508
            GT  Y+ PE   +      +  D++S G  ++++ +GK
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 319 LIGEGITGKVYKGKLSNN----QHVAIKHITNEG----NVETFVREVASSSHVRHPNLVA 370
           ++GEG  G V +G+LS +      VA+K +  +      +E F+ E A      HPN++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 371 LLGYCLRVDEC------FLIYELCPNGNLAEWLF-----GKDKCLSWIQRLEIAIDSARG 419
           L+G C             +I     +G+L  +L      G  + L     L+  +D A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV-RGTFGYL 478
           + +L + +    +HRD+   N +L  +    ++DFGLSK I  G+ Y    + +    ++
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             E  ++    S  DV++FG+ + +I +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 20/203 (9%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIKHITNEGNVETFVREVASSSHVRHPNLVALLG-- 373
           LN IG+G  G V+K     ++ V A+K I +   +    RE A    +    ++A L   
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQI-DLSKMNRREREEA----IDEARVLAKLDSS 59

Query: 374 YCLRVDECFL-------IYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHS 425
           Y +R  E FL       + E   NG+L + L  +    L   Q     I    GL  LHS
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                I+HRDIK  N+ L      K+ D G++K++     +A++ V GT  YL PE   +
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCED 175

Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
              N   DV++ G+VL +  +GK
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 35/208 (16%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALLGY 374
           IGEG  G VYKG+     Q VA+K I      EG   T +RE++    ++HPN+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 375 CLRVDECFLIYELCPNGNLAEWL--FGKDKCL------SWI-QRLEIAIDSARGLWFLHS 425
            ++    +LI+E   + +L ++L    K + +      S++ Q L+       G+ F HS
Sbjct: 68  LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ-------GILFCHS 119

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY--- 482
                ++HRD+KP N+L+      KL+DFGL++   I     + EV  T  Y  PE    
Sbjct: 120 RR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLG 175

Query: 483 --RSNCKVNSSGDVYSFGIVLLQILSGK 508
             R +  V    D++S G +  ++ + K
Sbjct: 176 SPRYSTPV----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 56/191 (29%), Positives = 100/191 (52%), Gaps = 10/191 (5%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVALLGYCLR 377
           +G+G  G+V+ G  +    VAIK +   G +  E F++E      +RH  LV L  Y + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVV 70

Query: 378 VDE-CFLIYELCPNGNLAEWLF-GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
            +E  +++ E    G+L ++L  G  K L   Q +++A   A G+ ++   +    +HRD
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127

Query: 436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
           ++  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 496 SFGIVLLQILS 506
           SFGI+L ++++
Sbjct: 188 SFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 26/204 (12%)

Query: 317 LNLIGEGITGKVYKG-KLSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALL 372
           L  IG+G  G+VYK      NQ VAIK I     E  +E   +E+   S  R P +    
Sbjct: 6   LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 373 GYCLRVDECFLIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAI---DSARGLWFLHSYSE 428
           G  L+  + ++I E C  G+  + L  GK      +    IA    +   GL +LH   E
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLLKPGK------LDETYIAFILREVLLGLEYLHE--E 117

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF-G---YLDPEYRS 484
           G I HRDIK  NILL    + KL+DFG+S     G+  ++   R TF G   ++ PE   
Sbjct: 118 GKI-HRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S GI  +++  G+
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 6/199 (3%)

Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT-NEGNVETFVREVASSSHVRHPNL 368
             E L  +  +G G  G+V+ G  + N  VA+K +     + E+F+ E      +RH  L
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLF-GKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           V L       +  +++ E    G+L ++L  G+ + L     +++A   A G+ ++   +
Sbjct: 64  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
               +HRD++  NIL+G     K++DFGL+++I+  E  A    +    +  PE     +
Sbjct: 123 ---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 488 VNSSGDVYSFGIVLLQILS 506
                DV+SFGI+L ++++
Sbjct: 180 FTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 25/208 (12%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALL 372
           + +IG G T  VY    L NN+ VAIK I  E    +V+   +EV + S   HPN+V   
Sbjct: 6   IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 373 GYCLRVDECFLIYELCPNGNLAEWL-------FGKDKCLSWIQRLEIAIDSARGLWFLHS 425
              +  DE +L+      G+L + +          +  ++ + +     +  +GL +LHS
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----EVLKGLEYLHS 120

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF----GYLDPE 481
             +   +HRDIK  NILLG +   K++DFG+S  +  G    + +VR TF     ++ PE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGTPCWMAPE 176

Query: 482 YRSNCK-VNSSGDVYSFGIVLLQILSGK 508
                   +   D++SFGI  +++ +G 
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 44/232 (18%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALLGY 374
           IGEG  G VYK +     + VA+K I      EG   T +RE++    + HPN+V LL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 375 CLRVDECFLIYEL-----------CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
               ++ +L++E             P   +   L       S++ +L       +GL F 
Sbjct: 68  IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK-----SYLFQL------LQGLAFC 116

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDPEY 482
           HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  PE 
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 171

Query: 483 RSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
              CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 172 LLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNL 368
           E    +  IG G  G VYK + ++  +  AIK I  E   +     +E+      +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           VA  G  LR D+ ++  E C  G+L + ++     LS  Q   ++ ++ +GL++LHS  +
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS---N 485
              +HRDIK  NILL  N   KL+DFG+S  I        S + GT  ++ PE  +    
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERK 183

Query: 486 CKVNSSGDVYSFGIVLLQI 504
              N   D+++ GI  +++
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 32/213 (15%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHI----TNEGN--------VETFVREVASSSHVRH 365
           LIG+G  G+VY    ++  + +A+K +    T  G         V+    E+ +   + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA------RG 419
            N+V  LG+    +   +  E  P G++         CL    R E  +          G
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIG-------SCLRTYGRFEEQLVRFFTEQVLEG 120

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGETYASSEVRGTFGYL 478
           L +LHS     I+HRD+K  N+L+  +   K+SDFG+SK   DI +   +  ++G+  ++
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 479 DPEYRSNCKVNSSG--DVYSFGIVLLQILSGKK 509
            PE   +     S   D++S G V+L++ +G++
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 58/278 (20%)

Query: 318 NLIGEGITGKVYKGKL----SNNQHVAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
            +IG+G  G VY G L        H A+K    IT+   VE F++E        HPN+++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 371 LLGYCLRVDECFLIYELCP---NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           LLG CL  +   L+  + P   +G+L  ++  +    +    +   +  A+G+ +L S  
Sbjct: 61  LLGICLPSEGSPLV--VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRS 484
               VHRD+   N +L  +F  K++DFGL++ I   E Y+     G      ++  E   
Sbjct: 119 ---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTL---- 540
             K  +  DV+SFG++L ++        +TR       A P  D    +++FD+T+    
Sbjct: 176 TQKFTTKSDVWSFGVLLWEL--------MTRG------APPYPD----VDSFDITVYLLQ 217

Query: 541 ---------------QLALSCTALTHQRPPMEQVFVTL 563
                          ++ LSC    H +P M   F  L
Sbjct: 218 GRRLLQPEYCPDPLYEVMLSC---WHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.2 bits (192), Expect = 9e-16
 Identities = 70/237 (29%), Positives = 110/237 (46%), Gaps = 22/237 (9%)

Query: 294 LKDPGCPRYTIREVHYATEKL-NELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE 351
           LKDP       +E     EKL  +L  IG G  G VY  + +  N+ VAIK ++  G   
Sbjct: 9   LKDPEIAELFFKE---DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS 65

Query: 352 T-----FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW 406
                  ++EV     ++HPN +   G  LR    +L+ E C  G+ ++ L    K L  
Sbjct: 66  NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 124

Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY 466
           ++   I   + +GL +LHS++   ++HRDIK  NILL    + KL+DFG + +     ++
Sbjct: 125 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF 181

Query: 467 ASSEVRGTFGYLDPEY---RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
                 GT  ++ PE        + +   DV+S GI  +++   K       A SAL
Sbjct: 182 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 76.9 bits (189), Expect = 9e-16
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 313 KLNELNLIGEGITGK-VYKGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNL 368
           + N L ++GEG  G+ +    ++++Q  A+K I    +   VE   +E    + ++HPN+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAE-------WLFGKDKCLSWIQRLEIAIDSARGLW 421
           VA           +++ E C  G+L +        LF +D  L W  ++ + +       
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH----- 115

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
            +H   E  ++HRDIK  NI L  N + KL DFG ++++     YA + V GT  Y+ PE
Sbjct: 116 -IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE 170

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
              N   N+  D++S G +L ++ + K
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 42/227 (18%)

Query: 312 EKLNELNLIGEGITGKVYK------GKLSNNQHVAIKHITNEGNVETFV-----REVASS 360
            +L  +N IG G  G VYK      G+L      A+K I   GN E  V     RE+   
Sbjct: 74  SELERVNRIGSGAGGTVYKVIHRPTGRL-----YALKVIY--GNHEDTVRRQICREIEIL 126

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR-- 418
             V HPN+V          E  ++ E    G+L       ++ L+         D AR  
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA---------DVARQI 177

Query: 419 --GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
             G+ +LH      IVHRDIKP+N+L+      K++DFG+S+++       +S V GT  
Sbjct: 178 LSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIA 233

Query: 477 YLDPEYRSNCKVNS------SGDVYSFGIVLLQILSGKKAKVLTRAG 517
           Y+ PE R N  +N       +GD++S G+ +L+   G+    + R G
Sbjct: 234 YMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279

Length = 353

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 22/198 (11%)

Query: 320 IGEGITGKVYKGKLSNNQHVA---IKHITNEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           +G+G  GKVYK +       A   I  I +E  +E F+ E+   S  +HPN+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
             ++ +++ E C  G L   +   ++ L+  Q   +       L FLHS+    ++HRD+
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDL 129

Query: 437 KPTNILLGPNFEAKLSDFGLS-KVID--------IGETY-ASSEVRGTFGYLDPEYRSNC 486
           K  NILL  + + KL+DFG+S K           IG  Y  + EV     + D  Y  + 
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY--DY 187

Query: 487 KVNSSGDVYSFGIVLLQI 504
           K     D++S GI L+++
Sbjct: 188 KA----DIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 52/192 (27%), Positives = 96/192 (50%), Gaps = 8/192 (4%)

Query: 320 IGEGITGKVYKGKL-SNNQHVAIKHITNEGNVE---TFVREVASSSHVRHPNLVALLGYC 375
           IG G  G+V+ G+L ++N  VA+K        +    F++E        HPN+V L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
            +    +++ EL   G+   +L  +   L   + +++  ++A G+ +L S      +HRD
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRD 119

Query: 436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT-FGYLDPEYRSNCKVNSSGDV 494
           +   N L+      K+SDFG+S+  + G   ++  ++     +  PE  +  + +S  DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 495 YSFGIVLLQILS 506
           +SFGI+L +  S
Sbjct: 180 WSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 23/207 (11%)

Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH----VAIKHIT----NEGNVETFVREVASSSHVR 364
           K  +L  IGEG  G V+K K   N+     VA+K +     +EG   + +RE+     ++
Sbjct: 1   KYEKLEKIGEGTYGTVFKAK---NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK 57

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI---AIDSARGLW 421
           H N+V L        +  L++E C + +L ++    D C   I    +        +GL 
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           F HS++   ++HRD+KP N+L+  N E KL+DFGL++   I     S+EV  T  Y  P+
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPD 169

Query: 482 YRSNCKV-NSSGDVYSFGIVLLQILSG 507
                K+ ++S D++S G +  ++ + 
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 8/198 (4%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLV 369
           E L  +  +G G  G+V+ G  + +  VAIK +  +G++  E F+ E      ++HP LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSE 428
            L     + +  ++I E   NG+L ++L   +   L+  + +++A   A G+ F+   + 
Sbjct: 65  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN- 122

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
              +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE  +    
Sbjct: 123 --YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 489 NSSGDVYSFGIVLLQILS 506
               DV+SFGI+L +I++
Sbjct: 181 TIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 33/213 (15%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN-NQHVAIKH-ITNEGNVET---FVREVASSSHVRHP 366
           EK   L L+GEG  G V K K     Q VAIK  + +E +       +RE+     +RH 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA--------- 417
           NLV L+    R    +L++E   +  L +           +++    +D +         
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDD-----------LEKYPNGLDESRVRKYLFQI 109

Query: 418 -RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTF 475
            RG+ F HS++   I+HRDIKP NIL+  +   KL DFG ++ +   GE Y  ++   T 
Sbjct: 110 LRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATR 164

Query: 476 GYLDPEYR-SNCKVNSSGDVYSFGIVLLQILSG 507
            Y  PE    + K   + D+++ G ++ ++L+G
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 38/217 (17%)

Query: 320 IGEGITGKVYKGKL------SNNQHVAIKHITNEGNV---ETFVREVASSSHVRHPNLVA 370
           +GE   GKVYKG L         Q VAIK + ++      E F  E    S ++HPN+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGK-----------DK----CLSWIQRLEIAID 415
           LLG   +     +I+  C + +L E+L  +           DK     L     + I   
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS--EVRG 473
            A G+ FL S+    +VH+D+   N+L+      K+SD GL +     E YA+   ++ G
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFR-----EVYAADYYKLMG 184

Query: 474 T----FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
                  ++ PE     K +   D++S+G+VL ++ S
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 313 KLNELNLIGEGITGK--VYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           K  ++  IGEG  GK  + K K    Q+V IK I     +    E   +EVA  S+++HP
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNMKHP 59

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEW-------LFGKDKCLSWIQRLEIAIDSARG 419
           N+V            +++ + C  G+L +        LF +D+ L W  ++ +A      
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------ 113

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L  +H      I+HRDIK  NI L  +   KL DFG+++V++     A + + GT  YL 
Sbjct: 114 LKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLS 169

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGKKA 510
           PE   N   N+  D+++ G VL ++ + K A
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 32/221 (14%)

Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNN------QHVAIKHIT---NEGNVETFVREVASS 360
             + +  L  +G G  G+VY+G             VA+K +    +E +   F+ E    
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAI 414
           S   H N+V L+G        F++ EL   G+L  +L        +   L+    L  A 
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEV 471
           D A+G  +L        +HRDI   N LL   GP   AK++DFG+++ I     Y +S  
Sbjct: 124 DVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-----YRASYY 175

Query: 472 RG------TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R          ++ PE   +    S  DV+SFG++L +I S
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 25/222 (11%)

Query: 312 EKL-NELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVET-----FVREVASSSHVR 364
           EKL  +L  IG G  G VY  +    N+ VAIK ++  G          ++EV     +R
Sbjct: 14  EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLW 421
           HPN +   G  LR    +L+ E C  G+ ++ L    K L   Q +EIA     + +GL 
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPL---QEVEIAAICHGALQGLA 129

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           +LHS+     +HRDIK  NILL      KL+DFG + ++    ++      GT  ++ PE
Sbjct: 130 YLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPE 181

Query: 482 Y---RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
                   + +   DV+S GI  +++   K       A SAL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 20/216 (9%)

Query: 308 HYATEKLNELNLIGEGITGKVYKGKLSNN------QHVAIK---HITNEGNVETFVREVA 358
            +    L E+  +G G  G+V+  K            V +K      +E     F RE+ 
Sbjct: 1   AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60

Query: 359 SSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL--------FGKDKCLSWIQRL 410
               + H N+V LLG C   +  ++I E    G+L ++L          K   LS  Q++
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
            +    A G+  L   S    VHRD+   N L+    E K+S   LSK +   E Y    
Sbjct: 121 ALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177

Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
                 +L PE       ++  DV+SFG+++ ++ +
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.5 bits (185), Expect = 7e-15
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 19/219 (8%)

Query: 312 EKL-NELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNV-----ETFVREVASSSHVR 364
           EKL ++L  IG G  G VY  + + N++ VAIK ++  G       +  ++EV     +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           HPN +   G  LR    +L+ E C  G+ ++ L    K L  ++   +   + +GL +LH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-- 482
           S++   ++HRD+K  NILL      KL DFG + ++     +      GT  ++ PE   
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184

Query: 483 -RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
                + +   DV+S GI  +++   K       A SAL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 24/195 (12%)

Query: 324 ITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLR-VDECF 382
            TG +Y  K+     +  K+  ++   E   R++ S    + P +V L  Y  +     +
Sbjct: 16  STGDIYAIKVIKKADMIRKNQVDQVLTE---RDILS--QAQSPYVVKLY-YSFQGKKNLY 69

Query: 383 LIYELCPNGNLAEWL--FGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
           L+ E  P G+LA  L   G  D+ ++ I   EI +     L +LHS     I+HRD+KP 
Sbjct: 70  LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL----ALEYLHSNG---IIHRDLKPD 122

Query: 440 NILLGPNFEAKLSDFGLSKVIDIGE-------TYASSEVRGTFGYLDPEYRSNCKVNSSG 492
           NIL+  N   KL+DFGLSKV  +               + GT  Y+ PE       + + 
Sbjct: 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTV 182

Query: 493 DVYSFGIVLLQILSG 507
           D +S G +L + L G
Sbjct: 183 DWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 24/205 (11%)

Query: 317 LNLIGEGITGKVYK-GKLSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVA 370
           L +IG+G  GKV    K    +  A+K++  +     G+V   + E      + HP LV 
Sbjct: 5   LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64

Query: 371 LLGYCLRVDE-CFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLH 424
           L  Y  + +E  +L+ +L   G+L   L     F +++   WI  + +A++      +LH
Sbjct: 65  LW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALE------YLH 117

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
           S     I+HRDIKP NILL       ++DF ++  +       ++   GT GY+ PE   
Sbjct: 118 SKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLC 172

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKK 509
               + + D +S G+   + L GK+
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 18/213 (8%)

Query: 317 LNLIGEGITGKVYKGKLSN-NQHVAIKHITNEGNV-----ETFVREVASSSHVRHPNLVA 370
           L+ IG G  G VY    S+ N+ VA+K ++  G       +  ++EV     ++HPN + 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             G  L+    +L+ E C  G+ ++ L    K L  ++   I   + +GL +LHS+    
Sbjct: 86  YKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---N 141

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY---RSNCK 487
           ++HRDIK  NILL    + KL+DFG +       ++      GT  ++ PE        +
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196

Query: 488 VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
            +   DV+S GI  +++   K       A SAL
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 20/202 (9%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRH---PNLV 369
           L LIG G  G VY+GK +   + VA+K I   T + +V    REVA  S +R    PN+ 
Sbjct: 6   LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSY 426
              G  L+    ++I E    G++   +      +K +S I R E+ +     L ++H  
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-EVLV----ALKYIHKV 120

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
               ++HRDIK  NIL+      KL DFG++ +++   +  S+ V GT  ++ PE  +  
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176

Query: 487 KV-NSSGDVYSFGIVLLQILSG 507
           K  ++  D++S GI + ++ +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 11/202 (5%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHIT---NEGNVETF-VREVASSSHVRHP 366
           EK  +L+ IGEG  G V+K +     Q VAIK      ++  ++   +RE+     ++HP
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           NLV L+    R  +  L++E C +  L E L    + +      +I   + + + F H +
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR-SN 485
              CI HRD+KP NIL+    + KL DFG ++++       +  V  T  Y  PE    +
Sbjct: 120 --NCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGD 175

Query: 486 CKVNSSGDVYSFGIVLLQILSG 507
            +     DV++ G V  ++L+G
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 13/199 (6%)

Query: 320 IGEGITGKVYKG--KLSNNQ-HVAIK--HITNEGNV-ETFVREVASSSHVRHPNLVALLG 373
           +G G  G V KG  K+   Q  VAIK     NE +V +  +RE      + +P +V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
            C   +   L+ E+   G L ++L GK   ++    +E+    + G+ +L        VH
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSS 491
           RD+   N+LL     AK+SDFGLSK +   ++Y  +   G +   +  PE  +  K +S 
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178

Query: 492 GDVYSFGIVLLQILS-GKK 509
            DV+S+GI + +  S G+K
Sbjct: 179 SDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 320 IGEGITGKVYKG---KLSNNQHVAIKHITNEGNVETFVREVASSSHV----RHPNLVALL 372
           +G G  G V KG      + + VA+K + N+ N      E+   ++V     +P +V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
           G C   +   L+ EL   G L ++L  K+K ++     E+    + G+ +L    E   V
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLE---ETNFV 117

Query: 433 HRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNS 490
           HRD+   N+LL     AK+SDFGLSK +   E Y  ++  G +   +  PE  +  K +S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177

Query: 491 SGDVYSFGIVLLQILS-GKK 509
             DV+SFG+++ +  S G+K
Sbjct: 178 KSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 27/210 (12%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITN----EGNVETFVREVASSSHVRH 365
           T +  +L  +G G  G V   +     Q+VAIK I          +   RE+    H+RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 366 PNLVALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
            N+++L    +  +++ + + EL    +L   L  +     +IQ     I   RGL ++H
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQI--LRGLKYVH 125

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEY- 482
           S     +VHRD+KP+NIL+  N + K+ DFGL+++ D   T Y S     T  Y  PE  
Sbjct: 126 SAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS-----TRYYRAPEIM 177

Query: 483 ----RSNCKVNSSGDVYSFGIVLLQILSGK 508
               + + +V    D++S G +  ++L GK
Sbjct: 178 LTWQKYDVEV----DIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 30/220 (13%)

Query: 320 IGEGITGKVYKGKLSNN--QHVAIKHI----TNEGNVETFVREVASSSHVR---HPNLVA 370
           IGEG  GKV+K +   N  + VA+K +      EG   + +REVA   H+    HPN+V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 371 LLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA----RGLW 421
           L   C      R  +  L++E   + +L  +L   DK        E   D      RGL 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           FLHS+    +VHRD+KP NIL+  + + KL+DFGL+++       A + V  T  Y  PE
Sbjct: 125 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 179

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE 521
                   +  D++S G +  ++    + K L R  S ++
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVD 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 28/217 (12%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNE----GNVETFVREVASSS 361
           EK+  +  +G+G  G VY+G             VAIK   NE         F+ E +   
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK-TVNENASMRERIEFLNEASVMK 64

Query: 362 HVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK----DKC-----LSWIQRLEI 412
                ++V LLG         ++ EL   G+L  +L  +    +        +  + +++
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEV 471
           A + A G+ +L +      VHRD+   N ++  +   K+ DFG+++  DI ET Y     
Sbjct: 125 AAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGG 179

Query: 472 RGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +G     ++ PE   +    +  DV+SFG+VL ++ +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 71.9 bits (176), Expect = 8e-14
 Identities = 49/187 (26%), Positives = 94/187 (50%), Gaps = 26/187 (13%)

Query: 339 VAIKHITNEGNVET---FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAE 395
           VA+K +  +        F++E+   S +++PN++ LLG C+  D   +I E   NG+L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 396 WLFGKD-----------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
           +L  ++             +S    L +A+  A G+ +L S +    VHRD+   N L+G
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVG 163

Query: 445 PNFEAKLSDFGLSKVIDIGETY-----ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGI 499
            ++  K++DFG+S+ +  G+ Y     A   +R    ++  E     K  ++ DV++FG+
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGV 219

Query: 500 VLLQILS 506
            L ++ +
Sbjct: 220 TLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 320 IGEGITGKVYKGK---LSNNQ---HVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +     LS +     VA+K +    +    E  + E+   SH+  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSE 428
            LLG C       +I E C  G+L  +L  K +  L+    L  +   A+G+ FL S + 
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN- 161

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS-SEVRGTFGYLDPEYRSNCK 487
            CI HRD+   N+LL      K+ DFGL++ I     Y      R    ++ PE   NC 
Sbjct: 162 -CI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219

Query: 488 VNSSGDVYSFGIVLLQILS 506
                DV+S+GI+L +I S
Sbjct: 220 YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 12/203 (5%)

Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL---SWIQRLEI 412
           E+   S ++HPN++A   + +  +   +  E    G L + +  +   L     +     
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
            I SA  + ++H      I+HRDIK  NI L      KL DFG+SK++   E   +  V 
Sbjct: 109 QIVSA--VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVV 162

Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYS 532
           GT  Y+ PE     K N   D+++ G VL ++L+ K+      A + L L    +   Y+
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT---FDATNPLNLVVKIVQGNYT 219

Query: 533 IEAFDLTLQLALSCTALTHQRPP 555
                 + +L     +L  Q P 
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPE 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 32/209 (15%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVE-TFVREVA---SSSHVRHPNLVAL 371
           IG G  G VYK +   +   VA+K +   TNE  +  + VREVA         HPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 372 LGYC--LRVD---ECFLIYELCPNGNLAEWL-------FGKDKCLSWIQRLEIAIDSARG 419
           +  C   R D   +  L++E   + +L  +L          +     +++        RG
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L FLH+    CIVHRD+KP NIL+    + KL+DFGL+++       A + V  T  Y  
Sbjct: 121 LDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRA 175

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE        +  D++S G +  ++   K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.0 bits (175), Expect = 1e-13
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 42/208 (20%)

Query: 320 IGEGITGKVYKGKL-SNNQHVAIK--------------HITNEGNVETFVREVASSSHVR 364
           +G G  G+V   +   + ++ A+K              H+ NE       + +  S  +R
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE-------KRILQS--IR 59

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARG 419
           HP LV L G        +L+ E  P G L   L     F +     +  ++ +A++    
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE---- 115

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
             +LHS     IV+RD+KP N+LL  +   K++DFG +K +  G TY      GT  YL 
Sbjct: 116 --YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYTLC---GTPEYLA 166

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           PE   +     + D ++ GI++ ++L+G
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)

Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIK--HITNEGNVET 352
           DPG PR            L+    IGEG TG V      S  + VA+K   +  +   E 
Sbjct: 13  DPGDPR----------SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL 62

Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
              EV      +HPN+V +    L  DE +++ E    G L + +       + +   +I
Sbjct: 63  LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQI 117

Query: 413 AIDSA---RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           A       + L FLH+     ++HRDIK  +ILL  +   KLSDFG    +       S 
Sbjct: 118 ATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV-------SK 167

Query: 470 EVR------GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           EV       GT  ++ PE  S     +  D++S GI++++++ G+
Sbjct: 168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 48/229 (20%)

Query: 320 IGEGITGKVYKGKLSNNQH-----------------VAIKHITNEGNVET---FVREVAS 359
           +GEG  G+V+  ++ N Q                  VA+K +  + N      F++EV  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCL 404
            S ++ PN++ LLG C+  D   +I E   NG+L ++L                    CL
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 405 ---SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
              S+   L +A+  A G+ +L S +    VHRD+   N L+G N   K++DFG+S+ + 
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 462 IGETYASSEVRG----TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            G+ Y    ++G       ++  E     K  ++ DV++FG+ L +IL 
Sbjct: 190 AGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 21/168 (12%)

Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPN 367
           K  +L  IG+G  G+V+K +     Q VA+K +  E   E F    +RE+     ++H N
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72

Query: 368 LVALLGYC----LRVDEC----FLIYELCPNGNLAEWLFGK--DKCLSWIQRLEIAIDSA 417
           +V L+  C       +      +L++E C + +LA  L  K     LS I+++   + + 
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN- 130

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
            GL+++H      I+HRD+K  NIL+  +   KL+DFGL++   + + 
Sbjct: 131 -GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 39/270 (14%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVAS--SSHVRHPNLVALLG 373
           + L+G G  G+VYKG+ +   Q  AIK +   G+ E  +++  +    +  H N+    G
Sbjct: 11  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 374 YCLRV------DECFLIYELCPNGNLAEWLFG------KDKCLSWIQRLEIAIDSARGLW 421
             ++       D+ +L+ E C  G++ + +        K++ +++I R     +  RGL 
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EILRGLS 125

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
            LH +    ++HRDIK  N+LL  N E KL DFG+S  +D      ++ + GT  ++ PE
Sbjct: 126 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 181

Query: 482 YRSNCKVNSSG------DVYSFGIVLLQILSGKKAKVLTRAGSALEL----ADPKLDREY 531
             + C  N         D++S GI  +++  G           AL L      P+L  + 
Sbjct: 182 VIA-CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Query: 532 SIEAFDLTLQLALSCTALTH-QRPPMEQVF 560
             + F   ++   SC    H QRP  EQ+ 
Sbjct: 241 WSKKFQSFIE---SCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 44/202 (21%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALL-- 372
           IGEG  G VYK +     + VA+K I     +EG   T +RE++    + HPN+V LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 373 ---GYCLRVDECFLIYEL-----------CPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
                 L     +L++E             P   L           S++ +L       +
Sbjct: 67  VHSENKL-----YLVFEFLDLDLKKYMDSSPLTGL-----DPPLIKSYLYQL------LQ 110

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGY 477
           G+ + HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y
Sbjct: 111 GIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWY 165

Query: 478 LDPEYRSNCKVNSSG-DVYSFG 498
             PE     +  S+  D++S G
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIG 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHITNEGN-------VETFVREVASSSHVRHPNLVA 370
           L+G+G  G+VY    +   + +A+K +  + +       V     E+    +++H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 371 LLGYCLRVDECFLIY-ELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
             G CLR DE   I+ E  P G++ + L  +G    L+     +       G+ +LHS  
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM 124

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSK---VIDIGETYASSEVRGTFGYLDPEYRS 484
              IVHRDIK  NIL       KL DFG SK    I    T   S V GT  ++ PE  S
Sbjct: 125 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVIS 180

Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
                   DV+S G  ++++L+ K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 49/197 (24%), Positives = 98/197 (49%), Gaps = 5/197 (2%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT-NEGNVETFVREVASSSHVRHPNLVA 370
           E +  +  +G G  G+V+ G  +N+  VA+K +     +V+ F+ E      ++H  LV 
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVR 65

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSEG 429
           L     + +  ++I E    G+L ++L   +     + +L + +   A G+ ++   +  
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             +HRD++  N+L+  +   K++DFGL++VI+  E  A    +    +  PE  +     
Sbjct: 124 -YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 490 SSGDVYSFGIVLLQILS 506
              DV+SFGI+L +I++
Sbjct: 183 IKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 42/278 (15%)

Query: 320 IGEGITGKVYKGKLSNNQH---VAIK----HITNEGNVETFVREVASSSHVRHPNLVALL 372
           +GEG  G V +G+L+ +     VA+K     I     +E F+ E        HPN++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 373 GYCLRVDEC------FLIYELCPNGNLAEWLF----GKDKCLSWIQRL-EIAIDSARGLW 421
           G CL+  E        +I     +G+L  +L     G        Q L +   D A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV-RGTFGYLDP 480
           +L S S    +HRD+   N +L  N    ++DFGLSK I  G+ Y    + +    ++  
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSGKKAKV----------LTRAGSALELADPKLDRE 530
           E  ++    +  DV+SFG+ + +I +  +               R G+ L+     LD  
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGL 243

Query: 531 YSIEAFDLTLQLALSCTALTHQ-RPPMEQVFVTLQKAL 567
           YS         L  SC  L  + RP  E +   L+KAL
Sbjct: 244 YS---------LMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 310 ATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHI---TNEGNVETFVREVASSSHVRH 365
           AT  LN L  +GEG    VYKG    N Q VA+K I   T EG   T +RE +    ++H
Sbjct: 4   ATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
            N+V L       +    ++E   + +LA+++      L             RGL ++H 
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                I+HRD+KP N+L+    E KL+DFGL++   I     SSEV  T  Y  P+    
Sbjct: 122 QH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLG 177

Query: 486 CKVNSSG-DVYSFGIVLLQILSGKKA 510
               SS  D++  G + +++L G+ A
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 44/234 (18%)

Query: 309 YATEKLNELNLIGEGITGKVYKGKLSNNQH-----------------VAIKHITNEGNVE 351
           +  + LN +  +GEG  G+V+  +    Q                  VA+K +  + +  
Sbjct: 2   FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN 61

Query: 352 T---FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---FGKDKCLS 405
               F++EV   S +  PN+  LLG C       +I E   NG+L ++L     +   L+
Sbjct: 62  AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121

Query: 406 WIQR-------LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK 458
              +       L +A   A G+ +L S +    VHRD+   N L+G N+  K++DFG+S+
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 459 VIDIGETYAS--SEVRGT----FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
                  Y+S    V+G       ++  E     K  +  DV++FG+ L +IL+
Sbjct: 179 -----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 37/210 (17%)

Query: 320 IGEGITGKVYKGKLS-NNQHVAIKHITN--EGNVETF--VREVASSSHVRHPNLVALLGY 374
           IG G  G V   K S  N+ VAIK I N  +  ++    +RE+    H+ H N++A+   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71

Query: 375 CLR------VDECFLIYELC---------PNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
            +        ++ +++YEL           +  L++     D C  ++ +L       RG
Sbjct: 72  IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSD-----DHCQYFLYQL------LRG 120

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L ++HS +   ++HRD+KP+N+LL  N + K+ DFGL++       + +  V  T  Y  
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176

Query: 480 PEYRSNC-KVNSSGDVYSFGIVLLQILSGK 508
           PE   NC +  ++ DV+S G +  ++L  K
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 58/268 (21%), Positives = 108/268 (40%), Gaps = 35/268 (13%)

Query: 320 IGEGITGKVYKGK---LSNNQHVAIKHITNEGNVE---TFVREVASSSHVRHPNLVALLG 373
           IG G  GKV  G+     +   V +K +      +    F++EV     + HPN++  LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQR----LEIAIDSARGLWFLHSYSEG 429
            C+      L+ E CP G+L  +L      ++ + +      +A + A GL +LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-----VRGTFGYLDPEYRS 484
             +H D+   N  L  +   K+ D+GL+      + Y + +     +R     L      
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 485 NCKV---NSSGDVYSFGIVLLQI----------LSGKKAKVLTRAGSALELADPKLDREY 531
           +          +++S G+ + ++          LS ++          ++L  P+LD +Y
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239

Query: 532 SIEAFDLTLQLALSCTALTHQRPPMEQV 559
           S   +++ +Q    C      RP  E+V
Sbjct: 240 SDRWYEV-MQF---CWLDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 13/207 (6%)

Query: 309 YATEKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEGNVETF---VREVASS 360
               +L +L L+G G+ G V+KG       S    VAIK I +    +TF      + + 
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
             + H  +V LLG C       L+ +L P G+L + +      L   + L   +  A+G+
Sbjct: 64  GSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGETYASSEVRGTFGYLD 479
           ++L    E  +VHR++   NILL  +   +++DFG++ ++    + Y  SE +    ++ 
Sbjct: 123 YYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILS 506
            E     +     DV+S+G+ + +++S
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 33/217 (15%)

Query: 320 IGEGITGKVYKGKLSN------NQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVAL 371
           +GEG  GKV+  +  N         VA+K +   +E   + F RE    + ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLF-----------GKDKC---LSWIQRLEIAIDSA 417
            G C       +++E   +G+L  +L            G+D     L+  Q L IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFG 476
            G+ +L S      VHRD+   N L+G     K+ DFG+S+ I   + Y           
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 477 YLDPE---YRSNCKVNSSGDVYSFGIVLLQILS-GKK 509
           ++ PE   YR   K  +  D++SFG+VL +I + GK+
Sbjct: 190 WMPPESILYR---KFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 20/197 (10%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           +G+G  GKVYK K      +A   +    +E  +E ++ E+   +   HP +V LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
              + +++ E CP G +   +   D+ L+  Q   I       L +LHS     I+HRD+
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDL 136

Query: 437 KPTNILLGPNFEAKLSDFGLS----KVIDIGETYASSEVRGTFGYLDPEY-----RSNCK 487
           K  N+LL  + + KL+DFG+S    K +   +++      GT  ++ PE        +  
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKDTP 191

Query: 488 VNSSGDVYSFGIVLLQI 504
            +   D++S GI L+++
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 28/215 (13%)

Query: 320 IGEGITGKVYKGKLSN------NQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVAL 371
           +GEG  GKV+  +  N         VA+K +        + F RE    ++++H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWL--FGKDKC-------------LSWIQRLEIAIDS 416
            G C   D   +++E   +G+L ++L   G D               L   Q L IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTF 475
           A G+ +L S      VHRD+   N L+G N   K+ DFG+S+ +   + Y          
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKK 509
            ++ PE     K  +  DV+SFG++L +I + GK+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 320 IGEGITGKVYKGKLSN------NQHVAIKHITNEGN--VETFVREVASSSHVRHPNLVAL 371
           +GEG  GKV+  +  N         VA+K + +  +   + F RE    ++++H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWL--FGKDKCL----------SWIQRLEIAIDSARG 419
            G C+  D   +++E   +G+L ++L   G D  L          +  Q L IA   A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYL 478
           + +L S      VHRD+   N L+G N   K+ DFG+S+ +   + Y           ++
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILS-GKK 509
            PE     K  +  DV+S G+VL +I + GK+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 29/211 (13%)

Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHITNE-----GNVETFVREVASSSH 362
           +L  + ++G G  G VYKG            VAIK I NE      NVE F+ E    + 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIMAS 65

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDS 416
           + HP+LV LLG CL      L+ +L P+G L +++       G    L+W       +  
Sbjct: 66  MDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQI 118

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTF 475
           A+G+ +L    E  +VHRD+   N+L+      K++DFGL+++++  E  Y +   +   
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++  E     K     DV+S+G+ + ++++
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 20/207 (9%)

Query: 312 EKLNELNLIGEGITGKVYKG--KLSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHP 366
           E   +L+ +GEG    V+KG  KL+ N  VA+K I     EG   T +REV+   +++H 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 367 NLVALLGYCLRVDECF-LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWF 422
           N+V L    +  + C  L++E   + +L ++L   D C + +    + I      RGL +
Sbjct: 64  NIVTLHD-IIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE- 481
            H      I+HRD+KP N+L+    E KL+DFGL++   +     S+EV  T  Y  P+ 
Sbjct: 119 CHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 174

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
              + + ++  D++  G +L ++ +G+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 18/202 (8%)

Query: 316 ELNLIGEGITGKVYKG--KLSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVA 370
           +L+ +GEG    VYKG  KL++N  VA+K I     EG   T +REV+    ++H N+V 
Sbjct: 10  KLDKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSYS 427
           L           L++E   + +L ++L   D C + I    + +      RGL + H   
Sbjct: 69  LHDIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNC 486
              ++HRD+KP N+L+    E KL+DFGL++   I     S+EV  T  Y  P+    + 
Sbjct: 125 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGST 180

Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             ++  D++  G +  ++ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 68.7 bits (168), Expect = 9e-13
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 317 LNLIGEGITGKVYKGKLSNN--QHVAIKHIT------------NEGNVETFVREVA-SSS 361
           L  +G G  G VYK +  NN    +A+K I              + ++   V EV     
Sbjct: 5   LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 362 HVRHPNLVALLGYCLRVDECFLIYEL---CPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
            +RHPN+V      L  D  +++ +L    P G     L  K +  +  +   I +    
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
            L +LH   E  IVHRD+ P NI+LG + +  ++DFGL+K          + V GT  Y 
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYS 180

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQI 504
            PE   N       DV++FG +L Q+
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.6 bits (167), Expect = 9e-13
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 10/201 (4%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L  IG+G  G+V+KG  +  Q V AIK I     E  +E   +E+   S    P 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  +   L   Q   I  +  +GL +LHS  
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK 121

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL  + E KL+DFG++  +   +   ++ V GT  ++ PE      
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +S  D++S GI  +++  G+
Sbjct: 178 YDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 68.2 bits (167), Expect = 9e-13
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 21/195 (10%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVALLG 373
           IG+G    VYK   L + + VA+K +      +    +  ++E+     + HPN++  L 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 374 YCLRVDECFLIYELCPNGNLAEWL--FGKDKCL-----SWIQRLEIAIDSARGLWFLHSY 426
             +  +E  ++ EL   G+L+  +  F K K L      W   +++       L  +HS 
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHSK 125

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
               I+HRDIKP N+ +      KL D GL +      T A S V GT  Y+ PE     
Sbjct: 126 R---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181

Query: 487 KVNSSGDVYSFGIVL 501
             N   D++S G +L
Sbjct: 182 GYNFKSDIWSLGCLL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 49/275 (17%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVAL 371
           + ++G G  G+VYKG+ +   Q  AIK +      E  ++  +  +   SH  H N+   
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH--HRNIATY 78

Query: 372 LGYCLRV------DECFLIYELCPNGNLAEWLFG------KDKCLSWIQRLEIAIDSARG 419
            G  ++       D+ +L+ E C  G++ + +        K+  +++I R     +  RG
Sbjct: 79  YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR-----EILRG 133

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID--IGETYASSEVRGTFGY 477
           L  LH++    ++HRDIK  N+LL  N E KL DFG+S  +D  +G     +   GT  +
Sbjct: 134 LAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYW 187

Query: 478 LDPEYRSNCKVNSSG------DVYSFGIVLLQILSGKKAKVLTRAGSALEL----ADPKL 527
           + PE  + C  N         D++S GI  +++  G           AL L      PKL
Sbjct: 188 MAPEVIA-CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246

Query: 528 -DREYSIEAFDLTLQLALSCTALTH-QRPPMEQVF 560
             +++S +  D        C    +  RP  EQ+ 
Sbjct: 247 KSKKWSKKFIDFI----EGCLVKNYLSRPSTEQLL 277

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 80/289 (27%), Positives = 121/289 (41%), Gaps = 64/289 (22%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHITNEGNVETFVR-----EVASSSHVRH 365
             L  L  IG G  G+VYK +     HV A+K +   GN E   R     +V   SH   
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DC 73

Query: 366 PNLVALLGYCLRVDECFLIYEL---C-------PNGNLAEWLFGKDKCLSWIQRLEIAID 415
           P +V   GY +   + F+  EL   C         G + E + GK         + +AI 
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK---------MTVAIV 124

Query: 416 SARGLWFL---HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEV 471
            A  L +L   H      ++HRD+KP+NILL  +   KL DFG+S +++D   + A +  
Sbjct: 125 KA--LHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRS 174

Query: 472 RGTFGYLDPEYRSNCKVNSS----GDVYSFGIVLLQILSGK--------KAKVLTRAGSA 519
            G   Y+ PE       N       DV+S GI L+++ +G+        + +VLT+    
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK---I 231

Query: 520 LELADPKLDREYSIEAFDLTLQ--LALSCTALTHQRPP----MEQVFVT 562
           L+   P L      E F       + L  T    +RP     ++  F+ 
Sbjct: 232 LQEEPPSLPPN---EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 49/279 (17%)

Query: 320 IGEGITGKVYKGKLS---NNQHVAIKHITNEGNVET---FVREVASSSHVRHPNLVALLG 373
           IG G  GKV  G+++       V +K +    +V+    F+ E      ++H NL+  LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKC------LSWIQRLEIAIDSARGLWFLHSYS 427
            C  V    L+ E CP G+L  +L    K        + +QR+  A + A GL  LH  +
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKNN 120

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-----VRGTFGYLDPEY 482
               +H D+   N LL  +   K+ D+GLS      + Y + +     +R     L  E 
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 483 RSNCKV---NSSGDVYSFGIVLLQI----------LSGKKAKVLTRAGSALELADPKL-- 527
             N  V       +V+S G+ + ++          LS ++    T     L+L  P+L  
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237

Query: 528 ---DREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTL 563
              DR Y +  F         C     QRP  E+V + L
Sbjct: 238 PLSDRWYEVMQF---------CWLQPEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 48/220 (21%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIK--------------HITNEGNVETFVRE 356
           + L  +  +G G  G+V+  +   +  + A+K              H+ NE  V      
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRV------ 54

Query: 357 VASSSHVRHPNLVALLGYCLRVDECFL--IYELCPNGNLAEWL-----FGKDKCLSWIQR 409
                 V HP ++ L  +    D+ FL  + E  P G L  +L     F     L +   
Sbjct: 55  ---LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGETYAS 468
           +  A++      +LHS     IV+RD+KP NILL      KL+DFG +K + D   T+  
Sbjct: 110 IVCALE------YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWT- 157

Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             + GT  YL PE   +   N + D ++ GI++ ++L G 
Sbjct: 158 --LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 70/236 (29%), Positives = 111/236 (47%), Gaps = 19/236 (8%)

Query: 319 LIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVE-TFVREVASSSHVRHPNLVAL 371
           ++G+G  GKV+  +L   NQ  AIK +  +      +VE T V +   S    HP L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW-IQRLEI-AIDSARGLWFLHSYSEG 429
                  +  F + E    G+L   +F    C  + + R    A +   GL FLHS    
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            IV+RD+K  NILL  +   K++DFG+ K   +G+   +    GT  Y+ PE     K N
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTFCGTPDYIAPEILLGQKYN 174

Query: 490 SSGDVYSFGIVLLQILSGKK---AKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
           +S D +SFG++L ++L G+             ++ + +P   R  + EA D+ ++L
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL 230

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 20/199 (10%)

Query: 320 IGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G G  G+V   K+ S N+  A+K     HI   G  E    E        HP +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 374 YCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA-IDSARGLWFLHSYSEGC 430
           Y    D+   +++ E C  G L   L  +     +  R  IA +  A    +LH+     
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLHNRG--- 113

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-TYASSEVRGTFGYLDPEYRSNCKVN 489
           I++RD+KP N+LL  N   KL DFG +K +  G+ T+      GT  Y+ PE   N   +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGYD 170

Query: 490 SSGDVYSFGIVLLQILSGK 508
            S D +S GI+L ++L+G+
Sbjct: 171 FSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 62/257 (24%), Positives = 112/257 (43%), Gaps = 25/257 (9%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVALLG 373
           IG G   +VY+   L + + VA+K +      +    +  V+E+     + HPN++  L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 374 YCLRVDECFLIYELCPNGNLAEWL--FGKDKCL---SWIQRLEIAIDSARGLWFLHSYSE 428
             +  +E  ++ EL   G+L++ +  F K K L     + +  + + SA  +  +HS   
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMHSRR- 126

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             ++HRDIKP N+ +      KL D GL +     +T A+  + GT  Y+ PE       
Sbjct: 127 --VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 489 NSSGDVYSFGIVLLQILS------GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
           N   D++S G +L ++ +      G K  + +      +   P L  E+  E     + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243

Query: 543 ALSCTALTHQRPPMEQV 559
            +       QRP +  V
Sbjct: 244 CIYPDP--DQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 15/205 (7%)

Query: 314 LNELNLIGEGITGKV----YKGKLSNN-QHVAIKHI---TNEGNVETFVREVASSSHVRH 365
           L  +  +GEG  GKV    Y  +  N  + VA+K +   +   ++    +E+    ++ H
Sbjct: 6   LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 65

Query: 366 PNLVALLGYCLRV--DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            N+V   G C     +   LI E  P+G+L E+L      ++  Q+L+ A+   +G+ +L
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS--SEVRGTFGYLDPE 481
            S      VHRD+   N+L+    + K+ DFGL+K I+  + Y +   ++     +  PE
Sbjct: 126 GSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILS 506
                K   + DV+SFG+ L ++L+
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 56/191 (29%), Positives = 93/191 (48%), Gaps = 11/191 (5%)

Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCL 376
           +G G  G VYK   L   +  A+K I  E   +     +E+      +H N+VA  G  L
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
             ++ ++  E C  G+L + ++     LS +Q   +  ++ +GL +LHS  +   +HRDI
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRDI 132

Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
           K  NILL  N + KL+DFG++  I        S + GT  ++ PE      N   N   D
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 494 VYSFGIVLLQI 504
           +++ GI  +++
Sbjct: 192 IWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 31/212 (14%)

Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           K   L ++GEG  G V K +     + VAIK       NE   ET +RE+     ++  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 368 LVALLGYCLRVDECFLIYELC-----------PNGNLAEWLFGKDKCLSWIQRLEIAIDS 416
           +V L     R  + +L++E             PNG         +K  S+I +L  AI  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP------EKVRSYIYQLIKAI-- 113

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
                  H   +  IVHRDIKP N+L+  N   KL DFG ++ +  G     +E   T  
Sbjct: 114 -------HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW 166

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           Y  PE         + D++S G +L ++  G+
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHP 366
           ++  ++  IGEG  G VYK +    N+ +A+K I     +EG   T +RE++    ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 367 NLVALLGYCLRVDECFLIYEL-----------CPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           N+V L          +L++E             P+       F K+  L      +I   
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD-------FAKNPRLIKTYLYQIL-- 112

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSDFGLSKVIDIGETYASSEVRGT 474
             RG+ + HS+    ++HRD+KP N+L+     A KL+DFGL++   I     + EV  T
Sbjct: 113 --RGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-T 166

Query: 475 FGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
             Y  PE     +  S+  D++S G +  ++++ K
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 10/201 (4%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L  IG+G  G+V+KG  +  Q V AIK I     E  +E   +E+   S    P 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  +       Q   +  +  +GL +LHS  
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL    + KL+DFG++  +   +   ++ V GT  ++ PE      
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 177

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +S  D++S GI  +++  G+
Sbjct: 178 YDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 314 LNELNLIGEGITGKV--YKGKLSNN---QHVAIKHITNE---GNVETFVREVASSSHVRH 365
           L ++ ++GEG  GKV  Y    +N+   + VA+K +  E    N   + +E+     + H
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 366 PNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            N+V   G C         LI E  P G+L ++L  K K L+  Q L  A     G+ +L
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHK-LNLAQLLLFAQQICEGMAYL 123

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDP 480
           HS      +HRD+   N+LL  +   K+ DFGL+K +  G  Y      G    F Y   
Sbjct: 124 HSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-V 179

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E     K + + DV+SFG+ L ++L+
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.2 bits (161), Expect = 8e-12
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 18/202 (8%)

Query: 316 ELNLIGEGITGKVYKG--KLSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVA 370
           +L  +GEG    V+KG  KL+ N  VA+K I     EG   T +REV+    ++H N+V 
Sbjct: 10  KLEKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSYS 427
           L           L++E   + +L +++   D C + +    + I      RGL + H   
Sbjct: 69  LHDIVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNC 486
              ++HRD+KP N+L+    E KL+DFGL++   +     S+EV  T  Y  P+    + 
Sbjct: 125 ---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180

Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
           + ++  D++  G +  ++ SG+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 65.2 bits (159), Expect = 9e-12
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 31/212 (14%)

Query: 319 LIGEGITGKVY------KGKLSNNQHVAIKHITNEGN------VETFVREVASSSHVRHP 366
           LIG G  G VY       G+L   + V +  ++          ++   RE+A    ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLW 421
           N+V  LG  L  D   +  E  P G++A  L     F +    ++++++       +GL 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLN 120

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-----GETYASSEVRGTFG 476
           +LH+     I+HRDIK  NIL+      K+SDFG+SK ++          A   ++G+  
Sbjct: 121 YLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           ++ PE           D++S G +++++L+GK
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 31/226 (13%)

Query: 309 YATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVREV 357
           ++ +KL     +GEG  G+V         K K      VA+K + +   E ++   V E+
Sbjct: 12  FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71

Query: 358 ASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------D 401
                + +H N++ LLG C +    ++I E    GNL E+L  +               D
Sbjct: 72  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131

Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           + +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 462 IGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 35/212 (16%)

Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPN 367
           +KL++L   GEG    VYKG+     Q VA+K I     EG   T +RE +    ++H N
Sbjct: 8   KKLDKL---GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN 64

Query: 368 LVALLGYCLRVDECF-LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFL 423
           +V  L   +   +   L++E   + +L +++   D C   +    + +      RGL + 
Sbjct: 65  IV-TLHDIIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDP-- 480
           H      ++HRD+KP N+L+    E KL+DFGL++   +  +TY S+EV  T  Y  P  
Sbjct: 120 HQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYRPPDV 174

Query: 481 -----EYRSNCKVNSSGDVYSFGIVLLQILSG 507
                EY      ++S D++  G +  ++ +G
Sbjct: 175 LLGSTEY------STSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 51/186 (27%), Positives = 92/186 (49%), Gaps = 25/186 (13%)

Query: 339 VAIKHITNEGNVET---FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAE 395
           VA+K +  + N      F++E+   S ++ PN++ LL  C+  D   +I E   NG+L +
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 396 WL----------FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP 445
           +L                +S+   + +A   A G+ +L S +    VHRD+   N L+G 
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165

Query: 446 NFEAKLSDFGLSKVIDIGETY-----ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
           N+  K++DFG+S+ +  G+ Y     A   +R    ++  E     K  ++ DV++FG+ 
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMSWESILLGKFTTASDVWAFGVT 221

Query: 501 LLQILS 506
           L +IL+
Sbjct: 222 LWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 10/201 (4%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L  IG+G  G+VYKG  +  + V AIK I     E  +E   +E+   S    P 
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  K   L       I  +  +GL +LHS  
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSER 121

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL    + KL+DFG++  +   +   ++ V GT  ++ PE      
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +   D++S GI  +++  G+
Sbjct: 178 YDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 30/209 (14%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV-----RHPNLVALLGY 374
           IG+G  GKVYK  ++N +  ++  +     +     E+ +  ++      HPN+V   G 
Sbjct: 30  IGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 375 CLRVDEC-----FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS------ARGLWFL 423
             + D+      +L+ ELC  G++ E + G   C    QRL+ A+ S        GL  L
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG---QRLDEAMISYILYGALLGLQHL 144

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY- 482
           H+     I+HRD+K  NILL      KL DFG+S  +       ++ V GT  ++ PE  
Sbjct: 145 HNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 200

Query: 483 ----RSNCKVNSSGDVYSFGIVLLQILSG 507
               + +   ++  DV+S GI  +++  G
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 6/189 (3%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT-NEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G G  G+V+    + +  VA+K +     +VE F+ E      ++H  LV L     + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72

Query: 379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  ++I E    G+L ++L   +     + +L + +   A G+ F+   +    +HRD++
Sbjct: 73  EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLR 129

Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+  +   K++DFGL++VI+  E  A    +    +  PE  +        DV+SF
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189

Query: 498 GIVLLQILS 506
           GI+L++I++
Sbjct: 190 GILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)

Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKH--ITNEGNVET 352
           DPG PR            L+    IGEG TG V    + S+ + VA+K   +  +   E 
Sbjct: 14  DPGDPR----------TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL 63

Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
              EV      +H N+V +    L  DE +++ E    G L + +      ++  Q   +
Sbjct: 64  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAV 121

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
            +   + L  LH+     ++HRDIK  +ILL  +   KLSDFG    +   E      + 
Sbjct: 122 CLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLV 177

Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           GT  ++ PE  S        D++S GI++++++ G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.5 bits (158), Expect = 3e-11
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 19/160 (11%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPNLVAL 371
           L  IG G  G V         + VAIK I+N  +        +RE+    H+RH N++ L
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 372 L-----GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLS--WIQRLEIAIDSARGLWFLH 424
           L           ++ +++ EL    +L + +      L+   IQ     I   RGL +LH
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP-LTDDHIQYFLYQI--LRGLKYLH 120

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE 464
           S +   ++HRD+KP+NIL+  N + K+ DFGL++ +D  E
Sbjct: 121 SAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 17/152 (11%)

Query: 362 HVRHPNLVALLGYCLRVD-ECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAID 415
            V HP +V L  Y  + + + +LI +    G+L      E +F ++    ++  L +A+D
Sbjct: 54  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 112

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
                   H +S G I++RD+KP NILL      KL+DFGLSK     E  A S   GT 
Sbjct: 113 --------HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTV 162

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            Y+ PE  +      S D +SFG+++ ++L+G
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 52/232 (22%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----V 354
           PRY              L+ IGEG  G V           VAIK I+     +TF    +
Sbjct: 5   PRYQN------------LSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTL 51

Query: 355 REVASSSHVRHPNLVALLGYCLRVD------ECFLIYELCPNG--------NLAEWLFGK 400
           RE+      +H N++ +L   +R        + +++ EL            +L+      
Sbjct: 52  REIKILRRFKHENIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN----- 105

Query: 401 DKCLSWI-QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
           D    ++ Q L       RGL ++HS +   ++HRD+KP+N+LL  N + K+ DFGL+++
Sbjct: 106 DHIQYFLYQIL-------RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Query: 460 IDIGETYAS--SEVRGTFGYLDPEYRSNCKVNS-SGDVYSFGIVLLQILSGK 508
            D    +    +E   T  Y  PE   N K  + + D++S G +L ++LS +
Sbjct: 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 5e-11
 Identities = 55/195 (28%), Positives = 82/195 (42%), Gaps = 50/195 (25%)

Query: 320 IGEGITGKVYKGKLSN---NQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVAL 371
           IG G  G+VYK K  N    +  AIK          G  ++  RE+A    ++H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 372 LGYCL-RVDEC-FLIYELCPNGNLAE---WLFGKD--------------KCLSWIQRLEI 412
           +   L   D+  +L+++       AE   W   K               K L W Q L  
Sbjct: 68  VEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QILN- 119

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILL-GPNFE---AKLSDFGLSKVID--IGETY 466
                 G+ +LHS     ++HRD+KP NIL+ G   E    K+ D GL+++ +  +    
Sbjct: 120 ------GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 467 ASSEVRGTFGYLDPE 481
               V  T  Y  PE
Sbjct: 171 DLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 70/288 (24%), Positives = 131/288 (45%), Gaps = 43/288 (14%)

Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K + ++    ++   V E+     + +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWL---------FGKDKC------LSWIQRLEI 412
           ++ LLG C +    +++ E    GNL E+L         +  D C      L++   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGETYASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ V +I     ++  
Sbjct: 140 AYQVARGMEYLA--SQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-------GKKAKVLTRAGSALELAD 524
           R    ++ PE   +       DV+SFG++L +I +       G   + L +    L    
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK----LLKEG 252

Query: 525 PKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALDISTT 572
            ++D+  +    +L + +     A+  QRP  +Q+   L + L +++T
Sbjct: 253 HRMDKPANC-THELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 19/216 (8%)

Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKV-YKGKLSNNQHVAIKH--ITNEGNVET 352
            PG PR          E L+    IGEG TG V    +    + VA+K   +  +   E 
Sbjct: 16  SPGDPR----------EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL 65

Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
              EV       H N+V +    L  DE +++ E    G L + +      ++  Q   +
Sbjct: 66  LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATV 123

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
            +   R L +LH+     ++HRDIK  +ILL  +   KLSDFG    +   E      + 
Sbjct: 124 CLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLV 179

Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           GT  ++ PE  S     +  D++S GI++++++ G+
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 40/133 (30%), Positives = 63/133 (47%), Gaps = 17/133 (12%)

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASS 469
           +I+I   RGL +L    +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 157

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK----------KAKVLTRAGSA 519
            V GT  Y+ PE           D++S G+ L+++  G+             +  R  S 
Sbjct: 158 FV-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE 216

Query: 520 LELADPKLDREYS 532
            E  +        
Sbjct: 217 GEAKESHRPVSGH 229

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 38/99 (38%), Positives = 57/99 (57%), Gaps = 9/99 (9%)

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVID-IGETYASS 469
           IA+    GL +L  Y+   I+HRDIKP+NIL+    + KL DFG+S ++I+ I +T+   
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-- 163

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              GT  Y+ PE     K     DV+S GI ++++  GK
Sbjct: 164 ---GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS+   +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I   + Y  ++  
Sbjct: 146 AYQVARGMEYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 19/207 (9%)

Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHI---TNEGNVETFVREVASSSHVRHPN 367
           EKL +L   GEG    VYKGK   N + VA+K I     EG   T +RE +    ++H N
Sbjct: 8   EKLEKL---GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLH 424
           +V L       +   L++E   + +L +++   DK    +    + +      RGL ++H
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YR 483
              +  I+HRD+KP N+L+    E KL+DFGL++   +     S+EV  T  Y  P+   
Sbjct: 121 ---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176

Query: 484 SNCKVNSSGDVYSFGIVLLQILSGKKA 510
            + + ++  D++  G + ++++ G  A
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)

Query: 317 LNLIGEGITGKVYKGKL----SNNQHVAIKHITNEGNVETFVREVASSSH---------- 362
           L ++G+G  GKV++ +        +  A+K +       T VR    ++H          
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA----TIVRNQKDTAHTKAERNILEA 56

Query: 363 VRHPNLVALLGYCLRVD-ECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDS 416
           V+HP +V L+ Y  +   + +LI E    G L      E +F +D    ++  + +A++ 
Sbjct: 57  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE- 114

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
                  H + +G I++RD+KP NILL      KL+DFGL K   I E   +    GT  
Sbjct: 115 -------HLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIE 165

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           Y+ PE         + D +S G ++  +L+G
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 19/201 (9%)

Query: 319 LIGEGITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           LI E     +YKG   NN+ V I+     H  ++  ++    E+ +   +   N++ + G
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 374 YCLRVDECF----LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
           + + + +      LI E C  G L E L  K+K LS+  +L++AID  +GL+ L+ Y+  
Sbjct: 86  FIIDIVDDLPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK 144

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC--K 487
              ++++   + L+  N++ K+   GL K++    +    +      Y   +  ++   +
Sbjct: 145 --PYKNLTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFSE 198

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
                D+YS G+VL +I +GK
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 62.9 bits (154), Expect = 8e-11
 Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 26/155 (16%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHITNE-GNVE--TFVREVASSSHV-RHPNLVALLGY 374
           +G+G  G VY  +     + VAIK +  +  + E    +REV S   +  HPN+V L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66

Query: 375 CLRVDECFLIYELCPNGNL-------AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-- 425
               DE + ++E    GNL           F +    S I ++       +GL  +H   
Sbjct: 67  FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQI------LQGLAHIHKHG 119

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           +      HRD+KP N+L+      K++DFGL++ I
Sbjct: 120 F-----FHRDLKPENLLVSGPEVVKIADFGLAREI 149

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 19/159 (11%)

Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQ 408
           +H N++ LLG C +    ++I E    GNL E+L  +               ++ LS+  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGETYA 467
            +  A   ARG+ +L   S  CI HRD+   N+L+  +   K++DFGL++ V DI     
Sbjct: 136 LVSCAYQVARGMEYLE--SRRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +S  R    ++ PE   +       DV+SFGI++ +I +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 23/208 (11%)

Query: 319 LIGEGITGKVYKG--KLSNN--QHVAIK----HITNEGNVETFVREVASSSHVRHPNLVA 370
           ++G+G  G V +   K  +   Q VA+K     I +  ++E F+RE A      HPN++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 371 LLGYCL------RVDECFLIYELCPNGNLAEWLF----GKDKCLSWIQRL-EIAIDSARG 419
           L+G  L      R+    +I     +G+L  +L     G++     +Q L    ID A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV-RGTFGYL 478
           + +L S +    +HRD+   N +L  N    ++DFGLSK I  G+ Y      +    +L
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             E  ++    +  DV++FG+ + +I++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 36/220 (16%)

Query: 320 IGEGITGKVYKGK------LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVA 370
           +GEG  GKV K         +    VA+K +    +   +   + E      V HP+++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 371 LLGYCLRVDECFLIYELCPNGNL----------------------AEWLFGKD-KCLSWI 407
           L G C +     LI E    G+L                      + +L   D + L+  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
             +  A   +RG+ +L   +E  +VHRD+   N+L+    + K+SDFGLS+ +   ++Y 
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 468 S-SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             S+ R    ++  E   +    +  DV+SFG++L +I++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 317 LNLIGEGITGKVYKGKL-----SNNQHVAIKHITN---EGNVETFVREVASSSHVRHPNL 368
            +L+ EG  G+++ G L        + V +K + +   E  V   ++E      + H N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 369 VALLGYCLRV-DECFLIYELCPNGNLAEWL-------FGKDKCLSWIQRLEIAIDSARGL 420
           + +L  C+   +  F++Y     GNL  +L           + LS  Q + +AI  A G+
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--ASSEVRGTFGYL 478
            +LH      ++H+DI   N ++    + K++D  LS+ +   + +    +E R    ++
Sbjct: 131 SYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWM 186

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             E   N + +S+ DV+SFG++L ++++
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 28/205 (13%)

Query: 319 LIGEGITGKVYKGKLSN-NQHVAIKHITNE-----GNVE-TFVREVASSSHVRHPNLVAL 371
           ++G+G  GKV   +L   N+  AIK +  +      +VE T V     +    HP L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--------GLWFL 423
             +C    +  L +       + E+L G D               AR        GL FL
Sbjct: 62  --FCTFQTKEHLFF-------VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFL 112

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           H      I++RD+K  N+LL  +   K++DFG+ K    GE  AS+   GT  Y+ PE  
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEIL 168

Query: 484 SNCKVNSSGDVYSFGIVLLQILSGK 508
              K N S D +SFG++L ++L G+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 22/198 (11%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCL 376
           +G+G  GKVYK +      +A   + +   E  +E ++ E+   +   HPN+V LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
             +  +++ E C  G +   +   ++ L+  Q   +   +   L +LH   E  I+HRD+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 437 KPTNILLGPNFEAKLSDFGLS----KVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS-- 490
           K  NIL   + + KL+DFG+S    + I   +++      GT  ++ PE    C+ +   
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEV-VMCETSKDR 183

Query: 491 ----SGDVYSFGIVLLQI 504
                 DV+S GI L+++
Sbjct: 184 PYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 28/234 (11%)

Query: 289 FKGVQL---KDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH--VAIKH 343
            K +QL   KD    +   R+     E  N +  +G G  G+V      N     VAIK 
Sbjct: 4   LKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR 63

Query: 344 -----ITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL- 397
                I  +  V+    E    +++ HP  V L G        +L+ E    G    +L 
Sbjct: 64  FEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR 123

Query: 398 ----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSD 453
               F  D    +  ++ +  +      +L S +   IV+RD+KP N+LL  +   K++D
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFE------YLQSLN---IVYRDLKPENLLLDKDGFIKMTD 174

Query: 454 FGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           FG +KV+D   TY    + GT  Y+ PE   N     + D ++ GI + +IL G
Sbjct: 175 FGFAKVVDT-RTYT---LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 27/210 (12%)

Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHITNEGNVETFVREVASSSHVR--- 364
           +L ++ ++G G  G VYKG    +       VAIK +  E       +E+   ++V    
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK-VLRENTSPKANKEILDEAYVMAGV 66

Query: 365 -HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSA 417
             P +  LLG CL      L+ +L P G L +++       G    L+W       +  A
Sbjct: 67  GSPYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIA 119

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFG 476
           +G+ +L    E  +VHRD+   N+L+      K++DFGL++++DI ET Y +   +    
Sbjct: 120 KGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           ++  E   + +     DV+S+G+ + ++++
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 10/99 (10%)

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK--VIDIGETYASS 469
           IA+   +GL +L S     I+HRD+KP+N+L+    + KL DFG+S   V  I +TY   
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-- 154

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              GT  Y+ PE  S  +     DV+S GI  +++  G+
Sbjct: 155 ---GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 55/188 (29%), Positives = 82/188 (43%), Gaps = 17/188 (9%)

Query: 324 ITGKVYKGKLSNNQHV----AIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD 379
             GK Y  K+   + +      KHI  E NV           +V+HP LV L       D
Sbjct: 18  ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL--------KNVKHPFLVGLHYSFQTAD 69

Query: 380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
           + + + +    G L   L  +++     +    A + A  L +LHS +   I++RD+KP 
Sbjct: 70  KLYFVLDYVNGGELFFHL-QRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPE 125

Query: 440 NILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGI 499
           NILL       L+DFGL K   I  +  +S   GT  YL PE       + + D +  G 
Sbjct: 126 NILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGA 184

Query: 500 VLLQILSG 507
           VL ++L G
Sbjct: 185 VLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 317 LNLIGEGITGKVYKGK---LSNN--QHVAIKHI--TNEGNVETFVREVASSSHVRHPNLV 369
           +  +G+G  G V   +   L +N  + VA+K +  +   ++  F RE+     ++H N+V
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 370 ALLGYC-------LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
              G C       LR     L+ E  P G+L ++L    + L   + L  A    +G+ +
Sbjct: 69  KYKGVCYSAGRRNLR-----LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLD 479
           L S      VHRD+   NIL+      K+ DFGL+KV+   + Y      G    F Y  
Sbjct: 124 LGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA- 179

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILS 506
           PE  +  K + + DV+SFG+VL ++ +
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 34/222 (15%)

Query: 310 ATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVET---FVREVASS 360
           + EK+  L  +G+G  G VY+G      K      VA+K +    ++     F+ E +  
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-------------SWI 407
                 ++V LLG   +     ++ EL  +G+L  +L    + L             +  
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQ 119

Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-Y 466
           + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET Y
Sbjct: 120 EMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDY 174

Query: 467 ASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
                +G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 47/188 (25%), Positives = 90/188 (47%), Gaps = 28/188 (14%)

Query: 339 VAIKHIT--------NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY-ELCP 389
           +A+K +T         E  VE   +E+   + + HP+++ +LG     D  F ++ E   
Sbjct: 28  MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG-ATCEDSHFNLFVEWMA 86

Query: 390 NGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL- 443
            G+++  L     F +   +++ ++L       RGL +LH   E  I+HRD+K  N+L+ 
Sbjct: 87  GGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLH---ENQIIHRDVKGANLLID 137

Query: 444 GPNFEAKLSDFGLSKVIDIGETYA---SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
                 +++DFG +  +    T A     ++ GT  ++ PE     +   S DV+S G V
Sbjct: 138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCV 197

Query: 501 LLQILSGK 508
           ++++ + K
Sbjct: 198 IIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 56/232 (24%)

Query: 318 NLIGEGITGKVYKGK-LSNNQHVAIKHITN-EGNVE---------------TFVREVASS 360
             +GEG  GKV K       + VAIK +   E + +               T +RE+   
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK-------DKCLSWIQRLEIA 413
           + ++H N++ L+   +  D   L+ ++    +L + +  K        KC+   Q L   
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILL-QIL--- 129

Query: 414 IDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS---------------K 458
                GL  LH +     +HRD+ P NI +      K++DFGL+               +
Sbjct: 130 ----NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 459 VIDIGETYASSEVRGTFGYLDPE--YRSNCKVNSSGDVYSFGIVLLQILSGK 508
            +   E   S  V  T  Y  PE    +    + + D++S G +  ++L+GK
Sbjct: 183 TMQRREEMTSKVV--TLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 28/158 (17%)

Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPNLVALLGY 374
           IG G  G V       + + VAIK I +  +V T     +RE+    H +H N++A+   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD- 71

Query: 375 CLRV-----DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA------RGLWFL 423
            LR       + +++ +L  + +L   +          Q L             RGL ++
Sbjct: 72  ILRPPGADFKDVYVVMDLMES-DLHHIIHSD-------QPLTEEHIRYFLYQLLRGLKYI 123

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           HS     ++HRD+KP+N+L+  + E ++ DFG+++ + 
Sbjct: 124 HS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 13/166 (7%)

Query: 342 KHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD 401
           KHI +E NV           +V+HP LV L       D+ + + +    G L  +   ++
Sbjct: 40  KHIMSERNVLL--------KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF-YHLQRE 90

Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           +C    +    A + A  L +LHS +   IV+RD+KP NILL       L+DFGL K  +
Sbjct: 91  RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE-N 146

Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           I     +S   GT  YL PE       + + D +  G VL ++L G
Sbjct: 147 IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 60.1 bits (145), Expect = 8e-10
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 20/162 (12%)

Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL--- 410
           +RE+        P +V   G      E  +  E    G+L       D+ L   +R+   
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKEAKRIPEE 103

Query: 411 ---EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETY 466
              +++I   RGL +L    +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + 
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SM 158

Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           A+S V GT  Y+ PE       +   D++S G+ L+++  G+
Sbjct: 159 ANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 26/216 (12%)

Query: 310 ATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVET---FVREVASS 360
           A EK+     +G+G  G VY+G      K      VAIK +    ++     F+ E +  
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFG--------KDKCLSWIQRL-E 411
                 ++V LLG   +     +I EL   G+L  +L            +    ++++ +
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSE 470
           +A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET Y    
Sbjct: 124 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKG 178

Query: 471 VRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
            +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 66/230 (28%), Positives = 94/230 (40%), Gaps = 53/230 (23%)

Query: 309 YATEKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHI---TNEGNVETFVRE---VASSS 361
           +  E L +L  IG G  G V K         +A+K I    +E   +  + +   V  SS
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 362 HVRHPNLVALLGYCLRVDECFLIYELCP--------------NGNLAEWLFGKDKCLSWI 407
               P +V   G   R  +C++  EL                   + E + GK       
Sbjct: 61  DC--PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------- 111

Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS--------KV 459
               IA+ + + L +L    E  I+HRD+KP+NILL  N   KL DFG+S        K 
Sbjct: 112 ----IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT 165

Query: 460 IDIG-ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            D G   Y + E       +DP  R    V S  DV+S GI L ++ +GK
Sbjct: 166 RDAGCRPYMAPE------RIDPSARDGYDVRS--DVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 22/257 (8%)

Query: 317 LNLIGEGITGKV--YKGKLSNNQHVAIKHITNEGNVETFVREVASS-----SHVRHPNLV 369
           + ++G+G  G+V   + +    Q+V IK + N  N     R+ A       S ++HPN+V
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYV-IKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 370 ALLGYCLRVD-ECFLIYELCPNGNLAEWLF-GKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           A        D   +++   C  G+L   L   K K L   Q +E  +  A  L +LH   
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--- 119

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           E  I+HRD+K  N+ L      K+ D G+++V++     AS+ + GT  Y+ PE  SN  
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKP 178

Query: 488 VNSSGDVYSFGIVLLQILSGKKAKVLTRAGS----ALELADPKLDREYSIEAFDLTLQLA 543
            N   DV++ G  + ++ + K A       S     +E   P + ++YS E  +L   +A
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL---IA 235

Query: 544 LSCTALTHQRPPMEQVF 560
              +    +RP ++ + 
Sbjct: 236 TMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 62/236 (26%), Positives = 93/236 (39%), Gaps = 34/236 (14%)

Query: 325 TGKVYKGKLSNNQHVAIKHITNEGN-VETFVREVASSSHVRHPNLVALLGYCLRVD-ECF 382
            GK+Y  K+     +  K  T E    E  V E      VR    +  L Y  + D +  
Sbjct: 27  AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE-----AVRRCPFLVTLHYAFQTDTKLH 81

Query: 383 LIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           LI +    G L   L     F + +   +I  + +A+D       LH      I++RDIK
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH------LHQLG---IIYRDIK 132

Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY--RSNCKVNSSGDVY 495
             NILL       L+DFGLSK     E   +    GT  Y+ PE     +   + + D +
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192

Query: 496 SFGIVLLQILSGKKAKVLTRAGSALELAD---------PKLDREYSIEAFDLTLQL 542
           S G++  ++L+G  A   T  G     ++         P   +  S EA D   +L
Sbjct: 193 SLGVLTFELLTG--ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 41/122 (33%), Positives = 57/122 (46%), Gaps = 18/122 (14%)

Query: 395 EWLFGKDKCLSWIQRL-EIAIDSAR--------GLWFLHSYSEGCIVHRDIKPTNILLGP 445
           E+L G D C S I+ L  +  D A+        G+  LH      I+HRDIKP N+L+  
Sbjct: 77  EYLNGGD-CASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQ 132

Query: 446 NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
               KL+DFGLS+         + +  GT  YL PE       +   D +S G V+ + L
Sbjct: 133 TGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL 187

Query: 506 SG 507
            G
Sbjct: 188 FG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 26/111 (23%)

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS--------KVIDI 462
           +IA+   + L +LHS     ++HRD+KP+N+L+  N + KL DFG+S        K ID 
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164

Query: 463 GETYASSEVRGTFGYLDPEYRSNCKVNSSG-----DVYSFGIVLLQILSGK 508
           G             Y+ PE R N ++N  G     DV+S GI ++++ +G+
Sbjct: 165 GCK----------PYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 30/213 (14%)

Query: 317 LNLIGEGITGKVYKGKLSN-NQHVAIKHITNEGNVETF----VREVASSSHVRHPNLVAL 371
           +  IGEG  G+VYK +  +  + VA+K +  +   E F    +RE+     + H N+V L
Sbjct: 12  IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71

Query: 372 ----------LGYCLRVDECFLIYELCPN---GNLAEWL--FGKDKCLSWIQRLEIAIDS 416
                     L +       +L++E   +   G L   L  F +D   S++++L      
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------ 125

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
             GL + H  +    +HRDIK +NILL    + KL+DFGL+++ +  E+   +    T  
Sbjct: 126 LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 477 YLDPE-YRSNCKVNSSGDVYSFGIVLLQILSGK 508
           Y  PE      +   + DV+S G +L ++ + K
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 31/159 (19%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPNLVAL 371
           LN I EG  G VY+ +     + VA+K +  E   E F    +RE+     ++HPN+V +
Sbjct: 10  LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69

Query: 372 ----LGYCLRVDECFLIYE--------LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
               +G    +D+ +++ E        L        +L  + KCL  +Q L        G
Sbjct: 70  KEVVVGS--NLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLM-LQLL-------SG 118

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK 458
           +  LH      I+HRD+K +N+LL      K+ DFGL++
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 19/104 (18%)

Query: 419 GLWFL-------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI------DIGET 465
           GL F+       H +S+  I HRDIK  NILL  N   KL DFG SK+       D+G T
Sbjct: 146 GLLFIQVLLAVHHVHSKHMI-HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK 509
           +      GT  Y+ PE       +   D++S G++L ++L+ K+
Sbjct: 205 FC-----GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 21/217 (9%)

Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKV--YKGKLSNNQHVAIK--HITNEGNVE 351
           D G PR            L     IGEG TG V   + K S  Q VA+K   +  +   E
Sbjct: 15  DQGDPRSL----------LENYIKIGEGSTGIVCIAREKHSGRQ-VAVKMMDLRKQQRRE 63

Query: 352 TFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               EV      +H N+V +    L  +E +++ E    G L + +      L+  Q   
Sbjct: 64  LLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIAT 121

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
           +     + L +LHS     ++HRDIK  +ILL  +   KLSDFG    I        S V
Sbjct: 122 VCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            GT  ++ PE  S     +  D++S GI++++++ G+
Sbjct: 179 -GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 38/210 (18%)

Query: 319 LIGEGITGKVYKGKLSN-NQHVAIKH-----ITNEGNVE-TFVREVASSSHVRHPNLVAL 371
           ++G+G  GKV   +L   ++  A+K      I  + +VE T   +   +   +HP L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-------------EIAIDSAR 418
                  D  F + E    G+L          +  IQR              EI +    
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDL----------MFHIQRSGRFDEPRARFYAAEIVL---- 107

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           GL FLH      I++RD+K  N+LL      K++DFG+ K   I     +S   GT  Y+
Sbjct: 108 GLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYI 163

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE  S      + D ++ G++L ++L+G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 50/223 (22%)

Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFV----REVASSSHVRHP 366
           ++   L+ +G G  G+V     +   + VAIK ++             RE+    H+ H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEW--------LFGKDKCLSWIQRLEIAIDSA- 417
           N++ LL       + F      P  +L ++        L G D  L+ I + +   D   
Sbjct: 75  NVIGLL-------DVF-----TPASSLEDFQDVYLVTHLMGAD--LNNIVKCQKLSDDHI 120

Query: 418 --------RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
                   RGL ++HS     I+HRD+KP+NI +  + E K+ DFGL++       +   
Sbjct: 121 QFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDD 170

Query: 470 EVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
           E+ G   T  Y  PE   N    N + D++S G ++ ++L+GK
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 317 LNLIGEGITGKV----YKGKLSNNQHVAIK-----HITNEGNVETF-----VREVASSSH 362
           L ++G G  GKV    YK      +  AIK      I     VE+      + E A+S  
Sbjct: 4   LAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS-- 58

Query: 363 VRHPNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
            RHP LV L   C + ++  CF++ E    G+L   +       S  + +  A     GL
Sbjct: 59  ERHPFLVNLFA-CFQTEDHVCFVM-EYAAGGDLM--MHIHTDVFSEPRAVFYAACVVLGL 114

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LH   E  IV+RD+K  N+LL      K++DFGL K   +G    +S   GT  +L P
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCGTPEFLAP 170

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E  +      + D +  G+++ ++L G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 14/198 (7%)

Query: 319 LIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVE-TFVREVASSSHVRHPNLVAL 371
           ++G+G  GKV   +L    ++ A+K +  +      +VE T V +   +    +P L  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                  +  F + E    G+L   +  +DK    + R    A +   GL FLHS     
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFYAAEIVCGLQFLHSKG--- 116

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           I++RD+K  N++L  +   K++DFG+ K    G+  AS+   GT  Y+ PE     K   
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTF 175

Query: 491 SGDVYSFGIVLLQILSGK 508
           S D +SFG++L ++L G+
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 37/213 (17%)

Query: 312 EKLNELNLIGEGITGKVYK------GKLSNNQ--HVAIK-HITNEGNVETFVREVASSSH 362
           EK++EL   G G  G V+K      G +   +  H+ IK  I N+      +RE+     
Sbjct: 8   EKISEL---GAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-----IIRELQVLHE 59

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL------EIAIDS 416
              P +V   G      E  +  E    G+L       D+ L    R+      +++I  
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKKAGRIPEQILGKVSIAV 112

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTF 475
            +GL +L    +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V GT 
Sbjct: 113 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV-GTR 166

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            Y+ PE       +   D++S G+ L+++  G+
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 63/242 (26%), Positives = 97/242 (40%), Gaps = 64/242 (26%)

Query: 314 LNELNLIGEGITGKVYKGKLSNNQHV-AIKHI-------TNEGNVETFVREVASSSHVRH 365
             ++ L+G+G  G+V+  +L     + A+K +        N+       +E+ ++    H
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL--DH 60

Query: 366 PNLVALLGYC-LRVDECF-LIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSAR---- 418
           P L  L  Y   + +    L+ + CP G L   L     KCLS         + AR    
Sbjct: 61  PFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS--------EEVARFYAA 110

Query: 419 ----GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK---------------- 458
                L +LH    G IV+RD+KP NILL  +    LSDF LSK                
Sbjct: 111 EVLLALEYLHL--LG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 459 -------------VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
                          +     ++S V GT  Y+ PE  S     S+ D ++ GI+L ++L
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFV-GTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Query: 506 SG 507
            G
Sbjct: 227 YG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 37/225 (16%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITN----EGNVETFVR 355
           RY I+EV            IG+G  G V         + VAIK I +      +    +R
Sbjct: 1   RYKIQEV------------IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR 48

Query: 356 EVASSSHVRHPNLVALLGYCLRVD-----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E+     +RHP++V +    L        + ++++EL    +L + +   D  L+     
Sbjct: 49  EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD-LTPEHHQ 106

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYAS 468
                  R L ++H+ +   + HRD+KP NIL   + + K+ DFGL++V   D       
Sbjct: 107 FFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163

Query: 469 SEVRGTFGYLDPEYRSNC-----KVNSSGDVYSFGIVLLQILSGK 508
           ++   T  Y  PE    C     K   + D++S G +  ++L+GK
Sbjct: 164 TDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 32/210 (15%)

Query: 320 IGEGITGKVYK-GKLSNNQHVAIK------HITNEGNVETFVREVASSSHVRHPNLVALL 372
           IG+G  GKV+K     N    A+K       I  E   E  + +  S     HPN+V   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD----HPNVVKFY 81

Query: 373 GYCLRVD-----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           G   + D     + +L+ ELC  G++ + + G  K    ++   IA      L  L    
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI---------DIGETY-ASSEVRGTFGY 477
               +HRD+K  NILL      KL DFG+S  +          +G  +  + EV      
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ 201

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           LD  Y + C      DV+S GI  +++  G
Sbjct: 202 LDSTYDARC------DVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 17/196 (8%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVALLG 373
           IG G   +VY+   L +   VA+K +      +       ++E+     + HPN++    
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 374 YCLRVDECFLIYELCPNGNLAEWL--FGKDKCL---SWIQRLEIAIDSARGLWFLHSYSE 428
             +  +E  ++ EL   G+L+  +  F K K L     + +  + + SA  L  +HS   
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEHMHSRR- 126

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             ++HRDIKP N+ +      KL D GL +      T A S V GT  Y+ PE       
Sbjct: 127 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 183

Query: 489 NSSGDVYSFGIVLLQI 504
           N   D++S G +L ++
Sbjct: 184 NFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 37/109 (33%), Positives = 61/109 (55%), Gaps = 9/109 (8%)

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFG 476
           RGL +LHS     I+HRDIKP N+L+  N   K+ DFGL++V +  E+ + + EV   + 
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 477 YLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD 524
           Y  PE     +   S+ D++S G +  ++L     ++L +A S ++  D
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR---RILFQAQSPIQQLD 215

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 28/204 (13%)

Query: 319 LIGEGITGKVYKGKLSNNQHV-AIKH-----ITNEGNVETFVRE--VASSSHVRHPNLVA 370
           ++G+G  GKV   +L  +  + A+K      I  + +VE  + E  + S +   HP L  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60

Query: 371 LLGYCLRV-DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE------IAIDSARGLWFL 423
           L   C +  D  F + E    G+L   +F   K     +R +       A +    L FL
Sbjct: 61  LY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKS----RRFDEARARFYAAEITSALMFL 112

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           H      I++RD+K  N+LL      KL+DFG+ K   I     +S   GT  Y+ PE  
Sbjct: 113 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEIL 168

Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
                  S D ++ G++L ++L G
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 22/152 (14%)

Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           I  G  GKVY G+  NN  + A+K      + N+  V     E  + +  + P +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY- 70

Query: 374 YCLR-VDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           Y L+  +  +L+ E    G++   L     F ++  + +I  + +A+D      +LH + 
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLHRHG 124

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
              I+HRD+KP N+L+      KL+DFGLSKV
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 44/209 (21%)

Query: 320 IGEGITGKVYKGKLSNNQH-VAIK--------------HITNEGNVETFVREVASSSHVR 364
           +G+G  G+V+  K  +    VA+K              H+  E ++ T           +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILT---------TTK 59

Query: 365 HPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSAR 418
              LV LL Y  + DE  +L  E  P G+    L        D    ++  +  A+D+  
Sbjct: 60  SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA-- 116

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
               LH   E   +HRD+KP N L+  +   KL+DFGLSK I    TYA+S V G+  Y+
Sbjct: 117 ----LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYM 165

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            PE       + + D +S G +L + L G
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 35/115 (30%), Positives = 53/115 (46%), Gaps = 10/115 (8%)

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNCKVN 489
           +V+RD+KP NILL  +   ++SD GL+      + +AS    GT GY+ PE  +     +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYD 174

Query: 490 SSGDVYSFGIVLLQILSGK------KAKVLTRAGSALELADPKLDREYSIEAFDL 538
           SS D +S G +L ++L G       K K              +L   +S E   L
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 229

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 52/224 (23%)

Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHITNEGNVETFV------REVASSSH 362
           E+   L  +G G  G V   Y  +L   Q VA+K ++     ++ +      RE+    H
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRL--RQKVAVKKLSRP--FQSLIHARRTYRELRLLKH 70

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGN---LAEWLFGKD-----KCLSWIQRLE--- 411
           ++H N++ LL       + F       N N   L   L G D     KC    Q+L    
Sbjct: 71  MKHENVIGLL-------DVFTPATSIENFNEVYLVTNLMGADLNNIVKC----QKLSDEH 119

Query: 412 ---IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
              +     RGL ++HS     I+HRD+KP+N+ +  + E ++ DFGL++  D       
Sbjct: 120 VQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD------- 169

Query: 469 SEVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            E+ G   T  Y  PE   N    N + D++S G ++ ++L GK
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 17/102 (16%)

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV------IDIGETYASSEVR- 472
           L +LH+Y    IVHRD+KP N+L+      KL+DFGLSK+       ++ E +   + R 
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 473 -------GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
                  GT  Y+ PE           D ++ GI+L + L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 28/204 (13%)

Query: 319 LIGEGITGKVYKGKL-SNNQHVAIK--------------HITNEGNVETFVREVASSSHV 363
           +IG+G  GKV   K  S+    A+K              HI  E NV           ++
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL--------KNL 53

Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           +HP LV L       ++ + + +    G L   L  +++C    +    A + A  + +L
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHL-QRERCFLEPRARFYAAEVASAIGYL 112

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS +   I++RD+KP NILL       L+DFGL K   +     +S   GT  YL PE  
Sbjct: 113 HSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVL 168

Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
                + + D +  G VL ++L G
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 13/166 (7%)

Query: 342 KHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD 401
           KHI  E NV           +V+HP LV L       ++ + + +    G L   L  ++
Sbjct: 40  KHIMAERNVLL--------KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHL-QRE 90

Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           +     +    A + A  L +LHS +   IV+RD+KP NILL       L+DFGL K   
Sbjct: 91  RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKE-G 146

Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           I ++  ++   GT  YL PE       +++ D +  G VL ++L G
Sbjct: 147 IAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 33/207 (15%)

Query: 320 IGEGITGKVYK------------GKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHP 366
           IG+G  G+VY+              LS  + VA K + +  G     VR +   S    P
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES----P 56

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLW 421
            +V L        + +L+ +    G L      E  F +D+   +I  L +A++      
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH----- 111

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
            LH Y    IV+RD+KP NILL       L DFGLSK  ++ +   ++   GT  YL PE
Sbjct: 112 -LHKYD---IVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPE 166

Query: 482 YRSNCK-VNSSGDVYSFGIVLLQILSG 507
              + K      D +S G+++ ++  G
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 53/217 (24%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF--VREVASSSHVR-------HP 366
           L  IGEG   +V K +     ++ AIK +        F  + +V +   ++       HP
Sbjct: 4   LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK-----HFKSLEQVNNLREIQALRRLSPHP 58

Query: 367 NLVALLGYCL-RVDECF-LIYELCPNGNLAEWLFGKDKCL------SWIQRLEIAIDSAR 418
           N++ L+     R      L++EL  + NL E + G+ + L      S++ +L  ++D   
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD--- 114

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA---------SS 469
                H +  G I HRDIKP NIL+  +   KL+DFG  + I     Y          + 
Sbjct: 115 -----HMHRNG-IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAP 167

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           E   T GY  P+           D+++ G V  +ILS
Sbjct: 168 ECLLTDGYYGPKM----------DIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 28/205 (13%)

Query: 319 LIGEGITGKVYKGKLSNNQHV-AIKHITNE----------GNVETFVREVASSSHVRHPN 367
           +IG G   KV   +L   + + A+K I  E             E  V E AS+    HP 
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN----HPF 57

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL---EIAIDSARGLWFLH 424
           LV L          F + E    G+L   +  + K      R    EI++     L FLH
Sbjct: 58  LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL----ALNFLH 113

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGTFGYLDPEYR 483
              E  I++RD+K  N+LL      KL+D+G+ K  I  G+T  +S   GT  Y+ PE  
Sbjct: 114 ---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEIL 168

Query: 484 SNCKVNSSGDVYSFGIVLLQILSGK 508
                  S D ++ G+++ ++++G+
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)

Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKL----SNNQHVAIKHITN-----EGNVETFV 354
           I ++    E  + + +IG G  G+V   +L    S+ Q  A+K ++        +   F 
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFW 91

Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFL--IYELCPNGNLAEWLFGKDKCLSW----IQ 408
            E    +H     +V L  +    D+ +L  + E  P G+L   +   D    W      
Sbjct: 92  EERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTA 149

Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
            + +A+D+      +HS      +HRD+KP N+LL  +   KL+DFG    +D       
Sbjct: 150 EVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200

Query: 469 SEVRGTFGYLDPE-YRSNCKVNSSG---DVYSFGIVLLQILSG 507
               GT  Y+ PE  +S       G   D +S G+ L ++L G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 29/261 (11%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFVREVASSS-------HVRHPNLVA 370
           L+G+G  G+VY    +   + +A K +  +       +EV++         +++H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 371 LLGYCLR--VDECFLIY-ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
             G CLR   ++   I+ E  P G++ + L         + R +       G+ +LHS  
Sbjct: 69  YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHS-- 124

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSK---VIDIGETYASSEVRGTFGYLDPEYRS 484
              IVHRDIK  NIL       KL DFG SK    I +  T   S V GT  ++ PE  S
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVIS 182

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-----ELADPKLDREYSIEAFDLT 539
                   DV+S G  ++++L+ K       A +A+     +  +P+L    S  A D  
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242

Query: 540 LQLALSCTALTHQRPPMEQVF 560
             + +        RP  E++ 
Sbjct: 243 GCIFVE----ARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)

Query: 303 TIREVHYATEKLNELNLIGEGITGKV-YKGKLSNNQHVAIKHITNEGNVETFV----REV 357
           TI EV    ++  +L  +G G  G V           VAIK +      E F     RE+
Sbjct: 9   TIWEVP---DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYREL 65

Query: 358 ASSSHVRHPNLVALLGYC---LRVDECFLIYELCP--NGNLAEWL----FGKDKCLSWIQ 408
               H++H N++ LL      L +D     Y + P    +L + +      +D+    IQ
Sbjct: 66  RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR----IQ 121

Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
            L   +   +GL ++H+     I+HRD+KP N+ +  + E K+ DFGL++  D       
Sbjct: 122 FLVYQM--LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD------- 169

Query: 469 SEVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
           SE+ G   T  Y  PE   N      + D++S G ++ ++L+GK
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.8 bits (129), Expect = 8e-08
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 68  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILL-GPNFEAKLSDFGLSKVIDIGE-TYASSEVRGTFG 476
           G+ +L    E  +VHRD+   N+L+  P    K++DFGL+K++   E  Y +   +    
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           ++  E   +       DV+S+G+ + ++++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 58/271 (21%), Positives = 108/271 (39%), Gaps = 42/271 (15%)

Query: 320 IGEGITGKVYKGKLSNNQHVA------IKHITNEGNVETFVREVASSSHVRHPNLVALLG 373
           IG G  GKV   ++  +  VA      +K   +      F+++      ++HPN++  LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 374 YCLRVDECFLIYELCPNGNLA------EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
            C+      L++E C  G+L       +W     + L  +QR+  A + A G+  +H ++
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL-LQRM--ACEIAAGVTHMHKHN 119

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG--YLDPEYRSN 485
               +H D+   N  L  +   K+ D+G+       E Y  +E        +L PE    
Sbjct: 120 ---FLHSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 486 -------CKVNSSGDVYSFGIVLLQILSGKKA--------KVLTRA--GSALELADPKLD 528
                   +     +V++ G+ L ++              +VL        ++L  P+L+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235

Query: 529 REYSIEAFDLTLQLALSCTALTHQRPPMEQV 559
             YS   +++ LQ    C     +R   E+V
Sbjct: 236 LPYSERWYEV-LQF---CWLSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 33/214 (15%)

Query: 312 EKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFV----REVASSSHVRHP 366
           E+   L  +G G  G V         + VAIK ++     E F     RE+    H++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 367 NLVALLGY---CLRVDECFLIYELCP--NGNLAEWL---FGKDKCLSWIQRLEIAIDSAR 418
           N++ LL      +  DE    Y + P    +L + +     +DK    +Q L        
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK----VQYL--VYQMLC 128

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TF 475
           GL ++HS     I+HRD+KP N+ +  + E K+ DFGL++       +A +E+ G   T 
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTR 178

Query: 476 GYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            Y  PE   N    N + D++S G ++ ++L+GK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 37/213 (17%)

Query: 320 IGEGITGKVYKGK---LSNNQHVAIKHITNEGNVETF----VREVASSSHVR-HPNLVAL 371
           +G+G  G V   +    S  + VAIK ITN  + +      +RE+    H R H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 372 LGYCLRV------DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA-IDS-----ARG 419
             Y + +      +E +L  EL    +L        + +   Q L  A   S       G
Sbjct: 68  --YDMDIVFPGNFNELYLYEELM-EADLH-------QIIRSGQPLTDAHFQSFIYQILCG 117

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG---ETYASSEVRGTFG 476
           L ++HS +   ++HRD+KP N+L+  + E K+ DFGL++             +E   T  
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 477 YLDPEYR-SNCKVNSSGDVYSFGIVLLQILSGK 508
           Y  PE   S      + DV+S G +L ++L  K
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 11/93 (11%)

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR---GTF 475
           GL  LH      IV+RD+KP NILL      ++SD GL+  I  GET     +R   GT 
Sbjct: 114 GLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-----IRGRVGTV 165

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           GY+ PE   N +   S D +  G ++ +++ GK
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.7 bits (131), Expect = 1e-07
 Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 44/235 (18%)

Query: 313 KLNELNLI---GEGITGKVYKGKLSNNQHV-AIKHITNEGNVE----TFVREVASSSHVR 364
           +LNE  +I   G G  G+V+  K    Q     K I+  G  E      V EV     ++
Sbjct: 11  RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70

Query: 365 HPNLVALLGYCLRV--DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSAR-- 418
           H N+V  +   L     + +++ E C  G+L+  +    KC     ++E    +D  R  
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHAIVDITRQL 127

Query: 419 --GLWFLHSYSEGC----IVHRDIKPTNILLGPNFE-----------------AKLSDFG 455
              L + H+  +G     ++HRD+KP NI L                      AK+ DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 456 LSKVIDIGETYASSEVRGTFGYLDPE--YRSNCKVNSSGDVYSFGIVLLQILSGK 508
           LSK I I E+ A S V GT  Y  PE         +   D+++ G ++ ++ SGK
Sbjct: 188 LSKNIGI-ESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 46/167 (27%), Positives = 65/167 (38%), Gaps = 58/167 (34%)

Query: 382 FLIYELCPNGNLAEWLFGKDKCL--SWIQ----RLEIAIDSARGLWFLHSYSEGCIVHRD 435
           +L+ E  P G+L   L  KD        +     L +A+DS   L F         +HRD
Sbjct: 77  YLVMEYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSVHKLGF---------IHRD 126

Query: 436 IKPTNILLGPNFEAKLSDFGLS-KVIDIGET----------------------------Y 466
           IKP NIL+  +   KL+DFGL  K+    +                              
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186

Query: 467 ASSEVRGTFGYLDPE------YRSNCKVNSSGDVYSFGIVLLQILSG 507
           A+S V GT  Y+ PE      Y   C      D +S G++L ++L G
Sbjct: 187 ANSTV-GTPDYIAPEVLRGTPYGLEC------DWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 4/78 (5%)

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNCKVN 489
           +V+RD+KP NILL  +   ++SD GL+      + +AS    GT GY+ PE  +     +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYD 174

Query: 490 SSGDVYSFGIVLLQILSG 507
           SS D +S G +L ++L G
Sbjct: 175 SSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 37/170 (21%)

Query: 315 NELNLIGEGITGKVYKG-KLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLV 369
             L  +GEG  G+VYK  ++   + VA+K I      +G   T +RE+     ++HPN+V
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVV 70

Query: 370 ALL-------GYCLRVDECF------LIYELC-----PNGNLAEWLFGKDKCLSWIQRLE 411
            L+           R           + ++L      P+  L E    + KC   +Q LE
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE---SQIKCY-MLQLLE 126

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
                  G+ +LH   E  I+HRDIK  NIL+      K++DFGL++  D
Sbjct: 127 -------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 20/205 (9%)

Query: 317 LNLIGEGITGKVY---------KGKLSNN---QHVAIKHITNEGNVETFVREVASSSHVR 364
           L ++G G  GKV+          GKL      Q  A+  +     VE    E     HVR
Sbjct: 5   LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL--VQKAKTVEHTRTERNVLEHVR 62

Query: 365 HPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
               +  L Y  + + +  LI +    G +   L+ +D         E+   S   +  L
Sbjct: 63  QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILAL 118

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-Y 482
               +  IV+RDIK  NILL       L+DFGLSK     E   +    GT  Y+ PE  
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSG 507
           R       + D +S GI++ ++L+G
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 21/199 (10%)

Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           IG+G  GKV + +  + Q + A+K     HI +   V   + E    + V  P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 374 YCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
                ++ +L+      G L      E  F   +   +   L  A+++      LH ++ 
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALEN------LHKFN- 113

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             +++RD+KP NILL       L DFGL K +++ +   ++   GT  YL PE       
Sbjct: 114 --VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGY 170

Query: 489 NSSGDVYSFGIVLLQILSG 507
             + D ++ G++L ++L+G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 13/187 (6%)

Query: 325 TGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVD-ECF 382
           +GK+Y  K+     +  K  T E    E  V E     H+R    +  L Y  + D +  
Sbjct: 27  SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE-----HIRQSPFLVTLHYAFQTDTKLH 81

Query: 383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL 442
           LI +    G L   L  +++     +  E+ I S   +  L    +  I++RDIK  NIL
Sbjct: 82  LILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137

Query: 443 LGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV--NSSGDVYSFGIV 500
           L  N    L+DFGLSK     E   +    GT  Y+ P+         + + D +S G++
Sbjct: 138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197

Query: 501 LLQILSG 507
           + ++L+G
Sbjct: 198 MYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 315 NELNLIGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNL 368
           N L ++G+G  GKV   +    ++  AIK      +  + +VE  + E    +    P  
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62

Query: 369 VALLGYCLR-VDECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           +  L  C + VD  + + E    G+L   +   GK K     Q +  A + + GL+FLH 
Sbjct: 63  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK---EPQAVFYAAEISVGLFFLH- 118

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                I++RD+K  N++L      K++DFG+ K   + +   +    GT  Y+ PE  + 
Sbjct: 119 --RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFCGTPDYIAPEIIAY 175

Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
                S D +++G++L ++L+G+
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 24/197 (12%)

Query: 319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           L+ E  +GK Y  K+   + +  K       V   + E     + RHP L +L  Y  + 
Sbjct: 13  LVREKASGKYYAMKILKKEVIIAKD-----EVAHTLTESRVLKNTRHPFLTSL-KYSFQT 66

Query: 379 DE--CFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            +  CF++ E    G L      E +F +D+   +   +  A+D      +LHS   G I
Sbjct: 67  KDRLCFVM-EYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD------YLHS---GKI 116

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           V+RD+K  N++L  +   K++DFGL K   I +        GT  YL PE   +     +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 492 GDVYSFGIVLLQILSGK 508
            D +  G+V+ +++ G+
Sbjct: 176 VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTF 475
           A+G+ FL S  + CI HRD+   NILL      K+ DFGL++ I     Y      R   
Sbjct: 224 AKGMSFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   NC      DV+S+GI+L +I S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 69/307 (22%), Positives = 129/307 (42%), Gaps = 52/307 (16%)

Query: 320 IGEGITGKVYKGKLSN---NQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           +G G  G VYK K  +    +  A+K I   G   +  RE+A    ++HPN++AL    L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 377 RVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQR--LEIAIDSARGLWF-----LHSYS 427
              +   +L+++   +     W   K    S   +  +++     + L +     +H   
Sbjct: 69  SHSDRKVWLLFDYAEHD---LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 428 EGCIVHRDIKPTNILL---GPNF-EAKLSDFGLSKVID--IGETYASSEVRGTFGYLDPE 481
              ++HRD+KP NIL+   GP     K++D G +++ +  +        V  TF Y  PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 482 YRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADP----KLDREYSIEAF 536
                +  +   D+++ G +  ++L+ +   +       ++ ++P    +LDR +S+  F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE--PIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243

Query: 537 -------DL-------TLQLALSCTALT----------HQRPPMEQVFVTLQKALDISTT 572
                  D+       TLQ     T             H+  P  +VF+ LQK L +  T
Sbjct: 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303

Query: 573 AKASTTQ 579
            + ++ Q
Sbjct: 304 KRITSEQ 310

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 35/170 (20%)

Query: 355 REVASSSHVRHPNLVALLGY---CLRVDECFLIYELCPNGNLAEWLFGKD-----KCLSW 406
           RE+    H++H N++ LL        ++E   +Y       L   L G D     KC   
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMGADLNNIVKCQKL 117

Query: 407 ----IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI 462
               +Q L   I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++    
Sbjct: 118 TDDHVQFLIYQI--LRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 168

Query: 463 GETYASSEVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
              +   E+ G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 169 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 8/98 (8%)

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
           EIAI    GL+FLHS     I++RD+K  N++L      K++DFG+ K  +I     +  
Sbjct: 109 EIAI----GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRT 160

Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             GT  Y+ PE  +      S D ++FG++L ++L+G+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 32/81 (39%), Positives = 46/81 (56%), Gaps = 8/81 (9%)

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR---GTFGYLDPEYRSNCK 487
           IV+RD+KP NILL      ++SD GL+  I  GET     VR   GT GY+ PE  +N K
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAPEVINNEK 177

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
              S D +  G ++ +++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 32/225 (14%)

Query: 320 IGEGITGKVYKGKLSNNQH-----------VAIKHITNEGNV-ETFVREVASSSHVRHPN 367
           +G+G    +YKG L                V +K + ++      F    +  S + H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           LV L G C+R DE  ++ E    G L  +L  +   +S   +L++A   A  L +L    
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118

Query: 428 EGCIVHRDIKPTNILL---GPNFE----AKLSDFGLSKVIDIGETYASSEVR-GTFGYLD 479
           +  +VH ++   NIL+   G N       KLSD G      I  T  S E R     ++ 
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG------IPITVLSREERVERIPWIA 172

Query: 480 PEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL 522
           PE   N    +  + D +SFG  LL+I S  +  + T + S  E 
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER 217

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 11/83 (13%)

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSK------VIDIGETYASSEVRGTFGYLDPEYR 483
            ++HRD+K  NI L P    KL DFG SK       +D+  ++      GT  YL PE  
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC-----GTPYYLAPELW 243

Query: 484 SNCKVNSSGDVYSFGIVLLQILS 506
              + +   D++S G++L ++L+
Sbjct: 244 ERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 20/153 (13%)

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNL---------AEWLFGKDKCLSWIQRLE 411
           S + HP +V      L  D   +I E C   +L               +++   W  +L 
Sbjct: 57  SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
           + +       ++H   +  I+HRD+K  NI L  N   K+ DFG+S+++ +G    ++  
Sbjct: 117 LGVH------YMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTF 165

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
            GT  Y+ PE   +   +S  D++S G +L ++
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 41/227 (18%)

Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           IR++    E  + + +IG G  G+V   +  ++Q V A+K      +    +   F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 358 ASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQ----RLE 411
              +    P +V L  +C   D+   +++ E  P G+L   +   D    W +     + 
Sbjct: 95  DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV 152

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID-IGETYASSE 470
           +A+D+      +HS     ++HRD+KP N+LL  +   KL+DFG    +D  G     + 
Sbjct: 153 LALDA------IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203

Query: 471 VRGTFGYLDPE----------YRSNCKVNSSGDVYSFGIVLLQILSG 507
           V GT  Y+ PE          Y   C      D +S G+ L ++L G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGREC------DWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 12/131 (9%)

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           GL  LH   +  IV+RD+KP N+LL  +   ++SD GL+  +++          GT GY+
Sbjct: 107 GLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYM 161

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK------KAKVLTRAGSALELADP-KLDREY 531
            PE       + S D ++ G  L ++++G+      K KV         L    +   ++
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF 221

Query: 532 SIEAFDLTLQL 542
           S EA DL   L
Sbjct: 222 SPEAKDLCEAL 232

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 28/78 (35%), Positives = 46/78 (58%), Gaps = 2/78 (2%)

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IV+RD+KP NILL  +   ++SD GL+  +  G+T       GT GY+ PE   N +   
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTF 180

Query: 491 SGDVYSFGIVLLQILSGK 508
           S D ++ G +L ++++G+
Sbjct: 181 SPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 35/156 (22%)

Query: 316 ELNLIGEGITGKVY------KGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLV 369
           E+ L+ +  TG +Y      K ++   + VA  H+  E       R++ + +   +P +V
Sbjct: 16  EVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA--HVRAE-------RDILAEAD--NPWVV 64

Query: 370 ALLGYCLRVDE--CFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWF 422
            L  Y    DE   +LI E  P G++   L     F +++   +I    +AIDS   L +
Sbjct: 65  KL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK 458
                    +HRDIKP N+LL      KLSDFGL  
Sbjct: 123 ---------IHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 61/215 (28%), Positives = 90/215 (41%), Gaps = 28/215 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV----ETFVREVASSSHVRHPN 367
           E    L +IG G  G+V   KL N   V    I N+  +    ET          V   N
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 368 -LVALLGYCLRVDE-CFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSARG 419
             +  L Y  + +   +L+ +    G+L   L        +D    ++  + IAIDS   
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYL 478
           L +         VHRDIKP NIL+  N   +L+DFG   K+++ G T  SS   GT  Y+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYI 170

Query: 479 DPEY-----RSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE          K     D +S G+ + ++L G+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 32/207 (15%)

Query: 319 LIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVE-TFVREVASSSHVRHPNLVAL 371
           ++G+G  GKV   +L     V AIK      I  + +V+ T   +   +   +HP L AL
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR----------GLW 421
                  D  F + E    G+L          +  IQR     D  R           L 
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDL----------MFQIQRSR-KFDEPRSRFYAAEVTLALM 110

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           FLH +    +++RD+K  NILL      KL+DFG+ K   I     ++   GT  Y+ PE
Sbjct: 111 FLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPE 166

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                +   S D ++ G+++ ++++G+
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)

Query: 313 KLNELNL---IGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSSHV 363
           KL++  +   +G G  G+V   K     ++ AIK      I     V+   +E +    +
Sbjct: 16  KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSAR 418
            HP +V ++      +  + + E    G L   L     F  D    +   L +A +   
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE--- 132

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGETYASSEVRGTFGY 477
              +LHS     I++RD+KP N+LL      K++DFG +K V D   T+    + GT  Y
Sbjct: 133 ---YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFT---LCGTPEY 181

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           L PE   +     + D ++ G++L + ++G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTF 475
           ARG+ FL S    CI HRD+   NILL  N   K+ DFGL++ I     Y      R   
Sbjct: 184 ARGMEFLAS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +    +  DV+SFG++L +I S
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 26/204 (12%)

Query: 319 LIGEGITGKVYKGKLSNNQHV-AIKHITNE----------GNVETFVREVASSSHVRHPN 367
           +IG G   KV   +L  N  + A+K +  E             E  V E ASS+    P 
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN----PF 57

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL---EIAIDSARGLWFLH 424
           LV L          FL+ E    G+L   +  + K      R    EI I     L FLH
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI----ALNFLH 113

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
              E  I++RD+K  N+LL  +   KL+D+G+ K   +G    +S   GT  Y+ PE   
Sbjct: 114 ---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILR 169

Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
             +   S D ++ G+++ ++++G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 47/160 (29%), Positives = 64/160 (40%), Gaps = 28/160 (17%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           E    L +IG G  G+V   +  +  HV    I  + ++     E     H+R    + +
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM----LEKEQVGHIRAERDILV 56

Query: 372 LGYCLRVDECF----------LIYELCPNGNLAEWLFGKDKCLS-----WIQRLEIAIDS 416
               L V + F          LI E  P G++   L  KD         +I    +AIDS
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL 456
              L F         +HRDIKP N+LL      KLSDFGL
Sbjct: 117 IHQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)

Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74

Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 120

Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 121 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 177

Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 44/220 (20%)

Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L   ++VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEW--------LFGKDKCLSWIQRLEIAIDS 416
           H N++ LL                P  +L E+        L   + C    Q +++ +D 
Sbjct: 82  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLC----QVIQMELDH 125

Query: 417 ARGLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
            R  + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMM 182

Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           +    T  Y  PE         + D++S G ++ +++ G 
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.4 bits (123), Expect = 6e-07
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTF 475
           ARG+ FL S    CI HRD+   NILL  N   K+ DFGL++ I     Y    + R   
Sbjct: 183 ARGMEFLAS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +    +  DV+SFG++L +I S
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
           EIAI    GL+FLHS     I++RD+K  N++L      K++DFG+ K  ++ +   +  
Sbjct: 109 EIAI----GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKT 160

Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             GT  Y+ PE  +      S D ++FG++L ++L+G+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 24/206 (11%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFVREVASSS-------HVRHPNLVA 370
           L+G G  G+VY        + +A+K +  + + +   +EV +         ++RH  +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 371 LLGYCLRVDE---CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
             G CLR  E     +  E  P G++ + L         + R        +G+ +LHS  
Sbjct: 69  YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHS-- 124

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS-----EVRGTFGYLDPEY 482
              IVHRDIK  NIL       KL DFG SK I   +T   S      V GT  ++ PE 
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPYWMSPEV 180

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
            S        DV+S    ++++L+ K
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 33/248 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPN 367
           E L+EL   G+G  G VYK         +A+K I    +E      + E+        P 
Sbjct: 4   EVLDEL---GKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWI---QRLEIAIDSARGLWFLH 424
           +V   G        ++  E    G+L + L+        I       I     +GL FL 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK--VIDIGETYASSEVRGTFGYLDPEY 482
              E  I+HRD+KPTN+L+  N + KL DFG+S   V  + +T       G   Y+ PE 
Sbjct: 120 E--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPER 172

Query: 483 RSNCKVNSSG------DVYSFGIVLLQILSGK-------KAKVLTRAGSALELADPKLDR 529
             +   N +       DV+S G+ +L++  G+        A +  +  + ++   P L  
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS 232

Query: 530 EYSIEAFD 537
            YS +A D
Sbjct: 233 GYSDDAQD 240

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 32/208 (15%)

Query: 316 ELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGY 374
           E+ ++ E  TG +Y  K +  +  +A + ++       F  E      + +   +  L Y
Sbjct: 16  EVQVVREKATGDIYAMKVMKKSVLLAQETVS-------FFEEERDILSISNSPWIPQLQY 68

Query: 375 CLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL-------HSY 426
             +  D  +L+ E  P G+L          LS + R E   D     ++L       HS 
Sbjct: 69  AFQDKDNLYLVMEYQPGGDL----------LSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY---- 482
            +   VHRDIKP N+L+      KL+DFG +  +   +   S    GT  Y+ PE     
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 483 --RSNCKVNSSGDVYSFGIVLLQILSGK 508
                       D +S G++  +++ G+
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 3/85 (3%)

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
             + E   V+RD+KP NILL      ++SD GL+  I  GE+       GT GY+ PE  
Sbjct: 117 DLHREN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVL 173

Query: 484 SNCKVNSSGDVYSFGIVLLQILSGK 508
           +N +   S D +  G ++ +++ G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 8/96 (8%)

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----G 473
           + L ++HS   G ++HRD+KP+NILL  +   KL+DFGL++ +   E    + V      
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y  PE        + G D++S G +L ++L GK
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 32/219 (14%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVALL 372
           LIG+G  G+VY       ++ VA+K I      N    + F+RE   ++ + HP +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS------- 425
             C   D  +          L   L    +  S  + L         L   H        
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 426 -YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV----------IDIGETYASS----- 469
            +S+G ++HRD+KP NILLG   E  + D+G +            ID+ E          
Sbjct: 129 VHSKG-VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187

Query: 470 --EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             ++ GT  Y+ PE       + S D+Y+ G++L Q+L+
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 34/114 (29%), Positives = 51/114 (44%), Gaps = 26/114 (22%)

Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
           ++  + +AIDS   L +         VHRDIKP N+LL  N   +L+DFG    +    T
Sbjct: 107 YLAEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157

Query: 466 YASSEVRGTFGYLDPE-----------YRSNCKVNSSGDVYSFGIVLLQILSGK 508
             S+   GT  Y+ PE           Y   C      D +S G+ + ++L G+
Sbjct: 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPEC------DWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 10/195 (5%)

Query: 319 LIGEGITGKVYKG--KLSNNQH--VAIKHI---TNEGNVETFVREVASSSHVRHPNLVAL 371
           ++G G  G++ +G  KL + +   VAI  +    ++     F+ E  +     H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   R +   ++ E   NG L  +L   +  L   Q + +    A G+ +L   SE   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           VH+ +    +L+  +   K+S F   +       Y +   +    +  PE       +S+
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188

Query: 492 GDVYSFGIVLLQILS 506
            DV+SFGIV+ +++S
Sbjct: 189 SDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 30/81 (37%), Positives = 40/81 (49%), Gaps = 14/81 (17%)

Query: 382 FLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +LI E  P G+L   L     F +D    ++    +AI++   L F         +HRDI
Sbjct: 77  YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF---------IHRDI 127

Query: 437 KPTNILLGPNFEAKLSDFGLS 457
           KP NIL+      KLSDFGLS
Sbjct: 128 KPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTF 475
           A+G+ FL S  + CI HRD+   N+LL     AK+ DFGL++ I     Y      R   
Sbjct: 222 AQGMDFLAS--KNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +C      DV+S+GI+L +I S
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           G+  LHS     IV+RD+KP N+LL      +LSD GL+  +++ +    ++  GT GY+
Sbjct: 107 GILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYM 161

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE       +   D ++ G  + ++++G+
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 34/213 (15%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           + +IG G  G+V   K+ + + +    I N+   E   R  A ++  R    V + G C 
Sbjct: 6   IKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKR--AETACFREERNVLVNGDCQ 61

Query: 377 RV--------DE--CFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSARGL 420
            +        DE   +L+ +    G+L   L        +D    +I  + +AI S   L
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +         VHRDIKP N+LL  N   +L+DFG    ++   T  SS   GT  Y+ P
Sbjct: 122 HY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172

Query: 481 EYRSNC-----KVNSSGDVYSFGIVLLQILSGK 508
           E          K     D +S G+ + ++L G+
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 25/198 (12%)

Query: 319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           L+ E  TG+ Y  K+   + +  K        E  V +     + RHP L AL  Y  + 
Sbjct: 13  LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----NSRHPFLTAL-KYSFQT 66

Query: 379 DE--CFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            +  CF++ E    G L      E +F +D+   +   +  A+D      +LHS     +
Sbjct: 67  HDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVSALD------YLHSEKN--V 117

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           V+RD+K  N++L  +   K++DFGL K  I  G T  +    GT  YL PE   +     
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGR 175

Query: 491 SGDVYSFGIVLLQILSGK 508
           + D +  G+V+ +++ G+
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 20/204 (9%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFVREVASSS-------HVRHPNLVA 370
           L+G+G  G+VY        + +A+K +  +       +EV +         ++ H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 371 LLGYCLR--VDECFLIY-ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
             G CLR  ++    I+ E  P G++ + L         + R +       G+ +LHS  
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHS-- 124

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSK---VIDIGETYASSEVRGTFGYLDPEYRS 484
              IVHRDIK  NIL       KL DFG SK    I +  T   S V GT  ++ PE  S
Sbjct: 125 -NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVIS 182

Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
                   D++S G  ++++L+ K
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 30/80 (37%), Positives = 38/80 (47%), Gaps = 14/80 (17%)

Query: 382 FLIYELCPNGNLAEWLFGKDKCLS-----WIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +LI E  P G++   L  KD         +I    +AID+   L F         +HRDI
Sbjct: 77  YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---------IHRDI 127

Query: 437 KPTNILLGPNFEAKLSDFGL 456
           KP N+LL      KLSDFGL
Sbjct: 128 KPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 19/167 (11%)

Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E+F    +  S + H +LV   G C+  DE  ++ E    G+L  +L      ++   +L
Sbjct: 44  ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL 103

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---------GPNFEAKLSDFGLSKVID 461
           E+A   A   W LH   +  + H ++   N+LL          P F  KLSD G+S  + 
Sbjct: 104 EVAKQLA---WALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPF-IKLSDPGISITVL 159

Query: 462 IGETYASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSG 507
             E            ++ PE   N + ++ + D +SFG  L +I SG
Sbjct: 160 PKEILLER-----IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 24/197 (12%)

Query: 319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           L+ E  TG+ Y  K+   + +  K       V   V E     + RHP L AL  Y  + 
Sbjct: 13  LVREKATGRYYAMKILRKEVIIAKD-----EVAHTVTESRVLQNTRHPFLTAL-KYAFQT 66

Query: 379 DE--CFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            +  CF++ E    G L      E +F +++   +   +  A++      +LHS     +
Sbjct: 67  HDRLCFVM-EYANGGELFFHLSRERVFTEERARFYGAEIVSALE------YLHSRD---V 116

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           V+RDIK  N++L  +   K++DFGL K   I +        GT  YL PE   +     +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 492 GDVYSFGIVLLQILSGK 508
            D +  G+V+ +++ G+
Sbjct: 176 VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 48/215 (22%), Positives = 91/215 (42%), Gaps = 26/215 (12%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIK----HITNEGNVETFVREVASSSHVRHP 366
           +   +L  IGEG  GKVYK +  +  + VA+K     +  EG   T +RE++    +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 367 NLVALLGYCLRVDE------CFLIYELCPNGNLAEWLFGKDKCL------SWIQRLEIAI 414
             +  L     V+E       +L++E   + +L +++    +          I+     +
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSDFGLSKVIDIGETYASSEVRG 473
              +G+   H +    ++HRD+KP N+L+       K++D GL +   I     + E+  
Sbjct: 120 --LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV- 173

Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSG 507
           T  Y  PE        S+  D++S G +  ++   
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTF 475
           A+G+ FL S    CI HRD+   NILL  N   K+ DFGL++ I     Y    + R   
Sbjct: 189 AKGMEFLAS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +       DV+SFG++L +I S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 16/199 (8%)

Query: 319 LIGEGITGKVYKGKLSNNQHV-AIKHITNE-GNVETFVREVASSSHV-----RHPNLVAL 371
           +IG G   KV   +L   + + A+K +  E  N +  +  V +  HV      HP LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
              C + +   F + E    G+L   +  + K      R   A + +  L +LH   E  
Sbjct: 62  HS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERG 116

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           I++RD+K  N+LL      KL+D+G+ K  +  G+T  +S   GT  Y+ PE        
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYG 174

Query: 490 SSGDVYSFGIVLLQILSGK 508
            S D ++ G+++ ++++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 12/94 (12%)

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET----YASSEVRGT 474
           GL  LH      I++RD+KP N+LL  +   ++SD GL+  +  G++    YA     GT
Sbjct: 109 GLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GT 160

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            G++ PE     + + S D ++ G+ L ++++ +
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 15/94 (15%)

Query: 369 VALLGYCLRVDEC-FLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWF 422
           V  L Y  +  +  + + +  P G++   L     F +D    +I  L  AI+S   + F
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL 456
                    +HRDIKP NIL+  +   KL+DFGL
Sbjct: 123 ---------IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 8/106 (7%)

Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           L+ +  L      ARG+ FL S  + C VHRD+   N+LL      K+ DFGL++ I   
Sbjct: 234 LTTLDLLSFTYQVARGMEFLAS--KNC-VHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 464 ETYASSEVRGTF---GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             Y S     TF    ++ PE   +    +  DV+S+GI+L +I S
Sbjct: 291 SNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 15/122 (12%)

Query: 390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA 449
           + +L  +L  + + L   Q L I      GL +LH+     I+HRD+K  NI +    + 
Sbjct: 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQV 196

Query: 450 KLSDFGLSKV-----IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
            + D G ++        +G       + GT     PE  +  K NS  D++S GIVL ++
Sbjct: 197 CIGDLGAAQFPVVAPAFLG-------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Query: 505 LS 506
           L+
Sbjct: 250 LA 251

Length = 357

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 64/312 (20%), Positives = 128/312 (41%), Gaps = 62/312 (19%)

Query: 320 IGEGITGKVYKGKLSN---NQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL----L 372
           +G G  G VYK K  +   ++  A+K I   G   +  RE+A    ++HPN+++L    L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR----------GLWF 422
            +  R  + +L+++   +     W   K    S   +  + +              G+ +
Sbjct: 69  SHADR--KVWLLFDYAEHD---LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 423 LHSYSEGCIVHRDIKPTNILL---GPNF-EAKLSDFGLSKVID--IGETYASSEVRGTFG 476
           LH+     ++HRD+KP NIL+   GP     K++D G +++ +  +        V  TF 
Sbjct: 124 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 477 YLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADP----KLDREY 531
           Y  PE     +  +   D+++ G +  ++L+ +   +       ++ ++P    +LDR +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE--PIFHCRQEDIKTSNPYHHDQLDRIF 238

Query: 532 SIEAF--------------------DLTLQLALSCTAL----THQRPPMEQVFVTLQKAL 567
           ++  F                    D       +C+ +     H+  P  + F  LQK L
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298

Query: 568 DISTTAKASTTQ 579
            +    + ++ Q
Sbjct: 299 TMDPIKRITSEQ 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 31/206 (15%)

Query: 319 LIGEGITGKVY--KGKLSNNQHVAIKHITNEGNVETFVREVA---SSSHV----RHPNLV 369
           L+G+G  GKV   + K +  ++ A+K +  E  V     EVA   + S V    RHP L 
Sbjct: 2   LLGKGTFGKVILVREK-ATGKYYAMKILKKE--VIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 370 ALLGYCLRVDE--CFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
           AL  Y  +  +  CF++ E    G L      E +F +D+   +   +  A+       +
Sbjct: 59  AL-KYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------Y 110

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           LHS     +V+RD+K  N++L  +   K++DFGL K   I +        GT  YL PE 
Sbjct: 111 LHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEV 166

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
             +     + D +  G+V+ +++ G+
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 8/121 (6%)

Query: 389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE 448
           P     + L  +   LS++  +  +   A G+ FL S  + C VHRD+   N+L+     
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNC-VHRDLAARNVLICEGKL 277

Query: 449 AKLSDFGLSKVIDIGETYASSEVRGTF---GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            K+ DFGL++ I     Y S     TF    ++ PE   N    +  DV+SFGI+L +I 
Sbjct: 278 VKICDFGLARDIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335

Query: 506 S 506
           +
Sbjct: 336 T 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.6 bits (109), Expect = 3e-05
 Identities = 41/133 (30%), Positives = 61/133 (45%), Gaps = 20/133 (15%)

Query: 382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNI 441
            LI +   +G+L + L  K+  LS  +  +I       L  LH ++   I+H DIK  N+
Sbjct: 85  VLIMDYIKDGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENV 140

Query: 442 LLGPNFEAK----LSDFGLSKVIDIGETYASSEVRGTFGYLDPE--YRSNCKVNSSGDVY 495
           L      AK    L D+GL K+I        S   GT  Y  PE     N  V  S D +
Sbjct: 141 LY---DRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPEKIKGHNYDV--SFDWW 190

Query: 496 SFGIVLLQILSGK 508
           + G++  ++L+GK
Sbjct: 191 AVGVLTYELLTGK 203

Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 11/97 (11%)

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA---KLSDFGLSKVIDIGETYAS--SEVR 472
           RGL ++HS +   ++HRD+KP N+ +  N E    K+ DFGL++++D   ++    SE  
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFI--NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179

Query: 473 GTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQILSGK 508
            T  Y  P    S      + D+++ G +  ++L+GK
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 37/225 (16%)

Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           IR++    E    + +IG G  G+V   +  + + V A+K      +    +   F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 358 ASSSHVRHPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQ----RLEI 412
              +    P +V L  Y  + D   +++ E  P G+L   +   D    W +     + +
Sbjct: 95  DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+D+   + F         +HRD+KP N+LL  +   KL+DFG    ++           
Sbjct: 154 ALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 473 GTFGYLDPE----------YRSNCKVNSSGDVYSFGIVLLQILSG 507
           GT  Y+ PE          Y   C      D +S G+ L ++L G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGREC------DWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 30/148 (20%), Positives = 53/148 (35%), Gaps = 11/148 (7%)

Query: 316 ELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLV-ALLG 373
            + L+  G+T +VY    + ++   +K   +        REVA    +      V  +L 
Sbjct: 2   SIKLLKGGLTNRVYLLG-TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
                   +L+ E      L E        +S  ++ +IA   A  L  LH      + H
Sbjct: 61  SGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVID 461
            D+ P NIL+       + D+  +    
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 20/203 (9%)

Query: 318 NLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGY-- 374
           N+IG G  G VY+   +  ++ VAIK +  +   +   RE+    ++ H N++ L  Y  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYY 129

Query: 375 --CLRVDE--CFL--IYELCPNG--NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
             C + +E   FL  + E  P       +     +  L        +    R L ++HS 
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS- 188

Query: 427 SEGCIVHRDIKPTNILLGPNFEA-KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR-S 484
               I HRD+KP N+L+ PN    KL DFG +K + +    + S +   F Y  PE    
Sbjct: 189 --KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSYICSRF-YRAPELMLG 244

Query: 485 NCKVNSSGDVYSFGIVLLQILSG 507
                +  D++S G ++ +++ G
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 20/149 (13%)

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNL----AEWLFGKDKCLS-WIQRLEIAIDSARGL 420
           PN+V L  Y +  D  FL+ +    G L    +++L   ++C+  W   + +A+D+    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG-LSKVIDIGETYASSEVRGTFGYLD 479
             LH   EG IV RD+ P NILL      +L+ F   S+V D  +  A   +     Y  
Sbjct: 101 --LHR--EG-IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCA 150

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE     +   + D +S G +L ++L+GK
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 39/236 (16%)

Query: 319 LIGEGITGKVYKGKLSNNQHV---AIKHITNEGNVETFVREVASSSHVRHPNLVAL---- 371
           LIG G  G VY+ + +++  +   A+  I N  N ET V E    +++   + +AL    
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLEN-ETIVMETLVYNNIYDIDKIALWKNI 77

Query: 372 -----LG-----------YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
                LG            C       L+ +L  N      +F + KC +      I  D
Sbjct: 78  HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKE---IFKRIKCKNKKLIKNIMKD 134

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG----ETYASSE- 470
               L ++H +    I H DIKP NI++  N    + D+G++    I     E     + 
Sbjct: 135 MLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191

Query: 471 -VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA--KVLTRAGSALELA 523
             RGT  Y   +  +   V   GD+ S G  +L+  +G K   K     G+ +  A
Sbjct: 192 LHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK-WAGIKLPWKGFGHNGNLIHAA 246

Length = 294

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 40/217 (18%)

Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++  +L  IG G  G V   +   L  N  VA+K ++    N+ + +   RE+     V 
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78

Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q + + +D  R
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLC-------------QVIHMELDHER 124

Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++       +  + 
Sbjct: 125 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTP 181

Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 14/83 (16%)

Query: 379 DECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
           D  + + +  P G++   L     F +D    +I  L  A++S   + F         +H
Sbjct: 74  DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF---------IH 124

Query: 434 RDIKPTNILLGPNFEAKLSDFGL 456
           RDIKP NIL+  +   KL+DFGL
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 42/165 (25%)

Query: 317 LNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLV 369
           L  IG G  G V   Y       Q+VAIK ++    N  + +   RE+     V H N++
Sbjct: 21  LKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNII 78

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEW--------LFGKDKCLSWIQRLEIAIDSARGLW 421
            LL         F      P  +L E+        L   + C    Q +++ +D  R  +
Sbjct: 79  GLL-------NVF-----TPQKSLEEFQDVYLVMELMDANLC----QVIQMDLDHERMSY 122

Query: 422 FL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK 458
            L        H +S G I+HRD+KP+NI++  +   K+ DFGL++
Sbjct: 123 LLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 37/147 (25%), Positives = 66/147 (44%), Gaps = 17/147 (11%)

Query: 319 LIGEGI----TGKVYKGKLSNNQHVAIKHITNEGNVETFV----REVASSSHVRHPNLVA 370
           LIG+         + K K   N  VA+K I  +   +  +    +E+ +S  ++HPN++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSYS 427
            +   +   E +++  L   G+  + L  K      +  L IA    D    L ++HS  
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHS-- 119

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDF 454
           +G I HR +K ++ILL  + +  LS  
Sbjct: 120 KGFI-HRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 64/214 (29%), Positives = 88/214 (41%), Gaps = 64/214 (29%)

Query: 313 KLNELNL---IGEGITGKVYKGKLSNNQH-----VAIKHITNEGNVETFVREVASSSHVR 364
           K ++  L   +GEG  G VYK  L N Q        +K  T  G VE ++ E      VR
Sbjct: 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-----RVR 184

Query: 365 H--PNLVA--LLGYCLRV-----DECFLI---------YELCPNG----NLAEWLFGKDK 402
              PN  A  + G+   V     DE +L+          +L  +     N+  +L GK +
Sbjct: 185 RACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQ 244

Query: 403 CL--------SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
            L          IQ +   I  A  L  LHS     IVHRD+KP NI+    F      F
Sbjct: 245 DLPKGLERENKIIQTIMRQILFA--LDGLHSTG---IVHRDVKPQNII----FSEGSGSF 295

Query: 455 GLSKVIDIGETYASSEVRGTFGY------LDPEY 482
              K+ID+G   A++++R    Y      LDP Y
Sbjct: 296 ---KIIDLG---AAADLRVGINYIPKEFLLDPRY 323

Length = 566

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 14/83 (16%)

Query: 379 DECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
           D  + + +  P G++   L     F +     +I  L +AI+S   + F         +H
Sbjct: 74  DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF---------IH 124

Query: 434 RDIKPTNILLGPNFEAKLSDFGL 456
           RDIKP NIL+  +   KL+DFGL
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 8/64 (12%)

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           GL  LH      IVHRDIKP N+L+  + + K+ DFG +  +  G  +        +G L
Sbjct: 321 GLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-----LYGML 372

Query: 479 DPEY 482
           DP Y
Sbjct: 373 DPRY 376

Length = 507

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 25/162 (15%)

Query: 356 EVAS-SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLE 411
           E AS  S V H +L  + G C+R  E  ++ E   +G L   L  K+K    ++W  ++ 
Sbjct: 65  ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAW--KIT 121

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILL-------GPNFEAKLSDFGLSKVIDIGE 464
           +A   A  L +L   +   +VH ++   NILL       G +   KLSD G      +  
Sbjct: 122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPG------VSF 172

Query: 465 TYASSEVR-GTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQI 504
           T  S E R     ++ PE       ++++ D +SFG  LL+I
Sbjct: 173 TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	588
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.91
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
PRK10345	210	hypothetical protein; Provisional	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
smart00090	237	RIO RIO-like kinase.	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
KOG1243	690	consensus Protein kinase [General function predict	99.15
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.04
KOG3087	229	consensus Serine/threonine protein kinase [General	98.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.92
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.91
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.84
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.84
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.7
COG4248	637	Uncharacterized protein with protein kinase and he	98.67
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.6
PRK09902	216	hypothetical protein; Provisional	98.42
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.42
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.39
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.35
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.32
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.3
PF01636	239	APH: Phosphotransferase enzyme family This family	98.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.11
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.07
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.06
PRK10593	297	hypothetical protein; Provisional	97.99
PLN02876	822	acyl-CoA dehydrogenase	97.98
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.83
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.83
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.81
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.64
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.63
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.53
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.47
PRK05231	319	homoserine kinase; Provisional	97.39
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.29
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.25
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.21
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.86
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.61
PLN02236	344	choline kinase	96.34
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.29
PLN02756	418	S-methyl-5-thioribose kinase	96.11
COG2334	331	Putative homoserine kinase type II (protein kinase	95.89
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.85
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.78
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.76
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.69
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.64
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.44
PRK11768	325	serine/threonine protein kinase; Provisional	94.93
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.93
KOG2270	520	consensus Serine/threonine protein kinase involved	94.83
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.55
PRK06148	1013	hypothetical protein; Provisional	94.48
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.05
PRK12396	409	5-methylribose kinase; Reviewed	93.85
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.85
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	92.79
KOG1236	565	consensus Predicted unusual protein kinase [Genera	92.77

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-55  Score=465.19  Aligned_cols=272  Identities=45%  Similarity=0.729  Sum_probs=239.8

Q ss_pred             CCCcccHHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCc--HHHHHHHHHHhccCCCCceeEEecce
Q 042871          298 GCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN--VETFVREVASSSHVRHPNLVALLGYC  375 (588)
Q Consensus       298 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~g~~  375 (588)
                      ....|+++++..||++|+..+.||+|+||.||+|.+++|..||||++.....  ..+|.+|++++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            5678999999999999999999999999999999999999999999986543  56799999999999999999999999


Q ss_pred             eccC-eeeEEeecCCCCChhhhhhcCCc-CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEe
Q 042871          376 LRVD-ECFLIYELCPNGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSD  453 (588)
Q Consensus       376 ~~~~-~~~LV~E~~~~gsL~~~L~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~D  453 (588)
                      .+.+ +++||||||+||+|.++|+.... .++|.+|++|+.++|+||+|||+...++|+||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999998776 899999999999999999999999999999999999999999999999999


Q ss_pred             cCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccc----------------ccc
Q 042871          454 FGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLT----------------RAG  517 (588)
Q Consensus       454 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~----------------~~~  517 (588)
                      ||+|+..............||.+|+||||+..+..+.|+|||||||+|+||+||+++....                ..+
T Consensus       221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            9999765431111111118999999999999999999999999999999999999865432                233


Q ss_pred             chhhhcCcccC-cccCH-HHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          518 SALELADPKLD-REYSI-EAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       518 ~~~~~~d~~l~-~~~~~-e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      +..+++|+.+. ..+.. +....+.+++.+|++ +|.+||+|.||+++|+.+...
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            67788899987 55654 678889999999999 689999999999999766554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=395.28  Aligned_cols=255  Identities=31%  Similarity=0.460  Sum_probs=215.3

Q ss_pred             ccccceeeccCceEEEEEEecCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccC-eeeEEeecC
Q 042871          314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVD-ECFLIYELC  388 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~LV~E~~  388 (588)
                      +...+.||+|+||+||+|.+.....||||++....    ..+.|.+|+.+|.+++|||||+++|+|.+.. ...+||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            34445699999999999999544449999997532    2568999999999999999999999999887 799999999


Q ss_pred             CCCChhhhhhc-CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcceecCCCcc
Q 042871          389 PNGNLAEWLFG-KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       389 ~~gsL~~~L~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~~~  466 (588)
                      ++|+|.++++. ....+++..+++++.|||+||.|||+++.  ||||||||+|||++.++ ++||+|||+++...... .
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            99999999987 36789999999999999999999999875  99999999999999997 99999999998764322 2


Q ss_pred             cccCccCCCCccCccccc--CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCcccCcccCHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRS--NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~--~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      ..+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.......... ++....+...+.++...+..|+
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~  279 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLM  279 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence            333478999999999999  5699999999999999999999999998655433333 3334445555555777788889


Q ss_pred             HHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          544 LSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      .+||+ +|.+||++.+++..|+.+.....
T Consensus       280 ~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  280 ERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             HHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            99998 79999999999999998876433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-47  Score=399.26  Aligned_cols=259  Identities=29%  Similarity=0.436  Sum_probs=232.5

Q ss_pred             HHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      +...+.+...+.||+|-||.||.|+++....||+|.++.. ...+.|.+|+++|++|+|+|||+++|+|..++.++||||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            3334455667799999999999999977779999999863 455899999999999999999999999999889999999


Q ss_pred             cCCCCChhhhhhc-CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFG-KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||++|+|.++|.. ....+...+.+.++.|||+||+||++++   +|||||.++|||++++..+||+||||||...++..
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999999999976 4567999999999999999999999999   99999999999999999999999999996665555


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                      .......-...|.|||.+..+.++.|||||||||+||||+| |+.|+......++.+.++...+-..+..+++.+.+|+.
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~  438 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMK  438 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHH
Confidence            55555566789999999999999999999999999999999 88898888888999999999888888888899999999


Q ss_pred             Hhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          545 SCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .||+ +|++|||++.+...|+.....
T Consensus       439 ~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  439 SCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            9999 799999999999999887543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5e-46  Score=400.86  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=236.4

Q ss_pred             ccccceeeccCceEEEEEEec----CCcEEEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          314 LNELNLIGEGITGKVYKGKLS----NNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ..+.+.||.|.||.|++|+++    ....||||.++.   ++...+|+.|..+|.++.||||++|.|+.......+||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            446789999999999999974    346899999985   4567799999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      ||+||+|+.||..+...+++.|...++++||.||.||-..+   ++||||.++|||++.+...|++||||+|.+.++...
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            99999999999988888999999999999999999999999   999999999999999999999999999988655432


Q ss_pred             c--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHH
Q 042871          467 A--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       467 ~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      .  +....-..+|.|||.+..+++|.+|||||||++|||.++ |.+|+..+.+.++...++..++-..+++++.-+.+|+
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM  867 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM  867 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence            2  233344679999999999999999999999999999999 9999999999999999999999999999999999999


Q ss_pred             HHhhcC-CCCCCCHHHHHHHHHHhhccCCccCCC
Q 042871          544 LSCTAL-THQRPPMEQVFVTLQKALDISTTAKAS  576 (588)
Q Consensus       544 ~~C~~~-p~~RPs~~evl~~L~~~~~~~~~~~~~  576 (588)
                      ++||+. ..+||.+.||+.+|++++..+.+.+.-
T Consensus       868 ldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~  901 (996)
T KOG0196|consen  868 LDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI  901 (996)
T ss_pred             HHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc
Confidence            999995 599999999999999999998876643

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.2e-45  Score=399.80  Aligned_cols=261  Identities=30%  Similarity=0.419  Sum_probs=227.4

Q ss_pred             HHHhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceecc
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRV  378 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~  378 (588)
                      +....+....+.||+|.||+||+|+.      ++.+.||||.+++..   ..++|.+|+++++.++|||||+|+|+|.++
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            34455667778999999999999984      245689999998754   357899999999999999999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcC-------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC
Q 042871          379 DECFLIYELCPNGNLAEWLFGK-------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP  445 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~  445 (588)
                      +..++|+|||..|+|.+||...             ..+|+..+.+.||.|||.||+||-++.   ++||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence            9999999999999999999531             123899999999999999999999999   999999999999999


Q ss_pred             CCcEEEEecCCcceecCCCccccc-CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhc
Q 042871          446 NFEAKLSDFGLSKVIDIGETYASS-EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELA  523 (588)
Q Consensus       446 ~~~~kL~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~  523 (588)
                      +..|||+||||+|.+...+.+... ...-.++||+||.++++++|.+||||||||+|||+++ |+.||......++.+.+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            999999999999977655555433 3445789999999999999999999999999999999 99999988888888877


Q ss_pred             CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          524 DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       524 d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      ...-.-..++.++..+..|+..||+ .|++||+++||-..|+.....++
T Consensus       719 ~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  719 RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            6655566778888889999999999 69999999999999998866543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=377.01  Aligned_cols=243  Identities=25%  Similarity=0.426  Sum_probs=213.9

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ..|...+.||+|||..+|.++. .+|+.||+|++..     ....+...+||++.++|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4678888999999999999997 8999999999864     445678899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+|++++|..++. .++.+++.+++.+..||+.||.|||+++   |+|||||-.|++|++++++||+|||||..+.... 
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            9999999999986 6678999999999999999999999999   9999999999999999999999999999886442 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh---hcCcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE---LADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~---~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      ....+.+|||.|+|||++....++..+||||+||++|-|+.|++||....-.+..+   .-+-.++...+.+..+++.+|
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHH
Confidence            34456899999999999999999999999999999999999999998654444333   334455566778888887666


Q ss_pred             HHHhhcCCCCCCCHHHHHHH
Q 042871          543 ALSCTALTHQRPPMEQVFVT  562 (588)
Q Consensus       543 ~~~C~~~p~~RPs~~evl~~  562 (588)
                      .   ..+|.+|||+++|+..
T Consensus       253 L---~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  253 L---RPNPSERPSLDEVLDH  269 (592)
T ss_pred             h---cCCcccCCCHHHHhcC
Confidence            5   4589999999999864

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-44  Score=360.17  Aligned_cols=239  Identities=27%  Similarity=0.385  Sum_probs=201.3

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceeccC-eeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVD-ECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~LV~E~  387 (588)
                      +++..+.||+|..|+|||++++ +++.+|+|.+..   +...+++.+|++++++.+|||||.++|.|..++ ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3455678999999999999985 788999999953   234578899999999999999999999999998 59999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |.+|||++++... +.+++...-+|+.++++||.|||+ ++   |+||||||+|||++.+|++||+|||.++.+...   
T Consensus       160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            9999999999543 558999999999999999999996 66   999999999999999999999999999876533   


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccc--ccchhhhcC-------cccCcc-cCHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTR--AGSALELAD-------PKLDRE-YSIEAF  536 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~--~~~~~~~~d-------~~l~~~-~~~e~~  536 (588)
                      .....+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+....  .....++++       |.++.. ++.|. 
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef-  311 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF-  311 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH-
Confidence            4456789999999999999999999999999999999999999987642  223333332       333333 55554 


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                         ..++..|++ +|.+|||++|+++.
T Consensus       312 ---~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  312 ---RSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ---HHHHHHHhcCCcccCCCHHHHhcC
Confidence               445688888 79999999999864

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=360.24  Aligned_cols=200  Identities=30%  Similarity=0.476  Sum_probs=178.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ..+|...+.||+|.||+||+|++ +++..||||.+...    ..++....|+.+|+.++|||||.+++++..++..||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35677778899999999999997 47899999999654    34667889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC------CcEEEEecCCcce
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN------FEAKLSDFGLSKV  459 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~------~~~kL~DFGla~~  459 (588)
                      |||.+|+|.+||+.++ .+++......+.|+|.||++||+++   |+||||||+||||+..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999997554 6999999999999999999999999   9999999999999764      4689999999998


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA  516 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  516 (588)
                      +..+.  .....+|++-|||||++..++|+.|+|+||+|++|||+++|+.||.....
T Consensus       165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            86443  34567999999999999999999999999999999999999999974433

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-43  Score=343.77  Aligned_cols=256  Identities=26%  Similarity=0.355  Sum_probs=207.2

Q ss_pred             cCccccceeeccCceEEEEEE-ecCCcEEEEEEec----CCCcHHHHHHHHHHhccCCCCceeEEec-ceeccCe-eeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLG-YCLRVDE-CFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g-~~~~~~~-~~LV  384 (588)
                      .+|.++++||+|.||+|||+. +.+|..||.|.+.    +....+....|+.+|++++|||||++++ .+.++++ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457888899999999999998 5799999999986    2345678899999999999999999999 4555555 8999


Q ss_pred             eecCCCCChhhhhh---cCCcCccHHHHHHHHHhhhccchhhccccC-CceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          385 YELCPNGNLAEWLF---GKDKCLSWIQRLEIAIDSARGLWFLHSYSE-GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       385 ~E~~~~gsL~~~L~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      |||+..|+|...+.   ...+.+++...|+++.|+++||..+|+.-. ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999994   234568999999999999999999999422 23999999999999999999999999999988


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccC-HHHHHHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYS-IEAFDLT  539 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~-~e~~~~v  539 (588)
                      ....+ .....+|||.||+||.+.+..|+.||||||+||++|||..-+.||....--.+.+.+...--...+ ...-..+
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l  257 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDL  257 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHH
Confidence            65443 345578999999999999999999999999999999999999999754333333333222111122 2333557


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      .+|+..|.. +|+.||+.-.++..++..++
T Consensus       258 ~~li~~ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  258 RELINMCIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             HHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence            777888987 78999997777776666544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-42  Score=349.68  Aligned_cols=245  Identities=25%  Similarity=0.270  Sum_probs=198.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC---------cHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG---------NVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      .+.|.+.+.||+|+||.|-+|.- .+|+.||||.+..+.         ......+|+++|++++|||||++.+++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            45677788999999999999975 689999999986421         22345799999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC---CcEEEEecCCc
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN---FEAKLSDFGLS  457 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~---~~~kL~DFGla  457 (588)
                      .|+||||++||+|.+++-.+ +.+.+..-..++.|++.|+.|||+.+   |+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999999643 45777777889999999999999999   9999999999999765   77999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCC---CchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccCcc---
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKV---NSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLDRE---  530 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~~~---  530 (588)
                      +....  .....+.+||+.|.|||++....+   ..+.|+||+||+||-+++|..||....... ..+++-..--..   
T Consensus       327 K~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~  404 (475)
T KOG0615|consen  327 KVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL  404 (475)
T ss_pred             hcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence            98753  334566899999999999877543   347899999999999999999998655544 455443222111   


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .-.+.-+....|+.+++. +|++|||+.|+++
T Consensus       405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  405 QWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            112333445556677666 8999999999985

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-42  Score=344.68  Aligned_cols=236  Identities=27%  Similarity=0.293  Sum_probs=200.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|+.++.||+|+||+||.++. ++++.+|+|+++..     .+.+...+|..+|.+++||+||+++..|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            56899999999999999999985 57899999999753     3466788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +||+.||.|..+|.++ ..+++....-++.+|+.||.|||+.+   |+||||||+|||||++|.++|+||||++..-.. 
T Consensus       104 ld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-  178 (357)
T ss_pred             EeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence            9999999999999644 45788878889999999999999999   999999999999999999999999999864322 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc----cCcccCHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK----LDREYSIEAFDLTL  540 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~----l~~~~~~e~~~~v~  540 (588)
                      ...+...+||+.|||||++.+..|+..+|.||+|+++|||++|..||......+..+.+...    .+.-.+.+..+++.
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~  258 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK  258 (357)
T ss_pred             CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence            23445589999999999999999999999999999999999999999866655544443221    12226777878777


Q ss_pred             HHHHHhhcCCCCCC
Q 042871          541 QLALSCTALTHQRP  554 (588)
Q Consensus       541 ~L~~~C~~~p~~RP  554 (588)
                      .|.   ..+|++|-
T Consensus       259 ~LL---~rdp~~RL  269 (357)
T KOG0598|consen  259 KLL---KRDPRQRL  269 (357)
T ss_pred             HHh---ccCHHHhc
Confidence            665   45788885

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=359.38  Aligned_cols=260  Identities=25%  Similarity=0.400  Sum_probs=216.8

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccC
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVD  379 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~  379 (588)
                      ..+++...+++.....||+|.||+||+|++. | .||||++.-    +...+.|.+|+..+++-+|.||+-+.|+|...+
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            3566667777888889999999999999984 3 699999963    345788999999999999999999999999887


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      . .||+.||+|.+|+.||+-.+..++..+.+.|+.|+++||.|||.++   |||||||+.||+|.+++.|||+||||+..
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence            7 9999999999999999988888999999999999999999999999   99999999999999999999999999865


Q ss_pred             ecCC-CcccccCccCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC-cc---c
Q 042871          460 IDIG-ETYASSEVRGTFGYLDPEYRSN---CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD-RE---Y  531 (588)
Q Consensus       460 ~~~~-~~~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~-~~---~  531 (588)
                      -..- .........|...|||||++..   .+|+..+||||||+++|||++|..|+.......+.-++-..+. ..   .
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~  617 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI  617 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence            3221 1112233457789999998764   4789999999999999999999999985555444444443321 11   2


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ...+...+.+|+..|+. ++++||.+.+|+.+|+.++.-
T Consensus       618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            24566778889999999 689999999999999988874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-41  Score=354.44  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=202.1

Q ss_pred             HhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceecc-
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRV-  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~-  378 (588)
                      ..++|...+.||+|+||.||+|+.      .+++.||||++....   ..+.+.+|+.++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            457899999999999999999974      245789999987532   345789999999999 899999999988764 


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC---------------------------------------------------------
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD---------------------------------------------------------  401 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------------  401 (588)
                      +..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            45899999999999999985421                                                         


Q ss_pred             ----cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc-cccCccCCCC
Q 042871          402 ----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFG  476 (588)
Q Consensus       402 ----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~  476 (588)
                          ..+++.+...++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                24778889999999999999999988   999999999999999999999999999865433222 2233456788


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccc-hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCC
Q 042871          477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGS-ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQR  553 (588)
Q Consensus       477 Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~-~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~R  553 (588)
                      |+|||++.+..++.++||||||+++|||++ |+.||....... ....+........+......+..++..|++ +|++|
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999999997 998886433211 111111111111122223456778899998 79999


Q ss_pred             CCHHHHHHHHHHhhc
Q 042871          554 PPMEQVFVTLQKALD  568 (588)
Q Consensus       554 Ps~~evl~~L~~~~~  568 (588)
                      ||+.|+++.|++++.
T Consensus       322 Ps~~el~~~l~~~~~  336 (338)
T cd05102         322 PTFSALVEILGDLLQ  336 (338)
T ss_pred             cCHHHHHHHHHHHHh
Confidence            999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.8e-41  Score=339.97  Aligned_cols=253  Identities=22%  Similarity=0.325  Sum_probs=207.8

Q ss_pred             hcCccccceeeccCceEEEEEEec----CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|++.+.||+|+||.||+|++.    .+..||+|.++...   ..+.|.+|+..+++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            456888899999999999999853    46789999987542   24578999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++......+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999765567899999999999999999999998   999999999999999999999999987654322


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      .........++..|+|||++.+..++.++||||||+++||+++ |+.||.........+.+........+......+.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL  240 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            2222223345678999999999999999999999999999886 999987554444333333222222333445567778


Q ss_pred             HHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          543 ALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      +..|++ +|.+||+++|+++.|++.
T Consensus       241 i~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         241 MLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHcCCCchhCCCHHHHHHHHHhh
Confidence            899998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=383.04  Aligned_cols=256  Identities=27%  Similarity=0.399  Sum_probs=218.7

Q ss_pred             hcCccccceeeccCceEEEEEEec--CCc----EEEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS--NNQ----HVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~--~g~----~VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++....+.||+|.||.||.|...  +|.    .||||.+..   .++..+|++|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            344556678999999999999864  343    489998875   34567899999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcC------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          382 FLIYELCPNGNLAEWLFGK------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                      +|++|||++|+|..||.+.      ...|+....+.++.|+|+|+.||++++   .|||||..+|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999766      567999999999999999999999999   9999999999999999999999999


Q ss_pred             CcceecCCCcccccC-ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCH
Q 042871          456 LSKVIDIGETYASSE-VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSI  533 (588)
Q Consensus       456 la~~~~~~~~~~~~~-~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~  533 (588)
                      ||+.+...+.+.... ..-..+|||||.+.++.++.|+|||||||+|||++| |..||.-.+..++...+-..-+-..+.
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~  927 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS  927 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence            999554444443332 244579999999999999999999999999999999 888888777766666332222555667


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          534 EAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .+.+.+.+++..||+ +|++||++..+++.++.+...
T Consensus       928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            788889999999998 799999999999999888764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.5e-40  Score=330.86  Aligned_cols=249  Identities=26%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ++|+..+.||+|+||.||++++.++..+|+|.+... ...+.|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            467888899999999999999988889999988753 3456899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++......+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++............
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence            9999999765556899999999999999999999998   9999999999999999999999999988654333222233


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+........+......+..++.+|++ 
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~  240 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHE  240 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccC
Confidence            345678999999988899999999999999999999 888886544333333322211111122223456778899998 


Q ss_pred             CCCCCCCHHHHHHHH
Q 042871          549 LTHQRPPMEQVFVTL  563 (588)
Q Consensus       549 ~p~~RPs~~evl~~L  563 (588)
                      +|.+||+++++++.|
T Consensus       241 ~p~~Rps~~~l~~~l  255 (256)
T cd05114         241 KPEGRPTFAELLRAI  255 (256)
T ss_pred             CcccCcCHHHHHHhh
Confidence            799999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.7e-39  Score=383.47  Aligned_cols=250  Identities=30%  Similarity=0.468  Sum_probs=204.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      ...|...+.||+|+||.||+|+. .+|..||||++.....  ...+|++.+++++|||||+++|++.+.+..++||||++
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~  766 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE  766 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence            45677788999999999999996 5899999999875432  22356888999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +|+|.+++.    .++|.++.+|+.|+++||+|||+...++|+||||||+||+++.++..++. ||.......     ..
T Consensus       767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~  836 (968)
T PLN00113        767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DT  836 (968)
T ss_pred             CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CC
Confidence            999999994    38999999999999999999997766669999999999999999988876 665543221     12


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc---------------cchhhhcCcccCcc--cC
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA---------------GSALELADPKLDRE--YS  532 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~---------------~~~~~~~d~~l~~~--~~  532 (588)
                      ...+|+.|+|||++.+..++.++|||||||++|||+||+.|+.....               .....++|+.+...  ..
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            23678999999999999999999999999999999999999753211               11223445555332  34


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      .+....+.+++.+|++ +|++||||+||++.|+++....+.
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  957 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS  957 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence            4556677889999998 799999999999999998765443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=339.27  Aligned_cols=255  Identities=27%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccC--eeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVD--ECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~LV~E  386 (588)
                      .++...+.||+|.||.||++... +|...|||.....  ...+.+.+|+.+|.+++|||||+.+|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            44666789999999999999974 5999999987643  12567899999999999999999999855544  6899999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCcceecC--C
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDI--G  463 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~~~~--~  463 (588)
                      |+++|+|.+++.+....+++..+..+..|+++||+|||+++   |+||||||+|||++. ++.+||+|||+++....  .
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999765547999999999999999999999999   999999999999999 79999999999987653  1


Q ss_pred             CcccccCccCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCccccc-ccc-chhhhcCcccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGKKAKVLT-RAG-SALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~-~~~-~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      .........||+.|||||++.++. ...++|||||||++.||+||+.||... ... ...........+.++....+...
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence            122334578999999999998632 335999999999999999999999863 111 11111111111233333444455


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      +++..|.+ +|..|||++++++..--..+.
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            56778887 799999999999877655433

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-39  Score=334.07  Aligned_cols=243  Identities=22%  Similarity=0.355  Sum_probs=199.4

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCC--c---HHHHHHHHHHhccCCCCceeEEecceec----cCeeeEEeec
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEG--N---VETFVREVASSSHVRHPNLVALLGYCLR----VDECFLIYEL  387 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV~E~  387 (588)
                      ...||+|++|.||+|++ +|+.||||++....  .   .+.|.+|+.++++++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            35899999999999998 78999999987431  1   4677899999999999999999999876    3468999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++|+|.+++... +.+++.....++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++......  
T Consensus       104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999999653 4689999999999999999999984 6   7899999999999999999999999988654221  


Q ss_pred             cccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-CcccCcccCHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~l~~~~~~e~~~~v~~L~  543 (588)
                        ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...........+ ........+......+..++
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li  255 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV  255 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHH
Confidence              23457899999999876  68999999999999999999999999755443333332 11112222323455677889


Q ss_pred             HHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          544 LSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ..|++ +|.+|||++|+++.|+....
T Consensus       256 ~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            99998 79999999999999997653

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.2e-40  Score=330.04  Aligned_cols=252  Identities=22%  Similarity=0.369  Sum_probs=208.6

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|+..++||+|+||.||+|...++..||+|.+... ...+.+.+|+.++++++|+||+++++.+.+.+..+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4678889999999999999999888889999988643 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          390 NGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      +|+|.+++... ...+++.+++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++..........
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence            99999999653 346889999999999999999999988   99999999999999999999999999987654332222


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....++..|+|||++....++.++||||||+++|||++ |+.||...........+.............+.+.+++.+|+
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCW  241 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            33446778999999988889999999999999999998 89898654443333333222222122223345677888999


Q ss_pred             c-CCCCCCCHHHHHHHHHH
Q 042871          548 A-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~  565 (588)
                      . +|++||+++++.+.|++
T Consensus       242 ~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         242 KEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             cCCcccCcCHHHHHHHHhc
Confidence            8 79999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-39  Score=339.03  Aligned_cols=258  Identities=21%  Similarity=0.342  Sum_probs=207.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCc----EEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQ----HVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ..+|+..+.||+|+||.||+|++. +++    .||+|.+...   ...+.+.+|+.+++.++||||++++|++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            356889999999999999999853 344    4899998643   2346789999999999999999999998764 578


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +|+||+++|+|.+++......+++...+.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999999776667899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          463 GETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       463 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...........+........+......+.
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  241 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            33221 122334678999999999999999999999999999998 9999864433333333322221111222234466


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      .++..|+. +|.+||++.+++..|..+...+..
T Consensus       242 ~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~  274 (316)
T cd05108         242 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  274 (316)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence            77889998 799999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=356.18  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=217.0

Q ss_pred             hcCccccceeeccCceEEEEEEec--CC---cEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS--NN---QHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~--~g---~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      .++....++||+|.||.||+|++.  ++   ..||||....     .....+|++|.++|++++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            344455579999999999999864  22   2389998874     2346789999999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      ++||||+|.||+|.+||......++..+++.++.+.|.||+|||+++   ++||||.++|+|++.++.+||+||||++..
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999999776667999999999999999999999999   999999999999999999999999998764


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhc-CcccCcccCHHHHHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELA-DPKLDREYSIEAFDL  538 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~-d~~l~~~~~~e~~~~  538 (588)
                      ..-. .......-..+|+|||.+....|+.++|||||||++||+++ |..|+......++...+ ....+...+......
T Consensus       313 ~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~  391 (474)
T KOG0194|consen  313 SQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKE  391 (474)
T ss_pred             ccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHH
Confidence            3111 11111234679999999999999999999999999999999 88898877777766666 445555556666777


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      +..++..|+. +|++||||.++.+.|+.+......
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            7778889988 799999999999999998876553

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=328.96  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=210.1

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++|+..+.||+|++|.||+|...+++.||+|.++.. ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35678889999999999999999878889999998753 34567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++++|.+++.... ..+++.++..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.........
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            9999999996543 46899999999999999999999988   9999999999999999999999999998765332222


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      ......+..|+|||++.+..++.++||||||+++|||++ |+.||...........++.......+....+.+.+++.+|
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDC  240 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence            222233568999999999899999999999999999999 8888865444444444433322223333446677788899


Q ss_pred             hc-CCCCCCCHHHHHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~L~~  565 (588)
                      ++ +|.+||++.++++.|++
T Consensus       241 l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         241 WKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             hhcCcccCCCHHHHHHHHhc
Confidence            98 79999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=329.88  Aligned_cols=254  Identities=27%  Similarity=0.421  Sum_probs=209.2

Q ss_pred             hcCccccceeeccCceEEEEEEec----CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+|++.    +...||||.+....   ....|.+|+.++++++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            467888999999999999999874    24589999886432   34578999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++++|.+++......+++.+++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999766567899999999999999999999988   999999999999999999999999999876421


Q ss_pred             -CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          464 -ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       464 -~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                       .........++..|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+........+......+.+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence             2222223345678999999999899999999999999999998 99898654444444433322222222334456778


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      ++.+|++ +|++||+++||++.|++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            8999998 7999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=344.22  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=217.7

Q ss_pred             HHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      +.+.....+.++||+|-||.|.......+..||||.++.+.   ...+|.+|+++|.+++||||++|+|+|..++.+++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            34455666778999999999999999888999999998643   357899999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcC-ccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          385 YELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      +|||++|+|.+|+..+..+ +.......|+.||+.||+||.+.+   ++||||.++|+|+|.++++||+|||++|.+..+
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999999765433 466677889999999999999999   999999999999999999999999999987767


Q ss_pred             Cccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCccccccccchhhhcCcccCc-------ccCH
Q 042871          464 ETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS--GKKAKVLTRAGSALELADPKLDR-------EYSI  533 (588)
Q Consensus       464 ~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~p~~~~~~~~~~~~~d~~l~~-------~~~~  533 (588)
                      ..+. ..+.+-.++|||||.+..++++.++|||+||+.+||+++  ..+|+.....+.+.+....-++.       ..+.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            6654 345567889999999999999999999999999999976  77888766665555544332221       1244


Q ss_pred             HHHHHHHHHHHHhhcC-CCCCCCHHHHHHHHHHhh
Q 042871          534 EAFDLTLQLALSCTAL-THQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       534 e~~~~v~~L~~~C~~~-p~~RPs~~evl~~L~~~~  567 (588)
                      -+...+.++++.|+.. ..+||+++++...|++..
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            5667778999999995 699999999999998764

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=326.92  Aligned_cols=249  Identities=26%  Similarity=0.381  Sum_probs=205.9

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      .+|+..+.||+|+||.||+|+..++..+|+|.+... ...+.|.+|++++++++|+||+++++++...+..++|+||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            357788899999999999999877789999998653 3456789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      ++|.+++......+++..++.++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++............
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence            9999999765557899999999999999999999998   9999999999999999999999999998654332222222


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+........+......+.+++.+|++ 
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  240 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE  240 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            234568999999998899999999999999999999 788886544444444333332222222334567778999998 


Q ss_pred             CCCCCCCHHHHHHHH
Q 042871          549 LTHQRPPMEQVFVTL  563 (588)
Q Consensus       549 ~p~~RPs~~evl~~L  563 (588)
                      +|++|||+.|+++.|
T Consensus       241 ~p~~Rpt~~~~l~~l  255 (256)
T cd05059         241 KPEDRPAFKKLLSQL  255 (256)
T ss_pred             ChhhCcCHHHHHHHh
Confidence            799999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-39  Score=326.91  Aligned_cols=250  Identities=27%  Similarity=0.375  Sum_probs=205.5

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ++|...+.||+|+||.||+|+..++..||||.+... ...+.|.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            457788899999999999999877778999988753 3356799999999999999999999999988899999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++......+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++............
T Consensus        84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence            9999999765557899999999999999999999998   9999999999999999999999999988664433222223


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ..++..|++||+..+..++.++||||||+++|||++ |+.||.........+.+........+....+.+.+++.+|++ 
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  240 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHE  240 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            345678999999998889999999999999999999 988886544433333322222211122233566778899998 


Q ss_pred             CCCCCCCHHHHHHHHH
Q 042871          549 LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       549 ~p~~RPs~~evl~~L~  564 (588)
                      +|.+||++.++++.|+
T Consensus       241 ~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         241 KAEERPTFQQLLSSIE  256 (256)
T ss_pred             CcccCCCHHHHHHhhC
Confidence            7999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=349.03  Aligned_cols=242  Identities=27%  Similarity=0.444  Sum_probs=205.4

Q ss_pred             CccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCC
Q 042871          313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs  392 (588)
                      ....++-||+|+.|.||+|++ .++.||||+++.-.     ..+|+-|++|+|+||+.+.|+|.....++||||||..|-
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-----ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-----ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             HhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-----hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            345567899999999999999 67899999875332     257889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCcc
Q 042871          393 LAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR  472 (588)
Q Consensus       393 L~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~  472 (588)
                      |...|... ..++......|..+||.||.|||.+.   |||||||+-||||..+..+||+|||-++.....  .....+.
T Consensus       199 L~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA  272 (904)
T ss_pred             HHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence            99999544 45777888899999999999999999   999999999999999999999999999876543  3345678


Q ss_pred             CCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcCcccCcccCHHHHHHHHHHHHHhhc-CC
Q 042871          473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELADPKLDREYSIEAFDLTLQLALSCTA-LT  550 (588)
Q Consensus       473 gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p  550 (588)
                      ||..|||||++.+.+.++|+|||||||+||||+||..||...+..-+. -+-...+.-..+.++++-+.-|++.||+ .|
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp  352 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP  352 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence            999999999999999999999999999999999999998754443222 2223344445667777888888999998 69


Q ss_pred             CCCCCHHHHHHHHHHh
Q 042871          551 HQRPPMEQVFVTLQKA  566 (588)
Q Consensus       551 ~~RPs~~evl~~L~~~  566 (588)
                      ..||++++++..|+=+
T Consensus       353 RNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  353 RNRPSFRQILLHLDIA  368 (904)
T ss_pred             CCCccHHHHHHHHhhc
Confidence            9999999999998733

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.2e-39  Score=327.42  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=208.1

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+|++.+++++|+||+++++++..++..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            45778889999999999999864 68899999987543 45679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          390 NGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      +++|.+++.... ..+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++..........
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence            999999996533 46899999999999999999999988   99999999999999999999999999987654332222


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....++.+|+|||++.+..++.++||||||+++|||++ |..|+......+....+........+......+..++.+|+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  242 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACW  242 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            23334678999999999999999999999999999998 88887644443433333333332333333455777788999


Q ss_pred             c-CCCCCCCHHHHHHHHHHh
Q 042871          548 A-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~  566 (588)
                      . +|++|||+.|++++|+.+
T Consensus       243 ~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         243 QWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             cCCcccCCCHHHHHHHHHhh
Confidence            8 799999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-40  Score=340.69  Aligned_cols=198  Identities=27%  Similarity=0.390  Sum_probs=175.3

Q ss_pred             hcCccccceeeccCceEEEEEE-ecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc--CeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV--DECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~L  383 (588)
                      .+.|+.+++||+|+||.|||++ ..+|+.||+|++.-+    .......+||.+|++|+||||++|.+...+.  +.+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4668888999999999999998 578999999998643    2344567999999999999999999998876  78999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      |+|||++ +|.-++....-.++..++..++.|++.||+|+|..+   |+|||||.+|||||.+|.+||+|||||+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999965 888888766667999999999999999999999999   999999999999999999999999999988766


Q ss_pred             CcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          464 ETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      .....+..+-|..|.|||.+++ ..|+.+.|+||.||||.||+.|+..+.
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~  321 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ  321 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence            6554555667999999999887 479999999999999999999998543

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.7e-40  Score=332.61  Aligned_cols=245  Identities=35%  Similarity=0.540  Sum_probs=195.6

Q ss_pred             ccceeeccCceEEEEEEec-----CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          316 ELNLIGEGITGKVYKGKLS-----NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ..+.||.|.||.||+|.+.     .+..|+||.++...   ..+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999975     36789999996532   357899999999999999999999999988889999999


Q ss_pred             CCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-
Q 042871          388 CPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-  465 (588)
                      +++|+|.++|... ...+++.+++.|+.|+++||.|||+.+   ++|+||+++||++++++.+||+|||+++....... 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            9999999999876 567999999999999999999999998   99999999999999999999999999987632222 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                      .......+...|+|||.+.+..++.++||||||+++|||++ |+.|+......+..+.+........+......+..++.
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence            22333456789999999998889999999999999999999 67887655544444433222222223334455677899


Q ss_pred             Hhhc-CCCCCCCHHHHHHHH
Q 042871          545 SCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L  563 (588)
                      .|+. +|++|||+.++++.|
T Consensus       240 ~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHT-SSGGGS--HHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHhcC
Confidence            9998 799999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-39  Score=347.97  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=202.5

Q ss_pred             HhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceeccC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRVD  379 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~  379 (588)
                      ..++|+..+.||+|+||.||+|+.      +++..||||+++..   ...+.+.+|+.++..+ +||||+++++++.+.+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            355788889999999999999963      34668999998643   2345788999999999 8999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCC----------------------------------------------------------
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD----------------------------------------------------------  401 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~----------------------------------------------------------  401 (588)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999985321                                                          


Q ss_pred             ----------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          402 ----------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       402 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                                      ..+++..++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                            14788899999999999999999988   99999999999999999999999999986643322


Q ss_pred             cc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccc-ccchhhhcCcccCcccCHHHHHHHHHH
Q 042871          466 YA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTR-AGSALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~-~~~~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      .. .....++..|+|||++.+..++.++||||||+++|||++ |..||.... .....+.+........+......+..+
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI  349 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence            11 222345678999999999999999999999999999998 777875432 222233333222211122223456778


Q ss_pred             HHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          543 ALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      +..|++ +|++|||+.||+++|++.
T Consensus       350 i~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         350 MKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHccCChhHCcCHHHHHHHHHhh
Confidence            899998 799999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-40  Score=323.55  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=196.0

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCc----HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGN----VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~----~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+.+.++|+|+||.|||++.+ +|+.||||++....+    .+-.++|+++|++++|+|+|.|+.+|..+..++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            56788889999999999999974 799999999975332    2346899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++. ++.+-|......++.....+++.|+++|+.|+|+++   ++||||||+||||+.++.+||+|||+|+.+.. ...
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence            9966 454555555566888999999999999999999999   99999999999999999999999999998863 223


Q ss_pred             cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchh---------------hhc-------
Q 042871          467 ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL---------------ELA-------  523 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~---------------~~~-------  523 (588)
                      ..+..+.|..|.|||.+.+ .+|+...|||++||++.||++|..-|.-..+-+-.               .++       
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            3455677999999998877 79999999999999999999999866522211100               000       


Q ss_pred             ---CcccC--cccC---HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 ---DPKLD--REYS---IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 ---d~~l~--~~~~---~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         -|...  +...   +.....+..++..|++ +|.+|++-+|++.
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               01110  1110   1122356788999999 7999999999874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.2e-39  Score=333.56  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=198.7

Q ss_pred             hcCccccceeeccCceEEEEEEecC-----------------CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN-----------------NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVA  370 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~  370 (588)
                      .++|...+.||+|+||.||++.+++                 +..||+|.+....   ....|.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4578888999999999999997532                 3479999987532   2457899999999999999999


Q ss_pred             EecceeccCeeeEEeecCCCCChhhhhhcCC------------------cCccHHHHHHHHHhhhccchhhccccCCceE
Q 042871          371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKD------------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIV  432 (588)
Q Consensus       371 l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~Iv  432 (588)
                      +++++.+.+..++||||+++|+|.+++....                  ..++|.+.++++.|++.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999984321                  24788899999999999999999998   99


Q ss_pred             ecCCCCCCeEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCC
Q 042871          433 HRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS--GKK  509 (588)
Q Consensus       433 HrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~  509 (588)
                      ||||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999866443322 2233456789999999988899999999999999999987  445


Q ss_pred             ccccccccchhhhcCc----c---cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          510 AKVLTRAGSALELADP----K---LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       510 p~~~~~~~~~~~~~d~----~---l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      |+.........+.+..    .   .....+......+.+++.+|++ +|++|||+.||.+.|++
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            6653332222221110    0   0001112233556778999998 79999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.3e-39  Score=329.10  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=207.4

Q ss_pred             cCccccceeeccCceEEEEEEecC------CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ++|+..+.||+|+||.||+|....      ...||+|.+....   ....|.+|+..+.+++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888899999999999998632      2579999986432   2456899999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC
Q 042871          383 LIYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~  447 (588)
                      ++|||+++|+|.+++....               ..+++.+.+.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            9999999999999995421               35788999999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCc
Q 042871          448 EAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADP  525 (588)
Q Consensus       448 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~  525 (588)
                      .+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986543322 12233456789999999998899999999999999999998 9999875555555554443


Q ss_pred             ccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          526 KLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       526 ~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ......+......+..|+.+|++ +|.+||++.||++.|++
T Consensus       242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            33333344455667788899998 79999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=329.95  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=202.4

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhc--cCCCCceeEEecceeccC----eeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSS--HVRHPNLVALLGYCLRVD----ECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~--~l~HpnIv~l~g~~~~~~----~~~LV~  385 (588)
                      ......++||+|+||.||||.+ +++.||||++... +.+.|.+|-++.+  .++|+||+++++.-....    +++||+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3445567899999999999999 5699999988654 4577887776654  578999999999877665    899999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc------cCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY------SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ||.++|+|.+||  +...++|....+|+..+++||+|||+.      .+|+|+|||||++|||+.+|++..|+|||||..
T Consensus       288 ~fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  288 EFHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             eeccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            999999999999  556799999999999999999999974      367899999999999999999999999999998


Q ss_pred             ecCCCcccc-cCccCCCCccCcccccCCC-CC-----chhhHHHHHHHHHHHHcCCCcc--------ccccc--------
Q 042871          460 IDIGETYAS-SEVRGTFGYLDPEYRSNCK-VN-----SSGDVYSFGIVLLQILSGKKAK--------VLTRA--------  516 (588)
Q Consensus       460 ~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~-~t-----~ksDVwS~Gvll~ElltG~~p~--------~~~~~--------  516 (588)
                      +..+..... ...+||.+|||||++.+.. +.     .+.||||+|.+||||+++-...        .+.-+        
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            876654432 2368999999999987642 22     3689999999999999865422        11111        


Q ss_pred             -cchhh-----hcCcccCccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          517 -GSALE-----LADPKLDREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       517 -~~~~~-----~~d~~l~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                       +++.+     ...|.++..+ ....+..+.+.+..||. +++.|.|+.=|-+++.++....+.
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence             11222     1223333322 12455678888999997 789999999999999988876654

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=344.65  Aligned_cols=245  Identities=27%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             cCccccceeeccCceEEEEEE-ecCCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..|....+||+|.-|.||.++ ..+++.||||++..  ....+-+++|+.+|+..+|+|||++++.+..++++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            456667799999999999997 46889999999864  344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++|+|.|.+  ....+++.++..|+.++++||+|||.++   |+|||||.+|||++.+|.+||+|||++.++..... ..
T Consensus       353 ~ggsLTDvV--t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR  426 (550)
T KOG0578|consen  353 EGGSLTDVV--TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR  426 (550)
T ss_pred             CCCchhhhh--hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence            999999999  4455999999999999999999999999   99999999999999999999999999988765544 34


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-cccCc-ccCHHHHHHHHHHHHHh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-PKLDR-EYSIEAFDLTLQLALSC  546 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-~~l~~-~~~~e~~~~v~~L~~~C  546 (588)
                      ...+||+.|||||+.....|++|.||||||++++||+-|..||.....-+...++. ..-.. ...+..-..+.+++.+|
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c  506 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC  506 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence            55789999999999999999999999999999999999999987544333333332 11111 11222223455557888


Q ss_pred             hc-CCCCCCCHHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~  562 (588)
                      ++ ++.+||++.|+|+.
T Consensus       507 L~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  507 LVVDVEQRASAKELLEH  523 (550)
T ss_pred             hhcchhcCCCHHHHhcC
Confidence            88 78999999999874

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-39  Score=345.52  Aligned_cols=256  Identities=28%  Similarity=0.397  Sum_probs=203.2

Q ss_pred             HHhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      ...++|+..+.||+|+||.||+++.      .++..||||++....   ..+.+.+|+.+++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            3456788999999999999999873      234689999997532   245688999999999 899999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC---------------------------------------------------------
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD---------------------------------------------------------  401 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------------  401 (588)
                      +..++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999999985321                                                         


Q ss_pred             ------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc-cc
Q 042871          402 ------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-AS  468 (588)
Q Consensus       402 ------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~-~~  468 (588)
                                  ..+++.+.++++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++........ ..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        23788889999999999999999988   999999999999999999999999999865433222 12


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccc-hhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGS-ALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~-~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      ....++..|+|||++....++.++||||||+++|||++ |+.||....... ....+........+......+..++..|
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence            22345678999999998899999999999999999997 999986443322 2222222221111111234566778899


Q ss_pred             hc-CCCCCCCHHHHHHHHHHhh
Q 042871          547 TA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      ++ +|++|||+.+|+++|++++
T Consensus       352 l~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         352 WNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCChhhCcCHHHHHHHHHHHh
Confidence            98 7999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-39  Score=326.02  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=211.5

Q ss_pred             HHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ....+|+..++||+|+||.||+|...+++.+|+|.+....  ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            3456788899999999999999998889999999987543  35678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++++|.+++... ...+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999653 346899999999999999999999988   99999999999999999999999999987643222


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                       ......++..|++||++....++.++||||||+++|||++ |+.||.........+.+........+......+.+++.
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence             2223446778999999988899999999999999999998 88888655444444444333333333344456677888


Q ss_pred             Hhhc-CCCCCCCHHHHHHHHHH
Q 042871          545 SCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      +|++ +|.+|||++++++.|+.
T Consensus       239 ~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         239 ECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHcCCCchhCcCHHHHHHHHhc
Confidence            9998 79999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.2e-39  Score=329.37  Aligned_cols=244  Identities=23%  Similarity=0.265  Sum_probs=198.0

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      |+..+.||+|+||.||++.. .+|+.||+|.+...     .....+.+|+.++++++|+||+++.+++.+++..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999986 57999999988632     2234678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++|+|.+++... ...+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........ 
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-  157 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence            9999999888643 346899999999999999999999998   99999999999999999999999999987543322 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc---CcccCHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL---DREYSIEAFDLTLQLA  543 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l---~~~~~~e~~~~v~~L~  543 (588)
                       .....||..|+|||++.+..++.++|||||||++|||++|+.||.........+.++..+   ...++.+....+..|+
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence             234568999999999999999999999999999999999999997544322222222111   1112222334556678


Q ss_pred             HHhhc-CCCCCCC-----HHHHHHH
Q 042871          544 LSCTA-LTHQRPP-----MEQVFVT  562 (588)
Q Consensus       544 ~~C~~-~p~~RPs-----~~evl~~  562 (588)
                      ..|++ +|.+||+     ++++++.
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            88887 7999997     7887763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.6e-39  Score=326.19  Aligned_cols=256  Identities=21%  Similarity=0.354  Sum_probs=204.5

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCc----EEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQ----HVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++|...+.||+|+||.||+|++ .+|+    .|++|.+....   ...++.+|+..+++++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            4677888999999999999986 3454    47888876432   2356778888999999999999999875 456789


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ++||+++|+|.+++......+++...+.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999776667999999999999999999999988   999999999999999999999999999876433


Q ss_pred             Cc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          464 ET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       464 ~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      .. .......++..|++||++.+..++.++||||||+++||+++ |+.||.........+.+........+......+..
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM  242 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence            22 22334567789999999998899999999999999999998 99888654443333333322211111122334566


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      ++..|+. +|.+|||+.|+++.|+.+...++
T Consensus       243 li~~c~~~~p~~Rps~~el~~~l~~~~~~~~  273 (279)
T cd05111         243 VMVKCWMIDENVRPTFKELANEFTRMARDPP  273 (279)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence            7888988 79999999999999999876553

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-38  Score=318.64  Aligned_cols=243  Identities=28%  Similarity=0.416  Sum_probs=200.6

Q ss_pred             eeeccCceEEEEEEecCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChhh
Q 042871          319 LIGEGITGKVYKGKLSNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAE  395 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~  395 (588)
                      .||+|+||.||+|..++++.||+|.+....   ....+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            699999999999998889999999987542   23468899999999999999999999999999999999999999999


Q ss_pred             hhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCC
Q 042871          396 WLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF  475 (588)
Q Consensus       396 ~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~  475 (588)
                      ++......+++.+++.++.|++.+|.|||+.+   ++||||||+||++++++.+||+|||++...............++.
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          82 FLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            99765567899999999999999999999988   999999999999999999999999998765433322222334567


Q ss_pred             CccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCC
Q 042871          476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQR  553 (588)
Q Consensus       476 ~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~R  553 (588)
                      .|+|||++....++.++||||||+++||+++ |+.||...........+........+......+..++..|++ +|++|
T Consensus       159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence            8999999998899999999999999999999 888886444333333333222222223344567778889998 79999


Q ss_pred             CCHHHHHHHHH
Q 042871          554 PPMEQVFVTLQ  564 (588)
Q Consensus       554 Ps~~evl~~L~  564 (588)
                      |++.|+++.|.
T Consensus       239 p~~~~l~~~l~  249 (250)
T cd05085         239 PKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHhc
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-38  Score=322.17  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=208.7

Q ss_pred             hcCccccceeeccCceEEEEEEec-CC---cEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NN---QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+|++. ++   ..+|+|.+...   ...+.+.+|++++++++|+|++++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888899999999999999874 33   37999998643   234678999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++++|.+++......+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999766667999999999999999999999998   999999999999999999999999998866432


Q ss_pred             Cccc--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          464 ETYA--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ....  ......+..|+|||++....++.++||||||+++|||++ |+.||...........+........+.+....+.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  240 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY  240 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            2211  112233567999999998899999999999999999998 9999865544444444433322223333445677


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      +++.+|++ +|.+||++.+|++.|++++
T Consensus       241 ~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         241 QLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            88999998 7999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-39  Score=339.87  Aligned_cols=242  Identities=29%  Similarity=0.386  Sum_probs=205.1

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|...+.||+|.||.||||+- .+.+.||+|.+.+    +++.+.+.+|+++++.++|||||.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5678888999999999999985 4789999999864    3456678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |+.| +|..+|.. ...+++.+...++.++..||.|||+..   |.|||+||.|||++.++.+|++|||+|+.... .+.
T Consensus        82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS  155 (808)
T ss_pred             hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence            9966 99999954 446999999999999999999999999   99999999999999999999999999997664 344


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L~  543 (588)
                      ..+.+.|||-|||||...++.|+..+|.||+||++||+++|++||....-..+.+.+   +...+...+.+...++.-|.
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL  235 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL  235 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence            556789999999999999999999999999999999999999999865554444443   22223344555555554443


Q ss_pred             HHhhcCCCCCCCHHHHHHH
Q 042871          544 LSCTALTHQRPPMEQVFVT  562 (588)
Q Consensus       544 ~~C~~~p~~RPs~~evl~~  562 (588)
                         ..+|.+|.|..+++..
T Consensus       236 ---~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  236 ---IKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---hcChhhcccHHHHhcC
Confidence               4589999999998753

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.8e-38  Score=320.95  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=207.3

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|.+.+.||+|+||.||+|+..+...||+|++... ...+.|.+|++++++++|+||+++++.+. .+..++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            4568889999999999999999877778999999753 33567899999999999999999999875 456799999999


Q ss_pred             CCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          390 NGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      +|+|.+++... ...+++.++..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++..........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~  160 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  160 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence            99999999653 345899999999999999999999988   99999999999999999999999999987654433233


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....++..|++||+..+..++.++||||||+++|||++ |+.||.........+.+........+.+....+.+++..|+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  240 (262)
T cd05071         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW  240 (262)
T ss_pred             cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHc
Confidence            33456778999999988899999999999999999999 77777544333333333222222223445566778899999


Q ss_pred             c-CCCCCCCHHHHHHHHHHhh
Q 042871          548 A-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~  567 (588)
                      + +|++||++.++++.|++..
T Consensus       241 ~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         241 RKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             cCCcccCCCHHHHHHHHHHhc
Confidence            8 7999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-38  Score=319.28  Aligned_cols=244  Identities=26%  Similarity=0.382  Sum_probs=199.9

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      +.||+|+||.||+|+. .+++.||+|.+....   ....+.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3699999999999987 478999999876432   245789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc-cCcc
Q 042871          394 AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS-SEVR  472 (588)
Q Consensus       394 ~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~~~  472 (588)
                      .+++......+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......... ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999765556899999999999999999999998   99999999999999999999999999876543221111 1112


Q ss_pred             CCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CC
Q 042871          473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LT  550 (588)
Q Consensus       473 gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p  550 (588)
                      .+..|+|||.+.+..++.++||||||+++|||++ |..|+...........+........+......+..++..|++ +|
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            3457999999998899999999999999999998 888886544444444443333333333344567778899998 79


Q ss_pred             CCCCCHHHHHHHHH
Q 042871          551 HQRPPMEQVFVTLQ  564 (588)
Q Consensus       551 ~~RPs~~evl~~L~  564 (588)
                      ++|||+.+++++|+
T Consensus       238 ~~Rps~~~~~~~l~  251 (252)
T cd05084         238 GQRPSFSTVHQELQ  251 (252)
T ss_pred             hhCcCHHHHHHHHh
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=336.42  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=208.3

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccC-CCCceeEEecceeccCee
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHV-RHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~  381 (588)
                      ...++|...+.||+|+|++|++++. ++++.+|||++..     +..++....|-+.|.+| .||.|++|+-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3356788888999999999999984 5899999999864     33455667888889999 799999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      |+|+||++||+|.++|... +.+++...+.++.+|+.||+|||+.+   ||||||||+|||||+||++||+|||.|+.+.
T Consensus       150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999999654 56899889999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCcc----------cc--cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh---hcCcc
Q 042871          462 IGETY----------AS--SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE---LADPK  526 (588)
Q Consensus       462 ~~~~~----------~~--~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~---~~d~~  526 (588)
                      .....          ..  ..++||-.|++||++.+...+..+|+|+|||+||+|+.|+.||....+.-..+   .++-.
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~  305 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE  305 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence            42211          11  34789999999999999999999999999999999999999997554443322   23455


Q ss_pred             cCcccCHHHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 042871          527 LDREYSIEAFDLTLQLALSCTALTHQRPPMEQVFVT  562 (588)
Q Consensus       527 l~~~~~~e~~~~v~~L~~~C~~~p~~RPs~~evl~~  562 (588)
                      +.+.+++...+++.+|.   ..+|.+|+|..||-+.
T Consensus       306 fp~~fp~~a~dLv~KLL---v~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  306 FPEGFPEDARDLIKKLL---VRDPSDRLTSQQIKAH  338 (604)
T ss_pred             CCCCCCHHHHHHHHHHH---ccCccccccHHHHhhC
Confidence            56677777777777766   5689999999888664

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.5e-39  Score=324.95  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=205.8

Q ss_pred             hcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+|+..      +++.||||.+....   ..+.|.+|++++++++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            456788889999999999999863      34789999987542   346899999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCC-------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc
Q 042871          382 FLIYELCPNGNLAEWLFGKD-------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE  448 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~  448 (588)
                      ++||||+++++|.+++....             ..+++.+...++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999996431             34789999999999999999999998   999999999999999999


Q ss_pred             EEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcc
Q 042871          449 AKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPK  526 (588)
Q Consensus       449 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~  526 (588)
                      +||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            99999999976533222 11233446788999999999999999999999999999998 99998654444444433322


Q ss_pred             cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          527 LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       527 l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      .....+......+..++..|++ +|.+||+++||++.|++
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            2222223344567778899998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=334.81  Aligned_cols=249  Identities=27%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-------CcHHHHHHHHHHhccCC-CCceeEEecceeccCe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-------GNVETFVREVASSSHVR-HPNLVALLGYCLRVDE  380 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-------~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~  380 (588)
                      ..++|...+.||+|+||+|+.|+. .+|..||+|.+..+       ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456888899999999999999985 57899999976543       12345668999999999 9999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-CcEEEEecCCcce
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKV  459 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-~~~kL~DFGla~~  459 (588)
                      .|+||||+.+|+|.+++.. .+.+.+.....++.|++.|++|+|+.+   |+||||||+|||+|.+ +++||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999977 567888999999999999999999999   9999999999999999 9999999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCC-CC-chhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCccc-CH
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCK-VN-SSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREY-SI  533 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~-~~  533 (588)
                      .. .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||...........+.   -.++... +.
T Consensus       171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~  249 (370)
T KOG0583|consen  171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSP  249 (370)
T ss_pred             cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCH
Confidence            74 2333445678999999999999987 86 68999999999999999999998644333333321   1122233 55


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          534 EAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ++..+    +..|+. +|.+|+|+.+++ .-.....
T Consensus       250 ~~~~L----i~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  250 EARSL----IEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             HHHHH----HHHHcCCCcccCCCHHHHh-hChhhcc
Confidence            55444    455555 899999999999 4444443

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.8e-38  Score=320.00  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=206.9

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|++.+.||+|+||.||+|..+++..||+|.+... ...+.|.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4568888999999999999999888889999998753 34568999999999999999999999875 456899999999


Q ss_pred             CCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          390 NGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      +++|.+++... ...+++.+++.++.+++.||.|||+.+   |+||||||+||++++++.++|+|||++...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence            99999999653 345899999999999999999999998   99999999999999999999999999987644332222


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+........+......+.+++.+|+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (260)
T cd05070         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCW  240 (260)
T ss_pred             cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHc
Confidence            23345678999999988899999999999999999999 88888654444444444333222333334456778899999


Q ss_pred             c-CCCCCCCHHHHHHHHHH
Q 042871          548 A-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~  565 (588)
                      . +|.+|||++++.+.|++
T Consensus       241 ~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         241 KKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ccCcccCcCHHHHHHHHhc
Confidence            8 79999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9.3e-39  Score=325.32  Aligned_cols=254  Identities=23%  Similarity=0.350  Sum_probs=203.6

Q ss_pred             HHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccC
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVD  379 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~  379 (588)
                      ..+++|+..+.||+|+||.||+|...      ++..||||++....   ...+|.+|+.+++.++||||+++++++.+++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35778999999999999999998752      35689999986432   3456889999999999999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCC---------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEE
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD---------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK  450 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~k  450 (588)
                      ..++||||+++|+|.+++....         ..+++.++..++.|+++||.|||+.+   ++||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            9999999999999999985422         23678899999999999999999988   99999999999999999999


Q ss_pred             EEecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccC
Q 042871          451 LSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLD  528 (588)
Q Consensus       451 L~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~  528 (588)
                      |+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.........+.+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999987654332221 122345778999999998899999999999999999999 6778764444333332222111


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ...+......+..++.+|++ +|++|||+.|+++.|++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            12223344567778999998 79999999999999873

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-38  Score=319.12  Aligned_cols=252  Identities=24%  Similarity=0.380  Sum_probs=207.2

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecC-CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITN-EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++|+..++||+|+||.||+|..++++.||+|.+.. ....+.|.+|+.++++++|+||+++++++. .+..++++||+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            3567888999999999999999988999999999875 334678999999999999999999999864 55789999999


Q ss_pred             CCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++++|.+++... ...+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence            999999998643 346899999999999999999999988   9999999999999999999999999998765333322


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      .....++..|+|||++....++.++||||||+++||+++ |+.||.........+.+........+......+.+++.+|
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC  239 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            333456778999999988889999999999999999999 9999864444333333332222222222334577788899


Q ss_pred             hc-CCCCCCCHHHHHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~L~~  565 (588)
                      +. +|++||++++++..|+.
T Consensus       240 l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         240 WKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ccCChhhCCCHHHHHHHhhc
Confidence            98 79999999999999974

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.5e-38  Score=324.84  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=207.4

Q ss_pred             cCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .+|...+.||+|+||.||+|+.      .++..+++|.+....  ..+.+.+|++.+++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            4577788999999999999974      245679999987543  23578999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc
Q 042871          384 IYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE  448 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~  448 (588)
                      ||||+++++|.+++....               ..+++.+++.++.|++.||+|||+.+   |+||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999995422               34899999999999999999999998   999999999999999999


Q ss_pred             EEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcc
Q 042871          449 AKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPK  526 (588)
Q Consensus       449 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~  526 (588)
                      +||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.........+.+...
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  241 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG  241 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence            99999999976543221 12234456788999999999999999999999999999999 99987654443333333222


Q ss_pred             cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          527 LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       527 l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ............+.+++.+|++ +|++|||+++|+++|+++.+.
T Consensus       242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            2222222334557788999998 799999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-39  Score=329.36  Aligned_cols=242  Identities=24%  Similarity=0.246  Sum_probs=197.7

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+++.. +|+.||+|++...     ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888899999999999999974 7899999998632     23456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... +.+++.....++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            999999999999643 45889999999999999999999998   999999999999999999999999999865422  


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~  545 (588)
                        .....|++.|+|||++.+..++.++||||||+++|||++|+.||.........+.+...- ..++......+..++..
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~  231 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKK  231 (291)
T ss_pred             --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHH
Confidence              223568999999999999899999999999999999999999986544333222221110 11122223345667788


Q ss_pred             hhc-CCCCCCC-----HHHHHHH
Q 042871          546 CTA-LTHQRPP-----MEQVFVT  562 (588)
Q Consensus       546 C~~-~p~~RPs-----~~evl~~  562 (588)
                      |++ +|.+||+     ++|+++.
T Consensus       232 ~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         232 LLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HcCCCHHHccCCccCCHHHHhcC
Confidence            887 7999995     8887765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=318.57  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=209.2

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++|.+.+.||+|+||.||++..++++.||||.+... ...+++.+|++++++++|+||+++++++......++||||+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            45788999999999999999999888889999998753 44678999999999999999999999999889999999999


Q ss_pred             CCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++++|.+++.... ..+++.++..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.........
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence            9999999996543 46899999999999999999999998   9999999999999999999999999988765332222


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      .....++..|+|||.+.+..++.++||||||+++||+++ |+.|+.........+.+........+.+....+.+++.+|
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  240 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQC  240 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            223345678999999998899999999999999999999 8888864443333333332222222223345577778888


Q ss_pred             hc-CCCCCCCHHHHHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~L~~  565 (588)
                      +. +|++||+++++++.|+.
T Consensus       241 l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         241 WDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             cccCcccCCCHHHHHHHHhc
Confidence            87 79999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.5e-38  Score=323.45  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=205.6

Q ss_pred             CccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          313 KLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      +|...+.||+|+||.||+|+..      ....+++|.+....   ..+.+.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999852      23578999887543   24578899999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcC-----------------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCC
Q 042871          384 IYELCPNGNLAEWLFGK-----------------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTN  440 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~-----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~N  440 (588)
                      |+||+++|+|.+++...                       ...+++.+++.++.|++.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            99999999999998531                       124789999999999999999999988   9999999999


Q ss_pred             eEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccc
Q 042871          441 ILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGS  518 (588)
Q Consensus       441 ILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~  518 (588)
                      ||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999999865433222 1223345678999999988889999999999999999999 988886555445


Q ss_pred             hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          519 ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       519 ~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ..+.+........+......+..++..|++ +|.+||+++|+++.|++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            444444333322233333456678899998 79999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.3e-38  Score=323.90  Aligned_cols=246  Identities=24%  Similarity=0.297  Sum_probs=196.7

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..+.||+|+||.||+++.. +++.||||++...    ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999974 6889999998642    234678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++++.+..+. .....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            99987776544 33456899999999999999999999998   999999999999999999999999999876543333


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh----hhc-------------Cccc--
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL----ELA-------------DPKL--  527 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----~~~-------------d~~l--  527 (588)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+..    +..             ++..  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            334457899999999999989999999999999999999999988643221110    000             0000  


Q ss_pred             ------Ccc------cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          528 ------DRE------YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       528 ------~~~------~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                            ...      +.......+..++..|++ +|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  000      000122346778888888 7999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.8e-38  Score=322.78  Aligned_cols=251  Identities=28%  Similarity=0.423  Sum_probs=202.7

Q ss_pred             cCccccceeeccCceEEEEEEe-----cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++|+..+.||+|+||.||+|+.     .++..|++|.+....   ....+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577788999999999999984     356789999987432   23578899999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcC----------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC
Q 042871          384 IYELCPNGNLAEWLFGK----------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~  447 (588)
                      ||||+++++|.+++...                ...+++.+.+.++.|++.||+|||+.+   |+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            99999999999998422                124788999999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCc
Q 042871          448 EAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADP  525 (588)
Q Consensus       448 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~  525 (588)
                      .+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.........+.++.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986543221 22233445778999999988889999999999999999999 8888865444344444433


Q ss_pred             ccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          526 KLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       526 ~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ......+......+..++.+|++ +|.+||++.+|++.|..
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            22222222334556777889998 79999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-38  Score=316.48  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=204.7

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      .+|+..+.||+|+||.||++.+.++..+|+|.+... .....|.+|++++++++|||++++++++......++|+||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            467788899999999999999877889999988753 3456899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      ++|.+++......+++..++.++.+++.+|+|||+.+   ++||||||+||+++.++.+||+|||+++............
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence            9999999766667899999999999999999999998   9999999999999999999999999987654332222223


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ..++.+|+|||++.+..++.++||||||+++|||++ |+.|+.........+.+........+....+.+.+++.+|++ 
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  240 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKE  240 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccc
Confidence            345678999999998899999999999999999998 888886444333333322211111111123557778999998 


Q ss_pred             CCCCCCCHHHHHHHHH
Q 042871          549 LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       549 ~p~~RPs~~evl~~L~  564 (588)
                      +|++|||+.|+++.|.
T Consensus       241 ~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         241 RPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ChhhCCCHHHHHHhhC
Confidence            6999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.9e-38  Score=316.42  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=203.9

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ++|...+.||+|+||.||++...++..||+|.+... ...+.+.+|+.++++++|+|++++++++. .+..++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            567888899999999999999877778999988753 33467899999999999999999999875 4568999999999


Q ss_pred             CChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          391 GNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       391 gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      ++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...........
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence            99999996533 45899999999999999999999988   999999999999999999999999999876443322222


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ...++..|+|||+..+..++.++||||||+++|||++ |+.||.........+.+........+......+..++.+|+.
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWK  241 (260)
T ss_pred             CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcc
Confidence            3346778999999998899999999999999999999 888886443333333332222222233444567778889998


Q ss_pred             -CCCCCCCHHHHHHHHHH
Q 042871          549 -LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       549 -~p~~RPs~~evl~~L~~  565 (588)
                       +|.+||++++|++.|++
T Consensus       242 ~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         242 KDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCcCHHHHHHHHhc
Confidence             79999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=311.59  Aligned_cols=224  Identities=27%  Similarity=0.347  Sum_probs=194.7

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||.|+||+|..++.+ +|..+|+|+++.+.     ..+...+|..+|+.+.||+++++.+.+.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888899999999999999974 78899999997543     3456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||++||.|..+|++. +.+++...+-++.+++.||+|||+.+   |++|||||+|||||.+|.+||+|||.|+.+...  
T Consensus       124 eyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             eccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            999999999999654 45889999999999999999999999   999999999999999999999999999987533  


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L  542 (588)
                        +-..+|||.|+|||.+....|..++|.|+|||++|||+.|..||.........+.+   +-.++..++.+..+++..|
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~L  275 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKL  275 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHH
Confidence              45679999999999999999999999999999999999999999876665444433   2233455677777777666


Q ss_pred             H
Q 042871          543 A  543 (588)
Q Consensus       543 ~  543 (588)
                      +
T Consensus       276 L  276 (355)
T KOG0616|consen  276 L  276 (355)
T ss_pred             H
Confidence            5

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.6e-38  Score=319.22  Aligned_cols=253  Identities=27%  Similarity=0.408  Sum_probs=205.1

Q ss_pred             hcCccccceeeccCceEEEEEEec----CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ..+|.+.+.||+|+||.||+|+..    .+..+|+|.+...   ...+.|.+|+.++++++||||+++++++.+++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            356788899999999999999863    2347999988643   234578999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++++|.+++......+++.+++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999766667899999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccc--cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          464 ETYAS--SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~--~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      .....  ....++..|++||++.+..++.++|+||||+++||+++ |+.||......+....+........+......+.
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH  239 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence            32211  22233568999999998899999999999999999987 9999865443333332222222222223344567


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      .++..|++ +|.+||+|.++++.|+++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            78889998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.2e-38  Score=316.54  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=203.1

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEeccee-ccCeeeEEeecCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCL-RVDECFLIYELCPN  390 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~LV~E~~~~  390 (588)
                      ++|...+.||+|+||.||++.. .|..||+|.++.+...+.|.+|+.++++++|+|++++++++. +++..++|+||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            4688889999999999999987 578899999987766778999999999999999999999765 45678999999999


Q ss_pred             CChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          391 GNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       391 gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      ++|.+++.... ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......    .
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~  157 (256)
T cd05082          85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D  157 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----C
Confidence            99999996543 35889999999999999999999998   9999999999999999999999999987643222    2


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ...++..|+|||++.+..++.++||||||+++|||++ |+.|+......+....+........+......+..++..|++
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWH  237 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence            2344678999999998899999999999999999998 888876443333333332222222223334566777889988


Q ss_pred             -CCCCCCCHHHHHHHHHHh
Q 042871          549 -LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       549 -~p~~RPs~~evl~~L~~~  566 (588)
                       +|++|||+.++++.|+++
T Consensus       238 ~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         238 LDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CChhhCcCHHHHHHHHhcC
Confidence             799999999999999853

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.9e-38  Score=323.95  Aligned_cols=257  Identities=25%  Similarity=0.380  Sum_probs=206.0

Q ss_pred             hcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+....  ..+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            35788889999999999999974      234678999887532  3457899999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCC------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEE
Q 042871          383 LIYELCPNGNLAEWLFGKD------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK  450 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~k  450 (588)
                      +||||+++++|.+++....            ..+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999985322            24899999999999999999999998   99999999999999999999


Q ss_pred             EEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccC
Q 042871          451 LSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLD  528 (588)
Q Consensus       451 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~  528 (588)
                      |+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+.....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~  240 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  240 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence            999999986543222 12233445788999999999899999999999999999998 8888865443333322222111


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      ...+......+..++..|++ +|.+|||+.||++.|+++.+..
T Consensus       241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            11111122346778899998 7999999999999999887543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.5e-38  Score=315.16  Aligned_cols=246  Identities=25%  Similarity=0.303  Sum_probs=204.5

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|++|.||+++. .+++.|++|.+..    ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477788999999999999986 4789999999863    23456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++... ...+++.+++.++.+++.||.|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999764 457899999999999999999999988   999999999999999999999999998876543222


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                       .....|++.|+|||+..+..++.++|+||||+++|||++|+.||...........+........+......+.+++.+|
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC  236 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence             2345688999999999998999999999999999999999999875544333332222222223333445677788999


Q ss_pred             hc-CCCCCCCHHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~  562 (588)
                      ++ +|++||++.++++.
T Consensus       237 l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         237 LTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCCcccCcCHHHHhhC
Confidence            98 79999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=334.83  Aligned_cols=196  Identities=26%  Similarity=0.382  Sum_probs=173.8

Q ss_pred             HhcCccccceeeccCceEEEEEE-ecCCcEEEEEEecCC-CcHHHH--HHHHHHhccCC-CCceeEEecceeccC-eeeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-GNVETF--VREVASSSHVR-HPNLVALLGYCLRVD-ECFL  383 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~-~~~~~~--~~Ei~~l~~l~-HpnIv~l~g~~~~~~-~~~L  383 (588)
                      ..++|...++||.|+||.||+|+ ..+|..||||++++. ...++.  ++|+..|++++ ||||++|..++.+.+ .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            35778889999999999999998 468999999999764 223433  68999999999 999999999999887 9999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||| ..+|.+++..+++.+++.+++.|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+||||||.+...
T Consensus        88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC
Confidence            99999 57999999888889999999999999999999999999   999999999999999999999999999987644


Q ss_pred             CcccccCccCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          464 ETYASSEVRGTFGYLDPEYRS-NCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      ..  .+..+.|..|.|||+++ .+-|+.+.|+|++|||++|+.+-+.-|
T Consensus       164 pP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF  210 (538)
T KOG0661|consen  164 PP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF  210 (538)
T ss_pred             CC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence            43  35668899999999764 567899999999999999999988754

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-38  Score=315.32  Aligned_cols=247  Identities=27%  Similarity=0.438  Sum_probs=205.7

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCc-HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN-VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|+..+.||+|+||.||+|.. .|+.||+|.+..... .+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            45788889999999999999987 588999999986544 6789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          390 NGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      +++|.+++.... ..+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.......   
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            999999996543 36899999999999999999999998   99999999999999999999999999987632221   


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                       ...++..|+|||++....++.++||||||+++||+++ |+.||.........+.+........+......+..++.+|+
T Consensus       158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (256)
T cd05039         158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCW  236 (256)
T ss_pred             -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence             2334678999999988899999999999999999997 98888655444433333322222222233455667788899


Q ss_pred             c-CCCCCCCHHHHHHHHHH
Q 042871          548 A-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~  565 (588)
                      . +|.+|||++|++++|+.
T Consensus       237 ~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         237 ELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ccChhhCcCHHHHHHHHhc
Confidence            8 79999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-38  Score=322.81  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=204.0

Q ss_pred             HhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      .+++|...+.||+|+||.||+|.+.      .+..||+|.+....   ....|.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4578999999999999999999874      35789999886432   24568999999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCC------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC---cEEE
Q 042871          381 CFLIYELCPNGNLAEWLFGKD------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF---EAKL  451 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~---~~kL  451 (588)
                      .++||||+++++|.+++....      ..+++.+++.++.|++.||+|||+.+   ++||||||+||++++++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            999999999999999996432      25899999999999999999999998   99999999999998754   5999


Q ss_pred             EecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCc
Q 042871          452 SDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDR  529 (588)
Q Consensus       452 ~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~  529 (588)
                      +|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+..+.+......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999998763222111 112234568999999998899999999999999999997 88888754444444444332222


Q ss_pred             ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          530 EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       530 ~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ..+......+.+++.+|++ +|++||++.+|++.|++
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            3333344567778899998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.9e-38  Score=338.02  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=204.0

Q ss_pred             HhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCC-CCceeEEecceeccC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVR-HPNLVALLGYCLRVD  379 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~  379 (588)
                      ..++|.+.+.||+|+||.||+|+..      .+..||||++....   ..+.+.+|+++++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567888899999999999999852      23479999996432   3467899999999996 999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCC----------------------------------------------------------
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD----------------------------------------------------------  401 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~----------------------------------------------------------  401 (588)
                      ..+|||||+++|+|.++|....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999885321                                                          


Q ss_pred             -------------------------------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC
Q 042871          402 -------------------------------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG  444 (588)
Q Consensus       402 -------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld  444 (588)
                                                           ..+++.++..++.|+++||.|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                 23778888999999999999999988   99999999999999


Q ss_pred             CCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccccc-chhh
Q 042871          445 PNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAG-SALE  521 (588)
Q Consensus       445 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~-~~~~  521 (588)
                      +++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            9999999999999865433222 2223456788999999998899999999999999999997 88887643221 1222


Q ss_pred             hcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          522 LADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       522 ~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      .+........+......+..++..|++ +|++||++.+|.++|++.++
T Consensus       352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            222211112223344567778899998 79999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-38  Score=324.77  Aligned_cols=257  Identities=25%  Similarity=0.429  Sum_probs=208.6

Q ss_pred             HHHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceec
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLR  377 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~  377 (588)
                      ....++|+..+.||+|+||.||++...      +...+|+|.+....   ....+.+|++++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344567888999999999999999863      33689999987532   235688999999999 79999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhhcC---------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeE
Q 042871          378 VDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL  442 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NIL  442 (588)
                      ++..+++|||+++|+|.+++...               ...+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            99999999999999999998532               246899999999999999999999988   999999999999


Q ss_pred             ECCCCcEEEEecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchh
Q 042871          443 LGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSAL  520 (588)
Q Consensus       443 ld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~  520 (588)
                      +++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            9999999999999998765432211 222345678999999988899999999999999999998 88887654444444


Q ss_pred             hhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          521 ELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       521 ~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      +.+........+......+.+++..|+. +|.+|||+.|+++.|+.++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            4443333223333344567778899998 7999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-38  Score=333.66  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             HhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceec-c
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLR-V  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~-~  378 (588)
                      ..++|++.+.||+|+||.||+|+.      .+++.||+|++....   ..+.+.+|+.++.++ +|+||+++++++.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            345788899999999999999963      235789999987532   234678899999999 79999999998865 4


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC---------------------------------------------------------
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD---------------------------------------------------------  401 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------------  401 (588)
                      ...++++||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            56889999999999999985321                                                         


Q ss_pred             ---cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCc
Q 042871          402 ---KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGY  477 (588)
Q Consensus       402 ---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y  477 (588)
                         ..++|.++..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...... ......++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               25799999999999999999999988   999999999999999999999999999876433322 22334567789


Q ss_pred             cCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccccc-chhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCC
Q 042871          478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAG-SALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRP  554 (588)
Q Consensus       478 ~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~-~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RP  554 (588)
                      +|||++.+..++.++|||||||++|||++ |+.||...... .....+........+......+.+++.+|++ +|++||
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            99999999999999999999999999998 99888543221 1112222211111122233456777888998 799999


Q ss_pred             CHHHHHHHHHHhhc
Q 042871          555 PMEQVFVTLQKALD  568 (588)
Q Consensus       555 s~~evl~~L~~~~~  568 (588)
                      ++.|++++|++++.
T Consensus       322 s~~ell~~l~~~~~  335 (337)
T cd05054         322 TFSELVEILGDLLQ  335 (337)
T ss_pred             CHHHHHHHHHHHHh
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-38  Score=332.53  Aligned_cols=235  Identities=24%  Similarity=0.280  Sum_probs=193.1

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      +.||+|+||.||+++. .+|+.||||++...     .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999986 57899999998642     23456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCc
Q 042871          392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV  471 (588)
Q Consensus       392 sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~  471 (588)
                      +|.+++.. ...+++.+...++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... .......
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~  155 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF  155 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccce
Confidence            99999864 346899999999999999999999998   999999999999999999999999998753221 1222345


Q ss_pred             cCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHHHHHhhc
Q 042871          472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       472 ~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||...........+   +..+....+.    .+..++..|++
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~----~~~~li~~~L~  231 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP----EAKSLLAGLLK  231 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHHcc
Confidence            7999999999999999999999999999999999999998654333332222   1222233343    45566777887


Q ss_pred             -CCCCCC-----CHHHHHH
Q 042871          549 -LTHQRP-----PMEQVFV  561 (588)
Q Consensus       549 -~p~~RP-----s~~evl~  561 (588)
                       +|++||     ++.++++
T Consensus       232 ~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHc
Confidence             799999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=321.87  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=203.0

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHH--hccCCCCceeEEecceecc----CeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVAS--SSHVRHPNLVALLGYCLRV----DECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~--l~~l~HpnIv~l~g~~~~~----~~~~LV  384 (588)
                      .++....+.||+|.||+||+|++ .|+.||||++....+ +.+.+|-++  ...|+|+||+.+++.-..+    .+++||
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEecccch-hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            56788889999999999999999 789999999987655 455555555  4567999999999886544    368999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-----ccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-----YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      +||.|+|||.|||  ....++....++++..+|.||++||.     +++|.|.|||||+.|||+..++...|+|+|||..
T Consensus       288 TdYHe~GSL~DyL--~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  288 TDYHEHGSLYDYL--NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             eecccCCcHHHHH--hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            9999999999999  44679999999999999999999995     5789999999999999999999999999999976


Q ss_pred             ecCCCc---ccccCccCCCCccCcccccCCCC------CchhhHHHHHHHHHHHHcC----C------Cccccc--cc--
Q 042871          460 IDIGET---YASSEVRGTFGYLDPEYRSNCKV------NSSGDVYSFGIVLLQILSG----K------KAKVLT--RA--  516 (588)
Q Consensus       460 ~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~------t~ksDVwS~Gvll~ElltG----~------~p~~~~--~~--  516 (588)
                      ......   ......+||.+|||||++...--      -..+||||||+++||+...    .      .||...  .+  
T Consensus       366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs  445 (513)
T KOG2052|consen  366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS  445 (513)
T ss_pred             ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence            544322   22345689999999999765321      1368999999999999753    2      244321  11  


Q ss_pred             -cchhhh-----cCcccCccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          517 -GSALEL-----ADPKLDREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       517 -~~~~~~-----~d~~l~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                       ++..++     +.|.++..+ +.+....+.+|+..||. +|..|-|+-.+-+.|.++.+.+.
T Consensus       446 ~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e  508 (513)
T KOG2052|consen  446 FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE  508 (513)
T ss_pred             HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence             122222     233333333 46788889999999998 89999999999999999886544

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.5e-38  Score=319.43  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=204.2

Q ss_pred             cCccccceeeccCceEEEEEEec-CC---cEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NN---QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ..|+..+.||+|+||.||+|++. ++   ..||||.+...   .....|.+|+..+++++||||+++.+++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34677889999999999999864 33   36999998743   2346899999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++......+++.+++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999766667899999999999999999999988   9999999999999999999999999987654322


Q ss_pred             ccc--ccCcc--CCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHH
Q 042871          465 TYA--SSEVR--GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLT  539 (588)
Q Consensus       465 ~~~--~~~~~--gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v  539 (588)
                      ...  .....  .+..|+|||++.+..++.++||||||+++||+++ |+.||......+..+.+........+.+....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL  240 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence            111  11111  2457999999999999999999999999999987 999986544444444332222222223344556


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ..++..|++ +|.+||++++|+..|+++
T Consensus       241 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         241 HQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            778899998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-38  Score=306.86  Aligned_cols=194  Identities=27%  Similarity=0.410  Sum_probs=172.1

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|...+.||+|.||.||+|+. .+|+.||||+++..    .-.....+||+.|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4577788999999999999985 68999999999743    223567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      ||+ .+|...+..+...++..+...++.++++||+|+|.+.   |+||||||.|+|++++|.+||+|||+|+........
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            995 6999999888888999999999999999999999999   999999999999999999999999999987654433


Q ss_pred             cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCc
Q 042871          467 ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKA  510 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p  510 (588)
                      ... .+-|..|.|||.+.+ ++|+...|+||.||++.||+-|.+-
T Consensus       158 ~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~  201 (318)
T KOG0659|consen  158 QTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF  201 (318)
T ss_pred             ccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC
Confidence            222 266899999998877 5799999999999999999999863

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-39  Score=336.56  Aligned_cols=247  Identities=21%  Similarity=0.281  Sum_probs=200.3

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|...+.||+|+||.||+++.. +|+.||||++...     .....+.+|++++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999974 7899999998632     34567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-  464 (588)
                      ||+++|+|.+++... ..+++...+.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999654 56899999999999999999999988   9999999999999999999999999998654332 


Q ss_pred             ---------------------------cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc
Q 042871          465 ---------------------------TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG  517 (588)
Q Consensus       465 ---------------------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~  517 (588)
                                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                       11223456899999999999999999999999999999999999998754432


Q ss_pred             chhh-hcC--cccCcccCHHHHHHHHHHHHHhhcCCCCCCC-HHHHHHH
Q 042871          518 SALE-LAD--PKLDREYSIEAFDLTLQLALSCTALTHQRPP-MEQVFVT  562 (588)
Q Consensus       518 ~~~~-~~d--~~l~~~~~~e~~~~v~~L~~~C~~~p~~RPs-~~evl~~  562 (588)
                      .... +..  ..+...........+..++..|+.+|.+||+ ++|+++.
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcC
Confidence            2221 111  1111100011223344556667778999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.3e-38  Score=315.84  Aligned_cols=244  Identities=26%  Similarity=0.411  Sum_probs=198.4

Q ss_pred             eeeccCceEEEEEEec---CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCC
Q 042871          319 LIGEGITGKVYKGKLS---NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs  392 (588)
                      .||+|+||.||+|++.   ++..||+|.+....   ..+.|.+|+.++++++|+||+++++++. .+..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999763   45679999987542   2456899999999999999999999875 457899999999999


Q ss_pred             hhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc--ccC
Q 042871          393 LAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA--SSE  470 (588)
Q Consensus       393 L~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~--~~~  470 (588)
                      |.+++......+++.++++++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.........  ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999766667999999999999999999999998   9999999999999999999999999998654333221  122


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ..++..|+|||++....++.++||||||+++||+++ |+.||...........+........+......+.+++..|++ 
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            234578999999988889999999999999999997 999987555444444443333223333344566678899998 


Q ss_pred             CCCCCCCHHHHHHHHHHh
Q 042871          549 LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       549 ~p~~RPs~~evl~~L~~~  566 (588)
                      +|++||++.+|.+.|+..
T Consensus       238 ~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         238 KWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ChhhCcCHHHHHHHHhhh
Confidence            799999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=332.41  Aligned_cols=243  Identities=23%  Similarity=0.278  Sum_probs=197.8

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+|+.. +++.||||++...     ...+.+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46888999999999999999975 6899999998642     23457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.+...++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            999999999999543 45889999999999999999999998   99999999999999999999999999976533   


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccC-cccC---HHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLD-REYS---IEAFDL  538 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~-~~~~---~e~~~~  538 (588)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+.   ..+. ....   ....+.
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~  232 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE  232 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence             2334578999999999999999999999999999999999999986443322221111   0010 0000   112234


Q ss_pred             HHHHHHHhhcC-CCCCCCHHHHHHH
Q 042871          539 TLQLALSCTAL-THQRPPMEQVFVT  562 (588)
Q Consensus       539 v~~L~~~C~~~-p~~RPs~~evl~~  562 (588)
                      +..++..|+.+ |.+||+++|+++.
T Consensus       233 ~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         233 AWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHHhhChhhhcCCHHHHHhC
Confidence            45566777774 6999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=338.65  Aligned_cols=263  Identities=23%  Similarity=0.377  Sum_probs=232.2

Q ss_pred             HHHHHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          305 REVHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       305 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ++++-...++...++||-|-||.||.|+|+ -.-.||||.++.+ ..+++|+.|..+|+.++|||+|+|+|+|..+..+|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            344445556777889999999999999985 4568999999864 57899999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCc-CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          383 LIYELCPNGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ||+|||..|+|.|||..-++ .++....+.++-||+.||+||..++   +|||||..+|.|+.++..+||+||||+++..
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999976443 5777788899999999999999999   9999999999999999999999999999876


Q ss_pred             CCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      .+.........-.+.|.|||.+.+..++.|+|||+|||+|||+.| |..|+.-.+..+++++++..++-+-++.+...+.
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVY  496 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVY  496 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHH
Confidence            444333333445778999999999999999999999999999999 8889988888889999999888888888889999


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      +|++.||+ .|.+||+++|+-+.+|.+....
T Consensus       497 eLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  497 ELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            99999999 7999999999999999987643

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=330.72  Aligned_cols=245  Identities=25%  Similarity=0.360  Sum_probs=207.9

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ..|...+.||+|.||.||||.. ..++.||+|++.-+   .+.+++.+|+.++.+++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            3466667999999999999986 57899999999743   4567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +.+|++.+.|... ..+++....-|..++..||.|||.++   .+|||||+.|||+.++|.+||+|||.+.++.......
T Consensus        93 ~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             hcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            9999999999432 33577778889999999999999999   9999999999999999999999999998876443333


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                       ..++||+-|||||++....|+.|+||||||++.+||.+|.+|+......+..-.+.+.-++.+....-..+.+++..|+
T Consensus       169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL  247 (467)
T ss_pred             -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence             6789999999999999889999999999999999999999999877666655555444333333333344666788999


Q ss_pred             c-CCCCCCCHHHHHH
Q 042871          548 A-LTHQRPPMEQVFV  561 (588)
Q Consensus       548 ~-~p~~RPs~~evl~  561 (588)
                      . +|+.||++.++++
T Consensus       248 ~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLK  262 (467)
T ss_pred             hcCcccCcCHHHHhh
Confidence            8 7999999999886

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.1e-38  Score=324.49  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=203.6

Q ss_pred             cCccccceeeccCceEEEEEEec-CCc--EEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQ--HVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ++|++.+.||+|+||.||+|+.. ++.  .+++|.++..   ...+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57888899999999999999874 333  4788888642   2345788999999999 799999999999999999999


Q ss_pred             eecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          385 YELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      +||+++|+|.+++....               ..+++.+++.++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999995421               24888999999999999999999988   9999999999999999999


Q ss_pred             EEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccC
Q 042871          450 KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLD  528 (588)
Q Consensus       450 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~  528 (588)
                      ||+|||++.......  .......+..|+|||++....++.++||||||+++|||++ |+.||......+..+.+.....
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            999999986432111  1111223567999999998899999999999999999998 9999865444444443333332


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      ...+......+..++..|+. +|.+|||++++++.|+.+....
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            22222334556778899998 6999999999999999888654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-38  Score=332.45  Aligned_cols=239  Identities=20%  Similarity=0.236  Sum_probs=197.1

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+|+.. +|+.||||.+...     ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888899999999999999974 6899999998642     23467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            999999999999643 45788888999999999999999998   9999999999999999999999999998654322 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Ccc--cCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPK--LDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~--l~~~~~~e~~~~v~~L  542 (588)
                         ....||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+ ...  +....+    ..+..+
T Consensus       173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~----~~~~~l  245 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD----GRARDL  245 (329)
T ss_pred             ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCC----HHHHHH
Confidence               2357899999999999999999999999999999999999998643332222222 111  112233    345567


Q ss_pred             HHHhhc-CCCCCCC-----HHHHHHH
Q 042871          543 ALSCTA-LTHQRPP-----MEQVFVT  562 (588)
Q Consensus       543 ~~~C~~-~p~~RPs-----~~evl~~  562 (588)
                      +..|++ +|.+||+     +++++..
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            788887 7999987     6777643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=322.38  Aligned_cols=248  Identities=23%  Similarity=0.310  Sum_probs=201.3

Q ss_pred             hcCccccceeeccCceEEEEEE-ecCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .+.|+....||.|.-++||+|+ .+.++.||||++.-+   .+.+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4678888999999999999998 468899999999743   346788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||.+||+.+.+... ...+++..+..|.+++++||.|||.++   .||||||+.||||+++|.+||+|||.+..+.....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999999643 235899999999999999999999999   99999999999999999999999998765533221


Q ss_pred             ---ccccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcCc--------ccCccc
Q 042871          466 ---YASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELADP--------KLDREY  531 (588)
Q Consensus       466 ---~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d~--------~l~~~~  531 (588)
                         ......+||+.|||||+++.  ..|+.|+||||||+...||.+|..||.....-++. .-+..        .+..+.
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~  261 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE  261 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence               11255689999999998543  57999999999999999999999998754433211 11111        111111


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .......+.+++..|++ +|.+|||+.++++
T Consensus       262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  262 DKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            12222457778899998 7999999999875

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.5e-38  Score=317.48  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=196.2

Q ss_pred             cccceeeccCceEEEEEEecC-Cc--EEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc------Cee
Q 042871          315 NELNLIGEGITGKVYKGKLSN-NQ--HVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV------DEC  381 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~  381 (588)
                      .+.+.||+|+||.||+|++.+ ++  .||+|.++..    ...+.+.+|+++++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999999754 33  6899987642    3356788999999999999999999987532      246


Q ss_pred             eEEeecCCCCChhhhhhc-----CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          382 FLIYELCPNGNLAEWLFG-----KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      ++++||+++|+|.+++..     ....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999998742     2245899999999999999999999988   99999999999999999999999999


Q ss_pred             cceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHH
Q 042871          457 SKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIE  534 (588)
Q Consensus       457 a~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e  534 (588)
                      ++......... .....+++.|++||+..+..++.++||||||+++|||++ |+.||.........+.+...-....+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD  238 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            98764433221 122345678999999999999999999999999999999 7888864433333332222111112223


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ..+.+.+++..|++ +|++|||+.++++.|+++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            34557788899998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.7e-38  Score=321.65  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=202.6

Q ss_pred             cCccccceeeccCceEEEEEEec------CCcEEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .+|...+.||+|+||.||+|+..      +++.||+|++.....   .+.+.+|+.++..++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34667789999999999999853      357899999975432   356889999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcC---------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC
Q 042871          383 LIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~  447 (588)
                      +++||+++++|.+++...               ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998421               124788889999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCc
Q 042871          448 EAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADP  525 (588)
Q Consensus       448 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~  525 (588)
                      .+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+..+.+..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999886543322 11233446789999999988889999999999999999998 7778765444444443322


Q ss_pred             ccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          526 KLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       526 ~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ......+......+..++..|++ +|.+||++++|+..|+.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22222333445567788999998 79999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-37  Score=327.11  Aligned_cols=247  Identities=22%  Similarity=0.272  Sum_probs=199.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||.||+++.. +|..||+|.+...   ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999974 7889999988643   224578999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |+++|+|.+++... ..+++..+..++.|++.||.|||+.+  .|+||||||+|||+++++.+||+|||+++.....   
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            99999999999543 45889999999999999999999752  2999999999999999999999999998765322   


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc-------------------
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL-------------------  527 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l-------------------  527 (588)
                      ......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+....                   
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            2234568999999999999899999999999999999999999985332221111110000                   


Q ss_pred             ---------------------------Cccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHH
Q 042871          528 ---------------------------DREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       528 ---------------------------~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L  563 (588)
                                                 .... .......+.+++.+|++ +|++|||++|+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                       0000 00122346778889998 799999999998764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.9e-38  Score=324.78  Aligned_cols=256  Identities=24%  Similarity=0.402  Sum_probs=205.7

Q ss_pred             hcCccccceeeccCceEEEEEEec--------CCcEEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS--------NNQHVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      .++|.+.+.||+|+||.||+++..        ++..+|+|.+...   .....+.+|++++..+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467889999999999999999752        2357999998753   2345688899999999 799999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl  443 (588)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999996432               24899999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEEecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhh
Q 042871          444 GPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALE  521 (588)
Q Consensus       444 d~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~  521 (588)
                      ++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.........+
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            999999999999987654322111 122234578999999998899999999999999999998 778876444333333


Q ss_pred             hcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          522 LADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       522 ~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .+........+......+.+++..|++ +|++|||+.+|++.|++++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         254 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            333222222233344566678889998 799999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.7e-38  Score=318.50  Aligned_cols=256  Identities=22%  Similarity=0.363  Sum_probs=205.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCc----EEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQ----HVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++|+..+.||+|+||.||+|++ .+|+    .||+|.+....   ..+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            45788889999999999999985 4554    48999986432   34578899999999999999999999875 4578


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +++||+++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999766667899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          463 GETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       463 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      .... ......++..|++||+..+..++.++||||||+++|||++ |+.||...........+........+......+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence            3221 1222345678999999999899999999999999999998 8888865444433333332222122222334566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .++..|+. +|++||++.++++.|+++...+
T Consensus       242 ~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         242 MIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            77888998 7999999999999999886655

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.3e-38  Score=318.99  Aligned_cols=256  Identities=22%  Similarity=0.351  Sum_probs=207.3

Q ss_pred             HhcCccccceeeccCceEEEEEEecC-----CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceec-cCe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSN-----NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLR-VDE  380 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~  380 (588)
                      ..++|...+.||+|+||.||+|...+     +..|++|++....   ..+.+.+|+.++++++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35788888999999999999999755     7889999987532   34568899999999999999999998776 467


Q ss_pred             eeEEeecCCCCChhhhhhcCC-------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEe
Q 042871          381 CFLIYELCPNGNLAEWLFGKD-------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSD  453 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~D  453 (588)
                      .++++||+++|+|.+++....       ..+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999985422       45899999999999999999999988   99999999999999999999999


Q ss_pred             cCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCccc
Q 042871          454 FGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREY  531 (588)
Q Consensus       454 FGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~  531 (588)
                      ||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+....+........
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            9999865433322 1223346778999999998899999999999999999999 9999865444333333322222112


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      .....+.+.+++.+|+. +|++|||+.|+++.|+.+..
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            22234456778899998 79999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7e-38  Score=323.62  Aligned_cols=257  Identities=23%  Similarity=0.416  Sum_probs=206.2

Q ss_pred             hcCccccceeeccCceEEEEEEe--------cCCcEEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL--------SNNQHVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~--------~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      .++|.+.+.||+|+||.||+++.        .++..||+|.+...   ...+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            56788889999999999999974        13457999988643   2346788999999999 899999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcC---------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE
Q 042871          379 DECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl  443 (588)
                      +..++||||+++|+|.+++...               ...+++.+++.++.|+++||.|||+.+   |+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            9999999999999999999642               135788899999999999999999998   9999999999999


Q ss_pred             CCCCcEEEEecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhh
Q 042871          444 GPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALE  521 (588)
Q Consensus       444 d~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~  521 (588)
                      ++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.|+.........+
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~  250 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  250 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            999999999999998764332221 223345678999999988889999999999999999998 777765433333333


Q ss_pred             hcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          522 LADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       522 ~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .+........+......+..++..|++ +|.+|||+.|+++.|++++...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            332222212222334556778889998 7999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=337.35  Aligned_cols=241  Identities=26%  Similarity=0.342  Sum_probs=206.3

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccC-CCCceeEEecceeccC
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHV-RHPNLVALLGYCLRVD  379 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~  379 (588)
                      .....++|...++||+|.||+|+++.++ +++.+|||++++     +.+++..+.|.+++... +||.|+.++.+|...+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3445678999999999999999999974 788999999975     34677788888887766 5999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ++|+||||+.||++..+.  +...+++..+.-++..++.||.|||+++   ||+||||.+|||||.+|.+||+||||++.
T Consensus       443 ~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             eEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            999999999999954444  4456999999999999999999999999   99999999999999999999999999997


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHH
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAF  536 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~  536 (588)
                      .. +....+++.+||+.|||||++.+..|+...|.|||||+||||+.|..||.-.++.++.+.+   |+.++...+.|..
T Consensus       518 ~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  518 GM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             cC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence            54 2233567899999999999999999999999999999999999999999876666665543   5555666788888


Q ss_pred             HHHHHHHHHhhcCCCCCCCH
Q 042871          537 DLTLQLALSCTALTHQRPPM  556 (588)
Q Consensus       537 ~~v~~L~~~C~~~p~~RPs~  556 (588)
                      ..+..|+   ..+|++|--+
T Consensus       597 ~il~~ll---~k~p~kRLG~  613 (694)
T KOG0694|consen  597 AIMRRLL---RKNPEKRLGS  613 (694)
T ss_pred             HHHHHHh---ccCcccccCC
Confidence            8877766   5578888776

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.6e-38  Score=332.62  Aligned_cols=243  Identities=21%  Similarity=0.255  Sum_probs=197.7

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|...+.||+|+||.||+++. .+|+.||+|++...     ...+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688899999999999999986 47899999998742     23456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++......+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999766567999999999999999999999998   99999999999999999999999999987654443


Q ss_pred             ccccCccCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCc----ccC--cccC
Q 042871          466 YASSEVRGTFGYLDPEYRS------NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADP----KLD--REYS  532 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~----~l~--~~~~  532 (588)
                      .......||+.|+|||++.      ...++.++||||||+++|||++|+.||.......... +...    ...  ...+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence            3334457899999999876      4567889999999999999999999986433222111 1110    011  1233


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 042871          533 IEAFDLTLQLALSCTALTHQRPPMEQVFV  561 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~~p~~RPs~~evl~  561 (588)
                      .+    +..|+..|+.+|.+|||+++++.
T Consensus       238 ~~----~~~li~~ll~~p~~R~t~~~l~~  262 (330)
T cd05601         238 SD----FLDLIQSLLCGQKERLGYEGLCC  262 (330)
T ss_pred             HH----HHHHHHHHccChhhCCCHHHHhC
Confidence            34    34445566678999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-38  Score=315.70  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=199.2

Q ss_pred             ccccceeeccCceEEEEEEec-C---CcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCe-----
Q 042871          314 LNELNLIGEGITGKVYKGKLS-N---NQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDE-----  380 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~-~---g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-----  380 (588)
                      |.+.+.||+|+||.||+|++. +   +..||+|+++.+.    ..+.+.+|++.++.++|+||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456789999999999999864 2   3689999987432    24578999999999999999999998876554     


Q ss_pred             -eeEEeecCCCCChhhhhhcC-----CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          381 -CFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       381 -~~LV~E~~~~gsL~~~L~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                       .++++||+++|+|.+++...     ...+++...+.++.|++.||.|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             79999999999999998532     236899999999999999999999988   999999999999999999999999


Q ss_pred             CCcceecCCCcccc-cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccC
Q 042871          455 GLSKVIDIGETYAS-SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYS  532 (588)
Q Consensus       455 Gla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~  532 (588)
                      |+++.......... ....++..|+|||++.+..++.++||||||+++|||++ |..||......+..+.+........+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99987654333221 22335678999999988899999999999999999999 88887644433333332222122222


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ......+..++..|++ +|.+|||+.|+++.|++.
T Consensus       238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            3344556777888998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=316.43  Aligned_cols=245  Identities=29%  Similarity=0.464  Sum_probs=195.6

Q ss_pred             ceeeccCceEEEEEEec-CCc--EEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS-NNQ--HVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+|++. ++.  .+++|.+...   ...+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999974 343  5788988742   2345788999999999 799999999999999999999999999


Q ss_pred             CChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          391 GNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       391 gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                      |+|.+++....               ..+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985422               24789999999999999999999988   9999999999999999999999999


Q ss_pred             CcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHH
Q 042871          456 LSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIE  534 (588)
Q Consensus       456 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e  534 (588)
                      +++.....  ........+..|+|||++....++.++||||||+++|||++ |+.||......+..+.+........+..
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  235 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN  235 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence            98643211  11112233567999999988889999999999999999997 9999864443333333333222222223


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      ....+..++..|++ +|.+|||+.+++..|++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            33456788899998 7999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.3e-38  Score=331.60  Aligned_cols=245  Identities=23%  Similarity=0.294  Sum_probs=196.4

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||+||+++. .+++.||||++...     .....+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4788999999999999999986 46899999998642     23356788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.+...++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            999999999999643 46899999999999999999999998   99999999999999999999999999875432110


Q ss_pred             ----------------------------------ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          466 ----------------------------------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       466 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                                                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              0012357999999999999999999999999999999999999999


Q ss_pred             ccccccchhhhc-C----cccCc--ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          512 VLTRAGSALELA-D----PKLDR--EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       512 ~~~~~~~~~~~~-d----~~l~~--~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ...........+ .    ..++.  ..+.+..+++.++.  |.. .+..||+++|+++.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~--~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC--CEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHc--CChhhcCCCCCHHHHhCC
Confidence            643332222211 1    11121  24566666665432  333 34578999999885

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=318.18  Aligned_cols=248  Identities=25%  Similarity=0.371  Sum_probs=197.2

Q ss_pred             cccceeeccCceEEEEEEe-----cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceecc--CeeeEE
Q 042871          315 NELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRV--DECFLI  384 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV  384 (588)
                      ...+.||+|+||+||++..     .+++.||+|.+....   ....|.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7788999999999988653     467899999987532   356788999999999999999999987653  458999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++..  ..+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++....+.
T Consensus        87 ~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            999999999999954  35899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             ccc--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc---------------chhhhcCccc
Q 042871          465 TYA--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG---------------SALELADPKL  527 (588)
Q Consensus       465 ~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---------------~~~~~~d~~l  527 (588)
                      ...  .....++..|+|||++....++.++||||||+++|||++|+.|+......               ...+.++...
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence            211  12234566799999998889999999999999999999999887532211               0111111111


Q ss_pred             CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          528 DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       528 ~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      ....+......+..++..|++ +|++|||+++++++|+++.
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111122234567778999998 7999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-37  Score=319.59  Aligned_cols=197  Identities=27%  Similarity=0.395  Sum_probs=170.7

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+...   .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888899999999999999864 7899999998642   2345678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++ |+|.+++......+++.....++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~  159 (288)
T cd07871          85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T  159 (288)
T ss_pred             CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence            96 5999998665556889999999999999999999998   99999999999999999999999999976543221 2


Q ss_pred             ccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          468 SSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            233467899999998765 5689999999999999999999998853

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=328.26  Aligned_cols=235  Identities=21%  Similarity=0.240  Sum_probs=188.9

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          320 IGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       320 LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      ||+|+||.||+++.. +++.||+|++..     ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999864 688999999863     23345788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccC
Q 042871          394 AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG  473 (588)
Q Consensus       394 ~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~g  473 (588)
                      .+++... ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++...... .......|
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g  155 (312)
T cd05585          81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG  155 (312)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence            9999653 45899999999999999999999998   9999999999999999999999999987543222 22344578


Q ss_pred             CCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-CcccCcccCHHHHHHHHHHHHHhhc-CCC
Q 042871          474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPKLDREYSIEAFDLTLQLALSCTA-LTH  551 (588)
Q Consensus       474 t~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~l~~~~~~e~~~~v~~L~~~C~~-~p~  551 (588)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||.........+.+ ...  ..++......+..++..|+. +|.
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--LRFPDGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcCCCHH
Confidence            99999999999999999999999999999999999998643332222211 111  11122223345566778887 799


Q ss_pred             CCCC---HHHHHH
Q 042871          552 QRPP---MEQVFV  561 (588)
Q Consensus       552 ~RPs---~~evl~  561 (588)
                      +||+   +.|++.
T Consensus       234 ~R~~~~~~~e~l~  246 (312)
T cd05585         234 RRLGYNGAQEIKN  246 (312)
T ss_pred             HcCCCCCHHHHHc
Confidence            9986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-37  Score=313.29  Aligned_cols=242  Identities=26%  Similarity=0.412  Sum_probs=197.6

Q ss_pred             eeeccCceEEEEEEe---cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          319 LIGEGITGKVYKGKL---SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      .||+|+||.||+|.+   .++..+|+|+++...    ..+.+.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999975   367899999986432    2457899999999999999999999875 45678999999999


Q ss_pred             ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc--cc
Q 042871          392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA--SS  469 (588)
Q Consensus       392 sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~--~~  469 (588)
                      +|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.........  ..
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999999543 46899999999999999999999988   9999999999999999999999999998764333221  12


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ...++..|+|||.+....++.++||||||+++|||++ |+.||.........+.++.......+......+.+++.+|++
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence            2344678999999988889999999999999999998 999987655544555554433323333344556778899998


Q ss_pred             -CCCCCCCHHHHHHHHHH
Q 042871          549 -LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       549 -~p~~RPs~~evl~~L~~  565 (588)
                       +|++||++.+|.+.|++
T Consensus       237 ~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         237 YGVDERPGFAVVELRLRN  254 (257)
T ss_pred             cCchhCcCHHHHHHHHhc
Confidence             79999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-37  Score=312.36  Aligned_cols=251  Identities=21%  Similarity=0.296  Sum_probs=204.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|++.+.||+|+||.||+|+. .+++.||||.+..     ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5788899999999999999986 4789999998753     123456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ||+++|+|.+++..   ....+++.+.+.++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988843   2345788999999999999999999988   99999999999999999999999999887543


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc--chhhhcCc-ccCcccCHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG--SALELADP-KLDREYSIEAFDLT  539 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~--~~~~~~d~-~l~~~~~~e~~~~v  539 (588)
                      ... ......|++.|+|||++.+..++.++|+||||+++|||++|+.||......  .....+.. .............+
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            221 122346888999999998888999999999999999999999998533221  12222211 11111222344667


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      .+++.+|+. +|.+||++++|++.|+++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            888999998 799999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-37  Score=319.22  Aligned_cols=257  Identities=22%  Similarity=0.347  Sum_probs=204.0

Q ss_pred             HHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccC
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVD  379 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~  379 (588)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.+....   ....+.+|+..++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999999753      24589999886433   2346789999999999999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCC---------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEE
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD---------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK  450 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~k  450 (588)
                      ..++||||+++|+|.+++....         ..+++..+.+++.|++.||.|||+.+   |+||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            9999999999999999995321         23567788999999999999999988   99999999999999999999


Q ss_pred             EEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccC
Q 042871          451 LSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLD  528 (588)
Q Consensus       451 L~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~  528 (588)
                      |+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+.....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999998865332221 1222345678999999998899999999999999999999 6778764443333332211111


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ...+.+....+.+++.+|++ +|++|||+.++++.|++.+.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            11222334567888999998 79999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.3e-38  Score=323.87  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=204.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCc--EEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQ--HVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+|++. ++.  .+++|++...   .....+.+|++++.++ +|+||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888899999999999999864 454  4688877642   2345788999999999 89999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc
Q 042871          384 IYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE  448 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~  448 (588)
                      |+||+++|+|.+++....               ..+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999996432               25789999999999999999999988   999999999999999999


Q ss_pred             EEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCccc
Q 042871          449 AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKL  527 (588)
Q Consensus       449 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l  527 (588)
                      +||+|||+++.....  .......++..|+|||++.+..++.++||||||+++|||+| |..||......+..+.+....
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            999999998643211  11112234668999999988889999999999999999998 999986444433333332222


Q ss_pred             CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          528 DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       528 ~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      ....+......+..++.+|++ +|++||++.+++..|++++....+
T Consensus       241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence            222222233456778899998 799999999999999988766544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.8e-37  Score=314.33  Aligned_cols=255  Identities=25%  Similarity=0.361  Sum_probs=204.3

Q ss_pred             hcCccccceeeccCceEEEEEEecC----CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN----NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|...+.||+|+||.||+|+..+    ...|+||......   ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3457788899999999999998643    2478999887543   34578999999999999999999998875 56789


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++......+++.+++.++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999765556899999999999999999999988   999999999999999999999999999876544


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      .........++..|+|||++....++.++||||||+++||+++ |+.||...........+........+......+.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  240 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence            3333333445678999999988889999999999999999986 999986544333222222111111222333456777


Q ss_pred             HHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          543 ALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      +.+|+. +|.+|||+.++++.|++....
T Consensus       241 i~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         241 MTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            888887 799999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.2e-38  Score=329.00  Aligned_cols=241  Identities=25%  Similarity=0.275  Sum_probs=194.3

Q ss_pred             CccccceeeccCceEEEEEEe----cCCcEEEEEEecCC------CcHHHHHHHHHHhccCC-CCceeEEecceeccCee
Q 042871          313 KLNELNLIGEGITGKVYKGKL----SNNQHVAIKHITNE------GNVETFVREVASSSHVR-HPNLVALLGYCLRVDEC  381 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~  381 (588)
                      +|+..+.||+|+||.||+++.    .+++.||+|++...      ...+.+.+|+.++.+++ |+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999875    36889999998632      23456788999999995 99999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++|+|.+++... ..+++.+...++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            9999999999999999643 45889999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhh-------hcCcccCcccCH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-------LADPKLDREYSI  533 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-------~~d~~l~~~~~~  533 (588)
                      ...........||+.|+|||++.+. .++.++||||||+++|||++|+.||..........       ..++.+....+.
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP  236 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence            3333333456799999999998765 47889999999999999999999986433222111       112222233333


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCC-----CHHHHHH
Q 042871          534 EAFDLTLQLALSCTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RP-----s~~evl~  561 (588)
                          .+..++..|++ +|++||     +++++++
T Consensus       237 ----~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         237 ----EAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                44556778887 799999     7778765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-37  Score=313.52  Aligned_cols=252  Identities=22%  Similarity=0.381  Sum_probs=205.6

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC-cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++|...+.||+|+||.||++...++..+|+|.+.... ..+.|.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            356788899999999999999998788889999887543 35689999999999999999999999887 7789999999


Q ss_pred             CCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++++|.+++... ...+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            999999999653 346889999999999999999999988   9999999999999999999999999997664433322


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      .....++..|+|||++....++.++|+||||+++||+++ |+.||.........+.+...............+..++.+|
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  239 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC  239 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHH
Confidence            233345678999999998889999999999999999999 8888865443333333332222222223334566778888


Q ss_pred             hc-CCCCCCCHHHHHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~L~~  565 (588)
                      ++ +|++||++.++.+.|+.
T Consensus       240 l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         240 WKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             cccCcccCcCHHHHHHHHhc
Confidence            87 79999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-38  Score=333.57  Aligned_cols=243  Identities=22%  Similarity=0.296  Sum_probs=194.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+++. .+|+.||||++...     .....+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4788999999999999999996 47899999998632     23456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999999653 35899999999999999999999998   99999999999999999999999999875432110


Q ss_pred             c-------------------------------------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCC
Q 042871          466 Y-------------------------------------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK  508 (588)
Q Consensus       466 ~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~  508 (588)
                      .                                     ......||+.|+|||++....++.++|||||||++|||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            0                                     011246999999999999999999999999999999999999


Q ss_pred             Cccccccccchhh-hcC--ccc--Cc--ccCHHHHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 042871          509 KAKVLTRAGSALE-LAD--PKL--DR--EYSIEAFDLTLQLALSCTALTHQRPP---MEQVFVT  562 (588)
Q Consensus       509 ~p~~~~~~~~~~~-~~d--~~l--~~--~~~~e~~~~v~~L~~~C~~~p~~RPs---~~evl~~  562 (588)
                      .||.......... ...  ..+  ..  ..+.+..++    +..|+.+|.+|++   ++|+++.
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l----i~~ll~~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDL----IKRLCCEAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHH----HHHHccCHhhcCCCCCHHHHhcC
Confidence            9986443322211 111  111  11  234444444    4455568888887   8888773

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=329.59  Aligned_cols=242  Identities=25%  Similarity=0.332  Sum_probs=190.4

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++....   ..+.+.+|+++++.++|+||+++++++.+++..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            3456677999999999999986 478999999986432   245788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++|+|.+..     ..++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++...... ..
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  224 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP  224 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence            9999997643     3456778889999999999999998   9999999999999999999999999998754321 12


Q ss_pred             ccCccCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc---cCcccCHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSN-----CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK---LDREYSIEAFDLT  539 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~---l~~~~~~e~~~~v  539 (588)
                      .....||..|+|||++..     ...+.++|||||||++|||++|+.||...........+...   ............+
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            234578999999998743     22346899999999999999999999744433322221111   0111122233446


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .+++..|++ +|++|||+.|+++.
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcC
Confidence            677888988 79999999999875

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5e-37  Score=309.54  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=205.7

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++.     ....+.+.+|++++++++|+|++++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999975 899999998752     223567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ||+++|+|.+++..   ....+++.+++.++.++++||.|||+.+   |+||||||+||++++++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999853   2345899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc--chhhhcCcccCcccCH-HHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG--SALELADPKLDREYSI-EAFDLT  539 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~--~~~~~~d~~l~~~~~~-e~~~~v  539 (588)
                      ... ......++..|+|||++.+..++.++||||||+++|||++|+.|+......  +..+.+........+. .....+
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence            221 123346788999999999888999999999999999999999998533211  1111111111112222 344567


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      .+++..|+. +|.+|||+.+|+++|+++.
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            788899998 7999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=342.00  Aligned_cols=245  Identities=20%  Similarity=0.204  Sum_probs=196.7

Q ss_pred             CccccceeeccCceEEEEEEec-C-CcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-N-NQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~-g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .|...+.||+|+||.||++... + ++.||+|.+...  .....+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888899999999999999753 3 678899976533  23346778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          389 PNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       389 ~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ++|+|.+++..   ....+++.+...++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999998853   2346888999999999999999999998   99999999999999999999999999987643322


Q ss_pred             -ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-CcccCcccCHHHHHHHHHHH
Q 042871          466 -YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       466 -~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~l~~~~~~e~~~~v~~L~  543 (588)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ .... ...+......+..++
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li  303 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-DPFPCPVSSGMKALL  303 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCccCCHHHHHHH
Confidence             2234567999999999999999999999999999999999999998644332222221 1111 111112223456677


Q ss_pred             HHhhc-CCCCCCCHHHHHH
Q 042871          544 LSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~  561 (588)
                      ..|+. +|++||++++++.
T Consensus       304 ~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        304 DPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhccChhhCcCHHHHHh
Confidence            78887 7999999999874

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=310.74  Aligned_cols=245  Identities=28%  Similarity=0.442  Sum_probs=198.6

Q ss_pred             ceeeccCceEEEEEEec--C--CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS--N--NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~--~--g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ++||+|+||.||+|+..  +  +..+|+|.+....   ..+.+.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999752  2  3689999987543   3457899999999999999999999876 4568999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc--
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS--  468 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~--  468 (588)
                      |+|.+++.... .+++..++.++.|++.+|+|||..+   ++||||||+||++++++.+||+|||+++..........  
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999996543 6899999999999999999999998   99999999999999999999999999987654433221  


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....++..|+|||...+..++.++||||||+++|||++ |+.||......+....+........+......+.+++.+|+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  235 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW  235 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            12234568999999998899999999999999999998 99998755444444443322222222333456777889999


Q ss_pred             c-CCCCCCCHHHHHHHHHHhh
Q 042871          548 A-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~  567 (588)
                      . +|.+||++.++++.|+++.
T Consensus       236 ~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         236 KYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCChhhCcCHHHHHHHHHhcc
Confidence            8 7999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=309.04  Aligned_cols=244  Identities=29%  Similarity=0.443  Sum_probs=201.9

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChh
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLA  394 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~  394 (588)
                      ++||+|+||.||++...+++.||+|.+....   ....+.+|++++++++|+||+++++++.+.+..++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            3699999999999998779999999887532   3457899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc-cCccC
Q 042871          395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS-SEVRG  473 (588)
Q Consensus       395 ~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~~~g  473 (588)
                      +++......+++...+.++.+++.+|.|||+.+   ++||||||+||++++++.+||+|||++.....+..... ....+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999765567899999999999999999999998   99999999999999999999999999986543222211 12234


Q ss_pred             CCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCC
Q 042871          474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTH  551 (588)
Q Consensus       474 t~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~  551 (588)
                      +..|+|||++.+..++.++|+||||+++|||++ |..||...........+........+......+..++..|+. +|.
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            567999999988899999999999999999999 788886555444444444332222333344567778888987 799


Q ss_pred             CCCCHHHHHHHHH
Q 042871          552 QRPPMEQVFVTLQ  564 (588)
Q Consensus       552 ~RPs~~evl~~L~  564 (588)
                      +|||+.|+++.|+
T Consensus       238 ~Rp~~~ell~~l~  250 (251)
T cd05041         238 NRPSFSEIYNELQ  250 (251)
T ss_pred             hCcCHHHHHHHhh
Confidence            9999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.6e-38  Score=327.82  Aligned_cols=236  Identities=24%  Similarity=0.284  Sum_probs=193.5

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      +.||+|+||.||+++. .+|+.||+|++...     .....+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999986 47899999998642     23457889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCc
Q 042871          392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV  471 (588)
Q Consensus       392 sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~  471 (588)
                      +|.+++... ..+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~  155 (328)
T cd05593          81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF  155 (328)
T ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence            999988543 46899999999999999999999998   9999999999999999999999999987542221 122345


Q ss_pred             cCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHHHHHhhc
Q 042871          472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       472 ~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.+   +..+....+.+    +..++..|++
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~----~~~li~~~L~  231 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSAD----AKSLLSGLLI  231 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHH----HHHHHHHHcC
Confidence            7999999999999989999999999999999999999999654433332222   12222333443    4556677777


Q ss_pred             -CCCCCC-----CHHHHHHH
Q 042871          549 -LTHQRP-----PMEQVFVT  562 (588)
Q Consensus       549 -~p~~RP-----s~~evl~~  562 (588)
                       +|.+||     ++.|+++.
T Consensus       232 ~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcC
Confidence             799997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.2e-38  Score=327.20  Aligned_cols=235  Identities=25%  Similarity=0.280  Sum_probs=192.2

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      +.||+|+||.||+++. .+|+.||+|.+...     .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999986 47899999998642     23456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCc
Q 042871          392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV  471 (588)
Q Consensus       392 sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~  471 (588)
                      +|.+++... ..+++...+.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  155 (323)
T cd05595          81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence            999888543 46899999999999999999999998   9999999999999999999999999987532211 222345


Q ss_pred             cCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHHHHHhhc
Q 042871          472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       472 ~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+   +..+...++.    .+.+++..|+.
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~----~~~~li~~~L~  231 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP----EAKSLLAGLLK  231 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH----HHHHHHHHHcc
Confidence            7899999999999999999999999999999999999998654433332222   1122233343    45566777887


Q ss_pred             -CCCCCC-----CHHHHHH
Q 042871          549 -LTHQRP-----PMEQVFV  561 (588)
Q Consensus       549 -~p~~RP-----s~~evl~  561 (588)
                       +|++||     ++.++++
T Consensus       232 ~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHc
Confidence             799998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.1e-37  Score=320.01  Aligned_cols=198  Identities=27%  Similarity=0.383  Sum_probs=171.4

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||.||+|+.. +++.||||++...   .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999975 7899999998642   223467899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++ ++|.+++......+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence            994 7888888666567899999999999999999999998   9999999999999999999999999987543222 2


Q ss_pred             cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          467 ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            2233567899999998765 4588999999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=315.63  Aligned_cols=252  Identities=22%  Similarity=0.357  Sum_probs=204.4

Q ss_pred             hcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+|...      ++..||+|.+....   ....+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            567888999999999999999863      34689999986443   234788999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCC---------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEE
Q 042871          382 FLIYELCPNGNLAEWLFGKD---------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLS  452 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~  452 (588)
                      ++||||+++|+|.+++....         ..+++.+++.++.|++.||.|||+.+   |+||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999995421         24788999999999999999999988   9999999999999999999999


Q ss_pred             ecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcc
Q 042871          453 DFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDRE  530 (588)
Q Consensus       453 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~  530 (588)
                      |||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.|+......+..+.+.......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD  241 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence            99998765433221 2233456789999999988889999999999999999998 888886444433333333221122


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      .+......+..++..|++ +|++|||+.+++..|++
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            233335567788999998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.7e-37  Score=311.16  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=193.8

Q ss_pred             ceeeccCceEEEEEEec----CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEeccee-ccCeeeEEeecCC
Q 042871          318 NLIGEGITGKVYKGKLS----NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCL-RVDECFLIYELCP  389 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~LV~E~~~  389 (588)
                      +.||+|+||.||+|++.    ++..||+|++...   ...+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    3457999988542   23567889999999999999999999776 4556899999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc---c
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET---Y  466 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~---~  466 (588)
                      +|+|.+++......+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++.......   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999765556788888999999999999999988   99999999999999999999999999976533221   1


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC-ccccccccchhhhcCcccCcccCHHHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK-AKVLTRAGSALELADPKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~-p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~  545 (588)
                      ......++..|+|||++....++.++||||||+++|||++|+. |+...........+........+....+.+..++..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            1123456778999999988899999999999999999999654 554333322222221111111112223456778899


Q ss_pred             hhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          546 CTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      |++ +|++||++.|+++.|+++..
T Consensus       238 cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         238 CWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HcCCChhhCCCHHHHHHHHHHHhc
Confidence            998 79999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-37  Score=318.14  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             cCccccceeeccCceEEEEEEe------cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++|...++||+|+||.||++..      .++..+|+|.+...  ...+.|.+|+++++.++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4667788999999999999963      24668999988643  234679999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCC--------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          384 IYELCPNGNLAEWLFGKD--------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      ++||+++++|.+++....              ..+++.+++.++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            999999999999996432              24889999999999999999999988   9999999999999999999


Q ss_pred             EEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCccc
Q 042871          450 KLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKL  527 (588)
Q Consensus       450 kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l  527 (588)
                      ||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+....
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            99999998765432221 1223345788999999999999999999999999999998 888885443333333332222


Q ss_pred             CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          528 DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       528 ~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ....+......+..++.+|++ +|.+||+++||++.|++
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            222222334556778899998 79999999999999873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-38  Score=312.51  Aligned_cols=195  Identities=27%  Similarity=0.381  Sum_probs=171.0

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHH----HHHHHHHHhccCCCCceeEEecceec--cCeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVE----TFVREVASSSHVRHPNLVALLGYCLR--VDECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~----~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV  384 (588)
                      ++|+.++.|++|+||.||+|+. ++++.||+|+++.+.+.+    .-++||.+|.+.+|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            5688889999999999999996 578999999998655433    45899999999999999999888764  4579999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||||+. +|...+......+...+...+..|+++|++|||...   |+|||||++|+|++..|.+||+||||||.+....
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999965 999999877778999999999999999999999999   9999999999999999999999999999876543


Q ss_pred             cccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          465 TYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      . ..+..+-|..|.|||.+.+ ..|+...|+||+|||+.||+++++-+
T Consensus       232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf  278 (419)
T KOG0663|consen  232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF  278 (419)
T ss_pred             c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence            2 2344567999999998877 46899999999999999999998744

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-37  Score=313.68  Aligned_cols=253  Identities=24%  Similarity=0.359  Sum_probs=198.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-----cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceec--cCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLR--VDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~  381 (588)
                      .++|.+.+.||+|+||.||++..     .++..||+|++....  ..+.|.+|++++++++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35678889999999999999974     358899999987543  34678999999999999999999998753  3568


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++|+||+++|+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999999765567899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccc--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc----------------hhhhc
Q 042871          462 IGETYA--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS----------------ALELA  523 (588)
Q Consensus       462 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~----------------~~~~~  523 (588)
                      ......  .....++..|+|||++.+..++.++||||||+++|||++|..++......-                ..+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            433211  112223456999999998899999999999999999999876543211100                00111


Q ss_pred             CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          524 DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       524 d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ...............+.+++..|+. +|++|||++||++.|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111111112233457788999998 799999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.4e-37  Score=323.73  Aligned_cols=245  Identities=25%  Similarity=0.356  Sum_probs=189.7

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc-----Ceee
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV-----DECF  382 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~  382 (588)
                      +|+..+.||+|+||.||+|+. .+|+.||||++...    .....+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999986 47899999998642    2345688999999999999999999987643     3479


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||++ ++|.+++... ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 6899888543 45899999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCc--ccccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh----------------
Q 042871          463 GET--YASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL----------------  522 (588)
Q Consensus       463 ~~~--~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~----------------  522 (588)
                      ...  .......||+.|+|||++..  ..++.++||||||+++|||++|+.||...........                
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            211  12234578999999998865  6789999999999999999999998853221111000                


Q ss_pred             -----------cCcccCcccCH---HHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          523 -----------ADPKLDREYSI---EAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       523 -----------~d~~l~~~~~~---e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                 +.+......+.   .....+..++..|+. +|++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                       00000000000   112335667888887 79999999999965

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.7e-38  Score=329.63  Aligned_cols=240  Identities=24%  Similarity=0.275  Sum_probs=195.9

Q ss_pred             hcCccccceeeccCceEEEEEEecC--CcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN--NQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|...+.||+|+||.||+|+..+  +..||+|++..     ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568889999999999999998643  36899999853     2345678899999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++... +.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999999643 45889999999999999999999998   999999999999999999999999999865422


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Cc--ccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DP--KLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~--~l~~~~~~e~~~~v~  540 (588)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..  .++...+.+    +.
T Consensus       185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~----~~  256 (340)
T PTZ00426        185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN----CK  256 (340)
T ss_pred             ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH----HH
Confidence                23457899999999999988999999999999999999999999754433222222 11  122333444    44


Q ss_pred             HHHHHhhc-CCCCC-----CCHHHHHHH
Q 042871          541 QLALSCTA-LTHQR-----PPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~R-----Ps~~evl~~  562 (588)
                      .++..|++ +|.+|     |+++++++.
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            55677776 68888     488888764

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-37  Score=317.37  Aligned_cols=244  Identities=27%  Similarity=0.413  Sum_probs=188.8

Q ss_pred             cCccccceeeccCceEEEEEEe--cCCcEEEEEEecCC----CcHHHHHHHHHHhccC---CCCceeEEeccee-----c
Q 042871          312 EKLNELNLIGEGITGKVYKGKL--SNNQHVAIKHITNE----GNVETFVREVASSSHV---RHPNLVALLGYCL-----R  377 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~-----~  377 (588)
                      ++|+..+.||+|+||.||+|+.  .+|+.||||++...    .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688889999999999999986  24688999988632    2234566777766655   6999999999885     2


Q ss_pred             cCeeeEEeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          378 VDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      ....++||||++ ++|.+++... ...+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 6999998643 345899999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcC-----------
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELAD-----------  524 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d-----------  524 (588)
                      ++.....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..++           
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            9865433  2234456899999999998889999999999999999999999988643221111 1100           


Q ss_pred             -------cccC-------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 -------PKLD-------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 -------~~l~-------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                             ..+.       .....+....+..++.+|++ +|++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                   0000       00011123445678889988 7999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.1e-37  Score=323.87  Aligned_cols=197  Identities=25%  Similarity=0.356  Sum_probs=172.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.+...   ...+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999975 6889999988643   224578999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++|+|.+++... +.+++.....++.++++||.|||+. +   |+||||||+|||+++++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            99999999999643 4588889999999999999999974 5   999999999999999999999999998765322  


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccc
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLT  514 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~  514 (588)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence             123346899999999999989999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-37  Score=318.21  Aligned_cols=252  Identities=28%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             hcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|+..+.||+|+||.||+++..      ++..||+|.+....   ....|.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            567889999999999999999863      46789999987542   245788999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCC---------------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCC
Q 042871          382 FLIYELCPNGNLAEWLFGKD---------------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTN  440 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~N  440 (588)
                      ++|+||+++|+|.+++....                     ..+++.+++.++.|++.||.|||..+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999995321                     24788899999999999999999988   9999999999


Q ss_pred             eEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccc
Q 042871          441 ILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGS  518 (588)
Q Consensus       441 ILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~  518 (588)
                      |++++++.+||+|||+++........ .......+..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998765432211 1222344678999999998899999999999999999998 777775332222


Q ss_pred             hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          519 ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       519 ~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ....+...-....+......+..++.+|++ +|.+|||+.|+++.|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            222222111111122233556778899998 79999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-37  Score=333.77  Aligned_cols=257  Identities=24%  Similarity=0.371  Sum_probs=203.8

Q ss_pred             HHHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCC-CCceeEEecceec
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVR-HPNLVALLGYCLR  377 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~  377 (588)
                      +...++|...+.||+|+||.||+|++.      .++.||||++....   ..+.+.+|++++.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344567888899999999999999853      34689999997532   2357889999999997 9999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCC--------------------------------------------------------
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKD--------------------------------------------------------  401 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~--------------------------------------------------------  401 (588)
                      .+..++|+||+++|+|.++++...                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999995421                                                        


Q ss_pred             -----------------------------------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCC
Q 042871          402 -----------------------------------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTN  440 (588)
Q Consensus       402 -----------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~N  440 (588)
                                                               ..+++.+.+.++.|++.||+|||+.+   |+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence                                                     13677888999999999999999988   9999999999


Q ss_pred             eEECCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccc
Q 042871          441 ILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGS  518 (588)
Q Consensus       441 ILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~  518 (588)
                      ||+++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986532222 11223456789999999998889999999999999999998 888875432221


Q ss_pred             -hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          519 -ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       519 -~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                       ..+.+........+......+..++..|++ +|.+||+++||++.|++++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             222222222111222233456777889998 7999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3e-37  Score=309.00  Aligned_cols=244  Identities=30%  Similarity=0.470  Sum_probs=202.3

Q ss_pred             ceeeccCceEEEEEEecC----CcEEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLSN----NQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++...    +..|++|.+.....   .+.+.+|++.+..++|+||+++++++.++...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999753    88999999875432   57889999999999999999999999999999999999999


Q ss_pred             CChhhhhhcC--------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          391 GNLAEWLFGK--------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       391 gsL~~~L~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ++|.+++...        ...+++.+++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999765        467999999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          463 GET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       463 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ... .......++..|+|||.+....++.++||||||+++|||++ |+.||.........+.+........+......+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            321 22334567889999999988889999999999999999999 5888875544443333332222222333345566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                      .++..|+. +|.+|||+.|+++.|+
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHhhC
Confidence            77888988 7999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.8e-37  Score=307.72  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=205.4

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|+..+.||+|+||.||+|+.. +++.+++|.+......+.+.+|++.+++++|+||+++++++.++...++++||++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            367888899999999999999975 4889999999765557889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +++|.+++......+++..++.++.|+++||.|||+.+   ++||||+|+||++++++.+||+|||++........ ...
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN  157 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence            99999999766667999999999999999999999998   99999999999999999999999999887643321 223


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcc--cCHHHHHHHHHHHHHhh
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDRE--YSIEAFDLTLQLALSCT  547 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~--~~~e~~~~v~~L~~~C~  547 (588)
                      ...++..|+|||++.+..++.++||||||+++|||++|+.|+...........+.......  .+......+.+++..|+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            3457889999999998899999999999999999999999986543333222222111111  11223345677788898


Q ss_pred             c-CCCCCCCHHHHHH
Q 042871          548 A-LTHQRPPMEQVFV  561 (588)
Q Consensus       548 ~-~p~~RPs~~evl~  561 (588)
                      + +|.+|||+.|+++
T Consensus       238 ~~~P~~Rps~~~il~  252 (256)
T cd06612         238 VKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcChhhCcCHHHHhc
Confidence            7 7999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.2e-37  Score=321.76  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=204.1

Q ss_pred             hcCccccceeeccCceEEEEEEec--------CCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS--------NNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      .++|.+.+.||+|+||.||+++..        ....||+|.+....   ....+.+|+++++++ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467888899999999999999741        34579999987532   345788999999999 699999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcC---------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE
Q 042871          379 DECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl  443 (588)
                      +..++|+||+++|+|.+++...               ...+++.+...++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            9999999999999999999542               135889999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEEecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhh
Q 042871          444 GPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALE  521 (588)
Q Consensus       444 d~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~  521 (588)
                      ++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.........+
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999998654322211 122234567999999988899999999999999999999 888876443333333


Q ss_pred             hcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          522 LADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       522 ~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .+........+......+..++.+|++ +|++|||+.|+++.|+++...
T Consensus       248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            332222112222333456678899998 799999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-37  Score=324.01  Aligned_cols=238  Identities=24%  Similarity=0.296  Sum_probs=190.3

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHH---hccCCCCceeEEecceeccCeeeEE
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVAS---SSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~---l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      |++.+.||+|+||.||+|+. .+|+.||||++...     ...+.+.+|+++   ++.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56778999999999999986 47899999998632     234456666554   4677899999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|..++.  ...+++.++..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999999884  346899999999999999999999998   9999999999999999999999999987532221


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                       .......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+   ........+.+    +..
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~----~~~  230 (324)
T cd05589         156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSRE----AIS  230 (324)
T ss_pred             -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence             2233467899999999999999999999999999999999999998754333322221   11222233433    455


Q ss_pred             HHHHhhc-CCCCCC-----CHHHHHH
Q 042871          542 LALSCTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RP-----s~~evl~  561 (588)
                      ++..|++ +|.+||     ++.++++
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            6777777 799999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-37  Score=342.20  Aligned_cols=252  Identities=20%  Similarity=0.224  Sum_probs=200.0

Q ss_pred             HHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC---
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD---  379 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~---  379 (588)
                      ....++|.+.+.||+|+||.||+++. .+|+.||||++...    .....+.+|+..+..++|+|++++...+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34467899999999999999999985 57999999998642    23456789999999999999999988765432   


Q ss_pred             -----eeeEEeecCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEE
Q 042871          380 -----ECFLIYELCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL  451 (588)
Q Consensus       380 -----~~~LV~E~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL  451 (588)
                           ..++||||+++|+|.+++...   ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 368999999999999999542   346889999999999999999999998   999999999999999999999


Q ss_pred             EecCCcceecCCC-cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcc
Q 042871          452 SDFGLSKVIDIGE-TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDRE  530 (588)
Q Consensus       452 ~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~  530 (588)
                      +|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.......
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            9999998754322 122344679999999999999999999999999999999999999986433322222111111111


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .+......+..++..|++ +|.+||++.++++.
T Consensus       265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            222233456667888888 79999999999864

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.6e-38  Score=333.39  Aligned_cols=244  Identities=21%  Similarity=0.266  Sum_probs=194.8

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ..++|+..+.||+|+||.||+++.. +++.||+|++..     ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4568999999999999999999864 688999999863     1234457889999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++..  ..++......++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus       121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999854  34777888889999999999999998   999999999999999999999999999876433


Q ss_pred             CcccccCccCCCCccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Ccc----cCc--ccC
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNC----KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPK----LDR--EYS  532 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~----l~~--~~~  532 (588)
                      .........||+.|+|||++...    .++.++|||||||++|||++|+.||...........+ +..    +..  .++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence            33233456799999999987653    4788999999999999999999998754332222221 111    111  233


Q ss_pred             HHHHHHHHHHHHHhhc-CCCC--CCCHHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQ--RPPMEQVFVT  562 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~--RPs~~evl~~  562 (588)
                      .+    +..++..|+. +|.+  ||+++|++..
T Consensus       276 ~~----~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         276 KQ----AKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HH----HHHHHHHHccChhhccCCCCHHHHhcC
Confidence            33    3445666666 4665  9999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4e-37  Score=318.14  Aligned_cols=257  Identities=22%  Similarity=0.369  Sum_probs=203.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCc----EEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQ----HVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++|+..+.||+|+||.||+|+. .+|.    .||+|.+.....   ..++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            45678888999999999999986 3454    578998865432   34688999999999999999999998754 567


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +++||+++|+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999999766667899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          463 GETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       463 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      .... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.........+.+........+......+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY  241 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            3221 1223345778999999999999999999999999999998 8888864433333333322211111112233456


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      .++..|+. +|++||+++++++.|+++...+.
T Consensus       242 ~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         242 MVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            67888887 79999999999999999876544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=328.70  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=227.6

Q ss_pred             hcCccccceeeccCceEEEEEEec---CC--cEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS---NN--QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~---~g--~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .+.....++||.|-||.||+|+..   .|  -.||||.-+.+   .+.+.|+.|..+|++++||||++|+|+|.+. ..|
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            344455678999999999999852   23  35899988753   4578899999999999999999999999754 689


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +|||+++-|.|..||..+...|+......++.|++.+|+|||+..   .+||||..+|||+.+.--+||+||||+|.+.+
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999999887778999999999999999999999999   99999999999999999999999999999988


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      ...+..+...-...|||||.+....++.++|||.|||.+||++. |.+||...++.++.-.++..-+...++.++..+..
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs  623 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS  623 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence            88888777777899999999999999999999999999999988 99999999888888888777777777888888889


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      |+..||. +|.+||++.|+...|++++.
T Consensus       624 lmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  624 LMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             HHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            9999999 79999999999999988876

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-37  Score=308.71  Aligned_cols=247  Identities=23%  Similarity=0.292  Sum_probs=199.6

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++|...+.||+|++|.||++.. .+++.||+|.+....       ..+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788899999999999999986 478999999885321       23568889999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      |+||+++++|.+++... ..+++.....++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            99999999999998543 45888999999999999999999998   999999999999999999999999999765432


Q ss_pred             Ccccc--cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccCcccCHHHHHHHH
Q 042871          464 ETYAS--SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~--~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      .....  ....++..|+|||++.+..++.++||||||+++|||++|+.||....... .............+......+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR  237 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence            22111  33467889999999999889999999999999999999999985432211 1111111112223333445566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .++..|+. +|.+|||++|+++.
T Consensus       238 ~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         238 NFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHHhhcCcccCCCHHHHhhC
Confidence            77888888 79999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-37  Score=332.03  Aligned_cols=250  Identities=20%  Similarity=0.261  Sum_probs=195.7

Q ss_pred             HHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      ....++|+..+.||+|+||.||+++.. +++.||+|.+..     ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            344578999999999999999999974 688999999863     12345678999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++|+|.+++..  ..+++.+...++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999999943  35788889999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccCccCCCCccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCccccccccch-hhhcCcccCcccC--HH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNC----KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-LELADPKLDREYS--IE  534 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~~~~d~~l~~~~~--~e  534 (588)
                      ...........||+.|+|||++...    .++.++||||||+++|||++|+.||........ ...++......++  .+
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  273 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE  273 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence            3333233456799999999998654    378899999999999999999999864332222 2222211111111  11


Q ss_pred             HHHHHHHHHHHhhcCC---CCCCCHHHHHHH
Q 042871          535 AFDLTLQLALSCTALT---HQRPPMEQVFVT  562 (588)
Q Consensus       535 ~~~~v~~L~~~C~~~p---~~RPs~~evl~~  562 (588)
                      .......++..|+.++   ..||++.|+++.
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            2233444555666543   348999998876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.7e-37  Score=310.30  Aligned_cols=245  Identities=31%  Similarity=0.459  Sum_probs=202.5

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      ++|...+.||+|+||.||++.. +++.||+|.+..+...+.+.+|+.++++++|||++++++++..+ ..++||||++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            4678889999999999999986 77889999998766667899999999999999999999998764 479999999999


Q ss_pred             ChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          392 NLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       392 sL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      +|.+++.... ..+++.+++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++......    ..
T Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~  156 (254)
T cd05083          84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DN  156 (254)
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----CC
Confidence            9999996543 35889999999999999999999988   9999999999999999999999999987643221    12


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ...+..|+|||++.+..++.++|+||||+++|||++ |+.||.........+.+...............+..++.+|++ 
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  236 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWET  236 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            234568999999988899999999999999999998 888886554444444443333222223334556778899998 


Q ss_pred             CCCCCCCHHHHHHHHHH
Q 042871          549 LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       549 ~p~~RPs~~evl~~L~~  565 (588)
                      +|++||+++++++.|++
T Consensus       237 ~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         237 EPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ChhhCcCHHHHHHHHcc
Confidence            79999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-37  Score=331.01  Aligned_cols=244  Identities=20%  Similarity=0.293  Sum_probs=195.3

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .|...+.||+|+||+||+|+. .+++.||||++...     ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999986 57889999998642     234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-  465 (588)
                      |+++|+|.+++... ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            99999999999643 35888888899999999999999998   99999999999999999999999999754311000 


Q ss_pred             ---------------------------------------------ccccCccCCCCccCcccccCCCCCchhhHHHHHHH
Q 042871          466 ---------------------------------------------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV  500 (588)
Q Consensus       466 ---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvl  500 (588)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123569999999999999899999999999999


Q ss_pred             HHHHHcCCCccccccccchh-hhcC----cccC--cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          501 LLQILSGKKAKVLTRAGSAL-ELAD----PKLD--REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       501 l~ElltG~~p~~~~~~~~~~-~~~d----~~l~--~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +|||++|+.||......... ..++    ..+.  ...+.+..+++.++.  |.. ++..||+++|++..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll--~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLC--CSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHc--cCcccccCCCCHHHHhcC
Confidence            99999999999754332211 1111    1111  135667777665542  443 45679999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-37  Score=324.39  Aligned_cols=237  Identities=22%  Similarity=0.241  Sum_probs=190.5

Q ss_pred             ceeeccCceEEEEEEe----cCCcEEEEEEecCC------CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          318 NLIGEGITGKVYKGKL----SNNQHVAIKHITNE------GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +.||+|+||.||+++.    .+++.||||.+...      .....+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5899999999999975    36889999998632      2234678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++|+|.+++... +.+.+.....++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++...... ..
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  156 (323)
T cd05584          82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TV  156 (323)
T ss_pred             CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cc
Confidence            9999999998543 45778888889999999999999998   9999999999999999999999999987543222 22


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-CcccCcccCHHHHHHHHHHHHHh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ....  ..+......+..++..|
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  234 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPYLTPEARDLLKKL  234 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            23457899999999999988999999999999999999999998654332222221 1111  11122223455667788


Q ss_pred             hc-CCCCCC-----CHHHHHH
Q 042871          547 TA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       547 ~~-~p~~RP-----s~~evl~  561 (588)
                      ++ +|++||     +++++++
T Consensus       235 l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         235 LKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             cccCHhHcCCCCCCCHHHHhc
Confidence            87 799999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.1e-37  Score=318.22  Aligned_cols=255  Identities=27%  Similarity=0.393  Sum_probs=204.1

Q ss_pred             HHhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      ...++|...+.||+|+||.||+++.      .++..||||+++...   ..+.+.+|+++++++ +|+||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            3356789999999999999999974      235689999887432   245789999999999 799999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      +..++||||+++|+|.+++.... ..+++.++..++.+++.||.|||+.+   |+|+||||+|||+++++.+||+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999996543 34899999999999999999999988   999999999999999999999999999


Q ss_pred             ceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccccc-chhhhcCcccCcccCHH
Q 042871          458 KVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAG-SALELADPKLDREYSIE  534 (588)
Q Consensus       458 ~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~-~~~~~~d~~l~~~~~~e  534 (588)
                      +........ ......++..|+|||++....++.++||||||+++|||++ |+.|+...... ...+.++.......+..
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH  268 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence            865433221 1223346778999999998899999999999999999998 88887533222 12222222222111112


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ....+..++..|++ +|++|||+.|+++.|+++
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            23456778889998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=316.51  Aligned_cols=245  Identities=23%  Similarity=0.260  Sum_probs=198.8

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      +|+..+.||+|+||.||++.. .+++.||||.+...     .....+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999986 47899999998642     123457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++|+|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999999999986533 46899999999999999999999998   99999999999999999999999999987543322


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc---ccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP---KLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~---~l~~~~~~e~~~~v~~L  542 (588)
                        .....|+..|+|||++.+..++.++||||||+++|||++|+.||.........+.+..   .....++......+..+
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence              2234689999999999988999999999999999999999999975433221111111   11112233344556778


Q ss_pred             HHHhhc-CCCCCC-----CHHHHHHH
Q 042871          543 ALSCTA-LTHQRP-----PMEQVFVT  562 (588)
Q Consensus       543 ~~~C~~-~p~~RP-----s~~evl~~  562 (588)
                      +..|++ +|.+||     +++++++.
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            889998 799999     78888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.5e-37  Score=322.08  Aligned_cols=234  Identities=26%  Similarity=0.312  Sum_probs=187.3

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhcc-CCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSH-VRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+|+. .+++.||||+++..     ...+.+..|.+++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999986 46889999998642     234456667776654 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... ..+++.+...++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~  155 (316)
T cd05592          81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence            9999998643 35888999999999999999999988   9999999999999999999999999997653322 22344


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.   +.+....+.    .+..++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~----~~~~ll~~~l  231 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISK----EAKDCLSKLF  231 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHHc
Confidence            578999999999999899999999999999999999999987544333332221   112222333    3455677888


Q ss_pred             c-CCCCCCCHH-HHH
Q 042871          548 A-LTHQRPPME-QVF  560 (588)
Q Consensus       548 ~-~p~~RPs~~-evl  560 (588)
                      . +|.+||++. +++
T Consensus       232 ~~~P~~R~~~~~~l~  246 (316)
T cd05592         232 ERDPTKRLGVDGDIR  246 (316)
T ss_pred             cCCHHHcCCChHHHH
Confidence            7 799999986 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-37  Score=312.12  Aligned_cols=256  Identities=23%  Similarity=0.370  Sum_probs=206.1

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCc----EEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQ----HVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ..+|...+.||+|+||.||+|... +|+    .||+|.+....   ....+.+|+..+++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            356788889999999999999863 333    58999887543   24578899999999999999999999987 7889


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +|+||+++|+|.+++......+++...+.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999999776667999999999999999999999988   99999999999999999999999999987653


Q ss_pred             CCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          463 GETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       463 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ..... .....++..|+|||......++.++|+||||+++||+++ |+.||......+....+........+......+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            33221 122234578999999988899999999999999999999 9999876554444443332211111111223456


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .++..|+. +|.+||++.++++.|+++...+
T Consensus       242 ~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         242 MVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            67788887 7999999999999999986644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.2e-37  Score=315.35  Aligned_cols=253  Identities=24%  Similarity=0.411  Sum_probs=199.4

Q ss_pred             cCccccceeeccCceEEEEEEe-----cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceecc--Cee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRV--DEC  381 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~  381 (588)
                      +.|...+.||+|+||.||++++     .++..||+|.+...   ...+.+.+|+.+++.++||||+++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4567888999999999999974     35789999998743   2345789999999999999999999998875  568


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++++|.+++......+++.+++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999999665556899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc----------c--c---hhhhcC
Q 042871          462 IGETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA----------G--S---ALELAD  524 (588)
Q Consensus       462 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~----------~--~---~~~~~d  524 (588)
                      .....  ......++..|+|||++.+..++.++||||||+++|||++++.|......          +  .   ..+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            33221  12234567789999999888999999999999999999998765321100          0  0   000000


Q ss_pred             cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          525 PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       525 ~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      ..............+.+++..|++ +|++|||++++++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            001111111233557778899998 7999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-37  Score=323.15  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=205.8

Q ss_pred             cCccccceeeccCceEEEEEEec--------CCcEEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceeccC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS--------NNQHVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRVD  379 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~  379 (588)
                      .+|.+.+.||+|+||.||+++..        .+..||+|.+...   ...+.+.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888899999999999999742        1237899988743   2346789999999999 7999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcC---------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC
Q 042871          380 ECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG  444 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld  444 (588)
                      ..++++||+++|+|.+++...               ...+++.++..++.|+++||.|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            999999999999999998542               234888999999999999999999988   99999999999999


Q ss_pred             CCCcEEEEecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhh
Q 042871          445 PNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALEL  522 (588)
Q Consensus       445 ~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~  522 (588)
                      +++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999998654332221 222334568999999999999999999999999999998 7888764443333333


Q ss_pred             cCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          523 ADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       523 ~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      +........+......+.+++..|++ +|.+|||+.|+++.|+++......
T Consensus       249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~  299 (334)
T cd05100         249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST  299 (334)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence            32222222222333456678899998 799999999999999999865543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-37  Score=308.94  Aligned_cols=243  Identities=25%  Similarity=0.389  Sum_probs=197.5

Q ss_pred             ceeeccCceEEEEEEecC--C--cEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLSN--N--QHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|++|.||+|.+.+  +  ..||||.+....   ..+.+.+|+..+++++||||+++++.+.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998643  3  369999987643   35678999999999999999999999988 889999999999


Q ss_pred             CChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc--c
Q 042871          391 GNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--A  467 (588)
Q Consensus       391 gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~--~  467 (588)
                      ++|.+++.... ..+++...+.++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997654 56899999999999999999999998   999999999999999999999999999876442221  1


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCc-ccCcccCHHHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADP-KLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~-~l~~~~~~e~~~~v~~L~~~  545 (588)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+..+.++. ......+......+..++.+
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            123456789999999999899999999999999999999 9999864433333322221 11111222334567778889


Q ss_pred             hhc-CCCCCCCHHHHHHHHH
Q 042871          546 CTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~~L~  564 (588)
                      |++ +|.+||++.++++.|.
T Consensus       237 ~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         237 CWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HCCCCcccCCCHHHHHHHhc
Confidence            998 7999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-37  Score=312.87  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=202.9

Q ss_pred             cCccccceeeccCceEEEEEEec-----CCcEEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceec--cCee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-----NNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLR--VDEC  381 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~  381 (588)
                      +.|...+.||+|+||.||+++++     ++..||||.+.....   .+.|.+|++.++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677789999999999999853     368999999975433   5689999999999999999999999887  5678


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++++|.+++......+++.+++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999766556999999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc---------------hhhhcC
Q 042871          462 IGETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS---------------ALELAD  524 (588)
Q Consensus       462 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~---------------~~~~~d  524 (588)
                      .....  ......++..|++||+.....++.++||||||+++|||++|+.|+.......               ..+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            32221  1112345567999999988899999999999999999999998865322111               111111


Q ss_pred             cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          525 PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       525 ~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      .......+......+.+++.+|++ +|.+|||+.||+++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111122333567788999998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-37  Score=317.46  Aligned_cols=252  Identities=24%  Similarity=0.407  Sum_probs=198.1

Q ss_pred             hcCccccceeeccCceEEEEEEecC---------------CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN---------------NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALL  372 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~---------------g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~  372 (588)
                      .++|+..+.||+|+||.||+++..+               ...||+|.+....   ..+.|.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4678888999999999999987532               2358999987542   245789999999999999999999


Q ss_pred             cceeccCeeeEEeecCCCCChhhhhhcCC-----------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCe
Q 042871          373 GYCLRVDECFLIYELCPNGNLAEWLFGKD-----------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNI  441 (588)
Q Consensus       373 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NI  441 (588)
                      +++...+..++||||+++++|.+++....           ..+++.+++.++.|+++||.|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999985421           24788999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCccccccccc
Q 042871          442 LLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS--GKKAKVLTRAGS  518 (588)
Q Consensus       442 Lld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~p~~~~~~~~  518 (588)
                      ++++++.+||+|||+++......... .....++..|+|||+..+..++.++||||||+++|||++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999997654332211 223345778999999988899999999999999999998  455665433322


Q ss_pred             hhhhc----C---cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          519 ALELA----D---PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       519 ~~~~~----d---~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      .....    +   .......+......+.+++.+|+. +|++|||+++|++.|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            22111    1   101011111233567888999998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-37  Score=331.40  Aligned_cols=241  Identities=26%  Similarity=0.353  Sum_probs=203.6

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      |...+.||+|+-|.|-.|++ .+|+.+|||.+...     .....+.+|+.+|+.+.|||+++++++++++.++|||.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            45567899999999999996 68999999998653     2345678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++|.|.+++..++ .+.+.+..+++.||..|+.|+|..+   |+||||||+|+|||.++++||+|||||..-..+.-. 
T Consensus        94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL-  168 (786)
T KOG0588|consen   94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL-  168 (786)
T ss_pred             cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCccc-
Confidence            99999999997554 5888999999999999999999999   999999999999999999999999999765444322 


Q ss_pred             ccCccCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCccccccccchhhhcCc---ccCcccCHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVN-SSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP---KLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~---~l~~~~~~e~~~~v~~L~  543 (588)
                       .+-+|++.|.+||++.+.+|. .++||||.|||||.|+||+.||.......+...+..   .++..++.++.+++.+|.
T Consensus       169 -eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml  247 (786)
T KOG0588|consen  169 -ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML  247 (786)
T ss_pred             -cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence             345899999999999999985 589999999999999999999984333333333332   223556778877776665


Q ss_pred             HHhhcCCCCCCCHHHHHHHH
Q 042871          544 LSCTALTHQRPPMEQVFVTL  563 (588)
Q Consensus       544 ~~C~~~p~~RPs~~evl~~L  563 (588)
                         ..+|..|.|++||++.-
T Consensus       248 ---~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  248 ---DVDPSTRITTEEILKHP  264 (786)
T ss_pred             ---ccCccccccHHHHhhCc
Confidence               56999999999999864

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.4e-37  Score=309.85  Aligned_cols=251  Identities=21%  Similarity=0.291  Sum_probs=202.7

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+++. .+++.+|||.+...     .....+.+|+.+++.++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677888999999999999995 58899999987531     23457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ||+++++|.+++..   ....+++.+.+.++.++++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998853   2346899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc--chhhhcCc-ccCcccCHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG--SALELADP-KLDREYSIEAFDLT  539 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~--~~~~~~d~-~l~~~~~~e~~~~v  539 (588)
                      ... ......|+..|+|||++.+..++.++|+||||+++|||++|+.||......  .....+.. .............+
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence            322 122346888999999998888999999999999999999999998532211  11111111 11111112234456


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ..++..|+. +|.+||||.+|+++++++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            777888987 799999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-37  Score=324.83  Aligned_cols=257  Identities=26%  Similarity=0.374  Sum_probs=199.6

Q ss_pred             HhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceecc-
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRV-  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~-  378 (588)
                      ..++|...+.||+|+||.||+|+.      .+++.||||+++...   ....+.+|+.++.++ +|+||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            356788999999999999999973      357899999997532   345688999999999 689999999988654 


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC---------------------------------------------------------
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD---------------------------------------------------------  401 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------------  401 (588)
                      ...++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56789999999999999985321                                                         


Q ss_pred             ---------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-ccccCc
Q 042871          402 ---------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEV  471 (588)
Q Consensus       402 ---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~  471 (588)
                               ..+++.++..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....... ......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     23678888999999999999999998   99999999999999999999999999986533222 122233


Q ss_pred             cCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccccc-chhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAG-SALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       472 ~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~-~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      .++..|+|||++.+..++.++||||||+++|||++ |..||...... .....+........+......+.+++..|++ 
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence            45678999999988899999999999999999997 88887543211 1111111111111111122346677888998 


Q ss_pred             CCCCCCCHHHHHHHHHHhhcc
Q 042871          549 LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       549 ~p~~RPs~~evl~~L~~~~~~  569 (588)
                      +|++|||+.||++.|+.+++.
T Consensus       322 ~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         322 EPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ChhhCcCHHHHHHHHHHHHhc
Confidence            799999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.6e-37  Score=314.76  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=200.4

Q ss_pred             hcCccccceeeccCceEEEEEEecC-----------------CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN-----------------NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVA  370 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~  370 (588)
                      .++|+..+.||+|+||.||+++..+                 +..||+|.+....   ..+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678889999999999999987532                 2468999987542   3567889999999999999999


Q ss_pred             EecceeccCeeeEEeecCCCCChhhhhhcCC----------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCC
Q 042871          371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKD----------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTN  440 (588)
Q Consensus       371 l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~N  440 (588)
                      +++++..++..++|+||+++++|.+++....          ..+++..++.++.|+++||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999996433          25899999999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCcccccccc
Q 042871          441 ILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS--GKKAKVLTRAG  517 (588)
Q Consensus       441 ILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~p~~~~~~~  517 (588)
                      |++++++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            99999999999999998865433221 2234456789999999988889999999999999999998  56666543332


Q ss_pred             chhhhcCcc-------cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          518 SALELADPK-------LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       518 ~~~~~~d~~-------l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ...+.+...       .....+......+.+++.+|++ +|.+|||+.||++.|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            222211111       0011111222457778899998 79999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.2e-37  Score=310.08  Aligned_cols=243  Identities=24%  Similarity=0.400  Sum_probs=188.5

Q ss_pred             eeeccCceEEEEEEec---CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCC
Q 042871          319 LIGEGITGKVYKGKLS---NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs  392 (588)
                      .||+|+||.||+|+..   ++..+|+|.++...   ....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            6899999999999864   34679999887543   23478899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCC----cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc-c
Q 042871          393 LAEWLFGKD----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-A  467 (588)
Q Consensus       393 L~~~L~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~-~  467 (588)
                      |.+++....    ...++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++........ .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999996422    24677788899999999999999998   999999999999999999999999998754332221 1


Q ss_pred             ccCccCCCCccCcccccCC-------CCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcC----cccC-cccCHH
Q 042871          468 SSEVRGTFGYLDPEYRSNC-------KVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELAD----PKLD-REYSIE  534 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~-------~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d----~~l~-~~~~~e  534 (588)
                      .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||......+......    ..+. ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            2334578899999987542       35789999999999999996 999986544333221110    1111 111111


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 042871          535 AFDLTLQLALSCTALTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       535 ~~~~v~~L~~~C~~~p~~RPs~~evl~~L~  564 (588)
                      ..+.+..++..|+.+|++|||++||++.|+
T Consensus       239 ~~~~~~~l~~~c~~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         239 LSDRWYEVMQFCWLQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CChHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence            223455677888888999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-37  Score=332.09  Aligned_cols=242  Identities=21%  Similarity=0.259  Sum_probs=193.5

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      +|++.+.||+|+||.||+++. .+++.||||.+...     .....+.+|++++++++|+||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            688899999999999999986 46899999998632     234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC--
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE--  464 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~--  464 (588)
                      |+++|+|.+++... ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....  
T Consensus        82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            99999999999643 45788888899999999999999998   9999999999999999999999999975321000  


Q ss_pred             ----------------------------------------cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHH
Q 042871          465 ----------------------------------------TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI  504 (588)
Q Consensus       465 ----------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~El  504 (588)
                                                              ........||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0011235799999999999999999999999999999999


Q ss_pred             HcCCCccccccccchhhhc-C--ccc----CcccCHHHHHHHHHHHHHhhcCCCCCC---CHHHHHHH
Q 042871          505 LSGKKAKVLTRAGSALELA-D--PKL----DREYSIEAFDLTLQLALSCTALTHQRP---PMEQVFVT  562 (588)
Q Consensus       505 ltG~~p~~~~~~~~~~~~~-d--~~l----~~~~~~e~~~~v~~L~~~C~~~p~~RP---s~~evl~~  562 (588)
                      ++|+.||...........+ .  ..+    ....+.+..+++.    .++.+|.+|+   ++.|++..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~----~l~~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLIL----RLCCGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHH----HHhcCHhhcCCCCCHHHHhCC
Confidence            9999999754432221111 1  111    1234555555544    3445899999   88888865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.3e-37  Score=310.93  Aligned_cols=245  Identities=28%  Similarity=0.467  Sum_probs=197.3

Q ss_pred             ceeeccCceEEEEEEecC-------CcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          318 NLIGEGITGKVYKGKLSN-------NQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +.||+|+||.||+|+..+       ++.+|+|.+...   .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998632       357999987643   3456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-----cEEEEecCC
Q 042871          388 CPNGNLAEWLFGK------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-----EAKLSDFGL  456 (588)
Q Consensus       388 ~~~gsL~~~L~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-----~~kL~DFGl  456 (588)
                      +++++|.+++...      ...+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999642      234789999999999999999999988   99999999999999877     899999999


Q ss_pred             cceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHH
Q 042871          457 SKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIE  534 (588)
Q Consensus       457 a~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e  534 (588)
                      ++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....++.......+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            97654332211 122345788999999999999999999999999999998 9988864443333333332222222233


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ....+.+++.+|+. +|.+||+++++++.|++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            44567788999998 79999999999999873

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-37  Score=329.93  Aligned_cols=255  Identities=20%  Similarity=0.239  Sum_probs=199.3

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceec
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLR  377 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~  377 (588)
                      ++++....++|+..+.||+|+||.||+++.. +++.||+|++..     ....+.+.+|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4556666789999999999999999999974 688999999853     1234457889999999999999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      ++..++||||+++|+|.+++..  ..++...+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            9999999999999999999843  34788888899999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Cc--ccCcc
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNC----KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DP--KLDRE  530 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~--~l~~~  530 (588)
                      +..............||+.|+|||++...    .++.++|||||||++|||++|+.||...........+ ..  .+.-.
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  269 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  269 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence            87654333333456799999999998654    3788999999999999999999999744332222221 11  11100


Q ss_pred             cCHHHHHHHHHHHHHhhcCCC---CCCCHHHHHHHH
Q 042871          531 YSIEAFDLTLQLALSCTALTH---QRPPMEQVFVTL  563 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~~p~---~RPs~~evl~~L  563 (588)
                      ........+..++..|+.+|.   .||+++|+++..
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            011122334445666666542   388999988854

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.9e-37  Score=313.94  Aligned_cols=239  Identities=19%  Similarity=0.257  Sum_probs=190.2

Q ss_pred             eeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          320 IGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       320 LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      ||+|+||+||+++. .+|+.||+|.+...     ...+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999986 47899999998642     2235678899999999999999999999999999999999999999


Q ss_pred             hhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          394 AEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       394 ~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      .+++..   ....+++.++..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.....+.. ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988853   2346899999999999999999999998   99999999999999999999999999976644332 2234


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccC--cccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLD--REYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~--~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..........  ..++......+..++..|+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            578999999999999999999999999999999999999986432211 1111111111  1112223344556677788


Q ss_pred             c-CCCCCC-----CHHHHHHH
Q 042871          548 A-LTHQRP-----PMEQVFVT  562 (588)
Q Consensus       548 ~-~p~~RP-----s~~evl~~  562 (588)
                      + +|++||     +++++++.
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcC
Confidence            7 799999     66777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.2e-37  Score=319.96  Aligned_cols=246  Identities=23%  Similarity=0.261  Sum_probs=194.2

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.+..     ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47888999999999999999974 578899999853     123345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999765567899999999999999999999998   99999999999999999999999999976543333


Q ss_pred             ccccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Ccc----cC---cccC
Q 042871          466 YASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPK----LD---REYS  532 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~----l~---~~~~  532 (588)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...........+ ...    +.   ...+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  237 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS  237 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence            3334457999999999876     346889999999999999999999998644332222211 111    11   1234


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .+..+++.++.  |.. ++..|++++|+++.
T Consensus       238 ~~~~~li~~ll--~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         238 EDAKDLIRRLI--CSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHHHHc--cChhhhcCCCCHHHHhCC
Confidence            55555444332  222 23458899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.4e-37  Score=321.13  Aligned_cols=235  Identities=23%  Similarity=0.304  Sum_probs=189.8

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCC-ceeEEecceeccCeeeEEe
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHP-NLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~LV~  385 (588)
                      +|+..+.||+|+||.||+|+.. +++.||||++..     ....+.+..|.+++..++|+ +|+++.+++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999864 678999999863     23456788899999999765 6888999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            999999999998543 35889999999999999999999998   9999999999999999999999999987532211 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~~~~v~~L  542 (588)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.   ..+....+.+    +..+
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----~~~l  231 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE----AVSI  231 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence            12234568999999999999999999999999999999999999986544333322221   1122233443    4455


Q ss_pred             HHHhhc-CCCCCCCH
Q 042871          543 ALSCTA-LTHQRPPM  556 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~  556 (588)
                      +..|+. +|.+|++.
T Consensus       232 i~~~l~~~P~~R~~~  246 (324)
T cd05587         232 CKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHHhhcCHHHcCCC
Confidence            677777 79999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-36  Score=307.88  Aligned_cols=251  Identities=25%  Similarity=0.333  Sum_probs=199.7

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++.+++++.....||+|+||.||+|+. +++..|++|.+....  ..+.+.+|++++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            456678888888999999999999985 467889999886542  45678999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCc--cHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCccee
Q 042871          384 IYELCPNGNLAEWLFGKDKCL--SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVI  460 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~~  460 (588)
                      |+||+++++|.+++......+  ++..+..++.|+++||+|||+.+   |+||||||+||+++. ++.+||+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999997654445  78888999999999999999988   999999999999976 679999999998765


Q ss_pred             cCCCcccccCccCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC--cccCcccCHHHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNC--KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--PKLDREYSIEAF  536 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d--~~l~~~~~~e~~  536 (588)
                      ..... ......|++.|+|||++...  .++.++||||||+++|||++|+.|+.............  .......+....
T Consensus       160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06624         160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS  238 (268)
T ss_pred             ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence            32222 22334578999999998654  37889999999999999999999986432211111100  011122233344


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +.+..++.+|++ +|.+|||+.|++.
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            556777899998 6999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-37  Score=320.53  Aligned_cols=246  Identities=22%  Similarity=0.260  Sum_probs=194.8

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+..     ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47888999999999999999964 689999999863     223456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++......+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999665566899999999999999999999998   99999999999999999999999999876654333


Q ss_pred             ccccCccCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcC--c--cc---CcccC
Q 042871          466 YASSEVRGTFGYLDPEYRSN-----CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LAD--P--KL---DREYS  532 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d--~--~l---~~~~~  532 (588)
                      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||......+... ...  .  .+   ....+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  237 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS  237 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence            33334568999999999863     457889999999999999999999986432221111 111  0  01   11245


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .+..+++.+++  |.. ++..||+++++++.
T Consensus       238 ~~~~~li~~ll--~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         238 EEAKDLIRRLI--CSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHHHHc--cCcccccCCCCHHHHhcC
Confidence            55555554433  332 24558999998876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=330.31  Aligned_cols=243  Identities=22%  Similarity=0.264  Sum_probs=191.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|...+.||+|+||.||+++. .+|+.||||++...     ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999985 57899999998532     23456888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999999643 45888888999999999999999998   99999999999999999999999999863211000


Q ss_pred             ------------c----------------------------------cccCccCCCCccCcccccCCCCCchhhHHHHHH
Q 042871          466 ------------Y----------------------------------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGI  499 (588)
Q Consensus       466 ------------~----------------------------------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gv  499 (588)
                                  .                                  ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                        0                                  001246999999999999999999999999999


Q ss_pred             HHHHHHcCCCccccccccchhhhc-C--cc--cCc--ccCHHHHHHHHHHHHHhhcCCCC---CCCHHHHHHH
Q 042871          500 VLLQILSGKKAKVLTRAGSALELA-D--PK--LDR--EYSIEAFDLTLQLALSCTALTHQ---RPPMEQVFVT  562 (588)
Q Consensus       500 ll~ElltG~~p~~~~~~~~~~~~~-d--~~--l~~--~~~~e~~~~v~~L~~~C~~~p~~---RPs~~evl~~  562 (588)
                      ++|||++|+.||...........+ .  ..  +..  ..+.+..+++    ..|+.+|.+   |+++.|++..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli----~~lL~~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLI----RRLITNAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHH----HHHhcCHhhcCCCCCHHHHhcC
Confidence            999999999998643332221111 1  11  111  2344544444    444455433   7799998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.6e-37  Score=321.50  Aligned_cols=230  Identities=23%  Similarity=0.287  Sum_probs=187.9

Q ss_pred             ceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++.. +++.||||++..     ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999974 688999999863     23456678888888776 699999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... .....
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~  155 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST  155 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence            9999988543 45889999999999999999999998   9999999999999999999999999987543221 22334


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc---ccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP---KLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~---~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+..   .+....+.    .+..++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~----~~~~li~~~L  231 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQ----DAVDILKAFM  231 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH----HHHHHHHHHc
Confidence            5789999999999998999999999999999999999999975544433333221   11222333    3455677777


Q ss_pred             c-CCCCCCCH
Q 042871          548 A-LTHQRPPM  556 (588)
Q Consensus       548 ~-~p~~RPs~  556 (588)
                      + +|.+||++
T Consensus       232 ~~dP~~R~~~  241 (320)
T cd05590         232 TKNPTMRLGS  241 (320)
T ss_pred             ccCHHHCCCC
Confidence            7 79999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-37  Score=324.51  Aligned_cols=236  Identities=25%  Similarity=0.270  Sum_probs=192.0

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      +.||+|+||.||+++. .+|+.||+|.+...     .....+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999986 57899999998642     23456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       392 sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      +|.+++... ..+++.++..++.|++.||.|||+ .+   |+||||||+|||+++++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (325)
T cd05594          81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT  155 (325)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence            999988543 468999999999999999999997 67   9999999999999999999999999987543221 12234


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+.   ..+....+.+    +..++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~----~~~li~~~L  231 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE----AKSLLSGLL  231 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH----HHHHHHHHh
Confidence            568999999999999999999999999999999999999986544333333221   2222334444    455667777


Q ss_pred             c-CCCCCC-----CHHHHHHH
Q 042871          548 A-LTHQRP-----PMEQVFVT  562 (588)
Q Consensus       548 ~-~p~~RP-----s~~evl~~  562 (588)
                      + +|++|+     ++.++++.
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcC
Confidence            7 799996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.9e-37  Score=312.06  Aligned_cols=244  Identities=24%  Similarity=0.321  Sum_probs=199.8

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+...   ...+.+.+|++++++++||||+++++++..++..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            466778899999999999986 46789999988632   23457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++++|.+++.  ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++....... ...
T Consensus        85 ~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  158 (277)
T cd06642          85 GGGSALDLLK--PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR  158 (277)
T ss_pred             CCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence            9999999984  346899999999999999999999988   9999999999999999999999999987654322 122


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ....|+..|+|||++.+..++.++||||||+++|||++|+.|+...........+...............+..++..|++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN  238 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            23467889999999999889999999999999999999999986443333333332222222222334456677888998


Q ss_pred             -CCCCCCCHHHHHHH
Q 042871          549 -LTHQRPPMEQVFVT  562 (588)
Q Consensus       549 -~p~~RPs~~evl~~  562 (588)
                       +|.+||++.++++.
T Consensus       239 ~~p~~Rp~~~~il~~  253 (277)
T cd06642         239 KDPRFRPTAKELLKH  253 (277)
T ss_pred             CCcccCcCHHHHHHh
Confidence             79999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.9e-37  Score=306.46  Aligned_cols=246  Identities=22%  Similarity=0.286  Sum_probs=199.6

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      +|+..+.||+|+||.||+++.. +++.+|+|.+...   ...+.+.+|+.+++.++|+||+++++.+.+++..++|+||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999864 7899999988532   34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhc-CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFG-KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++|+|.+++.. ....+++...+.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||+++....... .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            99999998854 3345888999999999999999999998   99999999999999999999999999876543222 2


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+........+......+..++..|+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMF  236 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHH
Confidence            23456889999999999889999999999999999999999998744332222222111111122223344666788888


Q ss_pred             c-CCCCCCCHHHHHHH
Q 042871          548 A-LTHQRPPMEQVFVT  562 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~  562 (588)
                      + +|++|||+.+++..
T Consensus       237 ~~~P~~Rp~~~~il~~  252 (255)
T cd08219         237 KRNPRSRPSATTILSR  252 (255)
T ss_pred             hCCcccCCCHHHHhhc
Confidence            8 79999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-37  Score=327.96  Aligned_cols=192  Identities=23%  Similarity=0.257  Sum_probs=168.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ++|+..+.||+|+||.||+++. .+++.||+|...    ...+.+|++++++++||||+++++++..+...++|+|++ +
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence            5688999999999999999986 578999999754    345789999999999999999999999999999999999 4


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      ++|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++............
T Consensus       167 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        167 TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence            7888888543 45889999999999999999999998   9999999999999999999999999997543222223344


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.|+.
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            679999999999999999999999999999999999998753

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-36  Score=304.95  Aligned_cols=247  Identities=30%  Similarity=0.482  Sum_probs=200.6

Q ss_pred             ccccceeeccCceEEEEEEecC-----CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          314 LNELNLIGEGITGKVYKGKLSN-----NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      |+..+.||.|+||.||+++..+     +..||+|.+....   ..+.+.+|+..+..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456789999999999998743     4889999997543   4568899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcC-ccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||+++++|.+++...... +++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999654443 899999999999999999999998   9999999999999999999999999998765543


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      ........++..|+|||.+....++.++||||||++++||++ |+.|+.........+.+...............+.+++
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM  237 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence            333223347789999999988889999999999999999998 7777764333333333322222222222344566678


Q ss_pred             HHhhc-CCCCCCCHHHHHHHH
Q 042871          544 LSCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~L  563 (588)
                      .+|+. +|++|||+.|+++.|
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      238 LQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHCcCChhhCcCHHHHHhhC
Confidence            88888 799999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.9e-37  Score=330.00  Aligned_cols=241  Identities=20%  Similarity=0.272  Sum_probs=191.8

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .|+..+.||+|+||.||+|+. .+++.||+|++...     ...+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999986 57889999998642     234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC--
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE--  464 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~--  464 (588)
                      |+++|+|.+++... ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999999998643 45788888999999999999999998   9999999999999999999999999975321000  


Q ss_pred             --------------------------------------------cccccCccCCCCccCcccccCCCCCchhhHHHHHHH
Q 042871          465 --------------------------------------------TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV  500 (588)
Q Consensus       465 --------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvl  500 (588)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000123468999999999999999999999999999


Q ss_pred             HHHHHcCCCccccccccchh-hhcC--ccc--C--cccCHHHHHHHHHHHHHhhcCCCCCCC---HHHHHH
Q 042871          501 LLQILSGKKAKVLTRAGSAL-ELAD--PKL--D--REYSIEAFDLTLQLALSCTALTHQRPP---MEQVFV  561 (588)
Q Consensus       501 l~ElltG~~p~~~~~~~~~~-~~~d--~~l--~--~~~~~e~~~~v~~L~~~C~~~p~~RPs---~~evl~  561 (588)
                      +|||++|+.||......... ....  ..+  .  ...+.+..+++.+|    +.+|.+|++   +.|+++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l----~~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL----CRGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHH----ccCHhHcCCCCCHHHHhc
Confidence            99999999999754332211 1111  111  1  23456666666442    347888887   877765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.2e-37  Score=314.04  Aligned_cols=252  Identities=25%  Similarity=0.419  Sum_probs=198.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-----------------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-----------------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVA  370 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-----------------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~  370 (588)
                      .++|+..+.||+|+||.||++...                 ++..||+|++....   ..+.|.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            467889999999999999998532                 24579999987532   3467899999999999999999


Q ss_pred             EecceeccCeeeEEeecCCCCChhhhhhcCC----------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCC
Q 042871          371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKD----------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTN  440 (588)
Q Consensus       371 l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~N  440 (588)
                      +++++...+..++||||+++|+|.+++....          ..+++.+.+.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999999985422          24778899999999999999999998   9999999999


Q ss_pred             eEECCCCcEEEEecCCcceecCCCccc-ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCcccccccc
Q 042871          441 ILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS--GKKAKVLTRAG  517 (588)
Q Consensus       441 ILld~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~p~~~~~~~  517 (588)
                      ||+++++.++|+|||+++......... .....++..|++||+...+.++.++||||||+++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999998654332211 222344678999999888889999999999999999998  66676533322


Q ss_pred             chhhhcCc-------ccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          518 SALELADP-------KLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       518 ~~~~~~d~-------~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      +.......       ......+......+.+++.+|++ +|.+||++.||++.|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            22111100       00001112233567788999998 79999999999999873

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.9e-37  Score=309.15  Aligned_cols=249  Identities=27%  Similarity=0.364  Sum_probs=196.1

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-CcHHHHHHHHHHhccC-CCCceeEEecceecc------C
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-GNVETFVREVASSSHV-RHPNLVALLGYCLRV------D  379 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~------~  379 (588)
                      .+++.|+..+.||+|+||.||+|.. .+++.||+|++... .....+.+|+.++.++ +|+||+++++++...      .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            3567888899999999999999986 46889999998643 3456788999999998 699999999998753      4


Q ss_pred             eeeEEeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          380 ECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence            589999999999999999653 346899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCcccccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc-cCcccC
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK-LDREYS  532 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~-l~~~~~  532 (588)
                      ...... .......|+..|+|||++.     +..++.++|||||||++|||++|+.|+............... ......
T Consensus       160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence            654322 1223456899999999875     346888999999999999999999998533222211111111 011111


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ......+..++.+|+. +|.+|||+.|+++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1222346677889988 7999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-36  Score=308.08  Aligned_cols=243  Identities=23%  Similarity=0.381  Sum_probs=186.3

Q ss_pred             eeeccCceEEEEEEec---CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCC
Q 042871          319 LIGEGITGKVYKGKLS---NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs  392 (588)
                      .||+|+||.||+|+..   ....+++|.+....   ....|.+|++.++.++|+||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            6899999999999753   34578999876432   24568899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCC----cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc-c
Q 042871          393 LAEWLFGKD----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-A  467 (588)
Q Consensus       393 L~~~L~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~-~  467 (588)
                      |.+++....    ...++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++........ .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999996533    23467788899999999999999998   999999999999999999999999998754322211 1


Q ss_pred             ccCccCCCCccCccccc-------CCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhh-c---CcccC-cccCHH
Q 042871          468 SSEVRGTFGYLDPEYRS-------NCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALEL-A---DPKLD-REYSIE  534 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~-------~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~-~---d~~l~-~~~~~e  534 (588)
                      .....++..|+|||+..       ...++.++||||||+++|||++ |+.||......+.... +   +..+. ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            23344677899999864       3456889999999999999999 7777764433221111 1   11111 111222


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 042871          535 AFDLTLQLALSCTALTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       535 ~~~~v~~L~~~C~~~p~~RPs~~evl~~L~  564 (588)
                      ....+..++..|+.+|++|||++||++.|.
T Consensus       239 ~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         239 YSDRWYEVMQFCWLDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCHHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence            334445567788889999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8e-37  Score=319.08  Aligned_cols=235  Identities=23%  Similarity=0.287  Sum_probs=189.8

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEe
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      +|+..+.||+|+||.||+|+.. +++.||+|.+...     ...+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999864 6789999998642     2334567788887776 5899999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            999999999998543 45889999999999999999999998   9999999999999999999999999987543221 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~~~~v~~L  542 (588)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.   ..+....+.    .+..+
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~----~~~~l  231 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK----EAVAI  231 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCH----HHHHH
Confidence            12334678999999999999999999999999999999999999997544433333221   111223333    34556


Q ss_pred             HHHhhc-CCCCCCCH
Q 042871          543 ALSCTA-LTHQRPPM  556 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~  556 (588)
                      +..|++ +|.+|++.
T Consensus       232 i~~~l~~~p~~R~~~  246 (323)
T cd05616         232 CKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHHcccCHHhcCCC
Confidence            777777 79999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-36  Score=305.36  Aligned_cols=236  Identities=24%  Similarity=0.355  Sum_probs=188.4

Q ss_pred             ceeeccCceEEEEEEecCCc-----------EEEEEEecCCCc-HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          318 NLIGEGITGKVYKGKLSNNQ-----------HVAIKHITNEGN-VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~-----------~VAVK~l~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      +.||+|+||.||+|++.+..           .|++|.+..... ...|.+|+.++++++||||+++++++.. ...++|+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            36999999999999975432           578888765433 6789999999999999999999999988 7889999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-------cEEEEecCCcc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-------EAKLSDFGLSK  458 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-------~~kL~DFGla~  458 (588)
                      ||+++|+|.+++......+++..++.++.|++.||.|||+.+   |+||||||+||+++.++       .+||+|||++.
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            999999999999765557899999999999999999999988   99999999999999887       79999999988


Q ss_pred             eecCCCcccccCccCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHcC-CCccccccccchhhhcCcccCcccCHHH
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNC--KVNSSGDVYSFGIVLLQILSG-KKAKVLTRAGSALELADPKLDREYSIEA  535 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~t~ksDVwS~Gvll~ElltG-~~p~~~~~~~~~~~~~d~~l~~~~~~e~  535 (588)
                      ....     .....++..|+|||++...  .++.++||||||+++|||++| ..|+...............  ...+...
T Consensus       157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~  229 (259)
T cd05037         157 TVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ--HRLPMPD  229 (259)
T ss_pred             cccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC--CCCCCCC
Confidence            6543     2223467789999998776  789999999999999999994 6666543222211111110  0111111


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                      ...+.+++..|+. +|.+|||+.+|++.|+
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1566778899998 7999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-37  Score=294.76  Aligned_cols=242  Identities=27%  Similarity=0.349  Sum_probs=205.4

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      -++|++.+.||+|-||.||.|+. +++-.||+|++...     ....++.+|+++-+.++||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46789999999999999999996 46789999998643     2345788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          385 YELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      +||.++|+|...|... .+.+++.....++.|+|.||.|+|..+   |+||||||+|+|++.++..||+|||.+...+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            9999999999999643 346888999999999999999999998   9999999999999999999999999987643  


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh---hcCcccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE---LADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~---~~d~~l~~~~~~e~~~~v~  540 (588)
                       .......+||..|.+||+..+..++...|+|++|++.||++.|.+||.-...++...   .+|-.++...+.+..++  
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl--  252 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL--  252 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH--
Confidence             223456789999999999999999999999999999999999999998665544433   23444445566666555  


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                        +..|+. +|.+|.+..|+++.
T Consensus       253 --I~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  253 --ISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             --HHHHhccCccccccHHHHhhh
Confidence              455565 79999999998763

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.3e-37  Score=318.79  Aligned_cols=235  Identities=23%  Similarity=0.297  Sum_probs=191.1

Q ss_pred             ceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++.. +++.||||++...     ...+.+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            37999999999999874 6789999998642     3355677888888877 699999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... ..+++.+...++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...... .....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST  155 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence            9999998543 35899999999999999999999998   9999999999999999999999999987532222 12234


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||...........+.   ..+....+    ..+..++..|+
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~~~li~~~l  231 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLS----KEAKSILKSFL  231 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCC----HHHHHHHHHHc
Confidence            568999999999999999999999999999999999999986544333322221   11122233    34566677888


Q ss_pred             c-CCCCCCCH-----HHHHH
Q 042871          548 A-LTHQRPPM-----EQVFV  561 (588)
Q Consensus       548 ~-~p~~RPs~-----~evl~  561 (588)
                      + +|.+||++     .++++
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhc
Confidence            7 79999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-36  Score=308.86  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=201.1

Q ss_pred             cCccccceeeccCceEEEEEEec------CCcEEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ++|+....||+|+||.||+|+..      +.+.|++|.+.....   .+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888899999999999999853      346799998865432   467999999999999999999999999989999


Q ss_pred             EEeecCCCCChhhhhhcCC--------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          383 LIYELCPNGNLAEWLFGKD--------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                      +||||+++|+|.+++....        ..+++.++..++.|+++||+|||+.+   |+||||||+||++++++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999996433        15899999999999999999999998   999999999999999999999999


Q ss_pred             CCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcC-cccCcccC
Q 042871          455 GLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELAD-PKLDREYS  532 (588)
Q Consensus       455 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d-~~l~~~~~  532 (588)
                      |+++..............++..|++||.+.+..++.++||||||+++|||++ |..||............. .......+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            9987543322222333456778999999988889999999999999999999 777775433322222221 11111112


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                      ......+.+++.+|++ +|.+|||+.|+++.|.
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            2334567778899998 7999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-37  Score=326.00  Aligned_cols=248  Identities=22%  Similarity=0.299  Sum_probs=208.6

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCe-eeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDE-CFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-~~LV  384 (588)
                      .++|...+++|+|+||.++..+.+ +++.+++|.+.-    +...+...+|+.++++++|||||.+.+.+++++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357888899999999999988864 678999999863    2345577899999999999999999999999988 9999


Q ss_pred             eecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          385 YELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      |+|++||+|.+.+...+ ..+++.++..++.|++.|+.|||+..   |+|||||+.||+++.+..+||+|||+|+.....
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999997655 56889999999999999999999888   999999999999999999999999999987654


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      .. ....+.||+.||.||.+.+.+|+.|+|||||||++|||++-+++|.-.+-..+...+-+......+......+..|+
T Consensus       160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv  238 (426)
T KOG0589|consen  160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV  238 (426)
T ss_pred             hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence            42 44567899999999999999999999999999999999999999876555444444333332333333334455567


Q ss_pred             HHhhc-CCCCCCCHHHHHHH
Q 042871          544 LSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..|+. +|..||++.+++.+
T Consensus       239 ~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHhhcCCccCCCHHHHhhC
Confidence            77777 79999999999986

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.5e-37  Score=320.62  Aligned_cols=200  Identities=23%  Similarity=0.287  Sum_probs=174.9

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|...+.||+|+||.||+++.. +++.||+|.+..     ......+.+|+.++..++|+||+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999964 688999999863     223445788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999765567899999999999999999999998   99999999999999999999999999987654333


Q ss_pred             ccccCccCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCccccc
Q 042871          466 YASSEVRGTFGYLDPEYRSN-----CKVNSSGDVYSFGIVLLQILSGKKAKVLT  514 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~  514 (588)
                      .......||+.|+|||++.+     ..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            33344579999999998865     46788999999999999999999998643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.7e-37  Score=318.16  Aligned_cols=234  Identities=27%  Similarity=0.354  Sum_probs=188.4

Q ss_pred             ceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhcc-CCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSH-VRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+|+.. +++.||||+++..     ...+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999974 6789999998642     334566778887775 5899999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... ..+++.+...++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....... ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence            9999999543 45889999999999999999999998   99999999999999999999999999875432221 2234


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+.   +.+....+.+    +..++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----~~~li~~~l  231 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTRE----AKDILVKLF  231 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH----HHHHHHHHh
Confidence            578999999999999899999999999999999999999986544333333221   2222223333    455567777


Q ss_pred             c-CCCCCCCHH-HHH
Q 042871          548 A-LTHQRPPME-QVF  560 (588)
Q Consensus       548 ~-~p~~RPs~~-evl  560 (588)
                      + +|.+||++. ++.
T Consensus       232 ~~~P~~R~~~~~~l~  246 (316)
T cd05619         232 VREPERRLGVKGDIR  246 (316)
T ss_pred             ccCHhhcCCChHHHH
Confidence            7 799999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-36  Score=306.25  Aligned_cols=236  Identities=22%  Similarity=0.307  Sum_probs=186.8

Q ss_pred             ceeeccCceEEEEEEecC-------------CcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          318 NLIGEGITGKVYKGKLSN-------------NQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~-------------g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      +.||+|+||.||+|+..+             ...|++|.+...  .....|.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             235899987653  23457889999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc-------EEEEecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE-------AKLSDFG  455 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~-------~kL~DFG  455 (588)
                      +||||+++|+|..++......+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998766667899999999999999999999998   999999999999987664       8999999


Q ss_pred             CcceecCCCcccccCccCCCCccCccccc-CCCCCchhhHHHHHHHHHHHH-cCCCccccccccchhhhcCcccCcccCH
Q 042871          456 LSKVIDIGETYASSEVRGTFGYLDPEYRS-NCKVNSSGDVYSFGIVLLQIL-SGKKAKVLTRAGSALELADPKLDREYSI  533 (588)
Q Consensus       456 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~t~ksDVwS~Gvll~Ell-tG~~p~~~~~~~~~~~~~d~~l~~~~~~  533 (588)
                      ++......     ....++..|+|||++. +..++.++||||||+++|||+ +|+.|+..................  ..
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~  230 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML--VT  230 (262)
T ss_pred             CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccC--CC
Confidence            98654321     2235788999999886 467899999999999999998 577776543322222222211111  11


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCCCHHHHHHHH
Q 042871          534 EAFDLTLQLALSCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L  563 (588)
                      ...+.+..++..|++ +|.+||+++++++.|
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            122446678889998 799999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-37  Score=323.29  Aligned_cols=235  Identities=24%  Similarity=0.230  Sum_probs=189.6

Q ss_pred             ceeeccCceEEEEEEe----cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          318 NLIGEGITGKVYKGKL----SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      +.||+|+||.||+++.    .+|+.||+|++...    .....+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    36899999998742    234467789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +|+|.+++... ..+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++...... ....
T Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~  156 (318)
T cd05582          82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY  156 (318)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence            99999999543 45899999999999999999999998   9999999999999999999999999987654322 1223


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||...........+.... ...+......+..++..|++ 
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence            4578999999999998889999999999999999999999987544333322221111 11122223345566788887 


Q ss_pred             CCCCCCCHHH
Q 042871          549 LTHQRPPMEQ  558 (588)
Q Consensus       549 ~p~~RPs~~e  558 (588)
                      +|.+||++.+
T Consensus       236 ~P~~R~~a~~  245 (318)
T cd05582         236 NPANRLGAGP  245 (318)
T ss_pred             CHhHcCCCCC
Confidence            7999999444

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-36  Score=303.91  Aligned_cols=247  Identities=21%  Similarity=0.259  Sum_probs=201.2

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|+||.||.++. .+++.+++|.+..    ......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999985 5789999998753    23456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++... ...+++.++..++.|++++|.|||+.+   ++||||||+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999654 346899999999999999999999988   99999999999999999999999999987643332 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      ......+++.|+|||+..+..++.++||||||+++|||++|+.|+......+....+...-...........+..++..|
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL  236 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            22345689999999999888899999999999999999999999865433322222211111111222334566678888


Q ss_pred             hc-CCCCCCCHHHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~L  563 (588)
                      +. +|.+||+++|+++.+
T Consensus       237 l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         237 LQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cccCcccCCCHHHHhhCc
Confidence            87 799999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-36  Score=344.79  Aligned_cols=259  Identities=24%  Similarity=0.290  Sum_probs=204.4

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|++.++||+|+||.||+|+.. +|+.||||++...     ...+.|.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999864 6899999998642     12457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcC----------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          386 ELCPNGNLAEWLFGK----------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       386 E~~~~gsL~~~L~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                      ||+++|+|.+++...          ...+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998531          123567788999999999999999998   9999999999999999999999999


Q ss_pred             CcceecCCC-----------------cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc
Q 042871          456 LSKVIDIGE-----------------TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS  518 (588)
Q Consensus       456 la~~~~~~~-----------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~  518 (588)
                      +++......                 ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            998652111                 011123569999999999999999999999999999999999999986533222


Q ss_pred             hhhh---cCcccCcccCHHHHHHHHHHHHHhhc-CCCCC-CCHHHHHHHHHHhhccCCccC
Q 042871          519 ALEL---ADPKLDREYSIEAFDLTLQLALSCTA-LTHQR-PPMEQVFVTLQKALDISTTAK  574 (588)
Q Consensus       519 ~~~~---~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~R-Ps~~evl~~L~~~~~~~~~~~  574 (588)
                      ....   .++.-.. ...+....+.+++.+|+. +|++| ++++++++.|+..+...+.+.
T Consensus       239 i~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~  298 (932)
T PRK13184        239 ISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWT  298 (932)
T ss_pred             hhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccc
Confidence            1111   0110000 011233446677888888 79999 567888888998877655443

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.3e-36  Score=302.12  Aligned_cols=246  Identities=22%  Similarity=0.261  Sum_probs=198.0

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec-cCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR-VDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~E  386 (588)
                      +|+..+.||+|++|.||+++.. +++.||+|++...    ...+.+.+|++++++++|+|++++.+.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999864 6789999998642    234568899999999999999999998764 446799999


Q ss_pred             cCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++++|.+++... ...+++.+++.++.+++.||+|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            99999999999653 346899999999999999999999998   9999999999999999999999999998764322 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~  545 (588)
                      .......+++.|+|||++.+..++.++||||||++++||++|+.|+...........+........+......+.+++..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT  236 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            22234568899999999999999999999999999999999999886433322222221111112223344556777888


Q ss_pred             hhc-CCCCCCCHHHHHHH
Q 042871          546 CTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~~  562 (588)
                      |++ +|++|||+.++++.
T Consensus       237 ~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         237 MLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HhccCcccCCCHHHHhcC
Confidence            887 79999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-36  Score=317.58  Aligned_cols=236  Identities=22%  Similarity=0.291  Sum_probs=190.3

Q ss_pred             ceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+|+.. +++.||||++...     ...+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999864 6889999998642     3345677888888765 799999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...... .....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT  155 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence            9999988543 45889999999999999999999998   9999999999999999999999999987543222 22334


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc---ccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP---KLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~---~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+..   ......+.+    +..++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~----~~~ll~~~L  231 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKE----AVSILKAFM  231 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHHh
Confidence            5789999999999998999999999999999999999999975544333332211   112223444    445566777


Q ss_pred             c-CCCCCC-------CHHHHHHH
Q 042871          548 A-LTHQRP-------PMEQVFVT  562 (588)
Q Consensus       548 ~-~p~~RP-------s~~evl~~  562 (588)
                      . +|++||       ++.++++.
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcC
Confidence            7 799999       77777644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-36  Score=323.85  Aligned_cols=245  Identities=24%  Similarity=0.303  Sum_probs=192.2

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC-----eee
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD-----ECF  382 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~  382 (588)
                      +|+..+.||+|+||.||+++. .+|+.||||++...    ...+.+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999996 57899999998642    23457889999999999999999999998776     789


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 678887743 346899999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-----------------
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-----------------  524 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-----------------  524 (588)
                      ..........+++.|+|||++.+. .++.++||||||+++|||++|+.||.........+.+.                 
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            333333445678999999998774 57899999999999999999999885332211111000                 


Q ss_pred             --------cccCc------ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          525 --------PKLDR------EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       525 --------~~l~~------~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                              +....      ....+..+.+..++..|++ +|.+|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                    00000      0001112345567788888 79999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=307.45  Aligned_cols=244  Identities=26%  Similarity=0.327  Sum_probs=199.8

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.+...   .....+.+|+.+++.++|+||+++.+++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778889999999999999964 7899999998643   2345788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++...  .+++.+.+.++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++...... ..
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  154 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK  154 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence            9999999999543  6899999999999999999999988   9999999999999999999999999998765432 22


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHH-HHHHHHHHHHHh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIE-AFDLTLQLALSC  546 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e-~~~~v~~L~~~C  546 (588)
                      .....++..|+|||++.+..++.++||||||+++|||++|+.|+...........+........... ....+..++..|
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence            3345678899999999988899999999999999999999999865443332222222221111111 233455667788


Q ss_pred             hc-CCCCCCCHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFV  561 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~  561 (588)
                      +. +|++|||++++++
T Consensus       235 l~~~p~~Rpt~~~il~  250 (274)
T cd06609         235 LNKDPKERPSAKELLK  250 (274)
T ss_pred             hhCChhhCcCHHHHhh
Confidence            87 7999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=336.77  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=219.3

Q ss_pred             cccceeeccCceEEEEEEe-cCCc----EEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          315 NELNLIGEGITGKVYKGKL-SNNQ----HVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ...++||+|.||+||||.+ ++|+    +||+|++...   +...++++|...|.+++||||++|+|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3456899999999999985 5554    6899988653   34678999999999999999999999998765 899999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-c
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-T  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-~  465 (588)
                      ||+.|+|.||++.++..+.-...+.|..|||+||.|||.+.   ++||||..+|||+.+-..+||.|||+++.+.... .
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999888888999999999999999999999888   9999999999999999999999999999886543 3


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                      +......-.+.|||-|.+....|+.++|||||||.+||++| |.+|+.-....++.+++....+-.-++.+.-.+..++.
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv  934 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV  934 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence            33444455778999999999999999999999999999999 99999877777777777666555556667777888899


Q ss_pred             Hhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          545 SCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      .||. ++..||+++++...+.+....+..
T Consensus       935 kCwmid~~~rp~fkel~~~fs~~ardpqr  963 (1177)
T KOG1025|consen  935 KCWMIDADSRPTFKELAEEFSRMARDPQR  963 (1177)
T ss_pred             HHhccCcccCccHHHHHHHHHHHhcCcce
Confidence            9999 569999999999999988876553

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-36  Score=306.57  Aligned_cols=245  Identities=25%  Similarity=0.336  Sum_probs=204.1

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ..|+..+.||+|+||.||+|+.. +++.||+|.+...   .....+.+|+.++++++|+||+++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677789999999999999864 6889999988643   2346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++|+|.+++..  ..+++.+...++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++....... ..
T Consensus        84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06640          84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence            999999999853  45888999999999999999999988   9999999999999999999999999997664332 22


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      .....++..|+|||++.+..++.++|+||||+++|||++|+.|+...........+...............+..++..|+
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence            23346788999999998888999999999999999999999998754443333333333333344455666778899999


Q ss_pred             c-CCCCCCCHHHHHHH
Q 042871          548 A-LTHQRPPMEQVFVT  562 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~  562 (588)
                      + +|.+||++.+++..
T Consensus       238 ~~~p~~Rp~~~~il~~  253 (277)
T cd06640         238 NKDPSFRPTAKELLKH  253 (277)
T ss_pred             ccCcccCcCHHHHHhC
Confidence            8 79999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.1e-36  Score=304.90  Aligned_cols=247  Identities=26%  Similarity=0.351  Sum_probs=197.5

Q ss_pred             CccccceeeccCceEEEEEEecC--CcEEEEEEecCC------------CcHHHHHHHHHHhcc-CCCCceeEEecceec
Q 042871          313 KLNELNLIGEGITGKVYKGKLSN--NQHVAIKHITNE------------GNVETFVREVASSSH-VRHPNLVALLGYCLR  377 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~------------~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~  377 (588)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+...            ....++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999754  788999987521            123457788887764 799999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEe
Q 042871          378 VDECFLIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSD  453 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~D  453 (588)
                      ++..++||||+++++|.+++..   ....+++..+++++.|++.||.|||+ .+   ++||||||+||++++++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999998843   34468999999999999999999996 56   99999999999999999999999


Q ss_pred             cCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-CcccCcccC
Q 042871          454 FGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPKLDREYS  532 (588)
Q Consensus       454 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~l~~~~~  532 (588)
                      ||++.......  ......|+..|++||+..+..++.++||||||+++|||++|+.|+...........+ +........
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE  235 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc
Confidence            99998754332  233456889999999999888999999999999999999999998644333222222 111111111


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                      ......+..++.+|++ +|++||++.|+..+++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1223456677889998 7999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.8e-37  Score=320.31  Aligned_cols=230  Identities=21%  Similarity=0.277  Sum_probs=183.9

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++. .+++.||+|.+...     ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999996 46889999998642     2345677888888766 799999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..... ......
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (329)
T cd05618          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTST  155 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccc
Confidence            9999888543 46899999999999999999999998   999999999999999999999999998753221 122334


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc---------hhhhc---CcccCcccCHHHHHH
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS---------ALELA---DPKLDREYSIEAFDL  538 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~---------~~~~~---d~~l~~~~~~e~~~~  538 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.......         ..+.+   ...++...+    ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~----~~  231 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS----VK  231 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC----HH
Confidence            578999999999999999999999999999999999999985321110         11111   111222233    34


Q ss_pred             HHHHHHHhhc-CCCCCCCH
Q 042871          539 TLQLALSCTA-LTHQRPPM  556 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~  556 (588)
                      +..++..|++ +|.+||+.
T Consensus       232 ~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         232 AASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHHHhcCCHHHcCCC
Confidence            5566778887 79999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.4e-36  Score=305.39  Aligned_cols=248  Identities=24%  Similarity=0.337  Sum_probs=196.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|+..+.||+|+||.||+|+. .+++.||+|++...  .....+.+|+.++++++||||+++++++..++..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35788899999999999999996 57899999998643  3345678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++... ..+++.++..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++....... .
T Consensus        88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~  162 (267)
T cd06646          88 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K  162 (267)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence            9999999998543 46899999999999999999999988   99999999999999999999999999986542211 1


Q ss_pred             ccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCccccccccch-hhhcCcccCcc-c--CHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-LELADPKLDRE-Y--SIEAFDLTL  540 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~~~~d~~l~~~-~--~~e~~~~v~  540 (588)
                      .....|+..|+|||.+.   ...++.++||||||+++|||++|+.|+........ .......+... .  .......+.
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence            23346888999999874   44578899999999999999999998753322111 11111111100 0  111224566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L  563 (588)
                      +++..|+. +|++|||++++++.|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCC
Confidence            67888887 799999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-37  Score=307.97  Aligned_cols=243  Identities=34%  Similarity=0.464  Sum_probs=196.8

Q ss_pred             ccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHH----HHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          314 LNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVE----TFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~----~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      |+..+.||+|+||+||+++.. +++.||+|.+.......    ...+|+..+++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999975 56789999997654322    3356999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++++|.+++. ....+++.+++.++.|+++||+|||+.+   |+||||||+||++++++.++|+|||.+.... ......
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF  155 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred             cccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence            9999999996 3456899999999999999999999998   9999999999999999999999999987642 222234


Q ss_pred             cCccCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC----cccC--HHHHHHHHH
Q 042871          469 SEVRGTFGYLDPEYRS-NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD----REYS--IEAFDLTLQ  541 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~----~~~~--~e~~~~v~~  541 (588)
                      ....++..|+|||++. +..++.++||||+|+++|+|++|+.||......+....+.....    ....  ......+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            4567899999999988 78899999999999999999999999875522222222221111    1111  011256777


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ++..|++ +|++||++.++++
T Consensus       236 li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            8888888 7999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8e-37  Score=320.12  Aligned_cols=235  Identities=21%  Similarity=0.289  Sum_probs=188.2

Q ss_pred             ceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++.. +++.||||+++..     ...+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999864 7889999998642     2345678899999888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... +.+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..... ......
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~  155 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTST  155 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccc
Confidence            9999988543 46999999999999999999999998   999999999999999999999999998753211 122334


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc---------hhh-hcC--cccCcccCHHHHHH
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS---------ALE-LAD--PKLDREYSIEAFDL  538 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~---------~~~-~~d--~~l~~~~~~e~~~~  538 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.......         ..+ ...  ..++...+.+    
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~----  231 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVK----  231 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHH----
Confidence            578999999999999999999999999999999999999996322111         111 111  1122233333    


Q ss_pred             HHHHHHHhhc-CCCCCCC------HHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPP------MEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs------~~evl~  561 (588)
                      +..++..|++ +|.+||+      ++++++
T Consensus       232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            4556777777 7999997      667753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-36  Score=310.44  Aligned_cols=244  Identities=22%  Similarity=0.260  Sum_probs=196.0

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      |+..+.||+|+||+||+++. .+++.||+|.+...     .....+.+|++++++++|+|++++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999986 47899999998642     1234578899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            99999999986533 46999999999999999999999998   99999999999999999999999999876543222 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc---CcccCHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL---DREYSIEAFDLTLQLA  543 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l---~~~~~~e~~~~v~~L~  543 (588)
                       .....|+..|+|||++.+..++.++|+||||+++|||++|+.||.........+.+....   ...++.+....+.+++
T Consensus       158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence             233468999999999998899999999999999999999999987543322222221111   1112223334456678


Q ss_pred             HHhhc-CCCCCCC-----HHHHHHH
Q 042871          544 LSCTA-LTHQRPP-----MEQVFVT  562 (588)
Q Consensus       544 ~~C~~-~p~~RPs-----~~evl~~  562 (588)
                      ..|++ +|++||+     +.+++..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcC
Confidence            88888 7999999     5566653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-36  Score=317.42  Aligned_cols=234  Identities=25%  Similarity=0.324  Sum_probs=188.7

Q ss_pred             ceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhcc-CCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSH-VRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+|+.. +|+.||+|.++..     ...+.+..|..++.. .+||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999974 6889999998642     334566778877765 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... ..+++.+...++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....... ....
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAST  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceec
Confidence            9999998543 45889999999999999999999998   99999999999999999999999999875432221 2344


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+.   +.+....+.+    +..++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~li~~~l  231 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE----SKDILEKLF  231 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHHc
Confidence            678999999999999999999999999999999999999987544333333221   2222233443    445677778


Q ss_pred             c-CCCCCCCHH-HHH
Q 042871          548 A-LTHQRPPME-QVF  560 (588)
Q Consensus       548 ~-~p~~RPs~~-evl  560 (588)
                      + +|.+||++. +++
T Consensus       232 ~~dP~~R~~~~~~~~  246 (316)
T cd05620         232 ERDPTRRLGVVGNIR  246 (316)
T ss_pred             cCCHHHcCCChHHHH
Confidence            7 799999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-36  Score=309.78  Aligned_cols=236  Identities=23%  Similarity=0.310  Sum_probs=185.8

Q ss_pred             eeeccCceEEEEEEecC-------------------------CcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEE
Q 042871          319 LIGEGITGKVYKGKLSN-------------------------NQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVAL  371 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~-------------------------g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l  371 (588)
                      .||+|+||.||+|++..                         ...|++|.+....  ....|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         1358999886432  24578899999999999999999


Q ss_pred             ecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC----
Q 042871          372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF----  447 (588)
Q Consensus       372 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~----  447 (588)
                      ++++.+.+..++||||+++|+|.+++......+++..+..++.|+++||+|||+.+   |+||||||+|||+++++    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999765667899999999999999999999988   99999999999997644    


Q ss_pred             ---cEEEEecCCcceecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHH-cCCCccccccccchhhh
Q 042871          448 ---EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQIL-SGKKAKVLTRAGSALEL  522 (588)
Q Consensus       448 ---~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~Ell-tG~~p~~~~~~~~~~~~  522 (588)
                         .+|++|||++......     ....++..|+|||++.+ ..++.++||||||+++|||+ +|+.|+...........
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence               3899999987643221     12356788999998865 56899999999999999995 68888864433332222


Q ss_pred             cCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          523 ADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       523 ~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                      .+....  .+......+..++..|++ +|++|||+++|++.|.
T Consensus       234 ~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         234 YEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHhccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            221111  111112346677889998 7999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-36  Score=309.15  Aligned_cols=240  Identities=21%  Similarity=0.271  Sum_probs=189.7

Q ss_pred             eeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          320 IGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       320 LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      ||+|+||.||+++. .+|+.||+|++...     .....+..|++++++++||||+++.+++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999986 46899999998632     1233556799999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCcc
Q 042871          394 AEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR  472 (588)
Q Consensus       394 ~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~  472 (588)
                      .+++.... ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            99886433 35899999999999999999999998   9999999999999999999999999987654322  223346


Q ss_pred             CCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccCccc---CHHHHHHHHHHHHHhhc
Q 042871          473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLDREY---SIEAFDLTLQLALSCTA  548 (588)
Q Consensus       473 gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~~~~---~~e~~~~v~~L~~~C~~  548 (588)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+.....+....   .......+.+|+..|++
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  235 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA  235 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence            8999999999999889999999999999999999999986432211 1111111111110   01122345667788887


Q ss_pred             -CCCCCCCHHHHHHHHH
Q 042871          549 -LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       549 -~p~~RPs~~evl~~L~  564 (588)
                       +|++||+++|+++.+.
T Consensus       236 ~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         236 KKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cCHhhCCCCccchhhhh
Confidence             7999999987764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.3e-36  Score=312.05  Aligned_cols=245  Identities=23%  Similarity=0.324  Sum_probs=192.3

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|...+.||+|+||.||+|+.. +++.||+|++...   .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999864 6789999998632   2345678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++ ++|.+++......+++.+...++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++....... .
T Consensus        86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  160 (309)
T cd07872          86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T  160 (309)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence            96 4888888666666889999999999999999999998   99999999999999999999999999876433221 2


Q ss_pred             ccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----------------------C
Q 042871          468 SSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----------------------D  524 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----------------------d  524 (588)
                      .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+                      +
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            223467899999998765 46889999999999999999999988533221111100                      0


Q ss_pred             cccCcc-------cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 PKLDRE-------YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ~~l~~~-------~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ......       ...........++..|++ +|.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000       000112234566778887 7999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.3e-36  Score=302.29  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=202.1

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec--cCeeeEEe
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR--VDECFLIY  385 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~  385 (588)
                      +|+..+.||+|+||.||++.. .+|+.||+|++...    ...+.+.+|++++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477888999999999999985 57889999988632    234568899999999999999999998764  45679999


Q ss_pred             ecCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhcccc--CCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          386 ELCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYS--EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       386 E~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      ||+++++|.+++...   ...+++.+.+.++.+++.||.|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999542   456899999999999999999999332  223999999999999999999999999999876


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ...... .....+++.|++||++.+..++.++|+||||+++|+|++|+.||.........+.+........+......+.
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence            543321 2334689999999999998899999999999999999999999876554444444433333334444456677


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .++..|++ +|++||++++|++.
T Consensus       240 ~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         240 EVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHHHccCCcccCCCHHHHhhC
Confidence            78889998 79999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.2e-37  Score=323.51  Aligned_cols=243  Identities=23%  Similarity=0.290  Sum_probs=192.5

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+++.. +++.||+|++..     ......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999864 689999999863     223456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            999999999999643 45889999999999999999999998   99999999999999999999999999875432110


Q ss_pred             ----------------------------------ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          466 ----------------------------------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       466 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                                                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                              0012346999999999999999999999999999999999999998


Q ss_pred             ccccccchhhhc-C--cc--cCc--ccCHHHHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 042871          512 VLTRAGSALELA-D--PK--LDR--EYSIEAFDLTLQLALSCTALTHQRPP---MEQVFVT  562 (588)
Q Consensus       512 ~~~~~~~~~~~~-d--~~--l~~--~~~~e~~~~v~~L~~~C~~~p~~RPs---~~evl~~  562 (588)
                      ...........+ .  ..  +..  ..+.+..+++.+    ++.+|.+|++   +.|+++.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~----l~~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILR----FCTDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHH----hccChhhcCCCCCHHHHhcC
Confidence            654433222211 1  11  111  234555555433    3357888875   5666544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-36  Score=317.15  Aligned_cols=231  Identities=25%  Similarity=0.308  Sum_probs=184.1

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHH-HhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVA-SSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+|+. .+|+.||+|++...     .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3699999999999997 47899999998632     22344555554 56789999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++.. ...+++.....++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++..... ......
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST  155 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence            999999864 346888999999999999999999998   999999999999999999999999998754222 122344


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--cccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--PKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+ .  ..+....+.+    +..++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----~~~li~~~l  231 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVS----ARHLLEGLL  231 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHHh
Confidence            57899999999999999999999999999999999999998654333222211 1  1222334444    445566677


Q ss_pred             c-CCCCCCCHH
Q 042871          548 A-LTHQRPPME  557 (588)
Q Consensus       548 ~-~p~~RPs~~  557 (588)
                      + +|.+||+++
T Consensus       232 ~~~p~~R~~~~  242 (323)
T cd05575         232 QKDRTKRLGAK  242 (323)
T ss_pred             hcCHHhCCCCC
Confidence            6 789999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.4e-36  Score=309.50  Aligned_cols=245  Identities=25%  Similarity=0.388  Sum_probs=200.0

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .+|+..+.||+|+||.||+|+. .+++.||+|.+...  ...+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788888999999999999985 57899999988643  34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++++|.+++..  ..+++.++..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........ ..
T Consensus       100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~  173 (296)
T cd06654         100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (296)
T ss_pred             CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence            99999999843  45889999999999999999999998   99999999999999999999999999876543221 12


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh--cCcccCcccCHHHHHHHHHHHHHh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL--ADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~--~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||...........  .........+.+....+..++.+|
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence            334688999999999888899999999999999999999999864433211111  111111112233445567788889


Q ss_pred             hc-CCCCCCCHHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~  562 (588)
                      +. +|++|||++++++.
T Consensus       254 l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         254 LDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CcCCcccCcCHHHHhhC
Confidence            88 79999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.7e-36  Score=301.86  Aligned_cols=245  Identities=24%  Similarity=0.283  Sum_probs=198.8

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|+||.||+++. .+|+.||+|++..    .....++.+|+.++++++||||+++.+++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999986 4789999999863    22345789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++.... ..+++.+.+.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999986533 35789999999999999999999988   99999999999999999999999999976543221 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      ......|++.|+|||+..+..++.++|+||||++++||++|+.|+...........+-.......+.+....+..++..|
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL  236 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence            22334578899999999988899999999999999999999998864332222211111111112223344567778888


Q ss_pred             hc-CCCCCCCHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFV  561 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~  561 (588)
                      ++ +|.+||++.+|++
T Consensus       237 l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         237 FKRNPRDRPSVNSILE  252 (256)
T ss_pred             hhCChhhCcCHHHHhh
Confidence            87 6999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.3e-36  Score=311.37  Aligned_cols=245  Identities=23%  Similarity=0.272  Sum_probs=197.4

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||+|+||.||+++. .++..+|+|.+..+.   ....+.+|++++.+++||||+++++++.+++..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4688999999999999999986 468889999886432   235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++... ..+++.....++.|+++||.|||+ .+   ++||||||+|||+++++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999644 458889999999999999999997 46   999999999999999999999999998765322   


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC------------------
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD------------------  528 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~------------------  528 (588)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.................                  
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            12335688999999999888899999999999999999999998753322222111111000                  


Q ss_pred             ------------------cccC-HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHH
Q 042871          529 ------------------REYS-IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       529 ------------------~~~~-~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L  563 (588)
                                        ...+ ......+.+++.+|+. +|++|||++||++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                              0000 0122346778899998 799999999998874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.9e-36  Score=307.76  Aligned_cols=246  Identities=22%  Similarity=0.280  Sum_probs=195.9

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .|+..+.||+|+||.||+|... ++..+++|.+...  ...+.+.+|+++++.++|||++++++++..++..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3567788999999999999974 5788899988643  335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +++|.+++......+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++....... ....
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~  161 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD  161 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence            99999988765667999999999999999999999998   9999999999999999999999999987643221 2223


Q ss_pred             CccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC--cccCHHHHHHHHHH
Q 042871          470 EVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD--REYSIEAFDLTLQL  542 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~--~~~~~e~~~~v~~L  542 (588)
                      ...++..|+|||++.     +..++.++|||||||++|||++|+.|+.................  ...+......+.++
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF  241 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence            456899999999873     44577899999999999999999999864332221111110000  01111223456677


Q ss_pred             HHHhhc-CCCCCCCHHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +..|++ +|.+||++.++++.
T Consensus       242 i~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         242 LKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             HHHHccCChhhCcCHHHHhcC
Confidence            889998 79999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5e-36  Score=302.80  Aligned_cols=244  Identities=25%  Similarity=0.361  Sum_probs=195.7

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-----------cHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-----------NVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      |...+.||+|+||.||+|.. .+++.||+|.+....           ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            56677999999999999986 468899999886321           124578899999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            9999999999999999543 45889999999999999999999988   9999999999999999999999999988764


Q ss_pred             CCCcc-----cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHH
Q 042871          462 IGETY-----ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAF  536 (588)
Q Consensus       462 ~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~  536 (588)
                      .....     ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+........+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS  237 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccC
Confidence            22111     1123457889999999998889999999999999999999999986433322111111111122223334


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +.+..++..|++ +|.+||++.|+++
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         238 SEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhh
Confidence            556667888888 7999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=319.07  Aligned_cols=238  Identities=25%  Similarity=0.305  Sum_probs=190.7

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ..++|+.+..||+|+||.||.++- ++|..+|+|+++.     ...++....|-.+|....+|+||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            357899999999999999999984 5899999999974     2456678889999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC-
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-  462 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~-  462 (588)
                      ||||++||++..+|... ..|++.....++.+++.|++-||+.+   ++||||||+|+|||..|.+||+||||+.-+.. 
T Consensus       219 iMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999999999544 46888888889999999999999999   99999999999999999999999999843211 


Q ss_pred             ---------------------CCcc-----c-------------------ccCccCCCCccCcccccCCCCCchhhHHHH
Q 042871          463 ---------------------GETY-----A-------------------SSEVRGTFGYLDPEYRSNCKVNSSGDVYSF  497 (588)
Q Consensus       463 ---------------------~~~~-----~-------------------~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~  497 (588)
                                           ....     .                   ....+|||.|||||++.+..|+..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0000     0                   012469999999999999999999999999


Q ss_pred             HHHHHHHHcCCCccccccccchhhhc---Cccc----CcccCHHHHHHHHHHHHHhhcCCCCCCC
Q 042871          498 GIVLLQILSGKKAKVLTRAGSALELA---DPKL----DREYSIEAFDLTLQLALSCTALTHQRPP  555 (588)
Q Consensus       498 Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l----~~~~~~e~~~~v~~L~~~C~~~p~~RPs  555 (588)
                      |||+|||+.|-+||.-.......+.+   +..+    ....+.|..+++.+|    +-+|.+|--
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rl----l~d~~~RLG  435 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRL----LCDPENRLG  435 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHH----hcCHHHhcC
Confidence            99999999999999754443332221   1111    122345555555433    337777655

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.4e-36  Score=302.51  Aligned_cols=241  Identities=25%  Similarity=0.389  Sum_probs=195.5

Q ss_pred             CccccceeeccCceEEEEEEecCCcEEEEEEecCCC--------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG--------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      +|...+.||+|+||.||+|...+|+.+|||.+....        ....+.+|++.+++++|+||+++.+++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            366778999999999999998889999999886321        234588899999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +||+++++|.+++... ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            9999999999999543 35789999999999999999999988   9999999999999999999999999987643211


Q ss_pred             -----cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh------cCcccCcccCH
Q 042871          465 -----TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL------ADPKLDREYSI  533 (588)
Q Consensus       465 -----~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~------~d~~l~~~~~~  533 (588)
                           ........|+..|+|||++.+..++.++||||||+++|||++|+.||...+.......      ..+.+...++ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS-  235 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC-
Confidence                 1112335688999999999998899999999999999999999999864332211111      1122222233 


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          534 EAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         ..+..++.+|+. +|.+||++.|++.
T Consensus       236 ---~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         236 ---AAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               445666788887 7999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.9e-36  Score=306.73  Aligned_cols=247  Identities=24%  Similarity=0.332  Sum_probs=196.1

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|++.+.||+|+||.||+|+.. +++.|++|.+....  ..+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            356888899999999999999974 58999999986542  356788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|..++......+++.+++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++...... ...
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~  166 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR  166 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence            9999999988766667999999999999999999999988   999999999999999999999999998754322 122


Q ss_pred             ccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCcccCc-ccCHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPKLDR-EYSIEAFDLTL  540 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~l~~-~~~~e~~~~v~  540 (588)
                      .....+++.|+|||++.     ...++.++||||||+++|||++|+.|+.......... ........ ..+......+.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            23446788999999874     3457889999999999999999999986433222111 11111000 01112223355


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .++..|+. +|++||+++|+++
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhc
Confidence            56788887 7999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.9e-36  Score=308.26  Aligned_cols=243  Identities=23%  Similarity=0.263  Sum_probs=195.7

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      |+..+.||+|+||.||++.. .+++.||||.+...     ...+.+.+|+.++++++|+|++++.+.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778999999999999986 47899999988632     1234577899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++.... ..+++.++..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.....+.. 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999999985433 35899999999999999999999988   99999999999999999999999999876543322 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc----hhhhcCcccCcccCHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS----ALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~----~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                       .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......    .....+ ......+......+.++
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSL  235 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHH
Confidence             123468999999999999999999999999999999999999997433211    111111 11111222223345667


Q ss_pred             HHHhhc-CCCCCCC-----HHHHHHH
Q 042871          543 ALSCTA-LTHQRPP-----MEQVFVT  562 (588)
Q Consensus       543 ~~~C~~-~p~~RPs-----~~evl~~  562 (588)
                      +..|++ +|.+|||     ++|+++.
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcC
Confidence            788888 7999999     8888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.1e-36  Score=314.88  Aligned_cols=235  Identities=22%  Similarity=0.299  Sum_probs=189.0

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEe
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      +|+..+.||+|+||.||+++. .+|+.||+|++...     ...+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467788999999999999986 47899999998642     33456788888888876 577888999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.+++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            999999999998543 45899999999999999999999998   9999999999999999999999999987543221 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--cccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--PKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--~~l~~~~~~e~~~~v~~L  542 (588)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+ .  ..+....+.    .+..+
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~----~~~~l  231 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSK----EAVSI  231 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH----HHHHH
Confidence            2233456899999999999989999999999999999999999998754433322222 1  112223333    34556


Q ss_pred             HHHhhc-CCCCCCCH
Q 042871          543 ALSCTA-LTHQRPPM  556 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~  556 (588)
                      +..|++ +|.+|++.
T Consensus       232 i~~~l~~~p~~R~~~  246 (323)
T cd05615         232 CKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHcccCHhhCCCC
Confidence            677777 79999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-36  Score=317.40  Aligned_cols=234  Identities=24%  Similarity=0.274  Sum_probs=184.1

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHH-HhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVA-SSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++. .+|+.||+|++...     .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3799999999999997 47889999998642     22344555554 57889999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++.. ...+++.+...++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++..... ......
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST  155 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccc
Confidence            999988854 345788888899999999999999998   999999999999999999999999998753221 122344


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-C
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-L  549 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~  549 (588)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.+.... ...+......+..++..|++ +
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~  234 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKD  234 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCC
Confidence            578999999999999899999999999999999999999986544333222221110 11122223345566777887 6


Q ss_pred             CCCCCCHH
Q 042871          550 THQRPPME  557 (588)
Q Consensus       550 p~~RPs~~  557 (588)
                      |.+||+..
T Consensus       235 p~~R~~~~  242 (321)
T cd05603         235 QRRRLGAK  242 (321)
T ss_pred             HhhcCCCC
Confidence            89998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-36  Score=300.02  Aligned_cols=243  Identities=26%  Similarity=0.341  Sum_probs=196.2

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      +|...+.||+|+||.||+|... +++.|++|.+....       ..+.+.+|+.+++.++|+||+++++++.++...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3566789999999999999975 78999999885322       346788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +||+++++|.+++... ..+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            9999999999999543 35889999999999999999999998   9999999999999999999999999987654332


Q ss_pred             cccccCccCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc-ccCcccCHHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP-KLDREYSIEAFDLTLQL  542 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~-~l~~~~~~e~~~~v~~L  542 (588)
                        ......|+..|++||.+.... ++.++|+||||+++|||++|+.||.............. ......+......+..+
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF  234 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHH
Confidence              223456889999999987766 89999999999999999999999864432221111111 11111222233455667


Q ss_pred             HHHhhc-CCCCCCCHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~  561 (588)
                      +.+|++ +|.+||++.+++.
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhc
Confidence            788887 7999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.1e-36  Score=301.47  Aligned_cols=246  Identities=23%  Similarity=0.283  Sum_probs=192.6

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-------CcHHHHHHHHHHhccCCCCceeEEecceec--cCee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-------GNVETFVREVASSSHVRHPNLVALLGYCLR--VDEC  381 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~  381 (588)
                      .+|...+.||+|+||.||++.. .++..|++|++...       ...+.+.+|+.++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788899999999999999986 46899999987532       123568889999999999999999998875  3568


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++++||+++++|.+++... ..+++...+.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            8999999999999999643 35889999999999999999999988   9999999999999999999999999987653


Q ss_pred             CCCc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccCcccCHHHHHH
Q 042871          462 IGET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLDREYSIEAFDL  538 (588)
Q Consensus       462 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~~~~~~e~~~~  538 (588)
                      ....  .......++..|+|||++.+..++.++||||||+++|||++|+.||....... .............+......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence            2211  11123457899999999998889999999999999999999999986432211 11111111112223333344


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHHH
Q 042871          539 TLQLALSCTALTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~~p~~RPs~~evl~  561 (588)
                      +..++.+|..+|++||+++||++
T Consensus       238 ~~~li~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         238 ARDFLGCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhc
Confidence            55555444458999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-36  Score=318.17  Aligned_cols=236  Identities=25%  Similarity=0.303  Sum_probs=185.1

Q ss_pred             ceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHH-HhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVA-SSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++.. +++.||+|++...     .....+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999864 6788999998642     22234444544 56789999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... ..+.+.+...++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++..... ......
T Consensus        81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~  155 (325)
T cd05602          81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST  155 (325)
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccc
Confidence            9999999643 45777888889999999999999998   999999999999999999999999998754221 122344


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Cc--ccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DP--KLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~--~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+ ..  .+....+.    .+.+++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----~~~~li~~~l  231 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITN----SARHLLEGLL  231 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCH----HHHHHHHHHc
Confidence            57999999999999999999999999999999999999998644433322222 11  11223333    3455566777


Q ss_pred             c-CCCCCCCHHHHHHH
Q 042871          548 A-LTHQRPPMEQVFVT  562 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~  562 (588)
                      + +|.+||++.+.+..
T Consensus       232 ~~~p~~R~~~~~~~~~  247 (325)
T cd05602         232 QKDRTKRLGAKDDFME  247 (325)
T ss_pred             ccCHHHCCCCCCCHHH
Confidence            7 78999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4e-36  Score=304.88  Aligned_cols=239  Identities=21%  Similarity=0.388  Sum_probs=183.8

Q ss_pred             eeeccCceEEEEEEecCC---cEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCC
Q 042871          319 LIGEGITGKVYKGKLSNN---QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs  392 (588)
                      .||+|+||.||+|+..++   ..+++|.+...   ...+.|.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999975433   34667766543   234679999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCC---cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-cccc
Q 042871          393 LAEWLFGKD---KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-TYAS  468 (588)
Q Consensus       393 L~~~L~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-~~~~  468 (588)
                      |.+++....   ...++...+.++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999996532   34667778899999999999999988   9999999999999999999999999986432111 1122


Q ss_pred             cCccCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHcC-CCccccccccchh---------hhcCcccCccc
Q 042871          469 SEVRGTFGYLDPEYRSN-------CKVNSSGDVYSFGIVLLQILSG-KKAKVLTRAGSAL---------ELADPKLDREY  531 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~-------~~~t~ksDVwS~Gvll~ElltG-~~p~~~~~~~~~~---------~~~d~~l~~~~  531 (588)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ +.|+......+..         ...++.+...+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            34567889999998743       3457899999999999999974 5566432222111         11222222223


Q ss_pred             CHHHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 042871          532 SIEAFDLTLQLALSCTALTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~~p~~RPs~~evl~~L~  564 (588)
                      +    +.+.+++..|+.+|++||+++||++.|.
T Consensus       239 ~----~~~~~l~~~c~~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         239 S----ERWYEVLQFCWLSPEKRATAEEVHRLLT  267 (268)
T ss_pred             c----HHHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence            3    3455567788888999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-35  Score=300.58  Aligned_cols=246  Identities=22%  Similarity=0.266  Sum_probs=193.9

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-------CcHHHHHHHHHHhccCCCCceeEEecceecc--Cee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-------GNVETFVREVASSSHVRHPNLVALLGYCLRV--DEC  381 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~  381 (588)
                      ++|...+.||+|+||.||+|+. ++|+.||||.+...       ...+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5788899999999999999986 46899999987521       1245788899999999999999999988763  467


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++++|.+++... ..+++.....++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            8999999999999998643 34788889999999999999999998   9999999999999999999999999987653


Q ss_pred             CCCc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccCcccCHHHHHH
Q 042871          462 IGET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLDREYSIEAFDL  538 (588)
Q Consensus       462 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~~~~~~e~~~~  538 (588)
                      ....  .......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ..+..........+......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH  237 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence            2111  11233468899999999988889999999999999999999999986432221 11111111112223333344


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHHH
Q 042871          539 TLQLALSCTALTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~~p~~RPs~~evl~  561 (588)
                      +..++..|+.+|.+||+++|+++
T Consensus       238 ~~~~i~~~l~~p~~Rp~~~~il~  260 (265)
T cd06652         238 CRDFLKRIFVEAKLRPSADELLR  260 (265)
T ss_pred             HHHHHHHHhcChhhCCCHHHHhc
Confidence            55556667778999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-36  Score=299.44  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=200.9

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|+..+.||+|+||.||++.. .+++.+++|.+...  ...+.+.+|++++++++||||+++++++.+++..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            46788899999999999999986 46789999998643  3457889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++......+++.+...++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... ..
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  157 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK  157 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence            9999999998765567899999999999999999999998   9999999999999999999999999987654321 12


Q ss_pred             ccCccCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-cccCc---ccCHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNC---KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-PKLDR---EYSIEAFDLTL  540 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~---~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-~~l~~---~~~~e~~~~v~  540 (588)
                      .....++..|+|||.+...   .++.++||||||+++|||++|+.|+...........+. ..+..   .........+.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            2335678899999998776   88999999999999999999999986433222111111 10110   11122334567


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +++.+|+. +|.+|||+.+|+.
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhc
Confidence            78899998 7999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.9e-36  Score=306.21  Aligned_cols=257  Identities=23%  Similarity=0.281  Sum_probs=200.2

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-cHHHHHHHHHHhccC-CCCceeEEeccee--
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-NVETFVREVASSSHV-RHPNLVALLGYCL--  376 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~--  376 (588)
                      +.++.+..+.++|+..+.||+|+||.||+++. .+++.+|+|.+.... ....+.+|+.+++.+ +||||+++++++.  
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            44566667889999999999999999999986 468899999886533 345688899999999 6999999999874  


Q ss_pred             ---ccCeeeEEeecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEE
Q 042871          377 ---RVDECFLIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK  450 (588)
Q Consensus       377 ---~~~~~~LV~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~k  450 (588)
                         .++..++||||+++++|.+++..   ....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence               34568999999999999998753   2346888999999999999999999988   99999999999999999999


Q ss_pred             EEecCCcceecCCCcccccCccCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc
Q 042871          451 LSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN-----CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP  525 (588)
Q Consensus       451 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~  525 (588)
                      |+|||+++...... .......|++.|+|||++..     ..++.++||||||+++|||++|+.|+..............
T Consensus       165 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~  243 (286)
T cd06638         165 LVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR  243 (286)
T ss_pred             EccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence            99999988664322 12233468999999998753     4578899999999999999999999764332111111111


Q ss_pred             ccCcc--cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          526 KLDRE--YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       526 ~l~~~--~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .....  .+......+..++..|++ +|++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11000  011112346677888997 79999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.4e-36  Score=307.57  Aligned_cols=245  Identities=25%  Similarity=0.378  Sum_probs=200.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|...+.||+|+||.||+++. .+++.||+|.+...  ...+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            46788889999999999999985 57999999998642  3346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++..  ..+++.++..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........ .
T Consensus        98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~  171 (297)
T cd06656          98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (297)
T ss_pred             cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence            999999999843  45889999999999999999999988   99999999999999999999999999876543322 2


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC--cccCcccCHHHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--PKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d--~~l~~~~~~e~~~~v~~L~~~  545 (588)
                      .....+++.|+|||+..+..++.++|+||||+++|||++|+.||.............  .......+......+..++..
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence            233468889999999999889999999999999999999999986433221111111  000111222334556777889


Q ss_pred             hhc-CCCCCCCHHHHHH
Q 042871          546 CTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~  561 (588)
                      |+. +|++||+++++++
T Consensus       252 ~l~~~p~~Rps~~~il~  268 (297)
T cd06656         252 CLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HccCChhhCcCHHHHhc
Confidence            998 7999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=332.27  Aligned_cols=258  Identities=21%  Similarity=0.271  Sum_probs=206.8

Q ss_pred             HHhcCccccceeeccCceEEEEEEecCC-cEEEEEEec--CCCcHHHHHHHHHHhccCC-CCceeEEecce-ec------
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIKHIT--NEGNVETFVREVASSSHVR-HPNLVALLGYC-LR------  377 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~~g-~~VAVK~l~--~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~-~~------  377 (588)
                      ....+..+.+.|.+|||+.||.+.+..+ ..+|+|++.  ++...+...+||++|++|+ |+|||.++|.. ..      
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3456777889999999999999998665 999999985  3455678899999999998 99999999942 21      


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      .-+++|.||||++|+|-|++..+. ..|++.++++|+.|+++|+++||... +||||||||-+||||+.+++.||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence            246899999999999999996432 34999999999999999999999985 6699999999999999999999999999


Q ss_pred             cceecCCCcccc--------cCccCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc
Q 042871          457 SKVIDIGETYAS--------SEVRGTFGYLDPEYR---SNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP  525 (588)
Q Consensus       457 a~~~~~~~~~~~--------~~~~gt~~Y~aPE~~---~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~  525 (588)
                      +...........        -...-|+.|+|||++   .+..+++|+|||+|||+||-|+-...||....   ...+++.
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---~laIlng  269 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---KLAILNG  269 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---ceeEEec
Confidence            864322221100        012358999999975   56789999999999999999999999997431   2333333


Q ss_pred             ccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          526 KLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       526 ~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .+.-.-.....+.+..|+..|++ +|.+||++-||+..+.++...+
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            33322234566778888899998 7999999999999999988654

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9e-36  Score=304.06  Aligned_cols=240  Identities=22%  Similarity=0.320  Sum_probs=191.9

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||+|+||.||+|+. .+++.||+|.+...   ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3677888999999999999985 57899999998643   2245788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|..+.     .+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++......   .
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~  149 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I  149 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence            9999997653     3678888899999999999999998   999999999999999999999999999765422   2


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-------hhhh-cCcccCcccCHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-------ALEL-ADPKLDREYSIEAFDLT  539 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-------~~~~-~d~~l~~~~~~e~~~~v  539 (588)
                      .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......       .... .++.............+
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            233578999999999999899999999999999999999999986422211       0111 11110000011112335


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..++..|++ +|++||+++|+++.
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcC
Confidence            566778887 79999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.7e-36  Score=315.80  Aligned_cols=195  Identities=24%  Similarity=0.332  Sum_probs=166.8

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC-----
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD-----  379 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----  379 (588)
                      ..++|...+.||+|+||.||+++. .+|+.||||++...    .....+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999986 46899999998642    33457889999999999999999999886543     


Q ss_pred             -eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          380 -ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       380 -~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                       ..++||||++ ++|.+.+..   .+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             4799999996 466666632   3788888999999999999999998   9999999999999999999999999997


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            64322  222345789999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=306.23  Aligned_cols=248  Identities=24%  Similarity=0.324  Sum_probs=198.5

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+...  ...+.|.+|++++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467888999999999999999974 6899999998643  2456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++......+++.+...++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K  159 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence            9999999999766667999999999999999999999998   99999999999999999999999999876432221 2


Q ss_pred             ccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcc--cCHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDRE--YSIEAFDLTL  540 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~--~~~e~~~~v~  540 (588)
                      .....+++.|++||++.     ...++.++||||||+++|||++|+.|+...........+.......  .+......+.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN  239 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence            23346889999999874     3456789999999999999999999986543322211111111000  1111223455


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .++..|++ +|.+||+++++++.
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         240 DFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHHHhccChhhCcCHHHHhcC
Confidence            66778887 79999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-36  Score=306.51  Aligned_cols=237  Identities=24%  Similarity=0.363  Sum_probs=186.8

Q ss_pred             ceeeccCceEEEEEEecC--------CcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          318 NLIGEGITGKVYKGKLSN--------NQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +.||+|+||.||+|....        ...|++|.+...  ...+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998532        234888887543  2346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc--------EEEEecCCcce
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE--------AKLSDFGLSKV  459 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~--------~kL~DFGla~~  459 (588)
                      +++|+|.+++......+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999766667899999999999999999999998   999999999999987765        69999998865


Q ss_pred             ecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCC-CccccccccchhhhcCcccCcccCHHHHH
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK-KAKVLTRAGSALELADPKLDREYSIEAFD  537 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~-~p~~~~~~~~~~~~~d~~l~~~~~~e~~~  537 (588)
                      ...     .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...............  ...+.....
T Consensus       158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  230 (258)
T cd05078         158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR--HQLPAPKWT  230 (258)
T ss_pred             cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc--ccCCCCCcH
Confidence            432     123457889999999876 45789999999999999999995 454432222222221111  111111224


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                      .+..++..|++ +|++|||++++++.|+
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            46677888998 7999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.5e-36  Score=315.04  Aligned_cols=230  Identities=23%  Similarity=0.292  Sum_probs=184.4

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++. .+++.||+|++...     ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3799999999999986 46789999999742     2345678899998888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++... +.+++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++..... ......
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (327)
T cd05617          81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST  155 (327)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence            9999988543 46899999999999999999999998   999999999999999999999999998753221 122234


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-------hhhh-cC--cccCcccCHHHHHHHH
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-------ALEL-AD--PKLDREYSIEAFDLTL  540 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-------~~~~-~d--~~l~~~~~~e~~~~v~  540 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.......       .... ..  ..++...+.+    +.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~----~~  231 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK----AS  231 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHH----HH
Confidence            578999999999999999999999999999999999999995322111       1111 11  1122223333    44


Q ss_pred             HHHHHhhc-CCCCCCCH
Q 042871          541 QLALSCTA-LTHQRPPM  556 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~  556 (588)
                      .++..|++ +|.+||++
T Consensus       232 ~li~~~L~~dP~~R~~~  248 (327)
T cd05617         232 HVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHHhccCHHHcCCC
Confidence            55677777 79999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.8e-36  Score=305.98  Aligned_cols=256  Identities=23%  Similarity=0.295  Sum_probs=200.8

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-cHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-NVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      ++..++..++++|...+.||+|+||.||++.. .+++.+|+|++.... ....+.+|+.++.++ +|||++++++++...
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            44556667789999999999999999999986 578899999987533 345678899999988 799999999998753


Q ss_pred             -----CeeeEEeecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEE
Q 042871          379 -----DECFLIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK  450 (588)
Q Consensus       379 -----~~~~LV~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~k  450 (588)
                           +..++|+||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence                 358999999999999998853   3356899999999999999999999988   99999999999999999999


Q ss_pred             EEecCCcceecCCCcccccCccCCCCccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc
Q 042871          451 LSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC-----KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP  525 (588)
Q Consensus       451 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~  525 (588)
                      |+|||+++....... ......|+..|+|||++...     .++.++||||||+++|||++|+.|+...........+..
T Consensus       169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~  247 (291)
T cd06639         169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR  247 (291)
T ss_pred             Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence            999999876543221 22334688999999987543     368899999999999999999999864332221111111


Q ss_pred             ccCcc--cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 KLDRE--YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 ~l~~~--~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .....  .+.+....+..++..|++ +|++||++.|+++
T Consensus       248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111  112233456777888988 7999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.1e-36  Score=302.26  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=195.9

Q ss_pred             ccccceeeccCceEEEEEEec----CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC------
Q 042871          314 LNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD------  379 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------  379 (588)
                      |.+.+.||+|+||.||+|.+.    +++.||||++..+    ...+.+.+|+.++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456778999999999999853    4689999998643    23457889999999999999999999886532      


Q ss_pred             eeeEEeecCCCCChhhhhhcC-----CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                      ..++++||+++|+|.+++...     ...+++...++++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            247899999999999887432     125788999999999999999999988   999999999999999999999999


Q ss_pred             CCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccC
Q 042871          455 GLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYS  532 (588)
Q Consensus       455 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~  532 (588)
                      |+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+......+....+........+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            999866433322 1223345678999999998889999999999999999999 78887543333322222111111112


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ......+.+++.+|++ +|++|||+.|+++.|+++
T Consensus       238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2334567778899998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-36  Score=305.55  Aligned_cols=247  Identities=25%  Similarity=0.320  Sum_probs=199.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||+||+++. ++|+.||+|.+...   ...+.+.+|+++++.++||||+++++++...+.+++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            35678888999999999999986 46899999987642   234678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++++|.+++.. .+.+++.....++.+++.+|.|||+ .+   ++||||||+||++++++.++|+|||++....... 
T Consensus        84 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          84 FMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             cCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            9999999998854 3468999999999999999999997 46   9999999999999999999999999986542221 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc--------chhhhcCcccC---ccc-CH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG--------SALELADPKLD---REY-SI  533 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~--------~~~~~~d~~l~---~~~-~~  533 (588)
                        .....|+..|+|||++.+..++.++||||||+++|||++|+.||......        ...+.+.....   ... ..
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS  236 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence              22356899999999998889999999999999999999999998743321        01111111110   111 12


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          534 EAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                      +....+..++..|++ +|++|||+.|++++..
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            234456778889998 7999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-35  Score=306.92  Aligned_cols=244  Identities=25%  Similarity=0.394  Sum_probs=199.2

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .+|+..+.||.|+||.||+|+. .+|+.|++|.+...  ...+.+.+|++.++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688889999999999999985 57899999988642  34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++++|.+++..  ..+++.++..++.+++.||+|||+.+   ++||||||+||++++++.+||+|||++........ ..
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  172 (296)
T cd06655          99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR  172 (296)
T ss_pred             CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence            99999999843  45899999999999999999999998   99999999999999999999999999876543322 22


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc--CcccCHHHHHHHHHHHHHh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL--DREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l--~~~~~~e~~~~v~~L~~~C  546 (588)
                      ....++..|+|||.+....++.++|||||||++|||++|+.||...........+....  ....+.+....+..++..|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  252 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC  252 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence            33468889999999998889999999999999999999999986544322221111110  0111222334566678888


Q ss_pred             hc-CCCCCCCHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFV  561 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~  561 (588)
                      +. +|.+||++.+++.
T Consensus       253 l~~dp~~Rpt~~~il~  268 (296)
T cd06655         253 LEMDVEKRGSAKELLQ  268 (296)
T ss_pred             hhcChhhCCCHHHHhh
Confidence            87 7999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.2e-35  Score=293.22  Aligned_cols=244  Identities=30%  Similarity=0.417  Sum_probs=201.3

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      +|+..+.||+|++|.||++... +++.+++|++....  ..+.+.+|++.+++++|+|++++++++..++..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677789999999999999975 78999999997654  56789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +++|.+++......+++..+..++.+++++|.|||..+   ++||||+|+||++++++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            99999999765567999999999999999999999988   99999999999999999999999999887654332  33


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccC--HHHHHHHHHHHHHhh
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYS--IEAFDLTLQLALSCT  547 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~--~e~~~~v~~L~~~C~  547 (588)
                      ...++..|++||++....++.++||||||++++||++|+.|+.....................  ......+.+++..|+
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL  235 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHc
Confidence            456889999999998888999999999999999999999998644222222111111111111  111345677788888


Q ss_pred             c-CCCCCCCHHHHHH
Q 042871          548 A-LTHQRPPMEQVFV  561 (588)
Q Consensus       548 ~-~p~~RPs~~evl~  561 (588)
                      . +|++|||+.|+++
T Consensus       236 ~~~p~~R~t~~~~l~  250 (253)
T cd05122         236 QKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCChhhCCCHHHHhc
Confidence            8 7999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-35  Score=297.79  Aligned_cols=244  Identities=25%  Similarity=0.324  Sum_probs=197.8

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|+||.||++.. .+++.+|||++...    .....+.+|+++++.++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            578889999999999999986 47889999998642    2356789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-CcEEEEecCCcceecCCCc
Q 042871          388 CPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-~~~kL~DFGla~~~~~~~~  465 (588)
                      +++++|.+++.... ..+++..+..++.+++++|.|||+.+   ++||||||+||+++++ +.+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999996543 45899999999999999999999998   9999999999999865 468999999998764332 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~  545 (588)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+........+......+..++..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence             2233567889999999998889999999999999999999999986543322222221111111222233456677888


Q ss_pred             hhc-CCCCCCCHHHHHH
Q 042871          546 CTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~  561 (588)
                      |++ +|.+|||++|++.
T Consensus       236 ~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         236 MLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HccCChhhCCCHHHHhh
Confidence            887 7999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-36  Score=305.41  Aligned_cols=245  Identities=22%  Similarity=0.335  Sum_probs=196.3

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||+|+||.||+++.. +|+.||+|.+...   .....+.+|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999975 7899999988643   2346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC--CcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          388 CPNGNLAEWLFGK--DKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       388 ~~~gsL~~~L~~~--~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +++++|.+++...  ...+++..+..++.+++.||.|||+ .+   |+||||||+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999998653  2368999999999999999999996 46   999999999999999999999999998765322 


Q ss_pred             cccccCccCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNC------KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEA  535 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~------~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~  535 (588)
                        ......+++.|+|||++.+.      .++.++|+||||+++|||++|+.||...........+.   .......+.+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence              12234578899999987543      35889999999999999999999986433322222111   11112223334


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ...+..++..|++ +|++||++++++..
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            4556677888887 79999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=308.02  Aligned_cols=253  Identities=26%  Similarity=0.310  Sum_probs=197.5

Q ss_pred             HHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----------------CcHHHHHHHHHHhccCCCCceeE
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----------------GNVETFVREVASSSHVRHPNLVA  370 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----------------~~~~~~~~Ei~~l~~l~HpnIv~  370 (588)
                      .+.-++|++.+.||+|.||.|-+|+. .+++.||||++...                ...+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34468899999999999999999985 58999999998521                12457899999999999999999


Q ss_pred             Eecceec--cCeeeEEeecCCCCChhhhhhcCCcC-ccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC
Q 042871          371 LLGYCLR--VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       371 l~g~~~~--~~~~~LV~E~~~~gsL~~~L~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~  447 (588)
                      |+.+..+  .+.+|||+|||..|.+...-  ..+. ++..+.++++.++..||+|||.++   |+||||||+|+||+++|
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            9999875  46799999999998887644  3344 999999999999999999999999   99999999999999999


Q ss_pred             cEEEEecCCcceecCCCc----ccccCccCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCccccccccch
Q 042871          448 EAKLSDFGLSKVIDIGET----YASSEVRGTFGYLDPEYRSNCK----VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA  519 (588)
Q Consensus       448 ~~kL~DFGla~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~----~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~  519 (588)
                      .+||+|||.+.....+..    ..-...+|||.|+|||...++.    -+.+.||||+||.||-|+-|+.||.....-.+
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            999999999876633211    1223478999999999876632    24578999999999999999999975444333


Q ss_pred             hhhc-CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          520 LELA-DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       520 ~~~~-d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      .+.+ ...+.-....+..+.+..|++..+. +|++|.+..+|....--
T Consensus       328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            3322 2222111122345555556666665 89999999998766543

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=305.18  Aligned_cols=245  Identities=22%  Similarity=0.339  Sum_probs=209.0

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      -|+++.+||+|+||.|||+.+ ..|+.||||.+.-+.+.+++..|+.+|++.+.|++|+++|.+.....+|+|||||..|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            477888999999999999986 4799999999988888999999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCc
Q 042871          392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV  471 (588)
Q Consensus       392 sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~  471 (588)
                      +..|.+..++++|++.++..++.+.++||+|||...   -+|||||..||||+.+|.+||+|||.|.++.+.. .....+
T Consensus       114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTV  189 (502)
T KOG0574|consen  114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTV  189 (502)
T ss_pred             cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCcc
Confidence            999999988999999999999999999999999988   7999999999999999999999999998765322 223457


Q ss_pred             cCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCccc--CHHHHHHHHHHHHHhhc-
Q 042871          472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY--SIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       472 ~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~--~~e~~~~v~~L~~~C~~-  548 (588)
                      .||+-|||||++..-.|+.++||||||+...||..|++|+.....-+..-++...-+..+  +++--+..-.+++.|+. 
T Consensus       190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK  269 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIK  269 (502)
T ss_pred             ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcC
Confidence            899999999999999999999999999999999999999875544444433322222211  23333444555778877 


Q ss_pred             CCCCCCCHHHHHH
Q 042871          549 LTHQRPPMEQVFV  561 (588)
Q Consensus       549 ~p~~RPs~~evl~  561 (588)
                      .|++|-|+.++++
T Consensus       270 ~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  270 KPEERKTALRLCE  282 (502)
T ss_pred             CHHHHHHHHHHhh
Confidence            6999999988765

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-36  Score=326.45  Aligned_cols=193  Identities=21%  Similarity=0.225  Sum_probs=168.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      ...|.+.+.||+|+||.||+++.. .++.||||...    ...+.+|++++++++|+|||++++++..++..++|||++ 
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-  242 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-  242 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence            457889999999999999999974 57899999643    235678999999999999999999999999999999999 


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-ccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-~~~  468 (588)
                      .++|.+++......++|.+++.|+.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus       243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence            57999988665567999999999999999999999998   99999999999999999999999999987643222 122


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            3457999999999999999999999999999999999987643

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.1e-35  Score=299.58  Aligned_cols=244  Identities=25%  Similarity=0.332  Sum_probs=199.1

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      -|+..+.||+|+||.||+|.. .+++.||||.+...   ...+.+.+|++.+++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            366778999999999999986 47889999987643   23457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++++|.+++.  ...+++.....++.+++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++....... ...
T Consensus        85 ~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  158 (277)
T cd06641          85 GGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR  158 (277)
T ss_pred             CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence            9999999984  345899999999999999999999988   9999999999999999999999999987654322 122


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ....++..|++||++.+..++.++|+||||+++|||++|+.|+...........+...............+..++..|++
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  238 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            33467889999999988889999999999999999999999986544333333322221222222233445667888887


Q ss_pred             -CCCCCCCHHHHHHH
Q 042871          549 -LTHQRPPMEQVFVT  562 (588)
Q Consensus       549 -~p~~RPs~~evl~~  562 (588)
                       +|.+||++.++++.
T Consensus       239 ~~p~~Rp~~~~~l~~  253 (277)
T cd06641         239 KEPSFRPTAKELLKH  253 (277)
T ss_pred             CChhhCcCHHHHHhC
Confidence             79999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.2e-36  Score=312.13  Aligned_cols=232  Identities=25%  Similarity=0.299  Sum_probs=183.3

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHH-HhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVA-SSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+++. .+|+.||+|++...     .....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3699999999999986 47899999998642     23345566655 46789999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++.. ...+++.+...++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++..... ......
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT  155 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence            999998854 346899999999999999999999998   999999999999999999999999998753221 122344


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--cccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--PKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+ .  ..+....+.+..    .++..|+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ll~~ll  231 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW----SILEELL  231 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHH----HHHHHHh
Confidence            57899999999999999999999999999999999999998654333222221 1  112223444444    4455555


Q ss_pred             c-CCCCCCCHHH
Q 042871          548 A-LTHQRPPMEQ  558 (588)
Q Consensus       548 ~-~p~~RPs~~e  558 (588)
                      . +|.+||++++
T Consensus       232 ~~~p~~R~~~~~  243 (325)
T cd05604         232 EKDRQRRLGAKE  243 (325)
T ss_pred             ccCHHhcCCCCC
Confidence            5 6788887753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-35  Score=306.64  Aligned_cols=191  Identities=24%  Similarity=0.372  Sum_probs=160.5

Q ss_pred             ceeeccCceEEEEEEec---CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceec--cCeeeEEeecCCCCC
Q 042871          318 NLIGEGITGKVYKGKLS---NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLR--VDECFLIYELCPNGN  392 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~gs  392 (588)
                      ++||+|+||.||+|+..   +++.||+|.+........+.+|+.++++++||||+++++++..  +...++|+||++ ++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~   85 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HD   85 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CC
Confidence            58999999999999864   5678999999876556678899999999999999999998864  456899999995 58


Q ss_pred             hhhhhhcC--------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE----CCCCcEEEEecCCccee
Q 042871          393 LAEWLFGK--------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       393 L~~~L~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl----d~~~~~kL~DFGla~~~  460 (588)
                      |.+++...        ...+++.....++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++..
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            88877421        125888899999999999999999998   9999999999999    45678999999999876


Q ss_pred             cCCCc--ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          461 DIGET--YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       461 ~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      .....  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence            43221  12234578999999999876 458999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.2e-35  Score=296.72  Aligned_cols=246  Identities=25%  Similarity=0.364  Sum_probs=202.2

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||+|++|.||+++.. +++.|+||++....   ..+.+.+|+..+.+++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888899999999999999975 59999999987543   357899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++... ..+++..++.++.|+++||.|||+ .+   ++||||+|+||++++++.++|+|||++.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999644 568999999999999999999999 88   999999999999999999999999998876433322


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc---hhhhcCcccCcccCHH-HHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS---ALELADPKLDREYSIE-AFDLTLQL  542 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~---~~~~~d~~l~~~~~~e-~~~~v~~L  542 (588)
                       .....++..|+|||.+....++.++|+||||+++|||++|+.|+.......   ....+........+.. ....+.++
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence             223467889999999999899999999999999999999999986543211   1111111111122222 34556667


Q ss_pred             HHHhhc-CCCCCCCHHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +..|+. +|++||++.|+++.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhC
Confidence            788887 69999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-35  Score=297.30  Aligned_cols=247  Identities=27%  Similarity=0.378  Sum_probs=199.4

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||.|+||+||+|.. .++..+++|++...   ...+.+.+|++.++.++|+||+++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4688899999999999999985 47889999998643   2456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          388 CPNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      +++++|.+++....  ..+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999996532  46899999999999999999999988   99999999999999999999999999876654332


Q ss_pred             c---cccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcC---cccCcccC-HHHH
Q 042871          466 Y---ASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELAD---PKLDREYS-IEAF  536 (588)
Q Consensus       466 ~---~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d---~~l~~~~~-~e~~  536 (588)
                      .   ......|+..|++||++... .++.++|+||||+++|||++|+.||......... +...   +.+..... ....
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS  237 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence            2   22344688999999998776 7899999999999999999999998643322111 1111   11111110 1233


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..+..++..|+. +|++||+++|+++
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         238 KSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            456677888888 7999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-35  Score=312.97  Aligned_cols=192  Identities=23%  Similarity=0.309  Sum_probs=167.2

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ...+|...+.||+|+||.||+|+.. +++.||+|.....    ....|+.++++++|+||+++++++...+..++|+||+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            3457999999999999999999974 5788999975433    2356899999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                       .++|.+++......+++.+++.|+.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus       140 -~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~  213 (357)
T PHA03209        140 -SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF  213 (357)
T ss_pred             -CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence             57999998766677999999999999999999999998   999999999999999999999999998753322  122


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      ....||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            3456899999999999999999999999999999999976543

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.7e-35  Score=301.63  Aligned_cols=245  Identities=25%  Similarity=0.340  Sum_probs=193.8

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++...    ...+.+.+|++++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999975 6899999988632    223567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |+++++|..++.. ...+++.+++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            9999888887643 345899999999999999999999988   99999999999999999999999999987644321 


Q ss_pred             cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----------------------
Q 042871          467 ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----------------------  523 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----------------------  523 (588)
                      ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+                      
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            1223457889999999876 55789999999999999999999988633221111000                      


Q ss_pred             ---CcccCcccC-----HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 ---DPKLDREYS-----IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 ---d~~l~~~~~-----~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         .+......+     ......+.+++..|++ +|++||++.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence               000000001     0112446678889998 7999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.7e-36  Score=298.45  Aligned_cols=245  Identities=26%  Similarity=0.354  Sum_probs=196.9

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|+||.||+|... +|..||+|.+...    ...+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999974 6889999998642    3456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcceecCCCc
Q 042871          388 CPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~~  465 (588)
                      +++++|.+++.... ..+++..+..++.|+++||.|||+.+   ++|+||||+||++++++ .+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999996533 35899999999999999999999998   99999999999999885 469999999876643221


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcCcccCcccCHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                       ......|++.|+|||+.....++.++|+||||+++|||++|+.|+......+.. ........ .........+.+++.
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLIS  235 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCCHHHHHHHH
Confidence             223346889999999998888999999999999999999999998643322222 22221111 111122344666778


Q ss_pred             Hhhc-CCCCCCCHHHHHHH
Q 042871          545 SCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~  562 (588)
                      +|+. +|++|||+.|+++.
T Consensus       236 ~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         236 QLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHhccChhhCcCHHHHhhC
Confidence            8887 79999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.4e-35  Score=302.42  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-CcHHHHHHHHHHhccC-CCCceeEEecceec-
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-GNVETFVREVASSSHV-RHPNLVALLGYCLR-  377 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~-  377 (588)
                      .++.++..+.+.|+..+.||+|+||.||+|+. .+++.||+|.+... .....+..|+.+++++ +|+||+++++++.. 
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            35566666788999999999999999999996 57899999988643 3446788899999888 69999999999863 


Q ss_pred             -----cCeeeEEeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEE
Q 042871          378 -----VDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL  451 (588)
Q Consensus       378 -----~~~~~LV~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL  451 (588)
                           ....+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence                 45789999999999999999643 345888889999999999999999998   999999999999999999999


Q ss_pred             EecCCcceecCCCcccccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc
Q 042871          452 SDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK  526 (588)
Q Consensus       452 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~  526 (588)
                      +|||++........ ......|+..|+|||.+.     ...++.++||||||+++|||++|+.||...........+...
T Consensus       163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  241 (282)
T cd06636         163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  241 (282)
T ss_pred             eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC
Confidence            99999876532211 223356889999999875     356788999999999999999999998643322211111111


Q ss_pred             cCccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          527 LDREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       527 l~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..... .......+.+++..|++ +|.+||++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11111 11223456677889998 7999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.7e-35  Score=301.76  Aligned_cols=195  Identities=28%  Similarity=0.428  Sum_probs=167.2

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|++|.||+|+.. +++.||+|++...    ...+.+.+|+.++++++||||+++++++.+++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778889999999999999974 7899999998632    2346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          388 CPNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ++ ++|.+++....  ..+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            96 68988885432  56899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          466 YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                       ......+++.|+|||++.+ ..++.++||||||+++|||++|+.|+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~  203 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH  203 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence             1223356889999998765 457899999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=288.94  Aligned_cols=257  Identities=27%  Similarity=0.331  Sum_probs=205.2

Q ss_pred             HhcCccccceeeccCceEEEEEE-ecCCcEEEEEEec--CCCcHHHHHHHHHHhccCCCCceeEEecceecc-----Cee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLRV-----DEC  381 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~  381 (588)
                      ..++|.+.++||+|||.-||.++ +.++..+|+|++.  ..++.+..++|++..++++|||+++++++...+     .+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35788999999999999999998 6789999999985  345677889999999999999999999998754     358


Q ss_pred             eEEeecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          382 FLIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ||+++|...|+|.+++..   ++..+++.+.+.|+.++++||++||... +++.||||||.|||+.+++.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999999953   3347999999999999999999999986 569999999999999999999999999987


Q ss_pred             eecCCCcc--------cccCccCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCccccc--cccchhhhc-C
Q 042871          459 VIDIGETY--------ASSEVRGTFGYLDPEYR---SNCKVNSSGDVYSFGIVLLQILSGKKAKVLT--RAGSALELA-D  524 (588)
Q Consensus       459 ~~~~~~~~--------~~~~~~gt~~Y~aPE~~---~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~--~~~~~~~~~-d  524 (588)
                      .....-..        ....-..|..|.|||.+   .+...++++|||||||+||+|+-|..||...  .++.+.-.+ .
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n  257 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN  257 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence            65321110        01123468899999975   4567889999999999999999999999743  222222222 2


Q ss_pred             cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          525 PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       525 ~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      +.+.-.-+....+.+.+++.+|++ +|.+||++.+++..++..+
T Consensus       258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            222111111244667788999998 7999999999999998754

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-35  Score=305.63  Aligned_cols=245  Identities=24%  Similarity=0.327  Sum_probs=192.9

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+...   .....+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999864 6889999998632   2345678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++ ++|.+++......+++.....++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++........ .
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~  160 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  160 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence            96 6999998766667899999999999999999999998   99999999999999999999999999876433221 1


Q ss_pred             ccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh----------------cC------
Q 042871          468 SSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL----------------AD------  524 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~----------------~d------  524 (588)
                      .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+....                .+      
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            223456889999998765 4578899999999999999999998864322111000                00      


Q ss_pred             ---cccCc----ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 ---PKLDR----EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ---~~l~~----~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         +....    .........+..|+..|++ +|.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               00000    0001122345667888888 7999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-36  Score=307.14  Aligned_cols=243  Identities=21%  Similarity=0.267  Sum_probs=203.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ..+|++.+.||+|.||.|-++.. ..|+.||||.++.+     ++.-.+.+||++|+.++||||+.++.+|+.++...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            34677778999999999999984 78999999988643     3445678999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||..+|.|+||+.. ...|++.+...++.||..|+.|.|.+.   ++|||||.+|||||.|+++||+||||+..+..+.
T Consensus       132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            999999999999954 456999999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccCccCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc-CcccCHHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVN-SSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL-DREYSIEAFDLTLQL  542 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l-~~~~~~e~~~~v~~L  542 (588)
                        .-+.++|++-|.+||.+.+.+|. +..|-|||||+||-|+.|..||.-.+-..+.+.+...- ++..   ......-|
T Consensus       208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gL  282 (668)
T KOG0611|consen  208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGL  282 (668)
T ss_pred             --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHH
Confidence              23567999999999999998884 68999999999999999999998776666666654322 2221   12222334


Q ss_pred             HHHhhc-CCCCCCCHHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ++|++. +|++|.|+.+|...
T Consensus       283 IRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhh
Confidence            666665 89999999998764

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-35  Score=299.68  Aligned_cols=246  Identities=26%  Similarity=0.368  Sum_probs=194.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|...+.||+|+||.||+|+. .+++.||+|.++..  .....+.+|+.+++.++||||+++++.+..++..++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            45778888999999999999986 47899999998643  2345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++... ..+++.+.+.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...... ...
T Consensus        88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~  162 (267)
T cd06645          88 CGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK  162 (267)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence            9999999998543 46899999999999999999999998   999999999999999999999999998765422 122


Q ss_pred             ccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCccccccccch-hhhcCcccCc-ccC--HHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-LELADPKLDR-EYS--IEAFDLTL  540 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~~~~d~~l~~-~~~--~e~~~~v~  540 (588)
                      .....|+..|+|||++.   ...++.++|||||||++|||++|+.|+........ .......... ...  ......+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            23456899999999874   45688999999999999999999998753322111 1111111100 000  01123456


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +++..|++ +|++||+++++++
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhc
Confidence            67888887 7999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-35  Score=302.31  Aligned_cols=243  Identities=28%  Similarity=0.362  Sum_probs=186.4

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccC---CCCceeEEecceec-----cC
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHV---RHPNLVALLGYCLR-----VD  379 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~-----~~  379 (588)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.+...    .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999864 7899999988632    1234566777766655   79999999998764     34


Q ss_pred             eeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ..++|+||++ ++|.+++.... ..+++.++..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999996 58988886433 35899999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh----hhcC----------
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL----ELAD----------  524 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----~~~d----------  524 (588)
                      ......  ......||..|+|||++.+..++.++|||||||++|||++|+.||......+..    ..+.          
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            654322  223456889999999999889999999999999999999999887532221100    0000          


Q ss_pred             -----cccC-------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 -----PKLD-------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 -----~~l~-------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                           ....       .....+..+.+.+++..|++ +|++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 0000       00111223445677788887 7999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.9e-35  Score=309.06  Aligned_cols=194  Identities=20%  Similarity=0.271  Sum_probs=163.0

Q ss_pred             ccceeecc--CceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          316 ELNLIGEG--ITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       316 ~~~~LG~G--~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++||+|  +||+||+++. .+|+.||+|++....    ..+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35689999  7899999986 588999999987432    2345678999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC-CCcc
Q 042871          389 PNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETY  466 (588)
Q Consensus       389 ~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~-~~~~  466 (588)
                      ++|+|.+++... ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.++++||+....... +...
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999643 345899999999999999999999998   99999999999999999999999986543321 1100


Q ss_pred             -----cccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          467 -----ASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       467 -----~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                           ......++..|+|||++.+  ..++.++||||||+++|||++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence                 1122346778999999876  468999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-35  Score=322.71  Aligned_cols=245  Identities=21%  Similarity=0.299  Sum_probs=186.5

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceecc--------Ce
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV--------DE  380 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--------~~  380 (588)
                      ..++|...+.||+|+||.||+|+. .+++.||||++....  ....+|+.+++.++||||+++++++...        ..
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            346799999999999999999986 478999999886543  2345799999999999999999876432        24


Q ss_pred             eeEEeecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCC
Q 042871          381 CFLIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGL  456 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGl  456 (588)
                      +++||||++ ++|.+++..   ....+++...+.++.|+++||.|||+.+   |+||||||+|||++.++ .+||+|||+
T Consensus       142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence            678999997 577776642   3456899999999999999999999998   99999999999999665 699999999


Q ss_pred             cceecCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccch-hhhc-----------
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-LELA-----------  523 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~~~~-----------  523 (588)
                      ++....+..  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. ...+           
T Consensus       218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            987643322  2335689999999988764 689999999999999999999998853221110 0000           


Q ss_pred             ---Cccc-----C--------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 ---DPKL-----D--------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 ---d~~l-----~--------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                         .+..     .        ..++......+..|+..|+. +|.+|||+.|+++.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence               0000     0        00111112345667888888 79999999999854

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.5e-36  Score=327.25  Aligned_cols=200  Identities=21%  Similarity=0.307  Sum_probs=164.8

Q ss_pred             HHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-CcHHHHHHHHHHhccCC------CCceeEEeccee
Q 042871          305 REVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-GNVETFVREVASSSHVR------HPNLVALLGYCL  376 (588)
Q Consensus       305 ~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~------HpnIv~l~g~~~  376 (588)
                      +++...+++|.+.++||+|+||+||+|+. .+++.||||+++.. .....+..|+.++..++      |.+++++++++.
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34455678999999999999999999986 46889999999653 22344556666666654      456899999887


Q ss_pred             cc-CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCC-------
Q 042871          377 RV-DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNF-------  447 (588)
Q Consensus       377 ~~-~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~-------  447 (588)
                      .+ +..++|||++ +++|.+++... ..+++.++..|+.|++.||.|||+ .+   |+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence            64 5788999988 78899988643 468999999999999999999997 47   99999999999998765       


Q ss_pred             ---------cEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          448 ---------EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       448 ---------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                               .+||+|||++....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                     49999999876422    223456799999999999999999999999999999999999999864

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-35  Score=301.73  Aligned_cols=246  Identities=24%  Similarity=0.327  Sum_probs=196.1

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|+||.||+|+. .+|+.||+|++...    .....+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            477888999999999999996 47899999998643    2346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      + +++|.+++......+++.+++.++.|++++|+|||+.+   ++|+||||+||++++++.++|+|||++..........
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 99999999766677999999999999999999999998   9999999999999999999999999988765433222


Q ss_pred             ccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----C-------c----------
Q 042871          468 SSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----D-------P----------  525 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----d-------~----------  525 (588)
                      .....|+..|+|||++.+. .++.++||||||++++||++|+.++...........+    .       +          
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            3345688999999987654 4689999999999999999997766422211100000    0       0          


Q ss_pred             -ccC-------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          526 -KLD-------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       526 -~l~-------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                       ...       .....+....+..++..|+. +|.+|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             000       00001223566777888888 79999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-35  Score=314.25  Aligned_cols=195  Identities=24%  Similarity=0.337  Sum_probs=167.2

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc------
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV------  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------  378 (588)
                      ..++|...+.||+|+||.||+++. ..++.||||++...    .....+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999986 46889999998642    2345788999999999999999999987643      


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ...++||||++ ++|.+++..   .+++.++..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            35799999995 577777732   4788899999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      .....  .......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            65322  222345689999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=299.95  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=197.1

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCC---CCceeEEecceeccCeeeEEe
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVR---HPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .|+..+.||+|+||.||+|+. .+++.||+|.+...   ...+.+.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 57899999998642   33567889999998886   999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++++|.+++..  ..+++...+.++.|+++||.|||+.+   |+||||+|+||++++++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            99999999999854  36899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCH-HHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI-EAFDLTLQLA  543 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~-e~~~~v~~L~  543 (588)
                       ......|+..|+|||++.. ..++.++||||||+++|||++|+.||...........+.......... .....+..++
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (277)
T cd06917         157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV  235 (277)
T ss_pred             -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHH
Confidence             2233468899999998765 456889999999999999999999986543332222222111111111 1334566778


Q ss_pred             HHhhc-CCCCCCCHHHHHHH
Q 042871          544 LSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..|++ +|++||++.|+++.
T Consensus       236 ~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         236 AACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             HHHcCCCcccCcCHHHHhhC
Confidence            88998 79999999999863

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=304.91  Aligned_cols=247  Identities=26%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+....     ..+.+.+|++.++.++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888899999999999999875 58999999986532     3456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||+++++|.+++... ...+++.....++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998643 346899999999999999999999998   9999999999999999999999999987553221


Q ss_pred             c----------------------------ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc
Q 042871          465 T----------------------------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA  516 (588)
Q Consensus       465 ~----------------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  516 (588)
                      .                            .......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            1                            011234688999999999998999999999999999999999999864433


Q ss_pred             cc-hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCC----HHHHHH
Q 042871          517 GS-ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPP----MEQVFV  561 (588)
Q Consensus       517 ~~-~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs----~~evl~  561 (588)
                      .. ..+..+..............+.+++.+|++ +|++|||    ++|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            22 222222222111111244567777888887 7999999    555555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-35  Score=299.68  Aligned_cols=245  Identities=23%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||+|+||.||++... +++.||+|++...   ...+.+.+|++.+++++||||+++++.+..++..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36778889999999999999975 6899999998753   2345789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++......+++.....++.|++++|.|||+ .+   ++||||||+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            99999999997654678899999999999999999999 77   99999999999999999999999999876532221 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc--cchhhhcCccc---CcccCHH-HHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELADPKL---DREYSIE-AFDLTL  540 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~~~~d~~l---~~~~~~e-~~~~v~  540 (588)
                        ....++..|+|||++.+..++.++||||||+++|||++|+.|+.....  ....+.++...   ....+.+ ....+.
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ  234 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence              125688899999999998999999999999999999999999864321  11112111111   1111121 334566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .++..|+. +|.+|||+.|++..
T Consensus       235 ~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         235 DFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HHHHHHcCCCchhCcCHHHHhhC
Confidence            77888987 79999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-35  Score=314.02  Aligned_cols=194  Identities=25%  Similarity=0.344  Sum_probs=166.5

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc------
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV------  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------  378 (588)
                      ..++|...+.||+|+||.||++.. ..++.||||++...    .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999986 46889999998642    2345778999999999999999999988643      


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ...++||||++ ++|.+.+..   .+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence            35799999995 567776632   4788899999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  219 (355)
T cd07874         168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP  219 (355)
T ss_pred             cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            65322  22234578999999999999999999999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.7e-35  Score=305.44  Aligned_cols=191  Identities=25%  Similarity=0.381  Sum_probs=160.1

Q ss_pred             ceeeccCceEEEEEEec---CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceec--cCeeeEEeecCCCCC
Q 042871          318 NLIGEGITGKVYKGKLS---NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLR--VDECFLIYELCPNGN  392 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~gs  392 (588)
                      .+||+|+||.||+|+..   ++..||+|.+........+.+|++++++++||||+++++++..  +...++|+||++ ++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~   85 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HD   85 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-Cc
Confidence            57999999999999864   4578999999876556678899999999999999999998854  567899999986 57


Q ss_pred             hhhhhhc--------CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE----CCCCcEEEEecCCccee
Q 042871          393 LAEWLFG--------KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       393 L~~~L~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl----d~~~~~kL~DFGla~~~  460 (588)
                      |.+++..        ....+++..+..++.|++.||.|||+.+   |+||||||+|||+    ++++.+||+|||+++..
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            7777632        1225888999999999999999999998   9999999999999    56779999999999876


Q ss_pred             cCCCc--ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          461 DIGET--YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       461 ~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      .....  .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||.
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence            43322  12234568999999999876 458999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=320.24  Aligned_cols=239  Identities=30%  Similarity=0.419  Sum_probs=199.1

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      +-|+.++.||.|+||.||-++. .+.+.||||++.-     ....++++.|+..|.+++|||++.+.|++..+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4577788999999999999985 5789999999862     223568899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||| -||-.|++.-..+++.+..+..|..+.+.||+|||+++   .||||||+.||||++.|.|||+|||.|....+.  
T Consensus       106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--  179 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--  179 (948)
T ss_pred             HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence            999 67888988767778999999999999999999999999   999999999999999999999999999876543  


Q ss_pred             ccccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhc---CcccCcccCHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELA---DPKLDREYSIEAFDL  538 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~---d~~l~~~~~~e~~~~  538 (588)
                         ..++|||.|||||++.   .++|+.|+||||||+...||.-.++|......-. ++.+.   .|.+.   +.+--+.
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq---s~eWS~~  253 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ---SNEWSDY  253 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC---CchhHHH
Confidence               3468999999999864   4789999999999999999999998864333222 22222   23332   3444555


Q ss_pred             HHHHHHHhhcC-CCCCCCHHHHHHH
Q 042871          539 TLQLALSCTAL-THQRPPMEQVFVT  562 (588)
Q Consensus       539 v~~L~~~C~~~-p~~RPs~~evl~~  562 (588)
                      +..++..|++. |.+|||.+++++.
T Consensus       254 F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  254 FRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHHHHHHHHhhCcccCCcHHHHhhc
Confidence            66678899995 7999999887753

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.7e-35  Score=301.16  Aligned_cols=249  Identities=26%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .+++|+..+.||+|++|.||+|..+ +++.|++|++.... ..+.+.+|++.++.++|+|++++++++...+..++|+||
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            4667888889999999999999975 68999999987543 356789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++......+++.++..++.+++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++........ .
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  172 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K  172 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence            9999999999765447999999999999999999999988   99999999999999999999999999865532221 2


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-CcccCcc-cCHHHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPKLDRE-YSIEAFDLTLQLALS  545 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~l~~~-~~~e~~~~v~~L~~~  545 (588)
                      .....++..|++||++.+..++.++||||||+++|||++|+.|+...........+ ....... ........+..++.+
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence            23345788999999998888999999999999999999999998644332222211 1111111 111134567778899


Q ss_pred             hhc-CCCCCCCHHHHHHH
Q 042871          546 CTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~~  562 (588)
                      |++ +|.+||++.++++.
T Consensus       253 ~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         253 CLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HhccChhhCcCHHHHhhC
Confidence            998 69999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-35  Score=303.53  Aligned_cols=245  Identities=28%  Similarity=0.364  Sum_probs=193.7

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..+.||+|+||.||+|... +++.||+|++....    ..+.+.+|+++++.++||||+++++++.+++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999975 68999999875321    24568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |+++++|.++... ...+++.+++.++.|+++||.|||+.+   ++||||+|+||++++++.+||+|||++....... .
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~  155 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E  155 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence            9999999887643 335899999999999999999999988   9999999999999999999999999988754332 2


Q ss_pred             cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccch----h-----------hhcC------
Q 042871          467 ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA----L-----------ELAD------  524 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~----~-----------~~~d------  524 (588)
                      ......++..|+|||+..+ ..++.++||||||+++|||++|+.|+......+.    .           ...+      
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            2233457889999998865 4578899999999999999999988753221100    0           0000      


Q ss_pred             ----cccCccc-----CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 ----PKLDREY-----SIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ----~~l~~~~-----~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                          +......     .......+..++..|+. +|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                0000000     01123457778899998 7999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-35  Score=301.76  Aligned_cols=244  Identities=25%  Similarity=0.320  Sum_probs=190.3

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|+||.||+|+. .+|+.||+|++...    .....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            477788999999999999997 47899999998642    2235678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++ ++|.+++......+++...+.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~  155 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C  155 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence            96 5888888655567999999999999999999999998   99999999999999999999999999986543222 1


Q ss_pred             ccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCcccccccc-chh-------------------hhcCc-
Q 042871          468 SSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SAL-------------------ELADP-  525 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~-------------------~~~d~-  525 (588)
                      .....++..|+|||++.+. .++.++||||||+++|||++|+.|+...... ...                   ...+. 
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            2234578899999988664 4789999999999999999999885321110 000                   00000 


Q ss_pred             ---ccCcc-----cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 ---KLDRE-----YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 ---~l~~~-----~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         .....     ........+.+++..|++ +|.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence               00000     001122345567888888 7999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-35  Score=311.18  Aligned_cols=243  Identities=24%  Similarity=0.319  Sum_probs=190.8

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc-----
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV-----  378 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----  378 (588)
                      ...++|...+.||+|+||.||++.. .+++.||||++...    ...+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3467899999999999999999986 57889999998643    2345678999999999999999999988643     


Q ss_pred             -CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          379 -DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       379 -~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                       ...++++|++ +++|.+++.  ...+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence             3578999998 789988873  345899999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------------
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------------  523 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------------  523 (588)
                      +.....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+             
T Consensus       166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865432    233468999999999876 56899999999999999999999988532211100000             


Q ss_pred             --C--------cccCcccCH--------HHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 --D--------PKLDREYSI--------EAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 --d--------~~l~~~~~~--------e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                        .        ..+. ..+.        .....+..|+..|++ +|.+|||+.|++..
T Consensus       242 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         242 KISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0        0000 0000        011235577888888 79999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.5e-35  Score=294.79  Aligned_cols=245  Identities=26%  Similarity=0.373  Sum_probs=196.3

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|...+.||+|+||.||+|.. .+++.|++|.+....    ..+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            477788999999999999986 478999999986432    456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++... ..+++..+..++.++++||.|||+.+   |+|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999999653 35788999999999999999999998   9999999999999999999999999988765433322


Q ss_pred             cc---CccCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccCcccCH--HHHHH
Q 042871          468 SS---EVRGTFGYLDPEYRSNCK---VNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLDREYSI--EAFDL  538 (588)
Q Consensus       468 ~~---~~~gt~~Y~aPE~~~~~~---~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~~~~~~--e~~~~  538 (588)
                      ..   ...++..|++||++....   ++.++||||||+++||+++|+.||....... ....+........+.  .....
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence            11   356788999999988766   8899999999999999999999986432111 111111111111111  12344


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..++..|++ +|.+|||++|++.
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhc
Confidence            5677889997 7999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-35  Score=306.20  Aligned_cols=243  Identities=23%  Similarity=0.317  Sum_probs=193.2

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      |.....||+|+||.||++.. .++..||||++...  ...+.+.+|+..++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            33345799999999999986 46889999998643  3345788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      ++|.+++..  ..+++.+.+.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........ ....
T Consensus       104 ~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  177 (292)
T cd06658         104 GALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS  177 (292)
T ss_pred             CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence            999998843  45889999999999999999999998   99999999999999999999999999876532221 2233


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCccc--CHHHHHHHHHHHHHhhc
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY--SIEAFDLTLQLALSCTA  548 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~--~~e~~~~v~~L~~~C~~  548 (588)
                      ..|+..|+|||+.....++.++||||||+++|||++|+.||...........+...+....  .......+..++..|+.
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence            4688999999999888899999999999999999999999864332222221111111111  11122345556777777


Q ss_pred             -CCCCCCCHHHHHHH
Q 042871          549 -LTHQRPPMEQVFVT  562 (588)
Q Consensus       549 -~p~~RPs~~evl~~  562 (588)
                       +|.+|||++|+++.
T Consensus       258 ~~P~~Rpt~~~il~~  272 (292)
T cd06658         258 REPSQRATAQELLQH  272 (292)
T ss_pred             CChhHCcCHHHHhhC
Confidence             79999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=314.93  Aligned_cols=233  Identities=22%  Similarity=0.241  Sum_probs=181.9

Q ss_pred             eeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccC---CCCceeEEecceeccCeeeEEeecCCC
Q 042871          320 IGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHV---RHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       320 LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ||+|+||+||+|+. .+|+.||||++...     .....+..|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999986 46899999998632     2233455666666554   699999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++.. ...+++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++...... .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~  155 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT  155 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence            999999854 345899999999999999999999998   9999999999999999999999999987543222 12334


Q ss_pred             ccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCc-ccCHHHHHHHHHHHHH
Q 042871          471 VRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDR-EYSIEAFDLTLQLALS  545 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~-~~~~e~~~~v~~L~~~  545 (588)
                      ..||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.   ..+.. ..+.    .+..++..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~----~~~~li~~  231 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD----EGRQFVKG  231 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH----HHHHHHHH
Confidence            5799999999998764 48999999999999999999999986543333222221   11111 1233    34456677


Q ss_pred             hhc-CCCCCC----CHHHHHH
Q 042871          546 CTA-LTHQRP----PMEQVFV  561 (588)
Q Consensus       546 C~~-~p~~RP----s~~evl~  561 (588)
                      |++ +|.+||    ++.++++
T Consensus       232 ~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         232 LLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HcCCCHHHCCCCCCCHHHHhc
Confidence            777 799998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.2e-35  Score=301.71  Aligned_cols=241  Identities=23%  Similarity=0.263  Sum_probs=197.3

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...     ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999864 6899999998642     23467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++++|.+++... ..+++..+..++.|+++||.|||+.+   |+||||+|+||++++++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999999654 46899999999999999999999988   999999999999999999999999998876433  


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~  545 (588)
                        .....+++.|+|||.+.+...+.++||||||+++|||++|+.||...........+... ....+......+..++..
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~  231 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRN  231 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHHH
Confidence              23456889999999998888999999999999999999999998654433222221110 011222223455667788


Q ss_pred             hhc-CCCCCC-----CHHHHHH
Q 042871          546 CTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       546 C~~-~p~~RP-----s~~evl~  561 (588)
                      |+. +|.+||     +++|+++
T Consensus       232 ~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         232 LLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HccCCHHHccCcccCCHHHHHc
Confidence            887 799998     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=297.80  Aligned_cols=249  Identities=29%  Similarity=0.370  Sum_probs=197.6

Q ss_pred             HHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-cHHHHHHHHHHhccC-CCCceeEEecceeccC------
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-NVETFVREVASSSHV-RHPNLVALLGYCLRVD------  379 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~------  379 (588)
                      .++++|+..+.||+|++|.||+|+.. +++.+++|.+.... ..+.+.+|+.+++++ +|+||+++++++.+..      
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            35788999999999999999999974 67899999987543 356789999999998 6999999999997644      


Q ss_pred             eeeEEeecCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          380 ECFLIYELCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      ..++||||+++++|.+++...   ...+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999998542   356899999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCcccccCccCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCccc
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRSN-----CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY  531 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~  531 (588)
                      +....... .......|+..|+|||++..     ..++.++||||||+++|||++|+.||...........+........
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            87654322 12233468899999998653     3567899999999999999999999864322221111111111111


Q ss_pred             --CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          532 --SIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       532 --~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                        +.+....+..++.+|+. +|.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              12233566778889997 7999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.3e-35  Score=295.21  Aligned_cols=245  Identities=21%  Similarity=0.331  Sum_probs=197.6

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC--------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG--------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      +|+..+.||+|+||.||+++. .+++.||+|.+....        ..+.+.+|+..+++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999985 678999999986422        24578899999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcceecC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDI  462 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~~  462 (588)
                      |+||+++++|.+++... ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++ .+||+|||++.....
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            99999999999998543 46889999999999999999999998   99999999999998776 599999999876643


Q ss_pred             CCc---ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----CcccCcccCHHH
Q 042871          463 GET---YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----DPKLDREYSIEA  535 (588)
Q Consensus       463 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----d~~l~~~~~~e~  535 (588)
                      ...   .......++..|+|||++.+..++.++||||+|++++||++|+.||...........+    ........+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL  236 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence            211   1123346789999999998888999999999999999999999998643322211111    111112233344


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...+.+++..|+. +|.+||++.++++
T Consensus       237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         237 SPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            4556677888887 7999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.1e-35  Score=295.48  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=193.5

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----C-------cHHHHHHHHHHhccCCCCceeEEecceeccC
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----G-------NVETFVREVASSSHVRHPNLVALLGYCLRVD  379 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~  379 (588)
                      +|...+.||+|+||.||+|.. .+|+.||+|.+...     .       ..+.+.+|+.++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            456678999999999999985 47899999987521     0       1245788999999999999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999999654 46899999999999999999999988   99999999999999999999999999876


Q ss_pred             ecCCCc-ccccCccCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhc----CcccCccc
Q 042871          460 IDIGET-YASSEVRGTFGYLDPEYRSNCK--VNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELA----DPKLDREY  531 (588)
Q Consensus       460 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~--~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~----d~~l~~~~  531 (588)
                      ...... .......|+..|+|||++....  ++.++|+||||+++||+++|+.||....... ..+..    ...+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            532211 1223456889999999887654  7899999999999999999999985332211 11111    11111112


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..+....+..++..|+. +|.+|||++||++.
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            12233556666778887 79999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.4e-35  Score=298.49  Aligned_cols=243  Identities=21%  Similarity=0.310  Sum_probs=188.8

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC---cHHHHHHHHHH-hccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVAS-SSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..+.||+|+||.||+++.. +|+.||+|++....   ....+..|+.. ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47888999999999999999974 79999999986432   23456666665 666789999999999999999999999


Q ss_pred             cCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          387 LCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       387 ~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      |++ |+|.+++..   ....+++..++.++.|++.||+|||++ +   ++||||||+||++++++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            995 788887743   234689999999999999999999986 6   99999999999999999999999999886532


Q ss_pred             CCcccccCccCCCCccCcccccC----CCCCchhhHHHHHHHHHHHHcCCCccccccc--cchhhhcCcccCcccC-HHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSN----CKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELADPKLDREYS-IEA  535 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~~~~d~~l~~~~~-~e~  535 (588)
                      .  .......++..|+|||++.+    ..++.++|+||||+++|||++|+.|+.....  ......... .....+ ...
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~  233 (283)
T cd06617         157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPAEKF  233 (283)
T ss_pred             c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCCcccc
Confidence            2  12233467889999998754    4568899999999999999999999853221  111121111 111111 112


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...+..++..|+. +|.+||++.++++
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2345667888887 7999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=299.69  Aligned_cols=196  Identities=28%  Similarity=0.401  Sum_probs=168.9

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||+|++|.||+|+.. +++.||||.+...   .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67888999999999999999975 7899999998642   2234678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++ ++|.+++......+++.....++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++....... .
T Consensus        85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~  159 (291)
T cd07844          85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T  159 (291)
T ss_pred             CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence            97 5999998765567899999999999999999999998   99999999999999999999999999875432211 1


Q ss_pred             ccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          468 SSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      .....++..|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~  205 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP  205 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            122346789999998765 458899999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.6e-35  Score=304.07  Aligned_cols=240  Identities=23%  Similarity=0.300  Sum_probs=193.5

Q ss_pred             cceeeccCceEEEEEEe-cCCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          317 LNLIGEGITGKVYKGKL-SNNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      ...||+|+||.||+++. .+++.||+|++..  ....+.+.+|+..+..++||||+++++++..++..++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            44799999999999986 4789999999853  23456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccC
Q 042871          394 AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG  473 (588)
Q Consensus       394 ~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~g  473 (588)
                      .+++.  ...+++.+++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++....... .......|
T Consensus       106 ~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~  179 (297)
T cd06659         106 TDIVS--QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVG  179 (297)
T ss_pred             HHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceec
Confidence            99874  345899999999999999999999998   9999999999999999999999999987554322 12233568


Q ss_pred             CCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcc--cCHHHHHHHHHHHHHhhc-CC
Q 042871          474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDRE--YSIEAFDLTLQLALSCTA-LT  550 (588)
Q Consensus       474 t~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~--~~~e~~~~v~~L~~~C~~-~p  550 (588)
                      +..|+|||++.+..++.++||||||+++|||++|+.||...........+.......  ........+..++..|++ +|
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P  259 (297)
T cd06659         180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREP  259 (297)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCc
Confidence            899999999998889999999999999999999999986433322222221111100  011122345666778887 79


Q ss_pred             CCCCCHHHHHHH
Q 042871          551 HQRPPMEQVFVT  562 (588)
Q Consensus       551 ~~RPs~~evl~~  562 (588)
                      .+||+++++++.
T Consensus       260 ~~Rps~~~ll~~  271 (297)
T cd06659         260 QERATAQELLDH  271 (297)
T ss_pred             ccCcCHHHHhhC
Confidence            999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.1e-35  Score=292.75  Aligned_cols=244  Identities=25%  Similarity=0.306  Sum_probs=203.2

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|++.+.||+|+||.||+++. .+++.+++|.+..    +.....+.+|++++++++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477888999999999999985 4788999999863    23355788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          388 CPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       388 ~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +++++|.+++...   ...+++..++.++.++++||.|||+.+   ++||||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998542   346899999999999999999999998   999999999999999999999999999876543 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                        ......+++.|++||++.+..++.++|+||||+++|||++|+.||...........+........+......+..++.
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence              222345788999999999989999999999999999999999998755544333333333223333445566778888


Q ss_pred             Hhhc-CCCCCCCHHHHHHH
Q 042871          545 SCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~  562 (588)
                      .|++ +|++||++.|+++.
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         235 SMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHcCCCcccCCCHHHHhcC
Confidence            9997 79999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=298.74  Aligned_cols=246  Identities=25%  Similarity=0.325  Sum_probs=196.2

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..+.||+|+||.||+|+.. +++.||||++..    ....+.+.+|++++++++|+||+++++++.+++..++|+|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999975 688999998864    2234678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++++.+..++. +...+++.++..++.++++||.|||+.+   ++||||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            998877766553 3455899999999999999999999998   999999999999999999999999999876544432


Q ss_pred             cccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhh---------------h--cCcccC
Q 042871          467 ASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE---------------L--ADPKLD  528 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~---------------~--~d~~l~  528 (588)
                      ......++..|+|||++... .++.++||||||+++|||++|+.||......+...               .  .++...
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            33445678899999999887 88999999999999999999998875321110000               0  000000


Q ss_pred             --------------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          529 --------------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       529 --------------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                    ..++......+..++..|+. +|++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                          00111124557788899998 7999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-35  Score=315.80  Aligned_cols=195  Identities=22%  Similarity=0.271  Sum_probs=170.1

Q ss_pred             hcCccccceeeccCceEEEEEEec---CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS---NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...   ..+.+|++++++++||||+++++++...+..++|||+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            457999999999999999999752   4678999988654   2456899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc-
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~-  466 (588)
                      +. ++|.+++. ....+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ 
T Consensus       168 ~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        168 YK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             cC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence            95 78888883 3456999999999999999999999998   999999999999999999999999999766443222 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  289 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG  289 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            22346799999999999999999999999999999999999998853

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.8e-35  Score=297.82  Aligned_cols=199  Identities=29%  Similarity=0.381  Sum_probs=169.3

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++++|...+.||+|+||.||+|.. .+|+.||+|++...   .....+.+|+..++.++|+||+++.+++.+++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            457899999999999999999986 47899999998643   22346789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+. ++|.+++......+.+.++..++.|+++||.|||+.+   |+||||||+||+++.++++||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 7887777655556888889999999999999999998   99999999999999999999999999876432211


Q ss_pred             ccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          466 YASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                       ......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             12233568899999998753 578899999999999999999999853

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-35  Score=336.78  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=193.5

Q ss_pred             HHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec--cCe
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR--VDE  380 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~  380 (588)
                      ....++|.+.+.||+|+||.||+++. .++..||+|.+...    .....|..|+.++++++|||||++++++.+  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34457899999999999999999986 46788999988632    235678999999999999999999998864  356


Q ss_pred             eeEEeecCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccC----CceEecCCCCCCeEECCC-------
Q 042871          381 CFLIYELCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSE----GCIVHRDIKPTNILLGPN-------  446 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~IvHrDLKp~NILld~~-------  446 (588)
                      +||||||+++|+|.++|...   ...+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999999542   3468999999999999999999998542    349999999999999643       


Q ss_pred             ----------CcEEEEecCCcceecCCCcccccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccccc
Q 042871          447 ----------FEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLT  514 (588)
Q Consensus       447 ----------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~  514 (588)
                                +.+||+|||+++......  ......||+.|+|||++..  ..++.++|||||||+||||++|+.||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                      348999999998654322  2234578999999999854  45889999999999999999999998643


Q ss_pred             ccc-chhhhcC--cccC-cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          515 RAG-SALELAD--PKLD-REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       515 ~~~-~~~~~~d--~~l~-~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ... .....+.  +.+. ...+    ..+..|+..|+. +|.+||++.|++.
T Consensus       247 ~~~~qli~~lk~~p~lpi~~~S----~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFSQLISELKRGPDLPIKGKS----KELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHHHHHHHHhcCCCCCcCCCC----HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            221 1111111  1111 1122    345566788888 7999999999984

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.4e-35  Score=292.56  Aligned_cols=245  Identities=27%  Similarity=0.292  Sum_probs=202.9

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|...+.||+|+||.||++... +++.|++|++...    ...+.+.+|++.++.++|+|++++.+.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778889999999999999974 6899999998743    3456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          388 CPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       388 ~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +++++|.+++...   ...+++.++..++.++++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999654   367999999999999999999999998   9999999999999999999999999998764433


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                       .......|++.|+|||......++.++|+||||+++++|++|+.|+......+.............+......+..++.
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS  236 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence             1223346888999999998888999999999999999999999998654433333322221122222233455667788


Q ss_pred             Hhhc-CCCCCCCHHHHHH
Q 042871          545 SCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~  561 (588)
                      +|+. +|++|||+.|+++
T Consensus       237 ~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         237 SLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHcCCChhhCcCHHHHhc
Confidence            8988 7999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=318.65  Aligned_cols=248  Identities=25%  Similarity=0.418  Sum_probs=213.4

Q ss_pred             ccccceeeccCceEEEEEEec--CCc--EEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          314 LNELNLIGEGITGKVYKGKLS--NNQ--HVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~--~g~--~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ....++||+|.||.|++|.|.  +|+  .||||.+..+.   ..++|++|+.+|.+|+|||+++|+|+..+ ....+|+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            344568999999999999874  454  68999998642   56899999999999999999999999887 77899999


Q ss_pred             cCCCCChhhhhhc-CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFG-KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      +++.|||.+.|+. ....+-......++.|||.||.||.+++   +|||||..+|+||-....+||+||||.+.+..++.
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999987 3446777888899999999999999999   99999999999999999999999999998876554


Q ss_pred             ccc--cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHH
Q 042871          466 YAS--SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~--~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      +..  ....-...|-|||.+....++.++|||+|||.||||+| |..||.-.....+.+.+|..-+-.-+..+.+.+.++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i  347 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI  347 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence            321  12233567999999999999999999999999999999 778999888888999998766666677788899999


Q ss_pred             HHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      ++.||. +|.+|||+..+.+.+-.
T Consensus       348 mk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  348 MKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHhccCCccccccHHHHHHhHHH
Confidence            999998 79999999999854433

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.4e-35  Score=302.39  Aligned_cols=252  Identities=23%  Similarity=0.277  Sum_probs=199.2

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||.||+++.. +++.|++|.+...     ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999864 6789999988643     23457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-  464 (588)
                      ||+++++|.+++... ..+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++...... 
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            999999999999544 45889999999999999999999988   9999999999999999999999999987421110 


Q ss_pred             -------------cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-CcccC-c
Q 042871          465 -------------TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPKLD-R  529 (588)
Q Consensus       465 -------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~l~-~  529 (588)
                                   ........++..|+|||++....++.++|+||||+++|||++|+.||............ ..... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                         01112345788999999998889999999999999999999999998643322222211 11100 0


Q ss_pred             ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          530 EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       530 ~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      .........+..++..|++ +|++||++.++.+.|+...
T Consensus       237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence            0011223446677888888 7999999887777777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-34  Score=289.32  Aligned_cols=245  Identities=25%  Similarity=0.334  Sum_probs=202.6

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceecc--CeeeEEe
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRV--DECFLIY  385 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~  385 (588)
                      +|...+.||+|++|.||+|+.. +++.|++|++....    ..+.+.+|++.+++++|+||+++++.+.+.  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677789999999999999975 78999999986543    367889999999999999999999999988  8899999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++++|.+++.... .+++.+++.++.+++++|.|||+.+   ++|+||+|+||++++++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999996544 7999999999999999999999988   99999999999999999999999999887654332


Q ss_pred             c-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc--cchhhhcCcccCcccCHHHHHHHHHH
Q 042871          466 Y-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      . ......++..|++||.......+.++||||||++++||++|+.||.....  ...............+......+.++
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence            1 12345688899999999888899999999999999999999999865441  11111111112223333445667778


Q ss_pred             HHHhhc-CCCCCCCHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~  561 (588)
                      +.+|+. +|.+||++.|++.
T Consensus       237 i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         237 LRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHhCcCChhhCCCHHHHhh
Confidence            889998 7999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-35  Score=298.48  Aligned_cols=196  Identities=27%  Similarity=0.396  Sum_probs=169.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCc----HHHHHHHHHHhccCCCCc-eeEEecceeccC-----
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGN----VETFVREVASSSHVRHPN-LVALLGYCLRVD-----  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~----~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~-----  379 (588)
                      ...|..+++||+|+||+||+|+. .+|+.||+|++.-+.+    -..-.+|+.++++++|+| ||+|.+++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45577778899999999999985 5889999999874322    345689999999999999 999999999877     


Q ss_pred             -eeeEEeecCCCCChhhhhhcCC---cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          380 -ECFLIYELCPNGNLAEWLFGKD---KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       380 -~~~LV~E~~~~gsL~~~L~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                       .+++|+||+ .-+|.+++....   ..++...+..++.|+++||+|||+++   |+||||||.||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             789999999 669999996544   35777889999999999999999999   9999999999999999999999999


Q ss_pred             CcceecCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          456 LSKVIDIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       456 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      +|+........ .+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|
T Consensus       166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF  221 (323)
T KOG0594|consen  166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF  221 (323)
T ss_pred             hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence            99966533322 3445679999999999887 7999999999999999999988744

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.8e-35  Score=299.34  Aligned_cols=244  Identities=25%  Similarity=0.260  Sum_probs=191.9

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      +|+..+.||+|+||.||+|... +|+.||||.+....       ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999964 68999999986432       134567899999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+ +|+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 99999999655446999999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc--------------------
Q 042871          465 TYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA--------------------  523 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~--------------------  523 (588)
                      . ......+++.|+|||++.+ ..++.++||||||+++|||++|..++......+..+.+                    
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            1 1223356788999998754 46789999999999999999997665422211100000                    


Q ss_pred             --CcccCcccC-----HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 --DPKLDREYS-----IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 --d~~l~~~~~-----~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                        ........+     ......+.+++..|++ +|.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence              000000011     1123456678888988 7999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.3e-35  Score=300.86  Aligned_cols=243  Identities=28%  Similarity=0.382  Sum_probs=194.7

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .+.|+..+.||+|+||.||+|+.. +|+.||+|.+...     ...+.+.+|+++++.++||||+++.+++.+++..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            355788889999999999999864 7899999988532     1235688999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +||++ |+|.+++......+++.++..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99996 6888877655567999999999999999999999998   999999999999999999999999998765322 


Q ss_pred             cccccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-cccCcccCHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-PKLDREYSIEAFDLTL  540 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-~~l~~~~~~e~~~~v~  540 (588)
                          ....++..|+|||++.   ...++.++||||||+++|||++|+.|+...........+. .........+....+.
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR  244 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence                2346788999999874   4568899999999999999999999875433222111111 1111111222344577


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .++..|+. +|++||++.+++..
T Consensus       245 ~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHHhcC
Confidence            78889998 79999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-36  Score=301.84  Aligned_cols=193  Identities=31%  Similarity=0.434  Sum_probs=160.8

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccC-----eeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD-----ECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~  385 (588)
                      -.|...+++|.|+||.||+|++ .+++.||||+.-.+...+  -+|+++|+.+.|||||+|+-+|....     ...|||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            3566778999999999999996 467999999886543222  36899999999999999998887432     235899


Q ss_pred             ecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-CcEEEEecCCcceec
Q 042871          386 ELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVID  461 (588)
Q Consensus       386 E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-~~~kL~DFGla~~~~  461 (588)
                      |||+. +|.+.+..   .+..++...+.-+..|+++||.|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.+.
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            99975 89888853   2456788888889999999999999988   9999999999999976 899999999999987


Q ss_pred             CCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      .++...+  ..-|.-|.|||.+.+ ..|+.+.||||.||++.||+-|+.-|.
T Consensus       178 ~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp  227 (364)
T KOG0658|consen  178 KGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP  227 (364)
T ss_pred             cCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence            6665432  334778999998877 579999999999999999999998554

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3e-35  Score=295.87  Aligned_cols=241  Identities=24%  Similarity=0.280  Sum_probs=198.6

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      +|+..+.||.|+||.||+++.. +++.||+|.+...     ...+.+.+|++.+++++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788899999999999999975 6899999998642     345688999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |+++++|.+++... ..+++.+...++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999544 46899999999999999999999988   9999999999999999999999999987654332  


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc---chhhhcCcccCcccCHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG---SALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||......   ........ .....+......+.+++
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAI  233 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHH
Confidence            223456888999999998888999999999999999999999998755431   11111111 11223333445666778


Q ss_pred             HHhhc-CCCCCCCH--HHHH
Q 042871          544 LSCTA-LTHQRPPM--EQVF  560 (588)
Q Consensus       544 ~~C~~-~p~~RPs~--~evl  560 (588)
                      ..|+. +|.+||++  +|++
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHccCChhHcCCccHHHHh
Confidence            88888 79999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-34  Score=298.61  Aligned_cols=246  Identities=26%  Similarity=0.390  Sum_probs=199.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|...+.||+|+||.||++.. .+++.||+|.+..  ....+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            36788889999999999999985 4788999999853  23456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++..  ..+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++........ .
T Consensus        98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~  171 (293)
T cd06647          98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (293)
T ss_pred             CCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence            999999999943  35789999999999999999999998   99999999999999999999999999876543322 2


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc--CcccCcccCHHHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA--DPKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~--d~~l~~~~~~e~~~~v~~L~~~  545 (588)
                      .....+++.|++||.+....++.++||||||+++||+++|+.||...........+  .+......+......+..++..
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence            23346888999999998888999999999999999999999998643322111111  1110111122233456778889


Q ss_pred             hhc-CCCCCCCHHHHHHH
Q 042871          546 CTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~~  562 (588)
                      |+. +|.+||++++++..
T Consensus       252 ~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         252 CLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HccCChhhCcCHHHHhcC
Confidence            998 79999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=307.87  Aligned_cols=242  Identities=29%  Similarity=0.340  Sum_probs=201.5

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCC-CCceeEEecceeccCeee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVR-HPNLVALLGYCLRVDECF  382 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~  382 (588)
                      ..+.|+..+.||+|.||.||+++.. +|+.+|+|.+...     ...+...+|+.+|+++. |||||.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3556777889999999999999975 5999999998643     23468899999999998 999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC----CcEEEEecCCcc
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN----FEAKLSDFGLSK  458 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~----~~~kL~DFGla~  458 (588)
                      +|||++.||.|.+.+...  .+++.....++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999766  3999999999999999999999999   9999999999999543    579999999999


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCcc--c----Cccc
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPK--L----DREY  531 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~--l----~~~~  531 (588)
                      ....  .......+||+.|+|||++....|+...||||+||++|.|++|..||.......... +....  +    ...+
T Consensus       188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i  265 (382)
T KOG0032|consen  188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI  265 (382)
T ss_pred             EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence            8765  334566899999999999999999999999999999999999999997554333222 22211  1    1223


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +...-+.    +..++. +|.+|+|+.++++.
T Consensus       266 s~~akd~----i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  266 SESAKDF----IRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CHHHHHH----HHHhcccCcccCCCHHHHhcC
Confidence            4444444    455555 89999999999983

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=288.98  Aligned_cols=242  Identities=24%  Similarity=0.312  Sum_probs=202.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      +++|+..+.||+|.|+.||+... ++|+.+|+|.+..    ..+.+++.+|+++-+.++||||++|.+...+.+..|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            56788888999999999999875 6899999987752    346778899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~DFGla~~~~~  462 (588)
                      |+|.|++|..-+..+ ...++...-..+.|++++|.|.|.++   |+|||+||+|+|+-+   .--+||+|||+|..+..
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999998776433 34677888889999999999999999   999999999999954   34589999999998873


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------CcccCcccCHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------DPKLDREYSIEA  535 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------d~~l~~~~~~e~  535 (588)
                      +  ......+|||+|||||++...+|+..+|||+.||+||-|+.|..||......++.+.+       ++......+++.
T Consensus       166 g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  166 G--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             c--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            2  3345568999999999999999999999999999999999999999875655555543       233334566777


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHHH
Q 042871          536 FDLTLQLALSCTALTHQRPPMEQVFV  561 (588)
Q Consensus       536 ~~~v~~L~~~C~~~p~~RPs~~evl~  561 (588)
                      .+++.++.   ..+|.+|.|+.|.++
T Consensus       244 k~LvrrML---~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  244 KSLIRRML---TVNPKKRITADEALK  266 (355)
T ss_pred             HHHHHHHh---ccChhhhccHHHHhC
Confidence            77766554   558999999988764

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-34  Score=294.84  Aligned_cols=244  Identities=28%  Similarity=0.367  Sum_probs=195.4

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceecc--CeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRV--DECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~  385 (588)
                      ++|+..+.||.|++|.||++.. .+++.+|+|.+...   .....+.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4688889999999999999997 46889999998643   2346789999999999999999999988653  4689999


Q ss_pred             ecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ||+++++|.+++..   ....+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999998742   3345888999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc-----cchhhhc-C---cccCcccC-
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA-----GSALELA-D---PKLDREYS-  532 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~-----~~~~~~~-d---~~l~~~~~-  532 (588)
                      ..   .....++..|++||.+.+..++.++||||||+++|||++|+.||.....     .+....+ +   +.+..... 
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN  234 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence            22   1234578899999999998999999999999999999999999864421     1111111 1   11111111 


Q ss_pred             -HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          533 -IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       533 -~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                       ....+.+.+++.+|+. +|.+|||+.|+++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             1223557788999998 7999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=295.61  Aligned_cols=197  Identities=28%  Similarity=0.421  Sum_probs=168.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceec-----cCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLR-----VDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~  380 (588)
                      ...|...+.||+|.||.|.+++. .+|+.||||++.+    ....+.-.+|+++|+.++|+||+.+++.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            44555578899999999999986 5899999999874    3456678899999999999999999998875     457


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .|+|+|+| +.+|...+.. ++.|+.....-++.|+++||.|+|+.+   |+||||||+|+|++.+-.+||+|||+|+..
T Consensus       101 vYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             eEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence            89999999 6788888843 344899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCc-ccccCccCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          461 DIGET-YASSEVRGTFGYLDPEYRS-NCKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       461 ~~~~~-~~~~~~~gt~~Y~aPE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      +.... ...+..+-|..|.|||.+. ...|+.+.||||.|||+.||++|+.-|.
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp  229 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP  229 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence            54311 1225567799999999764 4689999999999999999999998553

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=294.73  Aligned_cols=244  Identities=26%  Similarity=0.315  Sum_probs=193.0

Q ss_pred             ccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc--CeeeEEee
Q 042871          314 LNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV--DECFLIYE  386 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E  386 (588)
                      |+..+.||+|+||.||+|+.. +|+.+|+|++...    .....+.+|++++++++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999875 5899999999743    2345788999999999999999999999988  88999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++ ++|.+++......+++.+++.++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||++.........
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            997 5899988665567999999999999999999999998   999999999999999999999999999876544322


Q ss_pred             cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc--------------------
Q 042871          467 ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP--------------------  525 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~--------------------  525 (588)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..                    
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            2333456888999997664 4678999999999999999999998753322111110000                    


Q ss_pred             ccC--cc--------cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 KLD--RE--------YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 ~l~--~~--------~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...  ..        +.......+.+++..|+. +|.+||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000  00        000013456778889988 7999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-34  Score=297.95  Aligned_cols=248  Identities=25%  Similarity=0.301  Sum_probs=193.6

Q ss_pred             HHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC----
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD----  379 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----  379 (588)
                      ...++|++.+.||+|+||.||+|+.. +|+.||+|++...    .....+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999974 6899999998632    23356788999999999999999999987654    


Q ss_pred             ------eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEe
Q 042871          380 ------ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSD  453 (588)
Q Consensus       380 ------~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~D  453 (588)
                            ..++|+||+++ +|.+++......+++.+++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999975 777777655557899999999999999999999998   99999999999999999999999


Q ss_pred             cCCcceecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc------
Q 042871          454 FGLSKVIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK------  526 (588)
Q Consensus       454 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~------  526 (588)
                      ||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+.+...      
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99998765433222233356788999998764 45788999999999999999999888643221111000000      


Q ss_pred             ------------------------cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          527 ------------------------LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       527 ------------------------l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                              ..... ......+.+++..|++ +|.+||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                    00000 0123456777888888 7999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-34  Score=296.74  Aligned_cols=243  Identities=24%  Similarity=0.315  Sum_probs=195.1

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      +|...+.||+|++|.||++.. .+++.|++|++...  ...+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            344557999999999999986 47889999988643  234568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +++|.+++..  ..+++.++..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++....... ....
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~  173 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK  173 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence            9999999955  45899999999999999999999998   9999999999999999999999999887553322 1223


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCccc--CHHHHHHHHHHHHHhh
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY--SIEAFDLTLQLALSCT  547 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~--~~e~~~~v~~L~~~C~  547 (588)
                      ...|+..|+|||++.+..++.++||||||+++|||++|+.|+...........+........  .......+..++.+|+
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML  253 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence            34688999999999888899999999999999999999999754322222211111111111  1112345677788888


Q ss_pred             c-CCCCCCCHHHHHH
Q 042871          548 A-LTHQRPPMEQVFV  561 (588)
Q Consensus       548 ~-~p~~RPs~~evl~  561 (588)
                      . +|++|||+.++++
T Consensus       254 ~~~p~~Rpt~~~il~  268 (285)
T cd06648         254 VRDPAQRATAAELLN  268 (285)
T ss_pred             ccChhhCcCHHHHcc
Confidence            7 7999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=291.65  Aligned_cols=246  Identities=24%  Similarity=0.264  Sum_probs=196.5

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-------CcHHHHHHHHHHhccCCCCceeEEecceecc--Cee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-------GNVETFVREVASSSHVRHPNLVALLGYCLRV--DEC  381 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~  381 (588)
                      .+|+..+.||+|+||.||+|+. .+++.||+|.+...       .....+.+|++++++++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788899999999999999986 46899999987421       2345788999999999999999999998764  468


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            8999999999999998643 34888899999999999999999998   9999999999999999999999999998653


Q ss_pred             CCC--cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccCcccCHHHHHH
Q 042871          462 IGE--TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLDREYSIEAFDL  538 (588)
Q Consensus       462 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~~~~~~e~~~~  538 (588)
                      ...  ........++..|+|||++.+..++.++|+||||+++|||++|+.||....... .............+....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  237 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA  237 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence            211  111233568899999999998889999999999999999999999986432221 22222111222233344455


Q ss_pred             HHHHHHHhhcCCCCCCCHHHHHH
Q 042871          539 TLQLALSCTALTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~~p~~RPs~~evl~  561 (588)
                      +..++..|++.|.+||+..+++.
T Consensus       238 ~~~~i~~~l~~~~~r~~~~~~~~  260 (264)
T cd06653         238 CRDFLKQIFVEEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHHHhcCcccCccHHHHhc
Confidence            66677888888899999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=287.52  Aligned_cols=244  Identities=25%  Similarity=0.337  Sum_probs=198.5

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|++|.||+++.. +++.|++|.+....    ..+.+.+|++++++++|+|++++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677889999999999999864 67899999987542    456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++... ..+++..+..++.|++.+|.|||+.+   |+||||||+||++++++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998644 56899999999999999999999998   999999999999999999999999999876543322 


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      .....++..|+|||+..+..++.++|||+||+++|||++|+.|+....................+....+.+..++.+|+
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF  235 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence            23356788999999988888899999999999999999999988643322111111111111122223345666778888


Q ss_pred             c-CCCCCCCHHHHHH
Q 042871          548 A-LTHQRPPMEQVFV  561 (588)
Q Consensus       548 ~-~p~~RPs~~evl~  561 (588)
                      . +|++|||+.+++.
T Consensus       236 ~~~p~~R~~~~~~l~  250 (254)
T cd06627         236 QKDPNLRPTAKQLLK  250 (254)
T ss_pred             hCChhhCcCHHHHhc
Confidence            7 7999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.5e-34  Score=296.64  Aligned_cols=245  Identities=22%  Similarity=0.272  Sum_probs=192.2

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceecc--CeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRV--DECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV  384 (588)
                      ++|+..+.||+|+||.||+|+.. +++.+++|.++...    ....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888899999999999999975 68899999986422    233567899999999999999999998877  889999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +||++ ++|.+++......+++.+.+.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99996 5999988665557999999999999999999999998   9999999999999999999999999988764432


Q ss_pred             cccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc--------------------
Q 042871          465 TYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA--------------------  523 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~--------------------  523 (588)
                      . ......+++.|+|||++.+. .++.++|+||||+++|||++|+.|+...........+                    
T Consensus       161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            1 12234578899999988654 4688999999999999999999887532211100000                    


Q ss_pred             ----------CcccCcccCHH-HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 ----------DPKLDREYSIE-AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 ----------d~~l~~~~~~e-~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                ...+...++.. ..+.+.+++..|++ +|++|||++|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                      00000111111 23445667888888 7999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-34  Score=291.43  Aligned_cols=240  Identities=25%  Similarity=0.287  Sum_probs=193.5

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          320 IGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       320 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      ||+|+||.||+++.. +|+.+++|.+...     ...+.+.+|++++++++|+||+++++.+..++..++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999975 5999999998643     2345788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-------c
Q 042871          394 AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-------Y  466 (588)
Q Consensus       394 ~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-------~  466 (588)
                      .+++.... .+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.+||+|||++........       .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99996543 6899999999999999999999988   99999999999999999999999999876533221       1


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHH--HHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIE--AFDLTLQLAL  544 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e--~~~~v~~L~~  544 (588)
                      ......++..|++||+......+.++||||||+++|||++|+.||.........+.+.... ...+..  ....+..++.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-IEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCccccCCHHHHHHHH
Confidence            2234567889999999988889999999999999999999999986544333222221100 111111  1455667788


Q ss_pred             Hhhc-CCCCCCCHHHHHHHHH
Q 042871          545 SCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L~  564 (588)
                      .|++ +|.+|||+.++.+.|+
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHhc
Confidence            8887 7999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.8e-34  Score=297.97  Aligned_cols=246  Identities=28%  Similarity=0.395  Sum_probs=196.8

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .|+..+.||+|+||.||+++. .+++.||+|++...     .....+.+|++.+++++|+|++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            366778999999999999996 47899999998632     123468899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++ |+|.+++......+++.++..++.+++.||.|||+.+   |+||||+|+||+++.++.+||+|||++......   
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            996 5888888655667999999999999999999999998   999999999999999999999999998754322   


Q ss_pred             cccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcCcccCcccCHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                        ....|+..|+|||++.   .+.++.++||||||+++|||++|+.|+......... ..................+..+
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  256 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  256 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence              2346788999999873   457889999999999999999999987543322211 1211111111122233456778


Q ss_pred             HHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          543 ALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      +..|++ +|.+||++.++++.+....
T Consensus       257 i~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         257 VDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHHHccCCcccCcCHHHHHhChhhhc
Confidence            889998 7999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=328.02  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=215.7

Q ss_pred             HHHHHhcCccccceeeccCceEEEEEEec----C----CcEEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEec
Q 042871          306 EVHYATEKLNELNLIGEGITGKVYKGKLS----N----NQHVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLG  373 (588)
Q Consensus       306 el~~at~~f~~~~~LG~G~fG~Vykg~~~----~----g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g  373 (588)
                      .++...++..+.+.||+|.||.|++|...    .    ...||||.++..   .+.+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34555666666779999999999999742    1    457999998753   3467899999999998 5999999999


Q ss_pred             ceeccCeeeEEeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCC
Q 042871          374 YCLRVDECFLIYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKP  438 (588)
Q Consensus       374 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp  438 (588)
                      +|..++..++|.||++.|+|.++|...+               ..++..+.+.++.|||.|++||++..   ++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999997655               34889999999999999999999998   99999999


Q ss_pred             CCeEECCCCcEEEEecCCcceecCCCcccccCcc--CCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccc
Q 042871          439 TNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR--GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTR  515 (588)
Q Consensus       439 ~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~  515 (588)
                      +|||+.++..+||+|||+++.......+......  -...|||||.+....|+.|+|||||||+||||+| |..|+....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999976555544433223  2456999999999999999999999999999999 777876433


Q ss_pred             -ccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          516 -AGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       516 -~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                       ..++.+.+.+..+...+..+.+.+..+++.||+ +|++||++.|+++.++..+.
T Consensus       527 ~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence             344455555555555555666777788999998 79999999999999999653

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2e-34  Score=294.09  Aligned_cols=244  Identities=23%  Similarity=0.340  Sum_probs=189.8

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|+..+.||+|++|.||+|+. .+|+.||||++...    ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            578889999999999999986 47899999988642    2235788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +. ++|.+++... ...+++.++..++.|+++||+|||+.+   ++||||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 6899888543 346899999999999999999999988   99999999999999999999999999876543221 


Q ss_pred             cccCccCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhc---Cc----------------
Q 042871          467 ASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELA---DP----------------  525 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~---d~----------------  525 (588)
                      ......++..|+|||++.+.. ++.++||||||+++|||+||+.||......+ ..+.+   ..                
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            122335688999999876644 6889999999999999999999875322111 00000   00                


Q ss_pred             -ccC---c----ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 -KLD---R----EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 -~l~---~----~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                       .+.   .    .........+..++..|++ +|.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             000   0    0000112334567888887 7999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.7e-34  Score=292.22  Aligned_cols=241  Identities=25%  Similarity=0.245  Sum_probs=187.4

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCC-CCceeEEecceecc--CeeeEEee
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVR-HPNLVALLGYCLRV--DECFLIYE  386 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~E  386 (588)
                      |...+.||+|+||.||+|+. .+++.||+|++...   .......+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            55678999999999999986 47899999998642   22334567888888885 99999999999987  88999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++ |+|.+++......+++.+++.++.|++.||.|||+.+   ++||||||+||++++ +.+||+|||+++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            996 6888888665567999999999999999999999998   999999999999999 9999999999986643222 


Q ss_pred             cccCccCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---------------C------
Q 042871          467 ASSEVRGTFGYLDPEYRS-NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---------------D------  524 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---------------d------  524 (588)
                       .....++..|+|||++. +..++.++|||||||++|||++|+.||......+.....               .      
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence             22345788999999764 455788999999999999999999988533211110000               0      


Q ss_pred             cccCcc-------cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 PKLDRE-------YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ~~l~~~-------~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ......       ........+.+++..|++ +|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000       011223556777888888 7999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.2e-34  Score=291.37  Aligned_cols=244  Identities=24%  Similarity=0.343  Sum_probs=191.8

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      +|+..+.||+|++|.||+|+.. +|+.||||++...   ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999974 6899999998642   23567789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          389 PNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       389 ~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      + ++|.+++....  ..+++.++..++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            7 48988885433  46899999999999999999999998   99999999999999999999999999976543221 


Q ss_pred             cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----------------C-cccC
Q 042871          467 ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----------------D-PKLD  528 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----------------d-~~l~  528 (588)
                      ......++..|++||++.+ ..++.++||||||+++|||++|+.||......+....+                + +.+.
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            1223456889999998765 45688999999999999999999987532211100000                0 0000


Q ss_pred             cc-----------cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          529 RE-----------YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       529 ~~-----------~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..           ........+.+++..|++ +|.+||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00           001123445677888887 7999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=301.54  Aligned_cols=252  Identities=25%  Similarity=0.327  Sum_probs=193.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceecc-----Cee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRV-----DEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~  381 (588)
                      +++|++.+.||+|+||.||+|+. .+|+.||||++..   ......+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            57899999999999999999985 5789999999863   22345688999999999999999999886643     357


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++|+||++ ++|.+++.  ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 58888773  346899999999999999999999998   9999999999999999999999999988654


Q ss_pred             CCCcc--cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccc----------------hhhh
Q 042871          462 IGETY--ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS----------------ALEL  522 (588)
Q Consensus       462 ~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~----------------~~~~  522 (588)
                      .....  ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||.......                ....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32221  1233568899999998654 568999999999999999999999885322111                0000


Q ss_pred             cCcc-------cC--cccC-----HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH--HHHhhc
Q 042871          523 ADPK-------LD--REYS-----IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT--LQKALD  568 (588)
Q Consensus       523 ~d~~-------l~--~~~~-----~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~--L~~~~~  568 (588)
                      .+..       ..  ...+     ......+..++..|++ +|++|||+.|+++.  ++...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            0000       00  0000     0112346678888988 79999999999987  554443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=312.05  Aligned_cols=240  Identities=27%  Similarity=0.370  Sum_probs=198.1

Q ss_pred             eeeccCceEEEEEEec-CCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChhh
Q 042871          319 LIGEGITGKVYKGKLS-NNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAE  395 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~  395 (588)
                      .||+|.||+||.|+.. +...+|||.+...  ...+-+.+||.+-++++|.|||+++|.+.+++.+-+.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999964 5567899998653  445678999999999999999999999999999999999999999999


Q ss_pred             hhhcCCcCc--cHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEEecCCcceecCCCcccccCcc
Q 042871          396 WLFGKDKCL--SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLSDFGLSKVIDIGETYASSEVR  472 (588)
Q Consensus       396 ~L~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~  472 (588)
                      +|..+-+++  ++.+.--+..||++||.|||...   |+|||||-+|||++ -.|.+||+|||-++.+. +-+..+..+.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTETFT  737 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc-cCCccccccc
Confidence            998766666  66777778999999999999999   99999999999997 47899999999998764 3344556678


Q ss_pred             CCCCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCccccccccchh--hhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          473 GTFGYLDPEYRSNC--KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL--ELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       473 gt~~Y~aPE~~~~~--~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ||..|||||++..+  .|+.++|||||||.+.||.|||+||.........  ++---...++++.+.-.....++++|..
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            99999999998764  5889999999999999999999998643322211  1111122344566666666777889988


Q ss_pred             -CCCCCCCHHHHHHH
Q 042871          549 -LTHQRPPMEQVFVT  562 (588)
Q Consensus       549 -~p~~RPs~~evl~~  562 (588)
                       +|.+||++.+++..
T Consensus       818 pd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CCcccCccHHHhccC
Confidence             79999999999863

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4e-34  Score=288.34  Aligned_cols=236  Identities=23%  Similarity=0.279  Sum_probs=192.5

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          320 IGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       320 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      ||+|+||.||+++.. +++.||+|++...     ...+.+.+|+.+++.++||||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999974 5899999998642     2345788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccC
Q 042871          394 AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG  473 (588)
Q Consensus       394 ~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~g  473 (588)
                      .+++.+. ..+++.++..++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||+++......  ......+
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~  154 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG  154 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence            9999643 35889999999999999999999988   9999999999999999999999999998765432  2233467


Q ss_pred             CCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccc--ccchhh-hcCcccCcccCHHHHHHHHHHHHHhhc-C
Q 042871          474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTR--AGSALE-LADPKLDREYSIEAFDLTLQLALSCTA-L  549 (588)
Q Consensus       474 t~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~--~~~~~~-~~d~~l~~~~~~e~~~~v~~L~~~C~~-~  549 (588)
                      +..|++||++....++.++|+||||+++|||++|+.|+....  ..+... ..+......++......+..++..|+. +
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence            889999999988889999999999999999999999987554  212222 121111222333334567778888887 7


Q ss_pred             CCCCCC-----HHHHHH
Q 042871          550 THQRPP-----MEQVFV  561 (588)
Q Consensus       550 p~~RPs-----~~evl~  561 (588)
                      |++||+     ++|+++
T Consensus       235 p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         235 PEERLGNLKGGIKDIKK  251 (262)
T ss_pred             hhhCcCCcccCHHHHhc
Confidence            999999     666655

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2e-34  Score=294.89  Aligned_cols=244  Identities=24%  Similarity=0.352  Sum_probs=189.9

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|...+.||+|+||.||+++. .+++.||+|.+...   .....+.+|+..+.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            455667899999999999986 46899999998642   23457889999999996 99999999999999999999999


Q ss_pred             CCCCChhhhh---hc-CCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          388 CPNGNLAEWL---FG-KDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       388 ~~~gsL~~~L---~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ++ ++|.++.   .. ....+++.....++.+++.||+|||+. +   |+||||||+||++++++.+||+|||+++....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            85 4555543   22 235689999999999999999999974 6   99999999999999999999999999876532


Q ss_pred             CCcccccCccCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCccccccc--cchhhhc---CcccCcccCHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNC---KVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELA---DPKLDREYSIE  534 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~---~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~~~~---d~~l~~~~~~e  534 (588)
                      ..  ......|+..|+|||++...   .++.++||||||+++|||++|+.||.....  ....+..   .+.+.......
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            22  12334678899999998765   689999999999999999999999864331  1111111   11222221122


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ....+.+++.+|++ +|++|||+++|++.
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            34456778889998 79999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=291.57  Aligned_cols=243  Identities=22%  Similarity=0.319  Sum_probs=189.4

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      |+..+.||+|++|.||+|.. .+|+.||+|++...    ...+.+.+|++.+++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56678999999999999986 47999999998643    22357889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                       +++|.+++.... ..+++.+++.++.|+++||+|||+.+   ++||||+|+||++++++.++|+|||+++....... .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  155 (283)
T cd07835          81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T  155 (283)
T ss_pred             -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence             579999986543 36899999999999999999999988   99999999999999999999999999876543221 1


Q ss_pred             ccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcC----------------cc---
Q 042871          468 SSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELAD----------------PK---  526 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d----------------~~---  526 (588)
                      .....++..|+|||++.+. .++.++||||||+++|||++|+.||....... ..+..+                +.   
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            1223568899999987664 57889999999999999999999875322110 000000                00   


Q ss_pred             -cC-------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          527 -LD-------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       527 -l~-------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                       ..       ..........+.+++..|++ +|.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             00       00001111345567888888 7999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-35  Score=284.77  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=201.8

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC------CCc----HHHHHHHHHHhccCC-CCceeEEeccee
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN------EGN----VETFVREVASSSHVR-HPNLVALLGYCL  376 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~------~~~----~~~~~~Ei~~l~~l~-HpnIv~l~g~~~  376 (588)
                      ..-++|...+.||.|..+.|-+..+ ++|+..|+|++..      ...    .+.-.+|+.+|+++. ||||+.+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3456778888999999999988876 4788999998852      111    234567999999985 999999999999


Q ss_pred             ccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      .+..+++|+|.|+.|.|.|+|.. .-.+++....+|+.|+.+|++|||..+   |+||||||+|||+|++.++||+|||+
T Consensus        94 s~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence            99999999999999999999943 346999999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCcccccCccCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcc
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRS------NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDRE  530 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~  530 (588)
                      +..+.++..  -...+|||+|+|||.+.      ...|+...|+|+.||++|-|+.|-.||...+.--..+++...--.-
T Consensus       170 a~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF  247 (411)
T KOG0599|consen  170 ACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF  247 (411)
T ss_pred             eeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence            999877664  35679999999999764      3467889999999999999999999998655544444432221111


Q ss_pred             cCH---HHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          531 YSI---EAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       531 ~~~---e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      -++   +..+.+..|+..|++ +|.+|.|.+|++..
T Consensus       248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            111   233446667888887 89999999999863

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=292.89  Aligned_cols=197  Identities=24%  Similarity=0.343  Sum_probs=166.2

Q ss_pred             CccccceeeccCceEEEEEEec---CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceecc--Ceee
Q 042871          313 KLNELNLIGEGITGKVYKGKLS---NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRV--DECF  382 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~  382 (588)
                      +|+..+.||+|+||.||+|+..   +++.||+|.+..     +...+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778889999999999999974   579999999876     33346788999999999999999999999988  7899


Q ss_pred             EEeecCCCCChhhhhhcC----CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC----CCcEEEEec
Q 042871          383 LIYELCPNGNLAEWLFGK----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP----NFEAKLSDF  454 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~----~~~~kL~DF  454 (588)
                      +||||+++ +|.+++...    ...+++...+.++.|++.||.|||+.+   |+||||||+||++++    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999964 677666321    236888999999999999999999998   999999999999999    999999999


Q ss_pred             CCcceecCCCc--ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          455 GLSKVIDIGET--YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       455 Gla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      |+++.......  .......++..|+|||++.+ ..++.++||||||++++||++|+.||..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  218 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG  218 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            99986543222  12234567889999998766 4578999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.6e-34  Score=291.49  Aligned_cols=245  Identities=24%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ++|...+.||+|+||.||+++.. +|+.||+|++..     ....+.+.+|++++++++ |+||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999874 799999999864     223457889999999998 99999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++... ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            9999999999999644 36999999999999999999999998   9999999999999999999999999987654322


Q ss_pred             c-------------------ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc
Q 042871          465 T-------------------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP  525 (588)
Q Consensus       465 ~-------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~  525 (588)
                      .                   .......++..|++||......++.++||||||++++|+++|+.|+...........+. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-
Confidence            1                   12233457889999999988889999999999999999999999987544322222111 


Q ss_pred             ccCcccCHHHHHHHHHHHHHhhc-CCCCCCCH----HHHHH
Q 042871          526 KLDREYSIEAFDLTLQLALSCTA-LTHQRPPM----EQVFV  561 (588)
Q Consensus       526 ~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~----~evl~  561 (588)
                      ......+.+....+..++..|+. +|.+||++    +|+++
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11112222334456677888887 79999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.4e-34  Score=295.26  Aligned_cols=247  Identities=26%  Similarity=0.350  Sum_probs=190.4

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceecc--CeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRV--DECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~L  383 (588)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|.+....    ....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46789999999999999999997 468999999986321    123567899999999999999999998755  56899


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||++ ++|.+++......+++.+++.++.|+++||.|||+.+   ++||||||+||++++++.+||+|||++......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 5898888665567999999999999999999999999   999999999999999999999999999876433


Q ss_pred             CcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc-----------------
Q 042871          464 ETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP-----------------  525 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~-----------------  525 (588)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..                 
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            21 1222345788999998765 5578999999999999999999998753322111110000                 


Q ss_pred             -----ccCcc-cC------HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          526 -----KLDRE-YS------IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       526 -----~l~~~-~~------~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                           .+... ..      .........++..|++ +|++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 00000 00      0012334556777887 79999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.2e-34  Score=297.84  Aligned_cols=247  Identities=27%  Similarity=0.354  Sum_probs=192.0

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC----CCcHHHHHHHHHHhccC-CCCceeEEecceecc--Cee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN----EGNVETFVREVASSSHV-RHPNLVALLGYCLRV--DEC  381 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~--~~~  381 (588)
                      ..++|+..+.||+|+||.||+|... +|+.||+|++..    ......+.+|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888899999999999999975 688999998853    23345678899999999 999999999988653  468


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||++ ++|.+++...  .+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 6999988543  6889999999999999999999988   9999999999999999999999999998664


Q ss_pred             CCCcc----cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhh---------------
Q 042871          462 IGETY----ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE---------------  521 (588)
Q Consensus       462 ~~~~~----~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~---------------  521 (588)
                      .....    ......|+..|+|||++.. ..++.++||||||+++|||++|+.||......+...               
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            33221    2234568899999998755 457889999999999999999999875322111000               


Q ss_pred             ---------hcCcccCc------ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          522 ---------LADPKLDR------EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       522 ---------~~d~~l~~------~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                               .++.....      ....+....+.+++.+|++ +|.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                     00000000      0001123446677888988 79999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.7e-34  Score=292.27  Aligned_cols=245  Identities=21%  Similarity=0.270  Sum_probs=187.4

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCC-CCceeEEecceeccCe-----
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVR-HPNLVALLGYCLRVDE-----  380 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~-----  380 (588)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.+...    .....+.+|+.+++.++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688899999999999999996 47899999987642    22457889999999995 6999999999887665     


Q ss_pred             eeEEeecCCCCChhhhhhcC----CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecC
Q 042871          381 CFLIYELCPNGNLAEWLFGK----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFG  455 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFG  455 (588)
                      .|+||||+++ +|.+++...    ...+++.+.+.++.|+++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 898888542    235899999999999999999999998   999999999999998 8899999999


Q ss_pred             CcceecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccch-hhh---c-C-----
Q 042871          456 LSKVIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-LEL---A-D-----  524 (588)
Q Consensus       456 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~~~---~-d-----  524 (588)
                      +++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||........ .+.   + .     
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            9876532211 1122356788999998765 4578999999999999999999988753211100 000   0 0     


Q ss_pred             -------------cccC----cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 -------------PKLD----REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 -------------~~l~----~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                   +...    ..........+..++..|+. +|.+||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                         0000    00001123445667888887 7999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8e-34  Score=290.18  Aligned_cols=237  Identities=23%  Similarity=0.256  Sum_probs=182.9

Q ss_pred             eeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHH---hccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          319 LIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVAS---SSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~---l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .||+|+||.||+++. .+++.+|+|.+...     .....+.+|..+   +...+|||++.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999986 46899999988642     112234455443   334579999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +|+|.+++... +.+++.+...++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++.......   ..
T Consensus        81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~  153 (279)
T cd05633          81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (279)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence            99999998643 45899999999999999999999998   9999999999999999999999999987554322   12


Q ss_pred             CccCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh--cCcccCcccCHHHHHHHHHHHHHh
Q 042871          470 EVRGTFGYLDPEYRS-NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL--ADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~--~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      ...|+..|+|||... +..++.++||||||+++|||++|+.||...........  .........+......+.+++..|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHH
Confidence            346899999999886 45689999999999999999999999864332221111  111111122223334556667778


Q ss_pred             hc-CCCCCC-----CHHHHHHH
Q 042871          547 TA-LTHQRP-----PMEQVFVT  562 (588)
Q Consensus       547 ~~-~p~~RP-----s~~evl~~  562 (588)
                      +. +|.+||     +++|+++.
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhC
Confidence            87 799999     59988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.4e-34  Score=300.84  Aligned_cols=244  Identities=22%  Similarity=0.266  Sum_probs=192.3

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc------
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV------  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------  378 (588)
                      ..++|+..+.||+|+||.||+++. .+|+.||+|.+...    .....+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999986 47899999998632    2345678899999999999999999988643      


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ...++||||+. ++|.+.+...   +++.++..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999995 6888887432   888899999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-----------------
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-----------------  521 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-----------------  521 (588)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||..........                 
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            754322  2233467889999999999999999999999999999999999875322110000                 


Q ss_pred             ------hcCcc---------------cC----cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          522 ------LADPK---------------LD----REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       522 ------~~d~~---------------l~----~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                            ..+..               ..    ..........+.+++..|++ +|++|||+.|++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  00000               00    00011223456778899988 79999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.3e-34  Score=292.66  Aligned_cols=250  Identities=21%  Similarity=0.219  Sum_probs=196.4

Q ss_pred             CccccceeeccCceEEEEEEe----cCCcEEEEEEecCC------CcHHHHHHHHHHhccC-CCCceeEEecceeccCee
Q 042871          313 KLNELNLIGEGITGKVYKGKL----SNNQHVAIKHITNE------GNVETFVREVASSSHV-RHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~  381 (588)
                      +|+..+.||+|+||.||+++.    .+++.||||.+...      ...+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467788999999999999974    36789999988632      2345688999999999 599999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++|+|.+++... ..+++.....++.|++++|.|||+.+   ++||||||+||++++++.++|+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            9999999999999998643 45888999999999999999999988   9999999999999999999999999988754


Q ss_pred             CCCcccccCccCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCccccccccc----hhhhcCcccCcccCHHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCK--VNSSGDVYSFGIVLLQILSGKKAKVLTRAGS----ALELADPKLDREYSIEA  535 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~----~~~~~d~~l~~~~~~e~  535 (588)
                      ...........|+..|++||...+..  .+.++||||||+++|||++|+.||.......    ....+.... ...+...
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-PPFPKTM  235 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-CCCCccc
Confidence            43333333456889999999987654  7889999999999999999999985322111    111110000 1111222


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      ...+.+++..|++ +|++|||++++.+.|+...
T Consensus       236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence            3445667788887 7999999998888777553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.5e-34  Score=293.39  Aligned_cols=246  Identities=21%  Similarity=0.320  Sum_probs=191.2

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      -++|+..+.||+|+||.||+|+.. +++.||||.+...   .....+.+|+..+.+.. |+||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            356788899999999999999986 4899999998643   23345677887666665 999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||++ ++|.+++......+++.++..++.|+++||.|||+ .+   |+||||+|+||++++++.+||+|||++.......
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9984 57777775545578999999999999999999997 46   9999999999999999999999999987654322


Q ss_pred             cccccCccCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCcccccccc--chhhhcCcccCc-ccCHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCK----VNSSGDVYSFGIVLLQILSGKKAKVLTRAG--SALELADPKLDR-EYSIEAFD  537 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~----~t~ksDVwS~Gvll~ElltG~~p~~~~~~~--~~~~~~d~~l~~-~~~~e~~~  537 (588)
                      .  .....++..|+|||++....    ++.++||||||+++|||++|+.||......  .....++..... ........
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            2  22335788999999986543    788999999999999999999998642221  111222221111 01111234


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .+.+++.+|+. +|.+||+++++++.
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcC
Confidence            46777889998 79999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.7e-34  Score=291.05  Aligned_cols=246  Identities=23%  Similarity=0.283  Sum_probs=193.7

Q ss_pred             CccccceeeccCceEEEEEEe----cCCcEEEEEEecCC------CcHHHHHHHHHHhccC-CCCceeEEecceeccCee
Q 042871          313 KLNELNLIGEGITGKVYKGKL----SNNQHVAIKHITNE------GNVETFVREVASSSHV-RHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~  381 (588)
                      +|+..+.||+|+||.||+++.    .+|+.||+|++...      ...+.+.+|+.++.++ +|+||+++.+++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477788999999999999985    47899999998642      2245678899999999 599999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++|+||+++++|.+++... ..+++.+...++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            9999999999999999643 45888889999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcccccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCcccccccc-chhhhcCccc--CcccCHHHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SALELADPKL--DREYSIEAF  536 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~~~~d~~l--~~~~~~e~~  536 (588)
                      ...........|+..|+|||++..  ..++.++||||||+++|||++|+.|+...... ...+..+...  ...++....
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  236 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCC
Confidence            433333334568899999999865  34678999999999999999999998643221 1111111111  111223334


Q ss_pred             HHHHHHHHHhhc-CCCCCC-----CHHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRP-----PMEQVFVT  562 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RP-----s~~evl~~  562 (588)
                      ..+..++..|++ +|.+||     +.++++..
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            556677888888 699997     66777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9e-34  Score=288.80  Aligned_cols=237  Identities=22%  Similarity=0.255  Sum_probs=187.0

Q ss_pred             eeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          320 IGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       320 LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      ||+|+||+||++.. .+|+.||+|.+...     .....+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999985 47899999988532     2344678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCcc
Q 042871          394 AEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR  472 (588)
Q Consensus       394 ~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~  472 (588)
                      .+++.... ..+++.+++.++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.......  ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            99996543 36899999999999999999999998   9999999999999999999999999987654321  223345


Q ss_pred             CCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Ccc--cCcccCHHHHHHHHHHHHHhhc-
Q 042871          473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPK--LDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       473 gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~--l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ++..|++||++.+..++.++||||||+++|||++|+.||.........+.+ ...  .....+......+..++..|++ 
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence            788999999998888999999999999999999999998643321111111 100  0111222223445666778887 


Q ss_pred             CCCCCC-----CHHHHHH
Q 042871          549 LTHQRP-----PMEQVFV  561 (588)
Q Consensus       549 ~p~~RP-----s~~evl~  561 (588)
                      +|.+||     +..+++.
T Consensus       236 ~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         236 DPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ChhHccCCCcccHHHHHh
Confidence            799999     5555553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-33  Score=291.23  Aligned_cols=249  Identities=20%  Similarity=0.197  Sum_probs=181.4

Q ss_pred             hcCccccceeeccCceEEEEEEecC----CcEEEEEEecCCCc---H----------HHHHHHHHHhccCCCCceeEEec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN----NQHVAIKHITNEGN---V----------ETFVREVASSSHVRHPNLVALLG  373 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~---~----------~~~~~Ei~~l~~l~HpnIv~l~g  373 (588)
                      .++|.+.++||+|+||.||+|+..+    +..+|+|.......   .          .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4678899999999999999998643    45666665432111   0          11223445566788999999998


Q ss_pred             ceeccC----eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          374 YCLRVD----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       374 ~~~~~~----~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      ++....    ..++++|++. .++.+.+.. ....++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence            766543    3477888773 466666532 233577888999999999999999998   9999999999999999999


Q ss_pred             EEEecCCcceecCCCcc------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc-cchhh-
Q 042871          450 KLSDFGLSKVIDIGETY------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA-GSALE-  521 (588)
Q Consensus       450 kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~-~~~~~-  521 (588)
                      +|+|||+++........      ......||+.|+|||+..+..++.++||||||+++|||++|+.||..... ..... 
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999876432211      11234699999999999999999999999999999999999999975422 21111 


Q ss_pred             ----hcCcccCcc-cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          522 ----LADPKLDRE-YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       522 ----~~d~~l~~~-~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                          .+....... ........+.+++..|+. +|++||++.++++.|+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence                111111111 011223556777889998 7899999999998763

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.5e-34  Score=293.06  Aligned_cols=239  Identities=23%  Similarity=0.298  Sum_probs=192.4

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChh
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLA  394 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~  394 (588)
                      ..||+|+||.||++.. .+|+.||||++...  .....+.+|+..++.++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999987 57899999998642  23457889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCC
Q 042871          395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT  474 (588)
Q Consensus       395 ~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt  474 (588)
                      +++.  ...+++.....++.|++.+|+|||+.+   ++||||||+||++++++.++|+|||++....... .......|+
T Consensus       106 ~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~  179 (292)
T cd06657         106 DIVT--HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGT  179 (292)
T ss_pred             HHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccC
Confidence            9884  335889999999999999999999998   9999999999999999999999999987654322 122335688


Q ss_pred             CCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCccc--CHHHHHHHHHHHHHhhc-CCC
Q 042871          475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY--SIEAFDLTLQLALSCTA-LTH  551 (588)
Q Consensus       475 ~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~--~~e~~~~v~~L~~~C~~-~p~  551 (588)
                      ..|++||+.....++.++|+||||+++|||++|+.||...........+...+....  .......+..++..|+. +|.
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~  259 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA  259 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence            999999999888889999999999999999999999864333322222222221111  11122334556778887 799


Q ss_pred             CCCCHHHHHHH
Q 042871          552 QRPPMEQVFVT  562 (588)
Q Consensus       552 ~RPs~~evl~~  562 (588)
                      +||++.++++.
T Consensus       260 ~R~~~~~ll~~  270 (292)
T cd06657         260 QRATAAELLKH  270 (292)
T ss_pred             cCcCHHHHhcC
Confidence            99999998873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-33  Score=290.53  Aligned_cols=245  Identities=22%  Similarity=0.275  Sum_probs=188.0

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|.+...    ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            56888999999999999999974 7899999988632    224578899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCcceecCCC
Q 042871          387 LCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~  464 (588)
                      |++ ++|.+++.... ..+++.....++.|++.||+|||+.+   ++||||||+||++++ ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 58888875433 34678888899999999999999988   999999999999985 5679999999997653321


Q ss_pred             cccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhc-------------------
Q 042871          465 TYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELA-------------------  523 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~-------------------  523 (588)
                       .......+++.|+|||++.+ ..++.++||||||+++|||+||+.||......+ ..+.+                   
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             11233456889999998766 457899999999999999999999885322111 00000                   


Q ss_pred             ----CcccCcc----cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 ----DPKLDRE----YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 ----d~~l~~~----~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                          .+.....    ...+....+.+++..|++ +|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000000    001112335567788887 7999999999986

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=287.85  Aligned_cols=243  Identities=26%  Similarity=0.306  Sum_probs=194.2

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      |+..+.||+|++|.||+++. .+|+.+++|++....    ....+.+|+..+++++|+||+++++++.+++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            45677899999999999986 478999999986432    3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++ +|.+++......+++.+++.++.++++||.|||+.+   |+|+||||+||++++++.+||+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY  155 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence            64 898888665567999999999999999999999998   9999999999999999999999999987765433 122


Q ss_pred             cCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-----------CcccC--------
Q 042871          469 SEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-----------DPKLD--------  528 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-----------d~~l~--------  528 (588)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+           .+.+.        
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            234578889999998776 7899999999999999999999887532211100000           00000        


Q ss_pred             ----------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          529 ----------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       529 ----------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                .....+....+..++..|++ +|.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      00112234567788999998 7999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.2e-33  Score=291.56  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=188.8

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccC------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVD------  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------  379 (588)
                      -++|+..+.||+|+||.||+++.. +++.||||.+....    ....+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457889999999999999999864 78999999885321    2335678999999999999999999887543      


Q ss_pred             --eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          380 --ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       380 --~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                        ..++||||++ ++|.+++......+++.+.+.++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence              4599999995 5888888665557899999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCcc---cccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc-------c
Q 042871          458 KVIDIGETY---ASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP-------K  526 (588)
Q Consensus       458 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~-------~  526 (588)
                      .........   ......++..|+|||++.+. .++.++||||||+++|||++|+.|+...........+..       .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            765432211   11234578899999987664 478899999999999999999988753322111100000       0


Q ss_pred             ---------------cCcccCHH---------HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          527 ---------------LDREYSIE---------AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       527 ---------------l~~~~~~e---------~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                     +.......         ....+.+++..|+. +|.+|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                           00000000         01234568888988 7999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-34  Score=288.99  Aligned_cols=244  Identities=27%  Similarity=0.293  Sum_probs=196.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .+.|+.++.||.|.-|+||++++. ++..+|+|++.+.     ........|-++|+.+.||.++.|+..++.++..+||
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            345677789999999999999985 4589999999753     2345667788999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC-
Q 042871          385 YELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-  462 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~-  462 (588)
                      ||||+||+|..+++.+. +.+++..++-++.+++-||+|||-.+   ||.|||||+||||.++|.+.|+||.|+..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999997544 57899999999999999999999999   99999999999999999999999998643311 


Q ss_pred             --------------------------------CCc----------------------ccccCccCCCCccCcccccCCCC
Q 042871          463 --------------------------------GET----------------------YASSEVRGTFGYLDPEYRSNCKV  488 (588)
Q Consensus       463 --------------------------------~~~----------------------~~~~~~~gt~~Y~aPE~~~~~~~  488 (588)
                                                      ...                      ..+...+||..|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                      11123579999999999999999


Q ss_pred             CchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCccc--Cc--ccCHHHHHHHHHHHHHhhcCCCCCCC----HHHH
Q 042871          489 NSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKL--DR--EYSIEAFDLTLQLALSCTALTHQRPP----MEQV  559 (588)
Q Consensus       489 t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l--~~--~~~~e~~~~v~~L~~~C~~~p~~RPs----~~ev  559 (588)
                      +.++|+|+|||++|||+.|+.||.-..... ...++-..+  .+  ..+..+.+++.+|.   ..+|.+|-.    +.||
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL---vKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL---VKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHh---ccChhhhhccccchHHh
Confidence            999999999999999999999997655443 333333222  22  23355556665554   558999988    5555


Q ss_pred             H
Q 042871          560 F  560 (588)
Q Consensus       560 l  560 (588)
                      -
T Consensus       390 K  390 (459)
T KOG0610|consen  390 K  390 (459)
T ss_pred             h
Confidence            4

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-34  Score=285.31  Aligned_cols=237  Identities=23%  Similarity=0.206  Sum_probs=185.6

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEEecCCC-----cHHHHHHHHHH-hccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-----NVETFVREVAS-SSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+|+. .+|+.||||.+....     ....+..|... ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999986 468999999986421     12234455444 4556899999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      ++|.+++... ..+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.+||+|||+++....     ...
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~  152 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK  152 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence            9999999543 45888999999999999999999998   99999999999999999999999999876432     233


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc---ccCcccCHHHHHHHHHHHHHhh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP---KLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~---~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ..++..|++||...+..++.++||||||+++|||++|+.|+...........+..   .............+..++..|+
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  232 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL  232 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence            4678899999999888899999999999999999999999865443332222211   1111111223355677788888


Q ss_pred             c-CCCCCCCHHHHHHHH
Q 042871          548 A-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L  563 (588)
                      + +|++||++.++.+.|
T Consensus       233 ~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         233 CMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cCCHHHccCCCcHHHHH
Confidence            7 799999876655544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=295.75  Aligned_cols=242  Identities=22%  Similarity=0.331  Sum_probs=204.6

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .-|+..+.||+|.|..|-++++ -+|..||||++...    .....+++|++-|+.++|||||+|+.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3466677899999999999974 48999999999753    234578899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~DFGla~~~~~~~~  465 (588)
                      +-.+|+|.|||......+.+....+++.||..|+.|.|+.+   ++||||||+||.+- .-|-+||.|||++..+.++..
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999999888888999999999999999999999999   99999999999775 467899999999987766654


Q ss_pred             ccccCccCCCCccCcccccCCCCCc-hhhHHHHHHHHHHHHcCCCccccccccchhh-hcCc--ccCcccCHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNS-SGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADP--KLDREYSIEAFDLTLQ  541 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~-ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~--~l~~~~~~e~~~~v~~  541 (588)
                      .  ...+|+..|.|||++++..|+. +.||||||||||.|++|+.||+.....+... ++|=  .++...+.|+.+++..
T Consensus       175 L--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  175 L--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS  252 (864)
T ss_pred             h--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence            3  4468999999999999998875 7899999999999999999998665554444 3342  2345567777777654


Q ss_pred             HHHHhhcCCCCCCCHHHHHH
Q 042871          542 LALSCTALTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~~p~~RPs~~evl~  561 (588)
                      +.   ..+|++|.+.++|+.
T Consensus       253 ML---vRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  253 ML---VRDPKKRASLEEIVS  269 (864)
T ss_pred             HH---hcCchhhccHHHHhc
Confidence            44   558999999988864

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.3e-33  Score=291.32  Aligned_cols=247  Identities=23%  Similarity=0.269  Sum_probs=189.2

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc-------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV-------  378 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-------  378 (588)
                      .++|+..+.||+|+||.||+|+.. +++.||||++...    .....+.+|++++++++|+||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999964 6899999988532    2234678999999999999999999987543       


Q ss_pred             -CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          379 -DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       379 -~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                       ..+++|+||++ ++|.+.+......+++.++..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence             34699999995 5787777665567999999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCcc----------cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---
Q 042871          458 KVIDIGETY----------ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---  523 (588)
Q Consensus       458 ~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---  523 (588)
                      +........          ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||.........+.+   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            765432211          1123456888999998765 45889999999999999999999887532211110000   


Q ss_pred             -------------------CcccCcccC-------HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 -------------------DPKLDREYS-------IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 -------------------d~~l~~~~~-------~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                         +.......+       ......+.+++.+|++ +|++|||+.|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                               000000000       0111345677888888 7999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-33  Score=292.11  Aligned_cols=246  Identities=27%  Similarity=0.373  Sum_probs=194.7

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      +.|+..+.||+|+||.||+|+. .+++.||+|.+...     ...+.+.+|+++++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3466678899999999999996 46889999988531     22456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+. |+|.+++......+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 6888887655566899999999999999999999988   999999999999999999999999998765422  


Q ss_pred             ccccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCcccCcccCHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~l~~~~~~e~~~~v~~  541 (588)
                         ....++..|+|||++.   ...++.++||||||+++|||++|+.|+.......... .................+..
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence               2345788999999874   3567889999999999999999999875433222211 11111111111223345667


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ++.+|+. +|.+||++.++++...-.
T Consensus       246 li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             HHHHHhhCCcccCCCHHHHhhCcccc
Confidence            7889998 799999999998764433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.4e-33  Score=284.11  Aligned_cols=244  Identities=23%  Similarity=0.222  Sum_probs=190.6

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecC-------CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-------EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      +|.+.+.||+|+||.||+++.. .+..+++|.++.       ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4677889999999999999864 344555555542       12334577899999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          385 YELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      +||+++++|.+++..   ....+++.+++.++.|+++||.|||+.+   ++|+||||+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998853   3356899999999999999999999988   999999999999975 569999999987654


Q ss_pred             CCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      ... .......|++.|+|||+..+..++.++|+||||+++|+|++|+.|+....................+......+..
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS  235 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHH
Confidence            322 2223456788999999998888999999999999999999999988533322222221111111222333445666


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ++.+|+. +|++||++.|+++
T Consensus       236 li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         236 IMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHHHhcCChhhCcCHHHHhh
Confidence            7888887 7999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-34  Score=308.08  Aligned_cols=239  Identities=22%  Similarity=0.320  Sum_probs=191.9

Q ss_pred             ceeeccCceEEEEEEe-cCCcEEEEEE------ecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCe--eeEEeecC
Q 042871          318 NLIGEGITGKVYKGKL-SNNQHVAIKH------ITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELC  388 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~-~~g~~VAVK~------l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~--~~LV~E~~  388 (588)
                      ..||+|.|-+||||.+ .+|..||--.      .+.+...+.|..|+.+|+.|+|+||+++++++.+...  .-+|+|++
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            3799999999999986 3677776322      2234556899999999999999999999999987655  78999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ..|+|..|+.+. +.++......|++||++||.|||++. |||+|||||.+||+|+. -|.|||+|+|||.....  . .
T Consensus       126 TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--s-~  200 (632)
T KOG0584|consen  126 TSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--S-H  200 (632)
T ss_pred             cCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc--c-c
Confidence            999999999543 35888899999999999999999986 67999999999999975 58999999999987542  2 2


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccc-ccchhhhcCcccCc-ccCHHHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTR-AGSALELADPKLDR-EYSIEAFDLTLQLALS  545 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~-~~~~~~~~d~~l~~-~~~~e~~~~v~~L~~~  545 (588)
                      ...+.|||.|||||+.. ..|++..||||||+.++||+|+.-||..-. ...+++.+-..+.+ .++.-....+.+++..
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek  279 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK  279 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence            23488999999999888 589999999999999999999999986322 22334333333222 1221123457778999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 042871          546 CTALTHQRPPMEQVFVT  562 (588)
Q Consensus       546 C~~~p~~RPs~~evl~~  562 (588)
                      |+....+|||+.|+|..
T Consensus       280 Cl~~~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  280 CLATKSERLSAKELLKD  296 (632)
T ss_pred             HhcCchhccCHHHHhhC
Confidence            99989999999999864

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=285.65  Aligned_cols=242  Identities=23%  Similarity=0.302  Sum_probs=190.6

Q ss_pred             ccccceeeccCceEEEEEEec-CCcEEEEEEecCCC---cHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEeecC
Q 042871          314 LNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      |.+.+.||+|+||.||+|+.. +++.|+||++....   ......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999975 57899999986432   2234567999999999 999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                       +|+|.+++.... ..+++.++..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889999986544 46899999999999999999999998   99999999999999999999999999986543222  


Q ss_pred             ccCccCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCccccccccchh----h------------------hcC
Q 042871          468 SSEVRGTFGYLDPEYRS-NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL----E------------------LAD  524 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----~------------------~~d  524 (588)
                      .....++..|+|||++. ...++.++|+||||++++||++|+.||......+..    .                  .++
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            22345788999999774 456789999999999999999999887533211100    0                  000


Q ss_pred             cccCcc-------cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 PKLDRE-------YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ~~l~~~-------~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..+...       ........+..++..|++ +|.+|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000       000112557788999998 7999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.6e-34  Score=306.19  Aligned_cols=190  Identities=28%  Similarity=0.353  Sum_probs=165.5

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCc-HHHHHHHHHHhccCC-C-----CceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGN-VETFVREVASSSHVR-H-----PNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~~~~~Ei~~l~~l~-H-----pnIv~l~g~~~~~~~~~L  383 (588)
                      -+|++.+.||+|.||.|.|+.. .+++.||||++++... ..+-..|+.+|..|+ |     -|+|+++++|...++.+|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            3889999999999999999985 6799999999998643 456678999999987 3     389999999999999999


Q ss_pred             EeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC--cEEEEecCCccee
Q 042871          384 IYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF--EAKLSDFGLSKVI  460 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~--~~kL~DFGla~~~  460 (588)
                      |+|.+ .-+|.++|.... ..++....+.++.||+.||.+||..+   |||+||||+||||.+-.  .+||+|||.+...
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 669999996543 46899999999999999999999998   99999999999997543  6999999999875


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK  509 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~  509 (588)
                      ...-.    ....+.-|.|||++.+.+|+.+.||||||||+.||++|..
T Consensus       342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~P  386 (586)
T KOG0667|consen  342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEP  386 (586)
T ss_pred             CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcc
Confidence            43221    2345678999999999999999999999999999999976

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-34  Score=314.30  Aligned_cols=197  Identities=18%  Similarity=0.248  Sum_probs=160.4

Q ss_pred             HhcCccccceeeccCceEEEEEEec--CCcEEEEE------------------EecC-CCcHHHHHHHHHHhccCCCCce
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS--NNQHVAIK------------------HITN-EGNVETFVREVASSSHVRHPNL  368 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK------------------~l~~-~~~~~~~~~Ei~~l~~l~HpnI  368 (588)
                      ..++|.+.+.||+|+||+||++.++  ++..+++|                  .+.. ......+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998753  22222222                  1111 1224567899999999999999


Q ss_pred             eEEecceeccCeeeEEeecCCCCChhhhhhcCC----cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC
Q 042871          369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKD----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG  444 (588)
Q Consensus       369 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld  444 (588)
                      +++++++.+.+..|+|+|++ +++|.+++....    ......+...++.|++.||.|||+.+   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            99999999999999999999 567777774322    12335567789999999999999998   99999999999999


Q ss_pred             CCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCc
Q 042871          445 PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA  510 (588)
Q Consensus       445 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p  510 (588)
                      .++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            999999999999987654443334456799999999999999999999999999999999998754

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=284.24  Aligned_cols=242  Identities=28%  Similarity=0.379  Sum_probs=188.7

Q ss_pred             ccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccC---CCCceeEEecceeccCe-----
Q 042871          314 LNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHV---RHPNLVALLGYCLRVDE-----  380 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~-----  380 (588)
                      |++.+.||+|+||.||+|+.. +++.||+|++...    .....+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999975 5899999998632    1234566787766555   69999999999988776     


Q ss_pred             eeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          381 CFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      .+++|||+. ++|.+++.... ..+++.+++.++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 58998886533 35899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcC--------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELAD--------------  524 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d--------------  524 (588)
                      ......  .....++..|+|||++.+..++.++|+||||+++|||++|+.|+......+.. +..+              
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            643322  12335788999999999989999999999999999999998887643321111 0100              


Q ss_pred             ----cccCc-------ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 ----PKLDR-------EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ----~~l~~-------~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                          .....       ....+....+.+++..|++ +|.+||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                00000       0111233556778899998 7999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.7e-33  Score=290.13  Aligned_cols=240  Identities=28%  Similarity=0.374  Sum_probs=190.9

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      |...+.||+|+||.||+|+. .+|+.|++|++...     ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999986 47889999998632     1235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +. |+|.+++......+++.+++.++.|++.+|.|||+.+   ++||||||+||++++++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 6888888665667999999999999999999999998   99999999999999999999999999864321     


Q ss_pred             ccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCcccCcccCHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      .....|+..|+|||++.   ...++.++||||||+++|||++|+.|+.......... .................+..++
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV  253 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            22356888999999874   4568889999999999999999999976433222111 1111111111112223466778


Q ss_pred             HHhhc-CCCCCCCHHHHHHH
Q 042871          544 LSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..|++ +|.+||++.+++..
T Consensus       254 ~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         254 DYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHccCChhhCcCHHHHhcC
Confidence            88998 79999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-33  Score=293.86  Aligned_cols=251  Identities=25%  Similarity=0.316  Sum_probs=197.2

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC-----eee
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD-----ECF  382 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~  382 (588)
                      +|...+.||+|+||.||+|+.. +|+.||||++...    ...+.+.+|++.++.++|+||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778889999999999999974 5899999998652    23567899999999999999999999998775     789


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||++ ++|.+++.... .+++..++.++.++++||.|||+.+   |+||||||+|||+++++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58988885433 7999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc--ccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc------------
Q 042871          463 GET--YASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL------------  527 (588)
Q Consensus       463 ~~~--~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l------------  527 (588)
                      ...  .......++..|+|||++.+. .++.++|+||||+++|||++|+.||.........+.+....            
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            331  122334678899999998887 88999999999999999999999885332211111000000            


Q ss_pred             -----------C--cc-----cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH--HHHhhc
Q 042871          528 -----------D--RE-----YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT--LQKALD  568 (588)
Q Consensus       528 -----------~--~~-----~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~--L~~~~~  568 (588)
                                 .  ..     ...+....+..++..|++ +|.+|||+++++..  +++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                       0  00     001123446678888888 79999999999985  554433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-34  Score=300.37  Aligned_cols=247  Identities=23%  Similarity=0.301  Sum_probs=201.1

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecC----CCcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITN----EGNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV  384 (588)
                      -...|+++++||+||-+.||++...+.+.+|+|++..    ....+.|.+|+..|.+++ |.+|+.|++|-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            3467889999999999999999998889999998753    345678999999999997 89999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||= +-+|..+|..+...+....++.+..||+.++.++|.++   |||.||||.|+|+- +|.+||+|||+|..+..+.
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            9986 67999999766554442377789999999999999999   99999999999994 6799999999999876655


Q ss_pred             ccc-ccCccCCCCccCcccccCCC-----------CCchhhHHHHHHHHHHHHcCCCcccccc--ccchhhhcCcccCcc
Q 042871          465 TYA-SSEVRGTFGYLDPEYRSNCK-----------VNSSGDVYSFGIVLLQILSGKKAKVLTR--AGSALELADPKLDRE  530 (588)
Q Consensus       465 ~~~-~~~~~gt~~Y~aPE~~~~~~-----------~t~ksDVwS~Gvll~ElltG~~p~~~~~--~~~~~~~~d~~l~~~  530 (588)
                      +.. ....+||+.||+||.+....           .+.++||||+|||||+|+-|+.||....  ..++..+.+|...-+
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE  593 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence            432 34568999999999865433           4568999999999999999999997554  235666677754333


Q ss_pred             cCHH-HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          531 YSIE-AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       531 ~~~e-~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ++.- ....+..++..|++ +|++|||+.++|+
T Consensus       594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            3311 11126778999999 7999999999986

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4e-33  Score=291.65  Aligned_cols=241  Identities=20%  Similarity=0.225  Sum_probs=185.0

Q ss_pred             ceeecc--CceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEG--ITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G--~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ..||+|  +||+||+++. .+|+.||+|.+....    ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356776  9999999986 489999999986422    246788899999999999999999999999999999999999


Q ss_pred             CChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc---
Q 042871          391 GNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY---  466 (588)
Q Consensus       391 gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~---  466 (588)
                      ++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|++||+.+.........   
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999998653 235889999999999999999999988   999999999999999999999999865432111100   


Q ss_pred             ---cccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhcC----------------
Q 042871          467 ---ASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELAD----------------  524 (588)
Q Consensus       467 ---~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d----------------  524 (588)
                         ......++..|++||++.+  ..++.++||||||+++|||++|+.||....... ..+.+.                
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence               0111234667999999876  357899999999999999999999985322111 000000                


Q ss_pred             -----------------------------cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 -----------------------------PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 -----------------------------~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                                   ..+...........+..|+..|+. +|++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                         001111122334567788999998 7999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.1e-33  Score=280.95  Aligned_cols=244  Identities=21%  Similarity=0.224  Sum_probs=186.6

Q ss_pred             HHHHHHHhcCcccccee--eccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhcc-CCCCceeEEecceeccC
Q 042871          304 IREVHYATEKLNELNLI--GEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSH-VRHPNLVALLGYCLRVD  379 (588)
Q Consensus       304 ~~el~~at~~f~~~~~L--G~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~~~  379 (588)
                      ..+.....++|++.+.+  |+|+||.||+++. .++..+|+|.+....... .  |+..... .+||||+++++++...+
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~--e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-I--EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-h--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            34444455777777776  9999999999986 478899999886432111 1  2222221 26999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcc
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSK  458 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~  458 (588)
                      ..++||||+++++|.+++.... .+++.++..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||+++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            9999999999999999996543 7999999999999999999999998   99999999999999988 99999999987


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccch-----hhhcCcccCcccCH
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-----LELADPKLDREYSI  533 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-----~~~~d~~l~~~~~~  533 (588)
                      .....     ....++..|+|||++.+..++.++||||||+++|||++|+.||........     .......  .....
T Consensus       159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  231 (267)
T PHA03390        159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK--LPFIK  231 (267)
T ss_pred             ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc--CCccc
Confidence            65422     223578999999999998999999999999999999999999874332211     1111111  01111


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCCC-HHHHHH
Q 042871          534 EAFDLTLQLALSCTA-LTHQRPP-MEQVFV  561 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RPs-~~evl~  561 (588)
                      .....+..++..|++ +|.+||+ ++|+++
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            223345556677777 7999996 688874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-33  Score=294.15  Aligned_cols=246  Identities=21%  Similarity=0.294  Sum_probs=192.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec----cCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR----VDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~  381 (588)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++...    .....+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            47899999999999999999986 47999999998643    234567889999999999999999998763    3568


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++|+||++ ++|.+++... ..+++.....++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 6899988543 45899999999999999999999988   9999999999999999999999999997654


Q ss_pred             CCCcc---cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccc-------------------
Q 042871          462 IGETY---ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-------------------  518 (588)
Q Consensus       462 ~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-------------------  518 (588)
                      .....   ......|+..|+|||++.. ..++.++||||||+++|||++|+.||.......                   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211   1234568899999998765 568899999999999999999999985322110                   


Q ss_pred             -----hhhhcCcccC--ccc-----CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          519 -----ALELADPKLD--REY-----SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       519 -----~~~~~d~~l~--~~~-----~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                           ..+..+ ...  ...     ..+....+..++..|++ +|.+|||+.+++..
T Consensus       239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 000000 000  001     01123456778888888 79999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=293.06  Aligned_cols=237  Identities=25%  Similarity=0.304  Sum_probs=198.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .+.|..-++||+||||.||-.+. .+|+.+|.|++..     .....--++|-.+|.+++.+.||.+--.++.++.++||
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            45677788999999999999875 5799999987753     23334567899999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          385 YELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      +..|.||+|.-||.+.+ ..+++....-++.+|+-||++||+..   |+.|||||+|||||+.|+++|+|+|||..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999997654 46899999999999999999999999   999999999999999999999999999988777


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc-------CcccCHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL-------DREYSIEAF  536 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l-------~~~~~~e~~  536 (588)
                      ......  +||.||||||++.+..|+...|.|||||+||||+.|+.||...+.....+.+|...       .+.++++..
T Consensus       341 ~~~~~r--vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eak  418 (591)
T KOG0986|consen  341 KPIRGR--VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAK  418 (591)
T ss_pred             Cccccc--cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHH
Confidence            665443  89999999999999999999999999999999999999998777666555555443       344566665


Q ss_pred             HHHHHHHHHhhcCCCCCCC
Q 042871          537 DLTLQLALSCTALTHQRPP  555 (588)
Q Consensus       537 ~~v~~L~~~C~~~p~~RPs  555 (588)
                      ++...|.   ..+|.+|-.
T Consensus       419 slc~~LL---~Kdp~~RLG  434 (591)
T KOG0986|consen  419 SLCEGLL---TKDPEKRLG  434 (591)
T ss_pred             HHHHHHH---ccCHHHhcc
Confidence            5554443   335665543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=9.8e-34  Score=318.75  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=189.1

Q ss_pred             HHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceec------
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLR------  377 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------  377 (588)
                      .....+|++.+.||+||||.|||++.+ ||+.+|||++.-.   .......+|+..+++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678999999999999999999965 9999999999754   334568899999999999999998765421      


Q ss_pred             -------------------------------------------------c------------------------------
Q 042871          378 -------------------------------------------------V------------------------------  378 (588)
Q Consensus       378 -------------------------------------------------~------------------------------  378 (588)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             ----------------------------------CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhc
Q 042871          379 ----------------------------------DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH  424 (588)
Q Consensus       379 ----------------------------------~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH  424 (588)
                                                        ..+||-||||+..+|.+++..+...-.....|+++.+|++||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              0146789999888888877543322145677899999999999999


Q ss_pred             cccCCceEecCCCCCCeEECCCCcEEEEecCCcceec----C------------CCc-ccccCccCCCCccCcccccCCC
Q 042871          425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID----I------------GET-YASSEVRGTFGYLDPEYRSNCK  487 (588)
Q Consensus       425 ~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~----~------------~~~-~~~~~~~gt~~Y~aPE~~~~~~  487 (588)
                      +.+   ||||||||.||+||++..+||+|||+|....    .            +.. ...+..+||.-|+|||.+.+..
T Consensus       715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            999   9999999999999999999999999998721    0            011 1234568999999999987654


Q ss_pred             ---CCchhhHHHHHHHHHHHHcCCCccc--cccccchhhhcCcccCcc--cCHHHHHHHHHHHHHhhc-CCCCCCCHHHH
Q 042871          488 ---VNSSGDVYSFGIVLLQILSGKKAKV--LTRAGSALELADPKLDRE--YSIEAFDLTLQLALSCTA-LTHQRPPMEQV  559 (588)
Q Consensus       488 ---~t~ksDVwS~Gvll~ElltG~~p~~--~~~~~~~~~~~d~~l~~~--~~~e~~~~v~~L~~~C~~-~p~~RPs~~ev  559 (588)
                         |+.|+|+||+|||++||+.-   |.  +.+...+..+-++.++..  +.......-.+++.|.++ +|.+|||+.|+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence               99999999999999999963   43  222223333334454443  223334444566778787 89999999998


Q ss_pred             HH
Q 042871          560 FV  561 (588)
Q Consensus       560 l~  561 (588)
                      +.
T Consensus       869 L~  870 (1351)
T KOG1035|consen  869 LN  870 (1351)
T ss_pred             hh
Confidence            75

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-33  Score=293.49  Aligned_cols=250  Identities=26%  Similarity=0.335  Sum_probs=194.0

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceecc-----Ce
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRV-----DE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~  380 (588)
                      .++|...+.||+|+||.||+++. .+++.||||.+..    ......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46789999999999999999986 4789999999864    22345678899999999999999999988654     35


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++|+||+. ++|.+++... ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 7898888543 46899999999999999999999998   999999999999999999999999999866


Q ss_pred             cCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhh---------------h-c
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE---------------L-A  523 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~---------------~-~  523 (588)
                      .... .......++..|+|||++.. ..++.++||||||+++|||++|+.||..........               . .
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            4332 12233457889999998765 468899999999999999999999885321110000               0 0


Q ss_pred             Cccc-------C-------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH--HHHh
Q 042871          524 DPKL-------D-------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT--LQKA  566 (588)
Q Consensus       524 d~~l-------~-------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~--L~~~  566 (588)
                      +...       .       ..........+..++.+|++ +|++|||++|+++.  ++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            0000       0       00011123445678889998 79999999999987  6554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-34  Score=286.02  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=218.1

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecc
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGY  374 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~  374 (588)
                      ..++....+++....++-+|.||+||.|.+.      +.+.|-||.+++..   ....++.|--.+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3456666777888888999999999999653      34567778776543   35578899999999999999999999


Q ss_pred             eecc-CeeeEEeecCCCCChhhhhh-----c--CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC
Q 042871          375 CLRV-DECFLIYELCPNGNLAEWLF-----G--KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN  446 (588)
Q Consensus       375 ~~~~-~~~~LV~E~~~~gsL~~~L~-----~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~  446 (588)
                      +.++ ...++.|.++.-|+|+.||.     +  ..+.++..+...++.|++.|++|||+++   |+|.||..+|.+||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            8765 56789999999999999996     2  2246888899999999999999999999   9999999999999999


Q ss_pred             CcEEEEecCCcceecCCCcccc-cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcC
Q 042871          447 FEAKLSDFGLSKVIDIGETYAS-SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELAD  524 (588)
Q Consensus       447 ~~~kL~DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d  524 (588)
                      .++||+|-.++|.+.+++.+.- ..-.....||+||.+.+..|+.++|||||||+||||+| |+.|+...+..+....+.
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            9999999999998766655432 22234678999999999999999999999999999999 888998777777777776


Q ss_pred             cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          525 PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       525 ~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ...+-.-+..+++.+..++..||. .|++||+++|++.-|.+-
T Consensus       513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            666665666777888888999999 799999999999998764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-33  Score=283.11  Aligned_cols=243  Identities=26%  Similarity=0.353  Sum_probs=192.3

Q ss_pred             ccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          314 LNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      |+..+.||+|+||.||+|+.. +++.||+|.+...    ...+.+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999975 5999999998742    23467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      + ++|.+++......+++.++..++.++++||.|||+.+   |+||||+|+||++++++.+||+|||+++....... ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence            7 5999999765457999999999999999999999998   99999999999999999999999999887643322 12


Q ss_pred             cCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhh---------------------cCcc
Q 042871          469 SEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL---------------------ADPK  526 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~---------------------~d~~  526 (588)
                      ....++..|+|||++... .++.++||||||+++|||++|+.||...........                     .+..
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            223457789999998766 789999999999999999999988753221110000                     0000


Q ss_pred             cCc-------ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          527 LDR-------EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       527 l~~-------~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...       .........+.+++..|+. +|++||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000       0001113457778888988 7999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.1e-33  Score=286.70  Aligned_cols=240  Identities=21%  Similarity=0.262  Sum_probs=184.0

Q ss_pred             eeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChh
Q 042871          319 LIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLA  394 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~  394 (588)
                      .+|.|+++.||+++. +++.||||++...    ...+.+.+|++.++.++|+||+++++++.+.+..+++|||+++|+|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            445555656666655 7999999998643    34567899999999999999999999999999999999999999999


Q ss_pred             hhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc------cc
Q 042871          395 EWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET------YA  467 (588)
Q Consensus       395 ~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~------~~  467 (588)
                      +++... ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||.+........      ..
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            999653 345888899999999999999999998   99999999999999999999999999875532211      11


Q ss_pred             ccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccccccccch-hhhc---------------------
Q 042871          468 SSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-LELA---------------------  523 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~~~~---------------------  523 (588)
                      .....++..|+|||++..  ..++.++||||||+++|||++|+.||........ .+.+                     
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS  244 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence            123456788999999865  3588999999999999999999999863221110 0000                     


Q ss_pred             -------CcccC----cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 -------DPKLD----REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 -------d~~l~----~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                             ++...    ..........+..++..|+. +|++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                   00000    00111222456678888988 79999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-32  Score=281.53  Aligned_cols=232  Identities=24%  Similarity=0.276  Sum_probs=180.7

Q ss_pred             eeeccCceEEEEEEe-cCCcEEEEEEecCCC-----cHHHHHHHHH---HhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          319 LIGEGITGKVYKGKL-SNNQHVAIKHITNEG-----NVETFVREVA---SSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~~Ei~---~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .||+|+||.||+++. .+++.||+|.+....     ....+.+|..   .++...||||+++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999986 468999999886421     1123444443   3445679999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +|+|.+++.. ...+++.++..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++.......   ..
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~  153 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence            9999998854 346999999999999999999999988   9999999999999999999999999987553221   12


Q ss_pred             CccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhh---h---cCcccCcccCHHHHHHHHHH
Q 042871          470 EVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE---L---ADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~---~---~d~~l~~~~~~e~~~~v~~L  542 (588)
                      ...|+..|+|||++..+ .++.++||||||+++|||++|+.||..........   .   ....+....+.    .+..+
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~~l  229 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP----ELRSL  229 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCH----HHHHH
Confidence            34689999999998754 68999999999999999999999986542222111   1   12222223333    44455


Q ss_pred             HHHhhc-CCCCCC-----CHHHHHH
Q 042871          543 ALSCTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RP-----s~~evl~  561 (588)
                      +..|+. +|.+||     ++.++++
T Consensus       230 i~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         230 LEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHHHhhcCHHhccCCCCCCHHHHHh
Confidence            666676 689999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-32  Score=290.25  Aligned_cols=248  Identities=24%  Similarity=0.329  Sum_probs=190.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc------C
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV------D  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~  379 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...    .....+.+|+.++++++|+||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999986 47899999998642    2235688999999999999999999998754      3


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..++|+||+. .+|.+++   ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            4699999996 4777665   235888999999999999999999998   99999999999999999999999999876


Q ss_pred             ecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hc--------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LA--------------  523 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~--------------  523 (588)
                      ....    .....++..|+|||++.+ ..++.++||||||+++|||++|+.||.......... .+              
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            4321    223457889999998866 468899999999999999999999986322111000 00              


Q ss_pred             C-----------cccC-cccC---HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH--HHHhhcc
Q 042871          524 D-----------PKLD-REYS---IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT--LQKALDI  569 (588)
Q Consensus       524 d-----------~~l~-~~~~---~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~--L~~~~~~  569 (588)
                      +           +... ...+   ......+..++..|++ +|.+||++.|++..  ++...+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            0           0000 0000   0112335677888988 79999999999954  7666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.7e-33  Score=290.52  Aligned_cols=246  Identities=23%  Similarity=0.263  Sum_probs=188.1

Q ss_pred             cCccc-cceeeccCceEEEEEEec-CCcEEEEEEecCCCcH----------------HHHHHHHHHhccCCCCceeEEec
Q 042871          312 EKLNE-LNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNV----------------ETFVREVASSSHVRHPNLVALLG  373 (588)
Q Consensus       312 ~~f~~-~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~----------------~~~~~Ei~~l~~l~HpnIv~l~g  373 (588)
                      ++|.. .+.||+|+||.||+|+.. +++.||||.+......                ..+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45543 467999999999999864 7899999988642211                24779999999999999999999


Q ss_pred             ceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEe
Q 042871          374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSD  453 (588)
Q Consensus       374 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~D  453 (588)
                      ++..++..++||||++ |+|.+++.. ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 699998854 345889999999999999999999988   99999999999999999999999


Q ss_pred             cCCcceecCCC-------------cccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccch
Q 042871          454 FGLSKVIDIGE-------------TYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA  519 (588)
Q Consensus       454 FGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~  519 (588)
                      ||+++......             ........++..|+|||++.+. .++.++||||||+++|||++|+.||......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99987654111             1111223467889999988764 468999999999999999999998864332211


Q ss_pred             hhh----cC--------------------cccCcc---cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          520 LEL----AD--------------------PKLDRE---YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       520 ~~~----~d--------------------~~l~~~---~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ...    ..                    ......   ......+.+.+++..|+. +|++|||++|++..
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            110    00                    000000   000112445677888888 79999999999863

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-33  Score=275.95  Aligned_cols=233  Identities=25%  Similarity=0.273  Sum_probs=189.8

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCCh
Q 042871          320 IGEGITGKVYKGKLS-NNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       320 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      ||+|+||.||+++.. +++.+++|.+....     ..+.+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999974 68999999986432     345788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccC
Q 042871          394 AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG  473 (588)
Q Consensus       394 ~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~g  473 (588)
                      .+++... ..+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++....... .......+
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  155 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG  155 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence            9999644 35899999999999999999999988   9999999999999999999999999987754332 22344567


Q ss_pred             CCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCC
Q 042871          474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQ  552 (588)
Q Consensus       474 t~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~  552 (588)
                      +..|++||...+...+.++|+||||+++||+++|+.||...........+.. .....+......+.+++..|+. +|++
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~  234 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTK  234 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence            8899999999888889999999999999999999999865443222222211 1112222234455667788887 7999


Q ss_pred             CCCHHH
Q 042871          553 RPPMEQ  558 (588)
Q Consensus       553 RPs~~e  558 (588)
                      ||++++
T Consensus       235 R~~~~~  240 (250)
T cd05123         235 RLGSGG  240 (250)
T ss_pred             CCCccc
Confidence            999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-33  Score=296.64  Aligned_cols=243  Identities=25%  Similarity=0.327  Sum_probs=201.9

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ...|.+...||+|.|+.|..+++ .++..||||.+.+.    ...+.+.+|+++|+.++|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            46788889999999999999986 47999999998753    33456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||..+|.+.+++..... +.......++.|+.++++|+|++.   |+|||||++||||+.+.++||+|||++..+..+. 
T Consensus       135 eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-  209 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-  209 (596)
T ss_pred             EeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc-
Confidence            99999999999976554 444888889999999999999999   9999999999999999999999999999876443 


Q ss_pred             ccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCcccC--cccCHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPKLD--REYSIEAFDLTLQ  541 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~l~--~~~~~e~~~~v~~  541 (588)
                       ......|++.|.|||+..+.+| ++++|+||+|++||-|+.|..||+...-..+.+ .+...++  ..++.++-+++.+
T Consensus       210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk  288 (596)
T KOG0586|consen  210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK  288 (596)
T ss_pred             -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence             3455789999999999998776 568999999999999999999997433322222 2222222  2245677777766


Q ss_pred             HHHHhhcCCCCCCCHHHHHHH
Q 042871          542 LALSCTALTHQRPPMEQVFVT  562 (588)
Q Consensus       542 L~~~C~~~p~~RPs~~evl~~  562 (588)
                      ++   .-+|.+|++++++.+.
T Consensus       289 ~l---vl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  289 FL---VLNPSKRGPCDQIMKD  306 (596)
T ss_pred             hh---ccCccccCCHHHhhhh
Confidence            65   5589999999998753

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-32  Score=288.13  Aligned_cols=246  Identities=25%  Similarity=0.334  Sum_probs=192.0

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceec-cCe
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLR-VDE  380 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~  380 (588)
                      +...+++|+..+.||+|+||.||+++. .+++.||||++..    ....+.+.+|++++++++||||+++.+++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            345688999999999999999999985 4889999998753    2234678899999999999999999999875 567


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++|+||+ +++|.+++.  ...+++.....++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus        85 ~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            89999998 678988884  345788888899999999999999998   999999999999999999999999998754


Q ss_pred             cCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchh------------hhcC---
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL------------ELAD---  524 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~------------~~~d---  524 (588)
                      ...    .....++..|+|||++.+ ..++.++||||||+++|||++|+.||.........            ++.+   
T Consensus       159 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         159 DPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             CCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            321    123456889999998765 57899999999999999999999988533211000            0000   


Q ss_pred             -c-------cc--CcccCH-----HHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          525 -P-------KL--DREYSI-----EAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       525 -~-------~l--~~~~~~-----e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                       .       .+  ....+.     .....+..++..|++ +|++|||+.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0       00  000110     122456777888887 79999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=279.19  Aligned_cols=237  Identities=27%  Similarity=0.301  Sum_probs=201.7

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ..++|+.+++||+|.||.|-.++- .+|+.+|+|+++.+     .++..-+.|-++|+.-+||.+..|.-.|...+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            457899999999999999999985 47999999998764     234445678899999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||..||.|.-||.. .+.+++....-+-..|..||.|||+.+   |+.||||.+|.|+|.+|.+||+||||++.-- .
T Consensus       246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~  320 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-K  320 (516)
T ss_pred             EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-c
Confidence            9999999999999954 345777777778889999999999999   9999999999999999999999999998532 1


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~  540 (588)
                      ........+|||.|+|||++.+..|+...|.|.+||++|||++||.||...+.+.+.+++   |-.++...+.|...++.
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS  400 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence            122346689999999999999999999999999999999999999999988887777765   55566677888777775


Q ss_pred             HHHHHhhcCCCCCC
Q 042871          541 QLALSCTALTHQRP  554 (588)
Q Consensus       541 ~L~~~C~~~p~~RP  554 (588)
                      -|.   ..+|.+|.
T Consensus       401 GLL---~kdP~kRL  411 (516)
T KOG0690|consen  401 GLL---KKDPKKRL  411 (516)
T ss_pred             HHh---hcChHhhc
Confidence            554   55787775

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-32  Score=289.50  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=193.0

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV  378 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~  378 (588)
                      ..++...+++|...+.||+|+||.||+|.. .+|+.||+|++...    ...+.+.+|++++.+++||||+++.+++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            456677889999999999999999999985 57899999998642    1245688899999999999999999987643


Q ss_pred             ------CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEE
Q 042871          379 ------DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLS  452 (588)
Q Consensus       379 ------~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~  452 (588)
                            ...++++|++ +++|.+++..  ..+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence                  3468888887 7899888843  35899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCcceecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh---------
Q 042871          453 DFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL---------  522 (588)
Q Consensus       453 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~---------  522 (588)
                      |||+++.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........         
T Consensus       163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998764321    233467889999998766 5688899999999999999999998853221111000         


Q ss_pred             ------cCc-----------ccCc-ccC---HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          523 ------ADP-----------KLDR-EYS---IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       523 ------~d~-----------~l~~-~~~---~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                            +..           .... .+.   ......+.+++..|++ +|.+||++.+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                  000           0000 000   0012235677888887 79999999998865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=324.83  Aligned_cols=245  Identities=27%  Similarity=0.374  Sum_probs=194.9

Q ss_pred             HhcCccccceeeccCceEEEEEE-ecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .+-++...+.||.|.||.||.+. .++|+..|+|.+.-.    .....+.+|+.++..++|||+|+++|+=.+.+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            34566677899999999999998 578999999987632    2345678999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||||++|+|.+.+.. ....++....-+-.|++.|++|||+++   |+||||||.||+|+.+|.+|++|||.|..+....
T Consensus      1313 MEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999999999943 334566666678899999999999999   9999999999999999999999999998875442


Q ss_pred             ccc---ccCccCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCccccccccch-h----hhcCcccCcccCH
Q 042871          465 TYA---SSEVRGTFGYLDPEYRSNC---KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-L----ELADPKLDREYSI  533 (588)
Q Consensus       465 ~~~---~~~~~gt~~Y~aPE~~~~~---~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~----~~~d~~l~~~~~~  533 (588)
                      ...   -....||+-|||||++.+.   ....+.||||+||+++||+||++||...+.+-. .    .--.|.+++..+.
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence            111   2356899999999998764   355689999999999999999999986554321 1    1112333344444


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          534 EAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +-    ...+..|++ +|++|-++.|+++.
T Consensus      1469 ~g----~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1469 EG----RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hH----HHHHHHHHhcCchhhhHHHHHHHh
Confidence            44    344678887 89999887766654

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=299.43  Aligned_cols=242  Identities=24%  Similarity=0.363  Sum_probs=195.7

Q ss_pred             cCccccceeeccCceEEEEEEecC-CcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      +.|+++..||.|.||.|||++.++ +-..|-|++..  ....++|+-||++|+...||+||+|++.|..++.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            456777889999999999998754 44557787764  456789999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      .||-.+..+..-...|+..++.-++.+++.||.|||++.   |||||||+.|||++-+|.++|+|||.+..... .....
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR  187 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR  187 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence            999999999877788999999999999999999999999   99999999999999999999999998754321 11223


Q ss_pred             cCccCCCCccCcccc-----cCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC----cccC--cccCHHHHH
Q 042871          469 SEVRGTFGYLDPEYR-----SNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD----PKLD--REYSIEAFD  537 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~-----~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d----~~l~--~~~~~e~~~  537 (588)
                      ..+.|||.|||||+.     .+.+|+.++||||||+.|.||..+.+|-.....-++.-.+.    |.+.  ..++.+.  
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F--  265 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF--  265 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH--
Confidence            457899999999974     56789999999999999999999998865443333222221    2221  2344443  


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                        ..+...|+. +|..||++.++++
T Consensus       266 --~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  266 --SDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --HHHHHHHHhcCCccCCCHHHHhh
Confidence              334677877 7999999988875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=300.79  Aligned_cols=194  Identities=29%  Similarity=0.427  Sum_probs=170.3

Q ss_pred             cccceeeccCceEEEEEEe-cCCcEEEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceeccC------eeeEE
Q 042871          315 NELNLIGEGITGKVYKGKL-SNNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVD------ECFLI  384 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------~~~LV  384 (588)
                      ...+.||+|+||.||+|+. .+|+.||||.+..   ....+...+|+++|++++|+|||++++.=.+..      ...+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            3456899999999999995 6899999999976   456788999999999999999999999866544      46899


Q ss_pred             eecCCCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC--CCC--cEEEEecCCcc
Q 042871          385 YELCPNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG--PNF--EAKLSDFGLSK  458 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld--~~~--~~kL~DFGla~  458 (588)
                      ||||.+|||...|.+..  ..|++.+.+.+..++..||.|||+++   |+||||||.||++-  ++|  ..||+|||.|+
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            99999999999996543  36999999999999999999999888   99999999999983  334  47999999999


Q ss_pred             eecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      .++.+.  ....++||..|.+||.... +.|+...|.|||||++||..||..||..
T Consensus       173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            987665  4456899999999999885 7899999999999999999999999853

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-32  Score=288.96  Aligned_cols=194  Identities=25%  Similarity=0.359  Sum_probs=166.5

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC----
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD----  379 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----  379 (588)
                      ...++|...+.||+|+||.||++.. .+|..||||++...    ...+.+.+|+.++++++||||+++++++..+.    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3577899999999999999999985 57899999998542    12346889999999999999999999987553    


Q ss_pred             --eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          380 --ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       380 --~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                        ..++||||+ +++|.+++.  ...+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence              458999999 779998884  346899999999999999999999998   999999999999999999999999998


Q ss_pred             ceecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      ......    .....+++.|++||++.+ ..++.++|+||||+++|+|++|+.||.
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  217 (343)
T cd07880         166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK  217 (343)
T ss_pred             cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            765322    123457889999998876 458899999999999999999999885

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=6.1e-32  Score=283.22  Aligned_cols=245  Identities=25%  Similarity=0.317  Sum_probs=186.1

Q ss_pred             CccccceeeccCceEEEEEEec-C--CcEEEEEEecCC----CcHHHHHHHHHHhccC-CCCceeEEecceecc----Ce
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-N--NQHVAIKHITNE----GNVETFVREVASSSHV-RHPNLVALLGYCLRV----DE  380 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~--g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~----~~  380 (588)
                      +|...+.||+|+||.||+++.. +  +..||+|++...    ...+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999964 4  789999998642    2245688999999999 599999999875432    45


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++++||++ ++|.+++.. ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999985 689988854 346899999999999999999999998   999999999999999999999999999866


Q ss_pred             cCCCcc---cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchh----------------
Q 042871          461 DIGETY---ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL----------------  520 (588)
Q Consensus       461 ~~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----------------  520 (588)
                      ......   ......|+..|+|||+..+ ..++.++||||||+++|||++|+.||.........                
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            432221   1233568999999998765 56899999999999999999999887532211000                


Q ss_pred             hhcCcc----------c-Cc---ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          521 ELADPK----------L-DR---EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       521 ~~~d~~----------l-~~---~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ...++.          . ..   .........+..++.+|++ +|.+|||+.|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000          0 00   0000112456677888887 79999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.3e-32  Score=288.00  Aligned_cols=242  Identities=24%  Similarity=0.347  Sum_probs=189.8

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCe----
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDE----  380 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~----  380 (588)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++...    ...+.+.+|+.++++++|+|++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999974 6889999988642    234567889999999999999999998876554    


Q ss_pred             --eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          381 --CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       381 --~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                        .++|+||+ +++|.+++..  ..+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999999 6799998853  46899999999999999999999998   9999999999999999999999999988


Q ss_pred             eecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C------c----c
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D------P----K  526 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d------~----~  526 (588)
                      .....    .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+ +      +    .
T Consensus       167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            65432    233467889999998765 36788999999999999999999988532221110000 0      0    0


Q ss_pred             c----------------CcccC---HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          527 L----------------DREYS---IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       527 l----------------~~~~~---~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +                ...+.   ......+..++..|++ +|.+|||+.||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0                00000   0012345667888887 7999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=4.1e-32  Score=285.88  Aligned_cols=245  Identities=21%  Similarity=0.270  Sum_probs=185.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceecc---------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRV---------  378 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~---------  378 (588)
                      ..+|...+.||.|+||.||+|+. .+|+.||+|.+...  ...+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36788999999999999999986 47899999988643  3456788999999999999999999876643         


Q ss_pred             -----CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEE
Q 042871          379 -----DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLS  452 (588)
Q Consensus       379 -----~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~  452 (588)
                           ...++|+||++ ++|.+++.  ...+++...+.++.|+++||.|||+.+   |+||||||+||+++ +++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 58988884  345889999999999999999999998   99999999999997 45678999


Q ss_pred             ecCCcceecCCCcc--cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcC----
Q 042871          453 DFGLSKVIDIGETY--ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELAD----  524 (588)
Q Consensus       453 DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d----  524 (588)
                      |||+++........  ......++..|+|||++.. ..++.++||||||+++|||++|+.||......... ..++    
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999765322111  1122357889999997654 56788999999999999999999998532211000 0000    


Q ss_pred             --------------c-----ccCcccC-----HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 --------------P-----KLDREYS-----IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 --------------~-----~l~~~~~-----~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                    .     ......+     ......+..++..|+. +|.+|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                          0     0000000     0112345567888887 7999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=9.1e-32  Score=306.95  Aligned_cols=143  Identities=28%  Similarity=0.386  Sum_probs=129.3

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|.+.+.||+|+||.||+|+.. +++.||||++....     ....+.+|+.++..++|+||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999975 78999999986421     2357888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ||+++++|.+++... ..+++...+.++.|++.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999543 35888899999999999999999988   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.2e-31  Score=264.19  Aligned_cols=232  Identities=29%  Similarity=0.362  Sum_probs=191.5

Q ss_pred             CceEEEEEEec-CCcEEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChhhhhhc
Q 042871          324 ITGKVYKGKLS-NNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFG  399 (588)
Q Consensus       324 ~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~  399 (588)
                      +||.||+|+.. +|+.+++|++.....   .+.+.+|++.+++++|+|++++.+++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999975 589999999975432   67899999999999999999999999999999999999999999999865


Q ss_pred             CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccC
Q 042871          400 KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD  479 (588)
Q Consensus       400 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~a  479 (588)
                      ... +++.+++.++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  ......++..|++
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            433 889999999999999999999998   9999999999999999999999999998765432  2334567889999


Q ss_pred             cccccCCCCCchhhHHHHHHHHHHHHcCCCcccc-ccccchhhhcCcccCcccCHH--HHHHHHHHHHHhhc-CCCCCCC
Q 042871          480 PEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL-TRAGSALELADPKLDREYSIE--AFDLTLQLALSCTA-LTHQRPP  555 (588)
Q Consensus       480 PE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~-~~~~~~~~~~d~~l~~~~~~e--~~~~v~~L~~~C~~-~p~~RPs  555 (588)
                      ||......++.++|||+||++++||++|+.||.. .......+.+...........  ....+.+++.+|+. +|++||+
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            9999888899999999999999999999999865 333333333322221111111  34566778889988 7999999


Q ss_pred             HHHHHH
Q 042871          556 MEQVFV  561 (588)
Q Consensus       556 ~~evl~  561 (588)
                      +.++++
T Consensus       235 ~~~~~~  240 (244)
T smart00220      235 AEEALQ  240 (244)
T ss_pred             HHHHhh
Confidence            999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=265.18  Aligned_cols=242  Identities=23%  Similarity=0.370  Sum_probs=187.2

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCc---HHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecC
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGN---VETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .+.+..||.|+-|.|++.++ .+|...|||.+....+   .+.++..+.++.+- ..|+||+-+|+|..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            34456799999999999997 4689999999976544   34556666665544 4899999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                       ..-++.+|..-.+++++.-.-++...+.+||.||..++.  |+|||+||+|||+|+.|++||+|||++..+-+..  ..
T Consensus       174 -s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah  248 (391)
T KOG0983|consen  174 -STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH  248 (391)
T ss_pred             -HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence             456666666556678888888999999999999998653  9999999999999999999999999998765433  33


Q ss_pred             cCccCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCccccccc--cchhhhcC---cccCcccCHHHHHHHH
Q 042871          469 SEVRGTFGYLDPEYRSN---CKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELAD---PKLDREYSIEAFDLTL  540 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~~~~d---~~l~~~~~~e~~~~v~  540 (588)
                      +.-.|-+.|||||.+..   ..|+-++||||||+.|+||.||+-||...+.  +.+..+++   |.++...  ..-....
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~--gFSp~F~  326 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM--GFSPDFQ  326 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc--CcCHHHH
Confidence            45578899999998754   4788899999999999999999999875322  22222332   3332221  1223455


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ++...|+. ++.+||...++++.
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhcC
Confidence            56778887 68999999988753

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.2e-31  Score=265.55  Aligned_cols=220  Identities=21%  Similarity=0.195  Sum_probs=173.5

Q ss_pred             cCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChhhhhhcCC
Q 042871          323 GITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD  401 (588)
Q Consensus       323 G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~  401 (588)
                      |.||.||+++. .+++.+|+|++....   .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++... 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-
Confidence            88999999986 578999999987543   2334555555667999999999999999999999999999999998543 


Q ss_pred             cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcc
Q 042871          402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE  481 (588)
Q Consensus       402 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE  481 (588)
                      ..+++.....++.|+++||.|||+.+   |+||||||+||++++++.++++|||++......    .....++..|+|||
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE  152 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPE  152 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCc
Confidence            35899999999999999999999988   999999999999999999999999987654322    12234567899999


Q ss_pred             cccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHH
Q 042871          482 YRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQ  558 (588)
Q Consensus       482 ~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~e  558 (588)
                      +.....++.++||||+|+++|||++|+.++...... ........+...++    ..+..++.+|++ +|++||++.+
T Consensus       153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-INTHTTLNIPEWVS----EEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cccccccCCcccCC----HHHHHHHHHHccCCHHHhcCCCc
Confidence            998888999999999999999999999876532211 11111111222233    345566788887 7999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-32  Score=266.01  Aligned_cols=202  Identities=26%  Similarity=0.375  Sum_probs=169.6

Q ss_pred             cHHHHHHHhcCccccceeeccCceEEEEEE-ecCCcEEEEEEecCC--CcHHHHHHHHHHhccCC-CCceeEEecceecc
Q 042871          303 TIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE--GNVETFVREVASSSHVR-HPNLVALLGYCLRV  378 (588)
Q Consensus       303 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~  378 (588)
                      ++.++-+.|++     .||+|.|+.|-.++ +.+|..+|||++.+.  .......+|++++.+.+ |+||+.|+.+|+++
T Consensus        74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            45666666654     89999999999887 689999999999764  34668899999999986 99999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC---cEEEEecC
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF---EAKLSDFG  455 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~---~~kL~DFG  455 (588)
                      ..+|||||-|.||+|..+|+.. +.+++.+..++..+|+.||.|||.++   |.||||||+|||-.+..   -+||+||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccc
Confidence            9999999999999999999654 45889999999999999999999999   99999999999996544   38999999


Q ss_pred             CcceecCCC------cccccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          456 LSKVIDIGE------TYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       456 la~~~~~~~------~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      |........      +..-...+|+..|||||+..     ...|+.+.|.||||||||-|++|-.||.-
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG  293 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG  293 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence            876543221      12223457888999999642     23578899999999999999999999863

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.6e-31  Score=296.81  Aligned_cols=248  Identities=23%  Similarity=0.248  Sum_probs=169.6

Q ss_pred             HhcCccccceeeccCceEEEEEEec-C----CcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecc------eecc
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-N----NQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGY------CLRV  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~----g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~------~~~~  378 (588)
                      ..++|+..+.||+|+||.||+|++. +    +..||||++......+.+.+|.  +....+.++..++..      ...+
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER--VRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH--HHhhchhhHHHHHHhhhcccccccC
Confidence            4678999999999999999999974 4    7899999987654444333331  222222333222221      2456


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcC-------------------ccHHHHHHHHHhhhccchhhccccCCceEecCCCCC
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKC-------------------LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT  439 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~-------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~  439 (588)
                      ...++|+||+++++|.+++......                   .....+..++.|+++||+|||+.+   |+||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence            6899999999999999998543211                   122345679999999999999988   999999999


Q ss_pred             CeEECC-CCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCC----------------------CCCchhhHHH
Q 042871          440 NILLGP-NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC----------------------KVNSSGDVYS  496 (588)
Q Consensus       440 NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~t~ksDVwS  496 (588)
                      |||+++ ++.+||+|||+++....+.........++++|+|||.+...                      .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986 67999999999987655555555667889999999965322                      2345679999


Q ss_pred             HHHHHHHHHcCCCcccccc----------ccchh---hhcCcccCcccC--HH----HHHHHHHHHHHhhc-CCCCCCCH
Q 042871          497 FGIVLLQILSGKKAKVLTR----------AGSAL---ELADPKLDREYS--IE----AFDLTLQLALSCTA-LTHQRPPM  556 (588)
Q Consensus       497 ~Gvll~ElltG~~p~~~~~----------~~~~~---~~~d~~l~~~~~--~e----~~~~v~~L~~~C~~-~p~~RPs~  556 (588)
                      |||+||||+++..+.....          ..+..   ..+.+....+..  .+    .......|+..|++ +|++|||+
T Consensus       365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            9999999999876533110          00000   011111000000  00    01123367888887 79999999


Q ss_pred             HHHHHH
Q 042871          557 EQVFVT  562 (588)
Q Consensus       557 ~evl~~  562 (588)
                      +|+++.
T Consensus       445 ~e~L~H  450 (566)
T PLN03225        445 KAALAH  450 (566)
T ss_pred             HHHhCC
Confidence            999874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=271.39  Aligned_cols=235  Identities=25%  Similarity=0.332  Sum_probs=191.8

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ..+|..+..||+|+||.|.++.-+ +.+.+|||+++.+     .+++--+.|-++|+.. +-|.++.+..+|..-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457888999999999999999754 5678999998753     3344456677777766 57899999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+.||+|-.++.+-.+ +.+..+.-++.+||-||-+||+++   |+.||||.+|||||.+|.+||+|||+++.--.+
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999965443 666777889999999999999999   999999999999999999999999999864322


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--cccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--PKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--~~l~~~~~~e~~~~v~  540 (588)
                       ...+...+||+.|+|||++.+++|+..+|.|||||+||||+.|+.||.-.++.++...+ +  -.++..++.|......
T Consensus       504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ick  582 (683)
T KOG0696|consen  504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICK  582 (683)
T ss_pred             -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHH
Confidence             23456689999999999999999999999999999999999999999876666655443 2  2334566777777665


Q ss_pred             HHHHHhhcCCCCC
Q 042871          541 QLALSCTALTHQR  553 (588)
Q Consensus       541 ~L~~~C~~~p~~R  553 (588)
                      -++   +..|.+|
T Consensus       583 g~l---tK~P~kR  592 (683)
T KOG0696|consen  583 GLL---TKHPGKR  592 (683)
T ss_pred             HHh---hcCCccc
Confidence            554   4456544

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=6.2e-32  Score=266.20  Aligned_cols=195  Identities=27%  Similarity=0.389  Sum_probs=165.3

Q ss_pred             hcCccccceeeccCceEEEEEEec---C--CcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec-cCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS---N--NQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR-VDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~---~--g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~  380 (588)
                      ...|+....||+|.||.|||++-.   +  ...+|+|+++.+    .-.....+|+.+++.++|||++.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            356888899999999999999632   2  337899999865    334578899999999999999999999987 788


Q ss_pred             eeEEeecCCCCChhhhhhc----CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC----CcEEEE
Q 042871          381 CFLIYELCPNGNLAEWLFG----KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN----FEAKLS  452 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~----~~~kL~  452 (588)
                      +++++||.+. +|...++-    +.+.++......|+.|++.|+.|||++-   |+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999976 78887742    2356888899999999999999999999   9999999999999877    899999


Q ss_pred             ecCCcceecCCCc--ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCC
Q 042871          453 DFGLSKVIDIGET--YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKK  509 (588)
Q Consensus       453 DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~  509 (588)
                      |||++|.+...-.  .....++-|..|.|||.+.+ ..||++.|||+.|||+.||+|-++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~P  238 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEP  238 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCc
Confidence            9999998754322  23455777999999999887 468999999999999999999765

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=303.21  Aligned_cols=250  Identities=25%  Similarity=0.277  Sum_probs=201.9

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceec
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLR  377 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~  377 (588)
                      ++++..-.++|.+++.||+|+||.|..++. .+++.+|.|++..     ..+..-|.+|-.+|..-+.+-|+.+.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            456666678999999999999999999997 4688999999874     3455678889999999999999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      +.++|+|||||+||+|..++.... .+++.-..-++..|.-||.-||+.|   +|||||||+|||||..|.+||+|||.+
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            999999999999999999996555 6787777888899999999999999   999999999999999999999999999


Q ss_pred             ceecCCCcccccCccCCCCccCccccc----C-CCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhcCc----cc
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRS----N-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELADP----KL  527 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d~----~l  527 (588)
                      -.++.+....+...+|||.|++||++.    + +.|++..|.||+||++|||+.|..||....--..+ .+++.    .+
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F  302 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF  302 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence            888766666777789999999999864    3 57899999999999999999999999733221111 11111    11


Q ss_pred             C--cccCHHHHHHHHHHHHHhhcCCCCCCC---HHHHHH
Q 042871          528 D--REYSIEAFDLTLQLALSCTALTHQRPP---MEQVFV  561 (588)
Q Consensus       528 ~--~~~~~e~~~~v~~L~~~C~~~p~~RPs---~~evl~  561 (588)
                      +  ...+.+..+++..|+    -+|+.|-.   ++++-.
T Consensus       303 P~~~~VSeeakdLI~~ll----~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  303 PDETDVSEEAKDLIEALL----CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             CcccccCHHHHHHHHHHh----cChhhhcccccHHHHHh
Confidence            1  225666666665544    34555544   777654

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-31  Score=242.07  Aligned_cols=193  Identities=27%  Similarity=0.416  Sum_probs=166.7

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +|...++||+|.||+||||+. ++++.||+|+.+-+.    .-...++|+-+++.++|+|||++++....++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            456677999999999999985 578999999986332    235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      | ..+|..+...-+..++......++.|+++||.+.|+++   +.|||+||.|.||+.+|..|++|||+++.....-...
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            9 56898888777778999999999999999999999999   9999999999999999999999999999775443332


Q ss_pred             ccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCc
Q 042871          468 SSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKA  510 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p  510 (588)
                      +. .+-|..|.+|+++.+. -|+...|+||-||++.|+....+|
T Consensus       159 sa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  159 SA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             ec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            22 3458999999998875 578899999999999999884443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.8e-30  Score=284.14  Aligned_cols=199  Identities=22%  Similarity=0.293  Sum_probs=153.2

Q ss_pred             HhcCccccceeeccCceEEEEEEe-----------------cCCcEEEEEEecCCC--cHHHH--------------HHH
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-----------------SNNQHVAIKHITNEG--NVETF--------------VRE  356 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-----------------~~g~~VAVK~l~~~~--~~~~~--------------~~E  356 (588)
                      ..++|++.++||+|+||.||+|.+                 .+++.||||++....  ..++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999964                 245689999986432  12233              346


Q ss_pred             HHHhccCCCCce-----eEEecceec--------cCeeeEEeecCCCCChhhhhhcCC----------------------
Q 042871          357 VASSSHVRHPNL-----VALLGYCLR--------VDECFLIYELCPNGNLAEWLFGKD----------------------  401 (588)
Q Consensus       357 i~~l~~l~HpnI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~L~~~~----------------------  401 (588)
                      +..+.+++|.++     ++++++|..        ++..+|||||+++|+|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666777766654     677787753        356899999999999999986421                      


Q ss_pred             -cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCc
Q 042871          402 -KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP  480 (588)
Q Consensus       402 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aP  480 (588)
                       ..++|..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||+++....+.........+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             12467788899999999999999998   99999999999999999999999999976543332222233458899999


Q ss_pred             ccccCCCC----------------------CchhhHHHHHHHHHHHHcCCC-cc
Q 042871          481 EYRSNCKV----------------------NSSGDVYSFGIVLLQILSGKK-AK  511 (588)
Q Consensus       481 E~~~~~~~----------------------t~ksDVwS~Gvll~ElltG~~-p~  511 (588)
                      |.+.....                      ..+.||||+||+++||++|.. |+
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~  433 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV  433 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence            98754321                      234799999999999999875 44

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=9e-33  Score=267.19  Aligned_cols=244  Identities=24%  Similarity=0.355  Sum_probs=187.0

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC---CCcHHHHHHHHHH-hccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN---EGNVETFVREVAS-SSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~---~~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++.+.+..||.|.||+|+|-.+ +.|+..|||+++.   +.+..+++.|.+. ++.-+.||||+++|.+..++..|+-||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            3445567899999999999987 5799999999974   3456678888876 555679999999999999999999999


Q ss_pred             cCCCCChhhhh---hc-CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          387 LCPNGNLAEWL---FG-KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       387 ~~~~gsL~~~L---~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +| .-||+.+-   +. ....+++.-.-+|..-+.+||.||....+  |+|||+||+|||||..|.+||+|||++.++- 
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv-  219 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV-  219 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH-
Confidence            99 56766543   22 23457888888899999999999988653  9999999999999999999999999987653 


Q ss_pred             CCcccccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc------Ccc-cCccc-C
Q 042871          463 GETYASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA------DPK-LDREY-S  532 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~------d~~-l~~~~-~  532 (588)
                       .+...+.-+|-..|||||.+..  ..|+-+|||||||+.|+|+.||+-|+..+..  ..+.+      |+. +.... .
T Consensus       220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~~  296 (361)
T KOG1006|consen  220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKEC  296 (361)
T ss_pred             -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcccc
Confidence             2334455678889999998754  3588999999999999999999999876554  22222      221 11111 0


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .+.-..+...+..|+- +..+||...++.++
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1122334455677876 57999999998765

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=284.54  Aligned_cols=237  Identities=26%  Similarity=0.301  Sum_probs=190.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ++.|.....+|.|+|+.|-++.. .+++..+||++...  ..+-.+|+.++... +||||+++.+.+.++.+.|+|||++
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            66777788899999999998875 57889999999765  22334677655544 6999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE-CCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL-GPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl-d~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      .++-|.+.+.....  ...++..|+.+|+.++.|||.++   ++||||||+|||+ ++.++++|+|||.++.....    
T Consensus       399 ~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  399 DGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             cccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            99999888865433  22677789999999999999999   9999999999999 68999999999999876543    


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc-chhhhc-CcccCcccCHHHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SALELA-DPKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~~~~-d~~l~~~~~~e~~~~v~~L~~~  545 (588)
                      ....+-|..|.|||+.....|++++|+||||++||||++|+.|+.....+ ++...+ .+......+.+..++    +.+
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdL----l~~  545 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDL----LQQ  545 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHH----HHH
Confidence            22235588999999999999999999999999999999999998766555 333322 222334455555555    455


Q ss_pred             hhc-CCCCCCCHHHHHHH
Q 042871          546 CTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~~  562 (588)
                      |++ +|.+||+|.++...
T Consensus       546 LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAH  563 (612)
T ss_pred             hccCChhhCcChhhhccC
Confidence            566 89999999998753

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=277.35  Aligned_cols=219  Identities=30%  Similarity=0.357  Sum_probs=180.6

Q ss_pred             cceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          317 LNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      .+.||+|-||+||-|++ ++|+.||||++.+    ....+.+.+|+.+|+++.||.||.+...|+..+..|+|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            46899999999999986 5899999999864    234467889999999999999999999999999999999999554


Q ss_pred             ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC---CcEEEEecCCcceecCCCcccc
Q 042871          392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN---FEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       392 sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~---~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      -|.-.|......|++..-.-++.||+.||.|||.++   |+|+||||+|||+.+.   .++||+|||.||.+....  ..
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR  723 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR  723 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence            455555555567888888889999999999999999   9999999999999653   469999999999986433  34


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-------cccCcccCHHHHHHHHH
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-------PKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-------~~l~~~~~~e~~~~v~~  541 (588)
                      ..++||+.|+|||++.++.|...-|+||.|||+|--++|..||..  ++++.+.+.       +.-..+.+.+..+++..
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            568999999999999999999999999999999999999988863  334444332       33334566677766654


Q ss_pred             H
Q 042871          542 L  542 (588)
Q Consensus       542 L  542 (588)
                      |
T Consensus       802 L  802 (888)
T KOG4236|consen  802 L  802 (888)
T ss_pred             H
Confidence            4

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.7e-30  Score=279.40  Aligned_cols=255  Identities=26%  Similarity=0.358  Sum_probs=200.8

Q ss_pred             cHHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-CcHHHHHHHHHHhccC-CCCceeEEecceec--
Q 042871          303 TIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-GNVETFVREVASSSHV-RHPNLVALLGYCLR--  377 (588)
Q Consensus       303 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~--  377 (588)
                      .++.+...++.|++.+.||+|.+|.||+++. ++++.+|||++... ...++...|.++++.. .|||++.++|++..  
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3444455678899999999999999999984 68999999988754 3456778889998887 49999999999873  


Q ss_pred             ---cCeeeEEeecCCCCChhhhhhc-CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEe
Q 042871          378 ---VDECFLIYELCPNGNLAEWLFG-KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSD  453 (588)
Q Consensus       378 ---~~~~~LV~E~~~~gsL~~~L~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~D  453 (588)
                         ++++|||||||.+||..|++.+ ....+.|..+..|++.+++||.+||...   ++|||||-.|||+++++.+||.|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence               5689999999999999999954 2457999999999999999999999999   99999999999999999999999


Q ss_pred             cCCcceecCCCcccccCccCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC
Q 042871          454 FGLSKVIDIGETYASSEVRGTFGYLDPEYRSN-----CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD  528 (588)
Q Consensus       454 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~  528 (588)
                      ||++.+++... .......||+.|||||++.-     ..|+..+|+||||++..||--|.+|.......+..-.+.+.-+
T Consensus       167 FGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP  245 (953)
T KOG0587|consen  167 FGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP  245 (953)
T ss_pred             eeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence            99998875432 23345679999999998753     3567789999999999999999998764444333333222211


Q ss_pred             cc--cCHHHHHHHHHHHHHhhcC-CCCCCCHHHHHH
Q 042871          529 RE--YSIEAFDLTLQLALSCTAL-THQRPPMEQVFV  561 (588)
Q Consensus       529 ~~--~~~e~~~~v~~L~~~C~~~-p~~RPs~~evl~  561 (588)
                      ..  -+..-...+...+..|+.. -++||++.++++
T Consensus       246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            11  1233334455567788875 599999987764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=264.36  Aligned_cols=244  Identities=29%  Similarity=0.394  Sum_probs=185.3

Q ss_pred             cCccccceeeccCceEEEEEE-ecCCcEEEEEEecC-CC--------cHHHHHHHHHHhccCCCCceeEEeccee-ccCe
Q 042871          312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITN-EG--------NVETFVREVASSSHVRHPNLVALLGYCL-RVDE  380 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~-~~--------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~  380 (588)
                      ++|-.+++||+|||+.|||+. +...+.||||+-.- ..        ..+...+|..+-+.+.||.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            456667899999999999997 46788999997542 11        1234578999999999999999999987 4567


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC---CCCcEEEEecCCc
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG---PNFEAKLSDFGLS  457 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld---~~~~~kL~DFGla  457 (588)
                      ++-|+|||+|.+|+-||. ..+.+++.+...|++||..||.||.... +||+|-||||.||||-   .-|.+||.||||+
T Consensus       543 FCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            889999999999998884 3456899999999999999999998874 6799999999999994   4578999999999


Q ss_pred             ceecCCCcc------cccCccCCCCccCccccc----CCCCCchhhHHHHHHHHHHHHcCCCcccccccc-------chh
Q 042871          458 KVIDIGETY------ASSEVRGTFGYLDPEYRS----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-------SAL  520 (588)
Q Consensus       458 ~~~~~~~~~------~~~~~~gt~~Y~aPE~~~----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-------~~~  520 (588)
                      +..+.....      .++...||..|++||.+.    ....+.|.||||.|||+|..+-|++||......       .+.
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            988654322      234568999999999643    246788999999999999999999999632211       111


Q ss_pred             hhcCcccC--cccCHHHHHHHHHHHHHhhcC-CCCCCCHHHHHH
Q 042871          521 ELADPKLD--REYSIEAFDLTLQLALSCTAL-THQRPPMEQVFV  561 (588)
Q Consensus       521 ~~~d~~l~--~~~~~e~~~~v~~L~~~C~~~-p~~RPs~~evl~  561 (588)
                      ...+-.++  +..+.+.    ..++++|++. .++|...-++..
T Consensus       701 kAtEVqFP~KPvVsseA----kaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEA----KAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             cceeccCCCCCccCHHH----HHHHHHHHHhhhhhhhhHHHHcc
Confidence            11111111  1123333    3347888884 578877666543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=253.95  Aligned_cols=244  Identities=23%  Similarity=0.291  Sum_probs=187.0

Q ss_pred             HhcCcccc-ceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhcc-CCCCceeEEecceec----cCeee
Q 042871          310 ATEKLNEL-NLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSH-VRHPNLVALLGYCLR----VDECF  382 (588)
Q Consensus       310 at~~f~~~-~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~----~~~~~  382 (588)
                      .+++|.+. ++||-|--|.|-.... .+|+.+|+|++.+.   ....+|+++--. -.|||||.+++++..    ...+.
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence            35666653 5799999999998876 47999999998764   344578876443 369999999999874    34578


Q ss_pred             EEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEEecCCcc
Q 042871          383 LIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLSDFGLSK  458 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~DFGla~  458 (588)
                      +|||.|+||.|...+..++ ..+++.+.-+|..||+.|+.|||+.+   |.||||||+|+|...   |-.+||+|||+|+
T Consensus       136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccc
Confidence            9999999999999997654 46999999999999999999999999   999999999999964   5568999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC---cccCHHH
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD---REYSIEA  535 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~---~~~~~e~  535 (588)
                      .....  ..-...+-|+.|.|||++...+|+...|+||+||++|-|++|-.||.-....-+..-+..++.   -.++.+.
T Consensus       213 ~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE  290 (400)
T KOG0604|consen  213 ETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE  290 (400)
T ss_pred             ccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence            75432  223345679999999999999999999999999999999999999975433221111111111   1123222


Q ss_pred             H----HHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          536 F----DLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       536 ~----~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .    +....+++..+. +|.+|-|+.|++.
T Consensus       291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            2    223344555566 7999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-31  Score=273.03  Aligned_cols=241  Identities=23%  Similarity=0.286  Sum_probs=196.9

Q ss_pred             cCccccceeeccCceEEEEEEecCCc-EEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~-~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .+++.+..||-||||+|-.++..+.. .+|+|.++..     ...+....|-.+|...+.|.||+++-.|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45556678999999999999874333 4788887642     34456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |-|-||.|+..|..+ ..++.....-++..+.+|++|||+++   |+.|||||+|.+||.+|-+||.|||+|+.+..+. 
T Consensus       500 EaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-  574 (732)
T ss_pred             HhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence            999999999999654 45777777788889999999999999   9999999999999999999999999999876544 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC-----cccCHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD-----REYSIEAFDLTL  540 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~-----~~~~~e~~~~v~  540 (588)
                       .+.+++||+.|+|||++++...+.++|.||||+++|||++|++||.-.+.-.....+-..+.     ...+....+++ 
T Consensus       575 -KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li-  652 (732)
T KOG0614|consen  575 -KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI-  652 (732)
T ss_pred             -ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH-
Confidence             44568999999999999999999999999999999999999999988777666665544432     22333333443 


Q ss_pred             HHHHHhhcCCCCCCC-----HHHHHH
Q 042871          541 QLALSCTALTHQRPP-----MEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~~p~~RPs-----~~evl~  561 (588)
                        ...|-.+|.+|-.     +.+|-+
T Consensus       653 --k~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  653 --KKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             --HHHHhcCcHhhhccccCChHHHHh
Confidence              3446778877765     555544

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3e-31  Score=254.70  Aligned_cols=195  Identities=25%  Similarity=0.439  Sum_probs=162.1

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc--------
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV--------  378 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--------  378 (588)
                      ..|+...+||+|.||.||+++.. +|+.||+|+..-+    .--...++|+.+|..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34566779999999999999864 6788999876422    2234678999999999999999999988642        


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ..+|+|+++|+. +|.-.|.+....++..++.++..++.+||.|+|...   |+|||+|+.|+||+.++.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence            348999999965 888888666567888999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCc---ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCc
Q 042871          459 VIDIGET---YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKA  510 (588)
Q Consensus       459 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p  510 (588)
                      .+.....   ...+..+-|..|.+||.+.+ .+|+++.|||.-||++.||+||.+-
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi  228 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI  228 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc
Confidence            6643322   12233445899999998765 6899999999999999999999873

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-30  Score=261.22  Aligned_cols=200  Identities=23%  Similarity=0.312  Sum_probs=168.9

Q ss_pred             HHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCc-HHHHHHHHHHhccCC--CC----ceeEEecceeccC
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGN-VETFVREVASSSHVR--HP----NLVALLGYCLRVD  379 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~~~~~Ei~~l~~l~--Hp----nIv~l~g~~~~~~  379 (588)
                      ...+++|.+..++|+|.||.|-.... +.+..||||++++-.. .+.-+-|++++.++.  .|    -+|.+.+||.-.+
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            34488999999999999999999985 3578999999987433 445567999999984  23    2788899999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-------------
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-------------  445 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-------------  445 (588)
                      +.++|+|.+ |-|+.|+|..++ .+.+..++..|+.|++++++|||+..   ++|-||||+|||+.+             
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            999999999 779999996533 47888999999999999999999999   999999999999921             


Q ss_pred             -------CCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccc
Q 042871          446 -------NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTR  515 (588)
Q Consensus       446 -------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~  515 (588)
                             +..+||+|||.|.......    +.++.|..|.|||++++-.++.++||||+||||.|++||..-|+..+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                   3458999999998754322    55678999999999999999999999999999999999998665444

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=2.3e-28  Score=234.16  Aligned_cols=207  Identities=32%  Similarity=0.519  Sum_probs=180.6

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChhh
Q 042871          320 IGEGITGKVYKGKLS-NNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAE  395 (588)
Q Consensus       320 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~  395 (588)
                      ||+|.+|.||+++.. +++.+++|++.....   .+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999975 489999999986544   4789999999999999999999999999999999999999999999


Q ss_pred             hhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCcceecCCCcccccCccCC
Q 042871          396 WLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYASSEVRGT  474 (588)
Q Consensus       396 ~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt  474 (588)
                      ++......+++.+++.++.+++++|.|||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            99654346899999999999999999999998   999999999999999 89999999999986643321 12334577


Q ss_pred             CCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCC
Q 042871          475 FGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQ  552 (588)
Q Consensus       475 ~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~  552 (588)
                      ..|++||..... ..+.+.|+|++|+++++|                                ..+.+++..|+. +|.+
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~  204 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEK  204 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCccc
Confidence            899999998877 888999999999999999                                456667788887 7999


Q ss_pred             CCCHHHHHHH
Q 042871          553 RPPMEQVFVT  562 (588)
Q Consensus       553 RPs~~evl~~  562 (588)
                      ||++.++++.
T Consensus       205 R~~~~~l~~~  214 (215)
T cd00180         205 RPSAKEILEH  214 (215)
T ss_pred             CcCHHHHhhC
Confidence            9999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=8.2e-30  Score=238.80  Aligned_cols=204  Identities=24%  Similarity=0.331  Sum_probs=168.7

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC---CCcHHHHHHHHHHh-ccCCCCceeEEecceeccCee
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN---EGNVETFVREVASS-SHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~---~~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      ++...+.......||+|++|.|-+-++ .+|+..|+|++..   .+.....++|+.+. +....|.+|.++|...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            455566666777899999999998886 6899999999974   34556778888864 455799999999999999999


Q ss_pred             eEEeecCCCCChhhhh---hcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          382 FLIYELCPNGNLAEWL---FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ++.||.| ..||+.+-   ..++..+++.-.-+|+..+.+||.|||++-+  ++|||+||+|||||.+|++|++|||++.
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 56777664   3456678888999999999999999999754  9999999999999999999999999987


Q ss_pred             eecCCCcccccCccCCCCccCcccccC----CCCCchhhHHHHHHHHHHHHcCCCcccccc
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSN----CKVNSSGDVYSFGIVLLQILSGKKAKVLTR  515 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~  515 (588)
                      .+.+  +...+.-.|-..|||||.+..    ..|+-|+||||||+.+.||.+++.|+..+.
T Consensus       198 ~L~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  198 YLVD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             eehh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            7643  222233467789999998643    478899999999999999999999986443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=277.12  Aligned_cols=240  Identities=27%  Similarity=0.356  Sum_probs=180.5

Q ss_pred             ccccceeeccCceE-EEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCCC
Q 042871          314 LNELNLIGEGITGK-VYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       314 f~~~~~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      |...+.+|.|.-|+ ||+|.+ +|+.||||++-.+. .+-..+||..|+.- +|||||++++.-.+....||..|.| .-
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~  587 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC  587 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence            45556799998875 799999 78999999986442 23446899988776 5999999999988999999999999 67


Q ss_pred             ChhhhhhcCCc---CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---C--CcEEEEecCCcceecCC
Q 042871          392 NLAEWLFGKDK---CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---N--FEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       392 sL~~~L~~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~--~~~kL~DFGla~~~~~~  463 (588)
                      +|.|++.....   ...-...+.+..|+++||++||+.+   |+||||||.||||+.   +  .+++|+|||+++.+..+
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            99999966311   1111445778899999999999998   999999999999965   2  57999999999998766


Q ss_pred             Cccc--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCcccccccc--chhhhcCcccCcccCHHHHHH
Q 042871          464 ETYA--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG-KKAKVLTRAG--SALELADPKLDREYSIEAFDL  538 (588)
Q Consensus       464 ~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG-~~p~~~~~~~--~~~~~~d~~l~~~~~~e~~~~  538 (588)
                      ....  .....||.||+|||++....-+.++||||+||++|+.++| .+||......  ++..-...-..-....+.  .
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~--e  742 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC--E  742 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH--H
Confidence            5433  3567899999999999988888899999999999999996 7888633221  111100000000011111  3


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...|+..+.+ +|..||++.+|+.
T Consensus       743 A~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHhC
Confidence            3445555566 7999999999973

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=6e-28  Score=235.94  Aligned_cols=197  Identities=34%  Similarity=0.476  Sum_probs=171.4

Q ss_pred             ccccceeeccCceEEEEEEecC-CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          314 LNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      |...+.||+|++|.||++...+ ++.+++|.+....   ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4566799999999999999864 8999999987543   46788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +++|.+++......+++.....++.+++++|.|||..+   ++|+||+|+||+++.++.++|+|||++............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            99999999654433889999999999999999999998   999999999999999999999999999876543211223


Q ss_pred             CccCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          470 EVRGTFGYLDPEYR-SNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~-~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      ...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            44677889999998 667788899999999999999999999953

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.2e-29  Score=245.46  Aligned_cols=200  Identities=24%  Similarity=0.327  Sum_probs=174.9

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|..+..||+|+|.+|..+++ ++.+.+|+|+++.     +.+.+....|-.+..+. +||.+|.+..+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46788999999999999999997 4678899998763     34556667777776655 69999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      |.||++||+|--|+.+.+ .|+++...-+...|..+|.|||+.+   |+.||||.+|||||..|.+||.|||+.+.-- +
T Consensus       329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l-~  403 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-G  403 (593)
T ss_pred             EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-C
Confidence            999999999998886544 4888888888999999999999999   9999999999999999999999999998632 2


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccc
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTR  515 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~  515 (588)
                      ....++..+||+.|+|||.+.+..|....|.|++||+++||+.|+.||....
T Consensus       404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence            3345567899999999999999999999999999999999999999998643

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.1e-28  Score=259.12  Aligned_cols=227  Identities=22%  Similarity=0.309  Sum_probs=183.3

Q ss_pred             CccccceeeccCceEEEEEE-ecCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      -|..++.||-|.||+|.++. .++...+|.|.+++.     ..+.....|-.+|..-..+-||+|+-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            46667889999999999996 567778899988642     234556789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee------
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI------  460 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~------  460 (588)
                      |++||++-.+|.+.+ .+.+...+-++.++.-|+++.|..+   +|||||||+|||||.+|.+||.||||+.-+      
T Consensus       710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999986543 3666666677788999999999999   999999999999999999999999997422      


Q ss_pred             ---cCCCcc--------------------------------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHH
Q 042871          461 ---DIGETY--------------------------------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL  505 (588)
Q Consensus       461 ---~~~~~~--------------------------------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ell  505 (588)
                         ..++..                                .....+||+.|+|||++....|+.-.|.||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence               111000                                001246999999999999999999999999999999999


Q ss_pred             cCCCcccccccc-------chhhhcCcccCcccCHHHHHHHHHHH
Q 042871          506 SGKKAKVLTRAG-------SALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       506 tG~~p~~~~~~~-------~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      .|+.||.....+       +....++-....+.+.|+.+++.+|.
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc  910 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC  910 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh
Confidence            999998644333       23334444455678889988887553

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-28  Score=239.36  Aligned_cols=194  Identities=27%  Similarity=0.376  Sum_probs=162.2

Q ss_pred             cccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc-----CeeeEE
Q 042871          315 NELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV-----DECFLI  384 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV  384 (588)
                      +..+-||-|.||.||.++. ++|+.||+|++.+-    ...+.+.+|+++|..++|.|++..++.....     .+.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3445799999999999997 58999999998752    2356789999999999999999998876643     357899


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +|+| ..+|...+.. ...++.....-...||++||.|||+.+   |.||||||.|.|+++|-.+||+|||+++.-+..+
T Consensus       136 TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence            9999 5688887743 345777777788999999999999999   9999999999999999999999999999766554


Q ss_pred             cccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          465 TYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      ....+..+-|..|.|||.+++ ..|+.+.||||.|||+.||+..|.-|..
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            444444455888999999887 4689999999999999999988876653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=252.16  Aligned_cols=193  Identities=28%  Similarity=0.348  Sum_probs=165.8

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecCCC----------cHHHHHHHHHHhccCC---CCceeEEecceecc
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----------NVETFVREVASSSHVR---HPNLVALLGYCLRV  378 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~  378 (588)
                      +|...+.+|+|+||.|+.+.++ +...|+||.+.+++          ..-..--||.+|+.++   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            4788899999999999999975 56789999886532          1223456999999997   99999999999999


Q ss_pred             CeeeEEeecC-CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          379 DECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       379 ~~~~LV~E~~-~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      +.+||+||-- ++-+|.+++..+ +.+++.+...|+.|++.|+++||+++   |+|||||-+||+++.+|-+||+|||.+
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence            9999999975 345888988543 45999999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCccc
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKVN-SSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      .....+..   ...+||.+|.|||++.+..|- ..-|||++|++||-++-...|+.
T Consensus       718 a~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            87665543   346899999999999998874 45799999999999998888875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=3.7e-27  Score=223.95  Aligned_cols=192  Identities=23%  Similarity=0.362  Sum_probs=163.0

Q ss_pred             hcCccccceeeccCceEEEEEE-ecCCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCceeEEecceecc--CeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLRV--DECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~E  386 (588)
                      .++|++.+++|+|.|++||.|. ..+++.++||.++.- ..+.+.+|+.+|..++ ||||++|++...+.  ....||+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            5788999999999999999998 468889999998754 3468899999999998 99999999998764  45789999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+.|.+...+-    ..++...+...+.+++.||.|+|+.+   |+|||+||.|++||. .-.++|+|+|||.+..++..
T Consensus       116 ~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e  188 (338)
T KOG0668|consen  116 YVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  188 (338)
T ss_pred             hhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence            99888776654    34777888899999999999999999   999999999999996 45699999999998877665


Q ss_pred             ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          466 YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      +.-.  +.+.-|.-||.+.+ +.|+..-|+|||||++.+|+..+.||-
T Consensus       189 YnVR--VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  189 YNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             eeee--eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence            4322  33556788997654 568889999999999999999998874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=5.3e-26  Score=225.71  Aligned_cols=190  Identities=26%  Similarity=0.370  Sum_probs=160.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceecc------C
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRV------D  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~  379 (588)
                      ..+|..+..+|.|.- .|-.+-. -.+++||+|++..    ....+...+|...+..++|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            345666677888877 4544442 3688999998753    23456778999999999999999999998743      4


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      +.|+||||| ..+|.+.+.   -.++-.....|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+|+.
T Consensus        95 e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence            679999999 679999886   34788889999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCc
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA  510 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p  510 (588)
                      -...  ...+..+.|.-|.|||++.+..+.+.+||||+||++.||++|+.-
T Consensus       168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vl  216 (369)
T KOG0665|consen  168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVL  216 (369)
T ss_pred             cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEE
Confidence            5433  455666788899999999999999999999999999999999863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=2.7e-26  Score=267.43  Aligned_cols=196  Identities=18%  Similarity=0.240  Sum_probs=139.1

Q ss_pred             hccCCC-CceeEEecce-------eccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCce
Q 042871          360 SSHVRH-PNLVALLGYC-------LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI  431 (588)
Q Consensus       360 l~~l~H-pnIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~I  431 (588)
                      .+.++| +||++++++|       .+...+++++||+ +++|.++|......+++.+++.++.||++||.|||+++   |
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            345566 6888888887       2334578889988 67999999765567999999999999999999999998   9


Q ss_pred             EecCCCCCCeEECC-------------------CCcEEEEecCCcceecCCC---------------cccccCccCCCCc
Q 042871          432 VHRDIKPTNILLGP-------------------NFEAKLSDFGLSKVIDIGE---------------TYASSEVRGTFGY  477 (588)
Q Consensus       432 vHrDLKp~NILld~-------------------~~~~kL~DFGla~~~~~~~---------------~~~~~~~~gt~~Y  477 (588)
                      +||||||+||||+.                   ++.+|++|||+++......               ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4456666666665321100               0001124578899


Q ss_pred             cCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCH
Q 042871          478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPM  556 (588)
Q Consensus       478 ~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~  556 (588)
                      ||||++.+..++.++|||||||+||||++|..|+..... .........+..... ........++.+|++ +|.+||+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~  259 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSM  259 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence            999999999999999999999999999999887542111 111111111111111 112223456677887 79999999


Q ss_pred             HHHHH
Q 042871          557 EQVFV  561 (588)
Q Consensus       557 ~evl~  561 (588)
                      .|+++
T Consensus       260 ~eil~  264 (793)
T PLN00181        260 SELLQ  264 (793)
T ss_pred             HHHhh
Confidence            99976

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=2e-26  Score=246.32  Aligned_cols=244  Identities=27%  Similarity=0.385  Sum_probs=190.3

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ..++|+....+|+|+||.|||++. ..++..|||.++-+  .+.....+|+-+++.-+|||||.++|.+...+..++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            356788889999999999999996 57899999998753  445677889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |+.+|+|.+.-+. ...+++.++....+...+||+|||+.+   -+|||||-.|||+++.|.+|++|||.+..+..- ..
T Consensus        93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-i~  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IA  167 (829)
T ss_pred             ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-hh
Confidence            9999999997653 456999999999999999999999999   789999999999999999999999998765321 12


Q ss_pred             cccCccCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC------cccCcccCHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYR---SNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD------PKLDREYSIEAFD  537 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~---~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d------~~l~~~~~~e~~~  537 (588)
                      ......||+.|||||+.   ..+.|..++|||+.|+...|+---+.|.......+...++-      +.+.+.  ..-..
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk--~kws~  245 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK--TKWSE  245 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC--ccchH
Confidence            23456899999999964   55689999999999999999876665533222222222221      111111  11223


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVF  560 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl  560 (588)
                      .+-.+++.|+- +|++||+++.++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhhe
Confidence            34444556665 799999997654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.91  E-value=1.4e-25  Score=233.66  Aligned_cols=203  Identities=24%  Similarity=0.268  Sum_probs=169.7

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcH-HHHHHHHHHhccCC------CCceeEEec
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNV-ETFVREVASSSHVR------HPNLVALLG  373 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~-~~~~~Ei~~l~~l~------HpnIv~l~g  373 (588)
                      |.+.-.+.....|.+....|+|-|++|.+|.. ..|+.||||+|.+.... ..=+.|+++|++|+      -.|.++|+-
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            44444455678899999999999999999986 46889999999875433 44578999999996      348999999


Q ss_pred             ceeccCeeeEEeecCCCCChhhhhh--cCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEE
Q 042871          374 YCLRVDECFLIYELCPNGNLAEWLF--GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAK  450 (588)
Q Consensus       374 ~~~~~~~~~LV~E~~~~gsL~~~L~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~k  450 (588)
                      .|...++++||+|-+ .-+|.+.|.  +.+-.|.......++.|+.-||..|...+   |+|.||||+|||++++. .+|
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence            999999999999988 669999995  34456888899999999999999999999   99999999999999765 579


Q ss_pred             EEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          451 LSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       451 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      |+|||.|.....+..   +...-+.-|.|||++.+..|+...|+||.||.||||.||+..|
T Consensus       578 LCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF  635 (752)
T KOG0670|consen  578 LCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF  635 (752)
T ss_pred             eccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence            999999987654332   1112245699999999999999999999999999999999733

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.9e-24  Score=221.40  Aligned_cols=130  Identities=25%  Similarity=0.311  Sum_probs=111.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-cHHHHHHHHHHhccCC-----C---CceeEEecceec---
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-NVETFVREVASSSHVR-----H---PNLVALLGYCLR---  377 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~-----H---pnIv~l~g~~~~---  377 (588)
                      ..+|-..++||.|-|++||++.. .+.+.||+|+.+..+ ..+.-+.||++|++++     |   .+||+|++.|..   
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            46788899999999999999985 577899999998654 3566789999999884     3   369999999985   


Q ss_pred             -cCeeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE
Q 042871          378 -VDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       378 -~~~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl  443 (588)
                       +.++++|+|++ |.+|..+|.... +.++.....+|+.|++.||.|||.+..  |||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence             45799999999 778888885433 568999999999999999999999763  9999999999999

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=6e-25  Score=225.49  Aligned_cols=199  Identities=26%  Similarity=0.370  Sum_probs=167.2

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEec----CCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCceeEEecceeccCee
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLRVDEC  381 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~  381 (588)
                      +....+.|..+++||+|.|++||++.+.    ..+.||+|.+..........+|++.|..+. +.||+++.+++..++..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            3445678889999999999999999853    467999999987777788999999999986 89999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCccee
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVI  460 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~~  460 (588)
                      .+|+||+++....++...    ++..++..+++.+..||.++|+.+   |+||||||+|+|.+. -+.-.|.|||||...
T Consensus       111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence            999999999999988843    667888899999999999999999   999999999999975 467899999998621


Q ss_pred             cC-------------------CCc---------------c---------cccCccCCCCccCcccccC-CCCCchhhHHH
Q 042871          461 DI-------------------GET---------------Y---------ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYS  496 (588)
Q Consensus       461 ~~-------------------~~~---------------~---------~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS  496 (588)
                      +.                   +..               .         ......||+||.|||++.. ..-++++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            00                   000               0         0012359999999998765 45688999999


Q ss_pred             HHHHHHHHHcCCCccc
Q 042871          497 FGIVLLQILSGKKAKV  512 (588)
Q Consensus       497 ~Gvll~ElltG~~p~~  512 (588)
                      .|||++-+++++.||.
T Consensus       264 ~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFF  279 (418)
T ss_pred             ccceeehhhccccccc
Confidence            9999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2.6e-24  Score=204.10  Aligned_cols=160  Identities=20%  Similarity=0.155  Sum_probs=125.3

Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++......+++.+++.++.|+++||.|||+.+         ||+|||+++++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence            7899999765667999999999999999999999876         999999999999999  99988754322      


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc-c-hhhhcC---cccCc--ccCHHHHH--HHHH
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-S-ALELAD---PKLDR--EYSIEAFD--LTLQ  541 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~-~~~~~d---~~l~~--~~~~e~~~--~v~~  541 (588)
                      ..||+.|||||++.+..++.++||||||+++|||++|+.||...... . ......   +....  .......+  .+.+
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD  143 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence            25789999999999999999999999999999999999998543221 1 111111   11000  01112222  4788


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      ++.+|+. +|.+||++.|+++.+....
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHHHH
Confidence            8999998 7999999999999988764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-24  Score=210.80  Aligned_cols=193  Identities=24%  Similarity=0.377  Sum_probs=156.7

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-CcHHHHHHHHHHhccC-CCCceeEEecc-eeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-GNVETFVREVASSSHV-RHPNLVALLGY-CLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~-~~~~~~~~LV~E  386 (588)
                      .+.|.+.+.||+|.||.+-+++++ +.+.+++|-+..+ ....+|.+|..---.| .|.||+.-++. |+..+.+++++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            456889999999999999999985 6778999988764 4578999998765455 48999987765 566678889999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC--CCCcEEEEecCCcceecCCC
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG--PNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld--~~~~~kL~DFGla~~~~~~~  464 (588)
                      |++-|+|.+.+..  ..+.+....+++.|+++|+.|||+++   ++|||||.+||||-  +..++||+|||+.+..+.--
T Consensus       103 ~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             cCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            9999999998843  45788888999999999999999999   99999999999993  34589999999987643211


Q ss_pred             cccccCccCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          465 TYASSEVRGTFGYLDPEYRSN-----CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                          ....-+..|.+||....     -+..+.+|+|.||++++..+||+.||+
T Consensus       178 ----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  178 ----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             ----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence                11223557899996433     234678999999999999999999997

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=9.7e-24  Score=222.24  Aligned_cols=164  Identities=21%  Similarity=0.190  Sum_probs=129.8

Q ss_pred             HHHhcCccccceeeccCceEEEEEEec--CCcEEEEEEecCC-------CcHHHHHHHHHHhccCCCCceeE-Eecceec
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLS--NNQHVAIKHITNE-------GNVETFVREVASSSHVRHPNLVA-LLGYCLR  377 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~-------~~~~~~~~Ei~~l~~l~HpnIv~-l~g~~~~  377 (588)
                      ....++|...+.||+|+||+||+|.+.  +++.||||++...       ...+.|.+|+++|++++|+|+++ ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            445678999999999999999999864  5788899986532       12456899999999999999985 5432   


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCC-CCCCeEECCCCcEEEEecCC
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI-KPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDL-Kp~NILld~~~~~kL~DFGl  456 (588)
                       +..++||||+++++|....  ...      ...++.+++++|.|||+.+   |+|||| ||+|||++.++++||+|||+
T Consensus        91 -~~~~LVmE~~~G~~L~~~~--~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR--PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC--ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence             4679999999999996321  111      1457889999999999998   999999 99999999999999999999


Q ss_pred             cceecCCCccc-------ccCccCCCCccCcccccCC
Q 042871          457 SKVIDIGETYA-------SSEVRGTFGYLDPEYRSNC  486 (588)
Q Consensus       457 a~~~~~~~~~~-------~~~~~gt~~Y~aPE~~~~~  486 (588)
                      ++.........       -....+++.|++||++...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            98765432111       1346788899999987654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-22  Score=212.89  Aligned_cols=251  Identities=22%  Similarity=0.219  Sum_probs=189.2

Q ss_pred             CccccceeeccCceEEEEEEecCC--cEEEEEEecCCCc--HHHHHHHHHHhccCCC----CceeEEecce-eccCeeeE
Q 042871          313 KLNELNLIGEGITGKVYKGKLSNN--QHVAIKHITNEGN--VETFVREVASSSHVRH----PNLVALLGYC-LRVDECFL  383 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~~g--~~VAVK~l~~~~~--~~~~~~Ei~~l~~l~H----pnIv~l~g~~-~~~~~~~L  383 (588)
                      +|.+.+.||+|+||.||++...+.  ..+|+|.......  ...+..|..++..+.+    +++..+++.. ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999996543  5788887654321  1267778888887763    5888899888 47778899


Q ss_pred             EeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-----CcEEEEecCCc
Q 042871          384 IYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-----FEAKLSDFGLS  457 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-----~~~kL~DFGla  457 (588)
                      ||+.+ |.+|.++..... +.++..+.+.|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 889999885443 67999999999999999999999999   9999999999999754     46899999999


Q ss_pred             ceec---CCC----ccc--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc---
Q 042871          458 KVID---IGE----TYA--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP---  525 (588)
Q Consensus       458 ~~~~---~~~----~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~---  525 (588)
                      +...   ...    ...  ....+||.+|.+++...+...+.+.|+||++.++.|++.|..||...........+..   
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8322   111    111  2345699999999999999999999999999999999999999965443222211111   


Q ss_pred             -ccCc---ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          526 -KLDR---EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       526 -~l~~---~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                       ....   ....+.+..+   ...+-. +-.++|....+...|++.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKI---LEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hhccccccCCChHHHHHH---HHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence             1111   1122333333   333333 4589999999999998887654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.9e-23  Score=201.67  Aligned_cols=243  Identities=19%  Similarity=0.309  Sum_probs=187.0

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCC
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs  392 (588)
                      .-+|.+...|+.|+|++..+ .+++|++.-    ....++|.+|.-.|+.+.||||++++|.|....+..++..||+-||
T Consensus       195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            34688888999999999544 455576642    2234689999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCc-CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCc
Q 042871          393 LAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV  471 (588)
Q Consensus       393 L~~~L~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~  471 (588)
                      |...|++... ..+..|..+++.++|+|++|||+... -|.---|.+..|+||++.+++|+--. +++.     ......
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad-~kfs-----fqe~gr  346 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMAD-TKFS-----FQEVGR  346 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccc-ceee-----eecccc
Confidence            9999987554 57888999999999999999999753 24444789999999999998875211 1111     111122


Q ss_pred             cCCCCccCcccccCCCCC---chhhHHHHHHHHHHHHcCCCccccccccc-hhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          472 RGTFGYLDPEYRSNCKVN---SSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       472 ~gt~~Y~aPE~~~~~~~t---~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      .-.+.||+||.+...+.+   .++|+|||.+++|||.|...||.....-+ ..++.-+.++..+++.....+.+|+.-|.
T Consensus       347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icm  426 (448)
T KOG0195|consen  347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICM  426 (448)
T ss_pred             ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHh
Confidence            346889999988776544   47899999999999999999987544322 22333344455555555566777888898


Q ss_pred             c-CCCCCCCHHHHHHHHHHhh
Q 042871          548 A-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~  567 (588)
                      + +|.+||.+..|+-+||++.
T Consensus       427 nedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  427 NEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cCCCCcCCCcceehhhHHHhc
Confidence            8 7999999999999999874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=1.8e-21  Score=197.01  Aligned_cols=244  Identities=30%  Similarity=0.370  Sum_probs=190.8

Q ss_pred             ccccceeeccCceEEEEEEecCCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCC-ceeEEecceeccCeeeEEeec
Q 042871          314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG-----NVETFVREVASSSHVRHP-NLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~LV~E~  387 (588)
                      |...+.||.|+||.||++...  ..+++|.+....     ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566778999999999999986  789999886431     356799999999999988 799999999777778999999


Q ss_pred             CCCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcceecCCC
Q 042871          388 CPNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       388 ~~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~  464 (588)
                      +.++++.+++....  ..+.......+..+++.++.|+|+.+   ++|||+||+||+++..+ .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997774433  26888899999999999999999999   99999999999999988 79999999998654433


Q ss_pred             cc-----cccCccCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCccccccc----cchhhhcCccc----C
Q 042871          465 TY-----ASSEVRGTFGYLDPEYRSN---CKVNSSGDVYSFGIVLLQILSGKKAKVLTRA----GSALELADPKL----D  528 (588)
Q Consensus       465 ~~-----~~~~~~gt~~Y~aPE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~----~~~~~~~d~~l----~  528 (588)
                      ..     ......|+..|++||.+.+   ..+....|+|++|++++++++|+.|+.....    ....+.+....    .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            22     2356789999999999887   5788999999999999999999999655442    22222222111    1


Q ss_pred             cccCHH----HHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          529 REYSIE----AFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       529 ~~~~~e----~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ......    ....+..++..+.. +|..|.++.+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111111    11344455556665 68999999887765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=7.1e-21  Score=189.96  Aligned_cols=202  Identities=22%  Similarity=0.253  Sum_probs=173.7

Q ss_pred             hcCccccceeeccCceEEEEEE-ecCCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .-+|.+.++||+|.||..+.|+ +-++++||||.-....+.-++..|.+..+.|. .++|...+-+..++..-.||+|++
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            3478888999999999999998 46899999997666666678888888888775 688988888888888889999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-----CcEEEEecCCcceecCC
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-----FEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-----~~~kL~DFGla~~~~~~  463 (588)
                       |-||.|+..--...++..+...+|.|+..-++|+|++.   +|.|||||+|+||..-     ..+.|+|||+|+...+.
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence             88999988655667999999999999999999999999   9999999999999643     35899999999988654


Q ss_pred             Ccc------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc
Q 042871          464 ETY------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA  516 (588)
Q Consensus       464 ~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  516 (588)
                      .+.      ......||.+||+-...++.+.+.+.|+-|||-++.+.+.|..||.-.+.
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            432      22346799999999999999999999999999999999999999985443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=8.4e-22  Score=188.93  Aligned_cols=202  Identities=22%  Similarity=0.262  Sum_probs=172.1

Q ss_pred             HhcCccccceeeccCceEEEEEE-ecCCcEEEEEEecCCCcHHHHHHHHHHhccCCC-CceeEEecceeccCeeeEEeec
Q 042871          310 ATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRH-PNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ...+|..+++||+|+||.+|.|. +.+|+.||||.-++......+..|..+...++| ..|..+..+..++..-.+|||+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            35689999999999999999998 579999999987776655677888888888875 5777888888888888999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEEecCCcceecCCC
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~DFGla~~~~~~~  464 (588)
                      + |.||.++..--...++..+.+-++-|+..-++|+|.++   .+||||||+|+|..-   ...+.|+||||++...+..
T Consensus        93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            9 88999988655667888999999999999999999999   999999999999964   3468999999998764432


Q ss_pred             c------ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccc
Q 042871          465 T------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTR  515 (588)
Q Consensus       465 ~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~  515 (588)
                      +      .......||.+|.+-....+...+.+.|+-|+|.+|.++-.|..||+-..
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            2      12345679999999988888888899999999999999999999998543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1e-20  Score=182.95  Aligned_cols=137  Identities=19%  Similarity=0.177  Sum_probs=106.9

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCC----c-------HHHH-----------------HHHHHHhccCCCCce
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEG----N-------VETF-----------------VREVASSSHVRHPNL  368 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----~-------~~~~-----------------~~Ei~~l~~l~HpnI  368 (588)
                      ...||+|+||.||+|...+|+.||||+++...    .       ...|                 .+|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999998899999999986421    1       1122                 348899999987766


Q ss_pred             eEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhh-ccccCCceEecCCCCCCeEECCCC
Q 042871          369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL-HSYSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       369 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~IvHrDLKp~NILld~~~  447 (588)
                      .....+.  ....+|||||++++++...+. ....++..+...++.|++.+|.|| |+.+   |+||||||+|||++ ++
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence            3322221  223489999999887766542 234688899999999999999999 6778   99999999999998 47


Q ss_pred             cEEEEecCCccee
Q 042871          448 EAKLSDFGLSKVI  460 (588)
Q Consensus       448 ~~kL~DFGla~~~  460 (588)
                      .++|+|||++...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=5.3e-20  Score=177.94  Aligned_cols=138  Identities=17%  Similarity=0.150  Sum_probs=109.5

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCc----------------------------HHHHHHHHHHhccCCCCce
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN----------------------------VETFVREVASSSHVRHPNL  368 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~----------------------------~~~~~~Ei~~l~~l~HpnI  368 (588)
                      ...||+|+||.||+|+..+|+.||||++.....                            ...+.+|.+.+.+++|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            458999999999999987899999999864310                            1123578899999999887


Q ss_pred             eEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCC
Q 042871          369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       369 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~  447 (588)
                      .....+...  ..+|||||++++++..... ....++..+...++.+++.+|.+||+ .+   |+||||||+|||++ ++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence            444333322  3489999998886544322 23457788889999999999999999 88   99999999999998 88


Q ss_pred             cEEEEecCCcceec
Q 042871          448 EAKLSDFGLSKVID  461 (588)
Q Consensus       448 ~~kL~DFGla~~~~  461 (588)
                      .++|+|||++....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=8.2e-21  Score=212.39  Aligned_cols=242  Identities=22%  Similarity=0.268  Sum_probs=181.5

Q ss_pred             ccceeeccCceEEEEEEe-cCCcEEEEEEec----CCCcH----HHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          316 ELNLIGEGITGKVYKGKL-SNNQHVAIKHIT----NEGNV----ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~----~~~~~----~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ..+.+|.|.+|.|+.... ...+..+.|.+.    .....    ..+..|+.+-..++|+|++..+....+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            456899999998877763 233434444332    21111    125667888888999999998888887777777799


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-  465 (588)
                      |++. +|..++... ..++..++..++.|+.+|+.|||..+   |.|||+|++|++++.++.+||+|||.+.....+.. 
T Consensus       402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 999998543 35888889999999999999999999   99999999999999999999999999876644332 


Q ss_pred             --ccccCccCCCCccCcccccCCCCCc-hhhHHHHHHHHHHHHcCCCccccccccchh--hhcCcc-cC-----cccCHH
Q 042871          466 --YASSEVRGTFGYLDPEYRSNCKVNS-SGDVYSFGIVLLQILSGKKAKVLTRAGSAL--ELADPK-LD-----REYSIE  534 (588)
Q Consensus       466 --~~~~~~~gt~~Y~aPE~~~~~~~t~-ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--~~~d~~-l~-----~~~~~e  534 (588)
                        .....+.|+..|+|||.+.+.+|.+ ..||||.|+++..|.+|+.||......+-.  ...... ..     ......
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL  556 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence              5566788999999999999999987 589999999999999999999865544332  111110 00     111223


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .......++.+.++ +|.+|-|+++|++.
T Consensus       557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  557 LPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             chhhHHHHHHHHccCChhheecHHHHhhC
Confidence            33444455555566 89999999999863

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.1e-20  Score=186.26  Aligned_cols=172  Identities=12%  Similarity=0.144  Sum_probs=134.2

Q ss_pred             HHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC--c---HHH------HHHHHHHhccCCCCceeEEeccee
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG--N---VET------FVREVASSSHVRHPNLVALLGYCL  376 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~---~~~------~~~Ei~~l~~l~HpnIv~l~g~~~  376 (588)
                      ....++|...++||.|+||.||.... ++..+|||.+....  .   .+.      +.+|+..+.+++|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            35578999999999999999999765 67789999997431  1   112      578999999999999999988866


Q ss_pred             cc--------CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc
Q 042871          377 RV--------DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE  448 (588)
Q Consensus       377 ~~--------~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~  448 (588)
                      ..        +..+|||||++|.+|.++..     ++.    ....+++.+|..+|..+   ++|||+||+||++++++ 
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence            33        35789999999999988741     222    24558899999999999   99999999999999988 


Q ss_pred             EEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 042871          449 AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS  506 (588)
Q Consensus       449 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt  506 (588)
                      ++|+|||...........             ..+.+...+..++|+|+||+.+..+..
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999999987654211110             114445567779999999999877653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=3.3e-19  Score=172.54  Aligned_cols=186  Identities=14%  Similarity=0.088  Sum_probs=140.1

Q ss_pred             cccceeeccCceEEEEEEecCCcEEEEEEecCCCc-H-----HHHHHHHHHhccCC-CCceeEEecceeccCeeeEEeec
Q 042871          315 NELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN-V-----ETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~-----~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .....|++|+||+||.+.- .+.+++.+.+..... .     ..|.+|+++|++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3456899999999997766 678888887765332 1     24789999999996 5789999886    456999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCC-CCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI-KPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDL-Kp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      ++|.+|.+.+..  .      ...++.++.++|.++|+.+   |+|||| ||+|||+++++.++|+|||++.........
T Consensus        80 I~G~~L~~~~~~--~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998765421  1      1346788899999999999   999999 799999999999999999999865433210


Q ss_pred             ----c--------ccCccCCCCccCcccccCC-CCC-chhhHHHHHHHHHHHHcCCCccccccc
Q 042871          467 ----A--------SSEVRGTFGYLDPEYRSNC-KVN-SSGDVYSFGIVLLQILSGKKAKVLTRA  516 (588)
Q Consensus       467 ----~--------~~~~~gt~~Y~aPE~~~~~-~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~  516 (588)
                          .        ..-...++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.....+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                0        0112367889999853321 223 567899999999999999987654433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=2.2e-19  Score=192.97  Aligned_cols=208  Identities=26%  Similarity=0.407  Sum_probs=163.0

Q ss_pred             hccCCCCceeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCce-EecCCCC
Q 042871          360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI-VHRDIKP  438 (588)
Q Consensus       360 l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~I-vHrDLKp  438 (588)
                      |+.+.|.|+.+++|.+.+++..++|.+|+..|+|.|.+......++|........++++||.|||+..   | +|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence            46789999999999999999999999999999999999887778999999999999999999999865   4 9999999


Q ss_pred             CCeEECCCCcEEEEecCCcceecC-CCcccccCccCCCCccCcccccCC-------CCCchhhHHHHHHHHHHHHcCCCc
Q 042871          439 TNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNC-------KVNSSGDVYSFGIVLLQILSGKKA  510 (588)
Q Consensus       439 ~NILld~~~~~kL~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~-------~~t~ksDVwS~Gvll~ElltG~~p  510 (588)
                      .|.++|..+.+||+|||+...... ..........-..-|.|||.+...       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            999999999999999999876532 011111112234569999987663       146789999999999999999999


Q ss_pred             cccccccc----hhhhc----CcccCcccC-H-HHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          511 KVLTRAGS----ALELA----DPKLDREYS-I-EAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       511 ~~~~~~~~----~~~~~----d~~l~~~~~-~-e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      |.......    +...+    .+.+++... . +..+.+..++..||. .|.+||++++|-..++.+....
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            97522211    11111    111222221 1 445567888999998 5899999999999999877653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.77  E-value=1e-19  Score=204.14  Aligned_cols=240  Identities=20%  Similarity=0.232  Sum_probs=174.8

Q ss_pred             CccccceeeccCceEEEEEEecCCcEEEEEEecCCC---cHHHHHHHHHH--hccCCCCceeEEecceeccCeeeEEeec
Q 042871          313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG---NVETFVREVAS--SSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~---~~~~~~~Ei~~--l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++...+.||++.|=+|.++++++|. |+||++-++.   ..+.|.++++-  ...++|||.+++.-+-..+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6677789999999999999998887 8999986432   35566555443  5566899999999988888888999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee--cCCCc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~--~~~~~  465 (588)
                      +. -+|.|.|. .+..+...+..-|+.|++.||...|..+   |+|||||.+||||+.-..+.|+||..-+..  ..++.
T Consensus       103 vk-hnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  103 VK-HNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             Hh-hhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            94 58999883 3345777888889999999999999999   999999999999999999999999877643  22221


Q ss_pred             ccc----cCccCCCCccCcccccCC----------C-CCchhhHHHHHHHHHHHHc-CCCcccccccc--chhhhcCcc-
Q 042871          466 YAS----SEVRGTFGYLDPEYRSNC----------K-VNSSGDVYSFGIVLLQILS-GKKAKVLTRAG--SALELADPK-  526 (588)
Q Consensus       466 ~~~----~~~~gt~~Y~aPE~~~~~----------~-~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~--~~~~~~d~~-  526 (588)
                      ...    .+-..-..|+|||.+...          . .+++.||||+||++.||++ |+++|.+..--  +.....++. 
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence            111    111223479999965431          2 6789999999999999999 67777642110  000011111 


Q ss_pred             -cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          527 -LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       527 -l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                       +..-.+.    .++.|++.+.+ +|.+|-++++.++.
T Consensus       258 ~Le~Ied~----~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEKIEDV----SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhCcCc----cHHHHHHHHHccCchhccCHHHHHHh
Confidence             1011111    34455666667 79999999999987

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=3.2e-18  Score=173.71  Aligned_cols=228  Identities=22%  Similarity=0.276  Sum_probs=147.2

Q ss_pred             CccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCC-----------CceeE-----
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRH-----------PNLVA-----  370 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~H-----------pnIv~-----  370 (588)
                      .+...+.||.|+++.||.+++. +|+.+|||.+..     ....+.+.+|.-....+.+           +-+++     
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455678999999999999974 699999998752     2346777887766655432           22222     


Q ss_pred             Eec---ceecc---C-----eeeEEeecCCCCChhhhhh---cC---CcCccHHHHHHHHHhhhccchhhccccCCceEe
Q 042871          371 LLG---YCLRV---D-----ECFLIYELCPNGNLAEWLF---GK---DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH  433 (588)
Q Consensus       371 l~g---~~~~~---~-----~~~LV~E~~~~gsL~~~L~---~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvH  433 (588)
                      +.+   ++...   .     ..+++|+-+ .++|.+++.   ..   ...+....++.+..|+.+.+++||+.+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence            111   11111   1     236788877 678888863   11   124666777888899999999999999   999


Q ss_pred             cCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccC--------CCCCchhhHHHHHHHHHHHH
Q 042871          434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN--------CKVNSSGDVYSFGIVLLQIL  505 (588)
Q Consensus       434 rDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~t~ksDVwS~Gvll~Ell  505 (588)
                      +||||+|++++++|.++|+||+.....+  .....  ...+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g--~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAG--TRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETT--EEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecC--ceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999998765432  22221  234577999997533        25788999999999999999


Q ss_pred             cCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCC
Q 042871          506 SGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQR  553 (588)
Q Consensus       506 tG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~R  553 (588)
                      +|+.|+.....+...+.   .+ .... +..+.+..|+...++ +|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~---~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW---DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG---GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc---cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986654433332   12 2233 566677777777776 56665

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.5e-18  Score=198.45  Aligned_cols=254  Identities=21%  Similarity=0.243  Sum_probs=182.7

Q ss_pred             HHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCC---CCceeEEecceeccCee
Q 042871          305 REVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR---HPNLVALLGYCLRVDEC  381 (588)
Q Consensus       305 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~  381 (588)
                      .+.+...+.|.+.+.||+|+||+||+|+..+|+.||+|+-+.....+-+ =-.+++.+|+   -+-|..+...+.-.+..
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY-I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY-ICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee-ehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            3455567788999999999999999999888999999987654432211 1112233333   23455555566667788


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-------CCCcEEEEec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-------PNFEAKLSDF  454 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-------~~~~~kL~DF  454 (588)
                      +||+||.+-|+|.+++. ..+.++|.-.+.++.|+++.++.||..+   |||+||||+|.||.       ++..++|+||
T Consensus       770 ~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence            99999999999999996 5567999999999999999999999999   99999999999993       2445899999


Q ss_pred             CCcceecCC-CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCH
Q 042871          455 GLSKVIDIG-ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI  533 (588)
Q Consensus       455 Gla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~  533 (588)
                      |-+.-+..- +.......++|-.+--+|+..++.++.+.|.|.|+-+++-|+-|+...  ... .....++..++.-+..
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~-g~~~~~~~~~~Ry~~~  922 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKN-GSSWMVKTNFPRYWKR  922 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcC-CcceeccccchhhhhH
Confidence            987543221 123445667899999999999999999999999999999999998644  111 2222333334443444


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHhhc
Q 042871          534 EAFDLTLQLALSCTALTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       534 e~~~~v~~L~~~C~~~p~~RPs~~evl~~L~~~~~  568 (588)
                      +....+..+++-  .+-..=|...++...|++.+.
T Consensus       923 ~~W~~~F~~lLN--~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  923 DMWNKFFDLLLN--PDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             HHHHHHHHHHhC--cCcccchhHHHHHHHHHHHHH
Confidence            544444444422  122445666666666666553

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=8.8e-18  Score=164.57  Aligned_cols=134  Identities=20%  Similarity=0.181  Sum_probs=103.8

Q ss_pred             cccceeeccCceEEEEEEecCCcEEEEEEecCC--CcHHHHHHHHHHhccC-----CCCceeEEecceeccC---e-eeE
Q 042871          315 NELNLIGEGITGKVYKGKLSNNQHVAIKHITNE--GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD---E-CFL  383 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l-----~HpnIv~l~g~~~~~~---~-~~L  383 (588)
                      +..+.||+|+||.||. .-.++.. +||++...  ...+.+.+|+..++.+     .||||++++|++.++.   . +.+
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4456899999999996 2234444 79987642  3456789999999999     5799999999998763   3 337


Q ss_pred             Eeec--CCCCChhhhhhcCCcCccHHHHHHHHHhhhccc-hhhccccCCceEecCCCCCCeEECC----CCcEEEEecCC
Q 042871          384 IYEL--CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHSYSEGCIVHRDIKPTNILLGP----NFEAKLSDFGL  456 (588)
Q Consensus       384 V~E~--~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~IvHrDLKp~NILld~----~~~~kL~DFGl  456 (588)
                      |+||  +++|+|.+++.+.  .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +++++|+||+.
T Consensus        83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  5579999999542  35444  35577888777 9999999   999999999999974    34799999543


Q ss_pred             c
Q 042871          457 S  457 (588)
Q Consensus       457 a  457 (588)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=6.3e-19  Score=189.69  Aligned_cols=213  Identities=27%  Similarity=0.275  Sum_probs=163.4

Q ss_pred             eeccCceEEEEEE----ecCCcEEEEEEecCCC----cHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEeecCCC
Q 042871          320 IGEGITGKVYKGK----LSNNQHVAIKHITNEG----NVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       320 LG~G~fG~Vykg~----~~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +|+|.||.|+.++    .+.|..+|.|++....    .......|-.++...+ ||.+|++.-.+..+...+++.+|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7899999999764    3467788888775421    1124456777788887 99999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |.|..++.... ..+..........++-+++++|+.+   |+|||+|++||+++.+|.+++.|||+++..-..+..    
T Consensus        82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             chhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence            99999885433 3555566667778899999999999   999999999999999999999999999865332221    


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc--CcccCcccCHHHHHHHHHHHHHh
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA--DPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~--d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                       +||..|||||++.  ......|.||||++++||+||-.|+..   .....+.  ...++...+.+..+.+.++...+
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRILKAELEMPRELSAEARSLFRQLFKRN  225 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHHhhhccCCchhhhHHHHHHHHHHHhhC
Confidence             8999999999988  568889999999999999999999875   1111111  22233344455555555555443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=1.7e-17  Score=162.38  Aligned_cols=132  Identities=23%  Similarity=0.334  Sum_probs=112.7

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCCC----------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEG----------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      +.||+|++|.||+|+. +|..|+||+.....          ....+.+|++++..++|+++.....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999998 77889999865321          123577899999999999988777777777888999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ++|++|.+++....    + .+..++.+++.+|.+||+.+   ++|||++|+|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999984322    2 78889999999999999998   99999999999999 78999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=2.4e-17  Score=160.18  Aligned_cols=141  Identities=16%  Similarity=0.076  Sum_probs=110.2

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC------------------------cHHHHHHHHHHhcc
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG------------------------NVETFVREVASSSH  362 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~------------------------~~~~~~~Ei~~l~~  362 (588)
                      +......|...+.||+|+||.||++..++|+.||||++....                        ....+.+|+..+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            333334477778999999999999998889999999865321                        01135678888888


Q ss_pred             CCCCc--eeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCC
Q 042871          363 VRHPN--LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTN  440 (588)
Q Consensus       363 l~Hpn--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~N  440 (588)
                      +.|++  +...++.    ...++||||+++++|.+....       .....++.++++++.++|+.+   |+||||||+|
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N  155 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN  155 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence            87774  4444432    355899999999999876521       234568889999999999988   9999999999


Q ss_pred             eEECCCCcEEEEecCCcceec
Q 042871          441 ILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       441 ILld~~~~~kL~DFGla~~~~  461 (588)
                      |++++++.++|+|||++....
T Consensus       156 ill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEEcCCCcEEEEECCccccCC
Confidence            999999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=5.3e-17  Score=181.35  Aligned_cols=137  Identities=23%  Similarity=0.245  Sum_probs=112.2

Q ss_pred             HHhcCccccceeeccCceEEEEEEecCCcEEEEEEe-cC---C------CcHHHHHHHHHHhccCCCCceeEEecceecc
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI-TN---E------GNVETFVREVASSSHVRHPNLVALLGYCLRV  378 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l-~~---~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~  378 (588)
                      .....|...+.||+|+||.||+|.+.+. .+++|+. ..   .      ...+.+.+|++++..++|++++....++.+.
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3345556678999999999999997544 3444432 21   1      1124678999999999999998888777777


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ...++||||+++++|.+++.         ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||+++
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            78899999999999999884         35678999999999999998   9999999999999 67899999999987


Q ss_pred             e
Q 042871          459 V  459 (588)
Q Consensus       459 ~  459 (588)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=5.3e-17  Score=162.43  Aligned_cols=141  Identities=16%  Similarity=0.101  Sum_probs=109.8

Q ss_pred             CccccceeeccCceEEEEEE--ecCCcEEEEEEecCCCc--------------------------HHHHHHHHHHhccCC
Q 042871          313 KLNELNLIGEGITGKVYKGK--LSNNQHVAIKHITNEGN--------------------------VETFVREVASSSHVR  364 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~--~~~g~~VAVK~l~~~~~--------------------------~~~~~~Ei~~l~~l~  364 (588)
                      -|.+.+.||+|+||.||+|+  ..+|+.||||.+.....                          ...+.+|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46778899999999999998  56899999998863210                          023567999999997


Q ss_pred             CCc--eeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeE
Q 042871          365 HPN--LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL  442 (588)
Q Consensus       365 Hpn--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NIL  442 (588)
                      +.+  +.+++++    ...++||||+++++|....... ..+...+...++.|++.+|.+||..+.  |+||||||+||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIl  181 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNIL  181 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEE
Confidence            533  3444432    2358999999998887765322 345566678899999999999998763  999999999999


Q ss_pred             ECCCCcEEEEecCCcceec
Q 042871          443 LGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       443 ld~~~~~kL~DFGla~~~~  461 (588)
                      ++ +++++|+|||++....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999987543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=4.1e-17  Score=158.28  Aligned_cols=128  Identities=24%  Similarity=0.297  Sum_probs=105.8

Q ss_pred             eeeccCceEEEEEEecCCcEEEEEEecCCC----------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          319 LIGEGITGKVYKGKLSNNQHVAIKHITNEG----------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .||+|+||.||+|.+ +|..|++|+.....          ....+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 67899999864321          1245678999999999887655555555667789999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      +|++|.+++.....        .++.+++.+|.+||+.+   ++|||++|+||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998743211        78999999999999998   99999999999999 88999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=2.7e-17  Score=174.11  Aligned_cols=168  Identities=25%  Similarity=0.431  Sum_probs=125.4

Q ss_pred             eeeEEeecCCCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      .+|+.|++++..+|.++|.++.  ...++...+.++.|++.|++|   ++   .+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            5789999999999999996433  357888999999999999999   55   899999999999999999999999998


Q ss_pred             ceecCCC-----cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCccccccccchhhhcCcccCccc
Q 042871          458 KVIDIGE-----TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG-KKAKVLTRAGSALELADPKLDREY  531 (588)
Q Consensus       458 ~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG-~~p~~~~~~~~~~~~~d~~l~~~~  531 (588)
                      .......     ....+...||..||+||.+.+.+|+.|+||||||++|+|++.- ..++.  +.+...++-|..+++.+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e--r~~t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE--RIATLTDIRDGIIPPEF  481 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH--HHHhhhhhhcCCCChHH
Confidence            7765444     2233556899999999999999999999999999999999972 22221  11222233333333222


Q ss_pred             ---CHHHHHHHHHHHHHhhcCCCCCCCHHH
Q 042871          532 ---SIEAFDLTLQLALSCTALTHQRPPMEQ  558 (588)
Q Consensus       532 ---~~e~~~~v~~L~~~C~~~p~~RPs~~e  558 (588)
                         .++...++.+|.   ...|.+||++.+
T Consensus       482 ~~d~p~e~~ll~~ll---s~~p~~RP~~~~  508 (516)
T KOG1033|consen  482 LQDYPEEYTLLQQLL---SPSPEERPSAIE  508 (516)
T ss_pred             hhcCcHHHHHHHHhc---CCCcccCchHHH
Confidence               123445544443   447999994443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=9.4e-16  Score=156.60  Aligned_cols=194  Identities=19%  Similarity=0.239  Sum_probs=132.9

Q ss_pred             CCCceeEEecceec---------------------------cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhh
Q 042871          364 RHPNLVALLGYCLR---------------------------VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS  416 (588)
Q Consensus       364 ~HpnIv~l~g~~~~---------------------------~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~i  416 (588)
                      +|||||++.++|.+                           ...+|+||.-++ -+|.+++-.  ...+...+.-|+.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHH
Confidence            59999999988764                           234789999884 589999943  346667777899999


Q ss_pred             hccchhhccccCCceEecCCCCCCeEE--CCCC--cEEEEecCCcceecCC---Ccccc--cCccCCCCccCcccccCCC
Q 042871          417 ARGLWFLHSYSEGCIVHRDIKPTNILL--GPNF--EAKLSDFGLSKVIDIG---ETYAS--SEVRGTFGYLDPEYRSNCK  487 (588)
Q Consensus       417 a~gL~yLH~~~~~~IvHrDLKp~NILl--d~~~--~~kL~DFGla~~~~~~---~~~~~--~~~~gt~~Y~aPE~~~~~~  487 (588)
                      ++|+.|||.++   |.|||+|++|||+  |+|+  .+.|+|||.+.--+..   -.+.+  -...|.-.-||||+....+
T Consensus       351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999999   9999999999999  3443  4789999986432210   11111  1234677889999865422


Q ss_pred             ------CCchhhHHHHHHHHHHHHcCCCccccccccchhhh--cCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHH
Q 042871          488 ------VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL--ADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQ  558 (588)
Q Consensus       488 ------~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~--~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~e  558 (588)
                            --.|+|.|+.|-+.||+++...||... .+...+.  ..+.-....+..+...+.+|+...++ +|.+||+..-
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence                  134899999999999999999998741 1111110  11111122334444555666666666 7999999866


Q ss_pred             HHHHHH
Q 042871          559 VFVTLQ  564 (588)
Q Consensus       559 vl~~L~  564 (588)
                      ....|+
T Consensus       507 AANvl~  512 (598)
T KOG4158|consen  507 AANVLN  512 (598)
T ss_pred             HHhHHH
Confidence            555554

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=6.8e-16  Score=140.70  Aligned_cols=135  Identities=21%  Similarity=0.190  Sum_probs=115.4

Q ss_pred             ccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCC--CceeEEecceeccCeeeEEeecCCCCCh
Q 042871          316 ELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRH--PNLVALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      +.+.||+|.++.||+++..+ ..+++|..........+.+|+..+..++|  .++.+++++....+..++++||++++.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            35689999999999999854 78999998765435678899999999976  5889999888888889999999988877


Q ss_pred             hhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          394 AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       394 ~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..+        +......++.+++++|.+||.....+++|+|++|+||++++++.++++|||.++.
T Consensus        81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            654        4566777899999999999997555699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=4e-16  Score=175.60  Aligned_cols=202  Identities=30%  Similarity=0.384  Sum_probs=136.5

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      ..+|+.+++|..|+||.||..+++ ..+.+|.| +.++..   +.+-  ++.....|.+|                    
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l---ilRn--ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL---ILRN--ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch---hhhc--cccccCCccee--------------------
Confidence            357899999999999999999875 46778874 332211   1111  22222333333                    


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-----
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-----  464 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-----  464 (588)
                       |+=...+... +.++        .+++.+++|||+.+   |+|||+||+|.+|+.-|.+|+.|||+.+......     
T Consensus       136 -gDc~tllk~~-g~lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 -GDCATLLKNI-GPLP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             -chhhhhcccC-CCCc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence             3333444221 1222        12377899999999   9999999999999999999999999987542211     


Q ss_pred             ---------cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc------CcccCc
Q 042871          465 ---------TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA------DPKLDR  529 (588)
Q Consensus       465 ---------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~------d~~l~~  529 (588)
                               ......++||+.|+|||++..+.|...+|+|++|+|+||.+-|..||.-...+++...+      -+.-.+
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de  282 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE  282 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc
Confidence                     11234578999999999999999999999999999999999999998754333332222      111133


Q ss_pred             ccCHHHHHHHHHHHHHhhcCCCCCC
Q 042871          530 EYSIEAFDLTLQLALSCTALTHQRP  554 (588)
Q Consensus       530 ~~~~e~~~~v~~L~~~C~~~p~~RP  554 (588)
                      ..+.|..+++.+|.   .++|..|-
T Consensus       283 a~p~Ea~dli~~LL---~qnp~~Rl  304 (1205)
T KOG0606|consen  283 ALPPEAQDLIEQLL---RQNPLCRL  304 (1205)
T ss_pred             CCCHHHHHHHHHHH---HhChHhhc
Confidence            45566666665555   34565554

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=8.8e-16  Score=147.28  Aligned_cols=135  Identities=17%  Similarity=0.166  Sum_probs=95.8

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCc----HHHH----------------------HHHHHHhccCCCCc--e
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN----VETF----------------------VREVASSSHVRHPN--L  368 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~----~~~~----------------------~~Ei~~l~~l~Hpn--I  368 (588)
                      .+.||+|+||.||+|+..+|+.||||++.....    ...+                      ..|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            357999999999999988899999998864211    1111                      23444444443332  3


Q ss_pred             eEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCC
Q 042871          369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       369 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~  447 (588)
                      .+.+++    ...++||||++++.+......... .. .+...++.+++.++.++|. .+   |+||||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence            333332    246899999999654322211110 11 5677899999999999999 77   99999999999999 89


Q ss_pred             cEEEEecCCcceec
Q 042871          448 EAKLSDFGLSKVID  461 (588)
Q Consensus       448 ~~kL~DFGla~~~~  461 (588)
                      .++|+|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            99999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=1.3e-14  Score=145.46  Aligned_cols=132  Identities=16%  Similarity=0.122  Sum_probs=103.4

Q ss_pred             ceee-ccCceEEEEEEecCCcEEEEEEecCC---------------CcHHHHHHHHHHhccCCCCce--eEEecceeccC
Q 042871          318 NLIG-EGITGKVYKGKLSNNQHVAIKHITNE---------------GNVETFVREVASSSHVRHPNL--VALLGYCLRVD  379 (588)
Q Consensus       318 ~~LG-~G~fG~Vykg~~~~g~~VAVK~l~~~---------------~~~~~~~~Ei~~l~~l~HpnI--v~l~g~~~~~~  379 (588)
                      ..|| .||.|+||+++. ++..++||++...               .....+.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4788 899999999988 4778999987531               112457789999999998875  66676644322


Q ss_pred             ----eeeEEeecCCC-CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          380 ----ECFLIYELCPN-GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       380 ----~~~LV~E~~~~-gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                          ..++|+|++++ .+|.+++..  ..++..    .+.+++++|.+||..+   |+||||||+|||++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEEC
Confidence                23599999997 689988843  234432    3567899999999999   999999999999999899999999


Q ss_pred             CCcce
Q 042871          455 GLSKV  459 (588)
Q Consensus       455 Gla~~  459 (588)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=3.6e-15  Score=167.17  Aligned_cols=247  Identities=22%  Similarity=0.198  Sum_probs=180.5

Q ss_pred             cCccccceeeccCceEEEEEEe--cCCcEEEEEEecCCC-c---HHHHHHHHHHhccCC-CCceeEEecceeccCeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL--SNNQHVAIKHITNEG-N---VETFVREVASSSHVR-HPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~-~---~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ..|...+.||+|.|+.|-....  .....+|+|.+.... .   .+....|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            3455666799999999988765  344567777765432 1   223334777767776 99999999999999999999


Q ss_pred             eecCCCCChhhhh-hcCCcCccHHHHHHHHHhhhccchhhc-cccCCceEecCCCCCCeEECCCC-cEEEEecCCcceec
Q 042871          385 YELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSARGLWFLH-SYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVID  461 (588)
Q Consensus       385 ~E~~~~gsL~~~L-~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~  461 (588)
                      .||..++++.+.+ .......+....-.++.|+..++.|+| ..+   +.||||||+|.+++..+ ..+++|||+|....
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999998 443335666667778999999999999 777   99999999999999999 99999999998775


Q ss_pred             C--CCcccccCccC-CCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccc--hhhhcCcccC--cccCH
Q 042871          462 I--GETYASSEVRG-TFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS--ALELADPKLD--REYSI  533 (588)
Q Consensus       462 ~--~~~~~~~~~~g-t~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~--~~~~~d~~l~--~~~~~  533 (588)
                      .  +.........| ++.|+|||...+. -..+..|+||.|+++.-+++|..||.......  ...+......  .....
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            5  33334445567 9999999998874 44678999999999999999999998654433  2222222211  11111


Q ss_pred             HHHHHHHHHHHHhh-cCCCCCCCHHHHHH
Q 042871          534 EAFDLTLQLALSCT-ALTHQRPPMEQVFV  561 (588)
Q Consensus       534 e~~~~v~~L~~~C~-~~p~~RPs~~evl~  561 (588)
                      ........+...++ .+|..|.+.+++..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccc
Confidence            12222333344444 46788888877654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=2.1e-13  Score=148.20  Aligned_cols=137  Identities=21%  Similarity=0.206  Sum_probs=97.5

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCCCcHH-------------------------------------------HHH
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVE-------------------------------------------TFV  354 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-------------------------------------------~~~  354 (588)
                      +-||+|++|.||+|++.+|+.||||+.+... .+                                           +|.
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999999999999999875321 00                                           234


Q ss_pred             HHHHHhccC----CCCceeEEecce-eccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhc-cchhhccccC
Q 042871          355 REVASSSHV----RHPNLVALLGYC-LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR-GLWFLHSYSE  428 (588)
Q Consensus       355 ~Ei~~l~~l----~HpnIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~  428 (588)
                      +|...+.++    +|.+-+.+-..+ ...+..+|||||++|++|.+.........   .+.+++..+++ .+..+|..+ 
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g-  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG-  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC-
Confidence            455444444    232223332222 22456799999999999998874322122   23456665555 467888888 


Q ss_pred             CceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       429 ~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                        ++|+|+||.||+++++++++++|||++..++
T Consensus       278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             --ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence              9999999999999999999999999987764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=1.2e-12  Score=141.52  Aligned_cols=194  Identities=26%  Similarity=0.318  Sum_probs=157.9

Q ss_pred             cCccccceeec--cCceEEEEEEe---cCCcEEEEEEecC----CCcHHHHHHHHHHhccCC-CCceeEEecceeccCee
Q 042871          312 EKLNELNLIGE--GITGKVYKGKL---SNNQHVAIKHITN----EGNVETFVREVASSSHVR-HPNLVALLGYCLRVDEC  381 (588)
Q Consensus       312 ~~f~~~~~LG~--G~fG~Vykg~~---~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~  381 (588)
                      ..|...+.+|+  |.+|.||.+..   .++..+|+|+-+.    ......=.+|+...+.++ |+|.++....+.+.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34566678999  99999999986   4788999997332    222233356776666664 99999988899999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhc----cchhhccccCCceEecCCCCCCeEECCC-CcEEEEecCC
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR----GLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGL  456 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~IvHrDLKp~NILld~~-~~~kL~DFGl  456 (588)
                      |+-+|++ +.+|.++.+.....++....+.+..+..+    ||.++|+..   ++|-|+||.||++.++ ...+++|||+
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence            9999998 68999998777666788888888888888    999999999   9999999999999999 8899999999


Q ss_pred             cceecCCCccc----ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCc
Q 042871          457 SKVIDIGETYA----SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA  510 (588)
Q Consensus       457 a~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p  510 (588)
                      ...+..+....    .....|...|++||...+ .++..+|+|++|.++.|..++-..
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~  326 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHL  326 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccc
Confidence            98876554221    123357788999998776 688999999999999999988653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=3.1e-12  Score=120.39  Aligned_cols=130  Identities=21%  Similarity=0.182  Sum_probs=97.5

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCC-cHHHHHHHHHHhccCCCCcee-EEecceeccCeeeEEeecCCCCChh
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLV-ALLGYCLRVDECFLIYELCPNGNLA  394 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~~gsL~  394 (588)
                      .+.|+.|.++.||+++.. +..|++|...... ....+.+|+..+..+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            357889999999999974 7789999876543 234567899888888665544 444433  33458999999998886


Q ss_pred             hhhhcCCcCccHHHHHHHHHhhhccchhhcccc--CCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS--EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       395 ~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      +.-         .....++.+++++|..||...  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            531         112345678899999999987  23469999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.31  E-value=1.8e-11  Score=135.12  Aligned_cols=140  Identities=15%  Similarity=0.194  Sum_probs=91.6

Q ss_pred             hcCccccceeeccCceEEEEEEecC-CcEEEEEEecCCCc--------------------------------H----H--
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEGN--------------------------------V----E--  351 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--------------------------------~----~--  351 (588)
                      -.+|+. +-||+|++|.||+|++.+ |+.||||+++....                                .    +  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345665 689999999999999977 99999999863210                                0    0  


Q ss_pred             ----HHHHHHHHhccCC----CCceeEEecceec-cCeeeEEeecCCCCChhhhh--hcCCc---CccHHHHHHHHHhhh
Q 042871          352 ----TFVREVASSSHVR----HPNLVALLGYCLR-VDECFLIYELCPNGNLAEWL--FGKDK---CLSWIQRLEIAIDSA  417 (588)
Q Consensus       352 ----~~~~Ei~~l~~l~----HpnIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~L--~~~~~---~l~~~~~~~i~~~ia  417 (588)
                          +|.+|...+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.+.-  ...+.   .+.......++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                1333444333332    3333333333322 45678999999999998753  22111   23332333333343 


Q ss_pred             ccchhhccccCCceEecCCCCCCeEECCCC----cEEEEecCCcceec
Q 042871          418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNF----EAKLSDFGLSKVID  461 (588)
Q Consensus       418 ~gL~yLH~~~~~~IvHrDLKp~NILld~~~----~~kL~DFGla~~~~  461 (588)
                            +..+   ++|+|+||.||+++.++    ++++.|||+...++
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  3456   99999999999999888    99999999987653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=2.1e-12  Score=129.72  Aligned_cols=199  Identities=18%  Similarity=0.196  Sum_probs=135.6

Q ss_pred             HHhccCCCCceeEEecceecc-----CeeeEEeecCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccCC
Q 042871          358 ASSSHVRHPNLVALLGYCLRV-----DECFLIYELCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSEG  429 (588)
Q Consensus       358 ~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~E~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  429 (588)
                      ..|-++-|.|||++..|+.+.     .+..++.|||+.|+|..+|.+.   .+.+....-.+++-||..||.|||+.. |
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            345556799999999888754     3578999999999999999642   245777777889999999999999985 6


Q ss_pred             ceEecCCCCCCeEECCCCcEEEEecCCccee----cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHH
Q 042871          430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVI----DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL  505 (588)
Q Consensus       430 ~IvHrDLKp~NILld~~~~~kL~DFGla~~~----~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ell  505 (588)
                      +|+|+++..+-|++..++-+|+.--. ....    ............+.++|.+||+-.....+..+|||+||...+||-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            69999999999999999888874211 1111    001111223345778999999987778888999999999999998


Q ss_pred             cCCCcccccc-ccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          506 SGKKAKVLTR-AGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       506 tG~~p~~~~~-~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      -+..-..... .....+.+...+...    ...+=..++..|++ .|..||+|++++..
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~l----en~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGL----ENGLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeec----cCccccCcCcccccCCCCCCcchhhhhcC
Confidence            7764211100 001111111111000    00111224667888 69999999987643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=1e-10  Score=114.60  Aligned_cols=140  Identities=19%  Similarity=0.220  Sum_probs=108.8

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCC--ceeEEecceecc---CeeeEEeecCC
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEG---NVETFVREVASSSHVRHP--NLVALLGYCLRV---DECFLIYELCP  389 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~---~~~~LV~E~~~  389 (588)
                      +.|+.|..+.||+++..+|+.+++|......   ....+.+|+++++.+++.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            4689999999999998777899999876532   356788999999998763  456677766654   35689999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcccc------------------------------------------
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS------------------------------------------  427 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------  427 (588)
                      +.++.+.+..  ..++..++..++.++++.|.+||+..                                          
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988876632  34666777778888888888887521                                          


Q ss_pred             -----------CCceEecCCCCCCeEECC--CCcEEEEecCCcce
Q 042871          428 -----------EGCIVHRDIKPTNILLGP--NFEAKLSDFGLSKV  459 (588)
Q Consensus       428 -----------~~~IvHrDLKp~NILld~--~~~~kL~DFGla~~  459 (588)
                                 ...++|+|+++.||++++  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       246899999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.15  E-value=1.6e-10  Score=126.20  Aligned_cols=164  Identities=18%  Similarity=0.187  Sum_probs=123.6

Q ss_pred             ecCCcEEEEEEecCCCc--HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHH
Q 042871          333 LSNNQHVAIKHITNEGN--VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL  410 (588)
Q Consensus       333 ~~~g~~VAVK~l~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~  410 (588)
                      ..++.+|.|...+....  .+...+-++.|+.+|||||+++++..+.++..|||+|-+.  .|..++..    +......
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence            35788999988876544  4556778899999999999999999999999999999883  56666632    3344555


Q ss_pred             HHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCc
Q 042871          411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS  490 (588)
Q Consensus       411 ~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~  490 (588)
                      -.+.||+.||.|||..+.  ++|++|.-+.|++++.|..||++|.++........ ......--..|..|+.+....  -
T Consensus       108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence            678899999999986543  99999999999999999999999998754332111 011111123466676544322  3


Q ss_pred             hhhHHHHHHHHHHHHcC
Q 042871          491 SGDVYSFGIVLLQILSG  507 (588)
Q Consensus       491 ksDVwS~Gvll~ElltG  507 (588)
                      ..|.|.||++++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            46999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=9.9e-10  Score=106.26  Aligned_cols=135  Identities=14%  Similarity=0.104  Sum_probs=96.1

Q ss_pred             ceeeccCceEEEEEEecC-------CcEEEEEEecC--------------C----------CcHHHH----HHHHHHhcc
Q 042871          318 NLIGEGITGKVYKGKLSN-------NQHVAIKHITN--------------E----------GNVETF----VREVASSSH  362 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~--------------~----------~~~~~~----~~Ei~~l~~  362 (588)
                      ..||.|--+.||.|.-.+       +..+|||..+.              +          .....+    .+|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       57999997631              0          011223    378888888


Q ss_pred             CCC--CceeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhh-ccccCCceEecCCCCC
Q 042871          363 VRH--PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL-HSYSEGCIVHRDIKPT  439 (588)
Q Consensus       363 l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~IvHrDLKp~  439 (588)
                      +..  -++..++++    ..-+|||||+.++.+..-.. +...++..+...+..+++.+|.+| |..+   |+|+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence            853  455566654    46689999997654432211 112244455667788999999999 7788   999999999


Q ss_pred             CeEECCCCcEEEEecCCcceec
Q 042871          440 NILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       440 NILld~~~~~kL~DFGla~~~~  461 (588)
                      |||++ ++.+.|+|||.+...+
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCC
Confidence            99997 4689999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.04  E-value=1.5e-10  Score=125.40  Aligned_cols=195  Identities=20%  Similarity=0.240  Sum_probs=149.0

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEe--cCCcEEEEEEecCCC--cHHH--HHHHHHHhccC-CCCceeEEecceeccC
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKL--SNNQHVAIKHITNEG--NVET--FVREVASSSHV-RHPNLVALLGYCLRVD  379 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~--~~~~--~~~Ei~~l~~l-~HpnIv~l~g~~~~~~  379 (588)
                      ....+.+|..+..||.|.|+.|++...  .++..+++|.+.+..  ..++  -+.|+.+...+ .|.+.++....+....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            344567889999999999999999864  467889999876531  1111  24566555555 4888999888888888


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-CcEEEEecCCcc
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSK  458 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-~~~kL~DFGla~  458 (588)
                      ..|+--||++++++...+ .-...++...++.+..+++.++.++|+..   ++|+|+||+||++..+ +.-++.|||.+.
T Consensus       340 ~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            888999999999888776 22335777888999999999999999888   9999999999999875 788999999986


Q ss_pred             eecCCCcccccCccCCCCcc--CcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 042871          459 VIDIGETYASSEVRGTFGYL--DPEYRSNCKVNSSGDVYSFGIVLLQILSGKK  509 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~  509 (588)
                      .+....    .......+++  +++......+..+.|+||||.-+.|..++..
T Consensus       416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             ccceec----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            432111    1112233444  5566677788899999999999999999875

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.94  E-value=1.8e-09  Score=101.32  Aligned_cols=140  Identities=21%  Similarity=0.238  Sum_probs=102.4

Q ss_pred             ccceeeccCceEEEEEEecCCcEEEEEEe-c----CCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          316 ELNLIGEGITGKVYKGKLSNNQHVAIKHI-T----NEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l-~----~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ....|-+|+-+.|+++.+ .|+...||.- .    .+.     ....-.+|.+.+.+++--.|..-.-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456899999999999998 6777777742 2    111     2345678999988876555544444566666778999


Q ss_pred             ecCCC-CChhhhhhcCCcC-ccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC---cEEEEecCCcce
Q 042871          386 ELCPN-GNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF---EAKLSDFGLSKV  459 (588)
Q Consensus       386 E~~~~-gsL~~~L~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~---~~kL~DFGla~~  459 (588)
                      ||+++ .++.+++...-.. .+.......+..+-+.+.-||..+   |+|+||..+||+|.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99966 4888888543322 222233678888889999999999   99999999999996554   358999999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.92  E-value=5.6e-10  Score=126.82  Aligned_cols=210  Identities=20%  Similarity=0.219  Sum_probs=150.0

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ..+.|.+.+-+-+|.++.++.++- ..|...+.|....     ....+....+-.++-..+||-++...--+.-....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            346677777788999999987763 2343334443321     1112333334344444556777766655556778899


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      |++|..+++|...|+... .++..-....+..+...++|||...   +.|||++|.|+|+..++..+++|||.......-
T Consensus       882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccc
Confidence            999999999999997654 3444444556666788999999987   899999999999999999999999843221100


Q ss_pred             ---------------------C---c------ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          464 ---------------------E---T------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       464 ---------------------~---~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                                           .   .      .......||+.|.+||...+......+|+|++|+.++|.++|..|+..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                 0   0      012235689999999999999999999999999999999999999886


Q ss_pred             ccccchhhhc
Q 042871          514 TRAGSALELA  523 (588)
Q Consensus       514 ~~~~~~~~~~  523 (588)
                      ....++.+.+
T Consensus      1038 ~tpq~~f~ni 1047 (1205)
T KOG0606|consen 1038 ETPQQIFENI 1047 (1205)
T ss_pred             cchhhhhhcc
Confidence            6665555433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.91  E-value=1.8e-09  Score=101.64  Aligned_cols=128  Identities=23%  Similarity=0.292  Sum_probs=95.6

Q ss_pred             eeeccCceEEEEEEecCCcEEEEEEe-cC----CC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          319 LIGEGITGKVYKGKLSNNQHVAIKHI-TN----EG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g~~VAVK~l-~~----~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .+++|+-..+|.+.+. |.++.+|.= .+    +.     ..+.-.+|..++.+++--.|..-.=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999773 445666632 21    11     1234567888888886554444444555777889999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      +|..|.+.+...        +..++..+-+-+.-||..+   |+|+||.++||++..+ ++.++||||+..
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCC-cEEEEECCcccc
Confidence            999999998543        2456677777788899999   9999999999999765 499999999874

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.84  E-value=1.6e-08  Score=102.91  Aligned_cols=137  Identities=15%  Similarity=0.090  Sum_probs=99.4

Q ss_pred             eeeccCceEEEEEEecCCcEEEEEEecCCCcH-------------HHHHHHHHHhccCCCCce--eEEecceec-----c
Q 042871          319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNV-------------ETFVREVASSSHVRHPNL--VALLGYCLR-----V  378 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-------------~~~~~Ei~~l~~l~HpnI--v~l~g~~~~-----~  378 (588)
                      .+-......|++..+ +|+.+.||+.......             ..+.+|...+.++...+|  ..++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            444444556778777 7789999987543311             147788888877753332  334444432     2


Q ss_pred             CeeeEEeecCCCC-ChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-------CCcE
Q 042871          379 DECFLIYELCPNG-NLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-------NFEA  449 (588)
Q Consensus       379 ~~~~LV~E~~~~g-sL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-------~~~~  449 (588)
                      ...+||+|++++- +|.+++... ....+...+..++.+++..+.-||..+   |+|+|++++|||++.       ++.+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence            3578999999876 899988431 233455667789999999999999999   999999999999975       5689


Q ss_pred             EEEecCCcce
Q 042871          450 KLSDFGLSKV  459 (588)
Q Consensus       450 kL~DFGla~~  459 (588)
                      .|+||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.84  E-value=5.3e-08  Score=103.87  Aligned_cols=163  Identities=17%  Similarity=0.260  Sum_probs=126.5

Q ss_pred             eEEEEEEe-cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEeccee----ccCeeeEEeecCCC-CChhhhh
Q 042871          326 GKVYKGKL-SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCL----RVDECFLIYELCPN-GNLAEWL  397 (588)
Q Consensus       326 G~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~----~~~~~~LV~E~~~~-gsL~~~L  397 (588)
                      .+.||+.. -||..+++||+...+  ....-..-++.++++.|.|+|++..++.    .+..+.+||+|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            56799975 489999999994322  1223345678899999999999999987    34568999999987 5777766


Q ss_pred             hcC--------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          398 FGK--------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       398 ~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      +..              +...++...|.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|+..|....+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            431              224678899999999999999999999   888999999999999999999998877655433


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK  509 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~  509 (588)
                      ..               |-+.   --.+-|.=.||.+++.|.||..
T Consensus       447 ~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  447 PT---------------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            20               1111   1246799999999999999964

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=4.7e-08  Score=94.14  Aligned_cols=123  Identities=20%  Similarity=0.168  Sum_probs=81.0

Q ss_pred             EEEEEEecCCcEEEEEEecC---------------CC-------------cHHHHHHHHHHhccCCCC--ceeEEeccee
Q 042871          327 KVYKGKLSNNQHVAIKHITN---------------EG-------------NVETFVREVASSSHVRHP--NLVALLGYCL  376 (588)
Q Consensus       327 ~Vykg~~~~g~~VAVK~l~~---------------~~-------------~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~  376 (588)
                      .||.|...+|..||||..+.               ..             ......+|.+.|.++..-  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999998999999997531               00             022457899999999765  456666442 


Q ss_pred             ccCeeeEEeecCC--CCChhhhhhcCCcCccHHHHHHHHHhhhccchh-hccccCCceEecCCCCCCeEECCCCcEEEEe
Q 042871          377 RVDECFLIYELCP--NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF-LHSYSEGCIVHRDIKPTNILLGPNFEAKLSD  453 (588)
Q Consensus       377 ~~~~~~LV~E~~~--~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~IvHrDLKp~NILld~~~~~kL~D  453 (588)
                         .-.|||||++  +..+..+....   ++......++.++...+.. +|..+   |+|+||.+.|||++++ .+.|+|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence               4479999998  54454433211   2234455677777775555 57888   9999999999999888 999999


Q ss_pred             cCCccee
Q 042871          454 FGLSKVI  460 (588)
Q Consensus       454 FGla~~~  460 (588)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.67  E-value=6.3e-07  Score=93.60  Aligned_cols=244  Identities=16%  Similarity=0.133  Sum_probs=150.6

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecce------eccC-eeeEEeecC
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYC------LRVD-ECFLIYELC  388 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~------~~~~-~~~LV~E~~  388 (588)
                      ..-||+|+-+.+|..-- -+..|| |++........ .+.+..|... .||-+-.-+.|=      -+.+ ..-+.|..+
T Consensus        16 gr~LgqGgea~ly~l~e-~~d~VA-KIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          16 GRPLGQGGEADLYTLGE-VRDQVA-KIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             CccccCCccceeeecch-hhchhh-eeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            35699999999996432 122344 66654322111 1223333333 455332212111      1222 255777777


Q ss_pred             CCC-Chhhhhh-----cCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          389 PNG-NLAEWLF-----GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       389 ~~g-sL~~~L~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ++. -..++..     .+-...+|...++.+..++.+.+-||..+   ..-+|++++|+|+.+++.+.|.|-..-..-..
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n  169 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN  169 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccC
Confidence            654 2223321     11235799999999999999999999999   88999999999999999999998765433222


Q ss_pred             CCcccccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcC-CCccccccc----cchhh----------h
Q 042871          463 GETYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSG-KKAKVLTRA----GSALE----------L  522 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG-~~p~~~~~~----~~~~~----------~  522 (588)
                      +  ......+|...|.+||.-.     +..-+...|-|.|||++++++-| ++||.-...    ....+          .
T Consensus       170 g--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya  247 (637)
T COG4248         170 G--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA  247 (637)
T ss_pred             C--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence            2  2233457889999999643     44567789999999999999886 788752110    00000          0


Q ss_pred             cCc--cc---CcccCHH-HHHHHHHHHHHhhcC---CCCCCCHHHHHHHHHHhhc
Q 042871          523 ADP--KL---DREYSIE-AFDLTLQLALSCTAL---THQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       523 ~d~--~l---~~~~~~e-~~~~v~~L~~~C~~~---p~~RPs~~evl~~L~~~~~  568 (588)
                      -+.  .+   +..++-+ ....+.-|...|..+   +.-|||.+.-+..|..+.+
T Consensus       248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            011  11   1122322 334566667778765   4589999998888877654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.60  E-value=1.2e-08  Score=112.21  Aligned_cols=144  Identities=22%  Similarity=0.343  Sum_probs=97.8

Q ss_pred             HHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc--------ccCccCCCCccCccccc
Q 042871          413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA--------SSEVRGTFGYLDPEYRS  484 (588)
Q Consensus       413 ~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~--------~~~~~gt~~Y~aPE~~~  484 (588)
                      +.+++.||.|+|...+  ++|++|.|++|.++.++..||+.|+.+.....+..+.        ..-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4456699999998754  9999999999999999999999999876543321111        11122456799999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh----hc----CcccCcccCHHHHHHHHHHHHHhhcCCCCCCCH
Q 042871          485 NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE----LA----DPKLDREYSIEAFDLTLQLALSCTALTHQRPPM  556 (588)
Q Consensus       485 ~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~----~~----d~~l~~~~~~e~~~~v~~L~~~C~~~p~~RPs~  556 (588)
                      +...+.++|+||+|+++|.+..|+++...........    ..    ......+.+.|..+.+.++.   ..++.-||++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l---~~~~~~rp~~  259 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLL---NGDSAVRPTL  259 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHh---cCCcccCcch
Confidence            9888999999999999999996665432211111111    11    11122345566666665544   3467889987


Q ss_pred             HHHHH
Q 042871          557 EQVFV  561 (588)
Q Consensus       557 ~evl~  561 (588)
                      .++..
T Consensus       260 ~~l~~  264 (700)
T KOG2137|consen  260 DLLLS  264 (700)
T ss_pred             hhhhc
Confidence            76653

>PRK09902 hypothetical protein; Provisional

Probab=98.42  E-value=1.1e-06  Score=85.64  Aligned_cols=135  Identities=18%  Similarity=0.103  Sum_probs=102.4

Q ss_pred             eeccCceEEEEEEecCCcEEEEEEecC--------CCcHHHHHHHHHHhccCCCCc--eeEEeccee-c----cCeeeEE
Q 042871          320 IGEGITGKVYKGKLSNNQHVAIKHITN--------EGNVETFVREVASSSHVRHPN--LVALLGYCL-R----VDECFLI  384 (588)
Q Consensus       320 LG~G~fG~Vykg~~~~g~~VAVK~l~~--------~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~-~----~~~~~LV  384 (588)
                      -|+||-+-|++-.+ +|+.+=+|+-.+        +.....|.+|+..|.++...+  +.+.. ++. .    ...-+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            36789999999887 455788887652        234678999999999886433  44444 322 1    2246899


Q ss_pred             eecCCC-CChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc--EEEEecCCcce
Q 042871          385 YELCPN-GNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE--AKLSDFGLSKV  459 (588)
Q Consensus       385 ~E~~~~-gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~--~kL~DFGla~~  459 (588)
                      +|-++| -+|.+++.+.. ...+..++..++.++++.+.-||..+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997754 58888885432 34677778899999999999999999   999999999999986666  99999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.42  E-value=5.1e-07  Score=88.44  Aligned_cols=106  Identities=27%  Similarity=0.295  Sum_probs=81.9

Q ss_pred             HHHHHHHHHhccCCCC--ceeEEecceecc----CeeeEEeecCCCC-ChhhhhhcCCcCccHHHHHHHHHhhhccchhh
Q 042871          351 ETFVREVASSSHVRHP--NLVALLGYCLRV----DECFLIYELCPNG-NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL  423 (588)
Q Consensus       351 ~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~----~~~~LV~E~~~~g-sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yL  423 (588)
                      ....+|...+..+...  ...+.+++....    ...+||+|++++. +|.+++..... ++......++.++++.+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4567788777776533  334555555542    2458999999884 79998854322 56667788999999999999


Q ss_pred             ccccCCceEecCCCCCCeEECCCC---cEEEEecCCccee
Q 042871          424 HSYSEGCIVHRDIKPTNILLGPNF---EAKLSDFGLSKVI  460 (588)
Q Consensus       424 H~~~~~~IvHrDLKp~NILld~~~---~~kL~DFGla~~~  460 (588)
                      |..+   |+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   99999999999998887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.39  E-value=1.7e-06  Score=86.10  Aligned_cols=138  Identities=18%  Similarity=0.133  Sum_probs=85.1

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCc--eeEEecceeccCeeeEEeecCCCCC-hh
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPN--LVALLGYCLRVDECFLIYELCPNGN-LA  394 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~~LV~E~~~~gs-L~  394 (588)
                      ..||+|..+.||+.   .|..+++|............+|.+.++.+..-.  +.+.+++....+...+|||+++|.+ +.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~   83 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS   83 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence            47899999999983   245677888776555566788999998886443  3566777777777889999998863 21


Q ss_pred             hhh---------------------hcCC-cCccHHHHHH-HHHhh----------hc-cchhhcc-ccCCceEecCCCCC
Q 042871          395 EWL---------------------FGKD-KCLSWIQRLE-IAIDS----------AR-GLWFLHS-YSEGCIVHRDIKPT  439 (588)
Q Consensus       395 ~~L---------------------~~~~-~~l~~~~~~~-i~~~i----------a~-gL~yLH~-~~~~~IvHrDLKp~  439 (588)
                      ..+                     |.-. .......... +..++          .+ ...+|.. ...+.++|+|+.|.
T Consensus        84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~  163 (226)
T TIGR02172        84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG  163 (226)
T ss_pred             hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence            111                     1100 0001011000 00000          00 1112211 12345899999999


Q ss_pred             CeEECCCCcEEEEecCCcce
Q 042871          440 NILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       440 NILld~~~~~kL~DFGla~~  459 (588)
                      ||++++++ +.|+||+.+..
T Consensus       164 Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       164 NLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cEEEcCCC-cEEEechhcCc
Confidence            99999888 99999997753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.35  E-value=1.5e-06  Score=86.84  Aligned_cols=131  Identities=17%  Similarity=0.119  Sum_probs=92.3

Q ss_pred             ccceeeccCceEEEEEEecCCcEEEEEEec----------C-------C---C----cHHHHHHHHHHhccCCCC--cee
Q 042871          316 ELNLIGEGITGKVYKGKLSNNQHVAIKHIT----------N-------E---G----NVETFVREVASSSHVRHP--NLV  369 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~----------~-------~---~----~~~~~~~Ei~~l~~l~Hp--nIv  369 (588)
                      +.+.||.|--+.||.|..++|.++|||.=+          .       .   .    ......+|.+.|.++...  .+.
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            446899999999999999999999999421          0       0   0    122456788999888654  566


Q ss_pred             EEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       370 ~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      +.+++    +.-.+||||+++-.|...-.      +....-.++..|++-+.-+-..+   |+|+|+.+-||++++||.+
T Consensus       175 ~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         175 KPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             Ccccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCE
Confidence            66544    45689999998866654331      22223334444444444444566   9999999999999999999


Q ss_pred             EEEecCCcce
Q 042871          450 KLSDFGLSKV  459 (588)
Q Consensus       450 kL~DFGla~~  459 (588)
                      .++||--+..
T Consensus       242 ~vIDwPQ~v~  251 (304)
T COG0478         242 VVIDWPQAVP  251 (304)
T ss_pred             EEEeCccccc
Confidence            9999975543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.32  E-value=1e-07  Score=103.92  Aligned_cols=189  Identities=22%  Similarity=0.176  Sum_probs=141.1

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCc-eeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPN-LVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~E~~  388 (588)
                      -++.+...+-+++|.+++++|.+-.-.+....+.+...   ....-++++|.+++||| .+..++-+..+...+++++++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            34455556678999999999998533333336655543   44456889999999999 777777777778889999999


Q ss_pred             CCC-ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNG-NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~g-sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ..+ +-.+......-.+...+...+...-.++|+|||+..   =+|||    ||+..+ +..|..||+....+....  .
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~  386 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K  386 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--c
Confidence            877 333333222234556666777788889999999875   47998    777755 689999999988765443  3


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      .+...+++.++|||+.....+..+.|+|++|+-..++--|-.|.
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            45567899999999999999999999999998877777776553

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.30  E-value=1e-06  Score=97.14  Aligned_cols=139  Identities=23%  Similarity=0.263  Sum_probs=89.8

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCC------------------------C----c----HH----------HHHH
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNE------------------------G----N----VE----------TFVR  355 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~------------------------~----~----~~----------~~~~  355 (588)
                      +-|+.++-|.||+|++++|+.||||+.+..                        .    .    .+          +|.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            468899999999999999999999976421                        0    0    11          1333


Q ss_pred             HHHHhccCC-----CCceeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhcc-chhhccccCC
Q 042871          356 EVASSSHVR-----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG-LWFLHSYSEG  429 (588)
Q Consensus       356 Ei~~l~~l~-----HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~~  429 (588)
                      |...+.+++     .+++.--.=+..-.+...|+|||++|-.+.+...-+....+...   ++..++++ +..+-..+  
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~dg--  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRDG--  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhcC--
Confidence            444443332     33332222222335677899999999999888532333344222   22222222 12222245  


Q ss_pred             ceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       430 ~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                       ++|.|..|.||+++.++++.+.|||+...++.
T Consensus       286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 -FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             99999999999999999999999999877654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.26  E-value=2.7e-06  Score=83.52  Aligned_cols=142  Identities=17%  Similarity=0.166  Sum_probs=84.3

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCC--ceeEEeccee---ccCeeeEEeecCCCC
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHP--NLVALLGYCL---RVDECFLIYELCPNG  391 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~---~~~~~~LV~E~~~~g  391 (588)
                      ++.|+.|..+.||+....+ ..+++|..........+.+|..++..++..  .+.+++.+..   .....+++||++++.
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            3578999999999999877 689999877654456777888888777533  2455555332   233468999999998


Q ss_pred             Chhh----------------hh---hcC---CcCccHHH---------HHHH------------HHhhhc-cchhhcc--
Q 042871          392 NLAE----------------WL---FGK---DKCLSWIQ---------RLEI------------AIDSAR-GLWFLHS--  425 (588)
Q Consensus       392 sL~~----------------~L---~~~---~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~--  425 (588)
                      .+.+                .+   +..   .....+..         ....            ...+.+ .+..++.  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            8877                11   111   00111000         0000            011111 2333332  


Q ss_pred             --ccCCceEecCCCCCCeEEC-CCCcEEEEecCCcce
Q 042871          426 --YSEGCIVHRDIKPTNILLG-PNFEAKLSDFGLSKV  459 (588)
Q Consensus       426 --~~~~~IvHrDLKp~NILld-~~~~~kL~DFGla~~  459 (588)
                        .....++|+|+.|+|||++ +++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence              2345699999999999999 666678999997654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.11  E-value=1.5e-05  Score=78.11  Aligned_cols=137  Identities=15%  Similarity=0.164  Sum_probs=89.7

Q ss_pred             HHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCc--HH---------HHHHHHHHhccCCCC--------cee
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN--VE---------TFVREVASSSHVRHP--------NLV  369 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~---------~~~~Ei~~l~~l~Hp--------nIv  369 (588)
                      ...++|...+.+-......|.+-.. +|+.+.+|...++..  .+         ...+++..+.+++..        .++
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4567788888887777777777776 678889998764321  11         122334433333322        222


Q ss_pred             EEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       370 ~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      .-.-.+.-....+|+|||++|..|.++..     ++.    .++..+.+.+.-||..+   ++|+|..|+|++++++ .+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence            22222222345679999999988877652     221    24455667789999999   9999999999999855 59


Q ss_pred             EEEecCCcce
Q 042871          450 KLSDFGLSKV  459 (588)
Q Consensus       450 kL~DFGla~~  459 (588)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.07  E-value=1.7e-05  Score=79.40  Aligned_cols=138  Identities=17%  Similarity=0.140  Sum_probs=83.6

Q ss_pred             eeccCc-eEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEeecCCCCChhhhh
Q 042871          320 IGEGIT-GKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL  397 (588)
Q Consensus       320 LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L  397 (588)
                      |-.|.. ..||+...+ +..+.||+..... .....+|++++..+. +--+.+++++....+..++|||+++|.+|.+..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~   83 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALW   83 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhh
Confidence            344444 789999764 4688888876543 345677888887774 333556777776666789999999988776432


Q ss_pred             -------------------hcCCc---Ccc--HHHHHHH-HHhh-------------------hccchhhc----cccCC
Q 042871          398 -------------------FGKDK---CLS--WIQRLEI-AIDS-------------------ARGLWFLH----SYSEG  429 (588)
Q Consensus       398 -------------------~~~~~---~l~--~~~~~~i-~~~i-------------------a~gL~yLH----~~~~~  429 (588)
                                         +....   ...  ...+... ...+                   ...+..|-    ....+
T Consensus        84 ~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  163 (244)
T cd05150          84 EELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDL  163 (244)
T ss_pred             cccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCce
Confidence                               11100   000  0001100 0000                   00111111    11235


Q ss_pred             ceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       430 ~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      .++|+|+.|.|||++++....|+||+.+..
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            699999999999999987788999997653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.06  E-value=7e-06  Score=79.23  Aligned_cols=103  Identities=23%  Similarity=0.179  Sum_probs=83.0

Q ss_pred             HHHHHHhccCCC-CceeEEecceeccCeeeEEeecCCCCChhhhhh--cCCcCccHHHHHHHHHhhhccchhhccccCCc
Q 042871          354 VREVASSSHVRH-PNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC  430 (588)
Q Consensus       354 ~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  430 (588)
                      .+|..+++.+++ +++.+++|+|    ..++|.||.+.+++...-.  ..--..+|..|.+|+.++++.+++|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888876 6999999999    3478999998776643210  01124689999999999999999999876666


Q ss_pred             eEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       431 IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      +...|++++|+-+++++++|++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.99  E-value=5.3e-05  Score=78.53  Aligned_cols=80  Identities=13%  Similarity=0.012  Sum_probs=58.5

Q ss_pred             CccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCC---CceeEEecceec---cCeeeEEee
Q 042871          313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRH---PNLVALLGYCLR---VDECFLIYE  386 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~g~~~~---~~~~~LV~E  386 (588)
                      .....+.||.|..+.||+....++ .+.+|..+.......|.+|.+.++.+..   -.+.++++++..   .+..+||||
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            334456799999999999987666 4666765442345688899998888753   356777877654   366899999


Q ss_pred             cCCCCCh
Q 042871          387 LCPNGNL  393 (588)
Q Consensus       387 ~~~~gsL  393 (588)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>PLN02876 acyl-CoA dehydrogenase

Probab=97.98  E-value=4.8e-05  Score=89.68  Aligned_cols=77  Identities=13%  Similarity=0.248  Sum_probs=56.8

Q ss_pred             cceeeccCceEEEEEEecCC---cEEEEEEecCC---CcHHHHHHHHHHhccCC-CCce--eEEecceecc---CeeeEE
Q 042871          317 LNLIGEGITGKVYKGKLSNN---QHVAIKHITNE---GNVETFVREVASSSHVR-HPNL--VALLGYCLRV---DECFLI  384 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~-HpnI--v~l~g~~~~~---~~~~LV  384 (588)
                      .+.|+.|.+..+|+....++   ..+++|+....   .....+.+|+++++.+. |.++  .+++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56788999999999887554   36777775432   23457889999999985 6665  7777777654   467899


Q ss_pred             eecCCCCCh
Q 042871          385 YELCPNGNL  393 (588)
Q Consensus       385 ~E~~~~gsL  393 (588)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.96  E-value=2e-05  Score=86.79  Aligned_cols=139  Identities=21%  Similarity=0.241  Sum_probs=87.2

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCC-------------------------CcH--------------HHHHHHHH
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNE-------------------------GNV--------------ETFVREVA  358 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-------------------------~~~--------------~~~~~Ei~  358 (588)
                      +-||.-+.|.||+|++++|+.||||+-+..                         -..              -+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            469999999999999999999999975321                         000              02444443


Q ss_pred             Hhcc----CCCCc---eeEEecceec-cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCc
Q 042871          359 SSSH----VRHPN---LVALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC  430 (588)
Q Consensus       359 ~l~~----l~Hpn---Iv~l~g~~~~-~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  430 (588)
                      ...+    ++|-+   -|.+=.++.+ .....|+||||+|..+.|.-.-....++......-+.+.     |++..-..+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~-----~~~qIf~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA-----YLEQIFKTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH-----HHHHHHhcC
Confidence            3332    23444   1222222222 356799999999998877653333334444333333222     222211222


Q ss_pred             eEecCCCCCCeEECC----CCcEEEEecCCcceec
Q 042871          431 IVHRDIKPTNILLGP----NFEAKLSDFGLSKVID  461 (588)
Q Consensus       431 IvHrDLKp~NILld~----~~~~kL~DFGla~~~~  461 (588)
                      .+|+|=.|.||+++.    ++++.+-|||+...+.
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            899999999999984    6789999999987654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=3.4e-05  Score=77.01  Aligned_cols=73  Identities=10%  Similarity=0.075  Sum_probs=46.2

Q ss_pred             ceeeccCce-EEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCC---ceeEEecceecc---CeeeEEeecCCC
Q 042871          318 NLIGEGITG-KVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHP---NLVALLGYCLRV---DECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG-~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~~~---~~~~LV~E~~~~  390 (588)
                      +.|+.||.. .||+.    +..+.+|..........+.+|.+.+..+...   -+.+.++.....   ...+++||+++|
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            457777776 48875    2356678765544456788899888777532   233344433322   235889999998


Q ss_pred             CChh
Q 042871          391 GNLA  394 (588)
Q Consensus       391 gsL~  394 (588)
                      .++.
T Consensus        79 ~~l~   82 (235)
T cd05155          79 ETAT   82 (235)
T ss_pred             CCCC
Confidence            7764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.88  E-value=4e-05  Score=72.13  Aligned_cols=127  Identities=17%  Similarity=0.225  Sum_probs=89.1

Q ss_pred             ccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCcee-EEecceeccCeeeEEeecCCCCChh
Q 042871          316 ELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLV-ALLGYCLRVDECFLIYELCPNGNLA  394 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~~gsL~  394 (588)
                      ..+.|++|++|.||+|.+ .|..+|+|+-..+.....+..|.++|..++-.++- +++.|.    .-++.|||..|-.|.
T Consensus        26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~  100 (201)
T COG2112          26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG  100 (201)
T ss_pred             hhhhhhcccccEEEEeec-cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence            346799999999999999 55699999988888889999999999998866653 344443    234559999888887


Q ss_pred             hhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCC--CCeEECCCCcEEEEecCCcce
Q 042871          395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKP--TNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       395 ~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp--~NILld~~~~~kL~DFGla~~  459 (588)
                      +.-...    +-.+    ...+++.-.-|-..+   |-|+.|.-  .||++.+ ..+.|+||..|..
T Consensus       101 ~~~~~~----~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112         101 KLEIGG----DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcc----cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            765321    1222    223333333344445   77877764  5566654 4999999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.83  E-value=0.00014  Score=70.80  Aligned_cols=130  Identities=21%  Similarity=0.254  Sum_probs=90.5

Q ss_pred             ccceeeccCceEEEEEEecCCcEEEEEEecCCC------------------cHHHHHHHHHHhccCC------CCceeEE
Q 042871          316 ELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG------------------NVETFVREVASSSHVR------HPNLVAL  371 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~------------------~~~~~~~Ei~~l~~l~------HpnIv~l  371 (588)
                      ....||+|+.-.||.  +++.....||+.....                  ..++..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            345899999999996  4455667788876443                  2456667766554444      8899999


Q ss_pred             ecceeccCeeeEEeecCCC------CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC
Q 042871          372 LGYCLRVDECFLIYELCPN------GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP  445 (588)
Q Consensus       372 ~g~~~~~~~~~LV~E~~~~------gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~  445 (588)
                      +|+.+++...-+|+|.+.+      -+|.+++..  ..++. ...+.+.++   ..||-..+   |+.+|++|+||++..
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVVQR  153 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEEEe
Confidence            9999999889999998754      368888833  33554 444444444   44566666   999999999999953


Q ss_pred             C---C-cEEEEe-cCC
Q 042871          446 N---F-EAKLSD-FGL  456 (588)
Q Consensus       446 ~---~-~~kL~D-FGl  456 (588)
                      +   . .+.|+| ||-
T Consensus       154 ~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cCCCceEEEEEeCCCC
Confidence            2   2 577777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.83  E-value=8.2e-05  Score=73.83  Aligned_cols=152  Identities=20%  Similarity=0.206  Sum_probs=95.9

Q ss_pred             CcccHHHHHHHhcCccccceee---ccCceEEEEEEecCCcEEEEEEecCCC---------------------cH-----
Q 042871          300 PRYTIREVHYATEKLNELNLIG---EGITGKVYKGKLSNNQHVAIKHITNEG---------------------NV-----  350 (588)
Q Consensus       300 ~~~~~~el~~at~~f~~~~~LG---~G~fG~Vykg~~~~g~~VAVK~l~~~~---------------------~~-----  350 (588)
                      ...+...+....+...+....|   .|--..||+|...++..||||++....                     +.     
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3445566666666666665555   566678999998889999999875210                     11     


Q ss_pred             HHHHHHHHHhccCC--CCceeEEecceeccCeeeEEeecCCCCCh-hhhhhcCCcCccHHHHHHHHHhhhccchhhcc-c
Q 042871          351 ETFVREVASSSHVR--HPNLVALLGYCLRVDECFLIYELCPNGNL-AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-Y  426 (588)
Q Consensus       351 ~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~LV~E~~~~gsL-~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~  426 (588)
                      .+-.+|+..|.++.  +-.+.+-+++.    .-.|||||+....+ .-.|  +.-.+...+...+..++.+.+.-|-. .
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            11244565555553  22333333332    34699999955311 1111  11122332455666777777777766 4


Q ss_pred             cCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       427 ~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      +   ++|+||..-|||+. ++.+.|+|+|-+....
T Consensus       187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             C---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            5   99999999999999 8899999999776543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.81  E-value=0.00016  Score=70.00  Aligned_cols=135  Identities=26%  Similarity=0.355  Sum_probs=95.6

Q ss_pred             CCCCCCcccHHHHHHHhcCccccceeeccCc-eEEEEEEecCCcEEEEEEecC-----C------------------CcH
Q 042871          295 KDPGCPRYTIREVHYATEKLNELNLIGEGIT-GKVYKGKLSNNQHVAIKHITN-----E------------------GNV  350 (588)
Q Consensus       295 ~~~~~~~~~~~el~~at~~f~~~~~LG~G~f-G~Vykg~~~~g~~VAVK~l~~-----~------------------~~~  350 (588)
                      ..+.+..|+.     .+.+++.++.||.|.- |.|||+++ +|+.+|+|.+..     .                  ...
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~   98 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA   98 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence            4456666776     2378999999999999 99999999 788999998421     0                  112


Q ss_pred             HHHHHHHHHhccCC---CCce--eEEecceecc------------------CeeeEEeecCCCCChhhhhhcCCcCccHH
Q 042871          351 ETFVREVASSSHVR---HPNL--VALLGYCLRV------------------DECFLIYELCPNGNLAEWLFGKDKCLSWI  407 (588)
Q Consensus       351 ~~~~~Ei~~l~~l~---HpnI--v~l~g~~~~~------------------~~~~LV~E~~~~gsL~~~L~~~~~~l~~~  407 (588)
                      +.|..|.+...+++   +.++  |+.+||..-.                  ..+.||.||++...          .+...
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~  168 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR  168 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh
Confidence            35778888777765   5566  8888887422                  12467888775533          12222


Q ss_pred             HHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       408 ~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                          -+.+|.+-|..+|..+   |+-+|+|+.|..     .-||+|||.+
T Consensus       169 ----~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  169 ----DIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ----HHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence                3445556677889888   999999999986     4589999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.64  E-value=0.00013  Score=73.69  Aligned_cols=134  Identities=16%  Similarity=0.085  Sum_probs=76.4

Q ss_pred             eeccCceEEEEEEecCCcEEEEEEecCCCcH--HHHHHHHHHhccCCCCce-eEEecceeccCeeeEEeecCCCCChhhh
Q 042871          320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNL-VALLGYCLRVDECFLIYELCPNGNLAEW  396 (588)
Q Consensus       320 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E~~~~gsL~~~  396 (588)
                      +..|-...+|+... +++.+++|........  -...+|.++++.+....+ .+++...    .-++|+||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence            45677788998874 5678888876543211  235678888888764333 2333332    13689999998766431


Q ss_pred             -----------------hhcCC---cCccHHHH-HHHHHhhh---------ccchhhccc-----cCCceEecCCCCCCe
Q 042871          397 -----------------LFGKD---KCLSWIQR-LEIAIDSA---------RGLWFLHSY-----SEGCIVHRDIKPTNI  441 (588)
Q Consensus       397 -----------------L~~~~---~~l~~~~~-~~i~~~ia---------~gL~yLH~~-----~~~~IvHrDLKp~NI  441 (588)
                                       ||...   ..++...+ .....++.         +.+..+-..     ..+.++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111   11221111 11111111         111111111     134599999999999


Q ss_pred             EECCCCcEEEEecCCcce
Q 042871          442 LLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       442 Lld~~~~~kL~DFGla~~  459 (588)
                      ++++++ +.|+||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 78999997754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.63  E-value=0.00024  Score=70.55  Aligned_cols=73  Identities=23%  Similarity=0.240  Sum_probs=46.8

Q ss_pred             ceeeccCceEEEEEEecC--CcEEEEEEecCCCc-HHHHHHHHHHhccCCCCce-eEEecceeccCeeeEEeecCCCCCh
Q 042871          318 NLIGEGITGKVYKGKLSN--NQHVAIKHITNEGN-VETFVREVASSSHVRHPNL-VALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~~-~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      +.|..|-...+|+....+  ++.+.+|....... .....+|+.++..+...++ .++++...    -.++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            467778888999998764  67888997654321 1223468888777753333 34444332    2489999998776


Q ss_pred             h
Q 042871          394 A  394 (588)
Q Consensus       394 ~  394 (588)
                      .
T Consensus        80 ~   80 (235)
T cd05157          80 E   80 (235)
T ss_pred             C
Confidence            3

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.53  E-value=0.00025  Score=73.15  Aligned_cols=140  Identities=15%  Similarity=0.116  Sum_probs=83.7

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCc--eeEEecce------eccCeeeEEeecC
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPN--LVALLGYC------LRVDECFLIYELC  388 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~------~~~~~~~LV~E~~  388 (588)
                      .+.|..|.-..+|+...+++ .+++|+... ...+....|++++..+.+.+  +.+++...      ...+..++|+||+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45677777789999887544 688898765 34456667777777775332  34443321      2234568999999


Q ss_pred             CCCChhh----hh----------hcC------C----cCccHHHHHH----------HHHhhhccchhhcc----ccCCc
Q 042871          389 PNGNLAE----WL----------FGK------D----KCLSWIQRLE----------IAIDSARGLWFLHS----YSEGC  430 (588)
Q Consensus       389 ~~gsL~~----~L----------~~~------~----~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~~~  430 (588)
                      +|..+..    ..          |..      .    ....|.....          ....+...+.++..    .....
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            9877543    11          110      0    1122322210          01112223344432    11235


Q ss_pred             eEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          431 IVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       431 IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ++|+|+.|.|||++++....|+||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999988777899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.47  E-value=0.00065  Score=73.01  Aligned_cols=73  Identities=12%  Similarity=0.100  Sum_probs=52.8

Q ss_pred             ceeeccCceEEEEEEecCC-cEEEEEEecC---------CCcHHHHHHHHHHhccCC---CCceeEEecceeccCeeeEE
Q 042871          318 NLIGEGITGKVYKGKLSNN-QHVAIKHITN---------EGNVETFVREVASSSHVR---HPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~---------~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~LV  384 (588)
                      +.||.|.+..||++...+| +.|.||.-..         ....+.+..|.+.|..+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4789999999999998777 5899997431         123456677877777753   3456777766  44567899


Q ss_pred             eecCCCCC
Q 042871          385 YELCPNGN  392 (588)
Q Consensus       385 ~E~~~~gs  392 (588)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PRK05231 homoserine kinase; Provisional

Probab=97.39  E-value=0.0013  Score=68.74  Aligned_cols=139  Identities=18%  Similarity=0.128  Sum_probs=75.2

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCC-----CCceeEEe-c--ceeccCeeeEEeecCC
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR-----HPNLVALL-G--YCLRVDECFLIYELCP  389 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~-g--~~~~~~~~~LV~E~~~  389 (588)
                      +.|+.|....+|+...++| .+++|++. ....+....|+..+..+.     -|.+++-. |  +....+..++++||++
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~  105 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE  105 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence            4566677778999987666 67889876 223344444555554443     23333211 1  1122456789999998


Q ss_pred             CCChhh-----------hh---hcCC----------cCccH-HHHHHHH-------------Hhhhccchhhccc----c
Q 042871          390 NGNLAE-----------WL---FGKD----------KCLSW-IQRLEIA-------------IDSARGLWFLHSY----S  427 (588)
Q Consensus       390 ~gsL~~-----------~L---~~~~----------~~l~~-~~~~~i~-------------~~ia~gL~yLH~~----~  427 (588)
                      |..+..           .|   |...          ..+.| .+...-.             ..+...+..+...    -
T Consensus       106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l  185 (319)
T PRK05231        106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL  185 (319)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence            875421           11   1100          01112 1111111             1111122222211    2


Q ss_pred             CCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       428 ~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ..+++|+|+.+.|||++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            3359999999999999876556899999764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.29  E-value=0.0008  Score=69.61  Aligned_cols=74  Identities=24%  Similarity=0.266  Sum_probs=47.0

Q ss_pred             ceeeccCceEEEEEEecC-------CcEEEEEEecCCC-cHHHHHHHHHHhccCCCCce-eEEecceeccCeeeEEeecC
Q 042871          318 NLIGEGITGKVYKGKLSN-------NQHVAIKHITNEG-NVETFVREVASSSHVRHPNL-VALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E~~  388 (588)
                      +.|..|--..+|+....+       ++.+++|...... ......+|.+++..+....+ .++++++..    .+|+||+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            355556667899988755       5788999876532 22355678777777753333 344444432    3589999


Q ss_pred             CCCChhh
Q 042871          389 PNGNLAE  395 (588)
Q Consensus       389 ~~gsL~~  395 (588)
                      +|..+..
T Consensus        80 ~G~~l~~   86 (302)
T cd05156          80 PSRTLTT   86 (302)
T ss_pred             CCCcCCH
Confidence            8877643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.25  E-value=0.00061  Score=70.20  Aligned_cols=140  Identities=19%  Similarity=0.244  Sum_probs=73.5

Q ss_pred             ccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCC---CCceeEEecceeccCeeeEEeecCCC
Q 042871          314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR---HPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      .+..+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|.   --.+.+.+++...++..+||+||++.
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            3445678889999999988 578889999876 334457788888777773   44677888888777778999999987


Q ss_pred             CC--------hhhh---hhc-CC-c-------------------CccHHH-----HHHHHHhhhc---------------
Q 042871          391 GN--------LAEW---LFG-KD-K-------------------CLSWIQ-----RLEIAIDSAR---------------  418 (588)
Q Consensus       391 gs--------L~~~---L~~-~~-~-------------------~l~~~~-----~~~i~~~ia~---------------  418 (588)
                      +.        |...   ||. .. .                   .-+|..     |+.-..+.+.               
T Consensus        97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~  176 (288)
T PF03881_consen   97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER  176 (288)
T ss_dssp             ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence            61        1111   122 10 0                   123321     2111111111               


Q ss_pred             cchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          419 GLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       419 gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                      ....|+. ..+|.++|+||.+.|++.+.++.+.|.|=.
T Consensus       177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            1112232 235789999999999999999889988743

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.21  E-value=0.0028  Score=65.82  Aligned_cols=141  Identities=14%  Similarity=0.118  Sum_probs=80.7

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCc--eeEEecce------eccCeeeEEeecC
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPN--LVALLGYC------LRVDECFLIYELC  388 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~------~~~~~~~LV~E~~  388 (588)
                      .+.++.|.-..+|+...++| .+.+|+.......+....|++++..+....  +.+++...      ...+..++++||+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            44566776789999887555 566787755433455556666666664222  33333321      1245678999999


Q ss_pred             CCCChhhh--------------hhcCCc-----------CccHHHHHHH------------HHhhhccchhhcc----cc
Q 042871          389 PNGNLAEW--------------LFGKDK-----------CLSWIQRLEI------------AIDSARGLWFLHS----YS  427 (588)
Q Consensus       389 ~~gsL~~~--------------L~~~~~-----------~l~~~~~~~i------------~~~ia~gL~yLH~----~~  427 (588)
                      +|..+...              +|....           .-.|.....-            ...+.+.++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            88654211              111000           0122211100            1112223444432    22


Q ss_pred             CCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       428 ~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ...++|+|+.+.||++++++...|+||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3459999999999999988777899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.86  E-value=0.0039  Score=63.98  Aligned_cols=31  Identities=32%  Similarity=0.543  Sum_probs=25.9

Q ss_pred             CceEecCCCCCCeEECCCCc-EEEEecCCcce
Q 042871          429 GCIVHRDIKPTNILLGPNFE-AKLSDFGLSKV  459 (588)
Q Consensus       429 ~~IvHrDLKp~NILld~~~~-~kL~DFGla~~  459 (588)
                      +.++|+|+++.|||++++++ .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45999999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.76  E-value=0.0079  Score=62.63  Aligned_cols=126  Identities=18%  Similarity=0.161  Sum_probs=75.3

Q ss_pred             EEEEEecCCcEEEEEEecC----CCcHHHHHHHHHHhccCCC--CceeEEecceeccC--eeeEEeecCCCCChhhhhhc
Q 042871          328 VYKGKLSNNQHVAIKHITN----EGNVETFVREVASSSHVRH--PNLVALLGYCLRVD--ECFLIYELCPNGNLAEWLFG  399 (588)
Q Consensus       328 Vykg~~~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~--~~~LV~E~~~~gsL~~~L~~  399 (588)
                      +|.... +++..++. ...    ........+|+++++.+.-  .-..+.++.|.++.  ..|.||+|++|..+.+.+..
T Consensus        41 t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~  118 (321)
T COG3173          41 TFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP  118 (321)
T ss_pred             eEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence            344333 36777777 321    1234455677777777643  22345566676655  67999999988544443311


Q ss_pred             CCcCccHHHHHHHH-Hhhhccchhhcc-----------------------------------------------------
Q 042871          400 KDKCLSWIQRLEIA-IDSARGLWFLHS-----------------------------------------------------  425 (588)
Q Consensus       400 ~~~~l~~~~~~~i~-~~ia~gL~yLH~-----------------------------------------------------  425 (588)
                      ...  .    .+.+ ..+++.|.-||+                                                     
T Consensus       119 ~~~--~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p  192 (321)
T COG3173         119 ESL--G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRP  192 (321)
T ss_pred             ccc--h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCC
Confidence            100  0    0011 133333333332                                                     


Q ss_pred             --ccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          426 --YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       426 --~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                        .+++.++|+|+.+.||+++.+.-+=|.||+++..-+
T Consensus       193 ~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         193 PWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence              224579999999999999998889999999987643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.61  E-value=0.0042  Score=73.01  Aligned_cols=197  Identities=20%  Similarity=0.159  Sum_probs=130.2

Q ss_pred             HHHHHHhccCCCCceeEEecceeccCee----eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCC
Q 042871          354 VREVASSSHVRHPNLVALLGYCLRVDEC----FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG  429 (588)
Q Consensus       354 ~~Ei~~l~~l~HpnIv~l~g~~~~~~~~----~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  429 (588)
                      .-|.+.+.+++|+|++.++.|.......    .+..|++..-++.+.+... ...+..+.+.+..+..+||.|+|+..  
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~--  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLS--  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence            4466778889999999999987755333    3456778777888877433 34677788888999999999999986  


Q ss_pred             ceEecCCCCC---CeEECCCCcEEEE--ecCCcceecCCCcccccCccCCCCccCcccccCCCCCch--hhHHHHHHHHH
Q 042871          430 CIVHRDIKPT---NILLGPNFEAKLS--DFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS--GDVYSFGIVLL  502 (588)
Q Consensus       430 ~IvHrDLKp~---NILld~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~k--sDVwS~Gvll~  502 (588)
                       ..|.-+..+   +-..+..+...++  ||+..+.+........  ..-+..|.+||......++.+  .|+|.+|....
T Consensus       307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             -cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence             566555555   4455666777777  9988876654332211  123456778887766555554  79999999999


Q ss_pred             HHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          503 QILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       503 ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      .+..|..+-....  .....++.     ....   ........|.. ++++|++..+++...-.-
T Consensus       384 ~~~~~~~i~~~~~--~~~~~l~~-----~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  384 QLSQGEDISEKSA--VPVSLLDV-----LSTS---ELLDALPKCLDEDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             hhhhcCccccccc--chhhhhcc-----ccch---hhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence            9999875432111  11111111     1111   23334566766 579999999998876533

>PLN02236 choline kinase

Probab=96.34  E-value=0.012  Score=62.24  Aligned_cols=137  Identities=15%  Similarity=0.160  Sum_probs=76.7

Q ss_pred             eeeccCceEEEEEEecC-----CcEEEEEEecCCCc-HHHHHHHHHHhccCCCCcee-EEecceeccCeeeEEeecCCCC
Q 042871          319 LIGEGITGKVYKGKLSN-----NQHVAIKHITNEGN-VETFVREVASSSHVRHPNLV-ALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~-~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      .|-.|-.-.+|+....+     ++.|.+|....... .-+-.+|..+++.+...++- ++++.+..+    .|+||+++.
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            44446667888887532     36788887754321 11235677777777544432 445554322    589999877


Q ss_pred             Chhhh-----------------hhcCC----c-CccHHHHHHHHHhh-----------------hccchh----hcc-cc
Q 042871          392 NLAEW-----------------LFGKD----K-CLSWIQRLEIAIDS-----------------ARGLWF----LHS-YS  427 (588)
Q Consensus       392 sL~~~-----------------L~~~~----~-~l~~~~~~~i~~~i-----------------a~gL~y----LH~-~~  427 (588)
                      +|...                 +|...    . ..-|.+..++..++                 ...+..    +.. ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            76421                 11111    1 11222222222111                 111111    221 22


Q ss_pred             CCceEecCCCCCCeEECC-CCcEEEEecCCcce
Q 042871          428 EGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKV  459 (588)
Q Consensus       428 ~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~  459 (588)
                      ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            345999999999999986 46899999998764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.29  E-value=0.00063  Score=81.26  Aligned_cols=159  Identities=14%  Similarity=-0.016  Sum_probs=112.2

Q ss_pred             HHHHHHHhccCCCCceeEEecceec--cCeeeEEeecCCCCChhhhhhcCC---cCccHHHHHHHHHhhhccchhhccc-
Q 042871          353 FVREVASSSHVRHPNLVALLGYCLR--VDECFLIYELCPNGNLAEWLFGKD---KCLSWIQRLEIAIDSARGLWFLHSY-  426 (588)
Q Consensus       353 ~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~L~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~-  426 (588)
                      ...|...++...|+++.....-...  ..+-+.+++|+..|.+.+.|-+..   ..++..-....-.+......-.|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3455556667789988776554442  346789999999999999985432   2233333222222224444444432 


Q ss_pred             -cCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHH
Q 042871          427 -SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL  505 (588)
Q Consensus       427 -~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ell  505 (588)
                       ....-+|+++|+-|.+|..+.++|++++|+.+...+ .........+++-|+.|+....-.++.++|+|..|..+|+.-
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             234479999999999999999999999999984322 222233456788899999888888899999999999999999


Q ss_pred             cCCCccc
Q 042871          506 SGKKAKV  512 (588)
Q Consensus       506 tG~~p~~  512 (588)
                      -|..++-
T Consensus      1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred             cccHHHH
Confidence            9987764

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.11  E-value=0.04  Score=59.37  Aligned_cols=78  Identities=14%  Similarity=0.032  Sum_probs=50.6

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecC-----C----CcHHHHHHHHHHhccCC---CCceeEEecceeccCeeeEE
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITN-----E----GNVETFVREVASSSHVR---HPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~-----~----~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .+.||.|....||+...+ +..+.||+-..     .    ...+.-..|.+.|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            457899999999998874 55788997541     1    12333344455555443   347778888776  456788


Q ss_pred             eecCCC--CChhhhh
Q 042871          385 YELCPN--GNLAEWL  397 (588)
Q Consensus       385 ~E~~~~--gsL~~~L  397 (588)
                      |||+++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999976  2444443

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.89  E-value=0.05  Score=57.15  Aligned_cols=138  Identities=17%  Similarity=0.186  Sum_probs=82.0

Q ss_pred             eeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCc------eeEEeccee--cc--CeeeEEeecC
Q 042871          319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPN------LVALLGYCL--RV--DECFLIYELC  388 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~g~~~--~~--~~~~LV~E~~  388 (588)
                      .|.+ .-..+|+...++|+. ++|.........+...|+..+..+.-..      +..+-|-..  -.  ...+-+++|+
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            3444 456799999878877 8888776655667777787777764222      222222111  12  3678899999


Q ss_pred             CCCChhh-h----h----------h------c--CC---cCccHHH-------------HHHHHHhhhccchhhcccc--
Q 042871          389 PNGNLAE-W----L----------F------G--KD---KCLSWIQ-------------RLEIAIDSARGLWFLHSYS--  427 (588)
Q Consensus       389 ~~gsL~~-~----L----------~------~--~~---~~l~~~~-------------~~~i~~~ia~gL~yLH~~~--  427 (588)
                      +|..+.. .    +          +      .  +.   ....|..             ......++...++.+.+.-  
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9988772 1    1          1      0  11   1233320             0112222333333333321  


Q ss_pred             --CCc---eEecCCCCCCeEECCCCc-EEEEecCCcc
Q 042871          428 --EGC---IVHRDIKPTNILLGPNFE-AKLSDFGLSK  458 (588)
Q Consensus       428 --~~~---IvHrDLKp~NILld~~~~-~kL~DFGla~  458 (588)
                        ...   +||+|+.|.||+++++.. ..++|||-+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              222   899999999999998885 8999999664

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.85  E-value=0.045  Score=56.62  Aligned_cols=29  Identities=31%  Similarity=0.348  Sum_probs=25.0

Q ss_pred             CceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       429 ~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45999999999999987 678999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.78  E-value=0.026  Score=55.64  Aligned_cols=74  Identities=14%  Similarity=0.216  Sum_probs=50.3

Q ss_pred             eeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCC---CCceeEEecceeccCeeeEEeecCCCCChh
Q 042871          319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR---HPNLVALLGYCLRVDECFLIYELCPNGNLA  394 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~  394 (588)
                      .+--|.--.-|.... ...++-||+-.. .....|..|+.-|..|.   --++.+++.+..+.++.|+|+||++-|.+.
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n~~-~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCNQR-EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEecch-hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            344444444454443 556788886432 23466788877666654   456778888888899999999999987776

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.76  E-value=0.0075  Score=62.21  Aligned_cols=131  Identities=15%  Similarity=0.071  Sum_probs=86.8

Q ss_pred             ccccceeeccCceEEEEEEecCCcEEEEEEec----------CCC---------c-----HHHHHHHHHHhccCCCC--c
Q 042871          314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----------NEG---------N-----VETFVREVASSSHVRHP--N  367 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~----------~~~---------~-----~~~~~~Ei~~l~~l~Hp--n  367 (588)
                      ++..++||-|--+.||.+...+|++.++|.-+          +..         .     .-...+|+..|+.+..+  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            45678999999999999999999999998321          100         0     11234677777776431  2


Q ss_pred             eeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC
Q 042871          368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       368 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~  447 (588)
                      +.+.+++    +..++|||++.+-.|...-+-    .+..+...-+++   -+--|-.++   +||+|..-=||+++++.
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly~~lm~---~Iv~la~~G---lIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPTLYDDLMG---LIVRLANHG---LIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec----CChHHHHHHHHH---HHHHHHHcC---ceecccchheeEEecCC
Confidence            3344433    456899999988777654422    222222222222   223345566   99999999999999999


Q ss_pred             cEEEEecCCcc
Q 042871          448 EAKLSDFGLSK  458 (588)
Q Consensus       448 ~~kL~DFGla~  458 (588)
                      .++++||--..
T Consensus       240 ~i~vIDFPQmv  250 (465)
T KOG2268|consen  240 KIVVIDFPQMV  250 (465)
T ss_pred             CEEEeechHhh
Confidence            99999997543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.69  E-value=0.031  Score=60.98  Aligned_cols=70  Identities=11%  Similarity=0.117  Sum_probs=48.2

Q ss_pred             EEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccC-eeeEEeecCCCCChhhhhhc
Q 042871          328 VYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFG  399 (588)
Q Consensus       328 Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~LV~E~~~~gsL~~~L~~  399 (588)
                      .+.+....|... .--+.-.......+.....++.+.|+|+...+++..... ...+|+|++ +.||.+.+..
T Consensus         5 ~~~a~~~~~~~c-~nglplt~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPLTPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             EEehhcCCCccc-cCCCcCCCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            345554444432 222222334567778888999999999999998876543 467889998 7799998843

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.64  E-value=0.051  Score=57.54  Aligned_cols=71  Identities=10%  Similarity=0.095  Sum_probs=45.2

Q ss_pred             eeeccCceEEEEEEecCC-cEEEEEEecC---------CCcHHHHHHHHHHhccCC--CC-ceeEEecceeccCeeeEEe
Q 042871          319 LIGEGITGKVYKGKLSNN-QHVAIKHITN---------EGNVETFVREVASSSHVR--HP-NLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~g-~~VAVK~l~~---------~~~~~~~~~Ei~~l~~l~--Hp-nIv~l~g~~~~~~~~~LV~  385 (588)
                      .||-|...-||++..++| +.|+||.-..         +-..+.-.-|.+.|+...  -| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999998655 6899996421         122334445556665543  24 34445433  555667999


Q ss_pred             ecCCCC
Q 042871          386 ELCPNG  391 (588)
Q Consensus       386 E~~~~g  391 (588)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.44  E-value=0.016  Score=56.61  Aligned_cols=30  Identities=37%  Similarity=0.583  Sum_probs=21.7

Q ss_pred             ceEecCCCCCCeEE-CCCCcEEEEecCCcce
Q 042871          430 CIVHRDIKPTNILL-GPNFEAKLSDFGLSKV  459 (588)
Q Consensus       430 ~IvHrDLKp~NILl-d~~~~~kL~DFGla~~  459 (588)
                      .++|.|+.+.|||+ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            59999999999999 8899999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.93  E-value=0.2  Score=52.62  Aligned_cols=71  Identities=15%  Similarity=0.097  Sum_probs=44.4

Q ss_pred             cCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCc--eeEE---ec--ceeccCeeeEEeecCCCCCh
Q 042871          323 GITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPN--LVAL---LG--YCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       323 G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~Hpn--Iv~l---~g--~~~~~~~~~LV~E~~~~gsL  393 (588)
                      +.-..||+...++|..+++|..... ........|++.+..+....  ++..   -|  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            4556799999888889999987643 24556667777766553211  2221   11  11224567889999987643

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.93  E-value=0.086  Score=55.50  Aligned_cols=137  Identities=17%  Similarity=0.187  Sum_probs=76.0

Q ss_pred             eeeccCceEEEEEEecC----CcEEEEEEecCCCc-HHHHHHHHHHhccCCCCce-eEEecceeccCeeeEEeecCCCCC
Q 042871          319 LIGEGITGKVYKGKLSN----NQHVAIKHITNEGN-VETFVREVASSSHVRHPNL-VALLGYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       319 ~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~-~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E~~~~gs  392 (588)
                      .|..|---.+|+....+    +..|.+|....... .-+-.+|..+++.+..-++ .++++++. .+   +|.||+++..
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~   96 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART   96 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence            44446667788887543    23788887754321 1223567777777765444 34555553 22   5899997766


Q ss_pred             hhhh-------h----------hcCC----c-CccHHHHHHHHHhhh----------------------ccch----hhc
Q 042871          393 LAEW-------L----------FGKD----K-CLSWIQRLEIAIDSA----------------------RGLW----FLH  424 (588)
Q Consensus       393 L~~~-------L----------~~~~----~-~l~~~~~~~i~~~ia----------------------~gL~----yLH  424 (588)
                      |...       +          |...    . .--|....++..++.                      +-+.    ++.
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            5321       1          2111    1 112333222222211                      0011    111


Q ss_pred             c-ccCCceEecCCCCCCeEECC-CCcEEEEecCCcce
Q 042871          425 S-YSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKV  459 (588)
Q Consensus       425 ~-~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~  459 (588)
                      . ..+...+|.|+.+.|||+++ ++.++++||..|..
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 11235899999999999975 57899999998754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.83  E-value=0.071  Score=56.10  Aligned_cols=136  Identities=19%  Similarity=0.136  Sum_probs=85.9

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCC--------------------------Cc-H-HHHHHHHHHhccCCCCcee
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNE--------------------------GN-V-ETFVREVASSSHVRHPNLV  369 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--------------------------~~-~-~~~~~Ei~~l~~l~HpnIv  369 (588)
                      ..|..|--..||-+.-.+|..+|||+++..                          .. + -+...|++.|.+++.-.|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            367788889999999999999999976410                          00 1 1234577777776533322


Q ss_pred             EEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       370 ~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      .---...  ..-.|||+|+. ++=+..-.-+.-.++...+..+-.+++.-|.-|.+.+.  ++|.||.--|+|+ .+|.+
T Consensus       230 ~PePIlL--k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCceee--ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE-ECCEE
Confidence            1110000  12368999984 22111111122345655666667777777777766543  9999999999998 56789


Q ss_pred             EEEecCCcce
Q 042871          450 KLSDFGLSKV  459 (588)
Q Consensus       450 kL~DFGla~~  459 (588)
                      .|+|-+-+..
T Consensus       304 yiIDVSQSVE  313 (520)
T KOG2270|consen  304 YIIDVSQSVE  313 (520)
T ss_pred             EEEEcccccc
Confidence            9999886544

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.55  E-value=0.18  Score=52.37  Aligned_cols=31  Identities=13%  Similarity=0.230  Sum_probs=27.6

Q ss_pred             CceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       429 ~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      .+++|+|+.++|+|+++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4599999999999999999999999997653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06148 hypothetical protein; Provisional

Probab=94.48  E-value=0.16  Score=61.40  Aligned_cols=158  Identities=17%  Similarity=0.184  Sum_probs=85.0

Q ss_pred             CcccHHHHH-HHhcCccc---cceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccC-------CCCce
Q 042871          300 PRYTIREVH-YATEKLNE---LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV-------RHPNL  368 (588)
Q Consensus       300 ~~~~~~el~-~at~~f~~---~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-------~HpnI  368 (588)
                      |.++..++. .+.+.|..   .+.|+ |..-.+|+.+.++|+.+++|+............|...|..+       .-|.+
T Consensus         9 p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~   87 (1013)
T PRK06148          9 PEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRL   87 (1013)
T ss_pred             CCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCee
Confidence            445555442 33344443   23454 45678899988888899999987554433444454555433       22333


Q ss_pred             eEEe-cce----ec-cC--eeeEEeecCCCCChhhh-------h----------h------cC---CcCccHHH------
Q 042871          369 VALL-GYC----LR-VD--ECFLIYELCPNGNLAEW-------L----------F------GK---DKCLSWIQ------  408 (588)
Q Consensus       369 v~l~-g~~----~~-~~--~~~LV~E~~~~gsL~~~-------L----------~------~~---~~~l~~~~------  408 (588)
                      ++-. |-.    .. ++  ..+-+++|++|..|.+.       +          +      ..   ...+.|..      
T Consensus        88 i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l  167 (1013)
T PRK06148         88 IPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRA  167 (1013)
T ss_pred             eecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhh
Confidence            3322 111    11 22  35678999999777551       0          0      00   11233321      


Q ss_pred             -----------HHHHHHhhhccch-----hhccccCCceEecCCCCCCeEECCCC--cEE-EEecCCcce
Q 042871          409 -----------RLEIAIDSARGLW-----FLHSYSEGCIVHRDIKPTNILLGPNF--EAK-LSDFGLSKV  459 (588)
Q Consensus       409 -----------~~~i~~~ia~gL~-----yLH~~~~~~IvHrDLKp~NILld~~~--~~k-L~DFGla~~  459 (588)
                                 ...++.++.+.+.     .|.+ -...+||+|+.+.|||++.+.  ++. |+|||-+..
T Consensus       168 ~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        168 RDRLHFIDDPEDRALVERFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             hhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                       1111222222111     1211 123499999999999999875  555 999997653

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.05  E-value=0.19  Score=50.81  Aligned_cols=78  Identities=18%  Similarity=0.108  Sum_probs=54.6

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC-CCCChhhh
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC-PNGNLAEW  396 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~-~~gsL~~~  396 (588)
                      ..+-.|..+.|++++..+|+++++|..........-......|+..+-...|++++.-  ...-.|.+|.+ ++.+|.+.
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~~   85 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLASL   85 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCchhhc
Confidence            3456788899999999999999999887544322222222457777888889999874  33456888888 44566554


Q ss_pred             h
Q 042871          397 L  397 (588)
Q Consensus       397 L  397 (588)
                      .
T Consensus        86 ~   86 (253)
T PF04655_consen   86 P   86 (253)
T ss_pred             c
Confidence            3

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PRK12396 5-methylribose kinase; Reviewed

Probab=93.85  E-value=0.16  Score=54.57  Aligned_cols=72  Identities=14%  Similarity=0.068  Sum_probs=47.3

Q ss_pred             cceeeccCceEEEEEEecC-CcEEEEEEecC--------CCcHHHHHHHHHHhccCC--CC-ceeEEecceeccCeeeEE
Q 042871          317 LNLIGEGITGKVYKGKLSN-NQHVAIKHITN--------EGNVETFVREVASSSHVR--HP-NLVALLGYCLRVDECFLI  384 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~--------~~~~~~~~~Ei~~l~~l~--Hp-nIv~l~g~~~~~~~~~LV  384 (588)
                      .+.||-|.-.-||++...+ ++.|+||.-..        +-..+.-.-|.+.|+...  -| ++.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3578999999999999853 56899996431        123445555666666543  34 45555543  55567889


Q ss_pred             eecCCC
Q 042871          385 YELCPN  390 (588)
Q Consensus       385 ~E~~~~  390 (588)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.85  E-value=0.29  Score=48.27  Aligned_cols=137  Identities=18%  Similarity=0.121  Sum_probs=85.7

Q ss_pred             EEEEEEecC-C-C-cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHH
Q 042871          338 HVAIKHITN-E-G-NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI  414 (588)
Q Consensus       338 ~VAVK~l~~-~-~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~  414 (588)
                      +..+|++.. + . ...-|.++.++++++.  .|+++..-  +...+-++.|+|-.          .+.+.-   -.|..
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~----------~~i~~~---N~i~a  149 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYK----------IKINFS---NFITA  149 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccC----------cccchh---HHHHH
Confidence            344566653 2 1 3456788899988875  47777732  33456688998821          111111   01111


Q ss_pred             hhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhH
Q 042871          415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDV  494 (588)
Q Consensus       415 ~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV  494 (588)
                      + .+.|.-.|+.... .+|+|..|+||+-|..|.+||.|=+.-..             .+.-|..-|   +...|.++.+
T Consensus       150 g-i~~L~~fH~~~~~-~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~vN~~---Y~~lT~~aE~  211 (308)
T PF07387_consen  150 G-IKDLMDFHSENQH-CLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMVNIE---YESLTQEAEV  211 (308)
T ss_pred             h-HHHHHHhhccCCC-eecCCCChhheeecCCCCEEecChhhhhh-------------heeeEEeee---ccccChHHHH
Confidence            1 3567778876533 89999999999999999999999764211             112233322   2346788888


Q ss_pred             HHHHHHHHHHHcCCC
Q 042871          495 YSFGIVLLQILSGKK  509 (588)
Q Consensus       495 wS~Gvll~ElltG~~  509 (588)
                      =+|=.-++++....+
T Consensus       212 ~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  212 KVFVKSCLKLVEKQR  226 (308)
T ss_pred             HHHHHHHHHHHHHHh
Confidence            888888888876543

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=92.79  E-value=0.21  Score=52.56  Aligned_cols=72  Identities=21%  Similarity=0.157  Sum_probs=55.9

Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..|++|++- |++|.-     .+...|.+...++++.+..+.-+...-  +.=|||+.-.||||+ +|++.|+||-++|.
T Consensus       300 y~yl~~kdh-gt~is~-----ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         300 YLYLHFKDH-GTPISI-----IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             EEEEEEecC-Cceeee-----eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence            456777764 444432     234578899999999888888777654  378999999999999 99999999999985


Q ss_pred             e
Q 042871          460 I  460 (588)
Q Consensus       460 ~  460 (588)
                      .
T Consensus       371 ~  371 (488)
T COG5072         371 S  371 (488)
T ss_pred             c
Confidence            4

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=92.77  E-value=0.13  Score=54.83  Aligned_cols=59  Identities=17%  Similarity=0.129  Sum_probs=42.3

Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEEC
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLG  444 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld  444 (588)
                      ..||-+|+++-++..++..  +..++.-..+++.-.+++|.-+-- .+   .+|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence            4577788989899998843  334445566677666666654433 33   89999999999994

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	588
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-43
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-42
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-28
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-27
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		9e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-04

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 113/292 (38%), Positives = 162/292 (55%), Gaps = 26/292 (8%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN--VETFVREVA 358
           R  + ++  AT   +   LIG G+ GKVYKG L +   VA+K  T E +  +E F  E+ 
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 359 SSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD---KCLSWIQRLEIAID 415
           + S  RHP+LV+L+G+C   +E  LIY+   NGNL   L+G D     +SW QRLEI I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGT 474
           +ARGL +LH+ +   I+HRD+K  NILL  NF  K++DFG+SK   ++G+T+    V+GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKV--LTRA--------------GS 518
            GY+DPEY    ++    DVYSFG+VL ++L  + A V  L R               G 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 519 ALELADPKLDREYSIEAFDLTLQLALSCTALTHQ-RPPMEQVFVTLQKALDI 569
             ++ DP L  +   E+       A+ C AL+ + RP M  V   L+ AL +
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  170 bits (431), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 112/292 (38%), Positives = 161/292 (55%), Gaps = 26/292 (8%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN--VETFVREVA 358
           R  + ++  AT   +   LIG G+ GKVYKG L +   VA+K  T E +  +E F  E+ 
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 359 SSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD---KCLSWIQRLEIAID 415
           + S  RHP+LV+L+G+C   +E  LIY+   NGNL   L+G D     +SW QRLEI I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGT 474
           +ARGL +LH+ +   I+HRD+K  NILL  NF  K++DFG+SK   ++ +T+    V+GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKV--LTRA--------------GS 518
            GY+DPEY    ++    DVYSFG+VL ++L  + A V  L R               G 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 519 ALELADPKLDREYSIEAFDLTLQLALSCTALTHQ-RPPMEQVFVTLQKALDI 569
             ++ DP L  +   E+       A+ C AL+ + RP M  V   L+ AL +
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  170 bits (431), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/289 (35%), Positives = 158/289 (54%), Gaps = 25/289 (8%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE---GNVETFVREV 357
           R+++RE+  A++  +  N++G G  GKVYKG+L++   VA+K +  E   G    F  EV
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 358 ASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAI 414
              S   H NL+ L G+C+   E  L+Y    NG++A  L  + +    L W +R  IA+
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
            SARGL +LH + +  I+HRD+K  NILL   FEA + DFGL+K++D  + +    VRGT
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGT 206
Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS---------------- 518
            G++ PEY S  K +   DV+ +G++LL++++G++A  L R  +                
Sbjct: 207 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 266
Query: 519 -ALE-LADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQ 564
             LE L D  L   Y  E  +  +Q+AL CT  +  +RP M +V   L+
Sbjct: 267 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  167 bits (424), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 101/289 (34%), Positives = 156/289 (53%), Gaps = 25/289 (8%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE---GNVETFVREV 357
           R+++RE+  A++     N++G G  GKVYKG+L++   VA+K +  E   G    F  EV
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 358 ASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAI 414
              S   H NL+ L G+C+   E  L+Y    NG++A  L  + +    L W +R  IA+
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
            SARGL +LH + +  I+HRD+K  NILL   FEA + DFGL+K++D  + +    VRG 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGX 198
Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS---------------- 518
            G++ PEY S  K +   DV+ +G++LL++++G++A  L R  +                
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 519 -ALE-LADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQ 564
             LE L D  L   Y  E  +  +Q+AL CT  +  +RP M +V   L+
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 87/236 (36%), Positives = 125/236 (52%), Gaps = 20/236 (8%)
Query: 290 KGVQLKDPGCPRYTIREVHYATEKLNEL------NLIGEGITGKVYKGKLSNNQHVAIKH 343
           K +++ D     ++  E+   T   +E       N +GEG  G VYKG + NN  VA+K 
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK 61
Query: 344 ------ITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL 397
                 IT E   + F +E+   +  +H NLV LLG+    D+  L+Y   PNG+L + L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 398 FGKDKC--LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
              D    LSW  R +IA  +A G+ FLH   E   +HRDIK  NILL   F AK+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 456 LSKVID-IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA 510
           L++  +   +T   S + GT  Y+ PE     ++    D+YSFG+VLL+I++G  A
Sbjct: 179 LARASEKFAQTVMXSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 86/236 (36%), Positives = 124/236 (52%), Gaps = 20/236 (8%)
Query: 290 KGVQLKDPGCPRYTIREVHYATEKLNEL------NLIGEGITGKVYKGKLSNNQHVAIKH 343
           K +++ D     ++  E+   T   +E       N +GEG  G VYKG + NN  VA+K 
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK 61
Query: 344 ------ITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL 397
                 IT E   + F +E+   +  +H NLV LLG+    D+  L+Y   PNG+L + L
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 398 FGKDKC--LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
              D    LSW  R +IA  +A G+ FLH   E   +HRDIK  NILL   F AK+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 456 LSKVID-IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA 510
           L++  +   +T     + GT  Y+ PE     ++    D+YSFG+VLL+I++G  A
Sbjct: 179 LARASEKFAQTVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/202 (39%), Positives = 111/202 (54%), Gaps = 14/202 (6%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKH------ITNEGNVETFVREVASSSHVRHPNLVAL 371
           N +GEG  G VYKG + NN  VA+K       IT E   + F +E+   +  +H NLV L
Sbjct: 31  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKC--LSWIQRLEIAIDSARGLWFLHSYSEG 429
           LG+    D+  L+Y   PNG+L + L   D    LSW  R +IA  +A G+ FLH   E 
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---EN 146
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPEYRSNCKV 488
             +HRDIK  NILL   F AK+SDFGL++  +   +      + GT  Y+ PE     ++
Sbjct: 147 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG-EI 205
Query: 489 NSSGDVYSFGIVLLQILSGKKA 510
               D+YSFG+VLL+I++G  A
Sbjct: 206 TPKSDIYSFGVVLLEIITGLPA 227

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 81/202 (40%), Positives = 110/202 (54%), Gaps = 14/202 (6%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKH------ITNEGNVETFVREVASSSHVRHPNLVAL 371
           N  GEG  G VYKG + NN  VA+K       IT E   + F +E+   +  +H NLV L
Sbjct: 28  NKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKC--LSWIQRLEIAIDSARGLWFLHSYSEG 429
           LG+    D+  L+Y   PNG+L + L   D    LSW  R +IA  +A G+ FLH   E 
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH---EN 143
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPEYRSNCKV 488
             +HRDIK  NILL   F AK+SDFGL++  +   +    S + GT  Y  PE     ++
Sbjct: 144 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRG-EI 202
Query: 489 NSSGDVYSFGIVLLQILSGKKA 510
               D+YSFG+VLL+I++G  A
Sbjct: 203 TPKSDIYSFGVVLLEIITGLPA 224

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 6/203 (2%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G V+ G   N   VAIK I  EG +  E F+ E      + HP LV L G CL 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
                L++E   +G L+++L  +    +    L + +D   G+ +L    E C++HRD+ 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             N L+G N   K+SDFG+++ +   +  +S+  +    +  PE  S  + +S  DV+SF
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188
Query: 498 GIVLLQILSGKKAKVLTRAGSAL 520
           G+++ ++ S  K     R+ S +
Sbjct: 189 GVLMWEVFSEGKIPYENRSNSEV 211

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 6/210 (2%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVA 370
           +L  +  IG G  G V+ G   N   VAIK I  EG +  E F+ E      + HP LV 
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L G CL      L++E   +G L+++L  +    +    L + +D   G+ +L    E C
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 123
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           ++HRD+   N L+G N   K+SDFG+++ +   +  +S+  +    +  PE  S  + +S
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 491 SGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
             DV+SFG+++ ++ S  K     R+ S +
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 7/223 (3%)
Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREV 357
           PR ++  V   +E L  +  IG G  G V+ G   N   VAIK I  EG++  + F+ E 
Sbjct: 16  PRGSLHMVIDPSE-LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEA 73
Query: 358 ASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA 417
                + HP LV L G CL      L++E   +G L+++L  +    +    L + +D  
Sbjct: 74  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 133
Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGY 477
            G+ +L    E C++HRD+   N L+G N   K+SDFG+++ +   +  +S+  +    +
Sbjct: 134 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 190
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
             PE  S  + +S  DV+SFG+++ ++ S  K     R+ S +
Sbjct: 191 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 233

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 6/210 (2%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVA 370
           +L  +  IG G  G V+ G   N   VAIK I  EG +  E F+ E      + HP LV 
Sbjct: 11  ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L G CL      L++E   +G L+++L  +    +    L + +D   G+ +L    E C
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 126
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           ++HRD+   N L+G N   K+SDFG+++ +   +  +S+  +    +  PE  S  + +S
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 491 SGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
             DV+SFG+++ ++ S  K     R+ S +
Sbjct: 187 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV 216

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVA 370
           +L  +  IG G  G V+ G   N   VAIK I  EG +  E F+ E      + HP LV 
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L G CL      L+ E   +G L+++L  +    +    L + +D   G+ +L    E C
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 124
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           ++HRD+   N L+G N   K+SDFG+++ +   +  +S+  +    +  PE  S  + +S
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 491 SGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
             DV+SFG+++ ++ S  K     R+ S +
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVA 370
           +L  +  IG G  G V+ G   N   VAIK I  EG +  E F+ E      + HP LV 
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L G CL      L++E   +G L+++L  +    +    L + +D   G+ +L    E  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EAS 123
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           ++HRD+   N L+G N   K+SDFG+++ +   +  +S+  +    +  PE  S  + +S
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 491 SGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
             DV+SFG+++ ++ S  K     R+ S +
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLV 369
           LN    IG G  G V++ +   +  VA+K +  +      V  F+REVA    +RHPN+V
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLF--GKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
             +G   +     ++ E    G+L   L   G  + L   +RL +A D A+G+ +LH+ +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
              IVHRD+K  N+L+   +  K+ DFGLS+ +       S    GT  ++ PE   +  
Sbjct: 158 P-PIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDEP 215
Query: 488 VNSSGDVYSFGIVLLQI 504
            N   DVYSFG++L ++
Sbjct: 216 SNEKSDVYSFGVILWEL 232

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 119/257 (46%), Gaps = 8/257 (3%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLV 369
           E++  L  +G G  G V  GK      VA+K I  EG++  + F +E  +   + HP LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
              G C +    +++ E   NG L  +L    K L   Q LE+  D   G+ FL S+   
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ-- 124
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             +HRD+   N L+  +   K+SDFG+++ +   +  +S   +    +  PE     K +
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 490 SSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIE-AFDLTLQLALSC-T 547
           S  DV++FGI++ ++ S  K        S + L   +  R Y    A D   Q+  SC  
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWH 243
Query: 548 ALTHQRPPMEQVFVTLQ 564
            L  +RP  +Q+  +++
Sbjct: 244 ELPEKRPTFQQLLSSIE 260

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLV 369
           LN    IG G  G V++ +  +   VA+K +  +      V  F+REVA    +RHPN+V
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLF--GKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
             +G   +     ++ E    G+L   L   G  + L   +RL +A D A+G+ +LH+ +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDPEYRSNC 486
              IVHR++K  N+L+   +  K+ DFGLS++     T+ SS+   GT  ++ PE   + 
Sbjct: 158 P-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 487 KVNSSGDVYSFGIVLLQI 504
             N   DVYSFG++L ++
Sbjct: 215 PSNEKSDVYSFGVILWEL 232

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETF 353
           DP  P Y   E+      +   + +G G  G+VY+G     +  VA+K +  +   VE F
Sbjct: 4   DPSSPNYDKWEMERTDITMK--HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEI 412
           ++E A    ++HPNLV LLG C R    ++I E    GNL ++L   ++  +S +  L +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 121
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   +  + +L   +    +HRD+   N L+G N   K++DFGLS+++  G+TY A +  
Sbjct: 122 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGA 177
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           +    +  PE  +  K +   DV++FG++L +I
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 127/285 (44%), Gaps = 19/285 (6%)
Query: 299 CPRYTIREVHYATEKLNELNL-----IGEGITGKVYKGKLS----NNQHVAIKHIT---N 346
            PR + + VH   ++L+  N+     +G G  G+V  G+L         VAIK +     
Sbjct: 15  VPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 74
Query: 347 EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW 406
           E     F+ E +      HPN++ L G   +     ++ E   NG+L  +L   D   + 
Sbjct: 75  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 134
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGE 464
           IQ + +    A G+ +L   S+   VHRD+   NIL+  N   K+SDFGLS+V+  D   
Sbjct: 135 IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 191
Query: 465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELA 523
            Y +   +    +  PE  +  K  S+ DV+S+GIVL +++S G++          ++  
Sbjct: 192 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 251
Query: 524 DPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQKAL 567
           D        ++      QL L C     + RP  EQ+   L K +
Sbjct: 252 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 296

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 113/228 (49%), Gaps = 13/228 (5%)
Query: 288 SFKGVQLKDPGCPRYTIREV------HYATEKLNELNLIGEGITGKVYKG-KLSNNQHVA 340
           S + VQL++P  PR  ++++          E  + L  +GEG  G VYK       Q VA
Sbjct: 1   SLETVQLRNP--PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVA 58
Query: 341 IKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK 400
           IK +  E +++  ++E++       P++V   G   +  + +++ E C  G++++ +  +
Sbjct: 59  IKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           +K L+  +   I   + +GL +LH   +   +HRDIK  NILL     AKL+DFG++  +
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
                   + V GT  ++ PE       N   D++S GI  +++  GK
Sbjct: 176 -TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 17/229 (7%)
Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNL---IGEGITGKVYKGKLSNNQHVAIKHITNE 347
           G Q K+   PR      +Y   + +E+ L   IG G  G VYKGK   +  V I  + + 
Sbjct: 12  GTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDP 71
Query: 348 G--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLS 405
                + F  EVA     RH N++  +GY  + D   ++ + C   +L + L  ++    
Sbjct: 72  TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQ 130
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
             Q ++IA  +A+G+ +LH+ +   I+HRD+K  NI L      K+ DFGL+ V      
Sbjct: 131 MFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV--KSRW 185
Query: 466 YASSEVR---GTFGYLDPE---YRSNCKVNSSGDVYSFGIVLLQILSGK 508
             S +V    G+  ++ PE    + N   +   DVYS+GIVL ++++G+
Sbjct: 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETF 353
           DP  P Y   E+      +   + +G G  G+VY+G     +  VA+K +  +   VE F
Sbjct: 4   DPSSPNYDKWEMERTDITMK--HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEI 412
           ++E A    ++HPNLV LLG C R    ++I E    GNL ++L   ++  ++ +  L +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   +  + +L   +    +HRD+   N L+G N   K++DFGLS+++  G+TY A +  
Sbjct: 122 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGA 177
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           +    +  PE  +  K +   DV++FG++L +I
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETF 353
           DP  P Y   E+      +   + +G G  G+VY+G     +  VA+K +  +   VE F
Sbjct: 4   DPSSPNYDKWEMERTDITMK--HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEI 412
           ++E A    ++HPNLV LLG C R    ++I E    GNL ++L   ++  ++ +  L +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   +  + +L   +    +HRD+   N L+G N   K++DFGLS+++  G+TY A +  
Sbjct: 122 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGA 177
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           +    +  PE  +  K +   DV++FG++L +I
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETF 353
           DP  P Y   E+      +   + +G G  G+VY+G     +  VA+K +  +   VE F
Sbjct: 4   DPSSPNYDKWEMERTDITMK--HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEI 412
           ++E A    ++HPNLV LLG C R    ++I E    GNL ++L   ++  ++ +  L +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   +  + +L   +    +HRD+   N L+G N   K++DFGLS+++  G+TY A +  
Sbjct: 122 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGA 177
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           +    +  PE  +  K +   DV++FG++L +I
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 8/212 (3%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETF 353
           DP  P Y   E+      +   + +G G  G+VY+G     +  VA+K +  +   VE F
Sbjct: 4   DPSSPNYDKWEMERTDITMK--HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEI 412
           ++E A    ++HPNLV LLG C R    ++I E    GNL ++L   ++  ++ +  L +
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A   +  + +L   +    +HRD+   N L+G N   K++DFGLS+++      A +  +
Sbjct: 122 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 178
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
               +  PE  +  K +   DV++FG++L +I
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +    +HRD+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 197 AFGVLLWEI 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +    +HRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 197 AFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +    +HRD+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 197 AFGVLLWEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +    +HRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 197 AFGVLLWEI 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 16/219 (7%)
Query: 298 GCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ----HVAIKHITNE---GNV 350
           G P+Y I     A E +    ++GEG  G+VY+G  +N++    +VA+K    +    N 
Sbjct: 15  GSPQYGI-----AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK 69
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E F+ E     ++ HP++V L+G  +  +  ++I EL P G L  +L      L  +  +
Sbjct: 70  EKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 128
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             ++   + + +L S +    VHRDI   NIL+      KL DFGLS+ I+  + Y +S 
Sbjct: 129 LYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 185
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK 509
            R    ++ PE  +  +  ++ DV+ F + + +ILS  K
Sbjct: 186 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 224

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 111/230 (48%), Gaps = 18/230 (7%)
Query: 289 FKGVQLKDP--GCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-----HVAI 341
           F+G    DP     ++T  E+H +   +    +IG G  G+VYKG L  +       VAI
Sbjct: 22  FQGAMGSDPNQAVLKFTT-EIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAI 78
Query: 342 KHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF 398
           K +     E     F+ E        H N++ L G   +     +I E   NG L ++L 
Sbjct: 79  KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
Query: 399 GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK 458
            KD   S +Q + +    A G+ +L + +    VHRD+   NIL+  N   K+SDFGLS+
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195
Query: 459 VI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           V+  D   TY +S  +    +  PE  S  K  S+ DV+SFGIV+ ++++
Sbjct: 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 133/309 (43%), Gaps = 21/309 (6%)
Query: 275 KRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNL-----IGEGITGKVY 329
           KR +  N   K+   +     DP       + VH   ++L+  N+     +G G  G+V 
Sbjct: 5   KRLHFGNGHLKLPGLR--TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVC 62
Query: 330 KGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF 382
            G+L         VAIK +     E     F+ E +      HPN++ L G   +     
Sbjct: 63  SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL 442
           ++ E   NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNIL 179
Query: 443 LGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
           +  N   K+SDFGLS+V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIV
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 501 LLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQ 558
           L +++S G++          ++  D        ++      QL L C     + RP  EQ
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 559 VFVTLQKAL 567
           +   L K +
Sbjct: 300 IVSILDKLI 308

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 138
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 198 AFGVLLWEI 206

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 114/223 (51%), Gaps = 34/223 (15%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIK---HITNEG---NVETFVREVAS 359
           E+ +A   L E+  IG G  GKVY+     ++ VA+K   H  +E     +E   +E   
Sbjct: 3   EIDFAELTLEEI--IGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK----DKCLSWIQRLEIAID 415
            + ++HPN++AL G CL+     L+ E    G L   L GK    D  ++W      A+ 
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQ 113
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE--------AKLSDFGLSKVIDIGETYA 467
            ARG+ +LH  +   I+HRD+K +NIL+    E         K++DFGL++     E + 
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHR 168
Query: 468 SSEVR--GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           ++++   G + ++ PE       +   DV+S+G++L ++L+G+
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 27/303 (8%)
Query: 289 FKGVQLKDPGCPRYT--------IREVHYATEKLNELNL-----IGEGITGKVYKGKLS- 334
           F    LK PG   Y          + VH   ++L+  N+     +G G  G+V  G+L  
Sbjct: 9   FGNGHLKLPGLRTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 335 ---NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC 388
                  VAIK +     E     F+ E +      HPN++ L G   +     ++ E  
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE 448
            NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL+  N  
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLV 185
Query: 449 AKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            K+SDFGLS+V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIVL +++S
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
Query: 507 -GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQ 564
            G++          ++  D        ++      QL L C     + RP  EQ+   L 
Sbjct: 246 YGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 565 KAL 567
           K +
Sbjct: 306 KLI 308

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 139
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 199 AFGVLLWEI 207

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 27/303 (8%)
Query: 289 FKGVQLKDPGCPRYT--------IREVHYATEKLNELNL-----IGEGITGKVYKGKLS- 334
           F    LK PG   Y          + VH   ++L+  N+     +G G  G+V  G+L  
Sbjct: 7   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 66
Query: 335 ---NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC 388
                  VAIK +     E     F+ E +      HPN++ L G   +     ++ E  
Sbjct: 67  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 126
Query: 389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE 448
            NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL+  N  
Sbjct: 127 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLV 183
Query: 449 AKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            K+SDFGLS+V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIVL +++S
Sbjct: 184 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243
Query: 507 -GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQ 564
            G++          ++  D        ++      QL L C     + RP  EQ+   L 
Sbjct: 244 YGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 303
Query: 565 KAL 567
           K +
Sbjct: 304 KLI 306

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 141
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 201 AFGVLLWEI 209

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 27/303 (8%)
Query: 289 FKGVQLKDPGCPRYT--------IREVHYATEKLNELNL-----IGEGITGKVYKGKLS- 334
           F    LK PG   Y          + VH   ++L+  N+     +G G  G+V  G+L  
Sbjct: 9   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 335 ---NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC 388
                  VAIK +     E     F+ E +      HPN++ L G   +     ++ E  
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXM 128
Query: 389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE 448
            NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL+  N  
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLV 185
Query: 449 AKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            K+SDFGLS+V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIVL +++S
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
Query: 507 -GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQ 564
            G++          ++  D        ++      QL L C     + RP  EQ+   L 
Sbjct: 246 YGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 565 KAL 567
           K +
Sbjct: 306 KLI 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 27/303 (8%)
Query: 289 FKGVQLKDPGCPRYT--------IREVHYATEKLNELNL-----IGEGITGKVYKGKLS- 334
           F    LK PG   Y          + VH   ++L+  N+     +G G  G+V  G+L  
Sbjct: 9   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 335 ---NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC 388
                  VAIK +     E     F+ E +      HPN++ L G   +     ++ E  
Sbjct: 69  PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE 448
            NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL+  N  
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLV 185
Query: 449 AKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            K+SDFGLS+V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIVL +++S
Sbjct: 186 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
Query: 507 -GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQ 564
            G++          ++  D        ++      QL L C     + RP  EQ+   L 
Sbjct: 246 YGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 565 KAL 567
           K +
Sbjct: 306 KLI 308

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 150
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 209
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 210 AFGVLLWEI 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 139
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 199 AFGVLLWEI 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +    +HRD+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 135
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+T+ A +  +    +  PE  +  K +   DV+
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 195 AFGVLLWEI 203

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 16/219 (7%)
Query: 298 GCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ----HVAIKHITNE---GNV 350
           G P+Y I     A E +    ++GEG  G+VY+G  +N++    +VA+K    +    N 
Sbjct: 3   GGPQYGI-----AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK 57
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E F+ E     ++ HP++V L+G  +  +  ++I EL P G L  +L      L  +  +
Sbjct: 58  EKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 116
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             ++   + + +L S +    VHRDI   NIL+      KL DFGLS+ I+  + Y +S 
Sbjct: 117 LYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK 509
            R    ++ PE  +  +  ++ DV+ F + + +ILS  K
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 197 AFGVLLWEI 205

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 133/309 (43%), Gaps = 21/309 (6%)
Query: 275 KRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNL-----IGEGITGKVY 329
           KR +  N   K+   +     DP       + VH   ++L+  N+     +G G  G+V 
Sbjct: 5   KRLHFGNGHLKLPGLR--TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVC 62
Query: 330 KGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF 382
            G+L         VAIK +     E     F+ E +      HPN++ L G   +     
Sbjct: 63  SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL 442
           ++ E   NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL
Sbjct: 123 IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNIL 179
Query: 443 LGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
           +  N   K+SDFGLS+V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIV
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 501 LLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQ 558
           L +++S G++          ++  D        ++      QL L C     + RP  EQ
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 559 VFVTLQKAL 567
           +   L K +
Sbjct: 300 IVSILDKLI 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 133/309 (43%), Gaps = 21/309 (6%)
Query: 275 KRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNL-----IGEGITGKVY 329
           KR +  N   K+   +     DP       + VH   ++L+  N+     +G G  G+V 
Sbjct: 5   KRLHFGNGHLKLPGLR--TFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVC 62
Query: 330 KGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF 382
            G+L         VAIK +     E     F+ E +      HPN++ L G   +     
Sbjct: 63  SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL 442
           ++ E   NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 443 LGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
           +  N   K+SDFGLS+V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIV
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 501 LLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQ 558
           L +++S G++          ++  D        ++      QL L C     + RP  EQ
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 559 VFVTLQKAL 567
           +   L K +
Sbjct: 300 IVSILDKLI 308

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 13/234 (5%)
Query: 318 NLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVAL 371
           NL+G+G    VY+ + +     VAIK I  +     G V+    EV     ++HP+++ L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
             Y    +  +L+ E+C NG +  +L  + K  S  +          G+ +LHS+    I
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---I 133
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           +HRD+  +N+LL  N   K++DFGL+  + +      + + GT  Y+ PE  +       
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192
Query: 492 GDVYSFGIVLLQILSGK---KAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
            DV+S G +   +L G+       +    + + LAD ++    SIEA DL  QL
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 6/188 (3%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +    +HRD+
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 135
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
              N L+G N   K++DFGLS+++      A +  +    +  PE  +  K +   DV++
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 195
Query: 497 FGIVLLQI 504
           FG++L +I
Sbjct: 196 FGVLLWEI 203

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G + + L     F + +  ++I  L      A  L + HS   
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 133
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 184
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 133/309 (43%), Gaps = 21/309 (6%)
Query: 275 KRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNL-----IGEGITGKVY 329
           KR +  N   K+   +     DP       + VH   ++L+  N+     +G G  G+V 
Sbjct: 5   KRLHFGNGHLKLPGLR--TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVC 62
Query: 330 KGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF 382
            G+L         VAIK +     E     F+ E +      HPN++ L G   +     
Sbjct: 63  SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL 442
           ++ E   NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 443 LGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
           +  N   K+SDFGLS+V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIV
Sbjct: 180 INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 501 LLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQ 558
           L +++S G++          ++  D        ++      QL L C     + RP  EQ
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 559 VFVTLQKAL 567
           +   L K +
Sbjct: 300 IVSILDKLI 308

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 197 AFGVLLWEI 205

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 139
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 199 AFGVLLWEI 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G + + L     F + +  ++I  L      A  L + HS   
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 133
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDYLPPEMIE 184
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 6/188 (3%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +    +HRD+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 135
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
              N L+G N   K++DFGLS+++      A +  +    +  PE  +  K +   DV++
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 195
Query: 497 FGIVLLQI 504
           FG++L +I
Sbjct: 196 FGVLLWEI 203

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +  N++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKK- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPPEMIE 179
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 19/281 (6%)
Query: 303 TIREVHYATEKLNELNL-----IGEGITGKVYKGKLS----NNQHVAIKHIT---NEGNV 350
           + + VH   ++L+  N+     +G G  G+V  G+L         VAIK +     E   
Sbjct: 2   STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
             F+ E +      HPN++ L G   +     ++ E   NG+L  +L   D   + IQ +
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 121
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYAS 468
            +    A G+ +L   S+   VHRD+   NIL+  N   K+SDFGLS+V+  D    Y +
Sbjct: 122 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKL 527
              +    +  PE  +  K  S+ DV+S+GIVL +++S G++          ++  D   
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 238
Query: 528 DREYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQKAL 567
                ++      QL L C     + RP  EQ+   L K +
Sbjct: 239 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 19/281 (6%)
Query: 303 TIREVHYATEKLNELNL-----IGEGITGKVYKGKLS----NNQHVAIKHIT---NEGNV 350
           + + VH   ++L+  N+     +G G  G+V  G+L         VAIK +     E   
Sbjct: 2   STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
             F+ E +      HPN++ L G   +     ++ E   NG+L  +L   D   + IQ +
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 121
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYAS 468
            +    A G+ +L   S+   VHRD+   NIL+  N   K+SDFGLS+V+  D    Y +
Sbjct: 122 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKL 527
              +    +  PE  +  K  S+ DV+S+GIVL +++S G++          ++  D   
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 238
Query: 528 DREYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQKAL 567
                ++      QL L C     + RP  EQ+   L K +
Sbjct: 239 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +      + ++IA  +ARG+ +LH+ S   I+HRD+K
Sbjct: 80  -PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLK 135
Query: 438 PTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE    + +   +   D
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 195
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 196 VYAFGIVLYELMTGQ 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 438 PTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE    +     +   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 192 VYAFGIVLYELMTGQ 206

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 133/309 (43%), Gaps = 21/309 (6%)
Query: 275 KRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNL-----IGEGITGKVY 329
           KR +  N   K+   +     DP       + VH   ++L+  N+     +G G  G+V 
Sbjct: 5   KRLHFGNGHLKLPGLR--TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVC 62
Query: 330 KGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF 382
            G+L         VAIK +     E     F+ E +      HPN++ L G   +     
Sbjct: 63  SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL 442
           ++ E   NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 443 LGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
           +  N   K+SDFGL++V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIV
Sbjct: 180 INSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 501 LLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQ 558
           L +++S G++          ++  D        ++      QL L C     + RP  EQ
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 559 VFVTLQKAL 567
           +   L K +
Sbjct: 300 IVSILDKLI 308

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 81  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 136
Query: 438 PTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE    +     +   D
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 197 VYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 81  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 136
Query: 438 PTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE    +     +   D
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 197 VYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 78  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 133
Query: 438 PTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE    +     +   D
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 193
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 194 VYAFGIVLYELMTGQ 208

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 16/217 (7%)
Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ----HVAIKHITNE---GNVET 352
           P+Y I     A E +    ++GEG  G+VY+G  +N++    +VA+K    +    N E 
Sbjct: 1   PQYGI-----AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK 55
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
           F+ E     ++ HP++V L+G  +  +  ++I EL P G L  +L      L  +  +  
Sbjct: 56  FMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 114
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           ++   + + +L S +    VHRDI   NIL+      KL DFGLS+ I+  + Y +S  R
Sbjct: 115 SLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 171
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK 509
               ++ PE  +  +  ++ DV+ F + + +ILS  K
Sbjct: 172 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 208

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           ++G G  G V K K    + VAIK I +E   + F+ E+   S V HPN+V L G CL  
Sbjct: 16  VVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-- 72
Query: 379 DECFLIYELCPNGNLAEWLFGKDKCLSWI--QRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +   L+ E    G+L   L G +    +     +   +  ++G+ +LHS     ++HRD+
Sbjct: 73  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 132
Query: 437 KPTNILL-GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
           KP N+LL       K+ DFG +   DI +T+ ++  +G+  ++ PE       +   DV+
Sbjct: 133 KPPNLLLVAGGTVLKICDFGTA--CDI-QTHMTNN-KGSAAWMAPEVFEGSNYSEKCDVF 188
Query: 496 SFGIVLLQILSGKK 509
           S+GI+L ++++ +K
Sbjct: 189 SWGIILWEVITRRK 202

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 103 -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 158
Query: 438 PTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPEYRSNCKVNS---SGD 493
             NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE       N      D
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 218
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 219 VYAFGIVLYELMTGQ 233

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 154
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 155 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 205
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 99/188 (52%), Gaps = 6/188 (3%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HRD+
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 138
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
              N L+G N   K++DFGLS+++      A +  +    +  PE  +  K +   DV++
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 198
Query: 497 FGIVLLQI 504
           FG++L +I
Sbjct: 199 FGVLLWEI 206

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 104 -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 159
Query: 438 PTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPEYRSNCKVNS---SGD 493
             NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE       N      D
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 220 VYAFGIVLYELMTGQ 234

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIKHIT---NEGNVET------FVREVASSSHVRHPNLV 369
           IG+G  G V+KG+L  ++ V AIK +    +EG  E       F REV   S++ HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
            L  Y L  +   ++ E  P G+L   L  K   + W  +L + +D A G+ ++ + +  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP- 143
Query: 430 CIVHRDIKPTNILLGPNFE-----AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-- 482
            IVHRD++  NI L    E     AK++DFGLS+       ++ S + G F ++ PE   
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIG 199
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
                     D YSF ++L  IL+G+
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 132/309 (42%), Gaps = 21/309 (6%)
Query: 275 KRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNL-----IGEGITGKVY 329
           KR +  N   K+   +     DP       + VH   ++L+  N+     +G G  G+V 
Sbjct: 5   KRLHFGNGHLKLPGLR--TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVC 62
Query: 330 KGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF 382
            G+L         VAIK +     E     F+ E +      HPN++ L G   +     
Sbjct: 63  SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL 442
           ++ E   NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNIL 179
Query: 443 LGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
           +  N   K+SDFGL +V+  D    Y +   +    +  PE  +  K  S+ DV+S+GIV
Sbjct: 180 INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 501 LLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQ 558
           L +++S G++          ++  D        ++      QL L C     + RP  EQ
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 559 VFVTLQKAL 567
           +   L K +
Sbjct: 300 IVSILDKLI 308

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 154
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 155 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYLPPEMIE 205
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIE 179
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 31/203 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL------ANALSYCHSKR- 132
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG N E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 133 --VIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 485 NCKVNSSGDVYSFGIVLLQILSG 507
               +   D++S G++  + L G
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 31/203 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL------ANALSYCHSKR- 132
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG N E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 133 --VIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 485 NCKVNSSGDVYSFGIVLLQILSG 507
               +   D++S G++  + L G
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 319 LIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           ++G G  G V K K    + VAIK I +E   + F+ E+   S V HPN+V L G CL  
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 379 DECFLIYELCPNGNLAEWLFGKDKCLSWI--QRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +   L+ E    G+L   L G +    +     +   +  ++G+ +LHS     ++HRD+
Sbjct: 72  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 437 KPTNILL-GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
           KP N+LL       K+ DFG +   DI +T+ ++  +G+  ++ PE       +   DV+
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTA--CDI-QTHMTNN-KGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 496 SFGIVLLQILSGKK 509
           S+GI+L ++++ +K
Sbjct: 188 SWGIILWEVITRRK 201

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 438 PTNILLGPNFEAKLSDFGLSKVID-IGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE    +     +   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 192 VYAFGIVLYELMTGQ 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 145
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 146 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 196
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 131
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 182
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 130
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 131 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYLPPEMIE 181
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 133
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 184
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 133
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEXIE 184
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 129
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPEMIE 180
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 131
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPPEMIE 182
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 129
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIE 180
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 179
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 133
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIE 184
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTELCGTLDYLPPEMIE 179
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 131
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 182
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIE 179
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 318 NLIGEGITGKVYKGKLSNN---QHVAIKHITNEGNVETFVREVASSSHV-----RHPNLV 369
           ++IGEG  G+V K ++  +      AIK +    + +   R+ A    V      HPN++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 89
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLF---------------GKDKCLSWIQRLEIAI 414
            LLG C      +L  E  P+GNL ++L                     LS  Q L  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
           D ARG+ +L   S+   +HRD+   NIL+G N+ AK++DFGLS+  ++        V+ T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199
Query: 475 FGYLDPEYRSNCKVNSS-----GDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDR 529
            G L   + +   +N S      DV+S+G++L +I+S           + L    P+  R
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259
Query: 530 -EYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQKALD 568
            E  +   D    L   C     ++RP   Q+ V+L + L+
Sbjct: 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 318 NLIGEGITGKVYKGKLSNN---QHVAIKHITNEGNVETFVREVASSSHV-----RHPNLV 369
           ++IGEG  G+V K ++  +      AIK +    + +   R+ A    V      HPN++
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 79
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLF---------------GKDKCLSWIQRLEIAI 414
            LLG C      +L  E  P+GNL ++L                     LS  Q L  A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
           D ARG+ +L   S+   +HRD+   NIL+G N+ AK++DFGLS+  ++        V+ T
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 189
Query: 475 FGYLDPEYRSNCKVNSS-----GDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDR 529
            G L   + +   +N S      DV+S+G++L +I+S           + L    P+  R
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 249
Query: 530 -EYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQKALD 568
            E  +   D    L   C     ++RP   Q+ V+L + L+
Sbjct: 250 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDYLPPEMIE 179
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +    +HR++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNL 344
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 404 AFGVLLWEI 412

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 131
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYLPPEMIE 182
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 127
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 128 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 178
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTXLCGTLDYLPPEMIE 179
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 131
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYLPPEMIE 182
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 132
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 133 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYLPPEMIE 179
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +    + + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 125
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 126 --VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 176
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 177 GRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 129
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWS-------CHAPSSRRTTLSGTLDYLPPEMIE 180
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +      + ++IA  +ARG+ +LH+ S   I+HRD+K
Sbjct: 92  -PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLK 147
Query: 438 PTNILLGPNFEAKLSDFGL-SKVIDIGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL ++      ++   ++ G+  ++ PE    + +   +   D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 208 VYAFGIVLYELMTGQ 222

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 438 PTNILLGPNFEAKLSDFGL-SKVIDIGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL ++      ++   ++ G+  ++ PE    +     +   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 192 VYAFGIVLYELMTGQ 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +      + ++IA  +ARG+ +LH+ S   I+HRD+K
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLK 147
Query: 438 PTNILLGPNFEAKLSDFGL-SKVIDIGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL ++      ++   ++ G+  ++ PE    + +   +   D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 208 VYAFGIVLYELMTGQ 222

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 96  -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 151
Query: 438 PTNILLGPNFEAKLSDFGL-SKVIDIGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL ++      ++   ++ G+  ++ PE    +     +   D
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 211
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 212 VYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G VYKGK   +  V + ++T      ++ F  EV      RH N++  +GY  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
             +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+ S   I+HRD+K
Sbjct: 104 -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 159
Query: 438 PTNILLGPNFEAKLSDFGL-SKVIDIGETYASSEVRGTFGYLDPE---YRSNCKVNSSGD 493
             NI L  +   K+ DFGL ++      ++   ++ G+  ++ PE    +     +   D
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 494 VYSFGIVLLQILSGK 508
           VY+FGIVL ++++G+
Sbjct: 220 VYAFGIVLYELMTGQ 234

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVALLGYCLR 377
           +G+G  G+V+ G  +    VAIK +   GN+  E F++E      +RH  LV L    + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 250
Query: 378 VDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
            +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD+
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 307
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           +  NIL+G N   K++DFGL ++I+  E  A    +    +  PE     +     DV+S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 497 FGIVLLQILS 506
           FGI+L ++ +
Sbjct: 368 FGILLTELTT 377

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L  Y +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 379 DE-CFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +E  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD+
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           +  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 497 FGIVLLQILS 506
           FGI+L ++ +
Sbjct: 201 FGILLTELTT 210

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHIT--NEGNVETFVREVAS 359
           +I  V    +K      IG+G +G VY    ++  Q VAI+ +    +   E  + E+  
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
               ++PN+V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 128
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L FLHS     ++HRDIK  NILLG +   KL+DFG    I   E    SE+ GT  ++ 
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSEMVGTPYWMA 184
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE  +        D++S GI+ ++++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVSE 84
Query: 379 DECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 141
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 142 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 202 GILLTELTT 210

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIKHIT---NEGNVET------FVREVASSSHVRHPNLV 369
           IG+G  G V+KG+L  ++ V AIK +    +EG  E       F REV   S++ HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
            L  Y L  +   ++ E  P G+L   L  K   + W  +L + +D A G+ ++ + +  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP- 143
Query: 430 CIVHRDIKPTNILLGPNFE-----AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-- 482
            IVHRD++  NI L    E     AK++DFG S+       ++ S + G F ++ PE   
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWMAPETIG 199
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
                     D YSF ++L  IL+G+
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 18/206 (8%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           EK  +L  +GEG  G VYK K S  + VA+K I     +EG   T +RE++    + HPN
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 368 LVALLGYCLRVDECF-LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFL 423
           +V+L+   +  + C  L++E     +L + L   D+  + +Q  +I I      RG+   
Sbjct: 81  IVSLID-VIHSERCLTLVFEFM-EKDLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-Y 482
           H +    I+HRD+KP N+L+  +   KL+DFGL++   I     + EV  T  Y  P+  
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
             + K ++S D++S G +  ++++GK
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 14/192 (7%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC----LSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
               +++ E  P GNL ++L    +C    ++ +  L +A   +  + +L   +    +H
Sbjct: 100 EPPFYIVTEYMPYGNLLDYL---RECNREEVTAVVLLYMATQISSAMEYLEKKN---FIH 153
Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSG 492
           RD+   N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +    +   
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 493 DVYSFGIVLLQI 504
           DV++FG++L +I
Sbjct: 213 DVWAFGVLLWEI 224

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 31/237 (13%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           ++L  L  IG+G  G V  G    N+ VA+K I N+   + F+ E +  + +RH NLV L
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 372 LGYCLRVDE---CFLIYELCPNGNLAEWLFGKDK------CLSWIQRLEIAIDSARGLWF 422
           LG    V+E    +++ E    G+L ++L  + +      CL     L+ ++D    + +
Sbjct: 252 LGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEY 304
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           L   +    VHRD+   N+L+  +  AK+SDFGL+K     +      V+ T     PE 
Sbjct: 305 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 357
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--PKLDREYSIEAFD 537
               K ++  DV+SFGI+L +I S  +          + L D  P++++ Y ++A D
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGYKMDAPD 409

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 18/206 (8%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           EK  +L  +GEG  G VYK K S  + VA+K I     +EG   T +RE++    + HPN
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 368 LVALLGYCLRVDECF-LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFL 423
           +V+L+   +  + C  L++E     +L + L   D+  + +Q  +I I      RG+   
Sbjct: 81  IVSLID-VIHSERCLTLVFEFM-EKDLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-Y 482
           H +    I+HRD+KP N+L+  +   KL+DFGL++   I     + EV  T  Y  P+  
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
             + K ++S D++S G +  ++++GK
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 320 IGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLR 377
           +G G  G+VY+G     +  VA+K +  +   VE F++E A    ++HPNLV LLG C R
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 378 VDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
               ++I E    GNL ++L   ++  ++ +  L +A   +  + +L   +    +HR++
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRNL 383
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
              N L+G N   K++DFGLS+++  G+TY A +  +    +  PE  +  K +   DV+
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 442
Query: 496 SFGIVLLQI 504
           +FG++L +I
Sbjct: 443 AFGVLLWEI 451

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 130
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K+++FG S        +A S  R    GT  YL PE   
Sbjct: 131 --VIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 181
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIKHIT---NEGNVET------FVREVASSSHVRHPNLV 369
           IG+G  G V+KG+L  ++ V AIK +    +EG  E       F REV   S++ HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
            L  Y L  +   ++ E  P G+L   L  K   + W  +L + +D A G+ ++ + +  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP- 143
Query: 430 CIVHRDIKPTNILLGPNFE-----AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-- 482
            IVHRD++  NI L    E     AK++DF LS+       ++ S + G F ++ PE   
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWMAPETIG 199
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
                     D YSF ++L  IL+G+
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 31/204 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   ++ + A+K      +   G      REV   SH+RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +LI E  P G +   L     F + +  ++I  L      A  L + HS   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR- 131
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+LLG   E K+++FG S        +A S  R    GT  YL PE   
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDYLPPEMIE 182
Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
               +   D++S G++  + L GK
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 318 NLIGEGITGKVYKGKLSNN---QHVAIKHITNEGNVETFVREVASSSHV-----RHPNLV 369
           ++IGEG  G+V K ++  +      AIK +    + +   R+ A    V      HPN++
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 86
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLF---------------GKDKCLSWIQRLEIAI 414
            LLG C      +L  E  P+GNL ++L                     LS  Q L  A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
           D ARG+ +L   S+   +HR++   NIL+G N+ AK++DFGLS+  ++        V+ T
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 196
Query: 475 FGYLDPEYRSNCKVNSS-----GDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDR 529
            G L   + +   +N S      DV+S+G++L +I+S           + L    P+  R
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 256
Query: 530 -EYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQKALD 568
            E  +   D    L   C     ++RP   Q+ V+L + L+
Sbjct: 257 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 297

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 77
Query: 379 DECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 78  EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 134
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 135 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 194
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 195 GILLTELTT 203

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L  Y +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 379 DE-CFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +E  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD+
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           +  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 497 FGIVLLQILS 506
           FGI+L ++ +
Sbjct: 201 FGILLTELTT 210

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 31/237 (13%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           ++L  L  IG+G  G V  G    N+ VA+K I N+   + F+ E +  + +RH NLV L
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 372 LGYCLRVDE---CFLIYELCPNGNLAEWLFGKDK------CLSWIQRLEIAIDSARGLWF 422
           LG    V+E    +++ E    G+L ++L  + +      CL     L+ ++D    + +
Sbjct: 80  LGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEY 132
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           L   +    VHRD+   N+L+  +  AK+SDFGL+K     +      V+ T     PE 
Sbjct: 133 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 185
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--PKLDREYSIEAFD 537
               K ++  DV+SFGI+L +I S  +          + L D  P++++ Y ++A D
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGYKMDAPD 237

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 31/237 (13%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           ++L  L  IG+G  G V  G    N+ VA+K I N+   + F+ E +  + +RH NLV L
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 372 LGYCLRVDE---CFLIYELCPNGNLAEWLFGKDK------CLSWIQRLEIAIDSARGLWF 422
           LG    V+E    +++ E    G+L ++L  + +      CL     L+ ++D    + +
Sbjct: 65  LGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEY 117
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           L   +    VHRD+   N+L+  +  AK+SDFGL+K     +      V+ T     PE 
Sbjct: 118 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 170
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--PKLDREYSIEAFD 537
               K ++  DV+SFGI+L +I S  +          + L D  P++++ Y ++A D
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGYKMDAPD 222

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 73
Query: 379 DECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 130
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 131 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 190
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 191 GILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 75
Query: 379 DECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 76  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 132
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 133 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 192
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 193 GILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L  Y +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 379 DE-CFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +E  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           +  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 497 FGIVLLQILS 506
           FGI+L ++ +
Sbjct: 201 FGILLTELTT 210

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 379 DECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 307
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 368 GILLTELTT 376

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 89  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 147
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +   
Sbjct: 148 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 204
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 205 KWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 379 DECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 307
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 368 GILLTELTT 376

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 63  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +   
Sbjct: 122 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 178
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 179 KWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 66  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +   
Sbjct: 125 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 19/183 (10%)
Query: 336 NQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN 390
           N  VAIK I       E  ++ F REV +SS + H N+V+++      D  +L+ E    
Sbjct: 36  NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 391 GNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP 445
             L+E++        D  +++  ++   I  A  +          IVHRDIKP NIL+  
Sbjct: 96  PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---------IVHRDIKPQNILIDS 146
Query: 446 NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
           N   K+ DFG++K +       ++ V GT  Y  PE       +   D+YS GIVL ++L
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
Query: 506 SGK 508
            G+
Sbjct: 207 VGE 209

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 64  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 122
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +   
Sbjct: 123 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 179
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 180 KWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 61  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +   
Sbjct: 120 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 296 DPGCPRYTIREVHYATEKLNEL-----NLIGEGITGKVYKGKLS----NNQHVAIKHIT- 345
           DP       R VH   ++L+        +IG G  G+V  G+L      +  VAIK +  
Sbjct: 22  DPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKV 81
Query: 346 --NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC 403
              E     F+ E +      HPN+V L G   R     ++ E   NG L  +L   D  
Sbjct: 82  GYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ 141
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--D 461
            + IQ + +    A G+ +L   ++   VHRD+   NIL+  N   K+SDFGLS+VI  D
Sbjct: 142 FTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
               Y ++  +    +  PE     K  S+ DV+S+GIV+ +++S
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 61  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +   
Sbjct: 120 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 379 DECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 85  EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 141
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 142 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 202 GILLTELTT 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 379 DECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 251 EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 307
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 368 GILLTELTT 376

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 31/203 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   N+ + A+K      +  EG      RE+   SH+RHPN++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +L+ E  P G L + L     F + +  ++++ L  A         LH   E
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA---------LHYCHE 132
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+L+G   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 485 NCKVNSSGDVYSFGIVLLQILSG 507
               +   D++  G++  + L G
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 9/209 (4%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHIT--NEGNVETFVREVAS 359
           +I  V    +K      IG+G +G VY    ++  Q VAI+ +    +   E  + E+  
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
               ++PN+V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 128
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L FLHS     ++HRDIK  NILLG +   KL+DFG    I   ++  S+ V GT  ++ 
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 184
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE  +        D++S GI+ ++++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L  Y +  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 332
Query: 379 DE-CFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +E  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           +  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 497 FGIVLLQILS 506
           FGI+L ++ +
Sbjct: 450 FGILLTELTT 459

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L  Y +  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 73
Query: 379 DECF-LIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +E   ++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD+
Sbjct: 74  EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 130
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           +  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+S
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 497 FGIVLLQILS 506
           FGI+L ++ +
Sbjct: 191 FGILLTELTT 200

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 31/203 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G VY  +   N+ + A+K      +  EG      RE+   SH+RHPN++ +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 374 YCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           Y       +L+ E  P G L + L     F + +  ++++ L  A         LH   E
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA---------LHYCHE 133
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEYRS 484
             ++HRDIKP N+L+G   E K++DFG S        +A S  R    GT  YL PE   
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 485 NCKVNSSGDVYSFGIVLLQILSG 507
               +   D++  G++  + L G
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 96/189 (50%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 379 DECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 85  EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 141
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 142 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 202 GILLTELTT 210

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 31/237 (13%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           ++L  L  IG+G  G V  G    N+ VA+K I N+   + F+ E +  + +RH NLV L
Sbjct: 12  KELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 372 LGYCLRVDE---CFLIYELCPNGNLAEWLFGKDK------CLSWIQRLEIAIDSARGLWF 422
           LG    V+E    +++ E    G+L ++L  + +      CL     L+ ++D    + +
Sbjct: 71  LGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEY 123
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           L   +    VHRD+   N+L+  +  AK+SDFGL+K     +      V+ T     PE 
Sbjct: 124 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 176
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--PKLDREYSIEAFD 537
                 ++  DV+SFGI+L +I S  +          + L D  P++++ Y ++A D
Sbjct: 177 LREAAFSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGYKMDAPD 228

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L  Y +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 379 DE-CFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +E  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++   +    VHRD+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
              NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+S
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 497 FGIVLLQILS 506
           FGI+L ++ +
Sbjct: 201 FGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 96/189 (50%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 379 DECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G L ++L G+  K L   Q +++A   A G+ ++   +    VHRD++
Sbjct: 85  EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 141
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 142 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 202 GILLTELTT 210

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHIT--NEGNVETFVREVAS 359
           +I  V    +K      IG+G +G VY    ++  Q VAI+ +    +   E  + E+  
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
               ++PN+V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 128
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L FLHS     ++HRDIK  NILLG +   KL+DFG    I   E    S + GT  ++ 
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMA 184
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE  +        D++S GI+ ++++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 320 IGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVREVASSSHVRHPNLVALL 372
           IGEG  G V++G   + ++ A+       K+ T++   E F++E  +     HP++V L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
           G  +  +  ++I ELC  G L  +L  +   L     +  A   +  L +L S      V
Sbjct: 75  G-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 130
Query: 433 HRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSG 492
           HRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +    ++ PE  +  +  S+ 
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 493 DVYSFGIVLLQIL 505
           DV+ FG+ + +IL
Sbjct: 191 DVWMFGVCMWEIL 203

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHIT--NEGNVETFVREVAS 359
           +I  V    +K      IG+G +G VY    ++  Q VAI+ +    +   E  + E+  
Sbjct: 12  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
               ++PN+V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + 
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 129
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L FLHS     ++HRDIK  NILLG +   KL+DFG    I   E    S + GT  ++ 
Sbjct: 130 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMA 185
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE  +        D++S GI+ ++++ G+
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L    +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 379 DECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  +++ E    G+L ++L G+  K L   Q ++++   A G+ ++   +    VHRD++
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRDLR 138
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SF
Sbjct: 139 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 198
Query: 498 GIVLLQILS 506
           GI+L ++ +
Sbjct: 199 GILLTELTT 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 441 EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +   
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV L  Y +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 80
Query: 379 DE-CFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +E  +++ E    G+L ++L G+  K L   Q ++++   A G+ ++   +    VHRD+
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRDL 137
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           +  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +     DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 497 FGIVLLQILS 506
           FGI+L ++ +
Sbjct: 198 FGILLTELTT 207

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 8/192 (4%)
Query: 320 IGEGITGKVYKGKL-SNNQHVAIKHITNEGNVE---TFVREVASSSHVRHPNLVALLGYC 375
           IG G  G+V+ G+L ++N  VA+K        +    F++E        HPN+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
            +    +++ EL   G+   +L  +   L     L++  D+A G+ +L S    C +HRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRD 238
Query: 436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT-FGYLDPEYRSNCKVNSSGDV 494
           +   N L+      K+SDFG+S+    G   AS  +R     +  PE  +  + +S  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 495 YSFGIVLLQILS 506
           +SFGI+L +  S
Sbjct: 299 WSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 8/192 (4%)
Query: 320 IGEGITGKVYKGKL-SNNQHVAIKHITNEGNVE---TFVREVASSSHVRHPNLVALLGYC 375
           IG G  G+V+ G+L ++N  VA+K        +    F++E        HPN+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
            +    +++ EL   G+   +L  +   L     L++  D+A G+ +L S    C +HRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRD 238
Query: 436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT-FGYLDPEYRSNCKVNSSGDV 494
           +   N L+      K+SDFG+S+    G   AS  +R     +  PE  +  + +S  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 495 YSFGIVLLQILS 506
           +SFGI+L +  S
Sbjct: 299 WSFGILLWETFS 310

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 61  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+      KL DFGLS+ ++    Y +S+ +   
Sbjct: 120 LSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           IG+G +G VY    ++  Q VAI+ +    +   E  + E+      ++PN+V  L   L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
             DE +++ E    G+L + +   + C+   Q   +  +  + L FLHS     ++HR+I
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRNI 143
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           K  NILLG +   KL+DFG    I   ++  S+ V GT  ++ PE  +        D++S
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 497 FGIVLLQILSGK 508
            GI+ ++++ G+
Sbjct: 203 LGIMAIEMIEGE 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 15/222 (6%)
Query: 295 KDPG-CPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL----SNNQHVAIKHIT---N 346
           ++PG   R   RE+     +++   +IG G +G+V  G+L      +  VAIK +     
Sbjct: 33  EEPGRAGRSFTREIE--ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 347 EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW 406
           E     F+ E +      HPN++ L G   R     ++ E   NG+L  +L   D   + 
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGE 464
           +Q + +      G+ +L   S+   VHRD+   N+L+  N   K+SDFGLS+V+  D   
Sbjct: 151 MQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            Y ++  +    +  PE  +    +S+ DV+SFG+V+ ++L+
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 61  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+  N   KL DFGLS+ ++      +S+ +   
Sbjct: 120 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI 176
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAI-------KHITNEGNVETFVR 355
           + R+     E++     IGEG  G V++G   + ++ A+       K+ T++   E F++
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           E  +     HP++V L+G  +  +  ++I ELC  G L  +L  +   L     +  A  
Sbjct: 441 EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
            +  L +L S      VHRDI   N+L+      KL DFGLS+ ++    Y +S+ +   
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
            ++ PE  +  +  S+ DV+ FG+ + +IL
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 15/222 (6%)
Query: 295 KDPG-CPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL----SNNQHVAIKHIT---N 346
           ++PG   R   RE+     +++   +IG G +G+V  G+L      +  VAIK +     
Sbjct: 33  EEPGRAGRSFTREIE--ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 347 EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW 406
           E     F+ E +      HPN++ L G   R     ++ E   NG+L  +L   D   + 
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY 466
           +Q + +      G+ +L   S+   VHRD+   N+L+  N   K+SDFGLS+V++     
Sbjct: 151 MQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 467 ASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           A +   G     +  PE  +    +S+ DV+SFG+V+ ++L+
Sbjct: 208 AXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 319 LIGEGITGKVYKGKLS----NNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V  G+L         VAIK +     E     F+ E +      HPN++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     ++ E   NG+L  +L   D   + IQ + +    + G+ +L   S+   
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYL---SDMGY 145
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           VHRD+   NIL+  N   K+SDFGLS+V+  D    Y +   +    +  PE  +  K  
Sbjct: 146 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFT 205
Query: 490 SSGDVYSFGIVLLQILS 506
           S+ DV+S+GIV+ +++S
Sbjct: 206 SASDVWSYGIVMWEVVS 222

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 8/198 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVA 370
           E L  +  +G G  G+V+ G  + N  VAIK +     + E+F+ E      ++H  LV 
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 371 LLGYCLRVDE-CFLIYELCPNGNLAEWLF-GKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           L  Y +  +E  +++ E    G+L ++L  G+ + L     +++A   A G+ ++   + 
Sbjct: 69  L--YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN- 125
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
              +HRD++  NIL+G     K++DFGL+++I+  E  A    +    +  PE     + 
Sbjct: 126 --YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 183
Query: 489 NSSGDVYSFGIVLLQILS 506
               DV+SFGI+L ++++
Sbjct: 184 TIKSDVWSFGILLTELVT 201

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 319 LIGEGITGKVYKGKLSNNQH----VAIKHIT---NEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V  G+L         VAIK +     +     F+ E +      HPN++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     +I E   NG+L  +L   D   + IQ + +      G+ +L   S    
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA--- 152
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           VHRD+   NIL+  N   K+SDFG+S+V+  D    Y +   +    +  PE  +  K  
Sbjct: 153 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 212
Query: 490 SSGDVYSFGIVLLQILS 506
           S+ DV+S+GIV+ +++S
Sbjct: 213 SASDVWSYGIVMWEVMS 229

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 9/219 (4%)
Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV 350
           G Q + P  P +   E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++
Sbjct: 1   GSQTQKPQKPWWE-DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSM 58
Query: 351 --ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQ 408
             + F+ E      ++H  LV L     + +  ++I E   NG+L ++L         I 
Sbjct: 59  SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 409 RL-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
           +L ++A   A G+ F+    E   +HRD++  NIL+      K++DFGL+++I+  E  A
Sbjct: 118 KLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 174
Query: 468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
               +    +  PE  +        DV+SFGI+L +I++
Sbjct: 175 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 319 LIGEGITGKVYKGKLSNNQH----VAIKHIT---NEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V  G+L         VAIK +     +     F+ E +      HPN++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     +I E   NG+L  +L   D   + IQ + +      G+ +L   S    
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS---Y 131
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           VHRD+   NIL+  N   K+SDFG+S+V+  D    Y +   +    +  PE  +  K  
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 191
Query: 490 SSGDVYSFGIVLLQILS 506
           S+ DV+S+GIV+ +++S
Sbjct: 192 SASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 319 LIGEGITGKVYKGKLSNNQH----VAIKHIT---NEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V  G+L         VAIK +     +     F+ E +      HPN++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     +I E   NG+L  +L   D   + IQ + +      G+ +L   S    
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS---Y 137
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           VHRD+   NIL+  N   K+SDFG+S+V+  D    Y +   +    +  PE  +  K  
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 197
Query: 490 SSGDVYSFGIVLLQILS 506
           S+ DV+S+GIV+ +++S
Sbjct: 198 SASDVWSYGIVMWEVMS 214

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 127 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 182
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 183 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 223

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 112/233 (48%), Gaps = 26/233 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE
Sbjct: 119 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 174
Query: 482 YRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
               CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 217

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 6/195 (3%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVAL 371
           L  L  +G G  G V  GK      VAIK I  EG++  + F+ E     ++ H  LV L
Sbjct: 11  LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 69
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G C +    F+I E   NG L  +L          Q LE+  D    + +L S      
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 126
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           +HRD+   N L+      K+SDFGLS+ +   E  +S   +    +  PE     K +S 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 492 GDVYSFGIVLLQILS 506
            D+++FG+++ +I S
Sbjct: 187 SDIWAFGVLMWEIYS 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 175
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 174
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 215

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 174
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 215

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 6/195 (3%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVAL 371
           L  L  +G G  G V  GK      VAIK I  EG++  + F+ E     ++ H  LV L
Sbjct: 26  LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G C +    F+I E   NG L  +L          Q LE+  D    + +L S      
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 141
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           +HRD+   N L+      K+SDFGLS+ +   E  +S   +    +  PE     K +S 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 492 GDVYSFGIVLLQILS 506
            D+++FG+++ +I S
Sbjct: 202 SDIWAFGVLMWEIYS 216

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 6/195 (3%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVAL 371
           L  L  +G G  G V  GK      VAIK I  EG++  + F+ E     ++ H  LV L
Sbjct: 10  LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 68
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G C +    F+I E   NG L  +L          Q LE+  D    + +L S      
Sbjct: 69  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 125
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           +HRD+   N L+      K+SDFGLS+ +   E  +S   +    +  PE     K +S 
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 492 GDVYSFGIVLLQILS 506
            D+++FG+++ +I S
Sbjct: 186 SDIWAFGVLMWEIYS 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 118 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 124 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 179
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 180 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 6/195 (3%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVAL 371
           L  L  +G G  G V  GK      VAIK I  EG++  + F+ E     ++ H  LV L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G C +    F+I E   NG L  +L          Q LE+  D    + +L S      
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           +HRD+   N L+      K+SDFGLS+ +   E  +S   +    +  PE     K +S 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 492 GDVYSFGIVLLQILS 506
            D+++FG+++ +I S
Sbjct: 182 SDIWAFGVLMWEIYS 196

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 218

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 122 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 176
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 219

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 175
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 218

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLS----NNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V  G L         VAIK + +   E     F+ E +      HPN++ L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     +I E   NG+L  +L   D   + IQ + +    A G+ +L   ++   
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNY 156
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFG--YLDPEYRSNCK 487
           VHRD+   NIL+  N   K+SDFGLS+ +  D  +   +S + G     +  PE     K
Sbjct: 157 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 216
Query: 488 VNSSGDVYSFGIVLLQILS 506
             S+ DV+S+GIV+ +++S
Sbjct: 217 FTSASDVWSYGIVMWEVMS 235

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKD--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 218

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKD--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 219

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 119 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 217

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 6/195 (3%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVAL 371
           L  L  +G G  G V  GK      VAIK I  EG++  + F+ E     ++ H  LV L
Sbjct: 11  LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 69
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G C +    F+I E   NG L  +L          Q LE+  D    + +L S      
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 126
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           +HRD+   N L+      K+SDFGLS+ +   E  +S   +    +  PE     K +S 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 492 GDVYSFGIVLLQILS 506
            D+++FG+++ +I S
Sbjct: 187 SDIWAFGVLMWEIYS 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 119 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 217

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 219

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDPEY 482
           HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  PE 
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 483 RSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
              CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 LLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 217

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDPEY 482
           HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  PE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 173
Query: 483 RSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
              CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 174 LLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 215

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 120 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 6/195 (3%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVAL 371
           L  L  +G G  G V  GK      VAIK I  EG++  + F+ E     ++ H  LV L
Sbjct: 17  LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 75
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G C +    F+I E   NG L  +L          Q LE+  D    + +L S      
Sbjct: 76  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 132
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           +HRD+   N L+      K+SDFGLS+ +   E  +S   +    +  PE     K +S 
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 492 GDVYSFGIVLLQILS 506
            D+++FG+++ +I S
Sbjct: 193 SDIWAFGVLMWEIYS 207

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDPEY 482
           HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  PE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 173
Query: 483 RSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
              CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 174 LLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 6/195 (3%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLVAL 371
           L  L  +G G  G V  GK      VAIK I  EG++  + F+ E     ++ H  LV L
Sbjct: 26  LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G C +    F+I E   NG L  +L          Q LE+  D    + +L S      
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 141
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           +HRD+   N L+      K+SDFGLS+ +   E  +S   +    +  PE     K +S 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 492 GDVYSFGIVLLQILS 506
            D+++FG+++ +I S
Sbjct: 202 SDIWAFGVLMWEIYS 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 111/237 (46%), Gaps = 22/237 (9%)
Query: 294 LKDPGCPRYTIREVHYATEKL-NELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNV- 350
           LKDP       ++     EKL ++L  IG G  G VY  + + N++ VAIK ++  G   
Sbjct: 38  LKDPDVAELFFKD---DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 94
Query: 351 ----ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW 406
               +  ++EV     +RHPN +   G  LR    +L+ E C  G+ ++ L    K L  
Sbjct: 95  NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE 153
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY 466
           ++   +   + +GL +LHS++   ++HRD+K  NILL      KL DFG + ++     +
Sbjct: 154 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 210
Query: 467 ASSEVRGTFGYLDPEY---RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
                 GT  ++ PE        + +   DV+S GI  +++   K       A SAL
Sbjct: 211 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 8/198 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLV 369
           E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      ++H  LV
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSE 428
            L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F+    E
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
              +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE  +    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 489 NSSGDVYSFGIVLLQILS 506
               DV+SFGI+L +I++
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 320 IGEGITGKVYKG--KLSNNQ-HVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G G  G V +G  ++   Q  VAIK +   T + + E  +RE      + +P +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
            C + +   L+ E+   G L ++L GK + +      E+    + G+ +L    E   VH
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 133
Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSS 491
           RD+   N+LL     AK+SDFGLSK +   ++Y ++   G +   +  PE  +  K +S 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 492 GDVYSFGIVLLQILS 506
            DV+S+G+ + + LS
Sbjct: 194 SDVWSYGVTMWEALS 208

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 119 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 217

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 153
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 214 FTTKSDVWSFGVLLWELMT 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 148
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 209 FTTKSDVWSFGVLLWELMT 227

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 171
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 231
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 232 FTTKSDVWSFGVLLWELMT 250

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 121 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 219

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 145
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 205
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 206 FTTKSDVWSFGVLLWELMT 224

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 172
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 232
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 233 FTTKSDVWSFGVLLWELMT 251

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 9/217 (4%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV-- 350
           Q + P  P +   E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  
Sbjct: 1   QTQKPQKPWWE-DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSP 58
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           + F+ E      ++H  LV L     + +  ++I E   NG+L ++L         I +L
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 411 -EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
            ++A   A G+ F+    E   +HRD++  NIL+      K++DFGL+++I+  E  A  
Sbjct: 118 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 174
Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             +    +  PE  +        DV+SFGI+L +I++
Sbjct: 175 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 305 REVHYATEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHIT---NEGNVETFVREV 357
           +E+  +  K+ E+  IG G  G+V +G+L         VAIK +     E     F+ E 
Sbjct: 9   KEIDVSYVKIEEV--IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEA 66
Query: 358 ASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA 417
           +      HPN++ L G         ++ E   NG L  +L   D   + IQ + +    A
Sbjct: 67  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIA 126
Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE---TYASS-EVRG 473
            G+ +L   +E   VHRD+   NIL+  N   K+SDFGLS+ ++      TY SS   + 
Sbjct: 127 SGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
              +  PE  +  K  S+ D +S+GIV+ +++S
Sbjct: 184 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 150
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 210
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 211 FTTKSDVWSFGVLLWELMT 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 152
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 212
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 213 FTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 153
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 214 FTTKSDVWSFGVLLWELMT 232

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 151
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E Y+     G      ++  E     K
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 211
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 212 FTTKSDVWSFGVLLWELMT 230

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKV----YKGKLSNN-QHVAIKHITNE--GN-VE 351
           P   +   H+    L  +  +GEG  GKV    Y  +  N  + VA+K +  E  GN + 
Sbjct: 9   PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 352 TFVREVASSSHVRHPNLVALLGYCLRV--DECFLIYELCPNGNLAEWLFGKDKCLSWIQR 409
              +E+    ++ H N+V   G C     +   LI E  P+G+L E+L      ++  Q+
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE---TY 466
           L+ A+   +G+ +L S      VHRD+   N+L+    + K+ DFGL+K I+  +   T 
Sbjct: 129 LKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
                   F Y  PE     K   + DV+SFG+ L ++L+
Sbjct: 186 KDDRDSPVFWYA-PECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L    F     L+ I    I        +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKT--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 219

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 9/218 (4%)
Query: 292 VQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV- 350
           +Q + P  P +   E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++ 
Sbjct: 4   MQTQKPQKPWWE-DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMS 61
Query: 351 -ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQR 409
            + F+ E      ++H  LV L     + +  ++I E   NG+L ++L         I +
Sbjct: 62  PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINK 120
Query: 410 L-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
           L ++A   A G+ F+    E   +HRD++  NIL+      K++DFGL+++I+  E  A 
Sbjct: 121 LLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 177
Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
              +    +  PE  +        DV+SFGI+L +I++
Sbjct: 178 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           + E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLW 421
           HPN+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDP 480
           F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY    V  T  Y  P
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
           E    CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 219

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 34/238 (14%)
Query: 318 NLIGEGITGKVYKG----KLSNNQHVAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
            +IG+G  G VY G    +  N    AIK    IT    VE F+RE      + HPN++A
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 371 LLGYCLRVDEC--FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           L+G  L  +     L+  +C +G+L +++    +  +    +   +  ARG+ +L   +E
Sbjct: 87  LIGIMLPPEGLPHVLLPYMC-HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE---VRGTFGYLDPEYRSN 485
              VHRD+   N +L  +F  K++DFGL++ I   E Y+  +    R    +   E    
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 486 CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLA 543
            +  +  DV+SFG++L ++        LTR        DP          FDLT  LA
Sbjct: 203 YRFTTKSDVWSFGVLLWEL--------LTRGAPPYRHIDP----------FDLTHFLA 242

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 9/217 (4%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV-- 350
           Q + P  P +   E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  
Sbjct: 1   QTQKPQKPWWE-DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSP 58
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           + F+ E      ++H  LV L     + +  ++I E   NG+L ++L         I +L
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKL 117
Query: 411 -EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
            ++A   A G+ F+    E   +HRD++  NIL+      K++DFGL+++I+  E  A  
Sbjct: 118 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 174
Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             +    +  PE  +        DV+SFGI+L +I++
Sbjct: 175 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 320 IGEGITGKVYKGKLSNN--QHVAIKHIT----NEGNVETFVREVASSSHV---RHPNLVA 370
           IGEG  GKV+K +   N  + VA+K +      EG   + +REVA   H+    HPN+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 371 LLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA----RGLW 421
           L   C      R  +  L++E   + +L  +L   DK        E   D      RGL 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           FLHS+    +VHRD+KP NIL+  + + KL+DFGL+++       A + V  T  Y  PE
Sbjct: 135 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 189
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                   +  D++S G +  ++   K
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 320 IGEGITGKVYKGKLSNN--QHVAIKHIT----NEGNVETFVREVASSSHV---RHPNLVA 370
           IGEG  GKV+K +   N  + VA+K +      EG   + +REVA   H+    HPN+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 371 LLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA----RGLW 421
           L   C      R  +  L++E   + +L  +L   DK        E   D      RGL 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           FLHS+    +VHRD+KP NIL+  + + KL+DFGL+++       A + V  T  Y  PE
Sbjct: 135 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 189
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                   +  D++S G +  ++   K
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 5/197 (2%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT-NEGNVETFVREVASSSHVRHPNLVA 370
           E +  +  +G G  G+V+ G  +N+  VA+K +     +V+ F+ E      ++H  LV 
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVR 72
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSEG 429
           L     R +  ++I E    G+L ++L   +     + +L + +   A G+ ++   +  
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 130
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             +HRD++  N+L+  +   K++DFGL++VI+  E  A    +    +  PE  +     
Sbjct: 131 -YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 490 SSGDVYSFGIVLLQILS 506
              DV+SFGI+L +I++
Sbjct: 190 IKSDVWSFGILLYEIVT 206

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 320 IGEGITGKVYKGKLSNN--QHVAIKHIT----NEGNVETFVREVASSSHV---RHPNLVA 370
           IGEG  GKV+K +   N  + VA+K +      EG   + +REVA   H+    HPN+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 371 LLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA----RGLW 421
           L   C      R  +  L++E   + +L  +L   DK        E   D      RGL 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           FLHS+    +VHRD+KP NIL+  + + KL+DFGL+++       A + V  T  Y  PE
Sbjct: 135 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 189
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                   +  D++S G +  ++   K
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL S     
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 212
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   +    +  +  +    ++  E     K
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 273 FTTKSDVWSFGVLLWELMT 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL S     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 151
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   +    +  +  +    ++  E     K
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 211
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 212 FTTKSDVWSFGVLLWELMT 230

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHV 363
           E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      +
Sbjct: 16  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 74
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWF 422
           +H  LV L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F
Sbjct: 75  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 133
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           +    E   +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE 
Sbjct: 134 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 190
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
            +        DV+SFGI+L +I++
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHV 363
           E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      +
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWF 422
           +H  LV L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           +    E   +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE 
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
            +        DV+SFGI+L +I++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL S     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 153
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   +    +  +  +    ++  E     K
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 214 FTTKSDVWSFGVLLWELMT 232

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L    F     L+ I    I        +GL F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKT--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 174
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHV 363
           E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      +
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWF 422
           +H  LV L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           +    E   +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE 
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
            +        DV+SFGI+L +I++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL S     
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 154
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   +    +  +  +    ++  E     K
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 215 FTTKSDVWSFGVLLWELMT 233

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHV 363
           E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      +
Sbjct: 8   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 66
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWF 422
           +H  LV L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F
Sbjct: 67  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 125
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           +    E   +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE 
Sbjct: 126 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
            +        DV+SFGI+L +I++
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHV 363
           E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      +
Sbjct: 9   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 67
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWF 422
           +H  LV L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F
Sbjct: 68  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 126
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           +    E   +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE 
Sbjct: 127 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
            +        DV+SFGI+L +I++
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL S     
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 154
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   +    +  +  +    ++  E     K
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 215 FTTKSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL S     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 153
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   +    +  +  +    ++  E     K
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 214 FTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL S     
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--- 158
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   +    +  +  +    ++  E     K
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 218
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 219 FTTKSDVWSFGVLLWELMT 237

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+  I      EG   T +RE++    + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+  I      EG   T +RE++    + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
             CK  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 175 LGCKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 36/231 (15%)
Query: 309 YATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET---FVREVAS 359
           Y    +  +  IGEG  G+V++ +            VA+K +  E + +    F RE A 
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK----------------- 402
            +   +PN+V LLG C       L++E    G+L E+L                      
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 403 ------CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL 456
                  LS  ++L IA   A G+ +L   SE   VHRD+   N L+G N   K++DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 457 SKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           S+ I   + Y A         ++ PE     +  +  DV+++G+VL +I S
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHV 363
           E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      +
Sbjct: 12  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 70
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWF 422
           +H  LV L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F
Sbjct: 71  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           +    E   +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE 
Sbjct: 130 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
            +        DV+SFGI+L +I++
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHIT---NEGNVETF 353
           R   +E+  +  K+ E+  IG G  G+V +G+L         VAIK +     E     F
Sbjct: 7   REFAKEIDVSYVKIEEV--IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREF 64
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA 413
           + E +      HPN++ L G         ++ E   NG L  +L   D   + IQ + + 
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 124
Query: 414 IDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID--IGETYASSEV 471
              A G+ +L   +E   VHRD+   NIL+  N   K+SDFGLS+ ++    +   +S +
Sbjct: 125 RGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSL 181
Query: 472 RGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            G     +  PE  +  K  S+ D +S+GIV+ +++S
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 312 EKL-NELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNV-----ETFVREVASSSHVR 364
           EKL ++L  IG G  G VY  + + N++ VAIK ++  G       +  ++EV     +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           HPN +   G  LR    +L+ E C  G+ ++ L    K L  ++   +   + +GL +LH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-- 482
           S++   ++HRD+K  NILL      KL DFG + ++     +      GT  ++ PE   
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 483 -RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL 520
                + +   DV+S GI  +++   K       A SAL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 320 IGEGITGKVYKG--KLSNNQ-HVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G G  G V +G  ++   Q  VAIK +   T + + E  +RE      + +P +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
            C + +   L+ E+   G L ++L GK + +      E+    + G+ +L    E   VH
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 459
Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG--YLDPEYRSNCKVNSS 491
           R++   N+LL     AK+SDFGLSK +   ++Y ++   G +   +  PE  +  K +S 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 492 GDVYSFGIVLLQILS 506
            DV+S+G+ + + LS
Sbjct: 520 SDVWSYGVTMWEALS 534

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 8/204 (3%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHV 363
           E     E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      +
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWF 422
           +H  LV L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           +    E   +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE 
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
            +        DV+SFGI+L +I++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 17/216 (7%)
Query: 304 IREVHYATEKLNELNLIGEGITGKV----YKGKLSNN-QHVAIKHITNE--GN-VETFVR 355
           +   H+    L  +  +GEG  GKV    Y  +  N  + VA+K +  E  GN +    +
Sbjct: 1   VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK 60
Query: 356 EVASSSHVRHPNLVALLGYCLRV--DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA 413
           E+    ++ H N+V   G C     +   LI E  P+G+L E+L      ++  Q+L+ A
Sbjct: 61  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 120
Query: 414 IDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE---TYASSE 470
           +   +G+ +L S      VHRD+   N+L+    + K+ DFGL+K I+  +   T     
Sbjct: 121 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 177
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
               F Y  PE     K   + DV+SFG+ L ++L+
Sbjct: 178 DSPVFWYA-PECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 8/198 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLV 369
           E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      ++H  LV
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 66
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSE 428
            L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F+    E
Sbjct: 67  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 122
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
              +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE  +    
Sbjct: 123 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 182
Query: 489 NSSGDVYSFGIVLLQILS 506
               DV+SFGI+L +I++
Sbjct: 183 TIKSDVWSFGILLTEIVT 200

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYC 375
           +++G G  G +    + +N+ VA+K I  E     +  V+ +  S    HPN++    +C
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD--EHPNVIRY--FC 85
Query: 376 LRVDECF--LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
              D  F  +  ELC    L E++  KD     ++ + +   +  GL  LHS +   IVH
Sbjct: 86  TEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVH 141
Query: 434 RDIKPTNILLG-PN----FEAKLSDFGLSKVIDIGETYAS--SEVRGTFGYLDPEYRS-N 485
           RD+KP NIL+  PN     +A +SDFGL K + +G    S  S V GT G++ PE  S +
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 486 CKVNS--SGDVYSFGIVLLQILS 506
           CK N   + D++S G V   ++S
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 310 ATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHI---TNEGNVETFVREVASSSHVRH 365
           ++ +  +L  +G G    VYKG   +   +VA+K +   + EG   T +RE++    ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQR-LEIAI------DSAR 418
            N+V L       ++  L++E   N +L +++    + +    R LE+ +         +
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM--DSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           GL F H   E  I+HRD+KP N+L+    + KL DFGL++   I     SSEV  T  Y 
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYR 175
Query: 479 DPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
            P+     +  S+  D++S G +L ++++GK
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 114/253 (45%), Gaps = 34/253 (13%)
Query: 310 ATEKLNELNLIGEGITGK--VYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHV 363
           + EK   L  IGEG  GK  + K      Q+V IK I     +    E   REVA  +++
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYV-IKEINISRMSSKEREESRREVAVLANM 80
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEW-------LFGKDKCLSWIQRLEIAIDS 416
           +HPN+V            +++ + C  G+L +        LF +D+ L W  ++ +A   
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA--- 137
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
                 L    +  I+HRDIK  NI L  +   +L DFG+++V++     A + + GT  
Sbjct: 138 ------LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPY 190
Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL-------ADPKLDR 529
           YL PE   N   N+  D+++ G VL ++ + K A     AGS   L       + P +  
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLVLKIISGSFPPVSL 247
Query: 530 EYSIEAFDLTLQL 542
            YS +   L  QL
Sbjct: 248 HYSYDLRSLVSQL 260

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDEC------FLIYELCPNGNLAEWLFGKDKCLSW 406
           F RE  +++ + HP +VA+  Y     E       +++ E   +G     +   +  ++ 
Sbjct: 59  FRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTP 115
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGET 465
            + +E+  D+ + L F H   +  I+HRD+KP NI++      K+ DFG+++ I D G +
Sbjct: 116 KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 466 YA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              ++ V GT  YL PE      V++  DVYS G VL ++L+G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLSNNQ----HVAIK---HITNEGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G VY G L +N     H A+K    IT+ G V  F+ E        HPN+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           LG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L S     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--- 152
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT---FGYLDPEYRSNCK 487
            VHRD+   N +L   F  K++DFGL++ +   E  +     G      ++  E     K
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQK 212
Query: 488 VNSSGDVYSFGIVLLQILS 506
             +  DV+SFG++L ++++
Sbjct: 213 FTTKSDVWSFGVLLWELMT 231

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 319 LIGEGITGKVYKGKLS----NNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVAL 371
           +IG G  G+V  G L         VAIK + +   E     F+ E +      HPN++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     +I E   NG+L  +L   D   + IQ + +    A G+ +L   ++   
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNY 130
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFG--YLDPEYRSNCK 487
           VHR +   NIL+  N   K+SDFGLS+ +  D  +   +S + G     +  PE     K
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 190
Query: 488 VNSSGDVYSFGIVLLQILS 506
             S+ DV+S+GIV+ +++S
Sbjct: 191 FTSASDVWSYGIVMWEVMS 209

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 127 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 182
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
              K  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 183 LGXKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 223

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFL 423
           N+V LL      ++ +L++E   + +L +  F     L+ I    I        +GL F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           HS+    ++HRD+KP N+L+      KL+DFGL++   +     + EV  T  Y  PE  
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 175
Query: 484 SNCKVNSSG-DVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI 533
              K  S+  D++S G +         A+++TR   AL   D ++D+ + I
Sbjct: 176 LGXKYYSTAVDIWSLGCIF--------AEMVTR--RALFPGDSEIDQLFRI 216

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 319 LIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGY 374
           +IG G T  V     +   + VAIK I  E    +++  ++E+ + S   HPN+V+    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 375 CLRVDECFLIYELCPNGNLAEWLFG-------KDKCLSWIQRLEIAIDSARGLWFLHSYS 427
            +  DE +L+ +L   G++ + +         K   L       I  +   GL +LH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG----YLDPEYR 483
           +   +HRD+K  NILLG +   +++DFG+S  +  G     ++VR TF     ++ PE  
Sbjct: 142 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 484 SNCK-VNSSGDVYSFGIVLLQILSG 507
              +  +   D++SFGI  +++ +G
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATG 223

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 320 IGEGITGKVYK------GKLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +      GK      VA+K + +  +    E  + E+   SH+ +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS------------- 416
            LLG C       +I E C  G+L  +L  K + L       IA  +             
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTF 475
           A+G+ FL   S+ CI HRD+   N+LL     AK+ DFGL++ I     Y      R   
Sbjct: 174 AQGMAFLA--SKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +C      DV+S+GI+L +I S
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 320 IGEGITGKVYK------GKLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +      GK      VA+K + +  +    E  + E+   SH+ +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS------------- 416
            LLG C       +I E C  G+L  +L  K + L       IA  +             
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTF 475
           A+G+ FL S  + CI HRD+   N+LL     AK+ DFGL++ I     Y      R   
Sbjct: 174 AQGMAFLAS--KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +C      DV+S+GI+L +I S
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 318 NLIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLG 373
            +IG G T  V     +   + VAIK I  E    +++  ++E+ + S   HPN+V+   
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFG-------KDKCLSWIQRLEIAIDSARGLWFLHSY 426
             +  DE +L+ +L   G++ + +         K   L       I  +   GL +LH  
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 135
Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG----YLDPEY 482
            +   +HRD+K  NILLG +   +++DFG+S  +  G     ++VR TF     ++ PE 
Sbjct: 136 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 483 RSNCK-VNSSGDVYSFGIVLLQILSG 507
               +  +   D++SFGI  +++ +G
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATG 218

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEGNVETF----VREVASSSHVR 364
           + EK   L L+GEG  G V K +  +    VAIK      + +      +RE+     +R
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEW-LFGKDKCLSWIQRLEIAIDSARGLWFL 423
           H NLV LL  C +    +L++E   +  L +  LF        +Q+    I    G+ F 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI--INGIGFC 140
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEY 482
           HS++   I+HRDIKP NIL+  +   KL DFG ++ +   GE Y   EV  T  Y  PE 
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-DDEV-ATRWYRAPEL 195
Query: 483 R-SNCKVNSSGDVYSFGIVLLQILSGK 508
              + K   + DV++ G ++ ++  G+
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDEC------FLIYELCPNGNLAEWLFGKDKCLSW 406
           F RE  +++ + HP +VA+  Y     E       +++ E   +G     +   +  ++ 
Sbjct: 59  FRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTP 115
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGET 465
            + +E+  D+ + L F H   +  I+HRD+KP NIL+      K+ DFG+++ I D G +
Sbjct: 116 KRAIEVIADACQALNFSH---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNS 172
Query: 466 YA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              ++ V GT  YL PE      V++  DVYS G VL ++L+G+
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 314 LNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALL 372
             E+ LIG G  G+V+K K   + +   IK +  + N E   REV + + + H N+V   
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV--KYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 373 GYCLRVD---------------EC-FLIYELCPNGNLAEWLFGK-----DKCLSWIQRLE 411
           G     D               +C F+  E C  G L +W+  +     DK L+    LE
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA----LE 126
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
           +     +G+ ++HS     +++RD+KP+NI L    + K+ DFGL  V  +         
Sbjct: 127 LFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRXRS 181
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
           +GT  Y+ PE  S+       D+Y+ G++L ++L
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 8/198 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV--ETFVREVASSSHVRHPNLV 369
           E L  +  +G G  G+V+ G  + +  VA+K +  +G++  + F+ E      ++H  LV
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 67
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSE 428
            L     + +  ++I E   NG+L ++L         I +L ++A   A G+ F+    E
Sbjct: 68  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 123
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
              +HR+++  NIL+      K++DFGL+++I+  E  A    +    +  PE  +    
Sbjct: 124 RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 183
Query: 489 NSSGDVYSFGIVLLQILS 506
               DV+SFGI+L +I++
Sbjct: 184 TIKSDVWSFGILLTEIVT 201

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           +K  +L  IGEG  G V+K K    ++ VA+K +     +EG   + +RE+     ++H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           N+V L        +  L++E C + +L ++    +  L             +GL F HS 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           +   ++HRD+KP N+L+  N E KL+DFGL++   I     S+EV  T  Y  P+     
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV-VTLWYRPPDVLFGA 176
Query: 487 KVNSSG-DVYSFGIVLLQILSGKKA 510
           K+ S+  D++S G +  ++ +  + 
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQH---VAIKHITNEGNVETFVREVASSSHVR---- 364
           +K +  ++IG G++  V +       H   V I  +T E      + EV  ++       
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 365 -----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
                HP+++ L+         FL+++L   G L ++L  K   LS  +   I       
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEA 212
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           + FLH+ +   IVHRD+KP NILL  N + +LSDFG S  ++ GE     E+ GT GYL 
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLA 267
Query: 480 PEYRSNCKVNSSG-------DVYSFGIVLLQILSG 507
           PE    C ++ +        D+++ G++L  +L+G
Sbjct: 268 PEI-LKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 98/197 (49%), Gaps = 5/197 (2%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT-NEGNVETFVREVASSSHVRHPNLVA 370
           E +  +  +G G  G+V+ G  +N+  VA+K +     +V+ F+ E      ++H  LV 
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSEG 429
           L     + +  ++I E    G+L ++L   +     + +L + +   A G+ ++   +  
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 129
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             +HRD++  N+L+  +   K++DFGL++VI+  E  A    +    +  PE  +     
Sbjct: 130 -YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 490 SSGDVYSFGIVLLQILS 506
              +V+SFGI+L +I++
Sbjct: 189 IKSNVWSFGILLYEIVT 205

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDEC------FLIYELCPNGNLAEWLFGKDKCLSW 406
           F RE  +++ + HP +VA+  Y     E       +++ E   +G     +   +  ++ 
Sbjct: 59  FRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTP 115
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGET 465
            + +E+  D+ + L F H   +  I+HRD+KP NI++      K+ DFG+++ I D G +
Sbjct: 116 KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 466 YA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              ++ V GT  YL PE      V++  DVYS G VL ++L+G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDEC------FLIYELCPNGNLAEWLFGKDKCLSW 406
           F RE  +++ + HP +VA+  Y     E       +++ E   +G     +   +  ++ 
Sbjct: 59  FRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTP 115
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGET 465
            + +E+  D+ + L F H   +  I+HRD+KP NI++      K+ DFG+++ I D G +
Sbjct: 116 KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 466 YA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              ++ V GT  YL PE      V++  DVYS G VL ++L+G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDEC------FLIYELCPNGNLAEWLFGKDKCLSW 406
           F RE  +++ + HP +VA+  Y     E       +++ E   +G     +   +  ++ 
Sbjct: 59  FRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTP 115
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGET 465
            + +E+  D+ + L F H   +  I+HRD+KP NI++      K+ DFG+++ I D G +
Sbjct: 116 KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 466 YA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              ++ V GT  YL PE      V++  DVYS G VL ++L+G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G G  G+V+    + +  VA+K +     +VE F+ E      ++H  LV L     + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 81
Query: 379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  ++I E    G+L ++L   +     + +L + +   A G+ F+   +    +HRD++
Sbjct: 82  EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLR 138
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+  +   K++DFGL++VI+  E  A    +    +  PE  +        DV+SF
Sbjct: 139 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 198
Query: 498 GIVLLQILS 506
           GI+L++I++
Sbjct: 199 GILLMEIVT 207

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           +G+G  GKVYK K      +A   +    +E  +E ++ E+   +   HP +V LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
              + +++ E CP G +   +   D+ L+  Q   +       L FLHS     I+HRD+
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDL 135
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-----RSNCKVNSS 491
           K  N+L+    + +L+DFG+S   ++          GT  ++ PE        +   +  
Sbjct: 136 KAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK 194
Query: 492 GDVYSFGIVLLQI 504
            D++S GI L+++
Sbjct: 195 ADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           +G+G  GKVYK K      +A   +    +E  +E ++ E+   +   HP +V LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
              + +++ E CP G +   +   D+ L+  Q   +       L FLHS     I+HRD+
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDL 143
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-----RSNCKVNSS 491
           K  N+L+    + +L+DFG+S   ++          GT  ++ PE        +   +  
Sbjct: 144 KAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK 202
Query: 492 GDVYSFGIVLLQI 504
            D++S GI L+++
Sbjct: 203 ADIWSLGITLIEM 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 6/189 (3%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G G  G+V+    + +  VA+K +     +VE F+ E      ++H  LV L     + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 254
Query: 379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  ++I E    G+L ++L   +     + +L + +   A G+ F+   +    +HRD++
Sbjct: 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLR 311
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+  +   K++DFGL++VI+  E  A    +    +  PE  +        DV+SF
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371
Query: 498 GIVLLQILS 506
           GI+L++I++
Sbjct: 372 GILLMEIVT 380

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHIT----NEGNVETFVREVASSSHVR 364
           AT +   +  IG G  G VYK +  ++ H VA+K +      EG   + VREVA    + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 365 ---HPNLVALLGYCL--RVD---ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS 416
              HPN+V L+  C   R D   +  L++E   + +L  +L   DK        E   D 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 417 AR----GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
            R    GL FLH+    CIVHRD+KP NIL+      KL+DFGL+++       A   V 
Sbjct: 118 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV- 173
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            T  Y  PE        +  D++S G +  ++   K
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDEC------FLIYELCPNGNLAEWLFGKDKCLSW 406
           F RE  +++ + HP +VA+  Y     E       +++ E   +G     +   +  ++ 
Sbjct: 76  FRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTP 132
Query: 407 IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGET 465
            + +E+  D+ + L F H   +  I+HRD+KP NI++      K+ DFG+++ I D G +
Sbjct: 133 KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 466 YA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              ++ V GT  YL PE      V++  DVYS G VL ++L+G+
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 37/269 (13%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVAS--SSHVRHPNLVALLG 373
           + L+G G  G+VYKG+ +   Q  AIK +   G+ E  +++  +    +  H N+    G
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 374 YCLRV------DECFLIYELCPNGNLAEWLFG------KDKCLSWIQRLEIAIDSARGLW 421
             ++       D+ +L+ E C  G++ + +        K++ +++I R     +  RGL 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EILRGLS 143
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
            LH +    ++HRDIK  N+LL  N E KL DFG+S  +D      ++ + GT  ++ PE
Sbjct: 144 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 199
Query: 482 Y-----RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL----ADPKLDREYS 532
                   +   +   D++S GI  +++  G           AL L      P+L  +  
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259
Query: 533 IEAFDLTLQLALSCTALTH-QRPPMEQVF 560
            + F   ++   SC    H QRP  EQ+ 
Sbjct: 260 SKKFQSFIE---SCLVKNHSQRPATEQLM 285

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 320 IGEGITGKVYK------GKLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +      GK      VA+K + +  +    E  + E+   SH+ +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------DKCLSWIQRLEIAIDSARGL 420
            LLG C       +I E C  G+L  +L  K          + L     L  +   A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLD 479
            FL S  + CI HRD+   N+LL     AK+ DFGL++ I     Y      R    ++ 
Sbjct: 166 AFLAS--KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILS 506
           PE   +C      DV+S+GI+L +I S
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 16/173 (9%)
Query: 346 NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLS 405
           +E    TF++EV     + HPN++  +G   +      I E    G L   +   D    
Sbjct: 47  DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP 106
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
           W QR+  A D A G+ +LHS +   I+HRD+   N L+  N    ++DFGL++++   +T
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 466 YASS-------------EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
                             V G   ++ PE  +    +   DV+SFGIVL +I+
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 320 IGEGITGKVYK------GKLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +      GK      VA+K + +  +    E  + E+   SH+ +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------DKCLSWIQRLEIAIDSARGL 420
            LLG C       +I E C  G+L  +L  K          + L     L  +   A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLD 479
            FL S  + CI HRD+   N+LL     AK+ DFGL++ I     Y      R    ++ 
Sbjct: 174 AFLAS--KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILS 506
           PE   +C      DV+S+GI+L +I S
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNN-QHVAIKHITNEGNVETF----VREVASSSHVRHP 366
           EK  ++  IGEG  G V+K +  +  Q VAIK      +        +RE+     ++HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQR-------LEIAIDSARG 419
           NLV LL    R     L++E C +  L E        L   QR         I   + + 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQA 114
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           + F H ++  CI HRD+KP NIL+  +   KL DFG ++++     Y   EV  T  Y  
Sbjct: 115 VNFCHKHN--CI-HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRS 170
Query: 480 PEYR-SNCKVNSSGDVYSFGIVLLQILSG 507
           PE    + +     DV++ G V  ++LSG
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHITNE-----GNVETFVREVASSSH 362
           +L  + ++G G  G VYKG            VAIK I NE      NVE F+ E    + 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIMAS 96
Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDS 416
           + HP+LV LLG CL      L+ +L P+G L E++       G    L+W       +  
Sbjct: 97  MDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQI 149
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTF 475
           A+G+ +L    E  +VHRD+   N+L+      K++DFGL+++++  E  Y +   +   
Sbjct: 150 AKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 206
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++  E     K     DV+S+G+ + ++++
Sbjct: 207 KWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 42/230 (18%)
Query: 313 KLNELNL--------IGEGITGKVYKGKL------SNNQHVAIKHITN--EGNV-ETFVR 355
           KL E++L        +GE   GKVYKG L         Q VAIK + +  EG + E F  
Sbjct: 19  KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 78
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK------------- 402
           E    + ++HPN+V LLG   +     +I+  C +G+L E+L  +               
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 403 --CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
              L     + +    A G+ +L S+    +VH+D+   N+L+      K+SD GL + +
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 461 DIGETYASSEVRGT----FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
              + Y   ++ G       ++ PE     K +   D++S+G+VL ++ S
Sbjct: 196 YAADYY---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHITNE-----GNVETFVREVASSSH 362
           +L  + ++G G  G VYKG            VAIK I NE      NVE F+ E    + 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIMAS 73
Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDS 416
           + HP+LV LLG CL      L+ +L P+G L E++       G    L+W       +  
Sbjct: 74  MDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQI 126
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTF 475
           A+G+ +L    E  +VHRD+   N+L+      K++DFGL+++++  E  Y +   +   
Sbjct: 127 AKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 183
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++  E     K     DV+S+G+ + ++++
Sbjct: 184 KWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 309 YATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIKHITNE-----GNVETFVREVASSSH 362
           Y+ +    L  +G G  G+V+  +  +N ++ A+K +  E       VE    E    S 
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
           V HP ++ + G      + F+I +    G L   L    +  + + +   A +    L +
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEY 121
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGETYASSEVRGTFGYLDPE 481
           LHS     I++RD+KP NILL  N   K++DFG +K + D+  TY    + GT  Y+ PE
Sbjct: 122 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYX---LCGTPDYIAPE 173
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
             S    N S D +SFGI++ ++L+G
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHIT----NEGNVETFVREVASSSHVR 364
           AT +   +  IG G  G VYK +  ++ H VA+K +      EG   + VREVA    + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 365 ---HPNLVALLGYCL--RVD---ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS 416
              HPN+V L+  C   R D   +  L++E   + +L  +L   DK        E   D 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 417 AR----GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
            R    GL FLH+    CIVHRD+KP NIL+      KL+DFGL+++       A   V 
Sbjct: 118 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALDPVV 172
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            T  Y  PE        +  D++S G +  ++   K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 51/240 (21%)
Query: 306 EVHYATEK-----LNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVAS 359
           E  Y  +K       E+ LIG G  G+V+K K   + +   I+ +  + N E   REV +
Sbjct: 1   ETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV--KYNNEKAEREVKA 58
Query: 360 SSHVRHPNLVALLGYCLRVD----------------------------EC-FLIYELCPN 390
            + + H N+V   G     D                            +C F+  E C  
Sbjct: 59  LAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 391 GNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP 445
           G L +W+  +     DK L+    LE+     +G+ ++HS     ++HRD+KP+NI L  
Sbjct: 119 GTLEQWIEKRRGEKLDKVLA----LELFEQITKGVDYIHSKK---LIHRDLKPSNIFLVD 171
Query: 446 NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
             + K+ DFGL  V  +      +  +GT  Y+ PE  S+       D+Y+ G++L ++L
Sbjct: 172 TKQVKIGDFGL--VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 320 IGEGITGKVYKGKLSN------NQHVAIKHITNEGN--VETFVREVASSSHVRHPNLVAL 371
           +GEG  GKV+  +  N         VA+K + +  +   + F RE    ++++H ++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWL--FGKDKCL----------SWIQRLEIAIDSARG 419
            G C+  D   +++E   +G+L ++L   G D  L          +  Q L IA   A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYL 478
           + +L S      VHRD+   N L+G N   K+ DFG+S+ +   + Y           ++
Sbjct: 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGKK 509
            PE     K  +  DV+S G+VL +I +  K
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 42/230 (18%)
Query: 313 KLNELNL--------IGEGITGKVYKGKL------SNNQHVAIKHITN--EGNV-ETFVR 355
           KL E++L        +GE   GKVYKG L         Q VAIK + +  EG + E F  
Sbjct: 2   KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD-------------- 401
           E    + ++HPN+V LLG   +     +I+  C +G+L E+L  +               
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 402 -KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
              L     + +    A G+ +L S+    +VH+D+   N+L+      K+SD GL + +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 461 DIGETYASSEVRGT----FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
              + Y   ++ G       ++ PE     K +   D++S+G+VL ++ S
Sbjct: 179 YAADYY---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +C + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 103 Y-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 157
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 218 KSSDLWALGCIIYQLVAG 235

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 116
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 117 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 174 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV-----ETFVREVASSSHVRHPNLVAL 371
           L  IG G  G+  K +  ++  + +    + G++     +  V EV     ++HPN+V  
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 372 LGYCLRVDEC----FLIYELCPNGNLAEWLFGKDKCLSWIQR---LEIAIDSARGLWFLH 424
             Y   +D      +++ E C  G+LA  +    K   ++     L +       L   H
Sbjct: 71  --YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 425 SYSEG--CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
             S+G   ++HRD+KP N+ L      KL DFGL+++++  E +A  E  GT  Y+ PE 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA-KEFVGTPYYMSPEQ 187
Query: 483 RSNCKVNSSGDVYSFGIVLLQI 504
            +    N   D++S G +L ++
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 334 SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL 393
           SNN  ++IK        + F  E+   + +++   +   G     DE ++IYE   N ++
Sbjct: 76  SNNDKISIK-----SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI 130
Query: 394 A---EWLFGKDK---CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF 447
               E+ F  DK   C   IQ ++  I S     F + ++E  I HRD+KP+NIL+  N 
Sbjct: 131 LKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLN-SFSYIHNEKNICHRDVKPSNILMDKNG 189
Query: 448 EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSG--DVYSFGIVL 501
             KLSDFG S+ +   +   S   RGT+ ++ PE+ SN    +    D++S GI L
Sbjct: 190 RVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 116
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 117 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 174 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHIT----NEGNVETFVREVASSSHVR 364
           AT +   +  IG G  G VYK +  ++ H VA+K +      EG   + VREVA    + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 365 ---HPNLVALLGYCL--RVD---ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS 416
              HPN+V L+  C   R D   +  L++E   + +L  +L   DK        E   D 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 417 AR----GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
            R    GL FLH+    CIVHRD+KP NIL+      KL+DFGL+++       A   V 
Sbjct: 118 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALFPVV 172
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            T  Y  PE        +  D++S G +  ++   K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 320 IGEGITGKVYK------GKLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +      GK      VA+K + +  +    E  + E+   SH+ +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAI 414
            LLG C       +I E C  G+L  +L  K               ++ LS    L  + 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRG 473
             A+G+ FL S  + CI HRD+   N+LL     AK+ DFGL++ I     Y      R 
Sbjct: 174 QVAQGMAFLAS--KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
              ++ PE   +C      DV+S+GI+L +I S
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHP 366
           +K  +L  IGEG  G V+K K    ++ VA+K +     +EG   + +RE+     ++H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           N+V L        +  L++E C + +L ++    +  L             +GL F HS 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           +   ++HRD+KP N+L+  N E KL++FGL++   I     S+EV  T  Y  P+     
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV-VTLWYRPPDVLFGA 176
Query: 487 KVNSSG-DVYSFGIVLLQI 504
           K+ S+  D++S G +  ++
Sbjct: 177 KLYSTSIDMWSAGCIFAEL 195

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E   REV+    ++HPN++ L        +  LI EL   G L ++L  K+  L+  +  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEAT 117
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETY 466
           E       G+++LHS     I H D+KP NI+L     P    K+ DFGL+  ID G  +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 175 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV-----ETFVREVASSSHVRHPNLVAL 371
           L  IG G  G+  K +  ++  + +    + G++     +  V EV     ++HPN+V  
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 372 LGYCLRVDEC----FLIYELCPNGNLAEWLFGKDKCLSWIQR---LEIAIDSARGLWFLH 424
             Y   +D      +++ E C  G+LA  +    K   ++     L +       L   H
Sbjct: 71  --YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 425 SYSEG--CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
             S+G   ++HRD+KP N+ L      KL DFGL+++++   ++A + V GT  Y+ PE 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQ 187
Query: 483 RSNCKVNSSGDVYSFGIVLLQI 504
            +    N   D++S G +L ++
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV-----ETFVREVASSSHVRHPNLVAL 371
           L  IG G  G+  K +  ++  + +    + G++     +  V EV     ++HPN+V  
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 372 LGYCLRVDEC----FLIYELCPNGNLAEWLFGKDKCLSWIQR---LEIAIDSARGLWFLH 424
             Y   +D      +++ E C  G+LA  +    K   ++     L +       L   H
Sbjct: 71  --YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 425 SYSEG--CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
             S+G   ++HRD+KP N+ L      KL DFGL+++++   ++A + V GT  Y+ PE 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQ 187
Query: 483 RSNCKVNSSGDVYSFGIVLLQI 504
            +    N   D++S G +L ++
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 19/236 (8%)
Query: 319 LIGEGITGKVYKGKLSN-NQHVAIKHITNE-----GNVE-TFVREVASSSHVRHPNLVAL 371
           ++G+G  GKV+  +    NQ  AIK +  +      +VE T V +   S    HP L  +
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW-IQRLEI-AIDSARGLWFLHSYSEG 429
                  +  F + E    G+L   ++    C  + + R    A +   GL FLHS    
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG-- 139
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            IV+RD+K  NILL  +   K++DFG+ K   +G+   ++E  GT  Y+ PE     K N
Sbjct: 140 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNEFCGTPDYIAPEILLGQKYN 197
Query: 490 SSGDVYSFGIVLLQILSGK---KAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
            S D +SFG++L ++L G+     +       ++ + +P   R    EA DL ++L
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 253

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 320 IGEGITGKVYKGKLSN------NQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVAL 371
           +GEG  GKV+  +  N         VA+K + +      + F RE    ++++H ++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWL--FGKDKC-------------LSWIQRLEIAIDS 416
            G C   D   +++E   +G+L ++L   G D               L   Q L IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTF 475
           A G+ +L S      VHRD+   N L+G N   K+ DFG+S+ +   + Y          
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE     K  +  DV+SFG++L +I +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 29/205 (14%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETF------VREVASSSHVRHPNLVAL 371
           + +G G  GKV  GK     H     I N   + +        RE+ +    RHP+++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                   + F++ E    G L +++  K+  L   +   +      G+ + H +    +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRH---MV 137
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE---------TYASSEVRGTFGYLDPEY 482
           VHRD+KP N+LL  +  AK++DFGLS ++  GE          YA+ EV     Y  PE 
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEV 197
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSG 507
                     D++S G++L  +L G
Sbjct: 198 ----------DIWSSGVILYALLCG 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 99/231 (42%), Gaps = 25/231 (10%)
Query: 288 SFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIK---- 342
           S + V     G P    R  H+  +       +G+G  G VY  +   +   VA+K    
Sbjct: 1   SMQKVMENSSGTPDILTR--HFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFK 58
Query: 343 -HITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD 401
             I  EG      RE+   +H+ HPN++ L  Y       +LI E  P G L + L  + 
Sbjct: 59  SQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QK 116
Query: 402 KCLSWIQRLEIAIDS-ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
            C    QR    ++  A  L + H      ++HRDIKP N+LLG   E K++DFG S   
Sbjct: 117 SCTFDEQRTATIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADFGWS--- 170
Query: 461 DIGETYASSEVR----GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
                +A S  R    GT  YL PE       N   D++  G++  ++L G
Sbjct: 171 ----VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHI-------TNEGNVETFVREV 357
           +V    ++  +L+ +GEG    VYK +  N NQ VAIK I         +G   T +RE+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 358 ASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA 417
                + HPN++ LL          L+++     +L   +      L+        + + 
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGY 477
           +GL +LH +    I+HRD+KP N+LL  N   KL+DFGL+K           +V  T  Y
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWY 178
Query: 478 LDPEYRSNCKVNSSG-DVYSFGIVLLQIL 505
             PE     ++   G D+++ G +L ++L
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGN--VETFVREVASSSH 362
           E  Y  ++  +  ++G+G  G VY G+ LSN   +AIK I    +   +    E+A   H
Sbjct: 16  EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 75
Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR---G 419
           ++H N+V  LG         +  E  P G+L+  L  K   L   ++  I   + +   G
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEG 134
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           L +LH   +  IVHRDIK  N+L+   +   K+SDFG SK +  G    +    GT  Y+
Sbjct: 135 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYM 190
Query: 479 DPEY--RSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE   +       + D++S G  ++++ +GK
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 320 IGEGITGKVYKGKLSNNQH-VAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G G T  VY+ K    Q   A+K +    + +    E+     + HPN++ L       
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 379 DECFLIYELCPNGNLAEWLFGK------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
            E  L+ EL   G L + +  K      D   +  Q LE        + +LH   E  IV
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------AVAYLH---ENGIV 170
Query: 433 HRDIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           HRD+KP N+L     P+   K++DFGLSK+++         V GT GY  PE    C   
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 490 SSGDVYSFGIVLLQILSG 507
              D++S GI+   +L G
Sbjct: 229 PEVDMWSVGIITYILLCG 246

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 11/163 (6%)
Query: 344 ITNEGNVETFVREVASSSHVRHPNLVALLGYC--LRVDECFLIYELCPNGNLAEWLFGKD 401
           I   G +E   +E+A    + HPN+V L+        D  ++++EL   G + E      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTL 131
Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           K LS  Q      D  +G+ +LH      I+HRDIKP+N+L+G +   K++DFG+S    
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSG---DVYSFGIVL 501
             +   S+ V GT  ++ PE  S  +   SG   DV++ G+ L
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 316 ELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYC 375
           EL     G+  +V +    NN         +E + ET  +E+ + S +RHP LV L    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
              +E  +IYE    G L E +  +   +S  + +E      +GL  +H   E   VH D
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 280
Query: 436 IKPTNILLGP--NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGD 493
           +KP NI+     + E KL DFGL+  +D  ++   +   GT  +  PE      V    D
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTD 338
Query: 494 VYSFGIVLLQILSG 507
           ++S G++   +LSG
Sbjct: 339 MWSVGVLSYILLSG 352

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVRE--VASSSHVRHPNLV 369
           + L  L LIG G  G VYKG L + + VA+K + +  N + F+ E  +     + H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVK-VFSFANRQNFINEKNIYRVPLMEHDNIA 70
Query: 370 ALLGYCLRVD-----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
             +    RV      E  L+ E  PNG+L ++L        W+    +A    RGL +LH
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 425 S------YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS------KVIDIGE--TYASSE 470
           +      + +  I HRD+   N+L+  +    +SDFGLS      +++  GE    A SE
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 471 VRGTFGYLDPEYRS---NCKVNSSG----DVYSFGIVLLQIL 505
           V GT  Y+ PE      N +   S     D+Y+ G++  +I 
Sbjct: 189 V-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 316 ELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYC 375
           EL     G+  +V +    NN         +E + ET  +E+ + S +RHP LV L    
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
              +E  +IYE    G L E +  +   +S  + +E      +GL  +H   E   VH D
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 174
Query: 436 IKPTNILLGP--NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGD 493
           +KP NI+     + E KL DFGL+  +D  ++   +   GT  +  PE      V    D
Sbjct: 175 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTD 232
Query: 494 VYSFGIVLLQILSG 507
           ++S G++   +LSG
Sbjct: 233 MWSVGVLSYILLSG 246

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 337 QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVAL------LGYCLRVDECFLIYEL 387
           + VAIK    E    N E +  E+     + HPN+V+       L      D   L  E 
Sbjct: 40  EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99
Query: 388 CPNGNLAEWLFGKDKCLSW----IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL 443
           C  G+L ++L   + C       I+ L   I SA  L +LH   E  I+HRD+KP NI+L
Sbjct: 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLH---ENRIIHRDLKPENIVL 154
Query: 444 GPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
            P  +    K+ D G +K +D GE    +E  GT  YL PE     K   + D +SFG +
Sbjct: 155 QPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212
Query: 501 LLQILSG 507
             + ++G
Sbjct: 213 AFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 337 QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVAL------LGYCLRVDECFLIYEL 387
           + VAIK    E    N E +  E+     + HPN+V+       L      D   L  E 
Sbjct: 41  EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 100
Query: 388 CPNGNLAEWLFGKDKCLSW----IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL 443
           C  G+L ++L   + C       I+ L   I SA  L +LH   E  I+HRD+KP NI+L
Sbjct: 101 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLH---ENRIIHRDLKPENIVL 155
Query: 444 GPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
            P  +    K+ D G +K +D GE    +E  GT  YL PE     K   + D +SFG +
Sbjct: 156 QPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 213
Query: 501 LLQILSG 507
             + ++G
Sbjct: 214 AFECITG 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGN--VETFVREVASSSH 362
           E  Y  ++  +  ++G+G  G VY G+ LSN   +AIK I    +   +    E+A   H
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 61
Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR---G 419
           ++H N+V  LG         +  E  P G+L+  L  K   L   ++  I   + +   G
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEG 120
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           L +LH   +  IVHRDIK  N+L+   +   K+SDFG SK +  G    +    GT  Y+
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYM 176
Query: 479 DPEY--RSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE   +       + D++S G  ++++ +GK
Sbjct: 177 APEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S + H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 210
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL 383
           TGK Y  K    + ++    +  G + E   REV     +RHPN++ L        +  L
Sbjct: 36  TGKEYAAKFIKKRRLSS---SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 92
Query: 384 IYELCPNGNLAEWLFGKDKCL--SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNI 441
           I EL   G L ++L  K+        Q L+  +D   G+ +LHS     I H D+KP NI
Sbjct: 93  ILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKR---IAHFDLKPENI 146
Query: 442 LL----GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
           +L     PN   KL DFG++  I+ G  + +  + GT  ++ PE  +   +    D++S 
Sbjct: 147 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSI 204
Query: 498 GIVLLQILSG 507
           G++   +LSG
Sbjct: 205 GVITYILLSG 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S + H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 224
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 98  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 152
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL 383
           TGK Y  K    + ++    +  G + E   REV     +RHPN++ L        +  L
Sbjct: 29  TGKEYAAKFIKKRRLSS---SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85
Query: 384 IYELCPNGNLAEWLFGKDKCL--SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNI 441
           I EL   G L ++L  K+        Q L+  +D   G+ +LHS     I H D+KP NI
Sbjct: 86  ILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKR---IAHFDLKPENI 139
Query: 442 LL----GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
           +L     PN   KL DFG++  I+ G  + +  + GT  ++ PE  +   +    D++S 
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSI 197
Query: 498 GIVLLQILSG 507
           G++   +LSG
Sbjct: 198 GVITYILLSG 207

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 96  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 150
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 25/220 (11%)
Query: 307 VHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIK--HITNEGNVETFVREVASSSHVR 364
           +++ +  L  L +   G  G V+K +L N ++VA+K   I ++ + +    EV S   ++
Sbjct: 19  LYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY-EVYSLPGMK 76
Query: 365 HPNLVALLGYCLR---VD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
           H N++  +G   R   VD + +LI      G+L+++L  K   +SW +   IA   ARGL
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGL 134
Query: 421 WFLHSYSEG-------CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR- 472
            +LH    G        I HRDIK  N+LL  N  A ++DFGL+   + G++   +  + 
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 473 GTFGYLDPEYRSNCKVNSSG------DVYSFGIVLLQILS 506
           GT  Y+ PE      +N         D+Y+ G+VL ++ S
Sbjct: 195 GTRRYMAPEVLEGA-INFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 185 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 236
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 175 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 226
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 224
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 209
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 98  Y-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 152
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +    +
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 209
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 210
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL--SWIQ 408
           E   REV     +RHPN++ L        +  LI EL   G L ++L  K+        Q
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 133
Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGE 464
            L+  +D   G+ +LHS     I H D+KP NI+L     PN   KL DFG++  I+ G 
Sbjct: 134 FLKQILD---GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 187
Query: 465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            + +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 188 EFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           E+L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 105 EYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 161
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 162 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 316 ELNLIGEGITGKVYKGK--LSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVA 370
           +L+ +GEG    VYKGK  L++N  VA+K I     EG   T +REV+    ++H N+V 
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSYS 427
           L           L++E   + +L ++L   D C + I    + +      RGL + H   
Sbjct: 65  LHDIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNC 486
              ++HRD+KP N+L+    E KL+DFGL++   I      +EV  T  Y  P+    + 
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST 176
Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             ++  D++  G +  ++ +G+
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 165 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 216
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 120
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 121 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 172
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 173 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 120
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 121 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 172
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 173 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           EK + L  IGEG  G VYK + +  +  A+K I     +EG   T +RE++    ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V L           L++E   + +L + L   +  L  +      +    G+ + H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNC 486
              ++HRD+KP N+L+    E K++DFGL++   I     + EV  T  Y  P+    + 
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSK 176
Query: 487 KVNSSGDVYSFGIVLLQILSG 507
           K +++ D++S G +  ++++G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           EK + L  IGEG  G VYK + +  +  A+K I     +EG   T +RE++    ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V L           L++E   + +L + L   +  L  +      +    G+ + H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNC 486
              ++HRD+KP N+L+    E K++DFGL++   I     + EV  T  Y  P+    + 
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSK 176
Query: 487 KVNSSGDVYSFGIVLLQILSG 507
           K +++ D++S G +  ++++G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 224
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 96  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 150
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 461 -DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            +I     ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 99  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 153
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKV 488
           I+HRD+KP NILL  +   +++DFG +KV+  +  +  A+S V GT  Y+ PE  +    
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKSA 212
Query: 489 NSSGDVYSFGIVLLQILSG 507
             S D+++ G ++ Q+++G
Sbjct: 213 CKSSDLWALGCIIYQLVAG 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                  ++ +       NG L +++           R   A +    L +LH      I
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---I 130
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNS 490
           +HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +      
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 190
Query: 491 SGDVYSFGIVLLQILSG 507
           S D+++ G ++ Q+++G
Sbjct: 191 SSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                  ++ +       NG L +++           R   A +    L +LH      I
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---I 129
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNS 490
           +HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +      
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 189
Query: 491 SGDVYSFGIVLLQILSG 507
           S D+++ G ++ Q+++G
Sbjct: 190 SSDLWALGCIIYQLVAG 206

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 461 -DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            +I     ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 150 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPV 201
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 42  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 100
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 101 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 152
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEGNVE-------TFVREVASSS 361
           AT +   +  IG G  G VYK +  ++ H VA+K +              + VREVA   
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 362 HVR---HPNLVALLGYCL--RVD---ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA 413
            +    HPN+V L+  C   R D   +  L++E   + +L  +L   DK        E  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETI 122
Query: 414 IDSAR----GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
            D  R    GL FLH+    CIVHRD+KP NIL+      KL+DFGL+++       A +
Sbjct: 123 KDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALT 177
Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            V  T  Y  PE        +  D++S G +  ++   K
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 98  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 152
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                  ++ +       NG L +++           R   A +    L +LH      I
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHG---KGI 150
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           +HRD+KP NILL  +   +++DFG +KV+  +  +  A+S V GT  Y+ PE  +     
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTEKSAC 209
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 210 KSSDLWALGCIIYQLVAG 227

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 96  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 150
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 98  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 152
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 96  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 150
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 99  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 153
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 214 KSSDLWALGCIIYQLVAG 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 98  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 152
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                  ++ +       NG L +++           R   A +    L +LH      I
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---I 131
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNS 490
           +HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +      
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 191
Query: 491 SGDVYSFGIVLLQILSG 507
           S D+++ G ++ Q+++G
Sbjct: 192 SSDLWALGCIIYQLVAG 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                  ++ +       NG L +++           R   A +    L +LH      I
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---I 128
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNS 490
           +HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +      
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 188
Query: 491 SGDVYSFGIVLLQILSG 507
           S D+++ G ++ Q+++G
Sbjct: 189 SSDLWALGCIIYQLVAG 205

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG------TF 475
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y +S  R         
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDI-----YRASYYRKGGCAMLPV 210
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE        S  D +SFG++L +I S
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 40  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 98
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 99  NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 150
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 151 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 52  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 110
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 111 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 162
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 19/236 (8%)
Query: 319 LIGEGITGKVYKGKLSN-NQHVAIKHITNE-----GNVE-TFVREVASSSHVRHPNLVAL 371
           ++G+G  GKV+  +    NQ  AIK +  +      +VE T V +   S    HP L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW-IQRLEI-AIDSARGLWFLHSYSEG 429
                  +  F + E    G+L   ++    C  + + R    A +   GL FLHS    
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG-- 138
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            IV+RD+K  NILL  +   K++DFG+ K   +G+   ++   GT  Y+ PE     K N
Sbjct: 139 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNXFCGTPDYIAPEILLGQKYN 196
Query: 490 SSGDVYSFGIVLLQILSGK---KAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
            S D +SFG++L ++L G+     +       ++ + +P   R    EA DL ++L
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 252

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                  ++ +       NG L +++           R   A +    L +LH      I
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHG---KGI 150
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNS 490
           +HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +      
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 210
Query: 491 SGDVYSFGIVLLQILSG 507
           S D+++ G ++ Q+++G
Sbjct: 211 SSDLWALGCIIYQLVAG 227

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 60  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 118
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 119 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 170
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 171 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 46  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 104
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 105 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 156
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 157 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                  ++ +       NG L +++           R   A +    L +LH      I
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---I 135
Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNS 490
           +HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +      
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 195
Query: 491 SGDVYSFGIVLLQILSG 507
           S D+++ G ++ Q+++G
Sbjct: 196 SSDLWALGCIIYQLVAG 212

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 98  Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 152
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 320 IGEGITGKVYK------GKLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +      GK      VA+K + +  +    E  + E+   SH+ +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLF-------------GKD---------KCLSWI 407
            LLG C       +I E C  G+L  +L              G+D         + L   
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY- 466
             L  +   A+G+ FL S  + CI HRD+   N+LL     AK+ DFGL++ I     Y 
Sbjct: 159 DLLHFSSQVAQGMAFLAS--KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
                R    ++ PE   +C      DV+S+GI+L +I S
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           EK + L  IGEG  G VYK + +  +  A+K I     +EG   T +RE++    ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V L           L++E   + +L + L   +  L  +      +    G+ + H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNC 486
              ++HRD+KP N+L+    E K++DFGL++   I     + E+  T  Y  P+    + 
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSK 176
Query: 487 KVNSSGDVYSFGIVLLQILSG 507
           K +++ D++S G +  ++++G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 318 NLIGEG-ITGKVYKGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++GEG  +  V   +L+ ++  AIK     HI  E  V    RE    S + HP  V L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 372 LGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             +  + DE  +       NG L +++           R   A +    L +LH      
Sbjct: 101 Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG--- 155
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +     
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 490 SSGDVYSFGIVLLQILSG 507
            S D+++ G ++ Q+++G
Sbjct: 216 KSSDLWALGCIIYQLVAG 233

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 404 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 462
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 463 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 514
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 317 LNLIGEGITGKVYKGKL---SNNQHVAIKHITNEGNVETFVREVASSS-------HVRHP 366
           L ++G+G  GKV+  K    S+ + +    +  +  ++  VR+   +         V HP
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVNHP 86
Query: 367 NLVALLGYCLRVD-ECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGL 420
            +V L  Y  + + + +LI +    G+L      E +F ++    ++  L +A+D     
Sbjct: 87  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD----- 140
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
              H +S G I++RD+KP NILL      KL+DFGLSK     E  A S   GT  Y+ P
Sbjct: 141 ---HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAP 195
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E  +      S D +SFG+++ ++L+G
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 405 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 463
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 464 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 515
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E Y  ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 516 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDP 480
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y           ++ P
Sbjct: 199 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E        S  D +SFG++L +I S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 16/220 (7%)
Query: 299 CPRYTIREVHYATEKLNELNLIGEGITGKVYKGK---LSNN--QHVAIKHI--TNEGNVE 351
            PR +     +    L  L  +G+G  G V   +   L +N  + VA+K +  + E ++ 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 74
Query: 352 TFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQR 409
            F RE+     ++H N+V   G C         LI E  P G+L ++L    + +  I+ 
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           L+      +G+ +L +      +HRD+   NIL+      K+ DFGL+KV+   +     
Sbjct: 135 LQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 470 EVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 192 KEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 461 DIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 320 IGEGITGKVYKGKLSNNQH------VAIK---HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G G  G+VY+G++S   +      VA+K    + +E +   F+ E    S   H N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLH 424
            +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D A G  +L 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 425 SYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDP 480
              E   +HRDI   N LL   GP   AK+ DFG+++ I     Y           ++ P
Sbjct: 176 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E        S  D +SFG++L +I S
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 16/220 (7%)
Query: 299 CPRYTIREVHYATEKLNELNLIGEGITGKVYKGK---LSNN--QHVAIKHI--TNEGNVE 351
            PR +     +    L  L  +G+G  G V   +   L +N  + VA+K +  + E ++ 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 74
Query: 352 TFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQR 409
            F RE+     ++H N+V   G C         LI E  P G+L ++L    + +  I+ 
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           L+      +G+ +L +      +HRD+   NIL+      K+ DFGL+KV+   +     
Sbjct: 135 LQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 470 EVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 192 KEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 77
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 78  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 137
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 138 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLTARNVLVTENNVMKIADFGLARDI 194
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 195 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITNEGNVETFVREVAS 359
            +  +KL     +GEG  G+V         K K      VA+K + ++   E     V+ 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSE 90
Query: 360 SSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
              ++    H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 158
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   + +   +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 79
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 80  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 139
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 140 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 196
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 197 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHIT-NEGNVETFVREVASSSHVRHPNLVALL 372
           L  L +   G  G V+K +L N+  VA+K     +       RE+ S+  ++H NL+  +
Sbjct: 17  LQLLEIKARGRFGCVWKAQLMND-FVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFI 75
Query: 373 -----GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
                G  L V E +LI      G+L ++L  K   ++W +   +A   +RGL +LH   
Sbjct: 76  AAEKRGSNLEV-ELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYLHEDV 132
Query: 428 EGC--------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR-GTFGYL 478
             C        I HRD K  N+LL  +  A L+DFGL+   + G+    +  + GT  Y+
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 479 DPEYRSNCKVNSSG------DVYSFGIVLLQILSGKKA 510
            PE      +N         D+Y+ G+VL +++S  KA
Sbjct: 193 APEVLEGA-INFQRDAFLRIDMYAMGLVLWELVSRCKA 229

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 317 LNLIGEGITGKVYKGKL---SNNQHVAIKHITNEGNVETFVREVASSS-------HVRHP 366
           L ++G+G  GKV+  K    S+ + +    +  +  ++  VR+   +         V HP
Sbjct: 30  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVNHP 87
Query: 367 NLVALLGYCLRVD-ECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGL 420
            +V L  Y  + + + +LI +    G+L      E +F ++    ++  L +A+D     
Sbjct: 88  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD----- 141
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
              H +S G I++RD+KP NILL      KL+DFGLSK     E  A S   GT  Y+ P
Sbjct: 142 ---HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAP 196
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E  +      S D +SFG+++ ++L+G
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 23  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 82
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 83  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 142
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 143 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 199
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 200 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 317 LNLIGEGITGKVYKGKL---SNNQHVAIKHITNEGNVETFVREVASSS-------HVRHP 366
           L ++G+G  GKV+  K    S+ + +    +  +  ++  VR+   +         V HP
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVNHP 86
Query: 367 NLVALLGYCLRVD-ECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGL 420
            +V L  Y  + + + +LI +    G+L      E +F ++    ++  L +A+D     
Sbjct: 87  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD----- 140
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
              H +S G I++RD+KP NILL      KL+DFGLSK     E  A S   GT  Y+ P
Sbjct: 141 ---HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAP 195
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E  +      S D +SFG+++ ++L+G
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HR++   NIL+      K+ DF
Sbjct: 103 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRNLATRNILVENENRVKIGDF 159
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   + Y   +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 160 GLTKVLPQDKEYYKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVAS 359
           ++E     E+L    LIG+G  G+VY G+      VAI+ I     NE  ++ F REV +
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 360 SSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
               RH N+V  +G C+      +I  LC    L   +      L   +  +IA +  +G
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL---SKVIDIGETYASSEVR-GTF 475
           + +LH+     I+H+D+K  N+    N +  ++DFGL   S V+  G       ++ G  
Sbjct: 143 MGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 476 GYLDPEYRSNCKVNSSGDVYSF 497
            +L PE       ++  D   F
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPF 220

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I E    GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L   S+ CI HRD+   N+L+  N   +++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA--SQKCI-HRDLAARNVLVTENNVMRIADFGLARDI 207
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 317 LNLIGEGITGKVY---KGKLSNNQHVAIKHITNEGNVETFVR-----EVASSSHVRHPNL 368
           L ++G+G  GKV+   K    ++ H+    +  +  ++   R     E    + V HP  
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHP-F 91
Query: 369 VALLGYCLRVD-ECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
           V  L Y  + + + +LI +    G+L      E +F ++    ++  L + +D       
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLD------- 144
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
            H +S G I++RD+KP NILL      KL+DFGLSK     E  A S   GT  Y+ PE 
Sbjct: 145 -HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC-GTVEYMAPEV 201
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSG 507
            +    + S D +S+G+++ ++L+G
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 26/224 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-------- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L      +        
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIY 189
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET Y     +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 40/209 (19%)
Query: 320 IGEGITGKV-YKGKLSNNQHVAIKHITNE----GNVETFV-REVASSSHVRHPNLVALLG 373
           +GEG  GKV         Q VA+K I+ +     ++   V RE++    +RHP+++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSE 428
                 +  ++ E    G L +++  K     D+   + Q++  AI+      + H +  
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE------YCHRHK- 128
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE---------TYASSEVRGTFGYLD 479
             IVHRD+KP N+LL  N   K++DFGLS ++  G           YA+ EV     Y  
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE           DV+S GIVL  +L G+
Sbjct: 187 PEV----------DVWSCGIVLYVMLVGR 205

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 26/232 (11%)
Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNL------IGEGITGKVYKGKLSNNQHVAIKHI 344
           GV L        ++++  + T  LN  +       +G+G  GKVYK +      +A   +
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 345 TN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD 401
            +   E  +E ++ E+   +   HPN+V LL      +  +++ E C  G +   +   +
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 129
Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS---- 457
           + L+  Q   +   +   L +LH   +  I+HRD+K  NIL   + + KL+DFG+S    
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 186
Query: 458 KVIDIGETYASSEVRGTFGYLDPEY-----RSNCKVNSSGDVYSFGIVLLQI 504
           + I   +++      GT  ++ PE        +   +   DV+S GI L+++
Sbjct: 187 RTIQRRDSFI-----GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 320 IGEGITGKVYKGKLSN------NQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVAL 371
           +GEG  GKV+  +  N         VA+K +   +E   + F RE    + ++H ++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLF-----------GKDKC---LSWIQRLEIAIDSA 417
            G C       +++E   +G+L  +L            G+D     L   Q L +A   A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFG 476
            G+ +L        VHRD+   N L+G     K+ DFG+S+ I   + Y           
Sbjct: 146 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKK 509
           ++ PE     K  +  DV+SFG+VL +I + GK+
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 318 NLIGEGITGKVYKGKLSNNQ----HVAIKHI----TNEGNVETFVREVASSSHVRHPNLV 369
            ++GEG  G V +G L         VA+K +    +++  +E F+ E A      HPN++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 370 ALLGYCLR-----VDECFLIYELCPNGNLAEWLF-----GKDKCLSWIQRLEIAIDSARG 419
            LLG C+      + +  +I      G+L  +L         K +     L+  +D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV-RGTFGYL 478
           + +L   S    +HRD+   N +L  +    ++DFGLSK I  G+ Y    + +    ++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQI 504
             E  ++    S  DV++FG+ + +I
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 320 IGEGITGKVYKGKLSN------NQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVAL 371
           +GEG  GKV+  +  N         VA+K +   +E   + F RE    + ++H ++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLF-----------GKDKC---LSWIQRLEIAIDSA 417
            G C       +++E   +G+L  +L            G+D     L   Q L +A   A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFG 476
            G+ +L        VHRD+   N L+G     K+ DFG+S+ I   + Y           
Sbjct: 140 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKK 509
           ++ PE     K  +  DV+SFG+VL +I + GK+
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 26/224 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 5   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-------- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L      +        
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIY 179
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET Y     +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 24/192 (12%)
Query: 324 ITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL 383
           + G+ Y  K+ N + ++ +      + +   RE      ++HPN+V L          +L
Sbjct: 45  LAGQEYAAKIINTKKLSAR------DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 98
Query: 384 IYELCPNGNLAEWLFGKD-----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKP 438
           I++L   G L E +  ++          IQ++  A+        LH +  G +VHRD+KP
Sbjct: 99  IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV--------LHCHQMG-VVHRDLKP 149
Query: 439 TNILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
            N+LL    +    KL+DFGL+  ++ GE  A     GT GYL PE           D++
Sbjct: 150 ENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 208
Query: 496 SFGIVLLQILSG 507
           + G++L  +L G
Sbjct: 209 ACGVILYILLVG 220

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 189
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 190 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 108 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 164
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 165 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 105 DYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 161
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 162 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 303 TIREVHYATE--KLNELNLIGEGITGKVYKGKLSNNQHV-AIKHITNEGNVETFVR---- 355
           TI    Y  E   L  L  +G G  G+V+K +     HV A+K +   GN E   R    
Sbjct: 14  TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 356 -EVASSSHVRHPNLVALLGYCLRVDECFLIYELCP----------NGNLAEWLFGKDKCL 404
            +V   SH   P +V   G  +   + F+  EL             G + E + GK    
Sbjct: 74  LDVVLKSH-DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK---- 128
Query: 405 SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIG 463
                + +AI   + L++L    +  ++HRD+KP+NILL    + KL DFG+S +++D  
Sbjct: 129 -----MTVAI--VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177
Query: 464 ETYASSEVRGTFGYL-----DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              A     G   Y+     DP   +    +   DV+S GI L+++ +G+
Sbjct: 178 -DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 100 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 156
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 157 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 320 IGEGITGKVYKGKLSN------NQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVAL 371
           +GEG  GKV+  +  N         VA+K +   +E   + F RE    + ++H ++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLF-----------GKDKC---LSWIQRLEIAIDSA 417
            G C       +++E   +G+L  +L            G+D     L   Q L +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFG 476
            G+ +L        VHRD+   N L+G     K+ DFG+S+ I   + Y           
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           ++ PE     K  +  DV+SFG+VL +I +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 26/232 (11%)
Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNL------IGEGITGKVYKGKLSNNQHVAIKHI 344
           GV L        ++++  + T  LN  +       +G+G  GKVYK +      +A   +
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 345 TN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD 401
            +   E  +E ++ E+   +   HPN+V LL      +  +++ E C  G +   +   +
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 129
Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS---- 457
           + L+  Q   +   +   L +LH   +  I+HRD+K  NIL   + + KL+DFG+S    
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 186
Query: 458 KVIDIGETYASSEVRGTFGYLDPEY-----RSNCKVNSSGDVYSFGIVLLQI 504
           + I   +++      GT  ++ PE        +   +   DV+S GI L+++
Sbjct: 187 RXIQRRDSFI-----GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 107 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 163
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 164 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 158
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 159 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 18/228 (7%)
Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNL------IGEGITGKVYKGKLSNNQHVAIKHI 344
           GV L        ++++  + T  LN  +       +G+G  GKVYK +      +A   +
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 345 TN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD 401
            +   E  +E ++ E+   +   HPN+V LL      +  +++ E C  G +   +   +
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 129
Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           + L+  Q   +   +   L +LH   +  I+HRD+K  NIL   + + KL+DFG+S   +
Sbjct: 130 RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKN 185
Query: 462 IGETYASSEVRGTFGYLDPEY-----RSNCKVNSSGDVYSFGIVLLQI 504
                      GT  ++ PE        +   +   DV+S GI L+++
Sbjct: 186 TRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 105 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 161
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 162 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 109 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 165
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 166 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 158
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 159 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 106 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 162
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 163 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 318 NLIGEGITGKVYKGKLSNNQH-VAIKHITNE---GNVETFVREVASSSHVRHPNLVALLG 373
           +++G G   +V   +    Q  VAIK I  E   G   +   E+A    ++HPN+VAL  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-------FLHSY 426
                   +LI +L   G L + +  K     + +R     D++R ++       +LH  
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKG---FYTER-----DASRLIFQVLDAVKYLHDL 135
Query: 427 SEGCIVHRDIKPTNIL---LGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
               IVHRD+KP N+L   L  + +  +SDFGLSK+ D G   +++   GT GY+ PE  
Sbjct: 136 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVL 190
Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
           +    + + D +S G++   +L G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLA 394
           VA+K +  + E ++  F RE+     ++H N+V   G C         LI E  P G+L 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
           ++L    + +  I+ L+      +G+ +L +      +HRD+   NIL+      K+ DF
Sbjct: 101 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 157
Query: 455 GLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL+KV+   +     +  G    F Y  PE  +  K + + DV+SFG+VL ++ +
Sbjct: 158 GLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 28/254 (11%)
Query: 276 RYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEK------------------LNEL 317
           R     PPA+     G+  K PG PR   RE    + +                  L+  
Sbjct: 98  RRDSPPPPARARQENGMPEKPPG-PRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNF 156
Query: 318 NLIGEGITGKVYKGKL-SNNQHVAIKH--ITNEGNVETFVREVASSSHVRHPNLVALLGY 374
             IGEG TG V    + S+ + VA+K   +  +   E    EV      +H N+V +   
Sbjct: 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
            L  DE +++ E    G L + +         I  + +A+  A  L  LH+     ++HR
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQA--LSVLHAQG---VIHR 271
Query: 435 DIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDV 494
           DIK  +ILL  +   KLSDFG    +   E      + GT  ++ PE  S        D+
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 330
Query: 495 YSFGIVLLQILSGK 508
           +S GI++++++ G+
Sbjct: 331 WSLGIMVIEMVDGE 344

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 318 NLIGEGITGKVYKGKLSNNQH-VAIKHITNE---GNVETFVREVASSSHVRHPNLVALLG 373
           +++G G   +V   +    Q  VAIK I  E   G   +   E+A    ++HPN+VAL  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-------FLHSY 426
                   +LI +L   G L + +  K     + +R     D++R ++       +LH  
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKG---FYTER-----DASRLIFQVLDAVKYLHDL 135
Query: 427 SEGCIVHRDIKPTNIL---LGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
               IVHRD+KP N+L   L  + +  +SDFGLSK+ D G   +++   GT GY+ PE  
Sbjct: 136 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVL 190
Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
           +    + + D +S G++   +L G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 318 NLIGEGITGKVYKGKLSNNQH-VAIKHITNE---GNVETFVREVASSSHVRHPNLVALLG 373
           +++G G   +V   +    Q  VAIK I  E   G   +   E+A    ++HPN+VAL  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-------FLHSY 426
                   +LI +L   G L + +  K     + +R     D++R ++       +LH  
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKG---FYTER-----DASRLIFQVLDAVKYLHDL 135
Query: 427 SEGCIVHRDIKPTNIL---LGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
               IVHRD+KP N+L   L  + +  +SDFGLSK+ D G   +++   GT GY+ PE  
Sbjct: 136 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVL 190
Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
           +    + + D +S G++   +L G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 76/154 (49%), Gaps = 22/154 (14%)
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK----DKCLSWIQRLEIAIDSARGL 420
           HPN++ L          FL+++L   G L ++L  K    +K    I R  + +  A   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA--- 139
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
             LH  +   IVHRD+KP NILL  +   KL+DFG S  +D GE     EV GT  YL P
Sbjct: 140 --LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAP 192
Query: 481 EYRSNCKVNSSG-------DVYSFGIVLLQILSG 507
           E    C +N +        D++S G+++  +L+G
Sbjct: 193 EI-IECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 318 NLIGEGITGKVYKGKLSNNQH-VAIKHITN---EGNVETFVREVASSSHVRHPNLVALLG 373
           +++G G   +V   +    Q  VAIK I     EG   +   E+A    ++HPN+VAL  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-------FLHSY 426
                   +LI +L   G L + +  K     + +R     D++R ++       +LH  
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKG---FYTER-----DASRLIFQVLDAVKYLHDL 135
Query: 427 SEGCIVHRDIKPTNIL---LGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
               IVHRD+KP N+L   L  + +  +SDFGLSK+ D G   +++   GT GY+ PE  
Sbjct: 136 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVL 190
Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
           +    + + D +S G++   +L G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 30/237 (12%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++LN    +G G  G+V +       K +  + VA+K +  E
Sbjct: 9   DEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK-MLKE 67
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 68  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 401 ----------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK 450
                        L+    +  +   A+G+ FL S      +HRD+   NILL      K
Sbjct: 128 NEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVK 184
Query: 451 LSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           + DFGL++ I     Y    + R    ++ PE   +       DV+SFG++L +I S
Sbjct: 185 IXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 76/154 (49%), Gaps = 22/154 (14%)
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK----DKCLSWIQRLEIAIDSARGL 420
           HPN++ L          FL+++L   G L ++L  K    +K    I R  + +  A   
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA--- 126
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
             LH  +   IVHRD+KP NILL  +   KL+DFG S  +D GE     EV GT  YL P
Sbjct: 127 --LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAP 179
Query: 481 EYRSNCKVNSSG-------DVYSFGIVLLQILSG 507
           E    C +N +        D++S G+++  +L+G
Sbjct: 180 EI-IECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHP 366
           E+ N + ++G+G  G+V K K     Q  A+K I        +  T +REV     + HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           N++ L          +++ EL   G L + +  K K  S      I      G+ ++H +
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 427 SEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-- 481
           +   IVHRD+KP NILL     + + K+ DFGLS      +     +  GT  Y+ PE  
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVL 195
Query: 482 ---YRSNCKVNSSGDVYSFGIVLLQILSG 507
              Y   C      DV+S G++L  +LSG
Sbjct: 196 RGTYDEKC------DVWSAGVILYILLSG 218

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS    +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGETYASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I  I     ++  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHP 366
           E+ N + ++G+G  G+V K K     Q  A+K I        +  T +REV     + HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           N++ L          +++ EL   G L + +  K K  S      I      G+ ++H +
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 427 SEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-- 481
           +   IVHRD+KP NILL     + + K+ DFGLS      +     +  GT  Y+ PE  
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVL 195
Query: 482 ---YRSNCKVNSSGDVYSFGIVLLQILSG 507
              Y   C      DV+S G++L  +LSG
Sbjct: 196 RGTYDEKC------DVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHP 366
           E+ N + ++G+G  G+V K K     Q  A+K I        +  T +REV     + HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           N++ L          +++ EL   G L + +  K K  S      I      G+ ++H +
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 427 SEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-- 481
           +   IVHRD+KP NILL     + + K+ DFGLS      +     +  GT  Y+ PE  
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVL 195
Query: 482 ---YRSNCKVNSSGDVYSFGIVLLQILSG 507
              Y   C      DV+S G++L  +LSG
Sbjct: 196 RGTYDEKC------DVWSAGVILYILLSG 218

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 297 PGCPRYTIREVHYATEKLNELNLIGEGITGKV-YKGKLSNNQHVAIKH--ITNEGNVETF 353
           PG PR          E L     IGEG TG V    +    + VA+K   +  +   E  
Sbjct: 40  PGDPR----------EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL 89
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA 413
             EV       H N+V +    L  DE +++ E    G L + +      ++  Q   + 
Sbjct: 90  FNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVC 147
Query: 414 IDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG 473
           +   R L +LH+     ++HRDIK  +ILL  +   KLSDFG    +   E      + G
Sbjct: 148 LSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKXLVG 203
Query: 474 TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           T  ++ PE  S     +  D++S GI++++++ G+
Sbjct: 204 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS    +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I   + Y  ++  
Sbjct: 141 AYQVARGMEYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL-- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L  
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIY 183
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET Y     +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 184 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 76/154 (49%), Gaps = 22/154 (14%)
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK----DKCLSWIQRLEIAIDSARGL 420
           HPN++ L          FL+++L   G L ++L  K    +K    I R  + +  A   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA--- 139
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
             LH  +   IVHRD+KP NILL  +   KL+DFG S  +D GE   S  V GT  YL P
Sbjct: 140 --LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--VCGTPSYLAP 192
Query: 481 EYRSNCKVNSSG-------DVYSFGIVLLQILSG 507
           E    C +N +        D++S G+++  +L+G
Sbjct: 193 EI-IECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETF------VREVASSSHVRHPNLVAL 371
           + +G G  GKV  G+     H     I N   + +        RE+ +    RHP+++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW-IQRLEIAIDSARGLWFLHSYSEGC 430
                   + F++ E    G L +++    +      +RL   I SA      H      
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH-----M 131
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS-NCKVN 489
           +VHRD+KP N+LL  +  AK++DFGLS ++  GE   +S   G+  Y  PE  S      
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISGRLYAG 189
Query: 490 SSGDVYSFGIVLLQILSG 507
              D++S G++L  +L G
Sbjct: 190 PEVDIWSCGVILYALLCG 207

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS    +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I   + Y  ++  
Sbjct: 156 AYQVARGMEYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL-- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L  
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 134
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIY 189
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET Y     +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L  IG+G  G+V+KG  +  Q V AIK I     E  +E   +E+   S    P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  +   L   Q   I  +  +GL +LHS  
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK 124
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL  + E KL+DFG++  +   +   ++ V GT  ++ PE      
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 180
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +S  D++S GI  +++  G+
Sbjct: 181 YDSKADIWSLGITAIELARGE 201

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I      GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L S  + CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLAS--QKCI-HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L  IG+G  G+V+KG  +  Q V AIK I     E  +E   +E+   S    P 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  +   L   Q   I  +  +GL +LHS  
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK 144
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL  + E KL+DFG++  +   +   ++ V GT  ++ PE      
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 200
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +S  D++S GI  +++  G+
Sbjct: 201 YDSKADIWSLGITAIELARGE 221

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 31/206 (15%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETF------VREVASSSHVRHPNLVAL 371
           + +G G  GKV  G+     H     I N   + +        RE+ +    RHP+++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW-IQRLEIAIDSARGLWFLHSYSEGC 430
                   + F++ E    G L +++    +      +RL   I SA      H      
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH-----M 131
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE---------TYASSEVRGTFGYLDPE 481
           +VHRD+KP N+LL  +  AK++DFGLS ++  GE          YA+ EV     Y  PE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPE 191
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
                      D++S G++L  +L G
Sbjct: 192 V----------DIWSCGVILYALLCG 207

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS    +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I   + Y  ++  
Sbjct: 148 AYQVARGMEYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL-- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L  
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIY 182
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET Y     +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS    +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I   + Y  ++  
Sbjct: 156 AYQVARGMEYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 111/244 (45%), Gaps = 36/244 (14%)
Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIK 342
           G + + P  PR+ +       ++L     +GEG  G+V         K K +    VA+K
Sbjct: 1   GSEYELPEDPRWEL-----PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK 55
Query: 343 HI---TNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF 398
            +     E ++   + E+     + +H N++ LLG C +    ++I E    GNL E+L 
Sbjct: 56  MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ 115
Query: 399 GK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL 443
            +               ++ LS    +  A   ARG+ +L   S+ CI HRD+   N+L+
Sbjct: 116 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCI-HRDLAARNVLV 172
Query: 444 GPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLL 502
             +   K++DFGL++ I   + Y  ++  R    ++ PE   +       DV+SFG++L 
Sbjct: 173 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 232
Query: 503 QILS 506
           +I +
Sbjct: 233 EIFT 236

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL-- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L  
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIY 182
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET Y     +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS    +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I   + Y  ++  
Sbjct: 156 AYQVARGMEYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL-- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L  
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIX 183
Query: 464 ETYASSEVRGTFG-----YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET      +G  G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 184 ET--DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 320 IGEGITGKVYKGKLS-NNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLGYC 375
           +G G  G V++ K   ++ + AIK I     E   E  +REV + + + HP +V      
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 376 LRVDEC------------FLIYELCPNGNLAEWLFGKDKC-LSWIQR---LEIAIDSARG 419
           L  +              ++  +LC   NL +W+ G+  C +   +R   L I +  A  
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEA 130
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE----------TYASS 469
           + FLHS     ++HRD+KP+NI    +   K+ DFGL   +D  E           YA  
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 470 EVR-GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
             + GT  Y+ PE       +   D++S G++L ++L
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS    +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I   + Y  ++  
Sbjct: 149 AYQVARGMEYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 311 TEKLNELNLIGEGITGKVY--KGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHV 363
           +++   +  +G G  G+V   K KL+  +  AIK      +T   N    + EVA    +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAER-AIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            HPN++ L  +       +L+ E+   G L + +  + K  S +    I      G  +L
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLSGTTYL 137
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
           H ++   IVHRD+KP N+LL         K+ DFGLS   ++G      E  GT  Y+ P
Sbjct: 138 HKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM--KERLGTAYYIAP 192
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E     K +   DV+S G++L  +L G
Sbjct: 193 EVLRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 311 TEKLNELNLIGEGITGKVY--KGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHV 363
           +++   +  +G G  G+V   K KL+  +  AIK      +T   N    + EVA    +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAER-AIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            HPN++ L  +       +L+ E+   G L + +  + K  S +    I      G  +L
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLSGTTYL 120
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
           H ++   IVHRD+KP N+LL         K+ DFGLS   ++G      E  GT  Y+ P
Sbjct: 121 HKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM--KERLGTAYYIAP 175
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E     K +   DV+S G++L  +L G
Sbjct: 176 EVLRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITN--------EGNVETFVREVASSSHVRHPNLVA 370
           +GEG  GKV      +  Q VA+K I          +G +E   RE++    +RHP+++ 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE---REISYLRLLRHPHIIK 78
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----CLSWIQRLEIAIDSARGLWFLHS 425
           L       DE  ++ E   N  L +++  +DK        + Q++  A++      + H 
Sbjct: 79  LYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVE------YCHR 131
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS- 484
           +    IVHRD+KP N+LL  +   K++DFGLS ++  G    +S   G+  Y  PE  S 
Sbjct: 132 HK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVISG 186
Query: 485 NCKVNSSGDVYSFGIVLLQIL 505
                   DV+S G++L  +L
Sbjct: 187 KLYAGPEVDVWSCGVILYVML 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITN--------EGNVETFVREVASSSHVRHPNLVA 370
           +GEG  GKV      +  Q VA+K I          +G +E   RE++    +RHP+++ 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE---REISYLRLLRHPHIIK 68
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----CLSWIQRLEIAIDSARGLWFLHS 425
           L       DE  ++ E   N  L +++  +DK        + Q++  A++      + H 
Sbjct: 69  LYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVE------YCHR 121
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS- 484
           +    IVHRD+KP N+LL  +   K++DFGLS ++  G    +S   G+  Y  PE  S 
Sbjct: 122 HK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVISG 176
Query: 485 NCKVNSSGDVYSFGIVLLQIL 505
                   DV+S G++L  +L
Sbjct: 177 KLYAGPEVDVWSCGVILYVML 197

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 110/258 (42%), Gaps = 27/258 (10%)
Query: 320 IGEGITGKVY-KGKLSNNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYC 375
           +G G  G V+   + S+     IK I  + +   +E    E+     + HPN++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 376 LRVDECFLIYELCPNGNLAEWLF---GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
                 +++ E C  G L E +     + K LS     E+       L + HS     +V
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146
Query: 433 HRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           H+D+KP NIL     P+   K+ DFGL+++    E   S+   GT  Y+ PE      V 
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFKR-DVT 203
Query: 490 SSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL---DREYSIEAFDLTLQ----L 542
              D++S G+V+  +L+G     L   G++LE    K    +  Y++E   LT Q    L
Sbjct: 204 FKCDIWSAGVVMYFLLTG----CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259
Query: 543 ALSCTALTHQRPPMEQVF 560
               T    +RP   QV 
Sbjct: 260 KQMLTKDPERRPSAAQVL 277

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 308 HYATEKLNELNLIGEGITGKVY--------KGKLSNNQHVAIKHITN---EGNVETFVRE 356
            +  +KL     +GEG  G+V         K K      VA+K + +   E ++   V E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 357 VASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--------------- 400
           +     + +H N++ LLG C +    ++I      GNL E+L  +               
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
           ++ +++   +      ARG+ +L S  + CI HRD+   N+L+  N   K++DFGL++ I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLAS--QKCI-HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 461 DIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  + Y  ++  R    ++ PE   +       DV+SFG+++ +I +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 344 ITNEGNVETFVREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-- 397
           + NE N      E+ + ++V     +P +V ++G C   +   L+ E+   G L ++L  
Sbjct: 46  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 104
Query: 398 --FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
               KDK +     +E+    + G+ +L    E   VHRD+   N+LL     AK+SDFG
Sbjct: 105 NRHVKDKNI-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 156
Query: 456 LSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           LSK +   E    ++  G +   +  PE  +  K +S  DV+SFG+++ +  S
Sbjct: 157 LSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVY--------KGKLSNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPN 367
           +GEG  G+V         K K +    VA+K +     E ++   + E+     + +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEI 412
           ++ LLG C +    ++I E    GNL E+L  +               ++ LS    +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           A   ARG+ +L   S+ CI HRD+   N+L+  +   K++DFGL++ I   + Y  ++  
Sbjct: 197 AYQVARGMEYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   +       DV+SFG++L +I +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITN--------EGNVETFVREVASSSHVRHPNLVA 370
           +GEG  GKV      +  Q VA+K I          +G +E   RE++    +RHP+++ 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE---REISYLRLLRHPHIIK 77
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----CLSWIQRLEIAIDSARGLWFLHS 425
           L       DE  ++ E   N  L +++  +DK        + Q++  A++      + H 
Sbjct: 78  LYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVE------YCHR 130
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS- 484
           +    IVHRD+KP N+LL  +   K++DFGLS ++  G    +S   G+  Y  PE  S 
Sbjct: 131 HK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVISG 185
Query: 485 NCKVNSSGDVYSFGIVLLQIL 505
                   DV+S G++L  +L
Sbjct: 186 KLYAGPEVDVWSCGVILYVML 206

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITN--------EGNVETFVREVASSSHVRHPNLVA 370
           +GEG  GKV      +  Q VA+K I          +G +E   RE++    +RHP+++ 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE---REISYLRLLRHPHIIK 72
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----CLSWIQRLEIAIDSARGLWFLHS 425
           L       DE  ++ E   N  L +++  +DK        + Q++  A++      + H 
Sbjct: 73  LYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVE------YCHR 125
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS- 484
           +    IVHRD+KP N+LL  +   K++DFGLS ++  G    +S   G+  Y  PE  S 
Sbjct: 126 HK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVISG 180
Query: 485 NCKVNSSGDVYSFGIVLLQIL 505
                   DV+S G++L  +L
Sbjct: 181 KLYAGPEVDVWSCGVILYVML 201

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 314 LNELNLIGEGITGKV--YKGKLSNN---QHVAIKHITNEGNVET---FVREVASSSHVRH 365
           L ++  +GEG  GKV  Y    +N+   + VA+K +      +    + RE+     + H
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 69
Query: 366 PNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            ++V   G C    E    L+ E  P G+L ++L     C+   Q L  A     G+ +L
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYL 127
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDP 480
           H+      +HR +   N+LL  +   K+ DFGL+K +  G  Y      G    F Y  P
Sbjct: 128 HAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-P 183
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E    CK   + DV+SFG+ L ++L+
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L  IG+G  G+V+KG  +  Q V AIK I     E  +E   +E+   S    P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  +   L   Q   I  +  +GL +LHS  
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK 139
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL  + E KL+DFG++  +   +   +  V GT  ++ PE      
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSA 195
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +S  D++S GI  +++  G+
Sbjct: 196 YDSKADIWSLGITAIELARGE 216

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L  IG+G  G+V+KG  +  Q V AIK I     E  +E   +E+   S    P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  +   L   Q   I  +  +GL +LHS  
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK 124
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL  + E KL+DFG++  +   +   +  V GT  ++ PE      
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSA 180
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +S  D++S GI  +++  G+
Sbjct: 181 YDSKADIWSLGITAIELARGE 201

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 314 LNELNLIGEGITGKV--YKGKLSNN---QHVAIKHITNEGNVET---FVREVASSSHVRH 365
           L ++  +GEG  GKV  Y    +N+   + VA+K +      +    + RE+     + H
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 70
Query: 366 PNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            ++V   G C    E    L+ E  P G+L ++L     C+   Q L  A     G+ +L
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYL 128
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDP 480
           H+      +HR +   N+LL  +   K+ DFGL+K +  G  Y      G    F Y  P
Sbjct: 129 HAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-P 184
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E    CK   + DV+SFG+ L ++L+
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET--- 352
           Y   E   + EK+  L  +G+G  G VY+G   +         VA+K +    ++     
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--------GKDKCL 404
           F+ E +        ++V LLG   +     ++ EL  +G+L  +L            +  
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 405 SWIQRL-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
             +Q + ++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIX 181
Query: 464 ETYASSEVRGTFG-----YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           ET      +G  G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 182 ET--DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 37  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 96
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL-- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L  
Sbjct: 97  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 156
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI 
Sbjct: 157 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIY 211
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET Y     +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 212 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 280 SNPPAKITSFKGVQLKDPGC------PRYTIREVHYATEKLNELNLIGEGITGKVYKGKL 333
           SNP AK + F  +++   G        R+   EV YA + L +             K  L
Sbjct: 31  SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQK-------------KAIL 77
Query: 334 SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL 393
              +    KHI +E NV           +V+HP LV L       D+ + + +    G L
Sbjct: 78  KKKEE---KHIMSERNVLL--------KNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 394 AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSD 453
             +   +++C    +    A + A  L +LHS +   IV+RD+KP NILL       L+D
Sbjct: 127 F-YHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTD 182
Query: 454 FGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           FGL K  +I     +S   GT  YL PE       + + D +  G VL ++L G
Sbjct: 183 FGLCKE-NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKH--ITNEGNVET 352
           DPG PR            L+    IGEG TG V    + S+ + VA+K   +  +   E 
Sbjct: 14  DPGDPR----------SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 63
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
              EV      +H N+V +    L  DE +++ E    G L + +         I  + +
Sbjct: 64  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL 123
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+  A  L  LH+     ++HRDIK  +ILL  +   KLSDFG    +   E      + 
Sbjct: 124 AVLQA--LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLV 177
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           GT  ++ PE  S        D++S GI++++++ G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVREVAS 359
           E   A EK+     +G+G  G VY+G      K      VAIK +    ++   +  +  
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 360 SSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL---SWI 407
           +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L   S  
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-Y 466
           + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET Y
Sbjct: 130 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDY 184
Query: 467 ASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
                +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 185 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKH--ITNEGNVET 352
           DPG PR            L+    IGEG TG V    + S+ + VA+K   +  +   E 
Sbjct: 23  DPGDPR----------SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 72
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
              EV      +H N+V +    L  DE +++ E    G L + +         I  + +
Sbjct: 73  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL 132
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+  A  L  LH+     ++HRDIK  +ILL  +   KLSDFG    +   E      + 
Sbjct: 133 AVLQA--LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLV 186
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           GT  ++ PE  S        D++S GI++++++ G+
Sbjct: 187 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKH--ITNEGNVET 352
           DPG PR            L+    IGEG TG V    + S+ + VA+K   +  +   E 
Sbjct: 18  DPGDPR----------SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 67
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
              EV      +H N+V +    L  DE +++ E    G L + +         I  + +
Sbjct: 68  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL 127
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+  A  L  LH+     ++HRDIK  +ILL  +   KLSDFG    +   E      + 
Sbjct: 128 AVLQA--LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLV 181
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           GT  ++ PE  S        D++S GI++++++ G+
Sbjct: 182 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 30/237 (12%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++LN    +G G  G+V +       K +  + VA+K +  E
Sbjct: 9   DEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK-MLKE 67
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 68  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 401 ----------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK 450
                        L+    +  +   A+G+ FL S      +HRD+   NILL      K
Sbjct: 128 NEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVK 184
Query: 451 LSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           + DFGL++ I     Y    + R    ++ PE   +       DV+SFG++L +I S
Sbjct: 185 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVREVAS 359
           E   A EK+     +G+G  G VY+G      K      VAIK +    ++   +  +  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 360 SSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL---SWI 407
           +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L   S  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-Y 466
           + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET Y
Sbjct: 126 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDY 180
Query: 467 ASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
                +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKH--ITNEGNVET 352
           DPG PR            L+    IGEG TG V    + S+ + VA+K   +  +   E 
Sbjct: 25  DPGDPR----------SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 74
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
              EV      +H N+V +    L  DE +++ E    G L + +         I  + +
Sbjct: 75  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL 134
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+  A  L  LH+     ++HRDIK  +ILL  +   KLSDFG    +   E      + 
Sbjct: 135 AVLQA--LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLV 188
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           GT  ++ PE  S        D++S GI++++++ G+
Sbjct: 189 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVA 370
           +++  +  IG+G  G+V+ GK    + VA+K          F   E+  +  +RH N++ 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 371 LLGYCLR----VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS- 425
            +   ++      + +LI +   NG+L ++L  K   L     L++A  S  GL  LH+ 
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 426 ----YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK--VIDIGETYASSEVR-GTFGYL 478
                 +  I HRD+K  NIL+  N    ++D GL+   + D  E       R GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 479 DPEY------RSNCKVNSSGDVYSFGIVLLQI 504
            PE       R++ +     D+YSFG++L ++
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 298 GCPRYTIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIK---HITNEGNVETF 353
             P   +  +   TE L ++ ++G G  G VYKG  + + ++V I     +  E      
Sbjct: 4   AAPNQALLRILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA 62
Query: 354 VREVASSSHVR----HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKC 403
            +E+   ++V      P +  LLG CL      L+ +L P G L + +       G    
Sbjct: 63  NKEILDEAYVMAGVGSPYVSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDL 121
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           L+W  ++      A+G+ +L       +VHRD+   N+L+      K++DFGL++++DI 
Sbjct: 122 LNWCMQI------AKGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 172
Query: 464 ET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           ET Y +   +    ++  E     +     DV+S+G+ + ++++
Sbjct: 173 ETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 38/222 (17%)
Query: 305 REVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR 364
           RE+ Y   K+     IG G  G V++ KL  +  VAIK +  +   +   RE+     V+
Sbjct: 38  REIAYTNCKV-----IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN--RELQIMRIVK 90
Query: 365 HPNLVALLGYCL----RVDECFL--IYELCPNGNL-AEWLFGKDKCLSWIQRLEIAI-DS 416
           HPN+V L  +      + DE FL  + E  P     A   + K K    +  +++ +   
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSDFGLSKVIDIGET---------Y 466
            R L ++HS     I HRDIKP N+LL P     KL DFG +K++  GE          Y
Sbjct: 151 LRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYY 207
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            + E+   FG  +  Y +N       D++S G V+ +++ G+
Sbjct: 208 RAPEL--IFGATN--YTTNI------DIWSTGCVMAELMQGQ 239

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVREVAS 359
           E   A EK+     +G+G  G VY+G      K      VAIK +    ++   +  +  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 360 SSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL---SWI 407
           +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L   S  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
           + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET  
Sbjct: 124 KMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDX 178
Query: 468 SSEVRGTFG-----YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
               +G  G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 179 XR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 26/224 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   E   A EK+     +G+G  G VY+G      K      VAIK +    ++   + 
Sbjct: 2   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 356 EVASSSHVRHPN---LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCL-- 404
            +  +S ++  N   +V LLG   +     +I EL   G+L  +L         +  L  
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 405 -SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
            S  + +++A + A G+ +L++      VHRD+   N  +  +F  K+ DFG+++  DI 
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTR--DIY 176
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           ET Y     +G     ++ PE   +    +  DV+SFG+VL +I
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 37  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 83
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +L+  L    +L + L  K + 
Sbjct: 84  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL--KTQH 140
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 141 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 197
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 198 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 17  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 63
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 64  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 120
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 121 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPD 177
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET---FVRE 356
           E   + EK+  L  +G+G  G VY+G   +         VA+K +    ++     F+ E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 357 VASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--------GKDKCLSWIQ 408
            +        ++V LLG   +     ++ EL  +G+L  +L            +    +Q
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 409 RL-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-Y 466
            + ++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET Y
Sbjct: 131 EMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAY 185
Query: 467 ASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
                +G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET---FVRE 356
           E   + EK+  L  +G+G  G VY+G   +         VA+K +    ++     F+ E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 357 VASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--------GKDKCLSWIQ 408
            +        ++V LLG   +     ++ EL  +G+L  +L            +    +Q
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 409 RL-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-Y 466
            + ++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET Y
Sbjct: 131 EMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDY 185
Query: 467 ASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
                +G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 109
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET---FVRE 356
           E   + EK+  L  +G+G  G VY+G   +         VA+K +    ++     F+ E
Sbjct: 8   EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 67
Query: 357 VASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--------GKDKCLSWIQ 408
            +        ++V LLG   +     ++ EL  +G+L  +L            +    +Q
Sbjct: 68  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 127
Query: 409 RL-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
            + ++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET  
Sbjct: 128 EMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXET-- 180
Query: 468 SSEVRGTFG-----YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
               +G  G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 181 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 17  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 63
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 64  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 120
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 121 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 177
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET---FVREVASS 360
           + EK+  L  +G+G  G VY+G   +         VA+K +    ++     F+ E +  
Sbjct: 14  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 73
Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--------GKDKCLSWIQRL-E 411
                 ++V LLG   +     ++ EL  +G+L  +L            +    +Q + +
Sbjct: 74  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 133
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSE 470
           +A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET Y    
Sbjct: 134 MAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKG 188
Query: 471 VRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            +G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 189 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 21  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 67
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 68  YXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 124
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 125 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 181
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 333 LSNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLR----VDECFLIYE 386
           L +    A+K I    + + E   RE        HPN++ L+ YCLR      E +L+  
Sbjct: 51  LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 387 LCPNGNL---AEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL 443
               G L    E L  K   L+  Q L + +   RGL  +H+       HRD+KPTNILL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILL 167
Query: 444 GPNFEAKLSDFGL----------SKVIDIGETYASSEVRGTFGYLDPEY---RSNCKVNS 490
           G   +  L D G           S+     + +A+   R T  Y  PE    +S+C ++ 
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ--RCTISYRAPELFSVQSHCVIDE 225
Query: 491 SGDVYSFGIVLLQILSGKKA-KVLTRAGSALELA 523
             DV+S G VL  ++ G+    ++ + G ++ LA
Sbjct: 226 RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 14/208 (6%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASS 360
           ++H    +L  L  IG+G   KV   + +   + VA+K I     N  +++   REV   
Sbjct: 3   DLHIGNYRL--LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIM 60
Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
             + HPN+V L          +L+ E    G + ++L        W++  E      + +
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH----GWMKEKEARAKFRQIV 116
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
             +    +  IVHRD+K  N+LL  +   K++DFG S     G    +    G+  Y  P
Sbjct: 117 SAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAP 174
Query: 481 EYRSNCKVNSSG-DVYSFGIVLLQILSG 507
           E     K +    DV+S G++L  ++SG
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKH--ITNEGNVET 352
           DPG PR            L+    IGEG TG V    + S+ + VA+K   +  +   E 
Sbjct: 68  DPGDPR----------SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 117
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
              EV      +H N+V +    L  DE +++ E    G L + +         I  + +
Sbjct: 118 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCL 177
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+  A  L  LH+     ++HRDIK  +ILL  +   KLSDFG    +   E      + 
Sbjct: 178 AVLQA--LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLV 231
Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           GT  ++ PE  S        D++S GI++++++ G+
Sbjct: 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 17  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 63
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 64  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 120
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 121 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 177
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 306 EVHYATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET---FVRE 356
           E   + EK+  L  +G+G  G VY+G   +         VA+K +    ++     F+ E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 357 VASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--------GKDKCLSWIQ 408
            +        ++V LLG   +     ++ EL  +G+L  +L            +    +Q
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 409 RL-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
            + ++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++  DI ET  
Sbjct: 131 EMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXET-- 183
Query: 468 SSEVRGTFG-----YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
               +G  G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 21  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 67
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 124
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 125 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 181
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 319 LIGEGITGKVY--KGKLSNNQ----HVAIKHITNEGNVETFVREVASSSHVRHPNLVALL 372
           ++G+G  G+V   K K++  +     ++ + +  + + E+ +REV     + HPN++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
            +       +L+ E+   G L + +  + K  S +    I      G+ ++H   +  IV
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKIV 148
Query: 433 HRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVR---GTFGYLDPE----- 481
           HRD+KP N+LL     +   ++ DFGLS   +     AS +++   GT  Y+ PE     
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFE-----ASKKMKDKIGTAYYIAPEVLHGT 203
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
           Y   C      DV+S G++L  +LSG
Sbjct: 204 YDEKC------DVWSTGVILYILLSG 223

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 17  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 63
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 64  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 120
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 121 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 177
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET--- 352
           Y   E   + EK+  L  +G+G  G VY+G   +         VA+K +    ++     
Sbjct: 8   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 67
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--------GKDKCL 404
           F+ E +        ++V LLG   +     ++ EL  +G+L  +L            +  
Sbjct: 68  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 127
Query: 405 SWIQRL-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
             +Q + ++A + A G+ +L++      VHR++   N ++  +F  K+ DFG+++  DI 
Sbjct: 128 PTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTR--DIY 182
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           ET Y     +G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 183 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----C 403
           NVET   E+     + HP ++ +  +    ++ +++ EL   G L + + G  +     C
Sbjct: 61  NVET---EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC 116
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVI 460
             +  ++ +A+       +LH   E  I+HRD+KP N+LL    E    K++DFG SK+ 
Sbjct: 117 KLYFYQMLLAVQ------YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 166
Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKV---NSSGDVYSFGIVLLQILSG 507
            +GET     + GT  YL PE   +      N + D +S G++L   LSG
Sbjct: 167 -LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 283 PAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAI 341
           P ++   KG Q  D G PRYT            +L  IGEG  G V           VAI
Sbjct: 28  PGEVEMVKG-QPFDVG-PRYT------------QLQYIGEGAYGMVSSAYDHVRKTRVAI 73
Query: 342 KHIT---NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAE--- 395
           K I+   ++   +  +RE+      RH N++ +    LR      + ++    +L E   
Sbjct: 74  KKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD-ILRASTLEAMRDVYIVQDLMETDL 132
Query: 396 WLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
           +   K + LS            RGL ++HS     ++HRD+KP+N+L+    + K+ DFG
Sbjct: 133 YKLLKSQQLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFG 189
Query: 456 LSKVIDIGETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
           L+++ D    +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 190 LARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----C 403
           NVET   E+     + HP ++ +  +    ++ +++ EL   G L + + G  +     C
Sbjct: 61  NVET---EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC 116
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVI 460
             +  ++ +A+       +LH   E  I+HRD+KP N+LL    E    K++DFG SK+ 
Sbjct: 117 KLYFYQMLLAVQ------YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 166
Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKV---NSSGDVYSFGIVLLQILSG 507
            +GET     + GT  YL PE   +      N + D +S G++L   LSG
Sbjct: 167 -LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----C 403
           NVET   E+     + HP ++ +  +    ++ +++ EL   G L + + G  +     C
Sbjct: 61  NVET---EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC 116
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVI 460
             +  ++ +A+       +LH   E  I+HRD+KP N+LL    E    K++DFG SK+ 
Sbjct: 117 KLYFYQMLLAVQ------YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 166
Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKV---NSSGDVYSFGIVLLQILSG 507
            +GET     + GT  YL PE   +      N + D +S G++L   LSG
Sbjct: 167 -LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 319 LIGEGITGKVY--KGKLSNNQ----HVAIKHITNEGNVETFVREVASSSHVRHPNLVALL 372
           ++G+G  G+V   K K++  +     ++ + +  + + E+ +REV     + HPN++ L 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
            +       +L+ E+   G L + +  + K  S +    I      G+ ++H   +  IV
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKIV 171
Query: 433 HRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVR---GTFGYLDPE----- 481
           HRD+KP N+LL     +   ++ DFGLS   +     AS +++   GT  Y+ PE     
Sbjct: 172 HRDLKPENLLLESKSKDANIRIIDFGLSTHFE-----ASKKMKDKIGTAYYIAPEVLHGT 226
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
           Y   C      DV+S G++L  +LSG
Sbjct: 227 YDEKC------DVWSTGVILYILLSG 246

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----C 403
           NVET   E+     + HP ++ +  +    ++ +++ EL   G L + + G  +     C
Sbjct: 60  NVET---EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC 115
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVI 460
             +  ++ +A+       +LH   E  I+HRD+KP N+LL    E    K++DFG SK+ 
Sbjct: 116 KLYFYQMLLAVQ------YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 165
Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKV---NSSGDVYSFGIVLLQILSG 507
            +GET     + GT  YL PE   +      N + D +S G++L   LSG
Sbjct: 166 -LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET--- 352
           Y   E   + EK+  L  +G+G  G VY+G   +         VA+K +    ++     
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF--------GKDKCL 404
           F+ E +        ++V LLG   +     ++ EL  +G+L  +L            +  
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 405 SWIQRL-EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
             +Q + ++A + A G+ +L++      VHR++   N ++  +F  K+ DFG+++  DI 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTR--DIY 181
Query: 464 ET-YASSEVRGTFG--YLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           ET Y     +G     ++ PE   +    +S D++SFG+VL +I S
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 19  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 65
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 66  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 122
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 123 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 179
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 180 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 319 LIGEGITGKVY--KGKLSNNQ----HVAIKHITNEGNVETFVREVASSSHVRHPNLVALL 372
           ++G+G  G+V   K K++  +     ++ + +  + + E+ +REV     + HPN++ L 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
            +       +L+ E+   G L + +  + K  S +    I      G+ ++H   +  IV
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKIV 172
Query: 433 HRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVR---GTFGYLDPE----- 481
           HRD+KP N+LL     +   ++ DFGLS   +     AS +++   GT  Y+ PE     
Sbjct: 173 HRDLKPENLLLESKSKDANIRIIDFGLSTHFE-----ASKKMKDKIGTAYYIAPEVLHGT 227
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
           Y   C      DV+S G++L  +LSG
Sbjct: 228 YDEKC------DVWSTGVILYILLSG 247

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----C 403
           NVET   E+     + HP ++ +  +    ++ +++ EL   G L + + G  +     C
Sbjct: 67  NVET---EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC 122
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVI 460
             +  ++ +A+       +LH   E  I+HRD+KP N+LL    E    K++DFG SK+ 
Sbjct: 123 KLYFYQMLLAVQ------YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 172
Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKV---NSSGDVYSFGIVLLQILSG 507
            +GET     + GT  YL PE   +      N + D +S G++L   LSG
Sbjct: 173 -LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 318 NLIGEGITGKVY--KGKLSNNQ----HVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
            ++G+G  G+V   K K++  +     ++ + +  + + E+ +REV     + HPN++ L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
             +       +L+ E+   G L + +  + K  S +    I      G+ ++H   +  I
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKI 153
Query: 432 VHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVR---GTFGYLDPE---- 481
           VHRD+KP N+LL     +   ++ DFGLS   +     AS +++   GT  Y+ PE    
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-----ASKKMKDKIGTAYYIAPEVLHG 208
Query: 482 -YRSNCKVNSSGDVYSFGIVLLQILSG 507
            Y   C      DV+S G++L  +LSG
Sbjct: 209 TYDEKC------DVWSTGVILYILLSG 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 25  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 71
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 72  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 128
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 129 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 185
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 186 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 17  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 63
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 64  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 120
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 121 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 177
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 22  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 68
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 69  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 125
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 126 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 182
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 183 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 23  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 69
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 70  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 126
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 127 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 183
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 184 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 14  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 60
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 61  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 117
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 118 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 174
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 175 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 21  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 67
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 124
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 125 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 37  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 83
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 84  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 140
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 141 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 197
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 198 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 15  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 61
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 62  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 118
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 119 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 175
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 176 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 15  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 61
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 62  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 118
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 119 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 175
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 176 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  ++ +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 109
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 19  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 65
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 66  YCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 122
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 123 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPD 179
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 180 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 24/192 (12%)
Query: 324 ITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL 383
           + G+ Y   + N + ++ +      + +   RE      ++HPN+V L          +L
Sbjct: 34  LAGQEYAAMIINTKKLSAR------DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87
Query: 384 IYELCPNGNLAEWLFGKD-----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKP 438
           I++L   G L E +  ++          IQ++  A+        LH +  G +VHR++KP
Sbjct: 88  IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV--------LHCHQMG-VVHRNLKP 138
Query: 439 TNILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
            N+LL    +    KL+DFGL+  ++ GE  A     GT GYL PE           D++
Sbjct: 139 ENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 496 SFGIVLLQILSG 507
           + G++L  +L G
Sbjct: 198 ACGVILYILLVG 209

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           T +V+ GK+     +   H       E    E+A    + +P++V   G+    D  +++
Sbjct: 50  TKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVV 104
Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            E+C   +L E L  + K ++  +       + +G+ +LH+     ++HRD+K  N+ L 
Sbjct: 105 LEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLN 160
Query: 445 PNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQ 503
            + + K+ DFGL+  I+  GE     ++ GT  Y+ PE       +   D++S G +L  
Sbjct: 161 DDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 218
Query: 504 ILSGK 508
           +L GK
Sbjct: 219 LLVGK 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 19  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 65
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 66  YCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 122
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 123 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 179
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 180 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           T +V+ GK+     +   H       E    E+A    + +P++V   G+    D  +++
Sbjct: 66  TKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVV 120
Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            E+C   +L E L  + K ++  +       + +G+ +LH+     ++HRD+K  N+ L 
Sbjct: 121 LEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLN 176
Query: 445 PNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQ 503
            + + K+ DFGL+  I+  GE     ++ GT  Y+ PE       +   D++S G +L  
Sbjct: 177 DDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 504 ILSGK 508
           +L GK
Sbjct: 235 LLVGK 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 21  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 67
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEW-LFGKDKC--LS 405
             +  +RE+      RH N++ +    +R      + ++    +L E  L+   KC  LS
Sbjct: 68  YCQRTLREIKILLRFRHENIIGI-NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLS 126
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
                       RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D    
Sbjct: 127 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 466 YAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
           +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 91/189 (48%), Gaps = 16/189 (8%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           +G G  G+V+    + +  VA+K +     +VE F+ E      ++H  LV L     + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 248
Query: 379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-EIAIDSARGLWFLHSYSEGCIVHRDIK 437
           +  ++I E    G+L ++L   +     + +L + +   A G+ F+   +    +HRD++
Sbjct: 249 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLR 305
Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
             NIL+  +   K++DFGL++V   G  +          +  PE  +        DV+SF
Sbjct: 306 AANILVSASLVCKIADFGLARV---GAKFP-------IKWTAPEAINFGSFTIKSDVWSF 355
Query: 498 GIVLLQILS 506
           GI+L++I++
Sbjct: 356 GILLMEIVT 364

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L+ IG+G  G+VYKG  ++ + V AIK I     E  +E   +E+   S    P 
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  K   L       I  +  +GL +LHS  
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSER 136
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL    + KL+DFG++  +   +   +  V GT  ++ PE      
Sbjct: 137 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSA 192
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +   D++S GI  +++  G+
Sbjct: 193 YDFKADIWSLGITAIELAKGE 213

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----C 403
           NVET   E+     + HP ++ +  +    ++ +++ EL   G L + + G  +     C
Sbjct: 200 NVET---EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC 255
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVI 460
             +  ++ +A+       +LH   E  I+HRD+KP N+LL    E    K++DFG SK+ 
Sbjct: 256 KLYFYQMLLAVQ------YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 305
Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKV---NSSGDVYSFGIVLLQILSG 507
            +GET     + GT  YL PE   +      N + D +S G++L   LSG
Sbjct: 306 -LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 4   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 107
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 108 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 109
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-----C 403
           NVET   E+     + HP ++ +  +    ++ +++ EL   G L + + G  +     C
Sbjct: 186 NVET---EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATC 241
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVI 460
             +  ++ +A+       +LH   E  I+HRD+KP N+LL    E    K++DFG SK+ 
Sbjct: 242 KLYFYQMLLAVQ------YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 291
Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKV---NSSGDVYSFGIVLLQILSG 507
            +GET     + GT  YL PE   +      N + D +S G++L   LSG
Sbjct: 292 -LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHITNEG----NVETFVREVASSSHVR 364
           ++L  L  +G G  G V   Y  +L   Q VA+K ++       +     RE+    H++
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 365 HPNLVALLGYCLRV------DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             E +L+  L    +L   +  K + LS      +     R
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNNIV--KSQALSDEHVQFLVYQLLR 142
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TF 475
           GL ++HS     I+HRD+KP+N+ +  + E ++ DFGL++  D        E+ G   T 
Sbjct: 143 GLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQAD-------EEMTGYVATR 192
Query: 476 GYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            Y  PE   N    N + D++S G ++ ++L GK
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 109
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 109
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 109
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 109
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G   KV   + +   + VA++ I     N  +++   REV     + HPN+V L
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                     +L+ E    G + ++L    +      R +   I SA  + + H   +  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH---QKF 133
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IVHRD+K  N+LL  +   K++DFG S     G      E  G+  Y  PE     K + 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL--DEFCGSPPYAAPELFQGKKYDG 191
Query: 491 SG-DVYSFGIVLLQILSG 507
              DV+S G++L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAI+ I+   ++ 
Sbjct: 21  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQT 67
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 124
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 125 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +    +E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 21  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 67
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 68  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 124
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 125 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +     E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 182 HDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 31/228 (13%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ-HVAIKHIT---NEG 348
           Q+ D G PRYT             L+ IGEG  G V     + N+  VAIK I+   ++ 
Sbjct: 22  QVFDVG-PRYT------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT 68
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKC 403
             +  +RE+      RH N++ +          ++ + +++ +L    +L + L  K + 
Sbjct: 69  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQH 125
Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG 463
           LS            RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D  
Sbjct: 126 LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 182
Query: 464 ETYAS--SEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
             +     E   T  Y  PE   N K    S D++S G +L ++LS +
Sbjct: 183 HDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 109
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLS 405
           E   REV+    V HPN++ L        +  LI EL   G L ++L       +++  S
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG----PNFEAKLSDFGLSKVID 461
           +I+++   +D   G+ +LH+     I H D+KP NI+L     P    KL DFGL+  I+
Sbjct: 120 FIKQI---LD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            G  + +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 171 DGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 311 TEKLNELNLIGEGITGKVYKGKLSNN----QHVAIKHITNEGNV---ETFVREVASSSHV 363
            E  + +  +GEG  G+V   +L+ N    + VA+K +  +  V   E   +E+  +  +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE--IAIDSARGLW 421
            H N+V   G+    +  +L  E C  G L               R+E  I +       
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQR 108
Query: 422 FLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRG 473
           F H    G        I HRDIKP N+LL      K+SDFGL+ V          +++ G
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y+ PE     + ++   DV+S GIVL  +L+G+
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G   KV   + +   + VAIK I     N  +++   REV     + HPN+V L
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                     +LI E    G + ++L    +      R +   I SA  + + H   +  
Sbjct: 77  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCH---QKR 131
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG---ETYASSEVRGTFGYLDPEYRSNCK 487
           IVHRD+K  N+LL  +   K++DFG S    +G   +T+      G+  Y  PE     K
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC-----GSPPYAAPELFQGKK 186
Query: 488 VNSSG-DVYSFGIVLLQILSG 507
            +    DV+S G++L  ++SG
Sbjct: 187 YDGPEVDVWSLGVILYTLVSG 207

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 34/236 (14%)
Query: 307 VHYATEKLNELNLIGEGITG--KVYKGKLSNNQHVAIKHITNEGNV-ETFVREVASSSHV 363
           + + +++ + +  IG G  G  ++ + KL+  + VA+K+I     + E   RE+ +   +
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIERGAAIDENVQREIINHRSL 73
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSAR 418
           RHPN+V      L      +I E    G L E +     F +D+   + Q+L        
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LS 127
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILL--GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
           G+ + HS     I HRD+K  N LL   P    K+ DFG SK   +  +   S V GT  
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV-GTPA 182
Query: 477 YLDPEYRSNCKVNSS-GDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY 531
           Y+ PE     + +    DV+S G+ L  +L G           A    DP+  R+Y
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG-----------AYPFEDPEEPRDY 227

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 73/166 (43%), Gaps = 14/166 (8%)
Query: 349 NVETFVREVASS----SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL 404
           N+E F  E+ +       + HPN++ L          +L+ E    G L E +  + K  
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-F 143
Query: 405 SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN---FEAKLSDFGLSKVID 461
                  I      G+ +LH ++   IVHRDIKP NILL         K+ DFGLS    
Sbjct: 144 DECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF-- 198
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
             + Y   +  GT  Y+ PE     K N   DV+S G+++  +L G
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 32/239 (13%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  E
Sbjct: 11  DEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK-MLKE 69
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 70  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 129
Query: 401 ------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE 448
                          L+    +  +   A+G+ FL S      +HRD+   NILL     
Sbjct: 130 NEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNV 186
Query: 449 AKLSDFGLSKVIDIG-ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            K+ DFGL++ I    +     + R    ++ PE   +       DV+SFG++L +I S
Sbjct: 187 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           T +V+ GK+     +   H       E    E+A    + +P++V   G+    D  +++
Sbjct: 66  TKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVV 120
Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            E+C   +L E L  + K ++  +       + +G+ +LH+     ++HRD+K  N+ L 
Sbjct: 121 LEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLN 176
Query: 445 PNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQ 503
            + + K+ DFGL+  I+  GE   +  + GT  Y+ PE       +   D++S G +L  
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 504 ILSGK 508
           +L GK
Sbjct: 235 LLVGK 239

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++LN    +G G  G+V +       K +  + VA+K +  E
Sbjct: 10  DEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKE 68
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 69  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 128
Query: 401 -------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF 447
                           L+    +  +   A+G+ FL   S  CI HRD+   NILL    
Sbjct: 129 NEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKN 185
Query: 448 EAKLSDFGLSK-VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             K+ DFGL++ +    +     + R    ++ PE   +       DV+SFG++L +I S
Sbjct: 186 VVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TG  +  K+ N + ++ +      + +   RE      ++HPN+V L          +L+
Sbjct: 53  TGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106
Query: 385 YELCPNGNLAEWLFGKD--------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           ++L   G L E +  ++         C+  I  LE        + + HS     IVHR++
Sbjct: 107 FDLVTGGELFEDIVAREFYSEADASHCIQQI--LE-------SIAYCHS---NGIVHRNL 154
Query: 437 KPTNILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGD 493
           KP N+LL    +    KL+DFGL+  I++ ++ A     GT GYL PE       +   D
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 212
Query: 494 VYSFGIVLLQILSG 507
           +++ G++L  +L G
Sbjct: 213 IWACGVILYILLVG 226

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 87/185 (47%), Gaps = 12/185 (6%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           T +V+ GK+     +   H       E    E+A    + +P++V   G+    D  +++
Sbjct: 66  TKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVV 120
Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            E+C   +L E L  + K ++  +       + +G+ +LH+     ++HRD+K  N+ L 
Sbjct: 121 LEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLN 176
Query: 445 PNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQ 503
            + + K+ DFGL+  I+  GE      + GT  Y+ PE       +   D++S G +L  
Sbjct: 177 DDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 504 ILSGK 508
           +L GK
Sbjct: 235 LLVGK 239

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD 379
           I +  T +V+ GK+     +   H   + ++E  +    +  HV     V   G+    D
Sbjct: 40  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFFEDND 94
Query: 380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
             F++ ELC   +L E L  + K L+  +          G  +LH      ++HRD+K  
Sbjct: 95  FVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLG 150
Query: 440 NILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
           N+ L  + E K+ DFGL+  ++  GE   +  + GT  Y+ PE  S    +   DV+S G
Sbjct: 151 NLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIG 208
Query: 499 IVLLQILSGK 508
            ++  +L GK
Sbjct: 209 CIMYTLLVGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHITNEG----NVETFVREVASSSHVR 364
           ++L  L  +G G  G V   Y  +L   Q VA+K ++       +     RE+    H++
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 365 HPNLVALLGY---CLRVDECFLIYELCPNGNLAEWLFGKD-----KC--LSWIQRLEIAI 414
           H N++ LL        +++   +Y       L   L G D     KC  LS      +  
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVY-------LVTTLMGADLNNIVKCQALSDEHVQFLVY 138
Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG- 473
              RGL ++HS     I+HRD+KP+N+ +  + E ++ DFGL++  D        E+ G 
Sbjct: 139 QLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQAD-------EEMTGY 188
Query: 474 --TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
             T  Y  PE   N    N + D++S G ++ ++L GK
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSH----------VRHP 366
           L ++G+G  GKV++ +     +               VR    ++H          V+HP
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLW 421
            +V L+       + +LI E    G L      E +F +D    ++  + +A+       
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------ 135
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
             H + +G I++RD+KP NI+L      KL+DFGL K   I +   +    GT  Y+ PE
Sbjct: 136 --HLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHXFCGTIEYMAPE 191
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
                  N + D +S G ++  +L+G
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLV 369
            T   +E+ L  E  TGK++  K        I     +G   +   E+A    ++H N+V
Sbjct: 31  GTGAFSEVVLAEEKATGKLFAVK-------CIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWL----FGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           AL       +  +L+ +L   G L + +    F  +K  S + R  +       +++LH 
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVL-----DAVYYLHR 138
Query: 426 YSEGCIVHRDIKPTNIL-LGPNFEAK--LSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
                IVHRD+KP N+L    + E+K  +SDFGLSK+   G+  +++   GT GY+ PE 
Sbjct: 139 MG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA--CGTPGYVAPEV 193
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSG 507
            +    + + D +S G++   +L G
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 98/243 (40%), Gaps = 59/243 (24%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHI----------TNEGNVETFVREVASSSHVRHPNLV 369
           IG+G  G V       NQ  AI+ I           N  +VE    EV     + HPN+ 
Sbjct: 34  IGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 370 ALLGYCLRVDECF--LIYELCPNGNLAEWL------------------------------ 397
            L  Y +  DE +  L+ ELC  G+L + L                              
Sbjct: 92  RL--YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 398 -----FGKDKCLSWIQRLEIAIDSARGLW-FLHSYSEGCIVHRDIKPTNILLGPN--FEA 449
                 G  + L ++QR ++  +  R ++  LH      I HRDIKP N L   N  FE 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 450 KLSDFGLSK---VIDIGETYASSEVRGTFGYLDPEY--RSNCKVNSSGDVYSFGIVLLQI 504
           KL DFGLSK    ++ GE Y  +   GT  ++ PE    +N       D +S G++L  +
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 505 LSG 507
           L G
Sbjct: 270 LMG 272

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD 379
           I +  T +V+ GK+     +   H   + ++E  +    +  HV     V   G+    D
Sbjct: 36  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFFEDND 90
Query: 380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
             F++ ELC   +L E L  + K L+  +          G  +LH      ++HRD+K  
Sbjct: 91  FVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLG 146
Query: 440 NILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
           N+ L  + E K+ DFGL+  ++  GE   +  + GT  Y+ PE  S    +   DV+S G
Sbjct: 147 NLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 499 IVLLQILSGK 508
            ++  +L GK
Sbjct: 205 CIMYTLLVGK 214

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSH----------VRHP 366
           L ++G+G  GKV++ +     +               VR    ++H          V+HP
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 367 NLVALLGYCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLW 421
            +V L+       + +LI E    G L      E +F +D    ++  + +A+       
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------ 135
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
             H + +G I++RD+KP NI+L      KL+DFGL K   I +   +    GT  Y+ PE
Sbjct: 136 --HLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMAPE 191
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
                  N + D +S G ++  +L+G
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD 379
           I +  T +V+ GK+     +   H   + ++E  +    +  HV     V   G+    D
Sbjct: 36  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFFEDND 90
Query: 380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
             F++ ELC   +L E L  + K L+  +          G  +LH      ++HRD+K  
Sbjct: 91  FVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLG 146
Query: 440 NILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
           N+ L  + E K+ DFGL+  ++  GE   +  + GT  Y+ PE  S    +   DV+S G
Sbjct: 147 NLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 499 IVLLQILSGK 508
            ++  +L GK
Sbjct: 205 CIMYTLLVGK 214

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TG  +  K+ N + ++ +      + +   RE      ++HPN+V L          +L+
Sbjct: 29  TGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 82
Query: 385 YELCPNGNLAEWLFGKD--------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           ++L   G L E +  ++         C+   Q LE        + + HS     IVHR++
Sbjct: 83  FDLVTGGELFEDIVAREFYSEADASHCIQ--QILE-------SIAYCHS---NGIVHRNL 130
Query: 437 KPTNILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGD 493
           KP N+LL    +    KL+DFGL+  I++ ++ A     GT GYL PE       +   D
Sbjct: 131 KPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 188
Query: 494 VYSFGIVLLQILSG 507
           +++ G++L  +L G
Sbjct: 189 IWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TG  +  K+ N + ++ +      + +   RE      ++HPN+V L          +L+
Sbjct: 30  TGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83
Query: 385 YELCPNGNLAEWLFGKD--------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           ++L   G L E +  ++         C+   Q LE        + + HS     IVHR++
Sbjct: 84  FDLVTGGELFEDIVAREFYSEADASHCIQ--QILE-------SIAYCHS---NGIVHRNL 131
Query: 437 KPTNILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGD 493
           KP N+LL    +    KL+DFGL+  I++ ++ A     GT GYL PE       +   D
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 189
Query: 494 VYSFGIVLLQILSG 507
           +++ G++L  +L G
Sbjct: 190 IWACGVILYILLVG 203

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHITNEG----NVETFVREVASSSHVR 364
           ++L  L  +G G  G V   Y  +L   Q VA+K ++       +     RE+    H++
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 77
Query: 365 HPNLVALLGY---CLRVDECFLIYELCPNGNLAEWLFGKD-----KC--LSWIQRLEIAI 414
           H N++ LL        +++   +Y       L   L G D     KC  LS      +  
Sbjct: 78  HENVIGLLDVFTPATSIEDFSEVY-------LVTTLMGADLNNIVKCQALSDEHVQFLVY 130
Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG- 473
              RGL ++HS     I+HRD+KP+N+ +  + E ++ DFGL++  D        E+ G 
Sbjct: 131 QLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD-------EEMTGY 180
Query: 474 --TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
             T  Y  PE   N    N + D++S G ++ ++L GK
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G   KV   + +   + VA+K I     N  +++   REV     + HPN+V L
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                     +L+ E    G + ++L    +      R +   I SA  + + H   +  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH---QKF 133
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IVHRD+K  N+LL  +   K++DFG S     G    +    G+  Y  PE     K + 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKKYDG 191
Query: 491 SG-DVYSFGIVLLQILSG 507
              DV+S G++L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G   KV   + +   + VA+K I     N  +++   REV     + HPN+V L
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                     +L+ E    G + ++L    +      R +   I SA  + + H   +  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH---QKF 133
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IVHRD+K  N+LL  +   K++DFG S     G    +    G+  Y  PE     K + 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKKYDG 191
Query: 491 SG-DVYSFGIVLLQILSG 507
              DV+S G++L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 24/191 (12%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TG+ Y  K+ N + ++ +      + +   RE      ++HPN+V L          +L+
Sbjct: 28  TGQEYAAKIINTKKLSAR------DHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLV 81
Query: 385 YELCPNGNLAEWLFGKD-----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
           ++L   G L E +  ++          IQ++  +++        H +  G IVHRD+KP 
Sbjct: 82  FDLVTGGELFEDIVAREYYSEADASHCIQQILESVN--------HCHLNG-IVHRDLKPE 132
Query: 440 NILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           N+LL    +    KL+DFGL+  +  G+  A     GT GYL PE           D+++
Sbjct: 133 NLLLASKSKGAAVKLADFGLAIEVQ-GDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWA 191
Query: 497 FGIVLLQILSG 507
            G++L  +L G
Sbjct: 192 CGVILYILLVG 202

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 106/205 (51%), Gaps = 24/205 (11%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVRE--VASSSHVRHPNLVALLGYCL- 376
           +G+G  G+V++G L + + VA+K I +  + +++ RE  + ++  +RH N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 377 ---RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SYSE 428
                 + +LI     +G+L ++L  + + L     L +A+ +A GL  LH     +  +
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFL--QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGK 131
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY---ASSEVRGTFGYLDPEY--- 482
             I HRD K  N+L+  N +  ++D GL+ +   G  Y    ++   GT  Y+ PE    
Sbjct: 132 PAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDE 191
Query: 483 --RSNC-KVNSSGDVYSFGIVLLQI 504
             R++C +     D+++FG+VL +I
Sbjct: 192 QIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TG  +  K+ N + ++ +      + +   RE      ++HPN+V L          +L+
Sbjct: 30  TGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83
Query: 385 YELCPNGNLAEWLFGKD--------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           ++L   G L E +  ++         C+   Q LE        + + HS     IVHR++
Sbjct: 84  FDLVTGGELFEDIVAREFYSEADASHCIQ--QILE-------SIAYCHS---NGIVHRNL 131
Query: 437 KPTNILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGD 493
           KP N+LL    +    KL+DFGL+  I++ ++ A     GT GYL PE       +   D
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 189
Query: 494 VYSFGIVLLQILSG 507
           +++ G++L  +L G
Sbjct: 190 IWACGVILYILLVG 203

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 24/191 (12%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TG+ Y  K+ N + ++ +      + +   RE      ++HPN+V L          +L+
Sbjct: 28  TGQEYAAKIINTKKLSAR------DHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLV 81
Query: 385 YELCPNGNLAEWLFGKD-----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
           ++L   G L E +  ++          IQ++  +++        H +  G IVHRD+KP 
Sbjct: 82  FDLVTGGELFEDIVAREYYSEADASHCIQQILESVN--------HCHLNG-IVHRDLKPE 132
Query: 440 NILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           N+LL    +    KL+DFGL+  +  G+  A     GT GYL PE           D+++
Sbjct: 133 NLLLASKSKGAAVKLADFGLAIEVQ-GDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWA 191
Query: 497 FGIVLLQILSG 507
            G++L  +L G
Sbjct: 192 CGVILYILLVG 202

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 30/206 (14%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G   KV   + +   + VAIK I     N  +++   REV     + HPN+V L
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                     +LI E    G + ++L    +      R +   I SA  + + H   +  
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCH---QKR 134
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG---------ETYASSEVRGTFGYLDPE 481
           IVHRD+K  N+LL  +   K++DFG S    +G           YA+ E+     Y  PE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
                      DV+S G++L  ++SG
Sbjct: 195 V----------DVWSLGVILYTLVSG 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETF 353
           PR T+ E  Y       L L+G+G  GKV   K  +  ++ A+K +  E       V   
Sbjct: 5   PRVTMNEFEY-------LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT 57
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQ 408
           + E     + RHP L AL       D    + E    G L      E +F +D+   +  
Sbjct: 58  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 117
Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
            +  A+D      +LHS  E  +V+RD+K  N++L  +   K++DFGL K   I +    
Sbjct: 118 EIVSALD------YLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATM 168
Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
               GT  YL PE   +     + D +  G+V+ +++ G+
Sbjct: 169 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL-- 410
            +RE+        P +V   G      E  +  E    G+L       D+ L   +R+  
Sbjct: 61  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKEAKRIPE 113
Query: 411 ----EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGET 465
               +++I   RGL +L    +  I+HRD+KP+NIL+    E KL DFG+S ++ID   +
Sbjct: 114 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 168
Query: 466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            A+S V GT  Y+ PE       +   D++S G+ L+++  G+
Sbjct: 169 MANSFV-GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 12/190 (6%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD 379
           I +  T +V+ GK+     +   H   + ++E  +    +  HV     V   G+    D
Sbjct: 34  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFFEDND 88
Query: 380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
             F++ ELC   +L E L  + K L+  +          G  +LH      ++HRD+K  
Sbjct: 89  FVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLG 144
Query: 440 NILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
           N+ L  + E K+ DFGL+  ++  GE      + GT  Y+ PE  S    +   DV+S G
Sbjct: 145 NLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 499 IVLLQILSGK 508
            ++  +L GK
Sbjct: 203 CIMYTLLVGK 212

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L  IG+G  G+V+KG  +  Q V AIK I     E  +E   +E+   S      
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +    G  L+  + ++I E    G+  + L  +       Q   +  +  +GL +LHS  
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
           +   +HRDIK  N+LL    + KL+DFG++  +   +   ++ V GT  ++ PE      
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 196
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +S  D++S GI  +++  G+
Sbjct: 197 YDSKADIWSLGITAIELAKGE 217

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 289 FKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVY--KGKLSNNQHVAIKHITN 346
           F+G     PG   +   +  + +E    +  +G G  G+V   + K+++ +  AIK I  
Sbjct: 16  FQGDLQATPGM--FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER-AIK-IIR 71
Query: 347 EGNVET-----FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD 401
           + +V T      + EVA    + HPN++ L  +       +L+ E    G L + +  + 
Sbjct: 72  KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131
Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSK 458
           K  + +    I      G+ +LH ++   IVHRD+KP N+LL    +    K+ DFGLS 
Sbjct: 132 K-FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           V +        E  GT  Y+ PE     K +   DV+S G++L  +L+G
Sbjct: 188 VFE--NQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVALLG 373
           IG G   +VY+   L +   VA+K +      +       ++E+     + HPN++    
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 374 YCLRVDECFLIYELCPNGNLAEWL--FGKDKCL---SWIQRLEIAIDSARGLWFLHSYSE 428
             +  +E  ++ EL   G+L+  +  F K K L     + +  + + SA  L  +HS   
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--LEHMHSRR- 156
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             ++HRDIKP N+ +      KL D GL +      T A S V GT  Y+ PE       
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 489 NSSGDVYSFGIVLLQI 504
           N   D++S G +L ++
Sbjct: 214 NFKSDIWSLGCLLYEM 229

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 314 LNELNLIGEGITGKVYKGKLS----NNQHVAIK-----HITNEGNVETFVREVASSSHVR 364
           L  L  +G+G  G V +G+          VA+K      ++    ++ F+REV +   + 
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           H NL+ L G  L      ++ EL P G+L + L               A+  A G+ +L 
Sbjct: 80  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGT-FGYLDPEY 482
           S      +HRD+   N+LL      K+ DFGL + +   +  Y   E R   F +  PE 
Sbjct: 139 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
                 + + D + FG+ L ++ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 12/190 (6%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD 379
           I +  T +V+ GK+     +   H   + ++E  +    +  HV     V   G+    D
Sbjct: 58  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFFEDND 112
Query: 380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
             F++ ELC   +L E L  + K L+  +          G  +LH      ++HRD+K  
Sbjct: 113 FVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLG 168
Query: 440 NILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
           N+ L  + E K+ DFGL+  ++  GE      + GT  Y+ PE  S    +   DV+S G
Sbjct: 169 NLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 226
Query: 499 IVLLQILSGK 508
            ++  +L GK
Sbjct: 227 CIMYTLLVGK 236

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G   KV   + +   + VA+K I     N  +++   REV     + HPN+V L
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                     +L+ E    G + ++L    +      R +   I SA  + + H   +  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH---QKF 133
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IVHRD+K  N+LL  +   K++DFG S     G    +    G   Y  PE     K + 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA--FCGAPPYAAPELFQGKKYDG 191
Query: 491 SG-DVYSFGIVLLQILSG 507
              DV+S G++L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 36/232 (15%)
Query: 308 HYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNV---ETFVREVA 358
            +  E L    ++G G  GKV         K   +  VA+K +  + +    E  + E+ 
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 359 SSSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDK--------- 402
             + +  H N+V LLG C      +LI+E C  G+L  +L      F +D+         
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 403 -------CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
                   L++   L  A   A+G+ FL   S    VHRD+   N+L+      K+ DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFG 217
Query: 456 LSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           L++ I     Y      R    ++ PE           DV+S+GI+L +I S
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  E
Sbjct: 9   DEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKE 67
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 68  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 401 --------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
                            L+    +  +   A+G+ FL S    CI HRD+   NILL   
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEK 184
Query: 447 FEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
              K+ DFGL++ I     Y    + R    ++ PE   +       DV+SFG++L +I 
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 506 S 506
           S
Sbjct: 245 S 245

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 314 LNELNLIGEGITGKVYKGKLS----NNQHVAIK-----HITNEGNVETFVREVASSSHVR 364
           L  L  +G+G  G V +G+          VA+K      ++    ++ F+REV +   + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           H NL+ L G  L      ++ EL P G+L + L               A+  A G+ +L 
Sbjct: 70  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGT-FGYLDPEY 482
           S      +HRD+   N+LL      K+ DFGL + +   +  Y   E R   F +  PE 
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
                 + + D + FG+ L ++ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 19/167 (11%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E+F    +  S + H +LV   G C   DE  L+ E    G+L  +L     C++ + +L
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---------GPNFEAKLSDFGLSKVID 461
           E+A   A   W +H   E  ++H ++   NILL          P F  KLSD G+S  + 
Sbjct: 117 EVAKQLA---WAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF-IKLSDPGISITV- 171
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSG 507
                    ++    ++ PE   N K +N + D +SFG  L +I SG
Sbjct: 172 ----LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  E
Sbjct: 11  DEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKE 69
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 70  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 129
Query: 401 --------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
                            L+    +  +   A+G+ FL S    CI HRD+   NILL   
Sbjct: 130 NEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEK 186
Query: 447 FEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
              K+ DFGL++ I     Y    + R    ++ PE   +       DV+SFG++L +I 
Sbjct: 187 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 246
Query: 506 S 506
           S
Sbjct: 247 S 247

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 12/190 (6%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD 379
           I +  T +V+ GK+     +   H   + ++E  +    +  HV     V   G+    D
Sbjct: 60  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFFEDND 114
Query: 380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
             F++ ELC   +L E L  + K L+  +          G  +LH      ++HRD+K  
Sbjct: 115 FVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLG 170
Query: 440 NILLGPNFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
           N+ L  + E K+ DFGL+  ++  GE      + GT  Y+ PE  S    +   DV+S G
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 499 IVLLQILSGK 508
            ++  +L GK
Sbjct: 229 CIMYTLLVGK 238

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 312 EKLNELNLIGEGITGKVYKGKLS----NNQHVAIK-----HITNEGNVETFVREVASSSH 362
           + L  L  +G+G  G V +G+          VA+K      ++    ++ F+REV +   
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
           + H NL+ L G  L      ++ EL P G+L + L               A+  A G+ +
Sbjct: 72  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 130
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGT-FGYLDP 480
           L S      +HRD+   N+LL      K+ DFGL + +   +  Y   E R   F +  P
Sbjct: 131 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E       + + D + FG+ L ++ +
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 314 LNELNLIGEGITGKVYKGKLS----NNQHVAIK-----HITNEGNVETFVREVASSSHVR 364
           L  L  +G+G  G V +G+          VA+K      ++    ++ F+REV +   + 
Sbjct: 14  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           H NL+ L G  L      ++ EL P G+L + L               A+  A G+ +L 
Sbjct: 74  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGT-FGYLDPEY 482
           S      +HRD+   N+LL      K+ DFGL + +   +  Y   E R   F +  PE 
Sbjct: 133 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
                 + + D + FG+ L ++ +
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 285 KITSFKGVQLKDPGCPRY-TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK 342
           +  SF+G   +    P Y   R   +  +    L+ +G G  G+V+K +   +  + A+K
Sbjct: 29  RRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK 88
Query: 343 H----ITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDEC-------FLIYELCPN 390
                     +    + EV S   V +HP        C+R+++        +L  ELC  
Sbjct: 89  RSMSPFRGPKDRARKLAEVGSHEKVGQHPC-------CVRLEQAWEEGGILYLQTELC-G 140
Query: 391 GNLAEWLFGKDKCLSWIQRLEIA------IDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            +L      +  C +W   L  A       D+   L  LHS     +VH D+KP NI LG
Sbjct: 141 PSL------QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLG 191
Query: 445 PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           P    KL DFGL  ++++G   A     G   Y+ PE        ++ DV+S G+ +L++
Sbjct: 192 PRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQGS-YGTAADVFSLGLTILEV 248

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 319 LIGEGITGKVY--KGKLSNNQ----HVAIKHITNEGNVETFVREVASSSHVRHPNLVALL 372
           ++G+G  G+V   K K++  +     ++ + +  + + E+ +REV     + HPN+  L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
            +       +L+ E+   G L + +  + K  S +    I      G+ + H   +  IV
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYXH---KNKIV 148
Query: 433 HRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-----YRS 484
           HRD+KP N+LL     +   ++ DFGLS   +  +     +  GT  Y+ PE     Y  
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KXKDKIGTAYYIAPEVLHGTYDE 206
Query: 485 NCKVNSSGDVYSFGIVLLQILSG 507
            C      DV+S G++L  +LSG
Sbjct: 207 KC------DVWSTGVILYILLSG 223

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G   KV   + +   + VA++ I     N  +++   REV     + HPN+V L
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                     +L+ E    G + ++L    +      R +   I SA  + + H   +  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH---QKF 133
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IVHRD+K  N+LL  +   K++DFG S     G    +    G+  Y  PE     K + 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKKYDG 191
Query: 491 SG-DVYSFGIVLLQILSG 507
              DV+S G++L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  E
Sbjct: 46  DEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKE 104
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 105 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 164
Query: 401 --------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
                            L+    +  +   A+G+ FL S    CI HRD+   NILL   
Sbjct: 165 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI-HRDLAARNILLSEK 221
Query: 447 FEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
              K+ DFGL++ I     Y    + R    ++ PE   +       DV+SFG++L +I 
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281
Query: 506 S 506
           S
Sbjct: 282 S 282

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 314 LNELNLIGEGITGKVYKGKLS----NNQHVAIK-----HITNEGNVETFVREVASSSHVR 364
           L  L  +G+G  G V +G+          VA+K      ++    ++ F+REV +   + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           H NL+ L G  L      ++ EL P G+L + L               A+  A G+ +L 
Sbjct: 70  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGT-FGYLDPEY 482
           S      +HRD+   N+LL      K+ DFGL + +   +  Y   E R   F +  PE 
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
                 + + D + FG+ L ++ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  EG   +  R
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHR 66
Query: 356 EVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK--------- 400
            + S   +      H N+V LLG C +      +I E C  GNL+ +L  K         
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 401 ------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
                    L+    +  +   A+G+ FL S    CI HRD+   NILL      K+ DF
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEKNVVKICDF 183
Query: 455 GLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL++ I     Y    + R    ++ PE   +       DV+SFG++L +I S
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 312 EKLNELNLIGEGITGKVYK------GKLSNNQ--HVAIKH-ITNEGNVETFVREVASSSH 362
           EK++EL   G G  G V+K      G +   +  H+ IK  I N+      +RE+     
Sbjct: 71  EKISEL---GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ-----IIRELQVLHE 122
Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
              P +V   G      E  +  E    G+L + L    +    I   +++I   +GL +
Sbjct: 123 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTY 181
Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYLDPE 481
           L    +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V GT  Y+ PE
Sbjct: 182 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV-GTRSYMSPE 235
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                  +   D++S G+ L+++  G+
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIK---HITNEGNVET-FVREVASSSHVRHPN 367
           EK++EL   G G  G V+K     +  V  +   H+  +  +    +RE+        P 
Sbjct: 12  EKISEL---GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V   G      E  +  E    G+L + L    +    I   +++I   +GL +L    
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 127
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           +  I+HRD+KP+NIL+    E KL DFG+S ++ID      ++E  GT  Y+ PE     
Sbjct: 128 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----EMANEFVGTRSYMSPERLQGT 181
Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             +   D++S G+ L+++  G+
Sbjct: 182 HYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 29  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 79
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 80  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 137
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 138 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 194
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 195 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 244
Query: 505 LSGK 508
           L G+
Sbjct: 245 LLGQ 248

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGY 374
           IG+G   KV   + +   + VA+K I     N  +++   REV     + HPN+V L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGCIVH 433
                  +L+ E    G + ++L    +      R +   I SA  + + H   +  IVH
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH---QKYIVH 137
Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSG- 492
           RD+K  N+LL  +   K++DFG S    +G    +    G+  Y  PE     K +    
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELFQGKKYDGPEV 195
Query: 493 DVYSFGIVLLQILSG 507
           DV+S G++L  ++SG
Sbjct: 196 DVWSLGVILYTLVSG 210

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
            +RE+        P +V   G      E  +  E    G+L + L    +    I   ++
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KV 136
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEV 471
           +I   +GL +L    +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V
Sbjct: 137 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV 191
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            GT  Y+ PE       +   D++S G+ L+++  G+
Sbjct: 192 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL  + + VAIK
Sbjct: 35  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 85
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 86  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 143
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 144 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 201 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 250
Query: 505 LSGK 508
           L G+
Sbjct: 251 LLGQ 254

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  EG   +  R
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHR 66
Query: 356 EVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK--------- 400
            + S   +      H N+V LLG C +      +I E C  GNL+ +L  K         
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 401 ------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
                    L+    +  +   A+G+ FL S    CI HRD+   NILL      K+ DF
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEKNVVKICDF 183
Query: 455 GLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL++ I     Y    + R    ++ PE   +       DV+SFG++L +I S
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL  + + VAIK
Sbjct: 37  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 87
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 88  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 145
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 146 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 202
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 203 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 252
Query: 505 LSGK 508
           L G+
Sbjct: 253 LLGQ 256

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 35  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 85
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 86  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 143
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 144 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 201 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 250
Query: 505 LSGK 508
           L G+
Sbjct: 251 LLGQ 254

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 14  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 64
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 65  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 122
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 123 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 179
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 180 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 229
Query: 505 LSGK 508
           L G+
Sbjct: 230 LLGQ 233

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV 363
           ++E+    E    + +IG G  G+V   K+ N + +    I N+   E   R  A ++  
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKR--AETACF 121
Query: 364 RHPNLVALLGYCLRV----------DECFLIYELCPNGNLAEWL------FGKDKCLSWI 407
           R    V + G C  +          +  +L+ +    G+L   L        +D    +I
Sbjct: 122 REERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYI 181
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
             + +AIDS   L +         VHRDIKP N+LL  N   +L+DFG    ++   T  
Sbjct: 182 GEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ 232
Query: 468 SSEVRGTFGYLDPEYRSNC-----KVNSSGDVYSFGIVLLQILSGK 508
           SS   GT  Y+ PE          K     D +S G+ + ++L G+
Sbjct: 233 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
            +RE+        P +V   G      E  +  E    G+L + L    +    I   ++
Sbjct: 70  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KV 128
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEV 471
           +I   +GL +L    +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V
Sbjct: 129 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV 183
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            GT  Y+ PE       +   D++S G+ L+++  G+
Sbjct: 184 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G   KV   + +   + VA+K I     N  +++   REV     + HPN+V L
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSARGLWFLHSYSEGC 430
                     +L+ E    G + ++L    +      R +   I SA  + + H   +  
Sbjct: 79  FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSA--VQYCH---QKF 133
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IVHRD+K  N+LL  +   K++DFG S     G    +    G   Y  PE     K + 
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA--FCGAPPYAAPELFQGKKYDG 191
Query: 491 SG-DVYSFGIVLLQILSG 507
              DV+S G++L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIK---HITNEGNVET-FVREVASSSHVRHPN 367
           EK++EL   G G  G V+K     +  V  +   H+  +  +    +RE+        P 
Sbjct: 9   EKISEL---GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V   G      E  +  E    G+L + L    +    I   +++I   +GL +L    
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V GT  Y+ PE     
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV-GTRSYMSPERLQGT 178
Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             +   D++S G+ L+++  G+
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL  + + VAIK
Sbjct: 39  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 89
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 90  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 147
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 148 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 204
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 205 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 254
Query: 505 LSGK 508
           L G+
Sbjct: 255 LLGQ 258

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIK---HITNEGNVET-FVREVASSSHVRHPN 367
           EK++EL   G G  G V+K     +  V  +   H+  +  +    +RE+        P 
Sbjct: 9   EKISEL---GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V   G      E  +  E    G+L + L    +    I   +++I   +GL +L    
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V GT  Y+ PE     
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV-GTRSYMSPERLQGT 178
Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             +   D++S G+ L+++  G+
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIK---HITNEGNVET-FVREVASSSHVRHPN 367
           EK++EL   G G  G V+K     +  V  +   H+  +  +    +RE+        P 
Sbjct: 9   EKISEL---GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V   G      E  +  E    G+L + L    +    I   +++I   +GL +L    
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V GT  Y+ PE     
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV-GTRSYMSPERLQGT 178
Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             +   D++S G+ L+++  G+
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIK---HITNEGNVET-FVREVASSSHVRHPN 367
           EK++EL   G G  G V+K     +  V  +   H+  +  +    +RE+        P 
Sbjct: 9   EKISEL---GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V   G      E  +  E    G+L + L    +    I   +++I   +GL +L    
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V GT  Y+ PE     
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV-GTRSYMSPERLQGT 178
Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             +   D++S G+ L+++  G+
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 9   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 59
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 60  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 117
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 118 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 174
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 175 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 224
Query: 505 LSGK 508
           L G+
Sbjct: 225 LLGQ 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 20  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 70
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 71  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 128
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 129 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 185
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 186 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 235
Query: 505 LSGK 508
           L G+
Sbjct: 236 LLGQ 239

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 24/191 (12%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TG  Y  K+ N + ++ +      + +   RE      ++H N+V L          +L+
Sbjct: 28  TGHEYAAKIINTKKLSAR------DHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLV 81
Query: 385 YELCPNGNLAEWLFGKD-----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
           ++L   G L E +  ++          IQ++  A+        LH +  G +VHRD+KP 
Sbjct: 82  FDLVTGGELFEDIVAREYYSEADASHCIQQILEAV--------LHCHQMG-VVHRDLKPE 132
Query: 440 NILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
           N+LL    +    KL+DFGL+  +  G+  A     GT GYL PE           D+++
Sbjct: 133 NLLLASKCKGAAVKLADFGLAIEVQ-GDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWA 191
Query: 497 FGIVLLQILSG 507
            G++L  +L G
Sbjct: 192 CGVILYILLVG 202

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 13  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 63
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 64  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 121
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 122 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 178
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 179 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 228
Query: 505 LSGK 508
           L G+
Sbjct: 229 LLGQ 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL  + + VAIK
Sbjct: 6   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 56
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 57  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 114
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 115 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 171
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 172 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 221
Query: 505 LSGK 508
           L G+
Sbjct: 222 LLGQ 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 318 NLIGEGITGKVYKGKLSNNQ----HVAIK----HITNEGNVETFVREVASSSHVRHPNLV 369
            ++G+G  G V + +L         VA+K     I    ++E F+RE A      HP++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 370 ALLGYCLR------VDECFLIYELCPNGNLAEWLF----GKDKCLSWIQRL-EIAIDSAR 418
            L+G  LR      +    +I     +G+L  +L     G++     +Q L    +D A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS-EVRGTFGY 477
           G+ +L S +    +HRD+   N +L  +    ++DFGLS+ I  G+ Y      +    +
Sbjct: 149 GMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           L  E  ++       DV++FG+ + +I++
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 26/188 (13%)
Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPN 367
           K  +L  IG+G  G+V+K +     Q VA+K +  E   E F    +RE+     ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 368 LVALLGYCLR----VDEC----FLIYELCPN---GNLAEWLFGKDKCLSWIQRLEIAIDS 416
           +V L+  C       + C    +L+++ C +   G L+  L      LS I+R+   +  
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML-- 134
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG--- 473
             GL+++H      I+HRD+K  N+L+  +   KL+DFGL++   + +    +       
Sbjct: 135 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 474 TFGYLDPE 481
           T  Y  PE
Sbjct: 192 TLWYRPPE 199

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 13  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 63
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 64  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 121
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 122 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 178
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 179 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 228
Query: 505 LSGK 508
           L G+
Sbjct: 229 LLGQ 232

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV 363
           ++E+    E    + +IG G  G+V   K+ N + +    I N+   E   R  A ++  
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKR--AETACF 137
Query: 364 RHPNLVALLGYCLRV----------DECFLIYELCPNGNLAEWL------FGKDKCLSWI 407
           R    V + G C  +          +  +L+ +    G+L   L        +D    +I
Sbjct: 138 REERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYI 197
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
             + +AIDS   L +         VHRDIKP N+LL  N   +L+DFG    ++   T  
Sbjct: 198 GEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ 248
Query: 468 SSEVRGTFGYLDPEYRSNC-----KVNSSGDVYSFGIVLLQILSGK 508
           SS   GT  Y+ PE          K     D +S G+ + ++L G+
Sbjct: 249 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL  + + VAIK
Sbjct: 80  SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 130
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 131 KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 188
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 189 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 245
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 246 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 295
Query: 505 LSGK 508
           L G+
Sbjct: 296 LLGQ 299

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIK---HITNEGNVET-FVREVASSSHVRHPN 367
           EK++EL   G G  G V+K     +  V  +   H+  +  +    +RE+        P 
Sbjct: 9   EKISEL---GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V   G      E  +  E    G+L + L    +    I   +++I   +GL +L    
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           +  I+HRD+KP+NIL+    E KL DFG+S ++ID   + A+S V GT  Y+ PE     
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV-GTRSYMSPERLQGT 178
Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             +   D++S G+ L+++  G+
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGN--------LAEWLFGKDKCLSWIQRLEIAIDSA 417
           P ++ L        E  LI E    G         LAE +   D      Q LE      
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE------ 142
Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
            G+++LH   +  IVH D+KP NILL    P  + K+ DFG+S+   IG      E+ GT
Sbjct: 143 -GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGT 196
Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIE 534
             YL PE  +   + ++ D+++ GI+   +L+   +  +        L   +++ +YS E
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLT-HTSPFVGEDNQETYLNISQVNVDYSEE 255
Query: 535 AFDLTLQLA 543
            F    QLA
Sbjct: 256 TFSSVSQLA 264

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 2   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 52
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 53  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 110
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 111 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 167
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 168 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 217
Query: 505 LSGK 508
           L G+
Sbjct: 218 LLGQ 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 48/249 (19%)
Query: 280 SNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKV---YKGKLSNN 336
           S PPA+     G   ++     + +R V+       +L  +G G  G V     G+    
Sbjct: 3   SPPPAR----SGFYRQEVTKTAWEVRAVY------RDLQPVGSGAYGAVCSAVDGR--TG 50
Query: 337 QHVAIKHITNEGNVETFV----REVASSSHVRHPNLVALLGYCL---RVDECFLIYELCP 389
             VAIK +      E F     RE+    H+RH N++ LL        +D+    Y + P
Sbjct: 51  AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110
Query: 390 --NGNLAEWL----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL 443
               +L + +     G+D+    + ++       +GL ++H+     I+HRD+KP N+ +
Sbjct: 111 FMGTDLGKLMKHEKLGEDRIQFLVYQM------LKGLRYIHA---AGIIHRDLKPGNLAV 161
Query: 444 GPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGI 499
             + E K+ DFGL++        A SE+ G   T  Y  PE   N  +   + D++S G 
Sbjct: 162 NEDCELKILDFGLAR-------QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214
Query: 500 VLLQILSGK 508
           ++ ++++GK
Sbjct: 215 IMAEMITGK 223

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 31/226 (13%)
Query: 309 YATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNV---ETFVREVAS 359
           +   +L+    +G G  GKV +       K      VA+K +    ++   E  + E+  
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 360 SSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-------------- 404
            S++  H N+V LLG C       +I E C  G+L  +L  K                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 405 ---SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
                   L  +   A+G+ FL S  + CI HRD+   NILL      K+ DFGL++ I 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 462 IGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
               Y      R    ++ PE   NC      DV+S+GI L ++ S
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 314 LNELNLIGEGITGKVYKGKLS----NNQHVAIK-----HITNEGNVETFVREVASSSHVR 364
           L  L  +G+G  G V +G+          VA+K      ++    ++ F+REV +   + 
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           H NL+ L G  L      ++ EL P G+L + L               A+  A G+ +L 
Sbjct: 80  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA--SSEVRGTFGYLDPEY 482
           S      +HRD+   N+LL      K+ DFGL + +   + +       +  F +  PE 
Sbjct: 139 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 195
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
                 + + D + FG+ L ++ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 5   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 55
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 56  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 113
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 114 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 170
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 171 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 220
Query: 505 LSGK 508
           L G+
Sbjct: 221 LLGQ 224

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 1   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 51
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 52  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 167 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 216
Query: 505 LSGK 508
           L G+
Sbjct: 217 LLGQ 220

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 20/181 (11%)
Query: 336 NQHVAIKHITNEGNV-ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLA 394
           N+ VA+K+I     + E   RE+ +   +RHPN+V      L      ++ E    G L 
Sbjct: 44  NELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 103
Query: 395 EWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL--GPNF 447
           E +     F +D+   + Q+L        G+ + H+     + HRD+K  N LL   P  
Sbjct: 104 ERICNAGRFSEDEARFFFQQL------ISGVSYAHAMQ---VAHRDLKLENTLLDGSPAP 154
Query: 448 EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS-GDVYSFGIVLLQILS 506
             K++DFG SK   +  +   S V GT  Y+ PE     + +    DV+S G+ L  +L 
Sbjct: 155 RLKIADFGYSKA-SVLHSQPKSAV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212
Query: 507 G 507
           G
Sbjct: 213 G 213

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVYKG------KLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +       K      VA+K +    ++   E  + E+   S++  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-----------------SWIQRLEI 412
            LLG C       +I E C  G+L  +L  K                          L  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           +   A+G+ FL S  + CI HRD+   NILL      K+ DFGL++ I     Y      
Sbjct: 167 SYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   NC      DV+S+GI L ++ S
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  E
Sbjct: 9   DEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKE 67
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 68  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 401 --------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
                            L+    +  +   A+G+ FL   S  CI HRD+   NILL   
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI-HRDLAARNILLSEK 184
Query: 447 FEAKLSDFGLSK-VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
              K+ DFGL++ +    +     + R    ++ PE   +       DV+SFG++L +I 
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 506 S 506
           S
Sbjct: 245 S 245

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 314 LNELNLIGEGITGKVYKGKLS----NNQHVAIK-----HITNEGNVETFVREVASSSHVR 364
           L  L  +G+G  G V +G+          VA+K      ++    ++ F+REV +   + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           H NL+ L G  L      ++ EL P G+L + L               A+  A G+ +L 
Sbjct: 70  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA--SSEVRGTFGYLDPEY 482
           S      +HRD+   N+LL      K+ DFGL + +   + +       +  F +  PE 
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 185
Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
                 + + D + FG+ L ++ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 1   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 51
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 52  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 167 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 216
Query: 505 LSGK 508
           L G+
Sbjct: 217 LLGQ 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVYKG------KLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +       K      VA+K +    ++   E  + E+   S++  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-----------------SWIQRLEI 412
            LLG C       +I E C  G+L  +L  K                          L  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           +   A+G+ FL S  + CI HRD+   NILL      K+ DFGL++ I     Y      
Sbjct: 174 SYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   NC      DV+S+GI L ++ S
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 26/188 (13%)
Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPN 367
           K  +L  IG+G  G+V+K +     Q VA+K +  E   E F    +RE+     ++H N
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 368 LVALLGYCLR----VDEC----FLIYELCPN---GNLAEWLFGKDKCLSWIQRLEIAIDS 416
           +V L+  C       + C    +L+++ C +   G L+  L      LS I+R+   +  
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML-- 133
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG--- 473
             GL+++H      I+HRD+K  N+L+  +   KL+DFGL++   + +    +       
Sbjct: 134 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 474 TFGYLDPE 481
           T  Y  PE
Sbjct: 191 TLWYRPPE 198

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVYKG------KLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +       K      VA+K +    ++   E  + E+   S++  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-----------------SWIQRLEI 412
            LLG C       +I E C  G+L  +L  K                          L  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           +   A+G+ FL S  + CI HRD+   NILL      K+ DFGL++ I     Y      
Sbjct: 174 SYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   NC      DV+S+GI L ++ S
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL+             Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLS-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G+++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL+             Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLS-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G+++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 1   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 51
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 52  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 216
Query: 505 LSGK 508
           L G+
Sbjct: 217 LLGQ 220

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 296 DPGCPR--YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNE 347
           D  C R  Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  E
Sbjct: 9   DEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKE 67
Query: 348 GNVETFVREVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK- 400
           G   +  R + S   +      H N+V LLG C +      +I E C  GNL+ +L  K 
Sbjct: 68  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 401 --------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
                            L+    +  +   A+G+ FL   S  CI HRD+   NILL   
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI-HRDLAARNILLSEK 184
Query: 447 FEAKLSDFGLSK-VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
              K+ DFGL++ +    +     + R    ++ PE   +       DV+SFG++L +I 
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 506 S 506
           S
Sbjct: 245 S 245

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 31/215 (14%)
Query: 320 IGEGITGKVYKG------KLSNNQHVAIKHITNEGNV---ETFVREVASSSHV-RHPNLV 369
           +G G  GKV +       K      VA+K +    ++   E  + E+   S++  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL-----------------SWIQRLEI 412
            LLG C       +I E C  G+L  +L  K                          L  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEV 471
           +   A+G+ FL S  + CI HRD+   NILL      K+ DFGL++ I     Y      
Sbjct: 169 SYQVAKGMAFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           R    ++ PE   NC      DV+S+GI L ++ S
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 26/188 (13%)
Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPN 367
           K  +L  IG+G  G+V+K +     Q VA+K +  E   E F    +RE+     ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 368 LVALLGYCLR----VDEC----FLIYELCPN---GNLAEWLFGKDKCLSWIQRLEIAIDS 416
           +V L+  C       + C    +L+++ C +   G L+  L      LS I+R+   +  
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML-- 134
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG--- 473
             GL+++H      I+HRD+K  N+L+  +   KL+DFGL++   + +    +       
Sbjct: 135 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 474 TFGYLDPE 481
           T  Y  PE
Sbjct: 192 TLWYRPPE 199

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFV----REVASSSHVRHPNLVALL-- 372
           +G G  G V       + + VAIK ++     E F     RE+    H++H N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 373 ---GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
                 LR    F +       +L + + G +     IQ L       +GL ++HS    
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQK-IMGMEFSEEKIQYL--VYQMLKGLKYIHS---A 163
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEY-RSN 485
            +VHRD+KP N+ +  + E K+ DFGL++       +A +E+ G   T  Y  PE   S 
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILSW 216
Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
              N + D++S G ++ ++L+GK
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 26/188 (13%)
Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPN 367
           K  +L  IG+G  G+V+K +     Q VA+K +  E   E F    +RE+     ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 368 LVALLGYCLR----VDEC----FLIYELCPN---GNLAEWLFGKDKCLSWIQRLEIAIDS 416
           +V L+  C       + C    +L+++ C +   G L+  L      LS I+R+   +  
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML-- 134
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG--- 473
             GL+++H      I+HRD+K  N+L+  +   KL+DFGL++   + +    +       
Sbjct: 135 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 474 TFGYLDPE 481
           T  Y  PE
Sbjct: 192 TLWYRPPE 199

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPN 367
            N L ++G+G  GKV        + + AIK      +  + +VE  + E    + +  P 
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 368 LVALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
            +  L  C + VD  + + E    G+L   +    K     Q +  A + + GL+FLH  
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISIGLFFLHKR 139
Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
               I++RD+K  N++L      K++DFG+ K   + +   + E  GT  Y+ PE  +  
Sbjct: 140 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMMDGVTTREFCGTPDYIAPEIIAYQ 195
Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
               S D +++G++L ++L+G+
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 17/224 (7%)
Query: 293 QLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHIT----NE 347
           Q + PG    +      + ++   +  +GEG  G+VYK      N+ VAIK I      E
Sbjct: 15  QTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE 74
Query: 348 GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWI 407
           G   T +REV+    ++H N++ L           LI+E   N +L +++  K+  +S  
Sbjct: 75  GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMR 132
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-----KLSDFGLSKVIDI 462
                      G+ F H  S  C+ HRD+KP N+LL  +  +     K+ DFGL++   I
Sbjct: 133 VIKSFLYQLINGVNFCH--SRRCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
Query: 463 GETYASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQIL 505
                + E+  T  Y  PE     +  ++S D++S   +  ++L
Sbjct: 190 PIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 320 IGEGITGKV--YKGKLSNNQHVAIK--HITNEGNVETFVREVASSSHVRHPNLVALLGYC 375
           IGEG TG V   + K S  Q VA+K   +  +   E    EV      +H N+V +    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQ-VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA-----RGLWFLHSYSEGC 430
           L  +E +++ E    G L +        +S ++  E  I +      + L +LH+     
Sbjct: 112 LVGEELWVLMEFLQGGALTD-------IVSQVRLNEEQIATVCEAVLQALAYLHAQG--- 161
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           ++HRDIK  +ILL  +   KLSDFG    I   +      + GT  ++ PE  S     +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYAT 220
Query: 491 SGDVYSFGIVLLQILSGK 508
             D++S GI++++++ G+
Sbjct: 221 EVDIWSLGIMVIEMVDGE 238

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 22  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 137
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 138 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 185
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 43/227 (18%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 12  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 358 ASSSHVRHPNLVALLGY---CLRVDECFLIYELCPNGNLAEWLFGKD-----KCLSW--- 406
               H++H N++ LL        ++E   +Y       L   L G D     KC      
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMGADLNNIVKCAKLTDD 121
Query: 407 -IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
            +Q L   I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D    
Sbjct: 122 HVQFLIYQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 172
Query: 466 YASSEVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
               E+ G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  EG   +  R
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHR 66
Query: 356 EVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK--------- 400
            + S   +      H N+V LLG C +      +I E C  GNL+ +L  K         
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 401 ------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
                    L+    +  +   A+G+ FL   S  CI HRD+   NILL      K+ DF
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDF 183
Query: 455 GLSK-VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL++ +    +     + R    ++ PE   +       DV+SFG++L +I S
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVE--TFVREVASSSHVRHPNLVAL 371
            +E+ L+ + +TGK++          A+K I         +   E+A    ++H N+V L
Sbjct: 22  FSEVFLVKQRLTGKLF----------ALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFG------KDKCLSWIQRLEIAIDSARGLWFLHS 425
                     +L+ +L   G L + +        KD  L  IQ++  A+       +LH 
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLSAVK------YLH- 123
Query: 426 YSEGCIVHRDIKPTNIL-LGPNFEAK--LSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
             E  IVHRD+KP N+L L P   +K  ++DFGLSK+   G     S   GT GY+ PE 
Sbjct: 124 --ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEV 178
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSG 507
            +    + + D +S G++   +L G
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 12  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 127
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 128 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 175
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 36  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 151
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 152 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 199
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 200 XGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 36  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 151
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 152 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 199
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 200 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 12  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 127
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 128 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 175
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 176 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 302 YTIREVHYATEKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHITNEGNVETFVR 355
           Y   +  +  ++L     +G G  G+V +       K +  + VA+K +  EG   +  R
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHR 66
Query: 356 EVASSSHV-----RHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGK--------- 400
            + S   +      H N+V LLG C +      +I E C  GNL+ +L  K         
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 401 ------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF 454
                    L+    +  +   A+G+ FL   S  CI HRD+   NILL      K+ DF
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDF 183
Query: 455 GLSK-VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           GL++ +    +     + R    ++ PE   +       DV+SFG++L +I S
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFV 354
           R T+ E  Y       L L+G+G  GKV   K  +  ++ A+K +  E       V   +
Sbjct: 144 RVTMNEFEY-------LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 196
Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQR 409
            E     + RHP L AL       D    + E    G L      E +F +D+   +   
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYAS 468
           +  A+D      +LHS  E  +V+RD+K  N++L  +   K++DFGL K  I  G T  +
Sbjct: 257 IVSALD------YLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
               GT  YL PE   +     + D +  G+V+ +++ G+
Sbjct: 309 --FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           E+F    +  S + H +LV   G C+  DE  L+ E    G+L  +L     C++ + +L
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---------GPNFEAKLSDFGLSKVID 461
           E+A   A  + FL    E  ++H ++   NILL          P F  KLSD G+S  + 
Sbjct: 117 EVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPF-IKLSDPGISITV- 171
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSG 507
                    ++    ++ PE   N K +N + D +SFG  L +I SG
Sbjct: 172 ----LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 35  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 91
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 150
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 151 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 198
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 199 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 77  NPHVCRLLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAK 129
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 130 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFV 354
           R T+ E  Y       L L+G+G  GKV   K  +  ++ A+K +  E       V   +
Sbjct: 147 RVTMNEFEY-------LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 199
Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQR 409
            E     + RHP L AL       D    + E    G L      E +F +D+   +   
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 259
Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYAS 468
           +  A+D      +LHS  E  +V+RD+K  N++L  +   K++DFGL K  I  G T  +
Sbjct: 260 IVSALD------YLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 311
Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
               GT  YL PE   +     + D +  G+V+ +++ G+
Sbjct: 312 --FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFV 354
           R T+ E  Y       L L+G+G  GKV   K  +  ++ A+K +  E       V   +
Sbjct: 5   RVTMNEFEY-------LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 57
Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQR 409
            E     + RHP L AL       D    + E    G L      E +F +D+   +   
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 117
Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           +  A+D      +LHS  E  +V+RD+K  N++L  +   K++DFGL K   I +     
Sbjct: 118 IVSALD------YLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMK 168
Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              GT  YL PE   +     + D +  G+V+ +++ G+
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 33/206 (16%)
Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFV----REVASSSHVRHPNLVALL-- 372
           +G G  G V       + + VAIK ++     E F     RE+    H++H N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 373 ---GYCLRVDECFLIYELCPNGNLAEWL---FGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
                 LR    F +       +L + +   F ++K    + ++       +GL ++HS 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM------LKGLKYIHS- 144
Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEY- 482
               +VHRD+KP N+ +  + E K+ DFGL++       +A +E+ G   T  Y  PE  
Sbjct: 145 --AGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVI 195
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
            S    N + D++S G ++ ++L+GK
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 329 YKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC 388
           Y  K+ N + ++ +      + +   RE      ++HPN+V L          +L+++L 
Sbjct: 59  YAAKIINTKKLSAR------DHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLV 112
Query: 389 PNGNLAEWLFGKD--------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTN 440
             G L E +  ++         C+  I      ++S      +H +    IVHRD+KP N
Sbjct: 113 TGGELFEDIVAREYYSEADASHCIHQI------LESVN---HIHQHD---IVHRDLKPEN 160
Query: 441 ILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSF 497
           +LL    +    KL+DFGL+  +  GE  A     GT GYL PE           D+++ 
Sbjct: 161 LLLASKCKGAAVKLADFGLAIEVQ-GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWAC 219
Query: 498 GIVLLQILSG 507
           G++L  +L G
Sbjct: 220 GVILYILLVG 229

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFV 354
           R T+ E  Y       L L+G+G  GKV   K  +  ++ A+K +  E       V   +
Sbjct: 4   RVTMNEFEY-------LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 56
Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQR 409
            E     + RHP L AL       D    + E    G L      E +F +D+   +   
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           +  A+D      +LHS  E  +V+RD+K  N++L  +   K++DFGL K   I +     
Sbjct: 117 IVSALD------YLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMK 167
Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              GT  YL PE   +     + D +  G+V+ +++ G+
Sbjct: 168 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLX-------------QVIQMELDHER 127
Query: 419 GLWFLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             + L+    G        I+HRD+KP+NI++  +   K+ DFGL++    G ++  +  
Sbjct: 128 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPY 185
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             T  Y  PE         + D++S G ++ +++  K
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 110/247 (44%), Gaps = 37/247 (14%)
Query: 277 YYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKG-KLSN 335
           Y++SN   +  +F   +L        TI EV    E+   L+ +G G  G V        
Sbjct: 19  YFQSNASQERPTFYRQELNK------TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKT 69
Query: 336 NQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCL------RVDECFLIY 385
              VA+K ++       + +   RE+    H++H N++ LL            ++ +L+ 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP 445
            L    +L   +  +      +Q L   I   RGL ++HS     I+HRD+KP+N+ +  
Sbjct: 130 HLM-GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHS---ADIIHRDLKPSNLAVNE 183
Query: 446 NFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVL 501
           + E K+ DFGL++  D        E+ G   T  Y  PE   N    N + D++S G ++
Sbjct: 184 DCELKILDFGLARHTD-------DEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 236
Query: 502 LQILSGK 508
            ++L+G+
Sbjct: 237 AELLTGR 243

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ IG G  G V           VA+K ++       + +   RE+
Sbjct: 21  TIWEV---PERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 136
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 137 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-------DEM 184
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLS 405
           E   REV+    V H N++ L        +  LI EL   G L ++L       +++  S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG----PNFEAKLSDFGLSKVID 461
           +I+++        G+ +LH+     I H D+KP NI+L     P    KL DFGL+  I+
Sbjct: 120 FIKQI------LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            G  + +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 171 DGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 76  NPHVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLX-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 317 LNLIGEGITGKV-YKGKLSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVA 370
           L  IG+G  GKV    K    +  A+K++  +       V    +E+     + HP LV 
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           L       ++ F++ +L   G+L   L     F ++    +I  L +A+D  +       
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN------ 133
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY--- 482
                I+HRD+KP NILL  +    ++DF ++ ++   ET  ++ + GT  Y+ PE    
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT-MAGTKPYMAPEMFSS 188
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA 523
           R     + + D +S G+   ++L G++   +  + S+ E+ 
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 104/228 (45%), Gaps = 33/228 (14%)
Query: 307 VHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-EGNVETFVREV---ASSS 361
           + YA++   E+ ++G+G  G+V K + + ++++ AIK I + E  + T + EV   AS +
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 362 H---VRH-------PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
           H   VR+        N V  +    +    F+  E C NG L + +  ++      +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI----DI----- 462
           +       L ++HS     I+HRD+KP NI +  +   K+ DFGL+K +    DI     
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 463 ----GETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQIL 505
               G +   +   GT  Y+  E        N   D+YS GI+  +++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L  +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 26  TIWEV---PERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 82
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 83  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 141
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 142 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 189
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 190 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLS 405
           E   REV+    V H N++ L        +  LI EL   G L ++L       +++  S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG----PNFEAKLSDFGLSKVID 461
           +I+++   +D   G+ +LH+     I H D+KP NI+L     P    KL DFGL+  I+
Sbjct: 120 FIKQI---LD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            G  + +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 171 DGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLS 405
           E   REV+    V H N++ L        +  LI EL   G L ++L       +++  S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG----PNFEAKLSDFGLSKVID 461
           +I+++   +D   G+ +LH+     I H D+KP NI+L     P    KL DFGL+  I+
Sbjct: 120 FIKQI---LD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            G  + +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 171 DGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 110/269 (40%), Gaps = 38/269 (14%)
Query: 309 YATEKLNELNLIGEGITGKV---YKGKLSNNQH--VAIKHITNEG--NVETFVREVASSS 361
           +    L  ++ +G+G  G V       L +N    VA+K + + G      F RE+    
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 362 HVRHPNLVALLG--YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
            +    +V   G  Y        L+ E  P+G L ++L          QR    +D++R 
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----------QRHRARLDASRL 116
Query: 420 LWFLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           L +     +G         VHRD+   NIL+      K++DFGL+K++ + + Y      
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 176
Query: 473 GT---FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS------GKKAKVLTRAGSALELA 523
           G    F Y  PE  S+   +   DV+SFG+VL ++ +         A+ L   GS  ++ 
Sbjct: 177 GQSPIFWYA-PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDV- 234
Query: 524 DPKLDREYSIEAFDLTLQLALSCTALTHQ 552
            P L R   +      L    +C A  H+
Sbjct: 235 -PALSRLLELLEEGQRLPAPPACPAEVHE 262

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 320 IGEGITGKVYKGKL------SNNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVA 370
           +GEG  GKV K         +    VA+K +    +   +   + E      V HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL-----------------------FGKDKCLSWI 407
           L G C +     LI E    G+L  +L                          ++ L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
             +  A   ++G+ +L   +E  +VHRD+   NIL+    + K+SDFGLS+ +   ++Y 
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 468 S-SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             S+ R    ++  E   +    +  DV+SFG++L +I++
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 77  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 129
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 130 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 76  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 79  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 131
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLS 405
           E   REV+    V H N++ L        +  LI EL   G L ++L       +++  S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG----PNFEAKLSDFGLSKVID 461
           +I+++   +D   G+ +LH+     I H D+KP NI+L     P    KL DFGL+  I+
Sbjct: 120 FIKQI---LD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            G  + +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 171 DGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 21  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 136
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 137 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-------DEM 184
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 317 LNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVET----FVREVASSSHVRHPNLVAL 371
           +  IG G  G V   +     Q VAIK I N  +V T     +RE+    H +H N++A+
Sbjct: 59  IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 118
Query: 372 LGYCLR-------VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
               LR           +++ +L    +L + +    + L+            RGL ++H
Sbjct: 119 KD-ILRPTVPYGEFKSVYVVLDLM-ESDLHQ-IIHSSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPE 481
           S     ++HRD+KP+N+L+  N E K+ DFG+++ +        Y  +E   T  Y  PE
Sbjct: 176 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 482 YR-SNCKVNSSGDVYSFGIVLLQILSGKK 509
              S  +   + D++S G +  ++L+ ++
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 27  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 142
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 143 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-------DEM 190
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 191 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 78  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLS 405
           E   REV+    V H N++ L        +  LI EL   G L ++L       +++  S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG----PNFEAKLSDFGLSKVID 461
           +I+++   +D   G+ +LH+     I H D+KP NI+L     P    KL DFGL+  I+
Sbjct: 120 FIKQI---LD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            G  + +  + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 171 DGVEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 75/177 (42%), Gaps = 8/177 (4%)
Query: 335 NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLA 394
           +NQ  A+K I+      T     A      HPN+V L          FL+ EL   G L 
Sbjct: 35  SNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKL 451
           E +  K K  S  +   I       +  +H      +VHRD+KP N+L      N E K+
Sbjct: 95  ERI-KKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKI 150
Query: 452 SDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            DFG +++         +    T  Y  PE  +    + S D++S G++L  +LSG+
Sbjct: 151 IDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 317 LNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVET----FVREVASSSHVRHPNLVAL 371
           +  IG G  G V   +     Q VAIK I N  +V T     +RE+    H +H N++A+
Sbjct: 60  IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 119
Query: 372 LGYCLR-------VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
               LR           +++ +L    +L + +    + L+            RGL ++H
Sbjct: 120 KD-ILRPTVPYGEFKSVYVVLDLM-ESDLHQ-IIHSSQPLTLEHVRYFLYQLLRGLKYMH 176
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSEVRGTFGYLDPE 481
           S     ++HRD+KP+N+L+  N E K+ DFG+++ +        Y  +E   T  Y  PE
Sbjct: 177 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 482 YR-SNCKVNSSGDVYSFGIVLLQILSGKK 509
              S  +   + D++S G +  ++L+ ++
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 86  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 138
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 139 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 23  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 138
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++       + + E+
Sbjct: 139 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEM 186
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 1   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 51
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +      +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 52  KVLQGKAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 216
Query: 505 LSGK 508
           L G+
Sbjct: 217 LLGQ 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 80  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 132
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 1   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 51
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +      +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 52  KVLQGKAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 216
Query: 505 LSGK 508
           L G+
Sbjct: 217 LLGQ 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 43/227 (18%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 23  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 358 ASSSHVRHPNLVALLGY---CLRVDECFLIYELCPNGNLAEWLFGKD-----KCLSW--- 406
               H++H N++ LL        ++E   +Y       L   L G D     KC      
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMGADLNNIVKCQKLTDD 132
Query: 407 -IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
            +Q L   I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++       
Sbjct: 133 HVQFLIYQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR------- 180
Query: 466 YASSEVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
           + + E+ G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 181 HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 76  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 76  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 314 LNELNLIGEGITGKV--YKGKLSNN---QHVAIKHITNEGNVET---FVREVASSSHVRH 365
           L ++  +GEG  GKV  Y    +N+   + VA+K +  +   +    + +E+     + H
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 366 PNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            +++   G C    E    L+ E  P G+L ++L      +   Q L  A     G+ +L
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYL 133
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDP 480
           HS      +HR++   N+LL  +   K+ DFGL+K +  G  Y      G    F Y  P
Sbjct: 134 HSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-P 189
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E     K   + DV+SFG+ L ++L+
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 78/188 (41%), Gaps = 26/188 (13%)
Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITN---E 347
           G+Q K     R  I E+H           I  G  G V  G  S    VAIK + N   +
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 348 GNV----------ETFVREVASSSHVRHPNLVALLGYCLRVDE-----CFLIYELCPNGN 392
           G            +  +RE+   +H  HPN++ L    +  +E      +L+ EL    +
Sbjct: 61  GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTD 119
Query: 393 LAEWLFGKDKCLS--WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK 450
           LA+ +  +   +S   IQ     I     L  LH   E  +VHRD+ P NILL  N +  
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHI-----LLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174
Query: 451 LSDFGLSK 458
           + DF L++
Sbjct: 175 ICDFNLAR 182

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 79  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 131
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 79  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 131
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 82  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 134
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 135 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 309 YATEKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEGNVETF---VREVASS 360
           +   +L +L ++G G+ G V+KG       S    V IK I ++   ++F      + + 
Sbjct: 10  FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
             + H ++V LLG C       L+ +  P G+L + +      L     L   +  A+G+
Sbjct: 70  GSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-TYASSEVRGTFGYLD 479
           ++L  +    +VHR++   N+LL    + +++DFG++ ++   +     SE +    ++ 
Sbjct: 129 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILS 506
            E     K     DV+S+G+ + ++++
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 23  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 138
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++       + + E+
Sbjct: 139 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEM 186
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 320 IGEGITG--KVYKGKLSNNQHVAIKHITNEGNV-ETFVREVASSSHVRHPNLVALLGYCL 376
           IG G  G  ++ + K SN + VA+K+I     + E   RE+ +   +RHPN+V      L
Sbjct: 26  IGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 377 RVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                 ++ E    G L E +     F +D+   + Q+L        G+ + H+     +
Sbjct: 85  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCHAMQ---V 135
Query: 432 VHRDIKPTNILL--GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            HRD+K  N LL   P    K+ DFG SK   +  +   S V GT  Y+ PE     + +
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV-GTPAYIAPEVLLKKEYD 193
Query: 490 SS-GDVYSFGIVLLQILSG 507
               DV+S G+ L  +L G
Sbjct: 194 GKVADVWSCGVTLYVMLVG 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 309 YATEKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEGNVETF---VREVASS 360
           +   +L +L ++G G+ G V+KG       S    V IK I ++   ++F      + + 
Sbjct: 28  FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 87
Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
             + H ++V LLG C       L+ +  P G+L + +      L     L   +  A+G+
Sbjct: 88  GSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 146
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-TYASSEVRGTFGYLD 479
           ++L  +    +VHR++   N+LL    + +++DFG++ ++   +     SE +    ++ 
Sbjct: 147 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILS 506
            E     K     DV+S+G+ + ++++
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 70  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 122
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 123 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL+             Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLS-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL+             Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLS-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 79  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 131
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 83  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 135
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 18  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 133
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 134 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-------DEM 181
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 22  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 137
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 138 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-------DEM 185
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 43/227 (18%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     + +   +A+K ++       + +   RE+
Sbjct: 45  TIWEV---PERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYREL 101
Query: 358 ASSSHVRHPNLVALLGY---CLRVDECFLIYELCPNGNLAEWLFGKD-----KCLSW--- 406
               H++H N++ LL        ++E   +Y       L   L G D     KC      
Sbjct: 102 RLLKHMKHENVIGLLDVFTPATSLEEFNDVY-------LVTHLMGADLNNIVKCQKLTDD 154
Query: 407 -IQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
            +Q L   I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D    
Sbjct: 155 HVQFLIYQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 205
Query: 466 YASSEVRG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
               E+ G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 206 ---DEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 78  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKSQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL +  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 101 NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 153
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 154 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 1   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 51
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCL----RVDECFL--IYELCPNG--NLA 394
            +      +   RE+     + H N+V L  +      + DE +L  + +  P     +A
Sbjct: 52  KVLQGKAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVA 109
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 167 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 216
Query: 505 LSGK 508
           L G+
Sbjct: 217 LLGQ 220

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 320 IGEGITGKVYKGKL------SNNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVA 370
           +GEG  GKV K         +    VA+K +    +   +   + E      V HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL-----------------------FGKDKCLSWI 407
           L G C +     LI E    G+L  +L                          ++ L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGETY 466
             +  A   ++G+ +L   +E  +VHRD+   NIL+    + K+SDFGLS+ V +     
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             S+ R    ++  E   +    +  DV+SFG++L +I++
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 284 AKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN-QHVAIK 342
           +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL ++ + VAIK
Sbjct: 1   SKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGELVAIK 51
Query: 343 HITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE------CFLIYELCPNG--NLA 394
            +  +   +   RE+     + H N+V L  +     E        L+ +  P     +A
Sbjct: 52  KVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVA 109
Query: 395 EWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-KLSD 453
                  + L  I          R L ++HS+    I HRDIKP N+LL P+    KL D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 454 FGLSKVIDIGET---------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
           FG +K +  GE          Y + E+   FG  D          SS DV+S G VL ++
Sbjct: 167 FGSAKQLVRGEPNVSXICSRYYRAPEL--IFGATD--------YTSSIDVWSAGCVLAEL 216
Query: 505 LSGK 508
           L G+
Sbjct: 217 LLGQ 220

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLX-------------QVIQMELDHER 127
Query: 419 GLWFLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             + L+    G        I+HRD+KP+NI++  +   K+ DFGL++    G ++  +  
Sbjct: 128 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPY 185
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             T  Y  PE         + D++S G ++ +++  K
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 27  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 142
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 143 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 190
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 191 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAI-------KHITNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG  +   + V I       +  T+    +  + E    + V 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 110 NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 162
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 163 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 18  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 133
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 134 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 181
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 23  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 138
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 139 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 186
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVA----SSSHVRHP 366
           + L  +  +G G  G V K + + + Q +A+K I    N +   R +     S   V  P
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 367 NLVALLGYCLRVDECFLIYELCPNG--NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
             V   G   R  + ++  EL         + +  K + +      +IA+   + L  LH
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
           S  +  ++HRD+KP+N+L+    + K+ DFG+S    + ++ A +   G   Y+ PE R 
Sbjct: 171 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGY--LVDSVAKTIDAGCKPYMAPE-RI 225
Query: 485 NCKVNSSG-----DVYSFGIVLLQI 504
           N ++N  G     D++S GI ++++
Sbjct: 226 NPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 22/140 (15%)
Query: 382 FLIYELCPNGNLAEWLFGKDKCLSWIQR-----LEIAIDSARGLWFLHSYSEGCIVHRDI 436
           ++  +LC   NL +W+   ++  S   R     L I I  A  + FLHS     ++HRD+
Sbjct: 137 YIQMQLCRKENLKDWM---NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDL 190
Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGE----------TYASSEVR-GTFGYLDPEYRSN 485
           KP+NI    +   K+ DFGL   +D  E           YA+   + GT  Y+ PE    
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHG 250
Query: 486 CKVNSSGDVYSFGIVLLQIL 505
              +   D++S G++L ++L
Sbjct: 251 NNYSHKVDIFSLGLILFELL 270

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 28  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL 84
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 143
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 144 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 191
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 28  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 143
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 144 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 191
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLX-------------QVIQMELDHER 120
Query: 419 GLWFLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             + L+    G        I+HRD+KP+NI++  +   K+ DFGL++    G ++  +  
Sbjct: 121 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPY 178
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             T  Y  PE         + D++S G ++ +++  K
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 28  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 143
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 144 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 191
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 18  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 133
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 134 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 181
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++       +   E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL+             Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLS-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 46/78 (58%), Gaps = 2/78 (2%)
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IV+RD+KP NILL  +   ++SD GL+  +  G+T       GT GY+ PE   N +   
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTF 364
Query: 491 SGDVYSFGIVLLQILSGK 508
           S D ++ G +L ++++G+
Sbjct: 365 SPDWWALGCLLYEMIAGQ 382

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 21  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 136
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 137 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 184
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 15  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 71
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 72  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 130
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 131 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 178
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 179 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++       +   E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 46/78 (58%), Gaps = 2/78 (2%)
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           IV+RD+KP NILL  +   ++SD GL+  +  G+T       GT GY+ PE   N +   
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTF 364
Query: 491 SGDVYSFGIVLLQILSGK 508
           S D ++ G +L ++++G+
Sbjct: 365 SPDWWALGCLLYEMIAGQ 382

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 22  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 137
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 138 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 185
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 35  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 91
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 150
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 151 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 198
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 199 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 21  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 136
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 137 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 184
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 36  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 151
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 152 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 199
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 200 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 22  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 137
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 138 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 185
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 18  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 133
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 134 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 181
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 43/216 (19%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETF---------VREVASSSHVRHPNL 368
           +L+GEG  G V      +  H     I     +E F         +RE+    H +H N+
Sbjct: 17  SLLGEGAYGVV-----CSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 369 VALLGYCLRVD------ECFLIYELCP---NGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
           + +     R D      E ++I EL     +  ++  +   D    +I +      + R 
Sbjct: 72  ITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ------TLRA 124
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID---------IGETYASSE 470
           +  LH  +   ++HRD+KP+N+L+  N + K+ DFGL+++ID          G+    +E
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 471 VRGTFGYLDPEYR-SNCKVNSSGDVYSFGIVLLQIL 505
              T  Y  PE   ++ K + + DV+S G +L ++ 
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++       +   E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 13  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 69
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 128
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 129 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 176
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 177 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 13  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 69
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 128
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 129 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 176
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 177 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 15/188 (7%)
Query: 322 EGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDEC 381
           E  TG+V+  K  N  +   K+        T   E++  + + HP L+ L        E 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKY--------TVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNI 441
            LI E    G L + +  +D  +S  + +     +  GL  +H +S   IVH DIKP NI
Sbjct: 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENI 180
Query: 442 L--LGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGI 499
           +         K+ DFGL+  ++  E    +     F    PE      V    D+++ G+
Sbjct: 181 MCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAA--PEIVDREPVGFYTDMWAIGV 238
Query: 500 VLLQILSG 507
           +   +LSG
Sbjct: 239 LGYVLLSG 246

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETF---------VREVASSSHVRHPNL 368
           +L+GEG  G V      +  H     I     +E F         +RE+    H +H N+
Sbjct: 17  SLLGEGAYGVV-----CSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 369 VALLGYCLRVD------ECFLIYELCP---NGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
           + +     R D      E ++I EL     +  ++  +   D    +I +      + R 
Sbjct: 72  ITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ------TLRA 124
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID---------IGETYASSE 470
           +  LH      ++HRD+KP+N+L+  N + K+ DFGL+++ID          G+    +E
Sbjct: 125 VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 471 VRGTFGYLDPEYR-SNCKVNSSGDVYSFGIVLLQIL 505
              T  Y  PE   ++ K + + DV+S G +L ++ 
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 12  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 127
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 128 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 175
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 39  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 154
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 155 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 202
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 203 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 14  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 70
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 71  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 129
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D        E+
Sbjct: 130 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------DEM 177
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 178 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 309 YATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHI---TNEGNVETFVRE---VASSS 361
           +  E L +L  IG G  G V K     + Q +A+K I    +E   +  + +   V  SS
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 362 HVRHPNLVALLGYCLRVDECFLIYELCPNG--NLAEWLFGK-DKCLSWIQRLEIAIDSAR 418
               P +V   G   R  +C++  EL         ++++   D  +      +I + + +
Sbjct: 79  DC--PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
            L  L    +  I+HRDIKP+NILL  +   KL DFG+S    + ++ A +   G   Y+
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYM 192
Query: 479 DPEYRSNCKVNSSG-----DVYSFGIVLLQILSGK 508
            PE R +   +  G     DV+S GI L ++ +G+
Sbjct: 193 APE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 314 LNELNLIGEGITGKV--YKGKLSNN---QHVAIKHITNEGNVET---FVREVASSSHVRH 365
           L ++  +GEG  GKV  Y    +N+   + VA+K +  +   +    + +E+     + H
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 366 PNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            +++   G C    E    L+ E  P G+L ++L      +   Q L  A     G+ +L
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYL 133
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDP 480
           H+      +HR++   N+LL  +   K+ DFGL+K +  G  Y      G    F Y  P
Sbjct: 134 HAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-P 189
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E     K   + DV+SFG+ L ++L+
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A 
Sbjct: 73  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAE 125
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 126 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL+             Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLS-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 320 IGEGITGKVYKGKL------SNNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVA 370
           +GEG  GKV K         +    VA+K +    +   +   + E      V HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL-----------------------FGKDKCLSWI 407
           L G C +     LI E    G+L  +L                          ++ L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGETY 466
             +  A   ++G+ +L   +E  +VHRD+   NIL+    + K+SDFGLS+ V +     
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             S+ R    ++  E   +    +  DV+SFG++L +I++
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 320 IGEGITG--KVYKGKLSNNQHVAIKHITNEGNVETFV-REVASSSHVRHPNLVALLGYCL 376
           IG G  G  ++ + K SN + VA+K+I     +   V RE+ +   +RHPN+V      L
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 377 RVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                 ++ E    G L E +     F +D+   + Q+L        G+ + H+     +
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCHAMQ---V 136
Query: 432 VHRDIKPTNILL--GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            HRD+K  N LL   P    K+ DFG SK   +  +   S V GT  Y+ PE     + +
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV-GTPAYIAPEVLLKKEYD 194
Query: 490 SS-GDVYSFGIVLLQILSG 507
               DV+S G+ L  +L G
Sbjct: 195 GKVADVWSCGVTLYVMLVG 213

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 165
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 166 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 222
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 292 VQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKV--YKGKLSNN---QHVAIKHITN 346
           V  + PG P  T+    Y    L ++  +GEG  GKV  Y    +N+   + VA+K +  
Sbjct: 17  VLFQGPGDP--TVFHKRY----LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA 70
Query: 347 EGNVET---FVREVASSSHVRHPNLVALLGYCLRVDECFL--IYELCPNGNLAEWLFGKD 401
           +   +    + +E+     + H +++   G C       L  + E  P G+L ++L    
Sbjct: 71  DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PR 128
Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
             +   Q L  A     G+ +LH+      +HRD+   N+LL  +   K+ DFGL+K + 
Sbjct: 129 HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 462 IG-ETYASSEVRGT--FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            G E Y   E   +  F Y  PE     K   + DV+SFG+ L ++L+
Sbjct: 186 EGHEXYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           IR +    E  + + +IG G  G+V   +   +Q V A+K      +    +   F  E 
Sbjct: 67  IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 358 ASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQ----RLE 411
              +    P +V L  +C   D+   +++ E  P G+L   +   D    W +     + 
Sbjct: 127 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV 184
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL-SKVIDIGETYASSE 470
           +A+D+      +HS     ++HRD+KP N+LL  +   KL+DFG   K+ + G  +  + 
Sbjct: 185 LALDA------IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA 235
Query: 471 VRGTFGYLDPE-YRSNCKVNSSG---DVYSFGIVLLQILSG 507
           V GT  Y+ PE  +S       G   D +S G+ L ++L G
Sbjct: 236 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 128
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 129 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 185
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 80
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 126
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 127 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 183
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 184 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 312 EKLNELNLIGEGITGKVY---------KGKLSNNQHVAIKHITNEGNVETFVR-EVASSS 361
           E    L ++G G  GKV+          GKL   + +    I  +       R E     
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 362 HVRHPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
           H+R    +  L Y  + + +  LI +    G L   L  +++        E+ I     +
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH----EVQIYVGEIV 169
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
             L    +  I++RDIK  NILL  N    L+DFGLSK     ET  + +  GT  Y+ P
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 481 EY--RSNCKVNSSGDVYSFGIVLLQILSG 507
           +     +   + + D +S G+++ ++L+G
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 165
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 166 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 222
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 120
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 121 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 177
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 109/269 (40%), Gaps = 38/269 (14%)
Query: 309 YATEKLNELNLIGEGITGKV---YKGKLSNNQH--VAIKHITNEG--NVETFVREVASSS 361
           +    L  ++ +G+G  G V       L +N    VA+K + + G      F RE+    
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 362 HVRHPNLVALLG--YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
            +    +V   G  Y        L+ E  P+G L ++L          QR    +D++R 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----------QRHRARLDASRL 129
Query: 420 LWFLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           L +     +G         VHRD+   NIL+      K++DFGL+K++ + + Y      
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 473 GT---FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS------GKKAKVLTRAGSALELA 523
           G    F Y  PE  S+   +   DV+SFG+VL ++ +         A+ L   G   ++ 
Sbjct: 190 GQSPIFWYA-PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV- 247
Query: 524 DPKLDREYSIEAFDLTLQLALSCTALTHQ 552
            P L R   +      L    +C A  H+
Sbjct: 248 -PALSRLLELLEEGQRLPAPPACPAEVHE 275

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 121
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 122 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 178
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 28/200 (14%)
Query: 320 IGEGITGKVYKGKLSNNQHVAI------KHITNEGNVETFVREVASSSHVRHPNLVALLG 373
           IG G    VYKG L     V +           +   + F  E      ++HPN+V    
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 374 Y---CLRVDECF-LIYELCPNGNLAEWL----FGKDKCL-SWIQRLEIAIDSARGLWFLH 424
                ++  +C  L+ EL  +G L  +L      K K L SW +++       +GL FLH
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFLH 146
Query: 425 SYSEGCIVHRDIKPTNILL-GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           + +   I+HRD+K  NI + GP    K+ D GL+    +     +  V GT  +  PE  
Sbjct: 147 TRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFXAPEXY 202
Query: 484 SNCKVNSSGDVYSFGIVLLQ 503
              K + S DVY+FG   L+
Sbjct: 203 EE-KYDESVDVYAFGXCXLE 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 121
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 122 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 178
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNV----ETF-VREVA 358
           ++++    E    L +IG G  G+V   KL N   V    I N+  +    ET   RE  
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 359 SSSHVRHPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWL------FGKDKCLSWIQRLE 411
                     +  L Y  + D   +L+ +    G+L   L        ++    ++  + 
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV 185
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGETYASSE 470
           IAIDS   L +         VHRDIKP NIL+  N   +L+DFG   K+++ G T  SS 
Sbjct: 186 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSV 235
Query: 471 VRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGK 508
             GT  Y+ PE          +     D +S G+ + ++L G+
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 10/184 (5%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TGK+Y  K  + + + +K        E  +  + S+     P +V +       D+   I
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC--PFIVCMSYAFHTPDKLSFI 270
Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            +L   G+L  +   +    S       A +   GL  +H+     +V+RD+KP NILL 
Sbjct: 271 LDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLD 326
Query: 445 PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQ 503
            +   ++SD GL+      + +AS    GT GY+ PE  +     +SS D +S G +L +
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383
Query: 504 ILSG 507
           +L G
Sbjct: 384 LLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 10/184 (5%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TGK+Y  K  + + + +K        E  +  + S+     P +V +       D+   I
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC--PFIVCMSYAFHTPDKLSFI 270
Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            +L   G+L  +   +    S       A +   GL  +H+     +V+RD+KP NILL 
Sbjct: 271 LDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLD 326
Query: 445 PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQ 503
            +   ++SD GL+      + +AS    GT GY+ PE  +     +SS D +S G +L +
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383
Query: 504 ILSG 507
           +L G
Sbjct: 384 LLRG 387

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q +++ +D  R
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIQMELDHER 128
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 129 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 185
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 10/184 (5%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TGK+Y  K  + + + +K        E  +  + S+     P +V +       D+   I
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC--PFIVCMSYAFHTPDKLSFI 270
Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            +L   G+L  +   +    S       A +   GL  +H+     +V+RD+KP NILL 
Sbjct: 271 LDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLD 326
Query: 445 PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQ 503
            +   ++SD GL+      + +AS    GT GY+ PE  +     +SS D +S G +L +
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383
Query: 504 ILSG 507
           +L G
Sbjct: 384 LLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 10/184 (5%)
Query: 325 TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           TGK+Y  K  + + + +K        E  +  + S+     P +V +       D+   I
Sbjct: 212 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC--PFIVCMSYAFHTPDKLSFI 269
Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            +L   G+L  +   +    S       A +   GL  +H+     +V+RD+KP NILL 
Sbjct: 270 LDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLD 325
Query: 445 PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQ 503
            +   ++SD GL+      + +AS    GT GY+ PE  +     +SS D +S G +L +
Sbjct: 326 EHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 382
Query: 504 ILSG 507
           +L G
Sbjct: 383 LLRG 386

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETF 353
           P+ T+ +  Y       L L+G+G  GKV   +  +  ++ A+K +  E       V   
Sbjct: 5   PKVTMNDFDY-------LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT 57
Query: 354 VREVASSSHVRHPNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
           V E     + RHP L AL  Y  +  +  CF++     NG    +   +++  +  +   
Sbjct: 58  VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARF 114
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
              +    L +LHS     +V+RDIK  N++L  +   K++DFGL K   I +       
Sbjct: 115 YGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKXF 170
Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            GT  YL PE   +     + D +  G+V+ +++ G+
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ D+GL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 128
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 129 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 185
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 42/271 (15%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVA 370
           L  IG G + KV++      Q  AIK++  E      ++++  E+A  + ++     ++ 
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-----FLHS 425
           L  Y +     +++ E C N +L  WL  K     W           +  W      +H+
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW---------ERKSYWKNMLEAVHT 170
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEY- 482
             +  IVH D+KP N L+      KL DFG++  +  D       S+V GT  Y+ PE  
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 228
Query: 483 --RSNCKVNS--------SGDVYSFGIVLLQILSGKKA--KVLTRAGSALELADPKLDRE 530
              S+ + N           DV+S G +L  +  GK    +++ +      + DP  + E
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288
Query: 531 YSIEAFDLTLQLALSCTALTHQRPPMEQVFV 561
           +  +  +  LQ  L C     +R P +++ +
Sbjct: 289 FP-DIPEKDLQDVLKCCL---KRDPKQRISI 315

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 80  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 132
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFG +K++   E  Y +   +    +
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQH-VAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V     +   H VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ DF L++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNE------GNVETFVREVASSSHVRHPNLVAL 371
           N IG G  G+V   K++  +   I+    +       +V+ F +E+     + HPN++ L
Sbjct: 15  NTIGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                   + +L+ ELC  G L E +  K +         I  D    + + H  +   +
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---V 127
Query: 432 VHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-----YR 483
            HRD+KP N L     P+   KL DFGL+     G+   +    GT  Y+ P+     Y 
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEGLYG 185
Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
             C      D +S G+++  +L G
Sbjct: 186 PEC------DEWSAGVMMYVLLCG 203

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNE------GNVETFVREVASSSHVRHPNLVAL 371
           N IG G  G+V   K++  +   I+    +       +V+ F +E+     + HPN++ L
Sbjct: 32  NTIGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 88
Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                   + +L+ ELC  G L E +  K +         I  D    + + H  +   +
Sbjct: 89  YETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---V 144
Query: 432 VHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-----YR 483
            HRD+KP N L     P+   KL DFGL+     G+   +    GT  Y+ P+     Y 
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEGLYG 202
Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
             C      D +S G+++  +L G
Sbjct: 203 PEC------DEWSAGVMMYVLLCG 220

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETF---------VREVASSSHVRHPNL 368
           +L+GEG  G V      +  H     I     +E F         +RE+    H +H N+
Sbjct: 17  SLLGEGAYGVV-----CSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 369 VALLGYCLRVD------ECFLIYELCP---NGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
           + +     R D      E ++I EL     +  ++  +   D    +I +      + R 
Sbjct: 72  ITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ------TLRA 124
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID---------IGETYASSE 470
           +  LH  +   ++HRD+KP+N+L+  N + K+ DFGL+++ID          G+     E
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 471 VRGTFGYLDPEYR-SNCKVNSSGDVYSFGIVLLQIL 505
              T  Y  PE   ++ K + + DV+S G +L ++ 
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVA----SSSHVRHP 366
           + L  +  +G G  G V K + + + Q +A+K I    N +   R +     S   V  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 367 NLVALLGYCLRVDECFLIYELCPNG--NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
             V   G   R  + ++  EL         + +  K + +      +IA+   + L  LH
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK--VIDIGETYASSEVRGTFGYLDPEY 482
           S  +  ++HRD+KP+N+L+    + K+ DFG+S   V D+ +   +    G   Y+ PE 
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA----GCKPYMAPE- 179
Query: 483 RSNCKVNSSG-----DVYSFGIVLLQI 504
           R N ++N  G     D++S GI ++++
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 42/271 (15%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVA 370
           L  IG G + KV++      Q  AIK++  E      ++++  E+A  + ++     ++ 
Sbjct: 33  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-----FLHS 425
           L  Y +     +++ E C N +L  WL  K     W           +  W      +H+
Sbjct: 93  LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW---------ERKSYWKNMLEAVHT 142
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEY- 482
             +  IVH D+KP N L+      KL DFG++  +  D       S+V GT  Y+ PE  
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 200
Query: 483 --RSNCKVNS--------SGDVYSFGIVLLQILSGKKA--KVLTRAGSALELADPKLDRE 530
              S+ + N           DV+S G +L  +  GK    +++ +      + DP  + E
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260
Query: 531 YSIEAFDLTLQLALSCTALTHQRPPMEQVFV 561
           +  +  +  LQ  L C     +R P +++ +
Sbjct: 261 FP-DIPEKDLQDVLKCCL---KRDPKQRISI 287

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 78  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFG +K++   E  Y +   +    +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 78  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFG +K++   E  Y +   +    +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 42/271 (15%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVA 370
           L  IG G + KV++      Q  AIK++  E      ++++  E+A  + ++     ++ 
Sbjct: 17  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 76
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-----FLHS 425
           L  Y +     +++ E C N +L  WL  K     W           +  W      +H+
Sbjct: 77  LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW---------ERKSYWKNMLEAVHT 126
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEY- 482
             +  IVH D+KP N L+      KL DFG++  +  D       S+V GT  Y+ PE  
Sbjct: 127 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 184
Query: 483 --RSNCKVNS--------SGDVYSFGIVLLQILSGKKA--KVLTRAGSALELADPKLDRE 530
              S+ + N           DV+S G +L  +  GK    +++ +      + DP  + E
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 244
Query: 531 YSIEAFDLTLQLALSCTALTHQRPPMEQVFV 561
           +  +  +  LQ  L C     +R P +++ +
Sbjct: 245 FP-DIPEKDLQDVLKCCL---KRDPKQRISI 271

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++  G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 83  NPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 135
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 42/271 (15%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVA 370
           L  IG G + KV++      Q  AIK++  E      ++++  E+A  + ++     ++ 
Sbjct: 33  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-----FLHS 425
           L  Y +     +++ E C N +L  WL  K     W           +  W      +H+
Sbjct: 93  LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW---------ERKSYWKNMLEAVHT 142
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEY- 482
             +  IVH D+KP N L+      KL DFG++  +  D       S+V GT  Y+ PE  
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQV-GTVNYMPPEAI 200
Query: 483 --RSNCKVNS--------SGDVYSFGIVLLQILSGKKA--KVLTRAGSALELADPKLDRE 530
              S+ + N           DV+S G +L  +  GK    +++ +      + DP  + E
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260
Query: 531 YSIEAFDLTLQLALSCTALTHQRPPMEQVFV 561
           +  +  +  LQ  L C     +R P +++ +
Sbjct: 261 FP-DIPEKDLQDVLKCCL---KRDPKQRISI 287

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 42/271 (15%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVA 370
           L  IG G + KV++      Q  AIK++  E      ++++  E+A  + ++     ++ 
Sbjct: 14  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-----FLHS 425
           L  Y +     +++ E C N +L  WL  K     W           +  W      +H+
Sbjct: 74  LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW---------ERKSYWKNMLEAVHT 123
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEY- 482
             +  IVH D+KP N L+      KL DFG++  +  D       S+V GT  Y+ PE  
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 181
Query: 483 --RSNCKVNS--------SGDVYSFGIVLLQILSGKKA--KVLTRAGSALELADPKLDRE 530
              S+ + N           DV+S G +L  +  GK    +++ +      + DP  + E
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241
Query: 531 YSIEAFDLTLQLALSCTALTHQRPPMEQVFV 561
           +  +  +  LQ  L C     +R P +++ +
Sbjct: 242 FP-DIPEKDLQDVLKCCL---KRDPKQRISI 268

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 76  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFG +K++   E  Y +   +    +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 33/228 (14%)
Query: 307 VHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-EGNVETFVREV---ASSS 361
           + YA++   E+ ++G+G  G+V K + + ++++ AIK I + E  + T + EV   AS +
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 362 H---VRH-------PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
           H   VR+        N V  +    +    F+  E C N  L + +  ++      +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI----DI----- 462
           +       L ++HS     I+HRD+KP NI +  +   K+ DFGL+K +    DI     
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 463 ----GETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQIL 505
               G +   +   GT  Y+  E        N   D+YS GI+  +++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 42/271 (15%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVA 370
           L  IG G + KV++      Q  AIK++  E      ++++  E+A  + ++     ++ 
Sbjct: 13  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 72
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW-----FLHS 425
           L  Y +     +++ E C N +L  WL  K     W           +  W      +H+
Sbjct: 73  LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW---------ERKSYWKNMLEAVHT 122
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEY- 482
             +  IVH D+KP N L+      KL DFG++  +  D       S+V GT  Y+ PE  
Sbjct: 123 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 180
Query: 483 --RSNCKVNS--------SGDVYSFGIVLLQILSGKKA--KVLTRAGSALELADPKLDRE 530
              S+ + N           DV+S G +L  +  GK    +++ +      + DP  + E
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 240
Query: 531 YSIEAFDLTLQLALSCTALTHQRPPMEQVFV 561
           +  +  +  LQ  L C     +R P +++ +
Sbjct: 241 FP-DIPEKDLQDVLKCCL---KRDPKQRISI 267

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 318 NLIGEGITGKVYKGKLSNNQHV-AIKHITNEG---NVETFVREVASSSHVRHPNLVALLG 373
           +++G+G T  V++G+      + AIK   N      V+  +RE      + H N+V L  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 374 YC--LRVDECFLIYELCPNGNLAEWLFGKDKC--LSWIQRLEIAIDSARGLWFLHSYSEG 429
                      LI E CP G+L   L        L   + L +  D   G+  L    E 
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---REN 131
Query: 430 CIVHRDIKPTNIL--LGPNFEA--KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
            IVHR+IKP NI+  +G + ++  KL+DFG ++ ++  E + S  + GT  YL P+    
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYER 189
Query: 486 C--------KVNSSGDVYSFGIVLLQILSG 507
                    K  ++ D++S G+      +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 309 YATEKLNELNLIGEGITGKV---YKGKLSNNQH--VAIKHITNEG--NVETFVREVASSS 361
           +    L  ++ +G+G  G V       L +N    VA+K + + G      F RE+    
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 362 HVRHPNLVALLG--YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
            +    +V   G  Y        L+ E  P+G L ++L          QR    +D++R 
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----------QRHRARLDASRL 117
Query: 420 LWFLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           L +     +G         VHRD+   NIL+      K++DFGL+K++ + + Y      
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 473 GT---FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           G    F Y  PE  S+   +   DV+SFG+VL ++ +
Sbjct: 178 GQSPIFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 115/266 (43%), Gaps = 32/266 (12%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVA 370
           L  IG G + KV++      Q  AIK++  E      ++++  E+A  + ++     ++ 
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L  Y +     +++ E C N +L  WL  K     W ++          L  +H+  +  
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK----NMLEAVHTIHQHG 175
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEY---RSN 485
           IVH D+KP N L+      KL DFG++  +  D       S+V GT  Y+ PE     S+
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSS 233
Query: 486 CKVNS--------SGDVYSFGIVLLQILSGKKA--KVLTRAGSALELADPKLDREYSIEA 535
            + N           DV+S G +L  +  GK    +++ +      + DP  + E+  + 
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP-DI 292
Query: 536 FDLTLQLALSCTALTHQRPPMEQVFV 561
            +  LQ  L C     +R P +++ +
Sbjct: 293 PEKDLQDVLKCCL---KRDPKQRISI 315

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 314 LNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPN 367
            + L L+G+G  GKV   +  +  ++ A+K +  E       V   V E     + RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 368 LVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           L AL  Y  +  +  CF++     NG    +   +++  +  +      +    L +LHS
Sbjct: 67  LTAL-KYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                +V+RDIK  N++L  +   K++DFGL K   I +        GT  YL PE   +
Sbjct: 124 RD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKXFCGTPEYLAPEVLED 179
Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
                + D +  G+V+ +++ G+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVA 370
           L L+G+G  GKV   +  +  ++ A+K +  E       V   V E     + RHP L A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 371 LLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           L  Y  +  +  CF++     NG    +   +++  +  +      +    L +LHS   
Sbjct: 70  L-KYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD- 125
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             +V+RDIK  N++L  +   K++DFGL K   I +        GT  YL PE   +   
Sbjct: 126 --VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 489 NSSGDVYSFGIVLLQILSGK 508
             + D +  G+V+ +++ G+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 314 LNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPN 367
            + L L+G+G  GKV   +  +  ++ A+K +  E       V   V E     + RHP 
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 368 LVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           L AL  Y  +  +  CF++     NG    +   +++  +  +      +    L +LHS
Sbjct: 70  LTAL-KYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 126
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                +V+RDIK  N++L  +   K++DFGL K   I +        GT  YL PE   +
Sbjct: 127 RD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLED 182
Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
                + D +  G+V+ +++ G+
Sbjct: 183 NDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 83  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 135
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFG +K++   E  Y +   +    +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++  G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 76  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 128
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 78  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 130
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFG +K++   E  Y +   +    +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 77/188 (40%), Gaps = 26/188 (13%)
Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITN---E 347
            +Q K     R  I E+H           I  G  G V  G  S    VAIK + N   +
Sbjct: 1   SMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 348 GNV----------ETFVREVASSSHVRHPNLVALLGYCLRVDE-----CFLIYELCPNGN 392
           G            +  +RE+   +H  HPN++ L    +  +E      +L+ EL    +
Sbjct: 61  GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTD 119
Query: 393 LAEWLFGKDKCLS--WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK 450
           LA+ +  +   +S   IQ     I     L  LH   E  +VHRD+ P NILL  N +  
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHI-----LLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174
Query: 451 LSDFGLSK 458
           + DF L++
Sbjct: 175 ICDFNLAR 182

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 314 LNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPN 367
            + L L+G+G  GKV   +  +  ++ A+K +  E       V   V E     + RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 368 LVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           L AL  Y  +  +  CF++     NG    +   +++  +  +      +    L +LHS
Sbjct: 67  LTAL-KYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                +V+RDIK  N++L  +   K++DFGL K   I +        GT  YL PE   +
Sbjct: 124 RD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLED 179
Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
                + D +  G+V+ +++ G+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVA 370
           L L+G+G  GKV   +  +  ++ A+K +  E       V   V E     + RHP L A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 371 LLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           L  Y  +  +  CF++     NG    +   +++  +  +      +    L +LHS   
Sbjct: 70  L-KYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD- 125
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             +V+RDIK  N++L  +   K++DFGL K   I +        GT  YL PE   +   
Sbjct: 126 --VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 489 NSSGDVYSFGIVLLQILSGK 508
             + D +  G+V+ +++ G+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 313 KLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVR 364
           +  ++ ++  G  G VYKG            VAIK +   T+    +  + E    + V 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSAR 418
           +P++  LLG CL      LI +L P G L +++       G    L+W       +  A+
Sbjct: 83  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 135
Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGY 477
           G+ +L       +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +  E   +       DV+S+G+ + ++++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVA 370
           L L+G+G  GKV   +  +  ++ A+K +  E       V   V E     + RHP L A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 371 LLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           L  Y  +  +  CF++     NG    +   +++  +  +      +    L +LHS   
Sbjct: 70  L-KYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD- 125
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             +V+RDIK  N++L  +   K++DFGL K   I +        GT  YL PE   +   
Sbjct: 126 --VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 489 NSSGDVYSFGIVLLQILSGK 508
             + D +  G+V+ +++ G+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 83
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 129
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++    
Sbjct: 130 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVP 186
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 187 FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 24/172 (13%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQ 408
           + E   RE +    ++HP++V LL         ++++E         ++ G D C   ++
Sbjct: 69  STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE---------FMDGADLCFEIVK 119
Query: 409 RLE--------IAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGP---NFEAKLSDFGL 456
           R +        +A    R +     Y  +  I+HRD+KP N+LL     +   KL DFG+
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGV 179
Query: 457 SKVIDIGETYASSEVR-GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           +  I +GE+   +  R GT  ++ PE           DV+  G++L  +LSG
Sbjct: 180 A--IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 314 LNELNLIGEGITGKVY-KGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPN 367
            N L ++G+G  GKV    +   ++  A+K      +  + +VE  + E    +    P 
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 368 LVALLGYCLR-VDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLW 421
            +  L  C + +D  + + E    G+L   +     F +   + +    EIAI    GL+
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--EIAI----GLF 135
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           FL S     I++RD+K  N++L      K++DFG+ K  +I +   +    GT  Y+ PE
Sbjct: 136 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFCGTPDYIAPE 191
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
             +      S D ++FG++L ++L+G+
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 314 LNELNLIGEGITGKVY-KGKLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPN 367
            N L ++G+G  GKV    +   ++  A+K      +  + +VE  + E    +    P 
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 368 LVALLGYCLR-VDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLW 421
            +  L  C + +D  + + E    G+L   +     F +   + +    EIAI    GL+
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--EIAI----GLF 456
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           FL S     I++RD+K  N++L      K++DFG+ K  +I +   +    GT  Y+ PE
Sbjct: 457 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFCGTPDYIAPE 512
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
             +      S D ++FG++L ++L+G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 37/176 (21%)
Query: 365 HPNLVALLGYCLRVDECFLI--YELCPNGNLAEWLFGKD------KCLSWIQRLEIAIDS 416
           HPN++    YC    + FL    ELC N NL + +  K+      K       + +    
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILL-------------GPNFEAKLSDFGLSKVIDIG 463
           A G+  LHS     I+HRD+KP NIL+               N    +SDFGL K +D G
Sbjct: 125 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 464 ETYASSEVR---GTFGYLDPE-------YRSNCKVNSSGDVYSFGIVLLQILSGKK 509
           ++   + +    GT G+  PE        ++  ++  S D++S G V   ILS  K
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 309 YATEKLNELNLIGEGITGKV---YKGKLSNNQH--VAIKHITNEG--NVETFVREVASSS 361
           +    L  ++ +G+G  G V       L +N    VA+K + + G      F RE+    
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 362 HVRHPNLVALLG--YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
            +    +V   G  Y     E  L+ E  P+G L ++L          QR    +D++R 
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL----------QRHRARLDASRL 113
Query: 420 LWFLHSYSEGC-------IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           L +     +G         VHRD+   NIL+      K++DFGL+K++ + +        
Sbjct: 114 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREP 173
Query: 473 G--TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           G     +  PE  S+   +   DV+SFG+VL ++ +
Sbjct: 174 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYCLRV 378
           IG+G  G+V++GK    + VA+K  ++      F   E+  +  +RH N++  +    + 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 75
Query: 379 D----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SYSEG 429
           +    + +L+ +   +G+L ++L      +  +  +++A+ +A GL  LH     +  + 
Sbjct: 76  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 133
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGL-------SKVIDIGETYASSEVRGTFGYLDPEY 482
            I HRD+K  NIL+  N    ++D GL       +  IDI    A +   GT  Y+ PE 
Sbjct: 134 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRVGTKRYMAPEV 189
Query: 483 RSNCKVN-------SSGDVYSFGIVLLQI 504
             +  +N          D+Y+ G+V  +I
Sbjct: 190 LDDS-INMKHFESFKRADIYAMGLVFWEI 217

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 365 HPNLVALLGYCL--RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR---G 419
           H   +  L Y    + D C L+  +   G++   ++  D+     Q       +A+   G
Sbjct: 243 HSRFIVSLAYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L  LH  +   I++RD+KP N+LL  +   ++SD GL+  +  G+T  +    GT G++ 
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMA 357
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE     + + S D ++ G+ L ++++ +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYCLRV 378
           IG+G  G+V++GK    + VA+K  ++      F   E+  +  +RH N++  +    + 
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 95
Query: 379 D----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SYSEG 429
           +    + +L+ +   +G+L ++L      +  +  +++A+ +A GL  LH     +  + 
Sbjct: 96  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 153
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGL-------SKVIDIGETYASSEVRGTFGYLDPEY 482
            I HRD+K  NIL+  N    ++D GL       +  IDI    A +   GT  Y+ PE 
Sbjct: 154 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRVGTKRYMAPEV 209
Query: 483 RSNCKVN-------SSGDVYSFGIVLLQI 504
             +  +N          D+Y+ G+V  +I
Sbjct: 210 LDDS-INMKHFESFKRADIYAMGLVFWEI 237

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 33/172 (19%)
Query: 365 HPNLVALLGYCLRVDECFLI--YELCPNGNLAEWLFGKD------KCLSWIQRLEIAIDS 416
           HPN++    YC    + FL    ELC N NL + +  K+      K       + +    
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILL-------------GPNFEAKLSDFGLSKVIDIG 463
           A G+  LHS     I+HRD+KP NIL+               N    +SDFGL K +D G
Sbjct: 143 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 464 ETYASSEVR---GTFGYLDPEY---RSNCKVNSSGDVYSFGIVLLQILSGKK 509
           +      +    GT G+  PE     +  ++  S D++S G V   ILS  K
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYCLRV 378
           IG+G  G+V++GK    + VA+K  ++      F   E+  +  +RH N++  +    + 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 379 D----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SYSEG 429
           +    + +L+ +   +G+L ++L      +  +  +++A+ +A GL  LH     +  + 
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 166
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGL-------SKVIDIGETYASSEVRGTFGYLDPEY 482
            I HRD+K  NIL+  N    ++D GL       +  IDI    A +   GT  Y+ PE 
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRVGTKRYMAPEV 222
Query: 483 RSNCKVN-------SSGDVYSFGIVLLQI 504
             +  +N          D+Y+ G+V  +I
Sbjct: 223 LDDS-INMKHFESFKRADIYAMGLVFWEI 250

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 33/172 (19%)
Query: 365 HPNLVALLGYCLRVDECFLI--YELCPNGNLAEWLFGKD------KCLSWIQRLEIAIDS 416
           HPN++    YC    + FL    ELC N NL + +  K+      K       + +    
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILL-------------GPNFEAKLSDFGLSKVIDIG 463
           A G+  LHS     I+HRD+KP NIL+               N    +SDFGL K +D G
Sbjct: 143 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 464 ETYASSEVR---GTFGYLDPEY---RSNCKVNSSGDVYSFGIVLLQILSGKK 509
           +      +    GT G+  PE     +  ++  S D++S G V   ILS  K
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYCLRV 378
           IG+G  G+V++GK    + VA+K  ++      F   E+  +  +RH N++  +    + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 379 D----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SYSEG 429
           +    + +L+ +   +G+L ++L      +  +  +++A+ +A GL  LH     +  + 
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 127
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGL-------SKVIDIGETYASSEVRGTFGYLDPEY 482
            I HRD+K  NIL+  N    ++D GL       +  IDI    A +   GT  Y+ PE 
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRVGTKRYMAPEV 183
Query: 483 RSNCKVN-------SSGDVYSFGIVLLQI 504
             +  +N          D+Y+ G+V  +I
Sbjct: 184 LDDS-INMKHFESFKRADIYAMGLVFWEI 211

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 365 HPNLVALLGYCL--RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR---G 419
           H   +  L Y    + D C L+  +   G++   ++  D+     Q       +A+   G
Sbjct: 243 HSRFIVSLAYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L  LH  +   I++RD+KP N+LL  +   ++SD GL+  +  G+T  +    GT G++ 
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMA 357
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE     + + S D ++ G+ L ++++ +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYCLRV 378
           IG+G  G+V++GK    + VA+K  ++      F   E+  +  +RH N++  +    + 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 70
Query: 379 D----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SYSEG 429
           +    + +L+ +   +G+L ++L      +  +  +++A+ +A GL  LH     +  + 
Sbjct: 71  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 128
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGL-------SKVIDIGETYASSEVRGTFGYLDPEY 482
            I HRD+K  NIL+  N    ++D GL       +  IDI    A +   GT  Y+ PE 
Sbjct: 129 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRVGTKRYMAPEV 184
Query: 483 RSNCKVN-------SSGDVYSFGIVLLQI 504
             +  +N          D+Y+ G+V  +I
Sbjct: 185 LDDS-INMKHFESFKRADIYAMGLVFWEI 212

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 320 IGEGITG--KVYKGKLSNNQHVAIKHITNEGNVETFV-REVASSSHVRHPNLVALLGYCL 376
           IG G  G  ++ + K SN + VA+K+I     ++  V RE+ +   +RHPN+V      L
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 377 RVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                 ++ E    G L E +     F +D+   + Q+L        G+ + H+     +
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCHAMQ---V 136
Query: 432 VHRDIKPTNILL--GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            HRD+K  N LL   P    K+  FG SK   +  +   S V GT  Y+ PE     + +
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPKSTV-GTPAYIAPEVLLKKEYD 194
Query: 490 SS-GDVYSFGIVLLQILSG 507
               DV+S G+ L  +L G
Sbjct: 195 GKVADVWSCGVTLYVMLVG 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+  FGL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 365 HPNLVALLGYCL--RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR---G 419
           H   +  L Y    + D C L+  +   G++   ++  D+     Q       +A+   G
Sbjct: 243 HSRFIVSLAYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L  LH  +   I++RD+KP N+LL  +   ++SD GL+  +  G+T  +    GT G++ 
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMA 357
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE     + + S D ++ G+ L ++++ +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYCLRV 378
           IG+G  G+V++GK    + VA+K  ++      F   E+  +  +RH N++  +    + 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 72
Query: 379 D----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SYSEG 429
           +    + +L+ +   +G+L ++L      +  +  +++A+ +A GL  LH     +  + 
Sbjct: 73  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 130
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGL-------SKVIDIGETYASSEVRGTFGYLDPEY 482
            I HRD+K  NIL+  N    ++D GL       +  IDI    A +   GT  Y+ PE 
Sbjct: 131 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRVGTKRYMAPEV 186
Query: 483 RSNCKVN-------SSGDVYSFGIVLLQI 504
             +  +N          D+Y+ G+V  +I
Sbjct: 187 LDDS-INMKHFESFKRADIYAMGLVFWEI 214

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 365 HPNLVALLGYCL--RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR---G 419
           H   +  L Y    + D C L+  +   G++   ++  D+     Q       +A+   G
Sbjct: 243 HSRFIVSLAYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L  LH  +   I++RD+KP N+LL  +   ++SD GL+  +  G+T  +    GT G++ 
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMA 357
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE     + + S D ++ G+ L ++++ +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 106/230 (46%), Gaps = 33/230 (14%)
Query: 298 GCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-E 356
           G P    R V     ++  L  +G+G  G+V++G     ++VA+K  ++      F   E
Sbjct: 26  GLPFLVQRTV---ARQITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETE 81
Query: 357 VASSSHVRHPNLVALLGYCL----RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
           + ++  +RH N++  +   +       + +LI      G+L ++L  +   L  +  L I
Sbjct: 82  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRI 139
Query: 413 AIDSARGLWFLH-----SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-------I 460
            +  A GL  LH     +  +  I HRD+K  NIL+  N +  ++D GL+ +       +
Sbjct: 140 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 199
Query: 461 DIGETYASSEVRGTFGYLDPE-YRSNCKVN-----SSGDVYSFGIVLLQI 504
           D+G    ++   GT  Y+ PE      +V+        D+++FG+VL ++
Sbjct: 200 DVG----NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ D GL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTF 475
           ARG+ FL S    CI HRD+   NILL  N   K+ DFGL++ I     Y    + R   
Sbjct: 209 ARGMEFLSSRK--CI-HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPL 265
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +   ++  DV+S+G++L +I S
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ D GL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIKHITNE-GNVETFVREVASSSHV-----RHPNLV 369
           L +IG G   KV   +L     + A+K +  E  N +  +  V +  HV      HP LV
Sbjct: 25  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 84
Query: 370 ALLGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
            L   C + +   F + E    G+L   +  + K      R   A + +  L +LH   E
Sbjct: 85  GLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---E 139
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGTFGYLDPEYRSNCK 487
             I++RD+K  N+LL      KL+D+G+ K  +  G+T  +S   GT  Y+ PE      
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRGED 197
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
              S D ++ G+++ ++++G+
Sbjct: 198 YGFSVDWWALGVLMFEMMAGR 218

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 114/266 (42%), Gaps = 32/266 (12%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVA 370
           L  IG G + KV++      Q  AIK++  E      ++++  E+A  + ++     ++ 
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L  Y +     +++ E C N +L  WL  K     W ++          L  +H+  +  
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK----NMLEAVHTIHQHG 175
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVI--DIGETYASSEVRGTFGYLDPEY---RSN 485
           IVH D+KP N L+      KL DFG++  +  D       S+V G   Y+ PE     S+
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSS 233
Query: 486 CKVNS--------SGDVYSFGIVLLQILSGKKA--KVLTRAGSALELADPKLDREYSIEA 535
            + N           DV+S G +L  +  GK    +++ +      + DP  + E+  + 
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP-DI 292
Query: 536 FDLTLQLALSCTALTHQRPPMEQVFV 561
            +  LQ  L C     +R P +++ +
Sbjct: 293 PEKDLQDVLKCCL---KRDPKQRISI 315

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 121
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 122 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 178
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 75/176 (42%), Gaps = 37/176 (21%)
Query: 365 HPNLVALLGYCLRVDECFLI--YELCPNGNLAEWLFGKD------KCLSWIQRLEIAIDS 416
           HPN++    YC    + FL    ELC N NL + +  K+      K       + +    
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILL-------------GPNFEAKLSDFGLSKVIDIG 463
           A G+  LHS     I+HRD+KP NIL+               N    +SDFGL K +D G
Sbjct: 125 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 464 ETYASSEVR---GTFGYLDPE-------YRSNCKVNSSGDVYSFGIVLLQILSGKK 509
           +      +    GT G+  PE        ++  ++  S D++S G V   ILS  K
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEG----NVETFVREV 357
           TI EV    E+   L+ +G G  G V           VA+K ++       + +   RE+
Sbjct: 16  TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 358 ASSSHVRHPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
               H++H N++ LL            ++ +L+  L    +L   +  +      +Q L 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 131
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
             I   RGL ++HS     I+HRD+KP+N+ +  + E K+ D GL++  D        E+
Sbjct: 132 YQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTD-------DEM 179
Query: 472 RG---TFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGK 508
            G   T  Y  PE   N    N + D++S G ++ ++L+G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 86
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 132
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++  + 
Sbjct: 133 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 189
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 190 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIKHITNE-GNVETFVREVASSSHV-----RHPNLV 369
           L +IG G   KV   +L     + A+K +  E  N +  +  V +  HV      HP LV
Sbjct: 10  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 69
Query: 370 ALLGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
            L   C + +   F + E    G+L   +  + K      R   A + +  L +LH   E
Sbjct: 70  GLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---E 124
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGTFGYLDPEYRSNCK 487
             I++RD+K  N+LL      KL+D+G+ K  +  G+T  +S   GT  Y+ PE      
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRGED 182
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
              S D ++ G+++ ++++G+
Sbjct: 183 YGFSVDWWALGVLMFEMMAGR 203

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 318 NLIGEGITGKVYKGKLSNNQHV-AIKHITNEG---NVETFVREVASSSHVRHPNLVALLG 373
           +++G+G T  V++G+      + AIK   N      V+  +RE      + H N+V L  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 374 YC--LRVDECFLIYELCPNGNLAEWLFGKDKC--LSWIQRLEIAIDSARGLWFLHSYSEG 429
                      LI E CP G+L   L        L   + L +  D   G+  L    E 
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 430 CIVHRDIKPTNIL--LGPNFEA--KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
            IVHR+IKP NI+  +G + ++  KL+DFG ++ ++  E +    + GT  YL P+    
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMYER 189
Query: 486 C--------KVNSSGDVYSFGIVLLQILSG 507
                    K  ++ D++S G+      +G
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYC 375
           L  +G+G  G+V++G     ++VA+K  ++      F   E+ ++  +RH N++  +   
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 376 L----RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SY 426
           +       + +LI      G+L ++L  +   L  +  L I +  A GL  LH     + 
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-------IDIGETYASSEVRGTFGYLD 479
            +  I HRD+K  NIL+  N +  ++D GL+ +       +D+G    ++   GT  Y+ 
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG----NNPRVGTKRYMA 185
Query: 480 PEY-----RSNC-KVNSSGDVYSFGIVLLQI 504
           PE      + +C       D+++FG+VL ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHV-AIKHITNE-GNVETFVREVASSSHV-----R 364
           +  + L +IG G   KV   +L     + A+K +  E  N +  +  V +  HV      
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 365 HPNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           HP LV L   C + +   F + E    G+L   +  + K      R   A + +  L +L
Sbjct: 69  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYL 126
Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGTFGYLDPEY 482
           H   E  I++RD+K  N+LL      KL+D+G+ K  +  G+T  +S   GT  Y+ PE 
Sbjct: 127 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 181
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
                   S D ++ G+++ ++++G+
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYC 375
           L  +G+G  G+V++G     ++VA+K  ++      F   E+ ++  +RH N++  +   
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 376 L----RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-----SY 426
           +       + +LI      G+L ++L  +   L  +  L I +  A GL  LH     + 
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-------IDIGETYASSEVRGTFGYLD 479
            +  I HRD+K  NIL+  N +  ++D GL+ +       +D+G    ++   GT  Y+ 
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG----NNPRVGTKRYMA 185
Query: 480 PEY-----RSNC-KVNSSGDVYSFGIVLLQI 504
           PE      + +C       D+++FG+VL ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           IR++    E    + +IG G  G+V   +  + + V A+K      +    +   F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 358 ASSSHVRHPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQ----RLEI 412
              +    P +V L  Y  + D   +++ E  P G+L   +   D    W +     + +
Sbjct: 126 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 184
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+D+   + F         +HRD+KP N+LL  +   KL+DFG    ++           
Sbjct: 185 ALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 473 GTFGYLDPE-YRSNCKVNSSG---DVYSFGIVLLQILSG 507
           GT  Y+ PE  +S       G   D +S G+ L ++L G
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++    
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 320 IGEGITG--KVYKGKLSNNQHVAIKHITNEGNVETFV-REVASSSHVRHPNLVALLGYCL 376
           IG G  G  ++ + K SN + VA+K+I     ++  V RE+ +   +RHPN+V      L
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 377 RVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                 ++ E    G L E +     F +D+   + Q+L        G+ + H+     +
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCHAMQ---V 136
Query: 432 VHRDIKPTNILL--GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            HRD+K  N LL   P    K+  FG SK   +       +  GT  Y+ PE     + +
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ--PKDTVGTPAYIAPEVLLKKEYD 194
Query: 490 SS-GDVYSFGIVLLQILSG 507
               DV+S G+ L  +L G
Sbjct: 195 GKVADVWSCGVTLYVMLVG 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           IR++    E    + +IG G  G+V   +  + + V A+K      +    +   F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 358 ASSSHVRHPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQ----RLEI 412
              +    P +V L  Y  + D   +++ E  P G+L   +   D    W +     + +
Sbjct: 126 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 184
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+D+   + F         +HRD+KP N+LL  +   KL+DFG    ++           
Sbjct: 185 ALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 473 GTFGYLDPE-YRSNCKVNSSG---DVYSFGIVLLQILSG 507
           GT  Y+ PE  +S       G   D +S G+ L ++L G
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           IR++    E    + +IG G  G+V   +  + + V A+K      +    +   F  E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 358 ASSSHVRHPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQ----RLEI 412
              +    P +V L  Y  + D   +++ E  P G+L   +   D    W +     + +
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 179
Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A+D+   + F         +HRD+KP N+LL  +   KL+DFG    ++           
Sbjct: 180 ALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 473 GTFGYLDPE-YRSNCKVNSSG---DVYSFGIVLLQILSG 507
           GT  Y+ PE  +S       G   D +S G+ L ++L G
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 86  KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 139
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           D+KP N+L     PN   KL+DFG +K  +     + +E   T  Y+ PE     K + S
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKS 197
Query: 492 GDVYSFGIVLLQILSG 507
            D++S G+++  +L G
Sbjct: 198 CDMWSLGVIMYILLCG 213

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 112/243 (46%), Gaps = 34/243 (13%)
Query: 320 IGEGITGKVYK-GKLSNNQHVAIKHITNEGNVETFVR-EVASSSHVRHPNLVALLGYCLR 377
           +G G  G V++  + S+ +    K +  +G  +  V+ E++  +  RH N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 378 VDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
           ++E  +I+E     ++ E +        + + +S++ ++         L FLHS++ G  
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQV------CEALQFLHSHNIG-- 124
Query: 432 VHRDIKPTNILLGPNFEA--KLSDFGLSKVIDIGETYASSEVRGTFG---YLDPEYRSNC 486
            H DI+P NI+      +  K+ +FG ++ +  G+ +     R  F    Y  PE   + 
Sbjct: 125 -HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-----RLLFTAPEYYAPEVHQHD 178
Query: 487 KVNSSGDVYSFGIVLLQILSG-------KKAKVLTRAGSALELADPKLDREYSIEAFDLT 539
            V+++ D++S G ++  +LSG          +++    +A    D +  +E SIEA D  
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 540 LQL 542
            +L
Sbjct: 239 DRL 241

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIKHITNE-GNVETFVREVASSSHV-----RHPNLV 369
           L +IG G   KV   +L     + A++ +  E  N +  +  V +  HV      HP LV
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 370 ALLGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
            L   C + +   F + E    G+L   +  + K      R   A + +  L +LH   E
Sbjct: 117 GLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---E 171
Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKV-IDIGETYASSEVRGTFGYLDPEYRSNCK 487
             I++RD+K  N+LL      KL+D+G+ K  +  G+T  +S   GT  Y+ PE      
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGED 229
Query: 488 VNSSGDVYSFGIVLLQILSGK 508
              S D ++ G+++ ++++G+
Sbjct: 230 YGFSVDWWALGVLMFEMMAGR 250

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 132 KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 185
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 241 DKSCDMWSLGVIMYILLCG 259

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++   L  IG G  G V   Y   L  N  VAIK ++    N+ + +   RE+     V 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N++ LL             + +++ EL  + NL              Q +++ +D  R
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++    G ++    
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE         + D++S G ++ +++  K
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 94  KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 147
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 148 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 202
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 203 DKSCDMWSLGVIMYILLCG 221

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 138 KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 191
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 192 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 246
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 247 DKSCDMWSLGVIMYILLCG 265

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 88  KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 141
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 196
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 197 DKSCDMWSLGVIMYILLCG 215

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 86  KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 139
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 194
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 195 DKSCDMWSLGVIMYILLCG 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 93  KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 146
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 147 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 201
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 202 DKSCDMWSLGVIMYILLCG 220

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 88  KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 141
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 196
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 197 DKSCDMWSLGVIMYILLCG 215

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 92  KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 145
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 146 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 200
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 201 DKSCDMWSLGVIMYILLCG 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 87  KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 140
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 141 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 195
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 196 DKSCDMWSLGVIMYILLCG 214

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 102 KCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 155
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 156 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 210
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 211 DKSCDMWSLGVIMYILLCG 229

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 15/154 (9%)
Query: 318 NLIGEGITGKVYKGKLSN-NQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALL 372
           +LIG G  G VY     N N++VAIK +     +  + +  +RE+   + ++   ++ L 
Sbjct: 34  HLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLH 93
Query: 373 GYC-----LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
                   L+ DE +++ E+  + +L + LF     L+      I  +   G  F+H   
Sbjct: 94  DLIIPEDLLKFDELYIVLEIA-DSDLKK-LFKTPIFLTEQHVKTILYNLLLGEKFIH--- 148
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           E  I+HRD+KP N LL  +   K+ DFGL++ I+
Sbjct: 149 ESGIIHRDLKPANCLLNQDCSVKICDFGLARTIN 182

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 12/198 (6%)
Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIKH-----ITNEGNVETFVREVASSSHVR-HPNLV 369
           + ++G+G  GKV   ++     + A+K      I  + +VE  + E    S  R HP L 
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
            L       D  F + E    G+L  +   K +     +    A +    L FLH     
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEIISALMFLHDKG-- 144
Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            I++RD+K  N+LL      KL+DFG+ K   I     ++   GT  Y+ PE        
Sbjct: 145 -IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 490 SSGDVYSFGIVLLQILSG 507
            + D ++ G++L ++L G
Sbjct: 203 PAVDWWAMGVLLYEMLCG 220

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           ++LN L  + E  +G+++KG+   N  + +K +     +      F  E        HPN
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 368 LVALLGYCLR--VDECFLIYELCPNGNLAEWLF-GKDKCLSWIQRLEIAIDSARGLWFLH 424
           ++ +LG C         LI    P G+L   L  G +  +   Q ++ A+D ARG+ FLH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
           +  E  I    +   ++++  +  A++S      + D+  ++ S        ++ PE   
Sbjct: 129 TL-EPLIPRHALNSRSVMIDEDMTARIS------MADVKFSFQSPGRMYAPAWVAPEALQ 181
Query: 485 NCKVNS---SGDVYSFGIVLLQILS 506
               ++   S D++SF ++L ++++
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVA----SSSHVRHP 366
           + L  +  +G G  G V K + + + Q  A+K I    N +   R +     S   V  P
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 367 NLVALLGYCLRVDECFLIYELCPNG--NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
             V   G   R  + ++  EL         + +  K + +      +IA+   + L  LH
Sbjct: 94  FTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 153
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK--VIDIGETYASSEVRGTFGYLDPEY 482
           S  +  ++HRD+KP+N+L+    + K  DFG+S   V D+ +   +    G   Y  PE 
Sbjct: 154 S--KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA----GCKPYXAPE- 206
Query: 483 RSNCKVNSSG-----DVYSFGIVLLQI 504
           R N ++N  G     D++S GI  +++
Sbjct: 207 RINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  ++           V  
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQ---------QAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      K++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 368 LVALLGYCLRVDECFLIYE-LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E + P  +L +++          +R  +  + AR   W +  
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFI---------TERGALQEELARSFFWQVLE 125
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 182
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHI----TNEGNVETFVREVASSSHVR-HPNLVALLG 373
           +G+G  G V+K       + VA+K I     N  + +   RE+   + +  H N+V LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 374 YCLRVD---ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
             LR D   + +L+++       A     +   L  + +  +     + + +LHS   G 
Sbjct: 77  -VLRADNDRDVYLVFDYMETDLHA---VIRANILEPVHKQYVVYQLIKVIKYLHS---GG 129
Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKV------------IDIGETYAS--------SE 470
           ++HRD+KP+NILL      K++DFGLS+             + I E   +        ++
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 471 VRGTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQILSGK 508
              T  Y  PE    + K     D++S G +L +IL GK
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQR--LEIAIDSARGLWFLH 424
           ++ LL +  R D   LI E   P  +L +++  +      + R      +++ R     H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR-----H 125
Query: 425 SYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY- 482
            ++ G ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  PE+ 
Sbjct: 126 CHNXG-VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSG 507
           R +     S  V+S GI+L  ++ G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 12/195 (6%)
Query: 319 LIGEGITGKVYK-GKLSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYC 375
           ++G G  G+V+K  + +    +A K I   G  + E    E++  + + H NL+ L    
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
              ++  L+ E    G L + +  +   L+ +  +        G+  +H      I+H D
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLD 212
Query: 436 IKPTNILLGPNFEAK---LSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSG 492
           +KP NIL   N +AK   + DFGL++     E    +   GT  +L PE  +   V+   
Sbjct: 213 LKPENILC-VNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSFPT 269
Query: 493 DVYSFGIVLLQILSG 507
           D++S G++   +LSG
Sbjct: 270 DMWSVGVIAYMLLSG 284

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 64/137 (46%), Gaps = 21/137 (15%)
Query: 381 CFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
           C LI   C  G     LF +     D+  +  +  EI  D    + FLHS++   I HRD
Sbjct: 100 CLLIIMECMEGGE---LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRD 153
Query: 436 IKPTNILLGPNFE---AKLSDFGLSKVIDIGETYASSEVRGTFG--YLDPEYRSNCKVNS 490
           +KP N+L     +    KL+DFG +K     ET  ++     +   Y+ PE     K + 
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAK-----ETTQNALQTPCYTPYYVAPEVLGPEKYDK 208
Query: 491 SGDVYSFGIVLLQILSG 507
           S D++S G+++  +L G
Sbjct: 209 SCDMWSLGVIMYILLCG 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 64/137 (46%), Gaps = 21/137 (15%)
Query: 381 CFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
           C LI   C  G     LF +     D+  +  +  EI  D    + FLHS++   I HRD
Sbjct: 81  CLLIIMECMEGGE---LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRD 134
Query: 436 IKPTNILLGPNFE---AKLSDFGLSKVIDIGETYASSEVRGTFG--YLDPEYRSNCKVNS 490
           +KP N+L     +    KL+DFG +K     ET  ++     +   Y+ PE     K + 
Sbjct: 135 VKPENLLYTSKEKDAVLKLTDFGFAK-----ETTQNALQTPCYTPYYVAPEVLGPEKYDK 189
Query: 491 SGDVYSFGIVLLQILSG 507
           S D++S G+++  +L G
Sbjct: 190 SCDMWSLGVIMYILLCG 206

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 318 NLIGEGITGKVYKG-KLSNNQHVAIKHITNE-GNVETFV-REVASSSHVR-HPNLVALLG 373
           +++GEG   +V     L  +Q  A+K I  + G++ + V REV      + H N++ L+ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
           +    D  +L++E    G++   +  K +  + ++   +  D A  L FLH+     I H
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 434 RDIKPTNILL-GPN--FEAKLSDFGLSKVIDIG---ETYASSEVR---GTFGYLDPEYRS 484
           RD+KP NIL   PN     K+ DFGL   I +       ++ E+    G+  Y+ PE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 485 NCKVNSS-----GDVYSFGIVLLQILSG 507
                +S      D++S G++L  +LSG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++  +L  IG G  G V   +   L  N  VA+K ++    N+ + +   RE+     V 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVN 79
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q + + +D  R
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIHMELDHER 125
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++       +  + 
Sbjct: 126 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--ASTNFMMTP 182
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE         + D++S G ++ +++ G
Sbjct: 183 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 22/139 (15%)
Query: 380 ECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +C LI   C +G     LF +     D+  +  +  EI       + +LHS +   I HR
Sbjct: 132 KCLLIVXECLDGGE---LFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN---IAHR 185
Query: 435 DIKPTNILLG---PNFEAKLSDFGLSKVIDIGETYASSEVRG---TFGYLDPEYRSNCKV 488
           D+KP N+L     PN   KL+DFG +K     ET + + +     T  Y+ PE     K 
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D +S G++   +L G
Sbjct: 241 DKSCDXWSLGVIXYILLCG 259

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 307 VHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-EGNVETFVREV---ASSS 361
           + YA++   E+ ++G+G  G+V K + + ++++ AIK I + E  + T + EV   AS +
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLN 60
Query: 362 H---VRH-------PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
           H   VR+        N V       +    F+  E C N  L + +  ++      +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI----DI----- 462
           +       L ++HS     I+HR++KP NI +  +   K+ DFGL+K +    DI     
Sbjct: 121 LFRQILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 463 ----GETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQIL 505
               G +   +   GT  Y+  E        N   D YS GI+  + +
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 140
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 197
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 140
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 197
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEG-----NVETFVREVASSSHVRH 365
           ++   +  IG G  G+V   K +    H A+K +  +       +E  + E      V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G++   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      K++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEG-----NVETFVREVASSSHVRH 365
           ++   +  IG G  G+V   K +    H A+K +  +       +E  + E      V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G++   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      K++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 141
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 198
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           +HPN++ L          +L+ EL   G L + +  + K  S  +   +     + + +L
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL-RQKFFSEREASFVLHTIGKTVEYL 137
Query: 424 HSYSEGCIVHRDIKPTNILL---GPNFE-AKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           HS     +VHRD+KP+NIL      N E  ++ DFG +K +        +    T  ++ 
Sbjct: 138 HSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVA 193
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSG----------KKAKVLTRAGSA 519
           PE       +   D++S GI+L  +L+G             ++LTR GS 
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSG 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 126
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 183
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 125
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 182
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 168
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 225
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 141
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 198
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 141
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 198
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 153
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 210
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 154
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 211
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 325 TGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE 380
           TG  Y  K+ + Q V     I+H  NE  +            V  P LV L         
Sbjct: 65  TGNHYAMKILDKQKVVKLKEIEHTLNEKRI---------LQAVNFPFLVKLEFSFKDNSN 115
Query: 381 CFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
            +++ E  P G +   L     F +     +  ++ +  +      +LHS     +++RD
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------YLHSLD---LIYRD 166
Query: 436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
           +KP N+++      K++DFGL+K +  G T+    + GT  YL PE   +   N + D +
Sbjct: 167 LKPENLMIDQQGYIKVTDFGLAKRVK-GRTWX---LCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 496 SFGIVLLQILSG 507
           + G+++ ++ +G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVRH--PN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 154
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 211
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 153
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 210
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVRH--PN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 154
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 211
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 126
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 183
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 153
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 210
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 154
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 211
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 153
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 210
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 168
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 225
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 126
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 183
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 312 EKLNELNLIGEGITGKV---YKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVR 364
           ++  +L  IG G  G V   +   L  N  VA+K ++    N+ + +   RE+     V 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVN 81
Query: 365 HPNLVALLGYCL------RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
           H N+++LL             + +L+ EL  + NL              Q + + +D  R
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLC-------------QVIHMELDHER 127
Query: 419 GLWFL--------HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE 470
             + L        H +S G I+HRD+KP+NI++  +   K+ DFGL++       +  + 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTP 184
Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
              T  Y  PE        ++ D++S G ++ +++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 121
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 178
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 124
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 181
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 182 EWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           +HPN++ L          +L+ EL   G L + +  + K  S  +   +     + + +L
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL-RQKFFSEREASFVLHTIGKTVEYL 137
Query: 424 HSYSEGCIVHRDIKPTNILL---GPNFE-AKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           HS     +VHRD+KP+NIL      N E  ++ DFG +K +        +    T  ++ 
Sbjct: 138 HSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVA 193
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSG----------KKAKVLTRAGSA 519
           PE       +   D++S GI+L  +L+G             ++LTR GS 
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSG 243

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVRH--PN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 160
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 217
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVRH--PN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 173
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 230
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTF 475
           A+G+ FL S    CI HRD+   NILL      K+ DFGL++ I     Y    + R   
Sbjct: 203 AKGMEFLASRK--CI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +       DV+SFG++L +I S
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEG-----NVETFVREVASSSHVRH 365
           ++   +  IG G  G+V   K +    H A+K +  +       +E  + E      V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      K++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 121
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 178
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTF 475
           A+G+ FL S    CI HRD+   NILL      K+ DFGL++ I     Y    + R   
Sbjct: 210 AKGMEFLASRK--CI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +       DV+SFG++L +I S
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTF 475
           A+G+ FL S    CI HRD+   NILL      K+ DFGL++ I     Y    + R   
Sbjct: 208 AKGMEFLASRK--CI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +       DV+SFG++L +I S
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTF 475
           A+G+ FL S    CI HRD+   NILL      K+ DFGL++ I     Y    + R   
Sbjct: 201 AKGMEFLASRK--CI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            ++ PE   +       DV+SFG++L +I S
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 275 KRYYKSNPPAKIT-SFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKG-- 331
           K+++ S P A +       Q+ D    RY IR            +LIG G  G V +   
Sbjct: 31  KQHHSSKPTASMPRPHSDWQIPD----RYEIR------------HLIGTGSYGHVCEAYD 74
Query: 332 KLSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALLGYCL-----RVDECF 382
           KL   + VAIK I     +  + +  +RE+A  + + H ++V +L   +     + DE +
Sbjct: 75  KLEK-RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133
Query: 383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL 442
           ++ E+  +    + LF     L+ +    +  +   G+ ++HS     I+HRD+KP N L
Sbjct: 134 VVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCL 188
Query: 443 LGPNFEAKLSDFGLSKVIDIGET 465
           +  +   K+ DFGL++ +D  E 
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPEN 211

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKH-----ITNEGNVETFVR---EVASSSHVR--HPN 367
           L+G G  G VY G ++S+N  VAIKH     I++ G +    R   EV     V      
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 368 LVALLGYCLRVDECFLIYELC-PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL-WFLHS 425
           ++ LL +  R D   LI E   P  +L +++          +R  +  + AR   W +  
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQVLE 148
Query: 426 YSEGC----IVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
               C    ++HRDIK  NIL+  N  E KL DFG   ++   +    ++  GT  Y  P
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 205
Query: 481 EY-RSNCKVNSSGDVYSFGIVLLQILSG 507
           E+ R +     S  V+S GI+L  ++ G
Sbjct: 206 EWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/148 (23%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           +HPN++ L          +++ EL   G L + +  + K  S  +   +     + + +L
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYL 132
Query: 424 HSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           H+     +VHRD+KP+NIL     G     ++ DFG +K +        +    T  ++ 
Sbjct: 133 HAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFVA 188
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           PE       +++ D++S G++L  +L+G
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+++      K++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 309 YATEKLNELNLIGEGITGKVYK-GKLSNNQHVAIKH----ITNEGNVETFVREVASSSHV 363
           Y TE  +EL  IG G  G V+K  K  +    AIK     +    + +  +REV + + +
Sbjct: 7   YTTE-FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 364 -RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARG 419
            +H ++V         D   +  E C  G+LA+ +    + +S+ +  E+    +   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLG----PNF---EAKLSDFGLSKVI 460
           L ++HS S   +VH DIKP+NI +     PN    E    D+  +KV+
Sbjct: 126 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 170

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 309 YATEKLNELNLIGEGITGKVYK-GKLSNNQHVAIKH----ITNEGNVETFVREVASSSHV 363
           Y TE  +EL  IG G  G V+K  K  +    AIK     +    + +  +REV + + +
Sbjct: 9   YTTE-FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 364 -RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARG 419
            +H ++V         D   +  E C  G+LA+ +    + +S+ +  E+    +   RG
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 420 LWFLHSYSEGCIVHRDIKPTNILL 443
           L ++HS S   +VH DIKP+NI +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFI 148

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 309 YATEKLNELNLIGEGITGKVYK-GKLSNNQHVAIKH----ITNEGNVETFVREVASSSHV 363
           Y TE  +EL  IG G  G V+K  K  +    AIK     +    + +  +REV + + +
Sbjct: 7   YTTE-FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 364 -RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARG 419
            +H ++V         D   +  E C  G+LA+ +    + +S+ +  E+    +   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLG----PNF---EAKLSDFGLSKVI 460
           L ++HS S   +VH DIKP+NI +     PN    E    D+  +KV+
Sbjct: 126 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 170

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 15/154 (9%)
Query: 318 NLIGEGITGKVYKGKLSNNQ-HVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALL 372
           +LIG G  G VY     N + +VAIK +     +  + +  +RE+   + ++   ++ L 
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 373 GYC-----LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
                   L+ DE +++ E+  + +L + LF     L+      I  +   G  F+H   
Sbjct: 92  DLIIPDDLLKFDELYIVLEIA-DSDLKK-LFKTPIFLTEEHIKTILYNLLLGENFIH--- 146
Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           E  I+HRD+KP N LL  +   K+ DFGL++ I+
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 325 TGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE 380
           TG  Y  K+ + Q V     I+H  NE  +            V  P LV L         
Sbjct: 65  TGNHYAMKILDKQKVVKLKEIEHTLNEKRI---------LQAVNFPFLVKLEFSFKDNSN 115
Query: 381 CFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
            +++ E  P G +   L     F +     +  ++ +  +      +LHS     +++RD
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------YLHSLD---LIYRD 166
Query: 436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVY 495
           +KP N+++      +++DFGL+K +  G T+    + GT  YL PE   +   N + D +
Sbjct: 167 LKPENLMIDQQGYIQVTDFGLAKRVK-GRTWX---LCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 496 SFGIVLLQILSG 507
           + G+++ ++ +G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+++      K++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 309 YATEKLNELNLIGEGITGKVYK-GKLSNNQHVAIKH----ITNEGNVETFVREVASSSHV 363
           Y TE  +EL  IG G  G V+K  K  +    AIK     +    + +  +REV + + +
Sbjct: 5   YTTE-FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 364 -RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARG 419
            +H ++V         D   +  E C  G+LA+ +    + +S+ +  E+    +   RG
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLG----PNF---EAKLSDFGLSKVI 460
           L ++HS S   +VH DIKP+NI +     PN    E    D+  +KV+
Sbjct: 124 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 168

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 41/223 (18%)
Query: 320 IGEGITGKVYKG----KLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYC 375
           IGEG    VY      ++   + +A+KH+    +      E+   +     + V  + YC
Sbjct: 29  IGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYC 88
Query: 376 LRV-DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
            R  D   +      + +  + L      LS+ +  E  ++  + L  +H +    IVHR
Sbjct: 89  FRKNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFG---IVHR 141
Query: 435 DIKPTNILLGPNFEA-KLSDFGLSK--------VIDIGETYASSE--------------- 470
           D+KP+N L     +   L DFGL++        ++   ++ A  E               
Sbjct: 142 DVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQ 201
Query: 471 ----VRGTFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
                 GT G+  PE  + C   ++  D++S G++ L +LSG+
Sbjct: 202 QVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+++      K++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 43  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 93
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 148
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 149 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 200
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 71  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 121
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 176
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 177 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 228
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQ 408
           + E   RE +    ++HP++V LL         ++++E         ++ G D C   ++
Sbjct: 71  STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE---------FMDGADLCFEIVK 121
Query: 409 RLE--------IAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGP---NFEAKLSDFGL 456
           R +        +A    R +     Y  +  I+HRD+KP  +LL     +   KL  FG+
Sbjct: 122 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 181
Query: 457 SKVIDIGETYASSEVR-GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           +  I +GE+   +  R GT  ++ PE           DV+  G++L  +LSG
Sbjct: 182 A--IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           +HPN++ L          +++ EL   G L + +  + K  S  +   +     + + +L
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYL 132
Query: 424 HSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           H+     +VHRD+KP+NIL     G     ++ DFG +K +        +    T  ++ 
Sbjct: 133 HAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANFVA 188
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           PE       +++ D++S G++L   L+G
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 36  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 86
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 141
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 142 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWT---LCGTPEYLAP 193
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWT---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 349 NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQ 408
           + E   RE +    ++HP++V LL         ++++E         ++ G D C   ++
Sbjct: 69  STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE---------FMDGADLCFEIVK 119
Query: 409 RLE--------IAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGP---NFEAKLSDFGL 456
           R +        +A    R +     Y  +  I+HRD+KP  +LL     +   KL  FG+
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 457 SKVIDIGETYASSEVR-GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           +  I +GE+   +  R GT  ++ PE           DV+  G++L  +LSG
Sbjct: 180 A--IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 318 NLIGEGITGKVYKG-KLSNNQHVAIKHITNE-GNVETFV-REVASSSHVR-HPNLVALLG 373
            L+GEG   KV     L N +  A+K I  + G+  + V REV +    + + N++ L+ 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
           +       +L++E    G++   +  K K  +  +   +  D A  L FLH+     I H
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHI-QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 434 RDIKPTNIL------LGPNFEAKLSDFGLSKVIDIGET---YASSEVR---GTFGYLDPE 481
           RD+KP NIL      + P    K+ DF L   + +  +     + E+    G+  Y+ PE
Sbjct: 135 RDLKPENILCESPEKVSP---VKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 482 -----------YRSNCKVNSSGDVYSFGIVLLQILSG 507
                      Y   C      D++S G+VL  +LSG
Sbjct: 192 VVEVFTDQATFYDKRC------DLWSLGVVLYIMLSG 222

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 318 NLIGEGITGKVYKG-KLSNNQHVAIKHITNE-GNVETFV-REVASSSHVR-HPNLVALLG 373
           +++GEG   +V     L  +Q  A+K I  + G++ + V REV      + H N++ L+ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
           +    D  +L++E    G++   +  K +  + ++   +  D A  L FLH+     I H
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 434 RDIKPTNILL-GPN--FEAKLSDFGLSKVIDIG---ETYASSEVR---GTFGYLDPEYRS 484
           RD+KP NIL   PN     K+ DF L   I +       ++ E+    G+  Y+ PE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 485 NCKVNSS-----GDVYSFGIVLLQILSG 507
                +S      D++S G++L  +LSG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 43  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 93
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE----- 148
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 149 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 200
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 103/243 (42%), Gaps = 24/243 (9%)
Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           ++LN L  + E  +G+++KG+   N  + +K +     +      F  E        HPN
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 368 LVALLGYCLR--VDECFLIYELCPNGNLAEWLF-GKDKCLSWIQRLEIAIDSARGLWFLH 424
           ++ +LG C         LI    P G+L   L  G +  +   Q ++ A+D ARG  FLH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH 128
Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLS--DFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           +  E  I    +   ++ +  +  A++S  D   S     G  YA + V        PE 
Sbjct: 129 TL-EPLIPRHALNSRSVXIDEDXTARISXADVKFS-FQSPGRXYAPAWVAPEALQKKPED 186
Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
            +      S D +SF ++L ++        +TR     +L++ ++  + ++E    T+  
Sbjct: 187 TN----RRSADXWSFAVLLWEL--------VTREVPFADLSNXEIGXKVALEGLRPTIPP 234
Query: 543 ALS 545
            +S
Sbjct: 235 GIS 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+++      +++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 100
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P LV L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE----- 155
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL P
Sbjct: 156 -YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLAP 207
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 49/86 (56%), Gaps = 7/86 (8%)
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL PE
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LXGTPEYLAPE 208
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
              +   N + D ++ G+++ ++ +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 317 LNLIGEGITGKVYKGKLSN-NQHVAIKHITNEGNVETFVREVASS----SHVRHP----- 366
           L +IG+G  G+V K      +QHVA+K + NE   + F R+ A       H+R       
Sbjct: 102 LKVIGKGXFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 367 -NLVALL-GYCLRVDECFLIYELCPNGNLAEWLFGKDK----CLSWIQRLEIAIDSARGL 420
            N++ +L  +  R   C + +EL  + NL E L  K+K     L  +++   +I     L
Sbjct: 159 MNVIHMLENFTFRNHIC-MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSI-----L 210
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFG--- 476
             L +  +  I+H D+KP NILL     + +      KVID G + Y    V        
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGI------KVIDFGSSCYEHQRVYXXIQSRF 264
Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           Y  PE     +     D++S G +L ++L+G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P L  L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+++      K++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 312 EKLNELNLIGEGITGKVY--KGKLSNNQHVAIKHITNEG-----NVETFVREVASSSHVR 364
           ++   +  +G G  G+V   K K + N H A+K +  +       +E  + E      V 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGN-HFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARG 419
            P LV L          +++ E  P G +   L     F +     +  ++ +  +    
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---- 155
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
             +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL 
Sbjct: 156 --YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLA 206
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           PE   +   N + D ++ G+++ ++ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVA----IKHITNEGNVETFVREVASSSHVRH 365
            T     + L+    TG  Y  K+ + Q V     I+H  NE  +            V  
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---------LQAVNF 101
Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGL 420
           P L  L          +++ E  P G +   L     F +     +  ++ +  +     
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE----- 156
Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +++RD+KP N+++      K++DFG +K +  G T+    + GT  YL P
Sbjct: 157 -YLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX---LCGTPEYLAP 208
Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSG 507
           E   +   N + D ++ G+++ ++ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 49/86 (56%), Gaps = 7/86 (8%)
Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL PE
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LAGTPEYLAPE 208
Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
              +   N + D ++ G+++ ++ +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 312 EKLNELNLIGEGITGKVY--KGKLSNNQHVAIKHITNEG-----NVETFVREVASSSHVR 364
           ++   +  +G G  G+V   K K + N H A+K +  +       +E  + E      V 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGN-HFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARG 419
            P LV L          +++ E  P G +   L     F +     +  ++ +  +    
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---- 155
Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
             +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT  YL 
Sbjct: 156 --YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX---LCGTPEYLA 206
Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           PE   +   N + D ++ G+++ ++ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	588
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-105
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-102
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-89
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-51
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-51
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-49
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-48
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-46
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-45
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-35
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-31
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-30
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-28
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  317 bits (816), Expect = e-105
 Identities = 113/316 (35%), Positives = 160/316 (50%), Gaps = 28/316 (8%)

Query: 278 YKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQ 337
           Y     +   +     L      R  + ++  AT   +   LIG G+ GKVYKG L +  
Sbjct: 5   YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64

Query: 338 HVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLA 394
            VA+K  T E   G  E F  E+ + S  RHP+LV+L+G+C   +E  LIY+   NGNL 
Sbjct: 65  KVALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123

Query: 395 EWLFGKDKC---LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL 451
             L+G D     +SW QRLEI I +ARGL +LH      I+HRD+K  NILL  NF  K+
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKI 180

Query: 452 SDFGLSKVI-DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK- 509
           +DFG+SK   ++ +T+ S+ V+GT GY+DPEY    ++    DVYSFG+VL ++L  +  
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

Query: 510 ---------------AKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALT-HQR 553
                          A      G   ++ DP L  +   E+       A+ C AL+   R
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300

Query: 554 PPMEQVFVTLQKALDI 569
           P M  V   L+ AL +
Sbjct: 301 PSMGDVLWKLEYALRL 316

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  312 bits (802), Expect = e-102
 Identities = 99/284 (34%), Positives = 156/284 (54%), Gaps = 25/284 (8%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE---GNVETFVREV 357
           R+++RE+  A++  +  N++G G  GKVYKG+L++   VA+K +  E   G    F  EV
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 358 ASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAI 414
              S   H NL+ L G+C+   E  L+Y    NG++A  L  + +    L W +R  IA+
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
            SARGL +LH + +  I+HRD+K  NILL   FEA + DFGL+K++D  +T+ ++ VRGT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK------------------AKVLTRA 516
            G++ PEY S  K +   DV+ +G++LL++++G++                   K L + 
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 517 GSALELADPKLDREYSIEAFDLTLQLALSCT-ALTHQRPPMEQV 559
                L D  L   Y  E  +  +Q+AL CT +   +RP M +V
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  277 bits (711), Expect = 3e-89
 Identities = 92/311 (29%), Positives = 142/311 (45%), Gaps = 51/311 (16%)

Query: 292 VQLKDPGCPRYTIREVHYATE------KLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT 345
           +++ D     ++  E+   T            N +GEG  G VYKG + NN  VA+K + 
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63

Query: 346 NE-------GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF 398
                       + F +E+   +  +H NLV LLG+    D+  L+Y   PNG+L + L 
Sbjct: 64  AMVDITTEELKQQ-FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122

Query: 399 GKDKC--LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL 456
             D    LSW  R +IA  +A G+ FLH   E   +HRDIK  NILL   F AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGL 179

Query: 457 SKVIDIGE-TYASSEVRGTFGYLDPEYRSNCKVNSSG------DVYSFGIVLLQILSGKK 509
           ++  +    T  +S + GT  Y+ PE          G      D+YSFG+VLL+I++G  
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEA-------LRGEITPKSDIYSFGVVLLEIITGLP 232

Query: 510 A---------------KVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALT-HQR 553
           A               ++     +  +  D K+  +    + +    +A  C     ++R
Sbjct: 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291

Query: 554 PPMEQVFVTLQ 564
           P +++V   LQ
Sbjct: 292 PDIKKVQQLLQ 302

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  207 bits (528), Expect = 4e-62
 Identities = 71/297 (23%), Positives = 113/297 (38%), Gaps = 44/297 (14%)

Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNL 368
            +  L  L +   G  G V+K +L  N++VA+K     +        EV S   ++H N+
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 369 VALLGYCLR----VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           +  +G   R      + +LI      G+L+++L  K   +SW +   IA   ARGL +LH
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLH 138

Query: 425 SYSEG-------CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR-GTFG 476
               G        I HRDIK  N+LL  N  A ++DFGL+   + G++   +  + GT  
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198

Query: 477 YLDPEY-----RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL----------- 520
           Y+ PE                D+Y+ G+VL ++ S   A         L           
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258

Query: 521 ----------ELADPKLDREYSIEAFDLTL-QLALSCTALT-HQRPPMEQVFVTLQK 565
                     +   P L   +   A    L +    C       R     V   + +
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  188 bits (479), Expect = 3e-55
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 10/201 (4%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           +++    ++G G  G V K K    + VAIK I +E   + F+ E+   S V HPN+V L
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKC--LSWIQRLEIAIDSARGLWFLHSYSEG 429
            G CL  +   L+ E    G+L   L G +     +    +   +  ++G+ +LHS    
Sbjct: 67  YGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 430 CIVHRDIKPTNILLGPNFE-AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
            ++HRD+KP N+LL       K+ DFG +  I    T+ ++   G+  ++ PE       
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNK-GSAAWMAPEVFEGSNY 180

Query: 489 NSSGDVYSFGIVLLQILSGKK 509
           +   DV+S+GI+L ++++ +K
Sbjct: 181 SEKCDVFSWGIILWEVITRRK 201

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  184 bits (470), Expect = 6e-54
 Identities = 65/241 (26%), Positives = 113/241 (46%), Gaps = 11/241 (4%)

Query: 274 LKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL 333
           +K ++  +P +         L   G       ++ +    LN    IG G  G V++ + 
Sbjct: 1   MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPW--CDLNIKEKIGAGSFGTVHRAEW 58

Query: 334 SNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP 389
            +   VA+K +     +   V  F+REVA    +RHPN+V  +G   +     ++ E   
Sbjct: 59  -HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117

Query: 390 NGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF 447
            G+L   L      + L   +RL +A D A+G+ +LH+     IVHR++K  N+L+   +
Sbjct: 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY 176

Query: 448 EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
             K+ DFGLS++       + S   GT  ++ PE   +   N   DVYSFG++L ++ + 
Sbjct: 177 TVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235

Query: 508 K 508
           +
Sbjct: 236 Q 236

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  182 bits (464), Expect = 2e-53
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 26/227 (11%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI---------TNEGN 349
           P+  +  +     ++     IG+G  G V+KG+ + +   VAIK +              
Sbjct: 9   PKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66

Query: 350 VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQR 409
            + F REV   S++ HPN+V L G     +   ++ E  P G+L   L  K   + W  +
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK 124

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL-----GPNFEAKLSDFGLSKVIDIGE 464
           L + +D A G+ ++ +     IVHRD++  NI L          AK++DFGLS+      
Sbjct: 125 LRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----S 179

Query: 465 TYASSEVRGTFGYLDPE--YRSNCKVNSSGDVYSFGIVLLQILSGKK 509
            ++ S + G F ++ PE             D YSF ++L  IL+G+ 
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  176 bits (448), Expect = 3e-51
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 20/211 (9%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN------VETFVREVASSSHVRH 365
            +L    +IG G  GKVY+        VA+K   ++ +      +E   +E    + ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           PN++AL G CL+     L+ E    G L   L GK   +     +  A+  ARG+ +LH 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHD 123

Query: 426 YSEGCIVHRDIKPTNILLG--------PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGY 477
            +   I+HRD+K +NIL+          N   K++DFGL++      T   S   G + +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAW 180

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           + PE       +   DV+S+G++L ++L+G+
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  178 bits (452), Expect = 4e-51
 Identities = 67/319 (21%), Positives = 113/319 (35%), Gaps = 57/319 (17%)

Query: 310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVRE--VASSSHVRHPN 367
             + L  L LIG G  G VYKG L + + VA+K + +  N + F+ E  +     + H N
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK-VFSFANRQNFINEKNIYRVPLMEHDN 68

Query: 368 LVALLGYCLRVD-----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
           +   +    RV      E  L+ E  PNG+L ++L        W+    +A    RGL +
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAY 126

Query: 423 LHS------YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE------ 470
           LH+      + +  I HRD+   N+L+  +    +SDFGLS  +         E      
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 471 -VRGTFGYLDPEY-------RSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL 522
              GT  Y+ PE        R         D+Y+ G++  +I           +    ++
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246

Query: 523 A-----------------------DPKLDREYSIEAFDLTL--QLALSCTALT-HQRPPM 556
           A                        PK    +   +  +    +    C       R   
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306

Query: 557 EQVFVTLQKALDISTTAKA 575
           +     + + + I    K+
Sbjct: 307 QXAEERMAELMMIWERNKS 325

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  170 bits (433), Expect = 5e-49
 Identities = 43/207 (20%), Positives = 89/207 (42%), Gaps = 18/207 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
           ++LN L  + E  +G+++KG+      + +K +     +      F  E        HPN
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 368 LVALLGYCLR--VDECFLIYELCPNGNLAEWLF-GKDKCLSWIQRLEIAIDSARGLWFLH 424
           ++ +LG C         LI    P G+L   L  G +  +   Q ++ A+D ARG+ FLH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
           +  E  I    +   ++++  +  A++S   +           S        ++ PE   
Sbjct: 129 T-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQ 181

Query: 485 NCKVNSSG---DVYSFGIVLLQILSGK 508
               +++    D++SF ++L ++++ +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTRE 208

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  170 bits (433), Expect = 1e-48
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 41/281 (14%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPN 367
           E+L    LIG+G  G+VY G+   +  VAI+ I     NE  ++ F REV +    RH N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V  +G C+      +I  LC    L   +      L   +  +IA +  +G+ +LH+  
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDPEYR 483
              I+H+D+K  N+    N +  ++DFGL  +  + +     +      G   +L PE  
Sbjct: 151 ---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 484 SNCKVNSSG---------DVYSFGIVLLQILSGKK-------AKVLTRAGSAL--ELADP 525
                ++           DV++ G +  ++ + +          ++ + G+ +   L+  
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI 266

Query: 526 KLDREYSIEAFDLTLQLALSC-TALTHQRPPMEQVFVTLQK 565
            + +E S         + L C      +RP   ++   L+K
Sbjct: 267 GMGKEIS--------DILLFCWAFEQEERPTFTKLMDMLEK 299

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  169 bits (429), Expect = 3e-48
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 14/205 (6%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPN 367
            ++     IG G  G VYKGK   +  VA+K +         ++ F  EV      RH N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           ++  +GY     +  ++ + C   +L   L   +      + ++IA  +ARG+ +LH+ S
Sbjct: 82  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDPE---YR 483
              I+HRD+K  NI L  +   K+ DFGL+            E + G+  ++ PE    +
Sbjct: 141 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 484 SNCKVNSSGDVYSFGIVLLQILSGK 508
            +   +   DVY+FGIVL ++++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  168 bits (427), Expect = 9e-48
 Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 46/277 (16%)

Query: 320 IGEGITGKVYKGKL-SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCL 376
           +G+G  G+  K       + + +K +         TF++EV     + HPN++  +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           +      I E    G L   +   D    W QR+  A D A G+ +LHS +   I+HRD+
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDL 134

Query: 437 KPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-------------VRGTFGYLDPEYR 483
              N L+  N    ++DFGL++++   +T                  V G   ++ PE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 484 SNCKVNSSGDVYSFGIVLLQILSGKKA-----------KVLTRAGSALEL---ADPKLDR 529
           +    +   DV+SFGIVL +I+    A            +  R            P    
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSF-- 252

Query: 530 EYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQK 565
                       + + C  L   +RP   ++   L+ 
Sbjct: 253 ----------FPITVRCCDLDPEKRPSFVKLEHWLET 279

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  166 bits (423), Expect = 8e-47
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 24/216 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVRE--VASSSHVRHPNLV 369
           +++  +  IG+G  G+V+ GK    + VA+K         ++ RE  +  +  +RH N++
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENIL 94

Query: 370 ALLGYCLR----VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
             +   ++      + +LI +   NG+L ++L  K   L     L++A  S  GL  LH+
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 426 YSEG-----CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG---ETYASSEVRGTFGY 477
                     I HRD+K  NIL+  N    ++D GL+              +   GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 478 LDPE------YRSNCKVNSSGDVYSFGIVLLQILSG 507
           + PE       R++ +     D+YSFG++L ++   
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  164 bits (417), Expect = 2e-46
 Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVRE--VASSSHVRHPNL 368
              +  L  +G+G  G+V++G     ++VA+K  ++  + +++ RE  + ++  +RH N+
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENI 64

Query: 369 VALLGYCLRVD----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           +  +   +       + +LI      G+L ++L  +   L  +  L I +  A GL  LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLH 122

Query: 425 SYSEGC-----IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET---YASSEVRGTFG 476
               G      I HRD+K  NIL+  N +  ++D GL+ +           ++   GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 477 YLDPE------YRSNCKVNSSGDVYSFGIVLLQILSG 507
           Y+ PE                 D+++FG+VL ++   
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  162 bits (411), Expect = 3e-45
 Identities = 50/216 (23%), Positives = 97/216 (44%), Gaps = 24/216 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVRE--VASSSHVRHPNLV 369
             +     IG+G  G+V++GK    + VA+K  ++     ++ RE  +  +  +RH N++
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENIL 99

Query: 370 ALLGYCLRVD----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
             +    + +    + +L+ +   +G+L ++L      ++    +++A+ +A GL  LH 
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 426 YSEGC-----IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG---ETYASSEVRGTFGY 477
              G      I HRD+K  NIL+  N    ++D GL+   D        A +   GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 478 LDPE------YRSNCKVNSSGDVYSFGIVLLQILSG 507
           + PE         + +     D+Y+ G+V  +I   
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  135 bits (343), Expect = 2e-35
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 16/204 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E L     IG G  G+V+ G+L ++N  VA+K             F++E        HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V L+G C +    +++ EL   G+   +L  +   L     L++  D+A G+ +L   S
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--S 231

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-----VRGTFGYLDPEY 482
           + CI HRD+   N L+      K+SDFG+S+    G   AS       V+ T     PE 
Sbjct: 232 KCCI-HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEA 286

Query: 483 RSNCKVNSSGDVYSFGIVLLQILS 506
            +  + +S  DV+SFGI+L +  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  128 bits (325), Expect = 8e-34
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLV 369
           E++  L  +G G  G V  GK      VA+K I  EG  + + F +E  +   + HP LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
              G C +    +++ E   NG L  +L    K L   Q LE+  D   G+ FL      
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESH 123

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDPEYRSN 485
             +HRD+   N L+  +   K+SDFG+++ +   +  +S      V+ +     PE    
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHY 179

Query: 486 CKVNSSGDVYSFGIVLLQILS 506
            K +S  DV++FGI++ ++ S
Sbjct: 180 FKYSSKSDVWAFGILMWEVFS 200

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  134 bits (338), Expect = 8e-34
 Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 19/242 (7%)

Query: 274 LKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYAT-------EKLNELNLIGEGITG 326
           L  YY  +           +L    CP    +    A        E L     +G+G  G
Sbjct: 228 LVAYYSKHADGLCH-----RLTTV-CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFG 281

Query: 327 KVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY 385
           +V+ G  +    VAIK +     + E F++E      +RH  LV L       +  +++ 
Sbjct: 282 EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340

Query: 386 ELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
           E    G+L ++L G+  K L   Q +++A   A G+ ++        VHRD++  NIL+G
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVG 397

Query: 445 PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI 504
            N   K++DFGL+++I+  E  A    +    +  PE     +     DV+SFGI+L ++
Sbjct: 398 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457

Query: 505 LS 506
            +
Sbjct: 458 TT 459

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (325), Expect = 1e-33
 Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 14/201 (6%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLV 369
           + L  L  +G G  G V  GK      VAIK I  EG  + + F+ E     ++ H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
            L G C +    F+I E   NG L  +L          Q LE+  D    + +L      
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESK 139

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDPEYRSN 485
             +HRD+   N L+      K+SDFGLS+ +   E  +S      VR +     PE    
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMY 195

Query: 486 CKVNSSGDVYSFGIVLLQILS 506
            K +S  D+++FG+++ +I S
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS 216

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  128 bits (324), Expect = 1e-33
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 14/193 (7%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLR 377
           IG G  G V+ G   N   VAIK I  EG  + E F+ E      + HP LV L G CL 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
                L+ E   +G L+++L  +    +    L + +D   G+ +L    E C++HRD+ 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLA 131

Query: 438 PTNILLGPNFEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDPEYRSNCKVNSSGD 493
             N L+G N   K+SDFG+++ +   +  +S+     V+       PE  S  + +S  D
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSRYSSKSD 187

Query: 494 VYSFGIVLLQILS 506
           V+SFG+++ ++ S
Sbjct: 188 VWSFGVLMWEVFS 200

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (332), Expect = 2e-33
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 6/197 (3%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVA 370
           E L     +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEG 429
           L       +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++      
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERM 299

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             VHRD++  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +  
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 490 SSGDVYSFGIVLLQILS 506
              DV+SFGI+L ++ +
Sbjct: 360 IKSDVWSFGILLTELTT 376

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  125 bits (317), Expect = 2e-32
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGKL----SNNQHVAIK---HITNEGNVETFVREVASSSHVR 364
              +   +IG+G  G VY G+      N    AIK    IT    VE F+RE      + 
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 365 HPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           HPN++AL+G  L  +    ++     +G+L +++    +  +    +   +  ARG+ +L
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL----- 478
              +E   VHRD+   N +L  +F  K++DFGL++ I   E Y+  + R     L     
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH--ARLPVKWT 195

Query: 479 DPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
             E        +  +  DV+SFG++L ++L+
Sbjct: 196 ALESLQTY---RFTTKSDVWSFGVLLWELLT 223

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  125 bits (317), Expect = 3e-32
 Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 28/215 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHI---TNEGNVETFVREVASSSHV 363
            +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            +P++  LLG CL      LI +L P G L +++      +     L   +  A+G+ +L
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-----VRGTFGYL 478
               +  +VHRD+   N+L+      K++DFGL+K++   E    +E     ++      
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM---- 186

Query: 479 DPE---YRSNCKVNSSGDVYSFGIVLLQILS-GKK 509
             E   +R         DV+S+G+ + ++++ G K
Sbjct: 187 ALESILHR---IYTHQSDVWSYGVTVWELMTFGSK 218

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  128 bits (324), Expect = 4e-32
 Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 8/199 (4%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEGN--VETFVREVASSSHVRHPNL 368
             +   + +G G  G+VY+G     +  VA+K +  E    VE F++E A    ++HPNL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYS 427
           V LLG C R    ++I E    GNL ++L   ++  +S +  L +A   +  + +L   +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
               +HR++   N L+G N   K++DFGLS+++      A +  +    +  PE  +  K
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 488 VNSSGDVYSFGIVLLQILS 506
            +   DV++FG++L +I +
Sbjct: 396 FSIKSDVWAFGVLLWEIAT 414

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  124 bits (313), Expect = 6e-32
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGKL----SNNQHVAIK---HITNEGNVETFVREVASSSHVR 364
             ++   +IG G  G VY G L        H A+K    IT+ G V  F+ E        
Sbjct: 25  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84

Query: 365 HPNLVALLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           HPN+++LLG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ +L
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL----- 478
            S      VHRD+   N +L   F  K++DFGL++ +   E Y+     G    L     
Sbjct: 145 ASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWM 199

Query: 479 DPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
             E    +   K  +  DV+SFG++L ++++
Sbjct: 200 ALESLQTQ---KFTTKSDVWSFGVLLWELMT 227

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  124 bits (313), Expect = 2e-31
 Identities = 69/257 (26%), Positives = 108/257 (42%), Gaps = 23/257 (8%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IGEG  GK    K   + +   IK I     +    E   REVA  ++++HPN+V  
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
                     +++ + C  G+L + +   K       Q L+  +     L  +H      
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--- 145

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           I+HRDIK  NI L  +   +L DFG+++V++     A + + GT  YL PE   N   N+
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNN 204

Query: 491 SGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-------PKLDREYSIEAFDLTLQLA 543
             D+++ G VL ++ + K A     AGS   L         P +   YS +   L  QL 
Sbjct: 205 KSDIWALGCVLYELCTLKHA---FEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL- 260

Query: 544 LSCTALTHQRPPMEQVF 560
                    RP +  + 
Sbjct: 261 FKRNP--RDRPSVNSIL 275

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  125 bits (317), Expect = 2e-31
 Identities = 65/243 (26%), Positives = 102/243 (41%), Gaps = 23/243 (9%)

Query: 274 LKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELN--------LIGEGIT 325
           L  +Y ++     T      L  P     T+            LN         IG+G  
Sbjct: 152 LVEHYTTDADGLCTR-----LIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEF 206

Query: 326 GKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF-LI 384
           G V  G       VA+K I N+   + F+ E +  + +RH NLV LLG  +       ++
Sbjct: 207 GDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265

Query: 385 YELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL 443
            E    G+L ++L  +    L     L+ ++D    + +L        VHRD+   N+L+
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLV 322

Query: 444 GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQ 503
             +  AK+SDFGL+K     +      V+ T     PE     K ++  DV+SFGI+L +
Sbjct: 323 SEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWE 378

Query: 504 ILS 506
           I S
Sbjct: 379 IYS 381

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  121 bits (307), Expect = 2e-31
 Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 23/241 (9%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG G  G+  K +  S+ + +  K +      E   +  V EV     ++HPN+V  
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70

Query: 372 LG-YCLRVDECFLIY-ELCPNGNLAEWL---FGKDKCLSWIQRLEIAIDSARGLWFLHS- 425
                 R +    I  E C  G+LA  +     + + L     L +       L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 426 -YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
                 ++HRD+KP N+ L      KL DFGL+++++   ++A + V GT  Y+ PE  +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-------PKLDREYSIEAFD 537
               N   D++S G +L ++ +         A S  ELA         ++   YS E  +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP---FTAFSQKELAGKIREGKFRRIPYRYSDELNE 246

Query: 538 L 538
           +
Sbjct: 247 I 247

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  121 bits (307), Expect = 3e-31
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 18/198 (9%)

Query: 320 IGEGITGKVYKGKL---SNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G G  G V +G          VAIK +   T + + E  +RE      + +P +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
            C   +   L+ E+   G L ++L GK + +      E+    + G+ +L    E   VH
Sbjct: 78  VCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133

Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDPE---YRSNCKV 488
           RD+   N+LL     AK+SDFGLSK +   ++Y ++   G +   +  PE   +R   K 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---KF 190

Query: 489 NSSGDVYSFGIVLLQILS 506
           +S  DV+S+G+ + + LS
Sbjct: 191 SSRSDVWSYGVTMWEALS 208

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  121 bits (306), Expect = 3e-31
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLV 369
           E L  +  +G G  G+V+ G  + +  VA+K +  +G  + + F+ E      ++H  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
            L     + +  ++I E   NG+L ++L       L+  + L++A   A G+ F+    E
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EE 127

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDPEYRS 484
              +HRD++  NIL+      K++DFGL+++I+  E  A       ++ T     PE  +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183

Query: 485 NCKVNSSGDVYSFGIVLLQILS 506
                   DV+SFGI+L +I++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  122 bits (309), Expect = 4e-31
 Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 31/231 (13%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNN----QHVAIK----HITNEGNVE 351
            +  + +V    ++     ++G+G  G V + +L         VA+K     I    ++E
Sbjct: 11  LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70

Query: 352 TFVREVASSSHVRHPNLVALLGYCLRVDEC------FLIYELCPNGNLAEWL-----FGK 400
            F+RE A      HP++  L+G  LR           +I     +G+L  +L        
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130

Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
              L     +   +D A G+ +L   S    +HRD+   N +L  +    ++DFGLS+ I
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187

Query: 461 DIGETYASSE-----VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             G+ Y         V+        E  ++       DV++FG+ + +I++
Sbjct: 188 YSGDYYRQGCASKLPVKWL----ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  121 bits (306), Expect = 6e-31
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 15/207 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGKL-----SNNQHVAIK---HITNEGNVETFVREVASSSHV 363
             L  +  +GEG  GKV   +      +  + VA+K     +   ++    +E+    ++
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 364 RHPNLVALLGYCLRVDEC--FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW 421
            H N+V   G C         LI E  P+G+L E+L      ++  Q+L+ A+   +G+ 
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLD 479
           +L S      VHRD+   N+L+    + K+ DFGL+K I+  + Y + +        +  
Sbjct: 141 YLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILS 506
           PE     K   + DV+SFG+ L ++L+
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  124 bits (313), Expect = 8e-31
 Identities = 55/240 (22%), Positives = 103/240 (42%), Gaps = 16/240 (6%)

Query: 274 LKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYAT-----EKLNELNLIGEGITGKV 328
           L  +YK             +L  P       +           E L     +G G  G+V
Sbjct: 150 LVDHYKKGNDGLCQ-----KLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEV 204

Query: 329 YKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL 387
           +    + +  VA+K +     +VE F+ E      ++H  LV L     + +  ++I E 
Sbjct: 205 WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 263

Query: 388 CPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
              G+L ++L   +       + ++ +   A G+ F+    +   +HRD++  NIL+  +
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSAS 320

Query: 447 FEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
              K++DFGL++VI+  E  A    +    +  PE  +        DV+SFGI+L++I++
Sbjct: 321 LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  120 bits (303), Expect = 1e-30
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN-NQHVAIKHITNEG--NVETFVREVASSSHVRHPNL 368
             +   + +G G  G+VY+G     +  VA+K +  E    VE F++E A    ++HPNL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           V LLG C R    ++I E    GNL ++L     + +S +  L +A   +  + +L    
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---E 128

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDPEYR 483
           +   +HRD+   N L+G N   K++DFGLS+++      A +     ++ T     PE  
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESL 184

Query: 484 SNCKVNSSGDVYSFGIVLLQILS 506
           +  K +   DV++FG++L +I +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  121 bits (305), Expect = 1e-30
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 312 EKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHI---TNEGNVETFVREVASSSHV 363
            +  ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            +P++  LLG CL      LI +L P G L +++      +     L   +  A+G+ +L
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-TYASSEVRGTFGYLDPE- 481
               +  +VHRD+   N+L+      K++DFGL+K++   E  Y +   +    ++  E 
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 482 --YRSNCKVNSSGDVYSFGIVLLQILS 506
             +R         DV+S+G+ + ++++
Sbjct: 191 ILHR---IYTHQSDVWSYGVTVWELMT 214

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  120 bits (304), Expect = 2e-30
 Identities = 43/208 (20%), Positives = 90/208 (43%), Gaps = 21/208 (10%)

Query: 312 EKLNELNLIGEGITGKVYKGKL-----SNNQHVAIK---HITNEGNVETFVREVASSSHV 363
            +L +L ++G G+ G V+KG       S    V IK     +   + +     + +   +
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            H ++V LLG C       L+ +  P G+L + +      L     L   +  A+G+++L
Sbjct: 73  DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-----VRGTFGYL 478
               E  +VHR++   N+LL    + +++DFG++ ++   +           ++      
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM---- 184

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             E     K     DV+S+G+ + ++++
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMT 212

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  120 bits (304), Expect = 2e-30
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 36/233 (15%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSN----NQHVAIK----HITNEGNVE 351
            +  + +V      L    ++GEG  G V +G L      +  VA+K      +++  +E
Sbjct: 22  LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE 81

Query: 352 TFVREVASSSHVRHPNLVALLGYCLRVD-----ECFLIYELCPNGNLAEWL-----FGKD 401
            F+ E A      HPN++ LLG C+ +      +  +I      G+L  +L         
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141

Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
           K +     L+  +D A G+ +L   S    +HRD+   N +L  +    ++DFGLSK I 
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198

Query: 462 IGETYASSE-----VRGTFGYLDPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
            G+ Y         V+        E    R      S  DV++FG+ + +I +
Sbjct: 199 SGDYYRQGRIAKMPVKWI----AIESLADR---VYTSKSDVWAFGVTMWEIAT 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  122 bits (307), Expect = 2e-30
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKL----SNNQHVAIK---HITNEGNVETFVREVASSSHVR 364
             ++   +IG G  G VY G L        H A+K    IT+ G V  F+ E        
Sbjct: 89  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148

Query: 365 HPNLVALLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           HPN+++LLG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI---DIGETYASSE----VRGTFG 476
            S      VHRD+   N +L   F  K++DFGL++ +   +    +  +     V+    
Sbjct: 209 ASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-- 263

Query: 477 YLDPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
               E    +   K  +  DV+SFG++L ++++
Sbjct: 264 --ALESLQTQ---KFTTKSDVWSFGVLLWELMT 291

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (303), Expect = 2e-30
 Identities = 59/242 (24%), Positives = 89/242 (36%), Gaps = 24/242 (9%)

Query: 280 SNPPAKITSFKGVQLKDPGCPRYT-IREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQ 337
                +  SF+G   +    P Y   R   +  +    L+ +G G  G+V+K     + +
Sbjct: 24  HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGR 83

Query: 338 HVAIKHIT----NEGNVETFVREVAS-SSHVRHPNLVALLGYCLRVDECFLIYELCPNGN 392
             A+K          +    + EV S     +HP  V L          +L  ELC   +
Sbjct: 84  LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142

Query: 393 LAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLS 452
           L +        L   Q      D+   L  LHS     +VH D+KP NI LGP    KL 
Sbjct: 143 LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLG 199

Query: 453 DFGLSKVIDIGETYASSEVRGTFGYLDPE-----YRSNCKVNSSGDVYSFGIVLLQILSG 507
           DFGL   +         +  G   Y+ PE     Y          DV+S G+ +L++   
Sbjct: 200 DFGLLVELGTAGA-GEVQE-GDPRYMAPELLQGSY--GTAA----DVFSLGLTILEVACN 251

Query: 508 KK 509
            +
Sbjct: 252 ME 253

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  120 bits (302), Expect = 2e-30
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 13/203 (6%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVA 370
              IG G   +VY+   L +   VA+K +      +       ++E+     + HPN++ 
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL--FGKD-KCLSWIQRLEIAIDSARGLWFLHSYS 427
                +  +E  ++ EL   G+L+  +  F K  + +      +  +     L  +HS  
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
              ++HRDIKP N+ +      KL D GL +      T A S V GT  Y+ PE      
Sbjct: 157 ---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 212

Query: 488 VNSSGDVYSFGIVLLQILSGKKA 510
            N   D++S G +L ++ + +  
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP 235

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  121 bits (306), Expect = 2e-30
 Identities = 69/248 (27%), Positives = 110/248 (44%), Gaps = 23/248 (9%)

Query: 275 KRYYKSNPPAKITSFKG-VQLKDPGCPRYTIREV--HYATEKLNELNLIGEGITGKVYKG 331
           KR +  N   K+   +  V       P  T+ E         ++   ++G G  G+V  G
Sbjct: 5   KRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64

Query: 332 KL----SNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI 384
           +L         VAIK +     E     F+ E +      HPN++ L G   +     ++
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124

Query: 385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG 444
            E   NG+L  +L   D   + IQ + +    A G+ +L   S+   VHRD+   NIL+ 
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181

Query: 445 PNFEAKLSDFGLSKVI-DIGETYASSE-----VRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
            N   K+SDFGL +V+ D  E   ++      +R T     PE  +  K  S+ DV+S+G
Sbjct: 182 SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYG 237

Query: 499 IVLLQILS 506
           IVL +++S
Sbjct: 238 IVLWEVMS 245

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  119 bits (300), Expect = 3e-30
 Identities = 61/272 (22%), Positives = 107/272 (39%), Gaps = 47/272 (17%)

Query: 316 ELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGY 374
           E+ LIG G  G+V+K K   + +   IK +      E   REV + + + H N+V   G 
Sbjct: 15  EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGC 72

Query: 375 CLRVDEC----------------FLIYELCPNGNLAEWL-------FGKDKCLSWIQRLE 411
               D                  F+  E C  G L +W+         K   L   +++ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI- 131

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
                 +G+ ++HS     +++RD+KP+NI L    + K+ DFGL   +           
Sbjct: 132 -----TKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR--S 181

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY 531
           +GT  Y+ PE  S+       D+Y+ G++L ++L          +    +L D  +   +
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETSKFFTDLRDGIISDIF 240

Query: 532 SIEAFDLTLQLALSCTALT---HQRPPMEQVF 560
             +   L  +L      L+     RP   ++ 
Sbjct: 241 DKKEKTLLQKL------LSKKPEDRPNTSEIL 266

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (308), Expect = 3e-30
 Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 52/298 (17%)

Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSH 362
            + ++ +  + +     +G G  G +    + +N+ VA+K I  E       REV     
Sbjct: 20  IVGKISFCPKDV-----LGHGAEGTIVYRGMFDNRDVAVKRILPE-CFSFADREVQLLRE 73

Query: 363 V-RHPNLVALLGYCLRVDECF--LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
              HPN++    +C   D  F  +  ELC    L E++  KD     ++ + +   +  G
Sbjct: 74  SDEHPNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG 130

Query: 420 LWFLHSYSEGCIVHRDIKPTNILL-----GPNFEAKLSDFGLSKVIDIGETYAS--SEVR 472
           L  LHS +   IVHRD+KP NIL+         +A +SDFGL K + +G    S  S V 
Sbjct: 131 LAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 473 GTFGYLDPEY---RSNCKVNSSGDVYSFGIVLLQILSG----------KKAKVLTRAGSA 519
           GT G++ PE            + D++S G V   ++S           ++A +L  A S 
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS- 246

Query: 520 LELADPKLDREYSIEAFDLTLQLALSCTALTH---QRPPMEQV-----FVTLQKALDI 569
             L     ++   + A +L  ++      +     +RP  + V     F +L+K L  
Sbjct: 247 --LDCLHPEKHEDVIARELIEKM------IAMDPQKRPSAKHVLKHPFFWSLEKQLQF 296

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  119 bits (301), Expect = 3e-30
 Identities = 61/225 (27%), Positives = 91/225 (40%), Gaps = 24/225 (10%)

Query: 305 REVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSS 361
             V    +    +  +GEG    V   + L +    A+K I    + + E   RE     
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 362 HVRHPNLVALLGYCLR----VDECFLIYELCPNGNLAEWL---FGKDKCLSWIQRLEIAI 414
              HPN++ L+ YCLR      E +L+      G L   +     K   L+  Q L + +
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS----- 469
              RGL  +H+       HRD+KPTNILLG   +  L D G      I    +       
Sbjct: 142 GICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198

Query: 470 ---EVRGTFGYLDPE---YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                R T  Y  PE    +S+C ++   DV+S G VL  ++ G+
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  118 bits (298), Expect = 4e-30
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           ++L  L  IG+G  G V  G       VA+K I N+   + F+ E +  + +RH NLV L
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 79

Query: 372 LGYCLRVDEC-FLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEG 429
           LG  +      +++ E    G+L ++L  +    L     L+ ++D    + +L      
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGN 136

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             VHRD+   N+L+  +  AK+SDFGL+K     +      V+ T     PE     K +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192

Query: 490 SSGDVYSFGIVLLQILS 506
           +  DV+SFGI+L +I S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (306), Expect = 6e-30
 Identities = 74/318 (23%), Positives = 124/318 (38%), Gaps = 64/318 (20%)

Query: 304 IREVHYATEKLNEL----NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVAS 359
           I  +    + L  L     ++G G +G V        + VA+K +      +  + E+  
Sbjct: 3   IANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKL 61

Query: 360 SSHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKD------KCLSWIQRLEI 412
            +    HPN++            ++  ELC N NL + +  K+      K       + +
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILL-------------GPNFEAKLSDFGLSKV 459
               A G+  LHS     I+HRD+KP NIL+               N    +SDFGL K 
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 460 IDIGETYASSEVR---GTFGYLDPE-------YRSNCKVNSSGDVYSFGIVLLQILSG-- 507
           +D G++   + +    GT G+  PE        ++  ++  S D++S G V   ILS   
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 508 --------KKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTH---QRPPM 556
                   +++ ++ R   +L+      DR    EA DL  Q+      + H   +RP  
Sbjct: 238 HPFGDKYSRESNII-RGIFSLDEMKCLHDRSLIAEATDLISQM------IDHDPLKRPTA 290

Query: 557 EQV-----FVTLQKALDI 569
            +V     F    K L+ 
Sbjct: 291 MKVLRHPLFWPKSKKLEF 308

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  123 bits (310), Expect = 6e-30
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 12/195 (6%)

Query: 320 IGEGITGKVYKGKLSNNQH---VAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G G  G V +G     +    VAIK +   T + + E  +RE      + +P +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
            C   +   L+ E+   G L ++L GK + +      E+    + G+ +L    E   VH
Sbjct: 404 VCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 459

Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGY--LDPEYRSNCKVNSS 491
           R++   N+LL     AK+SDFGLSK +   ++Y ++   G +      PE  +  K +S 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519

Query: 492 GDVYSFGIVLLQILS 506
            DV+S+G+ + + LS
Sbjct: 520 SDVWSYGVTMWEALS 534

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  118 bits (297), Expect = 7e-30
 Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 31/207 (14%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVA 370
              +G+G  G VY  +   +   +A+K      +   G      REV   SH+RHPN++ 
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           L GY       +LI E  P G +   L     F + +  ++I  L  A+       + HS
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS------YCHS 127

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPE 481
                ++HRDIKP N+LLG   E K++DFG S        +A S  R    GT  YL PE
Sbjct: 128 KR---VIHRDIKPENLLLGSAGELKIADFGWSV-------HAPSSRRTDLCGTLDYLPPE 177

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                  +   D++S G++  + L GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  118 bits (299), Expect = 7e-30
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIK---HITNEGNVETFVREVASSSH 362
           + +  +  +G G  G+VY+G++S          VA+K    + +E +   F+ E    S 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDS 416
             H N+V  +G  L+    F++ EL   G+L  +L        +   L+ +  L +A D 
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRG 473
           A G  +L    E   +HRDI   N LL   GP   AK+ DFG+++ I     Y     +G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR----KG 202

Query: 474 TFGYL-----DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
               L      PE        S  D +SFG++L +I S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  117 bits (296), Expect = 8e-30
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 30/206 (14%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVALL 372
           L+G+G    VY+ + +     VAIK      +   G V+    EV     ++HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLS------WIQRLEIAIDSARGLWFLHSY 426
            Y    +  +L+ E+C NG +  +L  + K  S      ++ ++        G+ +LHS+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYLHSH 131

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEY 482
               I+HRD+  +N+LL  N   K++DFGL+  +         E      GT  Y+ PE 
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK-----MPHEKHYTLCGTPNYISPEI 183

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
            +        DV+S G +   +L G+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (297), Expect = 9e-30
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 14/206 (6%)

Query: 312 EKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHI--TNEGNVETFVREVASSSHVR 364
             L  L  +G+G  G V   +      +  + VA+K +  + E ++  F RE+     ++
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 365 HPNLVALLGYCLRVDEC--FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
           H N+V   G C         LI E  P G+L ++L    + +  I+ L+      +G+ +
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDP 480
           L +      +HRD+   NIL+      K+ DFGL+KV+   + +   +  G     +  P
Sbjct: 130 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E  +  K + + DV+SFG+VL ++ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  117 bits (296), Expect = 1e-29
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 42/227 (18%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIK---HITNEGNVETFVREVASSSH 362
             +  +  +GE   GKVYKG L         Q VAIK           E F  E    + 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCLSWI 407
           ++HPN+V LLG   +     +I+  C +G+L E+L                     L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
             + +    A G+ +L   S   +VH+D+   N+L+      K+SD GL + +   + Y 
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 468 SSE-----VRGTFGYLDPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
                   +R       PE   Y    K +   D++S+G+VL ++ S
Sbjct: 186 LLGNSLLPIRWM----APEAIMYG---KFSIDSDIWSYGVVLWEVFS 225

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  117 bits (295), Expect = 1e-29
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGKL----SNNQHVAIKHI---TNEGNVETFVREVASSSHVR 364
           E++     IGEG  G V++G      +    VAIK     T++   E F++E  +     
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           HP++V L+G     +  ++I ELC  G L  +L  +   L     +  A   +  L +L 
Sbjct: 75  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL- 132

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDP 480
                  VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+    ++       P
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----AP 186

Query: 481 E---YRSNCKVNSSGDVYSFGIVLLQILS 506
           E   +R   +  S+ DV+ FG+ + +IL 
Sbjct: 187 ESINFR---RFTSASDVWMFGVCMWEILM 212

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  117 bits (296), Expect = 1e-29
 Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 22/214 (10%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFV 354
           RY I +             +G G    VY  +    N  VAIK         E  ++ F 
Sbjct: 12  RYKIVD------------KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE 59

Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI 414
           REV +SS + H N+V+++      D  +L+ E      L+E++      LS    +    
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTN 118

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
               G+   H      IVHRDIKP NIL+  N   K+ DFG++K +       ++ V GT
Sbjct: 119 QILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             Y  PE       +   D+YS GIVL ++L G+
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  117 bits (296), Expect = 1e-29
 Identities = 46/202 (22%), Positives = 85/202 (42%), Gaps = 16/202 (7%)

Query: 320 IGEGITGKVYKGKL----SNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVA 370
           +G+G  G V +G+          VA+K      ++    ++ F+REV +   + H NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L G  L      ++ EL P G+L + L               A+  A G+ +L       
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKR 141

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGY--LDPEYRSNCKV 488
            +HRD+   N+LL      K+ DFGL + +   + +   +      +    PE       
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201

Query: 489 NSSGDVYSFGIVLLQILS-GKK 509
           + + D + FG+ L ++ + G++
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQE 223

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  118 bits (298), Expect = 1e-29
 Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 21/201 (10%)

Query: 320 IGEGITGKVYKGKLSN-----NQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVAL 371
           IG G  G+VYKG L          VAIK +     E     F+ E        H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
            G   +     +I E   NG L ++L  KD   S +Q + +    A G+ +L   +    
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNY 168

Query: 432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI-DIGETYASSE-----VRGTFGYLDPEYRSN 485
           VHRD+   NIL+  N   K+SDFGLS+V+ D  E   ++      +R T     PE  S 
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISY 224

Query: 486 CKVNSSGDVYSFGIVLLQILS 506
            K  S+ DV+SFGIV+ ++++
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT 245

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  117 bits (295), Expect = 1e-29
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 31/207 (14%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVA 370
              +G+G  G VY  +   N   +A+K      +  EG      RE+   SH+RHPN++ 
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           +  Y       +L+ E  P G L + L     F + +  ++++ L  A+       + H 
Sbjct: 79  MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH------YCHE 132

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPE 481
                ++HRDIKP N+L+G   E K++DFG S        +A S  R    GT  YL PE
Sbjct: 133 RK---VIHRDIKPENLLMGYKGELKIADFGWSV-------HAPSLRRRTMCGTLDYLPPE 182

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                  +   D++  G++  + L G 
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  117 bits (295), Expect = 1e-29
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 14/196 (7%)

Query: 320 IGEGITGKVYKGKLSNNQH---VAIKHI----TNEGNVETFVREVASSSHVRHPNLVALL 372
           +G G  G V KG     +    VA+K +     +    +  + E      + +P +V ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
           G C   +   L+ E+   G L ++L  +++ +     +E+    + G+ +L    E   V
Sbjct: 85  GICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYL---EESNFV 139

Query: 433 HRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKVNS 490
           HRD+   N+LL     AK+SDFGLSK +   E Y  ++  G +   +  PE  +  K +S
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199

Query: 491 SGDVYSFGIVLLQILS 506
             DV+SFG+++ +  S
Sbjct: 200 KSDVWSFGVLMWEAFS 215

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  118 bits (297), Expect = 1e-29
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 18/199 (9%)

Query: 320 IGEGITGKVYKGKL----SNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALL 372
           IG G +G+V  G+L      +  VAIK +     E     F+ E +      HPN++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
           G   R     ++ E   NG+L  +L   D   + +Q + +      G+ +L   S+   V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYV 173

Query: 433 HRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL--DPE---YRSNCK 487
           HRD+   N+L+  N   K+SDFGLS+V++     A +   G        PE   +R    
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR---T 230

Query: 488 VNSSGDVYSFGIVLLQILS 506
            +S+ DV+SFG+V+ ++L+
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  118 bits (297), Expect = 2e-29
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 14/198 (7%)

Query: 320 IGEGITGKVYKGKL-----SNNQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVALL 372
           +G+G  G V   +      +  + VA+K +  + E ++  F RE+     ++H N+V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 373 GYCLRVDEC--FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           G C         LI E  P G+L ++L    + +  I+ L+      +G+ +L +     
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDPEYRSNCKV 488
            +HRD+   NIL+      K+ DFGL+KV+   + Y   +  G     +  PE  +  K 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225

Query: 489 NSSGDVYSFGIVLLQILS 506
           + + DV+SFG+VL ++ +
Sbjct: 226 SVASDVWSFGVVLYELFT 243

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  116 bits (294), Expect = 2e-29
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQ----HVAIKHI---TNEGNVETFVREVASSSHVR 364
           E +    ++GEG  G+VY+G  +N++    +VA+K         N E F+ E     ++ 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           HP++V L+G     +  ++I EL P G L  +L      L  +  +  ++   + + +L 
Sbjct: 72  HPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL- 129

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDP 480
                  VHRDI   NIL+      KL DFGLS+ I+  + Y +S     ++       P
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SP 183

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E  +  +  ++ DV+ F + + +ILS
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS 209

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  118 bits (298), Expect = 3e-29
 Identities = 67/258 (25%), Positives = 106/258 (41%), Gaps = 38/258 (14%)

Query: 280 SNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNEL--------NLIGEGITGKVYKG 331
            +P  K++  +   +     P Y       +   L E+          +G G  G+VY+G
Sbjct: 31  QSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEG 90

Query: 332 KLSN------NQHVAIK---HITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF 382
           ++S          VA+K    + +E +   F+ E    S   H N+V  +G  L+    F
Sbjct: 91  QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150

Query: 383 LIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
           ++ EL   G+L  +L        +   L+ +  L +A D A G  +L    E   +HRDI
Sbjct: 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDI 207

Query: 437 KPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL-----DPEYRSNCKV 488
              N LL   GP   AK+ DFG+++ I     Y     +G    L      PE       
Sbjct: 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGCAMLPVKWMPPEAFMEGIF 263

Query: 489 NSSGDVYSFGIVLLQILS 506
            S  D +SFG++L +I S
Sbjct: 264 TSKTDTWSFGVLLWEIFS 281

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  116 bits (293), Expect = 3e-29
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET---FVREVASSSH 362
             +     +GEG  GKV+  +  N         VA+K +  +  +     F RE    ++
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTN 73

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCLSWI 407
           ++H ++V   G C   D   +++E   +G+L ++L                     L   
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
           Q L IA   A G+ +L   +    VHRD+   N L+G N   K+ DFG+S+ +   + Y 
Sbjct: 134 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190

Query: 468 SSE-----VRGTFGYLDPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
                   +R       PE   YR   K  +  DV+SFG++L +I +
Sbjct: 191 VGGHTMLPIRWM----PPESIMYR---KFTTESDVWSFGVILWEIFT 230

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  121 bits (305), Expect = 3e-29
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 11/202 (5%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN----NQHVAIKHI---TNEGNVETFVREVASSSHVR 364
           E++     IGEG  G V++G   +       VAIK     T++   E F++E  +     
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           HP++V L+G     +  ++I ELC  G L  +L  +   L     +  A   +  L +L 
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL- 507

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
                  VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +    ++ PE  +
Sbjct: 508 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

Query: 485 NCKVNSSGDVYSFGIVLLQILS 506
             +  S+ DV+ FG+ + +IL 
Sbjct: 566 FRRFTSASDVWMFGVCMWEILM 587

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  117 bits (294), Expect = 4e-29
 Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 30/218 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIK---HITNEGNVETFVREVASSSH 362
           EK+     +G+G  G VY+G             VAIK      +      F+ E +    
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---------FGKDKCLSWIQRLEIA 413
               ++V LLG   +     +I EL   G+L  +L                S  + +++A
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 414 IDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRG 473
            + A G+ +L   +    VHRD+   N ++  +F  K+ DFG+++ I   + Y     +G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKG 197

Query: 474 TFGYL-----DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             G L      PE   +    +  DV+SFG+VL +I +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (304), Expect = 4e-29
 Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 20/204 (9%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALL--- 372
           +G G  G V +       + VAIK      +  N E +  E+     + HPN+V+     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 373 ---GYCLRVDECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
                    D   L  E C  G+L ++L  F     L       +  D +  L +LH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141

Query: 428 EGCIVHRDIKPTNILLGPNFEA---KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
              I+HRD+KP NI+L P  +    K+ D G +K +D GE        GT  YL PE   
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQYLAPELLE 196

Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
             K   + D +SFG +  + ++G 
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGF 220

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (292), Expect = 5e-29
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 25/210 (11%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGY 374
           ++G+G T  V++G+        AIK   N      V+  +RE      + H N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 375 --CLRVDECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
                     LI E CP G+L   L        L   + L +  D   G+  L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132

Query: 431 IVHRDIKPTNILLGPNFEA----KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           IVHR+IKP NI+     +     KL+DFG ++ ++  E + S  + GT  YL P+     
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERA 190

Query: 487 KVNSSG--------DVYSFGIVLLQILSGK 508
            +            D++S G+      +G 
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  116 bits (292), Expect = 6e-29
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 17/207 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN-----NQHVAIK---HITNEGNVETFVREVASSSHV 363
             L ++  +GEG  GKV             + VA+K         +   + +E+     +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 364 RHPNLVALLGYCLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW 421
            H +++   G C         L+ E  P G+L ++L      +   Q L  A     G+ 
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMA 148

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLD 479
           +LH+      +HRD+   N+LL  +   K+ DFGL+K +  G  Y      G     +  
Sbjct: 149 YLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILS 506
           PE     K   + DV+SFG+ L ++L+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  117 bits (294), Expect = 6e-29
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNL--VA 370
           L  IG G + KV++      Q  AIK++     +   ++++  E+A  + ++  +   + 
Sbjct: 14  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L  Y +     +++ E C N +L  WL  K K +   +R     +    +  +H +    
Sbjct: 74  LYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDPE-------- 481
           IVH D+KP N L+  +   KL DFG++  +    T    +   GT  Y+ PE        
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 482 ---YRSNCKVNSSGDVYSFGIVLLQILSGK 508
               +S  K++   DV+S G +L  +  GK
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  115 bits (290), Expect = 9e-29
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNL--VA 370
           L  IG G + KV++      Q  AIK++     +   ++++  E+A  + ++  +   + 
Sbjct: 33  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L  Y +     +++ E C N +L  WL  K K +   +R     +    +  +H +    
Sbjct: 93  LYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDPE-------- 481
           IVH D+KP N L+  +   KL DFG++  +    T    +   GT  Y+ PE        
Sbjct: 148 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 482 ---YRSNCKVNSSGDVYSFGIVLLQILSGK 508
               +S  K++   DV+S G +L  +  GK
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (291), Expect = 1e-28
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 43/225 (19%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNN---QHVAIK---HITNEGNVETFVREVASSSHV-R 364
             +   ++IGEG  G+V K ++  +      AIK      ++ +   F  E+     +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCLSWIQR 409
           HPN++ LLG C      +L  E  P+GNL ++L                     LS  Q 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           L  A D ARG+ +L   S+   +HRD+   NIL+G N+ AK++DFGLS+  ++   Y   
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---Y--- 195

Query: 470 EVRGTFGYL-----DPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
            V+ T G L       E   Y       ++ DV+S+G++L +I+S
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVS 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  114 bits (288), Expect = 1e-28
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 29/215 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKL--------SNNQHVAIKHITNEGNVET---FVREVASS 360
           E L     +G+G   K++KG           +   V +K + ++ +      F    +  
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKAHRNYSESFFEAASMM 66

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
           S + H +LV   G C+  DE  L+ E    G+L  +L     C++ + +LE+A   A  +
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126

Query: 421 WFLHSYSEGCIVHRDIKPTNILL--------GPNFEAKLSDFGLSKVIDIGETYASSEVR 472
            FL    E  ++H ++   NILL        G     KLSD G+S  +   +      + 
Sbjct: 127 HFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL-PKDILQERIP 182

Query: 473 GTFGYLDPEYRSNCKVNSS-GDVYSFGIVLLQILS 506
                  PE   N K  +   D +SFG  L +I S
Sbjct: 183 WV----PPECIENPKNLNLATDKWSFGTTLWEICS 213

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  114 bits (287), Expect = 1e-28
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 18/206 (8%)

Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPN 367
           K +    IG G    VYKG        VA   +      +   + F  E      ++HPN
Sbjct: 29  KFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 368 LVALLGYCL---RVDECFLIY-ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           +V          +  +C ++  EL  +G L  +L  + K +             +GL FL
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFL 145

Query: 424 HSYSEGCIVHRDIKPTNILL-GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY 482
           H+     I+HRD+K  NI + GP    K+ D GL+ +     ++A + V GT  ++ PE 
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA-VIGTPEFMAPEM 201

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
               K + S DVY+FG+ +L++ + +
Sbjct: 202 YEE-KYDESVDVYAFGMCMLEMATSE 226

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  114 bits (288), Expect = 2e-28
 Identities = 57/227 (25%), Positives = 87/227 (38%), Gaps = 39/227 (17%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHI---TNEGNVETFVREVASSSH 362
            +L+    +G G  GKV +              VA+K +    +    E  + E+   S+
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 363 V-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----------------FGKDKCL 404
           +  H N+V LLG C       +I E C  G+L  +L                    +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 405 SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE 464
                L  +   A+G+ FL   +    +HRD+   NILL      K+ DFGL++ I    
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 465 TYASSE-----VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            Y         V+       PE   NC      DV+S+GI L ++ S
Sbjct: 200 NYVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  114 bits (287), Expect = 2e-28
 Identities = 58/269 (21%), Positives = 106/269 (39%), Gaps = 61/269 (22%)

Query: 316 ELNLIGEGITGKVYKGK-LSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVALLG 373
           E+ ++G+G  G+V K +   ++++ AIK I   E  + T + EV   + + H  +V    
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69

Query: 374 YCLRVDEC-------------FLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAI 414
             L                  F+  E C NG L + +        +D+     +++  A+
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR-- 472
                  ++HS  +G I+HRD+KP NI +  +   K+ DFGL+K +         + +  
Sbjct: 130 S------YIHS--QG-IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 473 -----------GTFGYLDPE-------YRSNCKVNSSGDVYSFGIVLLQILSG-----KK 509
                      GT  Y+  E       Y  N K+    D+YS GI+  +++       ++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEMIYPFSTGMER 234

Query: 510 AKVLTRAGSALELADPKLDREYSIEAFDL 538
             +L +  S      P  D         +
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKI 263

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  114 bits (288), Expect = 2e-28
 Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 44/232 (18%)

Query: 312 EKLNELNLIGEGITGKVYKGKL------SNNQHVAIK---HITNEGNVETFVREVASSSH 362
           + L     +GEG  GKV K         +    VA+K      +   +   + E      
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----------------------FG 399
           V HP+++ L G C +     LI E    G+L  +L                         
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 400 KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
            ++ L+    +  A   ++G+ +L   +E  +VHRD+   NIL+    + K+SDFGLS+ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 460 IDIGETYASSEVRGTFGYL-----DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           +   ++Y    V+ + G +       E   +    +  DV+SFG++L +I++
Sbjct: 200 VYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (290), Expect = 2e-28
 Identities = 57/306 (18%), Positives = 97/306 (31%), Gaps = 36/306 (11%)

Query: 286 ITSFKGVQLKDPGCPRYTI-REVHYATEKLNELNLIGEGITGKVYKGK------LSNNQH 338
           ++S+          P      E    ++ +   +L+GEG   +VY+          N Q 
Sbjct: 38  VSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK 97

Query: 339 VAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEW 396
             +K     N        + +           +      L  +   L+ EL   G L   
Sbjct: 98  FVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNA 157

Query: 397 L----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA--- 449
           +       +K +     +  A+     +  +H      I+H DIKP N +LG  F     
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214

Query: 450 --------KLSDFGLS---KVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFG 498
                    L D G S   K+   G  + +     T G+   E  SN   N   D +   
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVA 272

Query: 499 IVLLQILSGKKAKVLTRAGSALELADPK--LDREYSIEAFDLTLQL--ALSCTALTHQRP 554
             +  +L G   KV    G        +     +   E F + L +       +L   R 
Sbjct: 273 ATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332

Query: 555 PMEQVF 560
            +++VF
Sbjct: 333 KLKKVF 338

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  115 bits (289), Expect = 2e-28
 Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 42/226 (18%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGNVET---FVREVASSSH 362
             +     +GEG  GKV+  +  N         VA+K    E +      F RE    + 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQDFQREAELLTM 99

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL--------------FGKDKCLSWIQ 408
           ++H ++V   G C       +++E   +G+L  +L                    L   Q
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
            L +A   A G+ +L   +    VHRD+   N L+G     K+ DFG+S+ I   + Y  
Sbjct: 160 LLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216

Query: 469 SE-----VRGTFGYLDPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
                  +R       PE   YR   K  +  DV+SFG+VL +I +
Sbjct: 217 GGRTMLPIRWM----PPESILYR---KFTTESDVWSFGVVLWEIFT 255

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  116 bits (291), Expect = 3e-28
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 24/210 (11%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNL--VA 370
           L  IG G + KV++      Q  AIK++     +   ++++  E+A  + ++  +   + 
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L  Y +     +++ E C N +L  WL  K K +   +R     +    +  +H +    
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET------------YASSEVRGTFGYL 478
           IVH D+KP N L+  +   KL DFG++  +    T            Y   E        
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
               +S  K++   DV+S G +L  +  GK
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (285), Expect = 3e-28
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 32/219 (14%)

Query: 316 ELNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVAL 371
            +  +G G  G V++ K   ++ + AIK I     E   E  +REV + + + HP +V  
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68

Query: 372 LGYCL---------RVDECFLIY---ELCPNGNLAEWLFGKDKC--LSWIQRLEIAIDSA 417
               L                +Y   +LC   NL +W+ G+           L I +  A
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----- 472
             + FLHS     ++HRD+KP+NI    +   K+ DFGL   +D  E   +         
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 473 ------GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQIL 505
                 GT  Y+ PE       +   D++S G++L ++L
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  115 bits (290), Expect = 4e-28
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 25/210 (11%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGY 374
           ++G+G T  V++G+        AIK   N      V+  +RE      + H N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 375 --CLRVDECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
                     LI E CP G+L   L        L   + L +  D   G+  L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132

Query: 431 IVHRDIKPTNILLGPNFEA----KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
           IVHR+IKP NI+     +     KL+DFG ++ ++  E + S  + GT  YL P+     
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERA 190

Query: 487 KVNSSG--------DVYSFGIVLLQILSGK 508
            +            D++S G+      +G 
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  113 bits (286), Expect = 5e-28
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 14/206 (6%)

Query: 312 EKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEG--NVETFVREVASSSHVR 364
             L  ++ +G+G  G V   +      +    VA+K + + G      F RE+     + 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 365 HPNLVALLGYCLRVDEC--FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
              +V   G           L+ E  P+G L ++L      L   + L  +    +G+ +
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF--GYLDP 480
           L S      VHRD+   NIL+      K++DFGL+K++ + + Y      G     +  P
Sbjct: 143 LGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILS 506
           E  S+   +   DV+SFG+VL ++ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  113 bits (285), Expect = 6e-28
 Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 39/227 (17%)

Query: 312 EKLNELNLIGEGITGKVYKGKL--------SNNQHVAIK---HITNEGNVETFVREVASS 360
           +KL     +GEG  G+V   +              VA+K       E ++   V E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 361 SHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCL 404
             + +H N++ LLG C +    ++I E    GNL E+L                  ++ +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 405 SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE 464
           ++   +      ARG+ +L   +    +HRD+   N+L+  N   K++DFGL++ I+  +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 465 TYASSEVRGTFGYL-----DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            Y     + T G L      PE   +       DV+SFG+++ +I +
Sbjct: 212 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (284), Expect = 7e-28
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 28/220 (12%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFV 354
           RY + E            ++G G   +V+  + L +++ VA+K        +      F 
Sbjct: 13  RYELGE------------ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60

Query: 355 REVASSSHVRHPNLVALLGY----CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL 410
           RE  +++ + HP +VA+              +++ E      L + +   +  ++  + +
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAI 119

Query: 411 EIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--AS 468
           E+  D+ + L F H      I+HRD+KP NI++      K+ DFG+++ I         +
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           + V GT  YL PE      V++  DVYS G VL ++L+G+
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (285), Expect = 9e-28
 Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 36/218 (16%)

Query: 320 IGEGITGKVYKGKLSNNQHVAIK-------------------HITNEGNVETFVREVASS 360
           + +G   K+   +  +N+  A+K                    I+ +   + F  E+   
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 361 SHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR-- 418
           + +++   +   G     DE ++IYE   N ++ ++       L       I I   +  
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQVIKCI 156

Query: 419 ------GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
                    ++H+     I HRD+KP+NIL+  N   KLSDFG S+ +   +   S   R
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211

Query: 473 GTFGYLDPEYRSNCKV--NSSGDVYSFGIVLLQILSGK 508
           GT+ ++ PE+ SN      +  D++S GI L  +    
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  113 bits (284), Expect = 1e-27
 Identities = 58/223 (26%), Positives = 88/223 (39%), Gaps = 35/223 (15%)

Query: 312 EKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHI---TNEGNVETFVREVASSSH 362
             L     +G G  GKV +              VA+K +    +    E  + E+   SH
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 363 V-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-------------FGKDKCLSWIQ 408
           + +H N+V LLG C       +I E C  G+L  +L                +   S   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
            L  +   A+G+ FL   +    +HRD+   N+LL     AK+ DFGL++ I     Y  
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-- 220

Query: 469 SEVRGTFGYL-----DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
             +      L      PE   +C      DV+S+GI+L +I S
Sbjct: 221 --IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  116 bits (293), Expect = 1e-27
 Identities = 45/219 (20%), Positives = 84/219 (38%), Gaps = 37/219 (16%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK---LSNNQHVAIKHITNEGN---VETFV 354
           +Y ++              I  G  G +Y      + N + V +K + + G+       +
Sbjct: 81  QYEVKG------------CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAM 127

Query: 355 REVASSSHVRHPNLVALLGYCLRVDEC-----FLIYELCPNGNLAEWLFGKDKCLSWIQR 409
            E    + V HP++V +  +    D       +++ E     +L      K   L   + 
Sbjct: 128 AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEA 184

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           +   ++    L +LHS   G +V+ D+KP NI+L    + KL D G    I+     +  
Sbjct: 185 IAYLLEILPALSYLHS--IG-LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFG 235

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            + GT G+  PE        ++ D+Y+ G  L  +    
Sbjct: 236 YLYGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDL 273

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  112 bits (282), Expect = 1e-27
 Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 38/226 (16%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIK---HITNEGNVETFVREVASSSH 362
           ++L     +G G  G+V +            + VA+K              + E+    H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 363 V-RHPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWL---------------FGKDKCLS 405
           +  H N+V LLG C +      +I E C  GNL+ +L                     L+
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
               +  +   A+G+ FL   +    +HRD+   NILL      K+ DFGL++ I     
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 466 YASSEVRGTFGYL-----DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           Y    VR     L      PE   +       DV+SFG++L +I S
Sbjct: 204 Y----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  112 bits (283), Expect = 2e-27
 Identities = 57/232 (24%), Positives = 87/232 (37%), Gaps = 44/232 (18%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHI---TNEGNVETFVREVASSSH 362
           E L    ++G G  GKV             +  VA+K +    +    E  + E+   + 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 363 V-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL----------------------FG 399
           +  H N+V LLG C      +LI+E C  G+L  +L                        
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 400 KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
               L++   L  A   A+G+ FL        VHRD+   N+L+      K+ DFGL++ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 460 IDIGETYASSE-----VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS 506
           I     Y         V+       PE           DV+S+GI+L +I S
Sbjct: 222 IMSDSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (282), Expect = 2e-27
 Identities = 23/229 (10%), Positives = 57/229 (24%), Gaps = 46/229 (20%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVALL 372
            +  G    V+  + +   +  A+K        +   +E       +++ +   +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 373 GYC--------------------------LRVDECFLIYE-----LCPNGNLAEWLFGKD 401
                                          V    L+       L    +  ++++   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 402 KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
                +    +     R    L S     +VH    P N+ + P+    L D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK-- 243

Query: 462 IGETYASSEVRGTFGYLDPEY--RSNCKVNSSGDVYSFGIVLLQILSGK 508
           +G             Y   E+   S      + + +  G+ + ++    
Sbjct: 244 VGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  113 bits (284), Expect = 3e-27
 Identities = 35/238 (14%), Positives = 68/238 (28%), Gaps = 56/238 (23%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIK---------------------------HITNEGNV 350
           ++G+       +       +   +                             I N+   
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 351 ETFVREVASSSHVRHPNLVALL-----GYCLRVDECFLIYEL--CPNGNLAEWLFGK--- 400
           +  +R +     V+ P    ++        + V   F +Y           E L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
            K L    RL++ +   R L  LH Y    +VH  ++P +I+L       L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 461 DIGETYASSEVRGTFGYLDPEYRS----------NCKVNSSGDVYSFGIVLLQILSGK 508
                 AS+      G+  PE  +             +  + D ++ G+ +  I    
Sbjct: 262 G-----ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  112 bits (282), Expect = 3e-27
 Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 39/227 (17%)

Query: 312 EKLNELNLIGEGITGKVYKGKL--------SNNQHVAIK---HITNEGNVETFVREVASS 360
           +KL     +GEG  G+V   +              VA+K       E ++   V E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 361 SHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL---------------FGKDKCL 404
             + +H N++ LLG C +    ++I E    GNL E+L                  ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 405 SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE 464
           ++   +      ARG+ +L   +    +HRD+   N+L+  N   K++DFGL++ I+  +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 465 TYASSEVRGTFGYL-----DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            Y     + T G L      PE   +       DV+SFG+++ +I +
Sbjct: 258 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (278), Expect = 4e-27
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLV 369
            E  + L  +GEG  G VYK       Q VAIK +  E +++  ++E++       P++V
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVV 87

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSY 426
              G   +  + +++ E C  G++++ +  ++K L+  +   IA     + +GL +LH  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE---IATILQSTLKGLEYLH-- 142

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
               I HRDIK  NILL     AKL+DFG++  +       ++ + GT  ++ PE     
Sbjct: 143 FMRKI-HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 200

Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             N   D++S GI  +++  GK
Sbjct: 201 GYNCVADIWSLGITAIEMAEGK 222

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (277), Expect = 6e-27
 Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 22/214 (10%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFV 354
            Y +R             L+G G  G VY+ +     + VA+K       ++        
Sbjct: 35  PYRLRR------------LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ 82

Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI 414
           RE  ++  ++ P++V +  +     + ++   L    +LA  L  +   L+  + + I  
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVR 141

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGT 474
                L   H+   G   HRD+KP NIL+  +  A L DFG++      +        GT
Sbjct: 142 QIGSALDAAHA--AG-ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGT 198

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             Y+ PE  S        D+Y+   VL + L+G 
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGS 232

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  110 bits (278), Expect = 7e-27
 Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 50/235 (21%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSN------NQHVAIK---HITNEGNVETFVREVASSSH 362
             +  +  IGEG  G+V++ +            VA+K      +      F RE A  + 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 363 VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL-----------------------FG 399
             +PN+V LLG C       L++E    G+L E+L                         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 400 KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
               LS  ++L IA   A G+ +L   SE   VHRD+   N L+G N   K++DFGLS+ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 460 IDIGETYASSEVRGTFGYL-----DPE---YRSNCKVNSSGDVYSFGIVLLQILS 506
           I   + Y           +      PE   Y    +  +  DV+++G+VL +I S
Sbjct: 224 IYSADYY----KADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFS 271

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (275), Expect = 8e-27
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 31/206 (15%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVALL 372
            +G+G   K ++       +  A K      +      E    E++    + H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLS------WIQRLEIAIDSARGLWFLHSY 426
           G+    D  F++ ELC   +L E    + K L+      +++++        G  +LH  
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQI------VLGCQYLHRN 134

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEY 482
               ++HRD+K  N+ L  + E K+ DFGL+  ++        E +    GT  Y+ PE 
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-----YDGERKKVLCGTPNYIAPEV 186

Query: 483 RSNCKVNSSGDVYSFGIVLLQILSGK 508
            S    +   DV+S G ++  +L GK
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (276), Expect = 1e-26
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 39/210 (18%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVALL 372
            +G+G   K ++       +  A K      +      E    E++    + H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLS------WIQRLEIAIDSARGLWFLHSY 426
           G+    D  F++ ELC   +L E    + K L+      +++++        G  +LH  
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQI------VLGCQYLHRN 160

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR----GTFGYLDPEY 482
               ++HRD+K  N+ L  + E K+ DFGL+  ++        E +    GT  Y+ PE 
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-----YDGERKKVLCGTPNYIAPEV 212

Query: 483 RSN----CKVNSSGDVYSFGIVLLQILSGK 508
            S      +V    DV+S G ++  +L GK
Sbjct: 213 LSKKGHSFEV----DVWSIGCIMYTLLVGK 238

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  108 bits (273), Expect = 2e-26
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 16/216 (7%)

Query: 303 TIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVAS 359
            + E  Y  ++  +  ++G+G  G VY G+ LSN   +AIK I   +    +    E+A 
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72

Query: 360 SSHVRHPNLVALLGYCLRVDECFLIY-ELCPNGNLAEWLFGKDKCLSWIQRLEIAI---D 415
             H++H N+V  LG     +    I+ E  P G+L+  L  K   L   ++  I      
Sbjct: 73  HKHLKHKNIVQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQ 130

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYASSEVRGT 474
              GL +LH      IVHRDIK  N+L+   +   K+SDFG SK +        +   GT
Sbjct: 131 ILEGLKYLHD--NQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186

Query: 475 FGYLDPE--YRSNCKVNSSGDVYSFGIVLLQILSGK 508
             Y+ PE   +       + D++S G  ++++ +GK
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (272), Expect = 2e-26
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 9/201 (4%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVRHPN 367
            +K      IG+G +G VY    ++  Q VAI+ +    +   E  + E+      ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + L FLHS  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
              ++HRDIK  NILLG +   KL+DFG    I   ++  S+ V GT  ++ PE  +   
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
                D++S GI+ ++++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  109 bits (274), Expect = 2e-26
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 17/199 (8%)

Query: 318 NLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF-VREVASSSHVRHPNLVALLGYC 375
             +G G  G+V++ K        A+K +     +E F V E+ + + +  P +V L G  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYG-A 118

Query: 376 LRVDECFLIY-ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
           +R      I+ EL   G+L + L  +  CL   + L     +  GL +LH+     I+H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHG 174

Query: 435 DIKPTNILLGPN-FEAKLSDFGLSKVIDIGETYASSE----VRGTFGYLDPEYRSNCKVN 489
           D+K  N+LL  +   A L DFG +  +       S      + GT  ++ PE       +
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234

Query: 490 SSGDVYSFGIVLLQILSGK 508
           +  D++S   ++L +L+G 
Sbjct: 235 AKVDIWSSCCMMLHMLNGC 253

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  110 bits (276), Expect = 2e-26
 Identities = 59/268 (22%), Positives = 106/268 (39%), Gaps = 42/268 (15%)

Query: 274 LKRYYKSNPPAKITSFKGVQLKDPGCPRYTIR---EVHYATEKLNELNLIGEGITGKVYK 330
              ++  +     T     Q    G   Y +          ++L     +GEG  G+V  
Sbjct: 28  YHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVL 87

Query: 331 GKL--------SNNQHVAIKHI---TNEGNVETFVREVASSSHV-RHPNLVALLGYCLRV 378
            +         +    VA+K +     E ++   + E+     + +H N++ LLG C + 
Sbjct: 88  AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147

Query: 379 DECFLIYELCPNGNLAEWL---------------FGKDKCLSWIQRLEIAIDSARGLWFL 423
              ++I E    GNL E+L                  ++ LS    +  A   ARG+ +L
Sbjct: 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL----- 478
              +    +HRD+   N+L+  +   K++DFGL++ I   + Y     + T G L     
Sbjct: 208 ---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWM 260

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILS 506
            PE   +       DV+SFG++L +I +
Sbjct: 261 APEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (271), Expect = 4e-26
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 9/201 (4%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVRHPN 367
              L+    IGEG TG V   +   + + VA+K +    +   E    EV      +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V +    L  +E +++ E    G L + +      L+  Q   +     + L +LH+  
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
              ++HRDIK  +ILL  +   KLSDFG    I        S V GT  ++ PE  S   
Sbjct: 162 ---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSL 217

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
             +  D++S GI++++++ G+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (268), Expect = 7e-26
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 28/208 (13%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLG 373
           +  +G+G  GKVYK K        A K I  +    +E ++ E+   +   HP +V LLG
Sbjct: 24  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSYSEGC 430
                 + +++ E CP G +   +   D+ L+  Q   I +        L FLHS  +  
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHS--KRI 138

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVID---------IGETY-ASSEVRGTFGYLDP 480
           I HRD+K  N+L+    + +L+DFG+S             IG  Y  + EV       D 
Sbjct: 139 I-HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            Y  + K     D++S GI L+++   +
Sbjct: 198 PY--DYKA----DIWSLGITLIEMAQIE 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (267), Expect = 1e-25
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 41/219 (18%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALL 372
             +IG G T  V         + VAIK I     + +++  ++E+ + S   HPN+V+  
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRL----EIAI---DSARGLWFLHS 425
              +  DE +L+ +L   G++ + +            +     IA    +   GL +LH 
Sbjct: 80  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF---------- 475
              G I HRD+K  NILLG +   +++DFG+S  +  G     ++VR TF          
Sbjct: 140 --NGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 476 ------GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
                 GY       + K     D++SFGI  +++ +G 
Sbjct: 197 VMEQVRGY-------DFKA----DIWSFGITAIELATGA 224

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  108 bits (270), Expect = 1e-25
 Identities = 30/234 (12%), Positives = 61/234 (26%), Gaps = 47/234 (20%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIKHIT-----NEGNVETFVREVASSSHVR-------- 364
           ++G+       +       +   +             ++    EV     +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 365 -----------------HPNLVALLGYCLRVDEC--FLIYEL--CPNGNLAEWLFG---K 400
                               ++ +      +     F +Y           E L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 401 DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI 460
            K L    RL++ +   R L  LH Y    +VH  ++P +I+L       L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 461 DIGET------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
                      +   E+      +         +  S D ++ G+V+  I    
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (267), Expect = 2e-25
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETF---VREVASSSHVRHPN 367
           +   +++ +G G  G V+K     +   +A K I  E         +RE+        P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE------IAIDSARGLW 421
           +V   G      E  +  E    G+L       D+ L    R+       ++I   +GL 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKKAGRIPEQILGKVSIAVIKGLT 145

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           +L    +  I+HRD+KP+NIL+    E KL DFG+S  +   ++ A+S V GT  Y+ PE
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPE 200

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                  +   D++S G+ L+++  G+
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (265), Expect = 2e-25
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 16/199 (8%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALL 372
           L  IG+G  G+V+KG      + VAIK I     E  +E   +E+   S    P +    
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSYSEG 429
           G  L+  + ++I E    G+  + L  +   L      +IA    +  +GL +LHS  E 
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD---ETQIATILREILKGLDYLHS--EK 139

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            I HRDIK  N+LL  + E KL+DFG++  +   +   ++ V GT  ++ PE       +
Sbjct: 140 KI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 197

Query: 490 SSGDVYSFGIVLLQILSGK 508
           S  D++S GI  +++  G+
Sbjct: 198 SKADIWSLGITAIELARGE 216

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  108 bits (272), Expect = 3e-25
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 26/202 (12%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVALLG 373
           +G+G  G+V   K     Q  A+K I       + + E+ +REV     + HPN++ L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
           +       +L+ E+   G L + +  + K  S +    I      G+ ++H      IVH
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVH 149

Query: 434 RDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-----YRSN 485
           RD+KP N+LL     +   ++ DFGLS   +  +     +  GT  Y+ PE     Y   
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPEVLHGTYDEK 207

Query: 486 CKVNSSGDVYSFGIVLLQILSG 507
           C      DV+S G++L  +LSG
Sbjct: 208 C------DVWSTGVILYILLSG 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  107 bits (268), Expect = 7e-25
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 25/202 (12%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGY 374
           +G G  G+V   +    +   AIK I     +  +    + EVA    + HPN++ L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
                  +L+ E    G L + +  +    + +    I      G+ +LH ++   IVHR
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHR 160

Query: 435 DIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-----YRSNC 486
           D+KP N+LL     +   K+ DFGLS V +  +     E  GT  Y+ PE     Y   C
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRKKYDEKC 218

Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
                 DV+S G++L  +L+G 
Sbjct: 219 ------DVWSIGVILFILLAGY 234

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (257), Expect = 2e-24
 Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 37/222 (16%)

Query: 316 ELNLIGEGITGKVYKG-KLSNNQHVAIKHIT----NEGNVETFVREVAS-SSHVRHPNLV 369
           EL  IG G  G V+K  K  +    AIK          + +  +REV + +   +H ++V
Sbjct: 15  ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIA---IDSARGLWFLHSY 426
                    D   +  E C  G+LA+ +    + +S+ +  E+    +   RGL ++HS 
Sbjct: 75  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134

Query: 427 SEGCIVHRDIKPTNILLGPN-------------------FEAKLSDFGLSKVIDIGETYA 467
           S   +VH DIKP+NI +                         K+ D G    I   +   
Sbjct: 135 S---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-- 189

Query: 468 SSEVRGTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                G   +L  E  + N       D+++  + ++     +
Sbjct: 190 ---EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  105 bits (263), Expect = 4e-24
 Identities = 62/257 (24%), Positives = 95/257 (36%), Gaps = 47/257 (18%)

Query: 279 KSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNEL----NLIGEGITGKVYKGK-L 333
             +   +   F+G+ +     P   +R+      K+ E       +G G  G+V   K  
Sbjct: 6   HHSSGRENLYFQGIAIN----PGMYVRK---KEGKIGESYFKVRKLGSGAYGEVLLCKEK 58

Query: 334 SNNQHVAIKHI---------------TNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           + +   AIK I                 E   E    E++    + HPN++ L       
Sbjct: 59  NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118

Query: 379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKP 438
              +L+ E    G L E +  +           I      G+ +LH ++   IVHRDIKP
Sbjct: 119 KYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKP 174

Query: 439 TNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-----YRSNCKVNS 490
            NILL         K+ DFGLS            +  GT  Y+ PE     Y   C    
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLKKKYNEKC---- 228

Query: 491 SGDVYSFGIVLLQILSG 507
             DV+S G+++  +L G
Sbjct: 229 --DVWSCGVIMYILLCG 243

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 4e-24
 Identities = 41/211 (19%), Positives = 84/211 (39%), Gaps = 25/211 (11%)

Query: 317 LNLIGEGIT--GKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLV 369
           L +IG+G      V   +     ++V ++ I     +   V     E+  S    HPN+V
Sbjct: 30  LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSY 426
                 +  +E +++      G+  + +      +  +  L IA       + L ++H  
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHH- 146

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-KVIDIGE------TYASSEVRGTFGYLD 479
             G + HR +K ++IL+  + +  LS    +  +I  G+       +    V     +L 
Sbjct: 147 -MGYV-HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLS 203

Query: 480 PE--YRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE   ++    ++  D+YS GI   ++ +G 
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  104 bits (261), Expect = 5e-24
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 29/220 (13%)

Query: 305 REVHYATEKLNEL----NLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVR 355
           RE  Y      E      ++G+G  G+V K K     Q  A+K I        +  T +R
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70

Query: 356 EVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           EV     + HPN++ L          +++ EL   G L + +  + K  S      I   
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQ 129

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVR 472
              G+ ++H ++   IVHRD+KP NILL     + + K+ DFGLS            +  
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRI 184

Query: 473 GTFGYLDPE-----YRSNCKVNSSGDVYSFGIVLLQILSG 507
           GT  Y+ PE     Y   C      DV+S G++L  +LSG
Sbjct: 185 GTAYYIAPEVLRGTYDEKC------DVWSAGVILYILLSG 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (252), Expect = 2e-23
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF---VREVA-SSSHVRHP 366
           E L +L  IG G  G V K     + Q +A+K I +  + +     + ++         P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE------IAIDSARGL 420
            +V   G   R  +C++  EL  + +  ++   K         +       I + + + L
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
             L       I+HRDIKP+NILL  +   KL DFG+S  +   ++ A +   G   Y+ P
Sbjct: 139 NHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAP 194

Query: 481 EYRSNCKVNSSG-----DVYSFGIVLLQILSGK 508
           E R +   +  G     DV+S GI L ++ +G+
Sbjct: 195 E-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  100 bits (250), Expect = 2e-23
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF---VREVASSSH-VRHP 366
           + L  +  +G G  G V K + + + Q +A+K I    N +     + ++  S   V  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 367 NLVALLGYCLRVDECFLIYELCPNG--NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
             V   G   R  + ++  EL         + +  K + +      +IA+   + L  LH
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
           S  +  ++HRD+KP+N+L+    + K+ DFG+S  +   +  A     G   Y+ PE R 
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPE-RI 181

Query: 485 NCKVNSSG-----DVYSFGIVLLQILSGK 508
           N ++N  G     D++S GI ++++   +
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILR 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (251), Expect = 3e-23
 Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 29/239 (12%)

Query: 279 KSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQ 337
            ++      S       D G  R  + +  +  E       +G G T  VY+ K     +
Sbjct: 27  TASAAPGTASLVPDYWID-GSNRDALSD-FFEVESE-----LGRGATSIVYRCKQKGTQK 79

Query: 338 HVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL 397
             A+K +    + +    E+     + HPN++ L        E  L+ EL   G L + +
Sbjct: 80  PYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI 139

Query: 398 FGK------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFE 448
             K      D   +  Q LE        + +LH      IVHRD+KP N+L     P+  
Sbjct: 140 VEKGYYSERDAADAVKQILE-------AVAYLHENG---IVHRDLKPENLLYATPAPDAP 189

Query: 449 AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            K++DFGLSK+++         V GT GY  PE    C      D++S GI+   +L G
Sbjct: 190 LKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  100 bits (252), Expect = 3e-23
 Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 24/229 (10%)

Query: 293 QLKDPGCPRYTIREVHYATEKLNEL----NLIGEGITGKVYKGK-LSNNQHVAIKHI--T 345
           +  +    +Y  + V      + +       +G G  G V++    +  +    K I   
Sbjct: 28  KFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP 87

Query: 346 NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLS 405
              +  T   E++  + + HP L+ L        E  LI E    G L + +  +D  +S
Sbjct: 88  YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 147

Query: 406 WIQRLEI-AIDSAR----GLWFLHSYSEGCIVHRDIKPTNILLG--PNFEAKLSDFGLSK 458
                E   I+  R    GL  +H +S   IVH DIKP NI+         K+ DFGL+ 
Sbjct: 148 -----EAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT 199

Query: 459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            ++  E         T  +  PE      V    D+++ G++   +LSG
Sbjct: 200 KLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 22/201 (10%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT---NEGNVETFVREVASSSHVRHPNLVALLGYC 375
           +G G  G V+  +  S+     IK I    ++  +E    E+     + HPN++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 376 LRVDECFLIYELCPNGNLAEWL---FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
                 +++ E C  G L E +     + K LS     E+       L + HS     +V
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146

Query: 433 HRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE---YRSNC 486
           H+D+KP NIL     P+   K+ DFGL+++    E    +   GT  Y+ PE        
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFKRDVTF 204

Query: 487 KVNSSGDVYSFGIVLLQILSG 507
           K     D++S G+V+  +L+G
Sbjct: 205 KC----DIWSAGVVMYFLLTG 221

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 99.1 bits (247), Expect = 6e-23
 Identities = 54/224 (24%), Positives = 87/224 (38%), Gaps = 30/224 (13%)

Query: 313 KLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVR-HPNL 368
           +L    ++ EG    VY+ + + + +  A+K +    E      ++EV     +  HPN+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 369 VALLGYCL--------RVDECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSAR 418
           V                  E  L+ ELC  G L E+L        LS    L+I   + R
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS--------- 469
            +  +H   +  I+HRD+K  N+LL      KL DFG +  I     Y+ S         
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 470 --EVRGTFGYLDPE---YRSNCKVNSSGDVYSFGIVLLQILSGK 508
                 T  Y  PE     SN  +    D+++ G +L  +   +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 23/172 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE----TFVREVASSSHVRHP 366
           EK  ++  IGEG  G V+K +     Q VAIK      +        +RE+     ++HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKCLSWIQRLEIAIDSARGL 420
           NLV LL    R     L++E C +  +   L        +    S   +        + +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT------LQAV 115

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEV 471
            F H ++    +HRD+KP NIL+  +   KL DFG ++++    + Y   EV
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-DDEV 163

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYC 375
           ++G G   +V+  K     +  A+K I  +      +   E+A    ++H N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 376 LRVDECFLIYELCPNGNLAEWLFGK------DKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
                 +L+ +L   G L + +  +      D  L   Q L         + +LH     
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------AVKYLHENG-- 126

Query: 430 CIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
            IVHRD+KP N+L      N +  ++DFGLSK+   G         GT GY+ PE  +  
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS---TACGTPGYVAPEVLAQK 182

Query: 487 KVNSSGDVYSFGIVLLQILSG 507
             + + D +S G++   +L G
Sbjct: 183 PYSKAVDCWSIGVITYILLCG 203

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  100 bits (250), Expect = 2e-22
 Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 14/238 (5%)

Query: 279 KSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNEL----NLIGEGITGKVYKGK-L 333
           K        S            +Y  + V    + + +       +G G  G V++    
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 334 SNNQHVAIKHIT--NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG 391
           +   + A K +   +E + ET  +E+ + S +RHP LV L       +E  +IYE    G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA-- 449
            L E +  +   +S  + +E      +GL  +H  +    VH D+KP NI+         
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNEL 296

Query: 450 KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           KL DFGL+  +D  ++       GT  +  PE      V    D++S G++   +LSG
Sbjct: 297 KLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 25/201 (12%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGY 374
           +G+G  G+V K K     Q  A+K I        +  T +REV     + HPN++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
                  +++ EL   G L + +  + K  S      I      G+ ++H ++   IVHR
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHR 145

Query: 435 DIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-----YRSNC 486
           D+KP NILL     + + K+ DFGLS            +  GT  Y+ PE     Y   C
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVLRGTYDEKC 203

Query: 487 KVNSSGDVYSFGIVLLQILSG 507
                 DV+S G++L  +LSG
Sbjct: 204 ------DVWSAGVILYILLSG 218

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 35/235 (14%)

Query: 286 ITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI 344
           +  FK  +++D     Y I E             +G G    V K +  S     A K I
Sbjct: 2   MEPFKQQKVED----FYDIGEE------------LGSGQFAIVKKCREKSTGLEYAAKFI 45

Query: 345 --------TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEW 396
                       + E   REV+    V H N++ L        +  LI EL   G L ++
Sbjct: 46  KKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDF 105

Query: 397 LFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLS 452
           L  K+  LS  +          G+ +LH+     I H D+KP NI+L     P    KL 
Sbjct: 106 LAQKES-LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161

Query: 453 DFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           DFGL+  I+ G  +    + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 162 DFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 50/150 (33%), Positives = 72/150 (48%), Gaps = 16/150 (10%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVA 370
           L  IG G  G VY  + + N++ VAIK +      +    +  ++EV     +RHPN + 
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAI---DSARGLWFLHSYS 427
             G  LR    +L+ E C  G+ ++ L    K L     +EIA     + +GL +LHS  
Sbjct: 119 YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ---EVEIAAVTHGALQGLAYLHS-- 172

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLS 457
              I HRD+K  NILL      KL DFG +
Sbjct: 173 HNMI-HRDVKAGNILLSEPGLVKLGDFGSA 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 65/240 (27%), Positives = 98/240 (40%), Gaps = 45/240 (18%)

Query: 286 ITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI 344
           + +FK  +++D     Y I E             +G G    V K +  S     A K I
Sbjct: 2   METFKQQKVED----FYDIGEE------------LGSGQFAIVKKCREKSTGLEYAAKFI 45

Query: 345 --------TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEW 396
                         E   REV+    V HPN++ L        +  LI EL   G L ++
Sbjct: 46  KKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDF 105

Query: 397 LFGKDKCLSWIQRLEI-AIDSAR----GLWFLHSYSEGCIVHRDIKPTNILL----GPNF 447
           L  K+  LS     E  A    +    G+ +LH+     I H D+KP NI+L     P  
Sbjct: 106 LAQKES-LS-----EEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP 156

Query: 448 EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
             KL DFGL+  I+ G  +    + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 157 HIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 66/252 (26%), Positives = 102/252 (40%), Gaps = 48/252 (19%)

Query: 280 SNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQH 338
            +P   +       L+DP    + + E+            +G G  G+VYKG+ +   Q 
Sbjct: 5   DSPARSLDEIDLSALRDPA-GIFELVEL------------VGNGTYGQVYKGRHVKTGQL 51

Query: 339 VAIKHITNEG-NVETFVREVAS-SSHVRHPNLVALLG------YCLRVDECFLIYELCPN 390
            AIK +   G   E   +E+     +  H N+    G           D+ +L+ E C  
Sbjct: 52  AAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA 111

Query: 391 GNLAEWL-FGKDKCLSWIQRLEIAI---DSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
           G++ + +   K   L       IA    +  RGL  LH +    ++HRDIK  N+LL  N
Sbjct: 112 GSVTDLIKNTKGNTLKEEW---IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN 165

Query: 447 FEAKLSDFGLSKVID---------IGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYS 496
            E KL DFG+S  +D         IG  Y  + EV       D  Y  + K     D++S
Sbjct: 166 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY--DFKS----DLWS 219

Query: 497 FGIVLLQILSGK 508
            GI  +++  G 
Sbjct: 220 LGITAIEMAEGA 231

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 52/199 (26%), Positives = 80/199 (40%), Gaps = 23/199 (11%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           IG G  G+V            A K I      +V+ F +E+     + HPN++ L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
              + +L+ ELC  G L E +  K +         I  D    + + H  +   + HRD+
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDL 132

Query: 437 KPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-----YRSNCKV 488
           KP N L     P+   KL DFGL+     G+        GT  Y+ P+     Y   C  
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEGLYGPEC-- 188

Query: 489 NSSGDVYSFGIVLLQILSG 507
               D +S G+++  +L G
Sbjct: 189 ----DEWSAGVMMYVLLCG 203

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.8 bits (239), Expect = 6e-22
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 25/207 (12%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT-----------NEGNVETFVREVASSSHV-RHP 366
           +G G++  V +       +  A+K I             +   E  ++EV     V  HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           N++ L          FL+++L   G L ++L  K   LS  +  +I       +  LH  
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL 143

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSN 485
           +   IVHRD+KP NILL  +   KL+DFG S  +D GE     EV GT  YL PE    +
Sbjct: 144 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIECS 198

Query: 486 CKVNSSG-----DVYSFGIVLLQILSG 507
              N  G     D++S G+++  +L+G
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 27/189 (14%)

Query: 295 KDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE-- 351
            D G      + +    EK   L L+GEG  G V K +     + VAIK      + +  
Sbjct: 12  VDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV 67

Query: 352 --TFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKDKC 403
               +RE+     +RH NLV LL  C +    +L++E   +  + + L            
Sbjct: 68  KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVV 126

Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI- 462
             ++ ++        G+ F HS++   I+HRDIKP NIL+  +   KL DFG ++ +   
Sbjct: 127 QKYLFQI------INGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177

Query: 463 GETYASSEV 471
           GE Y   EV
Sbjct: 178 GEVY-DDEV 185

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 95.5 bits (238), Expect = 7e-22
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 15/207 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF---VREVA-SSSHVRHP 366
             L  L  +G G  G+V+K +       +A+K +   GN E     + ++         P
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
            +V   G  +   + F+  EL       +        +      ++ +   + L++L   
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE- 142

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE----- 481
            +  ++HRD+KP+NILL    + KL DFG+S  +   +  A     G   Y+ PE     
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMAPERIDPP 199

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK 508
             +    +   DV+S GI L+++ +G+
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQ 226

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 24/205 (11%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----------TNEGNVETFVREVASSSHVRHPNL 368
           +G G  G+V         + VAI+ I                     E+     + HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           + +  +    ++ +++ EL   G L + + G  K L               + +LH    
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG- 259

Query: 429 GCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
             I+HRD+KP N+LL     +   K++DFG SK++          + GT  YL PE   +
Sbjct: 260 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPEVLVS 315

Query: 486 CKVNSSG---DVYSFGIVLLQILSG 507
                     D +S G++L   LSG
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSG 340

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 14/196 (7%)

Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGY 374
           +G+G    V +    +     A K I     +  + +   RE      ++HPN+V L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
                  +L+++L   G L E +  + +  S              + + HS     IVHR
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHR 129

Query: 435 DIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           ++KP N+LL         KL+DFGL+  ++  E +      GT GYL PE       +  
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKP 187

Query: 492 GDVYSFGIVLLQILSG 507
            D+++ G++L  +L G
Sbjct: 188 VDIWACGVILYILLVG 203

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 50/220 (22%), Positives = 84/220 (38%), Gaps = 51/220 (23%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFV-REVASSSHVRHPNLVAL 371
           L+GEG  GKV +          A+K      +    N E  V +E+     +RH N++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 372 LG--YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--------GLW 421
           +   Y     + +++ E C  G + E +         +      +  A         GL 
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCG-MQE-MLDS------VPEKRFPVCQAHGYFCQLIDGLE 123

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG------ET------YASS 469
           +LHS     IVH+DIKP N+LL      K+S  G+++ +          T      +   
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 470 EV-RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           E+  G   +   +           D++S G+ L  I +G 
Sbjct: 181 EIANGLDTFSGFK----------VDIWSAGVTLYNITTGL 210

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 45/213 (21%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVALL 372
            +G G  GKV  G+       VA+K      I +   V    RE+ +    RHP+++ L 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--------GLWFLH 424
                  + F++ E    G L +++    +         +    AR         + + H
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCH 128

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE---------TYASSEVRGTF 475
            +    +VHRD+KP N+LL  +  AK++DFGLS ++  GE          YA+ EV    
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            Y  PE           D++S G++L  +L G 
Sbjct: 186 LYAGPE----------VDIWSCGVILYALLCGT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 29/206 (14%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI--------TNEGNVETFVREVASSSHVRHPNLVA 370
           +G G    V K +     +  A K I            + E   REV     +RHPN++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR----GLWFLHS 425
           L        +  LI EL   G L ++L  K+  L+     E  A    +    G+ +LHS
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKES-LT-----EDEATQFLKQILDGVHYLHS 126

Query: 426 YSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
                I H D+KP NI+L     PN   KL DFG++  I+ G  +    + GT  ++ PE
Sbjct: 127 KR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPE 181

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
             +   +    D++S G++   +LSG
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSG 207

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 44/211 (20%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGY 374
           IG+G   KV   + +   + VAIK I     N  +++   REV     + HPN+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--------GLWFLHSY 426
                  +LI E    G + ++L    +         +    AR         + + H  
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQK 133

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET---------YASSEVRGTFGY 477
               IVHRD+K  N+LL  +   K++DFG S    +G           YA+ E+     Y
Sbjct: 134 ---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             PE           DV+S G++L  ++SG 
Sbjct: 191 DGPEV----------DVWSLGVILYTLVSGS 211

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 47/216 (21%), Positives = 93/216 (43%), Gaps = 31/216 (14%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEG-NVETFVREVA 358
           +Y I E             +G G  G V++    S+ +    K +  +G +     +E++
Sbjct: 6   KYMIAED------------LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS 53

Query: 359 SSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSA 417
             +  RH N++ L      ++E  +I+E     ++ E +      L+     E   +   
Sbjct: 54  ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELN-----EREIVSYV 108

Query: 418 R----GLWFLHSYSEGCIVHRDIKPTNILLG--PNFEAKLSDFGLSKVIDIGETYASSEV 471
                 L FLHS++   I H DI+P NI+     +   K+ +FG ++ +  G+ +    +
Sbjct: 109 HQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLL 163

Query: 472 RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
                Y  PE   +  V+++ D++S G ++  +LSG
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 23/210 (10%)

Query: 308 HYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEG--NVETFVREVASSSHVR 364
            Y   K   L   G G  G+V+K +  +    +A K I   G  + E    E++  + + 
Sbjct: 88  FYTVSKTEIL---GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD 144

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR----G 419
           H NL+ L       ++  L+ E    G L + +  +   L+     E+  I   +    G
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-----ELDTILFMKQICEG 199

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEA--KLSDFGLSKVIDIGETYASSEVRGTFGY 477
           +  +H      I+H D+KP NIL         K+ DFGL++     E        GT  +
Sbjct: 200 IRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEF 254

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
           L PE  +   V+   D++S G++   +LSG
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 94.5 bits (235), Expect = 3e-21
 Identities = 58/240 (24%), Positives = 76/240 (31%), Gaps = 51/240 (21%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI-------TNEGNVETFVREVASSSHVRHPNLVAL 371
           IG+G  G V            AIK +        N  +VE    EV     + HPN+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 372 LGYCLRVDECFLIYELCPNGNL-----------------AEWLFGKDKCLSWIQRLEIAI 414
                      L+ ELC  G+L                          C    +      
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 415 DSARGLWFLHSYSEG---------------C----IVHRDIKPTNILLG--PNFEAKLSD 453
                        E                     I HRDIKP N L     +FE KL D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213

Query: 454 FGLSKVI---DIGETYASSEVRGTFGYLDPE--YRSNCKVNSSGDVYSFGIVLLQILSGK 508
           FGLSK     + GE Y  +   GT  ++ PE    +N       D +S G++L  +L G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----------TNEGNVETFVREVASSSHVR-HPN 367
           IG G++  V +    +     A+K +            E   E   RE      V  HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           ++ L+         FL+++L   G L ++L  K   LS  +   I       + FLH+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN 220

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-YRSNC 486
              IVHRD+KP NILL  N + +LSDFG S  ++ GE     E+ GT GYL PE  + + 
Sbjct: 221 ---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSM 275

Query: 487 KVNSSG-----DVYSFGIVLLQILSG 507
                G     D+++ G++L  +L+G
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAG 301

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 50/229 (21%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIK----------------------------HITNEGN 349
            IG+G  G V      ++N + A+K                             I   G 
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 350 VETFVREVASSSHVRHPNLVAL---LGYCLRVDECFLIYELCPNGNLAEWL----FGKDK 402
           +E   +E+A    + HPN+V L   L      D  ++++EL   G + E        +D+
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 403 CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI 462
              + Q L   I+      +LH      I+HRDIKP+N+L+G +   K++DFG+S     
Sbjct: 139 ARFYFQDLIKGIE------YLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 463 GETYASSEVRGTFGYLDPEYRSNCKVNSSG---DVYSFGIVLLQILSGK 508
            +   S+ V GT  ++ PE  S  +   SG   DV++ G+ L   + G+
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 63/239 (26%), Positives = 94/239 (39%), Gaps = 45/239 (18%)

Query: 287 TSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI- 344
           T F+   + D     Y   E             +G G    V K +  S     A K I 
Sbjct: 2   TVFRQENVDD----YYDTGEE------------LGSGQFAVVKKCREKSTGLQYAAKFIK 45

Query: 345 -------TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL 397
                      + E   REV+    ++HPN++ L        +  LI EL   G   E L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGG---E-L 101

Query: 398 FGKDKCLSWIQRLEI-AIDSAR----GLWFLHSYSEGCIVHRDIKPTNILL----GPNFE 448
           F  D         E  A +  +    G+++LHS     I H D+KP NI+L     P   
Sbjct: 102 F--DFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 156

Query: 449 AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            K+ DFGL+  ID G  +    + GT  ++ PE  +   +    D++S G++   +LSG
Sbjct: 157 IKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 27/204 (13%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRH-PNLVALLG 373
           +G G    V +    S  Q  A K +      +      + E+A     +  P ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLS-WIQRL--EIAIDSAR----GLWFLHSY 426
                 E  LI E    G   E +F    CL    + +     I   +    G+++LH  
Sbjct: 97  VYENTSEIILILEYAAGG---E-IF--SLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 427 SEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR 483
           +   IVH D+KP NILL    P  + K+ DFG+S+ I         E+ GT  YL PE  
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEIL 205

Query: 484 SNCKVNSSGDVYSFGIVLLQILSG 507
           +   + ++ D+++ GI+   +L+ 
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTH 229

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 24/201 (11%)

Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGY 374
           +G+G    V +    +     A K I     +  + +   RE      ++HPN+V L   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 375 CLRVDECFLIYELCPNGNLAEWL-----FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
                  +L+++L   G L E +     + +      IQ++         + + HS    
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI------LESIAYCHSNG-- 148

Query: 430 CIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
            IVHR++KP N+LL         KL+DFGL+  ++  E +      GT GYL PE     
Sbjct: 149 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKD 205

Query: 487 KVNSSGDVYSFGIVLLQILSG 507
             +   D+++ G++L  +L G
Sbjct: 206 PYSKPVDIWACGVILYILLVG 226

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 49/231 (21%), Positives = 81/231 (35%), Gaps = 60/231 (25%)

Query: 308 HYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----------TNEGNVETFVRE 356
            Y+T        +G G  G V+       N+ V +K I            +  +     E
Sbjct: 25  KYSTMSP-----LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79

Query: 357 VASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG-----------NLAEWLFGKDKCLS 405
           +A  S V H N++ +L          L+ E   +G            L E          
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLASY 134

Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE- 464
             ++L  A+       +L       I+HRDIK  NI++  +F  KL DFG +  ++ G+ 
Sbjct: 135 IFRQLVSAVG------YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185

Query: 465 --------TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
                    Y + EV     Y  PE           +++S G+ L  ++  
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPEL----------EMWSLGVTLYTLVFE 226

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 34/210 (16%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI----------TNEGNVETFVREVASSSHVRHPNL 368
           +G G  G+V         + VAIK I                     E+     + HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGK-----DKCLSWIQRLEIAIDSARGLWFL 423
           + +  +    ++ +++ EL   G L + + G        C  +  ++ +A+       +L
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ------YL 130

Query: 424 HSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
           H      I+HRD+KP N+LL     +   K++DFG SK++          + GT  YL P
Sbjct: 131 HENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAP 185

Query: 481 EYRSNCKVNSSG---DVYSFGIVLLQILSG 507
           E   +          D +S G++L   LSG
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 29/208 (13%)

Query: 317 LNLIGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVA 370
             ++GEG    V   +  + ++  AIK     HI  E  V    RE    S + HP  V 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR--------GLW 421
           L       ++ +       NG L          L +I+++        R         L 
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYTAEIVSALE 144

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGETYASSEVRGTFGYLDP 480
           +LH      I+HRD+KP NILL  +   +++DFG +K +    +   ++   GT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           E  +      S D+++ G ++ Q+++G 
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.9 bits (231), Expect = 3e-20
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 50/224 (22%)

Query: 308 HYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSS 361
           HY          +G G  GKV  GK       VA+K      I +   V    RE+ +  
Sbjct: 17  HYILGDT-----LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71

Query: 362 HVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--- 418
             RHP+++ L        + F++ E    G L +++    +         +    +R   
Sbjct: 72  LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---------LDEKESRRLF 122

Query: 419 -----GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-------- 465
                G+ + H +    +VHRD+KP N+LL  +  AK++DFGLS ++  GE         
Sbjct: 123 QQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP 179

Query: 466 -YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            YA+ EV     Y  PE           D++S G++L  +L G 
Sbjct: 180 NYAAPEVISGRLYAGPE----------VDIWSSGVILYALLCGT 213

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 92.4 bits (230), Expect = 4e-20
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 13/196 (6%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVALLGY 374
           +G+G    V +   +   Q  A   I     +  + +   RE      ++HPN+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
                  +LI++L   G L E +  + +  S              +   H      +VHR
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHR 134

Query: 435 DIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
           ++KP N+LL         KL+DFGL+  ++ GE  A     GT GYL PE          
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPYGKP 193

Query: 492 GDVYSFGIVLLQILSG 507
            D+++ G++L  +L G
Sbjct: 194 VDLWACGVILYILLVG 209

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 24/215 (11%)

Query: 305 REVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR 364
           RE+ Y   K+     IG G  G V++ KL  +  VAIK +  +   +   RE+     V+
Sbjct: 38  REIAYTNCKV-----IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN--RELQIMRIVK 90

Query: 365 HPNLVALLGY----CLRVDECF--LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS-- 416
           HPN+V L  +      + DE F  L+ E  P   +        K    +  L I +    
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 417 -ARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDIGETYASSEVRGT 474
             R L ++HS     I HRDIKP N+LL P     KL DFG +K++  GE    S +  +
Sbjct: 150 LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYI-CS 204

Query: 475 FGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGK 508
             Y  PE         ++ D++S G V+ +++ G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 46/213 (21%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLGY 374
            +GEG  G+V         + VA+K +         E   +E+  +  + H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--------GLWFLHSY 426
               +  +L  E C  G L + +              +    A+        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGI 124

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET------------YASSEVRGT 474
               I HRDIKP N+LL      K+SDFGL+ V                  Y + E+   
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
             +               DV+S GIVL  +L+G
Sbjct: 182 REFHAEP----------VDVWSCGIVLTAMLAG 204

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 89.5 bits (223), Expect = 7e-20
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 32/172 (18%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE----TFVREVASSSHVRHPNLVAL 371
           +  IGEG  G VYK +     + VA+K I  +   E    T +RE++    + HPN+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67

Query: 372 LGYCLRVDECFLIYELC-----------PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
           L      ++ +L++E                 +   L    K   + Q L       +GL
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI---KSYLF-QLL-------QGL 116

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEV 471
            F HS+    ++HRD+KP N+L+      KL+DFGL++   +   TY + EV
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEV 164

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 59/261 (22%), Positives = 87/261 (33%), Gaps = 62/261 (23%)

Query: 280 SNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQH 338
           + P     +  G     PG       E  Y    L     +G+G  G V+ G  L++   
Sbjct: 4   TKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPL-----LGKGGFGTVFAGHRLTDRLQ 58

Query: 339 VAIKHI--------TNEGNVETFVREVAS----SSHVRHPNLVALLGYCLRVDECFLIYE 386
           VAIK I        +   +  T   EVA      +   HP ++ LL +    +   L+ E
Sbjct: 59  VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118

Query: 387 -----------LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
                      +   G L E          +  ++  AI         HS     +VHRD
Sbjct: 119 RPLPAQDLFDYITEKGPLGE-----GPSRCFFGQVVAAIQ------HCHSRG---VVHRD 164

Query: 436 IKPTNILL-GPNFEAKLSDFGLSKVIDIGE--------TYASSEVRGTFGYLDPEYRSNC 486
           IK  NIL+      AKL DFG   ++             Y+  E      Y         
Sbjct: 165 IKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALP----- 219

Query: 487 KVNSSGDVYSFGIVLLQILSG 507
                  V+S GI+L  ++ G
Sbjct: 220 -----ATVWSLGILLYDMVCG 235

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 29/172 (16%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALL 372
           L  +G G    VYKG   +   +VA+K +   + EG   T +RE++    ++H N+V L 
Sbjct: 10  LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69

Query: 373 GYCLRVDECFLIYELC----------PNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGL 420
                 ++  L++E                        +  K   W Q L       +GL
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW-QLL-------QGL 121

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEV 471
            F H      I+HRD+KP N+L+    + KL DFGL++   I   T+ SSEV
Sbjct: 122 AFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEV 169

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 46/213 (21%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPNLVALLGY 374
            +GEG  G+V         + VA+K +         E   +E+  +  + H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--------GLWFLHSY 426
               +  +L  E C  G L + +              +    A+        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGI 124

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET------------YASSEVRGT 474
               I HRDIKP N+LL      K+SDFGL+ V                  Y + E+   
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
             +               DV+S GIVL  +L+G
Sbjct: 182 REFHAEP----------VDVWSCGIVLTAMLAG 204

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 44/241 (18%), Positives = 88/241 (36%), Gaps = 41/241 (17%)

Query: 344 ITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC 403
           +++   ++    ++         N V  L         ++  +LC   NL +W+    +C
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRC 156

Query: 404 LSWIQRLEIAIDSAR----GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
               +   + +         + FLHS     ++HRD+KP+NI    +   K+ DFGL   
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 460 IDIGETYASSEVR-----------GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           +D  E   +               GT  Y+ PE       +   D++S G++L ++L   
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273

Query: 509 -----KAKVLT--RAGSALELADPKLDREYSIEAFDLTLQLALSCTALTH---QRPPMEQ 558
                + +++T  R         P L  +   +   +   +      L+    +RP    
Sbjct: 274 STQMERVRIITDVRNLKF-----PLLFTQKYPQEHMMVQDM------LSPSPTERPEATD 322

Query: 559 V 559
           +
Sbjct: 323 I 323

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 26/168 (15%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALL 372
           L  +GEG  G VYK K S  + VA+K I     +EG   T +RE++    + HPN+V+L+
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85

Query: 373 GYCLRVDECFLIYELCPNGNLAEWL------FGKD--KCLSWIQRLEIAIDSARGLWFLH 424
                     L++E     +L + L            K   + Q L       RG+   H
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY-QLL-------RGVAHCH 136

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEV 471
            +    I+HRD+KP N+L+  +   KL+DFGL++   I   +Y + EV
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEV 180

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 27/239 (11%), Positives = 60/239 (25%), Gaps = 58/239 (24%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKG---KLSNNQHVAIK-----HITNEGNVET 352
           RY +                G     + ++     L  ++ VA+       +  +  ++ 
Sbjct: 32  RYRLLI------------FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQE 77

Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI 412
            +      S +  P +  +L          ++ E    G+L E     D   S +  +  
Sbjct: 78  TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRA 134

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
               A      H    G +      P+ + +  + +  L                     
Sbjct: 135 MQSLAAAADAAHR--AG-VALSIDHPSRVRVSIDGDVVL--------------------- 170

Query: 473 GTFGYLDPE-YRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDRE 530
                +     +         D+   G  L  +L  +         S L  A+     +
Sbjct: 171 AYPATMPDANPQD--------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 27/169 (15%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVAL 371
           L  IGEG  G V+K K    ++ VA+K +     +EG   + +RE+     ++H N+V L
Sbjct: 7   LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWL------FGKD--KCLSWIQRLEIAIDSARGLWFL 423
                   +  L++E C   +L ++          +  K   + Q L       +GL F 
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLF-QLL-------KGLGFC 117

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEV 471
           HS     ++HRD+KP N+L+  N E KL++FGL++   I    Y S+EV
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEV 162

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 26/168 (15%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVE----TFVREVASSSHVRHPNLVALL 372
           L  IGEG  G VYK + +  +  A+K I  E   E    T +RE++    ++H N+V L 
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 373 GYCLRVDECFLIYELCPNGNLAEWL------FGKD--KCLSWIQRLEIAIDSARGLWFLH 424
                     L++E     +L + L            K     Q L        G+ + H
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLL-QLL-------NGIAYCH 117

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEV 471
                 ++HRD+KP N+L+    E K++DFGL++   I    Y + E+
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEI 161

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 87.2 bits (217), Expect = 8e-19
 Identities = 50/172 (29%), Positives = 74/172 (43%), Gaps = 30/172 (17%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE-------TFVREVASSSHVRHPNL 368
           L+ +GEG    VYK +  + NQ VAIK I      E       T +RE+     + HPN+
Sbjct: 15  LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 74

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKD--------KCLSWIQRLEIAIDSARGL 420
           + LL          L+++     +L   +            K       L       +GL
Sbjct: 75  IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYML-MTL-------QGL 125

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEV 471
            +LH +    I+HRD+KP N+LL  N   KL+DFGL+K        Y + +V
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQV 173

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 51/224 (22%)

Query: 308 HYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSS 361
            Y   +      +GEG  GKV         Q VA+K      +          RE++   
Sbjct: 10  PYIIRET-----LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64

Query: 362 HVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--- 418
            +RHP+++ L        +  ++ E    G L +++  K +         +  D  R   
Sbjct: 65  LLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR---------MTEDEGRRFF 114

Query: 419 -----GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE--------- 464
                 + + H +    IVHRD+KP N+LL  N   K++DFGLS ++  G          
Sbjct: 115 QQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP 171

Query: 465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            YA+ EV     Y  PE           DV+S GIVL  +L G+
Sbjct: 172 NYAAPEVINGKLYAGPE----------VDVWSCGIVLYVMLVGR 205

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 54/182 (29%), Positives = 73/182 (40%), Gaps = 42/182 (23%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVE---TFVREVA---SSSHVRH 365
           +  IG G  G VYK +   +   VA+K +       G      + VREVA         H
Sbjct: 14  VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73

Query: 366 PNLVALL-----GYCLRVDECFLIYELC-----------PNGNLAEWLFGKDKCLSWIQR 409
           PN+V L+         R  +  L++E             P   L        K L   Q 
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---KDLMR-QF 129

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           L       RGL FLH+    CIVHRD+KP NIL+      KL+DFGL+++        + 
Sbjct: 130 L-------RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TP 178

Query: 470 EV 471
            V
Sbjct: 179 VV 180

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVR-HPNLVALLGY 374
           ++GEG   +V     L  +Q  A+K I            REV      + H N++ L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR 434
               D  +L++E    G++   +  + +  + ++   +  D A  L FLH+     I HR
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHR 135

Query: 435 DIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVR------GTFGYLDPEYRSN 485
           D+KP NIL          K+ DF L   I +    +           G+  Y+ PE    
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 486 CKVNSSG-----DVYSFGIVLLQILSG 507
               +S      D++S G++L  +LSG
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSG 222

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 54/239 (22%), Positives = 97/239 (40%), Gaps = 23/239 (9%)

Query: 279 KSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQ 337
           +  PP      +          +  I + +  T ++     +G GI GKV +       +
Sbjct: 34  QPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQV-----LGLGINGKVLQIFNKRTQE 88

Query: 338 HVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYC---LRVDECF-LIYELCPNGN 392
             A+K + +        REV       + P++V ++          +C  ++ E    G 
Sbjct: 89  KFALKMLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 145

Query: 393 LAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFE 448
           L   +  + D+  +  +  EI       + +LHS +   I HRD+KP N+L     PN  
Sbjct: 146 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 202

Query: 449 AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            KL+DFG +K      +   +    T  Y+ PE     K + S D++S G+++  +L G
Sbjct: 203 LKLTDFGFAKETTSHNSL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 58/245 (23%), Positives = 81/245 (33%), Gaps = 60/245 (24%)

Query: 295 KDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI--------T 345
           K          E  Y    L     +G G  G VY G  +S+N  VAIKH+         
Sbjct: 31  KLAPGKEKEPLESQYQVGPL-----LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85

Query: 346 NEGNVETFVREVASSSHVRH--PNLVALLGYCLRVDECFLIYELCP-----------NGN 392
              N      EV     V      ++ LL +  R D   LI E               G 
Sbjct: 86  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145

Query: 393 LAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKL 451
           L E     +   S+  ++  A+         H+     ++HRDIK  NIL+  N  E KL
Sbjct: 146 LQE-----ELARSFFWQVLEAVR------HCHNCG---VLHRDIKDENILIDLNRGELKL 191

Query: 452 SDFGLSKVIDIGE--------TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQ 503
            DFG   ++             Y+  E      Y                V+S GI+L  
Sbjct: 192 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS----------AAVWSLGILLYD 241

Query: 504 ILSGK 508
           ++ G 
Sbjct: 242 MVCGD 246

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 55/213 (25%), Positives = 77/213 (36%), Gaps = 49/213 (23%)

Query: 319 LIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALLG 373
            IG G  G     +     + VA+K+I      + NV+   RE+ +   +RHPN+V    
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKE 83

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--------GLWFLHS 425
             L      +I E    G L E +           R     D AR        G+ + HS
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNA-------GRFSE--DEARFFFQQLLSGVSYCHS 134

Query: 426 YSEGCIVHRDIKPTNILLGPNFEA--KLSDFGLSKVIDIGE---------TYASSEVRGT 474
                I HRD+K  N LL  +     K+ DFG SK   +            Y + EV   
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
             Y               DV+S G+ L  +L G
Sbjct: 192 QEYDGKI----------ADVWSCGVTLYVMLVG 214

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 85.3 bits (212), Expect = 3e-18
 Identities = 53/180 (29%), Positives = 80/180 (44%), Gaps = 40/180 (22%)

Query: 317 LNLIGEGITGKVYKGK--LSNNQHVAIKHI----TNEGNVETFVREVA---SSSHVRHPN 367
           +  IGEG  GKV+K +   +  + VA+K +      EG   + +REVA         HPN
Sbjct: 16  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75

Query: 368 LVALL-----GYCLRVDECFLIYELC-----------PNGNLAEWLFGKDKCLSWIQRLE 411
           +V L          R  +  L++E             P   +        K + + Q L 
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI---KDMMF-QLL- 130

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
                 RGL FLHS+    +VHRD+KP NIL+  + + KL+DFGL+++        +S V
Sbjct: 131 ------RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVV 180

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 19/199 (9%)

Query: 319 LIGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYC- 375
           ++G G+ GKV +       Q  A+K + +        +EV         P++V +L    
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR---QEVDHHWQASGGPHIVCILDVYE 92

Query: 376 --LRVDECF-LIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCI 431
                  C  +I E    G L   +  + D+  +  +  EI  D    + FLHS++   I
Sbjct: 93  NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---I 149

Query: 432 VHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
            HRD+KP N+L      +   KL+DFG +K               T  Y+ PE     K 
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ---TPCYTPYYVAPEVLGPEKY 206

Query: 489 NSSGDVYSFGIVLLQILSG 507
           + S D++S G+++  +L G
Sbjct: 207 DKSCDMWSLGVIMYILLCG 225

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 45/209 (21%), Positives = 79/209 (37%), Gaps = 32/209 (15%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHI-------TNEGNVETFVREVASSSHVRHPNLVAL 371
           IG+G    V +       Q  A+K +       +   + E   RE +    ++HP++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSW----------IQRLEIAIDSARGLW 421
           L         ++++E     +L   +  +                 Q LE        L 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------ALR 144

Query: 422 FLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           + H  +   I+HRD+KP  +LL     +   KL  FG++  +       +    GT  ++
Sbjct: 145 YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFM 200

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            PE           DV+  G++L  +LSG
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 33/161 (20%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE----TFVREVASSSHVRHPNLVAL 371
           +  +GEG  G+VYK      N+ VAIK I  E   E    T +REV+    ++H N++ L
Sbjct: 39  ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 372 LGYCLRVDECFLIYELC---------PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWF 422
                      LI+E            N +++  +    K   + Q +        G+ F
Sbjct: 99  KSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVI---KSFLY-QLI-------NGVNF 147

Query: 423 LHSYSEGCIVHRDIKPTNILLGPNFEA-----KLSDFGLSK 458
            HS      +HRD+KP N+LL  +  +     K+ DFGL++
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 54/173 (31%), Positives = 81/173 (46%), Gaps = 26/173 (15%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E   +L+ +GEG    VYKGK    +  VA+K I     EG   T +REV+    ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWL------FGKD--KCLSWIQRLEIAIDSARG 419
           +V L           L++E     +L ++L            K   + Q L       RG
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLF-QLL-------RG 112

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI-GETYASSEV 471
           L + H      ++HRD+KP N+L+    E KL+DFGL++   I  +TY  +EV
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEV 161

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.1 bits (211), Expect = 8e-18
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 36/206 (17%)

Query: 279 KSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLS-NNQ 337
           +    +K+T+      + P  P+    EV Y   K+     IG G  G VY+ KL  + +
Sbjct: 30  RDKDGSKVTTVVATPGQGPDRPQ----EVSYTDTKV-----IGNGSFGVVYQAKLCDSGE 80

Query: 338 HVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF------LIYELCPNG 391
            VAIK +  +   +   RE+     + H N+V L  +     E        L+ +  P  
Sbjct: 81  LVAIKKVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE- 137

Query: 392 NLAEWL--FGKDKCLSWIQRLEIA-IDS-----ARGLWFLHSYSEGCIVHRDIKPTNILL 443
            +      + + K     Q L +  +        R L ++HS+    I HRDIKP N+LL
Sbjct: 138 TVYRVARHYSRAK-----QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLL 189

Query: 444 GPN-FEAKLSDFGLSKVIDIGETYAS 468
            P+    KL DFG +K +  GE   S
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEPNVS 215

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 23/199 (11%)

Query: 320 IGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLR 377
           +GEG      K     +NQ  A+K I ++       +E+ +      HPN+V L      
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII-SKRMEANTQKEITALKLCEGHPNIVKLHEVFHD 77

Query: 378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK 437
               FL+ EL   G L E +  K K  S  +   I       +  +H      +VHRD+K
Sbjct: 78  QLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLK 133

Query: 438 PTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE------YRSNCKV 488
           P N+L      N E K+ DFG +++    +         T  Y  PE      Y  +C  
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCFTLHYAAPELLNQNGYDESC-- 190

Query: 489 NSSGDVYSFGIVLLQILSG 507
               D++S G++L  +LSG
Sbjct: 191 ----DLWSLGVILYTMLSG 205

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 38/222 (17%)

Query: 311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETF----VREVASSSHVRH 365
            ++     + G+G  G V  GK       VAIK +  +     F    ++ +   + + H
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHH 78

Query: 366 PNLVALLGYCLRV------DECFL--IYELCPN--GNLAEWLFGKDKCLSWI-------Q 408
           PN+V L              + +L  + E  P+         + +      I       Q
Sbjct: 79  PNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYA 467
            +       R +  LH  S   + HRDIKP N+L+   +   KL DFG +K +   E   
Sbjct: 138 LI-------RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN- 188

Query: 468 SSEVRGTFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
            + +  +  Y  PE     +  ++  D++S G +  +++ G+
Sbjct: 189 VAYI-CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 37/219 (16%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKG-KLSNNQHVAIKHITNEGNVETFVREVAS 359
            Y ++E             IG G      +    + N   A+K I  + +      E+  
Sbjct: 23  GYEVKED------------IGVGSYSVCKRCIHKATNMEFAVKII--DKSKRDPTEEIEI 68

Query: 360 SSH-VRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
                +HPN++ L          +++ EL   G L + +  + K  S  +   +     +
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITK 127

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILL---GPNFEA-KLSDFGLSKVIDIGETYASSEVRGT 474
            + +LH+     +VHRD+KP+NIL      N E+ ++ DFG +K +        +    T
Sbjct: 128 TVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183

Query: 475 FGYLDPE------YRSNCKVNSSGDVYSFGIVLLQILSG 507
             ++ PE      Y + C      D++S G++L  +L+G
Sbjct: 184 ANFVAPEVLERQGYDAAC------DIWSLGVLLYTMLTG 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 40/168 (23%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE----TFVREVASSSHVRHP 366
           EKL +   IG+G  G+V+K +     Q VA+K +  E   E    T +RE+     ++H 
Sbjct: 20  EKLAK---IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 367 NLVALLG--------YCLRVDECFLIYELC----------PNGNLAEWLFGKDKCLSWIQ 408
           N+V L+         Y       +L+++ C                     + K +    
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL---SEIKRVMQ-M 132

Query: 409 RLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL 456
            L        GL+++H      I+HRD+K  N+L+  +   KL+DFGL
Sbjct: 133 LLN-------GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 35/161 (21%)

Query: 320 IGEGITGKVYKGK---LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCL 376
           +G G  G VYK K     +++  A+K I   G   +  RE+A    ++HPN+++L    L
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 377 RVDEC--FLIYELC-------------PNGNLAEWLFGKD--KCLSWIQRLEIAIDSARG 419
              +   +L+++                  N       +   K L + Q L        G
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY-QIL-------DG 140

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEA----KLSDFGL 456
           + +LH+     ++HRD+KP NIL+          K++D G 
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 178

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 29/208 (13%)

Query: 317 LNLIGEGITGKVYKG-KLSNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVA 370
           L  IG+G  GKV    K    +  A+K            V    +E+     + HP LV 
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 371 LLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLS------WIQRLEIAIDSARGLWFL 423
           L  Y  + +E  F++ +L   G+L   L  ++          +I  L +A+D      +L
Sbjct: 80  LW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFICELVMALD------YL 131

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-Y 482
            +     I+HRD+KP NILL  +    ++DF ++ ++       +  + GT  Y+ PE +
Sbjct: 132 QNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186

Query: 483 RSNCKV--NSSGDVYSFGIVLLQILSGK 508
            S      + + D +S G+   ++L G+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 80.7 bits (199), Expect = 3e-16
 Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 26/212 (12%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRH 365
            ++   L  IG G  G V        +++VAIK ++     +T      RE+     V H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 366 PNLVALL------GYCLRVDECFLIYELCP---NGNLAEWLFGKDKCLSWIQRLEIAIDS 416
            N+++LL             + +L+ EL        +   L  +       Q L      
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML------ 174

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
             G+  LHS     I+HRD+KP+NI++  +   K+ DFGL++      ++  +    T  
Sbjct: 175 -CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 228

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           Y  PE         + D++S G ++ +++  K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 36/211 (17%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPNLVAL 371
           L  IG G  G V         ++VAIK ++     +T      RE+     V H N++ L
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89

Query: 372 L------GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA-------- 417
           L             + +++ EL             D  L  + ++E+  +          
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMEL------------MDANLCQVIQMELDHERMSYLLYQML 137

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGY 477
            G+  LHS     I+HRD+KP+NI++  +   K+ DFGL++      ++  +    T  Y
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYY 192

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             PE         + D++S G ++ +++ G 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 49/228 (21%), Positives = 78/228 (34%), Gaps = 38/228 (16%)

Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           ++EV    +    L +IG G   +V   K+     V A+K      +   G V  F  E 
Sbjct: 53  LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER 112

Query: 358 ASSSHVRHPNLVALLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS 416
               +     +  L  +  + +   +L+ E    G+L          L+ + +    I +
Sbjct: 113 DVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPA 161

Query: 417 AR----------GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY 466
                        +  +H       VHRDIKP NILL      +L+DFG    +    T 
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVY-------SFGIVLLQILSG 507
            S    GT  YL PE             Y       + G+   ++  G
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 33/223 (14%)

Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           IR++    E    + +IG G  G+V   +  + + V A+K      +    +   F  E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120

Query: 358 ASSSHVRHPNLVALLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS 416
              +    P +V L  Y  + D   +++ E  P G+L          ++ +   ++    
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKW 169

Query: 417 AR--------GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS 468
           AR         L  +HS      +HRD+KP N+LL  +   KL+DFG    ++       
Sbjct: 170 ARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226

Query: 469 SEVRGTFGYLDPE----YRSNCKVNSSGDVYSFGIVLLQILSG 507
               GT  Y+ PE       +       D +S G+ L ++L G
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.5 bits (191), Expect = 4e-15
 Identities = 42/209 (20%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 315 NELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNL 368
            +  ++G G  G+V+  ++     + A K      +      +  + E    + V    +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247

Query: 369 VALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR--------G 419
           V+L  Y      +  L+  +   G++   ++  D+              A         G
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDE-----DNPGFQEPRAIFYTAQIVSG 301

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
           L  LH  +   I++RD+KP N+LL  +   ++SD GL+  +  G+T       GT G++ 
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           PE     + + S D ++ G+ L ++++ +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 38/227 (16%)

Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREV 357
           ++++    E    L +IG G  G+V   KL N   V A+K      +        F  E 
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125

Query: 358 ASSSHVRHPNLVALLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS 416
               +     +  L  Y  + D   +L+ +    G+L          L+ + + E  +  
Sbjct: 126 DVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPE 174

Query: 417 AR----------GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK-VIDIGET 465
                        +  +H       VHRDIKP NIL+  N   +L+DFG    +++ G  
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 466 YASSEVRGTFGYLDPEYRSNCKVNSSG-----DVYSFGIVLLQILSG 507
            +S  V GT  Y+ PE     +          D +S G+ + ++L G
Sbjct: 232 QSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 77.1 bits (190), Expect = 4e-15
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 315 NELNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVREVASSSHVRHPNL 368
            +  ++G+G  G+V   ++     + A K      I         + E      V    +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246

Query: 369 VALLGYCL-RVDECFLIYELCPNGNL-------AEWLFGKDKCLSWIQRLEIAIDSARGL 420
           V+L  Y     D   L+  L   G+L        +  F + + + +    EI      GL
Sbjct: 247 VSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA--EICC----GL 299

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
             LH      IV+RD+KP NILL  +   ++SD GL+  +  G+T     V GT GY+ P
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAP 354

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           E   N +   S D ++ G +L ++++G+
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 42/203 (20%), Positives = 94/203 (46%), Gaps = 24/203 (11%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGY 374
           +  +G G   +V++   ++NN+ V +K +      +   RE+    ++R  PN++ L   
Sbjct: 41  VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITLAD- 98

Query: 375 CLRVDECF---LIYELCPNGNLAEWL--FGKDKCLSWI-QRLEIAIDSARGLWFLHSYSE 428
            ++        L++E   N +  +            ++ + L       + L + HS   
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------KALDYCHSMG- 150

Query: 429 GCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
             I+HRD+KP N+++   + + +L D+GL++    G+ Y +  V  +  +  PE   + +
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYFKGPELLVDYQ 206

Query: 488 V-NSSGDVYSFGIVLLQILSGKK 509
           + + S D++S G +L  ++  K+
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKE 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 30/208 (14%)

Query: 317 LNLIGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVA 370
           L L+G+G  GKV   K  +  ++ A+K      I  +  V   + E     + RHP L A
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 371 LLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR--------GL 420
           L  Y  +  +    + E    G L             + R  + + D AR         L
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGEL----------FFHLSRERVFSEDRARFYGAEIVSAL 261

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS  E  +V+RD+K  N++L  +   K++DFGL K   I +        GT  YL P
Sbjct: 262 DYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAP 318

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           E   +     + D +  G+V+ +++ G+
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 41/219 (18%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRH 365
            +       +G G  G V       + + VAIK ++     E F     RE+    H++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 366 PNLVALL------GYCLRVDECFLIYELCP-------NGNLAEWLFGKDKCLSWI-QRLE 411
            N++ LL             + +L+                +E     +K    + Q L 
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE-----EKIQYLVYQML- 136

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSE 470
                 +GL ++HS     +VHRD+KP N+ +  + E K+ DFGL++  D   T Y    
Sbjct: 137 ------KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-- 185

Query: 471 VRGTFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
              T  Y  PE   +    +   D++S G ++ ++L+GK
Sbjct: 186 ---TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 76.5 bits (188), Expect = 8e-15
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 29/208 (13%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVETFVRE---VASSSHVRHPN 367
             +IG G  G+VY  + ++   + A+K      I  +      + E   ++  S    P 
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 368 LVALLGYCLR-VDECFLIYELCPNGNL-----AEWLFGKDKCLSWIQRLEIAIDSARGLW 421
           +V +  Y     D+   I +L   G+L        +F +     +    EI +    GL 
Sbjct: 254 IVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA--EIIL----GLE 306

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
            +H+     +V+RD+KP NILL  +   ++SD GL+      + +AS    GT GY+ PE
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 360

Query: 482 -YRSNCKVNSSGDVYSFGIVLLQILSGK 508
             +     +SS D +S G +L ++L G 
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 39/229 (17%)

Query: 301 RYTIREVHY-ATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----V 354
           R  + +  +       +L  +G G  G V           VAIK +      E F     
Sbjct: 13  RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 72

Query: 355 REVASSSHVRHPNLVALL------GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWI- 407
           RE+    H+RH N++ LL             + +L+       +L + +  K + L    
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM--KHEKLGEDR 129

Query: 408 ------QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
                 Q L       +GL ++H+     I+HRD+KP N+ +  + E K+ DFGL++  D
Sbjct: 130 IQFLVYQML-------KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179

Query: 462 IGET-YASSEVRGTFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
              T Y       T  Y  PE   N    +   D++S G ++ ++++GK
Sbjct: 180 SEMTGYVV-----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 52/218 (23%), Positives = 81/218 (37%), Gaps = 39/218 (17%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFV-------------REVASSSHV 363
              I  G  G V  G  S    VAIK + N  +    V             RE+   +H 
Sbjct: 27  QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86

Query: 364 RHPNLVALL-----GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWI-------QRLE 411
            HPN++ L           + + +L+ EL    +LA+ +  +   +S           L 
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL- 144

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEV 471
                  GL  LH      +VHRD+ P NILL  N +  + DF L++          +  
Sbjct: 145 ------LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT--ADANKTHY 193

Query: 472 RGTFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
                Y  PE     K  +   D++S G V+ ++ + K
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 43/196 (21%), Positives = 71/196 (36%), Gaps = 35/196 (17%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPNLVAL 371
            +LIG G  G V +       + VAIK I             +RE+A  + + H ++V +
Sbjct: 58  RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKV 117

Query: 372 L-----GYCLRVDECFLIYELCP---------NGNLAEWLFGKDKCLSWI-QRLEIAIDS 416
           L         + DE +++ E+              L E         + +   L      
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE-----LHIKTLLYNLL------ 166

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
             G+ ++HS     I+HRD+KP N L+  +   K+ DFGL++ +D  E   S        
Sbjct: 167 -VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 477 YLDPEYRSNCKVNSSG 492
                       N   
Sbjct: 223 DDMNLVTFPHTKNLKR 238

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 41/236 (17%), Positives = 75/236 (31%), Gaps = 52/236 (22%)

Query: 317 LNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYC 375
              +G G  G V +     + +  A+K +  +       RE+     + H N++ L+   
Sbjct: 12  GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLV-DY 68

Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDS------------------- 416
                        P  +  +     +   +  + + +                       
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 417 ----------------------ARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSD 453
                                  R + F+HS     I HRDIKP N+L+       KL D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 454 FGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           FG +K +   E    + +  +  Y  PE        +   D++S G V  +++ GK
Sbjct: 186 FGSAKKLIPSEPS-VAYI-CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE----TFVREVASSSHVRH 365
             +   L+ IGEG  G V       N   VAIK I+   +      T  RE+      RH
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84

Query: 366 PNLVALL-----GYCLRVDECFLIYELCPNGNLAEWLFGK----DKCLSWI-QRLEIAID 415
            N++ +          ++ + +++ +L    +L + L  +    D    ++ Q L     
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL----- 138

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS--SEVRG 473
             RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D    +    +E   
Sbjct: 139 --RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y  PE   N K  +   D++S G +L ++LS +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 32/206 (15%)

Query: 317 LNLIGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVA 370
           +  +G G  G+V   K   +  H A+K      +     +E  + E      V  P LV 
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR--------GLW 421
           L          +++ E    G +    F      S ++R+   +   AR           
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEM----F------SHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           +LHS     +++RD+KP N+L+      +++DFG +K +  G T+    + GT   L PE
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWT---LCGTPEALAPE 208

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSG 507
              +   N + D ++ G+++ ++ +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 31/208 (14%)

Query: 317 LNLIGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPNLVA 370
           L L+G+G  GKV   +  +  ++ A+K      I  +  V   V E     + RHP L A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 371 LLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR--------GL 420
           L  Y  +  +    + E    G L             + R  +   + AR         L
Sbjct: 70  LK-YAFQTHDRLCFVMEYANGGEL----------FFHLSRERVFTEERARFYGAEIVSAL 118

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP 480
            +LHS     +V+RDIK  N++L  +   K++DFGL K   I +        GT  YL P
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 174

Query: 481 EYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           E   +     + D +  G+V+ +++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 44/217 (20%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVAS 359
           +  I + +  T ++     +G GI GKV +       +  A+K + +        REV  
Sbjct: 12  KNAIIDDYKVTSQV-----LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---REVEL 63

Query: 360 SSHV-RHPNLVALLGYC---LRVDECF-LIYELCPNGNLAEWLFGK-DKCLSWIQRLEIA 413
                + P++V ++          +C  ++ E    G L   +  + D+  +  +  EI 
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123

Query: 414 IDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSE 470
                 + +LHS +   I HRD+KP N+L     PN   KL+DFG +K           E
Sbjct: 124 KSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------E 169

Query: 471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
             G   Y D      C      D++S G+++  +L G
Sbjct: 170 TTGE-KY-DKS----C------DMWSLGVIMYILLCG 194

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 57/232 (24%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIK--------------HI 344
           P+Y++       +    L  +G G  G+V+  +   N ++ A+K              H 
Sbjct: 1   PKYSL-------QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT 53

Query: 345 TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCL 404
            +E  +          S V HP ++ + G      + F+I +    G L    F      
Sbjct: 54  NDERLM---------LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----F------ 94

Query: 405 SWIQRLEI-AIDSAR--------GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG 455
           S +++ +      A+         L +LHS     I++RD+KP NILL  N   K++DFG
Sbjct: 95  SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151

Query: 456 LSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            +K +    TY    + GT  Y+ PE  S    N S D +SFGI++ ++L+G
Sbjct: 152 FAKYVP-DVTYT---LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 34/216 (15%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRH 365
            E+   L+ +G G  G V           VA+K ++             RE+    H++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 366 PNLVALL------GYCLRVDECFLIYELCPNGNLAEWLFGK---DKCLSWI--QRLEIAI 414
            N++ LL            ++ +L+  L    +L   +  +   D  + ++  Q L    
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQIL---- 142

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRG 473
              RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++      T Y +     
Sbjct: 143 ---RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----- 191

Query: 474 TFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           T  Y  PE   N    +   D++S G ++ ++L+G+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 40/189 (21%), Positives = 71/189 (37%), Gaps = 35/189 (18%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVRHPNLVAL 371
            +LIG G  G VY     +  ++VAIK +             +RE+   + ++   ++ L
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90

Query: 372 L-----GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA--------- 417
                    L+ DE +++ E+             D  L  + +  I +            
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIA----------DSD--LKKLFKTPIFLTEEHIKTILYNL 138

Query: 418 -RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
             G  F+H      I+HRD+KP N LL  +   K+ DFGL++ I+  +            
Sbjct: 139 LLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 477 YLDPEYRSN 485
              P  ++ 
Sbjct: 196 EPGPHNKNL 204

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 69.1 bits (170), Expect = 6e-13
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 37/212 (17%)

Query: 317 LNLIGEGITGKVY----KGKLSNNQHVAIK-----HITNEGNVETFV-REVASSSHVRHP 366
           L ++G+G  GKV+           Q  A+K      +     V T + R++     V HP
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE--VNHP 86

Query: 367 NLVALLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR------ 418
            +V L  Y  + +   +LI +    G+L    F      + + +  +   +  +      
Sbjct: 87  FIVKLH-YAFQTEGKLYLILDFLRGGDL----F------TRLSKEVMFTEEDVKFYLAEL 135

Query: 419 --GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFG 476
              L  LHS     I++RD+KP NILL      KL+DFGLSK   I     +    GT  
Sbjct: 136 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVE 191

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           Y+ PE  +      S D +SFG+++ ++L+G 
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 50/239 (20%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE----TFV 354
           P+  +  +   +      +L+GEG  G V         + VAIK I           T  
Sbjct: 2   PKRIVYNI---SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL- 57

Query: 355 REVASSSHVRHPNLVALL-----GYCLRVDECFLIYELCP--------NGNLAEWLFGKD 401
           RE+    H +H N++ +            +E ++I EL             L       D
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML------SD 111

Query: 402 KCLSWI--QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
             + +   Q L       R +  LH      ++HRD+KP+N+L+  N + K+ DFGL+++
Sbjct: 112 DHIQYFIYQTL-------RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

Query: 460 IDIGETYASSEVRGTFG---------YLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
           ID      S       G         Y  PE        S   DV+S G +L ++   +
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 34/125 (27%), Positives = 49/125 (39%), Gaps = 12/125 (9%)

Query: 387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN 446
           L                L+    +  +   A+G+ FL S      +HRD+   NILL   
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEK 229

Query: 447 FEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD-----PEYRSNCKVNSSGDVYSFGIVL 501
              K+ DFGL++ I     Y    VR     L      PE   +       DV+SFG++L
Sbjct: 230 NVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285

Query: 502 LQILS 506
            +I S
Sbjct: 286 WEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 19/166 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGKL------SNNQHVAIK---HITNEGNVETFVREVASSSH 362
           ++L     +G G  G+V +         +  + VA+K              + E+    H
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 363 V-RHPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGL 420
           +  H N+V LLG C +      +I E C  GNL+ +L          +R E      +G 
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEFVPYKTKGA 133

Query: 421 WFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY 466
            F         +  D+K     +  +  +  S F   K +   E  
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 34/209 (16%)

Query: 317 LNLIGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVE-TFV-REVASSSHVRHPNL 368
             ++G+G  GKV+  +    NQ  AIK      +  + +VE T V + V S +   HP L
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFL 80

Query: 369 VALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR-------- 418
             +     +  +  F + E    G+L          +  IQ      +  A         
Sbjct: 81  THMF-CTFQTKENLFFVMEYLNGGDL----------MYHIQSCHKFDLSRATFYAAEIIL 129

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           GL FLHS     IV+RD+K  NILL  +   K++DFG+ K  ++     ++   GT  Y+
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYI 185

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSG 507
            PE     K N S D +SFG++L ++L G
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.8 bits (162), Expect = 4e-12
 Identities = 41/204 (20%), Positives = 59/204 (28%), Gaps = 54/204 (26%)

Query: 309 YATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN----------VETFVREVA 358
             TEKL     IGEG+ G+V++    ++  VAIK I  EG            E  + E+ 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 359 SSSHV---------RHPNLVALLGYCL------------------------------RVD 379
            S  +         R    + L                                   + D
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT 439
           + F++ E    G   E +    K  S      I       L    +       HRD+   
Sbjct: 136 QLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191

Query: 440 NILLGPNFEAKLSDFGLSKVIDIG 463
           N+LL      KL      K   I 
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIP 215

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVE-TFV-REVASSSHVRHPNL 368
           L ++G+G  GKV   +      + A+K      +  + +VE T V + V +    + P L
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPFL 404

Query: 369 VALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR-------- 418
             L   C + +D  + + E    G+L          +  IQ++       A         
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDL----------MYHIQQVGRFKEPHAVFYAAEIAI 453

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           GL+FL S     I++RD+K  N++L      K++DFG+ K  +I +   +    GT  Y+
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 509

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE  +      S D ++FG++L ++L+G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)

Query: 317 LNLIGEGITGKVY---KGKLSNNQHV-AIKHITNEGNVETFVREVASS-------SHVRH 365
           L ++G+G  GKV+   K   +N   + A+K +  +  +    ++ A +         V+H
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTAHTKAERNILEEVKH 80

Query: 366 PNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR----- 418
           P +V L+ Y  +     +LI E    G L             ++R  I   D+A      
Sbjct: 81  PFIVDLI-YAFQTGGKLYLILEYLSGGEL----------FMQLEREGIFMEDTACFYLAE 129

Query: 419 ---GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
               L  LH      I++RD+KP NI+L      KL+DFGL K   I +   +    GT 
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTI 185

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            Y+ PE       N + D +S G ++  +L+G 
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 47/223 (21%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVE---TFVREVASSSHVRHPNLVALL 372
           L  +G G  G V+       ++ VAIK I             RE+     + H N+V + 
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVF 74

Query: 373 --------------GYCLRVDECFLIYEL--------CPNGNLAEWLFGKDKCLSWI-QR 409
                         G    ++  +++ E            G L E     +    ++ Q 
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-----EHARLFMYQL 129

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL-GPNFEAKLSDFGLSKVIDIGETYAS 468
           L       RGL ++HS     ++HRD+KP N+ +   +   K+ DFGL++++D   ++  
Sbjct: 130 L-------RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 469 --SEVRGTFGYLDPEYRSNCKVNSSG-DVYSFGIVLLQILSGK 508
             SE   T  Y  P    +    +   D+++ G +  ++L+GK
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.5 bits (163), Expect = 6e-12
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVE-TFV-REVASSSHVRHPNL 368
           L ++G+G  GKV   +      + A+K      +  + +VE T V + V +    + P L
Sbjct: 25  LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPFL 83

Query: 369 VALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR-------- 418
             L   C + +D  + + E    G+L          +  IQ++       A         
Sbjct: 84  TQLH-SCFQTMDRLYFVMEYVNGGDL----------MYHIQQVGRFKEPHAVFYAAEIAI 132

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
           GL+FL S     I++RD+K  N++L      K++DFG+ K  +I +   +    GT  Y+
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 188

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE  +      S D ++FG++L ++L+G+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.5 bits (163), Expect = 7e-12
 Identities = 64/248 (25%), Positives = 97/248 (39%), Gaps = 41/248 (16%)

Query: 279 KSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQ 337
            +NP       + + L     P     + H+       L +IG+G  GKV   +  +   
Sbjct: 12  NANPAPPPAPSQQINLGPSSNPHAKPSDFHF-------LKVIGKGSFGKVLLARHKAEEV 64

Query: 338 HVAIK-----HITNEGNVE-TFV-REVASSSHVRHPNLVALLGYCLR-VDECFLIYELCP 389
             A+K      I  +   +     R V   + V+HP LV L  +  +  D+ + + +   
Sbjct: 65  FYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGLH-FSFQTADKLYFVLDYIN 122

Query: 390 NGNLAEWLFGKDKCLSWIQRLEI-AIDSAR--------GLWFLHSYSEGCIVHRDIKPTN 440
            G L             +QR        AR         L +LHS +   IV+RD+KP N
Sbjct: 123 GGEL----------FYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPEN 169

Query: 441 ILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIV 500
           ILL       L+DFGL K  +I     +S   GT  YL PE       + + D +  G V
Sbjct: 170 ILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAV 228

Query: 501 LLQILSGK 508
           L ++L G 
Sbjct: 229 LYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 65.7 bits (161), Expect = 9e-12
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 34/210 (16%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVE-TFV-REVASSSHVRHPNL 368
           L +IG G   KV   +L     + A+K      + ++ +++     + V   +   HP L
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFL 72

Query: 369 VALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR-------- 418
           V L   C +     F + E    G+L          +  +QR      + AR        
Sbjct: 73  VGLH-SCFQTESRLFFVIEYVNGGDL----------MFHMQRQRKLPEEHARFYSAEISL 121

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
            L +LH      I++RD+K  N+LL      KL+D+G+ K   +     +S   GT  Y+
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 177

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE         S D ++ G+++ ++++G+
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 34/210 (16%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVE-TFV-REVASSSHVRHPNL 368
           L +IG G   KV   +L     + A++      + ++ +++     + V   +   HP L
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFL 115

Query: 369 VALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR-------- 418
           V L   C +     F + E    G+L          +  +QR      + AR        
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDL----------MFHMQRQRKLPEEHARFYSAEISL 164

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
            L +LH      I++RD+K  N+LL      KL+D+G+ K   +     +S   GT  Y+
Sbjct: 165 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYI 220

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE         S D ++ G+++ ++++G+
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 34/210 (16%)

Query: 317 LNLIGEGITGKVYKGKLSNNQHV-AIK-----HITNEGNVE-TFV-REVASSSHVRHPNL 368
           + ++G+G  GKV   ++     + A+K      I  + +VE T   + + S +   HP L
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-RNHPFL 86

Query: 369 VALLGYCLR-VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AIDSAR-------- 418
             L   C +  D  F + E    G+L          +  IQ+        AR        
Sbjct: 87  TQLF-CCFQTPDRLFFVMEFVNGGDL----------MFHIQKSRRFDEARARFYAAEIIS 135

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
            L FLH      I++RD+K  N+LL      KL+DFG+ K   I     ++   GT  Y+
Sbjct: 136 ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYI 191

Query: 479 DPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            PE         + D ++ G++L ++L G 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 45/226 (19%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETF----VREVASSSHVR-HPNLVA 370
           +  +G+G  G V+K       + VA+K I +     T      RE+   + +  H N+V 
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73

Query: 371 LLGYCL--RVDECFLIYELCPNGNLAEWLFG---KDKCLSWI--QRLEIAIDSARGLWFL 423
           LL         + +L+++     +L   +     +     ++  Q +       + + +L
Sbjct: 74  LLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLI-------KVIKYL 125

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE-- 481
           HS   G ++HRD+KP+NILL      K++DFGLS+         ++         +    
Sbjct: 126 HS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 482 -------------YR------SNCKVNSSGDVYSFGIVLLQILSGK 508
                        YR       + K     D++S G +L +IL GK
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 53/223 (23%)

Query: 317 LNLIGEGITGKVY---KGKLSNNQHV-AIK---------------HITNEGNVETFVREV 357
           L ++G G  GKV+   K    +   + A+K               H   E  V      +
Sbjct: 59  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV------L 112

Query: 358 ASSSHVRHPNLVALLGYCLRVDE-CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEI-AID 415
                   P LV L  Y  + +    LI +    G L    F      + + + E     
Sbjct: 113 EHIRQ--SPFLVTLH-YAFQTETKLHLILDYINGGEL----F------THLSQRERFTEH 159

Query: 416 SAR--------GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA 467
             +         L  LH      I++RDIK  NILL  N    L+DFGLSK     ET  
Sbjct: 160 EVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216

Query: 468 SSEVRGTFGYLDPE--YRSNCKVNSSGDVYSFGIVLLQILSGK 508
           + +  GT  Y+ P+     +   + + D +S G+++ ++L+G 
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 13/147 (8%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           IG G  G++  GK L  N++VAIK    +        E      +   + +  + Y    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76

Query: 379 DEC-FLIYELCPNG-NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
            +   ++ EL   G +L +     D+  S    L IAI     + ++HS +   +++RD+
Sbjct: 77  GKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDV 131

Query: 437 KPTNILLG--PNFEAK---LSDFGLSK 458
           KP N L+G   N   +   + DF L+K
Sbjct: 132 KPENFLIGRPGNKTQQVIHIIDFALAK 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 38/208 (18%), Positives = 68/208 (32%), Gaps = 46/208 (22%)

Query: 275 KRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-L 333
           +  Y  + P      +G  L D    ++ + +             IG G  G +Y     
Sbjct: 16  ENLYFQSMPFP----EGKVLDDMEGNQWVLGK------------KIGSGGFGLIYLAFPT 59

Query: 334 SNNQHVAIKHI----------TNEGNVETFVREVASSSHVRHPNLVALLG-----YCLRV 378
           +  +  A   +           +E      V +            +  LG          
Sbjct: 60  NKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLT 119

Query: 379 DEC-----FLIYELCPNG-NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
           +       F++ E    G +L + + G++        L++ I     L ++H       V
Sbjct: 120 EFKGRSYRFMVMERL--GIDL-QKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YV 173

Query: 433 HRDIKPTNILLGPNFEAK--LSDFGLSK 458
           H DIK  N+LLG     +  L+D+GLS 
Sbjct: 174 HGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 44/236 (18%), Positives = 86/236 (36%), Gaps = 51/236 (21%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITN-EGNVETFVREV- 357
           RY +            +  +G G    V+  K + NN HVA+K +   +   E    E+ 
Sbjct: 20  RYIL------------VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK 67

Query: 358 -------ASSSHVRHPNLVALLGYCLRVDECF-----------LIYELCPNGNLAEWL-F 398
                  A ++            + L++ + F           +++E+    NL   +  
Sbjct: 68  LLQRVNDADNTKEDSMGA----NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK 122

Query: 399 GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK 458
            + + +  I   +I+     GL ++H      I+H DIKP N+L+         +    K
Sbjct: 123 YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLM--EIVDSPENLIQIK 178

Query: 459 VIDIGETYASSEVRGTFGYLDP-EYRS-----NCKVNSSGDVYSFGIVLLQILSGK 508
           + D+G   A          +   EYRS             D++S   ++ ++++G 
Sbjct: 179 IADLGN--ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 33/212 (15%), Positives = 65/212 (30%), Gaps = 47/212 (22%)

Query: 274 LKRYYKSNPPAKITSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK- 332
           L     +     + +  G  L D    ++ +             +       G +Y+   
Sbjct: 18  LYFQSMTTSLEALPT--GTVLTDKSGRQWKL------------KSFQTRDNQGILYEAAP 63

Query: 333 --------LSNNQHVAIK------HITNEGNVETF------VREVASSSHVRHPNLVALL 372
                       Q  ++K       + NE N          V +           +   +
Sbjct: 64  TSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM 123

Query: 373 GYCLRVDEC-FLIYELCPNG-NLAEWLFGK--DKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           G+ +  D+  FL+      G +L +          LS    L++A      L FLH    
Sbjct: 124 GFGVHQDKYRFLVLPSL--GRSL-QSALDVSPKHVLSERSVLQVACRLLDALEFLHENE- 179

Query: 429 GCIVHRDIKPTNILLGPNFEAK--LSDFGLSK 458
              VH ++   NI + P  +++  L+ +G + 
Sbjct: 180 --YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 38/147 (25%), Positives = 59/147 (40%), Gaps = 13/147 (8%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           IGEG  G +++G  L NNQ VAIK      +      E  +   +     +  + Y  + 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 379 DEC-FLIYELCPNG-NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
                L+ +L   G +L + L    +  S       A      +  +H  S   +V+RDI
Sbjct: 78  GLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDI 132

Query: 437 KPTNILLGPNFEAK-----LSDFGLSK 458
           KP N L+G           + DFG+ K
Sbjct: 133 KPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 53/282 (18%), Positives = 91/282 (32%), Gaps = 85/282 (30%)

Query: 292 VQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIK-HITNEGN 349
           V++ D    RY +            +  +G G    V+    +   + VA+K   + E  
Sbjct: 29  VKIGDLFNGRYHV------------IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76

Query: 350 VETFVREVASSSHVR-----HPNLVALLGYCLRVDECFLIYELCPNG------------N 392
            ET + E+     VR      PN        +++ + F I     NG            +
Sbjct: 77  TETALDEIRLLKSVRNSDPNDPNR----EMVVQLLDDFKISG--VNGTHICMVFEVLGHH 130

Query: 393 LAEWLFG-KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN----- 446
           L +W+     + L      +I     +GL +LH+  +  I+H DIKP NILL  N     
Sbjct: 131 LLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIR 188

Query: 447 ------------------------------------FEAKLSDFGLSKVIDIGETYASSE 470
                                                E K ++    K+ D+G      +
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248

Query: 471 VRG----TFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
                  T  Y   E       N+  D++S   +  ++ +G 
Sbjct: 249 HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 39/145 (26%), Positives = 63/145 (43%), Gaps = 11/145 (7%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           IG G  G++Y G  +  N+ VAIK    +      + E      ++    +  + +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 379 DEC-FLIYELCPNG-NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
            +   L+ +L   G +L +      + LS    L +A      + F+HS S    +HRDI
Sbjct: 75  GDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDI 129

Query: 437 KPTNILLGPNFEAK---LSDFGLSK 458
           KP N L+G    A    + DFGL+K
Sbjct: 130 KPDNFLMGLGRRANQVYIIDFGLAK 154

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 47/217 (21%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVR----EVASSSHVRH--PNLV 369
           L +IG+G  G+V K      +QHVA+K + N    + F R    E+    H+R    +  
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 370 ALLGYCLRVDECF-------LIYELCPNGNLAEWL-FGKDKCLSWIQRLEIAIDSARGLW 421
                 + + E F       + +EL  + NL E +   K +  S     + A    + L 
Sbjct: 159 M---NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEA--KLSDFGLSKVIDIGE---TYASSEVRGTFG 476
            LH      I+H D+KP NILL     +  K+ DFG S      +   TY  S  R  F 
Sbjct: 215 ALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQS--R--F- 264

Query: 477 YLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGK 508
                YR+       +     D++S G +L ++L+G 
Sbjct: 265 -----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 36/145 (24%), Positives = 61/145 (42%), Gaps = 11/145 (7%)

Query: 320 IGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV 378
           IG G  G +Y G  ++  + VAIK    +        E      ++    +  + +C   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 379 DEC-FLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDI 436
            +   ++ EL   G   E LF    +  S    L +A      + ++HS +    +HRD+
Sbjct: 77  GDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDV 131

Query: 437 KPTNILLGPNFEAK---LSDFGLSK 458
           KP N L+G   +     + DFGL+K
Sbjct: 132 KPDNFLMGLGKKGNLVYIIDFGLAK 156

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 3e-07
 Identities = 55/408 (13%), Positives = 115/408 (28%), Gaps = 110/408 (26%)

Query: 217 EKYAQNVFTCLAAQDIYITKQTLAEMKMTHKTGIWILI--GGLVVVGVVAIII------I 268
           +   +++ +      I ++K  ++          W L+     +V   V  ++      +
Sbjct: 39  QDMPKSILSKEEIDHIIMSKDAVSGTLRL----FWTLLSKQEEMVQKFVEEVLRINYKFL 94

Query: 269 ASCICLKRYYKSNPPAKITS---------FKGVQLKDPG-CPRYTIREVHYATEKLNEL- 317
            S I      +   P+ +T          +   Q+       R  ++      + L EL 
Sbjct: 95  MSPI----KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR--LQPYLKLRQALLELR 148

Query: 318 ---NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV--RHPNLV--A 370
              N++ +G+ G    GK                       +V  S  V  +    +   
Sbjct: 149 PAKNVLIDGVLGS---GK------------------TWVALDVCLSYKVQCKMDFKIFWL 187

Query: 371 LLGYCLRVDECF-----LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
            L  C   +        L+Y++ PN     W    D   +   R+       R L     
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPN-----WTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKL----SDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           Y    +V  +++        N   K+        ++  +    T   S    +      E
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTR---AGSALELA------DPKLDR--- 529
            +S               +LL+ L   + + L R     +   L+         L     
Sbjct: 303 VKS---------------LLLKYL-DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN 346

Query: 530 --EYSIEAFDLTLQLALSCTALTHQRPP-MEQVFVTL---QKALDIST 571
               + +     ++ +L+        P    ++F  L     +  I T
Sbjct: 347 WKHVNCDKLTTIIESSLN-----VLEPAEYRKMFDRLSVFPPSAHIPT 389

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 30/166 (18%), Positives = 59/166 (35%), Gaps = 31/166 (18%)

Query: 319 LIGEGITGKVYKGKLSNNQHVAIK-------------HITNEGNVETFVREVASSSHVRH 365
            IG+G  G +Y   +++++ V                 +  E        +         
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 366 PNLVALLG-----YCLRVDEC-----FLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAI 414
              +  LG          D+      F+I +    G+  + ++    K  S    L++++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 415 DSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK--LSDFGLSK 458
                L ++H +     VH DIK +N+LL      +  L D+GL+ 
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 39/214 (18%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVR----EVASSSHVRH--PNLV 369
            +LIG+G  G+V K       + VAIK I N    + F+     EV     +      + 
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEM- 114

Query: 370 ALLGYCLRVDECF-------LIYELCPNGNLAEWLFGKDKC---LSWIQRLEIAIDSARG 419
               Y + +   F       L++E+  + NL + L   +     L+  ++   A      
Sbjct: 115 --KYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTA 169

Query: 420 LWFLHSYSEGCIVHRDIKPTNILL--GPNFEAKLSDFGLSKVIDIGE---TYASSEVRGT 474
           L FL +  E  I+H D+KP NILL        K+ DFG S    +G+    Y  S  R  
Sbjct: 170 LLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQS--R-- 222

Query: 475 FGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
           F Y  PE       + + D++S G +L+++ +G+
Sbjct: 223 F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 49/237 (20%), Positives = 77/237 (32%), Gaps = 69/237 (29%)

Query: 317 LNLIGEGITGKVYKG--KLSNNQHVAIKHITNEGNVETFVR----EVASSSHVRH--PNL 368
           +  +GEG  GKV +          VA+K I N   V  +      E+     ++      
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKEN 80

Query: 369 VALLGYCLRVDECF-------LIYELCPNGNLAEWLFGKDKC-----LSWIQRLEIAIDS 416
                 C+ + + F       + +EL    N  E+L  K+       L  ++   +A   
Sbjct: 81  KF---LCVLMSDWFNFHGHMCIAFELL-GKNTFEFL--KENNFQPYPLPHVRH--MAYQL 132

Query: 417 ARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS-----------KVIDIGE- 464
              L FLH      + H D+KP NIL   +    L +   S           +V D G  
Sbjct: 133 CHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 465 --------TYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGK 508
                   T  ++  R         YR              DV+S G +L +   G 
Sbjct: 190 TFDHEHHTTIVAT--R--H------YRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.2 bits (105), Expect = 8e-05
 Identities = 53/252 (21%), Positives = 94/252 (37%), Gaps = 77/252 (30%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGK--LSNNQHVAIKHITNEGNVETFVR-- 355
            RY I            ++ +GEG  GKV +     +  +HVA+K + N   V+ +    
Sbjct: 14  ARYEI------------VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAA 58

Query: 356 --EVASSSHVRH--PNLVALLGYCLRVDECF-------LIYELCPNGNLAEWLFGKDKC- 403
             E+    H+    PN       C+++ E F       +++EL    +  +++       
Sbjct: 59  RSEIQVLEHLNTTDPNSTF---RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP 114

Query: 404 --LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS---- 457
             L  I++  +A    + + FLHS     + H D+KP NIL   +   +  +  +     
Sbjct: 115 FRLDHIRK--MAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDER 169

Query: 458 -------KVIDIGE---------TYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYS 496
                  KV+D G          T  S+  R         YR+         +   DV+S
Sbjct: 170 TLINPDIKVVDFGSATYDDEHHSTLVST--R--H------YRAPEVILALGWSQPCDVWS 219

Query: 497 FGIVLLQILSGK 508
            G +L++   G 
Sbjct: 220 IGCILIEYYLGF 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 45/269 (16%), Positives = 90/269 (33%), Gaps = 91/269 (33%)

Query: 292 VQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITN---- 346
            +        + +            +  +G+G  G+V   + + N ++ A+K + N    
Sbjct: 27  WKKGMLLNNAFLV------------IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY 74

Query: 347 ------EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF-------LIYELCPNGNL 393
                 E ++   ++    +++             ++    F       LI+E     +L
Sbjct: 75  TRSAKIEADILKKIQNDDINNN-----------NIVKYHGKFMYYDHMCLIFEPL-GPSL 122

Query: 394 AEWLFGKDKC---LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK 450
            E +   +     +  I+     I+  + L +L   S   + H D+KP NILL   +  K
Sbjct: 123 YEIITRNNYNGFHIEDIKL--YCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177

Query: 451 LSDFGLS-----------------KVIDIG---------ETYASSEVRGTFGYLDPEYRS 484
                                   K+ID G          +  ++  R         YR+
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINT--R--Q------YRA 227

Query: 485 -----NCKVNSSGDVYSFGIVLLQILSGK 508
                N   + S D++SFG VL ++ +G 
Sbjct: 228 PEVILNLGWDVSSDMWSFGCVLAELYTGS 256

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	588
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.46
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.45
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.36
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.29
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.05
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.9
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.77
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.57
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.38
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.29
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.2
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.05
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.92
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.8
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.68
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.39
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.91
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.66
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.1
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	87.64
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	86.99

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.3e-54  Score=451.27  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=208.2

Q ss_pred             cCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++|...++||+|+||+||+|++.      +++.||||+++...  ..++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56777889999999999999863      57899999997543  35689999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCC--------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          384 IYELCPNGNLAEWLFGKD--------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      |||||++|+|.++|+...              ..++|.+++.|+.|+++||+|||+.+   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999996432              35999999999999999999999988   9999999999999999999


Q ss_pred             EEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCccc
Q 042871          450 KLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKL  527 (588)
Q Consensus       450 kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l  527 (588)
                      ||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+....+....
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~  277 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR  277 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999987654332 23345679999999999999999999999999999999999 899997655544444433222


Q ss_pred             CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          528 DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       528 ~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      +...+..+...+.+|+..|++ +|++||||+||++.|+.+.+.++
T Consensus       278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence            222333344556778899998 79999999999999999877643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.8e-55  Score=448.55  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=213.6

Q ss_pred             cCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++|...+.||+|+||+||+|++.      +++.||||+++...  ..++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57788899999999999999863      47899999997543  35689999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcC------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEE
Q 042871          384 IYELCPNGNLAEWLFGK------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL  451 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL  451 (588)
                      |||||++|+|.++|...            ...++|.+++.|+.|+++||+|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999643            246999999999999999999999988   999999999999999999999


Q ss_pred             EecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCc
Q 042871          452 SDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDR  529 (588)
Q Consensus       452 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~  529 (588)
                      +|||+++........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......++...+......
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~  249 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  249 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            999999876443332 2334579999999999999999999999999999999999 89999765555444444322222


Q ss_pred             ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          530 EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       530 ~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      ..+......+.+|+..|++ +|++||||+||++.|+++.+..
T Consensus       250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            2333344556778899998 7999999999999999886643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.8e-54  Score=448.15  Aligned_cols=253  Identities=24%  Similarity=0.389  Sum_probs=213.4

Q ss_pred             cCccccceeeccCceEEEEEEe------cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++...++||+|+||+||+|++      .+++.||||+++..   ...++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            3456678999999999999986      25789999999743   34578999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcC---------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC
Q 042871          383 LIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~  447 (588)
                      ||||||++|+|.++|...               ...++|.+++.|+.|+|+||+|||+.+   |+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            999999999999999643               135899999999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCc
Q 042871          448 EAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADP  525 (588)
Q Consensus       448 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~  525 (588)
                      .+||+|||+++....... .......||++|||||++.++.|+.++|||||||+||||+| |+.||......++.+.+..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987654332 23445679999999999999999999999999999999999 8999976665555555543


Q ss_pred             ccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          526 KLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       526 ~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      ......+.++...+.+|+..|++ +|++||||+||++.|+...
T Consensus       263 ~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          263 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            33333444555667788999998 7999999999999998653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=433.92  Aligned_cols=252  Identities=26%  Similarity=0.442  Sum_probs=202.2

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ..+++...++||+|+||+||+|++.+  .||||+++..    ...+.|.+|++++++++|||||+++|++.+ +.++|||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            34678888999999999999999753  5999998632    235679999999999999999999998865 5689999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-  464 (588)
                      |||++|+|.++|+.....++|.+++.|+.|+++||+|||+.+   |+||||||+||||++++.+||+|||+|+...... 
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999877778999999999999999999999988   9999999999999999999999999998765332 


Q ss_pred             cccccCccCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhhc-----CcccCcccCHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSN---CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALELA-----DPKLDREYSIEA  535 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~~-----d~~l~~~~~~e~  535 (588)
                      ........||+.|||||++.+   ..|+.++|||||||+||||+||+.||....... ....+     .+.+ ...+.+.
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~  266 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL-SKLYKNC  266 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS-TTSCTTS
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc-ccccccc
Confidence            223455689999999999864   468999999999999999999999996433221 12211     1111 1122334


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ...+.+|+..|++ +|++||||.||++.|+.+..
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            4556778899998 79999999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.8e-51  Score=423.59  Aligned_cols=255  Identities=22%  Similarity=0.325  Sum_probs=201.1

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHH-HHHHHHHHhccCCCCceeEEecceeccC----eeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVE-TFVREVASSSHVRHPNLVALLGYCLRVD----ECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV~E  386 (588)
                      +++...+.||+|+||+||+|++ +|+.||||++......+ .+..|+..+.+++|||||+++|++.+++    .++||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            4577788999999999999998 68999999997654322 2345667778899999999999998654    5799999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc-----cCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY-----SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      |+++|+|.++|+.  ..++|.++.+++.|+++||+|||++     ..++|+||||||+|||||+++++||+|||+++...
T Consensus        82 y~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           82 YHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            9999999999954  4599999999999999999999987     23459999999999999999999999999998876


Q ss_pred             CCCcc---cccCccCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHcCCCcccccccc---------------
Q 042871          462 IGETY---ASSEVRGTFGYLDPEYRSNC------KVNSSGDVYSFGIVLLQILSGKKAKVLTRAG---------------  517 (588)
Q Consensus       462 ~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---------------  517 (588)
                      .....   ......||+.|||||++.+.      .++.++|||||||+||||+||+.|+......               
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            54332   22346799999999998764      4678999999999999999998765422111               


Q ss_pred             chhh-hc----CcccCccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          518 SALE-LA----DPKLDREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       518 ~~~~-~~----d~~l~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .... ..    ++.++... +.+....+.+|+..|++ +|++||||.||++.|+++.+.
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0111 11    22232222 34566778899999998 799999999999999988654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-51  Score=434.71  Aligned_cols=265  Identities=25%  Similarity=0.372  Sum_probs=216.4

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCC-CceeEE
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRH-PNLVAL  371 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~H-pnIv~l  371 (588)
                      ++.++++...++|+..+.||+|+||+||+|++.      .++.||||++....   ..+.|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            455667777889999999999999999999863      24689999997543   34679999999999975 899999


Q ss_pred             ecceecc-CeeeEEeecCCCCChhhhhhcC---------------CcCccHHHHHHHHHhhhccchhhccccCCceEecC
Q 042871          372 LGYCLRV-DECFLIYELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD  435 (588)
Q Consensus       372 ~g~~~~~-~~~~LV~E~~~~gsL~~~L~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrD  435 (588)
                      +|+|.+. +.++||||||++|+|.++|+..               ...++|.+++.++.|+|+||+|||+++   |+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9998764 5689999999999999999643               234899999999999999999999998   99999


Q ss_pred             CCCCCeEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccc
Q 042871          436 IKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVL  513 (588)
Q Consensus       436 LKp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~  513 (588)
                      |||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999976544332 3455679999999999999999999999999999999998 8999875


Q ss_pred             ccc-cchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          514 TRA-GSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       514 ~~~-~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ... ......+....+...+......+.+++..|++ +|++|||+.||++.|+++++.
T Consensus       291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            432 22333332222222222233446667889998 799999999999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-50  Score=423.16  Aligned_cols=255  Identities=22%  Similarity=0.230  Sum_probs=207.0

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .+.|...++||+|+||.||+|+. .+|+.||||+++.+..   +.+|+.++++++|||||++++++.+++.+||||||++
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            35688888999999999999996 4799999999975432   2479999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcceecCCCc---
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGET---  465 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~~---  465 (588)
                      +|+|.++|... +.+++.++..++.|+++||+|||+++   |+||||||+||||+.++ .+||+|||+|+.+.....   
T Consensus       134 gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          134 GGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            99999999643 46999999999999999999999999   99999999999999987 699999999997754322   


Q ss_pred             -ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC--cccCcccCHHHHHHHHHH
Q 042871          466 -YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--PKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 -~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d--~~l~~~~~~e~~~~v~~L  542 (588)
                       .....++||+.|||||++.+..|+.++|||||||++|||+||+.||...........+.  +......+......+..+
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  289 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA  289 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHH
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHH
Confidence             12234679999999999999999999999999999999999999997544433332221  100011222333445566


Q ss_pred             HHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          543 ALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      +..|++ +|.+|||+.|+++.|..++.....
T Consensus       290 i~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          290 IQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             HHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            788887 799999999999999988865443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-51  Score=430.68  Aligned_cols=242  Identities=26%  Similarity=0.352  Sum_probs=197.9

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...    ...+.|.+|++++++++|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999996 57999999999643    235679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++|+|.++|.... ..+++.+.+.|+.|++.||+|||+++   |+||||||+||||++++.+||+|||+|+...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            999999999996543 45789999999999999999999999   9999999999999999999999999998764321 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C---cccCcccCHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D---PKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d---~~l~~~~~~e~~~~v~~  541 (588)
                      ...+...||+.|||||++.+..|+.++|||||||++|||++|+.||...........+ .   +.+...++.+    +..
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~----~~~  255 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYD----LRS  255 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH----HHH
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHH----HHH
Confidence            1223467999999999999999999999999999999999999999754433322221 1   1223334544    455


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      |+..|++ +|++|||++|+++
T Consensus       256 li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            6777887 7999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-50  Score=423.93  Aligned_cols=240  Identities=24%  Similarity=0.337  Sum_probs=203.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      +.|+..++||+|+||.||+|+. .+|+.||||++..  ....+.+.+|+++|++++|||||++++++.+++.+||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            5688899999999999999997 4799999999863  334567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++|+|.+++..  ..+++.++..++.|++.||+|||+++   |+||||||+||||++++.+||+|||+++.+..... ..
T Consensus       154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~  227 (346)
T 4fih_A          154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR  227 (346)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred             CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence            99999999954  45999999999999999999999999   99999999999999999999999999987754332 33


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC----cccC--cccCHHHHHHHHHH
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD----PKLD--REYSIEAFDLTLQL  542 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d----~~l~--~~~~~e~~~~v~~L  542 (588)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+.    +.+.  ..++.+    +..|
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~----~~dl  303 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPS----LKGF  303 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHH----HHHH
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHH----HHHH
Confidence            45789999999999999999999999999999999999999997544333333221    1111  234444    4455


Q ss_pred             HHHhhc-CCCCCCCHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..|+. +|++|||++|+++
T Consensus       304 i~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          304 LDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHhc
Confidence            677887 7999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-49  Score=410.79  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=205.7

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++..     ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999996 5799999999863     345678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-  464 (588)
                      ||+++|+|.+++... +.+++.+...++.|++.||+|||+++   |+||||||+||||++++.+||+|||+|+.+.... 
T Consensus       112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999643 46999999999999999999999999   9999999999999999999999999999875433 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                      .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.........+.+   +..++..++.+.    ..
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~----~d  263 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKA----RD  263 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHH----HH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHH----HH
Confidence            23345678999999999999999999999999999999999999999754433332222   233344556554    44


Q ss_pred             HHHHhhc-CCCCCCCHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVF  560 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl  560 (588)
                      |+..|++ +|.+|||++|++
T Consensus       264 li~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHHHccCCHhHCcChHHHc
Confidence            5677777 799999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-49  Score=406.31  Aligned_cols=237  Identities=24%  Similarity=0.323  Sum_probs=192.2

Q ss_pred             cccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec----cCeeeEEe
Q 042871          315 NELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR----VDECFLIY  385 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV~  385 (588)
                      ...+.||+|+||.||+|+. .+++.||||++...    ...+.|.+|++++++++|||||++++++.+    ++.+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4556899999999999996 47899999998642    235679999999999999999999999865    35689999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||+++|+|.+++.. ...+++..+..++.|+++||+|||+++. +|+||||||+||||+ +++.+||+|||+|+....  
T Consensus       109 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  184 (290)
T ss_dssp             ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence            99999999999964 3469999999999999999999998763 499999999999998 489999999999986432  


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc-cchhhhcCcc-----cCcccCHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA-GSALELADPK-----LDREYSIEAFDL  538 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~-~~~~~~~d~~-----l~~~~~~e~~~~  538 (588)
                       .......||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ......+...     +....+.+    
T Consensus       185 -~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~----  258 (290)
T 3fpq_A          185 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE----  258 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH----
T ss_pred             -CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH----
Confidence             22345689999999998865 699999999999999999999999963322 2222222211     12223333    


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..|+..|++ +|++|||++|+++
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            5567788888 7999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=424.95  Aligned_cols=241  Identities=24%  Similarity=0.335  Sum_probs=204.0

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .+.|+..+.||+|+||.||+|+. .+|+.||||++..  ....+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            35699999999999999999997 4799999999863  33456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      |++|+|.+++..  ..+++.++..++.|+++||+|||+++   |+||||||+||||+.++.+||+|||+++.+..... .
T Consensus       230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  303 (423)
T 4fie_A          230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  303 (423)
T ss_dssp             CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred             CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence            999999999953  45999999999999999999999999   99999999999999999999999999987654322 3


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC----cccC--cccCHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD----PKLD--REYSIEAFDLTLQ  541 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d----~~l~--~~~~~e~~~~v~~  541 (588)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+.    +.+.  ..++.+    +..
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~----~~d  379 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPS----LKG  379 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHH----HHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHH----HHH
Confidence            345789999999999999999999999999999999999999996544333333221    1111  234444    445


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      |+..|+. +|++|||+.|+++
T Consensus       380 li~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            5677887 7999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-48  Score=394.81  Aligned_cols=239  Identities=23%  Similarity=0.304  Sum_probs=188.5

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...     ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999996 57999999998632     33567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+ +|+|.+++... ..+++.+...++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 78999999654 46999999999999999999999999   9999999999999999999999999998764332 


Q ss_pred             ccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                       ......||+.|||||++.+..+ +.++||||+||++|||++|+.||.........+.+   ...++...+.+.    ..
T Consensus       167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~----~~  241 (275)
T 3hyh_A          167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGA----AG  241 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHH----HH
T ss_pred             -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH----HH
Confidence             2345689999999999998876 57999999999999999999999754333322222   222333455544    45


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      |+..|++ +|++|||++|+++
T Consensus       242 li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          242 LIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHc
Confidence            5677787 7999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-48  Score=402.55  Aligned_cols=241  Identities=25%  Similarity=0.268  Sum_probs=193.8

Q ss_pred             cCccccceeeccCceEEEEEEe----cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL----SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++|++.+.||+|+||+||+|+.    .+++.||||++...    .....+.+|++++++++|||||++++++.+++..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999985    25789999998642    234578899999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++... +.+++.+...++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            99999999999999643 46999999999999999999999999   999999999999999999999999999865433


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~  540 (588)
                      .. ......||+.|||||++.+..|+.++|||||||++|||+||+.||...........+   ...++...+.+    +.
T Consensus       180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~----~~  254 (304)
T 3ubd_A          180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE----AQ  254 (304)
T ss_dssp             -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH----HH
T ss_pred             Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHH----HH
Confidence            22 234568999999999999999999999999999999999999999754443333222   22233445554    44


Q ss_pred             HHHHHhhc-CCCCCCCH-----HHHHH
Q 042871          541 QLALSCTA-LTHQRPPM-----EQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~-----~evl~  561 (588)
                      .|+..|++ +|++|||+     +|+++
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            55777887 79999984     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.3e-48  Score=397.11  Aligned_cols=243  Identities=23%  Similarity=0.384  Sum_probs=183.5

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccC--------
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVD--------  379 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--------  379 (588)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++...   ...+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4699999999999999999996 47999999998632   23467899999999999999999999987644        


Q ss_pred             ----eeeEEeecCCCCChhhhhhcCCc--CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEe
Q 042871          380 ----ECFLIYELCPNGNLAEWLFGKDK--CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSD  453 (588)
Q Consensus       380 ----~~~LV~E~~~~gsL~~~L~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~D  453 (588)
                          .+|+||||+++|+|.+++.....  ..++..++.++.|+++||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36999999999999999965432  3566678899999999999999999   99999999999999999999999


Q ss_pred             cCCcceecCCCcc-----------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc--cchh
Q 042871          454 FGLSKVIDIGETY-----------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSAL  520 (588)
Q Consensus       454 FGla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~  520 (588)
                      ||+|+........           ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||.....  ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            9999876543221           1234579999999999999999999999999999999997   5532111  0111


Q ss_pred             hhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          521 ELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       521 ~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...+...+... .+.......|+..|++ +|.+|||+.|+++
T Consensus       239 ~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          239 DVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11121111111 1222334567888888 7999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3e-45  Score=379.86  Aligned_cols=270  Identities=37%  Similarity=0.618  Sum_probs=233.6

Q ss_pred             CCCcccHHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecc
Q 042871          298 GCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGY  374 (588)
Q Consensus       298 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~  374 (588)
                      ....|+++++....++|+..+.||+|+||.||+|+..+|+.||||++....   ....+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            456789999999999999999999999999999998889999999987532   23378999999999999999999999


Q ss_pred             eeccCeeeEEeecCCCCChhhhhhcCC---cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEE
Q 042871          375 CLRVDECFLIYELCPNGNLAEWLFGKD---KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL  451 (588)
Q Consensus       375 ~~~~~~~~LV~E~~~~gsL~~~L~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL  451 (588)
                      +.+.+..++||||+++|+|.+++....   ..+++..++.++.|++.||.|||+...++|+||||||+|||+++++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999996543   34999999999999999999999993333999999999999999999999


Q ss_pred             EecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccc-----------------
Q 042871          452 SDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLT-----------------  514 (588)
Q Consensus       452 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~-----------------  514 (588)
                      +|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||...                 
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            999999887655555555667999999999998889999999999999999999999998522                 


Q ss_pred             -cccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          515 -RAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       515 -~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                       .........+..+......+....+.+++..|++ +|.+|||+.||+++|++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence             1223344455555566778888889999999998 7999999999999999753

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-44  Score=374.69  Aligned_cols=269  Identities=41%  Similarity=0.677  Sum_probs=228.2

Q ss_pred             cccHHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceecc
Q 042871          301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRV  378 (588)
Q Consensus       301 ~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~  378 (588)
                      .+++.++..++++|+..+.||+|+||.||+|++.+|+.||||++...  ...+.+.+|++++++++||||+++++++.+.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34445556678999999999999999999999888999999998743  3467899999999999999999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC---cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD---KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                      +..++||||+++|+|.+++....   ..+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999996543   35899999999999999999999998   9999999999999999999999999


Q ss_pred             CcceecCCC-cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc----------------c
Q 042871          456 LSKVIDIGE-TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG----------------S  518 (588)
Q Consensus       456 la~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~----------------~  518 (588)
                      +++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......                .
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            998754322 22334456899999999998889999999999999999999999988533221                1


Q ss_pred             hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          519 ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       519 ~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      ....+++.+......+....+..++..|++ +|++|||+.|+++.|+.++.....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~  319 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES  319 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence            223345555556677888889999999998 799999999999999999876543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-44  Score=381.71  Aligned_cols=197  Identities=23%  Similarity=0.353  Sum_probs=172.5

Q ss_pred             HHhcCccccceeeccCceEEEEEEec----CCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeE
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ...++|++.+.||+|+||+||+|+.+    +++.||||++........+.+|+++|+.+ +|||||++++++.+.+..|+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            34678999999999999999999752    57899999998777777889999999988 69999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-CcEEEEecCCcceecC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDI  462 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-~~~kL~DFGla~~~~~  462 (588)
                      ||||+++|+|.+++.    .+++.+...++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+....
T Consensus        98 vmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           98 AMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999999983    4889999999999999999999999   9999999999999877 7999999999986543


Q ss_pred             CCc---------------------------ccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          463 GET---------------------------YASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       463 ~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      ...                           ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            221                           112335799999999998875 58999999999999999999999984

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=385.86  Aligned_cols=243  Identities=23%  Similarity=0.328  Sum_probs=193.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceec------cC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLR------VD  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~  379 (588)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++....    ..+.+.+|+++|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            35799999999999999999996 579999999997532    34568899999999999999999998753      36


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      .+||||||++ |+|.+++.. .+.+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999995 789999964 456999999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCC---cccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-----------
Q 042871          460 IDIGE---TYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-----------  524 (588)
Q Consensus       460 ~~~~~---~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-----------  524 (588)
                      +....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+-           
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            64322   2233457899999999998875 46999999999999999999999986432221111110           


Q ss_pred             ----------------cc-------cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          525 ----------------PK-------LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       525 ----------------~~-------l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                      +.       +....+.+    ...|+..|+. +|.+|||++|+++.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~----~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQ----ALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHH----HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHH----HHHHHHHHCcCChhHCcCHHHHhcC
Confidence                            00       00112333    3456777887 89999999998863

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=374.58  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=214.7

Q ss_pred             hcCccccceeeccCceEEEEEEec----CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|.+.+.||+|+||.||+|++.    .+..||||++...   ...+.|.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467888899999999999999973    4456999999753   234678999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999766667999999999999999999999998   999999999999999999999999999876543


Q ss_pred             Cc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          464 ET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ..  .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+........+......+.
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  284 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH  284 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHH
Confidence            22  22233456788999999998899999999999999999999 9999876555554444433333333333445567


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCccCCC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDISTTAKAS  576 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~~~~  576 (588)
                      +++..|+. +|.+|||+.||++.|+.++..+....+.
T Consensus       285 ~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~  321 (325)
T 3kul_A          285 QLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT  321 (325)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-----
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHhCccccccc
Confidence            77889998 7999999999999999999876665543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.5e-44  Score=361.67  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=216.7

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|...+.||+|+||.||+|+..+++.||+|++... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            4678999999999999999999988999999999764 356789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +++|.+++......+++..++.++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++...........
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  165 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  165 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence            99999999776677999999999999999999999998   999999999999999999999999999876543333344


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+........+......+.+++..|++
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  245 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWR  245 (269)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHcc
Confidence            5567889999999998999999999999999999999 899987555444433332222222222223446677888888


Q ss_pred             -CCCCCCCHHHHHHHHHHhhcc
Q 042871          549 -LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       549 -~p~~RPs~~evl~~L~~~~~~  569 (588)
                       +|.+|||++|+++.|+++.+.
T Consensus       246 ~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          246 ERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCcccCcCHHHHHHHHHHHHHc
Confidence             799999999999999998653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.2e-44  Score=380.21  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=206.0

Q ss_pred             hcCccccceeeccCceEEEEEEec----CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+|++.    ++..||||++...   ...+.|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            467899999999999999999864    5778999998743   235679999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999776667999999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          464 ETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ...  ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.........+.+........+......+.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  280 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY  280 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            221  1222345788999999999999999999999999999998 9999876555555554444333333334445677


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      +++..|++ +|.+||+++||++.|++++..+.
T Consensus       281 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          281 QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             HHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence            78899998 79999999999999999987644

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.3e-44  Score=399.50  Aligned_cols=242  Identities=24%  Similarity=0.303  Sum_probs=205.0

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|++.+.||+|+||.||+++. .+|+.||+|++....  ..+.+.+|+++|+.++|||||++++++.+++.+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            46899999999999999999996 579999999987543  356788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC--CcEEEEecCCcceecCCCc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN--FEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~--~~~kL~DFGla~~~~~~~~  465 (588)
                      +++|+|.++|......+++.++..++.|++.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+.....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            9999999999766667999999999999999999999999   9999999999999854  8999999999998764432


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---C----cccCcccCHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---D----PKLDREYSIEAFDL  538 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d----~~l~~~~~~e~~~~  538 (588)
                        .....||+.|||||++.+..|+.++|||||||++|||++|+.||...........+   +    ......++.+.   
T Consensus       313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~---  387 (573)
T 3uto_A          313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG---  387 (573)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH---
T ss_pred             --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH---
Confidence              23457999999999999999999999999999999999999999754433332222   1    11112345444   


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                       ..|+..|++ +|.+|||+.|+++
T Consensus       388 -~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          388 -KDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHHHHHHccCChhHCcCHHHHhc
Confidence             445677887 7999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.6e-44  Score=358.68  Aligned_cols=257  Identities=26%  Similarity=0.390  Sum_probs=216.5

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++|...+.||+|+||.||+|+..++..||||++... ...+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            35789999999999999999999988889999999754 35678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++..........
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence            999999999776667999999999999999999999998   99999999999999999999999999987765544444


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+........+....+.+.+++..|+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  242 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCW  242 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTT
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHc
Confidence            45567788999999998889999999999999999999 99998755444333322222111112222345667788999


Q ss_pred             c-CCCCCCCHHHHHHHHHHhhcc
Q 042871          548 A-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      + +|.+|||++|+++.|+.+.+.
T Consensus       243 ~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          243 HELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCChhhCcCHHHHHHHHHHhhhc
Confidence            8 799999999999999987653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.6e-44  Score=362.01  Aligned_cols=258  Identities=26%  Similarity=0.345  Sum_probs=215.9

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++|...+.||+|+||.||+++..++..||||++... ...+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            36789999999999999999999988889999999864 35678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++..........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  178 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence            999999999776667999999999999999999999998   99999999999999999999999999987644333333


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........+.+........+....+.+.+++..|+
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  258 (283)
T 3gen_A          179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW  258 (283)
T ss_dssp             TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred             cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHc
Confidence            44567888999999998899999999999999999998 99998765554444433333222222222345667788999


Q ss_pred             c-CCCCCCCHHHHHHHHHHhhccC
Q 042871          548 A-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      + +|.+|||++|+++.|+++++..
T Consensus       259 ~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          259 HEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCChhHCcCHHHHHHHHHHHhhcc
Confidence            8 7999999999999999987653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.7e-43  Score=375.04  Aligned_cols=257  Identities=23%  Similarity=0.399  Sum_probs=214.1

Q ss_pred             hcCccccceeeccCceEEEEEEe--------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL--------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~--------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      .++|...+.||+|+||.||+|+.        .++..||||++....   ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            47889999999999999999985        245679999997543   345789999999999 899999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl  443 (588)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|+++||+|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999996532               34899999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhh
Q 042871          444 GPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALE  521 (588)
Q Consensus       444 d~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~  521 (588)
                      ++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999987654332 22334567889999999999999999999999999999999 999987655544444


Q ss_pred             hcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          522 LADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       522 ~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .+........+......+..++..|++ +|.+|||+.|+++.|++++...
T Consensus       317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            433332223333334456777889998 7999999999999999988653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=363.23  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=209.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|...+.||+|+||.||+++. .+++.||+|++...  ...+.|.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46788999999999999999997 46899999988643  3456799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999876677999999999999999999999999   9999999999999999999999999998764332211


Q ss_pred             -------------ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc------hhhhcCcccC
Q 042871          468 -------------SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS------ALELADPKLD  528 (588)
Q Consensus       468 -------------~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~------~~~~~d~~l~  528 (588)
                                   .....||+.|+|||++.+..++.++||||||+++|||++|..|+.......      .....+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP  245 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence                         114579999999999999999999999999999999999998875432221      1111111122


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ...+    ..+..++..|++ +|++|||++|+++.|+++...
T Consensus       246 ~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          246 PNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             TTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            2233    346667888998 799999999999999988654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-43  Score=377.19  Aligned_cols=256  Identities=27%  Similarity=0.367  Sum_probs=214.2

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ..++|...+.||+|+||.||+|++. +++.||||.+....   ..+.|.+|++++++++||||+++++++.+++..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3568889999999999999999985 78999999987542   2346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999999766667999999999999999999999998   99999999999999999999999999986543322


Q ss_pred             ccc-cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHH
Q 042871          466 YAS-SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       466 ~~~-~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      ... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........+.+........+....+.+.+++
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            111 12235778999999998899999999999999999999 9999876555555544433332223333345567788


Q ss_pred             HHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          544 LSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ..|++ +|.+|||++++++.|+++.+
T Consensus       349 ~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            99998 79999999999999998764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.9e-43  Score=390.64  Aligned_cols=240  Identities=23%  Similarity=0.274  Sum_probs=196.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHH---HHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFV---REVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~---~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|++.+.||+|+||.||+++. .+|+.||||++..     ........   +++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            36799999999999999999996 4799999999853     22223333   346778889999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ||||||++||+|.++|... ..+++.....++.||+.||+|||+++   |+||||||+||||+++|.+||+|||+|+...
T Consensus       268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999999643 46999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh------cCcccCcccCHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL------ADPKLDREYSIE  534 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~------~d~~l~~~~~~e  534 (588)
                      ...   ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||......+..++      ....++..++.+
T Consensus       344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~  420 (689)
T 3v5w_A          344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  420 (689)
T ss_dssp             SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence            432   344689999999999964 5799999999999999999999999975433332221      123334455666


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCC-----HHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPP-----MEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs-----~~evl~  561 (588)
                      ..+    |+..|+. +|.+|++     ++||++
T Consensus       421 a~d----LI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          421 LRS----LLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHH----HHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHH----HHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            544    4566666 8999998     677764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-43  Score=384.83  Aligned_cols=261  Identities=21%  Similarity=0.353  Sum_probs=217.0

Q ss_pred             HHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          305 REVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       305 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++++...++|...+.||+|+||.||+|++.++..||||++... ...+.|.+|++++++++||||+++++++. .+..++
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            3344567889999999999999999999988999999999753 45788999999999999999999999986 667899


Q ss_pred             EeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          384 IYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999999996543 36889999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      ..........+++.|+|||++....++.++||||||+++|||++ |+.||......+....+........+......+..
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  416 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN  416 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            32222334456889999999998999999999999999999999 99998755444444433332222223333455677


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ++..|+. +|++|||+++|++.|+.....
T Consensus       417 li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          417 IMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            7889998 799999999999999987654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5e-42  Score=352.30  Aligned_cols=266  Identities=34%  Similarity=0.526  Sum_probs=223.3

Q ss_pred             CCCCCcccHHHHHHHhcCcccc------ceeeccCceEEEEEEecCCcEEEEEEecCC------CcHHHHHHHHHHhccC
Q 042871          296 DPGCPRYTIREVHYATEKLNEL------NLIGEGITGKVYKGKLSNNQHVAIKHITNE------GNVETFVREVASSSHV  363 (588)
Q Consensus       296 ~~~~~~~~~~el~~at~~f~~~------~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l  363 (588)
                      +.....|++.++..++++|+..      +.||+|+||.||+|+. +++.||||++...      ...+.+.+|+.+++++
T Consensus         9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l   87 (307)
T 2nru_A            9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC   87 (307)
T ss_dssp             --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred             CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence            3456789999999999999988      8999999999999997 6889999998642      2356789999999999


Q ss_pred             CCCceeEEecceeccCeeeEEeecCCCCChhhhhhcC--CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCe
Q 042871          364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK--DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNI  441 (588)
Q Consensus       364 ~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NI  441 (588)
                      +||||+++++++.+.+..++||||+++|+|.+++...  ...+++..++.++.|+++||.|||+.+   |+||||||+||
T Consensus        88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni  164 (307)
T 2nru_A           88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI  164 (307)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred             CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence            9999999999999999999999999999999999643  346999999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc--
Q 042871          442 LLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS--  518 (588)
Q Consensus       442 Lld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~--  518 (588)
                      ++++++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......  
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  243 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL  243 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence            999999999999999987654322 22345679999999998765 58999999999999999999999986443322  


Q ss_pred             -------------hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          519 -------------ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       519 -------------~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                                   ..+.+++.+ ...+......+.+++..|++ +|.+|||+++|++.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                         112222222 23456667788889999998 7999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-43  Score=367.53  Aligned_cols=256  Identities=21%  Similarity=0.362  Sum_probs=208.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCc----EEEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQ----HVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++|+..+.||+|+||.||+|++ .+++    +||+|.+..   ....+.|.+|+.++++++||||+++++++.+.+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            46789999999999999999985 3444    368888753   234678999999999999999999999998754 78


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +|+||+++|+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999877778999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          463 GET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       463 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+........+......+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  249 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            332 22334567889999999999999999999999999999999 9999986666555555543333333333344566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .++..|++ +|.+|||++|+++.|+++...+
T Consensus       250 ~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          250 MIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            77889998 7999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-43  Score=363.83  Aligned_cols=262  Identities=25%  Similarity=0.377  Sum_probs=204.0

Q ss_pred             HHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          305 REVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       305 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      .++....++|++.+.||+|+||.||+|+. +|+.||||++....    ..+.+.+|++++++++||||+++++++.+.+.
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            33444567899999999999999999987 78899999986532    34578999999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          381 CFLIYELCPNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      .++||||+++|+|.+++....  ..+++..++.++.|+++||+|||+.+ ++|+||||||+|||+++++.+||+|||+++
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            999999999999999996543  24899999999999999999999876 349999999999999999999999999997


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-cccCcccCHHHHH
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-PKLDREYSIEAFD  537 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-~~l~~~~~~e~~~  537 (588)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. .......+.....
T Consensus       188 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (309)
T 3p86_A          188 LKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP  266 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred             cccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            643321 22344578999999999999999999999999999999999999997554433332221 1111112222233


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .+..++..|+. +|.+|||++|+++.|+..++.
T Consensus       267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            46667888988 799999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-43  Score=351.71  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=214.0

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|...+.||+|+||.||+++..+++.||+|++... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            4678899999999999999999988999999999764 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +++|.+++......+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++...........
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  163 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence            99999999776667899999999999999999999998   999999999999999999999999999876433222334


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.........+.+........+......+.+++..|+.
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~  243 (267)
T 3t9t_A          164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWR  243 (267)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHcc
Confidence            4567889999999998899999999999999999999 898887544433333322222111122223446667888988


Q ss_pred             -CCCCCCCHHHHHHHHHHhhc
Q 042871          549 -LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       549 -~p~~RPs~~evl~~L~~~~~  568 (588)
                       +|.+|||+.|+++.|+++.+
T Consensus       244 ~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          244 ERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHHHh
Confidence             79999999999999998865

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-42  Score=377.51  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=212.5

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccC-eeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVD-ECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~LV~E~~  388 (588)
                      ..++|...+.||+|+||.||+|++ .|+.||||+++.....+.|.+|+.++++++||||+++++++.+.+ ..++||||+
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            357788899999999999999998 478999999988777789999999999999999999999987655 789999999


Q ss_pred             CCCChhhhhhcCCc-CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++|+|.+++..... .+++..++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.....    
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  342 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence            99999999975443 4799999999999999999999998   999999999999999999999999999864322    


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+........+......+.+|+..|
T Consensus       343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  422 (450)
T 1k9a_A          343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC  422 (450)
T ss_dssp             ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence            122357889999999999999999999999999999999 9999976555555444433333333333445667778899


Q ss_pred             hc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          547 TA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ++ +|.+|||+.++++.|+.+...
T Consensus       423 l~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          423 WHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCChhHCcCHHHHHHHHHHHHHh
Confidence            98 799999999999999988654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.1e-43  Score=363.87  Aligned_cols=257  Identities=19%  Similarity=0.334  Sum_probs=208.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcE----EEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQH----VAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~----VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++|...+.||+|+||.||+|++. +++.    ||+|.+...   ...+.+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357888999999999999999863 4554    888887543   23456789999999999999999999886 56789


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +|+||+++|+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999776667999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          463 GET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       463 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ... .......||..|+|||++.+..++.++||||||+++|||++ |+.||.........+.+........+......+.
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY  247 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTT
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHH
Confidence            332 22345567889999999999999999999999999999999 9999976555544444433222222222233456


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      .++..|+. +|.+|||+.|+++.|+++...+.
T Consensus       248 ~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          248 MVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            67888988 79999999999999999876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.7e-43  Score=385.17  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=219.8

Q ss_pred             HHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ...++|...+.||+|+||.||+|++. ++..||||.+... ...+.|.+|+.++++++||||+++++++.+.+..++|||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34677889999999999999999975 4889999999754 457889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++|+|.+++... ...+++..++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999999753 346899999999999999999999998   99999999999999999999999999987654433


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                      .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.........+.+........+......+.+|+.
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  453 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  453 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            33344567789999999999899999999999999999999 89998766655555555444433333344456677789


Q ss_pred             Hhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          545 SCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .|++ +|.+|||+.+|++.|+.+...
T Consensus       454 ~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          454 ACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             HHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            9998 799999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-42  Score=356.95  Aligned_cols=253  Identities=24%  Similarity=0.310  Sum_probs=210.2

Q ss_pred             CcccHHHHHHHhcC----------ccccceeeccCceEEEEEEec-CCcEEEEEEecC--CCcHHHHHHHHHHhccCCCC
Q 042871          300 PRYTIREVHYATEK----------LNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN--EGNVETFVREVASSSHVRHP  366 (588)
Q Consensus       300 ~~~~~~el~~at~~----------f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~Hp  366 (588)
                      +.++.++++.+++.          |+..+.||+|+||.||+|+.. +|+.||||++..  ....+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            56888888888865          677789999999999999975 799999999864  34467899999999999999


Q ss_pred             ceeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC
Q 042871          367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN  446 (588)
Q Consensus       367 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~  446 (588)
                      ||+++++++...+..++||||+++|+|.+++.  ...+++.++..++.|+++||.|||+.+   |+||||||+|||++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence            99999999999999999999999999999984  346999999999999999999999998   9999999999999999


Q ss_pred             CcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---
Q 042871          447 FEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---  523 (588)
Q Consensus       447 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---  523 (588)
                      +.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  256 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS  256 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence            9999999999987654322 234567999999999999999999999999999999999999998644333222221   


Q ss_pred             -CcccC--cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 -DPKLD--REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 -d~~l~--~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                       .+.+.  ...+    ..+..++..|++ +|.+|||++|+++.
T Consensus       257 ~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          257 PPPKLKNSHKVS----PVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             SCCCCTTGGGSC----HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCcCccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             11111  1233    345566788888 79999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-42  Score=360.89  Aligned_cols=253  Identities=26%  Similarity=0.344  Sum_probs=204.2

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC-cHHHHHHHHHHhccCCCCceeEEecceeccC----eeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLRVD----ECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV~  385 (588)
                      .++|+..+.||+|+||.||+|+. .++.||||++.... ....+.+|+.++++++||||+++++++.+..    ..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            57899999999999999999998 48999999997543 3345677999999999999999999998754    369999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc----------cCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY----------SEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                      ||+++|+|.+++..  ..+++..++.++.|+++||.|||+.          +   |+||||||+|||+++++.+||+|||
T Consensus       102 e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          102 AFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCC
Confidence            99999999999954  4599999999999999999999998          6   9999999999999999999999999


Q ss_pred             CcceecCCCcc-cccCccCCCCccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCccccccccc-----------
Q 042871          456 LSKVIDIGETY-ASSEVRGTFGYLDPEYRSNC-----KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-----------  518 (588)
Q Consensus       456 la~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-----------  518 (588)
                      +++........ ......||+.|+|||++.+.     .++.++||||||+++|||++|+.||.......           
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            99877544332 23346799999999998763     45668899999999999999999875322110           


Q ss_pred             -----hhhh-c----CcccCccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          519 -----ALEL-A----DPKLDREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       519 -----~~~~-~----d~~l~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                           ..+. .    .+.+...+ .......+.+|+..|++ +|.+|||+.||++.|+++.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                 1111 1    11111111 22445568889999998 799999999999999988653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-42  Score=353.24  Aligned_cols=256  Identities=27%  Similarity=0.368  Sum_probs=199.0

Q ss_pred             HhcCccccceeeccCceEEEEEEec----CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ..++|+..+.||+|+||.||+|+..    .+..||+|++....   ..+.+.+|+.++++++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            3578899999999999999999863    34579999987532   3467899999999999999999999984 56789


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+++|+|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999999766667999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+........+......+..
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  248 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  248 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            44333444567889999999998899999999999999999997 88898765544443333222111222233345666


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ++..|+. +|.+|||+.|+++.|+++++.
T Consensus       249 li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          249 LMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            7888888 799999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-43  Score=363.77  Aligned_cols=262  Identities=26%  Similarity=0.377  Sum_probs=212.3

Q ss_pred             HHHHHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEeccee
Q 042871          306 EVHYATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCL  376 (588)
Q Consensus       306 el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~  376 (588)
                      .+....++|...+.||+|+||.||+|+..      +++.||||++....   ..+.+.+|+.++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34456789999999999999999999974      35899999997543   2467899999999999999999999999


Q ss_pred             ccCeeeEEeecCCCCChhhhhhcCC-----------------------cCccHHHHHHHHHhhhccchhhccccCCceEe
Q 042871          377 RVDECFLIYELCPNGNLAEWLFGKD-----------------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH  433 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvH  433 (588)
                      +.+..++||||+++|+|.+++....                       ..+++.+++.++.|+++||.|||+.+   |+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            9999999999999999999996532                       46899999999999999999999998   999


Q ss_pred             cCCCCCCeEECCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcc
Q 042871          434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAK  511 (588)
Q Consensus       434 rDLKp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~  511 (588)
                      |||||+|||+++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999986543222 22234567899999999999899999999999999999999 99998


Q ss_pred             ccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          512 VLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       512 ~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      ...........+........+......+..++..|+. +|.+|||+.++++.|+++.+..
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            7544433333221111111222233456677888998 7999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=367.53  Aligned_cols=262  Identities=23%  Similarity=0.381  Sum_probs=216.7

Q ss_pred             HhcCccccceeeccCceEEEEEEe--------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceec
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL--------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLR  377 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~--------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~  377 (588)
                      ..++|...+.||+|+||.||+|+.        .++..||||++....   ..+.+.+|+++++++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            357899999999999999999985        234679999997543   346789999999999 89999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeE
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL  442 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NIL  442 (588)
                      ++..++||||+++|+|.+++....               ..+++.+++.++.|+++||.|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            999999999999999999996533               35899999999999999999999998   999999999999


Q ss_pred             ECCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchh
Q 042871          443 LGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSAL  520 (588)
Q Consensus       443 ld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~  520 (588)
                      +++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987654332 22344567889999999999999999999999999999999 99998765554444


Q ss_pred             hhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCccC
Q 042871          521 ELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTAK  574 (588)
Q Consensus       521 ~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~~  574 (588)
                      +.+........+......+.+++..|++ +|.+|||++||++.|++++.......
T Consensus       304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence            4443332222222333456677889998 79999999999999999987655443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.5e-42  Score=358.10  Aligned_cols=254  Identities=20%  Similarity=0.167  Sum_probs=212.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++......+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            46799999999999999999996 689999999997665556789999999999 8999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc-----EEEEecCCcceecCC
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE-----AKLSDFGLSKVIDIG  463 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~-----~kL~DFGla~~~~~~  463 (588)
                       +++|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.     +||+|||+++.....
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence             99999999765667999999999999999999999998   999999999999999887     999999999876443


Q ss_pred             Ccc------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC--cccCHH-
Q 042871          464 ETY------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD--REYSIE-  534 (588)
Q Consensus       464 ~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~--~~~~~e-  534 (588)
                      ...      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+.....  ...+.+ 
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  243 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV  243 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence            321      12456799999999999999999999999999999999999999976544333322211100  011111 


Q ss_pred             ----HHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          535 ----AFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       535 ----~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                          .. .+..++..|+. +|.+||++++|++.|+++.+.
T Consensus       244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence                12 67778889998 799999999999999988754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.7e-43  Score=356.19  Aligned_cols=256  Identities=23%  Similarity=0.367  Sum_probs=203.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-----cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceecc--Cee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRV--DEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~  381 (588)
                      .++|+..+.||+|+||.||++++     .+++.||||++....  ..+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            57889999999999999999984     368999999997543  346789999999999999999999998653  568


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++|+|.+++......+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999776667999999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc----------------chhhhc
Q 042871          462 IGET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG----------------SALELA  523 (588)
Q Consensus       462 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~----------------~~~~~~  523 (588)
                      ....  .......++..|+|||.+.+..++.++||||||+++|||++|..|+......                ...+.+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            4322  1223345778899999999999999999999999999999999876532211                011111


Q ss_pred             CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          524 DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       524 d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ........+....+.+.+++..|++ +|.+|||++|+++.|+++.+.
T Consensus       246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            1111111222333556777889998 799999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.7e-43  Score=379.78  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=210.0

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++...++|...+.||+|+||.||+|++.++..||||++... ...+.|.+|++++++++||||+++++++.+ +..++||
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            33456789999999999999999999988889999999753 356789999999999999999999999876 6789999


Q ss_pred             ecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||+++|+|.+++... ...+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            999999999999643 245899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..+.+........+......+..++
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  414 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  414 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            333334567889999999999999999999999999999999 8999875544444444333332223333445567788


Q ss_pred             HHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          544 LSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ..|++ +|++|||++++++.|+.....
T Consensus       415 ~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          415 CQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            99998 799999999999999988654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.8e-42  Score=354.13  Aligned_cols=244  Identities=26%  Similarity=0.407  Sum_probs=203.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++..  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999985 5799999999863  34567789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++|+|.+++..  ..+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++........ .
T Consensus        99 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  172 (297)
T 3fxz_A           99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (297)
T ss_dssp             CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence            999999999954  35899999999999999999999998   99999999999999999999999999987654332 2


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----CcccCcccCHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----DPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----d~~l~~~~~~e~~~~v~~L~  543 (588)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+    .+.+  ..+......+..++
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li  250 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDFL  250 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SCGGGSCHHHHHHH
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCccccCHHHHHHH
Confidence            34567999999999999999999999999999999999999998644332221111    1111  11122234456678


Q ss_pred             HHhhc-CCCCCCCHHHHHHH
Q 042871          544 LSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..|++ +|.+|||++|+++.
T Consensus       251 ~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHccCChhHCcCHHHHhhC
Confidence            88888 79999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-42  Score=351.76  Aligned_cols=257  Identities=23%  Similarity=0.360  Sum_probs=212.9

Q ss_pred             HHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ...++|...+.||+|+||.||+|+..+++.||||.+... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            345789999999999999999999988889999999754 35678999999999999999999999986 4568999999


Q ss_pred             CCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.+++.... ..+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            99999999996433 26899999999999999999999998   999999999999999999999999999877554433


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALS  545 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~  545 (588)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+........+......+.+++..
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  245 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHH
Confidence            3445567889999999988889999999999999999999 888886544433333332222212222233456677888


Q ss_pred             hhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          546 CTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      |+. +|++|||+.++++.|++....
T Consensus       246 ~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          246 CWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhccChhhCCCHHHHHHHHHHHHHh
Confidence            888 799999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.7e-43  Score=367.27  Aligned_cols=266  Identities=24%  Similarity=0.366  Sum_probs=212.6

Q ss_pred             cccHHHHHHHhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeE
Q 042871          301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVA  370 (588)
Q Consensus       301 ~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~  370 (588)
                      .+...+++...++|...+.||+|+||.||+|++      .+++.||||++....   ..+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            345667777889999999999999999999973      356899999997643   245689999999999 7999999


Q ss_pred             EecceeccC-eeeEEeecCCCCChhhhhhcCCc-----------------------------------------------
Q 042871          371 LLGYCLRVD-ECFLIYELCPNGNLAEWLFGKDK-----------------------------------------------  402 (588)
Q Consensus       371 l~g~~~~~~-~~~LV~E~~~~gsL~~~L~~~~~-----------------------------------------------  402 (588)
                      +++++.+.+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999988755 48999999999999999965432                                               


Q ss_pred             ------------------CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          403 ------------------CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       403 ------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                                        .+++..++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                              2899999999999999999999998   9999999999999999999999999998664332


Q ss_pred             c-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccc-hhhhcCcccCcccCHHHHHHHHH
Q 042871          465 T-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGS-ALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~-~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      . .......||+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+........+......+.+
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  327 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ  327 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            2 23345678999999999999999999999999999999998 999986443221 11222111111111222234566


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ++..|++ +|.+|||++|+++.|++++..
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            6788888 799999999999999998753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.1e-42  Score=354.31  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=213.6

Q ss_pred             HhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      ..++|...+.||+|+||.||+++.      .+++.||||++....   ..+.+.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            367899999999999999999985      345899999997542   34678899999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCC-----------------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCC
Q 042871          381 CFLIYELCPNGNLAEWLFGKD-----------------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK  437 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLK  437 (588)
                      .++||||+++|+|.+++....                       ..+++.+++.++.|+++||.|||+.+   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            999999999999999996432                       24899999999999999999999998   9999999


Q ss_pred             CCCeEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccc
Q 042871          438 PTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTR  515 (588)
Q Consensus       438 p~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~  515 (588)
                      |+|||+++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876543322 2334567889999999999899999999999999999999 999987655


Q ss_pred             ccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          516 AGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       516 ~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .....+.+........+......+..++..|++ +|.+|||+.|+++.|++++..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            555444443332222223333456677888988 799999999999999998753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-42  Score=357.56  Aligned_cols=265  Identities=22%  Similarity=0.377  Sum_probs=197.7

Q ss_pred             HHhcCccccceeeccCceEEEEEEecC-C---cEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLSN-N---QHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      ...++|...+.||+|+||.||+|+... +   ..||||++...    ...+.+.+|++++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            346789999999999999999998643 3   27999998643    345789999999999999999999999987765


Q ss_pred             e------eEEeecCCCCChhhhhhcCC-----cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          381 C------FLIYELCPNGNLAEWLFGKD-----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       381 ~------~LV~E~~~~gsL~~~L~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      .      ++||||+++|+|.+++....     ..+++.+++.++.|+++||.|||+.+   |+||||||+|||+++++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence            5      99999999999999995322     25899999999999999999999998   9999999999999999999


Q ss_pred             EEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCccc
Q 042871          450 KLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKL  527 (588)
Q Consensus       450 kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l  527 (588)
                      ||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+....
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            99999999876443322 2233456889999999999999999999999999999999 899987655544444332222


Q ss_pred             CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCccCCC
Q 042871          528 DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTAKAS  576 (588)
Q Consensus       528 ~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~~~~  576 (588)
                      ....+.+....+..++..|++ +|.+|||+.++++.|++++..+.....+
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            222223333456777899998 7999999999999999999876544433

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8e-43  Score=354.62  Aligned_cols=258  Identities=25%  Similarity=0.408  Sum_probs=219.4

Q ss_pred             HHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ...++|...+.||+|+||.||+|+.. +++.||||.+... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            35778999999999999999999975 5889999999764 346789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++++|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999999653 346899999999999999999999998   99999999999999999999999999987654444


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                      .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........+.+........+......+.+++.
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  246 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  246 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            44445567889999999999999999999999999999999 99998766555555544433333333333455677788


Q ss_pred             Hhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          545 SCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .|+. +|.+|||++|+++.|+.+...
T Consensus       247 ~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          247 ACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            8888 799999999999999988764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=370.01  Aligned_cols=260  Identities=23%  Similarity=0.326  Sum_probs=212.8

Q ss_pred             hcCccccceeeccCceEEEEEEec------CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+|++.      +++.||||++...   .....+.+|+.++++++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467889999999999999999842      5678999999653   2345788999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCC------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC---cEEEE
Q 042871          382 FLIYELCPNGNLAEWLFGKD------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF---EAKLS  452 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~---~~kL~  452 (588)
                      ++||||+++|+|.+++....      ..+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996432      35899999999999999999999998   99999999999999554   59999


Q ss_pred             ecCCcceecCCC-cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcc
Q 042871          453 DFGLSKVIDIGE-TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDRE  530 (588)
Q Consensus       453 DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~  530 (588)
                      |||+++...... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||.........+.+.......
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~  306 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  306 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            999998653222 222334567899999999999999999999999999999998 999987655554444443322222


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCcc
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTA  573 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~  573 (588)
                      .+......+.+|+..|++ +|.+|||+.||++.|+.....+...
T Consensus       307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~  350 (367)
T 3l9p_A          307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI  350 (367)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred             CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence            233333456777889998 7999999999999999988765443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6e-42  Score=349.57  Aligned_cols=255  Identities=20%  Similarity=0.168  Sum_probs=211.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++......+.+.+|+..++.+ +|+|++++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            46799999999999999999995 689999999997666666788999999999 7999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc-----EEEEecCCcceecCC
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE-----AKLSDFGLSKVIDIG  463 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~-----~kL~DFGla~~~~~~  463 (588)
                       +++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.     +||+|||+++.....
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence             99999999766667999999999999999999999998   999999999999987776     999999999876543


Q ss_pred             Ccc------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc-------Ccc
Q 042871          464 ETY------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL-------DRE  530 (588)
Q Consensus       464 ~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l-------~~~  530 (588)
                      ...      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+....       ...
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  244 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence            321      2345679999999999999999999999999999999999999997543322221111000       000


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ........+.+++..|++ +|.+|||+++|++.|+++++.
T Consensus       245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            111223456677888988 799999999999999998864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.5e-42  Score=349.37  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=199.0

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhcc--CCCCceeEEecceec----cCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSH--VRHPNLVALLGYCLR----VDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~----~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+. +|+.||||++... ....+.+|.+++..  ++||||+++++++..    ....++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            57899999999999999999998 7899999998754 34556666666555  899999999998654    3568999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhc--------cccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH--------SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      |||+++|+|.+++.  ...+++..++.++.|+++||.|||        +.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           85 THYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             ECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             hhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCC
Confidence            99999999999993  456999999999999999999999        666   99999999999999999999999999


Q ss_pred             cceecCCCccc---ccCccCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHcC----------CCcccccccc
Q 042871          457 SKVIDIGETYA---SSEVRGTFGYLDPEYRSNC------KVNSSGDVYSFGIVLLQILSG----------KKAKVLTRAG  517 (588)
Q Consensus       457 a~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~t~ksDVwS~Gvll~ElltG----------~~p~~~~~~~  517 (588)
                      ++.........   .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.||......
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            98765433221   2345799999999998876      455799999999999999999          6676432211


Q ss_pred             c-----hhhhc-----CcccCcc-cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          518 S-----ALELA-----DPKLDRE-YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       518 ~-----~~~~~-----d~~l~~~-~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      .     ....+     .+.+... .+......+.+++..|++ +|.+|||+.||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            1     11111     1112111 234466778889999998 799999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=351.65  Aligned_cols=251  Identities=26%  Similarity=0.446  Sum_probs=200.4

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      .++|+..+.||+|+||.||+|+. .++.||||++......+.|.+|++++++++||||+++++++.+  ..++||||+++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~   83 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG   83 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence            35788899999999999999998 5789999999877777889999999999999999999999874  48999999999


Q ss_pred             CChhhhhhcCCc--CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc-EEEEecCCcceecCCCccc
Q 042871          391 GNLAEWLFGKDK--CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE-AKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       391 gsL~~~L~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~-~kL~DFGla~~~~~~~~~~  467 (588)
                      |+|.+++.....  .+++..++.++.|+++||+|||+.+..+|+||||||+|||+++++. +||+|||++......    
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----  159 (307)
T 2eva_A           84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----  159 (307)
T ss_dssp             CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence            999999975443  4788999999999999999999943333999999999999998886 799999999765322    


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccch--h----hhcCcccCcccCHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA--L----ELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--~----~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||........  .    ....+......+    ..+.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~  235 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP----KPIES  235 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC----HHHHH
T ss_pred             cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC----HHHHH
Confidence            2234689999999999999999999999999999999999999864322211  1    111122222333    34566


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      ++..|++ +|.+|||++|+++.|+.+....+.
T Consensus       236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            7888988 799999999999999998865543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=357.78  Aligned_cols=260  Identities=27%  Similarity=0.409  Sum_probs=206.8

Q ss_pred             hcCccccceeeccCceEEEEEEecC-----CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN-----NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++|...+.||+|+||.||+|+...     +..||||.+....   ....+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567778899999999999998642     2469999997532   3457899999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+++|+|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999776677999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHH
Q 042871          463 GET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLT  539 (588)
Q Consensus       463 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v  539 (588)
                      ...  .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........+.+........+......+
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l  279 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI  279 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHH
Confidence            322  12223456788999999999999999999999999999999 999987554444433332222222222334556


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCcc
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTA  573 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~  573 (588)
                      .+++..|++ +|.+||++.|+++.|++++......
T Consensus       280 ~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  314 (333)
T 1mqb_A          280 YQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL  314 (333)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence            778899998 7999999999999999988765443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.8e-42  Score=350.62  Aligned_cols=257  Identities=26%  Similarity=0.343  Sum_probs=204.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+++. .+++.||+|.+...     ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46799999999999999999996 47899999998532     2346789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++... ..+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            9999999999999643 46899999999999999999999998   9999999999999999999999999998765444


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccch-hhhcCcccC---cccCHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-LELADPKLD---REYSIEAFDLTL  540 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~~~~d~~l~---~~~~~e~~~~v~  540 (588)
                      ........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.....   .....+....+.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            3444556799999999999999999999999999999999999999864332221 111111111   112222334566


Q ss_pred             HHHHHhhc-CCCCCC-CHHHHHHHHHHhhccCC
Q 042871          541 QLALSCTA-LTHQRP-PMEQVFVTLQKALDIST  571 (588)
Q Consensus       541 ~L~~~C~~-~p~~RP-s~~evl~~L~~~~~~~~  571 (588)
                      .++..|++ +|.+|| +++++.+.|+..+....
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            77888888 799998 99999999998876543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.4e-42  Score=347.84  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=206.7

Q ss_pred             HhcCccccceeeccCceEEEEEEecC----CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSN----NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ..++|...+.||+|+||.||+|+..+    +..||||.+....   ..+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            35789999999999999999998632    3469999987542   35678999999999999999999999865 4578


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+++++|.+++......+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999999766667999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+........+......+..
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  245 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT  245 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence            44333445567889999999998899999999999999999998 99998755544444333222111122223344667


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ++..|+. +|.+|||+.|+++.|+++...
T Consensus       246 li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          246 LMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            7888988 799999999999999988754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.7e-42  Score=355.82  Aligned_cols=262  Identities=23%  Similarity=0.314  Sum_probs=208.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-----cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEeccee--ccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCL--RVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~  381 (588)
                      .++|...+.||+|+||.||++++     .+++.||||++....  ..+.+.+|++++++++||||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            46889999999999999999984     478899999997543  3456899999999999999999999886  45668


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++++|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999999765567999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc---------------chhhhcC
Q 042871          462 IGETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG---------------SALELAD  524 (588)
Q Consensus       462 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---------------~~~~~~d  524 (588)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......               ...+.+.
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            43322  233456888899999999988999999999999999999999987643221               1111111


Q ss_pred             cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCccCC
Q 042871          525 PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTAKA  575 (588)
Q Consensus       525 ~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~~~  575 (588)
                      .......+......+.+++..|++ +|.+|||++|+++.|+.+.........
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  310 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET  310 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence            111222223334556777888998 799999999999999999876655443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.8e-42  Score=349.31  Aligned_cols=255  Identities=24%  Similarity=0.375  Sum_probs=206.9

Q ss_pred             hcCccccceeeccCceEEEEEEe-----cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceecc--Ce
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRV--DE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~  380 (588)
                      .++|+..+.||+|+||.||++++     .+++.||||++...   ...+.+.+|++++++++||||+++++++.+.  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            45688899999999999999983     47899999998743   3457899999999999999999999999876  66


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++||||+++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence            89999999999999999766667999999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc---------------cchhhhc
Q 042871          461 DIGET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA---------------GSALELA  523 (588)
Q Consensus       461 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~---------------~~~~~~~  523 (588)
                      .....  .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.....               ......+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            54432  223445688899999999998999999999999999999999987642211               0111111


Q ss_pred             CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          524 DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       524 d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ........+......+.+++..|++ +|.+|||+.|+++.|+++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            1111111222233456677889998 79999999999999998763

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.7e-42  Score=356.72  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=214.6

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEe
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALL  372 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~  372 (588)
                      +..++++...++|...+.||+|+||.||+|+..      +++.||||.+....   ....+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444555667889999999999999999999853      47889999997543   345688999999999999999999


Q ss_pred             cceeccCeeeEEeecCCCCChhhhhhcCC---------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE
Q 042871          373 GYCLRVDECFLIYELCPNGNLAEWLFGKD---------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       373 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl  443 (588)
                      +++.+.+..++||||+++|+|.+++....         ..+++..++.++.|+++||.|||+.+   |+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            99999999999999999999999995422         35689999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhh
Q 042871          444 GPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALE  521 (588)
Q Consensus       444 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~  521 (588)
                      ++++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            99999999999999865433221 2233457889999999999899999999999999999999 888886544443333


Q ss_pred             hcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          522 LADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       522 ~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .+........+......+..++..|++ +|.+|||+.|+++.|++.+..
T Consensus       252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          252 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            221111111222233446677888988 799999999999999988764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-42  Score=355.77  Aligned_cols=257  Identities=21%  Similarity=0.357  Sum_probs=205.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcE----EEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQH----VAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~----VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++|+..+.||+|+||.||+|+. .+++.    ||+|.+..   ....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            46789999999999999999986 35554    57777753   345678999999999999999999999998754 78


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +|+||+++|+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999877777999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          463 GET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       463 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+........+......+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  249 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  249 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            322 22334457889999999999999999999999999999999 9999986665555554443332222223334466


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      .++..|++ +|.+|||+.|+++.|+++...+.
T Consensus       250 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  281 (327)
T 3lzb_A          250 MIMRKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence            77888998 79999999999999999986543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.2e-42  Score=356.03  Aligned_cols=242  Identities=24%  Similarity=0.316  Sum_probs=202.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...    ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999997 68999999998643    23567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++....+. 
T Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            999999999999654 45899999999999999999999998   9999999999999999999999999998765433 


Q ss_pred             ccccCccCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVN-SSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e~~~~v~~  541 (588)
                       ......||+.|+|||++.+..++ .++||||||+++|||++|+.||.........+.+.   ..++...+.+    +..
T Consensus       169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~----~~~  243 (328)
T 3fe3_A          169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD----CEN  243 (328)
T ss_dssp             -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH----HHH
T ss_pred             -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence             23456799999999999888775 79999999999999999999997544333332221   1222233444    445


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ++..|+. +|.+|||++|+++.
T Consensus       244 li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHHHCCCChhHCcCHHHHhcC
Confidence            6777887 79999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1e-41  Score=345.25  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=204.1

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceecc-CeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV-DECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-~~~~LV~E~~~  389 (588)
                      .++|...+.||+|+||.||+++. +|+.||||++..+...+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            56899999999999999999988 58899999998877778899999999999999999999987654 57899999999


Q ss_pred             CCChhhhhhcCCc-CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          390 NGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      +++|.+++..... .+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.....    .
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~  171 (278)
T 1byg_A           99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q  171 (278)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc----c
Confidence            9999999965432 3789999999999999999999998   999999999999999999999999998765422    1


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+........+......+.+++..|+
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  251 (278)
T 1byg_A          172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW  251 (278)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHh
Confidence            23357889999999999899999999999999999998 99998765555544444333322333333455667788899


Q ss_pred             c-CCCCCCCHHHHHHHHHHhhcc
Q 042871          548 A-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      + +|.+|||+.|+++.|+++...
T Consensus       252 ~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          252 HLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCChhhCCCHHHHHHHHHHHHhh
Confidence            8 799999999999999988653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=384.09  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=215.5

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++...++|...+.||+|+||.||+|++.++..||||++... ...+.|.+|+++|++++||||+++++++.+ +..+|||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            34456788999999999999999999988889999999753 356789999999999999999999999876 6789999


Q ss_pred             ecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||+++|+|.++|... ...+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999999643 245899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                      ........++..|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+........+......+.+|+
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  497 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  497 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            222334457889999999999999999999999999999999 8999875544444444433322222333445567778


Q ss_pred             HHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          544 LSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ..|++ +|++|||+++|++.|+.+...
T Consensus       498 ~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          498 CQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            89998 799999999999999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=345.84  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=212.6

Q ss_pred             hcCccccc-eeeccCceEEEEEEec---CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELN-LIGEGITGKVYKGKLS---NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|.+.+ .||+|+||.||+|+..   ++..||||++....   ..+.+.+|++++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            45666666 8999999999999853   67889999997632   356789999999999999999999999 5567899


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999766677999999999999999999999998   999999999999999999999999999876543


Q ss_pred             Cccc--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          464 ETYA--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ....  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+........+......+.
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  243 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  243 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHH
Confidence            3222  233456889999999988889999999999999999999 9999976555444443332222223333345567


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      +++..|+. +|.+||++.|+++.|+++......
T Consensus       244 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          244 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            77899998 799999999999999998765433

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-41  Score=353.83  Aligned_cols=260  Identities=24%  Similarity=0.411  Sum_probs=211.6

Q ss_pred             HhcCccccceeeccCceEEEEEEe--------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceec
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL--------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLR  377 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~--------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~  377 (588)
                      ..++|...+.||+|+||.||+|+.        .+++.||||++....   ..+.+.+|+++++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            357899999999999999999986        357789999997543   345789999999999 89999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeE
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL  442 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NIL  442 (588)
                      .+..++||||+++|+|.+++....               ..+++.+++.++.|+++||.|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            999999999999999999996543               24899999999999999999999998   999999999999


Q ss_pred             ECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchh
Q 042871          443 LGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSAL  520 (588)
Q Consensus       443 ld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~  520 (588)
                      ++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            999999999999999876543322 2334567889999999988889999999999999999999 99998754443333


Q ss_pred             hhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          521 ELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       521 ~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      ..+........+......+.+++..|++ +|.+|||+.|+++.|++++.....
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            3332222222222233456677888998 799999999999999999876443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=355.59  Aligned_cols=263  Identities=26%  Similarity=0.391  Sum_probs=210.2

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEeccee
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCL  376 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~  376 (588)
                      .+...++|...+.||+|+||.||+|+.      .++..||||++...   ...+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            344568899999999999999999985      24668999999743   3456799999999999 8999999999999


Q ss_pred             ccCeeeEEeecCCCCChhhhhhcCCc----------------------CccHHHHHHHHHhhhccchhhccccCCceEec
Q 042871          377 RVDECFLIYELCPNGNLAEWLFGKDK----------------------CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHR  434 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~~~~----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHr  434 (588)
                      ..+..++||||+++|+|.+++.....                      .+++.+++.++.|+++||.|||+.+   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            99999999999999999999965432                      3789999999999999999999998   9999


Q ss_pred             CCCCCCeEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccc
Q 042871          435 DIKPTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKV  512 (588)
Q Consensus       435 DLKp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~  512 (588)
                      ||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999876543322 2334567889999999999999999999999999999998 999986


Q ss_pred             ccccc-chhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          513 LTRAG-SALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       513 ~~~~~-~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      ..... .....+........+......+..++..|+. +|.+|||+.|+++.|+.++.....
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            54322 2222222222222222233456667888988 799999999999999998765443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-41  Score=342.36  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=196.3

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC------CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE------GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|+..+.||+|+||.||+|+. .|+.||||++...      ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46788999999999999999997 5899999998642      2346789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC--------CCcEEEEecCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP--------NFEAKLSDFGL  456 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~--------~~~~kL~DFGl  456 (588)
                      |||+++++|.+++.  ...+++.+++.++.|+++||.|||+.+..+|+||||||+|||+++        ++.+||+|||+
T Consensus        85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            99999999999994  456899999999999999999999988666899999999999986        77899999999


Q ss_pred             cceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCcccCcccCHHH
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPKLDREYSIEA  535 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~l~~~~~~e~  535 (588)
                      ++......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ..........+...
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            98654322   223568999999999999999999999999999999999999987543322221 11222222222233


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      ...+.+++..|++ +|.+|||+.|+++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            3456677888998 799999999999999853

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-41  Score=349.49  Aligned_cols=259  Identities=26%  Similarity=0.386  Sum_probs=211.7

Q ss_pred             HHhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      ...++|...+.||+|+||.||+|+.      .+++.||||++....   ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3467899999999999999999984      357899999997543   346789999999999 899999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCc-----------------CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCe
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDK-----------------CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNI  441 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NI  441 (588)
                      +..++||||+++|+|.+++.....                 .+++.+++.++.|+++||.|||+.+   |+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence            999999999999999999965432                 4899999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccccc-c
Q 042871          442 LLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAG-S  518 (588)
Q Consensus       442 Lld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~-~  518 (588)
                      ++++++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            9999999999999999876544332 2334567889999999999999999999999999999999 99888644322 1


Q ss_pred             hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          519 ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       519 ~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      ....+........+......+..++..|+. +|.+|||+.|+++.|+++++..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            222222222111122233456667888888 7999999999999999988654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-41  Score=358.62  Aligned_cols=252  Identities=17%  Similarity=0.174  Sum_probs=201.3

Q ss_pred             HhcCccccceeeccCceEEEEEEecC------CcEEEEEEecCCCc-------------HHHHHHHHHHhccCCCCceeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSN------NQHVAIKHITNEGN-------------VETFVREVASSSHVRHPNLVA  370 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-------------~~~~~~Ei~~l~~l~HpnIv~  370 (588)
                      ..++|...+.||+|+||.||+|++.+      ++.||||++.....             ...+.+|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998754      47899999865431             123445666778889999999


Q ss_pred             Eecceecc----CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC--
Q 042871          371 LLGYCLRV----DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG--  444 (588)
Q Consensus       371 l~g~~~~~----~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld--  444 (588)
                      +++++...    ...++||||+ +++|.+++......+++.+++.++.|++.||.|||+.+   |+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence            99998865    4589999999 99999999776677999999999999999999999998   99999999999999  


Q ss_pred             CCCcEEEEecCCcceecCCCcc------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc-
Q 042871          445 PNFEAKLSDFGLSKVIDIGETY------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-  517 (588)
Q Consensus       445 ~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-  517 (588)
                      .++.+||+|||+++........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... 
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999876432211      113345999999999999999999999999999999999999999742211 


Q ss_pred             ch------------hhhcCcccC-cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          518 SA------------LELADPKLD-REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       518 ~~------------~~~~d~~l~-~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ..            .+.+++.+. ...    ...+..++..|++ +|.+||++.+|++.|++++..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            11            111111111 112    3446677888988 799999999999999998864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4e-41  Score=347.88  Aligned_cols=246  Identities=25%  Similarity=0.314  Sum_probs=198.0

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||.||+|+..+|+.||||++...    ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            5789999999999999999999988999999998643    234678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++ |+|.+++......+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            997 5898888776667999999999999999999999998   99999999999999999999999999987643222 


Q ss_pred             cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC----c----------------
Q 042871          467 ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD----P----------------  525 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d----~----------------  525 (588)
                      ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.    .                
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            2334578999999999876 568999999999999999999999986433322111110    0                


Q ss_pred             --ccC--cc-----cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 --KLD--RE-----YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 --~l~--~~-----~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                        ...  ..     ........+..|+..|++ +|.+|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              000  00     000111335567788888 7999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.5e-41  Score=341.82  Aligned_cols=249  Identities=28%  Similarity=0.411  Sum_probs=202.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC---------cHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG---------NVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      .++|+..+.||+|+||.||+|+. .+++.||||++....         ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46789999999999999999997 578999999985321         1267899999999999999999999987655 


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc-----EEEEecC
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE-----AKLSDFG  455 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~-----~kL~DFG  455 (588)
                       ++||||+++|+|.+++......+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++.     +||+|||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence             7999999999999999877778999999999999999999999876 34999999999999988776     9999999


Q ss_pred             CcceecCCCcccccCccCCCCccCcccc--cCCCCCchhhHHHHHHHHHHHHcCCCccccccccch---hhhcCcccCcc
Q 042871          456 LSKVIDIGETYASSEVRGTFGYLDPEYR--SNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA---LELADPKLDRE  530 (588)
Q Consensus       456 la~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~---~~~~d~~l~~~  530 (588)
                      +++....    ......||+.|+|||++  ....++.++||||||+++|||++|+.||........   ...........
T Consensus       175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            9975432    23345789999999998  455678999999999999999999999975443322   11111122222


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      .+......+.+++..|++ +|.+|||++|+++.|+++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            223333456677888988 799999999999999863

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5e-41  Score=347.38  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=194.5

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceeccC-------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVD-------  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-------  379 (588)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++..   ....+.+.+|++++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999975 899999999863   234578999999999999999999999986543       


Q ss_pred             --------------------------------------------------eeeEEeecCCCCChhhhhhcCC--cCccHH
Q 042871          380 --------------------------------------------------ECFLIYELCPNGNLAEWLFGKD--KCLSWI  407 (588)
Q Consensus       380 --------------------------------------------------~~~LV~E~~~~gsL~~~L~~~~--~~l~~~  407 (588)
                                                                        ..++||||+++|+|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2799999999999999996543  245667


Q ss_pred             HHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-----------ccccCccCCCC
Q 042871          408 QRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-----------YASSEVRGTFG  476 (588)
Q Consensus       408 ~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~  476 (588)
                      .++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999998   99999999999999999999999999987654321           12234579999


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCC
Q 042871          477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPP  555 (588)
Q Consensus       477 Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs  555 (588)
                      |+|||++.+..++.++||||||+++|||++|..|+..... ........... .........+..++..|++ +|.+|||
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps  319 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-IITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPE  319 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-HHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-HHHHhhccCCC-cccccCChhHHHHHHHHccCCCCcCCC
Confidence            9999999999999999999999999999999876532111 11111111111 1112223445677888988 7999999


Q ss_pred             HHHHHH
Q 042871          556 MEQVFV  561 (588)
Q Consensus       556 ~~evl~  561 (588)
                      ++|+++
T Consensus       320 ~~~~l~  325 (332)
T 3qd2_B          320 ATDIIE  325 (332)
T ss_dssp             HHHHHH
T ss_pred             HHHHhh
Confidence            999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.7e-41  Score=339.27  Aligned_cols=250  Identities=20%  Similarity=0.298  Sum_probs=202.3

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc--CeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV--DECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+. +|+.||||++...    ...+.|.+|+.++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            46788999999999999999998 5899999999743    2345789999999999999999999999877  788999


Q ss_pred             eecCCCCChhhhhhcCCc-CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          385 YELCPNGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      |||+++|+|.+++..... .+++.+++.++.|+++||.|||+.+ ++|+||||||+||++++++.++|+|||++....  
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence            999999999999976543 5899999999999999999999875 349999999999999999999999998865422  


Q ss_pred             CcccccCccCCCCccCcccccCCCCCc---hhhHHHHHHHHHHHHcCCCccccccccchh-hhcCcccCcccCHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNS---SGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELADPKLDREYSIEAFDLT  539 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~---ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~d~~l~~~~~~e~~~~v  539 (588)
                          .....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||......... ...........+......+
T Consensus       165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred             ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence                23346899999999988765544   899999999999999999998754433221 1111111122222233446


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ..++..|++ +|.+|||++|+++.|+++.+
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            667788888 79999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=343.19  Aligned_cols=253  Identities=23%  Similarity=0.293  Sum_probs=208.8

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccC--eeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVD--ECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...   ...+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467889999999999999999975 5899999999752   34678899999999999999999999988655  77999


Q ss_pred             eecCCCCChhhhhhcCCc--CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE----CCCCcEEEEecCCcc
Q 042871          385 YELCPNGNLAEWLFGKDK--CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSK  458 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl----d~~~~~kL~DFGla~  458 (588)
                      |||+++|+|.+++.....  .+++.+++.++.|+++||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999965433  3899999999999999999999998   9999999999999    888889999999998


Q ss_pred             eecCCCcccccCccCCCCccCccccc--------CCCCCchhhHHHHHHHHHHHHcCCCccccccccc-----hhhhcC-
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRS--------NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-----ALELAD-  524 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-----~~~~~d-  524 (588)
                      .......  .....||+.|+|||++.        +..++.++||||||+++|||++|+.||.......     ....+. 
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            7654332  23457899999999876        5788999999999999999999999986322211     000000 


Q ss_pred             ----------------------cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          525 ----------------------PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       525 ----------------------~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                                            -......+......+..++..|++ +|++|||++|+++..++...
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence                                  011123456777888889999998 79999999999999987654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=381.24  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=208.4

Q ss_pred             cCccccc-eeeccCceEEEEEEec---CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          312 EKLNELN-LIGEGITGKVYKGKLS---NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       312 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      +++...+ .||+|+||.||+|++.   ++..||||+++..   ...+.|.+|++++++++||||+++++++.+ +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999863   5678999999753   356789999999999999999999999976 568999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999999999999776677999999999999999999999998   9999999999999999999999999998764333


Q ss_pred             ccc--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          465 TYA--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      ...  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+..+.+........+......+.+
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  570 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  570 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            222  122345789999999999999999999999999999998 99999866665555555443333333444456777


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      |+..|+. +|.+||++++|++.|+......
T Consensus       571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            8899998 7999999999999999886543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-41  Score=351.29  Aligned_cols=247  Identities=20%  Similarity=0.237  Sum_probs=204.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .++|...+.||+|+||.||+++.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            568999999999999999999974 68999999987543 3456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC--CCcEEEEecCCcceecCCCcc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP--NFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~--~~~~kL~DFGla~~~~~~~~~  466 (588)
                      ++|+|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||++.  ++.+||+|||+++....+.. 
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~-  159 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-  159 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence            999999999766667999999999999999999999998   999999999999987  78999999999987654332 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Cccc--CcccCHHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPKL--DREYSIEAFDLTLQLA  543 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~l--~~~~~~e~~~~v~~L~  543 (588)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+ ....  ......+....+..++
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             -cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence             23457899999999999988999999999999999999999999754433322222 1111  1000001123456678


Q ss_pred             HHhhc-CCCCCCCHHHHHHH
Q 042871          544 LSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..|+. +|.+|||+.|+++.
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHcCCChhHCcCHHHHhcC
Confidence            88888 79999999999873

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=348.65  Aligned_cols=243  Identities=24%  Similarity=0.301  Sum_probs=192.7

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ..++|+..++||+|+||+||+|+.. +|+.||||++...    .....+..|+..+.++ +||||+++++++.+++..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3478999999999999999999975 7999999998642    2233455666655554 89999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+ +++|.+++......+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999 78999999776677999999999999999999999998   999999999999999999999999999875432


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLA  543 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~  543 (588)
                        .......||++|+|||++.+ .++.++||||||+++|||++|+.++....  ....+................+..++
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li  285 (311)
T 3p1a_A          211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--GWQQLRQGYLPPEFTAGLSSELRSVL  285 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--HHHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred             --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHhccCCCcccccCCCHHHHHHH
Confidence              22344569999999998876 79999999999999999999976553221  11122222222111112234566678


Q ss_pred             HHhhc-CCCCCCCHHHHHH
Q 042871          544 LSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       544 ~~C~~-~p~~RPs~~evl~  561 (588)
                      ..|++ +|++|||++|+++
T Consensus       286 ~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          286 VMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            88888 7999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-41  Score=358.17  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             CccccceeeccCceEEEEEEec--CC--cEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceec-cCeeeEE
Q 042871          313 KLNELNLIGEGITGKVYKGKLS--NN--QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLR-VDECFLI  384 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~--~g--~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV  384 (588)
                      .|...+.||+|+||.||+|++.  ++  ..||||.+...   ...+.|.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4666789999999999999863  22  46899998643   345689999999999999999999998654 5678999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999776677999999999999999999999998   9999999999999999999999999998664332


Q ss_pred             c---ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          465 T---YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       465 ~---~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      .   .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+........+......+.
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            1   12234467889999999999999999999999999999999 5666654443333322211111111222334566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      +++..|++ +|.+|||+.|+++.|+++......
T Consensus       327 ~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            77889998 799999999999999999865443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2e-41  Score=367.04  Aligned_cols=253  Identities=22%  Similarity=0.241  Sum_probs=207.7

Q ss_pred             cHHHHHHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEeccee
Q 042871          303 TIREVHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCL  376 (588)
Q Consensus       303 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~  376 (588)
                      .++++....++|+..+.||+|+||+||+|+.. +++.||||++...     ...+.+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            45566667899999999999999999999975 5889999998642     22345889999999999999999999999


Q ss_pred             ccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      +.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999999775667999999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCcccccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C------
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D------  524 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d------  524 (588)
                      ++..............||+.|+|||++.     ...++.++|||||||++|||++|+.||......+....+ .      
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ  301 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence            9877655554555678999999999987     567899999999999999999999999754333222211 1      


Q ss_pred             -cccCcccCHHHHHHHHHHHHHhhc-CCCC--CCCHHHHHHH
Q 042871          525 -PKLDREYSIEAFDLTLQLALSCTA-LTHQ--RPPMEQVFVT  562 (588)
Q Consensus       525 -~~l~~~~~~e~~~~v~~L~~~C~~-~p~~--RPs~~evl~~  562 (588)
                       +......+.+..++    +..|+. +|++  ||+++|+++.
T Consensus       302 ~p~~~~~~s~~~~dL----i~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          302 FPTQVTDVSENAKDL----IRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             CCSSCCCSCHHHHHH----HHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             CCcccccCCHHHHHH----HHHHhcccccccCCCCHHHHhCC
Confidence             11112355555554    455554 4555  9999999863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.9e-41  Score=350.14  Aligned_cols=248  Identities=24%  Similarity=0.304  Sum_probs=199.1

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||.||+|+.. +++.||||++....   ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999975 78999999986432   23568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-c
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-T  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-~  465 (588)
                      |+++|+|.+++.. ...+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... .
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999999999954 345999999999999999999999998   9999999999999999999999999998764332 2


Q ss_pred             ccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccc--hhhhcCcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGS--ALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~--~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......  ....................+..|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            22345679999999999988775 778999999999999999999996443321  111111111111111122334566


Q ss_pred             HHHhhc-CCCCCCCHHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +..|++ +|.+|||++|+++.
T Consensus       242 i~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHccCChhhCcCHHHHhhC
Confidence            788887 79999999999874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.3e-41  Score=341.73  Aligned_cols=245  Identities=24%  Similarity=0.330  Sum_probs=194.5

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|...+.||+|+||.||+|+..+|+.||||++...    ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            578899999999999999999988999999998643    2346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++ ++|.+++......+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ..
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  156 (288)
T 1ob3_A           82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK  156 (288)
T ss_dssp             CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence            97 4999999766677999999999999999999999998   9999999999999999999999999998654322 12


Q ss_pred             ccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh---------------------cCc
Q 042871          468 SSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL---------------------ADP  525 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~---------------------~d~  525 (588)
                      .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....                     .++
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            234568999999999876 4589999999999999999999999864322111100                     011


Q ss_pred             ccC-------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 KLD-------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 ~l~-------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .+.       ..........+..++..|++ +|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100       00011122345567788888 7999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=343.18  Aligned_cols=241  Identities=24%  Similarity=0.312  Sum_probs=193.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----------------------------cHHHHHHHHHHhc
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----------------------------NVETFVREVASSS  361 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----------------------------~~~~~~~Ei~~l~  361 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....                            ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46799999999999999999986 478999999986432                            1346889999999


Q ss_pred             cCCCCceeEEecceec--cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCC
Q 042871          362 HVRHPNLVALLGYCLR--VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPT  439 (588)
Q Consensus       362 ~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~  439 (588)
                      +++||||+++++++.+  .+..++||||+++++|.+++  ....+++.+++.++.|+++||+|||+.+   |+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence            9999999999999986  56789999999999999976  3456999999999999999999999998   999999999


Q ss_pred             CeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCccccccc
Q 042871          440 NILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK---VNSSGDVYSFGIVLLQILSGKKAKVLTRA  516 (588)
Q Consensus       440 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~t~ksDVwS~Gvll~ElltG~~p~~~~~~  516 (588)
                      |||++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999987654322 233457999999999987765   37889999999999999999999864433


Q ss_pred             cchhhhcC-ccc----CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          517 GSALELAD-PKL----DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       517 ~~~~~~~d-~~l----~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ......+. ...    ....+    ..+..++..|++ +|++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHHHCCCCCCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHhcccCCCCCccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            22222111 111    11233    345667788888 7999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-40  Score=352.39  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=201.5

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC--------cHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG--------NVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+++.. +|+.||+|.+....        ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            567999999999999999999974 78999999986421        357899999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC----cEEEEecCCc
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF----EAKLSDFGLS  457 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~----~~kL~DFGla  457 (588)
                      ++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999954 346999999999999999999999998   99999999999998877    7999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Ccc--cCcccCHH
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPK--LDREYSIE  534 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~--l~~~~~~e  534 (588)
                      +....+.  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ...  +.......
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence            8765432  234467999999999999999999999999999999999999999654333322222 111  11110011


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ....+..++..|+. +|.+|||+.|+++
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            12345566778887 7999999999984

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.8e-41  Score=343.48  Aligned_cols=257  Identities=21%  Similarity=0.324  Sum_probs=203.1

Q ss_pred             hcCccccceeeccCceEEEEEEecC----CcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEeccee-ccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN----NQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCL-RVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~  382 (588)
                      ..+|...+.||+|+||.||+|+..+    +..||+|.+....   ..+.+.+|+.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3467788999999999999998632    2368999987533   3467899999999999999999999854 556789


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+++|+|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999776677899999999999999999999998   99999999999999999999999999986643


Q ss_pred             CCc---ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCC-CccccccccchhhhcCcccCcccCHHHHHH
Q 042871          463 GET---YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK-KAKVLTRAGSALELADPKLDREYSIEAFDL  538 (588)
Q Consensus       463 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~-~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~  538 (588)
                      ...   .......+|+.|+|||.+.+..++.++||||||+++|||++|+ .|+...........+........+....+.
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence            321   1233456788999999999999999999999999999999954 455443333332222111111112222345


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      +.+++..|++ +|.+|||++|+++.|++++..-
T Consensus       261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            6677888988 7999999999999999988643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=342.63  Aligned_cols=263  Identities=24%  Similarity=0.338  Sum_probs=202.9

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhcc--CCCCceeEEecceecc---
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSH--VRHPNLVALLGYCLRV---  378 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~---  378 (588)
                      ........++|...+.||+|+||.||+|+. .|+.||||++.... ...+.+|.+++..  ++||||+++++++...   
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            333445568999999999999999999998 48999999986543 3444555555444  5899999999999877   


Q ss_pred             -CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcccc-----CCceEecCCCCCCeEECCCCcEEEE
Q 042871          379 -DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS-----EGCIVHRDIKPTNILLGPNFEAKLS  452 (588)
Q Consensus       379 -~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~IvHrDLKp~NILld~~~~~kL~  452 (588)
                       ...++||||+++|+|.+++..  ..+++.+++.++.|++.||.|||+..     .++|+||||||+|||++.++.+||+
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence             688999999999999999954  35899999999999999999999881     1229999999999999999999999


Q ss_pred             ecCCcceecCCCcc---cccCccCCCCccCcccccCCCCCch------hhHHHHHHHHHHHHcC----------CCcccc
Q 042871          453 DFGLSKVIDIGETY---ASSEVRGTFGYLDPEYRSNCKVNSS------GDVYSFGIVLLQILSG----------KKAKVL  513 (588)
Q Consensus       453 DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~t~k------sDVwS~Gvll~ElltG----------~~p~~~  513 (588)
                      |||+++........   ......||+.|+|||++.+...+.+      +||||||+++|||++|          +.||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            99999766433222   1234579999999999988766665      9999999999999999          555542


Q ss_pred             ccccc-----hhhh-----cCcccCccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          514 TRAGS-----ALEL-----ADPKLDREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       514 ~~~~~-----~~~~-----~d~~l~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .....     ....     ..+.+...+ +.+....+.+++..|++ +|.+|||+.||++.|+++.+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            21111     1111     112222211 23666778899999998 7999999999999999987653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.5e-41  Score=349.00  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=204.4

Q ss_pred             ccccceeeccCceEEEEEEe-----cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceecc--CeeeE
Q 042871          314 LNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRV--DECFL  383 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~L  383 (588)
                      |...+.||+|+||.||++.+     .+|+.||||++....   ..+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48889999999999988864     368899999997643   345789999999999999999999999874  67899


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++..  ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            9999999999999954  34899999999999999999999998   999999999999999999999999999877544


Q ss_pred             Ccc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc---------------chhhhcCcc
Q 042871          464 ETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG---------------SALELADPK  526 (588)
Q Consensus       464 ~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---------------~~~~~~d~~  526 (588)
                      ...  ......+|..|+|||++.+..++.++||||||+++|||++|+.||......               ...+.++..
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            321  233456788899999999989999999999999999999999988643211               111222222


Q ss_pred             cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          527 LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       527 l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .....+......+.+++..|++ +|.+|||++|+++.|+++.+.-
T Consensus       268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            2222223333456777889998 7999999999999999887543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-41  Score=341.02  Aligned_cols=256  Identities=22%  Similarity=0.315  Sum_probs=205.4

Q ss_pred             CccccceeeccCceEEEEEEec-CC---cEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCee-eEE
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NN---QHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDEC-FLI  384 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~-~LV  384 (588)
                      .|...+.||+|+||.||+|++. ++   ..||+|.+....   ..+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4555689999999999999853 22   379999987533   346789999999999999999999999876655 999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +||+.+|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999876678999999999999999999999998   9999999999999999999999999997654322


Q ss_pred             ---cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCc-cccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          465 ---TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA-KVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       465 ---~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p-~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                         ........+++.|+|||.+.+..++.++||||||+++|||++|+.| +...........+........+....+.+.
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  258 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY  258 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence               1223345678999999999999999999999999999999996655 443333333333322222222222334566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      +++..|++ +|.+|||++++++.|+++++...
T Consensus       259 ~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          259 QVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            77888988 79999999999999999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=346.94  Aligned_cols=245  Identities=24%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC--------cHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG--------NVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+++.. +|+.||||.+....        ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467899999999999999999974 68999999986421        357899999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC----cEEEEecCCc
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF----EAKLSDFGLS  457 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~----~~kL~DFGla  457 (588)
                      ++||||+++|+|.+++.. ...+++.+++.++.|+++||.|||+.+   |+||||||+|||+++++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999954 346999999999999999999999998   99999999999999887    8999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHH
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIE  534 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e  534 (588)
                      +.......  .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   ...........
T Consensus       166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            87654332  23457999999999999999999999999999999999999998643332222211   11111111011


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ....+..++..|+. +|.+|||+.|+++
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            12345667888887 7999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.1e-41  Score=343.60  Aligned_cols=256  Identities=18%  Similarity=0.177  Sum_probs=203.8

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecce-eccCeeeEEeec
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYC-LRVDECFLIYEL  387 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~LV~E~  387 (588)
                      ..++|...+.||+|+||.||+|+. .+++.||||++......+.+.+|+++++.++|+|++..++.+ .+.+..++||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            457899999999999999999996 688999999887655556788999999999988877666655 566778999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE---CCCCcEEEEecCCcceecCCC
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl---d~~~~~kL~DFGla~~~~~~~  464 (588)
                      + +++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||+   ++++.+||+|||+++......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9 99999999766667999999999999999999999998   9999999999999   789999999999998765433


Q ss_pred             c------ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC--cccC----
Q 042871          465 T------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD--REYS----  532 (588)
Q Consensus       465 ~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~--~~~~----  532 (588)
                      .      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.....  ...+    
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence            2      123356799999999999999999999999999999999999999975433222111110000  0011    


Q ss_pred             -HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          533 -IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       533 -~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                       ......+..++..|++ +|++|||+.++++.|+++...
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence             1113456777888988 799999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-40  Score=347.01  Aligned_cols=243  Identities=24%  Similarity=0.283  Sum_probs=202.8

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++..     ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999974 799999999863     34567789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            9999999999999643 45899999999999999999999998   9999999999999999999999999998643222


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+   ...+....+.+    +..
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~----~~~  234 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE----AKS  234 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH----HHH
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH----HHH
Confidence             2234567999999999999999999999999999999999999999754433332222   12223334444    455


Q ss_pred             HHHHhhc-CCCCCC-----CHHHHHHH
Q 042871          542 LALSCTA-LTHQRP-----PMEQVFVT  562 (588)
Q Consensus       542 L~~~C~~-~p~~RP-----s~~evl~~  562 (588)
                      ++..|++ +|.+||     +++|+++.
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            5677777 799999     89998763

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.2e-41  Score=342.30  Aligned_cols=256  Identities=18%  Similarity=0.189  Sum_probs=207.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecce-eccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYC-LRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~LV~E~~  388 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++......+.+.+|+.+++.++|++++..++++ .+.+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            57899999999999999999996 689999999988766667899999999999988866666555 5667789999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE---CCCCcEEEEecCCcceecCCCc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl---d~~~~~kL~DFGla~~~~~~~~  465 (588)
                       +++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||+   ++++.+||+|||+++.......
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence             99999999766667999999999999999999999998   9999999999999   4889999999999987654432


Q ss_pred             c------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----CcccCc---ccC
Q 042871          466 Y------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----DPKLDR---EYS  532 (588)
Q Consensus       466 ~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----d~~l~~---~~~  532 (588)
                      .      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........+.+    ......   ...
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  243 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence            1      124567999999999999999999999999999999999999999753322211111    100000   000


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      ......+.+++..|++ +|.+|||+.++++.|+++....
T Consensus       244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            1122446677888988 7999999999999999987654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.1e-41  Score=347.14  Aligned_cols=257  Identities=28%  Similarity=0.445  Sum_probs=207.7

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcE--EEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQH--VAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~--VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ++|...+.||+|+||.||+|+.. +|..  ||||++...   ...+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67899999999999999999864 5664  499988642   3445789999999999 899999999999999999999


Q ss_pred             eecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          385 YELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      |||+++|+|.+++....               ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996543               36899999999999999999999998   9999999999999999999


Q ss_pred             EEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccC
Q 042871          450 KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLD  528 (588)
Q Consensus       450 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~  528 (588)
                      ||+|||+++....  ........+++.|+|||++.+..++.++||||||+++|||++ |+.||.........+.+.....
T Consensus       182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            9999999874321  112233456889999999998889999999999999999998 9999875554444443333222


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCcc
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTA  573 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~  573 (588)
                      ...+......+..++..|+. +|.+|||++|+++.|+++++.....
T Consensus       260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  305 (327)
T 1fvr_A          260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  305 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence            22222333456677888888 7999999999999999998765443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=364.65  Aligned_cols=253  Identities=21%  Similarity=0.224  Sum_probs=206.2

Q ss_pred             cHHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEeccee
Q 042871          303 TIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCL  376 (588)
Q Consensus       303 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~  376 (588)
                      .++++....++|+..+.||+|+||.||+++. .+|+.||||++...     ...+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4455666778999999999999999999997 47999999998642     23345889999999999999999999999


Q ss_pred             ccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      +.+..|+||||+++|+|.+++......+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence            999999999999999999999765557999999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCcccccCccCCCCccCccccc-------CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcC----
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRS-------NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LAD----  524 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d----  524 (588)
                      ++..............||+.|+|||++.       ...++.++|||||||++|||++|+.||.......... ++.    
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  288 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH  288 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            9887654444445568999999999987       4578999999999999999999999996543332221 111    


Q ss_pred             ---cccCcccCHHHHHHHHHHHHHhhcCCCCC---CCHHHHHHH
Q 042871          525 ---PKLDREYSIEAFDLTLQLALSCTALTHQR---PPMEQVFVT  562 (588)
Q Consensus       525 ---~~l~~~~~~e~~~~v~~L~~~C~~~p~~R---Ps~~evl~~  562 (588)
                         +.....++.+    +..++..|+.+|.+|   |+++|+++.
T Consensus       289 ~~~p~~~~~~s~~----~~dli~~lL~~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          289 LSLPLVDEGVPEE----ARDFIQRLLCPPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             CCCC----CCCHH----HHHHHHTTSSCGGGCTTTTTHHHHHTS
T ss_pred             cCCCccccCCCHH----HHHHHHHHcCChhhcCCCCCHHHHhcC
Confidence               1112234444    444566677777665   799998753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-41  Score=344.80  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=200.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CC-------cEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NN-------QHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g-------~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      .++|...+.||+|+||.||+|+.. ++       ..||+|++...  ...+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467889999999999999999864 33       47999998643  446789999999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc--------EEEE
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE--------AKLS  452 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~--------~kL~  452 (588)
                      .++||||+++|+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999776666999999999999999999999999   999999999999998887        9999


Q ss_pred             ecCCcceecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCcc-ccccccchhhhc--CcccC
Q 042871          453 DFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAK-VLTRAGSALELA--DPKLD  528 (588)
Q Consensus       453 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~-~~~~~~~~~~~~--d~~l~  528 (588)
                      |||++.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+ ............  ...+.
T Consensus       164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (289)
T 4fvq_A          164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP  238 (289)
T ss_dssp             CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence            9999865432     123457889999999887 67999999999999999999965544 322222221111  11122


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                      ...+    ..+..++..|++ +|.+|||++|+++.|++++.-..
T Consensus       239 ~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          239 APKA----AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             CCSS----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             CCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            2222    335667888888 79999999999999998876433

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-41  Score=352.51  Aligned_cols=260  Identities=27%  Similarity=0.389  Sum_probs=209.4

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEec-C-----CcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEeccee
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKLS-N-----NQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCL  376 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~-----g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~  376 (588)
                      ++...++|...+.||+|+||.||+|+.. +     +..||+|.+....   ..+.+.+|+.+++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4455788999999999999999999863 2     2479999997543   346789999999999 8999999999999


Q ss_pred             ccCeeeEEeecCCCCChhhhhhcC-------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE
Q 042871          377 RVDECFLIYELCPNGNLAEWLFGK-------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl  443 (588)
                      +.+..++||||+++|+|.+++...             ...+++..++.++.|+++||.|||+.+   |+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            999999999999999999999642             235789999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccc-hh
Q 042871          444 GPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGS-AL  520 (588)
Q Consensus       444 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~-~~  520 (588)
                      ++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            99999999999999866433322 2334567889999999999999999999999999999999 888886433221 22


Q ss_pred             hhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          521 ELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       521 ~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ..+........+......+..++..|++ +|.+|||+.|+++.|++....
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            2222211111122223456667888998 799999999999999987653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.3e-41  Score=347.02  Aligned_cols=265  Identities=25%  Similarity=0.368  Sum_probs=211.5

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEE
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVAL  371 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l  371 (588)
                      +...+.....++|...+.||+|+||.||+|+.      .+++.||||++....   ..+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44555666788999999999999999999974      357899999997643   345788999999999 69999999


Q ss_pred             ecceeccC-eeeEEeecCCCCChhhhhhcCCc---------------CccHHHHHHHHHhhhccchhhccccCCceEecC
Q 042871          372 LGYCLRVD-ECFLIYELCPNGNLAEWLFGKDK---------------CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD  435 (588)
Q Consensus       372 ~g~~~~~~-~~~LV~E~~~~gsL~~~L~~~~~---------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrD  435 (588)
                      ++++...+ ..++||||+++|+|.+++.....               .+++..++.++.|+++||.|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987654 58999999999999999965432               2899999999999999999999998   99999


Q ss_pred             CCCCCeEECCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccc
Q 042871          436 IKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVL  513 (588)
Q Consensus       436 LKp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~  513 (588)
                      |||+||++++++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987643332 22344567889999999999999999999999999999998 9999864


Q ss_pred             ccccc-hhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          514 TRAGS-ALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       514 ~~~~~-~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ..... ....+........+......+.+++..|++ +|.+|||+.|+++.|+.++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            33221 111111111111111122345666788888 799999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5e-41  Score=353.30  Aligned_cols=243  Identities=20%  Similarity=0.243  Sum_probs=199.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-------CCcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-------EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .++|+..+.||+|+||.||+++. .+|+.||||++..       ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999986 4789999999852       124678999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc---EEEEecCC
Q 042871          383 LIYELCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGL  456 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~---~kL~DFGl  456 (588)
                      +||||+++|+|.+++...   ...+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999888543   235899999999999999999999998   999999999999987655   99999999


Q ss_pred             cceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC------cc
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD------RE  530 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~------~~  530 (588)
                      ++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.................      ..
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccccc
Confidence            987654322 23445799999999999999999999999999999999999999865332211111111111      12


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .+    ..+..++..|++ +|.+|||+.|+++
T Consensus       259 ~s----~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          259 IS----ESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             SC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            23    345666788887 7999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.9e-41  Score=347.82  Aligned_cols=263  Identities=24%  Similarity=0.387  Sum_probs=201.4

Q ss_pred             HHHHHHhcCccccceeeccCceEEEEEEec----CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEeccee
Q 042871          305 REVHYATEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCL  376 (588)
Q Consensus       305 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~  376 (588)
                      +++....++|...+.||+|+||.||+|+..    +++.||||++...    ...+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            334445678999999999999999999863    3458999998643    23467899999999999999999999998


Q ss_pred             ccC-----eeeEEeecCCCCChhhhhhc-----CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC
Q 042871          377 RVD-----ECFLIYELCPNGNLAEWLFG-----KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN  446 (588)
Q Consensus       377 ~~~-----~~~LV~E~~~~gsL~~~L~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~  446 (588)
                      +.+     ..++||||+++|+|.+++..     ....+++.+++.++.|+++||.|||+.+   |+||||||+||+++++
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence            755     35999999999999999842     3356999999999999999999999998   9999999999999999


Q ss_pred             CcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcC
Q 042871          447 FEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELAD  524 (588)
Q Consensus       447 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d  524 (588)
                      +.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+.
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  263 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL  263 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence            99999999999876443322 2234457889999999999999999999999999999999 888887554444333332


Q ss_pred             cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          525 PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       525 ~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .......+......+.+++..|+. +|.+|||+.++++.|+++++..
T Consensus       264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            221222222333456677889998 7999999999999999987643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.3e-41  Score=341.04  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=192.8

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ..++|...+.||+|+||.||+|+..  ..||||++...    ...+.|.+|++++++++||||++++++. ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3578999999999999999999864  35999998643    2346789999999999999999999965 556789999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-  464 (588)
                      ||+++++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999999777778999999999999999999999998   9999999999999999999999999997654322 


Q ss_pred             cccccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCcccccccc-chhhhcCc-ccC---cccCHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SALELADP-KLD---REYSIEAF  536 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~~~~d~-~l~---~~~~~e~~  536 (588)
                      ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||...... ...+.+.. ...   ........
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP  255 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence            22234457899999999886   667889999999999999999999998643322 11111111 000   11112233


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ..+..++..|++ +|.+|||++|+++.|+++..
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            456677888988 79999999999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=346.67  Aligned_cols=258  Identities=25%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHH--HHHhccCCCCceeEEeccee-----ccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVRE--VASSSHVRHPNLVALLGYCL-----RVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~E--i~~l~~l~HpnIv~l~g~~~-----~~~~~~L  383 (588)
                      .++|...+.||+|+||.||+|+. +++.||||++.... ...+..|  +..+..++||||+++++.+.     .....++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            46889999999999999999987 78999999987543 3444444  44456689999999997543     2346789


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc---------cCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY---------SEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                      ||||+++|+|.+++...  ..++..++.++.|+++||.|||+.         +   |+||||||+|||++.++.+||+||
T Consensus        90 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence            99999999999999543  458899999999999999999998         6   999999999999999999999999


Q ss_pred             CCcceecCCCc-------ccccCccCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHcCCCccccccccch-
Q 042871          455 GLSKVIDIGET-------YASSEVRGTFGYLDPEYRSN-------CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-  519 (588)
Q Consensus       455 Gla~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~-------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-  519 (588)
                      |+++.......       .......||+.|+|||++.+       ..++.++||||||+++|||++|+.|+........ 
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987643221       12234569999999999876       4566789999999999999999877642211100 


Q ss_pred             -----------------h-----hhcCcccCccc--CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCccC
Q 042871          520 -----------------L-----ELADPKLDREY--SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTAK  574 (588)
Q Consensus       520 -----------------~-----~~~d~~l~~~~--~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~~  574 (588)
                                       .     ....+.+...+  .......+.+++..|+. +|.+|||++|+++.|+++++.-....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence                             0     00011111111  12345568888999998 79999999999999999997655544


Q ss_pred             C
Q 042871          575 A  575 (588)
Q Consensus       575 ~  575 (588)
                      .
T Consensus       325 ~  325 (336)
T 3g2f_A          325 S  325 (336)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4e-40  Score=342.96  Aligned_cols=261  Identities=22%  Similarity=0.320  Sum_probs=210.4

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhcc--CCCCceeEEecceeccC
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSH--VRHPNLVALLGYCLRVD  379 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~~  379 (588)
                      .++.......++|...+.||+|+||.||+|+. +|+.||||++... ..+.+.+|.+++..  ++||||+++++++...+
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            33444455678999999999999999999998 6899999999754 34677888888876  78999999999998775


Q ss_pred             ----eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhc--------cccCCceEecCCCCCCeEECCCC
Q 042871          380 ----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH--------SYSEGCIVHRDIKPTNILLGPNF  447 (588)
Q Consensus       380 ----~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~IvHrDLKp~NILld~~~  447 (588)
                          ..++||||+++|+|.+++..  ..+++.+++.++.|+++||.|||        +.+   |+||||||+|||+++++
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred             CccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence                78999999999999999954  45899999999999999999999        666   99999999999999999


Q ss_pred             cEEEEecCCcceecCCCcc---cccCccCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHcC----------C
Q 042871          448 EAKLSDFGLSKVIDIGETY---ASSEVRGTFGYLDPEYRSNCK------VNSSGDVYSFGIVLLQILSG----------K  508 (588)
Q Consensus       448 ~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~------~t~ksDVwS~Gvll~ElltG----------~  508 (588)
                      .+||+|||+++........   ......||+.|+|||++.+..      ++.++||||||+++|||++|          +
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            9999999999877544322   234557999999999987752      33689999999999999999          6


Q ss_pred             Ccccccccc-----chhh-hcCcccCccc-----CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          509 KAKVLTRAG-----SALE-LADPKLDREY-----SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       509 ~p~~~~~~~-----~~~~-~~d~~l~~~~-----~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .||......     ...+ .....+....     +.+..+.+.+|+..|++ +|.+|||+.||++.|+++.+.
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            676533211     1111 1122222222     34667788999999998 799999999999999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.9e-41  Score=343.52  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=209.1

Q ss_pred             HhcCccccc-eeeccCceEEEEEEe---cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          310 ATEKLNELN-LIGEGITGKVYKGKL---SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       310 at~~f~~~~-~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      ..++|...+ .||+|+||.||+|.+   .+++.||||++....    ..+.+.+|+++++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346777777 999999999999964   357899999987532    256799999999999999999999999 56778


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++++|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            9999999999999999653 45899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccc--ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHH
Q 042871          462 IGETYA--SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDL  538 (588)
Q Consensus       462 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~  538 (588)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+........+......
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE  248 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            443322  223456789999999988889999999999999999999 99999765554444443332222223333455


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      +..++..|+. +|.+|||+.++++.|++.......
T Consensus       249 l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            6777889998 799999999999999998865443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-41  Score=364.11  Aligned_cols=250  Identities=21%  Similarity=0.261  Sum_probs=204.5

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceec
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLR  377 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~  377 (588)
                      ++++....++|+..+.||+|+||.||+++.. +++.||+|++..     ....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455566789999999999999999999974 689999999863     2234468899999999999999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      .+..|+||||+++|+|.+++..  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence            9999999999999999999954  35889999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Cc----ccC
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCK----VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DP----KLD  528 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~----~l~  528 (588)
                      +..............||+.|+|||++.+..    ++.++||||||+++|||++|+.||...........+ ..    ..+
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence            877554444445678999999999988765    789999999999999999999999744333222221 11    111


Q ss_pred             --cccCHHHHHHHHHHHHHhhcC-CCC--CCCHHHHHHH
Q 042871          529 --REYSIEAFDLTLQLALSCTAL-THQ--RPPMEQVFVT  562 (588)
Q Consensus       529 --~~~~~e~~~~v~~L~~~C~~~-p~~--RPs~~evl~~  562 (588)
                        ..++.+..    .|+..|+.. |.+  ||+++||++.
T Consensus       296 ~~~~~s~~~~----~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          296 DDNDISKEAK----NLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             TTCCCCHHHH----HHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             CcccccHHHH----HHHHHHccChhhhCCCCCHHHHhcC
Confidence              23455444    445666664 577  9999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=346.89  Aligned_cols=253  Identities=20%  Similarity=0.214  Sum_probs=204.7

Q ss_pred             HHHhcCccccceeeccCceEEEEEE------ecCCcEEEEEEecCCCcHHHHHHHHHHhccCC---CCceeEEecceecc
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGK------LSNNQHVAIKHITNEGNVETFVREVASSSHVR---HPNLVALLGYCLRV  378 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~------~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~  378 (588)
                      +...++|...+.||+|+||.||+|+      ..+++.||||++... ...++.+|++++..++   |+||+++++++...
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            3446789999999999999999994      457899999999754 3567778888777776   99999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhc----CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---------
Q 042871          379 DECFLIYELCPNGNLAEWLFG----KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---------  445 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---------  445 (588)
                      +..++||||+++|+|.+++..    ....+++.+++.++.|+++||+|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            999999999999999999964    3456999999999999999999999998   999999999999998         


Q ss_pred             --CCcEEEEecCCcceecC-CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh
Q 042871          446 --NFEAKLSDFGLSKVIDI-GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL  522 (588)
Q Consensus       446 --~~~~kL~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~  522 (588)
                        ++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||.....+.  ..
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~  294 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--CK  294 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--EE
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--ee
Confidence              89999999999976542 22233455679999999999999999999999999999999999999986443322  11


Q ss_pred             cCcccCcccCHHHHHHHHHHHHHhhc-CC-CCCCCHHHHHHHHHHhhcc
Q 042871          523 ADPKLDREYSIEAFDLTLQLALSCTA-LT-HQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       523 ~d~~l~~~~~~e~~~~v~~L~~~C~~-~p-~~RPs~~evl~~L~~~~~~  569 (588)
                      +...+......   +.+..++..|++ +| +++|+++++.+.|++.+..
T Consensus       295 ~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          295 PEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             echhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            22222222223   334455667777 56 4558999999999988765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-40  Score=337.04  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=205.7

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceec-----------
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLR-----------  377 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----------  377 (588)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||++....  +.+.+|++++++++||||+++++++..           
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            4577999999999999999999975 79999999997543  467799999999999999999998854           


Q ss_pred             -----cCeeeEEeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEE
Q 042871          378 -----VDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL  451 (588)
Q Consensus       378 -----~~~~~LV~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL  451 (588)
                           ....++||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+   |+||||||+|||+++++.+||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEE
Confidence                 44589999999999999999653 346899999999999999999999998   999999999999999999999


Q ss_pred             EecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCccc
Q 042871          452 SDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY  531 (588)
Q Consensus       452 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~  531 (588)
                      +|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ......+..+...+
T Consensus       164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~  240 (284)
T 2a19_B          164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-FFTDLRDGIISDIF  240 (284)
T ss_dssp             CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-HHHHHHTTCCCTTS
T ss_pred             Ccchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-HHHHhhcccccccC
Confidence            9999998765432  22345689999999999999999999999999999999999988753211 11122233333344


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCcc
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTA  573 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~  573 (588)
                      +.+    +..++..|++ +|.+|||+.|+++.|+...+.....
T Consensus       241 ~~~----~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          241 DKK----EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             CHH----HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             CHH----HHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence            444    4566788887 7999999999999999887655443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=349.62  Aligned_cols=246  Identities=24%  Similarity=0.303  Sum_probs=186.7

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++......+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            4678999999999999999999975 688999999987666678889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEEecCCcceecCCCc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~DFGla~~~~~~~~  465 (588)
                      ++|+|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...... 
T Consensus       131 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-  205 (349)
T 2w4o_A          131 TGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-  205 (349)
T ss_dssp             CSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence            999999999643 45899999999999999999999998   999999999999975   8899999999998654322 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-h-hhhcCccc--CcccCHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-A-LELADPKL--DREYSIEAFDLTLQ  541 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~-~~~~d~~l--~~~~~~e~~~~v~~  541 (588)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ........  ......+....+..
T Consensus       206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  284 (349)
T 2w4o_A          206 -LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD  284 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             -ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence             2234578999999999999999999999999999999999999986433321 1 11111111  11111222344566


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      |+..|+. +|++|||+.|+++
T Consensus       285 li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          285 LVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            7888988 7999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-40  Score=347.95  Aligned_cols=242  Identities=24%  Similarity=0.292  Sum_probs=201.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++..     ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35789999999999999999996 6889999999863     22346789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+ +|+|.+++... ..+++.+++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....+.
T Consensus        88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 78999988643 45899999999999999999999998   9999999999999999999999999998654332


Q ss_pred             cccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc---cCcccCHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK---LDREYSIEAFDLTL  540 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~---l~~~~~~e~~~~v~  540 (588)
                        ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...........+...   ++...+.    .+.
T Consensus       163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~----~~~  236 (336)
T 3h4j_B          163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP----GAQ  236 (336)
T ss_dssp             --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCH----HHH
T ss_pred             --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCH----HHH
Confidence              2344579999999999988776 68999999999999999999999754433333322211   1222343    455


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L  563 (588)
                      .++..|+. +|.+|||++|+++.-
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             HHHHHHcCCChhHCcCHHHHHhCh
Confidence            66888888 799999999998753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=348.45  Aligned_cols=253  Identities=18%  Similarity=0.179  Sum_probs=195.9

Q ss_pred             hcCccccceeeccCceEEEEEEec----CCcEEEEEEecCCCc-------------HHHHHHHHHHhccCCCCceeEEec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNEGN-------------VETFVREVASSSHVRHPNLVALLG  373 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~-------------~~~~~~Ei~~l~~l~HpnIv~l~g  373 (588)
                      .++|...+.||+|+||.||+|+..    ++..||||++.....             ...+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999974    678999999865321             234677888999999999999999


Q ss_pred             ceec----cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC--
Q 042871          374 YCLR----VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF--  447 (588)
Q Consensus       374 ~~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~--  447 (588)
                      ++..    ....++||||+ +++|.+++.... .+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence            9987    67899999999 999999996443 7999999999999999999999998   99999999999999887  


Q ss_pred             cEEEEecCCcceecCCCcc------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc-chh
Q 042871          448 EAKLSDFGLSKVIDIGETY------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SAL  520 (588)
Q Consensus       448 ~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~  520 (588)
                      .+||+|||+++........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432211      124457999999999999999999999999999999999999999532111 111


Q ss_pred             hhcCcccCcccCH---------HHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          521 ELADPKLDREYSI---------EAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       521 ~~~d~~l~~~~~~---------e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ...........+.         .....+.+++..|+. +|.+|||+++|++.|++..-
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1111111111111         122356777889988 79999999999999997643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-40  Score=350.08  Aligned_cols=243  Identities=22%  Similarity=0.285  Sum_probs=200.9

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ..++|...+.||+|+||.||+++.. +|+.||+|++...    ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4678999999999999999999874 7899999999643    2346788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC---cEEEEecCCcceec
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF---EAKLSDFGLSKVID  461 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~---~~kL~DFGla~~~~  461 (588)
                      |||+++|+|.+++... ..+++.++..++.|+++||.|||+.+   |+||||||+|||++.++   .+||+|||+++...
T Consensus       107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            9999999999999643 46899999999999999999999998   99999999999998654   59999999998765


Q ss_pred             CCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc---c----CcccCHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK---L----DREYSIE  534 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~---l----~~~~~~e  534 (588)
                      ...  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+...   .    ....+. 
T Consensus       183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  259 (362)
T 2bdw_A          183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP-  259 (362)
T ss_dssp             TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH-
T ss_pred             CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH-
Confidence            332  233467999999999999999999999999999999999999998654433332222111   1    112333 


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                         .+..++..|+. +|.+|||+.|+++.
T Consensus       260 ---~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          260 ---EAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               35566778887 79999999998753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=334.70  Aligned_cols=243  Identities=26%  Similarity=0.413  Sum_probs=181.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...     ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46789999999999999999996 58999999998632     2356789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999776677999999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+   +.......+.    .+..
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  241 (278)
T 3cok_A          167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI----EAKD  241 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCH----HHHH
T ss_pred             C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCH----HHHH
Confidence            2 223456899999999999989999999999999999999999998754332222111   1112222333    4556


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ++..|++ +|.+|||++|+++
T Consensus       242 li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHcccCHhhCCCHHHHhc
Confidence            7888888 7999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-40  Score=336.06  Aligned_cols=245  Identities=24%  Similarity=0.301  Sum_probs=194.5

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++...    ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999974 7899999998632    234678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |++ |+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  156 (292)
T 3o0g_A           82 FCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R  156 (292)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred             cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence            996 4677776655667999999999999999999999998   9999999999999999999999999998764322 2


Q ss_pred             cccCccCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCcccccccc-chhhh----cCc---------------
Q 042871          467 ASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SALEL----ADP---------------  525 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~~~----~d~---------------  525 (588)
                      ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+...... .....    ...               
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            234457899999999987765 799999999999999999998885321110 00000    000               


Q ss_pred             ----c-----cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 ----K-----LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 ----~-----l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                          .     ............+..++..|++ +|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                0     0000111222345567788888 7999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-40  Score=343.09  Aligned_cols=259  Identities=19%  Similarity=0.200  Sum_probs=198.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+++.. +++.||||++....     ..+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999974 78999999986431     236788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      +||+++++|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            9999999999999643 45899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC--cccCHHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD--REYSIEAFDLTLQL  542 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~--~~~~~e~~~~v~~L  542 (588)
                      ........|++.|+|||++.+..++.++||||||+++|||++|+.||...........+.....  ..........+..+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  268 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV  268 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence            3333456789999999999999999999999999999999999999875443322222211111  11122223446667


Q ss_pred             HHHhhc-CCCCCC-CHHHHHHHHHHhhccCCcc
Q 042871          543 ALSCTA-LTHQRP-PMEQVFVTLQKALDISTTA  573 (588)
Q Consensus       543 ~~~C~~-~p~~RP-s~~evl~~L~~~~~~~~~~  573 (588)
                      +..|+. +|++|| +++++++.|++.+......
T Consensus       269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~  301 (309)
T 2h34_A          269 IARGMAKNPEDRYVTCGDLSAAAHAALATADQD  301 (309)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred             HHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence            888888 799999 9999999999987665433

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-40  Score=343.18  Aligned_cols=256  Identities=21%  Similarity=0.288  Sum_probs=194.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCe----
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDE----  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~----  380 (588)
                      .++|+..+.||+|+||.||+++. .+++.||||++....     ....+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999996 688999999997531     23578899999999999999999999886544    


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++||||+++|+|.+++... ..+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            49999999999999999643 45899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCc-ccC-cccCHHH
Q 042871          461 DIGET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADP-KLD-REYSIEA  535 (588)
Q Consensus       461 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~-~l~-~~~~~e~  535 (588)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .... ... .......
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            43322  22334568999999999999999999999999999999999999986443322211 1111 000 0001112


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHH-HHHHHHHhhccC
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQ-VFVTLQKALDIS  570 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~e-vl~~L~~~~~~~  570 (588)
                      ...+..++..|++ +|.+||+..+ +.+.|.+.....
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  283 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE  283 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence            2445667888888 7999996555 555666655443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-40  Score=351.16  Aligned_cols=247  Identities=21%  Similarity=0.245  Sum_probs=202.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|.+....  ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999874 78999999987543  345788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC--CCcEEEEecCCcceecCCCc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP--NFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~--~~~~kL~DFGla~~~~~~~~  465 (588)
                      +++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.......
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            9999999999766667999999999999999999999998   999999999999974  57799999999987654322


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L  542 (588)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   +..............+..+
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  284 (387)
T 1kob_A          207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  284 (387)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence              23346899999999999999999999999999999999999998754332222211   1111111111222345567


Q ss_pred             HHHhhc-CCCCCCCHHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +..|+. +|.+|||+.|+++.
T Consensus       285 i~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          285 IKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCChhHCcCHHHHhhC
Confidence            888888 79999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=345.19  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=206.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-----cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccC--ee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-----SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVD--EC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~  381 (588)
                      .++|...+.||+|+||.||++++     .+|+.||||++....  ..+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46788999999999999999984     468999999997543  3567999999999999999999999987654  78


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||+++++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999776667999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc----------------chhhhc
Q 042871          462 IGETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG----------------SALELA  523 (588)
Q Consensus       462 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~----------------~~~~~~  523 (588)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......                ...+.+
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            43322  123345778899999999888999999999999999999999887532110                011111


Q ss_pred             CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          524 DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       524 d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ........+......+.+++..|++ +|.+|||+.|+++.|+++.+
T Consensus       277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111111222233456777889998 79999999999999998864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=357.91  Aligned_cols=243  Identities=21%  Similarity=0.268  Sum_probs=200.7

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ..++|+..+.||+|+||.||+++. .+|+.||+|++....    ..+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            467899999999999999999986 579999999987532    345688999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC---CCCcEEEEecCCcceec
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG---PNFEAKLSDFGLSKVID  461 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld---~~~~~kL~DFGla~~~~  461 (588)
                      |||+++|+|.+++... ..+++.++..++.|+++||.|||+.+   |+||||||+|||++   +++.+||+|||+++...
T Consensus        89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            9999999999999654 45899999999999999999999998   99999999999998   46789999999998765


Q ss_pred             CCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc---cC----cccCHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK---LD----REYSIE  534 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~---l~----~~~~~e  534 (588)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+...   ..    ...+. 
T Consensus       165 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-  242 (444)
T 3soa_A          165 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP-  242 (444)
T ss_dssp             TTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH-
T ss_pred             CCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH-
Confidence            332 2234567999999999999999999999999999999999999998654443333322111   11    12333 


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         .+..++..|++ +|.+|||+.|+++
T Consensus       243 ---~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          243 ---EAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHHHHHHcCCChhHCCCHHHHhc
Confidence               35556777887 7999999999987

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-40  Score=339.66  Aligned_cols=239  Identities=26%  Similarity=0.304  Sum_probs=200.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++...     ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999974 7999999998642     3456788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            9999999999999643 45899999999999999999999998   999999999999999999999999999875432 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh-c--CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL-A--DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~-~--d~~l~~~~~~e~~~~v~~  541 (588)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........+. +  ...+...++.+    +..
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~----~~~  232 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED----VKD  232 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHH----HHH
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence               2346799999999999999999999999999999999999999864433222221 1  12223334444    445


Q ss_pred             HHHHhhc-CCCCCC-----CHHHHHH
Q 042871          542 LALSCTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RP-----s~~evl~  561 (588)
                      ++..|+. +|.+||     +++|+++
T Consensus       233 li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          233 LLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            5667776 799999     8888874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=350.92  Aligned_cols=242  Identities=21%  Similarity=0.293  Sum_probs=193.9

Q ss_pred             cccceeeccCceEEEEEEe-cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCCC
Q 042871          315 NELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      ...+.||+|+||.||+|+. .+|+.||+|++....  ..+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            3356899999999999986 579999999997643  4567999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE--CCCCcEEEEecCCcceecCCCccccc
Q 042871          392 NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL--GPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       392 sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl--d~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||+  ++++.+||+|||+++.......  ..
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~  246 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK  246 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence            999999766667999999999999999999999998   9999999999999  6778999999999987654332  23


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hcCcc--cCcccCHHHHHHHHHHHHHh
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPK--LDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~--l~~~~~~e~~~~v~~L~~~C  546 (588)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||.......... +....  +...........+..++..|
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  326 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL  326 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence            4569999999999999899999999999999999999999986443322221 11111  11110011223456678888


Q ss_pred             hc-CCCCCCCHHHHHH
Q 042871          547 TA-LTHQRPPMEQVFV  561 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~  561 (588)
                      ++ +|.+|||+.|+++
T Consensus       327 L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          327 LIKEKSWRISASEALK  342 (373)
T ss_dssp             SCSSGGGSCCHHHHHH
T ss_pred             cCCChhhCCCHHHHhc
Confidence            88 7999999999987

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-40  Score=344.19  Aligned_cols=253  Identities=25%  Similarity=0.248  Sum_probs=198.4

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-------CCcHHHHHHHHHHhccCCCCceeEEecceecc
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-------EGNVETFVREVASSSHVRHPNLVALLGYCLRV  378 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~  378 (588)
                      +....++|...+.||+|+||.||+|+. .+++.||+|++..       ....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            455688999999999999999999986 5788999999853       24457899999999999999999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcC---------------------------------------CcCccHHHHHHHHHhhhcc
Q 042871          379 DECFLIYELCPNGNLAEWLFGK---------------------------------------DKCLSWIQRLEIAIDSARG  419 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~---------------------------------------~~~l~~~~~~~i~~~ia~g  419 (588)
                      +..++||||+++|+|.+++...                                       ...+++..++.++.|+++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998410                                       1124677888999999999


Q ss_pred             chhhccccCCceEecCCCCCCeEECCCC--cEEEEecCCcceecCCC---cccccCccCCCCccCcccccC--CCCCchh
Q 042871          420 LWFLHSYSEGCIVHRDIKPTNILLGPNF--EAKLSDFGLSKVIDIGE---TYASSEVRGTFGYLDPEYRSN--CKVNSSG  492 (588)
Q Consensus       420 L~yLH~~~~~~IvHrDLKp~NILld~~~--~~kL~DFGla~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~--~~~t~ks  492 (588)
                      |+|||+.+   |+||||||+|||++.++  .+||+|||+++......   ........||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999998   99999999999998776  89999999998764322   222345679999999999865  6789999


Q ss_pred             hHHHHHHHHHHHHcCCCccccccccchhh-hcCcccC--cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          493 DVYSFGIVLLQILSGKKAKVLTRAGSALE-LADPKLD--REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       493 DVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~d~~l~--~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ||||||+++|||++|+.||.......... .......  ..........+..++..|++ +|.+|||+.|+++.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            99999999999999999986443332222 1111111  11111122345667788888 79999999999873

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.3e-40  Score=347.39  Aligned_cols=239  Identities=19%  Similarity=0.231  Sum_probs=201.5

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|+..+.||+|+||.||+++.. +|+.||||++..     ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367899999999999999999974 799999999863     23467889999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            9999999999999643 35899999999999999999999999   999999999999999999999999999876432 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+   ...+...++.+    +..
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~----~~~  267 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD----LKD  267 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHH----HHH
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH----HHH
Confidence               23457999999999999999999999999999999999999998754433332222   12222334444    455


Q ss_pred             HHHHhhc-CCCCCCC-----HHHHHH
Q 042871          542 LALSCTA-LTHQRPP-----MEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs-----~~evl~  561 (588)
                      ++..|++ +|.+||+     ++|+++
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHh
Confidence            6777887 7999998     888865

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.7e-41  Score=347.33  Aligned_cols=260  Identities=23%  Similarity=0.329  Sum_probs=206.9

Q ss_pred             hcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+|++      .+++.||||++...   .....+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            57899999999999999999984      35779999999643   2345789999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCC------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEE
Q 042871          382 FLIYELCPNGNLAEWLFGKD------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLS  452 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~  452 (588)
                      ++||||+++|+|.+++....      ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999996543      35899999999999999999999998   999999999999984   4569999


Q ss_pred             ecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcc
Q 042871          453 DFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDRE  530 (588)
Q Consensus       453 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~  530 (588)
                      |||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.........+.+.......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~  265 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  265 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            9999976543322 22234567899999999998899999999999999999998 888887554444333332221222


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCcc
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTTA  573 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~  573 (588)
                      .+......+.+++..|++ +|.+|||+.|+++.|+.....+...
T Consensus       266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~  309 (327)
T 2yfx_A          266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI  309 (327)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence            222233456677888998 7999999999999999887655433

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=348.68  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=195.7

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCC--CceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRH--PNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|++.+.||+|+||.||++...+++.||||++...    ...+.+.+|+.++.+++|  +||+++++++.+++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            5679999999999999999999989999999998643    234678999999999986  9999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      || +.+++|.+++... ..+++.++..++.|+++||.|||+.+   |+||||||+|||++ ++.+||+|||+++......
T Consensus        88 ~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             Ee-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            99 5689999999653 46899999999999999999999998   99999999999997 5789999999998765433


Q ss_pred             cc-cccCccCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCccccccc--cchhhhcCcccCcc
Q 042871          465 TY-ASSEVRGTFGYLDPEYRSN-----------CKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELADPKLDRE  530 (588)
Q Consensus       465 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~~~~d~~l~~~  530 (588)
                      .. ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||.....  ......+++.....
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            22 2345679999999999864           6789999999999999999999999864322  22333344333333


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ++......+..++..|++ +|.+|||+.|+++.
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            332223445677888988 79999999999865

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=349.40  Aligned_cols=243  Identities=21%  Similarity=0.282  Sum_probs=196.5

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccC-CCCceeEEecceeccCeee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~  382 (588)
                      ..++|+..+.||+|+||.||+++.. +|+.||||++..     ....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999964 689999999864     23456788999999988 6999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            999999999999999643 45899999999999999999999998   99999999999999999999999999985432


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLT  539 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v  539 (588)
                      . ........||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+   ...+....+.+    +
T Consensus       177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~----~  251 (353)
T 3txo_A          177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED----A  251 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH----H
T ss_pred             C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH----H
Confidence            2 22334567999999999999989999999999999999999999999755443333322   11222334444    4


Q ss_pred             HHHHHHhhc-CCCCCCCH------HHHHH
Q 042871          540 LQLALSCTA-LTHQRPPM------EQVFV  561 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~------~evl~  561 (588)
                      ..++..|+. +|.+||++      +|+++
T Consensus       252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          252 TGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            455677777 79999998      66664

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=341.45  Aligned_cols=256  Identities=27%  Similarity=0.294  Sum_probs=201.0

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEeccee----ccCeee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCL----RVDECF  382 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~----~~~~~~  382 (588)
                      ..++|...+.||+|+||.||+++. .+|+.||||++...  ...+.+.+|++++++++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            357899999999999999999996 68999999988543  34567899999999999999999999987    345789


Q ss_pred             EEeecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          383 LIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      +|+||+++|+|.+++..   ....+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999964   3457999999999999999999999998   99999999999999999999999999876


Q ss_pred             ecCCCcc--------cccCccCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCcccccc--ccchhhhcCcc
Q 042871          460 IDIGETY--------ASSEVRGTFGYLDPEYRSNCK---VNSSGDVYSFGIVLLQILSGKKAKVLTR--AGSALELADPK  526 (588)
Q Consensus       460 ~~~~~~~--------~~~~~~gt~~Y~aPE~~~~~~---~t~ksDVwS~Gvll~ElltG~~p~~~~~--~~~~~~~~d~~  526 (588)
                      .......        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||....  .......+...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  263 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ  263 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence            4321110        012345799999999987654   6889999999999999999999986421  11111111111


Q ss_pred             cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          527 LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       527 l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ............+.+++..|++ +|.+|||++|+++.|+.+..
T Consensus       264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            1111111223456667888888 79999999999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-40  Score=348.31  Aligned_cols=208  Identities=23%  Similarity=0.286  Sum_probs=182.6

Q ss_pred             CCCcccHHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-CcHHHHHHHHHHhccCC-----CCceeE
Q 042871          298 GCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-GNVETFVREVASSSHVR-----HPNLVA  370 (588)
Q Consensus       298 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~-----HpnIv~  370 (588)
                      ....+++++.....++|...+.||+|+||.||+|+. .+++.||||++... ...+.+..|+++++.++     ||||++
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            445666666677789999999999999999999997 57899999999753 33456788999988886     999999


Q ss_pred             EecceeccCeeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC----
Q 042871          371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP----  445 (588)
Q Consensus       371 l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~----  445 (588)
                      +++++...+..++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+.+   |+||||||+|||+++    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence            999999999999999999 999999996543 35899999999999999999999998   999999999999976    


Q ss_pred             ---------------------CCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHH
Q 042871          446 ---------------------NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQI  504 (588)
Q Consensus       446 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~El  504 (588)
                                           ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                 789999999999864322    2345789999999999999999999999999999999


Q ss_pred             HcCCCcccc
Q 042871          505 LSGKKAKVL  513 (588)
Q Consensus       505 ltG~~p~~~  513 (588)
                      ++|+.||..
T Consensus       253 l~g~~pf~~  261 (360)
T 3llt_A          253 YTGSLLFRT  261 (360)
T ss_dssp             HHSSCSCCC
T ss_pred             HHCCCCCCC
Confidence            999999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-40  Score=337.99  Aligned_cols=256  Identities=20%  Similarity=0.273  Sum_probs=195.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...     ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999996 57999999998642     2346789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          385 YELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      |||+++++|.+++..   ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999853   3456899999999999999999999998   9999999999999999999999999988654


Q ss_pred             CCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc--chhhhc-CcccCcccCHHHHHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG--SALELA-DPKLDREYSIEAFDL  538 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~--~~~~~~-d~~l~~~~~~e~~~~  538 (588)
                      .... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......  .....+ ...............
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            3222 223456899999999999999999999999999999999999998633211  111111 111111111122334


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      +.+++..|+. +|.+|||+++|++.|+++....
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            6667888988 7999999999999999987543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.9e-40  Score=337.09  Aligned_cols=243  Identities=27%  Similarity=0.383  Sum_probs=204.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .+.|...+.||+|+||.||+|+. .+++.||||++...   ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            45689999999999999999986 47899999998642   346789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |+++++|.+++.  ...+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++....... .
T Consensus       101 ~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  174 (303)
T 3a7i_A          101 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I  174 (303)
T ss_dssp             CCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred             eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence            999999999994  356899999999999999999999998   9999999999999999999999999998765332 2


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----CcccCcccCHHHHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----DPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----d~~l~~~~~~e~~~~v~~L  542 (588)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+    .+.+...++.    .+..+
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~l  250 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSK----PLKEF  250 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCH----HHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCH----HHHHH
Confidence            234457899999999999999999999999999999999999998754433322222    1222233443    45667


Q ss_pred             HHHhhc-CCCCCCCHHHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~L  563 (588)
                      +..|+. +|.+|||+.|+++..
T Consensus       251 i~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          251 VEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTCH
T ss_pred             HHHHcCCChhhCcCHHHHhhCh
Confidence            888887 799999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.5e-40  Score=343.32  Aligned_cols=242  Identities=22%  Similarity=0.243  Sum_probs=191.2

Q ss_pred             hcCccccceeeccCceEEEEEEe----cCCcEEEEEEecCC------CcHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL----SNNQHVAIKHITNE------GNVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      .++|+..+.||+|+||.||+++.    .+|+.||+|++...      .....+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999986    47899999998743      234567899999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999643 45889999999999999999999998   999999999999999999999999999764


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFD  537 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~  537 (588)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   ...+....+.    
T Consensus       172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~----  246 (327)
T 3a62_A          172 IHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ----  246 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCH----
T ss_pred             ccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH----
Confidence            3222 2234467999999999999999999999999999999999999999754333222211   1122233343    


Q ss_pred             HHHHHHHHhhc-CCCCCC-----CHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RP-----s~~evl~  561 (588)
                      .+..++..|+. +|.+||     +++|+++
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            45566778887 799999     7778765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=338.41  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=200.6

Q ss_pred             HHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ...++|+..+.||+|+||.||+|+.. +|+.||||.+......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            34678999999999999999999974 68999999998777778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++......+++.+++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ .
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~  181 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K  181 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence            9999999999755667999999999999999999999998   99999999999999999999999999987643322 2


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCc--ccCHHHHHHHHHHHHH
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDR--EYSIEAFDLTLQLALS  545 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~--~~~~e~~~~v~~L~~~  545 (588)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+......  ..+......+..++..
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  261 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ  261 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence            33457899999999999999999999999999999999999998643332221111110000  0111122345667888


Q ss_pred             hhc-CCCCCCCHHHHHH
Q 042871          546 CTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       546 C~~-~p~~RPs~~evl~  561 (588)
                      |+. +|.+|||+.|+++
T Consensus       262 ~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          262 CLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HTCSCTTTSCCHHHHTT
T ss_pred             HccCChhhCcCHHHHHh
Confidence            888 7999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.4e-40  Score=349.50  Aligned_cols=241  Identities=22%  Similarity=0.299  Sum_probs=199.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+++. .+++.||+|++..     ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            36799999999999999999986 4688999999863     34567889999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            999999999999964 346899999999999999999999999   9999999999999999999999999998764332


Q ss_pred             cccccCccCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc------CcccCcccCHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSN---CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA------DPKLDREYSIEA  535 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~------d~~l~~~~~~e~  535 (588)
                        ......||+.|+|||++..   ..++.++||||||+++|||++|+.||.........+.+      .......++.  
T Consensus       170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~--  245 (384)
T 4fr4_A          170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ--  245 (384)
T ss_dssp             --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH--
T ss_pred             --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH--
Confidence              3345679999999999864   45899999999999999999999999744333322221      1222233444  


Q ss_pred             HHHHHHHHHHhhc-CCCCCCC-HHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPP-MEQVFV  561 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs-~~evl~  561 (588)
                        .+..|+..|++ +|.+||+ ++++.+
T Consensus       246 --~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          246 --EMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              45556777887 7999999 666654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.5e-40  Score=359.13  Aligned_cols=242  Identities=23%  Similarity=0.266  Sum_probs=192.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|+..+.||+|+||.||+++. .+|+.||||++..     ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            57899999999999999999986 5789999999863     23446788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      |||+++|+|.+++... ..+++..+..++.|+++||+|||+ .+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999999543 468999999999999999999998 77   999999999999999999999999999754322


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~  540 (588)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+   ...+....+.    .+.
T Consensus       303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~----~~~  377 (446)
T 4ejn_A          303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAK  377 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH----HHH
T ss_pred             C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH----HHH
Confidence            2 2234568999999999999999999999999999999999999999654443333322   1222233444    355


Q ss_pred             HHHHHhhc-CCCCCC-----CHHHHHH
Q 042871          541 QLALSCTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RP-----s~~evl~  561 (588)
                      .|+..|++ +|.+||     +++|+++
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            56777887 799999     9999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-40  Score=375.24  Aligned_cols=246  Identities=25%  Similarity=0.381  Sum_probs=201.4

Q ss_pred             ceeeccCceEEEEEEe---cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKL---SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      +.||+|+||.||+|.+   .+++.||||+++..    ...+.|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965   35678999999753    235789999999999999999999999864 568999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc--cc
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--AS  468 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~--~~  468 (588)
                      |+|.+++.. ...+++.+++.|+.|+++||+|||+.+   |+||||||+||||++++.+||+|||+++........  ..
T Consensus       454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            999999954 346899999999999999999999998   999999999999999999999999999876543322  22


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........+.+........+......+..|+..|+
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  609 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  609 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            33456789999999999999999999999999999999 99999766655555555444333333344455677788999


Q ss_pred             c-CCCCCCCHHHHHHHHHHhhc
Q 042871          548 A-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      + +|++|||+++|++.|++...
T Consensus       610 ~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          610 TYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHHHHHHH
Confidence            8 79999999999999998753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.5e-40  Score=351.96  Aligned_cols=237  Identities=21%  Similarity=0.292  Sum_probs=193.4

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+++.. +++.||||++...     ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999974 6889999998642     2334678899998876 89999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            99999999999999643 45899999999999999999999998   999999999999999999999999999863222


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc---------hhhh---cCcccCccc
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS---------ALEL---ADPKLDREY  531 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~---------~~~~---~d~~l~~~~  531 (588)
                       ........||+.|+|||++.+..++.++||||||+++|||++|+.||.......         ..+.   ....++..+
T Consensus       207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  285 (396)
T 4dc2_A          207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  285 (396)
T ss_dssp             -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred             -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence             223445689999999999999999999999999999999999999995321110         1111   122233334


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCH
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPM  556 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~  556 (588)
                      +.+    +..|+..|++ +|.+||++
T Consensus       286 s~~----~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          286 SVK----AASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CHH----HHHHHHHHTCSCTTTSTTC
T ss_pred             CHH----HHHHHHHHhcCCHhHcCCC
Confidence            444    4455677777 79999995

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-39  Score=337.83  Aligned_cols=245  Identities=24%  Similarity=0.307  Sum_probs=202.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC--------cHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG--------NVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+++.. +|+.||||.+....        ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            567999999999999999999974 78999999986421        357899999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC----cEEEEecCCc
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF----EAKLSDFGLS  457 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~----~~kL~DFGla  457 (588)
                      ++||||+++++|.+++.. ...+++..++.++.|+++||.|||+.+   |+||||||+||++++++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999964 346899999999999999999999998   99999999999999888    7999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc---ccCcccCHH
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP---KLDREYSIE  534 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~---~l~~~~~~e  534 (588)
                      +......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..   .........
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence            8765432  22345789999999999999999999999999999999999999864433322222111   111110011


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ....+..++..|+. +|.+|||+.|+++
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            22346677888988 7999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-39  Score=337.99  Aligned_cols=243  Identities=24%  Similarity=0.355  Sum_probs=183.4

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++...   ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46788999999999999999986 47899999998642   334688999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCC-----cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          387 LCPNGNLAEWLFGKD-----KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      |++ |+|.+++....     ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 69999985422     35899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-----------------
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-----------------  523 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-----------------  523 (588)
                      .... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+                 
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence            3222 2234578999999999876 46899999999999999999999998643322111100                 


Q ss_pred             --------------------CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 --------------------DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 --------------------d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                          .+......+    ..+..++..|++ +|.+|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLD----GNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCC----HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccchhHHHhhcccccccCC----HHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                                000111222    345667788888 79999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-39  Score=347.26  Aligned_cols=200  Identities=19%  Similarity=0.226  Sum_probs=174.9

Q ss_pred             hcCccccceeecc--CceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEG--ITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|++.+.||+|  +||.||+++.. +|+.||||++...    ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            5679999999999  99999999975 7999999999643    224567889999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          384 IYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      ||||+++|+|.+++... ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999654 246899999999999999999999998   99999999999999999999999999865432


Q ss_pred             CCc------ccccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          463 GET------YASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       463 ~~~------~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      ...      .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||..
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            111      11223478999999999887  6799999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-40  Score=346.42  Aligned_cols=244  Identities=26%  Similarity=0.336  Sum_probs=200.8

Q ss_pred             HHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccC-CCCceeEEecceeccCe
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHV-RHPNLVALLGYCLRVDE  380 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~  380 (588)
                      ....++|...+.||+|+||.||+|+.. +|+.||||++..     ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999974 789999999864     33456788899998876 89999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99999999999999999643 45899999999999999999999998   999999999999999999999999999864


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFD  537 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~  537 (588)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+   .+.+....+.+   
T Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~---  244 (345)
T 1xjd_A          169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE---  244 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH---
T ss_pred             ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHH---
Confidence            3322 2234568999999999999999999999999999999999999999754433332222   22233334444   


Q ss_pred             HHHHHHHHhhc-CCCCCCCHH-HHH
Q 042871          538 LTLQLALSCTA-LTHQRPPME-QVF  560 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~-evl  560 (588)
                       +..++..|+. +|.+||++. |++
T Consensus       245 -~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          245 -AKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -HHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -HHHHHHHHhcCCHhHcCCChHHHH
Confidence             4455677777 799999997 654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.3e-40  Score=352.32  Aligned_cols=246  Identities=23%  Similarity=0.348  Sum_probs=196.1

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCC--CCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVR--HPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||++...+++.||||++...    ...+.+.+|+.++++++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999999888999999998643    23467899999999997  59999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      || +.+++|.+++... ..+++.++..++.|+++||.|||+.+   |+||||||+|||++ ++.+||+|||+++......
T Consensus       135 ~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             Ee-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99 5689999999654 36889999999999999999999998   99999999999995 5799999999998765433


Q ss_pred             cc-cccCccCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCccccccc--cchhhhcCcccCcc
Q 042871          465 TY-ASSEVRGTFGYLDPEYRSN-----------CKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELADPKLDRE  530 (588)
Q Consensus       465 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~~~~d~~l~~~  530 (588)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....  ......+++.....
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence            22 2345679999999999865           4689999999999999999999999964322  22333444433322


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ++......+..++..|+. +|.+|||+.|+++.
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            222223345667888988 79999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=335.59  Aligned_cols=247  Identities=26%  Similarity=0.323  Sum_probs=192.7

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCc----HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGN----VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~----~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .++|...+.||+|+||.||+|+.. +|+.||||++.....    .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            367899999999999999999974 689999999865332    456789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++++|.+++.. ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            99999999998754 345899999999999999999999998   99999999999999999999999999987643222


Q ss_pred             ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc------------------
Q 042871          466 YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK------------------  526 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~------------------  526 (588)
                       ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...                  
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             2234578999999999876 67899999999999999999999998643322211111000                  


Q ss_pred             ----cCc--c-cC-----HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          527 ----LDR--E-YS-----IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       527 ----l~~--~-~~-----~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                          +..  . .+     ......+..++..|++ +|.+|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                000  0 00     0112335667888988 79999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-40  Score=337.05  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             hcCccccceeeccCceEEEEEEec--CCc--EEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS--NNQ--HVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~--~g~--~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|+..+.||+|+||.||+|++.  +++  .||||++...     ...+.+.+|++++++++||||+++++++.+.+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467999999999999999999853  333  6899988642     34568899999999999999999999998765 8


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++|+||+++++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence            9999999999999999766667999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhc-CcccCcccCHHHHH
Q 042871          462 IGETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELA-DPKLDREYSIEAFD  537 (588)
Q Consensus       462 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~-d~~l~~~~~~e~~~  537 (588)
                      .....  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ........+.....
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence            43321  2234467889999999988889999999999999999999 99998754443332222 11111111222334


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      .+.+++..|+. +|.+|||+.++++.|+++....
T Consensus       253 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            56667888888 7999999999999999886543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-39  Score=329.63  Aligned_cols=243  Identities=23%  Similarity=0.299  Sum_probs=201.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|...+.||+|+||.||+|+.. ++..||+|++..  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            567999999999999999999974 578999999864  34567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE---CCCCcEEEEecCCcceecCCC
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl---d~~~~~kL~DFGla~~~~~~~  464 (588)
                      +++++|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+||++   +.++.+||+|||++.......
T Consensus        88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9999999998643 45899999999999999999999998   9999999999999   788999999999998765433


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCH----HHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSI----EAFDLTL  540 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~----e~~~~v~  540 (588)
                        ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........+..... ..+.    .....+.
T Consensus       164 --~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          164 --MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF-TFPEKDWLNVSPQAE  239 (277)
T ss_dssp             --CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCHHHHTTSCHHHH
T ss_pred             --chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCchhhhcCCHHHH
Confidence              2334578999999998876 499999999999999999999999875444333322211110 1111    1224566


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .++..|++ +|.+|||+.|+++
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            67888888 7999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.9e-41  Score=338.75  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=200.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEeccee--ccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCL--RVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++...    ...+.+.+|+.++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999974 7899999998642    23567899999999999999999999875  4678999


Q ss_pred             EeecCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhcccc--CCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          384 IYELCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYS--EGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ||||+++++|.+++...   ...+++.+++.++.|+++||+|||+.+  ..+|+||||||+||++++++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999643   235899999999999999999999876  2349999999999999999999999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHH
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDL  538 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~  538 (588)
                      ....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........+.+........+......
T Consensus       165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  243 (279)
T ss_dssp             HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHH
Confidence            7543322 122346899999999999989999999999999999999999998755443333322111111122222344


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFVTLQ  564 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~~L~  564 (588)
                      +.+++..|++ +|.+|||+.|+++.+.
T Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            6667888888 7999999999998654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=348.62  Aligned_cols=254  Identities=23%  Similarity=0.288  Sum_probs=209.1

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccC--eeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVD--ECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...   ...+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467889999999999999999975 5899999999752   34678889999999999999999999988655  67999


Q ss_pred             eecCCCCChhhhhhcCCc--CccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE----CCCCcEEEEecCCcc
Q 042871          385 YELCPNGNLAEWLFGKDK--CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSDFGLSK  458 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl----d~~~~~kL~DFGla~  458 (588)
                      |||+++|+|.+++.....  .+++.+++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965432  3899999999999999999999998   9999999999999    788889999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccC--------CCCCchhhHHHHHHHHHHHHcCCCccccccccc-----hhhhcC-
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSN--------CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-----ALELAD-  524 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-----~~~~~d-  524 (588)
                      ......  ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||.......     ....+. 
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            764332  2334579999999998765        467789999999999999999999986322111     000000 


Q ss_pred             ----------------------cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          525 ----------------------PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       525 ----------------------~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                                            .......+......+..++..|+. +|++|||++|+++.++++++.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence                                  001123456777888889999998 799999999999999998875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.6e-40  Score=346.67  Aligned_cols=240  Identities=29%  Similarity=0.445  Sum_probs=197.9

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .+.|...+.||+|+||.||+|+. .+|+.||||++....     ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            45688899999999999999996 589999999986421     235788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||++ |+|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++....  
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            99996 7898888666667999999999999999999999998   99999999999999999999999999976532  


Q ss_pred             cccccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCccccccccch-hhhc---Cccc-CcccCHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA-LELA---DPKL-DREYSIEAF  536 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~~~~---d~~l-~~~~~~e~~  536 (588)
                         .....||+.|+|||++.   ...++.++||||||+++|||++|+.||........ ....   .+.. ...++    
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  279 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS----  279 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSC----
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC----
Confidence               23457899999999874   56789999999999999999999999864332211 1111   1111 12233    


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFVTL  563 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~~L  563 (588)
                      +.+..++..|++ +|.+|||++|+++..
T Consensus       280 ~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          280 EYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            345667888998 799999999998643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.5e-40  Score=331.72  Aligned_cols=242  Identities=27%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      +.++|...+.||+|+||.||+|+.. +++.||||++...     ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3578999999999999999999864 6789999998532     235678999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999999643 45899999999999999999999998   999999999999999999999999988654322


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~  540 (588)
                         ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+   ...+....+    ..+.
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  235 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT----EGAR  235 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSC----HHHH
T ss_pred             ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCC----HHHH
Confidence               223457899999999999999999999999999999999999998754433322221   222223333    3455


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .++..|++ +|.+|||++|+++.
T Consensus       236 ~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          236 DLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHhccChhhCCCHHHHhhC
Confidence            66788887 79999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-39  Score=330.97  Aligned_cols=246  Identities=22%  Similarity=0.278  Sum_probs=201.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|++...    ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999986 46899999998643    23467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc---EEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~---~kL~DFGla~~~~~  462 (588)
                      ||+++++|.+++... ..+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999988643 45899999999999999999999998   999999999999986655   99999999977643


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc---CcccCHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL---DREYSIEAFDLT  539 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l---~~~~~~e~~~~v  539 (588)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+....   ...........+
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          161 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             SC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             Cc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            32  2234678999999999999999999999999999999999999986544333332221111   110001122345


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..++..|++ +|++|||+.|+++.
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHcccChhhCCCHHHHhcC
Confidence            667788888 79999999999884

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=340.85  Aligned_cols=257  Identities=23%  Similarity=0.283  Sum_probs=187.3

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCC-CCceeEEeccee--------
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVR-HPNLVALLGYCL--------  376 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~--------  376 (588)
                      ....+|...+.||+|+||.||+++. .+|+.||||++...  ...+.+.+|+.++.++. ||||+++++++.        
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            3456899999999999999999996 47899999988543  23567899999999996 999999999984        


Q ss_pred             ccCeeeEEeecCCCCChhhhhhc--CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          377 RVDECFLIYELCPNGNLAEWLFG--KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                      .....++|+||++ |+|.+++..  ....+++.+++.++.|++.||.|||+.+ ++|+||||||+|||+++++.+||+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence            3445899999995 899999854  3456999999999999999999999875 34999999999999999999999999


Q ss_pred             CCcceecCCCccc-----------ccCccCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh
Q 042871          455 GLSKVIDIGETYA-----------SSEVRGTFGYLDPEYR---SNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL  520 (588)
Q Consensus       455 Gla~~~~~~~~~~-----------~~~~~gt~~Y~aPE~~---~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~  520 (588)
                      |+++.........           .....||+.|+|||++   .+..++.++||||||+++|||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765432211           1134589999999998   56778999999999999999999999986433222  


Q ss_pred             hhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          521 ELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       521 ~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                       .................+..++..|++ +|.+|||+.|+++.|+.+....
T Consensus       261 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          261 -IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence             222111111111122335667888988 7999999999999999987643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.4e-40  Score=342.77  Aligned_cols=238  Identities=22%  Similarity=0.296  Sum_probs=199.1

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----------cHHHHHHHHHHhccCCCCceeEEecceecc
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----------NVETFVREVASSSHVRHPNLVALLGYCLRV  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~  378 (588)
                      ..++|...+.||+|+||.||+|+. .+|+.||||++....          ..+.+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            357899999999999999999985 578999999987532          234678899999999999999999999999


Q ss_pred             CeeeEEeecCCCC-ChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          379 DECFLIYELCPNG-NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       379 ~~~~LV~E~~~~g-sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      +..++||||+.+| +|.+++... ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 999998543 45999999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc--CcccCHH
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL--DREYSIE  534 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l--~~~~~~e  534 (588)
                      +.......  .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....     ......  ...++.+
T Consensus       178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~  250 (335)
T 3dls_A          178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TVEAAIHPPYLVSKE  250 (335)
T ss_dssp             EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----GTTTCCCCSSCCCHH
T ss_pred             eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----HHhhccCCCcccCHH
Confidence            87654332  234578999999999988777 7899999999999999999999864322     111111  1223443


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                          +..++..|++ +|.+|||++|+++.
T Consensus       251 ----l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          251 ----LMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----HHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----HHHHHHHHccCChhhCcCHHHHhcC
Confidence                5566778888 79999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-39  Score=327.74  Aligned_cols=247  Identities=24%  Similarity=0.306  Sum_probs=199.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||.||+|+.. +++.||||++...   ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999974 7899999998642   335788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-  465 (588)
                      |+++++|.+++.. ...+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++........ 
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999999999953 346899999999999999999999998   99999999999999999999999999986543322 


Q ss_pred             ccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccc--hhhhcCcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGS--ALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~--~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......  ....................+..+
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence            22345678999999999987765 779999999999999999999986543321  111111111100001122345567


Q ss_pred             HHHhhc-CCCCCCCHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..|++ +|.+|||++|+++
T Consensus       242 i~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHCCCCchhCCCHHHHhc
Confidence            888887 7999999999876

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.6e-40  Score=345.83  Aligned_cols=242  Identities=23%  Similarity=0.251  Sum_probs=190.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .++|...+.||+|+||.||+++.. +++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            568999999999999999999975 7899999999753 33567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc--EEEEecCCcceecCCCcc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE--AKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~--~kL~DFGla~~~~~~~~~  466 (588)
                      ++|+|.+++... ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.  +||+|||+++......  
T Consensus        99 ~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--  172 (361)
T 3uc3_A           99 SGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  172 (361)
T ss_dssp             CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence            999999999543 35899999999999999999999998   999999999999987765  9999999997543222  


Q ss_pred             cccCccCCCCccCcccccCCCCCch-hhHHHHHHHHHHHHcCCCccccccccch-hh----hcCccc--Cc--ccCHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSS-GDVYSFGIVLLQILSGKKAKVLTRAGSA-LE----LADPKL--DR--EYSIEAF  536 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~k-sDVwS~Gvll~ElltG~~p~~~~~~~~~-~~----~~d~~l--~~--~~~~e~~  536 (588)
                      ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||........ ..    ......  ..  ..+.   
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---  249 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP---  249 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH---
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH---
Confidence            2234579999999999988888766 8999999999999999999975433211 11    111111  11  2333   


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                       .+..|+..|++ +|.+|||+.|+++.
T Consensus       250 -~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          250 -ECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -HHHHHHHHHccCChhHCcCHHHHHhC
Confidence             44566788888 79999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-39  Score=342.96  Aligned_cols=237  Identities=21%  Similarity=0.289  Sum_probs=193.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++...     ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367899999999999999999974 6899999998642     2345678899999887 89999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999643 45899999999999999999999998   999999999999999999999999999864322


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc---------chhhhc---CcccCccc
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG---------SALELA---DPKLDREY  531 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---------~~~~~~---d~~l~~~~  531 (588)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||......         .....+   ...++...
T Consensus       164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  242 (345)
T 3a8x_A          164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  242 (345)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred             C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence            2 2334568999999999999999999999999999999999999999642111         111111   12222334


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCH
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPM  556 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~  556 (588)
                      +.+    +..++..|++ +|.+||++
T Consensus       243 s~~----~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 SVK----AASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CHH----HHHHHHHHTCSSTTTSTTC
T ss_pred             CHH----HHHHHHHHhcCCHhHCCCC
Confidence            444    4556677777 79999995

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.6e-39  Score=341.07  Aligned_cols=243  Identities=21%  Similarity=0.281  Sum_probs=200.0

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccC-CCCceeEEecceeccCeee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~  382 (588)
                      ..++|+..+.||+|+||.||+++.. +|+.||||++..     ....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999975 588999999864     24567788999999888 7999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999999643 35899999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLT  539 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v  539 (588)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+   ...++..++.+    +
T Consensus       174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~----~  248 (353)
T 2i0e_A          174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE----A  248 (353)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH----H
T ss_pred             CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH----H
Confidence            22 2334567999999999999999999999999999999999999999754433332222   12223334444    4


Q ss_pred             HHHHHHhhc-CCCCCCC-----HHHHHH
Q 042871          540 LQLALSCTA-LTHQRPP-----MEQVFV  561 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs-----~~evl~  561 (588)
                      ..++..|+. +|.+||+     ++|+++
T Consensus       249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          249 VAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            455677777 7999995     466654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=348.74  Aligned_cols=250  Identities=17%  Similarity=0.198  Sum_probs=200.9

Q ss_pred             hcCccccceeeccCceEEEEEEec---------CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeE-----------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS---------NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVA-----------  370 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~---------~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~-----------  370 (588)
                      .++|...+.||+|+||.||+|+..         +++.||||++...   +.+.+|++++++++||||++           
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            468999999999999999999975         3889999998754   46789999999999999988           


Q ss_pred             ----Eecceec-cCeeeEEeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC
Q 042871          371 ----LLGYCLR-VDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG  444 (588)
Q Consensus       371 ----l~g~~~~-~~~~~LV~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld  444 (588)
                          +++++.. ++..++||||+ +++|.+++... ...+++.+++.++.|+++||.|||+.+   |+||||||+|||++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~  193 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVD  193 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEc
Confidence                4556655 67889999999 99999999754 357999999999999999999999998   99999999999999


Q ss_pred             CCC--cEEEEecCCcceecCCCcc------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc
Q 042871          445 PNF--EAKLSDFGLSKVIDIGETY------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA  516 (588)
Q Consensus       445 ~~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  516 (588)
                      .++  .+||+|||+++........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  8999999999876432211      12345799999999999999999999999999999999999999975431


Q ss_pred             --cchhhhcC------cccC------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCC
Q 042871          517 --GSALELAD------PKLD------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIST  571 (588)
Q Consensus       517 --~~~~~~~d------~~l~------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~  571 (588)
                        ........      +.+.      ..++    ..+.+++..|+. +|.+|||++++++.|++++....
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             CHHHHHHHHHHHHHSCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHhccCChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence              11111110      0000      1123    445666788887 79999999999999999986543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-39  Score=330.89  Aligned_cols=241  Identities=26%  Similarity=0.371  Sum_probs=194.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|...+.||+|+||.||+++. .+++.||+|++...   ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            46799999999999999999986 47899999998643   346789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE---CCCCcEEEEecCCccee
Q 042871          387 LCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       387 ~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl---d~~~~~kL~DFGla~~~  460 (588)
                      |+++|+|.+++...   ...+++..++.++.|+++||+|||+.+   |+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998542   356999999999999999999999998   9999999999999   45688999999999865


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccC---cccCHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLD---REYSIE  534 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~---~~~~~e  534 (588)
                      ....  ......||+.|+|||++. ..++.++||||||+++|||++|+.||............   .+...   ...+. 
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  253 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP-  253 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH-
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH-
Confidence            4322  234457899999999876 47899999999999999999999998654333222211   11111   11233 


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         .+..++..|++ +|.+|||+.|+++
T Consensus       254 ---~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          254 ---QAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---HHHHHHHHHccCChhhCcCHHHHhc
Confidence               34566788888 7999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-40  Score=335.92  Aligned_cols=246  Identities=28%  Similarity=0.344  Sum_probs=192.5

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-------CcHHHHHHHHHHhccCC---CCceeEEecceecc
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-------GNVETFVREVASSSHVR---HPNLVALLGYCLRV  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-------~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~  378 (588)
                      ..++|+..+.||+|+||.||+|+. .+|+.||||++...       .....+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467999999999999999999996 57899999998621       12356777887777664   99999999999875


Q ss_pred             C-----eeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEE
Q 042871          379 D-----ECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLS  452 (588)
Q Consensus       379 ~-----~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~  452 (588)
                      .     ..++||||++ |+|.+++.... ..+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence            4     4799999996 69999996544 34999999999999999999999999   9999999999999999999999


Q ss_pred             ecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC--------
Q 042871          453 DFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--------  524 (588)
Q Consensus       453 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d--------  524 (588)
                      |||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.        
T Consensus       163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            999998654322  2344678999999999999999999999999999999999999986433222111110        


Q ss_pred             cc-----------cC-------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 PK-----------LD-------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ~~-----------l~-------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..           +.       .....+..+.+.+++..|++ +|++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00           00       00001122445667788888 7999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.7e-40  Score=330.33  Aligned_cols=240  Identities=21%  Similarity=0.272  Sum_probs=194.3

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++...    .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3578999999999999999999975 7999999998742    2356788999999998 89999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCC---cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---------------
Q 042871          384 IYELCPNGNLAEWLFGKD---KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---------------  445 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---------------  445 (588)
                      ||||+++|+|.+++....   ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999996432   45899999999999999999999998   999999999999984               


Q ss_pred             ----CCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCcccccccc-ch
Q 042871          446 ----NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SA  519 (588)
Q Consensus       446 ----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~  519 (588)
                          +..+||+|||++......     ....||+.|+|||.+.+. .++.++||||||+++|||++|+.++...... ..
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~  240 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI  240 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred             ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence                447999999999875432     223589999999998765 5668999999999999999998765322110 11


Q ss_pred             hhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          520 LELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       520 ~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .....+.+...++.    .+..++..|++ +|.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          241 RQGRLPRIPQVLSQ----EFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HTTCCCCCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCCCCCCcccCH----HHHHHHHHHhCCCcccCCCHHHHhh
Confidence            11112223333444    45566788888 7999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.3e-40  Score=372.49  Aligned_cols=260  Identities=26%  Similarity=0.363  Sum_probs=207.8

Q ss_pred             HHHHHhcCccccceeeccCceEEEEEEec----CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceecc
Q 042871          306 EVHYATEKLNELNLIGEGITGKVYKGKLS----NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRV  378 (588)
Q Consensus       306 el~~at~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~  378 (588)
                      +.+...++|...+.||+|+||.||+|++.    .+..||||++....   ..+.|.+|+.++++++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            33444677888999999999999999863    35679999987532   2467899999999999999999999985 4


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      +..++||||+++|+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence            5689999999999999999766667999999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHH
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFD  537 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~  537 (588)
                      ..............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+........+.....
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  619 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  619 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence            765444434444567889999999998899999999999999999997 8889875544443333322211122223334


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .+..++..|+. +|.+|||+.|+++.|+++++.
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            56677888988 799999999999999998753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-39  Score=329.02  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=201.8

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC--------CcHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE--------GNVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+++.. +|+.||+|.+...        ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999975 7899999998632        1367899999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC----cEEEEecCCc
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF----EAKLSDFGLS  457 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~----~~kL~DFGla  457 (588)
                      ++||||+++++|.+++.. ...+++.+++.++.|+++||.|||+.+   |+||||||+||++++++    .+||+|||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999954 346899999999999999999999998   99999999999998877    8999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHH
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIE  534 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e  534 (588)
                      ........  .....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+.   ..........
T Consensus       160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T 3bhy_A          160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN  237 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence            87643322  234568999999999999999999999999999999999999986543332222111   1111111111


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH--HHHHhh
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV--TLQKAL  567 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~--~L~~~~  567 (588)
                      ....+..++..|+. +|.+|||+.|+++  .++...
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            22446677889998 7999999999997  344443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-39  Score=354.26  Aligned_cols=241  Identities=23%  Similarity=0.332  Sum_probs=201.5

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...     ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            357888999999999999999974 7999999998632     3356789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++.. ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....+.
T Consensus        95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999999964 346999999999999999999999998   9999999999999999999999999998765433


Q ss_pred             cccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Ccc--cCcccCHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DPK--LDREYSIEAFDLTL  540 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~~--l~~~~~~e~~~~v~  540 (588)
                        ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...........+ +..  .....+.    .+.
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~----~~~  244 (476)
T 2y94_A          171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNP----SVI  244 (476)
T ss_dssp             --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCH----HHH
T ss_pred             --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCH----HHH
Confidence              2334579999999999988765 68999999999999999999998754433322222 111  1122343    345


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .|+..|++ +|.+|||++|+++
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCchhCcCHHHHHh
Confidence            56778887 7999999999997

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.5e-40  Score=340.73  Aligned_cols=238  Identities=24%  Similarity=0.276  Sum_probs=174.3

Q ss_pred             ceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEeecCCCCChhh
Q 042871          318 NLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIYELCPNGNLAE  395 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~  395 (588)
                      +.||+|+||.||+++.. +|+.||||++... ....+.+|+.+++.++ ||||+++++++.+++..++||||+++|+|.+
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            68999999999999974 7899999999754 3467889999999997 9999999999999999999999999999999


Q ss_pred             hhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC---cEEEEecCCcceecCCCcccccCcc
Q 042871          396 WLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF---EAKLSDFGLSKVIDIGETYASSEVR  472 (588)
Q Consensus       396 ~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~---~~kL~DFGla~~~~~~~~~~~~~~~  472 (588)
                      ++... ..+++.++..++.|+++||+|||+.+   |+||||||+|||++.++   .+||+|||+++....... ......
T Consensus        96 ~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~  170 (325)
T 3kn6_A           96 RIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPC  170 (325)
T ss_dssp             HHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccccC
Confidence            99654 46999999999999999999999998   99999999999997665   899999999986543322 233456


Q ss_pred             CCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc-------chhhhc-Cccc--CcccCHHHHHHHHHH
Q 042871          473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-------SALELA-DPKL--DREYSIEAFDLTLQL  542 (588)
Q Consensus       473 gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-------~~~~~~-d~~l--~~~~~~e~~~~v~~L  542 (588)
                      ||+.|+|||++.+..++.++||||||+++|||++|+.||......       .....+ ....  ...........+..|
T Consensus       171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  250 (325)
T 3kn6_A          171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL  250 (325)
T ss_dssp             -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred             CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence            899999999999999999999999999999999999998643321       111111 1111  110001122445667


Q ss_pred             HHHhhc-CCCCCCCHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..|+. +|.+|||++|+++
T Consensus       251 i~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          251 IQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHCCCChhHCCCHHHHhc
Confidence            788887 7999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.1e-40  Score=347.41  Aligned_cols=242  Identities=25%  Similarity=0.302  Sum_probs=190.4

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHH-hccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVAS-SSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+++.. +++.||||++...     .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999974 6889999998642     234456777776 577899999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999643 45888899999999999999999998   999999999999999999999999999864322


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--cccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--PKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--~~l~~~~~~e~~~~v~  540 (588)
                       ........||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+ .  ..+...++.+    +.
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~----~~  267 (373)
T 2r5t_A          193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNS----AR  267 (373)
T ss_dssp             -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHH----HH
T ss_pred             -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH----HH
Confidence             22344568999999999999999999999999999999999999999654433332221 1  1222334444    45


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .++..|++ +|.+||++.+.++
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHH
T ss_pred             HHHHHHcccCHHhCCCCCCCHH
Confidence            55677777 7999999864433

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-40  Score=347.84  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             hcCccccceeeccCceEEEEEEe----cCCcEEEEEEecCC------CcHHHHHHHHHHhccC-CCCceeEEecceeccC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL----SNNQHVAIKHITNE------GNVETFVREVASSSHV-RHPNLVALLGYCLRVD  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~  379 (588)
                      .++|...+.||+|+||.||+++.    .+|+.||||++...      ...+.+.+|++++.++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999987    47899999998632      2345678899999999 6999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..++||||+++|+|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            999999999999999999643 35899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hh------cCcccCcc
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-EL------ADPKLDRE  530 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~------~d~~l~~~  530 (588)
                      .............||+.|+|||++.+  ..++.++||||||+++|||++|+.||......... .+      ..+.+...
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  288 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence            65444444445679999999999885  35789999999999999999999998643322111 11      11222223


Q ss_pred             cCHHHHHHHHHHHHHhhc-CCCCCC-----CHHHHHHHH
Q 042871          531 YSIEAFDLTLQLALSCTA-LTHQRP-----PMEQVFVTL  563 (588)
Q Consensus       531 ~~~e~~~~v~~L~~~C~~-~p~~RP-----s~~evl~~L  563 (588)
                      +    ...+..|+..|+. +|.+||     +++|+++..
T Consensus       289 ~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          289 M----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             c----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            3    3445667888888 799999     999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-40  Score=351.71  Aligned_cols=237  Identities=16%  Similarity=0.119  Sum_probs=186.9

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHH---HHhccCCCCceeEEe-------cc
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREV---ASSSHVRHPNLVALL-------GY  374 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei---~~l~~l~HpnIv~l~-------g~  374 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++..     ....+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            56788899999999999999996 5799999999852     23457889999   566667899999998       44


Q ss_pred             eeccC-----------------eeeEEeecCCCCChhhhhhcCC------cCccHHHHHHHHHhhhccchhhccccCCce
Q 042871          375 CLRVD-----------------ECFLIYELCPNGNLAEWLFGKD------KCLSWIQRLEIAIDSARGLWFLHSYSEGCI  431 (588)
Q Consensus       375 ~~~~~-----------------~~~LV~E~~~~gsL~~~L~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~I  431 (588)
                      +.+.+                 ..++||||+ +|+|.+++....      ..+++..++.|+.|+++||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            44332                 278999999 689999996422      23557889999999999999999998   9


Q ss_pred             EecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCC-----------CCCchhhHHHHHHH
Q 042871          432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC-----------KVNSSGDVYSFGIV  500 (588)
Q Consensus       432 vHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~t~ksDVwS~Gvl  500 (588)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986322    2334567 999999999887           89999999999999


Q ss_pred             HHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          501 LLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       501 l~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +|||++|+.||...........+.+.. ..++.    .+..++..|++ +|.+|||+.|+++
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~----~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIFRSC-KNIPQ----PVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGGSSC-CCCCH----HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccchhhhhhhc-cCCCH----HHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999987544433333322211 23444    35556788888 7999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-39  Score=356.63  Aligned_cols=255  Identities=21%  Similarity=0.212  Sum_probs=208.0

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCC-CceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRH-PNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++........+.+|+++++.++| +++..+..++.+.+..+|||||+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            46899999999999999999996 57999999998766555678899999999987 55666666777788899999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE---CCCCcEEEEecCCcceecCCCc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl---d~~~~~kL~DFGla~~~~~~~~  465 (588)
                       +++|.+++......+++.+++.|+.|++.||.|||+.+   |+||||||+||||   ++++.+||+|||+++.......
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence             99999999765667999999999999999999999998   9999999999999   6889999999999987754332


Q ss_pred             c------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCc-------ccC
Q 042871          466 Y------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDR-------EYS  532 (588)
Q Consensus       466 ~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~-------~~~  532 (588)
                      .      ......||+.|+|||++.+..++.++||||||++||||++|+.||.........+.+......       ...
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~  241 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC  241 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence            1      123567999999999999999999999999999999999999999754443322222111000       000


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      ......+..++..|++ +|++||++.+|++.|++++..
T Consensus       242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            1112456677888998 799999999999999998653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=341.45  Aligned_cols=245  Identities=23%  Similarity=0.282  Sum_probs=190.8

Q ss_pred             cCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|...+.||+|+||.||+|+.. +++.||||++.....   ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999975 789999999864322   12456899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++ |+|.+++......+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ..
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence            96 6999999776677999999999999999999999998   9999999999999999999999999997654322 22


Q ss_pred             ccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC--------cccCcc--------
Q 042871          468 SSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--------PKLDRE--------  530 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d--------~~l~~~--------  530 (588)
                      .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.        ......        
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            234568999999999876 568999999999999999999999986433222111110        000000        


Q ss_pred             -------------cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          531 -------------YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       531 -------------~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                   ........+..++..|++ +|.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                         000112345667888888 7999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.1e-39  Score=328.08  Aligned_cols=240  Identities=25%  Similarity=0.347  Sum_probs=201.2

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+.. +++.||||++..     ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367899999999999999999974 688999999853     23356789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++... ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            9999999999999643 35899999999999999999999998   999999999999999999999999998765432 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.||...........+   +..+....+.    .+..
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  241 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD----GSKD  241 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCH----HHHH
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCH----HHHH
Confidence              223457899999999999999999999999999999999999998754433222211   2222233343    4556


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ++..|+. +|.+|||++|+++
T Consensus       242 li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhcCHhhCCCHHHHhh
Confidence            6788887 7999999999987

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-39  Score=347.16  Aligned_cols=199  Identities=26%  Similarity=0.359  Sum_probs=162.6

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCC-CCceeEEecceeccC--e
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVR-HPNLVALLGYCLRVD--E  380 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~--~  380 (588)
                      ...++|...+.||+|+||.||+|+. .+|+.||||++...    ...+.+.+|+.++.+++ ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999986 57999999998642    33567889999999997 999999999997543  6


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .|+||||++ |+|.+++..  ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999996 699999854  46899999999999999999999999   999999999999999999999999999865


Q ss_pred             cCCC--------------------cccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          461 DIGE--------------------TYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       461 ~~~~--------------------~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      ....                    ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            3211                    112234579999999999876 6789999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-39  Score=330.75  Aligned_cols=243  Identities=21%  Similarity=0.295  Sum_probs=202.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+++.. +++.||+|.+...     ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467888999999999999999975 6889999998642     2356788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++.. ...+++.+++.++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999999998854 346899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--cccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--PKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--~~l~~~~~~e~~~~v~~  541 (588)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .  ..+....+    ..+..
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  244 (294)
T 2rku_A          170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAAS  244 (294)
T ss_dssp             C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSC----HHHHH
T ss_pred             c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccC----HHHHH
Confidence            2 233457899999999999989999999999999999999999998654332222111 1  11222333    34566


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ++..|++ +|++|||++|+++.
T Consensus       245 li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHcccChhhCcCHHHHhhC
Confidence            7788888 79999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-39  Score=341.20  Aligned_cols=254  Identities=24%  Similarity=0.267  Sum_probs=196.6

Q ss_pred             cHHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC-------------cHHHHHHHHHHhccCCCCcee
Q 042871          303 TIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG-------------NVETFVREVASSSHVRHPNLV  369 (588)
Q Consensus       303 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-------------~~~~~~~Ei~~l~~l~HpnIv  369 (588)
                      .+.++....++|...+.||+|+||.||+|+..+|+.||||++....             ..+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4567888899999999999999999999998889999999985321             126789999999999999999


Q ss_pred             EEecceec-----cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC
Q 042871          370 ALLGYCLR-----VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG  444 (588)
Q Consensus       370 ~l~g~~~~-----~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld  444 (588)
                      ++++++..     ....++||||++ |+|.+++......+++..++.++.|+++||.|||+.+   |+||||||+|||++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEc
Confidence            99999853     346899999996 7999998776667999999999999999999999998   99999999999999


Q ss_pred             CCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh-
Q 042871          445 PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL-  522 (588)
Q Consensus       445 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~-  522 (588)
                      .++.+||+|||+++......  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... 
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999997543322  2334578999999998876 6789999999999999999999999864322111110 


Q ss_pred             -----------------------cCcccCc-------ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          523 -----------------------ADPKLDR-------EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       523 -----------------------~d~~l~~-------~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                             +......       .........+..|+..|++ +|.+|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence                                   0000000       0011112346677888888 79999999999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.3e-39  Score=340.69  Aligned_cols=197  Identities=25%  Similarity=0.349  Sum_probs=173.6

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|...+.||+|+||.||+++.. +|+.||+|++....   ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467899999999999999999974 78999999987542   34678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++++|.+++... ..+++..+..++.+++.||.|||+. +   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            99999999999643 3589999999999999999999985 7   999999999999999999999999998755321  


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccc
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLT  514 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~  514 (588)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence             223457899999999999999999999999999999999999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.4e-39  Score=344.77  Aligned_cols=244  Identities=21%  Similarity=0.258  Sum_probs=187.6

Q ss_pred             hcCcccc-ceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHh-ccCCCCceeEEecceec----cCeeeE
Q 042871          311 TEKLNEL-NLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASS-SHVRHPNLVALLGYCLR----VDECFL  383 (588)
Q Consensus       311 t~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~----~~~~~L  383 (588)
                      .++|... +.||+|+||.||+++.. +|+.||||++...   ..+.+|++++ +..+||||+++++++..    .+..++
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            3566665 68999999999999974 7899999999643   4677888876 45589999999999875    567899


Q ss_pred             EeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEEecCCcce
Q 042871          384 IYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLSDFGLSKV  459 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~DFGla~~  459 (588)
                      ||||+++|+|.+++.... ..+++.++..++.|+++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++.
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            999999999999997643 46999999999999999999999998   999999999999997   78999999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccch----h-hhc--CcccCcccC
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSA----L-ELA--DPKLDREYS  532 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~----~-~~~--d~~l~~~~~  532 (588)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........    . ...  ...+.....
T Consensus       214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~  291 (400)
T 1nxk_A          214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW  291 (400)
T ss_dssp             CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred             cCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence            54322  22345789999999999999999999999999999999999999864332211    1 111  001111000


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ......+..|+..|+. +|.+|||+.|+++.
T Consensus       292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1122345667888988 79999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.4e-39  Score=353.53  Aligned_cols=194  Identities=25%  Similarity=0.335  Sum_probs=164.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc------C
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV------D  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~  379 (588)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++...    ...+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999986 47899999999643    3356788999999999999999999998654      4


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..|+||||+++ +|.+.+..   .+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            57999999965 56666632   3889999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      ....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            6432  223456799999999999999999999999999999999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.5e-39  Score=338.11  Aligned_cols=244  Identities=21%  Similarity=0.277  Sum_probs=199.8

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC-----c--------------HHHHHHHHHHhccCCCCceeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG-----N--------------VETFVREVASSSHVRHPNLVAL  371 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-----~--------------~~~~~~Ei~~l~~l~HpnIv~l  371 (588)
                      .++|...+.||+|+||.||+|+. +|+.||||++....     .              .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 99999999986321     1              1789999999999999999999


Q ss_pred             ecceeccCeeeEEeecCCCCChhhh------hhcC-CcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEE
Q 042871          372 LGYCLRVDECFLIYELCPNGNLAEW------LFGK-DKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       372 ~g~~~~~~~~~LV~E~~~~gsL~~~------L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILl  443 (588)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..++.++.|+++||.|||+ .+   |+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence            9999999999999999999999999      5432 4579999999999999999999998 88   9999999999999


Q ss_pred             CCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCC-CCCc-hhhHHHHHHHHHHHHcCCCccccccc-cchh
Q 042871          444 GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC-KVNS-SGDVYSFGIVLLQILSGKKAKVLTRA-GSAL  520 (588)
Q Consensus       444 d~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~-ksDVwS~Gvll~ElltG~~p~~~~~~-~~~~  520 (588)
                      +.++.+||+|||++......   ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||..... ....
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            99999999999999876433   33446789999999999887 6666 99999999999999999999875433 2222


Q ss_pred             hhcCcc-cCcc-----------------cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          521 ELADPK-LDRE-----------------YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       521 ~~~d~~-l~~~-----------------~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +.+... ....                 ........+..++..|++ +|.+|||+.|+++
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222111 1000                 002223455667888888 7999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.3e-39  Score=335.66  Aligned_cols=258  Identities=21%  Similarity=0.261  Sum_probs=203.9

Q ss_pred             CcccHHHHHHHhcCcccc-ceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCC-CCceeEEe
Q 042871          300 PRYTIREVHYATEKLNEL-NLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVR-HPNLVALL  372 (588)
Q Consensus       300 ~~~~~~el~~at~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~-HpnIv~l~  372 (588)
                      +...+...+...+.|... +.||+|+||.||+|+.. +|+.||||++...    .....+.+|+.++..++ ||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            334444455567778877 88999999999999874 6999999998642    34678999999999985 69999999


Q ss_pred             cceeccCeeeEEeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCc
Q 042871          373 GYCLRVDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFE  448 (588)
Q Consensus       373 g~~~~~~~~~LV~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~  448 (588)
                      +++.+.+..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.   ++.
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence            9999999999999999999999998543 356999999999999999999999998   999999999999988   789


Q ss_pred             EEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---Cc
Q 042871          449 AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DP  525 (588)
Q Consensus       449 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~  525 (588)
                      +||+|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   ..
T Consensus       173 ~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  250 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV  250 (327)
T ss_dssp             EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             EEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc
Confidence            9999999998764322  223457999999999999999999999999999999999999998654433222211   11


Q ss_pred             ccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          526 KLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       526 ~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .............+..++..|++ +|.+|||++|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11111112233446667888888 79999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1e-38  Score=337.51  Aligned_cols=251  Identities=27%  Similarity=0.354  Sum_probs=202.5

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC----------cHHHHHHHHHHhccC-CCCceeEE
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----------NVETFVREVASSSHV-RHPNLVAL  371 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l-~HpnIv~l  371 (588)
                      ........++|...+.||+|+||.||+|++. +|+.||||++....          ..+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444556788999999999999999999985 79999999986432          134678899999999 79999999


Q ss_pred             ecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEE
Q 042871          372 LGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL  451 (588)
Q Consensus       372 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL  451 (588)
                      ++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999999643 46899999999999999999999998   999999999999999999999


Q ss_pred             EecCCcceecCCCcccccCccCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc
Q 042871          452 SDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN------CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP  525 (588)
Q Consensus       452 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~  525 (588)
                      +|||++.......  ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||...........+..
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  319 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME  319 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            9999998765433  2344679999999998753      3688899999999999999999999864433222222111


Q ss_pred             ccCcccCH----HHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 KLDREYSI----EAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 ~l~~~~~~----e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ... ....    .....+..++..|++ +|.+|||++|+++
T Consensus       320 ~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          320 GQY-QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             TCC-CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC-CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            100 0111    112345667888887 7999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=339.41  Aligned_cols=249  Identities=25%  Similarity=0.275  Sum_probs=193.4

Q ss_pred             HHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-------cHHHHHHHHHHhccCCCCceeEEecceeccCe
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-------NVETFVREVASSSHVRHPNLVALLGYCLRVDE  380 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~  380 (588)
                      ...++|...+.||+|+||.||+|+.. +|+.||||++....       ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34678999999999999999999974 68999999986421       12468899999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++||||+++ +|.+++......+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999975 899999766667999999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C----------ccc-
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D----------PKL-  527 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d----------~~l-  527 (588)
                      .... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+ .          +.. 
T Consensus       163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            4322 223445789999999998664 5899999999999999999999887543221111100 0          000 


Q ss_pred             ----------CcccC-----HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          528 ----------DREYS-----IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       528 ----------~~~~~-----~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                ....+     ......+..++..|+. +|.+|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                      00000     1122456677888888 79999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.9e-40  Score=342.62  Aligned_cols=246  Identities=21%  Similarity=0.261  Sum_probs=195.1

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeec
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ..++|+..+.||+|+||.||+++.. +|+.||||++.....  .+.+|++++.++ +||||+++++++.+++..++||||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            3577999999999999999999974 789999999975432  345788888877 799999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC----CcEEEEecCCcceecCC
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN----FEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~----~~~kL~DFGla~~~~~~  463 (588)
                      +++|+|.+++... ..+++.++..++.|++.||+|||+.+   |+||||||+|||+.++    +.+||+|||+++.....
T Consensus        98 ~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           98 MKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            9999999999644 45899999999999999999999998   9999999999998543    35999999999876543


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC------cccCcccCHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD------PKLDREYSIEAFD  537 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d------~~l~~~~~~e~~~  537 (588)
                      .. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+++.      ..+.........+
T Consensus       174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  252 (342)
T 2qr7_A          174 NG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD  252 (342)
T ss_dssp             TC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred             CC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence            32 2334578999999999988889999999999999999999999997432222222111      1111111111223


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .+..|+..|+. +|++|||+.|+++.
T Consensus       253 ~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          253 TAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            44556777887 79999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-39  Score=338.01  Aligned_cols=243  Identities=21%  Similarity=0.296  Sum_probs=202.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+++.. +++.||+|++...     ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467889999999999999999974 6889999998642     2356788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++.. ...+++.+++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999998854 346899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                      . ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   ...+...++.    .+..
T Consensus       196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  270 (335)
T 2owb_A          196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP----VAAS  270 (335)
T ss_dssp             C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCH----HHHH
T ss_pred             c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCH----HHHH
Confidence            2 234457899999999999989999999999999999999999998654332222111   1122233343    4556


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ++..|++ +|.+|||++|+++.
T Consensus       271 li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            7788888 79999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-39  Score=330.08  Aligned_cols=246  Identities=21%  Similarity=0.269  Sum_probs=183.6

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCc----HHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGN----VETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~----~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ..++|+..+.||+|+||.||+++. .+|+.||||++.....    .+.+.++...++.++||||+++++++.+++..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            357899999999999999999996 5899999999975322    22344555568889999999999999999999999


Q ss_pred             eecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          385 YELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      |||++ |+|.+++..   ....+++..++.++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99996 588888743   445799999999999999999999997 8   999999999999999999999999999876


Q ss_pred             cCCCcccccCccCCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHcCCCccccccc--cchhhhcCcccCcccCHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYR----SNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSALELADPKLDREYSIE  534 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~~~~d~~l~~~~~~e  534 (588)
                      ....  ......||+.|+|||++    ....++.++||||||+++|||++|+.||.....  ......+...........
T Consensus       161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T 3fme_A          161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK  238 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred             cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence            4332  22334689999999995    566789999999999999999999999863221  111222211111111112


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ....+..++..|++ +|.+|||+.|+++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          239 FSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            22345667788888 7999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.4e-39  Score=325.77  Aligned_cols=242  Identities=21%  Similarity=0.322  Sum_probs=193.4

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...     ...+.+.+|+..++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467889999999999999999975 7999999998632     3456889999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999999643 35899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc---ccCcccCHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP---KLDREYSIEAFDLTL  540 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~---~l~~~~~~e~~~~v~  540 (588)
                        ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.........+.+..   .+....+    ..+.
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~  239 (276)
T 2h6d_A          166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN----RSVA  239 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC----HHHH
T ss_pred             --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcC----HHHH
Confidence              2234568999999999988765 6899999999999999999999865433333222211   1222233    3456


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .++..|++ +|.+|||++|+++.
T Consensus       240 ~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          240 TLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCChhhCCCHHHHHhC
Confidence            67788888 79999999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.5e-39  Score=339.23  Aligned_cols=248  Identities=23%  Similarity=0.335  Sum_probs=196.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec--------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR--------  377 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--------  377 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...    .....+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999997 57999999998542    234578899999999999999999999886        


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      .+..++||||++ |+|.+.+......+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            446899999996 5888888766667999999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCc---ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------Ccc
Q 042871          458 KVIDIGET---YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------DPK  526 (588)
Q Consensus       458 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------d~~  526 (588)
                      +.......   .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+       .+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            87653222   22344578999999998876 45899999999999999999999988643322111111       000


Q ss_pred             cC-----------------cccC-HHH------HHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          527 LD-----------------REYS-IEA------FDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       527 l~-----------------~~~~-~e~------~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..                 .... .+.      ...+..|+..|++ +|.+|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00                 0000 000      1335678888988 79999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=341.09  Aligned_cols=261  Identities=24%  Similarity=0.353  Sum_probs=201.3

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD  379 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~  379 (588)
                      ..+.....++|...+.||+|+||.||+|+..+  .||+|.+...    ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34444456789999999999999999999743  5999998632    23456789999999999999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..++||||+++++|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||++ ++.+||+|||+++.
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999999766667999999999999999999999998   99999999999998 67999999999876


Q ss_pred             ecCCC----cccccCccCCCCccCcccccC---------CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc
Q 042871          460 IDIGE----TYASSEVRGTFGYLDPEYRSN---------CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK  526 (588)
Q Consensus       460 ~~~~~----~~~~~~~~gt~~Y~aPE~~~~---------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~  526 (588)
                      .....    ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||...........+...
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  258 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG  258 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence            53211    112233468999999998864         45789999999999999999999998754433332222111


Q ss_pred             cCccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccC
Q 042871          527 LDREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       527 l~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~  570 (588)
                      ..... .......+..++..|+. +|.+|||+.+++++|+++....
T Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111 11122345667888888 7999999999999999887653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-39  Score=359.88  Aligned_cols=242  Identities=22%  Similarity=0.272  Sum_probs=201.8

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+++.. +|+.||||++..     ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999974 799999999853     23456789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          385 YELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      |||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....+
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999996543 35899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc----hhhh---cCcccCcccCHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS----ALEL---ADPKLDREYSIEAF  536 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~----~~~~---~d~~l~~~~~~e~~  536 (588)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ....   ....+...++.+  
T Consensus       340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~--  415 (576)
T 2acx_A          340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ--  415 (576)
T ss_dssp             CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH--
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH--
Confidence            32  234579999999999999899999999999999999999999997543221    1111   122233334444  


Q ss_pred             HHHHHHHHHhhc-CCCCCC-----CHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RP-----s~~evl~  561 (588)
                        +..|+..|+. +|.+||     +++||++
T Consensus       416 --~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          416 --ARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --HHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --HHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence              4455677777 799999     7888875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6e-39  Score=345.74  Aligned_cols=245  Identities=23%  Similarity=0.304  Sum_probs=188.3

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----------cHHHHHHHHHHhccCCCCceeEEecceec
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----------NVETFVREVASSSHVRHPNLVALLGYCLR  377 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~  377 (588)
                      ...++|...+.||+|+||.||+|+. .+++.||||++....          ....+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            3478899999999999999999986 468999999986421          1225789999999999999999999975 


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC---CcEEEEec
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN---FEAKLSDF  454 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~---~~~kL~DF  454 (588)
                      .+..++||||+++|+|.+++... ..+++.+++.++.|+++||+|||+.+   |+||||||+|||++.+   +.+||+||
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence            45689999999999999998543 46999999999999999999999998   9999999999999754   45999999


Q ss_pred             CCcceecCCCcccccCccCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCcccccccc-chhhhcCcccCcc
Q 042871          455 GLSKVIDIGETYASSEVRGTFGYLDPEYRSN---CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SALELADPKLDRE  530 (588)
Q Consensus       455 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~~~~d~~l~~~  530 (588)
                      |+++.....  .......||+.|+|||++..   ..++.++||||||+++|||++|+.||...... ...+.+..... .
T Consensus       287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~-~  363 (419)
T 3i6u_A          287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-N  363 (419)
T ss_dssp             STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC-C
T ss_pred             ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC-C
Confidence            999876432  22345679999999999753   67888999999999999999999998643322 12222111110 0


Q ss_pred             cCH----HHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          531 YSI----EAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       531 ~~~----e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...    +..+.+..++..|++ +|.+|||++|+++
T Consensus       364 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            111    122446667888888 7999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.1e-39  Score=327.67  Aligned_cols=246  Identities=21%  Similarity=0.347  Sum_probs=192.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceec-----------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLR-----------  377 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----------  377 (588)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+.++++++||||+++++++.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            56899999999999999999996 47999999998643 345678999999999999999999998764           


Q ss_pred             --cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          378 --VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       378 --~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                        .+..++||||+++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCc
Confidence              45689999999999999999766667888999999999999999999998   9999999999999999999999999


Q ss_pred             CcceecCCC-------------cccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhh
Q 042871          456 LSKVIDIGE-------------TYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE  521 (588)
Q Consensus       456 la~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~  521 (588)
                      +++......             ........||+.|+|||++.+. .++.++||||||+++|||+++..+..  .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~--~~~~~~~  239 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM--ERVNILK  239 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHH--HHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCch--hHHHHHH
Confidence            997654221             1122345689999999998764 78999999999999999999332211  1111111


Q ss_pred             ---hcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          522 ---LADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       522 ---~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         .....+...++......+..++..|++ +|.+|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               112222333344444556778889988 7999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-39  Score=331.76  Aligned_cols=246  Identities=24%  Similarity=0.387  Sum_probs=182.5

Q ss_pred             HHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ...++|...+.||+|+||.||+|+. .+++.||||++...   ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3467899999999999999999986 47899999998643   3456788999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhc-------CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          385 YELCPNGNLAEWLFG-------KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      |||+++++|.+++..       ....+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999953       2346899999999999999999999998   999999999999999999999999998


Q ss_pred             ceecCCCc----ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhh-c--------
Q 042871          458 KVIDIGET----YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL-A--------  523 (588)
Q Consensus       458 ~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~-~--------  523 (588)
                      ........    .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... .        
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            76543221    11234578999999998865 5689999999999999999999999865433221111 0        


Q ss_pred             ----CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 ----DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 ----d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                          ++.....++    ..+..++..|++ +|.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          249 TGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             C-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence                111112223    345667888888 7999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=325.71  Aligned_cols=244  Identities=22%  Similarity=0.252  Sum_probs=194.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC------CcHHHHHHHHHHhccCCCCceeEEeccee--ccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE------GNVETFVREVASSSHVRHPNLVALLGYCL--RVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~  381 (588)
                      .++|...+.||+|+||.||+++. .+++.||||++...      ...+.+.+|+.++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999997 47899999998642      34567999999999999999999999984  45678


Q ss_pred             eEEeecCCCCChhhhhhc-CCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          382 FLIYELCPNGNLAEWLFG-KDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      ++||||++++ |.+++.. ....+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 7777654 3456899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCC-cccccCccCCCCccCcccccCCCC--CchhhHHHHHHHHHHHHcCCCccccccccchhhhcC---cccCcccCHH
Q 042871          461 DIGE-TYASSEVRGTFGYLDPEYRSNCKV--NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD---PKLDREYSIE  534 (588)
Q Consensus       461 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~--t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d---~~l~~~~~~e  534 (588)
                      .... ........||+.|+|||++.+...  +.++||||||+++|||++|+.||.........+.+.   ..+....+. 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~-  238 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP-  238 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCH-
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCH-
Confidence            4322 222344568999999999876443  779999999999999999999987543332222221   122223333 


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                         .+..++..|+. +|.+|||++|+++.
T Consensus       239 ---~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          239 ---PLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence               45566788888 79999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-39  Score=332.74  Aligned_cols=243  Identities=25%  Similarity=0.349  Sum_probs=196.1

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++..  ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            578999999999999999999975 689999999864  34567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +++++|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++...... ...
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  173 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK  173 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence            9999999999765667999999999999999999999998   999999999999999999999999987543211 111


Q ss_pred             ccCccCCCCccCcccc-----cCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----Ccc--cCcccCHHHH
Q 042871          468 SSEVRGTFGYLDPEYR-----SNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----DPK--LDREYSIEAF  536 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~-----~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----d~~--l~~~~~~e~~  536 (588)
                      .....||+.|+|||++     ....++.++||||||+++|||++|+.||...........+    .+.  ....++    
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  249 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS----  249 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC----
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC----
Confidence            2335689999999987     4677899999999999999999999998754332221111    011  112233    


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..+..++..|+. +|.+|||+.|+++
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            345667788888 7999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.6e-39  Score=326.53  Aligned_cols=242  Identities=26%  Similarity=0.351  Sum_probs=194.2

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ++|.....||+|+||.||+|+. .+++.||||.+...  ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            3455666999999999999996 57889999998653  34577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCcceecCCCc
Q 042871          389 PNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       389 ~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla~~~~~~~~  465 (588)
                      ++++|.+++....  ..+++..+..++.|+++||.|||+.+   |+||||||+||+++. ++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            9999999996543  24678889999999999999999998   999999999999987 8999999999998754322 


Q ss_pred             ccccCccCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCccccccccchh--h----hcCcccCcccCHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCK--VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL--E----LADPKLDREYSIEAFD  537 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~--~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--~----~~d~~l~~~~~~e~~~  537 (588)
                      .......||+.|+|||++.+..  ++.++||||||+++|||++|+.||.........  .    ...+.+....+    .
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  253 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS----A  253 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC----H
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC----H
Confidence            1233457899999999987643  889999999999999999999998643222111  1    11223333344    3


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .+..++..|++ +|++|||+.|+++
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhc
Confidence            45567888988 7999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-39  Score=343.56  Aligned_cols=242  Identities=13%  Similarity=0.063  Sum_probs=176.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-----cHHHHHHHH---HHhccCCCCceeEEec-------c
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-----NVETFVREV---ASSSHVRHPNLVALLG-------Y  374 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~~Ei---~~l~~l~HpnIv~l~g-------~  374 (588)
                      ..+|...+.||+|+||.||+|+. .+|+.||||++....     ..+.+.+|+   ..++. +||||++++.       +
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            45688899999999999999996 478999999997632     244567774   55555 7999888553       3


Q ss_pred             eecc-----------------CeeeEEeecCCCCChhhhhhcCCcCccHHHH------HHHHHhhhccchhhccccCCce
Q 042871          375 CLRV-----------------DECFLIYELCPNGNLAEWLFGKDKCLSWIQR------LEIAIDSARGLWFLHSYSEGCI  431 (588)
Q Consensus       375 ~~~~-----------------~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~I  431 (588)
                      +...                 ...++||||++ |+|.+++......+.+..+      +.++.|+++||+|||+.+   |
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            3222                 34799999998 8999999765555666667      788899999999999998   9


Q ss_pred             EecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCC
Q 042871          432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKK  509 (588)
Q Consensus       432 vHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~  509 (588)
                      +||||||+|||+++++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++||||||+++|||++|+.
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999865321    113456799999999987  789999999999999999999999


Q ss_pred             ccccccccchhhhc--------CcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          510 AKVLTRAGSALELA--------DPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       510 p~~~~~~~~~~~~~--------d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ||............        ...............+..|+..|++ +|++|||+.|+++
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            98754322111110        1111111111223445667788887 7999999999974

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.8e-39  Score=328.99  Aligned_cols=244  Identities=21%  Similarity=0.314  Sum_probs=198.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|...+.||+|+||.||+++.. +|+.||||.+....  ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            567999999999999999999974 79999999987532  345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE---CCCCcEEEEecCCcceecCCC
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl---d~~~~~kL~DFGla~~~~~~~  464 (588)
                      +++++|.+++... ..+++.+++.++.|++.||.|||+.+   |+||||||+||++   ++++.+||+|||+++..... 
T Consensus        88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            9999999998543 45899999999999999999999998   9999999999999   78899999999998764322 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc---cCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK---LDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~---l~~~~~~e~~~~v~~  541 (588)
                        ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........+.+...   ............+..
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (304)
T 2jam_A          163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD  240 (304)
T ss_dssp             --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred             --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence              123346899999999999999999999999999999999999998654433322222111   111111122234556


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ++..|+. +|.+|||++|+++
T Consensus       241 li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          241 FICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            6778887 7999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.1e-39  Score=337.38  Aligned_cols=248  Identities=24%  Similarity=0.275  Sum_probs=187.5

Q ss_pred             HHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          308 HYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       308 ~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ....++|...+.||+|+||.||+|+. .+|+.||||++....    ..+.+.+|++++++++||||+++++++.+++..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34567899999999999999999985 578999999986432    2456789999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE-----CCCCcEEEEecCCc
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL-----GPNFEAKLSDFGLS  457 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl-----d~~~~~kL~DFGla  457 (588)
                      +||||++ |+|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+|||+     ++++.+||+|||++
T Consensus       110 lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999997 5999999644 35899999999999999999999998   9999999999999     45566999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------C-----
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------D-----  524 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------d-----  524 (588)
                      +....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+       +     
T Consensus       185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            87643222 23345689999999998774 4899999999999999999999998643221111100       0     


Q ss_pred             ------------cccCcc-----cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 ------------PKLDRE-----YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ------------~~l~~~-----~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                  +.....     ........+..|+..|++ +|.+|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                        000000     000012345667888888 7999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.1e-39  Score=331.19  Aligned_cols=246  Identities=23%  Similarity=0.301  Sum_probs=190.7

Q ss_pred             hcCcccc-ceeeccCceEEEEEEe-cCCcEEEEEEecCC--CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNEL-NLIGEGITGKVYKGKL-SNNQHVAIKHITNE--GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~-~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .+.|.+. +.||+|+||.||+++. .+++.||||++...  ...+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567664 6899999999999995 47999999999643  3467899999999884 7999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc---EEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~---~kL~DFGla~~~~~  462 (588)
                      ||+++|+|.+++... ..+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.   +||+|||+++....
T Consensus        91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999999653 45899999999999999999999998   999999999999998776   99999999876542


Q ss_pred             CCc------ccccCccCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCccccccccc-------------
Q 042871          463 GET------YASSEVRGTFGYLDPEYRSN-----CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-------------  518 (588)
Q Consensus       463 ~~~------~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-------------  518 (588)
                      ...      .......||+.|+|||++..     ..++.++||||||+++|||++|+.||......+             
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211      11223468999999999865     457899999999999999999999986432211             


Q ss_pred             --hhhhcCcccCcccCH----HHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          519 --ALELADPKLDREYSI----EAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       519 --~~~~~d~~l~~~~~~----e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                        ..+.+.... ...+.    .....+..++..|++ +|.+|||+.|+++
T Consensus       247 ~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              111110000 01111    122346677888888 7999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.7e-38  Score=328.96  Aligned_cols=245  Identities=24%  Similarity=0.305  Sum_probs=192.5

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----------cHHHHHHHHHHhccCCCCceeEEecceecc
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----------NVETFVREVASSSHVRHPNLVALLGYCLRV  378 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~  378 (588)
                      ..++|...+.||+|+||.||+|+. .+++.||||.+....          ....+.+|++++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            357899999999999999999986 468999999986421          223588999999999999999999998765


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc---EEEEecC
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFG  455 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~---~kL~DFG  455 (588)
                      + .++||||+++++|.+++.. ...+++.+.+.++.|+++||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            4 8999999999999999854 346899999999999999999999998   999999999999987664   9999999


Q ss_pred             CcceecCCCcccccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCcccccccc-chhhhcCccc---C
Q 042871          456 LSKVIDIGETYASSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SALELADPKL---D  528 (588)
Q Consensus       456 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~~~~d~~l---~  528 (588)
                      +++......  ......||+.|+|||++.   ...++.++||||||+++|||++|+.||...... .....+....   .
T Consensus       163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  240 (322)
T ss_dssp             TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred             cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence            998764322  223456899999999863   567899999999999999999999998643322 1222111110   0


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .....+....+..++..|+. +|.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            00001122445667888888 7999999999984

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-38  Score=324.25  Aligned_cols=244  Identities=23%  Similarity=0.315  Sum_probs=193.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec----cCeee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR----VDECF  382 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~  382 (588)
                      +.|...+.||+|+||.||+|+. .++..||+|.+...    ...+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3467778999999999999986 47889999998642    235678999999999999999999998875    35689


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEEecCCcceec
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLSDFGLSKVID  461 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~DFGla~~~~  461 (588)
                      +||||+++|+|.+++... ..+++..++.++.|+++||.|||+.+ ++|+||||||+|||++ +++.+||+|||++....
T Consensus       106 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            999999999999999543 45899999999999999999999875 3499999999999997 78999999999997543


Q ss_pred             CCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc-cchhhhcCccc-CcccCHHHHHHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA-GSALELADPKL-DREYSIEAFDLT  539 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~-~~~~~~~d~~l-~~~~~~e~~~~v  539 (588)
                      ..   ......||+.|+|||++.+ .++.++||||||+++|||++|+.||..... ......+.... ....+......+
T Consensus       184 ~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  259 (290)
T 1t4h_A          184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             cc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence            22   2234568999999998775 699999999999999999999999864322 12222221111 111111122346


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHH
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..++..|+. +|.+|||+.|+++
T Consensus       260 ~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          260 KEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHhh
Confidence            677888988 7999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.4e-39  Score=354.61  Aligned_cols=238  Identities=17%  Similarity=0.264  Sum_probs=197.6

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+++.. +|+.||+|++..     ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999974 799999999863     23456789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcC---CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          385 YELCPNGNLAEWLFGK---DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      |||+++|+|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999653   346899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccccc----chhhh-c--CcccCcccCHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG----SALEL-A--DPKLDREYSIE  534 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~----~~~~~-~--d~~l~~~~~~e  534 (588)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..... .  ...+...++.+
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~  419 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPA  419 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHH
Confidence            4332 233458999999999999999999999999999999999999999753221    11111 1  11222334444


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPM  556 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~  556 (588)
                          +..++..|++ +|.+||++
T Consensus       420 ----~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          420 ----SKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ----HHHHHHHHSCSSGGGSCCC
T ss_pred             ----HHHHHHHhccCCHhHCCCC
Confidence                4555677777 79999976

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=335.78  Aligned_cols=252  Identities=27%  Similarity=0.407  Sum_probs=195.9

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-CcHHHHHHHHHHhccC-CCCceeEEecceec-
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-GNVETFVREVASSSHV-RHPNLVALLGYCLR-  377 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~-  377 (588)
                      +++.++....++|...+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+.+++++ +||||+++++++.. 
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            34444555678999999999999999999997 57899999998643 4457899999999998 79999999999986 


Q ss_pred             -----cCeeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEE
Q 042871          378 -----VDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL  451 (588)
Q Consensus       378 -----~~~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL  451 (588)
                           .+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence                 467899999999999999996543 46899999999999999999999998   999999999999999999999


Q ss_pred             EecCCcceecCCCcccccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---
Q 042871          452 SDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---  523 (588)
Q Consensus       452 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---  523 (588)
                      +|||++....... .......||+.|+|||++.     ...++.++||||||+++|||++|+.||...........+   
T Consensus       171 ~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  249 (326)
T 2x7f_A          171 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  249 (326)
T ss_dssp             CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             eeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence            9999998654322 1223456899999999986     567899999999999999999999998643322221111   


Q ss_pred             -Cccc-CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 -DPKL-DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 -d~~l-~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                       .+.. ...++    ..+..++..|+. +|.+|||++|+++
T Consensus       250 ~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          250 PAPRLKSKKWS----KKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCCCSCSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccCCccccC----HHHHHHHHHHhccChhhCCCHHHHhh
Confidence             1111 12233    345566788887 7999999999987

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.9e-39  Score=334.53  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=193.3

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .++|+..+.||+|+||.||+++.. +|+.||||++....    ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467999999999999999999974 68999999986432    2345789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++++|.+++.. ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       104 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            99999999887643 345999999999999999999999998   99999999999999999999999999986543222


Q ss_pred             ccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhh----------------------
Q 042871          466 YASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL----------------------  522 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~----------------------  522 (588)
                       ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........                      
T Consensus       180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence             22345689999999998775 789999999999999999999999864332111100                      


Q ss_pred             ---cCcccCcccC-----HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          523 ---ADPKLDREYS-----IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       523 ---~d~~l~~~~~-----~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                         ..+.+....+     ....+.+..++..|++ +|.+|||++|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               0011111111     1123456777888998 79999999998863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-38  Score=360.40  Aligned_cols=243  Identities=21%  Similarity=0.283  Sum_probs=201.4

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccC-CCCceeEEecceeccCeee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~  382 (588)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++..     ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999964 688999999863     34456788999999887 7999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      |||||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+   |+||||||+||||++++.+||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999999654 45899999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--cccCcccCHHHHHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--PKLDREYSIEAFDLT  539 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--~~l~~~~~~e~~~~v  539 (588)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+ .  ..++..++.+    +
T Consensus       495 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~----~  569 (674)
T 3pfq_A          495 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE----A  569 (674)
T ss_dssp             TT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHH----H
T ss_pred             CC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH----H
Confidence            22 2345578999999999999999999999999999999999999999755443333322 1  2223334444    4


Q ss_pred             HHHHHHhhc-CCCCCCCH-----HHHHH
Q 042871          540 LQLALSCTA-LTHQRPPM-----EQVFV  561 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~-----~evl~  561 (588)
                      ..|+..|++ +|.+||++     +||++
T Consensus       570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          570 VAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            455667777 79999998     66654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-38  Score=349.31  Aligned_cols=241  Identities=24%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|...+.||+|+||.||+++.. +|+.||||++..     ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            567999999999999999999974 799999999853     33567899999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE---CCCCcEEEEecCCcceec
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl---d~~~~~kL~DFGla~~~~  461 (588)
                      |||+++|+|.+++... ..+++.+++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++...
T Consensus       105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999999999999654 45999999999999999999999998   9999999999999   567899999999998765


Q ss_pred             CCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc-c------CcccCHH
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK-L------DREYSIE  534 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~-l------~~~~~~e  534 (588)
                      ....  .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+... .      ....+. 
T Consensus       181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-  256 (484)
T 3nyv_A          181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-  256 (484)
T ss_dssp             CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH-
T ss_pred             cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH-
Confidence            4332  233468999999999876 6999999999999999999999999754443333222111 1      112333 


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                         .+..++..|++ +|.+|||++|+++.
T Consensus       257 ---~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          257 ---SAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHHHHHHHHCCCChhHCcCHHHHhhC
Confidence               45566788888 79999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.6e-38  Score=346.89  Aligned_cols=241  Identities=27%  Similarity=0.364  Sum_probs=198.7

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .++|.+.+.||+|+||.||+++.. +|+.||||++..    ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            567999999999999999999974 789999999852    345678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC---CCCcEEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG---PNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld---~~~~~kL~DFGla~~~~~  462 (588)
                      ||+++|+|.+++... ..+++.++..++.|++.||.|||+.+   |+||||||+|||++   .++.+||+|||+++....
T Consensus       101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            999999999998643 45899999999999999999999998   99999999999995   456799999999986643


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc-cc------CcccCHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP-KL------DREYSIEA  535 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~-~l------~~~~~~e~  535 (588)
                      ..  ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+.. ..      ....+.  
T Consensus       177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~--  251 (486)
T 3mwu_A          177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD--  251 (486)
T ss_dssp             C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH--
T ss_pred             CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH--
Confidence            32  2334579999999999876 599999999999999999999999865443332222211 11      122333  


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                        .+..++..|++ +|.+|||+.|+++.
T Consensus       252 --~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          252 --DAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              35566788888 79999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-38  Score=339.14  Aligned_cols=247  Identities=22%  Similarity=0.234  Sum_probs=190.1

Q ss_pred             HHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceecc-------
Q 042871          307 VHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV-------  378 (588)
Q Consensus       307 l~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-------  378 (588)
                      ++...++|...+.||+|+||.||+|+. .+|+.||||++..+.  ....+|+++++.++||||+++++++...       
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            345678899999999999999999986 589999999986542  2234799999999999999999998543       


Q ss_pred             -------------------------------CeeeEEeecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhc
Q 042871          379 -------------------------------DECFLIYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLH  424 (588)
Q Consensus       379 -------------------------------~~~~LV~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH  424 (588)
                                                     ...++||||++ |+|.+.+..   ....+++..+..++.|+++||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           34889999997 688877742   3457999999999999999999999


Q ss_pred             cccCCceEecCCCCCCeEEC-CCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHH
Q 042871          425 SYSEGCIVHRDIKPTNILLG-PNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLL  502 (588)
Q Consensus       425 ~~~~~~IvHrDLKp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~  502 (588)
                      +.+   |+||||||+|||++ +++.+||+|||+++.......  .....||+.|+|||.+.+. .++.++||||||+++|
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            998   99999999999998 688999999999987644332  2345689999999998765 4899999999999999


Q ss_pred             HHHcCCCccccccccchhhhc---------------Ccc-------------cCcccCHHHHHHHHHHHHHhhc-CCCCC
Q 042871          503 QILSGKKAKVLTRAGSALELA---------------DPK-------------LDREYSIEAFDLTLQLALSCTA-LTHQR  553 (588)
Q Consensus       503 ElltG~~p~~~~~~~~~~~~~---------------d~~-------------l~~~~~~e~~~~v~~L~~~C~~-~p~~R  553 (588)
                      ||++|+.||......+....+               ++.             .....+......+..|+..|++ +|.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999998643222111100               000             0000111122345667888888 79999


Q ss_pred             CCHHHHHH
Q 042871          554 PPMEQVFV  561 (588)
Q Consensus       554 Ps~~evl~  561 (588)
                      ||+.|+++
T Consensus       314 ~t~~e~l~  321 (383)
T 3eb0_A          314 INPYEAMA  321 (383)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999984

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-38  Score=344.75  Aligned_cols=193  Identities=25%  Similarity=0.388  Sum_probs=154.1

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec-----cCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR-----VDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~  380 (588)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...    ...+.+.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999864 7899999998642    234678999999999999999999999854     356


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .|+||||+ +|+|.+++.. ...+++..+..++.|+++||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 6799998854 346999999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCc--------------------------ccccCccCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHcCC
Q 042871          461 DIGET--------------------------YASSEVRGTFGYLDPEYR-SNCKVNSSGDVYSFGIVLLQILSGK  508 (588)
Q Consensus       461 ~~~~~--------------------------~~~~~~~gt~~Y~aPE~~-~~~~~t~ksDVwS~Gvll~ElltG~  508 (588)
                      .....                          .......||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            43211                          112345789999999976 5567999999999999999999953

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.4e-38  Score=346.74  Aligned_cols=242  Identities=26%  Similarity=0.339  Sum_probs=198.5

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC---------------CcHHHHHHHHHHhccCCCCceeEEec
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---------------GNVETFVREVASSSHVRHPNLVALLG  373 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---------------~~~~~~~~Ei~~l~~l~HpnIv~l~g  373 (588)
                      ..++|...+.||+|+||.||+|+.. +++.||||++...               ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3678999999999999999999974 6889999998642               23467899999999999999999999


Q ss_pred             ceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC---cEE
Q 042871          374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF---EAK  450 (588)
Q Consensus       374 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~---~~k  450 (588)
                      ++.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence            999999999999999999999999643 45999999999999999999999998   99999999999998776   699


Q ss_pred             EEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc-c--
Q 042871          451 LSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK-L--  527 (588)
Q Consensus       451 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~-l--  527 (588)
                      |+|||+++......  ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+... .  
T Consensus       190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             EEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999998765432  2344579999999999874 6999999999999999999999999754443333322111 1  


Q ss_pred             C----cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          528 D----REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       528 ~----~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .    ...+    ..+..++..|++ +|.+|||++|+++.
T Consensus       267 ~~~~~~~~s----~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          267 DFNDWKNIS----DEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CccccCCCC----HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0    1223    345666788887 79999999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.8e-38  Score=347.51  Aligned_cols=241  Identities=25%  Similarity=0.327  Sum_probs=195.8

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .++|...+.||+|+||.||+|+.. ++..||||++...    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            567999999999999999999974 7899999998642    34578899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC---CcEEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN---FEAKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~---~~~kL~DFGla~~~~~  462 (588)
                      ||+++|+|.+++... ..+++.++..++.|+++||.|||+.+   |+||||||+|||++.+   +.+||+|||+++....
T Consensus       116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            999999999988543 45899999999999999999999998   9999999999999764   4599999999987654


Q ss_pred             CCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcc-------cCcccCHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPK-------LDREYSIEA  535 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~-------l~~~~~~e~  535 (588)
                      ..  ......||+.|+|||++. ..++.++||||||+++|||++|+.||...........+...       .....+.  
T Consensus       192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~--  266 (494)
T 3lij_A          192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE--  266 (494)
T ss_dssp             TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH--
T ss_pred             Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH--
Confidence            32  234457999999999876 47999999999999999999999999754443333322111       1112333  


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                        .+..++..|++ +|.+|||+.|+++.
T Consensus       267 --~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          267 --GAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             --HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --HHHHHHHHHCCCChhhCccHHHHhcC
Confidence              35566788887 79999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-38  Score=323.35  Aligned_cols=246  Identities=27%  Similarity=0.346  Sum_probs=199.4

Q ss_pred             HhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-----------cHHHHHHHHHHhccCC-CCceeEEeccee
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-----------NVETFVREVASSSHVR-HPNLVALLGYCL  376 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----------~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~  376 (588)
                      ..++|...+.||+|+||.||+|+.. +|+.||||++....           ..+.+.+|++++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999974 78999999986431           2356789999999996 999999999999


Q ss_pred             ccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          377 RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                      +.+..++||||+++++|.+++... ..+++.+++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999999643 46899999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCcccccCccCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-cc--c
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRS------NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-PK--L  527 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-~~--l  527 (588)
                      +.......  ......|++.|+|||++.      ...++.++||||||+++|||++|+.||...........+. ..  .
T Consensus       171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            98765432  233457899999999874      4568899999999999999999999986443322222111 11  1


Q ss_pred             CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          528 DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       528 ~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...........+..++..|++ +|.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111011223446677888888 7999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1e-37  Score=323.40  Aligned_cols=192  Identities=21%  Similarity=0.323  Sum_probs=170.4

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCceeEEecceec--cCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLR--VDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~--~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||.||+|+. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+  ....++|||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            36799999999999999999986 57899999998754 3578999999999997 9999999999987  667899999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~~  465 (588)
                      |+++++|.+++.    .+++.++..++.|+++||+|||+.+   |+||||||+|||++.++ .+||+|||+++.......
T Consensus       114 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~  186 (330)
T 3nsz_A          114 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE  186 (330)
T ss_dssp             CCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             ccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence            999999999883    3888999999999999999999998   99999999999999776 899999999987654332


Q ss_pred             ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          466 YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                        .....|+..|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus       187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~  232 (330)
T 3nsz_A          187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  232 (330)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence              234578999999999877 678999999999999999999999984

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=337.29  Aligned_cols=242  Identities=23%  Similarity=0.305  Sum_probs=187.9

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD------  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------  379 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...    ...+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            56799999999999999999997 57999999998542    22457889999999999999999999987653      


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..++||||+ +++|.+++..  ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 8899999954  45899999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC--------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD--------------  524 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d--------------  524 (588)
                      ....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+-              
T Consensus       178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            5432    234578999999999877 689999999999999999999999986332211110000              


Q ss_pred             ------------ccc-C---cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          525 ------------PKL-D---REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       525 ------------~~l-~---~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                  +.. .   ..........+..|+..|+. +|.+|||++|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                        000 0   00111112345566778887 89999999999873

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.9e-38  Score=333.35  Aligned_cols=246  Identities=26%  Similarity=0.303  Sum_probs=194.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceecc-----Cee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRV-----DEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~  381 (588)
                      .++|...+.||+|+||.||+++. .+++.||||++....   ..+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            46899999999999999999986 478899999997432   246789999999999999999999998754     468


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++|+||++ |+|.+++..  ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999996 699999843  45899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc--cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc-----------
Q 042871          462 IGETY--ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL-----------  527 (588)
Q Consensus       462 ~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l-----------  527 (588)
                      .....  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...+           
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            33222  1244579999999998654 458999999999999999999999986433222211110000           


Q ss_pred             --------------Cccc-----CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          528 --------------DREY-----SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       528 --------------~~~~-----~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                    ....     .......+..|+..|+. +|.+|||++|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                          0000     01112345667888888 79999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-38  Score=338.40  Aligned_cols=243  Identities=22%  Similarity=0.258  Sum_probs=196.9

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-cHHHHHHHHHHhccCC--------CCceeEEeccee----
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-NVETFVREVASSSHVR--------HPNLVALLGYCL----  376 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~--------HpnIv~l~g~~~----  376 (588)
                      .++|...+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++.++        |+||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            47899999999999999999986 578999999997543 3567889999998885        788999999988    


Q ss_pred             ccCeeeEEeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCC-------
Q 042871          377 RVDECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNF-------  447 (588)
Q Consensus       377 ~~~~~~LV~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~-------  447 (588)
                      +....++||||+ +++|.+++... ...+++.+++.++.|+++||.|||++ +   |+||||||+|||++.++       
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhh
Confidence            566899999999 66776666543 35699999999999999999999998 8   99999999999999775       


Q ss_pred             ------------------------------------------cEEEEecCCcceecCCCcccccCccCCCCccCcccccC
Q 042871          448 ------------------------------------------EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN  485 (588)
Q Consensus       448 ------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  485 (588)
                                                                .+||+|||+++.....    .....||+.|+|||++.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence                                                      7999999999875432    234578999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHcCCCccccccccchh----------hhcCc--------------------cc--------
Q 042871          486 CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL----------ELADP--------------------KL--------  527 (588)
Q Consensus       486 ~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----------~~~d~--------------------~l--------  527 (588)
                      ..++.++||||||+++|||++|+.||.........          +....                    .+        
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            99999999999999999999999998643221100          00000                    00        


Q ss_pred             ---------CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          528 ---------DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       528 ---------~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                               ....+.+....+..|+..|++ +|++|||++|+++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     012345566778889999998 7999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-38  Score=334.49  Aligned_cols=243  Identities=21%  Similarity=0.277  Sum_probs=187.0

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD------  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------  379 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...    ...+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999986 47899999998642    23457889999999999999999999987654      


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..++||||++ |+|.+++.   ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            7899999996 58888884   24889999999999999999999998   99999999999999999999999999986


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--------------  524 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--------------  524 (588)
                      ....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ .              
T Consensus       177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            5432  2233457899999999999999999999999999999999999998643221111000 0              


Q ss_pred             ----------cccC-------------cc---cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          525 ----------PKLD-------------RE---YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       525 ----------~~l~-------------~~---~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                +...             ..   ........+..|+..|+. +|.+|||++|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                      0000             00   011224557788899998 79999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.6e-38  Score=327.62  Aligned_cols=243  Identities=21%  Similarity=0.258  Sum_probs=197.8

Q ss_pred             hcCccccceeeccCceEEEEEEe--cCCcEEEEEEecCCC-cHHHHHHHHHHhccCCCC------ceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL--SNNQHVAIKHITNEG-NVETFVREVASSSHVRHP------NLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~Hp------nIv~l~g~~~~~~~~  381 (588)
                      .++|+..+.||+|+||.||+++.  .+|+.||||++.... ..+.+.+|+++++.++|+      +++++++++.+.+..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            46899999999999999999986  378999999997543 356788899998888655      499999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---------------
Q 042871          382 FLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---------------  445 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---------------  445 (588)
                      ++||||+ +++|.+++.... ..+++.+++.++.|+++||+|||+.+   |+||||||+|||++.               
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccc
Confidence            9999999 899999996544 36889999999999999999999998   999999999999987               


Q ss_pred             ----CCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh
Q 042871          446 ----NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE  521 (588)
Q Consensus       446 ----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~  521 (588)
                          ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                678999999999864322    234578999999999999999999999999999999999999986443322111


Q ss_pred             hcCccc-----------------------------------------C--cccCHHHHHHHHHHHHHhhc-CCCCCCCHH
Q 042871          522 LADPKL-----------------------------------------D--REYSIEAFDLTLQLALSCTA-LTHQRPPME  557 (588)
Q Consensus       522 ~~d~~l-----------------------------------------~--~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~  557 (588)
                      .+....                                         .  ........+.+..|+..|+. +|.+|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            110000                                         0  00122344667788999998 799999999


Q ss_pred             HHHH
Q 042871          558 QVFV  561 (588)
Q Consensus       558 evl~  561 (588)
                      |+++
T Consensus       325 ell~  328 (339)
T 1z57_A          325 EALK  328 (339)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.3e-39  Score=331.16  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=197.8

Q ss_pred             cccHHHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCC--CCceeEEecc
Q 042871          301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVR--HPNLVALLGY  374 (588)
Q Consensus       301 ~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~--HpnIv~l~g~  374 (588)
                      .+.+..+....++|...+.||+|+||.||+++..+++.||||++...    ...+.+.+|+.++.+++  |+||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            34444445557889999999999999999999988999999998643    23467899999999997  5999999999


Q ss_pred             eeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       375 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                      +.+.+..++||| +.+++|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+|||+++ +.+||+||
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Df  170 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDF  170 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeec
Confidence            999999999999 5689999999654 46899999999999999999999998   999999999999964 89999999


Q ss_pred             CCcceecCCCcc-cccCccCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHcCCCccccccc--cchh
Q 042871          455 GLSKVIDIGETY-ASSEVRGTFGYLDPEYRSN-----------CKVNSSGDVYSFGIVLLQILSGKKAKVLTRA--GSAL  520 (588)
Q Consensus       455 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-----------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~--~~~~  520 (588)
                      |+++........ ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||.....  ....
T Consensus       171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  250 (313)
T 3cek_A          171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH  250 (313)
T ss_dssp             SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred             cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence            999876543322 2234568999999999865           4788899999999999999999999864322  1223


Q ss_pred             hhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          521 ELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       521 ~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..+++......+......+..++..|+. +|.+|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            3333333222222223456667888888 79999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.1e-38  Score=326.50  Aligned_cols=246  Identities=27%  Similarity=0.380  Sum_probs=194.1

Q ss_pred             HhcCccccceeeccCceEEEEEEe--cCCcEEEEEEecCC----CcHHHHHHHHHHhccC---CCCceeEEeccee----
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL--SNNQHVAIKHITNE----GNVETFVREVASSSHV---RHPNLVALLGYCL----  376 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~----  376 (588)
                      +.++|...+.||+|+||.||+|+.  .+|+.||||++...    .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            467899999999999999999997  46889999998632    2233566777776665   8999999999987    


Q ss_pred             -ccCeeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          377 -RVDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       377 -~~~~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                       .....++||||++ |+|.+++.... ..+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence             5667899999997 69999996543 35899999999999999999999998   999999999999999999999999


Q ss_pred             CCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC----------
Q 042871          455 GLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD----------  524 (588)
Q Consensus       455 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d----------  524 (588)
                      |+++.....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.          
T Consensus       165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            999865422  22344678999999999999999999999999999999999999986432211110000          


Q ss_pred             ----------------cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          525 ----------------PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       525 ----------------~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                      ..............+..++..|+. +|.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                            000001111223445667888888 7999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.1e-38  Score=339.58  Aligned_cols=195  Identities=26%  Similarity=0.269  Sum_probs=170.0

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-cHHHHHHHHHHhccC------CCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-NVETFVREVASSSHV------RHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l------~HpnIv~l~g~~~~~~~~~  382 (588)
                      ..+|+..+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++.+      +|+||+++++++...+..+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            56799999999999999999986 468999999997653 245677787777666      5789999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc--EEEEecCCcce
Q 042871          383 LIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE--AKLSDFGLSKV  459 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~--~kL~DFGla~~  459 (588)
                      +||||++ ++|.+++.... ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.  +||+|||+++.
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            9999995 79999986543 45899999999999999999999998   999999999999999887  99999999976


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            4322    2345789999999999999999999999999999999999998854

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-37  Score=336.82  Aligned_cols=196  Identities=24%  Similarity=0.349  Sum_probs=166.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc-----Ce
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV-----DE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~  380 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...    ...+.+.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            56899999999999999999986 46889999999752    2346789999999999999999999999766     57


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .|+||||++ |+|.+++.. ...+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999995 699999954 346999999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCcc---------------------cccCccCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          461 DIGETY---------------------ASSEVRGTFGYLDPEYR-SNCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       461 ~~~~~~---------------------~~~~~~gt~~Y~aPE~~-~~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      ......                     ......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            433211                     12456799999999985 5667999999999999999999876554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=325.56  Aligned_cols=246  Identities=21%  Similarity=0.271  Sum_probs=186.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC--CcHHHHHHHHHHhccCCCCceeEEeccee-----------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE--GNVETFVREVASSSHVRHPNLVALLGYCL-----------  376 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-----------  376 (588)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  ...+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467899999999999999999975 5899999998643  34567899999999999999999998873           


Q ss_pred             ---ccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEE
Q 042871          377 ---RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLS  452 (588)
Q Consensus       377 ---~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~  452 (588)
                         +.+..++||||++ |+|.+++.  ...+++..++.++.|+++||+|||+.+   |+||||||+|||++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence               4467899999997 69999994  356899999999999999999999998   99999999999997 57799999


Q ss_pred             ecCCcceecCCCc--ccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc--
Q 042871          453 DFGLSKVIDIGET--YASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL--  527 (588)
Q Consensus       453 DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l--  527 (588)
                      |||+++.......  .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||...........+....  
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999987643221  12233467899999998765 678999999999999999999999986433221111110000  


Q ss_pred             ---------------------C-c-----ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          528 ---------------------D-R-----EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       528 ---------------------~-~-----~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                           . .     .........+..++..|++ +|.+|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence                                 0 0     0001123446677889998 79999999999863

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=338.40  Aligned_cols=197  Identities=23%  Similarity=0.358  Sum_probs=156.2

Q ss_pred             cCccc-cceeeccCceEEEEEEec---CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEeccee--ccCeeeEEe
Q 042871          312 EKLNE-LNLIGEGITGKVYKGKLS---NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCL--RVDECFLIY  385 (588)
Q Consensus       312 ~~f~~-~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~LV~  385 (588)
                      +.|+. .++||+|+||.||+|+..   +++.||||++........+.+|+.++++++||||+++++++.  .....++||
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            44555 347999999999999964   578999999987766678999999999999999999999995  467899999


Q ss_pred             ecCCCCChhhhhhcC--------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE----CCCCcEEEEe
Q 042871          386 ELCPNGNLAEWLFGK--------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSD  453 (588)
Q Consensus       386 E~~~~gsL~~~L~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl----d~~~~~kL~D  453 (588)
                      ||++ |+|.+++...        ...+++..++.++.|++.||.|||+.+   |+||||||+|||+    ++++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9995 6888887421        124899999999999999999999999   9999999999999    7789999999


Q ss_pred             cCCcceecCCCc--ccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          454 FGLSKVIDIGET--YASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       454 FGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      ||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  237 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  237 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence            999987643221  223446789999999998874 58999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.8e-38  Score=329.78  Aligned_cols=245  Identities=23%  Similarity=0.294  Sum_probs=192.1

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceecc-----Cee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRV-----DEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~  381 (588)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            578999999999999999999974 78999999996432   245788999999999999999999987654     678


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceec
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID  461 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~  461 (588)
                      ++||||++ |+|.+++..  ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 699999854  46899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc---------cccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc--------
Q 042871          462 IGETY---------ASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA--------  523 (588)
Q Consensus       462 ~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~--------  523 (588)
                      .....         ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...........+        
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            32211         1223578999999998754 77899999999999999999999998643221110000        


Q ss_pred             -----------------C--cccC----cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 -----------------D--PKLD----REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 -----------------d--~~l~----~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                       .  +...    ..........+..++..|++ +|.+|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                             0  0000    00001122345667888888 7999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.4e-38  Score=329.50  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=186.4

Q ss_pred             HHHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCe--
Q 042871          305 REVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDE--  380 (588)
Q Consensus       305 ~el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~--  380 (588)
                      .......++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+|++.+..++||||+++++++...+.  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            44566788999999999999999999997 47899999988643 334567788888999999999999999976443  


Q ss_pred             -----eeEEeecCCCCChhhhhh---cCCcCccHHHHHHHHHhhhccchhhc--cccCCceEecCCCCCCeEECC-CCcE
Q 042871          381 -----CFLIYELCPNGNLAEWLF---GKDKCLSWIQRLEIAIDSARGLWFLH--SYSEGCIVHRDIKPTNILLGP-NFEA  449 (588)
Q Consensus       381 -----~~LV~E~~~~gsL~~~L~---~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~IvHrDLKp~NILld~-~~~~  449 (588)
                           .++||||+++ +|.+.+.   .....+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                 7899999975 5555443   24456889999999999999999999  777   999999999999997 8999


Q ss_pred             EEEecCCcceecCCCcccccCccCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-----
Q 042871          450 KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-----  523 (588)
Q Consensus       450 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-----  523 (588)
                      ||+|||+++......  ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+     
T Consensus       172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            999999998765433  223457899999999986654 899999999999999999999998643322111111     


Q ss_pred             ----------Cccc----------------CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 ----------DPKL----------------DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 ----------d~~l----------------~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                ++..                ......+....+..|+..|++ +|.+|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                      0000                000111133557778899998 79999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.5e-38  Score=317.81  Aligned_cols=246  Identities=26%  Similarity=0.348  Sum_probs=198.7

Q ss_pred             HHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ...++|...+.||+|+||.||+|+.. +++.||||++..    ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999975 789999999853    2356789999999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC---CcEEEEecCCccee
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN---FEAKLSDFGLSKVI  460 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~---~~~kL~DFGla~~~  460 (588)
                      |+||+++++|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+||+++.+   +.+||+|||++...
T Consensus        99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999999988643 35899999999999999999999998   9999999999999764   46999999999865


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc-ccCccc--CHHHHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP-KLDREY--SIEAFD  537 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~-~l~~~~--~~e~~~  537 (588)
                      ....  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........+.. ......  ......
T Consensus       175 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 2wei_A          175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD  251 (287)
T ss_dssp             CCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred             cCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence            4332  2233458899999998876 589999999999999999999999875443332222211 110000  011223


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .+..++..|+. +|.+|||+.|+++
T Consensus       252 ~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          252 DAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhc
Confidence            45667788888 7999999999997

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-38  Score=334.57  Aligned_cols=242  Identities=24%  Similarity=0.331  Sum_probs=177.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceecc------C
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRV------D  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~  379 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...    ...+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999985 57899999998643    2346788999999999999999999998654      5


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..++|+||+ +++|.+++..  ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 7899999843  56999999999999999999999998   99999999999999999999999999986


Q ss_pred             ecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc-------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP-------------  525 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~-------------  525 (588)
                      ....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+..             
T Consensus       182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            5422    234578999999999877 6789999999999999999999999864332111110000             


Q ss_pred             ----------ccC--cccC-----HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          526 ----------KLD--REYS-----IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       526 ----------~l~--~~~~-----~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                .+.  ....     ......+..|+..|+. +|.+|||++|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                      000  0000     0112345667888888 79999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.4e-38  Score=338.36  Aligned_cols=243  Identities=26%  Similarity=0.301  Sum_probs=187.2

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceecc------CeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV------DECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~L  383 (588)
                      ..+|...+.||+|+||.||+|++. +|+.||||++....  +.+.+|++++++++||||+++++++...      ...++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            346888999999999999999974 69999999986542  2334799999999999999999998542      23679


Q ss_pred             EeecCCCCChhhhhh---cCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-CcEEEEecCCcce
Q 042871          384 IYELCPNGNLAEWLF---GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKV  459 (588)
Q Consensus       384 V~E~~~~gsL~~~L~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-~~~kL~DFGla~~  459 (588)
                      ||||+++ +|.+.+.   .....+++..++.++.|+++||+|||+.+   |+||||||+|||++.+ +.+||+|||+++.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999975 6666653   23457999999999999999999999998   9999999999999965 5789999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccc-hhhh--------------c
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-ALEL--------------A  523 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-~~~~--------------~  523 (588)
                      ...+..  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ..++              .
T Consensus       207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            644332  2345789999999998764 79999999999999999999999986432211 1000              0


Q ss_pred             CcccC--------c-----ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 DPKLD--------R-----EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 d~~l~--------~-----~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ++...        .     .+.......+..|+..|+. +|.+|||+.|+++
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            11000        0     0111122445667888888 7999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.7e-38  Score=324.49  Aligned_cols=245  Identities=24%  Similarity=0.348  Sum_probs=174.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC---cHHHHHHHHH-HhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG---NVETFVREVA-SSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....   ....+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            46788899999999999999997 479999999997542   2345566665 788889999999999999999999999


Q ss_pred             ecCCCCChhhhhhc----CCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          386 ELCPNGNLAEWLFG----KDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       386 E~~~~gsL~~~L~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      ||++ |+|.+++..    ....+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            9997 588887742    245689999999999999999999998 8   999999999999999999999999999876


Q ss_pred             cCCCcccccCccCCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHcCCCcccccccc--chhhhcC---cccCccc
Q 042871          461 DIGETYASSEVRGTFGYLDPEYR----SNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG--SALELAD---PKLDREY  531 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~--~~~~~~d---~~l~~~~  531 (588)
                      ....  ......||+.|+|||++    .+..++.++||||||+++|||++|+.||......  .......   +.+....
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE  254 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence            4322  22334689999999998    5667899999999999999999999998643211  1111111   1111111


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .......+.+++..|+. +|.+|||+.|+++
T Consensus       255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          255 EREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            11223456667888988 7999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-37  Score=324.52  Aligned_cols=243  Identities=21%  Similarity=0.243  Sum_probs=194.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CC-cEEEEEEecCCC-cHHHHHHHHHHhccCCCCc------eeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NN-QHVAIKHITNEG-NVETFVREVASSSHVRHPN------LVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g-~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~Hpn------Iv~l~g~~~~~~~~  381 (588)
                      .++|...+.||+|+||.||+++.. ++ +.||||++.... ..+.+.+|+.++++++|+|      ++.+.+++...+..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            578999999999999999999863 44 789999997543 3567888999998887665      99999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE-----------------
Q 042871          382 FLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL-----------------  443 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl-----------------  443 (588)
                      ++||||+ +++|.+++.... ..+++.+++.++.|+++||+|||+.+   |+||||||+|||+                 
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccc
Confidence            9999999 677777775443 46999999999999999999999998   9999999999999                 


Q ss_pred             --CCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh
Q 042871          444 --GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE  521 (588)
Q Consensus       444 --d~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~  521 (588)
                        +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence              56889999999999864322    234578999999999999999999999999999999999999986433222111


Q ss_pred             hcCcccC-------------------------------------------cccCHHHHHHHHHHHHHhhc-CCCCCCCHH
Q 042871          522 LADPKLD-------------------------------------------REYSIEAFDLTLQLALSCTA-LTHQRPPME  557 (588)
Q Consensus       522 ~~d~~l~-------------------------------------------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~  557 (588)
                      .+.....                                           ..........+..|+..|+. +|.+|||++
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            1100000                                           00011223467788999998 799999999


Q ss_pred             HHHH
Q 042871          558 QVFV  561 (588)
Q Consensus       558 evl~  561 (588)
                      |+++
T Consensus       330 e~l~  333 (355)
T 2eu9_A          330 EALL  333 (355)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.9e-38  Score=333.48  Aligned_cols=245  Identities=23%  Similarity=0.312  Sum_probs=188.1

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceeccCe------eeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDE------CFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~------~~LV  384 (588)
                      ..+|...+.||+|+||.||+|+..++..||+|++.....  ...+|+++++.++||||+++++++...+.      .++|
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            457899999999999999999987777799998865322  22379999999999999999999965433      7899


Q ss_pred             eecCCCCChhhhhh--cCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEEecCCcceec
Q 042871          385 YELCPNGNLAEWLF--GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLSDFGLSKVID  461 (588)
Q Consensus       385 ~E~~~~gsL~~~L~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~DFGla~~~~  461 (588)
                      |||++++.+.....  .....+++..++.++.|+++||+|||+.+   |+||||||+|||++ +++.+||+|||+++...
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            99997654433332  23456899999999999999999999998   99999999999999 79999999999998764


Q ss_pred             CCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhh-h--------------cCc
Q 042871          462 IGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-L--------------ADP  525 (588)
Q Consensus       462 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~--------------~d~  525 (588)
                      .+..  .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+... .              .++
T Consensus       194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            4332  2345789999999998764 58999999999999999999999986432211100 0              000


Q ss_pred             c-----cC--------cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          526 K-----LD--------REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       526 ~-----l~--------~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .     +.        ..+.......+..|+..|+. +|.+|||+.|+++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            0     00        00111122346667888888 79999999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.1e-37  Score=327.95  Aligned_cols=241  Identities=22%  Similarity=0.256  Sum_probs=189.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCee----
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDEC----  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~----  381 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....    ..+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            56889999999999999999986 478999999997532    246788999999999999999999999877654    


Q ss_pred             --eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          382 --FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       382 --~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                        ++||||++ ++|.+++.   ..+++.++..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 68888873   24899999999999999999999998   99999999999999999999999999986


Q ss_pred             ecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---------------  523 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---------------  523 (588)
                      ....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+               
T Consensus       194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            5422    234578999999999877 78999999999999999999999998643221111100               


Q ss_pred             ------------CcccCcc---cCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 ------------DPKLDRE---YSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 ------------d~~l~~~---~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                  .......   ........+..|+..|++ +|.+|||++|+++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                        0000000   001112446667888888 79999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.8e-37  Score=324.05  Aligned_cols=243  Identities=22%  Similarity=0.239  Sum_probs=169.6

Q ss_pred             hcCccccc-eeeccCceEEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceec----cCeeeEE
Q 042871          311 TEKLNELN-LIGEGITGKVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLR----VDECFLI  384 (588)
Q Consensus       311 t~~f~~~~-~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV  384 (588)
                      .++|...+ .||+|+||.||+|+.. +|+.||||++....  ....+....++.++||||+++++++..    +...++|
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            67888855 6999999999999975 79999999997542  222223334667799999999999876    4558999


Q ss_pred             eecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEEecCCccee
Q 042871          385 YELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLSDFGLSKVI  460 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~DFGla~~~  460 (588)
                      |||+++|+|.+++.... ..+++.+++.++.|+++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            99999999999997544 46999999999999999999999998   999999999999976   455999999999865


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCc-------ccCcccCH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADP-------KLDREYSI  533 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~-------~l~~~~~~  533 (588)
                      ...   ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............       ........
T Consensus       182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (336)
T 3fhr_A          182 TQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS  258 (336)
T ss_dssp             -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTST
T ss_pred             ccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhc
Confidence            422   22345689999999999888899999999999999999999999864433222111100       01111111


Q ss_pred             HHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          534 EAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       534 e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .....+.+++..|+. +|.+|||++|+++
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          259 EVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            223345667788887 7999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1e-37  Score=331.47  Aligned_cols=204  Identities=25%  Similarity=0.263  Sum_probs=171.9

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-cHHHHHHHHHHhccCC-CC-----ceeEEecce
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-NVETFVREVASSSHVR-HP-----NLVALLGYC  375 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~-Hp-----nIv~l~g~~  375 (588)
                      +.......++|...+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++..++ |+     +|+++++++
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            3334445789999999999999999999864 78899999997543 3456778888887775 44     599999999


Q ss_pred             eccCeeeEEeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC--CCCcEEEE
Q 042871          376 LRVDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG--PNFEAKLS  452 (588)
Q Consensus       376 ~~~~~~~LV~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld--~~~~~kL~  452 (588)
                      ...+..++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++. .+|+||||||+|||++  .++.+||+
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEE
Confidence            99999999999995 69999997544 46899999999999999999999531 2299999999999994  57889999


Q ss_pred             ecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          453 DFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       453 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                      |||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999876422    2345789999999999999999999999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=336.37  Aligned_cols=247  Identities=27%  Similarity=0.344  Sum_probs=188.5

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ...+|...+.||+|+||+||.....+|+.||||++..+. ...+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            345788899999999999665555689999999997543 23466899999998 7999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-----CCcEEEEecCCcceecCC
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-----NFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-----~~~~kL~DFGla~~~~~~  463 (588)
                      + |+|.+++........+.+.+.++.|+++||.|||+.+   |+||||||+|||++.     +..+||+|||+++.....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            5 6999999776656666777899999999999999998   999999999999943     346889999999876543


Q ss_pred             Cc--ccccCccCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcc--cCHHH
Q 042871          464 ET--YASSEVRGTFGYLDPEYRS---NCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDRE--YSIEA  535 (588)
Q Consensus       464 ~~--~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~--~~~e~  535 (588)
                      ..  .......||+.|+|||++.   ...++.++||||||+++|||++ |+.||...................  .....
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE  256 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence            22  2234567999999999987   4677889999999999999999 888885433322222221111111  11223


Q ss_pred             HHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ...+..|+..|++ +|.+|||++||++
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            3446678899998 7999999999983

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-38  Score=321.99  Aligned_cols=243  Identities=26%  Similarity=0.326  Sum_probs=188.0

Q ss_pred             HHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC--------cHHHHHHHHHHhccC----CCCceeEEe
Q 042871          306 EVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG--------NVETFVREVASSSHV----RHPNLVALL  372 (588)
Q Consensus       306 el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--------~~~~~~~Ei~~l~~l----~HpnIv~l~  372 (588)
                      +.+...++|...+.||+|+||.||+|+. .+++.||||++....        ....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4455678899999999999999999986 578999999986432        223456788888888    899999999


Q ss_pred             cceeccCeeeEEeec-CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEE
Q 042871          373 GYCLRVDECFLIYEL-CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAK  450 (588)
Q Consensus       373 g~~~~~~~~~LV~E~-~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~k  450 (588)
                      +++.+.+..++|+|| +++++|.+++... ..+++.+++.++.|+++||.|||+.+   |+||||||+||+++ +++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 7899999999653 35899999999999999999999998   99999999999999 889999


Q ss_pred             EEecCCcceecCCCcccccCccCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCc
Q 042871          451 LSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN-SSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDR  529 (588)
Q Consensus       451 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~  529 (588)
                      |+|||+++......   .....|+..|+|||++.+..+. .++||||||+++|||++|+.||.....  .. .....+..
T Consensus       181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~-~~~~~~~~  254 (312)
T 2iwi_A          181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--IL-EAELHFPA  254 (312)
T ss_dssp             ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH-HTCCCCCT
T ss_pred             EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hh-hhccCCcc
Confidence            99999998765332   2345689999999998776664 489999999999999999999864321  11 11112223


Q ss_pred             ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          530 EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       530 ~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ..+.    .+.+++..|++ +|++|||++|+++.
T Consensus       255 ~~~~----~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          255 HVSP----DCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             TSCH----HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cCCH----HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            3343    45567788888 79999999999873

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-37  Score=325.93  Aligned_cols=243  Identities=19%  Similarity=0.235  Sum_probs=195.4

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-cHHHHHHHHHHhccCC-----------CCceeEEecceec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-NVETFVREVASSSHVR-----------HPNLVALLGYCLR  377 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~-----------HpnIv~l~g~~~~  377 (588)
                      .++|...+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++++++           |+||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            46799999999999999999996 578999999997543 3567889999988876           8999999999886


Q ss_pred             cC----eeeEEeecCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEEC------C
Q 042871          378 VD----ECFLIYELCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLG------P  445 (588)
Q Consensus       378 ~~----~~~LV~E~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld------~  445 (588)
                      .+    ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+. +   |+||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcC
Confidence            54    789999999 99999999653 34589999999999999999999998 8   99999999999994      4


Q ss_pred             CCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccc-------
Q 042871          446 NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-------  518 (588)
Q Consensus       446 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-------  518 (588)
                      ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......       
T Consensus       174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            458999999999875432    234578999999999999999999999999999999999999986432110       


Q ss_pred             hhhhc---Cc-----------------------------------cc--CcccCHHHHHHHHHHHHHhhc-CCCCCCCHH
Q 042871          519 ALELA---DP-----------------------------------KL--DREYSIEAFDLTLQLALSCTA-LTHQRPPME  557 (588)
Q Consensus       519 ~~~~~---d~-----------------------------------~l--~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~  557 (588)
                      ...++   .+                                   .+  ...++......+..|+..|++ +|.+|||++
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            00000   00                                   00  012345566778889999998 799999999


Q ss_pred             HHHH
Q 042871          558 QVFV  561 (588)
Q Consensus       558 evl~  561 (588)
                      |+++
T Consensus       330 ell~  333 (373)
T 1q8y_A          330 GLVN  333 (373)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            9987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.2e-37  Score=333.78  Aligned_cols=243  Identities=24%  Similarity=0.312  Sum_probs=184.0

Q ss_pred             CccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEEeecCCCC
Q 042871          313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLIYELCPNG  391 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~g  391 (588)
                      .|...+.||+|+||+||.+...+|+.||||++..+. .+.+.+|+.++.++ +||||+++++++.+++..++||||++ |
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g   93 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L   93 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence            344567899999999987666689999999986543 45678999999876 89999999999999999999999995 7


Q ss_pred             ChhhhhhcCCcC------ccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCC-------------CcEEEE
Q 042871          392 NLAEWLFGKDKC------LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-------------FEAKLS  452 (588)
Q Consensus       392 sL~~~L~~~~~~------l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~-------------~~~kL~  452 (588)
                      +|.+++......      .++..++.++.|++.||+|||+.+   |+||||||+|||++.+             +.+||+
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            999999654321      234456789999999999999998   9999999999999654             489999


Q ss_pred             ecCCcceecCCCcc---cccCccCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHc-CCCccccccccchhh
Q 042871          453 DFGLSKVIDIGETY---ASSEVRGTFGYLDPEYRSN-------CKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALE  521 (588)
Q Consensus       453 DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~-------~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~  521 (588)
                      |||+++........   ......||+.|+|||++.+       ..++.++||||||+++|||++ |+.||....... ..
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~  249 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SN  249 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HH
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HH
Confidence            99999887543322   1234579999999999865       678999999999999999999 898885332211 11


Q ss_pred             hcC-----cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          522 LAD-----PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       522 ~~d-----~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .+.     +.............+..++..|++ +|.+|||+.||++
T Consensus       250 i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            111     111111234555677888999998 7999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.5e-37  Score=314.27  Aligned_cols=227  Identities=13%  Similarity=0.091  Sum_probs=180.9

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++....     ..+.+.+|+..+.+++||||+++++++.+++..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467999999999999999999974 58999999997532     236789999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++..  . ....+..+++.|+++||+|||+.+   |+||||||+|||+++++.+||+++|         
T Consensus       110 ~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999999943  2 345578889999999999999998   9999999999999999999997443         


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCc------ccCHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDR------EYSIEAFDL  538 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~------~~~~e~~~~  538 (588)
                                  |++       .++.++||||||+++|||++|+.||...............+..      .........
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                        443       3689999999999999999999998754433222111111111      111122344


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      +..++..|++ +|.+| |+.|+++.|+++......
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~  269 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR  269 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence            6677888988 79999 999999999998865543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=323.59  Aligned_cols=241  Identities=22%  Similarity=0.252  Sum_probs=189.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC----cHHHHHHHHHHhccCCCCceeEEecceeccCe-----
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG----NVETFVREVASSSHVRHPNLVALLGYCLRVDE-----  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-----  380 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....    ..+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46788899999999999999996 479999999996532    24578899999999999999999999987654     


Q ss_pred             -eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          381 -CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       381 -~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                       .++||||++ ++|.+++..   .+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999996 699888732   4899999999999999999999998   99999999999999999999999999986


Q ss_pred             ecCCCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---------------  523 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---------------  523 (588)
                      ....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+               
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            5422    234578999999999876 67899999999999999999999998643221111000               


Q ss_pred             ------------CcccCc---ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 ------------DPKLDR---EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 ------------d~~l~~---~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                  ......   .........+..++..|+. +|.+|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                        000000   0111223445667788887 79999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=318.15  Aligned_cols=241  Identities=22%  Similarity=0.349  Sum_probs=175.2

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCCCc----HHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNEGN----VETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~----~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.....    .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467889999999999999999974 789999999975432    223444555788889999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||+ ++.+..+.......+++..++.++.|+++||.|||+. +   |+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5555555544456799999999999999999999985 7   9999999999999999999999999997654322


Q ss_pred             cccccCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCcccccccc-ch-hhhc---CcccC--cccC
Q 042871          465 TYASSEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SA-LELA---DPKLD--REYS  532 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~-~~~~---d~~l~--~~~~  532 (588)
                        ......||+.|+|||++.     ...++.++||||||+++|||++|+.||...... .. ....   .+.+.  ..++
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS  257 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence              223456899999999984     567889999999999999999999998642211 11 1111   11111  1233


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .    .+..++..|++ +|.+|||++|+++
T Consensus       258 ~----~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          258 G----DFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             H----HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H----HHHHHHHHHccCChhHCcCHHHHhh
Confidence            3    45566788888 7999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.1e-38  Score=325.68  Aligned_cols=243  Identities=26%  Similarity=0.301  Sum_probs=196.2

Q ss_pred             HHHHHhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC--------cHHHHHHHHHHhccCC--CCceeEEecc
Q 042871          306 EVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG--------NVETFVREVASSSHVR--HPNLVALLGY  374 (588)
Q Consensus       306 el~~at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--------~~~~~~~Ei~~l~~l~--HpnIv~l~g~  374 (588)
                      +.....++|...+.||+|+||.||+|+. .+|+.||||++....        ..+.+.+|+.++++++  |+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3344567899999999999999999985 578999999986431        2245778999999996  5999999999


Q ss_pred             eeccCeeeEEeecCCC-CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEE
Q 042871          375 CLRVDECFLIYELCPN-GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLS  452 (588)
Q Consensus       375 ~~~~~~~~LV~E~~~~-gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~  452 (588)
                      +.+.+..++|+|++.+ ++|.+++.. ...+++..++.++.|+++||+|||+.+   |+||||||+|||++ +++.+||+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999999976 899999964 346899999999999999999999998   99999999999999 78999999


Q ss_pred             ecCCcceecCCCcccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCccc
Q 042871          453 DFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREY  531 (588)
Q Consensus       453 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~  531 (588)
                      |||+++.....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......   .........+
T Consensus       193 Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~  266 (320)
T 3a99_A          193 DFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII---RGQVFFRQRV  266 (320)
T ss_dssp             CCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---HCCCCCSSCC
T ss_pred             eCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh---cccccccccC
Confidence            99999876532   2234568999999999877665 678999999999999999999986432111   0111122334


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +.    .+..++..|++ +|.+|||++|+++.
T Consensus       267 ~~----~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          267 SS----ECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CH----HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CH----HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            44    35566788888 79999999999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-36  Score=346.85  Aligned_cols=237  Identities=21%  Similarity=0.262  Sum_probs=191.4

Q ss_pred             hcCccccceeeccCceEEEEEEec--CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCe-----
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS--NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDE-----  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-----  380 (588)
                      .++|.+.+.||+|+||.||+|++.  +|+.||||++....   ..+.+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            468999999999999999999974  68999999986532   34578899999999999999999999987665     


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .||||||+++++|.+++..   .+++.+++.++.|+++||.|||+.+   |+||||||+|||++++ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence            7999999999999998743   6999999999999999999999998   9999999999999886 9999999999875


Q ss_pred             cCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ...     ....||++|+|||++.+. ++.++||||||+++|||++|..|+.........       ...........+.
T Consensus       232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------~~~~~~~~~~~l~  298 (681)
T 2pzi_A          232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------EDDPVLKTYDSYG  298 (681)
T ss_dssp             TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-------TTCHHHHHCHHHH
T ss_pred             ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-------ccccccccCHHHH
Confidence            432     345799999999998765 489999999999999999998877532111110       0111112235567


Q ss_pred             HHHHHhhc-CCCCCC-CHHHHHHHHHHhh
Q 042871          541 QLALSCTA-LTHQRP-PMEQVFVTLQKAL  567 (588)
Q Consensus       541 ~L~~~C~~-~p~~RP-s~~evl~~L~~~~  567 (588)
                      .++..|++ +|.+|| +++++.+.|...+
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            78899998 799999 5677777777664

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-36  Score=327.32  Aligned_cols=236  Identities=17%  Similarity=0.146  Sum_probs=178.4

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCC-Ccee--------------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRH-PNLV--------------  369 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~H-pnIv--------------  369 (588)
                      +.+|...+.||+|+||.||+|++ .+|+.||||++...     ...+.|.+|+.+++.++| +|..              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            45677788999999999999995 57999999998732     235679999999999987 3221              


Q ss_pred             -EE------ecceec-----cCeeeEEeecCCCCChhhhhh------cCCcCccHHHHHHHHHhhhccchhhccccCCce
Q 042871          370 -AL------LGYCLR-----VDECFLIYELCPNGNLAEWLF------GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCI  431 (588)
Q Consensus       370 -~l------~g~~~~-----~~~~~LV~E~~~~gsL~~~L~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~I  431 (588)
                       .+      ..++..     ....+++|+++ +++|.+++.      .....+++..++.++.|+++||+|||+.+   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence             11      111111     22457777766 789999983      23456899999999999999999999998   9


Q ss_pred             EecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccc----------cCCCCCchhhHHHHHHHH
Q 042871          432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYR----------SNCKVNSSGDVYSFGIVL  501 (588)
Q Consensus       432 vHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~t~ksDVwS~Gvll  501 (588)
                      +||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999998864322    334567 999999998          556688999999999999


Q ss_pred             HHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHH
Q 042871          502 LQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVF  560 (588)
Q Consensus       502 ~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl  560 (588)
                      |||++|+.||.........+.+-+.. ..++    +.+..|+..|++ +|.+|||+.|++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSEWIFRSC-KNIP----QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSGGGGSSC-CCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhhHHHHHhhc-ccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999997544333322221111 2334    346667788888 799999976663

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.2e-36  Score=338.12  Aligned_cols=255  Identities=25%  Similarity=0.308  Sum_probs=200.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceec------cCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLR------VDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~  380 (588)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...   ...+.+.+|++++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999986 57899999998753   235678999999999999999999998765      677


Q ss_pred             eeEEeecCCCCChhhhhhcCC--cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCc---EEEEecC
Q 042871          381 CFLIYELCPNGNLAEWLFGKD--KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFE---AKLSDFG  455 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~---~kL~DFG  455 (588)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999996543  26899999999999999999999998   999999999999997665   9999999


Q ss_pred             CcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc-----------cchhhhcC
Q 042871          456 LSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA-----------GSALELAD  524 (588)
Q Consensus       456 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~-----------~~~~~~~d  524 (588)
                      +++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....           ........
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            998765433  23446789999999999999999999999999999999999999853100           00000000


Q ss_pred             ----------cc--cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHH-----HHHHHHHhhccC
Q 042871          525 ----------PK--LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQ-----VFVTLQKALDIS  570 (588)
Q Consensus       525 ----------~~--l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~e-----vl~~L~~~~~~~  570 (588)
                                ..  .....+......+..++..|+. +|.+|||++|     ..+.++.+++..
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence                      00  0112334456677888999998 7999999988     567777777654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-35  Score=300.43  Aligned_cols=223  Identities=22%  Similarity=0.296  Sum_probs=176.0

Q ss_pred             hcCcccc-ceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHh-ccCCCCceeEEecceec----cCeeeE
Q 042871          311 TEKLNEL-NLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASS-SHVRHPNLVALLGYCLR----VDECFL  383 (588)
Q Consensus       311 t~~f~~~-~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~----~~~~~L  383 (588)
                      .++|... +.||+|+||.||+++. .+++.||||++...   ..+.+|++++ +..+||||+++++++..    ....++
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            4567776 7799999999999986 57899999999653   5677888887 66789999999999876    677899


Q ss_pred             EeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEEecCCcce
Q 042871          384 IYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLSDFGLSKV  459 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~DFGla~~  459 (588)
                      ||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            999999999999997543 46999999999999999999999998   999999999999998   78999999999875


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccC-c--ccCH---
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLD-R--EYSI---  533 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~-~--~~~~---  533 (588)
                      ..                       +..++.++||||||+++|||++|+.||...............+. .  ..+.   
T Consensus       170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (299)
T 3m2w_A          170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW  226 (299)
T ss_dssp             CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred             cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence            32                       13467899999999999999999999864433222111111111 0  1111   


Q ss_pred             -HHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          534 -EAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       534 -e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                       .....+..++..|++ +|.+|||+.|+++.
T Consensus       227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             123446667888888 79999999999973

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.6e-36  Score=312.69  Aligned_cols=233  Identities=20%  Similarity=0.157  Sum_probs=180.2

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC----------cHHHHHHHHHHhccCC---------CCceeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG----------NVETFVREVASSSHVR---------HPNLVAL  371 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l~---------HpnIv~l  371 (588)
                      .++|...+.||+|+||.||+|+. +|+.||||++....          ..+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            56788999999999999999998 78999999986431          2378889999888876         5555555


Q ss_pred             e-----------------cceec-------------cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccch
Q 042871          372 L-----------------GYCLR-------------VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW  421 (588)
Q Consensus       372 ~-----------------g~~~~-------------~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~  421 (588)
                      .                 +++.+             .+..++||||+++|++.+.+.+  ..+++.+++.++.|++.||.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            4                 44443             6789999999999987777733  56899999999999999999


Q ss_pred             hhc-cccCCceEecCCCCCCeEECCCC--------------------cEEEEecCCcceecCCCcccccCccCCCCccCc
Q 042871          422 FLH-SYSEGCIVHRDIKPTNILLGPNF--------------------EAKLSDFGLSKVIDIGETYASSEVRGTFGYLDP  480 (588)
Q Consensus       422 yLH-~~~~~~IvHrDLKp~NILld~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aP  480 (588)
                      ||| +.+   |+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+||
T Consensus       176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred             HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence            999 888   99999999999999887                    8999999999876532      34789999999


Q ss_pred             ccccCCCCCchhhHHHHHHH-HHHHHcCCCcccccc--ccchhhhc-----CcccCcccCHHHHHHHHHHHHHhhcCCCC
Q 042871          481 EYRSNCKVNSSGDVYSFGIV-LLQILSGKKAKVLTR--AGSALELA-----DPKLDREYSIEAFDLTLQLALSCTALTHQ  552 (588)
Q Consensus       481 E~~~~~~~t~ksDVwS~Gvl-l~ElltG~~p~~~~~--~~~~~~~~-----d~~l~~~~~~e~~~~v~~L~~~C~~~p~~  552 (588)
                      |++.+.. +.++||||||.+ .+++++|..|+....  ........     ...............+..|+..|++.+  
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--  323 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--  323 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence            9998766 899999998777 788999999885311  00011111     111111122345566778888998833  


Q ss_pred             CCCHHHHH
Q 042871          553 RPPMEQVF  560 (588)
Q Consensus       553 RPs~~evl  560 (588)
                        |++|++
T Consensus       324 --sa~e~l  329 (336)
T 2vuw_A          324 --SATDLL  329 (336)
T ss_dssp             --SHHHHH
T ss_pred             --CHHHHH
Confidence              888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=4.5e-30  Score=286.77  Aligned_cols=184  Identities=15%  Similarity=0.077  Sum_probs=131.0

Q ss_pred             eeeccCceEEEEEE-ecCCcEEEEEEecCC------------CcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEE
Q 042871          319 LIGEGITGKVYKGK-LSNNQHVAIKHITNE------------GNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       319 ~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~------------~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ..+.|++|.+..++ .-.|+.+++|++..+            ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35667777666654 346889999998632            2345799999999999 699999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||++|++|.++|... ..++..   +|+.||++||+|||+++   |+||||||+||||++++++||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            9999999999999654 345543   58999999999999999   9999999999999999999999999998765432


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      . ......||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus       394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            2 2344679999999999876 5677899999999999888776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2e-27  Score=263.90  Aligned_cols=182  Identities=19%  Similarity=0.207  Sum_probs=145.0

Q ss_pred             cccceeeccCceEEEEEEecCCcEEEEEEecCCC----------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          315 NELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG----------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ...+.||+|+||.||+|+. .++.+++|+.....          ..+.+.+|++++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999965 67889999864321          134589999999999999999766666677888999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++++|.+++..         +..++.|+++||.|||+++   |+||||||+|||+++  ++||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999954         5689999999999999998   999999999999998  99999999999875432


Q ss_pred             ccc------ccCccCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCcc
Q 042871          465 TYA------SSEVRGTFGYLDPEYRSN--CKVNSSGDVYSFGIVLLQILSGKKAK  511 (588)
Q Consensus       465 ~~~------~~~~~gt~~Y~aPE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~  511 (588)
                      ...      .....||+.|||||++..  ..|+...|+|+..+-.++-+.++.++
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            211      235679999999999876  56888899999999988888776654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=1.5e-23  Score=213.77  Aligned_cols=150  Identities=15%  Similarity=0.032  Sum_probs=121.1

Q ss_pred             HHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCCC--------------------cHHHHHHHHHHhccCCC
Q 042871          306 EVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG--------------------NVETFVREVASSSHVRH  365 (588)
Q Consensus       306 el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--------------------~~~~~~~Ei~~l~~l~H  365 (588)
                      .+......|...+.||+|+||.||+|+..+|+.||||.+....                    ....+.+|+.++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            3444455666779999999999999999889999999986321                    2456889999999999 


Q ss_pred             CceeEEecceeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC
Q 042871          366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP  445 (588)
Q Consensus       366 pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~  445 (588)
                       | +++.+++ +.+..++||||+++|+|.+ +..       .....++.|+++||.|||+.+   |+||||||+|||++ 
T Consensus       163 -~-~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 -G-LAVPKVY-AWEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-  227 (282)
T ss_dssp             -T-SSSCCEE-EEETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred             -C-CCcCeEE-eccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence             4 6666654 3456799999999999998 521       234469999999999999998   99999999999999 


Q ss_pred             CCcEEEEecCCcceecCCCcccccCccCCCCccCcccccC
Q 042871          446 NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN  485 (588)
Q Consensus       446 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  485 (588)
                      ++.+||+|||+++.              +..|+|||++..
T Consensus       228 ~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence            99999999999864              345789998643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=7.5e-20  Score=183.76  Aligned_cols=134  Identities=17%  Similarity=0.140  Sum_probs=105.7

Q ss_pred             ccccceeeccCceEEEEEEe-cCCcE--EEEEEecCCC-c-------------------------HHHHHHHHHHhccCC
Q 042871          314 LNELNLIGEGITGKVYKGKL-SNNQH--VAIKHITNEG-N-------------------------VETFVREVASSSHVR  364 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~-~~g~~--VAVK~l~~~~-~-------------------------~~~~~~Ei~~l~~l~  364 (588)
                      |+..+.||+|+||.||+|+. .+|+.  ||||+++... .                         ...+.+|+..+.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999997 78999  9999875321 0                         136788999999998


Q ss_pred             CCce--eEEecceeccCeeeEEeecCCC-C----ChhhhhhcCCcCccHHHHHHHHHhhhccchhhc-cccCCceEecCC
Q 042871          365 HPNL--VALLGYCLRVDECFLIYELCPN-G----NLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH-SYSEGCIVHRDI  436 (588)
Q Consensus       365 HpnI--v~l~g~~~~~~~~~LV~E~~~~-g----sL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~IvHrDL  436 (588)
                      |+++  ..++++    +..+|||||+.+ |    +|.++...    .++.....++.|++.+|.||| +.+   |+||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE---LVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence            7754  333332    356899999942 4    56555421    345567889999999999999 888   999999


Q ss_pred             CCCCeEECCCCcEEEEecCCccee
Q 042871          437 KPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       437 Kp~NILld~~~~~kL~DFGla~~~  460 (588)
                      ||+|||+++  .++|+|||++...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=5.1e-17  Score=171.54  Aligned_cols=136  Identities=12%  Similarity=0.033  Sum_probs=98.1

Q ss_pred             ccccceeeccCceEEEEEEecCCcEEEEEEecCC----------------CcHHHHHHHHHHhccCCCCceeEEecceec
Q 042871          314 LNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----------------GNVETFVREVASSSHVRHPNLVALLGYCLR  377 (588)
Q Consensus       314 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----------------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~  377 (588)
                      |++.+.||+|+||.||+|...+|+.||||+++..                ........++++.....|+|+.++......
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            7888999999999999999999999999987421                111223333333333334444444332221


Q ss_pred             c------CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC----
Q 042871          378 V------DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF----  447 (588)
Q Consensus       378 ~------~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~----  447 (588)
                      .      ...+|||||+++++|.++...       .....++.|++.+|.|||+.+   |+||||||.|||+++++    
T Consensus       177 vp~p~~~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          177 VPEPIAQSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CCCEEEEETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSC
T ss_pred             CCeeeeccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCccc
Confidence            1      223699999999888776521       123567899999999999998   99999999999998876    


Q ss_pred             ------cEEEEecCCcce
Q 042871          448 ------EAKLSDFGLSKV  459 (588)
Q Consensus       448 ------~~kL~DFGla~~  459 (588)
                            .+.|+||+-+..
T Consensus       247 ~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECCCTTCEE
T ss_pred             ccccccceEEEEeCCccc
Confidence                  389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=7.1e-12  Score=124.93  Aligned_cols=144  Identities=18%  Similarity=0.069  Sum_probs=112.3

Q ss_pred             HHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC--CcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEe
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE--GNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ..-+.|.....++.|+.+.||+... +++.+++|+....  .....+.+|+.+++.+. |.++.+++++..+.+..|+||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            3446787778888889999999986 4689999998642  23346888999988885 667888999988888999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc---------------------------------------
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY---------------------------------------  426 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------  426 (588)
                      ||++|.+|.+.+.      +..+...++.+++++|..||+.                                       
T Consensus        90 e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            9999999987642      1123346788888999999981                                       


Q ss_pred             -----------------cCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          427 -----------------SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       427 -----------------~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                                       ..+.++|+|+++.|||++++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                             114599999999999998765667999997653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=1.3e-11  Score=122.01  Aligned_cols=137  Identities=16%  Similarity=0.105  Sum_probs=98.6

Q ss_pred             CccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCc--eeEEecceeccCeeeEEeecCCC
Q 042871          313 KLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPN--LVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ++......+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+++.+  +.+++++....+..++||||++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   99 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence            34433333456669999998878889999987654 3356778999888886544  45688888777789999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhcccc-------------------------------------------
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS-------------------------------------------  427 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------  427 (588)
                      .+|.  ...    .+   ...++.++++.|..||+..                                           
T Consensus       100 ~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          100 QDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             EETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            8884  211    11   1245566666666666532                                           


Q ss_pred             ------------CCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          428 ------------EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       428 ------------~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                                  ...++|+|++|.|||++++..+.|+|||.+..
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                        12399999999999998776677999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=1.4e-10  Score=118.39  Aligned_cols=184  Identities=18%  Similarity=0.199  Sum_probs=120.4

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCc--eeEEecceeccC---eeeEEeecCCC
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR-HPN--LVALLGYCLRVD---ECFLIYELCPN  390 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-Hpn--Iv~l~g~~~~~~---~~~LV~E~~~~  390 (588)
                      .+.++.|....||+..    ..+++|+.........+.+|.++++.+. +..  +.+++......+   ..|+|||+++|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            3468999999999863    5688898765544567889999988773 322  334444433332   34899999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc--------------------------------------------
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY--------------------------------------------  426 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------  426 (588)
                      .+|.+...   ..++..++..++.++++.|..||+.                                            
T Consensus       101 ~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  177 (304)
T 3sg8_A          101 VPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY  177 (304)
T ss_dssp             EECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred             eECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence            88876432   2355666667777777777777751                                            


Q ss_pred             -----------cCCceEecCCCCCCeEECC--CCcEEEEecCCcceecCCCcccccCccCCCCc---cCccccc-----C
Q 042871          427 -----------SEGCIVHRDIKPTNILLGP--NFEAKLSDFGLSKVIDIGETYASSEVRGTFGY---LDPEYRS-----N  485 (588)
Q Consensus       427 -----------~~~~IvHrDLKp~NILld~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y---~aPE~~~-----~  485 (588)
                                 ..+.++|+|+++.||++++  +..+.|+||+.+...+......     ....+   ..|+...     +
T Consensus       178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHHHHHHHc
Confidence                       1245899999999999998  4567899999987643211100     00011   2222110     1


Q ss_pred             CCCC---------chhhHHHHHHHHHHHHcCCCccc
Q 042871          486 CKVN---------SSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       486 ~~~t---------~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      +..+         ...+.|+++.++|++.+|+.++.
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1111         13689999999999999987653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.01  E-value=4.6e-10  Score=117.35  Aligned_cols=141  Identities=17%  Similarity=0.193  Sum_probs=106.5

Q ss_pred             ccceeeccCceEEEEEEecCCcEEEEEEec--CCC---cHHHHHHHHHHhccCC--CCceeEEecceecc---CeeeEEe
Q 042871          316 ELNLIGEGITGKVYKGKLSNNQHVAIKHIT--NEG---NVETFVREVASSSHVR--HPNLVALLGYCLRV---DECFLIY  385 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~--~~~---~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~---~~~~LV~  385 (588)
                      ..+.|+.|.++.||+....+ ..+++|+..  ...   ....+.+|+.+++.++  +..+.+++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            45678999999999998754 578888776  321   2346788999988887  45577888887765   4589999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcccc--------------------------------------
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS--------------------------------------  427 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------  427 (588)
                      ||++|..+.+..   ...++..++..++.++++.|..||+..                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998886532   123677888889999999999999731                                      


Q ss_pred             -----------------CCceEecCCCCCCeEECCCCc--EEEEecCCccee
Q 042871          428 -----------------EGCIVHRDIKPTNILLGPNFE--AKLSDFGLSKVI  460 (588)
Q Consensus       428 -----------------~~~IvHrDLKp~NILld~~~~--~kL~DFGla~~~  460 (588)
                                       .+.++|+|+++.|||+++++.  +.|+||+.+...
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             246999999999999997753  689999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.46  E-value=5.9e-07  Score=91.79  Aligned_cols=137  Identities=15%  Similarity=0.149  Sum_probs=90.7

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCC---ceeEEeccee-ccCeeeEEeecCCCCC
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHP---NLVALLGYCL-RVDECFLIYELCPNGN  392 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~-~~~~~~LV~E~~~~gs  392 (588)
                      .+.++.|....||+.    |..++||.-........+.+|..+|..+++.   .+.+.+.+.. ..+..++||||++|.+
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            456888888899987    5678888865443456788999999988753   2455555553 4456789999999988


Q ss_pred             hhhhhhcCCcCccHHHHHHHHHhhhccchhhccc----------------------------------------------
Q 042871          393 LAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY----------------------------------------------  426 (588)
Q Consensus       393 L~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------  426 (588)
                      |.+....   .++..++..++.++++.|..||+.                                              
T Consensus       100 l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  176 (306)
T 3tdw_A          100 LGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF  176 (306)
T ss_dssp             CHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred             Cchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence            8763211   122223333333333333333321                                              


Q ss_pred             -----------cCCceEecCCCCCCeEECC---CCc-EEEEecCCccee
Q 042871          427 -----------SEGCIVHRDIKPTNILLGP---NFE-AKLSDFGLSKVI  460 (588)
Q Consensus       427 -----------~~~~IvHrDLKp~NILld~---~~~-~kL~DFGla~~~  460 (588)
                                 ..+.++|+|+++.|||+++   ++. ..|+||+.+...
T Consensus       177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                       2345899999999999987   455 489999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.36  E-value=9.2e-07  Score=87.96  Aligned_cols=135  Identities=17%  Similarity=0.134  Sum_probs=91.4

Q ss_pred             eeeccCce-EEEEEEec-CCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCceeEEecceeccCeeeEEeecCCCCChhh
Q 042871          319 LIGEGITG-KVYKGKLS-NNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLRVDECFLIYELCPNGNLAE  395 (588)
Q Consensus       319 ~LG~G~fG-~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~  395 (588)
                      .+..|.-| .||+.... ++..+.||+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            44455544 69988764 5667889976543 3457788988887774 3336678888888889999999999988766


Q ss_pred             hhhcCCcCccHHHHHHHHHhhhccchhhccc-------------------------------------------------
Q 042871          396 WLFGKDKCLSWIQRLEIAIDSARGLWFLHSY-------------------------------------------------  426 (588)
Q Consensus       396 ~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------------  426 (588)
                      .....     ......+..++++.|..||..                                                 
T Consensus       110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            54211     111223333444444444431                                                 


Q ss_pred             ------cCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          427 ------SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       427 ------~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                            ..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                  123489999999999999877777999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=5.4e-07  Score=93.66  Aligned_cols=79  Identities=5%  Similarity=-0.049  Sum_probs=54.5

Q ss_pred             ccee-eccCceEEEEEEec-------CCcEEEEEEecCCC-----cHHHHHHHHHHhccCCC---CceeEEecceecc--
Q 042871          317 LNLI-GEGITGKVYKGKLS-------NNQHVAIKHITNEG-----NVETFVREVASSSHVRH---PNLVALLGYCLRV--  378 (588)
Q Consensus       317 ~~~L-G~G~fG~Vykg~~~-------~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~H---pnIv~l~g~~~~~--  378 (588)
                      .+.| +.|....+|+....       +++.+++|+.....     ....+.+|+.+++.++.   -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999998764       26788898765432     12456778888777642   2456677766554  


Q ss_pred             -CeeeEEeecCCCCChhh
Q 042871          379 -DECFLIYELCPNGNLAE  395 (588)
Q Consensus       379 -~~~~LV~E~~~~gsL~~  395 (588)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.05  E-value=8.8e-06  Score=83.34  Aligned_cols=139  Identities=17%  Similarity=0.182  Sum_probs=79.2

Q ss_pred             ceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCC-----CCceeEEe-c--ceeccCeeeEEeecCC
Q 042871          318 NLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR-----HPNLVALL-G--YCLRVDECFLIYELCP  389 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~-g--~~~~~~~~~LV~E~~~  389 (588)
                      +.|+.|..+.||+...++| .+++|+....  ...+..|..++..+.     .|.++... |  +....+..++++||++
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            4566677899999988655 5889988753  233344555444442     34443311 1  1124567899999999


Q ss_pred             CCChh--------------hhhhc--C----C-------cCccHHHHH-------------------------------H
Q 042871          390 NGNLA--------------EWLFG--K----D-------KCLSWIQRL-------------------------------E  411 (588)
Q Consensus       390 ~gsL~--------------~~L~~--~----~-------~~l~~~~~~-------------------------------~  411 (588)
                      |..+.              ..+|.  .    .       ....|...+                               .
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            86553              01111  0    0       001232111                               0


Q ss_pred             HHHhhhccchhhcc----------ccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          412 IAIDSARGLWFLHS----------YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       412 i~~~ia~gL~yLH~----------~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      +...+.+++.+|+.          ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            11123345666653          1245699999999999998888999999997653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.90  E-value=2.2e-05  Score=79.11  Aligned_cols=78  Identities=13%  Similarity=0.194  Sum_probs=56.2

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC--CcHHHHHHHHHHhccCCC---CceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE--GNVETFVREVASSSHVRH---PNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~H---pnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .+....+.+|.|..+.||+.++.||+.|.||+....  .....|..|...|+.+..   --+.+++++    +..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence            456667789999999999999999999999987543  223457789888877642   123444443    23478999


Q ss_pred             cCCCCCh
Q 042871          387 LCPNGNL  393 (588)
Q Consensus       387 ~~~~gsL  393 (588)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.89  E-value=1.9e-05  Score=83.32  Aligned_cols=73  Identities=12%  Similarity=0.079  Sum_probs=48.4

Q ss_pred             cceeeccCceEEEEEEec-CCcEEEEEEecCC---------CcHHHHHHHHHHhccCCC--Cc-eeEEecceeccCeeeE
Q 042871          317 LNLIGEGITGKVYKGKLS-NNQHVAIKHITNE---------GNVETFVREVASSSHVRH--PN-LVALLGYCLRVDECFL  383 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---------~~~~~~~~Ei~~l~~l~H--pn-Iv~l~g~~~~~~~~~L  383 (588)
                      .+.||.|..+.||+++.. +++.++||.....         ...+.+..|.++++.++.  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457999999999999764 5688999976421         123456778888876632  33 3345543  3445689


Q ss_pred             EeecCCCC
Q 042871          384 IYELCPNG  391 (588)
Q Consensus       384 V~E~~~~g  391 (588)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.77  E-value=5.4e-05  Score=77.55  Aligned_cols=137  Identities=13%  Similarity=0.059  Sum_probs=91.1

Q ss_pred             ccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCC---CCceeEEecceeccCeeeEEeecCCCCC
Q 042871          316 ELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVR---HPNLVALLGYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~LV~E~~~~gs  392 (588)
                      ..+.|+.|....+|+... ++..++||+.... ....+..|...|+.+.   ...+.+++.+....+..++||||+++..
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            345789999999999987 5678888977543 3567888988888774   3567788888877788999999999886


Q ss_pred             hhh-----------hhhcCCc---------------------CccHHHHH-----HHHHhhh---------------ccc
Q 042871          393 LAE-----------WLFGKDK---------------------CLSWIQRL-----EIAIDSA---------------RGL  420 (588)
Q Consensus       393 L~~-----------~L~~~~~---------------------~l~~~~~~-----~i~~~ia---------------~gL  420 (588)
                      +..           .||....                     .-+|....     .-..+.+               ...
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            532           1122110                     12454321     1111111               111


Q ss_pred             hhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecC
Q 042871          421 WFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFG  455 (588)
Q Consensus       421 ~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFG  455 (588)
                      ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22321 2356799999999999999887 8888974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=2.3e-05  Score=83.50  Aligned_cols=80  Identities=6%  Similarity=0.054  Sum_probs=49.9

Q ss_pred             CCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccCccCCCCccCcccccCCC---CCchhhHHHHHHHHHHH
Q 042871          428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK---VNSSGDVYSFGIVLLQI  504 (588)
Q Consensus       428 ~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~t~ksDVwS~Gvll~El  504 (588)
                      .+.++|+|+++.|||+++++ ++|+||+.+...+..-........-...|.+|++.....   -....++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            34599999999999998876 999999988764321110000000013466666554211   12235666888888888


Q ss_pred             HcCC
Q 042871          505 LSGK  508 (588)
Q Consensus       505 ltG~  508 (588)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.57  E-value=0.00012  Score=74.52  Aligned_cols=157  Identities=10%  Similarity=0.037  Sum_probs=85.6

Q ss_pred             ccHHHHHHHhcCccc-----cceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCc--eeEEecc
Q 042871          302 YTIREVHYATEKLNE-----LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPN--LVALLGY  374 (588)
Q Consensus       302 ~~~~el~~at~~f~~-----~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~  374 (588)
                      ++.+++.....+|..     .+.|+.|....+|+....+| .+++|........+.+..|+.++..++...  +.+++..
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~   85 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR   85 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence            444555555555653     34566787889999988666 677898875323345556777666654222  2233321


Q ss_pred             ------eeccCeeeEEeecCCCCChhh----h----------hhcC------C-----cCccHHHHHHHHH---------
Q 042871          375 ------CLRVDECFLIYELCPNGNLAE----W----------LFGK------D-----KCLSWIQRLEIAI---------  414 (588)
Q Consensus       375 ------~~~~~~~~LV~E~~~~gsL~~----~----------L~~~------~-----~~l~~~~~~~i~~---------  414 (588)
                            ....+..++++||++|..+..    .          ++..      .     ....|...+.-..         
T Consensus        86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~  165 (322)
T 2ppq_A           86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  165 (322)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence                  112356789999998865421    0          1110      0     0012332211110         


Q ss_pred             ---hhhccchhhcc----ccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          415 ---DSARGLWFLHS----YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       415 ---~ia~gL~yLH~----~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                         .+.+.+++++.    .....++|+|+++.|||++++..+.|+||+.+..
T Consensus       166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               01222333332    1234599999999999998876668999997653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.38  E-value=0.00019  Score=76.84  Aligned_cols=73  Identities=19%  Similarity=0.223  Sum_probs=50.2

Q ss_pred             cceeeccCceEEEEEEecC--------CcEEEEEEecCCCcHHHHHHHHHHhccCCCCce-eEEecceeccCeeeEEeec
Q 042871          317 LNLIGEGITGKVYKGKLSN--------NQHVAIKHITNEGNVETFVREVASSSHVRHPNL-VALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E~  387 (588)
                      .+.|+.|-...+|+....+        ++.+.+|+.......+.+.+|..+++.+...++ .++++.+.+    .+|+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            3467778889999998753        578999988543222566789888887753333 456665432    389999


Q ss_pred             CCCCCh
Q 042871          388 CPNGNL  393 (588)
Q Consensus       388 ~~~gsL  393 (588)
                      ++|.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.29  E-value=0.0017  Score=66.03  Aligned_cols=156  Identities=10%  Similarity=0.077  Sum_probs=88.5

Q ss_pred             ccHHHHHHHhcCccc-----cceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCC--ceeEEec
Q 042871          302 YTIREVHYATEKLNE-----LNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHP--NLVALLG  373 (588)
Q Consensus       302 ~~~~el~~at~~f~~-----~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~Hp--nIv~l~g  373 (588)
                      .+.+++....+.|..     ...|+ |....||+....+|+.+++|..... ...+.+..|..++..++..  .+.+++.
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~   89 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVA   89 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceee
Confidence            344455444444432     34566 7788999988877888999998743 3456677788777766422  2344443


Q ss_pred             c-----eeccCeeeEEeecCCCCChhh----h----------hhc--C------CcCccHHHH----HHHHHh-------
Q 042871          374 Y-----CLRVDECFLIYELCPNGNLAE----W----------LFG--K------DKCLSWIQR----LEIAID-------  415 (588)
Q Consensus       374 ~-----~~~~~~~~LV~E~~~~gsL~~----~----------L~~--~------~~~l~~~~~----~~i~~~-------  415 (588)
                      .     ....+..++++||++|..+..    .          +|.  .      ....++...    ..+...       
T Consensus        90 ~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  169 (328)
T 1zyl_A           90 FNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSG  169 (328)
T ss_dssp             BTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTT
T ss_pred             cCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHH
Confidence            3     112455688999998765431    1          111  0      011222111    111110       


Q ss_pred             --------hhccchhhcc----ccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          416 --------SARGLWFLHS----YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       416 --------ia~gL~yLH~----~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                              +.+.++.+..    .....++|+|+++.|||++ + .+.|+||+.+...
T Consensus       170 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          170 LKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             THHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                    0011112211    1234589999999999999 4 8999999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.20  E-value=0.0011  Score=67.69  Aligned_cols=34  Identities=29%  Similarity=0.400  Sum_probs=28.6

Q ss_pred             CCceEecCCCCCCeEECCC----CcEEEEecCCcceec
Q 042871          428 EGCIVHRDIKPTNILLGPN----FEAKLSDFGLSKVID  461 (588)
Q Consensus       428 ~~~IvHrDLKp~NILld~~----~~~kL~DFGla~~~~  461 (588)
                      .+.++|||+.+.|||++.+    ..+.|+||+.+....
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            3469999999999999875    689999999887543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.05  E-value=0.00047  Score=69.62  Aligned_cols=136  Identities=11%  Similarity=0.022  Sum_probs=74.0

Q ss_pred             cceeeccCceEEEEEEecCCcEEEEEEecCCCc-HHHHHHHHHHhccCCCCce-eEEecceeccCeeeEEeecC-CCCCh
Q 042871          317 LNLIGEGITGKVYKGKLSNNQHVAIKHITNEGN-VETFVREVASSSHVRHPNL-VALLGYCLRVDECFLIYELC-PNGNL  393 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E~~-~~gsL  393 (588)
                      .+.|+.|....+|+.     +.+++|+...... .....+|+..++.+...++ .+++++.  .+.-++++||+ ++.+|
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            567888999999998     5678887754211 1123457766665542222 3444433  33457899999 66555


Q ss_pred             hhh------------------hhcCCcC----cc-HHHHHHHHHhhh--------------ccc----hhhc-cccCCce
Q 042871          394 AEW------------------LFGKDKC----LS-WIQRLEIAIDSA--------------RGL----WFLH-SYSEGCI  431 (588)
Q Consensus       394 ~~~------------------L~~~~~~----l~-~~~~~~i~~~ia--------------~gL----~yLH-~~~~~~I  431 (588)
                      ...                  +|.....    .+ +.....+...+.              +.+    ..|. ......+
T Consensus        96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l  175 (301)
T 3dxq_A           96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA  175 (301)
T ss_dssp             CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred             CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence            321                  1111110    11 111111111110              001    1111 1223459


Q ss_pred             EecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          432 VHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       432 vHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      +|+|+.+.||+ .+++.+.|+||..+...
T Consensus       176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          176 CHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             ECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            99999999999 56678899999987653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.92  E-value=0.0015  Score=68.55  Aligned_cols=138  Identities=19%  Similarity=0.144  Sum_probs=81.8

Q ss_pred             ceeeccCceEEEEEEec--------CCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCc-eeEEecceeccCeeeEEeec
Q 042871          318 NLIGEGITGKVYKGKLS--------NNQHVAIKHITNE-GNVETFVREVASSSHVRHPN-LVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~E~  387 (588)
                      +.|..|--..+|+....        +++.+.+|+.... .......+|..+++.+...+ -.++++.+.+    .+|+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            35666777888998864        3578899886432 24566778998887775222 2456665543    299999


Q ss_pred             CCCCChhhh-----------------hhcCC----cCc--cHHHHHHHHHhhhcc-------------------chhhc-
Q 042871          388 CPNGNLAEW-----------------LFGKD----KCL--SWIQRLEIAIDSARG-------------------LWFLH-  424 (588)
Q Consensus       388 ~~~gsL~~~-----------------L~~~~----~~l--~~~~~~~i~~~ia~g-------------------L~yLH-  424 (588)
                      ++|.+|..-                 ||...    +..  -|.+..++..++...                   +..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665421                 11111    111  244444454433221                   22221 


Q ss_pred             ---c-ccCCceEecCCCCCCeEECCC----CcEEEEecCCcce
Q 042871          425 ---S-YSEGCIVHRDIKPTNILLGPN----FEAKLSDFGLSKV  459 (588)
Q Consensus       425 ---~-~~~~~IvHrDLKp~NILld~~----~~~kL~DFGla~~  459 (588)
                         . .....++|+|+.+.|||++++    +.+.|+||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               1 123469999999999999876    7899999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.80  E-value=0.0018  Score=69.73  Aligned_cols=74  Identities=19%  Similarity=0.143  Sum_probs=46.8

Q ss_pred             cceeeccCceEEEEEEecC-CcEEEEEEecCCC-cHHHHHHHHHHhccCCCCce-eEEecceeccCeeeEEeecCCCCCh
Q 042871          317 LNLIGEGITGKVYKGKLSN-NQHVAIKHITNEG-NVETFVREVASSSHVRHPNL-VALLGYCLRVDECFLIYELCPNGNL  393 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E~~~~gsL  393 (588)
                      .+.|+.|--..+|+....+ +..+.+|+..... ..-+-.+|..++..+...++ .++++.+.  +  .+|+||++|.+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            3468778889999998865 4788888875321 11112478888887765444 45666653  2  259999987655


Q ss_pred             h
Q 042871          394 A  394 (588)
Q Consensus       394 ~  394 (588)
                      .
T Consensus       189 ~  189 (458)
T 2qg7_A          189 S  189 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.68  E-value=0.0012  Score=68.76  Aligned_cols=72  Identities=15%  Similarity=0.091  Sum_probs=41.8

Q ss_pred             ceeeccCceEEEEEEecC---------CcEEEEEEecCCCc-HHHHHHHHHHhccCCCCc-eeEEecceeccCeeeEEee
Q 042871          318 NLIGEGITGKVYKGKLSN---------NQHVAIKHITNEGN-VETFVREVASSSHVRHPN-LVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~-~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~E  386 (588)
                      +.|+.|....+|+....+         ++.+++|+...... ......|..+++.+...+ ..++++..  .  -++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            467778788999998754         26788887654321 112356777777664333 33555443  2  368999


Q ss_pred             cCCCCCh
Q 042871          387 LCPNGNL  393 (588)
Q Consensus       387 ~~~~gsL  393 (588)
                      |++|..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.52  E-value=0.01  Score=57.03  Aligned_cols=149  Identities=14%  Similarity=0.037  Sum_probs=92.9

Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      -||.+.|...+.++++.++|.++.|.++.|.-+-....+  ..+=+-|..|+|..+|.+.+.+ ..+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence            479999988888999999999999999988766211111  1223346899999999988764 1110            


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh---
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT---  547 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~---  547 (588)
                       .....+.+||... ...+.+.-|||||++||.-+--..+..              .....+.+.-.++..|...|-   
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~--------------eE~eLS~~LE~LL~~Mt~~~~d~~  161 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN--------------EERELSPPLEQLIDHMANTVEADG  161 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT--------------EEECCCHHHHHHHHHHTTCCC---
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc--------------cchhhCHHHHHHHHHHHhcccccc
Confidence             0122466888653 355789999999999999987544322              112344444444433322221   


Q ss_pred             -------------------cCCCCCCCHHHHHHHHHHhhccC
Q 042871          548 -------------------ALTHQRPPMEQVFVTLQKALDIS  570 (588)
Q Consensus       548 -------------------~~p~~RPs~~evl~~L~~~~~~~  570 (588)
                                         ..+..|++.++|++.-..-+..+
T Consensus       162 ~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~p  203 (229)
T 2yle_A          162 SNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTE  203 (229)
T ss_dssp             -----------------CCSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred             cccccccccccccccccccccccCcCCHHHHHHHHHhhccCc
Confidence                               12468999999999888777654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.39  E-value=0.0071  Score=62.23  Aligned_cols=33  Identities=21%  Similarity=0.341  Sum_probs=28.7

Q ss_pred             CCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       428 ~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      ...++|+|+.+.||++++++.+.|+||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            346999999999999998888999999887653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.66  E-value=0.11  Score=55.10  Aligned_cols=73  Identities=12%  Similarity=0.054  Sum_probs=45.3

Q ss_pred             cceeeccCceEEEEEEecC--------CcEEEEEEecCCC-cHHHHHHHHHHhccCCCCc-eeEEecceeccCeeeEEee
Q 042871          317 LNLIGEGITGKVYKGKLSN--------NQHVAIKHITNEG-NVETFVREVASSSHVRHPN-LVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~E  386 (588)
                      .+.|..|--..+|+....+        ++.+.+|+..... ..-+..+|..+++.+...+ ..++++.+.    -++|+|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            3467667778899998753        5788988865421 1112346777776664222 234444332    278999


Q ss_pred             cCCCCCh
Q 042871          387 LCPNGNL  393 (588)
Q Consensus       387 ~~~~gsL  393 (588)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998765

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.10  E-value=0.054  Score=56.95  Aligned_cols=31  Identities=32%  Similarity=0.375  Sum_probs=26.1

Q ss_pred             ceEecCCCCCCeEE------CCCCcEEEEecCCccee
Q 042871          430 CIVHRDIKPTNILL------GPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       430 ~IvHrDLKp~NILl------d~~~~~kL~DFGla~~~  460 (588)
                      .++|+|+.+.|||+      +++..++++||..|..-
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            36899999999999      45678999999988653

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=87.64  E-value=0.39  Score=33.67  Aligned_cols=15  Identities=7%  Similarity=0.246  Sum_probs=6.9

Q ss_pred             HHHHHHHHHhhhccc
Q 042871          265 IIIIASCICLKRYYK  279 (588)
Q Consensus       265 ~~~i~~~~~~~r~~k  279 (588)
                      ++++++++++||+++
T Consensus        26 ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           26 VVALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHhhhhHh
Confidence            334444555555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=86.99  E-value=0.41  Score=33.50  Aligned_cols=16  Identities=13%  Similarity=0.200  Sum_probs=7.3

Q ss_pred             HHHHHHHHHhhhcccC
Q 042871          265 IIIIASCICLKRYYKS  280 (588)
Q Consensus       265 ~~~i~~~~~~~r~~k~  280 (588)
                      ++++++++++||++++
T Consensus        25 ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           25 IVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHhhhhhhh
Confidence            3334444555554433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	588
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-51
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-49
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-49
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-48
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 6e-59
 Identities = 63/272 (23%), Positives = 114/272 (41%), Gaps = 28/272 (10%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPN 367
            ++     IG G  G VYKGK   +  VA+K +         ++ F  EV      RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           ++  +GY     +  ++ + C   +L   L   +     I+ ++IA  +A+G+ +LH+  
Sbjct: 66  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK- 123

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-TYASSEVRGTFGYLDPEY---R 483
              I+HRD+K  NI L  +   K+ DFGL+ V      ++   ++ G+  ++ PE    +
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 484 SNCKVNSSGDVYSFGIVLLQILSGKK---------AKVLTRAGSALELADPKLDREYSIE 534
                +   DVY+FGIVL ++++G+            +       L     K+       
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241

Query: 535 AFDLTLQLALSCTALT-HQRPPMEQVFVTLQK 565
                  L   C      +RP   Q+  +++ 
Sbjct: 242 MKR----LMAECLKKKRDERPLFPQILASIEL 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 7e-58
 Identities = 60/265 (22%), Positives = 112/265 (42%), Gaps = 22/265 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVA 370
           E L  +  +G G  G+V+ G  + +  VA+K +     + + F+ E      ++H  LV 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC-LSWIQRLEIAIDSARGLWFLHSYSEG 429
           L     + +  ++I E   NG+L ++L       L+  + L++A   A G+ F+      
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             +HRD++  NIL+      K++DFGL+++I+  E  A    +    +  PE  +     
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 490 SSGDVYSFGIVLLQILSGKK--------AKVLTRAGSALELADPKLDREYSIEAFDLTLQ 541
              DV+SFGI+L +I++  +         +V+        +  P        E +     
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---NCPEELYQ---- 241

Query: 542 LALSCTALT-HQRPPMEQVFVTLQK 565
           L   C       RP  + +   L+ 
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLED 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-56
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 20/267 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVA 370
            +L  +  IG G  G V+ G   N   VAIK I     + E F+ E      + HP LV 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L G CL      L++E   +G L+++L  +    +    L + +D   G+ +L    E C
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 121

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           ++HRD+   N L+G N   K+SDFG+++ +   +  +S+  +    +  PE  S  + +S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 491 SGDVYSFGIVLLQILSGKK--------AKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
             DV+SFG+++ ++ S  K        ++V+    +   L  P+L    S   +     +
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL---ASTHVYQ----I 234

Query: 543 ALSCTALT-HQRPPMEQVFVTLQKALD 568
              C       RP   ++   L +  +
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 3e-54
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 10/203 (4%)

Query: 310 ATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRH 365
             +   +++ +G G  G V+K     +   +A K I            +RE+        
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           P +V   G      E  +  E    G+L + L  K   +      +++I   +GL +L  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLR- 121

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
             +  I+HRD+KP+NIL+    E KL DFG+S  +   ++ A+S V GT  Y+ PE    
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQG 177

Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
              +   D++S G+ L+++  G+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 3e-54
 Identities = 70/268 (26%), Positives = 109/268 (40%), Gaps = 23/268 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVA 370
           + L  L  +G G  G V  GK      VAIK I     + + F+ E     ++ H  LV 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L G C +    F+I E   NG L  +L          Q LE+  D    + +L S     
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 120

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
            +HRD+   N L+      K+SDFGLS+ +   E  +S   +    +  PE     K +S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 491 SGDVYSFGIVLLQILSGKK--------AKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
             D+++FG+++ +I S  K        ++        L L  P L    S + +     +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL---ASEKVYT----I 233

Query: 543 ALSCTALT-HQRPPMEQVFVTLQKALDI 569
             SC      +RP  + +   L   LD+
Sbjct: 234 MYSCWHEKADERPTFKIL---LSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-53
 Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 22/265 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVASSSHVRHPNLVA 370
           E L     +G+G  G+V+ G  +    VAIK +     + E F++E      +RH  LV 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEG 429
           L       +  +++ E    G+L ++L G+  K L   Q +++A   A G+ ++      
Sbjct: 77  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 132

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             VHRD++  NIL+G N   K++DFGL+++I+  E  A    +    +  PE     +  
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 490 SSGDVYSFGIVLLQILSGKK--------AKVLTRAGSALELADPKLDREYSIEAFDLTLQ 541
              DV+SFGI+L ++ +  +         +VL +      +  P    E      D    
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP---ECPESLHD---- 245

Query: 542 LALSCTALT-HQRPPMEQVFVTLQK 565
           L   C      +RP  E +   L+ 
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLED 270

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (457), Expect = 7e-53
 Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 10/277 (3%)

Query: 296 DPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHI-TNEGNVETF 353
           DP  P Y   E+      +   + +G G  G+VY+G     +  VA+K +  +   VE F
Sbjct: 3   DPSSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60

Query: 354 VREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK-CLSWIQRLEI 412
           ++E A    ++HPNLV LLG C R    ++I E    GNL ++L   ++  +S +  L +
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 413 AIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVR 472
           A   +  + +L        +HRD+   N L+G N   K++DFGLS+++      A +  +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

Query: 473 GTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELADPKLDREY 531
               +  PE  +  K +   DV++FG++L +I +   +       S + EL +     E 
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237

Query: 532 SIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQKAL 567
                +   +L  +C       RP   ++    +   
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 3e-52
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 18/261 (6%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVAL 371
           ++L  L  IG+G  G V  G       VA+K I N+   + F+ E +  + +RH NLV L
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 372 LGYCLRVDEC-FLIYELCPNGNLAEWLFGKDK-CLSWIQRLEIAIDSARGLWFLHSYSEG 429
           LG  +      +++ E    G+L ++L  + +  L     L+ ++D    + +L      
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 122

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
             VHRD+   N+L+  +  AK+SDFGL+K     +       +    +  PE     K +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFS 178

Query: 490 SSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLT----LQLALS 545
           +  DV+SFGI+L +I S  +   +      L+   P++++ Y ++A D       ++  +
Sbjct: 179 TKSDVWSFGILLWEIYSFGR---VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235

Query: 546 CTALT-HQRPPMEQVFVTLQK 565
           C  L    RP   Q+   L+ 
Sbjct: 236 CWHLDAAMRPSFLQLREQLEH 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (448), Expect = 2e-51
 Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 25/296 (8%)

Query: 302 YTIREVHYATEKLNE---------LNLIGEGITGKVYKGKL----SNNQHVAIKHI---T 345
           +T  + + A  +  +           +IG G  G+V  G L         VAIK +    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 346 NEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLS 405
            E     F+ E +      HPN++ L G   +     +I E   NG+L  +L   D   +
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
            IQ + +    A G+ +L        VHRD+   NIL+  N   K+SDFGLS+ ++   +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 466 YASSE----VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSAL 520
             +       +    +  PE     K  S+ DV+S+GIV+ +++S G++          +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243

Query: 521 ELADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQKALDISTTAKA 575
              +        ++      QL L C     + RP   Q+  TL K +    + KA
Sbjct: 244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKA 299

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 9e-51
 Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 27/277 (9%)

Query: 305 REVHYATEKLNELNL-IGEGITGKVYKGKL---SNNQHVAIKHI---TNEGNVETFVREV 357
           +++    + L   ++ +G G  G V +G          VAIK +   T + + E  +RE 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 358 ASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSA 417
                + +P +V L+G C + +   L+ E+   G L ++L GK + +      E+    +
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 418 RGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--ASSEVRGTF 475
            G+ +L   +    VHRD+   N+LL     AK+SDFGLSK +   ++Y  A S  +   
Sbjct: 120 MGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-------PKLD 528
            +  PE  +  K +S  DV+S+G+ + + LS  +     +     E+          +  
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRMECP 234

Query: 529 REYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQ 564
            E   E +     L   C       RP    V   ++
Sbjct: 235 PECPPELYA----LMSDCWIYKWEDRPDFLTVEQRMR 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 2e-50
 Identities = 63/266 (23%), Positives = 109/266 (40%), Gaps = 22/266 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHP 366
           E    L  IG G  G+  K +  S+ + +  K +      E   +  V EV     ++HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 367 NLVALLGYCLRVDEC--FLIYELCPNGNLAEWLFGKDK---CLSWIQRLEIAIDSARGLW 421
           N+V      +       +++ E C  G+LA  +    K    L     L +       L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 422 FLHSYSEG--CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLD 479
             H  S+G   ++HRD+KP N+ L      KL DFGL+++++   ++A +   GT  Y+ 
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182

Query: 480 PEYRSNCKVNSSGDVYSFGIVLLQILSGKK----AKVLTRAGSALELADPKLDREYSIEA 535
           PE  +    N   D++S G +L ++ +             AG   E    ++   YS E 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242

Query: 536 FDLTLQLALSCTALT-HQRPPMEQVF 560
            +    +      L  + RP +E++ 
Sbjct: 243 NE----IITRMLNLKDYHRPSVEEIL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 3e-50
 Identities = 71/268 (26%), Positives = 115/268 (42%), Gaps = 15/268 (5%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHV 363
             +    +IG G  G+VYKG L  +       VAIK +     E     F+ E       
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 364 RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
            H N++ L G   +     +I E   NG L ++L  KD   S +Q + +    A G+ +L
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE--TYASSEVRGTFGYLDPE 481
            +      VHRD+   NIL+  N   K+SDFGLS+V++     TY +S  +    +  PE
Sbjct: 127 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL-TRAGSALELADPKLDREYSIEAFDLTL 540
             S  K  S+ DV+SFGIV+ ++++  +           ++  +        ++      
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243

Query: 541 QLALSCTALT-HQRPPMEQVFVTLQKAL 567
           QL + C      +RP    +   L K +
Sbjct: 244 QLMMQCWQQERARRPKFADIVSILDKLI 271

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 6e-50
 Identities = 62/271 (22%), Positives = 112/271 (41%), Gaps = 22/271 (8%)

Query: 313 KLNELNLIGEGITGKVYKGKLSNN----QHVAIKHI---TNEGNVETFVREVASSSHVRH 365
            ++   +IG G  G VY G L +N     H A+K +   T+ G V  F+ E        H
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 366 PNLVALLGYCLRVD-ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           PN+++LLG CLR +    ++     +G+L  ++  +    +    +   +  A+G+ FL 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA---SSEVRGTFGYLDPE 481
           S      VHRD+   N +L   F  K++DFGL++ +   E  +    +  +    ++  E
Sbjct: 148 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGKK----AKVLTRAGSALELADPKLDREYSIEAFD 537
                K  +  DV+SFG++L ++++                 L      L  EY  +   
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL- 263

Query: 538 LTLQLALSCTALT-HQRPPMEQVFVTLQKAL 567
              ++ L C       RP   ++   +    
Sbjct: 264 --YEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-49
 Identities = 61/306 (19%), Positives = 116/306 (37%), Gaps = 56/306 (18%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI-TNEGNVETFVREVAS 359
              ++E             IG+G  G+V++GK    + VA+K   + E        E+  
Sbjct: 4   TIVLQES------------IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQ 50

Query: 360 SSHVRHPNLVALLGYCLRVD----ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
           +  +RH N++  +    + +    + +L+ +   +G+L ++L      ++    +++A+ 
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALS 108

Query: 416 SARGLWFLHSYSEGC-----IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY---A 467
           +A GL  LH    G      I HRD+K  NIL+  N    ++D GL+   D        A
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168

Query: 468 SSEVRGTFGYLDPEYRSNC------KVNSSGDVYSFGIVLLQILSGKKAKVLT------- 514
            +   GT  Y+ PE   +       +     D+Y+ G+V  +I        +        
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 515 -------------RAGSALELADPKL-DREYSIEAFDLTLQLALSCTALT-HQRPPMEQV 559
                        R     +   P + +R  S EA  +  ++   C       R    ++
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 560 FVTLQK 565
             TL +
Sbjct: 289 KKTLSQ 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (433), Expect = 2e-49
 Identities = 69/304 (22%), Positives = 115/304 (37%), Gaps = 46/304 (15%)

Query: 304 IREVHYATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHI---TNEGNVETFV 354
           +  + Y    +  +  IGEG  G+V++ +            VA+K +    +      F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 355 REVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC----------- 403
           RE A  +   +PN+V LLG C       L++E    G+L E+L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 404 ------------LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKL 451
                       LS  ++L IA   A G+ +L        VHRD+   N L+G N   K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181

Query: 452 SDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA 510
           +DFGLS+ I   + Y A         ++ PE     +  +  DV+++G+VL +I S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 511 KVLTRAGSAL-----ELADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQ 564
                A   +     +           +E ++    L   C +     RP    +   LQ
Sbjct: 242 PYYGMAHEEVIYYVRDGNILACPENCPLELYN----LMRLCWSKLPADRPSFCSIHRILQ 297

Query: 565 KALD 568
           +  +
Sbjct: 298 RMCE 301

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-49
 Identities = 70/261 (26%), Positives = 105/261 (40%), Gaps = 19/261 (7%)

Query: 308 HYATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIK-----HITNEGNVETFVREVASSS 361
            +A E       +G+G  G VY  +   +   +A+K      +   G      REV   S
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 362 HVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW 421
           H+RHPN++ L GY       +LI E  P G +   L  K       +      + A  L 
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALS 120

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE 481
           + HS     ++HRDIKP N+LLG   E K++DFG S             + GT  YL PE
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPE 174

Query: 482 YRSNCKVNSSGDVYSFGIVLLQILSGK---KAKVLTRAGSALELADPKLDREYSIEAFDL 538
                  +   D++S G++  + L GK   +A         +   +       +  A DL
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234

Query: 539 TLQLALSCTALTHQRPPMEQV 559
             +L         QRP + +V
Sbjct: 235 ISRL---LKHNPSQRPMLREV 252

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 6e-49
 Identities = 67/291 (23%), Positives = 109/291 (37%), Gaps = 34/291 (11%)

Query: 312 EKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHI---TNEGNVETFVREVASSSH 362
            +L+    +G G  GKV +              VA+K +    +    E  + E+   S+
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 363 V-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGK-----------------DKCL 404
           +  H N+V LLG C       +I E C  G+L  +L  K                 +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 405 SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE 464
                L  +   A+G+ FL S      +HRD+   NILL      K+ DFGL++ I    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 465 TYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKV--LTRAGSALE 521
            Y      R    ++ PE   NC      DV+S+GI L ++ S   +    +       +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 522 LADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQKALDIST 571
           +            A      +  +C      +RP  +Q+   ++K +  ST
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-48
 Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 24/264 (9%)

Query: 316 ELNLIGEGITGKVYKGKLSN---NQHVAIKHITNEGN----VETFVREVASSSHVRHPNL 368
           E   +G G  G V KG        + VA+K + NE N     +  + E      + +P +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           V ++G C   +   L+ E+   G L ++L  +++ +     +E+    + G+ +L    E
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---E 125

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--ASSEVRGTFGYLDPEYRSNC 486
              VHRD+   N+LL     AK+SDFGLSK +   E Y  A +  +    +  PE  +  
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 487 KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-----DPKLDREYSIEAFDLTLQ 541
           K +S  DV+SFG+++ +  S  +       GS +                  E +D    
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD---- 241

Query: 542 LALSCTALT-HQRPPMEQVFVTLQ 564
           L   C       RP    V + L+
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLR 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (430), Expect = 1e-48
 Identities = 61/263 (23%), Positives = 108/263 (41%), Gaps = 26/263 (9%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVR 364
            +  ++L  IG G  G VY  + + N++ VAIK +      +    +  ++EV     +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           HPN +   G  LR    +L+ E C           K K L  ++   +   + +GL +LH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH 132

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-- 482
           S++   ++HRD+K  NILL      KL DFG + ++    ++      GT  ++ PE   
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 184

Query: 483 -RSNCKVNSSGDVYSFGIVLLQILSGK----KAKVLTRAGSALELADPKL-DREYSIEAF 536
                + +   DV+S GI  +++   K        ++      +   P L    +S    
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244

Query: 537 DLTLQLALSCTALTHQRPPMEQV 559
           +           +   RP  E +
Sbjct: 245 NFVDSC---LQKIPQDRPTSEVL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-48
 Identities = 59/258 (22%), Positives = 105/258 (40%), Gaps = 23/258 (8%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLG 373
           +  +G+G  GKVYK +    +   A K I   +E  +E ++ E+   +   HPN+V LL 
Sbjct: 17  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 76

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
                +  +++ E C  G +   +   ++ L+  Q   +   +   L +LH      I+H
Sbjct: 77  AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIH 133

Query: 434 RDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-----RSNCKV 488
           RD+K  NIL   + + KL+DFG+S           S + GT  ++ PE        +   
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192

Query: 489 NSSGDVYSFGIVLLQILSGKK-------AKVLTRAGSALELADPKLDREYSIEAFDLTLQ 541
           +   DV+S GI L+++   +         +VL +   + E         +S    D   +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSNFKDFLKK 251

Query: 542 LALSCTALTHQRPPMEQV 559
                      R    Q+
Sbjct: 252 C---LEKNVDARWTTSQL 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-48
 Identities = 66/270 (24%), Positives = 114/270 (42%), Gaps = 21/270 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQH----VAIKHI---TNEGNVETFVREVASSSHVR 364
           E++     IGEG  G V++G   + ++    VAIK     T++   E F++E  +     
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLH 424
           HP++V L+G     +  ++I ELC  G L  +L  +   L     +  A   +  L +L 
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 425 SYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
           S      VHRDI   N+L+  N   KL DFGLS+ ++    Y +S+ +    ++ PE  +
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-----ELADPKLDREYSIEAFDLT 539
             +  S+ DV+ FG+ + +IL            + +           +        +   
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-- 240

Query: 540 LQLALSCTALT-HQRPPMEQVFVTLQKALD 568
             L   C A    +RP   ++   L   L+
Sbjct: 241 --LMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 7e-48
 Identities = 57/260 (21%), Positives = 97/260 (37%), Gaps = 19/260 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVREVASSSHVRHPN 367
           E  + +  +GEG  G+V         + VA+K +         E   +E+  +  + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V   G+    +  +L  E C  G L + +   D  +              G+ +LH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGI- 122

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRSNC 486
              I HRDIKP N+LL      K+SDFGL+ V          +++ GT  Y+ PE     
Sbjct: 123 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 487 KVNS-SGDVYSFGIVLLQILSGKKAKVLTRAGSALELA------DPKLDREYSIEAFDLT 539
           + ++   DV+S GIVL  +L+G+                          ++       L 
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240

Query: 540 LQLALSCTALTHQRPPMEQV 559
            ++          R  +  +
Sbjct: 241 HKI---LVENPSARITIPDI 257

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-47
 Identities = 57/258 (22%), Positives = 99/258 (38%), Gaps = 27/258 (10%)

Query: 320 IGEGITGKVYKGKL-SNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVALLGY 374
           IG G    VYKG        VA   +      +   + F  E      ++HPN+V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 375 CLRVDE----CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
                +      L+ EL  +G L  +L  + K +             +GL FLH+ +   
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPP- 134

Query: 431 IVHRDIKPTNILL-GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           I+HRD+K  NI + GP    K+ D GL+ +           V GT  ++ PE     K +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEE-KYD 190

Query: 490 SSGDVYSFGIVLLQILSGKKAKVLTRAGSAL------ELADPKLDREYSIEAFDLTLQLA 543
            S DVY+FG+ +L++ + +      +  + +       +     D+    E  +    + 
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE----II 246

Query: 544 LSCTALT-HQRPPMEQVF 560
             C      +R  ++ + 
Sbjct: 247 EGCIRQNKDERYSIKDLL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-47
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 9/201 (4%)

Query: 311 TEKLNELNLIGEGITGKVYKGK-LSNNQHVAIK--HITNEGNVETFVREVASSSHVRHPN 367
            +K      IG+G +G VY    ++  Q VAI+  ++  +   E  + E+      ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V  L   L  DE +++ E    G+L + +   + C+   Q   +  +  + L FLHS  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
              ++HRDIK  NILLG +   KL+DFG    I   ++  S+ V GT  ++ PE  +   
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
                D++S GI+ ++++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  166 bits (421), Expect = 5e-47
 Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 20/255 (7%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI--TNEGNVETFVREVASSSHVRHPNLVALLG 373
              +G G  G V++    +   + A K +   +E + ET  +E+ + S +RHP LV L  
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 90

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
                +E  +IYE    G L E +  +   +S  + +E      +GL  +H   E   VH
Sbjct: 91  AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVH 147

Query: 434 RDIKPTNILLGP--NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
            D+KP NI+     + E KL DFGL+  +D  ++       GT  +  PE      V   
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPVGYY 205

Query: 492 GDVYSFGIVLLQILSGK-------KAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL 544
            D++S G++   +LSG          + L    S     D       S +  D   +L  
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL-- 263

Query: 545 SCTALTHQRPPMEQV 559
              A  + R  + Q 
Sbjct: 264 -LLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-46
 Identities = 62/261 (23%), Positives = 107/261 (40%), Gaps = 23/261 (8%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRH 365
           E      ++GEG    V   + L+ ++  AIK     HI  E  V    RE    S + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           P  V L       ++ +       NG L +++  K              +    L +LH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA-SSEVRGTFGYLDPEYRS 484
                I+HRD+KP NILL  +   +++DFG +KV+      A ++   GT  Y+ PE  +
Sbjct: 127 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL------ADPKLDREYSIEAFDL 538
                 S D+++ G ++ Q+++G       RAG+   +       +     ++  +A DL
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240

Query: 539 TLQLALSCTALTHQRPPMEQV 559
             +L         +R   E++
Sbjct: 241 VEKL---LVLDATKRLGCEEM 258

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-46
 Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 43/288 (14%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNN---QHVAIKHI---TNEGNVETFVREVASSSHV-R 364
             +   ++IGEG  G+V K ++  +      AIK +    ++ +   F  E+     +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 365 HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC---------------LSWIQR 409
           HPN++ LLG C      +L  E  P+GNL ++L                     LS  Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
           L  A D ARG+ +L        +HRD+   NIL+G N+ AK++DFGLS+  ++      +
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK--------AKVLTRAGSALE 521
             R    ++  E  +     ++ DV+S+G++L +I+S           A++  +      
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244

Query: 522 LADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQKALD 568
           L  P        E +D    L   C     ++RP   Q+ V+L + L+
Sbjct: 245 LEKPL---NCDDEVYD----LMRQCWREKPYERPSFAQILVSLNRMLE 285

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 5e-46
 Identities = 56/269 (20%), Positives = 112/269 (41%), Gaps = 29/269 (10%)

Query: 315 NELNLIGEGITGKVYKGKLSNNQH-----VAIKHI---TNEGNVETFVREVASSSHVRHP 366
            ++ ++G G  G VYKG            VAIK +   T+    +  + E    + V +P
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           ++  LLG CL      LI +L P G L +++      +     L   +  A+G+ +L   
Sbjct: 72  HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE-VRGTFGYLDPEYRSN 485
               +VHRD+   N+L+      K++DFGL+K++   E    +E  +    ++  E   +
Sbjct: 131 R---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 486 CKVNSSGDVYSFGIVLLQILSGKK--------AKVLTRAGSALELADPKLDREYSIEAFD 537
                  DV+S+G+ + ++++           +++ +       L  P      +I+ + 
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---ICTIDVYM 244

Query: 538 LTLQLALSCTALT-HQRPPMEQVFVTLQK 565
               + + C  +    RP   ++ +   K
Sbjct: 245 ----IMVKCWMIDADSRPKFRELIIEFSK 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 5e-46
 Identities = 57/268 (21%), Positives = 105/268 (39%), Gaps = 26/268 (9%)

Query: 317 LNLIGEGITGKVYKGKL----SNNQHVAIK-----HITNEGNVETFVREVASSSHVRHPN 367
           L  +G+G  G V +G+          VA+K      ++    ++ F+REV +   + H N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           L+ L G  L      ++ EL P G+L + L               A+  A G+ +L S  
Sbjct: 73  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 130

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--ASSEVRGTFGYLDPEYRSN 485
               +HRD+   N+LL      K+ DFGL + +   + +       +  F +  PE    
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 486 CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL------ELADPKLDREYSIEAFDLT 539
              + + D + FG+ L ++ +  +   +   GS +      E        +   + ++  
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN-- 246

Query: 540 LQLALSCTALT-HQRPPMEQVFVTLQKA 566
             + + C A     RP    +   L +A
Sbjct: 247 --VMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 2e-45
 Identities = 68/292 (23%), Positives = 107/292 (36%), Gaps = 39/292 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQH------VAIKHI---TNEGNVETFVREVASSSH 362
           E L    ++G G  GKV                VA+K +    +    E  + E+   + 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 363 V-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDK------------------- 402
           +  H N+V LLG C      +LI+E C  G+L  +L  K +                   
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 403 ---CLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV 459
               L++   L  A   A+G+ FL   S    VHRD+   N+L+      K+ DFGL++ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 460 IDIGETYAS-SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA--KVLTRA 516
           I     Y      R    ++ PE           DV+S+GI+L +I S        +   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 517 GSALELADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQKAL 567
            +  +L       +    A +    +  SC A    +RP    +   L   L
Sbjct: 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-43
 Identities = 57/273 (20%), Positives = 111/273 (40%), Gaps = 37/273 (13%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEG-NVETFVREVA 358
           +Y I E             +G G  G V++    S+ +    K +  +G +     +E++
Sbjct: 6   KYMIAED------------LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS 53

Query: 359 SSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
             +  RH N++ L      ++E  +I+E     ++ E +      L+  + +        
Sbjct: 54  ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEA--KLSDFGLSKVIDIGETYASSEVRGTFG 476
            L FLHS+    I H DI+P NI+      +  K+ +FG ++ +  G+ +    +     
Sbjct: 114 ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPE 168

Query: 477 YLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK-------AKVLTRAGSALELADPKLDR 529
           Y  PE   +  V+++ D++S G ++  +LSG          +++    +A    D +  +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228

Query: 530 EYSIEAFDLTLQLALSCTALT---HQRPPMEQV 559
           E SIEA D   +L      L      R    + 
Sbjct: 229 EISIEAMDFVDRL------LVKERKSRMTASEA 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  154 bits (391), Expect = 1e-42
 Identities = 57/255 (22%), Positives = 92/255 (36%), Gaps = 20/255 (7%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLG 373
           L  +G G  G V++    +  +    K I      +  T   E++  + + HP L+ L  
Sbjct: 34  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 93

Query: 374 YCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVH 433
                 E  LI E    G L + +  +D  +S  + +     +  GL  +H +S   IVH
Sbjct: 94  AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVH 150

Query: 434 RDIKPTNILL--GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSS 491
            DIKP NI+         K+ DFGL+  ++  E         T  +  PE      V   
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFY 208

Query: 492 GDVYSFGIVLLQILSGK-------KAKVLTRAGSALELADPKLDREYSIEAFDLTLQLAL 544
            D+++ G++   +LSG          + L          D       S EA D    L  
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL-- 266

Query: 545 SCTALTHQRPPMEQV 559
                  +R  +   
Sbjct: 267 -LQKEPRKRLTVHDA 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 1e-42
 Identities = 60/290 (20%), Positives = 114/290 (39%), Gaps = 24/290 (8%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHI---TNEGNV 350
             Y   E   A EK+     +G+G  G VY+G             VAIK +    +    
Sbjct: 8   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 67

Query: 351 ETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKC------- 403
             F+ E +        ++V LLG   +     +I EL   G+L  +L             
Sbjct: 68  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127

Query: 404 --LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID 461
              S  + +++A + A G+ +L++      VHRD+   N ++  +F  K+ DFG+++ I 
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184

Query: 462 IGETYA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-A 519
             + Y    +      ++ PE   +    +  DV+SFG+VL +I +  +      +    
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244

Query: 520 LELADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQKALD 568
           L         +      D+  +L   C       RP   ++  ++++ ++
Sbjct: 245 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 3e-41
 Identities = 66/257 (25%), Positives = 104/257 (40%), Gaps = 23/257 (8%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITN---EGNVETFVREVASSSHVRHPNLVALL 372
            +++G G   +V   +     + VAIK I     EG   +   E+A    ++HPN+VAL 
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73

Query: 373 GYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
                    +LI +L   G L + +  +    +      +       + +LH      IV
Sbjct: 74  DIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDL---GIV 129

Query: 433 HRDIKPTNILL---GPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
           HRD+KP N+L      + +  +SDFGLSK+ D G     S   GT GY+ PE  +    +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVAPEVLAQKPYS 187

Query: 490 SSGDVYSFGIVLLQILSGK-------KAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
            + D +S G++   +L G         AK+  +   A    D     + S  A D    L
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247

Query: 543 ALSCTALTHQRPPMEQV 559
                    +R   EQ 
Sbjct: 248 ---MEKDPEKRFTCEQA 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  146 bits (370), Expect = 1e-40
 Identities = 54/245 (22%), Positives = 104/245 (42%), Gaps = 23/245 (9%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVA 370
             ++G G   +V+  + L  ++ VA+K +      +      F RE  +++ + HP +VA
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 371 LLGYCLRVDE----CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           +              +++ E      L + +   +  ++  + +E+  D+ + L F H  
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQN 130

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA--SSEVRGTFGYLDPEYRS 484
               I+HRD+KP NI++      K+ DFG+++ I         ++ V GT  YL PE   
Sbjct: 131 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKK-------AKVLTRAGSALELADPKLDREYSIEAFD 537
              V++  DVYS G VL ++L+G+          V  +      +         S +   
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247

Query: 538 LTLQL 542
           + L+ 
Sbjct: 248 VVLKA 252

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  144 bits (364), Expect = 9e-40
 Identities = 67/274 (24%), Positives = 107/274 (39%), Gaps = 35/274 (12%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI-----------TNEGNVETFVREVAS 359
           E      ++G G++  V +       +  A+K I             +   E  ++EV  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 360 SSHVR-HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSAR 418
              V  HPN++ L          FL+++L   G L ++L  +   LS  +  +I      
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLE 121

Query: 419 GLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYL 478
            +  LH      IVHRD+KP NILL  +   KL+DFG S  +D GE     EV GT  YL
Sbjct: 122 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 176

Query: 479 DPEY------RSNCKVNSSGDVYSFGIVLLQILSGK-------KAKVLTRAGSALELADP 525
            PE        ++       D++S G+++  +L+G        +  +L    S       
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236

Query: 526 KLDREYSIEAFDLTLQLALSCTALTHQRPPMEQV 559
               +YS    DL  +          +R   E+ 
Sbjct: 237 PEWDDYSDTVKDLVSRF---LVVQPQKRYTAEEA 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 63/294 (21%), Positives = 118/294 (40%), Gaps = 41/294 (13%)

Query: 312 EKLNELNLIGEGITGKVYKGKL--------SNNQHVAIKHI---TNEGNVETFVREVASS 360
           ++L     +GEG  G+V   +         +    VA+K +     E ++   + E+   
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 361 SHV-RHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLF---------------GKDKCL 404
             + +H N++ LLG C +    ++I E    GNL E+L                  ++ L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 405 SWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE 464
           S    +  A   ARG+ +L S      +HRD+   N+L+  +   K++DFGL++ I   +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 465 TYASSEV-RGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL--- 520
            Y  +   R    ++ PE   +       DV+SFG++L +I +   +         L   
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 521 --ELADPKLDREYSIEAFDLTLQLALSCTALT-HQRPPMEQVFVTLQKALDIST 571
             E          + E +     +   C      QRP  +Q+   L + + +++
Sbjct: 250 LKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 4e-39
 Identities = 69/288 (23%), Positives = 108/288 (37%), Gaps = 37/288 (12%)

Query: 312 EKLNELNLIGEGITGKVYKG------KLSNNQHVAIKHI---TNEGNVETFVREVAS-SS 361
           ++L     +G G  G+V +       K +  + VA+K +            + E+     
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 362 HVRHPNLVALLGYCLRVDEC-FLIYELCPNGNLAEWLFGKDK---------------CLS 405
              H N+V LLG C +      +I E C  GNL+ +L  K                  L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
               +  +   A+G+ FL S      +HRD+   NILL      K+ DFGL++ I     
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 466 YA-SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD 524
           Y    + R    ++ PE   +       DV+SFG++L +I S   +          E   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFC 247

Query: 525 PKLDREYSIEAFDLT----LQLALSCTALT-HQRPPMEQVFVTLQKAL 567
            +L     + A D T     Q  L C      QRP   ++   L   L
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 4e-39
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 15/236 (6%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVAS-SSHVRHPNLV 369
             ++G+G  GKV+  +    NQ  AIK +       + +VE  + E    S    HP L 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 370 ALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEG 429
            +       +  F + E    G+L   +    K     +    A +   GL FLHS    
Sbjct: 67  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSK--- 122

Query: 430 CIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVN 489
            IV+RD+K  NILL  +   K++DFG+ K   +G+   ++   GT  Y+ PE     K N
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYN 181

Query: 490 SSGDVYSFGIVLLQILSGK---KAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
            S D +SFG++L ++L G+     +       ++ + +P   R    EA DL ++L
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-38
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 14/201 (6%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI-------TNEGNVETFVREVASSSHVRHPNL 368
           L+ +GEG    VYK +  + NQ VAIK I         +G   T +RE+     + HPN+
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 369 VALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSE 428
           + LL          L+++          +      L+        + + +GL +LH +  
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 429 GCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKV 488
             I+HRD+KP N+LL  N   KL+DFGL+K         + +V  T  Y  PE     ++
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARM 177

Query: 489 NS-SGDVYSFGIVLLQILSGK 508
                D+++ G +L ++L   
Sbjct: 178 YGVGVDMWAVGCILAELLLRV 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-38
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 8/202 (3%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHP 366
           E   ++  IGEG  G VYK +     + VA+K I      EG   T +RE++    + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           N+V LL      ++ +L++E                 +             +GL F HS+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
               ++HRD+KP N+L+      KL+DFGL++   +     + EV   +           
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 487 KVNSSGDVYSFGIVLLQILSGK 508
             +++ D++S G +  ++++ +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (354), Expect = 5e-38
 Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 17/235 (7%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVA 370
           L  +G G  G+V+  +   N ++ A+K +          VE    E    S V HP ++ 
Sbjct: 9   LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           + G      + F+I +    G L   L    +  + + +   A         L       
Sbjct: 69  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----VCLALEYLHSKD 124

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           I++RD+KP NILL  N   K++DFG +K +          + GT  Y+ PE  S    N 
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTKPYNK 180

Query: 491 SGDVYSFGIVLLQILSGKK---AKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
           S D +SFGI++ ++L+G          +    +  A+ +    ++ +  DL  +L
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  141 bits (357), Expect = 5e-38
 Identities = 56/242 (23%), Positives = 93/242 (38%), Gaps = 23/242 (9%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT--------NEGNVETFVREVASSSHVRHPN 367
             +IG G  G+VY  +     +  A+K +          E         ++  S    P 
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V +       D+   I +L   G+L   L  +    S       A +   GL  +H+  
Sbjct: 69  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHN-- 125

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEY-RSNC 486
              +V+RD+KP NILL  +   ++SD GL+      + +      GT GY+ PE  +   
Sbjct: 126 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGV 181

Query: 487 KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA------DPKLDREYSIEAFDLTL 540
             +SS D +S G +L ++L G       +     E+         +L   +S E   L  
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241

Query: 541 QL 542
            L
Sbjct: 242 GL 243

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  139 bits (350), Expect = 8e-38
 Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 8/201 (3%)

Query: 312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPN 367
           EK + L  IGEG  G VYK + +  +  A+K I     +EG   T +RE++    ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 368 LVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS 427
           +V L           L++E   + +L + L   +  L  +      +    G+ + H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 428 EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK 487
              ++HRD+KP N+L+    E K++DFGL++   I     + E+   +         + K
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 488 VNSSGDVYSFGIVLLQILSGK 508
            +++ D++S G +  ++++G 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGT 198

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 28/220 (12%)

Query: 300 PRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI---TNEGNVETFVR 355
           PRYT             L+ IGEG  G V       N   VAIK I    ++   +  +R
Sbjct: 8   PRYTN------------LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 55

Query: 356 EVASSSHVRHPNLVALLGYC----LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLE 411
           E+      RH N++ +        +   +   +       +L + L  K + LS      
Sbjct: 56  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICY 113

Query: 412 IAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS--S 469
                 RGL ++HS     ++HRD+KP+N+LL    + K+ DFGL++V D    +    +
Sbjct: 114 FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170

Query: 470 EVRGTFGYLDPEY-RSNCKVNSSGDVYSFGIVLLQILSGK 508
           E   T  Y  PE   ++     S D++S G +L ++LS +
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 7e-37
 Identities = 47/273 (17%), Positives = 87/273 (31%), Gaps = 29/273 (10%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYC 375
              IG G  G +Y G  ++  + VAIK    +        E      ++    +  + +C
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
               +  ++       +L +      +  S    L +A      + ++HS +    +HRD
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128

Query: 436 IKPTNIL---LGPNFEAKLSDFGLSKVIDIGETYA------SSEVRGTFGYLDPEYRSNC 486
           +KP N L           + DFGL+K      T+       +  + GT  Y         
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 487 KVNSSGDVYSFGIVLLQILSGK-----------KAKVLTRAGSALELADPKLDREYSIEA 535
           + +   D+ S G VL+    G            + K    +   +      L + Y  E 
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248

Query: 536 FDLTLQLALSCTALT-HQRPPMEQVFVTLQKAL 567
                     C +L    +P    +    +   
Sbjct: 249 AT----YLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-36
 Identities = 67/293 (22%), Positives = 110/293 (37%), Gaps = 45/293 (15%)

Query: 287 TSFKGVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI- 344
           T F+   + D     Y   E             +G G    V K +  S     A K I 
Sbjct: 1   TVFRQENVDD----YYDTGEE------------LGSGQFAVVKKCREKSTGLQYAAKFIK 44

Query: 345 -------TNEGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWL 397
                      + E   REV+    ++HPN++ L        +  LI EL   G L ++ 
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF- 103

Query: 398 FGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL----GPNFEAKLSD 453
             + + L+  +  E       G+++LHS     I H D+KP NI+L     P    K+ D
Sbjct: 104 LAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160

Query: 454 FGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK----- 508
           FGL+  ID G  +    + GT  ++ PE  +   +    D++S G++   +LSG      
Sbjct: 161 FGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218

Query: 509 --KAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTALTHQRPPMEQV 559
             K + L    +     + +     S  A D   +L         +R  ++  
Sbjct: 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRL---LVKDPKKRMTIQDS 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  134 bits (339), Expect = 3e-36
 Identities = 50/271 (18%), Positives = 89/271 (32%), Gaps = 23/271 (8%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYC 375
              IGEG  G +++G  L NNQ VAIK      +      E  +   +     +  + Y 
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 376 LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD 435
            +     ++       +L + L    +  S       A      +  +H      +V+RD
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD 126

Query: 436 IKPTNILLG-----PNFEAKLSDFGLSKVIDIGET------YASSEVRGTFGYLDPEYRS 484
           IKP N L+G           + DFG+ K      T           + GT  Y+      
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 485 NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAFDLT----- 539
             + +   D+ + G V +  L G       +A +  +  +   +++ S    +L      
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246

Query: 540 --LQLALSCTALT-HQRPPMEQVFVTLQKAL 567
              +       L     P  + +     K L
Sbjct: 247 EFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 4e-36
 Identities = 57/204 (27%), Positives = 83/204 (40%), Gaps = 16/204 (7%)

Query: 315 NELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLG 373
            +  +IG G  G VY+ KL  + + VAIK +  +       RE+     + H N+V L  
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQIMRKLDHCNIVRLRY 80

Query: 374 YCLRVDEC------FLIYELCPNGNLAEWLFG--KDKCLSWIQRLEIAIDSARGLWFLHS 425
           +     E        L+ +  P              + L  I          R L ++HS
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140

Query: 426 YSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRS 484
                I HRDIKP N+LL P+    KL DFG +K +  GE   S  +   +         
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFG 196

Query: 485 NCKVNSSGDVYSFGIVLLQILSGK 508
                SS DV+S G VL ++L G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 4e-36
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 19/213 (8%)

Query: 310 ATEKLNELNLIGEGITGKVYKGK--LSNNQHVAIKHI----TNEGNVETFVREVASSSH- 362
           A ++   +  IGEG  GKV+K +   +  + VA+K +      EG   + +REVA   H 
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 363 --VRHPNLVALLGYCL-----RVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAID 415
               HPN+V L   C      R  +  L++E              +  +      ++   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 416 SARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTF 475
             RGL FLHS+    +VHRD+KP NIL+  + + KL+DFGL+++        S  V  T 
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179

Query: 476 GYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            Y  PE        +  D++S G +  ++   K
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-35
 Identities = 60/272 (22%), Positives = 93/272 (34%), Gaps = 37/272 (13%)

Query: 301 RYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNE--------GNVE 351
           +Y +  +            +G G  G VY G  +S+N  VAIKH+  +         N  
Sbjct: 5   QYQVGPL------------LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 52

Query: 352 TFVREVASSSHVR--HPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQR 409
               EV     V      ++ LL +  R D   LI E             +   L     
Sbjct: 53  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 112

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDIGETYAS 468
                     +   H+     ++HRDIK  NIL+  N  E KL DFG   ++        
Sbjct: 113 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 166

Query: 469 SEVRGTFGYLDPEYRSNCKVNS-SGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL 527
           ++  GT  Y  PE+    + +  S  V+S GI+L  ++ G    +       +       
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG---DIPFEHDEEIIRGQVFF 223

Query: 528 DREYSIEAFDLTLQLALSCTALTHQRPPMEQV 559
            +  S E   L              RP  E++
Sbjct: 224 RQRVSSECQHLIRWC---LALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-35
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 9/203 (4%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHP 366
           +K  +L  IGEG  G V+K K    ++ VA+K +     +EG   + +RE+     ++H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 367 NLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY 426
           N+V L        +  L++E C       +       L             +GL F HS 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 427 SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNC 486
               ++HRD+KP N+L+  N E KL++FGL++   I     S+EV   +           
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 487 KVNSSGDVYSFGIVLLQILSGKK 509
             ++S D++S G +  ++ +  +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGR 200

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 5e-35
 Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 14/235 (5%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI-----TNEGNVETFVREVASSSHVRHPNLVA 370
           L L+G+G  GKV   +  +  ++ A+K +       +  V   V E     + RHP L A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 371 LLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGC 430
           L       D    + E    G L   L  +++  +  +      +    L +LHS     
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR---D 125

Query: 431 IVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNS 490
           +V+RDIK  N++L  +   K++DFGL K          +   GT  YL PE   +     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 184

Query: 491 SGDVYSFGIVLLQILSGK---KAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
           + D +  G+V+ +++ G+     +   R    + + + +  R  S EA  L   L
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-33
 Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 28/228 (12%)

Query: 291 GVQLKDPGCPRYTIREVHYATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGN 349
           G+Q+K     +  I + +  T ++     +G GI GKV +       +  A+K + +   
Sbjct: 1   GLQIK-----KNAIIDDYKVTSQV-----LGLGINGKVLQIFNKRTQEKFALKMLQD--- 47

Query: 350 VETFVREVASSSHV-RHPNLVALLGYCLRV----DECFLIYELCPNGNLAEWLFGK-DKC 403
                REV       + P++V ++     +        ++ E    G L   +  + D+ 
Sbjct: 48  CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 107

Query: 404 LSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL---GPNFEAKLSDFGLSKVI 460
            +  +  EI       + +LHS +   I HRD+KP N+L     PN   KL+DFG +K  
Sbjct: 108 FTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164

Query: 461 DIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
               +  +     T  Y+ PE     K + S D++S G+++  +L G 
Sbjct: 165 TSHNSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (318), Expect = 8e-33
 Identities = 47/240 (19%), Positives = 91/240 (37%), Gaps = 17/240 (7%)

Query: 312 EKLNELNLIGEGITGKVYKGK-LSNNQHVAIK-----HITNEGNVETFVREVASSSHVRH 365
           ++ + +  +G G  G+V   K   +  H A+K      +     +E  + E      V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           P LV L          +++ E    G +   L  +    S       A        +LHS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                +++RD+KP N+L+      +++DFG +K +          + GT   L PE   +
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILS 212

Query: 486 CKVNSSGDVYSFGIVLLQILSGK---KAKVLTRAGSALELADPKLDREYSIEAFDLTLQL 542
              N + D ++ G+++ ++ +G     A    +    +     +    +S +  DL   L
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-32
 Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 21/209 (10%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG+G  G+V+K +     Q VA+K +      EG   T +RE+     ++H N+V L
Sbjct: 15  LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74

Query: 372 LGYCLRVDE--------CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFL 423
           +  C              +L+++ C +           K  +  +   +      GL+++
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYI 133

Query: 424 HSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET---YASSEVRGTFGYLDP 480
           H      I+HRD+K  N+L+  +   KL+DFGL++   + +       +    T  Y  P
Sbjct: 134 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 481 EYRSNCK-VNSSGDVYSFGIVLLQILSGK 508
           E     +      D++  G ++ ++ +  
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 4e-31
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 18/219 (8%)

Query: 302 YTIREVHYATEKLNE----LNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNVET 352
           +  +EV     ++      L  +G G  G V           VAIK +     +E   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 353 FVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPNGNLAEWLFG---KDKCLSWIQR 409
             RE+    H+RH N++ LL      +      +            G   K + L   + 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 410 LEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS 469
             +     +GL ++H+     I+HRD+KP N+ +  + E K+ DFGL++  D   +  + 
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTG 177

Query: 470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
            V   +        +  +   + D++S G ++ ++++GK
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (292), Expect = 2e-29
 Identities = 41/198 (20%), Positives = 89/198 (44%), Gaps = 16/198 (8%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGY 374
           +  +G G   +V++   ++NN+ V +K +      +   RE+    ++R  PN++ L   
Sbjct: 40  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADI 98

Query: 375 CLRVDE--CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIV 432
                     L++E   N +  +      + L+         +  + L + HS     I+
Sbjct: 99  VKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIM 151

Query: 433 HRDIKPTNILLGP-NFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCK-VNS 490
           HRD+KP N+++   + + +L D+GL++    G+ Y  +    +  +  PE   + +  + 
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDY 209

Query: 491 SGDVYSFGIVLLQILSGK 508
           S D++S G +L  ++  K
Sbjct: 210 SLDMWSLGCMLASMIFRK 227

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 20/203 (9%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHIT----NEGNVETFVREVASSSHVRHPNLVAL 371
           L  IG G  G V        +++VAIK ++    N+ + +   RE+     V H N+++L
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 372 LGYCLR------VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           L             + +L+ EL                L   +   +      G+  LHS
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHLHS 137

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSN 485
                I+HRD+KP+NI++  +   K+ DFGL++          +    T  Y  PE    
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILG 192

Query: 486 CKVNSSGDVYSFGIVLLQILSGK 508
                + D++S G ++ +++  K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 6e-28
 Identities = 49/223 (21%), Positives = 92/223 (41%), Gaps = 19/223 (8%)

Query: 297 PGCPRYTIREVHY-ATEKLNELNLIGEGITGKVYKGK-LSNNQHVAIKHI----TNEGNV 350
           P   R  + +  +   E+   L+ +G G  G V           VA+K +     +  + 
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 351 ETFVREVASSSHVRHPNLVALLGYC-----LRVDECFLIYELCPNGNLAEWLFGKDKCLS 405
           +   RE+    H++H N++ LL        L       +       +L      K + L+
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLT 119

Query: 406 WIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET 465
                 +     RGL ++HS     I+HRD+KP+N+ +  + E K+ DFGL++  D   T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176

Query: 466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
                V   +        +    N + D++S G ++ ++L+G+
Sbjct: 177 ---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 9e-27
 Identities = 57/246 (23%), Positives = 98/246 (39%), Gaps = 24/246 (9%)

Query: 317 LNLIGEGITGKVYKGKL----SNNQHVAIKHI------TNEGNVETFVREVASSSHVRH- 365
           L ++G G  GKV+  +        +  A+K +            E    E     H+R  
Sbjct: 29  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88

Query: 366 PNLVALLGYCLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHS 425
           P LV L        +  LI +    G L   L  +++      ++ +       +  L  
Sbjct: 89  PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIVLALEH 144

Query: 426 YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSEVRGTFGYLDPE--YR 483
             +  I++RDIK  NILL  N    L+DFGLSK     ET  + +  GT  Y+ P+    
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204

Query: 484 SNCKVNSSGDVYSFGIVLLQILSGK-------KAKVLTRAGSALELADPKLDREYSIEAF 536
            +   + + D +S G+++ ++L+G        +          +  ++P   +E S  A 
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264

Query: 537 DLTLQL 542
           DL  +L
Sbjct: 265 DLIQRL 270

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.8 bits (242), Expect = 1e-22
 Identities = 37/211 (17%), Positives = 72/211 (34%), Gaps = 21/211 (9%)

Query: 317 LNLIGEGITGKVYKGK-LSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGY 374
           +  +G G    V+  K + NN HVA+K +  +    E    E+     V   +       
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 375 CLR---------------VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARG 419
                                  +++E+     LA     + + +  I   +I+     G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 420 LWFLHSYSEGCIVHRDIKPTNILLGPN-FEAKLSDFGLSKVIDIGETYASSE-VRGTFGY 477
           L ++H      I+H DIKP N+L+        L    ++ + +             T  Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 478 LDPEYRSNCKVNSSGDVYSFGIVLLQILSGK 508
             PE           D++S   ++ ++++G 
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 3e-19
 Identities = 31/194 (15%), Positives = 52/194 (26%), Gaps = 30/194 (15%)

Query: 318 NLIGEGITGKVYKGKLSNNQHVAIK------------HITNEGNVETFVREVASSSHVRH 365
            L+GEG    V+           +K                +     F      S+    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 366 PNLVALLGYC----LRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLW 421
             L  L G         +   ++ EL                +      E+       + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKE--------LYRVRVENPDEVLDMILEEVA 117

Query: 422 FLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVID--IGETYASSEVRGTFGYLD 479
             +      IVH D+   N+L+       + DF  S  +           +VR    Y  
Sbjct: 118 KFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 480 PEYRSNCKVNSSGD 493
             YR+   +NS+ D
Sbjct: 174 RTYRTEKDINSAID 187

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	588
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.47
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.03
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.45
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.98
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.78
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.39

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=426.47  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=203.9

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ++|+..+.||+|+||.||+|++.+++.||||+++.. ...++|.+|++++++++|||||+++|++.+++..++||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            578889999999999999999988999999999753 3567899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccccC
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASSE  470 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~  470 (588)
                      |+|.+++......++|..++.++.|+++||+|||+.+   |+||||||+|||+|+++.+||+|||+++............
T Consensus        85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence            9999999877778999999999999999999999998   9999999999999999999999999998775544444455


Q ss_pred             ccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC-ccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-
Q 042871          471 VRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK-AKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-  548 (588)
Q Consensus       471 ~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~-p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-  548 (588)
                      ..||+.|+|||++.+..++.++|||||||++|||+|++. |+.........+.+........+......+.+|+..|++ 
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~  241 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE  241 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccC
Confidence            679999999999999999999999999999999999654 444333333333332222222222333456778899998 


Q ss_pred             CCCCCCCHHHHHHHHHHhhc
Q 042871          549 LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       549 ~p~~RPs~~evl~~L~~~~~  568 (588)
                      +|++||||+||++.|+++.+
T Consensus       242 ~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         242 RPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             SGGGSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHHHHHHh
Confidence            79999999999999998854

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-52  Score=429.85  Aligned_cols=259  Identities=26%  Similarity=0.395  Sum_probs=205.8

Q ss_pred             CccccceeeccCceEEEEEEec-CC---cEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          313 KLNELNLIGEGITGKVYKGKLS-NN---QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      +|+..++||+|+||+||+|++. +|   ..||||++...   ...+.|.+|+++|++++|||||+++|++.+++..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            4555689999999999999874 33   36899998653   23467999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++......++|.+++.++.|+++||+|||+.+   |+||||||+||||++++.+||+|||+++.......
T Consensus       107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            999999999999876778999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             c----cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          466 Y----ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       466 ~----~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      .    ......||+.|||||++.+..++.++|||||||++|||+| |+.||......+....+........+.+....+.
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  263 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH  263 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHH
Confidence            1    1223457899999999999999999999999999999998 8999876555555554443333333444455677


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCccC
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKALDISTTAK  574 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~~~  574 (588)
                      +|+..|++ +|++||||.||++.|+++++.+...+
T Consensus       264 ~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~slk  298 (299)
T d1jpaa_         264 QLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK  298 (299)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGT
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhCC
Confidence            78999998 79999999999999999987665443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=422.23  Aligned_cols=255  Identities=23%  Similarity=0.361  Sum_probs=212.1

Q ss_pred             HhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ..++|+..+.||+|+||.||+|++++++.||||+++.. ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            45788999999999999999999988899999999753 456789999999999999999999998754 5679999999


Q ss_pred             CCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          389 PNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       389 ~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++|+|.+++.... ..++|.+++.|+.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++.........
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            9999999885443 36999999999999999999999998   9999999999999999999999999999876655555


Q ss_pred             ccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcc-ccccccchhhhcCcccCcccCHHHHHHHHHHHHHh
Q 042871          468 SSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAK-VLTRAGSALELADPKLDREYSIEAFDLTLQLALSC  546 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~-~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C  546 (588)
                      .....||+.|||||++.+..++.++|||||||++|||+||+.|+ ......+....+........+....+.+.+|+..|
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  246 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC  246 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHH
Confidence            56678999999999999999999999999999999999976654 33333333333322222222222334566778999


Q ss_pred             hc-CCCCCCCHHHHHHHHHHhhc
Q 042871          547 TA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       547 ~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ++ +|++||||+||+++|+....
T Consensus       247 l~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         247 WKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhhhhh
Confidence            98 79999999999999998654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=411.20  Aligned_cols=252  Identities=26%  Similarity=0.346  Sum_probs=218.8

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|+..++||+|+||+||+|++++++.||||+++.. ...++|.+|++++++++||||++++|++.+++..++||||++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            3688999999999999999999988999999999753 456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccccc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYASS  469 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~~  469 (588)
                      +|+|.+++......+++..+++++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++...........
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            99999999877778999999999999999999999998   999999999999999999999999999877655544455


Q ss_pred             CccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc
Q 042871          470 EVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA  548 (588)
Q Consensus       470 ~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~  548 (588)
                      ...||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+....+....+...+......+..|+..|++
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~  239 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH  239 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHcc
Confidence            5679999999999999999999999999999999998 788987655555544443333333333334556778999998


Q ss_pred             -CCCCCCCHHHHHHHHHH
Q 042871          549 -LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       549 -~p~~RPs~~evl~~L~~  565 (588)
                       +|++|||++|+++.|.+
T Consensus       240 ~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         240 EKADERPTFKILLSNILD  257 (258)
T ss_dssp             SSGGGSCCHHHHHHHHHC
T ss_pred             CCHhHCcCHHHHHHHhhC
Confidence             79999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-52  Score=422.10  Aligned_cols=258  Identities=25%  Similarity=0.397  Sum_probs=218.6

Q ss_pred             HHhcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ...++|+..+.||+|+||+||+|++. +|+.||||+++.+ ...++|.+|+.+|++++|||||+++|++.+++..++|||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            34678999999999999999999974 6889999999753 456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcC-CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          387 LCPNGNLAEWLFGK-DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      |+++|+|.+++... ...+++..++.++.|+++||+|||+.+   |+||||||+||||++++.+||+|||+++.......
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999999653 457999999999999999999999998   99999999999999999999999999998765554


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccc-cccccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKV-LTRAGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~-~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.|+. ........+.+........+....+.+.+|+.
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  250 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  250 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence            44555678999999999999999999999999999999999776653 33333444444433333333334455677889


Q ss_pred             Hhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          545 SCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .|++ +|++|||++||++.|+.+.+.
T Consensus       251 ~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         251 ACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            9998 799999999999999987654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-51  Score=414.14  Aligned_cols=259  Identities=27%  Similarity=0.397  Sum_probs=209.2

Q ss_pred             hcCccccceeeccCceEEEEEEecCC-----cEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNN-----QHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g-----~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      .+.|+..++||+|+||.||+|++++.     ..||||++....   ....|.+|++++++++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35688889999999999999987532     479999996432   3457899999999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+.+|+|.+++......++|.+++.++.|+++||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999998777778999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccc-cccccchhhhcCcccCcccCHHHHHHH
Q 042871          463 GET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKV-LTRAGSALELADPKLDREYSIEAFDLT  539 (588)
Q Consensus       463 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~-~~~~~~~~~~~d~~l~~~~~~e~~~~v  539 (588)
                      ...  .......||+.|||||++.+..++.++|||||||++|||++|+.|+. ........+.+........+.+....+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  242 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI  242 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence            332  22334568999999999999999999999999999999999766543 333334444444444444444455667


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      .+|+.+|++ +|++||||.||+++|+++++.+..
T Consensus       243 ~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~  276 (283)
T d1mqba_         243 YQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  276 (283)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             HHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence            888999998 799999999999999998876544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=415.11  Aligned_cols=251  Identities=25%  Similarity=0.428  Sum_probs=202.1

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|...+.||+|+||+||+|+++  ..||||+++.    ....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            567888999999999999999874  3699999863    3446789999999999999999999998754 56899999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-  465 (588)
                      |+++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+||||++++.+||+|||+++....... 
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877777999999999999999999999998   99999999999999999999999999987654322 


Q ss_pred             ccccCccCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCcccccccc-chhhhc-----CcccCcccCHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSN---CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAG-SALELA-----DPKLDREYSIEAF  536 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~~~~-----d~~l~~~~~~e~~  536 (588)
                      .......||+.|||||++.+   ..++.++|||||||++|||+||+.||...... .....+     .+.+ ...+.+..
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~  239 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL-SKVRSNCP  239 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG-GGSCTTCC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc-hhccccch
Confidence            23455689999999999864   35899999999999999999999998643322 111111     1111 12223334


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      +.+.+|+..|+. +|++|||++||++.|+.+..
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            556777899998 79999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=410.93  Aligned_cols=253  Identities=26%  Similarity=0.404  Sum_probs=210.9

Q ss_pred             hcCccccce-eeccCceEEEEEEec---CCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNL-IGEGITGKVYKGKLS---NNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~-LG~G~fG~Vykg~~~---~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|...+. ||+|+||+||+|++.   ++..||||+++..   ...+.|.+|+++|++++|||||+++|++.+ +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            356666664 999999999999763   4568999999753   235679999999999999999999999865 56899


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999999998776678999999999999999999999998   999999999999999999999999999987544


Q ss_pred             Ccc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHH
Q 042871          464 ETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~  540 (588)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+....+...+......+.
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  242 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  242 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence            332  2334568999999999999999999999999999999998 8999976555554444433333333333445567


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHHHHHHhh
Q 042871          541 QLALSCTA-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~~L~~~~  567 (588)
                      .|+..|++ +|++||||.+|++.|+...
T Consensus       243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         243 ALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            78899998 7999999999999998765

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=409.01  Aligned_cols=254  Identities=25%  Similarity=0.398  Sum_probs=204.9

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~  389 (588)
                      .++|++.+.||+|+||.||+|++++++.||||++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4689999999999999999999988889999999753 356789999999999999999999999854 56899999999


Q ss_pred             CCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          390 NGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      +|+|.+++.... ..++|.+++.++.|+++||+|||+.+   |+||||||+|||||+++++||+|||+++..........
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            999999986543 46999999999999999999999998   99999999999999999999999999987755544444


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc-ccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL-TRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~-~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....||+.|+|||++....++.++||||||+++|||++|+.|+.. .........+........+.+..+.+.+++.+|+
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl  251 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW  251 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHc
Confidence            556799999999999999999999999999999999997666543 3333333333322222333334455677889999


Q ss_pred             c-CCCCCCCHHHHHHHHHHhhc
Q 042871          548 A-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      + +|++||||++|+++|++...
T Consensus       252 ~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         252 RKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ccCHhHCcCHHHHHHHHhhhhc
Confidence            8 79999999999999998664

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=405.35  Aligned_cols=246  Identities=22%  Similarity=0.336  Sum_probs=191.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec--cCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR--VDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~L  383 (588)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...    ...+.+.+|++++++++|||||++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36899999999999999999986 57999999998643    234568999999999999999999999865  456899


Q ss_pred             EeecCCCCChhhhhhc---CCcCccHHHHHHHHHhhhccchhhcccc--CCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          384 IYELCPNGNLAEWLFG---KDKCLSWIQRLEIAIDSARGLWFLHSYS--EGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ||||+++|+|.+++..   ....+++.+++.++.|+++||.|||+.+  ..+|+||||||+||||++++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999853   2356999999999999999999999865  2359999999999999999999999999998


Q ss_pred             eecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC----cccCcccCHH
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD----PKLDREYSIE  534 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d----~~l~~~~~~e  534 (588)
                      ....... ......||+.|||||++.+..++.++|||||||++|||+||+.||......+....+.    +.+...++.+
T Consensus       163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  241 (269)
T d2java1         163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  241 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            7654332 2345689999999999999999999999999999999999999997544443333221    2223344544


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                          +..|+.+|++ +|.+|||+.|+++
T Consensus       242 ----l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         242 ----LNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHHHcCCChhHCcCHHHHHh
Confidence                5566788888 7999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=403.14  Aligned_cols=245  Identities=25%  Similarity=0.385  Sum_probs=201.5

Q ss_pred             ceeeccCceEEEEEEec---CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecCCC
Q 042871          318 NLIGEGITGKVYKGKLS---NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELCPN  390 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~  390 (588)
                      ++||+|+||+||+|.+.   .++.||||+++..    ...+.|.+|++++++++|||||+++|++.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999864   3568999999643    234679999999999999999999999865 467899999999


Q ss_pred             CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc--cc
Q 042871          391 GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--AS  468 (588)
Q Consensus       391 gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~--~~  468 (588)
                      |+|.+++... ..+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++........  ..
T Consensus        92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999999643 45999999999999999999999998   999999999999999999999999999876544332  22


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....||+.|||||.+.+..++.++|||||||++|||+| |+.||......+....+....+...+......+.+|+..|+
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence            34578999999999999999999999999999999998 89999765555555544433333333334455667889999


Q ss_pred             c-CCCCCCCHHHHHHHHHHhh
Q 042871          548 A-LTHQRPPMEQVFVTLQKAL  567 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~  567 (588)
                      + +|++|||+++|+++|+...
T Consensus       248 ~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         248 TYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHhhCHH
Confidence            8 7999999999999988754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=401.21  Aligned_cols=243  Identities=24%  Similarity=0.332  Sum_probs=199.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++...   ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            35799999999999999999997 47999999998643   234568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc-
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-  465 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-  465 (588)
                      |+++|+|.+++.. ...+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++++||+|||+++....... 
T Consensus        84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999999999953 446999999999999999999999999   99999999999999999999999999997654332 


Q ss_pred             ccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccch--hhhcCccc----CcccCHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSA--LELADPKL----DREYSIEAFDL  538 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--~~~~d~~l----~~~~~~e~~~~  538 (588)
                      .......||+.|||||++.+..+ +.++|||||||++|||++|+.||........  ........    ....+.+    
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~----  235 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA----  235 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH----
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHH----
Confidence            23455789999999999988776 5789999999999999999999964433211  11111111    1233444    


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..|+..|++ +|++|||++|+++
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhc
Confidence            4456778887 7999999999865

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=398.64  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=207.2

Q ss_pred             hcCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceec-cCeeeEEeecCC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLR-VDECFLIYELCP  389 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~E~~~  389 (588)
                      .++|+..+.||+|+||.||+|++ .|+.||||+++++...+.|.+|++++++++||||++++|++.+ .+.+++||||++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            46788889999999999999998 5789999999888778899999999999999999999999865 456899999999


Q ss_pred             CCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          390 NGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       390 ~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      +|+|.++|.... ..++|..+++|+.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....    .
T Consensus        85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~  157 (262)
T d1byga_          85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q  157 (262)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----C
Confidence            999999996543 35899999999999999999999988   999999999999999999999999999865432    2


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhh
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCT  547 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~  547 (588)
                      ....+|..|+|||++.+..++.++||||||+++|||+| |+.|+......+....+........+......+.+|+.+|+
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl  237 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW  237 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence            33467899999999999999999999999999999998 67788766666666665544444444444456778899999


Q ss_pred             c-CCCCCCCHHHHHHHHHHhhc
Q 042871          548 A-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       548 ~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      . +|.+||||.|++++|+++..
T Consensus       238 ~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         238 HLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCHhHCcCHHHHHHHHHHHHh
Confidence            8 79999999999999998753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-49  Score=406.73  Aligned_cols=262  Identities=26%  Similarity=0.363  Sum_probs=213.9

Q ss_pred             HHHHHHHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecc
Q 042871          304 IREVHYATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGY  374 (588)
Q Consensus       304 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~  374 (588)
                      +.+++...++|+..+.||+|+||+||+|+..      +++.||||++....   ..+.|.+|++++++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3456667889999999999999999999863      46789999997543   24579999999999999999999999


Q ss_pred             eeccCeeeEEeecCCCCChhhhhhcCC-----------------------cCccHHHHHHHHHhhhccchhhccccCCce
Q 042871          375 CLRVDECFLIYELCPNGNLAEWLFGKD-----------------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCI  431 (588)
Q Consensus       375 ~~~~~~~~LV~E~~~~gsL~~~L~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~I  431 (588)
                      +.+.+..++||||+++|+|.+++....                       ..+++.+++.|+.|++.||+|||+.+   |
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence            999999999999999999999995321                       24889999999999999999999998   9


Q ss_pred             EecCCCCCCeEECCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC-
Q 042871          432 VHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK-  509 (588)
Q Consensus       432 vHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~-  509 (588)
                      +||||||+|||+|.++.+||+|||+++....... ...+...||+.|+|||.+.+..++.++|||||||++|||++|.. 
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999999999999986643332 23345678999999999999999999999999999999999964 


Q ss_pred             ccccccccchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          510 AKVLTRAGSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       510 p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      |+......+....+........+......+..|+..|++ +|++||||.||+++|+++.+
T Consensus       242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            665444443333332222222233333456778999998 79999999999999998863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=396.35  Aligned_cols=239  Identities=27%  Similarity=0.373  Sum_probs=203.2

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++..     ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999997 4789999999852     344677899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.++..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            999999999999643 45999999999999999999999998   9999999999999999999999999998754332 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L  542 (588)
                        .....||+.|||||++.+..++.++|||||||++|||++|+.||...........+   +..++...+.+    +..|
T Consensus       161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~----~~~l  234 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARDL  234 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH----HHHH
T ss_pred             --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHH----HHHH
Confidence              23467999999999999999999999999999999999999999754433333222   22233334444    4556


Q ss_pred             HHHhhc-CCCCCCCHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..|++ +|++|||++|+++
T Consensus       235 i~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHccCCHhHCcCHHHHHc
Confidence            778888 7999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-49  Score=400.20  Aligned_cols=240  Identities=26%  Similarity=0.405  Sum_probs=202.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++..  ....+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999996 5799999999863  345678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++|+|.+++..  +.+++.++..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++....... ..
T Consensus       100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~  173 (293)
T d1yhwa1         100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (293)
T ss_dssp             TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred             CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence            99999998853  45999999999999999999999998   99999999999999999999999999987754332 33


Q ss_pred             cCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc------CcccCcccCHHHHHHHHHH
Q 042871          469 SEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA------DPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~------d~~l~~~~~~e~~~~v~~L  542 (588)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+      +......++.    .+..|
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~~l  249 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA----IFRDF  249 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCH----HHHHH
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCH----HHHHH
Confidence            4567999999999999999999999999999999999999998643332221111      1111223344    45556


Q ss_pred             HHHhhc-CCCCCCCHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..|++ +|.+|||++|+++
T Consensus       250 i~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         250 LNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHccCChhHCcCHHHHhc
Confidence            788888 7999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=399.28  Aligned_cols=255  Identities=27%  Similarity=0.374  Sum_probs=201.2

Q ss_pred             hcCccccceeeccCceEEEEEEecC----CcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLSN----NQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      .++|+..+.||+|+||.||+|++..    +..||||.++..   ...+.|.+|++++++++|||||+++|++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999998642    356899998643   23467999999999999999999999986 467899


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ||||+++|+|.+++......+++.+++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998777778999999999999999999999999   999999999999999999999999999887655


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~L  542 (588)
                      .........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+........+....+.+..|
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  241 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  241 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            5555566778999999999999999999999999999999998 888887665555444332222222333334456677


Q ss_pred             HHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          543 ALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      +..|++ +|++|||+.||++.|+++++.
T Consensus       242 i~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         242 MTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            899998 799999999999999988753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=407.61  Aligned_cols=253  Identities=27%  Similarity=0.402  Sum_probs=206.8

Q ss_pred             HhcCccccceeeccCceEEEEEEecC-C-----cEEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEEecceeccC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKLSN-N-----QHVAIKHITNE---GNVETFVREVASSSHV-RHPNLVALLGYCLRVD  379 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~~~-g-----~~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~  379 (588)
                      ..++|+..+.||+|+||+||+|++.. +     ..||||.+...   .....|.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34789999999999999999998632 2     36999998642   3456789999999998 8999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCC----------------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCC
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD----------------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIK  437 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLK  437 (588)
                      ..++||||+++|+|.++|....                      ..+++..++.++.|+++||+|||+++   |+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            9999999999999999996542                      24899999999999999999999998   9999999


Q ss_pred             CCCeEECCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCcccccc
Q 042871          438 PTNILLGPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTR  515 (588)
Q Consensus       438 p~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~  515 (588)
                      |+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876544332 2345678999999999999999999999999999999998 899986433


Q ss_pred             c-cchhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHH
Q 042871          516 A-GSALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQK  565 (588)
Q Consensus       516 ~-~~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~  565 (588)
                      . ....+.+........+....+.+..|+..|++ +|++|||++||+++|..
T Consensus       272 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            2 22333333333333333334556777899998 79999999999999964

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=400.65  Aligned_cols=242  Identities=24%  Similarity=0.338  Sum_probs=201.8

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC--CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN--EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      +.|++.+.||+|+||+||+|+. .+|+.||||++..  ....+.|.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5688899999999999999996 5789999999864  344578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcccc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYAS  468 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~~  468 (588)
                      ++|+|.+++......+++.++..++.|+++||.|||+++   |+||||||+|||++.++++||+|||+++...... ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence            999999998766667999999999999999999999999   9999999999999999999999999997653221 123


Q ss_pred             cCccCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C---ccc--CcccCHHHHH
Q 042871          469 SEVRGTFGYLDPEYRS-----NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D---PKL--DREYSIEAFD  537 (588)
Q Consensus       469 ~~~~gt~~Y~aPE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d---~~l--~~~~~~e~~~  537 (588)
                      ....||+.|||||++.     ...|+.++|||||||++|||++|+.||......+....+ .   +.+  ....+.    
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~----  243 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS----  243 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH----
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH----
Confidence            4567999999999874     456899999999999999999999998754433322211 1   111  123344    


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .+..|+..|++ +|.+|||++|+++
T Consensus       244 ~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            44556788888 7999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=403.74  Aligned_cols=254  Identities=21%  Similarity=0.347  Sum_probs=208.4

Q ss_pred             cCccccceeeccCceEEEEEEec-CCc----EEEEEEecC---CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQ----HVAIKHITN---EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFL  383 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L  383 (588)
                      ++|+..++||+|+||+||+|++. +|+    +||||++..   ....+.|.+|++++++++|||||+++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999863 444    689998864   23467899999999999999999999999865 5678


Q ss_pred             EeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCC
Q 042871          384 IYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~  463 (588)
                      ++||+.+|+|.+++......+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999999877778999999999999999999999998   999999999999999999999999999876544


Q ss_pred             Ccc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhcCcccCcccCHHHHHHHHH
Q 042871          464 ETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELADPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       464 ~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~d~~l~~~~~~e~~~~v~~  541 (588)
                      ... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...........+........+......+.+
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            332 2344578999999999999999999999999999999999 78888765555555555433333333334455677


Q ss_pred             HHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          542 LALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      |+.+|++ +|.+|||+.||++.|+.+...
T Consensus       245 li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         245 IMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            8899998 799999999999999987654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=401.83  Aligned_cols=197  Identities=25%  Similarity=0.357  Sum_probs=176.0

Q ss_pred             HhcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ..++|+..+.||+|+||+||+|+. .+|+.||+|+++.+   ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            367899999999999999999996 57999999998642   33567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc-cCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY-SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||+++|+|.+++.+. ..+++..+..++.|+++||.|||+. +   |+||||||+||||++++++||+|||+|+..... 
T Consensus        84 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             ECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            999999999999643 4599999999999999999999974 7   999999999999999999999999999875432 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccc
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVL  513 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  513 (588)
                        ......||+.|||||++.+..|+.++||||+||++|||++|+.||..
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              22346899999999999999999999999999999999999999853

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=386.73  Aligned_cols=237  Identities=24%  Similarity=0.328  Sum_probs=191.4

Q ss_pred             cccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec----cCeeeEEe
Q 042871          315 NELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR----VDECFLIY  385 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV~  385 (588)
                      ...++||+|+||+||+|+. .+++.||+|++...    ...+.|.+|+++|++++|||||++++++.+    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4456899999999999997 47889999998643    234678999999999999999999999865    35689999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC-CCCcEEEEecCCcceecCCC
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG-PNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld-~~~~~kL~DFGla~~~~~~~  464 (588)
                      ||+++|+|.+++... ..+++.+++.++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+++..... 
T Consensus        92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence            999999999999643 46899999999999999999999875 3499999999999996 5889999999999864322 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccc-cchhhhcCc-----ccCcccCHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRA-GSALELADP-----KLDREYSIEAFDL  538 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~-~~~~~~~d~-----~l~~~~~~e~~~~  538 (588)
                        ......||+.|||||++.+ .++.++|||||||++|||++|+.||..... ....+.+..     .+....+.+    
T Consensus       169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~----  241 (270)
T d1t4ha_         169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE----  241 (270)
T ss_dssp             --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH----
T ss_pred             --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH----
Confidence              2345689999999998875 699999999999999999999999964322 222222221     112223333    


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      +.+|+..|++ +|++|||++|+++
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhC
Confidence            5667889998 7999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=395.00  Aligned_cols=242  Identities=21%  Similarity=0.289  Sum_probs=201.6

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++..     +...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            6799999999999999999997 5799999999863     345678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC-
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE-  464 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~-  464 (588)
                      ||+++|+|.+++... +.+++.+++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.... 
T Consensus        88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            999999999988543 46999999999999999999999999   9999999999999999999999999998775433 


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                      ........||+.|||||++.+..++.++|||||||++|||++|+.||...........+   +..++...+.+    +..
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~----~~~  239 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARD  239 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHH----HHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHH----HHH
Confidence            22334567999999999999999999999999999999999999999754333322221   22233344444    556


Q ss_pred             HHHHhhc-CCCCCCCHHHHHH
Q 042871          542 LALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~evl~  561 (588)
                      |+..|++ +|.+|||++|++.
T Consensus       240 li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHHHccCCHhHCcCHHHHcC
Confidence            6888888 7999999999754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=392.91  Aligned_cols=256  Identities=28%  Similarity=0.436  Sum_probs=207.4

Q ss_pred             cCccccceeeccCceEEEEEEec-CCc--EEEEEEecC---CCcHHHHHHHHHHhccC-CCCceeEEecceeccCeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS-NNQ--HVAIKHITN---EGNVETFVREVASSSHV-RHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ++|+..+.||+|+||.||+|++. +|.  .||||++..   ....+.|.+|+++|+++ +|||||+++|++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67888999999999999999974 444  578888753   23456799999999998 799999999999999999999


Q ss_pred             eecCCCCChhhhhhcC---------------CcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcE
Q 042871          385 YELCPNGNLAEWLFGK---------------DKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEA  449 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~  449 (588)
                      |||+++|+|.++|+..               ...+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999643               246999999999999999999999998   9999999999999999999


Q ss_pred             EEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC-ccccccccchhhhcCcccC
Q 042871          450 KLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK-AKVLTRAGSALELADPKLD  528 (588)
Q Consensus       450 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~-p~~~~~~~~~~~~~d~~l~  528 (588)
                      ||+|||+++.....  .......||..|+|||.+.+..++.++||||||+++|||++|.. ||......+..+.+.....
T Consensus       167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            99999999764322  22234568999999999999999999999999999999999765 5654444444444433322


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhccCCc
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDISTT  572 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~~~~  572 (588)
                      ...+....+.+..|+.+|++ +|++||||+||++.|+++++....
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~  289 (309)
T d1fvra_         245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  289 (309)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence            33333334556777889998 799999999999999999865443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-47  Score=393.37  Aligned_cols=245  Identities=25%  Similarity=0.343  Sum_probs=187.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      .+.|+..+.||+|+||+||+|+. .+|+.||||++...   ...+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            56799999999999999999997 47899999998643   234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC---CCCcEEEEecCCcceecCC
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG---PNFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld---~~~~~kL~DFGla~~~~~~  463 (588)
                      |+++|+|.+++.. ...+++.++..++.|++.||+|||+.+   |+||||||+|||+.   +++.+||+|||+++.....
T Consensus        88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999964 346999999999999999999999998   99999999999994   5789999999999876543


Q ss_pred             CcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Cc--ccCcccCHHHHHHHH
Q 042871          464 ETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DP--KLDREYSIEAFDLTL  540 (588)
Q Consensus       464 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~--~l~~~~~~e~~~~v~  540 (588)
                      ..  .....||+.|||||++.+..++.++|||||||++|||++|+.||...........+ ..  ........+....+.
T Consensus       164 ~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         164 SV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             Ce--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            32  23467999999999999999999999999999999999999999754433332221 11  111111112223455


Q ss_pred             HHHHHhhc-CCCCCCCHHHHHH
Q 042871          541 QLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       541 ~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .|+..|++ +|.+|||++|+++
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHhc
Confidence            66788888 7999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-48  Score=389.92  Aligned_cols=251  Identities=23%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             cCccccceeeccCceEEEEEEec--CC--cEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccCeee
Q 042871          312 EKLNELNLIGEGITGKVYKGKLS--NN--QHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~--~g--~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ++|+..+.||+|+||.||+|++.  ++  ..||||++..+     ...+.|.+|++++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            67899999999999999999863  23  37899988632     235689999999999999999999999975 4678


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+++|+|.+++......+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999999777778999999999999999999999998   99999999999999999999999999998754


Q ss_pred             CCcc--cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhhhc-CcccCcccCHHHHHH
Q 042871          463 GETY--ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALELA-DPKLDREYSIEAFDL  538 (588)
Q Consensus       463 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~~~-d~~l~~~~~~e~~~~  538 (588)
                      ....  ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+ ........+......
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            3322  2334568889999999999999999999999999999998 89998754444333322 222222222233345


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHHHHHHh
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFVTLQKA  566 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~~L~~~  566 (588)
                      +.+|+..|++ +|++||||.||++.|+++
T Consensus       244 l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            6778999998 799999999999999876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-47  Score=395.23  Aligned_cols=237  Identities=29%  Similarity=0.428  Sum_probs=196.1

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-----cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-----NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      +.|+..+.||+|+||+||+|+. .+|+.||||++....     ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4589999999999999999986 578999999986432     2356899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|..++.. .+.+++.+++.++.|+++||.|||+++   |+||||||+|||+++++.+||+|||+++....   
T Consensus        95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            99999999776643 456999999999999999999999999   99999999999999999999999999986532   


Q ss_pred             ccccCccCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCccccccccchh-hhc---Cccc-CcccCHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSN---CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-ELA---DPKL-DREYSIEAFD  537 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-~~~---d~~l-~~~~~~e~~~  537 (588)
                        .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||......... ...   .+.+ ...++.    
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~----  241 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE----  241 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCH----
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCH----
Confidence              234579999999999854   46899999999999999999999998643332211 111   1111 122344    


Q ss_pred             HHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          538 LTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       538 ~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .+..|+..|++ +|.+|||++|+++
T Consensus       242 ~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHHh
Confidence            45566788888 7999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.2e-47  Score=396.66  Aligned_cols=243  Identities=24%  Similarity=0.298  Sum_probs=204.2

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      -++|++.+.||+|+||.||+|+. .+|+.||||++....  ..+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999996 579999999997543  356788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC--CCCcEEEEecCCcceecCCCc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG--PNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld--~~~~~kL~DFGla~~~~~~~~  465 (588)
                      +++|+|.+++......+++.++..++.|++.||.|||+++   |+||||||+|||++  .++.+||+|||+++...... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999766667999999999999999999999999   99999999999996  46789999999998765433 


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------CcccCcccCHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------DPKLDREYSIEAFDL  538 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------d~~l~~~~~~e~~~~  538 (588)
                       ......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+       +.......+.+    
T Consensus       181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~----  255 (350)
T d1koaa2         181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED----  255 (350)
T ss_dssp             -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH----
T ss_pred             -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH----
Confidence             233467899999999999999999999999999999999999998644333322221       11111234444    


Q ss_pred             HHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          539 TLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       539 v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      +..|+..|++ +|++|||++|+++.
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            4556778887 79999999999873

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=392.61  Aligned_cols=264  Identities=24%  Similarity=0.350  Sum_probs=201.1

Q ss_pred             ccHHHHHHHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCC---CcHHHHHHHHHHhccC-CCCceeEE
Q 042871          302 YTIREVHYATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNE---GNVETFVREVASSSHV-RHPNLVAL  371 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l  371 (588)
                      ++.++++...++|+..+.||+|+||.||+|++.      +++.||||++...   ...+.+.+|...+.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            344555556688999999999999999999852      3568999998753   2345678888887776 68999999


Q ss_pred             ecceecc-CeeeEEeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecC
Q 042871          372 LGYCLRV-DECFLIYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRD  435 (588)
Q Consensus       372 ~g~~~~~-~~~~LV~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrD  435 (588)
                      ++++.+. +..++||||+++|+|.+++....               ..+++.+++.++.|+++||.|||+++   |+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence            9987754 56899999999999999996432               34899999999999999999999998   99999


Q ss_pred             CCCCCeEECCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCC-cccc
Q 042871          436 IKPTNILLGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKK-AKVL  513 (588)
Q Consensus       436 LKp~NILld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~-p~~~  513 (588)
                      |||+||||++++.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+||.. ||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654333 23445689999999999999999999999999999999999764 5643


Q ss_pred             cccc-chhhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          514 TRAG-SALELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       514 ~~~~-~~~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      .... .....+........+......+.+++.+|++ +|.+|||++||++.|+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            3221 1222222221222222223345677889998 79999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-47  Score=390.16  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=202.2

Q ss_pred             cceeeccCceEEEEEEecCC----cEEEEEEecCC---CcHHHHHHHHHHhccCCCCceeEEecceec-cCeeeEEeecC
Q 042871          317 LNLIGEGITGKVYKGKLSNN----QHVAIKHITNE---GNVETFVREVASSSHVRHPNLVALLGYCLR-VDECFLIYELC  388 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~E~~  388 (588)
                      .++||+|+||+||+|++.++    ..||||+++..   ...++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            36899999999999997432    36899998642   345679999999999999999999999875 56899999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc--
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY--  466 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~--  466 (588)
                      ++|+|.+++......+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999877778899999999999999999999998   999999999999999999999999999876543322  


Q ss_pred             -cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCcccccc-ccchhhhcCcccCcccCHHHHHHHHHHHH
Q 042871          467 -ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTR-AGSALELADPKLDREYSIEAFDLTLQLAL  544 (588)
Q Consensus       467 -~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~-~~~~~~~~d~~l~~~~~~e~~~~v~~L~~  544 (588)
                       ......||+.|+|||++....++.++||||||+++|||+||+.|+.... ..+....+........+....+.+.+|+.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence             2334678999999999999999999999999999999999888765322 11222221111111122223345677889


Q ss_pred             Hhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          545 SCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       545 ~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .|++ +|++||||.||++.|+++++.
T Consensus       269 ~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            9998 799999999999999999764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=391.00  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=208.2

Q ss_pred             hcCccccceeeccCceEEEEEEec--------CCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceecc
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS--------NNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRV  378 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~  378 (588)
                      .++|+..+.||+|+||.||+|+..        ++..||||+++.+.   ...++.+|+..+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            568889999999999999999852        23579999997543   346788899988888 799999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCC---------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEE
Q 042871          379 DECFLIYELCPNGNLAEWLFGKD---------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILL  443 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILl  443 (588)
                      +..++||||+++|+|.++|....               ..+++.+++.++.|+++||.|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999996432               35899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEEecCCcceecCCCcc-cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCccccccccchhh
Q 042871          444 GPNFEAKLSDFGLSKVIDIGETY-ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILS-GKKAKVLTRAGSALE  521 (588)
Q Consensus       444 d~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~~  521 (588)
                      +.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++||||||+++|||++ |+.||.........+
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~  248 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  248 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            99999999999999877544332 3345678999999999999999999999999999999998 677776555444544


Q ss_pred             hcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          522 LADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       522 ~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .+........+......+.+|+.+|++ +|.+|||+.||+++|++++..
T Consensus       249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            443333333333333457778999998 799999999999999998654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=393.42  Aligned_cols=257  Identities=22%  Similarity=0.332  Sum_probs=210.6

Q ss_pred             HHhcCccccceeeccCceEEEEEEec------CCcEEEEEEecCCCc---HHHHHHHHHHhccCCCCceeEEecceeccC
Q 042871          309 YATEKLNELNLIGEGITGKVYKGKLS------NNQHVAIKHITNEGN---VETFVREVASSSHVRHPNLVALLGYCLRVD  379 (588)
Q Consensus       309 ~at~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~  379 (588)
                      ...++|...+.||+|+||.||+|++.      +++.||||+++....   ...|.+|++++++++||||++++|++..++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            34578899999999999999999863      367899999975432   346899999999999999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCC---------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEE
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD---------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAK  450 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~k  450 (588)
                      ..++||||+++|+|.+++....         ..+++.++.+++.|+++||.|||+.+   |+||||||+|||+|+++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence            9999999999999999985321         34789999999999999999999998   99999999999999999999


Q ss_pred             EEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCC-CccccccccchhhhcCcccC
Q 042871          451 LSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGK-KAKVLTRAGSALELADPKLD  528 (588)
Q Consensus       451 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~-~p~~~~~~~~~~~~~d~~l~  528 (588)
                      |+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+||+ .|+......+....+.....
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            999999987644332 2334456899999999999999999999999999999999985 56654443333333222112


Q ss_pred             cccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          529 REYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       529 ~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      ...+......+.+|+.+|++ +|.+||||+||+++|++.++
T Consensus       254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            22223333567778999998 79999999999999998765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-47  Score=387.18  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=199.7

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCCCcHHHHH--HHHHHhccCCCCceeEEecceeccC----eeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFV--REVASSSHVRHPNLVALLGYCLRVD----ECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~--~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV~  385 (588)
                      ++|...+.||+|+||.||+|++ +|+.||||+++.+.. +.+.  .|+..+.+++|||||++++++.+.+    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4677788999999999999997 789999999976543 3443  4556667889999999999998654    579999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccc-----cCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSY-----SEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      ||+++|+|.++|..  ..++|.++++++.|++.||+|||+.     ..++|+||||||+||||++++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            99999999999954  3599999999999999999999975     2345999999999999999999999999999987


Q ss_pred             cCCCcc---cccCccCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHcCCCccccccccc-------------
Q 042871          461 DIGETY---ASSEVRGTFGYLDPEYRSNCK------VNSSGDVYSFGIVLLQILSGKKAKVLTRAGS-------------  518 (588)
Q Consensus       461 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~------~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~-------------  518 (588)
                      ......   ......||++|+|||++.+..      ++.++|||||||+||||+||..|+.......             
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            554322   234567999999999987643      5778999999999999999987764321110             


Q ss_pred             ---hhhhcC----cccCccc-CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          519 ---ALELAD----PKLDREY-SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       519 ---~~~~~d----~~l~~~~-~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                         .....+    +.+.... +.+....+..|+..|++ +|.+|||+.||++.|+++.+.
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence               011122    2222222 33456678889999998 799999999999999988654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-46  Score=394.07  Aligned_cols=246  Identities=22%  Similarity=0.247  Sum_probs=204.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC--cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG--NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++....  ..+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999996 579999999987543  345788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC--CCCcEEEEecCCcceecCCCc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG--PNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld--~~~~~kL~DFGla~~~~~~~~  465 (588)
                      +++|+|.+++......+++.+++.++.|++.||.|||+.+   |+||||||+||||+  .++.+||+|||+++.......
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            9999999988766667999999999999999999999998   99999999999998  678999999999988754332


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L  542 (588)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+   +..............+..|
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence              33457899999999999999999999999999999999999999754433322221   1111211111222334566


Q ss_pred             HHHhhc-CCCCCCCHHHHHH
Q 042871          543 ALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RPs~~evl~  561 (588)
                      +..|++ +|.+|||++|+++
T Consensus       263 i~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHccCChhHCcCHHHHhc
Confidence            788888 7999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=384.73  Aligned_cols=245  Identities=25%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--------CcHHHHHHHHHHhccCCCCceeEEecceeccCee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--------GNVETFVREVASSSHVRHPNLVALLGYCLRVDEC  381 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~  381 (588)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++...        ...+.+.+|+.+|++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999997 57999999998531        2357899999999999999999999999999999


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC----cEEEEecCCc
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF----EAKLSDFGLS  457 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~----~~kL~DFGla  457 (588)
                      |+||||+++|+|.+++... +.+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++    .+||+|||++
T Consensus        89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence            9999999999999999643 46999999999999999999999999   99999999999998776    5999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-C--cccCcccCHH
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-D--PKLDREYSIE  534 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d--~~l~~~~~~e  534 (588)
                      +....+.  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .  ..........
T Consensus       165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (293)
T d1jksa_         165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  242 (293)
T ss_dssp             EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence            8875433  234457899999999999999999999999999999999999999754433332221 1  1111111111


Q ss_pred             HHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          535 AFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       535 ~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ....+..|+..|++ +|.+|||++|+++
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22345567888998 7999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-47  Score=389.32  Aligned_cols=257  Identities=25%  Similarity=0.351  Sum_probs=212.0

Q ss_pred             HhcCccccceeeccCceEEEEEEe------cCCcEEEEEEecCCC---cHHHHHHHHHHhccC-CCCceeEEecceeccC
Q 042871          310 ATEKLNELNLIGEGITGKVYKGKL------SNNQHVAIKHITNEG---NVETFVREVASSSHV-RHPNLVALLGYCLRVD  379 (588)
Q Consensus       310 at~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~  379 (588)
                      ..++|+..+.||+|+||.||+|++      .+++.||||+++...   ....|.+|+.+++++ +|||||+++|++.+.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            457889999999999999999985      356789999997532   345789999999998 6999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhhcCC-----------------cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeE
Q 042871          380 ECFLIYELCPNGNLAEWLFGKD-----------------KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNIL  442 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NIL  442 (588)
                      ..++||||+++|+|.++++...                 ..+++..+..++.|+++||+|||+++   |+||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence            9999999999999999996432                 25899999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEEecCCcceecCCCc-ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCc-cccccc-cch
Q 042871          443 LGPNFEAKLSDFGLSKVIDIGET-YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKA-KVLTRA-GSA  519 (588)
Q Consensus       443 ld~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p-~~~~~~-~~~  519 (588)
                      ++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+|++.| +..... ...
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987754433 333456789999999999999999999999999999999995554 433222 223


Q ss_pred             hhhcCcccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          520 LELADPKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       520 ~~~~d~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      .+.++...+...+......+..|+.+|++ +|++||||+||+++|++.++.
T Consensus       258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            34443333333333334556777899998 799999999999999998765

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3e-46  Score=378.27  Aligned_cols=254  Identities=22%  Similarity=0.304  Sum_probs=197.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHHHHHHhccCCCCceeEEecceeccC----e
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVREVASSSHVRHPNLVALLGYCLRVD----E  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~  380 (588)
                      .++|++.+.||+|+||.||+|+. .+|+.||||+++..     ...+.|.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999996 58999999999642     22457899999999999999999999988654    3


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .|+||||+++|+|.+++... +.+++.+++.++.|+++||+|||+.+   |+||||||+|||++.++..+|+|||.++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence            79999999999999988543 46999999999999999999999998   999999999999999999999999998765


Q ss_pred             cCCCc--ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-hc--CcccCcccCHHH
Q 042871          461 DIGET--YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-LA--DPKLDREYSIEA  535 (588)
Q Consensus       461 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-~~--d~~l~~~~~~e~  535 (588)
                      .....  .......||+.|||||++.+..++.++|||||||++|||+||+.||......+... .+  ++..........
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            43322  23345679999999999999999999999999999999999999996433322211 11  111111111112


Q ss_pred             HHHHHHHHHHhhc-CCCCCC-CHHHHHHHHHHhhc
Q 042871          536 FDLTLQLALSCTA-LTHQRP-PMEQVFVTLQKALD  568 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RP-s~~evl~~L~~~~~  568 (588)
                      ...+.+++.+|++ +|.+|| |++++++.|.++.+
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            2345566778888 799999 89999999988753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=383.26  Aligned_cols=242  Identities=25%  Similarity=0.286  Sum_probs=204.8

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEE
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++..     ....+.+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999996 5899999999863     34567889999999999999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++... ..+++...+.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999999998643 45888999999999999999999999   9999999999999999999999999998754322


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                       .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.........+.+   ...++..++.+..    .
T Consensus       160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~----d  234 (337)
T d1o6la_         160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK----S  234 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH----H
T ss_pred             -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHH----H
Confidence             2334568999999999999999999999999999999999999999755443333322   2333445666544    4


Q ss_pred             HHHHhhc-CCCCCCC-----HHHHHH
Q 042871          542 LALSCTA-LTHQRPP-----MEQVFV  561 (588)
Q Consensus       542 L~~~C~~-~p~~RPs-----~~evl~  561 (588)
                      |+..|++ +|.+||+     ++|+++
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhhccCCchhhcccccccHHHHHc
Confidence            5667777 7999995     788876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-45  Score=379.46  Aligned_cols=238  Identities=26%  Similarity=0.299  Sum_probs=200.2

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++..     ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999997 5799999999863     345678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+++|+|.+++... ..+++.....++.|++.||+|||+++   |+||||||+||||++++.+||+|||+++.....  
T Consensus        84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            999999999988543 45788888999999999999999998   999999999999999999999999999876432  


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L  542 (588)
                        .....||+.|||||++.+..++.++|||||||++|||++|+.||...........+   ...++...+.+.    ..+
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~----~~l  231 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV----KDL  231 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHH----HHH
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence              23468999999999999999999999999999999999999999754433322221   223334455554    445


Q ss_pred             HHHhhc-CCCCCC-----CHHHHHH
Q 042871          543 ALSCTA-LTHQRP-----PMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~RP-----s~~evl~  561 (588)
                      +..|+. +|.+||     |++|+++
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHhhhCHHhccccchhhHHHHHc
Confidence            666676 687775     9999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3e-45  Score=371.22  Aligned_cols=240  Identities=28%  Similarity=0.380  Sum_probs=199.4

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-----------cHHHHHHHHHHhccCC-CCceeEEecceecc
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-----------NVETFVREVASSSHVR-HPNLVALLGYCLRV  378 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----------~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~  378 (588)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++....           ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999996 579999999986421           1235889999999997 99999999999999


Q ss_pred             CeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          379 DECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       379 ~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      +..||||||+++|+|.++|.. ...+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence            999999999999999999964 346999999999999999999999998   9999999999999999999999999999


Q ss_pred             eecCCCcccccCccCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Cc--cc--
Q 042871          459 VIDIGETYASSEVRGTFGYLDPEYRS------NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DP--KL--  527 (588)
Q Consensus       459 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~--~l--  527 (588)
                      ....+.  ......||+.|+|||++.      ...++.++||||+||++|||++|+.||.........+.+ ..  ..  
T Consensus       159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            875433  234567999999999875      345788999999999999999999999754433322211 11  11  


Q ss_pred             --CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          528 --DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       528 --~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                        ...++.+    +..|+..|++ +|++|||++||++
T Consensus       237 ~~~~~~s~~----~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         237 PEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             TTGGGSCHH----HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cccccCCHH----HHHHHHHHccCChhHCcCHHHHHc
Confidence              1234444    5556788888 7999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=380.33  Aligned_cols=242  Identities=21%  Similarity=0.270  Sum_probs=203.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .++|.+.+.||+|+||+||+|+. .+|+.||||.++... +...+.+|+++|++++|||||++++++.+++..|+||||+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            46799999999999999999997 478999999997654 3446789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC--CCcEEEEecCCcceecCCCcc
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP--NFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~--~~~~kL~DFGla~~~~~~~~~  466 (588)
                      ++|+|.+++......+++.+++.++.|+++||+|||+.+   |+||||||+|||++.  ...+||+|||+++....... 
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-  159 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-  159 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence            999999999766667999999999999999999999998   999999999999985  45899999999987654332 


Q ss_pred             cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-Cc--ccC----cccCHHHHHHH
Q 042871          467 ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-DP--KLD----REYSIEAFDLT  539 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-d~--~l~----~~~~~e~~~~v  539 (588)
                       .....||+.|+|||...+..++.++|||||||++|||++|+.||......+....+ ..  .+.    ..++.    .+
T Consensus       160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~----~~  234 (321)
T d1tkia_         160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI----EA  234 (321)
T ss_dssp             -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH----HH
T ss_pred             -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH----HH
Confidence             33457899999999999999999999999999999999999999755444333322 11  111    12333    34


Q ss_pred             HHHHHHhhc-CCCCCCCHHHHHH
Q 042871          540 LQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       540 ~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..|+..|+. +|.+|||++|+++
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            566888888 7999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.4e-45  Score=383.37  Aligned_cols=239  Identities=23%  Similarity=0.281  Sum_probs=195.9

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC-----CcHHHHHH---HHHHhccCCCCceeEEecceeccCeee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE-----GNVETFVR---EVASSSHVRHPNLVALLGYCLRVDECF  382 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~~---Ei~~l~~l~HpnIv~l~g~~~~~~~~~  382 (588)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++...     .....+.+   |+.+++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            6799999999999999999996 47999999998531     22233444   477788889999999999999999999


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +||||+++|+|.++|... ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999999643 45889999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc------CcccCcccCHHH
Q 042871          463 GETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA------DPKLDREYSIEA  535 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~------d~~l~~~~~~e~  535 (588)
                      ..   .....||+.|+|||++.. ..++.++|||||||++|||+||+.||............      ...+...++.+ 
T Consensus       160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~-  235 (364)
T d1omwa3         160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE-  235 (364)
T ss_dssp             SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH-
T ss_pred             Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH-
Confidence            32   344679999999999864 56899999999999999999999999754443332221      12223345555 


Q ss_pred             HHHHHHHHHHhhc-CCCCCCC-----HHHHHH
Q 042871          536 FDLTLQLALSCTA-LTHQRPP-----MEQVFV  561 (588)
Q Consensus       536 ~~~v~~L~~~C~~-~p~~RPs-----~~evl~  561 (588)
                         +..|+..|++ +|.+|||     ++|+++
T Consensus       236 ---~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         236 ---LRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---HHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---HHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence               4555677887 7999999     688864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-44  Score=378.62  Aligned_cols=238  Identities=19%  Similarity=0.238  Sum_probs=201.4

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIY  385 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~  385 (588)
                      ++|++++.||+|+||.||+|+. .+|+.||||++..     ....+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999997 5799999999853     345678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCc
Q 042871          386 ELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGET  465 (588)
Q Consensus       386 E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~  465 (588)
                      ||+.+|+|.+++... +.+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            999999999999644 46899999999999999999999999   999999999999999999999999999876532  


Q ss_pred             ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHHH
Q 042871          466 YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQL  542 (588)
Q Consensus       466 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~L  542 (588)
                        .....||+.|||||++.+..++.++|||||||++|||+||+.||...........+   .......++.+    +..+
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~----~~~l  268 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD----LKDL  268 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHH----HHHH
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHH----HHHH
Confidence              23467999999999999999999999999999999999999999754333322222   22223344554    4455


Q ss_pred             HHHhhc-CCCCC-----CCHHHHHH
Q 042871          543 ALSCTA-LTHQR-----PPMEQVFV  561 (588)
Q Consensus       543 ~~~C~~-~p~~R-----Ps~~evl~  561 (588)
                      +..|++ +|.+|     ||++|+++
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHhhhCHHhccccccccHHHHHc
Confidence            677777 78777     59999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=376.00  Aligned_cols=244  Identities=21%  Similarity=0.269  Sum_probs=194.8

Q ss_pred             hcCccccc-eeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhcc-CCCCceeEEecceec----cCeeeE
Q 042871          311 TEKLNELN-LIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSH-VRHPNLVALLGYCLR----VDECFL  383 (588)
Q Consensus       311 t~~f~~~~-~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~----~~~~~L  383 (588)
                      .++|.+.+ .||+|+||.||+|+. .+|+.||||+++..   ..+.+|++++.+ .+|||||++++++.+    +..+|+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i   86 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   86 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence            46788775 599999999999986 57999999999653   567789988655 589999999999875    467899


Q ss_pred             EeecCCCCChhhhhhcCC-cCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC---CCcEEEEecCCcce
Q 042871          384 IYELCPNGNLAEWLFGKD-KCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP---NFEAKLSDFGLSKV  459 (588)
Q Consensus       384 V~E~~~~gsL~~~L~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~---~~~~kL~DFGla~~  459 (588)
                      ||||++||+|.++|.... ..+++.+++.++.|++.||+|||+.+   |+||||||+|||+++   ++.+||+|||+++.
T Consensus        87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeee
Confidence            999999999999997543 46999999999999999999999999   999999999999985   56799999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcCccc-Cc--ccC----
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKL-DR--EYS----  532 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l-~~--~~~----  532 (588)
                      ......  .....||+.|||||++.+..|+.++|||||||++|||+||+.||...........+...+ ..  .++    
T Consensus       164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~  241 (335)
T d2ozaa1         164 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW  241 (335)
T ss_dssp             CCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred             ccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence            654332  345679999999999999999999999999999999999999997544332222111111 00  011    


Q ss_pred             HHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          533 IEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       533 ~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ......+..|+..|++ +|.+|||+.|+++.
T Consensus       242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1222445667788888 79999999999873

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=379.00  Aligned_cols=240  Identities=27%  Similarity=0.340  Sum_probs=200.2

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecC-----CCcHHHHHHHHHHhc-cCCCCceeEEecceeccCeeeEE
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN-----EGNVETFVREVASSS-HVRHPNLVALLGYCLRVDECFLI  384 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-----~~~~~~~~~Ei~~l~-~l~HpnIv~l~g~~~~~~~~~LV  384 (588)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++.     +...+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999997 4799999999963     345567777877765 68999999999999999999999


Q ss_pred             eecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCC
Q 042871          385 YELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGE  464 (588)
Q Consensus       385 ~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~  464 (588)
                      |||+++|+|.+++... ..+++.+++.++.|++.||+|||+++   |+||||||+|||+++++++||+|||+++......
T Consensus        82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence            9999999999999643 45888999999999999999999999   9999999999999999999999999998654332


Q ss_pred             cccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc---CcccCcccCHHHHHHHHH
Q 042871          465 TYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA---DPKLDREYSIEAFDLTLQ  541 (588)
Q Consensus       465 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~---d~~l~~~~~~e~~~~v~~  541 (588)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+   .+.++...+.+    +..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~----~~d  232 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE----AKD  232 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH----HHH
T ss_pred             -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHH----HHH
Confidence             2334567999999999999999999999999999999999999999754433333222   23333344554    455


Q ss_pred             HHHHhhc-CCCCCCCHH-HHH
Q 042871          542 LALSCTA-LTHQRPPME-QVF  560 (588)
Q Consensus       542 L~~~C~~-~p~~RPs~~-evl  560 (588)
                      |+..|+. +|.+|||+. |++
T Consensus       233 li~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHhcccCCCCCcCHHHHHH
Confidence            6777887 799999996 675

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=369.54  Aligned_cols=241  Identities=26%  Similarity=0.257  Sum_probs=187.9

Q ss_pred             ccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-------cHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          316 ELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-------NVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       316 ~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      .+++||+|+||+||+|+. .+|+.||||++....       ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            457899999999999996 479999999986321       124688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      ++++++..+. .....+++.++..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~  156 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A  156 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence            9887766655 44556899999999999999999999999   99999999999999999999999999986543322 2


Q ss_pred             ccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------------------Cc-c
Q 042871          468 SSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------------------DP-K  526 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------------------d~-~  526 (588)
                      .....||+.|+|||++... .++.++|||||||++|||++|+.||......+....+                   .. .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            2345789999999988654 5799999999999999999999988533221111000                   00 0


Q ss_pred             c--CcccCH-----HHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          527 L--DREYSI-----EAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       527 l--~~~~~~-----e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      .  ....+.     ...+.+..|+..|++ +|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0  000000     111345566788888 7999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-44  Score=364.57  Aligned_cols=243  Identities=23%  Similarity=0.323  Sum_probs=193.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..++||+|+||+||+|+. .+|+.||||+++..    ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999996 57999999998642    235688999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      |+.++.+..........+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence            99654444433445567999999999999999999999999   9999999999999999999999999998764332 2


Q ss_pred             cccCccCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCccccccccchhh-----------hc----------C
Q 042871          467 ASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-----------LA----------D  524 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-----------~~----------d  524 (588)
                      ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+...           ..          .
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            334457999999999877665 5789999999999999999999985322111000           00          0


Q ss_pred             ccc-----------CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          525 PKL-----------DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       525 ~~l-----------~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      ...           ....+    ..+..|+..|++ +|.+|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s----~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLD----EDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccchhhhccCCC----HHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000           01122    234556778888 79999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-43  Score=360.88  Aligned_cols=245  Identities=24%  Similarity=0.309  Sum_probs=191.8

Q ss_pred             cCccccceeeccCceEEEEEEecCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~  387 (588)
                      ++|+..+.||+|+||+||+|+..+|+.||||++...    ...+.+.+|+.+|++++||||+++++++.+++..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            689999999999999999999999999999999643    2356899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCccc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETYA  467 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~~  467 (588)
                      +.++.+..+. ...+.+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++....... ..
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~  156 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK  156 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence            9776665555 44567999999999999999999999998   9999999999999999999999999998764322 22


Q ss_pred             ccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhh-------------------h--cCc
Q 042871          468 SSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALE-------------------L--ADP  525 (588)
Q Consensus       468 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~-------------------~--~d~  525 (588)
                      .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...                   .  .+.
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            334468999999998865 456899999999999999999999985322111000                   0  000


Q ss_pred             cc-------CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          526 KL-------DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       526 ~l-------~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                      ..       ...........+..++..|++ +|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00       000111112334556778888 7999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=362.95  Aligned_cols=242  Identities=27%  Similarity=0.358  Sum_probs=191.5

Q ss_pred             hcCccccceeeccCceEEEEEEe-cC-CcEEEEEEecC----CCcHHHHHHHHHHhccC---CCCceeEEecceec----
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SN-NQHVAIKHITN----EGNVETFVREVASSSHV---RHPNLVALLGYCLR----  377 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~-g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~----  377 (588)
                      .++|++.+.||+|+||+||+|+. .+ ++.||||++..    +.....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            57899999999999999999996 34 67899999853    22234566777776655   79999999999853    


Q ss_pred             -cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCC
Q 042871          378 -VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGL  456 (588)
Q Consensus       378 -~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGl  456 (588)
                       ....++++||++++++..........+++...+.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence             35689999999888777666666667999999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------------
Q 042871          457 SKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------------  523 (588)
Q Consensus       457 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------------  523 (588)
                      ++.....  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....+             
T Consensus       163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            8865322  2344568999999999999999999999999999999999999998643221110000             


Q ss_pred             ----------C-------cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 ----------D-------PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 ----------d-------~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                                .       +.+....+.    .+..|+..|++ +|++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDE----LGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCH----HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhhccccccchhhccccCCH----HHHHHHHHHCcCChhHCcCHHHHhc
Confidence                      0       001112233    34456777887 7999999999976

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-44  Score=360.02  Aligned_cols=237  Identities=26%  Similarity=0.328  Sum_probs=193.1

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC--------CcHHHHHHHHHHhccCC--CCceeEEecceeccC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE--------GNVETFVREVASSSHVR--HPNLVALLGYCLRVD  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--------~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~  379 (588)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...        .....+.+|+.++++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            35799999999999999999996 57999999998632        11234678999999987  899999999999999


Q ss_pred             eeeEEeecCCC-CChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-CCcEEEEecCCc
Q 042871          380 ECFLIYELCPN-GNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-NFEAKLSDFGLS  457 (588)
Q Consensus       380 ~~~LV~E~~~~-gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-~~~~kL~DFGla  457 (588)
                      ..++||||+.+ +++.+++.. ...+++.+++.++.|+++||+|||+.+   |+||||||+|||++. ++.+||+|||++
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 577777743 346999999999999999999999998   999999999999985 479999999999


Q ss_pred             ceecCCCcccccCccCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCccccccccchhhhcCcccCcccCHHHH
Q 042871          458 KVIDIGETYASSEVRGTFGYLDPEYRSNCKV-NSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELADPKLDREYSIEAF  536 (588)
Q Consensus       458 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d~~l~~~~~~e~~  536 (588)
                      +.....   ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....   .......++..++.+. 
T Consensus       159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---i~~~~~~~~~~~s~~~-  231 (273)
T d1xwsa_         159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---IIRGQVFFRQRVSSEC-  231 (273)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HHHCCCCCSSCCCHHH-
T ss_pred             eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---HhhcccCCCCCCCHHH-
Confidence            875432   2345679999999999887766 5678999999999999999999864321   1111223334456554 


Q ss_pred             HHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          537 DLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       537 ~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                         .+|+.+|++ +|.+|||++|+++
T Consensus       232 ---~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         232 ---QHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHccCCHhHCcCHHHHhc
Confidence               456778887 7999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.4e-43  Score=357.35  Aligned_cols=251  Identities=20%  Similarity=0.190  Sum_probs=207.0

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCC-CceeEEecceeccCeeeEEeecC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRH-PNLVALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~LV~E~~  388 (588)
                      .++|.+.+.||+|+||+||+|+. .+|+.||||++........+.+|++.++.++| +|++.+++++.++...++||||+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            46899999999999999999996 47899999998765555677889999998875 89999999999999999999999


Q ss_pred             CCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECC-----CCcEEEEecCCcceecCC
Q 042871          389 PNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGP-----NFEAKLSDFGLSKVIDIG  463 (588)
Q Consensus       389 ~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~-----~~~~kL~DFGla~~~~~~  463 (588)
                       +++|.+++......+++.++..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+++.....
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence             78999999777778999999999999999999999999   999999999999964     578999999999876533


Q ss_pred             Cc------ccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----C-------cc
Q 042871          464 ET------YASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----D-------PK  526 (588)
Q Consensus       464 ~~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----d-------~~  526 (588)
                      ..      .......||+.|||||.+.+..++.++||||||+++|||+||+.||............    +       +.
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence            21      1234567999999999999999999999999999999999999999643332221111    0       01


Q ss_pred             cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhcc
Q 042871          527 LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALDI  569 (588)
Q Consensus       527 l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~~  569 (588)
                      +....+    +.+.+++..|+. +|++||+++.+.+.|+++++.
T Consensus       240 l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         240 LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            112233    346667788887 799999999999999988753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-43  Score=358.72  Aligned_cols=249  Identities=19%  Similarity=0.198  Sum_probs=199.3

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCcee-EEecceeccCeeeEEeecCC
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLV-ALLGYCLRVDECFLIYELCP  389 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~  389 (588)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++..+...+++..|+++++.++|+|++ .+.++..+.+..++||||+ 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            5799999999999999999986 578999999987665556788999999999877655 4555667778899999999 


Q ss_pred             CCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEEC---CCCcEEEEecCCcceecCCCcc
Q 042871          390 NGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLG---PNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       390 ~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld---~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      +++|.+.+......+++..+..++.|+++||+|||+++   |+||||||+|||++   .+..+||+|||+++........
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            67787777666677999999999999999999999999   99999999999986   3557999999999987543322


Q ss_pred             ------cccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhcC-----------cccCc
Q 042871          467 ------ASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELAD-----------PKLDR  529 (588)
Q Consensus       467 ------~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~d-----------~~l~~  529 (588)
                            ......||+.|||||.+.+..++.++|||||||++|||++|+.||...........+.           +.+..
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK  242 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence                  2345679999999999999999999999999999999999999996543332221110           11112


Q ss_pred             ccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHHHHHhhc
Q 042871          530 EYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVTLQKALD  568 (588)
Q Consensus       530 ~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~L~~~~~  568 (588)
                      .++    ..+.+++..|++ +|++||++.++.+.|+....
T Consensus       243 ~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         243 GYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             TSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            233    345667888888 79999999999999987754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-42  Score=356.89  Aligned_cols=243  Identities=26%  Similarity=0.287  Sum_probs=187.8

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCceeEEecceecc------CeeeEEe
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVRHPNLVALLGYCLRV------DECFLIY  385 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~LV~  385 (588)
                      +|+..++||+|+||+||+|+. .+|+.||||++..+..  .+.+|+++|++++||||+++++++...      ...+|||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            578889999999999999997 4799999999975432  234799999999999999999998643      3478999


Q ss_pred             ecCCCCChhhhhh--cCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcceecC
Q 042871          386 ELCPNGNLAEWLF--GKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDI  462 (588)
Q Consensus       386 E~~~~gsL~~~L~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~~  462 (588)
                      ||++++.+..+..  .....+++.++..++.|+++||+|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            9997664444332  24457999999999999999999999998   99999999999999775 899999999987654


Q ss_pred             CCcccccCccCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc------------------
Q 042871          463 GETYASSEVRGTFGYLDPEYRSN-CKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA------------------  523 (588)
Q Consensus       463 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~------------------  523 (588)
                      ...  .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+                  
T Consensus       176 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         176 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             Ccc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            432  234578999999998765 57899999999999999999999998643321111000                  


Q ss_pred             --Ccc------------cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH--HHHh
Q 042871          524 --DPK------------LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT--LQKA  566 (588)
Q Consensus       524 --d~~------------l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~--L~~~  566 (588)
                        +..            .....+.+    +..|+.+|+. +|++|||+.|+++.  +++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~----~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPE----AIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHH----HHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhhccccccccCchhhhcccCCCHH----HHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence              000            01112333    4556777887 79999999999863  4444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=349.29  Aligned_cols=248  Identities=21%  Similarity=0.321  Sum_probs=189.6

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecC----CCcHHHHHHHHHHhccCCCCceeEEecceec--------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITN----EGNVETFVREVASSSHVRHPNLVALLGYCLR--------  377 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--------  377 (588)
                      -++|++.+.||+|+||+||+|+. .+|+.||||++..    +...+.+.+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            37899999999999999999996 5899999999853    2345678999999999999999999998865        


Q ss_pred             cCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCc
Q 042871          378 VDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLS  457 (588)
Q Consensus       378 ~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla  457 (588)
                      ++..++||||++++.+..+. .....++..+.+.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence            34689999999877666544 34456888899999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCcc---cccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------Ccc
Q 042871          458 KVIDIGETY---ASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------DPK  526 (588)
Q Consensus       458 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------d~~  526 (588)
                      +........   ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+       .+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            876533221   22335699999999998765 6899999999999999999999998632221111100       000


Q ss_pred             c-----------------CcccC-HHH------HHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          527 L-----------------DREYS-IEA------FDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       527 l-----------------~~~~~-~e~------~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                      .                 ..... .+.      ...+..|+.+|++ +|++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0                 00000 010      1233457888888 89999999999853

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=354.62  Aligned_cols=243  Identities=26%  Similarity=0.284  Sum_probs=188.4

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC---cHHHHHHHHHHhccCCCCceeEEecceeccC----eee
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG---NVETFVREVASSSHVRHPNLVALLGYCLRVD----ECF  382 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~  382 (588)
                      +++|+..+.||+|+||+||+|+. .+|+.||||++....   ..+.+++|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999986 589999999997432   3457899999999999999999999987543    234


Q ss_pred             EEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecC
Q 042871          383 LIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDI  462 (588)
Q Consensus       383 LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~  462 (588)
                      +++||+.+|+|.+++..  ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            45566679999999953  35899999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCc--ccccCccCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----------------
Q 042871          463 GET--YASSEVRGTFGYLDPEYRS-NCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----------------  523 (588)
Q Consensus       463 ~~~--~~~~~~~gt~~Y~aPE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----------------  523 (588)
                      ...  .......||+.|+|||++. ...++.++||||+|+++|||++|+.||......+.....                
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            322  2234567999999999874 456789999999999999999999998533221111000                


Q ss_pred             ----------Ccc--------cCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          524 ----------DPK--------LDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       524 ----------d~~--------l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                .+.        +....+.    .+..|+..|++ +|.+|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADS----KALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCH----HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCH----HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      000        0011222    34566788888 79999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-41  Score=342.43  Aligned_cols=196  Identities=27%  Similarity=0.382  Sum_probs=172.1

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccCeeeEEee
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVDECFLIYE  386 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E  386 (588)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..    ...+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999996 57899999998532    345788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcceecCCCcc
Q 042871          387 LCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       387 ~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~~~~~~~  466 (588)
                      ++.+++|..++. ..+.+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++....... 
T Consensus        82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999998888774 4456889999999999999999999998   99999999999999999999999999987654332 


Q ss_pred             cccCccCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCccc
Q 042871          467 ASSEVRGTFGYLDPEYRSNCK-VNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                      ......+++.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence            223345778899999887654 6899999999999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=353.78  Aligned_cols=238  Identities=22%  Similarity=0.289  Sum_probs=185.7

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceeccC------
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLRVD------  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------  379 (588)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++..    ...+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999996 57999999999743    22457889999999999999999999987654      


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..++||||+ +.+|.+++.  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence            579999999 667777763  346999999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhh----------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALEL----------------  522 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~----------------  522 (588)
                      ....    .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........                
T Consensus       171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            6432    2345789999999998764 568999999999999999999999854322111000                


Q ss_pred             -----------cC-------cccCcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          523 -----------AD-------PKLDREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       523 -----------~d-------~~l~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                 ..       ..+....+.+    +..|+..|+. +|.+|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~----~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPL----AVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHH----HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHH----HHHHHHHHCcCChhHCcCHHHHhcC
Confidence                       00       0001122333    4456778887 89999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-42  Score=353.73  Aligned_cols=242  Identities=24%  Similarity=0.293  Sum_probs=197.4

Q ss_pred             cCccccceeeccCceEEEEEEe----cCCcEEEEEEecC------CCcHHHHHHHHHHhccCCC-CceeEEecceeccCe
Q 042871          312 EKLNELNLIGEGITGKVYKGKL----SNNQHVAIKHITN------EGNVETFVREVASSSHVRH-PNLVALLGYCLRVDE  380 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~------~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~  380 (588)
                      ++|+..+.||+|+||+||+|+.    .+|+.||||.+..      ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999985    2588999999853      2335678899999999977 899999999999999


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++||||+.+|+|.+++.... .+.......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999996443 4677888899999999999999998   999999999999999999999999999877


Q ss_pred             cCCCcccccCccCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc-------CcccCccc
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNC--KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA-------DPKLDREY  531 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~-------d~~l~~~~  531 (588)
                      ............|++.|++||.+.+.  .++.++|||||||+||||++|+.||...........+       .+.+....
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            55444445556799999999988654  4688999999999999999999999755443332222       12222334


Q ss_pred             CHHHHHHHHHHHHHhhc-CCCCCCC-----HHHHHH
Q 042871          532 SIEAFDLTLQLALSCTA-LTHQRPP-----MEQVFV  561 (588)
Q Consensus       532 ~~e~~~~v~~L~~~C~~-~p~~RPs-----~~evl~  561 (588)
                      +.+    +..++..|+. +|++|||     ++|+++
T Consensus       260 s~~----~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         260 SAL----AKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CHH----HHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CHH----HHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            444    4455778887 7999994     788875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.7e-40  Score=342.09  Aligned_cols=191  Identities=21%  Similarity=0.335  Sum_probs=167.5

Q ss_pred             cCccccceeeccCceEEEEEEe-cCCcEEEEEEecCCCcHHHHHHHHHHhccCC-CCceeEEecceec--cCeeeEEeec
Q 042871          312 EKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEGNVETFVREVASSSHVR-HPNLVALLGYCLR--VDECFLIYEL  387 (588)
Q Consensus       312 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~--~~~~~LV~E~  387 (588)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++..  ....++||||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence            6899999999999999999996 57999999999754 3578899999999996 9999999999874  4568999999


Q ss_pred             CCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCC-cEEEEecCCcceecCCCcc
Q 042871          388 CPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNF-EAKLSDFGLSKVIDIGETY  466 (588)
Q Consensus       388 ~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~-~~kL~DFGla~~~~~~~~~  466 (588)
                      +++++|.++.    +.+++.++..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++....... 
T Consensus       114 ~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-  185 (328)
T d3bqca1         114 VNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-  185 (328)
T ss_dssp             CCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC-
T ss_pred             cCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc-
Confidence            9999998765    35899999999999999999999999   99999999999998655 699999999987654432 


Q ss_pred             cccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccc
Q 042871          467 ASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKV  512 (588)
Q Consensus       467 ~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~  512 (588)
                       .....||+.|+|||.+.+. .++.++||||+|++++||++|+.||.
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~  231 (328)
T d3bqca1         186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  231 (328)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence             3445789999999997765 47999999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-40  Score=344.07  Aligned_cols=243  Identities=21%  Similarity=0.238  Sum_probs=182.7

Q ss_pred             hcCccccceeeccCceEEEEEEec-CCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec------cC
Q 042871          311 TEKLNELNLIGEGITGKVYKGKLS-NNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR------VD  379 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~  379 (588)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++...    .....+.+|+.++++++|||||++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999974 7999999999743    234568899999999999999999999863      36


Q ss_pred             eeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          380 ECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       380 ~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                      ..|+||||+.++ +.+.+.   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||+++.
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence            789999999655 444442   34889999999999999999999999   99999999999999999999999999887


Q ss_pred             ecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh-------------------
Q 042871          460 IDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL-------------------  520 (588)
Q Consensus       460 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-------------------  520 (588)
                      .....  ......||+.|+|||++.+..++.++||||+||+++||++|+.||.........                   
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            54332  334557899999999999999999999999999999999999988422111100                   


Q ss_pred             -------------------hhcCcccCccc---CHHHHHHHHHHHHHhhc-CCCCCCCHHHHHHH
Q 042871          521 -------------------ELADPKLDREY---SIEAFDLTLQLALSCTA-LTHQRPPMEQVFVT  562 (588)
Q Consensus       521 -------------------~~~d~~l~~~~---~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~~  562 (588)
                                         ...........   .......+..|+.+|+. +|++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                               00000000001   11233446678889998 79999999999854

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-40  Score=343.94  Aligned_cols=238  Identities=23%  Similarity=0.290  Sum_probs=186.3

Q ss_pred             hcCccccceeeccCceEEEEEEe-cCCcEEEEEEecCC----CcHHHHHHHHHHhccCCCCceeEEecceec-----cCe
Q 042871          311 TEKLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNE----GNVETFVREVASSSHVRHPNLVALLGYCLR-----VDE  380 (588)
Q Consensus       311 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~  380 (588)
                      +++|+..+.||+|+||+||+|+. .+|+.||||++...    ...+.+.+|+++|++++|||+|++++++..     +..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56899999999999999999996 58999999999743    234578899999999999999999999863     334


Q ss_pred             eeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEecCCccee
Q 042871          381 CFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSKVI  460 (588)
Q Consensus       381 ~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~~~  460 (588)
                      .++++||+.+|+|.+++..  +.+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence            5677788889999999943  46999999999999999999999999   999999999999999999999999998764


Q ss_pred             cCCCcccccCccCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCccccccccchhhhc----------------
Q 042871          461 DIGETYASSEVRGTFGYLDPEYRSNC-KVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSALELA----------------  523 (588)
Q Consensus       461 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~~~~----------------  523 (588)
                      .    .......||+.|+|||...+. .++.++|||||||++|||++|+.||...........+                
T Consensus       172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             C----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            3    223445789999999987665 4688999999999999999999998532211111100                


Q ss_pred             --------C--ccc--------CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHHH
Q 042871          524 --------D--PKL--------DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVFV  561 (588)
Q Consensus       524 --------d--~~l--------~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl~  561 (588)
                              .  ...        ....+.    .+..|+..|+. +|.+|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANP----LAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCH----HHHHHHHHHCcCChhhCcCHHHHhc
Confidence                    0  000        011233    34556778887 7999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-36  Score=313.16  Aligned_cols=243  Identities=18%  Similarity=0.191  Sum_probs=183.9

Q ss_pred             CccccceeeccCceEEEEEEe-cCCcEEEEEEecCCC-cHHHHHHHHHHhccCC-----------CCceeEEecceecc-
Q 042871          313 KLNELNLIGEGITGKVYKGKL-SNNQHVAIKHITNEG-NVETFVREVASSSHVR-----------HPNLVALLGYCLRV-  378 (588)
Q Consensus       313 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~Ei~~l~~l~-----------HpnIv~l~g~~~~~-  378 (588)
                      +|.+.++||+|+||+||+|+. .+|+.||||+++.+. ..+.+.+|+.+++.++           |+||+++++++... 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            488999999999999999996 589999999998653 3467788998887775           57899999988653 


Q ss_pred             -CeeeEEeecCCCCChhhhh--hcCCcCccHHHHHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCc------
Q 042871          379 -DECFLIYELCPNGNLAEWL--FGKDKCLSWIQRLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFE------  448 (588)
Q Consensus       379 -~~~~LV~E~~~~gsL~~~L--~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~------  448 (588)
                       ...+++++++..+......  ......+++..+..++.|+++||+|||+ .+   |+||||||+||||+.++.      
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccce
Confidence             4556666666555433332  2344568889999999999999999997 77   999999999999986653      


Q ss_pred             EEEEecCCcceecCCCcccccCccCCCCccCcccccCCCCCchhhHHHHHHHHHHHHcCCCccccccccchh--------
Q 042871          449 AKLSDFGLSKVIDIGETYASSEVRGTFGYLDPEYRSNCKVNSSGDVYSFGIVLLQILSGKKAKVLTRAGSAL--------  520 (588)
Q Consensus       449 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--------  520 (588)
                      +|++|||.+.....    ......||+.|+|||++.+..++.++||||+|++++||++|+.||.........        
T Consensus       171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            99999999876432    224457999999999999999999999999999999999999987532211000        


Q ss_pred             --------------------hhcCc-----cc--------------CcccCHHHHHHHHHHHHHhhc-CCCCCCCHHHHH
Q 042871          521 --------------------ELADP-----KL--------------DREYSIEAFDLTLQLALSCTA-LTHQRPPMEQVF  560 (588)
Q Consensus       521 --------------------~~~d~-----~l--------------~~~~~~e~~~~v~~L~~~C~~-~p~~RPs~~evl  560 (588)
                                          ...+.     .+              ...........+..|+..|+. +|.+|||++|++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence                                00000     00              011234455667888999998 799999999998


Q ss_pred             HH
Q 042871          561 VT  562 (588)
Q Consensus       561 ~~  562 (588)
                      +.
T Consensus       327 ~H  328 (362)
T d1q8ya_         327 NH  328 (362)
T ss_dssp             TC
T ss_pred             cC
Confidence            74

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=3.5e-23  Score=196.26  Aligned_cols=161  Identities=15%  Similarity=0.091  Sum_probs=119.0

Q ss_pred             cccceeeccCceEEEEEEecCCcEEEEEEecCC-------C-------------cHHHHHHHHHHhccCCCCceeEEecc
Q 042871          315 NELNLIGEGITGKVYKGKLSNNQHVAIKHITNE-------G-------------NVETFVREVASSSHVRHPNLVALLGY  374 (588)
Q Consensus       315 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-------~-------------~~~~~~~Ei~~l~~l~HpnIv~l~g~  374 (588)
                      .+.++||+|+||.||+|+..+|+.||||+++..       .             ......+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            345799999999999999989999999986421       0             01234568888999999999888765


Q ss_pred             eeccCeeeEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhccccCCceEecCCCCCCeEECCCCcEEEEec
Q 042871          375 CLRVDECFLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYSEGCIVHRDIKPTNILLGPNFEAKLSDF  454 (588)
Q Consensus       375 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IvHrDLKp~NILld~~~~~kL~DF  454 (588)
                      .    ..+++|||++++.+.+        ++......++.|++++|.|||+.+   |+||||||+|||++++ .++|+||
T Consensus        83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred             c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence            3    2379999998765543        334445678999999999999999   9999999999999865 5899999


Q ss_pred             CCcceecCCCcccccCccCCCCccCc------ccccCCCCCchhhHHHHHHHH
Q 042871          455 GLSKVIDIGETYASSEVRGTFGYLDP------EYRSNCKVNSSGDVYSFGIVL  501 (588)
Q Consensus       455 Gla~~~~~~~~~~~~~~~gt~~Y~aP------E~~~~~~~t~ksDVwS~Gvll  501 (588)
                      |+|.........         .|...      |. ..+.|+.++|+||..--+
T Consensus       147 G~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            999765322110         11111      11 134678889999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.47  E-value=1.6e-07  Score=90.61  Aligned_cols=148  Identities=18%  Similarity=0.097  Sum_probs=94.7

Q ss_pred             HHHHHHhcCccccceeeccCceEEEEEEecCCcEEEEEEecCC--CcHHHHHHHHHHhccCC-CCceeEEecceeccCee
Q 042871          305 REVHYATEKLNELNLIGEGITGKVYKGKLSNNQHVAIKHITNE--GNVETFVREVASSSHVR-HPNLVALLGYCLRVDEC  381 (588)
Q Consensus       305 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~  381 (588)
                      .++...-++|...+..+.++...||+... +++.+.||+....  .....+.+|...+..+. +--+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45666667777665544444578999876 5566778887542  23345677877766553 33356677777788889


Q ss_pred             eEEeecCCCCChhhhhhcCCcCccHHHHHHHHHhhhccchhhcccc----------------------------------
Q 042871          382 FLIYELCPNGNLAEWLFGKDKCLSWIQRLEIAIDSARGLWFLHSYS----------------------------------  427 (588)
Q Consensus       382 ~LV~E~~~~gsL~~~L~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------  427 (588)
                      ++|||++++.++.+......      +...++.++++.|..||+..                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999887755432110      11112233333333333211                                  


Q ss_pred             ----------------------CCceEecCCCCCCeEECCCCcEEEEecCCcce
Q 042871          428 ----------------------EGCIVHRDIKPTNILLGPNFEAKLSDFGLSKV  459 (588)
Q Consensus       428 ----------------------~~~IvHrDLKp~NILld~~~~~kL~DFGla~~  459 (588)
                                            .+.++|+|+.|.|||+++++..-|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  23489999999999999876677999997754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.03  E-value=3.6e-06  Score=80.38  Aligned_cols=75  Identities=15%  Similarity=0.148  Sum_probs=52.7

Q ss_pred             eeccC-ceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCC--CceeEEecceeccCeeeEEeecCCCCChhh
Q 042871          320 IGEGI-TGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRH--PNLVALLGYCLRVDECFLIYELCPNGNLAE  395 (588)
Q Consensus       320 LG~G~-fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~  395 (588)
                      +..|. -..||+...+++..+.+|...... ...+..|...++.+..  -.+.+++.+..+.+..++|||+++|.++.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT-TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC-HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            34444 367999998888888999765432 3346677777666543  335667777778888999999998876643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.45  E-value=0.00015  Score=74.05  Aligned_cols=75  Identities=13%  Similarity=0.087  Sum_probs=47.4

Q ss_pred             cceeeccCceEEEEEEecC-CcEEEEEEecC------C---CcHHHHHHHHHHhccCC-C--CceeEEecceeccCeeeE
Q 042871          317 LNLIGEGITGKVYKGKLSN-NQHVAIKHITN------E---GNVETFVREVASSSHVR-H--PNLVALLGYCLRVDECFL  383 (588)
Q Consensus       317 ~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~------~---~~~~~~~~Ei~~l~~l~-H--pnIv~l~g~~~~~~~~~L  383 (588)
                      .+.||.|....||+....+ ++.|+||.-..      +   ...+....|.+.|+.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998754 67899996431      1   12334456777766552 2  345555544  4556689


Q ss_pred             EeecCCCCCh
Q 042871          384 IYELCPNGNL  393 (588)
Q Consensus       384 V~E~~~~gsL  393 (588)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.98  E-value=0.00065  Score=67.20  Aligned_cols=67  Identities=12%  Similarity=0.148  Sum_probs=45.8

Q ss_pred             eEEEEEEecCCcEEEEEEecCC-CcHHHHHHHHHHhccCCCCce-----eEEe--cceeccCeeeEEeecCCCCC
Q 042871          326 GKVYKGKLSNNQHVAIKHITNE-GNVETFVREVASSSHVRHPNL-----VALL--GYCLRVDECFLIYELCPNGN  392 (588)
Q Consensus       326 G~Vykg~~~~g~~VAVK~l~~~-~~~~~~~~Ei~~l~~l~HpnI-----v~l~--g~~~~~~~~~LV~E~~~~gs  392 (588)
                      -.||+.+.++|+.+++|..+.. ...+++..|...+..+....+     +..-  .....++..+.++++++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            5799999999999999988653 356778888887777643222     1111  12234566788999997644

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.78  E-value=0.00089  Score=68.00  Aligned_cols=73  Identities=19%  Similarity=0.209  Sum_probs=49.2

Q ss_pred             ceeeccCceEEEEEEecCC--------cEEEEEEecCCCcHHHHHHHHHHhccCCCCce-eEEecceeccCeeeEEeecC
Q 042871          318 NLIGEGITGKVYKGKLSNN--------QHVAIKHITNEGNVETFVREVASSSHVRHPNL-VALLGYCLRVDECFLIYELC  388 (588)
Q Consensus       318 ~~LG~G~fG~Vykg~~~~g--------~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E~~  388 (588)
                      +.|+.|--=.+|+...+++        +.|.+++...........+|..+++.+.-.++ .++++++.+    .+|+||+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi  123 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  123 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence            4677777788999987543        45777766544444556688888887753344 467776643    6899999


Q ss_pred             CCCChh
Q 042871          389 PNGNLA  394 (588)
Q Consensus       389 ~~gsL~  394 (588)
                      ++.+|.
T Consensus       124 ~g~~l~  129 (395)
T d1nw1a_         124 PSRPLS  129 (395)
T ss_dssp             CEEECC
T ss_pred             ccccCC
Confidence            876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.39  E-value=0.0023  Score=62.39  Aligned_cols=156  Identities=12%  Similarity=0.010  Sum_probs=79.2

Q ss_pred             ccHHHHHHHhcCccccce-----eeccCceEEEEEEecCCcEEEEEEecCCCcHHHHHHHHHHhccCCCCce-----eEE
Q 042871          302 YTIREVHYATEKLNELNL-----IGEGITGKVYKGKLSNNQHVAIKHITNEGNVETFVREVASSSHVRHPNL-----VAL  371 (588)
Q Consensus       302 ~~~~el~~at~~f~~~~~-----LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~Ei~~l~~l~HpnI-----v~l  371 (588)
                      .+.+|+.....+|...+.     |..|---+.|+.+.++|+ +++|++......++...|++++..+...++     +..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~   81 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR   81 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhcccccccccee
Confidence            455777777788876433     334545678999987665 788988654333445556666666542222     111


Q ss_pred             e-c--ceeccCeeeEEeecCCCCChhhh--------------hh------cCC----cCccH----------------HH
Q 042871          372 L-G--YCLRVDECFLIYELCPNGNLAEW--------------LF------GKD----KCLSW----------------IQ  408 (588)
Q Consensus       372 ~-g--~~~~~~~~~LV~E~~~~gsL~~~--------------L~------~~~----~~l~~----------------~~  408 (588)
                      . |  +...+.....++.+..+......              ++      ...    ....+                ..
T Consensus        82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (316)
T d2ppqa1          82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  161 (316)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence            1 0  11123445666666655332211              00      000    00000                00


Q ss_pred             HHHHHHhhhccchhhcc-ccCCceEecCCCCCCeEECCCCcEEEEecCCcc
Q 042871          409 RLEIAIDSARGLWFLHS-YSEGCIVHRDIKPTNILLGPNFEAKLSDFGLSK  458 (588)
Q Consensus       409 ~~~i~~~ia~gL~yLH~-~~~~~IvHrDLKp~NILld~~~~~kL~DFGla~  458 (588)
                      ....+......+.-.+. .-..+++|+|+.++||+++.+...-|.||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11111111111111111 123359999999999999988777899999775